data_1j7h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j7h _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.006 0.431 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.542 ' HA ' ' N ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 6' ' ' ILE . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' C' ' 107' ' ' ARG . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.45 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.542 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.0 m120 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.9 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 9.2 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.607 0.241 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 21' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' CB ' ' CE1' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.519 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' HG13 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.42 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.513 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CE1' ' CB ' ' A' ' 69' ' ' ALA . 3.3 m170 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' B' ' 17' ' ' PRO . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.439 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.425 HG13 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 123' ' ' ILE . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.977 0.417 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.538 ' HA ' ' N ' ' B' ' 23' ' ' ASP . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.449 HG23 HD12 ' B' ' 6' ' ' ILE . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.45 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.538 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' B' ' 35' ' ' PRO . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 9.3 p . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.595 0.236 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' B' ' 21' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.521 ' CB ' ' CE1' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.484 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' B' ' 69' ' ' ALA . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.516 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.425 ' CD2' HG13 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.514 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.521 ' CE1' ' CB ' ' B' ' 69' ' ' ALA . 3.4 m170 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.416 ' CD1' ' HA ' ' C' ' 17' ' ' PRO . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.425 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . 0.429 HG13 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.451 HG21 HD13 ' B' ' 123' ' ' ILE . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . 0.537 ' HA ' ' N ' ' C' ' 23' ' ' ASP . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.451 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . 0.416 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' B' ' 107' ' ' ARG . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.452 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . 0.486 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.401 HG23 ' CB ' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 32.8 t . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 9.3 p . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.582 0.229 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.404 HD21 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' C' ' 21' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.518 ' CB ' ' CE1' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.476 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.515 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.429 ' CD2' HG13 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' C' ' 95' ' ' PHE . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.521 ' NE2' ' HB3' ' C' ' 99' ' ' ASN . 3.3 m170 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 17' ' ' PRO . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.418 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 123' ' ' ILE . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 21.8 m . . . . . 0 N--CA 1.46 0.051 0 CA-C-O 120.813 0.34 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.491 ' HA ' ' N ' ' A' ' 23' ' ' ASP . 12.3 pt20 43.77 -165.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.743 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.466 HG12 ' HG3' ' A' ' 4' ' ' GLN . 34.3 mm 68.69 116.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.959 0.409 . . . . 0.0 111.633 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.412 HG12 ' HB2' ' A' ' 23' ' ' ASP . 36.3 mt -142.11 91.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.77 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -102.22 128.98 48.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.991 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 t -144.86 153.74 41.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 30.7 3.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -117.6 -36.82 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . -99.88 122.47 50.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.273 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 7.5 Cg_exo -72.93 3.07 4.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.67 2.247 . . . . 0.0 112.829 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.32 -178.17 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.998 0.428 . . . . 0.0 111.809 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 18' ' ' TYR . . . 64.05 118.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.048 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -146.79 17.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.342 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.92 -148.64 4.79 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.449 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.401 ' HA ' ' CE2' ' C' ' 104' ' ' PHE . 84.8 Cg_endo -87.57 34.33 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.859 2.373 . . . . 0.0 112.957 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.434 ' CD2' ' HB2' ' C' ' 107' ' ' ARG . 9.9 p90 -130.39 164.97 23.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.776 0.322 . . . . 0.0 110.821 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG13 ' O ' ' C' ' 104' ' ' PHE . 19.9 m -91.54 147.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -46.11 -48.85 17.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.44 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.58 -175.28 5.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.1 m -136.23 129.26 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.114 0.483 . . . . 0.0 111.922 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.491 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 44.1 t0 -113.14 103.97 11.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.803 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.6 mt -84.04 -18.69 36.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.105 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.05 -108.68 0.91 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.827 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.6 -30.19 62.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 110.065 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.92 127.88 50.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.581 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -105.75 179.4 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.243 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.9 146.83 16.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.0 p -121.1 142.25 50.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.8 m -79.03 165.99 22.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.26 74.4 0.28 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.987 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -66.46 165.21 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.031 0.444 . . . . 0.0 111.352 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 3.4 pt -138.99 159.07 68.44 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.243 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 85.5 Cg_exo -42.28 -45.39 7.74 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.64 2.227 . . . . 0.0 111.932 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.565 178.764 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.1 p . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 120.347 0.118 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 4.9 Cg_exo -76.58 153.12 34.23 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.684 2.256 . . . . 0.0 112.091 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.1 -30.85 55.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.074 0.464 . . . . 0.0 110.741 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.48 94.24 0.55 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.885 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.9 mm -40.32 -33.3 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.34 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.12 -46.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.699 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.37 -36.19 79.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.706 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.408 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 10.4 pt20 -77.61 -28.39 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.608 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.11 -31.55 25.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.248 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -38.35 29.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.17 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.55 -31.06 66.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.871 0.367 . . . . 0.0 110.823 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -30.85 68.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.4 mt -74.6 -33.85 62.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.38 -48.69 64.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.999 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -57.6 -48.2 80.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.092 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 t -59.63 -29.97 43.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.033 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -79.15 -39.83 32.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.043 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.04 -36.41 81.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.976 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' CG1' ' CB ' ' A' ' 11' ' ' ALA . 8.1 mt -70.21 -51.87 35.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 127' ' ' ALA . 3.7 tt -65.26 -22.43 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.076 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -82.95 -37.74 23.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.891 0.377 . . . . 0.0 110.31 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -11.15 60.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.97 -29.93 35.22 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.925 0.393 . . . . 0.0 110.335 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.3 28.5 1.0 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.141 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.405 ' CD1' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -146.84 -166.97 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.329 . . . . 0.0 110.69 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.58 153.73 49.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB1' ' CD2' ' A' ' 101' ' ' HIS . . . -57.25 -38.92 74.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.19 -29.86 15.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.06 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.74 -22.4 58.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 76.6 mt -47.76 114.88 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.97 0.414 . . . . 0.0 110.97 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.417 ' CG1' ' CG1' ' A' ' 128' ' ' VAL . 32.8 m -89.62 -31.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.702 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -134.44 163.0 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 111.055 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -158.75 139.56 12.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.303 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.427 HG23 ' CE1' ' A' ' 78' ' ' PHE . 96.7 m -123.63 147.41 47.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.176 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.9 t -149.22 109.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 111.697 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.427 ' CE1' HG23 ' A' ' 76' ' ' THR . 8.6 m-85 -89.0 110.23 20.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.47 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.38 144.89 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -85.03 -1.55 56.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.221 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.2 127.22 1.46 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.512 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.15 -11.92 52.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.65 -20.82 45.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.361 . . . . 0.0 110.693 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.6 -27.25 20.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 44.3 t80 -57.68 -28.77 64.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.13 -32.28 67.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.263 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.49 -34.95 18.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.221 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.7 -39.71 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 32.8 t30 -68.89 -36.55 78.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.51 -32.39 66.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.61 -30.35 19.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.088 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -58.43 -43.93 88.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.91 -29.36 35.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.18 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.48 75.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.036 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -89.32 -36.54 15.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.636 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.48 ' CG ' ' HB2' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -54.99 -53.59 53.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.807 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -72.82 -26.43 61.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.387 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -76.47 -13.32 60.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 12.6 m-80 -101.4 -17.29 16.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.011 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 5.2 p-10 103.5 35.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.154 0.909 . . . . 0.0 110.396 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.531 ' CE1' ' HB3' ' A' ' 99' ' ' ASN . 2.0 m-70 -114.97 55.27 0.87 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.376 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 88.8 Cg_endo -79.12 2.74 8.04 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.661 2.241 . . . . 0.0 113.112 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 2.0 t30 -64.48 -30.08 71.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.765 0.317 . . . . 0.0 111.477 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 2.5 m-85 70.91 110.21 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.547 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.448 ' HG3' ' CZ ' ' A' ' 96' ' ' PHE . 66.2 Cg_endo -96.03 153.39 1.4 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.064 2.509 . . . . 0.0 112.443 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.27 163.09 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.236 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.422 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -134.49 143.43 47.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.147 0.499 . . . . 0.0 111.607 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.73 63.81 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.305 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.09 134.69 40.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.025 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.22 138.49 29.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.26 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -68.23 83.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.686 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.21 163.91 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.233 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.55 -38.16 62.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.982 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.62 -177.65 6.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.761 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 77.8 mt -151.82 156.37 34.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.756 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.31 137.96 78.46 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.59 2.194 . . . . 0.0 112.099 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 74.74 14.21 3.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.244 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.76 16.88 8.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.07 175.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.831 0.348 . . . . 0.0 111.079 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.54 12.79 15.69 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.676 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 pp -176.75 148.17 0.67 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.025 0.441 . . . . 0.0 111.298 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.74 161.05 28.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.037 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -143.54 129.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.115 0.484 . . . . 0.0 112.012 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.09 109.51 2.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.895 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -126.73 174.61 8.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.137 0.494 . . . . 0.0 112.039 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.3 mt -125.63 156.41 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.422 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -146.34 151.07 36.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.551 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' A' ' 129' ' ' ARG . 5.1 p -147.99 159.95 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.128 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.436 ' N ' ' CG2' ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.81 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.421 ' O ' ' HG3' ' B' ' 4' ' ' GLN . 22.1 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.794 0.33 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.486 ' HA ' ' N ' ' B' ' 23' ' ' ASP . 12.3 pt20 43.82 -165.68 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.636 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.457 HG12 ' HG3' ' B' ' 4' ' ' GLN . 34.2 mm 68.65 116.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.023 0.439 . . . . 0.0 111.6 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.43 HG23 HD13 ' B' ' 6' ' ' ILE . 36.4 mt -142.12 91.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.782 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -102.15 129.02 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.949 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.7 t -144.87 153.74 41.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.05 30.67 3.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -117.55 -36.78 3.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -99.9 122.3 51.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.214 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 7.4 Cg_exo -72.87 3.05 4.73 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.68 2.254 . . . . 0.0 112.84 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.24 -178.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.005 0.431 . . . . 0.0 111.796 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.432 ' HA ' ' CZ ' ' B' ' 18' ' ' TYR . . . 64.01 118.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -146.78 17.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.341 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.9 -148.71 4.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.422 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . 0.401 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 84.1 Cg_endo -87.49 34.26 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.869 2.379 . . . . 0.0 113.005 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.432 ' CZ ' ' HA ' ' B' ' 14' ' ' ALA . 10.0 p90 -130.4 164.95 23.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 110.835 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 104' ' ' PHE . 20.2 m -91.46 147.76 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -46.18 -48.97 17.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.414 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.39 -175.35 5.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.71 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 29.2 m -136.25 129.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.09 0.471 . . . . 0.0 111.941 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.486 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 44.1 t0 -113.11 103.92 11.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.834 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.2 mt -83.97 -18.71 36.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.109 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.03 -108.75 0.91 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.792 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.55 -30.21 62.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.093 0.473 . . . . 0.0 110.068 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.87 127.93 51.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.603 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' B' ' 127' ' ' ALA . 0.3 OUTLIER -105.81 179.4 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.94 146.84 16.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 35.9 p -121.11 141.98 50.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.89 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 17.6 m -78.68 165.97 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.25 74.36 0.28 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.968 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.408 ' HB2' HG12 ' B' ' 123' ' ' ILE . 17.2 mm-40 -66.42 165.32 14.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 111.374 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.4 ' HB ' ' HD2' ' B' ' 35' ' ' PRO . 3.4 pt -139.08 159.05 68.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.199 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 85.6 Cg_exo -42.28 -45.46 7.72 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.635 2.224 . . . . 0.0 111.87 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.508 178.76 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.365 0.126 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' B' ' 50' ' ' GLN . 5.0 Cg_exo -76.59 153.09 34.14 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.699 2.266 . . . . 0.0 112.115 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.11 -30.79 55.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.453 . . . . 0.0 110.715 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.55 94.24 0.56 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.864 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.2 mm -40.23 -33.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.387 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.08 -46.46 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.684 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.19 79.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.742 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.41 ' CB ' ' HD2' ' B' ' 44' ' ' PRO . 10.4 pt20 -77.57 -28.33 51.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.575 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.19 -31.56 25.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.271 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -38.31 30.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.254 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.6 -31.08 66.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.772 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.97 -30.88 68.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.801 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' B' ' 95' ' ' PHE . 57.3 mt -74.58 -33.88 62.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.46 -48.59 64.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.994 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -57.67 -48.16 80.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 t -59.64 -29.92 43.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.052 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -79.26 -39.78 32.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.01 -36.47 81.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.975 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -70.09 -51.89 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.998 0.428 . . . . 0.0 110.737 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.415 ' CD1' ' HB3' ' B' ' 127' ' ' ALA . 3.8 tt -65.23 -22.45 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.0 -37.73 23.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 110.3 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -11.1 60.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.737 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.93 -29.96 35.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.0 110.367 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.29 28.49 1.0 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.153 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.83 -167.02 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.7 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.52 153.76 49.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' B' ' 101' ' ' HIS . . . -57.34 -38.85 74.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.26 -29.92 16.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.76 -22.48 58.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.96 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 76.5 mt -47.72 114.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.893 0.377 . . . . 0.0 110.995 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.404 ' CG1' ' CG1' ' B' ' 128' ' ' VAL . 32.9 m -89.66 -31.57 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.66 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -134.39 163.08 30.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.017 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -158.76 139.6 12.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.297 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.418 HG23 ' CE1' ' B' ' 78' ' ' PHE . 96.8 m -123.68 147.41 47.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.172 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.8 t -149.22 109.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.863 0.363 . . . . 0.0 111.746 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.418 ' CE1' HG23 ' B' ' 76' ' ' THR . 8.6 m-85 -88.97 110.22 20.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.424 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.37 144.86 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.447 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -85.03 -1.68 57.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.145 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.12 127.14 1.48 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.507 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.01 -12.04 52.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.68 -20.74 45.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.789 0.328 . . . . 0.0 110.653 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.69 -27.16 20.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' B' ' 89' ' ' ASN . 44.5 t80 -57.74 -28.76 64.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.29 67.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.303 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.53 -34.96 18.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.16 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.79 -39.56 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.153 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 32.7 t30 -69.0 -36.45 77.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.47 -32.46 66.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.42 -30.43 19.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.418 ' CD2' HD23 ' B' ' 55' ' ' LEU . 9.8 t80 -58.36 -43.98 88.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.94 -29.35 35.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.54 75.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.069 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.421 ' CD2' HD13 ' B' ' 55' ' ' LEU . 0.9 OUTLIER -89.2 -36.64 15.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.646 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.483 ' CG ' ' HB2' ' B' ' 101' ' ' HIS . 0.2 OUTLIER -54.88 -53.63 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.863 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -72.77 -26.49 61.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.436 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -76.48 -13.29 60.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.568 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.543 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 12.6 m-80 -101.39 -17.35 16.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.01 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 5.3 p-10 103.6 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.148 0.905 . . . . 0.0 110.328 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 2.0 m-70 -115.06 55.25 0.89 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.387 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 89.3 Cg_endo -79.09 2.77 8.01 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.626 2.217 . . . . 0.0 113.141 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 2.0 t30 -64.4 -30.21 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 111.512 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 2.5 m-85 70.97 110.2 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.505 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.454 ' HG3' ' CZ ' ' B' ' 96' ' ' PHE . 66.0 Cg_endo -95.98 153.44 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.141 2.561 . . . . 0.0 112.438 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.37 163.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.292 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.444 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -134.4 143.44 47.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 111.607 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.77 63.88 0.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.283 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.05 134.74 40.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.04 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.32 139.3 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.294 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.67 84.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.78 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 m -67.4 163.95 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.133 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.55 -38.11 62.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.987 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.63 -177.74 6.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 77.7 mt -151.72 156.41 34.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.772 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.37 137.92 78.59 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.577 2.185 . . . . 0.0 112.093 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 74.8 14.2 3.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.26 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.78 16.89 8.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.069 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 29.6 m -57.18 175.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.83 0.347 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.34 13.04 16.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.71 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 pp -176.83 148.19 0.65 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 111.275 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.79 161.0 28.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.021 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.469 ' N ' HD13 ' B' ' 123' ' ' ILE . 0.0 OUTLIER -143.43 129.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 112.109 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 109.48 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.888 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -126.74 174.63 8.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.134 0.493 . . . . 0.0 111.985 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 15.2 mt -125.64 156.34 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.444 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -146.28 150.97 36.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.57 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' B' ' 129' ' ' ARG . 5.1 p -147.83 159.99 7.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.435 ' N ' ' CG2' ' B' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.881 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' THR . . . . . 0.417 ' O ' ' HG3' ' C' ' 4' ' ' GLN . 21.9 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.808 0.337 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . 0.492 ' HA ' ' N ' ' C' ' 23' ' ' ASP . 12.3 pt20 43.79 -165.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.691 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . 0.467 HG12 ' HG3' ' C' ' 4' ' ' GLN . 34.4 mm 68.76 116.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.005 0.431 . . . . 0.0 111.628 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.465 HG23 HD13 ' C' ' 6' ' ' ILE . 36.6 mt -142.11 91.74 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.767 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -102.24 128.95 48.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 12.7 t -144.76 153.75 41.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.1 30.75 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -117.6 -37.08 3.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.016 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.406 ' CB ' ' CG1' ' C' ' 61' ' ' ILE . . . -99.59 122.48 51.29 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.186 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.84 2.94 4.82 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.731 2.288 . . . . 0.0 112.823 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.2 -178.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.966 0.412 . . . . 0.0 111.812 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.431 ' HA ' ' CZ ' ' C' ' 18' ' ' TYR . . . 63.97 118.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.096 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -146.74 17.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.364 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.9 -148.65 4.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.415 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -87.48 34.26 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.849 2.366 . . . . 0.0 113.037 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.444 ' CD2' ' HB2' ' B' ' 107' ' ' ARG . 9.9 p90 -130.41 164.91 23.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.775 0.322 . . . . 0.0 110.829 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.438 HG13 ' O ' ' B' ' 104' ' ' PHE . 20.4 m -91.44 147.8 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.947 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -46.18 -48.73 17.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.47 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.43 -175.26 5.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.677 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.27 129.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.062 0.458 . . . . 0.0 111.902 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . 0.492 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 44.2 t0 -113.18 103.9 11.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.819 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.97 -18.73 36.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.108 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.05 -108.7 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.811 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.6 -30.14 62.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.146 0.498 . . . . 0.0 110.118 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.91 127.9 50.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.624 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.409 HG23 ' CD1' ' C' ' 67' ' ' LEU . 0.3 OUTLIER -105.78 179.3 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.216 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.86 146.82 16.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.833 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 35.7 p -121.07 142.33 49.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 18.1 m -78.99 165.78 23.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.3 74.41 0.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.991 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.402 ' HB2' HG12 ' C' ' 123' ' ' ILE . 17.3 mm-40 -66.43 165.28 14.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.021 0.438 . . . . 0.0 111.325 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -139.04 159.1 68.2 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.232 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -42.36 -45.41 7.89 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.623 2.216 . . . . 0.0 111.867 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.556 178.795 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' C' ' 44' ' ' PRO . 7.1 p . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 120.351 0.119 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' C' ' 43' ' ' VAL . 4.8 Cg_exo -76.68 153.14 33.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.664 2.243 . . . . 0.0 112.067 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.16 -30.76 55.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.091 0.472 . . . . 0.0 110.738 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.54 94.31 0.56 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.888 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 29.2 mm -40.31 -33.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.397 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.13 -46.48 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.665 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.28 79.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.766 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . 0.407 ' CB ' ' HD2' ' C' ' 44' ' ' PRO . 10.4 pt20 -77.63 -28.11 51.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.594 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.4 -31.59 24.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.337 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -38.38 30.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.55 -31.12 66.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.807 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -30.87 68.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.81 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.405 HD23 ' CD2' ' C' ' 92' ' ' TYR . 57.4 mt -74.48 -33.94 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.37 -48.66 64.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.02 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -57.56 -48.24 79.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 t -59.59 -29.93 43.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -79.21 -39.81 32.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.996 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.23 81.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.078 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . 0.406 ' CG1' ' CB ' ' C' ' 11' ' ' ALA . 8.1 mt -70.33 -51.9 34.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' C' ' 127' ' ' ALA . 3.8 tt -65.23 -22.42 31.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.094 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.02 -37.71 23.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.917 0.389 . . . . 0.0 110.287 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -11.08 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.713 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.99 35.06 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.964 0.412 . . . . 0.0 110.327 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.29 28.51 1.0 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.165 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.409 ' CD1' HG23 ' C' ' 28' ' ' VAL . 0.2 OUTLIER -146.88 -167.02 2.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.638 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.49 153.73 50.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.478 ' HB1' ' CD2' ' C' ' 101' ' ' HIS . . . -57.43 -38.71 74.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.16 -29.76 14.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.073 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.85 -22.56 58.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 76.3 mt -47.66 114.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 111.013 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.411 ' CG1' ' CG1' ' C' ' 128' ' ' VAL . 32.8 m -89.66 -31.47 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.696 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -134.5 162.99 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.752 0.311 . . . . 0.0 111.01 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 30.5 m -158.75 139.58 12.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.424 . . . . 0.0 111.302 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.43 HG23 ' CE1' ' C' ' 78' ' ' PHE . 96.8 m -123.64 147.44 47.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.197 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.7 t -149.27 109.27 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.745 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.43 ' CE1' HG23 ' C' ' 76' ' ' THR . 8.5 m-85 -88.95 110.19 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.476 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -101.4 144.87 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.461 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -85.02 -1.77 57.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.175 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.0 127.05 1.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.517 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.07 -11.98 52.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.63 -20.79 45.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.803 0.335 . . . . 0.0 110.673 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.63 -27.23 20.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' C' ' 89' ' ' ASN . 44.5 t80 -57.68 -28.83 64.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.102 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.29 67.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.255 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.46 -35.06 18.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.7 -39.62 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.152 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . 0.423 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 32.8 t30 -68.94 -36.5 78.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.49 -32.47 66.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -30.47 19.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.022 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.405 ' CD2' HD23 ' C' ' 55' ' ' LEU . 10.0 t80 -58.29 -44.01 88.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.89 -29.35 35.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.178 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.51 75.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.055 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.9 OUTLIER -89.27 -36.59 15.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 110.647 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.483 ' CG ' ' HB2' ' C' ' 101' ' ' HIS . 0.2 OUTLIER -54.95 -53.56 54.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.876 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -72.82 -26.48 61.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -76.48 -13.24 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.608 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.542 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 12.6 m-80 -101.46 -17.29 16.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.988 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 5.2 p-10 103.49 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.138 0.899 . . . . 0.0 110.372 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' C' ' 99' ' ' ASN . 2.0 m-70 -115.04 55.35 0.89 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.352 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 88.4 Cg_endo -79.2 2.82 7.98 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.628 2.219 . . . . 0.0 113.115 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 2.0 t30 -64.51 -30.06 71.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 111.534 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 2.5 m-85 70.93 110.21 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.543 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.45 ' HG3' ' CZ ' ' C' ' 96' ' ' PHE . 65.9 Cg_endo -96.03 153.38 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.116 2.544 . . . . 0.0 112.434 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.31 163.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.278 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.434 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -134.44 143.45 47.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.13 0.49 . . . . 0.0 111.563 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.76 63.82 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.332 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.05 134.76 40.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.034 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . 0.419 HG13 ' CD2' ' A' ' 78' ' ' PHE . 26.8 m -142.4 139.24 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.317 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.7 83.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.749 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.11 164.04 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.196 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.65 -38.19 62.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.975 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.59 -177.6 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.775 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 77.3 mt -151.76 156.42 34.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.755 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.48 137.95 79.01 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.588 2.192 . . . . 0.0 112.057 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 74.8 14.2 3.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.79 16.9 8.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.073 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 29.3 m -57.08 175.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.818 0.342 . . . . 0.0 111.123 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.36 13.25 16.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.766 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 pp -177.36 148.25 0.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.976 0.417 . . . . 0.0 111.249 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.69 161.02 28.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.054 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . 0.474 HD13 ' N ' ' C' ' 123' ' ' ILE . 0.0 OUTLIER -143.49 129.19 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.142 0.496 . . . . 0.0 112.039 -179.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.04 109.52 2.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.9 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -126.8 174.63 8.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.115 0.483 . . . . 0.0 112.026 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 15.3 mt -125.68 156.36 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.435 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -146.36 151.02 36.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 111.503 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' C' ' 129' ' ' ARG . 5.0 p -147.84 159.92 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . 0.431 ' N ' ' CG2' ' C' ' 128' ' ' VAL . 0.0 OUTLIER -148.41 58.89 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.817 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.817 0.341 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 132.97 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -55.2 152.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mt -103.43 139.26 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.137 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.58 117.18 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.7 t -133.88 165.99 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.33 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -121.62 -36.89 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.032 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.516 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . . . -67.82 172.05 4.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 11' ' ' ALA . 18.9 Cg_endo -59.39 -16.05 33.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.695 2.263 . . . . 0.0 112.85 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.24 151.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 111.317 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.67 120.71 41.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -133.51 15.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.072 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.85 -146.17 4.73 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.987 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' C' ' 104' ' ' PHE . 93.9 Cg_endo -87.39 44.53 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.536 2.158 . . . . 0.0 112.901 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.19 154.59 17.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.867 0.365 . . . . 0.0 111.033 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -110.91 169.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.284 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -58.96 -53.53 57.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.69 -177.09 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 m -142.33 132.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.166 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -103.47 105.01 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.51 -16.36 54.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.371 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.05 -104.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.28 -29.62 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.166 0.508 . . . . 0.0 110.21 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.2 140.65 45.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.435 ' CG1' ' CB ' ' A' ' 127' ' ' ALA . 9.9 p -120.04 160.88 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.123 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mp -145.87 127.37 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 p -106.5 136.11 46.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.983 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 t -59.36 179.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.07 95.55 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.244 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.433 ' HG2' ' CG2' ' A' ' 58' ' ' VAL . 2.9 mp0 -62.07 138.14 58.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.275 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.5 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -146.04 170.18 8.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.679 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -54.26 -137.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.313 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.411 -178.926 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.81 140.71 81.58 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.592 2.195 . . . . 0.0 112.433 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.37 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.4 93.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.791 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.9 mm -38.93 -33.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.5 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.08 -48.07 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.696 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.82 -55.04 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.498 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.93 -44.36 63.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -63.33 -51.54 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.79 -31.18 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.445 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 1.3 m -68.31 -46.48 70.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.29 -26.36 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.971 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -57.95 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.108 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.8 OUTLIER -54.88 -30.36 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.985 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.433 ' CG2' ' HG2' ' A' ' 33' ' ' GLN . 39.6 t -62.1 -34.54 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 110.517 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.99 -31.75 34.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.755 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.55 89.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.1 mt -70.93 -46.2 69.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.667 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.8 -32.62 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.28 -38.4 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.9 -24.33 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.145 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.71 -22.11 21.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.914 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.43 64.8 0.83 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -158.9 139.2 12.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.028 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 44.0 p -96.12 145.0 25.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.29 -31.75 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.518 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -59.77 -18.48 43.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 68' ' ' THR . 3.2 p-10 -88.58 -21.27 24.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 64.3 mt -59.35 109.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.414 ' CG1' HG22 ' A' ' 128' ' ' VAL . 2.8 m -81.11 -36.84 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.971 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.452 ' HB3' ' CD ' ' A' ' 107' ' ' ARG . 8.6 mtmt -130.55 175.23 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.319 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.539 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 13.4 t 177.71 110.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 111.36 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.489 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -70.18 130.1 41.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.33 91.6 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CZ ' ' HB ' ' A' ' 76' ' ' THR . 5.3 m-85 -91.7 143.77 26.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.089 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 35.3 m -139.31 150.0 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.023 0.44 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.95 -4.31 56.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.796 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.04 108.99 0.46 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -17.25 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.97 -24.64 59.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 110.282 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.46 -15.34 58.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.832 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 0.3 OUTLIER -55.52 -22.98 23.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.01 -46.63 84.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 -33.22 19.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.6 t -70.08 -49.66 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.673 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.417 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 36.4 t-20 -63.09 -35.99 82.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.14 94.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.016 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.62 -31.1 19.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.448 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 48.7 t80 -57.67 -51.35 69.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.727 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 7.7 tt0 -73.32 -27.34 61.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -25.11 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.765 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -79.31 -41.02 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.934 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 95' ' ' PHE . 57.1 m-85 -56.45 -50.43 71.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.8 69.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.77 58.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.402 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -110.54 -6.88 14.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 11.7 m-20 89.68 30.9 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 19.9 t-160 -127.57 72.17 77.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.96 -11.04 16.65 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.539 2.159 . . . . 0.0 112.153 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -79.14 -35.03 42.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.447 . . . . 0.0 110.439 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.453 ' CG ' ' HA ' ' B' ' 17' ' ' PRO . 92.7 m-85 70.99 144.0 0.1 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.515 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HG2' HG22 ' A' ' 75' ' ' THR . 2.0 Cg_endo -82.96 165.82 15.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.057 2.504 . . . . 0.0 112.0 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.28 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.779 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.539 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -169.27 -163.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.944 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.36 107.57 16.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.3 m -95.25 129.16 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.798 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -157.79 165.71 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.949 0.405 . . . . 0.0 111.666 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 9.4 tt0 -99.75 102.87 14.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.777 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.82 162.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.07 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.81 168.08 20.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.722 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mt -144.19 161.9 42.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.7 135.94 67.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.649 2.233 . . . . 0.0 112.183 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.58 18.28 7.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.87 17.47 8.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 m -55.18 172.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.61 14.08 20.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.011 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -176.64 149.0 0.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.123 0.487 . . . . 0.0 111.508 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -150.86 137.85 19.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.918 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -144.67 138.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 112.101 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.36 149.91 28.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.03 125.99 32.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.414 . . . . 0.0 112.027 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.42 132.16 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.876 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -121.74 153.14 38.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.063 0.459 . . . . 0.0 112.038 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.414 HG22 ' CG1' ' A' ' 73' ' ' VAL . 34.6 m -124.13 116.37 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.72 132.95 5.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -55.2 152.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mt -103.43 139.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.07 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.59 117.19 9.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.6 t -133.86 165.97 23.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.804 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 26.32 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -121.6 -36.61 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.982 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . . . -68.18 172.03 4.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' B' ' 11' ' ' ALA . 18.7 Cg_endo -59.33 -16.06 32.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.632 2.221 . . . . 0.0 112.905 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.23 151.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.411 . . . . 0.0 111.281 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.006 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -133.53 15.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.79 -146.1 4.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . 0.453 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . 94.4 Cg_endo -87.38 44.49 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.637 2.224 . . . . 0.0 112.916 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.26 154.53 17.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.915 0.388 . . . . 0.0 110.991 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.83 169.25 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.304 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -59.04 -53.58 56.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.46 -177.16 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 m -142.31 132.63 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.147 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -103.51 104.94 15.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.777 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.44 -16.4 54.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -103.96 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.972 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.3 -29.56 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.082 0.468 . . . . 0.0 110.189 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.3 140.65 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.52 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.444 ' CG1' ' CB ' ' B' ' 127' ' ' ALA . 9.9 p -120.07 160.84 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mp -145.87 127.42 15.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.68 136.36 46.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.06 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.1 t -59.69 179.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.961 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.01 95.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.435 ' HG2' ' CG2' ' B' ' 58' ' ' VAL . 2.9 mp0 -61.92 138.09 58.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.479 ' HB ' ' HD2' ' B' ' 35' ' ' PRO . 0.7 OUTLIER -145.98 170.19 8.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.665 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 52.2 Cg_exo -54.34 -137.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.069 2.513 . . . . 0.0 112.319 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -178.922 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.83 140.7 81.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.662 2.242 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.39 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.35 93.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 28.9 mm -38.94 -33.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.443 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.02 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.91 -54.98 38.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.1 -26.16 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.522 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.18 -44.2 63.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.901 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.33 -51.54 65.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.22 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' SER . . . . . 0.448 ' HA ' ' OD1' ' B' ' 57' ' ' ASN . 1.3 m -68.4 -46.37 70.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.32 -26.38 68.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.963 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -57.99 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.163 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.8 OUTLIER -54.86 -30.39 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.931 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.435 ' CG2' ' HG2' ' B' ' 33' ' ' GLN . 39.7 t -62.13 -34.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.95 -31.77 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.49 89.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -71.25 -46.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.83 -32.53 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.656 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.31 -38.49 60.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.34 65.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.136 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 -22.06 21.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.919 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 64.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -158.91 139.2 12.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.022 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' B' ' 71' ' ' ASP . 43.8 p -96.1 144.99 25.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.26 -31.79 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.574 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.486 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -59.83 -18.27 42.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.425 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 68' ' ' THR . 3.3 p-10 -88.65 -21.23 24.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.714 0.292 . . . . 0.0 110.87 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 64.4 mt -59.4 109.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.874 0.369 . . . . 0.0 110.839 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.423 ' CG1' HG22 ' B' ' 128' ' ' VAL . 2.8 m -81.12 -36.88 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.969 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.443 ' HB3' ' CD ' ' B' ' 107' ' ' ARG . 8.6 mtmt -130.56 175.22 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.302 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.541 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 13.4 t 177.67 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 111.337 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.481 ' N ' ' HG2' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -70.15 130.12 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.325 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.43 91.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' B' ' 76' ' ' THR . 5.3 m-85 -91.66 143.72 26.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.151 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 35.1 m -139.32 150.01 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.072 0.463 . . . . 0.0 111.718 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.94 -4.12 56.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.839 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -169.23 109.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.321 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -17.32 20.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.228 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.94 -24.63 59.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.275 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -15.37 58.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.422 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 0.3 OUTLIER -55.46 -23.03 23.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.267 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.99 -46.62 84.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.09 -33.23 19.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 t -70.09 -49.59 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.721 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 36.4 t-20 -63.21 -35.96 82.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.04 94.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.67 -31.19 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 48.8 t80 -57.62 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.423 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 7.7 tt0 -73.41 -27.32 61.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.462 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -25.19 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.786 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -79.25 -41.09 28.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.97 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 95' ' ' PHE . 57.2 m-85 -56.36 -50.45 71.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.818 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.82 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.945 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.8 58.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.98 14.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.505 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 11.7 m-20 89.78 30.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.0 t-160 -127.48 72.19 77.52 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.98 -11.02 16.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.537 2.158 . . . . 0.0 112.153 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.03 0.443 . . . . 0.0 110.445 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.45 ' CG ' ' HA ' ' C' ' 17' ' ' PRO . 92.7 m-85 70.89 144.04 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.494 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.457 ' HG2' HG22 ' B' ' 75' ' ' THR . 2.0 Cg_endo -83.02 165.85 14.91 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.016 2.477 . . . . 0.0 111.917 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.27 137.95 51.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.541 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -169.23 -163.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.38 107.56 16.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.571 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -95.21 129.11 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.845 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -157.71 165.59 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.409 . . . . 0.0 111.632 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' B' ' 79' ' ' VAL . 9.3 tt0 -99.57 102.86 14.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.785 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.73 162.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.05 -46.27 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.82 168.11 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mt -144.21 161.87 42.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.62 135.97 67.82 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.157 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.53 18.29 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.88 17.46 8.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 m -55.18 172.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.082 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.63 13.95 20.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.025 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 pp -176.62 148.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -150.78 137.88 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.935 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -144.68 138.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 112.14 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.33 149.81 28.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.627 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.94 126.01 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.956 0.408 . . . . 0.0 112.041 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.33 132.14 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.947 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.444 ' CB ' ' CG1' ' B' ' 28' ' ' VAL . . . -121.75 153.2 38.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.096 0.474 . . . . 0.0 111.994 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.423 HG22 ' CG1' ' B' ' 73' ' ' VAL . 34.7 m -124.26 116.32 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.842 0.353 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.68 132.97 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -55.18 152.35 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mt -103.46 139.23 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -143.59 117.2 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 11.7 t -133.93 165.96 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.32 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -121.59 -36.84 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.01 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.506 ' CB ' ' HD2' ' C' ' 12' ' ' PRO . . . -67.93 172.02 4.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' C' ' 11' ' ' ALA . 18.8 Cg_endo -59.31 -16.11 32.83 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.675 2.25 . . . . 0.0 112.899 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.24 151.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.977 0.418 . . . . 0.0 111.304 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.69 120.76 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.002 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mm -133.54 15.81 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.042 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.81 -146.14 4.73 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.001 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . 0.45 ' HA ' ' CG ' ' B' ' 104' ' ' PHE . 94.1 Cg_endo -87.37 44.51 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 112.917 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.23 154.55 17.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.026 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.87 169.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.36 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.02 -53.38 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.6 -177.19 2.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 m -142.24 132.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -103.48 104.98 15.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.47 -16.35 54.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.0 -104.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.27 -29.59 33.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.22 140.64 45.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.575 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.441 ' CG1' ' CB ' ' C' ' 127' ' ' ALA . 9.9 p -120.04 160.84 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.4 ' HB3' ' NZ ' ' B' ' 74' ' ' LYS . 2.9 mp -145.85 127.45 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 p -106.6 136.31 46.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 t -59.62 179.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.13 95.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.25 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.431 ' HG2' ' CG2' ' C' ' 58' ' ' VAL . 2.9 mp0 -62.06 138.17 58.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.259 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.49 ' HB ' ' HD2' ' C' ' 35' ' ' PRO . 0.7 OUTLIER -146.0 170.23 8.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.654 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' C' ' 34' ' ' ILE . 52.4 Cg_exo -54.36 -137.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.063 2.509 . . . . 0.0 112.29 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.427 -178.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.762 0.315 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.88 140.74 81.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.637 2.225 . . . . 0.0 112.358 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.45 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.083 0.468 . . . . 0.0 110.913 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 93.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 28.7 mm -39.01 -33.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.447 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.711 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -54.96 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.474 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.07 -44.36 63.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.36 -51.5 65.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.24 72.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.354 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' C' ' 57' ' ' ASN . 1.3 m -68.35 -46.4 70.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.58 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.32 -26.36 68.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -58.01 4.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.8 OUTLIER -54.9 -30.36 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.984 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.431 ' CG2' ' HG2' ' C' ' 33' ' ' GLN . 39.6 t -62.07 -34.62 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -80.86 -31.79 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.52 89.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -70.95 -46.31 68.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.733 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.89 -32.54 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.33 -38.39 60.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.093 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.31 65.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.139 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.1 21.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.87 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.445 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -158.9 139.23 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.036 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.0 p -96.16 145.01 25.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.21 -31.81 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.598 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.482 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -59.74 -18.28 41.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.477 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -88.78 -21.16 23.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 110.896 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 64.2 mt -59.39 109.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.426 ' CG1' HG22 ' C' ' 128' ' ' VAL . 2.8 m -81.04 -36.88 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.933 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . 0.444 ' HB3' ' CD ' ' C' ' 107' ' ' ARG . 8.6 mtmt -130.6 175.25 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.369 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' THR . . . . . 0.525 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 13.4 t 177.72 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.313 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.48 ' N ' ' HG2' ' C' ' 107' ' ' ARG . 0.0 OUTLIER -70.23 130.2 41.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 t -115.43 91.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' C' ' 76' ' ' THR . 5.3 m-85 -91.64 143.8 26.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.143 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 34.8 m -139.35 149.98 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 111.691 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.99 -4.23 56.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.816 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.1 109.04 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.305 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -17.19 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.0 -24.62 59.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.297 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.5 -15.28 58.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.827 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 0.3 OUTLIER -55.53 -23.04 24.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.261 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.63 84.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.01 -33.32 19.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.969 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.06 -49.66 54.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . 0.428 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 36.4 t-20 -63.12 -35.99 82.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.337 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.22 -42.14 94.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.973 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.68 -31.16 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.567 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.457 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 48.7 t80 -57.64 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . 0.414 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 7.7 tt0 -73.36 -27.37 61.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -25.19 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.77 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -79.32 -41.03 28.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 95' ' ' PHE . 56.7 m-85 -56.38 -50.4 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.781 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -28.72 69.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.954 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.91 -3.78 58.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.362 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.91 14.79 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 11.7 m-20 89.79 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.822 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.482 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.0 t-160 -127.55 72.17 77.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.705 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.03 -10.97 16.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.495 2.13 . . . . 0.0 112.146 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.998 0.428 . . . . 0.0 110.429 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.451 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 92.8 m-85 70.91 144.1 0.1 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.453 ' HG2' HG22 ' C' ' 75' ' ' THR . 2.0 Cg_endo -83.05 165.85 14.87 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.028 2.485 . . . . 0.0 111.948 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.29 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.525 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -169.22 -163.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.4 p -111.36 107.48 16.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.589 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -95.21 129.18 42.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.788 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 m -157.82 165.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' C' ' 79' ' ' VAL . 9.4 tt0 -99.76 102.86 14.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.75 162.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.08 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.83 168.09 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mt -144.21 161.82 43.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.52 135.99 68.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.608 2.205 . . . . 0.0 112.221 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.51 18.29 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 61.8 17.55 8.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 m -55.18 172.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.79 14.08 19.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.988 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 pp -176.62 148.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.489 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -150.83 137.93 19.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -144.74 138.35 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.11 0.481 . . . . 0.0 112.142 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.3 149.82 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.648 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.98 126.13 33.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 112.004 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.41 132.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.441 ' CB ' ' CG1' ' C' ' 28' ' ' VAL . . . -121.76 153.11 38.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.082 0.468 . . . . 0.0 112.029 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . 0.426 HG22 ' CG1' ' C' ' 73' ' ' VAL . 34.6 m -124.15 116.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.27 56.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.99 0.424 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.797 0.332 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -173.58 122.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.023 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.404 ' CD1' ' ND2' ' C' ' 103' ' ' ASN . 2.0 mp -57.27 153.16 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.6 mt -114.16 154.75 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -153.69 126.15 8.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.725 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -130.46 151.73 50.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.037 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -98.22 30.11 3.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.76 -39.33 5.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.745 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.64 120.68 67.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.162 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.26 -11.59 23.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.491 2.127 . . . . 0.0 112.587 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.33 -169.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 0.0 111.396 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 58.37 -164.75 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.189 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.8 mm 80.32 16.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.107 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.69 -138.67 4.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.958 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -84.03 46.13 1.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.569 2.179 . . . . 0.0 112.624 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.517 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -176.11 -169.07 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.939 0.399 . . . . 0.0 111.051 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.407 HG11 ' O ' ' C' ' 104' ' ' PHE . 14.8 m -120.65 -179.64 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.804 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -71.16 -52.5 18.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.18 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -159.48 -178.52 7.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -137.54 134.18 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.165 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -113.89 93.3 4.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 mt -62.6 -20.44 64.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.043 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.93 -109.57 0.81 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.922 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.31 -30.37 64.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.058 0.456 . . . . 0.0 110.19 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.6 128.03 53.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.787 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.59 175.11 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.044 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.84 146.11 5.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -109.44 147.49 32.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.044 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.9 t -81.86 162.33 22.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.008 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.73 92.96 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.621 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -65.64 151.82 45.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.842 0.353 . . . . 0.0 111.093 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 34' ' ' ILE . 4.6 mp -126.58 134.01 25.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.634 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 61.2 Cg_endo -73.91 72.63 3.86 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.891 2.394 . . . . 0.0 112.321 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 179.57 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 11.2 p . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.509 0.195 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.1 140.38 60.41 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.396 2.064 . . . . 0.0 112.126 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.0 -31.44 70.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.061 0.458 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.86 95.87 2.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.736 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.73 -31.28 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.321 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.97 -51.45 20.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.385 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.64 87.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.227 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.407 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -69.14 -28.07 66.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.298 179.305 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.23 -34.95 36.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.902 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -69.03 -42.28 76.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.794 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.53 82.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m -71.07 -36.88 72.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -68.02 -40.45 82.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.752 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.73 -38.58 86.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.741 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.17 -43.69 97.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.8 t -61.15 -35.99 69.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.65 -32.76 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.698 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.9 89.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.81 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mt -69.23 -46.57 77.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.689 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mt -67.45 -32.67 58.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.492 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.6 -41.08 66.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.196 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -61.3 -21.95 64.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.344 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.54 -28.45 21.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.651 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.35 47.15 0.55 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.594 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -156.56 138.02 13.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.859 0.361 . . . . 0.0 110.95 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.6 m -93.27 159.4 15.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.798 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.476 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -57.32 -34.09 68.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.908 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 101' ' ' HIS . . . -51.93 -28.27 15.87 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.883 0.373 . . . . 0.0 110.711 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.68 -26.69 60.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.395 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 71.4 mt -47.61 118.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.5 m -92.14 -30.73 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.112 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -138.32 160.12 40.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.567 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.8 m -153.31 137.97 16.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.989 0.423 . . . . 0.0 111.49 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 58.5 m -126.98 140.65 52.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.043 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.26 115.61 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 111.617 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -89.35 112.08 23.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.482 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -97.46 148.34 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.575 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 -5.62 29.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.97 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 97.4 2.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.481 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mt -57.61 -18.11 18.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.226 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.45 -25.3 54.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.928 0.394 . . . . 0.0 110.49 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -87.13 -19.53 28.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.83 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -56.8 -22.48 36.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.09 -36.15 67.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 0.0 111.185 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.46 -44.66 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.54 -38.16 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.777 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -66.28 -41.91 89.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.81 84.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.208 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.29 -30.84 25.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.415 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 84.2 t80 -53.71 -44.36 69.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.893 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -85.86 -21.97 27.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.284 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.13 -21.27 59.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.429 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.2 p90 -91.78 -35.04 14.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.713 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 101' ' ' HIS . 0.8 OUTLIER -56.14 -60.2 3.84 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.145 0.498 . . . . 0.0 110.093 179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -28.85 70.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.576 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -77.33 -9.97 59.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.711 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 57.5 m-20 -113.46 -6.01 13.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.461 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.1 m120 88.04 34.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.169 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.476 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 1.6 m-70 -116.6 53.35 1.13 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.67 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 73.6 Cg_endo -73.62 -19.26 21.66 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.739 2.293 . . . . 0.0 112.907 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -46.16 -35.64 5.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.873 0.368 . . . . 0.0 111.399 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 13.4 m-85 68.18 106.36 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.372 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 98.6 Cg_endo -85.08 160.43 11.57 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.747 2.298 . . . . 0.0 112.319 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.97 154.45 5.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.575 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.413 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -113.73 150.39 33.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.0 111.315 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.07 53.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.447 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.93 146.78 27.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.019 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' B' ' 78' ' ' PHE . 29.7 m -153.23 156.23 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.303 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.99 95.36 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.8 m -83.21 148.45 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.65 -46.33 90.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.996 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -155.16 171.32 20.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.728 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.31 160.14 52.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -46.72 136.74 16.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.443 2.095 . . . . 0.0 112.236 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.85 17.86 7.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 61.67 17.14 8.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.034 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.16 154.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.055 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.8 26.49 24.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.666 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.91 158.01 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.113 0.482 . . . . 0.0 111.154 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -152.49 148.32 27.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.179 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.5 mm -122.94 146.13 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 111.766 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 99.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.101 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.03 166.8 15.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 111.877 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.0 mm -114.51 154.05 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.404 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -141.09 151.5 44.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.97 0.414 . . . . 0.0 111.573 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -105.88 -179.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.942 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.834 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -173.52 122.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.418 ' CD1' ' ND2' ' A' ' 103' ' ' ASN . 2.0 mp -57.32 153.21 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 29.5 mt -114.22 154.67 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.201 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -153.63 126.08 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.75 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -130.46 151.77 50.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.99 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -98.19 30.18 3.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.894 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -39.76 4.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.33 120.74 67.43 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.168 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.25 -11.65 23.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.48 2.12 . . . . 0.0 112.613 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.29 -169.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.011 0.434 . . . . 0.0 111.391 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.518 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 58.36 -164.75 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.266 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' B' ' 14' ' ' ALA . 23.7 mm 80.34 16.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.126 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.74 -138.69 4.33 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.91 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -84.03 46.15 1.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.583 2.189 . . . . 0.0 112.653 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.518 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -176.16 -169.15 0.3 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 111.058 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 104' ' ' PHE . 14.5 m -120.55 -179.67 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.771 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -70.95 -51.33 26.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 0.0 111.038 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -161.19 -178.17 6.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.059 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.54 134.13 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.159 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -113.87 93.25 4.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.58 -20.34 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.046 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.87 -109.59 0.81 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.99 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.32 -30.38 64.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.462 . . . . 0.0 110.175 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.62 127.98 53.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.797 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.53 175.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.026 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -166.88 146.05 5.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 17.3 p -109.35 147.25 33.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 16.9 t -81.64 162.36 23.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.68 92.87 0.01 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.614 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -65.61 151.75 45.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 111.117 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.415 ' N ' HD13 ' B' ' 34' ' ' ILE . 4.6 mp -126.56 134.1 25.68 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.627 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 61.1 Cg_endo -74.0 72.73 3.89 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.88 2.387 . . . . 0.0 112.231 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.623 179.563 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 11.2 p . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.521 0.2 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.13 140.37 60.74 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.347 2.032 . . . . 0.0 112.158 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.96 -31.48 70.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.89 95.92 2.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.743 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.71 -31.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.313 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.3 t -76.03 -51.4 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.387 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.63 87.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.254 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.408 ' HG3' ' CG2' ' B' ' 43' ' ' VAL . 0.9 OUTLIER -69.14 -28.05 66.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.337 179.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.38 -34.97 35.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.927 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -68.99 -42.28 76.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.775 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -39.51 82.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.622 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m -71.04 -36.97 72.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.717 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.401 HD22 ' CE2' ' B' ' 95' ' ' PHE . 13.2 mt -67.97 -40.54 83.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.62 -38.64 87.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.758 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.09 -43.77 97.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.72 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.15 -36.05 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.792 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.48 -32.87 42.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.687 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.88 89.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mt -69.45 -46.66 75.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mt -67.48 -32.57 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.566 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.7 -41.05 65.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.183 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -61.26 -21.98 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.358 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.55 -28.41 21.98 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.35 47.16 0.55 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.616 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -156.54 137.98 13.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.975 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 9.4 m -93.27 159.4 15.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.819 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.468 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -57.29 -34.07 68.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' B' ' 101' ' ' HIS . . . -51.88 -28.12 15.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.975 0.417 . . . . 0.0 110.666 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.74 -26.62 60.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.416 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 71.4 mt -47.66 118.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.026 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 26.0 m -92.21 -30.55 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.08 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -138.43 160.02 40.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.596 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 42.0 m -153.27 137.97 16.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 0.0 111.461 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 58.5 m -126.98 140.65 52.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.08 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.26 115.58 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 111.551 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.409 ' CD2' HG11 ' A' ' 110' ' ' VAL . 9.1 m-85 -89.29 112.13 23.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.485 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -97.51 148.3 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.647 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 -5.73 29.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.95 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.67 97.43 2.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.508 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mt -57.63 -18.13 18.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.203 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.42 -25.33 54.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -87.08 -19.51 28.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.894 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -56.8 -22.52 36.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.204 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.18 67.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 111.214 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.53 -44.65 14.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.03 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.52 -38.15 81.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.818 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.23 -41.95 89.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.834 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.99 85.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.221 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.27 -31.0 25.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.415 ' O ' ' CE2' ' B' ' 95' ' ' PHE . 84.1 t80 -53.66 -44.46 69.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -85.8 -21.99 27.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.287 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.11 -21.27 59.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.438 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' B' ' 95' ' ' PHE . 1.2 p90 -91.83 -35.0 14.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.759 0.314 . . . . 0.0 110.695 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.414 ' CD1' ' HB2' ' B' ' 101' ' ' HIS . 0.8 OUTLIER -56.29 -60.12 3.97 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.174 0.512 . . . . 0.0 110.101 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -28.74 70.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.545 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -77.47 -9.91 59.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 110.658 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 57.1 m-20 -113.44 -6.02 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.482 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.1 m120 88.13 34.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.189 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' B' ' 69' ' ' ALA . 1.6 m-70 -116.47 53.38 1.1 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.701 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 73.5 Cg_endo -73.78 -19.21 21.3 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.771 2.314 . . . . 0.0 112.895 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 0.1 OUTLIER -46.12 -35.64 5.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.937 0.399 . . . . 0.0 111.409 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 13.5 m-85 68.15 106.37 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.36 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 97.0 Cg_endo -85.08 160.38 11.57 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.711 2.274 . . . . 0.0 112.327 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.88 154.53 5.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.615 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.468 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -113.78 150.46 33.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.015 0.436 . . . . 0.0 111.351 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.06 53.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.508 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.99 146.65 28.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.997 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' C' ' 78' ' ' PHE . 30.0 m -153.06 155.65 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.244 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.77 95.29 4.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.843 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 9.9 m -83.18 148.44 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.127 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.7 -46.34 90.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -155.16 171.26 20.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.719 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.29 160.19 52.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.706 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.75 136.75 16.45 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.459 2.106 . . . . 0.0 112.255 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.89 17.76 7.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 61.69 17.17 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.059 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.2 154.66 6.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.004 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.07 26.28 25.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.708 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.89 158.06 0.93 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.12 0.486 . . . . 0.0 111.191 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -152.48 148.25 27.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.23 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 23.5 mm -122.92 146.06 28.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.065 0.46 . . . . 0.0 111.799 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.88 99.82 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.144 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.05 166.7 15.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.877 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -114.47 154.0 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.422 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -141.03 151.58 44.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.914 0.388 . . . . 0.0 111.557 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.0 -179.42 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.894 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.947 0.403 . . . . 0.0 110.934 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.844 0.354 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -173.53 122.4 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.29 153.21 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.834 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 29.0 mt -114.17 154.71 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.2 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -153.71 126.06 8.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.728 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -130.38 151.77 50.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.018 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -98.27 30.12 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.84 -39.33 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.72 120.72 67.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.18 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.31 -11.58 23.23 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.486 2.124 . . . . 0.0 112.593 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.32 -169.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.0 111.415 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.51 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 58.39 -164.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.231 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . 0.402 ' HB ' ' O ' ' C' ' 14' ' ' ALA . 23.8 mm 80.32 16.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.107 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.68 -138.61 4.33 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.0 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.08 46.17 1.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.621 2.214 . . . . 0.0 112.67 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.51 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -176.18 -169.12 0.3 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.92 0.391 . . . . 0.0 111.082 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.431 HG11 ' O ' ' B' ' 104' ' ' PHE . 14.6 m -120.58 -179.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.769 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -71.21 -52.52 18.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.271 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -159.65 -178.44 7.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.54 134.27 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -113.95 93.36 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 17.5 mt -62.68 -20.45 64.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.004 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.01 -109.57 0.81 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.926 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.33 -30.37 64.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.052 0.453 . . . . 0.0 110.187 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.6 128.02 53.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.776 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.55 175.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -166.83 146.1 5.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 17.4 p -109.61 147.62 32.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.915 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 16.9 t -81.76 162.24 22.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.002 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.61 92.9 0.01 OUTLIER Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.654 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -65.6 151.8 45.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 0.0 111.107 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.42 ' N ' HD13 ' C' ' 34' ' ' ILE . 4.6 mp -126.57 133.98 25.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.619 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 61.2 Cg_endo -73.88 72.61 3.84 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.888 2.392 . . . . 0.0 112.292 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.68 179.543 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 11.1 p . . . . . 0 CA--C 1.53 0.183 0 CA-C-O 120.499 0.19 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.07 140.4 60.14 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.327 2.018 . . . . 0.0 112.155 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.04 -31.38 70.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.008 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.94 95.97 2.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.684 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.79 -31.31 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.231 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.95 -51.47 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.383 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.6 87.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.246 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . 0.41 ' HG3' ' CG2' ' C' ' 43' ' ' VAL . 0.9 OUTLIER -69.17 -27.91 65.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.301 179.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.52 -34.96 35.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.951 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -69.07 -42.29 76.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -39.49 82.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.698 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m -71.03 -36.98 72.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.689 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -67.96 -40.52 83.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.728 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.68 -38.66 87.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.71 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.05 -43.8 97.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.717 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 24.8 t -61.12 -36.08 70.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.786 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.49 -32.77 42.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.676 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.0 90.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.799 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mt -69.18 -46.65 77.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.655 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 22.0 mt -67.43 -32.65 58.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.532 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.65 -41.03 65.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.18 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -61.3 -21.89 64.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.41 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.63 -28.41 21.89 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.623 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.32 47.14 0.55 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.613 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -156.52 138.0 13.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.853 0.358 . . . . 0.0 110.963 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 9.4 m -93.19 159.39 15.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.857 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.476 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -57.3 -34.19 68.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' C' ' 101' ' ' HIS . . . -51.9 -28.33 15.9 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.91 0.386 . . . . 0.0 110.712 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.55 -26.64 60.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.435 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 71.4 mt -47.66 118.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.033 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 26.4 m -92.09 -30.7 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.093 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -138.34 160.12 40.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 40.6 m -153.29 137.9 16.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.043 0.449 . . . . 0.0 111.517 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 58.8 m -126.94 140.61 52.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -146.22 115.66 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.616 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.421 ' CD2' HG11 ' B' ' 110' ' ' VAL . 9.1 m-85 -89.33 112.07 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.494 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -97.44 148.37 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.115 0.483 . . . . 0.0 111.575 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 -5.59 29.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.995 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.69 97.4 2.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.53 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mt -57.64 -18.15 18.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.38 -25.33 54.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.48 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -87.12 -19.51 28.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.888 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -56.73 -22.54 36.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.06 -36.11 67.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.55 -44.65 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.983 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.53 -38.18 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.31 -41.89 89.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.837 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.82 84.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.201 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.41 -30.97 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.418 ' O ' ' CE2' ' C' ' 95' ' ' PHE . 84.2 t80 -53.61 -44.47 69.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -85.82 -22.01 27.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.281 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -21.25 60.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.456 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 1.2 p90 -91.8 -35.13 14.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' C' ' 101' ' ' HIS . 0.8 OUTLIER -56.17 -60.21 3.82 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.117 0.484 . . . . 0.0 110.084 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -28.84 70.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.539 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.36 -9.96 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 0.0 110.681 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 57.2 m-20 -113.43 -6.01 13.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.491 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 11.9 m120 88.02 34.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.181 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.476 ' CD2' ' HB2' ' C' ' 69' ' ' ALA . 1.6 m-70 -116.56 53.35 1.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.664 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 73.5 Cg_endo -73.67 -19.29 21.51 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.797 2.332 . . . . 0.0 112.907 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 0.1 OUTLIER -46.18 -35.58 5.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.88 0.371 . . . . 0.0 111.388 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 13.5 m-85 68.12 106.39 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.36 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.421 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 96.7 Cg_endo -85.14 160.42 11.49 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.711 2.274 . . . . 0.0 112.353 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.9 154.46 5.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.556 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.464 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -113.75 150.46 33.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.998 0.428 . . . . 0.0 111.297 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.1 53.96 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.425 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.92 146.75 27.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.959 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 30.0 m -153.11 155.34 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.288 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 95.38 4.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.721 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 10.0 m -83.2 148.45 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.31 90.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -155.17 171.35 19.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.36 160.17 52.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.661 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.76 136.73 16.52 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.496 2.131 . . . . 0.0 112.243 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.95 17.79 7.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.7 17.08 8.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.049 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 35.7 m -63.17 154.6 6.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.044 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.77 26.41 24.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.652 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.76 157.98 0.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.08 0.467 . . . . 0.0 111.173 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.403 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 4.4 tt0 -152.46 148.28 27.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.226 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 23.2 mm -122.93 146.05 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.057 0.455 . . . . 0.0 111.81 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 99.84 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.068 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.08 166.86 15.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.037 0.446 . . . . 0.0 111.828 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 8.8 mm -114.52 154.0 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.463 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -141.1 151.46 43.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.898 0.38 . . . . 0.0 111.576 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.9 -179.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.884 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.71 48.1 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 tttp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.926 179.937 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.8 136.84 3.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -58.55 158.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.244 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 mt -115.13 160.58 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.043 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -160.73 124.48 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.997 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -127.65 165.52 19.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.973 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.76 51.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.25 -50.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.757 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . . . -66.41 172.34 3.25 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.03 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 11' ' ' ALA . 32.1 Cg_endo -64.37 -11.95 30.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.586 2.19 . . . . 0.0 112.714 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.27 171.61 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.987 0.423 . . . . 0.0 111.352 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' HB1' ' CZ ' ' A' ' 18' ' ' TYR . . . -166.98 122.75 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.799 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mm -141.42 17.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.377 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.58 -103.85 2.44 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.274 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.17 4.88 6.65 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.536 2.157 . . . . 0.0 112.788 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.427 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -160.74 177.21 10.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.448 HG12 ' O ' ' C' ' 103' ' ' ASN . 28.4 m -132.32 166.37 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.051 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -52.82 -46.43 67.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.21 176.79 1.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.997 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.19 133.89 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -97.26 139.69 32.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.654 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -112.94 -15.86 12.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.34 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 97.01 104.45 2.23 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.294 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 15.6 m-80 84.05 -35.72 0.06 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.2 101.5 6.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.771 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 127' ' ' ALA . 3.4 m -94.89 170.34 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.377 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mp -152.77 148.92 27.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 p -125.97 149.1 49.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 t -75.26 170.7 15.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.03 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.92 77.21 0.41 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.062 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.14 162.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.964 0.411 . . . . 0.0 111.536 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 7.5 pt -146.91 154.21 46.87 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.773 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.453 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 72.2 Cg_endo -77.11 48.79 2.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.925 2.416 . . . . 0.0 113.292 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.407 ' CG2' ' CD1' ' A' ' 34' ' ' ILE . 45.9 t . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 121.229 0.537 . . . . 0.0 110.473 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 9.9 p . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.551 0.215 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 50' ' ' GLN . 52.7 Cg_exo -54.4 141.77 71.38 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.453 2.102 . . . . 0.0 112.235 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.01 70.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 93.87 1.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.774 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.4 tp -42.25 -33.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.638 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.56 -46.38 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.15 -46.99 88.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.64 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.414 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 3.5 pt20 -64.89 -28.89 69.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.52 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.8 -40.87 54.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.859 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -67.81 -52.31 38.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.62 -27.97 63.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.622 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.86 -42.41 99.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.629 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.416 HD22 ' CD2' ' A' ' 92' ' ' TYR . 7.5 mt -74.98 -30.0 61.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.5 -36.16 83.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.086 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.418 ' OD1' HG21 ' A' ' 58' ' ' VAL . 22.4 p30 -72.43 -27.8 62.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.793 0.33 . . . . 0.0 110.598 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.418 HG21 ' OD1' ' A' ' 57' ' ' ASN . 35.2 t -67.63 -45.86 84.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -28.24 57.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.18 94.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mt -72.83 -40.9 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.584 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 mt -70.07 -33.07 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.68 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.53 -40.98 63.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.274 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -21.8 65.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.349 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.3 -28.41 17.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.734 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.24 56.65 0.26 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.606 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -172.77 144.17 1.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.0 p -99.43 166.06 11.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.763 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.512 ' HB1' ' CE1' ' A' ' 101' ' ' HIS . . . -62.48 -31.05 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.837 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -52.59 -26.85 14.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.911 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.15 -24.5 35.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.898 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.9 108.31 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.922 0.392 . . . . 0.0 110.954 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -74.31 -45.29 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.816 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.479 ' HB3' ' HG2' ' A' ' 107' ' ' ARG . 5.9 mttp -125.06 163.72 21.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.626 0.25 . . . . 0.0 111.263 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.5 ' N ' ' HG3' ' A' ' 107' ' ' ARG . 31.7 p -157.8 102.4 1.84 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.831 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.422 HG23 ' CZ ' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -70.03 124.64 24.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -116.28 110.36 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CZ ' HG23 ' A' ' 76' ' ' THR . 15.8 m-30 -107.88 119.92 40.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.973 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -114.26 152.21 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.13 0.491 . . . . 0.0 111.777 -179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.99 1.05 57.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.846 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.3 108.56 0.28 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.546 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 mt -57.84 -17.31 15.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.274 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.23 -22.18 60.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 0.0 110.458 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -87.05 -15.49 38.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.017 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.408 ' CE2' ' OD1' ' A' ' 89' ' ' ASN . 0.2 OUTLIER -57.35 -29.67 64.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.193 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.01 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.325 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.91 -28.84 22.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.322 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.76 -41.65 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.287 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.408 ' OD1' ' CE2' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -68.17 -36.56 79.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.91 75.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.321 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.59 -32.48 18.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.052 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.416 ' CD2' HD22 ' A' ' 55' ' ' LEU . 17.2 t80 -61.25 -49.89 75.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.041 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.52 -21.53 57.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.468 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -27.29 50.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.554 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.516 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -85.67 -39.07 17.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 110.752 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 4.3 m-85 -55.15 -54.5 42.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.154 0.502 . . . . 0.0 110.209 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -31.93 71.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.23 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.72 -4.18 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.713 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 4.1 t-20 -112.5 -5.54 14.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.535 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 5.6 m120 86.29 30.69 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.62 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.713 ' CE1' ' HB3' ' A' ' 99' ' ' ASN . 2.9 m170 -117.35 54.55 1.56 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.6 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.411 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 63.4 Cg_endo -72.09 -10.05 25.4 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.704 2.269 . . . . 0.0 113.362 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.452 ' O ' HG12 ' B' ' 19' ' ' VAL . 7.7 m-20 -56.7 -40.74 76.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.794 0.331 . . . . 0.0 110.921 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 102' ' ' PRO . 26.8 m-85 72.37 90.36 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.988 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.48 ' CB ' HG23 ' A' ' 75' ' ' THR . 77.0 Cg_exo -49.27 162.06 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.557 2.172 . . . . 0.0 112.322 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' B' ' 31' ' ' SER . . . -125.4 131.18 52.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.534 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -163.73 -166.47 1.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.57 114.93 28.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.219 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 14.3 m -96.94 130.37 44.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.127 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.4 m -148.74 167.64 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.924 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 30.7 tt0 -102.28 92.34 4.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.71 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.5 m -62.6 157.94 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.203 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.32 -51.44 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.17 178.45 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.718 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.3 mt -150.85 153.99 34.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.749 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.39 137.48 51.29 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.483 2.122 . . . . 0.0 112.21 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.66 14.84 2.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.303 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.58 14.48 9.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.095 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.3 m -58.78 160.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 111.027 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.48 21.75 21.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.782 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -178.86 154.9 0.74 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 0.0 111.208 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.55 150.59 43.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.044 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.8 mm -136.8 119.67 21.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -138.4 115.87 11.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.11 168.67 17.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.0 mm -116.55 146.03 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.488 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.413 ' CB ' HG22 ' A' ' 28' ' ' VAL . . . -132.63 148.48 52.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.171 0.51 . . . . 0.0 111.944 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.8 m -132.14 162.81 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.883 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.98 -179.912 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.776 0.322 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.83 136.88 3.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.026 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -58.61 158.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.242 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 mt -115.1 160.59 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -160.75 124.47 3.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.949 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -127.69 165.57 19.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.967 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.8 51.28 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.19 -49.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.512 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . . . -66.79 172.41 3.41 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.073 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' B' ' 11' ' ' ALA . 32.2 Cg_endo -64.37 -11.93 30.6 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.651 2.234 . . . . 0.0 112.758 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.26 171.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.422 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.434 ' HB1' ' CZ ' ' B' ' 18' ' ' TYR . . . -167.04 122.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.827 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 17.6 mm -141.41 17.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.399 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.49 -103.89 2.45 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.308 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.11 4.83 6.69 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.567 2.178 . . . . 0.0 112.843 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.434 ' CZ ' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -160.79 177.18 10.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.911 0.386 . . . . 0.0 111.291 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 103' ' ' ASN . 28.3 m -132.27 166.41 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.06 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -52.89 -46.44 67.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.806 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.47 176.84 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.875 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.27 133.84 34.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.122 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -97.2 139.75 32.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -112.98 -15.91 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 97.01 104.45 2.23 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.297 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 15.7 m-80 84.07 -35.74 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.19 101.52 6.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.791 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.412 HG22 ' CB ' ' B' ' 127' ' ' ALA . 3.4 m -94.91 170.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.392 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mp -152.85 148.81 27.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.4 p -125.79 148.08 49.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.755 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 106' ' ' ALA . 4.3 t -74.59 170.06 16.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.842 0.354 . . . . 0.0 110.953 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.87 77.14 0.41 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.026 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.15 162.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 111.448 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.405 ' CD1' ' CG2' ' B' ' 36' ' ' VAL . 7.5 pt -146.84 154.2 47.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 72.6 Cg_endo -77.23 48.85 2.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.903 2.402 . . . . 0.0 113.248 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.405 ' CG2' ' CD1' ' B' ' 34' ' ' ILE . 45.8 t . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.238 0.542 . . . . 0.0 110.545 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 9.8 p . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.566 0.222 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.8 Cg_exo -54.39 141.78 71.23 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.52 2.147 . . . . 0.0 112.21 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.77 -31.03 70.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.983 0.42 . . . . 0.0 110.941 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.13 93.77 1.86 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.817 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.4 tp -42.15 -33.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.714 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.59 -46.46 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.682 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.99 88.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.701 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.415 ' CB ' ' HD2' ' B' ' 44' ' ' PRO . 3.5 pt20 -65.11 -28.9 69.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.536 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.2 -41.11 42.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.319 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -67.69 -52.27 39.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.813 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.69 -27.92 63.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.88 -42.44 99.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.602 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mt -74.87 -30.03 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.019 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.51 -36.2 83.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.069 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . 0.403 ' OD1' HG21 ' B' ' 58' ' ' VAL . 22.2 p30 -72.37 -27.83 62.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.883 0.373 . . . . 0.0 110.59 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.403 HG21 ' OD1' ' B' ' 57' ' ' ASN . 35.1 t -67.7 -45.81 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -28.3 57.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.991 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.28 94.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.984 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 15.9 mt -72.95 -41.05 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.565 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 mt -70.0 -33.14 54.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.663 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.45 -41.0 63.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.286 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.48 -21.76 65.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.392 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.36 -28.37 17.76 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.751 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.27 56.57 0.26 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.583 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -172.8 144.12 1.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.355 . . . . 0.0 111.126 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -99.39 166.1 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.772 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.509 ' HB1' ' CE1' ' B' ' 101' ' ' HIS . . . -62.54 -31.0 71.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.788 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.54 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -52.49 -26.61 13.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.897 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.13 -24.59 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.88 108.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.008 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -74.29 -45.23 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.841 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.471 ' C ' HG23 ' B' ' 75' ' ' THR . 5.9 mttp -125.05 163.77 21.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.289 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.506 ' N ' ' HG3' ' B' ' 107' ' ' ARG . 31.8 p -157.83 102.5 1.84 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.787 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.423 HG23 ' CZ ' ' B' ' 78' ' ' PHE . 0.1 OUTLIER -70.12 124.69 24.72 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.38 110.37 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.423 ' CZ ' HG23 ' B' ' 76' ' ' THR . 15.7 m-30 -107.85 119.96 40.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.989 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 0.7 OUTLIER -114.29 152.2 15.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.154 0.502 . . . . 0.0 111.752 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.9 0.94 57.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.849 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.26 108.55 0.28 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.507 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 mt -57.8 -17.26 14.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.302 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.23 -22.26 60.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.834 0.35 . . . . 0.0 110.397 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -86.98 -15.52 38.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.031 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.413 ' CE2' ' OD1' ' B' ' 89' ' ' ASN . 0.2 OUTLIER -57.28 -29.69 64.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.232 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.94 68.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.32 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.96 -28.85 22.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.301 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.77 -41.57 28.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.295 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.413 ' OD1' ' CE2' ' B' ' 85' ' ' PHE . 0.3 OUTLIER -68.28 -36.53 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.828 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.57 -36.0 75.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.308 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.53 -32.48 18.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -61.29 -49.9 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.017 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.48 -21.6 57.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.457 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -27.27 50.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.591 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.52 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -85.68 -39.01 17.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.704 0.288 . . . . 0.0 110.765 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.52 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 4.3 m-85 -55.18 -54.5 42.54 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.136 0.493 . . . . 0.0 110.187 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -31.91 71.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.267 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.71 -4.18 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.584 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.713 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 4.1 t-20 -112.53 -5.51 14.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.547 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 5.6 m120 86.32 30.79 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.621 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.713 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 2.9 m170 -117.35 54.56 1.56 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.679 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 63.9 Cg_endo -72.08 -10.13 25.54 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.74 2.293 . . . . 0.0 113.359 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.449 ' O ' HG12 ' C' ' 19' ' ' VAL . 7.7 m-20 -56.6 -40.78 75.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.914 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' B' ' 102' ' ' PRO . 26.8 m-85 72.21 90.52 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.969 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.478 ' CB ' HG23 ' B' ' 75' ' ' THR . 78.1 Cg_exo -49.37 162.11 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.594 2.196 . . . . 0.0 112.274 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.5 131.1 52.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.505 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.506 ' HG3' ' N ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -163.57 -166.4 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.6 114.98 28.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.176 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 14.4 m -96.9 130.38 44.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.138 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 29.8 m -148.81 167.9 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.987 0.423 . . . . 0.0 111.982 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 79' ' ' VAL . 30.4 tt0 -102.42 92.46 4.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.708 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 24.1 m -62.76 158.05 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.37 -51.41 29.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.067 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.19 178.5 7.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.685 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 73.3 mt -150.88 153.99 34.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.769 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.37 137.56 51.73 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.428 2.085 . . . . 0.0 112.201 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.6 14.84 2.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.339 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.53 14.54 9.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.085 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 m -58.87 160.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.762 0.315 . . . . 0.0 110.99 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.5 21.68 21.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.682 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -178.88 154.86 0.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.077 0.465 . . . . 0.0 111.204 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.61 150.57 43.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.083 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 21.0 mm -136.85 119.55 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . 0.423 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.0 OUTLIER -138.32 115.87 11.3 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -132.12 168.68 17.56 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.0 mm -116.56 146.06 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.511 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' B' ' 28' ' ' VAL . . . -132.69 148.47 52.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.163 0.506 . . . . 0.0 111.937 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.09 162.78 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.945 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.004 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.815 0.34 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.75 136.87 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.054 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -58.54 158.24 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.181 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 mt -115.02 160.68 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.029 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -160.76 124.45 3.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.964 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -127.7 165.47 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.953 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.78 51.29 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.09 -49.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.704 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.502 ' CB ' ' HD2' ' C' ' 12' ' ' PRO . . . -67.43 172.3 3.98 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' C' ' 11' ' ' ALA . 32.1 Cg_endo -64.42 -11.95 30.84 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.598 2.199 . . . . 0.0 112.713 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.32 171.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.948 0.404 . . . . 0.0 111.365 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.443 ' HB1' ' CZ ' ' C' ' 18' ' ' TYR . . . -166.98 122.82 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.798 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mm -141.47 17.53 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.377 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.47 -103.89 2.45 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.296 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.14 4.83 6.68 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.565 2.177 . . . . 0.0 112.805 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.443 ' CZ ' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -160.72 177.18 10.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.897 0.38 . . . . 0.0 111.259 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.449 HG12 ' O ' ' B' ' 103' ' ' ASN . 28.1 m -132.28 166.39 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.054 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -52.86 -46.55 67.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -175.62 176.44 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.004 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.2 133.86 35.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -97.19 139.71 32.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.92 -15.87 12.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.352 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 97.03 104.41 2.23 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.344 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 16.0 m-80 84.1 -35.77 0.06 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.16 101.63 6.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.792 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' C' ' 127' ' ' ALA . 3.4 m -95.0 170.4 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.315 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.414 ' CD2' ' HD2' ' B' ' 74' ' ' LYS . 3.6 mp -152.78 148.89 27.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.962 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.4 p -125.91 148.95 49.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 4.4 t -75.36 170.27 16.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.82 77.16 0.4 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.033 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.21 162.95 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.008 0.432 . . . . 0.0 111.412 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 pt -146.9 154.29 46.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.681 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 72.5 Cg_endo -77.21 48.81 2.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.911 2.407 . . . . 0.0 113.23 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 121.178 0.513 . . . . 0.0 110.469 179.167 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 10.0 p . . . . . 0 CA--C 1.53 0.2 0 CA-C-O 120.496 0.189 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' C' ' 50' ' ' GLN . 52.7 Cg_exo -54.46 141.82 71.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.443 2.095 . . . . 0.0 112.224 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.0 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.059 0.457 . . . . 0.0 110.994 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.15 93.75 1.86 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.803 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 7.4 tp -42.11 -33.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.677 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.53 -46.41 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.705 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.99 88.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.688 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . 0.41 ' CB ' ' HD2' ' C' ' 44' ' ' PRO . 3.5 pt20 -65.05 -28.8 69.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.453 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.29 -40.86 50.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.051 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -67.82 -52.22 39.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.79 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -27.98 63.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.644 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.82 -42.41 98.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' C' ' 92' ' ' TYR . 7.5 mt -74.94 -30.0 61.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.008 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.48 -36.15 83.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.149 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . 0.42 ' OD1' HG21 ' C' ' 58' ' ' VAL . 22.3 p30 -72.43 -27.82 62.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.42 HG21 ' OD1' ' C' ' 57' ' ' ASN . 34.5 t -67.65 -45.78 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -28.34 57.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.17 93.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.969 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 mt -73.06 -41.2 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.629 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 mt -69.9 -33.17 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.712 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.51 -40.96 63.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.229 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -21.83 65.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.325 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.29 -28.4 17.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.3 56.65 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.545 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -172.86 144.16 1.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.893 0.377 . . . . 0.0 111.063 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -99.41 166.08 11.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.764 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.513 ' HB1' ' CE1' ' C' ' 101' ' ' HIS . . . -62.44 -31.08 71.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.843 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.543 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -52.4 -26.62 13.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.973 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.47 -24.51 34.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.84 108.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.989 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -74.29 -45.26 47.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.818 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . 0.472 ' C ' HG23 ' C' ' 75' ' ' THR . 5.8 mttp -125.09 163.68 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.662 0.268 . . . . 0.0 111.248 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 31.8 p -157.74 102.44 1.86 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.788 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.43 HG23 ' CZ ' ' C' ' 78' ' ' PHE . 0.1 OUTLIER -70.04 124.63 24.54 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.33 110.39 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' C' ' 76' ' ' THR . 15.8 m-30 -107.86 119.97 40.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.94 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 0.8 OUTLIER -114.3 152.18 15.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.103 0.477 . . . . 0.0 111.773 -179.224 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.89 0.85 57.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.866 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.13 108.49 0.29 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.51 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 mt -57.76 -17.3 14.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -73.3 -22.19 60.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.384 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -87.01 -15.51 38.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.021 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.415 ' CE2' ' OD1' ' C' ' 89' ' ' ASN . 0.2 OUTLIER -57.33 -29.64 64.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.218 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.98 68.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.292 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.93 -28.89 22.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.273 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.72 -41.61 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.313 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . 0.415 ' OD1' ' CE2' ' C' ' 85' ' ' PHE . 0.3 OUTLIER -68.2 -36.6 79.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.881 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.95 75.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.274 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.51 -32.43 18.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.422 ' CD2' HD22 ' C' ' 55' ' ' LEU . 17.2 t80 -61.28 -49.86 75.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.084 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.5 -21.57 57.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.501 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -27.26 50.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.57 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.52 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -85.7 -39.02 17.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.703 0.287 . . . . 0.0 110.778 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.52 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 4.3 m-85 -55.12 -54.5 42.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.193 0.521 . . . . 0.0 110.231 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -31.9 71.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.264 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.73 -4.17 55.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.592 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.712 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 4.1 t-20 -112.54 -5.5 14.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.583 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 5.6 m120 86.29 30.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.631 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' C' ' 99' ' ' ASN . 2.9 m170 -117.25 54.58 1.51 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.626 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . 0.419 ' O ' ' CD2' ' C' ' 104' ' ' PHE . 63.4 Cg_endo -72.1 -10.04 25.37 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.744 2.296 . . . . 0.0 113.344 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . 0.448 ' O ' HG12 ' A' ' 19' ' ' VAL . 7.7 m-20 -56.75 -40.73 76.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.421 ' O ' HG12 ' A' ' 19' ' ' VAL . 26.7 m-85 72.34 90.39 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.965 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.48 ' CB ' HG23 ' C' ' 75' ' ' THR . 77.2 Cg_exo -49.31 162.1 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.569 2.179 . . . . 0.0 112.303 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.51 131.07 52.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.488 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.495 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -163.52 -166.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.64 114.99 28.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.195 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 14.2 m -96.9 130.33 44.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.163 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 30.2 m -148.88 168.12 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.906 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' C' ' 79' ' ' VAL . 30.6 tt0 -102.48 92.33 4.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 24.4 m -62.52 158.01 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.37 -51.44 29.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.18 178.51 7.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.706 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 73.3 mt -150.89 153.98 33.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.786 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.36 137.47 51.4 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.513 2.142 . . . . 0.0 112.184 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.62 14.9 2.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.307 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.52 14.52 8.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.84 160.86 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.323 . . . . 0.0 110.969 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.45 22.05 20.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.75 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.19 155.05 0.7 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.122 0.487 . . . . 0.0 111.144 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -140.63 150.62 43.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.036 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 20.8 mm -136.88 119.55 20.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.132 0.491 . . . . 0.0 112.286 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' C' ' 78' ' ' PHE . 0.0 OUTLIER -138.33 115.89 11.31 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -132.17 168.66 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . 0.408 ' CG2' ' HG ' ' C' ' 29' ' ' LEU . 4.0 mm -116.5 146.05 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.527 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' C' ' 28' ' ' VAL . . . -132.65 148.45 52.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.186 0.517 . . . . 0.0 111.895 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.09 162.82 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.932 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -157.05 65.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.984 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.4 pttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.449 179.924 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.4 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.827 0.346 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.89 127.17 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -56.47 153.7 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.177 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.9 mt -109.85 157.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -159.46 134.84 8.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -147.78 160.75 42.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.93 21.01 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.042 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -116.59 -35.91 4.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.913 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.445 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -52.7 177.79 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.343 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 17.1 Cg_exo -67.13 -8.28 21.37 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.831 2.354 . . . . 0.0 112.705 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.45 147.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 110.953 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.81 121.02 39.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.199 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.36 16.52 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.971 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.8 -148.87 4.85 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.307 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.73 38.75 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.869 2.379 . . . . 0.0 113.047 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.06 164.26 28.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.884 0.374 . . . . 0.0 111.05 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.6 m -113.32 175.4 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.963 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -48.22 81.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.936 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -175.53 178.97 1.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.922 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.17 132.95 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -111.25 118.42 35.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mt -94.1 -16.96 23.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.218 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.33 -99.99 0.9 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -59.08 -29.16 67.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.193 0.52 . . . . 0.0 109.717 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.55 139.52 51.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.547 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.413 ' CG1' ' CB ' ' A' ' 127' ' ' ALA . 4.2 p -127.92 151.34 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.009 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.66 135.46 42.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.743 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.3 p -108.85 136.18 48.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.066 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -63.94 143.23 58.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.827 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.55 92.17 0.01 OUTLIER Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.365 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -74.55 163.75 27.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.47 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.436 HG23 HD11 ' A' ' 34' ' ' ILE . 2.1 pt -146.27 160.26 43.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.672 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.542 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 17.6 Cg_exo -66.82 54.23 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.052 2.501 . . . . 0.0 113.262 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.168 0.509 . . . . 0.0 110.384 179.158 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 9.2 p . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.591 0.234 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.46 140.98 74.06 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.353 2.035 . . . . 0.0 112.118 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.29 -31.55 71.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.068 0.461 . . . . 0.0 110.901 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.48 91.47 0.57 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.781 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mm -41.1 -32.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.542 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.9 -42.66 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.29 -36.51 77.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.766 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -20.66 50.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.605 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.94 -36.76 23.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.291 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -33.2 58.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.931 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.02 -26.68 59.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.696 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.7 p -70.57 -35.35 73.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.421 HD13 ' CE2' ' A' ' 95' ' ' PHE . 8.7 mt -77.38 -33.6 55.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.074 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -51.59 69.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.977 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -59.45 -39.85 84.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.947 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.5 t -61.76 -35.76 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.851 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -31.53 43.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.17 92.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.47 -46.25 76.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.789 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mt -65.33 -31.44 53.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.765 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -41.36 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.401 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -63.2 -20.44 65.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.512 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.77 -21.51 20.66 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.064 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.03 53.19 0.8 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.383 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -155.65 137.1 14.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 157.16 16.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.754 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.13 -36.76 31.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -58.47 -21.24 50.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.363 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.88 -26.45 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.884 0.373 . . . . 0.0 110.588 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 35.5 mt -59.35 114.21 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 m -84.39 -33.14 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.72 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.404 ' CG ' ' CB ' ' A' ' 106' ' ' ALA . 0.6 OUTLIER -139.86 152.68 46.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.693 0.283 . . . . 0.0 111.009 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.8 p -141.9 135.0 29.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 111.336 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.5 m -114.82 150.85 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.213 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.3 t -148.87 112.94 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 111.613 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -92.7 107.85 19.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.549 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 m -102.42 146.43 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.413 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.69 -3.07 58.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.031 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.85 125.89 2.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.25 -11.11 56.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.164 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.07 -20.52 52.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 110.632 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -95.24 7.01 47.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.291 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -84.24 -27.96 27.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.768 0.318 . . . . 0.0 111.124 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.88 77.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.176 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.7 -33.89 27.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 t -77.97 -43.29 28.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.029 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -61.72 -33.07 73.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.027 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.35 -48.63 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.299 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.47 -29.85 59.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.186 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.524 ' CE1' ' CE1' ' A' ' 96' ' ' PHE . 11.5 t80 -63.99 -37.51 87.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.148 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.47 -27.33 29.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.191 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -33.72 76.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.187 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.467 ' CZ ' ' CD1' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -85.7 -34.63 21.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.553 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.524 ' CE1' ' CE1' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -57.8 -55.05 39.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.287 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -32.74 71.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.049 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -85.8 -0.86 56.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.407 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 2.6 m-20 -98.88 -18.38 17.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.189 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 20.2 m-20 104.89 25.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.11 0.881 . . . . 0.0 110.948 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.46 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.1 t-80 -123.95 66.67 40.46 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.05 -16.87 22.58 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.533 2.155 . . . . 0.0 112.393 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.13 -35.21 77.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.793 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 76.2 120.44 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.3 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 93.9 Cg_endo -82.41 168.87 14.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.848 2.365 . . . . 0.0 112.218 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.404 ' CB ' ' CG ' ' A' ' 74' ' ' LYS . . . -56.35 159.47 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.406 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -127.97 142.77 51.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.033 0.444 . . . . 0.0 111.528 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 t -150.43 66.6 0.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.453 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 11.8 m -96.75 138.76 33.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.033 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.6 m -145.5 139.56 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.303 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' B' ' 114' ' ' ARG . 1.0 OUTLIER -70.87 86.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.822 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.7 m -71.18 155.94 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.238 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.87 -46.82 70.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 0.0 OUTLIER -153.79 176.96 11.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.799 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.0 mt -147.48 155.38 45.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.814 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.97 136.97 77.51 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.593 2.196 . . . . 0.0 112.045 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 74.88 13.91 3.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.244 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.98 15.95 8.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.109 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.1 m -55.56 146.31 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.185 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.45 -15.1 64.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.9 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.2 mt -151.18 147.6 27.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.085 0.469 . . . . 0.0 111.016 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -122.53 155.32 36.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.211 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 30.3 mm -130.88 133.57 62.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 0.0 111.767 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -152.42 155.88 38.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.007 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -177.45 165.07 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.081 0.467 . . . . 0.0 111.833 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.52 143.66 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.393 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -129.76 157.99 40.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.0 0.429 . . . . 0.0 111.775 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -115.95 155.0 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.956 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.826 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.78 0.324 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.86 127.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.004 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -56.49 153.73 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.207 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 31.7 mt -109.89 157.1 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.122 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -159.48 134.78 8.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -147.72 160.76 42.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.94 21.06 10.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.962 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -116.68 -35.83 4.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.439 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -52.77 177.77 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.424 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 17.1 Cg_exo -67.05 -8.38 21.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.9 2.4 . . . . 0.0 112.689 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.51 147.76 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 111.002 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.81 120.93 39.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.206 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.27 16.6 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.984 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.81 -148.88 4.85 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.308 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.72 38.78 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.853 2.369 . . . . 0.0 113.063 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.07 164.34 28.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 111.05 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 25.6 m -113.43 175.4 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -48.3 81.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.981 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -175.62 178.98 1.49 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 m -134.09 132.95 56.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.131 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -111.3 118.46 35.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mt -94.07 -16.98 23.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.249 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.37 -100.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.468 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -59.05 -29.19 67.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.719 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.57 139.47 51.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.564 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.416 ' CG1' ' CB ' ' B' ' 127' ' ' ALA . 4.2 p -127.99 151.39 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.964 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.62 135.45 42.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.76 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -108.99 136.24 48.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.028 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.15 143.35 57.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.55 92.1 0.01 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.358 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -74.53 163.76 27.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.429 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.439 HD11 HG23 ' B' ' 34' ' ' ILE . 2.2 pt -146.28 160.29 42.89 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.625 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.552 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 18.0 Cg_exo -66.96 54.35 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.058 2.505 . . . . 0.0 113.205 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 121.167 0.508 . . . . 0.0 110.361 179.125 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 9.1 p . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.589 0.233 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.43 140.89 73.79 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.355 2.037 . . . . 0.0 112.183 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.18 -31.56 71.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.44 91.48 0.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.782 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mm -41.16 -32.75 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.514 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.82 -42.65 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.906 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.29 -36.55 77.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.768 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -20.85 49.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.614 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.8 -36.8 23.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.295 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 -33.1 58.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.01 -26.83 59.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' SER . . . . . 0.403 ' HA ' ' ND2' ' B' ' 57' ' ' ASN . 90.3 p -70.53 -35.25 73.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.42 HD13 ' CD2' ' B' ' 95' ' ' PHE . 8.7 mt -77.41 -33.6 54.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -51.6 69.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' B' ' 54' ' ' SER . 10.3 p30 -59.47 -39.85 85.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 31.5 t -61.77 -35.79 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.824 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -31.53 43.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.874 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.29 93.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.46 -46.21 76.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.77 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.25 -31.49 54.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -41.37 60.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.327 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -63.17 -20.43 65.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.556 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.83 -21.47 20.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.049 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.02 53.16 0.81 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.363 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -155.59 137.05 14.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.71 157.12 16.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.1 -36.77 30.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.445 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -58.61 -21.2 52.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.364 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.74 -26.49 49.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 110.583 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.505 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 35.2 mt -59.39 114.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 m -84.34 -33.13 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.745 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.91 152.68 46.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.747 0.308 . . . . 0.0 110.953 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 40.7 p -141.86 135.02 29.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.997 0.427 . . . . 0.0 111.353 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -114.8 150.86 34.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.19 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.2 t -148.83 112.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 111.637 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -92.74 107.88 19.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.543 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.41 146.42 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.467 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -3.13 59.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.028 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.8 125.9 2.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.581 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.19 -11.09 56.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.202 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.06 -20.58 52.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.831 0.348 . . . . 0.0 110.615 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -95.25 7.0 47.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -84.25 -27.95 27.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.145 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.26 -34.92 77.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.264 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.63 -34.01 27.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 t -77.95 -43.28 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.061 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -61.67 -33.19 73.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.008 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.29 -48.55 33.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.332 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.61 -29.93 59.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.524 ' CE1' ' CE1' ' B' ' 96' ' ' PHE . 11.4 t80 -63.94 -37.63 88.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.37 -27.39 29.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.213 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -33.79 76.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.132 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.468 ' CZ ' ' CD1' ' B' ' 96' ' ' PHE . 0.3 OUTLIER -85.7 -34.59 21.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 0.0 110.578 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.524 ' CE1' ' CE1' ' B' ' 92' ' ' TYR . 0.4 OUTLIER -57.83 -55.1 39.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.258 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -32.77 71.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.033 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -85.76 -1.0 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.381 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.547 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 2.6 m-20 -98.77 -18.42 17.99 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.192 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 20.4 m-20 104.98 25.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.117 0.885 . . . . 0.0 110.921 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.445 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.1 t-80 -124.15 66.62 42.3 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.01 -16.8 22.73 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.477 2.118 . . . . 0.0 112.393 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -35.11 77.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.851 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 76.14 120.4 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.287 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 92.8 Cg_endo -82.36 168.9 14.5 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.798 2.332 . . . . 0.0 112.266 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.31 159.54 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.404 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -128.0 142.79 51.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.082 0.468 . . . . 0.0 111.535 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 27.8 t -150.46 66.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.426 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 11.8 m -96.78 138.78 33.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 34.6 m -145.44 139.32 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.388 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.58 86.89 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.698 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m -71.29 155.8 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.74 -46.89 70.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -153.79 176.92 11.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 30.5 mt -147.43 155.32 45.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.809 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.93 136.97 77.4 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.161 . . . . 0.0 112.099 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 74.91 13.86 3.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.287 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 63.05 15.93 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.058 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 13.9 m -55.63 146.35 4.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.875 0.369 . . . . 0.0 111.177 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.44 -15.19 64.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.868 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 37.1 mt -151.1 147.41 27.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.07 0.462 . . . . 0.0 111.045 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -122.52 155.28 36.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.246 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 30.3 mm -130.83 133.6 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.424 . . . . 0.0 111.76 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -152.5 155.87 38.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.93 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -177.44 165.04 2.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 111.814 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.53 143.67 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.367 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -129.74 158.0 40.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.999 0.428 . . . . 0.0 111.756 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.91 155.03 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.982 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.854 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.794 0.33 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.84 127.13 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.013 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -56.48 153.7 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 31.4 mt -109.8 157.18 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -159.57 134.76 8.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -147.71 160.7 42.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.9 21.05 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.041 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -116.62 -35.99 4.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.863 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.447 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -52.76 177.85 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.313 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 17.1 Cg_exo -67.09 -8.38 21.64 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.868 2.379 . . . . 0.0 112.653 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.56 147.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.898 0.38 . . . . 0.0 110.967 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.77 120.94 39.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.36 16.63 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.84 -148.84 4.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.269 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -88.72 38.76 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.827 2.351 . . . . 0.0 113.071 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.01 164.28 28.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.823 0.344 . . . . 0.0 111.055 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 25.0 m -113.36 175.41 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.907 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -48.24 81.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -175.67 178.98 1.47 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.932 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 m -134.12 132.91 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -111.2 118.43 35.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.723 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mt -94.04 -17.02 23.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.256 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.32 -100.01 0.9 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.489 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -59.04 -29.17 67.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.223 0.535 . . . . 0.0 109.755 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.59 139.55 51.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.522 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.417 ' CG1' ' CB ' ' C' ' 127' ' ' ALA . 4.2 p -127.96 151.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.61 135.5 42.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.767 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 32.9 p -108.9 136.34 48.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.103 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -64.01 143.24 58.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.77 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.5 92.12 0.01 OUTLIER Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.325 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -74.53 163.77 27.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.036 0.446 . . . . 0.0 111.432 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.406 HD11 HG23 ' C' ' 34' ' ' ILE . 2.1 pt -146.33 160.27 42.79 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.618 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.548 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 17.9 Cg_exo -66.84 54.24 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.113 2.542 . . . . 0.0 113.184 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 110.355 179.185 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 9.2 p . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.572 0.225 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.49 140.94 74.44 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.326 2.017 . . . . 0.0 112.19 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.54 71.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.49 91.5 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.78 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 mm -41.15 -32.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.471 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.88 -42.58 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.925 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.31 -36.6 77.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.704 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -20.74 50.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.88 -36.69 23.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.286 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.72 -33.12 58.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.935 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -74.99 -26.82 59.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.682 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.401 ' HA ' ' ND2' ' C' ' 57' ' ' ASN . 90.8 p -70.45 -35.38 73.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.418 HD13 ' CD2' ' C' ' 95' ' ' PHE . 8.6 mt -77.32 -33.64 55.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -51.56 69.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.993 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' C' ' 54' ' ' SER . 10.3 p30 -59.5 -39.85 85.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.929 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 31.5 t -61.77 -35.81 69.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.831 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -31.63 44.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.13 92.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.64 -46.28 75.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -65.34 -31.42 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -41.42 60.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.368 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -63.14 -20.46 65.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.521 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.79 -21.51 20.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.002 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.04 53.14 0.81 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.373 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -155.63 137.09 14.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 110.978 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 157.13 16.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.738 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.11 -36.71 30.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.451 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -58.63 -21.24 53.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.322 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.72 -26.49 50.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.551 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 35.3 mt -59.38 114.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -84.35 -33.19 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.729 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . 0.402 ' CG ' ' CB ' ' C' ' 106' ' ' ALA . 0.6 OUTLIER -139.87 152.66 46.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.771 0.319 . . . . 0.0 110.942 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 40.8 p -141.9 135.0 29.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.991 0.424 . . . . 0.0 111.381 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 4.5 m -114.83 150.78 34.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.185 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -148.73 112.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 0.0 111.622 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -92.68 107.83 19.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.616 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 m -102.44 146.49 10.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.391 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -2.81 58.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.058 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.15 125.94 1.96 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.624 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.28 -11.05 56.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.09 -20.53 52.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.836 0.35 . . . . 0.0 110.606 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -95.31 7.04 47.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.263 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -84.25 -28.0 27.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.728 0.299 . . . . 0.0 111.096 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.25 -35.0 77.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.197 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.6 -33.92 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.201 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.89 -43.3 28.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.099 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -61.66 -33.15 73.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.011 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.37 -48.45 34.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.337 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -29.83 59.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.14 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.522 ' CE1' ' CE1' ' C' ' 96' ' ' PHE . 11.6 t80 -63.94 -37.65 88.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.071 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.42 -27.36 29.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.167 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -33.7 76.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.151 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.459 ' CZ ' ' CD1' ' C' ' 96' ' ' PHE . 0.3 OUTLIER -85.76 -34.59 21.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 110.544 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.522 ' CE1' ' CE1' ' C' ' 92' ' ' TYR . 0.4 OUTLIER -57.81 -55.13 38.87 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.232 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -32.77 71.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.022 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -85.71 -0.98 56.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.43 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 2.6 m-20 -98.88 -18.33 17.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.179 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 20.3 m-20 104.8 25.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.869 0.868 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.451 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.1 t-80 -124.07 66.67 41.69 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.846 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.05 -16.8 22.61 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.483 2.122 . . . . 0.0 112.476 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.21 -35.14 77.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.852 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 76.18 120.49 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.264 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 94.2 Cg_endo -82.4 168.93 14.41 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.831 2.354 . . . . 0.0 112.206 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . 0.402 ' CB ' ' CG ' ' C' ' 74' ' ' LYS . . . -56.42 159.6 3.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.393 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -128.1 142.79 51.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.083 0.468 . . . . 0.0 111.471 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 27.7 t -150.47 66.68 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.387 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 11.7 m -96.76 138.78 33.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.068 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 34.6 m -145.54 139.53 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.372 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 1.0 OUTLIER -70.63 87.01 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 21.6 m -71.33 156.03 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.97 -46.81 70.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.75 176.92 11.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 30.5 mt -147.44 155.35 45.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.03 137.03 77.86 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.572 2.182 . . . . 0.0 112.058 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 74.91 13.88 3.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 20.1 t70 63.0 15.96 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 14.1 m -55.61 146.38 4.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.856 0.36 . . . . 0.0 111.217 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.41 -15.12 64.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.878 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 37.0 mt -150.81 147.46 27.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.0 0.429 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -122.6 155.27 36.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.249 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 30.2 mm -130.78 133.6 63.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.004 0.43 . . . . 0.0 111.771 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -152.47 155.87 38.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.981 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -177.42 165.04 2.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.834 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.49 143.65 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.372 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -129.74 157.99 40.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.962 0.41 . . . . 0.0 111.787 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.94 154.94 17.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.005 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.7 46.99 2.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.899 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.963 -179.961 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 23' ' ' ASP . 5.9 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.762 0.315 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -177.96 132.51 0.15 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.008 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -57.51 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.1 mt -113.55 150.64 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.203 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -147.84 134.25 19.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.83 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.7 t -148.14 163.27 37.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.93 28.67 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -110.31 -49.88 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.776 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.46 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -67.85 179.3 0.62 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.981 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 31.4 Cg_exo -59.08 -15.57 28.69 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.74 2.293 . . . . 0.0 112.614 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.78 153.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -110.37 119.94 40.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.201 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.22 16.23 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.833 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.38 -137.96 4.61 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.417 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HB2' ' CE1' ' C' ' 92' ' ' TYR . 87.1 Cg_endo -84.33 16.61 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.755 2.303 . . . . 0.0 113.641 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -137.41 177.85 7.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.454 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' C' ' 103' ' ' ASN . 10.6 m -128.82 169.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.047 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -59.54 -55.85 29.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.006 0.431 . . . . 0.0 110.458 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.99 178.04 4.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.596 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 m -144.58 131.51 16.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.954 0.407 . . . . 0.0 111.164 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 3' ' ' THR . 3.6 t70 -98.98 110.55 23.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.439 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.48 -11.52 60.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.504 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.51 -102.86 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.669 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.11 -30.05 64.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.176 0.512 . . . . 0.0 109.979 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.58 167.54 18.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.55 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.5 160.83 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.83 122.78 20.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.28 137.71 41.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.046 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 t -71.25 172.67 8.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.32 82.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.074 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.38 147.51 21.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 0.0 111.385 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 5.0 pt -142.3 149.75 52.66 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.576 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 34' ' ' ILE . 1.6 Cg_endo -83.17 51.09 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.921 2.414 . . . . 0.0 112.481 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.0 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.185 179.878 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 5.4 p . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.556 0.217 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.7 147.51 91.75 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.514 2.143 . . . . 0.0 112.1 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.39 -31.0 57.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 110.943 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.65 95.79 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.28 -32.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.835 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 t -83.26 -43.23 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.11 96.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.794 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -74.27 -30.09 61.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.266 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.95 -33.37 59.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.369 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -30.16 29.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.12 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.21 -33.33 59.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -69.43 -35.74 76.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.573 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 92' ' ' TYR . 68.5 mt -63.0 -39.71 95.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.531 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -72.22 -40.56 67.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.673 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -57.82 -41.07 81.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.4 t -60.11 -40.76 84.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.792 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -32.41 59.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.769 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.46 86.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.9 -41.65 82.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.722 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.3 mt -69.28 -36.58 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.588 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -40.3 72.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -65.32 -19.04 65.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.539 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.33 -34.17 17.73 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.73 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.48 44.84 0.3 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.812 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.0 -170.54 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.716 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.78 157.25 44.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.441 ' O ' ' CD2' ' A' ' 101' ' ' HIS . . . -58.12 -36.58 73.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.03 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -57.49 -26.09 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.319 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -76.29 -24.48 54.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.879 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.3 mm -54.14 118.27 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.977 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.4 ' CG1' HG22 ' A' ' 128' ' ' VAL . 5.2 m -90.85 -32.86 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.929 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -143.25 163.97 31.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.658 0.266 . . . . 0.0 111.198 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.423 ' CB ' ' HB3' ' A' ' 125' ' ' ALA . 3.4 t -162.15 112.52 1.56 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.376 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -92.87 160.17 15.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.318 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.6 t -150.54 142.73 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.041 0.448 . . . . 0.0 111.945 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.428 ' CD2' HG12 ' C' ' 110' ' ' VAL . 3.2 m-85 -121.15 102.56 8.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.189 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 m -100.55 150.28 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.701 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.08 -1.86 58.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.839 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.59 124.5 1.38 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.477 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.79 -10.67 58.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.196 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.97 -22.81 42.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.827 0.346 . . . . 0.0 110.574 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -88.16 -20.27 25.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -57.52 -22.25 43.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.358 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.49 -60.41 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.57 79.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.3 t -61.67 -37.4 77.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.915 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.574 ' HA ' ' CE2' ' A' ' 92' ' ' TYR . 36.0 t-20 -62.28 -41.94 98.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.77 -23.46 42.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.351 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.16 -42.33 19.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.77 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.574 ' CE2' ' HA ' ' A' ' 89' ' ' ASN . 0.3 OUTLIER -77.34 -28.7 53.15 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.083 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.88 -33.72 39.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.966 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -72.63 -29.75 63.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.178 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -74.26 -41.65 60.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.782 0.325 . . . . 0.0 110.508 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.477 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 6.9 m-85 -52.04 -50.84 60.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.088 0.47 . . . . 0.0 110.377 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.04 -28.9 69.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.135 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.88 2.73 55.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.42 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -119.25 -1.52 10.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.3 t30 85.75 28.73 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.189 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.471 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -121.52 53.63 4.02 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.617 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 45.5 Cg_endo -68.3 -20.49 42.7 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.56 2.173 . . . . 0.0 112.676 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 2.1 m-20 -60.85 -40.34 92.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.942 0.401 . . . . 0.0 110.501 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 27.6 m-85 77.36 120.98 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.833 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HD3' ' NE2' ' A' ' 101' ' ' HIS . 84.7 Cg_endo -83.99 162.03 13.76 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.844 2.363 . . . . 0.0 112.303 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.32 163.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.447 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.463 ' CZ ' ' CZ ' ' A' ' 92' ' ' TYR . 13.7 ttm-85 -146.59 144.52 29.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.159 0.504 . . . . 0.0 111.876 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.14 63.31 1.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.996 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 19.8 p -79.92 134.78 36.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.278 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.438 HG12 ' CD2' ' B' ' 78' ' ' PHE . 33.9 m -146.25 146.62 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.193 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.42 88.05 5.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.7 m -71.75 155.4 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.88 -44.01 64.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.1 174.71 13.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.0 mt -147.16 156.01 46.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.23 136.33 67.88 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.595 2.197 . . . . 0.0 112.169 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt 74.7 14.1 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.232 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.48 17.8 8.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 m -52.1 162.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.845 0.355 . . . . 0.0 111.188 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.42 -25.55 13.66 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.737 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -157.51 148.87 21.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.164 0.507 . . . . 0.0 111.127 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.43 155.98 33.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.199 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mp -144.06 119.99 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.071 0.462 . . . . 0.0 112.016 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 149.01 50.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.437 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HB3' ' CB ' ' A' ' 75' ' ' THR . . . -163.83 161.18 23.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.313 0.578 . . . . 0.0 112.455 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.0 mt -118.0 152.44 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.058 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -133.3 149.9 51.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.139 0.495 . . . . 0.0 111.9 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.4 HG22 ' CG1' ' A' ' 73' ' ' VAL . 36.0 m -122.65 139.4 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.815 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 -179.895 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' B' ' 23' ' ' ASP . 5.9 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.829 0.347 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -177.95 132.5 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.084 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -57.54 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.2 mt -113.53 150.57 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -147.82 134.24 19.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 2.7 t -148.17 163.24 37.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.85 28.67 7.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -110.26 -49.84 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.782 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.466 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -67.98 179.29 0.63 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 31.5 Cg_exo -59.01 -15.59 28.38 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.742 2.295 . . . . 0.0 112.627 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.77 153.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -110.38 119.93 40.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.23 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.2 16.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.826 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.44 -137.96 4.6 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.429 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . 0.409 ' HB2' ' CE1' ' A' ' 92' ' ' TYR . 88.9 Cg_endo -84.32 16.52 1.92 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.75 2.3 . . . . 0.0 113.653 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -137.37 177.84 7.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.962 0.411 . . . . 0.0 111.456 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 103' ' ' ASN . 10.5 m -128.75 169.45 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.028 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -59.76 -55.74 30.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 110.466 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.94 178.12 4.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.594 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 m -144.62 131.54 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.954 0.407 . . . . 0.0 111.191 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' B' ' 3' ' ' THR . 3.6 t70 -98.96 110.65 23.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.405 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.55 -11.54 60.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.503 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.58 -102.87 0.68 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.668 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.19 -29.98 64.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.146 0.498 . . . . 0.0 109.972 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.59 167.53 18.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.523 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' B' ' 127' ' ' ALA . 7.1 p -129.52 160.78 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.057 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.8 122.76 20.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.736 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.24 137.82 40.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.041 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 16.6 t -71.27 172.54 9.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.96 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.21 82.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.113 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.4 147.49 21.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.022 0.439 . . . . 0.0 111.352 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.3 149.69 52.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.552 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 1.6 Cg_endo -83.12 51.04 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.956 2.437 . . . . 0.0 112.483 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.188 179.889 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 5.4 p . . . . . 0 N--CA 1.465 0.304 0 CA-C-O 120.495 0.188 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.76 147.61 91.53 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.458 2.105 . . . . 0.0 112.073 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.51 -30.99 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.438 . . . . 0.0 110.912 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.6 95.73 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.862 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.22 -32.41 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.806 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -83.25 -43.22 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.61 -44.17 96.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.787 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -74.13 -29.15 61.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.228 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.58 -33.46 58.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.429 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' B' ' 53' ' ' GLN . 0.0 OUTLIER -82.53 -30.23 29.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.123 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.4 ' N ' ' HG3' ' B' ' 52' ' ' ARG . 3.3 mm-40 -76.11 -33.3 59.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.787 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -69.54 -35.66 75.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.565 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' B' ' 92' ' ' TYR . 68.4 mt -62.97 -39.78 95.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.504 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -72.11 -40.66 68.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.717 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.75 -41.12 81.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 t -60.09 -40.74 84.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.783 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -32.53 59.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.747 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.33 -40.59 86.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.99 -41.56 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.753 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 12.3 mt -69.33 -36.58 72.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.536 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -40.21 72.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.229 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.33 -19.06 65.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.533 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.32 -34.16 17.75 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.748 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.49 44.82 0.3 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.769 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 mt -142.99 -170.47 3.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 110.702 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.79 157.28 44.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' B' ' 101' ' ' HIS . . . -58.19 -36.57 73.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.991 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.473 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -57.31 -25.8 59.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.294 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -76.7 -24.37 53.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.924 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 39.4 mm -54.21 118.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 5.2 m -90.79 -32.87 5.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.958 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -143.28 163.98 31.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.695 0.283 . . . . 0.0 111.164 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.428 ' CB ' ' HB3' ' B' ' 125' ' ' ALA . 3.3 t -162.23 112.46 1.53 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.321 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 27.6 m -92.8 160.16 15.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.301 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 13.6 t -150.52 142.74 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.098 0.475 . . . . 0.0 111.941 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.438 ' CD2' HG12 ' A' ' 110' ' ' VAL . 3.2 m-85 -121.11 102.58 8.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.181 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 m -100.58 150.33 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.069 0.461 . . . . 0.0 111.671 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.08 -2.11 58.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.846 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.16 124.33 1.48 Allowed 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.509 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.86 -10.69 58.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.95 -22.76 42.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.799 0.333 . . . . 0.0 110.578 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -88.22 -20.24 25.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -57.53 -22.33 43.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.32 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.34 -60.46 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 0.0 111.267 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.56 79.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 19.1 t -61.64 -37.46 78.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.894 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.579 ' HA ' ' CE2' ' B' ' 92' ' ' TYR . 36.0 t-20 -62.25 -41.99 98.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.799 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.79 -23.5 42.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.34 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.04 -42.32 19.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.817 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' B' ' 89' ' ' ASN . 0.3 OUTLIER -77.35 -28.71 53.12 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.094 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.92 -33.66 39.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -72.62 -29.79 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.14 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -74.23 -41.69 60.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.736 0.303 . . . . 0.0 110.473 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 6.9 m-85 -52.08 -50.78 60.91 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.071 0.462 . . . . 0.0 110.372 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' B' ' 98' ' ' GLU . 0.4 OUTLIER -62.12 -28.85 69.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.116 179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . 0.401 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 0.4 OUTLIER -90.93 2.76 55.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.433 178.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.1 OUTLIER -119.22 -1.58 10.82 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 7.3 t30 85.76 28.61 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.244 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.473 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 0.8 OUTLIER -121.36 53.65 3.87 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.593 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 45.7 Cg_endo -68.32 -20.44 42.6 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.617 2.211 . . . . 0.0 112.694 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 2.1 m-20 -60.92 -40.31 92.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 0.0 110.492 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 27.6 m-85 77.28 121.03 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.825 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.418 ' HD3' ' NE2' ' B' ' 101' ' ' HIS . 84.2 Cg_endo -83.98 162.06 13.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.83 2.354 . . . . 0.0 112.303 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' C' ' 31' ' ' SER . . . -52.46 163.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.445 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.467 ' CZ ' ' CZ ' ' B' ' 92' ' ' TYR . 13.6 ttm-85 -146.57 144.58 29.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.163 0.506 . . . . 0.0 111.836 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.14 63.11 1.49 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.966 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 20.1 p -79.7 134.8 36.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.37 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' C' ' 78' ' ' PHE . 33.9 m -146.43 147.1 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.236 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.92 88.07 5.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 5.7 m -71.78 155.47 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.145 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.91 -44.01 64.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.13 174.71 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.925 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 14.0 mt -147.15 156.04 46.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.38 136.36 67.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.608 2.205 . . . . 0.0 112.135 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt 74.64 14.13 3.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.293 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.52 17.76 8.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.961 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 m -52.16 162.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.216 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.24 -25.06 14.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.697 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' B' ' 121' ' ' LEU . 0.0 OUTLIER -158.2 149.06 20.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.109 0.48 . . . . 0.0 111.099 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.39 156.01 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.188 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mp -144.07 119.97 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.097 0.475 . . . . 0.0 111.994 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.88 148.97 50.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.434 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' B' ' 75' ' ' THR . . . -163.78 161.22 23.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.297 0.57 . . . . 0.0 112.449 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.01 152.43 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.044 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.41 ' HB2' ' CG1' ' B' ' 28' ' ' VAL . . . -133.23 149.98 51.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.129 0.49 . . . . 0.0 111.96 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.62 139.4 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.861 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 111.022 -179.955 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' C' ' 23' ' ' ASP . 5.9 m . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.826 0.346 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -178.02 132.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.057 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -57.54 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.45 HD12 HG22 ' C' ' 6' ' ' ILE . 32.3 mt -113.49 150.54 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.243 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -147.75 134.26 19.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.7 t -148.15 163.28 37.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.94 28.63 8.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -110.2 -49.69 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.752 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.457 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -68.1 179.27 0.65 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.984 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 31.7 Cg_exo -59.08 -15.58 28.74 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.755 2.303 . . . . 0.0 112.645 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.79 154.0 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -110.38 119.96 40.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.228 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.29 16.23 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.764 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 -137.97 4.61 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.429 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . 0.419 ' HB2' ' CE1' ' B' ' 92' ' ' TYR . 88.4 Cg_endo -84.32 16.58 1.9 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.692 2.261 . . . . 0.0 113.657 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -137.36 177.88 7.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.975 0.416 . . . . 0.0 111.435 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' B' ' 103' ' ' ASN . 10.6 m -128.78 169.41 20.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -59.63 -55.51 33.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.457 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.61 178.2 4.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.537 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 m -144.53 131.5 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.888 0.375 . . . . 0.0 111.179 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' C' ' 3' ' ' THR . 3.6 t70 -99.0 110.63 23.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.447 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.57 -11.48 60.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.51 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.53 -102.89 0.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.627 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.12 -30.06 64.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.173 0.511 . . . . 0.0 109.975 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.53 167.48 18.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' C' ' 127' ' ' ALA . 7.1 p -129.5 160.77 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.1 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.74 122.79 20.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.741 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.25 137.71 41.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.958 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' SER . . . . . 0.419 ' HB2' ' CB ' ' B' ' 106' ' ' ALA . 16.6 t -71.76 172.78 9.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.034 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.33 82.74 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.11 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.36 147.48 21.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.039 0.447 . . . . 0.0 111.34 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 5.0 pt -142.3 149.73 52.58 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.554 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' C' ' 34' ' ' ILE . 1.6 Cg_endo -83.2 51.08 3.5 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.938 2.425 . . . . 0.0 112.469 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 87.2 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.157 179.905 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 5.4 p . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 120.539 0.209 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.74 147.62 91.44 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.478 2.119 . . . . 0.0 112.088 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.45 -31.03 57.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.439 . . . . 0.0 110.91 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.64 95.69 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.27 -32.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.826 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -83.24 -43.26 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -44.17 96.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.781 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -74.14 -29.65 61.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.319 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.18 -33.47 59.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.327 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -30.21 29.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.135 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.11 -33.32 59.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -69.45 -35.76 75.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.575 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.433 HD13 ' HB3' ' C' ' 92' ' ' TYR . 68.5 mt -62.94 -39.81 95.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.495 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -72.12 -40.65 67.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.703 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.73 -41.14 81.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.843 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 t -60.04 -40.78 84.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -32.51 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.713 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.57 87.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mt -68.67 -41.58 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.72 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 12.2 mt -69.27 -36.59 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.628 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -40.27 72.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.294 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.26 -19.16 65.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.526 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.29 -34.13 17.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.734 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.44 44.88 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.788 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.02 -170.55 3.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.728 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.74 157.28 44.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.432 ' O ' ' CD2' ' C' ' 101' ' ' HIS . . . -58.1 -36.56 73.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.459 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -57.51 -25.87 60.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.258 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -76.35 -24.45 54.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.996 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 39.4 mm -54.15 118.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.83 -32.87 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.908 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -143.23 163.98 31.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.662 0.268 . . . . 0.0 111.188 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' THR . . . . . 0.423 ' CB ' ' HB3' ' C' ' 125' ' ' ALA . 3.4 t -162.16 112.46 1.55 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -92.8 160.17 15.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.305 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.402 HG13 ' N ' ' C' ' 78' ' ' PHE . 13.6 t -150.52 142.76 17.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.102 0.477 . . . . 0.0 111.918 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.462 ' CD2' HG12 ' B' ' 110' ' ' VAL . 3.2 m-85 -121.09 102.49 8.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.206 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 m -100.57 150.26 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.008 0.433 . . . . 0.0 111.715 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.05 -1.7 58.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.893 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.92 124.59 1.29 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.458 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.76 -10.78 58.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.148 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.88 -22.83 42.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.796 0.332 . . . . 0.0 110.598 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -88.18 -20.3 25.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -57.54 -22.26 43.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.322 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.4 -60.47 3.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 111.28 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.69 -48.59 79.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 t -61.7 -37.4 77.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.944 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . 0.579 ' HA ' ' CE2' ' C' ' 92' ' ' TYR . 36.0 t-20 -62.32 -41.91 98.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.774 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.76 -23.33 42.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.347 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.31 -42.34 18.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.778 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' C' ' 89' ' ' ASN . 0.3 OUTLIER -77.41 -28.68 52.72 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.071 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.92 -33.78 39.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -72.48 -29.85 64.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.198 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.478 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -74.18 -41.71 61.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.478 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 7.0 m-85 -52.08 -50.8 60.87 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.358 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -28.88 69.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.145 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.89 2.76 55.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.437 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.1 OUTLIER -119.22 -1.63 10.81 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 7.3 t30 85.84 28.69 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.172 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.459 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 0.8 OUTLIER -121.34 53.63 3.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.627 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 45.9 Cg_endo -68.37 -20.39 42.35 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 112.675 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 2.2 m-20 -61.01 -40.17 92.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.882 0.372 . . . . 0.0 110.482 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 27.6 m-85 77.21 121.02 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.805 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.421 ' HD3' ' NE2' ' C' ' 101' ' ' HIS . 85.0 Cg_endo -83.99 161.98 13.74 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.854 2.369 . . . . 0.0 112.288 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.28 163.61 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.434 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.47 ' CZ ' ' CZ ' ' C' ' 92' ' ' TYR . 13.6 ttm-85 -146.62 144.5 29.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.199 0.524 . . . . 0.0 111.898 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.11 63.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.988 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 20.0 p -79.91 134.75 36.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.339 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 78' ' ' PHE . 33.9 m -146.07 145.89 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.96 88.2 4.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.761 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 5.8 m -71.84 155.45 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.129 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.9 -44.01 64.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.13 174.69 13.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.874 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 13.9 mt -147.13 155.99 46.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.942 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.21 136.38 68.22 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.621 2.214 . . . . 0.0 112.156 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt 74.59 14.13 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.309 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.54 17.75 8.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 23.2 m -52.15 162.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.48 -25.36 13.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.726 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' C' ' 121' ' ' LEU . 0.0 OUTLIER -157.81 148.96 21.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.146 0.498 . . . . 0.0 111.191 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.42 156.03 33.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.187 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mp -144.05 120.05 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.062 0.458 . . . . 0.0 112.056 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.97 148.93 50.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.429 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . 0.423 ' HB3' ' CB ' ' C' ' 75' ' ' THR . . . -163.8 161.2 23.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.28 0.562 . . . . 0.0 112.429 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.03 152.36 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.053 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.41 ' HB2' ' CG1' ' C' ' 28' ' ' VAL . . . -133.25 150.01 51.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.093 0.473 . . . . 0.0 111.946 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 35.2 m -122.69 139.39 49.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.803 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -135.51 52.48 2.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.987 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.031 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.827 0.346 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.57 122.74 7.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 mm -55.67 144.39 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.8 mt -109.49 143.51 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -146.99 141.8 26.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.1 159.34 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.1 28.54 4.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.007 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -122.39 -44.16 2.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.778 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . . . -67.22 171.64 4.59 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.114 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 11' ' ' ALA . 30.4 Cg_endo -63.86 -12.68 33.0 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.538 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.82 147.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.009 0.433 . . . . 0.0 111.336 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -106.15 123.23 47.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.011 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.6 mm -131.9 16.96 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.861 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.24 -128.05 3.19 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.385 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -90.02 24.61 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.782 2.322 . . . . 0.0 113.484 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.419 ' HB3' ' HB2' ' C' ' 107' ' ' ARG . 0.7 OUTLIER -152.1 174.53 13.58 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.752 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.41 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 15.8 m -123.12 173.24 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.826 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -40.41 87.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.399 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 175.62 175.22 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.803 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 m -140.22 134.87 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.35 108.86 15.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.18 -16.93 41.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.165 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.0 -105.75 0.86 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.993 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -53.83 -30.13 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.066 0.46 . . . . 0.0 110.298 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.9 132.8 52.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.843 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -131.3 151.99 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.659 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.15 140.01 29.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.809 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.3 p -106.28 142.44 35.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.6 p -69.67 155.89 39.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.142 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.02 94.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.518 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -78.23 156.22 29.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.992 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.0 pt -136.02 146.65 57.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 53.3 Cg_endo -69.36 61.56 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.863 2.375 . . . . 0.0 112.729 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.085 0.469 . . . . 0.0 110.584 179.403 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 11.3 p . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.52 0.2 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.65 140.48 51.72 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.272 1.982 . . . . 0.0 112.055 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.12 -30.96 60.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.121 0.486 . . . . 0.0 111.077 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.02 95.68 0.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.64 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.4 tp -45.05 -30.54 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.307 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.77 -38.68 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.485 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.98 -53.94 51.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.307 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -62.81 -29.43 70.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.104 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.18 -35.01 71.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.893 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -80.79 -41.23 23.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.808 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -40.54 96.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.403 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 13.1 p -64.29 -29.92 70.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.761 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.418 HD22 ' CD2' ' A' ' 92' ' ' TYR . 8.8 mt -82.04 -18.84 41.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.807 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.49 -49.04 9.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.453 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 54' ' ' SER . 24.4 p30 -62.79 -33.18 74.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.278 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.16 -40.84 58.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.508 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -73.05 -33.38 65.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.581 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.44 91.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.76 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.2 mt -68.6 -41.78 83.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.8 mt -67.37 -38.83 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.696 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.8 -37.43 67.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.292 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.59 -20.2 66.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.514 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.15 19.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.985 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.15 47.89 0.79 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.429 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.416 ' CD1' HG11 ' A' ' 28' ' ' VAL . 26.3 mt -149.05 136.09 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -87.91 163.25 16.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.161 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 72' ' ' ILE . . . -54.71 -30.24 55.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.119 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -67.93 -22.16 65.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.249 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.04 -30.8 69.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 110.213 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 4.0 mp -67.21 108.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.623 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.6 m -78.88 -32.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.828 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -131.85 156.61 45.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.769 0.319 . . . . 0.0 110.918 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -146.8 117.4 7.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.327 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -105.34 144.89 31.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.208 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.8 t -151.57 121.21 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 0.0 111.666 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.403 ' CD2' HG13 ' C' ' 110' ' ' VAL . 6.6 m-85 -95.85 118.88 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.274 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.5 m -110.54 151.98 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.187 0.518 . . . . 0.0 111.757 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -6.6 31.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.785 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.48 94.18 2.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.364 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.61 -13.93 46.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.271 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.3 -27.94 53.12 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.84 -17.5 25.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.503 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 22.4 t80 -57.95 -24.53 58.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.93 -41.96 35.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.841 0.353 . . . . 0.0 111.378 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.2 -33.57 20.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.441 ' O ' ' CD1' ' A' ' 92' ' ' TYR . 28.8 t -65.8 -54.52 26.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.665 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 17.1 t-20 -56.62 -43.95 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.972 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.96 70.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.786 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -34.91 77.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 88' ' ' VAL . 53.3 m-85 -67.36 -45.9 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 0.0 110.156 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -25.36 66.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.335 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -77.0 -38.2 53.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.231 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -37.94 24.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.851 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 7.5 m-85 -53.36 -52.02 60.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.168 0.508 . . . . 0.0 110.225 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -30.33 70.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.318 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.66 3.22 53.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.642 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -116.34 -6.25 11.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.877 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER 89.13 26.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.303 0.573 . . . . 0.0 110.505 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.561 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 12.9 t-160 -118.87 54.52 2.3 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.532 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.68 -18.64 32.57 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.702 2.268 . . . . 0.0 112.862 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.416 ' O ' ' CG1' ' B' ' 19' ' ' VAL . 1.9 m-20 -57.78 -39.26 77.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.85 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 81.07 123.36 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.427 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' A' ' 101' ' ' HIS . 97.1 Cg_endo -86.74 162.41 9.2 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.748 2.298 . . . . 0.0 112.707 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.45 140.74 44.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.533 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.424 ' HB2' ' HB3' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -102.07 138.45 39.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.032 0.444 . . . . 0.0 111.553 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.0 t -148.17 55.14 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.1 m -103.0 151.34 22.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.193 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.421 HG13 ' CD2' ' B' ' 78' ' ' PHE . 29.4 m -156.89 160.53 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -86.98 94.21 9.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.87 171.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.216 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.41 -50.01 8.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.991 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.13 171.36 15.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.731 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.49 160.05 52.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.859 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -50.83 135.93 42.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.506 2.137 . . . . 0.0 112.159 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.28 15.96 8.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.159 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 62.78 16.6 9.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.6 m -53.13 170.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.832 0.349 . . . . 0.0 111.147 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -101.9 -2.93 52.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.964 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 pp -175.92 148.49 0.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.899 0.381 . . . . 0.0 111.286 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.93 163.63 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.302 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.6 mm -139.75 129.93 30.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 111.862 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.86 119.04 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.082 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -133.88 161.95 33.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.03 0.443 . . . . 0.0 111.852 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.8 mm -111.93 150.65 14.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.474 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -127.43 157.86 38.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.038 0.447 . . . . 0.0 111.783 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.04 116.25 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.891 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -179.827 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.821 0.343 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.53 122.69 7.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 mm -55.56 144.39 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.217 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.0 mt -109.44 143.41 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.156 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -146.98 141.76 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.09 159.35 43.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.16 28.48 4.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.977 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.18 -44.09 2.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.495 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . . . -67.34 171.73 4.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.931 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' B' ' 11' ' ' ALA . 30.7 Cg_endo -63.81 -12.71 33.03 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.544 2.162 . . . . 0.0 112.612 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.82 147.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.378 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.404 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -106.14 123.19 47.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 17.6 mm -131.92 17.01 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.834 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.25 -128.06 3.19 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.441 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.99 24.59 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.769 2.312 . . . . 0.0 113.494 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -152.08 174.48 13.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.038 0.447 . . . . 0.0 111.758 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 103' ' ' ASN . 15.8 m -123.14 173.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -40.37 86.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.016 0.436 . . . . 0.0 110.505 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 174.86 175.35 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.854 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.32 134.84 35.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.37 108.87 15.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.31 -16.86 41.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.095 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.01 -105.75 0.86 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -53.84 -30.16 44.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.076 0.465 . . . . 0.0 110.288 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.86 132.87 52.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.812 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.434 ' CG1' ' CB ' ' B' ' 127' ' ' ALA . 0.1 OUTLIER -131.37 151.97 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.66 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.2 139.98 29.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.812 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.3 p -106.09 141.36 37.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 79.1 p -69.3 156.1 39.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.087 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.97 94.05 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.521 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -78.15 156.2 30.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 7.0 pt -136.06 146.64 57.4 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.447 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 53.5 Cg_endo -69.31 61.49 1.49 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.868 2.379 . . . . 0.0 112.733 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.105 0.478 . . . . 0.0 110.612 179.435 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 11.3 p . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.507 0.194 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.61 140.46 51.85 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.294 1.996 . . . . 0.0 112.077 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.2 -30.9 60.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 111.046 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.98 95.59 0.39 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.732 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 tp -45.06 -30.48 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.305 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.85 -38.68 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.452 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.88 -54.09 49.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.313 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -62.66 -29.55 70.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.072 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.07 -34.94 71.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.802 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -80.83 -41.23 23.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.786 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -40.53 96.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.689 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 13.0 p -64.24 -30.0 71.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.759 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.432 HD22 ' CD2' ' B' ' 92' ' ' TYR . 8.8 mt -82.05 -18.76 42.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.51 -49.1 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.409 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -62.66 -33.27 74.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.289 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.07 -40.87 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.967 0.413 . . . . 0.0 110.535 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -73.11 -33.31 65.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.573 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.43 91.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.71 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -68.61 -41.75 83.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.698 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 13.0 mt -67.36 -38.86 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.81 -37.45 67.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.281 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.53 -20.13 66.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.563 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.01 -25.1 18.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.971 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.14 47.87 0.8 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.417 ' CD1' HG11 ' B' ' 28' ' ' VAL . 26.4 mt -149.06 136.2 19.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.365 . . . . 0.0 110.813 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -88.05 163.27 16.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.151 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' B' ' 72' ' ' ILE . . . -54.73 -30.29 55.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.069 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.548 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -67.84 -22.12 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.285 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.21 -30.75 68.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 110.228 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 4.0 mp -67.23 108.58 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.705 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.402 ' CG1' HG21 ' B' ' 128' ' ' VAL . 6.5 m -78.94 -31.96 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.834 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -131.91 156.6 45.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.735 0.302 . . . . 0.0 110.96 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -146.81 117.4 7.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.309 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 86.7 m -105.38 144.88 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.235 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 38.8 t -151.5 121.22 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.946 0.403 . . . . 0.0 111.735 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.421 ' CD2' HG13 ' A' ' 110' ' ' VAL . 6.5 m-85 -95.84 118.84 33.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.25 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 13.5 m -110.52 152.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 0.0 111.78 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -6.58 31.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.715 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -149.66 94.25 2.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.347 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mt -63.57 -13.97 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.31 -27.9 53.1 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.79 -17.55 25.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.519 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' B' ' 89' ' ' ASN . 22.2 t80 -57.96 -24.43 57.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.222 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.03 -41.96 36.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.799 0.333 . . . . 0.0 111.354 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.17 -33.52 20.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . 0.45 ' O ' ' CD1' ' B' ' 92' ' ' TYR . 28.4 t -65.84 -54.59 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 17.1 t-20 -56.62 -43.91 80.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.998 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.96 70.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.729 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -34.9 77.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' B' ' 88' ' ' VAL . 52.9 m-85 -67.38 -45.92 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.147 0.499 . . . . 0.0 110.119 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -25.41 66.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.403 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -76.96 -38.25 53.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.228 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.1 OUTLIER -82.56 -37.99 24.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.812 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' B' ' 92' ' ' TYR . 7.5 m-85 -53.32 -52.03 60.46 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.185 0.517 . . . . 0.0 110.265 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -30.27 70.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.337 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.58 3.19 53.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.488 ' O ' ' ND2' ' B' ' 100' ' ' ASN . 0.6 OUTLIER -116.39 -6.17 11.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.871 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 99' ' ' ASN . 0.0 OUTLIER 89.08 25.82 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.326 0.584 . . . . 0.0 110.495 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.548 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 12.8 t-160 -118.63 54.52 2.18 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.492 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CZ ' ' B' ' 104' ' ' PHE . 58.1 Cg_endo -70.65 -18.65 32.68 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.687 2.258 . . . . 0.0 112.862 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.42 ' O ' ' CG1' ' C' ' 19' ' ' VAL . 1.9 m-20 -57.77 -39.24 76.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.773 0.32 . . . . 0.0 110.819 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.408 ' CZ ' ' O ' ' B' ' 102' ' ' PRO . 8.1 m-85 81.02 123.27 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.494 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.455 ' HD3' ' CE1' ' B' ' 101' ' ' HIS . 97.1 Cg_endo -86.72 162.37 9.22 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.746 2.297 . . . . 0.0 112.648 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.37 140.71 44.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.553 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.403 ' HB2' ' HB3' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -102.07 138.45 39.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.08 0.467 . . . . 0.0 111.503 -179.409 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 12.0 t -148.2 55.16 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.009 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 5.1 m -102.99 151.37 22.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.187 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . 0.412 HG13 ' CD2' ' C' ' 78' ' ' PHE . 29.5 m -156.89 160.75 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.102 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -87.14 94.3 9.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.94 171.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.253 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.34 -50.14 8.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.02 171.39 14.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.742 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.57 160.01 52.44 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.812 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.78 135.89 42.6 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.558 2.172 . . . . 0.0 112.137 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.31 15.98 8.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.064 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 62.82 16.54 9.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.021 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 15.6 m -53.13 170.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.832 0.349 . . . . 0.0 111.177 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -101.98 -3.1 51.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.988 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 pp -175.76 148.37 0.87 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 111.255 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.86 163.69 17.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.326 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 15.7 mm -139.77 129.89 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 111.881 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.87 118.99 5.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.074 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -133.84 161.91 33.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.979 0.419 . . . . 0.0 111.884 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.8 mm -111.86 150.6 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.515 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -127.4 157.85 38.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 111.764 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.402 HG21 ' CG1' ' B' ' 73' ' ' VAL . 34.1 m -130.0 116.24 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.837 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.999 -179.829 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.79 0.329 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.6 122.73 7.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 39.1 mm -55.65 144.42 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.176 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mt -109.52 143.46 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -146.99 141.73 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.0 159.39 43.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.15 28.5 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.33 -44.18 2.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.712 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.498 ' CB ' ' HD2' ' C' ' 12' ' ' PRO . . . -67.26 171.74 4.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.036 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' C' ' 11' ' ' ALA . 30.7 Cg_endo -63.8 -12.74 33.12 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.567 2.178 . . . . 0.0 112.615 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.88 147.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.322 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -106.14 123.22 47.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.053 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 17.6 mm -131.94 17.03 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.857 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.24 -128.05 3.19 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.399 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -90.1 24.63 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.769 2.313 . . . . 0.0 113.444 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' B' ' 107' ' ' ARG . 0.7 OUTLIER -152.06 174.52 13.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.093 0.473 . . . . 0.0 111.727 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' B' ' 103' ' ' ASN . 15.8 m -123.12 173.28 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.802 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -39.94 85.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 110.374 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 174.75 175.44 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.852 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.33 134.79 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.32 108.9 15.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.27 -16.9 41.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.96 -105.74 0.86 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.0 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -53.88 -30.13 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.082 0.468 . . . . 0.0 110.253 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.94 132.8 52.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.858 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.438 ' CG1' ' CB ' ' C' ' 127' ' ' ALA . 0.1 OUTLIER -131.29 152.06 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.656 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.22 139.95 28.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.838 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 25.5 p -106.15 141.46 37.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.773 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 79.6 p -69.17 155.82 39.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.97 94.08 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.481 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -78.17 156.07 30.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 7.0 pt -135.94 146.69 57.87 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.001 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.454 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 53.1 Cg_endo -69.37 61.51 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.821 2.347 . . . . 0.0 112.756 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 0.0 110.602 179.403 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 11.3 p . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.504 0.193 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.55 140.42 52.02 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.315 2.01 . . . . 0.0 112.077 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.14 -30.98 60.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.019 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.95 95.6 0.38 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.698 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 tp -45.02 -30.52 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.29 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.86 -38.62 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.496 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.96 -53.93 51.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.292 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -62.97 -29.53 70.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.052 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.34 -35.06 71.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.959 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -80.81 -41.19 23.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.754 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -40.47 96.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.662 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' C' ' 57' ' ' ASN . 13.3 p -64.27 -30.06 71.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' C' ' 92' ' ' TYR . 8.8 mt -81.98 -18.81 42.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.53 -49.02 9.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.424 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' C' ' 54' ' ' SER . 24.4 p30 -62.75 -33.24 74.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.263 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 91.6 t -73.1 -40.88 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.381 . . . . 0.0 110.54 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -73.05 -33.28 65.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.639 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.55 92.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.775 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -68.63 -41.78 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.742 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 12.9 mt -67.41 -38.8 81.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.734 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.86 -37.39 67.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.275 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.52 -20.21 66.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.589 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.18 19.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.2 47.91 0.79 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.41 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.409 ' CD1' HG11 ' C' ' 28' ' ' VAL . 26.3 mt -149.08 136.15 19.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 110.846 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -88.02 163.23 16.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.157 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' C' ' 72' ' ' ILE . . . -54.7 -30.2 55.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.137 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.561 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -67.8 -22.14 65.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.244 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.13 -30.77 69.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.985 0.422 . . . . 0.0 110.181 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 4.0 mp -67.25 108.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.684 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 6.5 m -79.04 -31.92 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.826 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -131.91 156.54 45.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -146.76 117.44 7.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.306 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 86.4 m -105.35 144.95 31.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.219 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 38.8 t -151.59 121.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.391 . . . . 0.0 111.714 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.412 ' CD2' HG13 ' B' ' 110' ' ' VAL . 6.4 m-85 -95.74 118.81 33.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.323 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 13.4 m -110.56 151.96 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.148 0.499 . . . . 0.0 111.737 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.12 -6.74 30.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.758 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.41 94.24 2.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.342 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.61 -14.01 47.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.247 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.34 -27.91 52.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.74 -17.57 25.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.526 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' C' ' 89' ' ' ASN . 22.3 t80 -58.02 -24.38 58.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.198 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.02 -41.94 36.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.841 0.353 . . . . 0.0 111.393 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.15 -33.59 20.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.766 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . 0.443 ' O ' ' CD1' ' C' ' 92' ' ' TYR . 29.4 t -65.88 -54.54 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.571 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . 0.419 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 17.1 t-20 -56.58 -43.96 80.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.976 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.06 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.795 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.63 -34.89 77.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' C' ' 88' ' ' VAL . 53.4 m-85 -67.35 -45.92 74.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.154 0.502 . . . . 0.0 110.112 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.83 -25.45 66.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.378 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -76.98 -38.24 53.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.235 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.1 OUTLIER -82.54 -37.96 24.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.819 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.426 ' CD2' ' O ' ' C' ' 92' ' ' TYR . 7.5 m-85 -53.35 -52.01 60.6 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.201 0.524 . . . . 0.0 110.247 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -30.3 70.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.298 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.6 3.1 53.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.666 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' C' ' 100' ' ' ASN . 0.6 OUTLIER -116.3 -6.23 11.81 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.889 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' C' ' 99' ' ' ASN . 0.0 OUTLIER 89.16 26.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.305 0.574 . . . . 0.0 110.516 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.561 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 12.9 t-160 -118.82 54.62 2.31 Favored Pre-proline 0 CA--C 1.529 0.154 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.529 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . 0.403 ' O ' ' CE1' ' C' ' 104' ' ' PHE . 58.4 Cg_endo -70.69 -18.69 32.47 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.726 2.284 . . . . 0.0 112.868 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . 0.409 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 1.9 m-20 -57.77 -39.2 76.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.76 0.314 . . . . 0.0 110.849 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.403 ' CE1' ' O ' ' C' ' 102' ' ' PRO . 8.1 m-85 81.05 123.26 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.463 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.447 ' HD3' ' CE1' ' C' ' 101' ' ' HIS . 98.1 Cg_endo -86.7 162.3 9.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.779 2.319 . . . . 0.0 112.713 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.35 140.81 44.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.565 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -102.15 138.37 39.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.057 0.456 . . . . 0.0 111.502 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 12.0 t -148.14 55.26 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.058 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -103.09 151.35 22.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.17 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . 0.403 HG13 ' CD2' ' A' ' 78' ' ' PHE . 29.3 m -156.98 160.74 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.123 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -87.04 94.17 9.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.8 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.88 171.19 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.237 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.4 -49.99 8.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.029 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.14 171.35 15.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.51 160.02 52.6 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.833 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -50.92 135.9 43.63 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.477 2.118 . . . . 0.0 112.149 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.32 16.01 8.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.103 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 62.8 16.58 9.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.987 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.16 170.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.819 0.342 . . . . 0.0 111.163 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -101.88 -3.23 52.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.997 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 pp -175.72 148.29 0.87 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.219 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.87 163.65 17.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.278 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 15.6 mm -139.78 129.87 30.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.894 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.82 118.98 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.172 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -133.77 161.99 33.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 0.0 111.871 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 5.8 mm -111.97 150.65 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.471 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -127.42 157.89 38.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.043 0.449 . . . . 0.0 111.804 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.09 116.26 36.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.866 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -120.07 70.89 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.978 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.887 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.934 0.397 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.57 ' NE2' ' HB ' ' C' ' 73' ' ' VAL . 3.0 mm100 63.2 -165.74 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.258 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 1.2 mp 70.25 118.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.671 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 23' ' ' ASP . 22.3 mt -152.99 74.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.678 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -84.76 145.49 27.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.411 ' N ' ' OE1' ' A' ' 20' ' ' GLN . 1.7 t -149.83 153.46 36.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.71 35.83 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -121.13 -38.07 2.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.095 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.74 110.65 46.78 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.192 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.28 -16.41 46.56 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.516 2.144 . . . . 0.0 112.469 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.15 -167.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.221 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.49 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 64.87 -165.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.435 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mt 79.61 17.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.119 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.91 -134.64 4.22 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.223 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.64 28.59 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.724 2.283 . . . . 0.0 113.098 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -162.3 177.28 9.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' C' ' 104' ' ' PHE . 33.6 m -106.07 162.3 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.22 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.42 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 3.6 mt-30 -55.65 -52.8 62.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.135 0.493 . . . . 0.0 110.442 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.44 -172.75 3.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.166 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' GLN . 27.6 m -145.51 130.36 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.025 0.44 . . . . 0.0 111.851 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 48.0 t0 -108.69 102.88 11.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.3 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -14.17 62.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 111.188 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.02 -93.08 0.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -61.26 -28.82 69.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.249 0.547 . . . . 0.0 109.593 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.97 140.49 47.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.417 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 ' CB ' ' A' ' 127' ' ' ALA . 2.8 m -105.05 -179.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.197 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.89 136.78 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -108.64 135.78 49.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.744 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.2 p -81.07 177.16 9.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.49 95.67 0.1 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.544 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.67 150.95 47.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.906 0.384 . . . . 0.0 111.053 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.06 121.91 20.96 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.869 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.4 Cg_exo -67.76 58.96 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.695 2.263 . . . . 0.0 113.094 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 121.322 0.582 . . . . 0.0 110.639 179.198 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 11.2 p . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.522 0.201 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.56 140.96 94.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.415 2.077 . . . . 0.0 112.251 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.8 -31.1 72.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 0.0 110.929 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.5 93.1 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.8 mm -42.49 -31.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.114 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.37 -42.52 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.788 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.98 -44.72 84.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.551 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.78 67.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.449 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.28 -40.84 67.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.86 -32.59 57.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.36 -41.14 76.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -64.27 -38.91 92.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.76 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.32 -41.18 77.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.34 -44.06 92.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -60.77 -37.26 81.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.8 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.0 -45.97 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.426 ' HE2' ' CD1' ' A' ' 95' ' ' PHE . 7.5 mttt -71.97 -32.62 67.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.782 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.51 87.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.04 -40.76 78.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.873 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 mt -70.5 -34.6 58.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.421 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -69.99 -42.61 72.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.402 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -15.73 63.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.595 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.99 -33.64 18.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.942 0.401 . . . . 0.0 110.627 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.24 41.42 0.36 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.793 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.9 mt -150.25 -177.55 6.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.733 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.08 164.88 28.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.799 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.75 -35.02 55.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.491 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -60.86 -22.35 64.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.216 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.03 -18.49 46.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.767 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.401 ' O ' ' CE1' ' A' ' 101' ' ' HIS . 28.2 mm -58.44 123.61 10.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.543 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 34.8 m -92.63 -27.4 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.382 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 36.8 tttm -150.49 164.69 35.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -156.4 113.27 3.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.777 0.322 . . . . 0.0 111.526 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -100.02 152.41 20.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.303 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.74 127.36 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.821 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CE2' ' OE1' ' A' ' 124' ' ' GLU . 10.6 m-85 -105.39 115.54 30.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.328 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.414 HG11 ' CD2' ' A' ' 85' ' ' PHE . 4.8 m -105.49 148.57 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.638 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.76 -4.52 56.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.051 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -164.59 134.23 3.8 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.549 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -8.89 56.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.274 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.35 -24.23 23.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.791 0.329 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -75.44 -22.3 57.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.084 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 109' ' ' CYS . 0.2 OUTLIER -61.68 -18.2 58.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.448 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.13 -41.12 68.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.852 0.358 . . . . 0.0 111.271 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -27.8 22.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.983 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.3 t -73.71 -47.07 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.25 -40.08 95.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.407 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.16 84.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.947 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -87.89 -28.25 21.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.554 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.406 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 81.0 t80 -53.39 -44.74 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.945 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -86.9 -25.26 24.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -21.36 60.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.473 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.446 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -91.13 -33.62 15.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.863 0.363 . . . . 0.0 110.613 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.457 ' CZ ' ' CG ' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -56.45 -58.01 9.85 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.316 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -64.58 -30.74 71.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.006 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -78.16 -9.23 59.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.233 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 3.5 m120 -109.82 -5.01 15.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.393 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 21.9 m-80 84.5 38.58 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.759 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.491 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 17.2 t-160 -130.69 68.86 82.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.337 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.35 -17.46 7.67 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.971 2.447 . . . . 0.0 112.824 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.532 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -59.27 -36.78 76.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.878 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 27.9 m-85 78.76 114.77 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.395 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' CG ' ' CZ ' ' A' ' 96' ' ' PHE . 62.3 Cg_endo -87.2 163.12 8.53 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.164 2.576 . . . . 0.0 112.147 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.46 175.6 0.23 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -173.0 163.48 4.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.331 0.586 . . . . 0.0 112.049 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.89 83.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.032 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.436 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 14.1 p -89.4 123.63 33.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.6 m -142.89 148.68 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.297 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.69 97.34 7.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.824 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.46 160.43 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.152 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.61 -45.65 68.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.023 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -156.89 176.98 12.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.8 mt -145.27 160.65 44.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.811 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -51.04 135.75 44.46 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.545 2.163 . . . . 0.0 112.218 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.3 14.45 5.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.226 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.24 14.24 9.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.212 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.57 171.22 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.865 0.364 . . . . 0.0 111.162 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.21 21.96 16.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.37 156.91 1.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.12 0.486 . . . . 0.0 111.213 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -149.89 156.34 41.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mm -133.41 136.73 54.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.153 0.502 . . . . 0.0 112.109 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 6.6 pt-20 -155.48 106.6 2.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.298 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 74' ' ' LYS . . . -129.05 175.28 8.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.258 0.552 . . . . 0.0 112.374 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.71 157.81 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.1 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.412 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -148.8 149.11 30.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.97 0.414 . . . . 0.0 111.459 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 m -96.96 156.43 3.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.077 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 -179.951 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 11.1 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.917 0.389 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.543 ' NE2' ' HB ' ' A' ' 73' ' ' VAL . 2.9 mm100 63.27 -165.77 0.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.258 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' B' ' 5' ' ' ILE . 1.2 mp 70.29 118.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.644 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.409 HD13 ' HB2' ' B' ' 23' ' ' ASP . 22.3 mt -153.02 74.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.648 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -84.67 145.48 27.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.7 t -149.85 153.4 36.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.65 35.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -121.18 -38.05 2.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.73 110.71 47.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.193 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.27 -16.5 47.06 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.511 2.14 . . . . 0.0 112.447 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.08 -167.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.262 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.486 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 64.89 -165.09 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.369 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mt 79.65 17.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.102 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.91 -134.59 4.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.201 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -87.7 28.6 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.712 2.275 . . . . 0.0 113.089 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -162.28 177.37 9.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 111.201 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 104' ' ' PHE . 33.7 m -106.11 162.33 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.18 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . 0.428 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 3.6 mt-30 -55.55 -52.65 63.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.221 0.534 . . . . 0.0 110.453 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.65 -172.72 3.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.189 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' B' ' 4' ' ' GLN . 27.7 m -145.53 130.41 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.059 0.457 . . . . 0.0 111.745 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.459 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 47.9 t0 -108.76 102.84 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.278 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -14.12 62.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.17 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.01 -93.05 0.59 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -61.27 -28.82 69.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 140.45 47.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.426 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.401 HG21 ' CB ' ' B' ' 127' ' ' ALA . 2.8 m -105.08 -179.25 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.183 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.82 136.78 3.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 66.7 p -108.68 135.64 49.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 42.8 p -80.88 177.25 9.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.48 95.62 0.1 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.537 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.65 150.94 47.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.908 0.385 . . . . 0.0 111.086 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.12 121.97 20.94 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.823 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.81 58.93 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.719 2.28 . . . . 0.0 113.037 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 121.281 0.562 . . . . 0.0 110.576 179.216 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 11.2 p . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.525 0.202 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.68 141.07 95.37 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.364 2.043 . . . . 0.0 112.188 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.79 -31.21 72.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.43 93.09 1.92 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mm -42.48 -31.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.125 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.47 -42.5 21.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.723 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.72 84.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.565 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.71 67.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.526 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.88 67.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.82 -32.64 57.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.32 -41.17 77.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.748 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -64.23 -38.9 92.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.788 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.33 -41.2 76.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.36 -43.99 92.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -60.79 -37.29 81.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.758 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 26.5 t -63.04 -46.01 97.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.406 ' HE2' ' CD1' ' B' ' 95' ' ' PHE . 7.4 mttt -71.92 -32.64 67.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.808 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.42 -39.53 87.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.18 -40.77 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.839 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 mt -70.54 -34.59 58.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.391 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -69.98 -42.68 72.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.362 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -15.82 63.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.677 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.96 -33.62 18.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.632 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.28 41.39 0.36 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.812 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 64.2 mt -150.32 -177.57 6.02 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.004 0.43 . . . . 0.0 110.714 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.04 164.89 28.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.8 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.74 -35.11 55.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.941 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.494 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -60.79 -22.24 63.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.208 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.09 -18.43 46.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.787 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.403 ' O ' ' CE1' ' B' ' 101' ' ' HIS . 28.2 mm -58.53 123.65 10.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.564 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 34.9 m -92.69 -27.37 4.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.368 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' B' ' 125' ' ' ALA . 36.7 tttm -150.45 164.73 35.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' B' ' 107' ' ' ARG . 0.2 OUTLIER -156.48 113.23 3.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.727 0.299 . . . . 0.0 111.481 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -99.97 152.44 20.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.77 127.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.984 0.421 . . . . 0.0 111.801 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.403 ' CE2' ' OE1' ' B' ' 124' ' ' GLU . 10.5 m-85 -105.39 115.54 30.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.279 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.403 HG11 ' CD2' ' B' ' 85' ' ' PHE . 4.9 m -105.51 148.52 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.634 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.7 -4.63 56.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.978 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -164.65 134.18 3.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.609 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.87 -8.89 56.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.248 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.29 -24.28 23.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.804 0.335 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -75.42 -22.25 57.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' B' ' 109' ' ' CYS . 0.3 OUTLIER -61.7 -18.2 58.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.406 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.21 -41.09 68.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.804 0.335 . . . . 0.0 111.27 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -27.84 22.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' B' ' 92' ' ' TYR . 27.5 t -73.67 -47.11 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.941 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.15 -40.18 95.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.426 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.97 -40.21 84.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.945 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.09 -28.18 21.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.538 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 81.3 t80 -53.4 -44.79 68.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.9 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -86.9 -25.17 24.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.052 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -21.37 60.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.455 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.459 ' C ' ' CD1' ' B' ' 95' ' ' PHE . 1.0 OUTLIER -91.1 -33.69 15.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 110.623 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.444 ' CZ ' ' CG ' ' B' ' 105' ' ' PRO . 0.8 OUTLIER -56.39 -58.09 9.51 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.317 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -64.5 -30.72 71.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.051 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -78.17 -9.31 59.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.209 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' B' ' 100' ' ' ASN . 3.5 m120 -109.83 -4.97 15.7 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.389 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 21.9 m-80 84.53 38.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.812 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.494 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 17.2 t-160 -130.68 68.92 82.17 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.343 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.33 -17.48 7.69 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.006 2.471 . . . . 0.0 112.857 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 0.1 OUTLIER -59.25 -36.84 76.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 0.0 110.867 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 28.0 m-85 78.75 114.73 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.475 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' B' ' 101' ' ' HIS . 62.4 Cg_endo -87.22 163.04 8.51 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.167 2.578 . . . . 0.0 112.108 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.38 175.59 0.23 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' B' ' 75' ' ' THR . 0.9 OUTLIER -173.02 163.55 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.317 0.58 . . . . 0.0 112.078 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.94 83.87 1.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.089 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . 0.418 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 14.5 p -89.38 123.68 33.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.081 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 35.6 m -143.12 149.19 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.379 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.85 97.15 7.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.644 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.35 160.34 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.6 -45.58 68.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.026 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -156.94 176.92 12.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 12.7 mt -145.24 160.64 45.03 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.86 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -51.07 135.76 44.68 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.511 2.141 . . . . 0.0 112.249 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.23 14.51 5.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.223 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.26 14.24 9.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.145 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.56 171.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.879 0.371 . . . . 0.0 111.13 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.05 22.08 16.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.568 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.26 156.78 1.67 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.107 0.48 . . . . 0.0 111.151 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -149.84 156.39 41.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.104 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 22.7 mm -133.4 136.69 54.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.194 0.521 . . . . 0.0 112.091 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . 0.403 ' OE1' ' CE2' ' B' ' 78' ' ' PHE . 6.6 pt-20 -155.5 106.55 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.329 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' B' ' 74' ' ' LYS . . . -128.99 175.31 8.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.307 0.575 . . . . 0.0 112.37 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.68 157.89 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.134 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' B' ' 28' ' ' VAL . . . -148.97 149.08 30.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.0 0.429 . . . . 0.0 111.424 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 m -96.96 156.4 3.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.049 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 11.1 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.9 0.381 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . 0.564 ' NE2' ' HB ' ' B' ' 73' ' ' VAL . 3.0 mm100 63.24 -165.76 0.23 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.292 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' C' ' 4' ' ' GLN . 1.2 mp 70.26 118.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.613 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.417 HD13 ' HB2' ' C' ' 23' ' ' ASP . 22.3 mt -153.05 74.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.674 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -84.67 145.56 27.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.216 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.42 ' N ' ' OE1' ' C' ' 20' ' ' GLN . 1.7 t -149.91 153.38 36.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.69 35.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -121.09 -38.06 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.87 110.79 47.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.147 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.33 -16.39 46.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.506 2.137 . . . . 0.0 112.444 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.15 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.243 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.488 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 64.78 -165.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.38 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mt 79.72 17.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.034 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.89 -134.6 4.22 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.3 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -87.64 28.61 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.784 2.323 . . . . 0.0 113.14 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.488 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -162.35 177.35 9.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 111.23 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' B' ' 104' ' ' PHE . 33.7 m -106.08 162.35 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . 0.425 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 3.6 mt-30 -55.66 -52.92 62.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.144 0.497 . . . . 0.0 110.516 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.14 -172.77 4.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.152 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' C' ' 4' ' ' GLN . 27.6 m -145.53 130.41 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.043 0.449 . . . . 0.0 111.855 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . 0.457 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 48.2 t0 -108.75 102.88 11.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.244 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.75 -14.14 62.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.214 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.08 -93.13 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -61.27 -28.79 69.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.232 0.539 . . . . 0.0 109.574 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 140.47 47.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.397 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.405 ' CG2' ' CB ' ' C' ' 127' ' ' ALA . 2.8 m -105.05 -179.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.246 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.8 136.86 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.824 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -108.85 136.27 48.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.842 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 41.9 p -81.07 177.26 9.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.57 95.67 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.66 151.02 47.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 111.061 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 0.6 OUTLIER -129.18 121.96 20.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.85 58.9 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.715 2.277 . . . . 0.0 113.068 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 0.0 110.593 179.239 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 11.2 p . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.531 0.205 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.57 141.01 95.14 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.376 2.051 . . . . 0.0 112.23 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.83 -31.17 72.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.034 0.445 . . . . 0.0 110.91 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.4 93.11 1.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.935 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mm -42.45 -31.76 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.157 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.47 -42.43 21.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.756 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -44.71 83.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.506 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -27.6 67.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.46 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.95 68.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.986 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.79 -32.63 57.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -41.12 77.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -64.23 -38.95 92.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.777 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 18.6 mt -69.33 -41.18 76.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.839 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.27 -44.09 92.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -60.8 -37.26 81.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.755 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -62.96 -46.08 97.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.835 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.425 ' HE2' ' CD1' ' C' ' 95' ' ' PHE . 7.4 mttt -71.92 -32.62 67.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.809 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.16 -39.58 86.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.29 -40.75 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.839 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 mt -70.52 -34.56 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.433 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -69.98 -42.69 72.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -15.77 63.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.653 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.0 -33.69 18.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.548 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.29 41.32 0.37 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.841 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 64.0 mt -150.27 -177.58 6.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.936 0.398 . . . . 0.0 110.723 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.07 164.85 28.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.795 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.69 -35.1 54.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.493 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -60.9 -22.4 64.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.186 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.0 -18.42 46.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.788 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.47 123.64 10.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.57 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 34.7 m -92.7 -27.33 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.397 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' C' ' 125' ' ' ALA . 36.7 tttm -150.47 164.76 35.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.304 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' C' ' 107' ' ' ARG . 0.2 OUTLIER -156.45 113.32 3.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.732 0.301 . . . . 0.0 111.479 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 94.2 m -99.97 152.44 20.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.261 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.78 127.31 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.982 0.42 . . . . 0.0 111.83 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.407 ' CE2' ' OE1' ' C' ' 124' ' ' GLU . 10.6 m-85 -105.32 115.56 30.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.3 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' C' ' 85' ' ' PHE . 4.8 m -105.55 148.61 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.591 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.62 -4.21 55.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.082 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -165.03 134.31 3.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.549 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -8.94 56.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.236 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.22 -24.28 23.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.79 0.329 . . . . 0.0 110.888 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -75.38 -22.35 57.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' C' ' 109' ' ' CYS . 0.2 OUTLIER -61.66 -18.2 58.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.416 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.18 -41.16 68.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.34 . . . . 0.0 111.229 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.5 -27.82 22.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.974 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 28.0 t -73.76 -47.03 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.18 -40.17 95.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.457 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.07 83.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.937 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.05 -28.18 21.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.571 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 81.2 t80 -53.38 -44.82 68.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.904 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.84 -25.2 24.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.076 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.34 -21.37 60.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.441 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.46 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 1.0 OUTLIER -91.14 -33.72 15.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 110.576 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.454 ' CZ ' ' CG ' ' C' ' 105' ' ' PRO . 0.7 OUTLIER -56.36 -58.07 9.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.126 0.488 . . . . 0.0 110.285 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -64.56 -30.77 71.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.994 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -78.19 -9.21 59.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.248 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' C' ' 100' ' ' ASN . 3.5 m120 -109.87 -4.98 15.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.439 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 22.1 m-80 84.48 38.55 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.77 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.493 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 17.2 t-160 -130.8 68.87 82.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.35 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.27 -17.51 7.75 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.974 2.449 . . . . 0.0 112.828 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . 0.554 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 0.1 OUTLIER -59.28 -36.81 76.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 110.828 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.554 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 27.9 m-85 78.73 114.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.469 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.454 ' CG ' ' CZ ' ' C' ' 96' ' ' PHE . 62.3 Cg_endo -87.18 163.13 8.55 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.181 2.587 . . . . 0.0 112.094 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.44 175.59 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' C' ' 75' ' ' THR . 0.9 OUTLIER -173.04 163.44 4.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.263 0.554 . . . . 0.0 112.074 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.81 83.91 1.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.061 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . 0.441 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 13.8 p -89.42 123.65 33.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 35.6 m -143.06 149.53 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.351 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.02 97.26 8.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.46 160.52 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.211 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.65 -45.67 67.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.061 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -156.89 176.99 12.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 mt -145.28 160.6 45.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -50.96 135.72 43.81 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.513 2.142 . . . . 0.0 112.289 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.21 14.57 5.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.238 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.2 14.2 9.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.184 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.5 171.18 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 111.206 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.99 22.12 16.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.538 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.16 156.88 1.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.098 0.475 . . . . 0.0 111.158 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -149.95 156.41 41.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.054 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mm -133.42 136.75 54.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.163 0.506 . . . . 0.0 112.093 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 6.6 pt-20 -155.51 106.66 2.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.346 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' C' ' 74' ' ' LYS . . . -129.11 175.31 8.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.292 0.567 . . . . 0.0 112.368 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.69 157.85 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.127 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.405 ' CB ' ' CG2' ' C' ' 28' ' ' VAL . . . -148.91 149.05 30.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.995 0.426 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 m -96.93 156.35 3.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.035 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 54.1 ttt-85 -151.36 51.62 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.82 0.343 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.58 114.65 15.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tp -53.34 132.64 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.312 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 mm -98.59 143.32 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -168.08 106.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.81 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.7 t -124.99 169.34 12.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.86 29.85 3.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.2 -40.68 2.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.438 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -72.38 177.37 1.82 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.173 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 22.0 Cg_exo -65.01 -10.92 27.38 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.865 2.377 . . . . 0.0 112.728 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.73 151.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.021 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -114.35 122.47 46.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.187 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.4 mm -123.1 17.13 5.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.8 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.33 -132.0 3.64 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.355 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -89.95 20.73 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.793 2.329 . . . . 0.0 113.355 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -140.54 178.58 7.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.951 0.405 . . . . 0.0 111.462 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.424 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 15.7 m -132.87 -179.26 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.861 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -48.9 79.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.72 -172.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.825 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -142.19 132.63 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -113.94 109.77 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.816 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 mt -81.05 -14.65 57.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.269 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.82 -100.09 0.71 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.53 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -57.62 -29.77 64.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.162 0.506 . . . . 0.0 109.775 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.05 141.85 50.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.512 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 p -125.49 144.66 34.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.18 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.435 ' CD2' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -118.1 146.98 43.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.79 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 p -124.16 155.22 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.83 167.2 12.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.93 94.62 0.15 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.342 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -58.83 150.06 24.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.363 . . . . 0.0 111.171 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 22.3 mm -133.42 134.91 24.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.49 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.0 Cg_exo -68.02 56.16 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.898 2.399 . . . . 0.0 112.803 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 121.332 0.587 . . . . 0.0 110.654 179.45 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' A' ' 119' ' ' VAL . 7.4 p . . . . . 0 CA--C 1.53 0.183 0 CA-C-O 120.512 0.196 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.04 140.27 50.12 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.315 2.01 . . . . 0.0 112.165 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.64 -30.99 69.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.46 94.95 3.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.799 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.7 tp -43.4 -31.88 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.601 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.62 -45.5 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.669 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.23 -48.13 79.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.569 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -61.41 -29.53 69.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.392 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.75 -39.61 61.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.927 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -62.42 -48.47 79.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.06 -34.63 78.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -31.15 71.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.726 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.415 HD13 ' CE2' ' A' ' 95' ' ' PHE . 75.6 mt -69.69 -49.84 49.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -40.83 84.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.83 -38.45 70.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.26 -25.86 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.88 -39.15 20.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.806 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.27 -39.68 79.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.91 -53.05 28.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.917 0.389 . . . . 0.0 110.729 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.66 -28.89 45.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.708 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.45 -42.54 53.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.53 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -16.07 63.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.45 -28.68 20.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.59 43.65 0.63 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.587 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -149.78 -167.15 2.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.0 110.837 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.17 154.86 38.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.66 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.512 ' CB ' ' CE1' ' A' ' 101' ' ' HIS . . . -58.12 -36.7 73.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.943 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 100' ' ' ASN . . . -50.1 -26.3 4.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.251 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.73 -23.63 33.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.414 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.442 HG13 ' HA ' ' A' ' 69' ' ' ALA . 88.5 mt -44.39 120.44 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.917 0.389 . . . . 0.0 111.415 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.3 m -90.31 -38.02 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.651 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.72 155.45 49.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.599 0.238 . . . . 0.0 110.974 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 125' ' ' ALA . 17.3 p -143.43 152.07 41.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.027 0.441 . . . . 0.0 111.51 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.422 HG21 ' CE1' ' A' ' 78' ' ' PHE . 5.2 m -133.74 142.32 47.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.064 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -143.02 105.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 111.811 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.427 ' CD2' HG13 ' C' ' 110' ' ' VAL . 7.8 m-85 -86.98 106.28 17.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.469 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.71 152.59 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.549 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.13 -2.61 46.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.844 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.36 113.51 3.7 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.585 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.1 mt -65.27 -13.57 58.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.056 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -81.94 -23.2 36.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.875 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.84 -23.72 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.403 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 2.0 t80 -56.26 -23.88 39.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.382 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.92 74.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.199 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.44 -38.71 17.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.29 -36.06 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.6 t30 -69.31 -43.1 74.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.82 74.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.026 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -86.08 -23.26 26.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.2 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 10.3 t80 -77.82 -27.55 50.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.565 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.1 -39.42 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -67.25 -23.13 65.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -90.85 -32.8 15.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.553 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 1.7 m-85 -60.15 -58.85 6.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.3 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -63.55 -28.17 69.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.159 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -77.79 -10.89 59.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.54 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 2.2 m-80 -111.15 -5.92 14.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.379 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.5 OUTLIER 94.52 37.32 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.871 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.512 ' CE1' ' CB ' ' A' ' 69' ' ' ALA . 1.8 m170 -117.9 51.98 1.33 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 65.1 Cg_endo -71.91 -21.67 24.25 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.453 2.102 . . . . 0.0 112.56 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.411 ' O ' HG12 ' B' ' 19' ' ' VAL . 7.6 t30 -53.34 -32.98 51.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.728 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.43 ' O ' HG12 ' B' ' 19' ' ' VAL . 15.6 m-85 60.98 83.67 0.21 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.131 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 17.1 Cg_endo -58.15 159.42 18.78 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.44 2.093 . . . . 0.0 112.018 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.19 169.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.783 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.4 146.42 51.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.018 0.437 . . . . 0.0 111.308 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 p -152.56 58.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.411 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 25.4 p -96.01 142.85 27.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.431 HG13 ' CD2' ' B' ' 78' ' ' PHE . 33.9 m -147.6 153.92 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.93 83.63 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.78 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.5 m -71.99 160.82 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.111 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.56 -53.57 27.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.243 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -151.25 -178.59 6.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.964 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 122' ' ' GLU . 2.1 mp -153.55 159.37 32.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.572 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 9.6 Cg_endo -52.16 140.19 51.45 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.578 2.185 . . . . 0.0 112.21 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 66.84 14.0 9.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.559 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.71 19.23 5.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.069 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.501 ' HA ' HG22 ' A' ' 43' ' ' VAL . 3.0 p -52.33 -49.36 42.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.31 -7.37 81.61 Favored Glycine 0 C--N 1.308 -0.978 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.293 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.428 ' O ' HG21 ' A' ' 119' ' ' VAL . 16.7 mt -140.37 146.75 38.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.237 0.542 . . . . 0.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 115' ' ' LEU . 26.1 tt0 -147.67 152.42 37.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.941 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 26.9 mt -138.07 127.41 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.192 0.52 . . . . 0.0 112.229 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.45 132.18 18.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.391 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 75' ' ' THR . . . -149.39 159.42 44.3 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.8 mm -105.24 153.57 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.893 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.2 152.57 50.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.013 0.435 . . . . 0.0 111.828 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.98 178.09 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.804 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.873 0.368 . . . . 0.0 111.039 -179.885 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.828 0.347 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.6 114.63 15.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tp -53.3 132.69 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.33 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 mm -98.57 143.34 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.402 ' CD2' ' OE1' ' B' ' 20' ' ' GLN . 1.1 m80 -168.15 106.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 3.8 t -124.97 169.3 12.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.009 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.85 29.89 3.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.34 -40.9 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.441 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -72.01 177.26 1.79 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.11 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 22.2 Cg_exo -65.01 -10.87 27.2 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.892 2.395 . . . . 0.0 112.677 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.66 151.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 111.083 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -114.27 122.43 46.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.202 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 26.5 mm -123.08 17.13 5.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.765 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.29 -131.98 3.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.422 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -89.93 20.66 1.0 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.809 2.339 . . . . 0.0 113.392 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -140.44 178.6 7.19 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.507 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 104' ' ' PHE . 15.6 m -132.92 -179.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.867 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . 0.402 ' OE1' ' CD2' ' B' ' 7' ' ' HIS . 0.1 OUTLIER -58.92 -48.7 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.953 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -178.07 -172.71 0.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 m -142.2 132.67 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.145 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -113.95 109.76 19.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 mt -81.07 -14.71 57.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.265 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.86 -100.05 0.7 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.548 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -57.61 -29.77 64.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.177 0.513 . . . . 0.0 109.81 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.0 141.88 50.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.537 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.4 HG12 ' CB ' ' B' ' 127' ' ' ALA . 4.7 p -125.57 144.68 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.145 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' B' ' 29' ' ' LEU . 0.0 OUTLIER -118.06 146.94 43.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.83 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 16.1 p -124.18 155.03 39.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.832 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.99 167.11 12.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.91 94.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.329 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -58.82 150.07 24.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.376 . . . . 0.0 111.153 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' B' ' 35' ' ' PRO . 22.2 mm -133.42 134.88 24.36 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.096 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.492 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.0 Cg_exo -68.03 56.2 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.836 2.358 . . . . 0.0 112.79 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 121.366 0.603 . . . . 0.0 110.623 179.442 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' B' ' 119' ' ' VAL . 7.4 p . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.391 0.139 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.12 140.29 50.91 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.249 1.966 . . . . 0.0 112.189 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.95 69.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.032 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.41 94.95 3.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.818 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 2.7 tp -43.39 -31.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.61 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.62 -45.51 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.04 79.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -61.56 -29.6 70.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.371 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.97 -39.6 61.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.999 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -62.37 -48.48 79.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.818 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.12 -34.58 78.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.708 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.09 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.733 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 75.6 mt -69.75 -49.81 49.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.83 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -40.86 84.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.85 -38.48 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.64 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -65.23 -25.88 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.66 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.86 -39.21 20.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.91 80.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 50.6 mt -68.67 -53.01 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.733 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.7 -28.82 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.47 -42.54 52.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.546 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -16.09 63.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.643 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.42 -28.64 20.77 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.706 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.58 43.67 0.63 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.523 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -149.83 -167.14 2.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 110.775 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 154.85 38.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.693 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.522 ' CB ' ' CE1' ' B' ' 101' ' ' HIS . . . -58.12 -36.66 73.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' B' ' 100' ' ' ASN . . . -50.18 -26.36 4.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.281 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -23.67 34.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.404 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.454 HG13 ' HA ' ' B' ' 69' ' ' ALA . 88.8 mt -44.44 120.36 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-O 120.923 0.392 . . . . 0.0 111.438 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.2 -38.02 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.66 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 155.47 48.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.625 0.25 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 17.3 p -143.38 152.1 41.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 111.543 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.43 HG21 ' CE1' ' B' ' 78' ' ' PHE . 5.2 m -133.8 142.32 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.026 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.4 t -143.0 105.82 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 111.838 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.431 ' CD2' HG13 ' A' ' 110' ' ' VAL . 7.7 m-85 -86.98 106.29 17.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.69 152.6 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.576 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.19 -2.51 46.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.808 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.62 113.54 3.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 6.1 mt -65.19 -13.5 58.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.095 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.96 -23.26 36.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.883 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.82 -23.67 39.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.192 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.408 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 2.0 t80 -56.3 -23.9 39.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.336 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.33 -36.91 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 0.0 111.209 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.48 -38.7 17.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.18 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.28 -36.07 65.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.408 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.6 t30 -69.34 -43.04 74.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.06 74.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.08 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . 0.527 ' HA ' ' HG2' ' B' ' 94' ' ' ARG . 0.1 OUTLIER -85.95 -23.3 26.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.482 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 10.3 t80 -77.8 -27.54 50.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.541 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.19 -39.41 12.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . 0.527 ' HG2' ' HA ' ' B' ' 91' ' ' GLU . 0.0 OUTLIER -67.35 -23.02 65.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -90.82 -32.85 15.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.835 0.35 . . . . 0.0 110.57 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 1.6 m-85 -60.12 -58.79 7.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.309 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -63.53 -28.24 69.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.162 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -77.78 -10.85 59.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 2.2 m-80 -111.22 -5.87 14.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.349 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 0.5 OUTLIER 94.5 37.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.873 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.522 ' CE1' ' CB ' ' B' ' 69' ' ' ALA . 1.8 m170 -117.92 52.02 1.34 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.706 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 64.2 Cg_endo -72.05 -21.58 23.9 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.449 2.099 . . . . 0.0 112.536 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.41 ' O ' HG12 ' C' ' 19' ' ' VAL . 7.6 t30 -53.34 -33.02 51.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.894 0.378 . . . . 0.0 110.723 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.415 ' O ' HG12 ' C' ' 19' ' ' VAL . 15.6 m-85 61.05 83.67 0.21 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.122 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 16.9 Cg_endo -58.12 159.42 18.65 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.463 2.109 . . . . 0.0 112.025 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.17 169.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.805 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.46 146.45 51.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.994 0.426 . . . . 0.0 111.286 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 1.7 p -152.61 58.43 0.81 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.42 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 25.3 p -96.04 142.78 27.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.129 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . 0.425 HG13 ' CD2' ' C' ' 78' ' ' PHE . 33.9 m -147.44 153.52 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.153 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.7 83.64 6.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 9.7 m -71.87 160.8 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.59 -53.54 27.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.235 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -151.28 -178.52 6.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.402 ' CD2' ' HB2' ' B' ' 122' ' ' GLU . 2.2 mp -153.57 159.29 32.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.577 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' B' ' 117' ' ' LYS . 9.5 Cg_endo -52.15 140.19 51.38 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.573 2.182 . . . . 0.0 112.195 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 0.0 OUTLIER 66.86 13.97 9.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.537 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.76 19.16 5.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.078 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . 0.501 ' HA ' HG22 ' B' ' 43' ' ' VAL . 3.1 p -52.28 -49.38 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 121.655 0.741 . . . . 0.0 111.194 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.23 -7.47 81.48 Favored Glycine 0 C--N 1.308 -1.012 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.338 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.421 ' O ' HG21 ' B' ' 119' ' ' VAL . 16.7 mt -140.12 146.7 39.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.213 0.53 . . . . 0.0 111.128 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . 0.402 ' HB2' ' CD2' ' B' ' 115' ' ' LEU . 26.1 tt0 -147.56 152.42 37.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.976 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 26.7 mt -138.1 127.39 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.258 0.552 . . . . 0.0 112.237 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.43 132.19 18.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.417 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.43 159.4 44.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 14.8 mm -105.28 153.43 6.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.889 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -137.09 152.63 50.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.012 0.434 . . . . 0.0 111.845 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.06 178.05 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.834 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 -179.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.819 0.342 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.57 114.64 15.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tp -53.3 132.71 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.3 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 12.4 mm -98.67 143.4 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -168.16 106.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.789 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 3.7 t -124.97 169.31 12.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.8 29.87 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.21 -40.76 2.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.434 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -72.21 177.24 1.84 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.213 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 22.2 Cg_exo -65.04 -10.89 27.33 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.947 2.432 . . . . 0.0 112.682 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.68 151.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.064 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -114.35 122.48 46.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.114 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -123.1 17.09 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.833 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.3 -131.92 3.63 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.36 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -90.03 20.77 0.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.759 2.306 . . . . 0.0 113.337 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -140.48 178.62 7.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.964 0.411 . . . . 0.0 111.516 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.421 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 15.7 m -132.92 -179.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.84 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -49.01 79.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.58 -172.78 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.825 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -142.24 132.64 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.161 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -113.97 109.83 19.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.81 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 mt -81.09 -14.72 57.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.231 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.88 -100.1 0.7 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.53 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -57.6 -29.79 64.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.194 0.521 . . . . 0.0 109.839 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.03 141.92 50.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.527 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' C' ' 127' ' ' ALA . 4.7 p -125.55 144.71 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.2 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.436 ' CD2' ' N ' ' C' ' 29' ' ' LEU . 0.0 OUTLIER -118.08 147.01 43.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 16.2 p -124.15 155.18 38.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.96 167.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.958 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.89 94.6 0.14 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.314 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -58.83 150.04 25.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 111.206 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -133.4 134.97 24.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.108 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.494 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.0 Cg_exo -68.09 56.2 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.874 2.383 . . . . 0.0 112.789 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 121.295 0.569 . . . . 0.0 110.595 179.467 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 7.4 p . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.478 0.18 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.98 140.26 49.6 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.297 1.998 . . . . 0.0 112.204 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.67 -31.0 69.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.009 0.433 . . . . 0.0 111.065 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.44 94.91 3.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 2.7 tp -43.38 -31.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.636 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 32.2 t -79.66 -45.51 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.646 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.09 79.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.587 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -61.53 -29.47 70.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.359 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.91 -39.61 61.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.964 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -62.38 -48.48 79.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.794 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.04 -34.62 78.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.17 -31.1 71.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.409 HD13 ' CE2' ' C' ' 95' ' ' PHE . 75.5 mt -69.72 -49.89 48.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -40.82 84.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.87 -38.51 70.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.671 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 38.9 t -65.15 -25.97 38.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.678 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.79 -39.22 20.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.755 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.26 -39.84 80.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . 0.401 HD13 HG22 ' C' ' 61' ' ' ILE . 50.3 mt -68.69 -53.07 29.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 50.9 mt -64.65 -28.87 45.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.731 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.49 -42.53 52.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.558 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -16.2 64.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.615 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.34 -28.74 20.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.929 0.395 . . . . 0.0 110.741 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.62 43.66 0.62 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.545 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -149.74 -167.13 2.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.939 0.4 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.16 154.91 38.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.71 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.522 ' CB ' ' CE1' ' C' ' 101' ' ' HIS . . . -58.16 -36.68 73.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.371 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' C' ' 100' ' ' ASN . . . -50.09 -26.35 4.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.285 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -23.75 34.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.381 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.443 HG13 ' HA ' ' C' ' 69' ' ' ALA . 88.8 mt -44.34 120.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.883 0.373 . . . . 0.0 111.416 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.17 -38.02 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.716 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 155.5 48.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 17.4 p -143.37 152.03 41.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.034 0.445 . . . . 0.0 111.579 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.429 HG21 ' CE1' ' C' ' 78' ' ' PHE . 5.3 m -133.72 142.31 47.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.007 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -143.03 105.88 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 111.787 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.429 ' CE1' HG21 ' C' ' 76' ' ' THR . 7.7 m-85 -86.96 106.21 17.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.544 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.66 152.59 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.624 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.08 -2.58 46.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.802 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -154.45 113.44 3.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.635 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 6.1 mt -65.2 -13.56 58.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.044 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.95 -23.17 36.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.88 -23.69 38.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.156 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.405 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 2.0 t80 -56.25 -23.92 39.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.384 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.85 74.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.214 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.46 -38.68 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.242 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.37 -36.04 65.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . 0.405 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.6 t30 -69.24 -43.22 74.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.12 -32.9 74.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.08 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . 0.552 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 0.1 OUTLIER -86.0 -23.2 26.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.156 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.484 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 10.3 t80 -77.94 -27.5 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.538 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.1 -39.52 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . 0.552 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 0.0 OUTLIER -67.25 -23.12 65.67 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.497 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -90.88 -32.75 15.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.784 0.326 . . . . 0.0 110.529 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.497 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 1.6 m-85 -60.2 -58.81 6.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.059 0.457 . . . . 0.0 110.259 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -63.53 -28.22 69.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.141 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -77.75 -10.9 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.566 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 2.2 m-80 -111.17 -5.85 14.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.397 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 0.5 OUTLIER 94.5 37.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.86 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.522 ' CE1' ' CB ' ' C' ' 69' ' ' ALA . 1.8 m170 -117.93 51.99 1.34 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.723 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 64.3 Cg_endo -72.0 -21.57 24.07 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.442 2.095 . . . . 0.0 112.574 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . 0.408 ' O ' HG12 ' A' ' 19' ' ' VAL . 7.6 t30 -53.36 -33.01 51.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.936 0.398 . . . . 0.0 110.718 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.422 ' O ' HG12 ' A' ' 19' ' ' VAL . 15.5 m-85 60.98 83.75 0.2 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.074 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 17.1 Cg_endo -58.17 159.46 18.72 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.45 2.1 . . . . 0.0 112.005 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.26 169.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.779 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.31 146.44 51.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.0 0.429 . . . . 0.0 111.341 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 1.7 p -152.59 58.5 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.457 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 25.4 p -96.05 142.85 27.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.093 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 78' ' ' PHE . 33.9 m -147.62 153.93 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.85 83.63 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 9.6 m -71.95 160.81 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.55 -53.57 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.22 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -151.25 -178.6 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.987 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . 0.404 ' CD2' ' HB2' ' C' ' 122' ' ' GLU . 2.1 mp -153.56 159.39 32.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . 0.437 ' O ' ' HB2' ' C' ' 117' ' ' LYS . 9.6 Cg_endo -52.18 140.17 51.75 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.598 2.199 . . . . 0.0 112.195 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 0.0 OUTLIER 66.89 13.99 9.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.515 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.72 19.21 5.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . 0.472 HG22 ' CG2' ' C' ' 43' ' ' VAL . 3.1 p -52.34 -49.34 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.658 0.742 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.3 -7.49 81.41 Favored Glycine 0 C--N 1.308 -0.984 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.333 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . 0.419 ' O ' HG21 ' C' ' 119' ' ' VAL . 16.7 mt -140.16 146.72 39.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.246 0.546 . . . . 0.0 111.134 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.404 ' HB2' ' CD2' ' C' ' 115' ' ' LEU . 26.1 tt0 -147.67 152.39 37.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.953 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 26.7 mt -138.05 127.47 33.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.229 0.538 . . . . 0.0 112.189 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.48 132.13 18.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.431 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.37 159.39 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.211 0.529 . . . . 0.0 112.412 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 14.7 mm -105.22 153.43 6.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.917 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -137.11 152.56 50.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.031 0.443 . . . . 0.0 111.79 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.99 178.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.842 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -167.74 59.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 111.035 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.916 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.798 0.332 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -157.82 118.17 3.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -58.25 138.3 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.081 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.9 mt -94.83 138.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.158 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -150.97 136.94 18.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.51 162.81 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.75 26.61 5.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -118.03 -40.57 2.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.64 119.65 72.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.171 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.05 -10.84 28.61 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.42 2.08 . . . . 0.0 112.596 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.45 172.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.928 0.394 . . . . 0.0 111.464 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.468 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 62.84 130.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.187 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.94 -36.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.504 0.669 . . . . 0.0 110.768 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.03 -145.11 11.19 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.368 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.69 57.97 5.78 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.731 2.287 . . . . 0.0 112.873 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -168.46 -177.3 3.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 111.08 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.8 -178.45 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.297 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -80.2 -50.94 9.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.982 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -156.95 179.8 8.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.268 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 m -139.57 147.3 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.082 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -123.23 94.32 4.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mt -69.96 -17.37 63.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.268 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.62 -105.42 0.95 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.146 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -52.6 -29.99 28.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.054 0.454 . . . . 0.0 110.525 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.24 134.16 35.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.773 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.405 HG23 ' CD1' ' A' ' 67' ' ' LEU . 3.0 m -113.07 172.32 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.218 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.67 165.71 27.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.3 p -130.13 135.98 48.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m -69.23 154.54 41.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.97 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.26 93.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.631 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -67.65 173.7 4.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.776 0.322 . . . . 0.0 111.009 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.6 pt -159.38 152.54 18.48 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.441 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.661 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 43.8 Cg_endo -68.09 74.8 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.05 2.5 . . . . 0.0 112.325 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--N 1.32 -0.698 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.587 179.36 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 7.1 p . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.507 0.194 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -55.58 140.62 83.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.296 1.998 . . . . 0.0 112.144 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.06 71.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.044 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.75 94.93 3.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.4 tp -44.5 -31.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.427 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -38.29 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.713 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.24 -39.97 78.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.497 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.44 -21.88 57.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.223 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.5 -41.5 27.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.161 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.24 -34.45 63.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.76 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.15 -31.59 64.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.529 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.41 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 68.7 p -67.31 -30.79 70.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.703 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.436 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 34.2 mt -79.39 -30.72 42.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.802 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.55 -55.91 20.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.985 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 9.3 p-10 -55.79 -44.99 78.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.25 -31.02 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -79.2 -38.42 35.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.766 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.27 81.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.06 -51.26 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.771 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.8 mt -63.21 -32.63 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.592 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.68 -40.71 63.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.241 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.52 -21.0 65.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.94 -25.66 20.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.812 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 47.91 0.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.482 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.405 ' CD1' HG23 ' A' ' 28' ' ' VAL . 7.2 mt -156.68 -171.62 3.74 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.724 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.6 p -142.82 -179.58 6.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.981 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -78.63 -24.89 45.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.58 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -59.81 -36.54 76.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.981 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.01 -26.51 63.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.072 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 88.3 mt -46.76 115.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.83 0.348 . . . . 0.0 110.933 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.26 -26.01 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.766 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -138.03 164.46 29.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.735 0.302 . . . . 0.0 110.899 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.9 m -163.63 126.58 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.045 0.45 . . . . 0.0 111.492 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.423 HG22 ' CE1' ' A' ' 78' ' ' PHE . 2.8 m -109.25 144.8 36.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.881 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.08 108.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 111.782 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 76' ' ' THR . 6.6 m-85 -91.47 107.11 18.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.278 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' A' ' 85' ' ' PHE . 30.0 m -102.21 149.95 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.201 0.524 . . . . 0.0 111.804 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.74 -6.18 49.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.818 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.44 111.99 3.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.54 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.28 -15.18 32.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.241 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -78.32 -19.45 53.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.758 0.313 . . . . 0.0 110.869 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -90.65 7.18 40.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.411 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.431 ' CD1' HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -82.18 -27.46 32.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 111.172 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -36.76 76.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.123 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.38 -36.6 29.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 t -75.6 -30.52 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 85' ' ' PHE . 9.9 m120 -67.19 -48.88 66.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.02 -39.18 90.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.177 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.89 -23.94 55.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.196 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -81.73 -33.29 31.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.401 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.65 -29.76 18.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.696 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -75.86 -21.59 57.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.663 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.503 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -92.01 -33.13 14.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 0.0 110.671 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.503 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 2.6 m-85 -58.98 -59.13 5.96 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.063 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -31.5 72.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.246 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.57 -11.5 60.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.419 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 4.9 m-20 -110.91 -6.53 14.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.336 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 8.1 t-20 90.11 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.548 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.469 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 1.6 m-70 -115.21 53.41 0.81 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.025 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.1 Cg_endo -74.63 -14.51 22.07 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.51 2.14 . . . . 0.0 112.55 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -51.68 -33.28 33.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.093 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 61.47 96.46 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.031 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 59.9 Cg_endo -73.33 159.09 47.53 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.443 2.095 . . . . 0.0 112.258 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.71 147.69 18.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.445 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.64 142.52 45.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.005 0.431 . . . . 0.0 111.442 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t -149.58 62.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.376 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.5 p -94.64 145.38 24.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.9 m -153.28 135.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.212 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.76 91.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.802 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.4 m -76.26 164.43 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.66 -44.8 14.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.54 158.62 34.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.734 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 0.9 OUTLIER -141.34 168.99 12.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.485 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 115' ' ' LEU . 74.4 Cg_exo -50.18 136.87 38.28 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.351 2.034 . . . . 0.0 112.362 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.13 14.31 9.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.359 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.53 20.11 5.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.021 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -53.12 149.75 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.244 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.52 -15.01 77.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.754 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.1 mt -152.3 148.65 27.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 110.848 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -129.8 146.71 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.21 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 123' ' ' ILE . 29.0 mm -120.1 150.27 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.035 0.445 . . . . 0.0 111.763 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.22 147.45 6.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.694 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -173.83 164.34 4.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.098 0.475 . . . . 0.0 112.129 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.6 mm -117.59 151.83 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.362 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -131.49 147.53 52.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.976 0.417 . . . . 0.0 111.739 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.6 152.01 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.055 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.78 179.958 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.778 0.323 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -157.81 118.18 3.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.009 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -58.22 138.26 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.83 138.11 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -150.94 136.92 18.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.52 162.77 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.72 26.67 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -118.11 -40.86 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.24 119.68 72.61 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.03 -10.88 28.71 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.424 2.083 . . . . 0.0 112.572 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.43 172.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.525 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 62.86 130.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.207 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.95 -36.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.509 0.671 . . . . 0.0 110.773 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.04 -145.18 11.29 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.313 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.64 58.01 5.82 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.715 2.276 . . . . 0.0 112.896 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.471 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -168.54 -177.29 3.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 111.067 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.77 -178.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.298 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -80.3 -51.05 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -156.59 179.75 8.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.272 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.56 147.32 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.076 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -123.24 94.39 4.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mt -70.02 -17.42 63.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.61 -105.32 0.95 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.12 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -52.66 -29.97 29.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.472 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.29 134.17 35.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.776 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' B' ' 67' ' ' LEU . 3.0 m -113.03 172.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.7 165.69 28.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.672 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 44.2 p -130.13 136.0 48.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 48.6 m -69.34 154.41 42.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' B' ' 123' ' ' ILE . . . -55.21 93.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.608 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -67.66 173.66 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.734 0.302 . . . . 0.0 111.004 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 pt -159.37 152.59 18.55 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.004 0.43 . . . . 0.0 111.467 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.645 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 44.0 Cg_endo -68.14 74.81 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.108 2.538 . . . . 0.0 112.338 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.55 179.432 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 7.1 p . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.496 0.189 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -55.63 140.64 84.07 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.331 2.021 . . . . 0.0 112.153 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.1 71.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.74 94.91 3.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 tp -44.43 -31.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.408 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.19 -38.27 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.733 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.28 -39.99 78.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.463 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.52 -21.83 57.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.239 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.6 -41.49 26.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.213 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.26 -34.47 63.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.15 -31.51 64.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.57 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' SER . . . . . 0.421 ' HA ' ' OD1' ' B' ' 57' ' ' ASN . 68.9 p -67.31 -30.82 70.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.402 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 34.4 mt -79.38 -30.7 42.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.6 -55.9 20.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . 0.421 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 9.3 p-10 -55.76 -45.03 78.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.27 -30.94 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.768 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -79.22 -38.47 35.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.16 81.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.02 -51.41 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.792 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 45.8 mt -63.19 -32.64 57.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.598 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.64 -40.69 63.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.266 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.56 -21.0 65.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.485 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.89 -25.68 20.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.1 47.96 0.54 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.461 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.419 ' CD1' HG23 ' B' ' 28' ' ' VAL . 7.2 mt -156.75 -171.65 3.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.764 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 76.8 p -142.82 -179.65 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -78.59 -24.93 45.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.577 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -59.79 -36.47 76.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.029 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.06 -26.51 63.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.055 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' B' ' 105' ' ' PRO . 88.3 mt -46.8 115.63 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.21 -25.95 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.762 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -138.11 164.42 29.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 91.7 m -163.58 126.63 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.048 0.451 . . . . 0.0 111.484 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.417 HG22 ' CE1' ' B' ' 78' ' ' PHE . 2.8 m -109.28 144.78 36.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.03 108.4 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.914 0.388 . . . . 0.0 111.828 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.417 ' CE1' HG22 ' B' ' 76' ' ' THR . 6.6 m-85 -91.46 107.16 19.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.24 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.42 HG12 ' CD1' ' B' ' 85' ' ' PHE . 30.2 m -102.22 149.97 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.158 0.504 . . . . 0.0 111.838 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.89 -6.14 49.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.747 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.45 111.96 3.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.516 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.15 -15.24 31.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.242 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -78.31 -19.52 53.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -90.62 7.26 40.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.448 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.42 ' CD1' HG12 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -82.25 -27.48 32.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.749 0.309 . . . . 0.0 111.114 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.19 -36.8 75.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.157 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.36 -36.63 29.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 28.8 t -75.63 -30.48 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' B' ' 85' ' ' PHE . 9.9 m120 -67.21 -48.93 66.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.94 -39.32 90.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.78 -23.98 55.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -81.78 -33.29 30.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.399 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.71 -29.68 18.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.657 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -75.88 -21.57 57.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.668 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.495 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -92.04 -33.13 14.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 110.671 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.495 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 2.6 m-85 -58.95 -59.11 5.99 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.09 0.472 . . . . 0.0 110.138 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -31.46 72.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.297 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.49 -11.6 60.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.436 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 4.9 m-20 -110.88 -6.44 14.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.336 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 8.1 t-20 90.11 35.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.619 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 1.6 m-70 -115.3 53.43 0.83 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.959 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.41 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 71.8 Cg_endo -74.56 -14.61 22.21 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.541 2.161 . . . . 0.0 112.577 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -51.59 -33.33 32.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.135 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 61.49 96.48 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.997 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.426 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 59.9 Cg_endo -73.34 159.05 47.56 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.404 2.069 . . . . 0.0 112.255 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.59 147.72 17.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.458 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.76 142.49 45.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.032 0.444 . . . . 0.0 111.471 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 31.2 t -149.52 62.87 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.352 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 18.8 p -94.62 145.41 24.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.233 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . 0.404 HG11 ' CD2' ' C' ' 78' ' ' PHE . 35.9 m -153.33 135.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.244 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' C' ' 114' ' ' ARG . 0.0 OUTLIER -64.78 91.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.77 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 m -76.35 164.45 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.236 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.6 -44.88 14.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.51 158.68 34.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.706 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.44 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.9 OUTLIER -141.4 168.95 12.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.495 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' B' ' 115' ' ' LEU . 74.5 Cg_exo -50.16 136.89 38.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.352 2.035 . . . . 0.0 112.325 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.11 14.28 9.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.398 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.56 20.07 5.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.041 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -53.1 149.77 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.198 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.56 -15.15 76.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.769 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 42.5 mt -152.21 148.63 27.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.959 0.409 . . . . 0.0 110.848 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -129.68 146.63 51.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.284 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.409 ' O ' ' HA2' ' B' ' 32' ' ' GLY . 29.3 mm -120.11 150.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 111.748 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.16 147.48 6.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.69 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -173.87 164.4 4.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 112.133 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.6 mm -117.74 151.85 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.334 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -131.45 147.54 52.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 111.781 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.62 151.93 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.086 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.79 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.793 0.33 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -157.87 118.22 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -58.19 138.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.092 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 31.6 mt -94.73 138.08 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.169 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -151.0 136.91 18.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.49 162.77 34.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.71 26.65 5.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -118.06 -40.69 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.791 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' C' ' 12' ' ' PRO . . . -85.5 119.67 72.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.124 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' C' ' 11' ' ' ALA . 17.8 Cg_exo -66.03 -10.88 28.73 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.496 2.131 . . . . 0.0 112.601 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.5 172.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.472 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.468 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 62.94 130.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.16 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.91 -36.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.495 0.664 . . . . 0.0 110.741 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.06 -145.12 11.23 Favored Glycine 0 C--N 1.315 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.364 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.68 57.95 5.78 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.702 2.268 . . . . 0.0 112.901 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -168.45 -177.37 3.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.086 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.73 -178.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.328 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -80.31 -51.2 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.05 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -156.41 179.68 9.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.282 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.5 147.37 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -123.25 94.36 4.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mt -69.99 -17.4 63.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.232 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.62 -105.37 0.95 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.178 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -52.53 -30.07 28.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.038 0.447 . . . . 0.0 110.517 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.21 134.14 35.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.824 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.407 HG23 ' CD1' ' C' ' 67' ' ' LEU . 3.0 m -113.0 172.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.256 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.68 165.65 28.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.69 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 44.1 p -130.14 135.96 48.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -69.43 154.44 42.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.032 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.26 93.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.647 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -67.58 173.7 4.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.742 0.306 . . . . 0.0 110.991 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 pt -159.37 152.52 18.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.484 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.651 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 43.7 Cg_endo -68.14 74.84 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.112 2.541 . . . . 0.0 112.304 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.589 179.389 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 7.2 p . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.487 0.184 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.67 140.65 84.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.304 2.002 . . . . 0.0 112.151 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.13 71.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.979 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.76 94.9 3.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.822 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 tp -44.43 -31.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.39 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.25 -38.21 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.723 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.25 -40.05 78.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.46 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.5 -21.95 57.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.241 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.69 -41.59 26.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.181 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.28 -34.36 63.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.786 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.16 -31.56 64.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.556 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.414 ' HA ' ' OD1' ' C' ' 57' ' ' ASN . 69.0 p -67.28 -30.87 70.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.696 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 34.4 mt -79.34 -30.71 42.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.53 -55.89 20.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.031 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . 0.414 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 9.3 p-10 -55.77 -45.06 78.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 45.1 t -59.19 -31.03 45.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -79.24 -38.5 35.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.701 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.9 80.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.32 -51.52 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.826 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 mt -63.18 -32.69 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.6 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.66 -40.66 63.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.28 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.58 -20.96 65.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.485 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.9 -25.67 20.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.858 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.11 47.91 0.54 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.453 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.407 ' CD1' HG23 ' C' ' 28' ' ' VAL . 7.2 mt -156.71 -171.64 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.712 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 77.7 p -142.77 -179.6 6.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.468 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -78.64 -24.95 44.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.52 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -59.82 -36.54 77.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.11 -26.34 62.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.062 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' C' ' 105' ' ' PRO . 88.4 mt -46.81 115.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.87 0.367 . . . . 0.0 110.953 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.2 -26.0 5.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.78 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -138.08 164.45 29.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.704 0.288 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -163.54 126.62 2.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.994 0.426 . . . . 0.0 111.502 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.41 HG22 ' CE1' ' C' ' 78' ' ' PHE . 2.8 m -109.34 144.79 37.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.845 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.01 108.39 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 111.844 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.41 ' CE1' HG22 ' C' ' 76' ' ' THR . 6.6 m-85 -91.44 107.11 18.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.332 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' C' ' 85' ' ' PHE . 29.9 m -102.14 149.94 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.137 0.494 . . . . 0.0 111.837 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.81 -6.36 49.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.858 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.13 111.91 3.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.488 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.22 -15.21 32.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.282 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -78.33 -19.51 53.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.767 0.318 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -90.64 7.26 40.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.372 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.431 ' CD1' HG12 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -82.32 -27.41 32.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 111.117 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.31 -36.67 76.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.162 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.41 -36.66 29.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.63 -30.47 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' C' ' 85' ' ' PHE . 9.9 m120 -67.16 -48.95 66.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.1 90.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.91 -23.91 55.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.248 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -81.71 -33.32 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.378 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.69 -29.72 18.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.651 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -75.88 -21.54 57.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.686 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -92.02 -33.18 14.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.795 0.331 . . . . 0.0 110.669 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 2.6 m-85 -59.03 -59.05 6.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.032 0.444 . . . . 0.0 110.124 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -31.5 72.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.279 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.53 -11.5 60.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.436 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 4.9 m-20 -110.93 -6.49 14.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.302 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 8.1 t-20 90.21 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.539 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' C' ' 69' ' ' ALA . 1.6 m-70 -115.37 53.38 0.84 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.0 Cg_endo -74.57 -14.61 22.2 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.514 2.143 . . . . 0.0 112.563 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -51.61 -33.27 32.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.125 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 61.5 96.45 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.016 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 60.2 Cg_endo -73.26 159.17 47.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.389 2.059 . . . . 0.0 112.293 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.77 147.64 18.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.65 142.47 45.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.034 0.445 . . . . 0.0 111.476 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 31.0 t -149.49 62.84 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.346 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 18.5 p -94.59 145.36 24.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.221 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 35.8 m -153.24 134.88 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.195 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 91.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.761 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 8.4 m -76.28 164.41 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.286 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.68 -44.81 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' B' ' 111' ' ' GLU . 0.1 OUTLIER -158.56 158.61 34.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.746 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . 0.438 ' HB3' ' HD2' ' C' ' 116' ' ' PRO . 0.9 OUTLIER -141.37 168.98 12.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.501 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' C' ' 115' ' ' LEU . 74.1 Cg_exo -50.19 136.88 38.37 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.37 2.047 . . . . 0.0 112.275 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.11 14.35 9.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.366 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.54 20.14 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.009 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -53.21 149.81 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.72 -15.13 76.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.794 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 41.9 mt -152.16 148.53 27.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -129.68 146.68 51.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.26 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 29.3 mm -120.18 150.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.064 0.459 . . . . 0.0 111.742 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.09 147.46 6.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.65 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -173.83 164.38 4.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.111 0.482 . . . . 0.0 112.119 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 5.6 mm -117.67 151.85 19.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.303 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.46 147.58 52.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 111.771 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.66 151.97 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.062 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' C' ' 67' ' ' LEU . 11.7 ttp180 -173.09 73.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.759 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.12 110.6 17.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 tp -54.99 129.66 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.192 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.1 mt -90.53 151.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.412 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.78 108.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.818 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.09 170.28 10.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.69 22.27 10.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.926 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.5 -37.96 6.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.638 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.407 ' CB ' ' CG1' ' A' ' 61' ' ' ILE . . . -100.46 127.87 31.73 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.058 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 7.8 Cg_exo -72.1 -1.67 10.41 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.668 2.246 . . . . 0.0 112.701 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.92 170.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.862 0.363 . . . . 0.0 111.586 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.27 119.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.115 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.4 HG22 HD12 ' A' ' 15' ' ' ILE . 13.5 mt -154.79 15.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.858 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.36 -114.64 0.5 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.974 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.434 ' HB2' ' CD1' ' C' ' 92' ' ' TYR . 92.8 Cg_endo -81.01 50.98 3.76 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.664 2.242 . . . . 0.0 112.981 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.472 ' CG ' ' HB2' ' C' ' 107' ' ' ARG . 1.7 p90 -178.7 156.84 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.0 111.002 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.435 HG11 ' O ' ' C' ' 103' ' ' ASN . 31.2 m -106.69 -174.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.174 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.68 -43.8 58.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.93 177.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.38 133.75 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -103.86 102.8 12.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.07 -17.88 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.16 -103.57 0.9 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.954 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.35 -29.11 63.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.086 0.47 . . . . 0.0 110.286 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.18 122.98 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.923 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.429 ' CG1' ' HB1' ' A' ' 127' ' ' ALA . 4.2 p -109.28 145.75 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.98 139.53 53.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.9 p -112.93 161.84 16.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.771 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.6 p -95.65 165.55 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.099 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.53 94.34 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.342 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.19 146.14 54.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.248 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 9.5 pt -134.46 142.08 41.44 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.794 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.51 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 7.8 Cg_exo -72.56 55.16 2.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.961 2.441 . . . . 0.0 113.138 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.418 ' HB ' ' CB ' ' A' ' 12' ' ' PRO . 20.5 t . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.241 0.544 . . . . 0.0 110.554 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 11.4 p . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 120.665 0.269 . . . . 0.0 111.379 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.53 140.44 54.62 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.477 2.118 . . . . 0.0 112.422 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.64 -32.05 70.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 92.69 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.615 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mm -40.12 -32.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.373 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.87 -56.46 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.08 -28.74 70.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.772 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.407 ' HG3' HG21 ' A' ' 43' ' ' VAL . 3.0 tt0 -80.59 -28.83 37.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.675 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.28 -34.8 42.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.538 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -28.79 52.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.179 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.25 -48.17 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 110.838 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.65 -35.74 75.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.759 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -64.3 -54.76 28.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.15 -31.44 68.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -67.96 -33.84 75.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.791 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.95 -49.44 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -29.67 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.988 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.42 95.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.407 ' CG1' ' CB ' ' A' ' 11' ' ' ALA . 5.3 mt -72.39 -42.57 64.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.536 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.1 mt -69.15 -30.85 47.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.822 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.11 -40.79 59.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.328 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.73 -19.49 65.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.602 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.54 -26.81 19.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.47 41.59 0.67 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.529 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -155.28 147.11 23.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 110.669 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -101.49 -179.65 4.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.747 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB1' ' CE1' ' A' ' 101' ' ' HIS . . . -78.8 -23.07 45.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -62.98 -33.52 75.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' OD1' ' HB2' ' A' ' 127' ' ' ALA . 10.7 p30 -75.47 -21.76 57.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.71 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 26.4 mm -52.44 121.02 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.86 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 m -89.55 -32.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.013 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.11 165.67 21.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.571 0.224 . . . . 0.0 110.937 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.1 p -162.47 105.91 1.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.831 0.348 . . . . 0.0 111.544 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.423 HG22 ' CE1' ' A' ' 78' ' ' PHE . 4.6 m -91.92 155.34 18.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.158 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.93 103.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.911 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 76' ' ' THR . 10.8 m-85 -89.7 99.73 12.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.358 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 m -98.41 147.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.588 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.21 -3.71 50.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.231 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -160.98 142.24 11.78 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.627 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 mt -82.91 1.55 38.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.26 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -98.67 -24.3 15.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.824 0.345 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.81 -27.01 60.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.01 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -59.31 -18.65 39.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.58 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.28 -57.78 10.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 111.382 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.93 71.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 t -70.73 -41.27 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.981 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.11 -47.36 80.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.726 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.49 75.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -92.31 -15.95 26.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.685 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.428 ' CD1' ' HB2' ' B' ' 17' ' ' PRO . 12.4 t80 -81.66 -38.33 26.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.729 0.299 . . . . 0.0 111.281 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.0 -28.71 22.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.346 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.21 -21.81 59.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.649 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.505 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -92.07 -34.39 14.4 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.983 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.505 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 3.1 m-85 -57.3 -57.79 11.1 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.091 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.28 -29.81 70.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.097 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.92 -10.17 59.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.49 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.709 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 1.7 t-20 -108.57 -8.83 15.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.311 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 4.3 t30 88.96 33.24 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.445 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.709 ' CE1' ' HB3' ' A' ' 99' ' ' ASN . 4.2 m170 -116.83 54.35 1.31 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.842 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.22 -11.59 21.08 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.618 2.212 . . . . 0.0 112.823 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.431 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -47.96 -37.55 14.78 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 63.96 83.89 0.19 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.387 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.76 156.16 63.23 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.611 2.207 . . . . 0.0 112.018 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.38 162.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.572 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.469 ' HB2' ' CG ' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -133.01 143.74 49.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.22 0.534 . . . . 0.0 111.734 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 t -143.64 65.23 1.32 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.802 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.91 140.26 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.275 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' B' ' 78' ' ' PHE . 35.7 m -149.94 132.48 6.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.018 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.73 86.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.923 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.57 161.22 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.115 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.17 -45.81 25.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.57 168.08 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mp -142.7 160.62 52.95 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.708 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.75 136.03 27.89 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.486 2.124 . . . . 0.0 112.228 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm 64.39 16.73 10.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.319 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.72 17.76 9.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.913 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.2 m -53.31 122.52 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.302 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.32 -21.45 26.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.909 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mp -152.77 147.67 26.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.278 0.561 . . . . 0.0 111.53 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -139.21 151.48 46.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.407 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.8 pt -150.29 139.28 15.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.4 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 1.1 pm0 -138.74 142.94 38.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.053 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.62 172.6 14.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.4 mt -125.68 153.96 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.064 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.505 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . . . -135.4 152.96 51.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.035 0.445 . . . . 0.0 111.797 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.98 164.15 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.999 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.894 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.13 110.63 17.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.946 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 tp -55.02 129.66 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.22 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 31.4 mt -90.43 151.53 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.413 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.81 108.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.06 170.32 10.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.981 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.73 22.24 10.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.55 -38.05 6.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.645 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -100.32 127.88 31.91 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.05 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 7.7 Cg_exo -72.11 -1.67 10.42 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.618 2.212 . . . . 0.0 112.751 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.88 170.17 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.867 0.365 . . . . 0.0 111.544 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.18 119.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.053 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 13.3 mt -154.73 15.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.908 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.33 -114.66 0.5 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.977 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . 0.428 ' HB2' ' CD1' ' A' ' 92' ' ' TYR . 92.5 Cg_endo -80.95 50.93 3.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.7 2.267 . . . . 0.0 112.992 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.469 ' CG ' ' HB2' ' A' ' 107' ' ' ARG . 1.7 p90 -178.69 156.81 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.9 0.381 . . . . 0.0 110.996 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 103' ' ' ASN . 30.8 m -106.69 -174.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.17 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.53 -43.54 59.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.06 177.46 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.37 133.78 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.146 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -103.93 102.84 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 11.9 mt -81.08 -17.93 48.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.2 -103.6 0.9 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.895 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.32 -29.1 63.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.088 0.471 . . . . 0.0 110.287 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.21 122.96 26.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.44 ' CG1' ' HB1' ' B' ' 127' ' ' ALA . 4.2 p -109.29 145.8 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.844 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.95 139.52 53.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.993 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 77.3 p -112.97 161.89 16.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.745 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 27.6 p -95.6 165.59 12.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.51 94.27 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.335 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.21 146.18 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' B' ' 35' ' ' PRO . 9.4 pt -134.5 142.06 41.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.815 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.501 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 7.9 Cg_exo -72.58 55.18 2.58 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.964 2.443 . . . . 0.0 113.146 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.419 ' HB ' ' CB ' ' B' ' 12' ' ' PRO . 20.5 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.585 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 11.5 p . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 120.649 0.261 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.65 140.45 55.82 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.46 2.107 . . . . 0.0 112.407 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.0 70.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.2 92.7 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.613 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 22.4 mm -40.16 -32.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.35 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.87 -56.43 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.749 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.05 -28.79 70.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.752 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.402 ' HG3' HG21 ' B' ' 43' ' ' VAL . 3.0 tt0 -80.4 -28.3 37.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.634 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.43 -34.86 41.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.535 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -28.84 52.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.169 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.24 -48.11 65.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.82 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -35.79 75.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.411 HD11 ' CE2' ' B' ' 95' ' ' PHE . 9.8 mt -64.24 -54.8 27.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.24 -31.31 68.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -68.04 -33.71 75.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.2 t -70.0 -49.39 56.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -29.7 65.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.937 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.49 95.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.822 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.41 ' CG1' ' CB ' ' B' ' 11' ' ' ALA . 5.3 mt -72.29 -42.51 65.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.532 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 21.1 mt -69.1 -30.92 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.815 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -75.16 -40.7 59.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.337 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.78 -19.51 65.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.56 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.49 -26.85 19.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.47 41.69 0.67 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.469 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -155.28 147.16 23.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 110.695 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -101.58 -179.73 4.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.719 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.554 ' HB1' ' CE1' ' B' ' 101' ' ' HIS . . . -78.75 -23.1 45.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 110.465 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.522 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -62.86 -33.55 75.52 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' B' ' 127' ' ' ALA . 10.6 p30 -75.35 -21.81 58.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.702 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 26.6 mm -52.54 121.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.79 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 m -89.61 -32.72 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.019 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.19 165.65 21.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.567 0.222 . . . . 0.0 110.916 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 6.1 p -162.43 105.9 1.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 111.523 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.423 HG22 ' CE1' ' B' ' 78' ' ' PHE . 4.6 m -91.89 155.4 18.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.219 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.97 103.15 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.834 0.349 . . . . 0.0 111.908 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' B' ' 76' ' ' THR . 10.9 m-85 -89.84 99.86 12.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.247 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 19.0 m -98.52 147.71 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.58 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.27 -3.7 50.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.222 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -161.03 142.26 11.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.646 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 mt -82.97 1.58 39.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.256 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -98.68 -24.21 15.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.85 -26.96 60.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -59.3 -18.73 40.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.586 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.23 -57.82 10.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.36 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.96 71.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.158 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.3 t -70.72 -41.29 77.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.99 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.16 -47.32 80.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.733 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.52 75.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -92.2 -15.98 26.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.667 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.433 ' CD1' ' HB2' ' C' ' 17' ' ' PRO . 12.5 t80 -81.65 -38.29 26.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.771 0.32 . . . . 0.0 111.314 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.02 -28.78 22.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.329 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.15 -21.81 59.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.695 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.489 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -92.07 -34.47 14.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.941 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.489 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 3.1 m-85 -57.31 -57.76 11.22 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.07 0.462 . . . . 0.0 110.092 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.29 -29.78 70.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.121 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.96 -10.16 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.476 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.712 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 1.7 t-20 -108.58 -8.79 15.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.34 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 4.3 t30 88.97 33.13 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.457 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 4.2 m170 -116.73 54.45 1.29 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.859 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.3 -11.62 20.95 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.68 2.253 . . . . 0.0 112.777 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.425 ' O ' HG11 ' C' ' 19' ' ' VAL . 0.1 OUTLIER -47.91 -37.59 14.56 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.941 0.4 . . . . 0.0 111.035 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 64.01 83.84 0.19 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.396 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.75 156.17 63.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.604 2.203 . . . . 0.0 112.022 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.36 162.55 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.519 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.463 ' HB2' ' CG ' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -133.07 143.71 49.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.178 0.513 . . . . 0.0 111.689 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.6 t -143.66 65.29 1.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.759 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.99 140.25 30.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.245 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . 0.408 HG12 ' CD2' ' C' ' 78' ' ' PHE . 35.8 m -150.01 132.54 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.984 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.71 86.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.84 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 6.8 m -72.43 161.2 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.18 -45.85 25.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.58 168.03 27.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mp -142.64 160.63 53.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.711 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.74 136.02 27.85 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.443 2.096 . . . . 0.0 112.259 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm 64.45 16.66 10.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.331 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.81 17.76 9.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.875 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -53.4 122.63 3.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.265 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.28 -21.71 27.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.894 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mp -152.6 147.58 26.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.268 0.556 . . . . 0.0 111.496 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -139.18 151.52 46.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.407 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 5.8 pt -150.29 139.23 15.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -138.73 142.98 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.041 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.61 172.62 14.74 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.69 154.04 34.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.008 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.502 ' HB2' ' OD1' ' B' ' 71' ' ' ASP . . . -135.39 153.03 51.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.016 0.436 . . . . 0.0 111.849 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.02 164.09 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.908 -179.949 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.828 0.347 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.1 110.64 17.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 tp -55.01 129.66 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 31.2 mt -90.51 151.59 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.4 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.81 108.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.801 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.11 170.27 10.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.69 22.32 10.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.83 -38.3 6.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' C' ' 12' ' ' PRO . . . -99.92 127.96 32.25 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.115 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' C' ' 11' ' ' ALA . 7.8 Cg_exo -72.11 -1.75 10.53 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.653 2.235 . . . . 0.0 112.731 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.83 170.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.864 0.364 . . . . 0.0 111.592 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.18 119.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.088 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 mt -154.73 15.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.881 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.42 -114.73 0.51 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.929 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . 0.433 ' HB2' ' CD1' ' B' ' 92' ' ' TYR . 93.3 Cg_endo -80.97 51.0 3.76 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.647 2.231 . . . . 0.0 113.018 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.463 ' CG ' ' HB2' ' B' ' 107' ' ' ARG . 1.7 p90 -178.65 156.84 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.952 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.425 HG11 ' O ' ' B' ' 103' ' ' ASN . 30.9 m -106.72 -174.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.15 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.6 -43.49 59.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.956 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.95 177.6 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.088 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.42 133.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.149 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -103.97 102.68 12.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 mt -80.91 -17.94 48.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.109 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.22 -103.57 0.9 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.915 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.38 -29.04 63.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.084 0.468 . . . . 0.0 110.279 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.23 122.87 25.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.431 ' CG1' ' HB1' ' C' ' 127' ' ' ALA . 4.2 p -109.22 145.77 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.893 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.89 139.63 53.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 0.0 110.979 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 76.2 p -113.17 162.2 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.747 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 27.5 p -95.94 165.57 12.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.111 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.55 94.3 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.325 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.19 146.16 54.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 9.5 pt -134.47 142.06 41.37 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.847 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.508 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 7.9 Cg_exo -72.54 55.2 2.56 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.939 2.426 . . . . 0.0 113.138 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' C' ' 34' ' ' ILE . 20.6 t . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.194 0.521 . . . . 0.0 110.513 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 11.4 p . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 120.64 0.257 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.59 140.45 55.26 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.488 2.125 . . . . 0.0 112.443 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.74 -32.01 70.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 92.77 0.12 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.635 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mm -40.23 -32.4 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.351 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.86 -56.45 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.71 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.1 -28.71 70.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.773 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . 0.418 ' HG3' HG21 ' C' ' 43' ' ' VAL . 3.0 tt0 -80.54 -28.77 37.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.626 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.19 -34.82 42.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.581 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -28.86 52.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.181 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.24 -48.11 65.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.836 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -35.72 75.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.28 -54.79 27.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.925 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.19 -31.4 68.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -67.97 -33.8 75.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.828 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.91 -49.47 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -29.8 65.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.67 -41.25 94.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 5.3 mt -72.51 -42.58 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.574 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 21.0 mt -69.13 -30.85 47.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.852 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.19 -40.67 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.923 0.392 . . . . 0.0 110.335 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -19.44 65.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.531 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.52 -26.86 19.54 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.907 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.49 41.64 0.67 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.512 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 18.5 mt -155.29 147.1 23.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.661 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -101.47 -179.74 4.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.556 ' HB1' ' CE1' ' C' ' 101' ' ' HIS . . . -78.72 -23.06 45.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.789 0.328 . . . . 0.0 110.49 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.523 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -62.98 -33.37 75.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' C' ' 127' ' ' ALA . 10.7 p30 -75.81 -21.64 57.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 26.4 mm -52.53 121.12 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.848 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 m -89.68 -32.7 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.013 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.25 165.62 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.576 0.227 . . . . 0.0 110.888 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 6.1 p -162.44 105.84 1.13 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.811 0.338 . . . . 0.0 111.559 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.427 HG22 ' CE1' ' C' ' 78' ' ' PHE . 4.6 m -91.87 155.39 18.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.177 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 21.1 t -151.02 103.12 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.909 0.385 . . . . 0.0 111.935 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' C' ' 76' ' ' THR . 10.9 m-85 -89.78 99.82 12.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.301 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 19.0 m -98.49 147.72 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.527 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.21 -3.43 49.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.176 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -161.27 142.17 11.29 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.639 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 mt -82.92 1.61 38.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.233 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -98.66 -24.21 15.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.768 0.318 . . . . 0.0 110.9 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.86 -27.01 60.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.034 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -59.35 -18.6 39.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.619 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.35 -57.81 10.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 111.338 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.0 71.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 t -70.77 -41.19 77.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.17 -47.36 80.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.704 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.42 75.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.298 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -92.28 -15.88 26.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.721 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.434 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 12.5 t80 -81.71 -38.33 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.307 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.05 -28.68 22.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.333 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.15 -21.89 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.69 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.497 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.98 -34.49 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.972 -179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.497 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 3.1 m-85 -57.23 -57.79 11.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 110.13 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.25 -29.83 70.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.128 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.98 -10.09 59.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.489 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.717 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 1.7 t-20 -108.67 -8.8 15.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.29 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 4.3 t30 89.0 33.3 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.454 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.717 ' CE1' ' HB3' ' C' ' 99' ' ' ASN . 4.2 m170 -116.97 54.48 1.37 Allowed Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.84 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -75.32 -11.62 20.91 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.646 2.23 . . . . 0.0 112.761 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . 0.435 ' O ' HG11 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -47.91 -37.52 14.44 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.876 0.37 . . . . 0.0 111.089 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 63.93 83.84 0.19 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.41 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 33.8 Cg_endo -64.64 156.15 62.82 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.618 2.212 . . . . 0.0 112.076 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.44 162.6 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.567 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.472 ' HB2' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -133.14 143.74 49.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.185 0.516 . . . . 0.0 111.681 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.6 t -143.63 65.23 1.32 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.787 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.88 140.29 29.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.306 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 35.7 m -150.11 132.55 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.044 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.59 86.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.48 161.21 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.188 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.2 -45.79 25.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.114 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.61 168.12 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mp -142.73 160.62 52.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.693 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.76 136.06 27.92 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.41 2.073 . . . . 0.0 112.273 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm 64.46 16.65 10.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.286 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.74 17.85 9.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.879 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -53.41 122.54 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.264 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.14 -21.53 25.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.905 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mp -152.56 147.58 26.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.321 0.582 . . . . 0.0 111.489 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -139.23 151.5 46.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.394 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 5.8 pt -150.28 139.22 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 1.1 pm0 -138.72 142.98 38.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.06 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.6 172.62 14.74 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 9.4 mt -125.69 154.05 34.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.046 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.503 ' HB2' ' OD1' ' C' ' 71' ' ' ASP . . . -135.46 153.16 51.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.001 0.429 . . . . 0.0 111.834 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.12 164.16 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.0 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -164.07 64.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.779 0.323 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.41 131.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -59.0 155.13 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.444 HD13 HG23 ' A' ' 6' ' ' ILE . 31.3 mt -121.13 133.61 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.33 149.19 28.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.3 t -150.84 165.59 33.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.946 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.89 25.56 5.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -110.06 -50.97 2.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.13 114.03 50.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.58 -12.53 36.19 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.358 2.038 . . . . 0.0 112.621 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.83 -169.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.527 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 62.18 -169.42 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.25 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 mt 77.17 17.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.228 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.11 -127.96 2.92 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.245 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -87.44 33.91 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.759 2.306 . . . . 0.0 112.861 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.527 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -175.87 156.8 1.85 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.025 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -92.26 152.6 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.06 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.93 -36.51 70.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.409 . . . . 0.0 110.451 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.31 163.13 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.941 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.15 136.88 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.878 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -110.25 120.43 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.231 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.53 -20.68 22.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.916 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.12 -108.66 0.77 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.672 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -60.38 -29.2 68.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.126 0.489 . . . . 0.0 110.067 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -126.44 115.2 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.811 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -105.37 176.24 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.197 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 mp -150.53 161.66 42.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.4 p -126.16 159.21 33.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.074 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -95.06 168.07 10.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.196 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.09 94.74 0.1 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.263 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -73.6 165.73 24.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.909 0.385 . . . . 0.0 111.19 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 pt -149.93 143.05 16.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.015 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 73.7 Cg_endo -75.05 59.38 5.21 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.794 2.33 . . . . 0.0 112.875 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--N 1.326 -0.453 0 CA-C-O 121.263 0.554 . . . . 0.0 110.643 179.365 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 11.2 p . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.543 0.211 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 31.8 Cg_exo -58.26 150.18 68.27 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.388 2.059 . . . . 0.0 112.035 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.47 -30.79 68.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.978 0.418 . . . . 0.0 110.893 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.51 97.45 1.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.2 tp -42.14 -32.22 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.767 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -48.62 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.04 93.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.752 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.401 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -70.01 -30.85 68.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.583 179.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.34 -37.49 71.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.196 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -78.95 -35.62 42.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.92 -36.08 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.81 -31.67 61.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.752 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.6 mt -72.74 -36.28 67.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.8 -44.31 73.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -58.68 -46.57 86.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.72 -31.85 50.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.96 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -80.61 -32.51 36.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.14 -35.98 80.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 mt -69.7 -45.24 78.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.485 ' CG2' ' HB3' ' A' ' 67' ' ' LEU . 11.0 mt -65.75 -35.28 74.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.458 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.94 75.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.327 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -21.42 63.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.422 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.45 -28.31 20.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.71 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.92 54.44 0.35 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.615 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 158.01 23.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.878 0.37 . . . . 0.0 110.671 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -115.33 156.85 24.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.161 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 72' ' ' ILE . . . -57.97 -35.91 71.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.057 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.64 -26.74 5.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.455 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.43 ' HB2' HD21 ' A' ' 67' ' ' LEU . 4.7 m-20 -85.5 -18.67 32.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.297 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -54.5 117.89 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.506 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.13 -33.73 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.92 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 125' ' ' ALA . 4.2 tttm -128.32 169.77 13.84 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -169.93 112.97 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.875 0.369 . . . . 0.0 111.409 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.7 m -99.96 151.77 20.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.173 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.0 m -146.48 128.85 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 111.929 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -107.6 129.68 54.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.144 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.8 149.5 27.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.463 . . . . 0.0 111.721 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -88.41 -4.2 58.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.781 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -160.57 115.55 2.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.384 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.38 -11.23 50.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.088 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -80.83 -19.06 45.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.779 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -87.02 -19.53 28.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.07 -20.93 43.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.31 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.73 -39.2 65.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 111.283 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.54 -29.25 21.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.0 t -72.39 -44.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.31 -42.36 93.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.615 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.4 73.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -27.52 19.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.515 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.43 ' O ' ' CD2' ' A' ' 96' ' ' PHE . 68.6 t80 -54.08 -49.03 69.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.891 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.6 -27.44 25.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.54 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.23 -20.24 60.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.619 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.3 OUTLIER -90.14 -38.84 13.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.933 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.452 ' HB3' ' O ' ' A' ' 101' ' ' HIS . 14.6 m-85 -55.61 -58.81 6.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.604 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -64.74 -28.15 69.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.704 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -72.88 -13.58 61.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.317 . . . . 0.0 110.883 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 58.7 m-80 -111.18 -10.75 14.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.472 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.4 p-10 99.56 33.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.907 0.754 . . . . 0.0 111.004 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.493 ' CE1' ' HB3' ' A' ' 99' ' ' ASN . 1.2 m-70 -115.11 56.43 0.98 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.552 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 54.4 Cg_endo -68.64 -15.14 40.84 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.659 2.239 . . . . 0.0 113.363 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 3.1 m-20 -53.86 -43.19 69.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.913 0.387 . . . . 0.0 110.606 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 30.4 m-85 71.85 84.13 0.13 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.959 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 19.1 Cg_endo -59.25 155.67 39.14 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.772 2.314 . . . . 0.0 112.327 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.39 158.16 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.234 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.415 ' NH1' ' CG ' ' B' ' 18' ' ' TYR . 2.9 ttp-105 -134.66 141.38 46.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.131 0.491 . . . . 0.0 111.854 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.42 66.12 1.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.064 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 28.0 p -79.49 130.88 35.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.188 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.5 m -148.82 144.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.981 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -86.68 94.6 9.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.817 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 36.0 m -73.49 159.9 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.94 -37.13 72.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.406 ' CB ' ' HB3' ' C' ' 111' ' ' GLU . 0.0 OUTLIER -160.84 166.96 27.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.976 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 mt -143.39 155.71 60.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.673 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.34 135.85 70.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.563 2.175 . . . . 0.0 112.018 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? 69.62 20.36 7.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.18 26.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.118 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.1 m -55.66 174.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.206 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.04 -15.13 43.14 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.569 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -172.49 148.88 2.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.046 0.45 . . . . 0.0 111.168 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -116.4 167.25 11.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.322 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.9 mm -141.88 131.87 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.206 0.527 . . . . 0.0 112.196 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.53 117.75 4.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.204 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 74' ' ' LYS . . . -140.3 176.03 9.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.7 mt -119.88 154.69 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.038 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.447 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -139.37 150.75 45.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.908 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.1 126.67 71.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.402 ' CB ' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.042 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.819 0.342 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.49 131.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -58.96 155.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.414 HG23 HD13 ' B' ' 6' ' ' ILE . 31.6 mt -121.23 133.67 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.34 149.19 28.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.789 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.3 t -150.85 165.56 33.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.92 25.62 5.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.014 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -110.13 -50.88 2.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.677 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.16 114.04 50.14 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.966 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.66 -12.5 36.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.35 2.034 . . . . 0.0 112.595 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.74 -169.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.534 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 62.18 -169.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.196 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 mt 77.19 17.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.22 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.06 -127.91 2.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.225 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.51 33.94 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 112.892 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.534 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -175.85 156.78 1.85 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.85 0.357 . . . . 0.0 110.999 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -92.27 152.59 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.064 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.88 -36.52 70.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 110.492 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.58 163.15 2.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.037 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.13 136.95 58.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.835 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -110.3 120.48 42.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.219 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.5 -20.77 22.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.18 -108.79 0.78 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.64 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -60.26 -29.32 68.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.04 0.448 . . . . 0.0 109.998 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 7.3 mp -126.37 115.15 19.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.795 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' B' ' 127' ' ' ALA . 0.9 OUTLIER -105.28 176.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.198 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 mp -150.48 161.68 42.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.933 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.8 p -126.1 158.89 34.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.033 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.6 m -94.6 168.14 11.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.037 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.13 94.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.293 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -73.59 165.81 24.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 111.16 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 pt -150.03 143.03 16.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.992 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 73.7 Cg_endo -75.03 59.38 5.19 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.755 2.304 . . . . 0.0 112.898 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 121.297 0.57 . . . . 0.0 110.627 179.372 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 11.1 p . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.475 0.179 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' B' ' 50' ' ' GLN . 31.3 Cg_exo -58.34 150.18 68.94 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.373 2.049 . . . . 0.0 112.036 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.5 -30.69 68.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.026 0.441 . . . . 0.0 110.921 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.55 97.43 1.68 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.829 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 9.1 tp -42.02 -32.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.756 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.22 -48.67 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.827 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.11 93.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.768 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.403 ' CB ' ' HD2' ' B' ' 44' ' ' PRO . 0.9 OUTLIER -69.97 -30.91 68.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.562 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.41 -37.57 71.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.257 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -79.01 -35.7 42.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -36.16 73.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.78 -31.78 61.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 34.9 mt -72.69 -36.24 67.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.86 -44.25 73.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -58.71 -46.56 87.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.73 -31.87 50.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.949 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -80.66 -32.48 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.95 -35.95 81.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 mt -69.77 -45.21 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.838 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.48 ' CG2' ' HB3' ' B' ' 67' ' ' LEU . 11.0 mt -65.75 -35.34 74.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.47 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 -42.94 76.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.303 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -21.47 63.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.403 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.51 -28.2 20.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.698 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.85 54.42 0.36 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.649 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.48 ' HB3' ' CG2' ' B' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 157.96 23.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.84 0.353 . . . . 0.0 110.672 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -115.29 156.92 24.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.222 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.507 ' HA ' HD12 ' B' ' 72' ' ' ILE . . . -58.06 -35.86 71.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.051 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -26.75 5.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.413 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.417 ' HB3' HD23 ' B' ' 67' ' ' LEU . 4.7 m-20 -85.49 -18.68 32.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.361 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' B' ' 69' ' ' ALA . 0.5 OUTLIER -54.51 117.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 110.556 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 28.7 m -88.17 -33.7 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.876 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' B' ' 125' ' ' ALA . 4.2 tttm -128.32 169.83 13.78 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.79 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -170.02 112.86 0.47 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.86 0.362 . . . . 0.0 111.378 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -99.9 151.84 20.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.147 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 m -146.57 128.85 7.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.017 0.437 . . . . 0.0 111.901 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -107.58 129.68 54.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.125 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.8 149.49 27.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.065 0.46 . . . . 0.0 111.774 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -88.45 -4.4 58.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.735 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.48 115.51 2.24 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.387 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mt -66.33 -11.28 50.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -80.8 -19.08 45.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -86.98 -19.57 28.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.172 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.08 -20.9 43.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.339 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.27 65.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.817 0.341 . . . . 0.0 111.289 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.51 -29.19 21.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 28.5 t -72.37 -44.94 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.36 -42.35 92.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.559 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.41 73.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -27.52 18.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.517 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.433 ' O ' ' CD2' ' B' ' 96' ' ' PHE . 68.6 t80 -54.06 -49.13 69.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.885 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.54 -27.45 25.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.54 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.16 -20.26 60.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.648 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.498 ' C ' ' CD1' ' B' ' 95' ' ' PHE . 0.3 OUTLIER -90.13 -38.86 13.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.0 110.932 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' B' ' 101' ' ' HIS . 14.8 m-85 -55.55 -58.88 5.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.584 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -64.75 -28.11 69.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.743 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -72.87 -13.59 61.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 110.919 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 58.8 m-80 -111.13 -10.83 14.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.482 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 2.3 p-10 99.57 33.26 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.832 0.707 . . . . 0.0 110.99 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.5 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 1.2 m-70 -115.01 56.36 0.94 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.553 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.401 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 53.8 Cg_endo -68.65 -15.17 40.85 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 113.335 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 3.1 m-20 -53.91 -43.08 69.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.62 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 30.3 m-85 71.77 84.15 0.13 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.966 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 19.1 Cg_endo -59.22 155.67 39.0 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.749 2.299 . . . . 0.0 112.358 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.32 158.34 0.84 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.291 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.424 ' NH1' ' CG ' ' C' ' 18' ' ' TYR . 2.9 ttp-105 -134.84 141.31 46.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.13 0.491 . . . . 0.0 111.838 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.39 66.03 1.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.11 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 28.0 p -79.42 130.89 35.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.18 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 20.9 m -148.79 143.91 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.982 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -86.45 94.33 9.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.744 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 35.8 m -73.29 159.87 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.12 72.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.87 166.91 27.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.004 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 mt -143.33 155.73 61.08 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.41 135.83 70.94 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.578 2.186 . . . . 0.0 112.031 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? 69.69 20.31 6.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.975 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.19 26.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 m -55.78 174.49 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.08 -15.58 41.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.554 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' B' ' 121' ' ' LEU . 0.0 OUTLIER -172.09 148.74 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 111.184 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -116.4 167.23 11.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.264 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 22.6 mm -141.91 131.85 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.188 0.518 . . . . 0.0 112.219 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.57 117.69 4.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.166 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' B' ' 74' ' ' LYS . . . -140.22 176.05 9.08 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 6.7 mt -119.86 154.68 22.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.072 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.443 ' HB3' HG21 ' B' ' 28' ' ' VAL . . . -139.36 150.82 45.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.833 0.349 . . . . 0.0 111.902 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.22 126.66 71.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.07 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.845 0.355 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.42 131.19 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mm -58.94 155.15 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.479 HD13 HG23 ' C' ' 6' ' ' ILE . 31.3 mt -121.25 133.55 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.25 149.17 28.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.84 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 11.3 t -150.83 165.6 33.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.951 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.93 25.62 5.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.028 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -110.11 -51.18 2.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.662 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.84 114.15 50.27 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.902 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.53 -12.57 36.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.369 2.046 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -169.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.533 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 62.24 -169.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.186 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 mt 77.2 17.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.191 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.09 -128.0 2.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.23 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.4 33.88 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.728 2.285 . . . . 0.0 112.918 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.533 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -175.82 156.83 1.87 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.91 0.386 . . . . 0.0 110.987 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -92.29 152.59 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.048 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -36.54 70.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.439 . . . . 0.0 110.573 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.26 163.09 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.934 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.07 136.92 58.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -110.31 120.49 42.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.201 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.57 -20.66 22.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.1 -108.67 0.77 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.664 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -60.42 -29.22 68.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.147 0.498 . . . . 0.0 110.072 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 7.3 mp -126.42 115.15 19.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.795 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' C' ' 127' ' ' ALA . 0.9 OUTLIER -105.31 176.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.203 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 mp -150.56 161.64 42.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.3 p -126.22 158.99 34.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.006 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -94.64 167.99 11.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.1 94.8 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.251 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -73.59 165.78 24.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.204 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 pt -149.98 143.06 16.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.993 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.415 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 73.6 Cg_endo -75.01 59.31 5.16 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.782 2.321 . . . . 0.0 112.941 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 121.222 0.534 . . . . 0.0 110.612 179.416 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 11.3 p . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.528 0.204 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' C' ' 35' ' ' PRO . 31.2 Cg_exo -58.42 150.21 69.42 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.355 2.037 . . . . 0.0 112.016 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.5 -30.7 68.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.034 0.445 . . . . 0.0 110.9 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.51 97.41 1.66 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 9.2 tp -42.17 -32.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.754 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -48.68 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.791 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.09 93.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.789 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -30.88 68.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.627 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.54 -37.63 71.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.192 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -79.0 -35.6 42.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -36.13 73.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.89 -31.68 61.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.694 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 34.8 mt -72.74 -36.3 67.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.789 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.75 -44.27 74.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.951 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -58.71 -46.56 87.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.72 -31.93 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -80.61 -32.44 36.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.02 -35.94 81.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.023 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.7 -45.32 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . 0.486 ' CG2' ' HB3' ' C' ' 67' ' ' LEU . 10.9 mt -65.66 -35.32 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.9 75.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -21.54 63.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.409 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.43 -28.26 21.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.692 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.9 54.43 0.35 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.578 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.486 ' HB3' ' CG2' ' C' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 157.96 23.84 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.632 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -115.37 156.88 24.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.188 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' C' ' 72' ' ' ILE . . . -58.05 -35.84 71.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.065 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -26.62 5.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.448 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . 0.423 ' HB2' HD21 ' C' ' 67' ' ' LEU . 4.7 m-20 -85.64 -18.69 32.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.323 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' C' ' 69' ' ' ALA . 0.5 OUTLIER -54.49 117.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.521 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 28.4 m -88.16 -33.73 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.874 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' C' ' 125' ' ' ALA . 4.2 tttm -128.27 169.75 13.84 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.811 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -169.95 112.94 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.852 0.358 . . . . 0.0 111.442 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -99.96 151.83 20.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.159 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 5.0 m -146.49 128.86 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.935 0.398 . . . . 0.0 112.004 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -107.65 129.64 54.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.143 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.83 149.5 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.026 0.441 . . . . 0.0 111.772 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -88.46 -4.53 58.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.773 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.21 115.44 2.31 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.384 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.35 -11.25 50.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.126 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -80.79 -19.1 45.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.817 0.342 . . . . 0.0 110.83 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -86.98 -19.55 28.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.223 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.07 -20.91 43.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.342 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.72 -39.2 65.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.837 0.351 . . . . 0.0 111.315 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -29.2 21.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.962 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 29.3 t -72.39 -45.01 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.32 -42.37 93.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.561 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.52 73.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.974 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -27.49 19.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.494 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.427 ' O ' ' CD2' ' C' ' 96' ' ' PHE . 68.8 t80 -54.08 -49.04 69.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.892 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.6 -27.47 25.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.542 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.16 -20.29 60.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.604 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.501 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 0.3 OUTLIER -90.19 -38.77 13.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.826 0.346 . . . . 0.0 110.954 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' C' ' 101' ' ' HIS . 14.7 m-85 -55.58 -58.85 6.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -64.7 -28.22 69.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.684 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -72.86 -13.54 61.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.783 0.325 . . . . 0.0 110.94 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.511 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 58.9 m-80 -111.11 -10.93 14.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.476 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 2.4 p-10 99.66 33.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.524 0.73 . . . . 0.0 110.95 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.498 ' CE1' ' HB3' ' C' ' 99' ' ' ASN . 1.2 m-70 -115.13 56.3 0.98 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.581 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . 0.404 ' O ' ' CD2' ' C' ' 104' ' ' PHE . 53.9 Cg_endo -68.6 -15.21 41.06 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.659 2.239 . . . . 0.0 113.35 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 3.1 m-20 -53.81 -43.14 69.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 110.601 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 30.4 m-85 71.8 84.12 0.13 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.988 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 19.0 Cg_endo -59.23 155.72 38.78 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.768 2.312 . . . . 0.0 112.298 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.4 158.1 0.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.253 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.428 ' NH1' ' CG ' ' A' ' 18' ' ' TYR . 2.9 ttp-105 -134.65 141.37 46.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.107 0.479 . . . . 0.0 111.827 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.42 66.11 1.47 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.063 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 28.0 p -79.45 130.87 35.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.18 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 20.6 m -148.9 144.74 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.053 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . 0.406 ' HB3' ' CB ' ' A' ' 114' ' ' ARG . 2.3 tt0 -87.02 94.51 9.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.76 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 36.0 m -73.43 159.89 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.171 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.97 -37.08 72.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.069 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.88 166.9 27.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.036 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 mt -143.35 155.72 61.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.743 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.39 135.91 71.26 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.577 2.184 . . . . 0.0 111.979 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? 69.6 20.38 7.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.938 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.16 26.31 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.095 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.9 m -55.67 174.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.246 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.12 -15.22 42.55 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.537 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' C' ' 121' ' ' LEU . 0.0 OUTLIER -172.18 148.74 2.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.993 0.425 . . . . 0.0 111.204 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -116.33 167.31 11.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.289 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mm -141.99 131.8 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.208 0.527 . . . . 0.0 112.177 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.52 117.75 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.166 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' C' ' 74' ' ' LYS . . . -140.28 176.03 9.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 6.7 mt -119.85 154.67 22.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.038 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.435 ' HB3' HG21 ' C' ' 28' ' ' VAL . . . -139.4 150.79 45.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.839 0.352 . . . . 0.0 111.884 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.14 126.69 71.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.092 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . 0.401 ' CB ' HD12 ' C' ' 67' ' ' LEU . 0.4 OUTLIER -94.89 43.5 1.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.095 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.935 179.867 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.006 0.431 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.542 ' HA ' ' N ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 6' ' ' ILE . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' C' ' 107' ' ' ARG . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.45 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.542 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.0 m120 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.9 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 9.2 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.607 0.241 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 21' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' CB ' ' CE1' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.519 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' HG13 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.42 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.513 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CE1' ' CB ' ' A' ' 69' ' ' ALA . 3.3 m170 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' B' ' 17' ' ' PRO . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.439 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.425 HG13 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 123' ' ' ILE . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.977 0.417 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.538 ' HA ' ' N ' ' B' ' 23' ' ' ASP . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.449 HG23 HD12 ' B' ' 6' ' ' ILE . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.45 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.538 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' B' ' 35' ' ' PRO . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 9.3 p . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.595 0.236 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' B' ' 21' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.521 ' CB ' ' CE1' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.484 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' B' ' 69' ' ' ALA . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.516 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.425 ' CD2' HG13 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.514 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.521 ' CE1' ' CB ' ' B' ' 69' ' ' ALA . 3.4 m170 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.416 ' CD1' ' HA ' ' C' ' 17' ' ' PRO . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.425 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . 0.429 HG13 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.451 HG21 HD13 ' B' ' 123' ' ' ILE . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . 0.537 ' HA ' ' N ' ' C' ' 23' ' ' ASP . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.451 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . 0.416 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' B' ' 107' ' ' ARG . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.452 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . 0.486 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.401 HG23 ' CB ' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 32.8 t . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 9.3 p . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.582 0.229 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.404 HD21 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' C' ' 21' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.518 ' CB ' ' CE1' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.476 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.515 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.429 ' CD2' HG13 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' C' ' 95' ' ' PHE . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.521 ' NE2' ' HB3' ' C' ' 99' ' ' ASN . 3.3 m170 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 17' ' ' PRO . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.418 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 123' ' ' ILE . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.817 0.341 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 132.97 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -55.2 152.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mt -103.43 139.26 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.137 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.58 117.18 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.7 t -133.88 165.99 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.33 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -121.62 -36.89 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.032 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.516 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . . . -67.82 172.05 4.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 11' ' ' ALA . 18.9 Cg_endo -59.39 -16.05 33.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.695 2.263 . . . . 0.0 112.85 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.24 151.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 111.317 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.67 120.71 41.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -133.51 15.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.072 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.85 -146.17 4.73 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.987 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' C' ' 104' ' ' PHE . 93.9 Cg_endo -87.39 44.53 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.536 2.158 . . . . 0.0 112.901 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.19 154.59 17.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.867 0.365 . . . . 0.0 111.033 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -110.91 169.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.284 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -58.96 -53.53 57.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.69 -177.09 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 m -142.33 132.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.166 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -103.47 105.01 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.51 -16.36 54.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.371 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.05 -104.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.28 -29.62 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.166 0.508 . . . . 0.0 110.21 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.2 140.65 45.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.435 ' CG1' ' CB ' ' A' ' 127' ' ' ALA . 9.9 p -120.04 160.88 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.123 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mp -145.87 127.37 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 p -106.5 136.11 46.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.983 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 t -59.36 179.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.07 95.55 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.244 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.433 ' HG2' ' CG2' ' A' ' 58' ' ' VAL . 2.9 mp0 -62.07 138.14 58.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.275 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.5 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -146.04 170.18 8.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.679 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -54.26 -137.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.313 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.411 -178.926 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.81 140.71 81.58 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.592 2.195 . . . . 0.0 112.433 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.37 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.4 93.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.791 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.9 mm -38.93 -33.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.5 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.08 -48.07 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.696 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.82 -55.04 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.498 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.93 -44.36 63.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -63.33 -51.54 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.79 -31.18 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.445 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 1.3 m -68.31 -46.48 70.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.29 -26.36 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.971 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -57.95 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.108 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.8 OUTLIER -54.88 -30.36 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.985 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.433 ' CG2' ' HG2' ' A' ' 33' ' ' GLN . 39.6 t -62.1 -34.54 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 110.517 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.99 -31.75 34.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.755 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.55 89.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.1 mt -70.93 -46.2 69.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.667 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.8 -32.62 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.28 -38.4 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.9 -24.33 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.145 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.71 -22.11 21.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.914 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.43 64.8 0.83 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -158.9 139.2 12.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.028 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 44.0 p -96.12 145.0 25.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.29 -31.75 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.518 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -59.77 -18.48 43.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 68' ' ' THR . 3.2 p-10 -88.58 -21.27 24.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 64.3 mt -59.35 109.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.414 ' CG1' HG22 ' A' ' 128' ' ' VAL . 2.8 m -81.11 -36.84 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.971 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.452 ' HB3' ' CD ' ' A' ' 107' ' ' ARG . 8.6 mtmt -130.55 175.23 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.319 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.539 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 13.4 t 177.71 110.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 111.36 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.489 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -70.18 130.1 41.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.33 91.6 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CZ ' ' HB ' ' A' ' 76' ' ' THR . 5.3 m-85 -91.7 143.77 26.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.089 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 35.3 m -139.31 150.0 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.023 0.44 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.95 -4.31 56.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.796 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.04 108.99 0.46 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -17.25 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.97 -24.64 59.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 110.282 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.46 -15.34 58.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.832 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 0.3 OUTLIER -55.52 -22.98 23.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.01 -46.63 84.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 -33.22 19.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.6 t -70.08 -49.66 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.673 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.417 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 36.4 t-20 -63.09 -35.99 82.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.14 94.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.016 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.62 -31.1 19.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.448 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 48.7 t80 -57.67 -51.35 69.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.727 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 7.7 tt0 -73.32 -27.34 61.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -25.11 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.765 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -79.31 -41.02 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.934 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 95' ' ' PHE . 57.1 m-85 -56.45 -50.43 71.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.8 69.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.77 58.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.402 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -110.54 -6.88 14.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 11.7 m-20 89.68 30.9 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 19.9 t-160 -127.57 72.17 77.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.96 -11.04 16.65 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.539 2.159 . . . . 0.0 112.153 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -79.14 -35.03 42.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.447 . . . . 0.0 110.439 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.453 ' CG ' ' HA ' ' B' ' 17' ' ' PRO . 92.7 m-85 70.99 144.0 0.1 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.515 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HG2' HG22 ' A' ' 75' ' ' THR . 2.0 Cg_endo -82.96 165.82 15.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.057 2.504 . . . . 0.0 112.0 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.28 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.779 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.539 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -169.27 -163.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.944 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.36 107.57 16.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.3 m -95.25 129.16 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.798 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -157.79 165.71 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.949 0.405 . . . . 0.0 111.666 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 9.4 tt0 -99.75 102.87 14.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.777 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.82 162.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.07 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.81 168.08 20.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.722 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mt -144.19 161.9 42.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.7 135.94 67.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.649 2.233 . . . . 0.0 112.183 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.58 18.28 7.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.87 17.47 8.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 m -55.18 172.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.61 14.08 20.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.011 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -176.64 149.0 0.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.123 0.487 . . . . 0.0 111.508 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -150.86 137.85 19.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.918 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -144.67 138.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 112.101 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.36 149.91 28.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.03 125.99 32.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.414 . . . . 0.0 112.027 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.42 132.16 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.876 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -121.74 153.14 38.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.063 0.459 . . . . 0.0 112.038 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.414 HG22 ' CG1' ' A' ' 73' ' ' VAL . 34.6 m -124.13 116.37 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.72 132.95 5.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -55.2 152.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mt -103.43 139.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.07 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.59 117.19 9.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.6 t -133.86 165.97 23.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.804 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 26.32 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -121.6 -36.61 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.982 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . . . -68.18 172.03 4.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' B' ' 11' ' ' ALA . 18.7 Cg_endo -59.33 -16.06 32.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.632 2.221 . . . . 0.0 112.905 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.23 151.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.411 . . . . 0.0 111.281 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.006 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -133.53 15.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.79 -146.1 4.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . 0.453 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . 94.4 Cg_endo -87.38 44.49 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.637 2.224 . . . . 0.0 112.916 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.26 154.53 17.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.915 0.388 . . . . 0.0 110.991 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.83 169.25 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.304 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -59.04 -53.58 56.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.46 -177.16 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 m -142.31 132.63 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.147 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -103.51 104.94 15.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.777 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.44 -16.4 54.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -103.96 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.972 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.3 -29.56 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.082 0.468 . . . . 0.0 110.189 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.3 140.65 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.52 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.444 ' CG1' ' CB ' ' B' ' 127' ' ' ALA . 9.9 p -120.07 160.84 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mp -145.87 127.42 15.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.68 136.36 46.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.06 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.1 t -59.69 179.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.961 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.01 95.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.435 ' HG2' ' CG2' ' B' ' 58' ' ' VAL . 2.9 mp0 -61.92 138.09 58.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.479 ' HB ' ' HD2' ' B' ' 35' ' ' PRO . 0.7 OUTLIER -145.98 170.19 8.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.665 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 52.2 Cg_exo -54.34 -137.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.069 2.513 . . . . 0.0 112.319 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -178.922 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.83 140.7 81.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.662 2.242 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.39 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.35 93.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 28.9 mm -38.94 -33.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.443 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.02 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.91 -54.98 38.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.1 -26.16 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.522 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.18 -44.2 63.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.901 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.33 -51.54 65.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.22 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' SER . . . . . 0.448 ' HA ' ' OD1' ' B' ' 57' ' ' ASN . 1.3 m -68.4 -46.37 70.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.32 -26.38 68.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.963 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -57.99 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.163 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.8 OUTLIER -54.86 -30.39 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.931 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.435 ' CG2' ' HG2' ' B' ' 33' ' ' GLN . 39.7 t -62.13 -34.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.95 -31.77 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.49 89.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -71.25 -46.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.83 -32.53 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.656 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.31 -38.49 60.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.34 65.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.136 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 -22.06 21.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.919 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 64.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -158.91 139.2 12.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.022 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' B' ' 71' ' ' ASP . 43.8 p -96.1 144.99 25.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.26 -31.79 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.574 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.486 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -59.83 -18.27 42.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.425 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 68' ' ' THR . 3.3 p-10 -88.65 -21.23 24.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.714 0.292 . . . . 0.0 110.87 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 64.4 mt -59.4 109.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.874 0.369 . . . . 0.0 110.839 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.423 ' CG1' HG22 ' B' ' 128' ' ' VAL . 2.8 m -81.12 -36.88 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.969 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.443 ' HB3' ' CD ' ' B' ' 107' ' ' ARG . 8.6 mtmt -130.56 175.22 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.302 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.541 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 13.4 t 177.67 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 111.337 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.481 ' N ' ' HG2' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -70.15 130.12 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.325 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.43 91.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' B' ' 76' ' ' THR . 5.3 m-85 -91.66 143.72 26.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.151 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 35.1 m -139.32 150.01 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.072 0.463 . . . . 0.0 111.718 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.94 -4.12 56.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.839 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -169.23 109.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.321 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -17.32 20.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.228 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.94 -24.63 59.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.275 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -15.37 58.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.422 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 0.3 OUTLIER -55.46 -23.03 23.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.267 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.99 -46.62 84.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.09 -33.23 19.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 t -70.09 -49.59 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.721 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 36.4 t-20 -63.21 -35.96 82.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.04 94.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.67 -31.19 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 48.8 t80 -57.62 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.423 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 7.7 tt0 -73.41 -27.32 61.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.462 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -25.19 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.786 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -79.25 -41.09 28.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.97 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 95' ' ' PHE . 57.2 m-85 -56.36 -50.45 71.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.818 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.82 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.945 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.8 58.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.98 14.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.505 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 11.7 m-20 89.78 30.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.0 t-160 -127.48 72.19 77.52 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.98 -11.02 16.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.537 2.158 . . . . 0.0 112.153 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.03 0.443 . . . . 0.0 110.445 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.45 ' CG ' ' HA ' ' C' ' 17' ' ' PRO . 92.7 m-85 70.89 144.04 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.494 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.457 ' HG2' HG22 ' B' ' 75' ' ' THR . 2.0 Cg_endo -83.02 165.85 14.91 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.016 2.477 . . . . 0.0 111.917 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.27 137.95 51.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.541 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -169.23 -163.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.38 107.56 16.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.571 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -95.21 129.11 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.845 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -157.71 165.59 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.409 . . . . 0.0 111.632 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' B' ' 79' ' ' VAL . 9.3 tt0 -99.57 102.86 14.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.785 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.73 162.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.05 -46.27 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.82 168.11 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mt -144.21 161.87 42.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.62 135.97 67.82 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.157 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.53 18.29 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.88 17.46 8.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 m -55.18 172.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.082 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.63 13.95 20.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.025 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 pp -176.62 148.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -150.78 137.88 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.935 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -144.68 138.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 112.14 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.33 149.81 28.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.627 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.94 126.01 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.956 0.408 . . . . 0.0 112.041 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.33 132.14 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.947 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.444 ' CB ' ' CG1' ' B' ' 28' ' ' VAL . . . -121.75 153.2 38.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.096 0.474 . . . . 0.0 111.994 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.423 HG22 ' CG1' ' B' ' 73' ' ' VAL . 34.7 m -124.26 116.32 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.842 0.353 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.68 132.97 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -55.18 152.35 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mt -103.46 139.23 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -143.59 117.2 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 11.7 t -133.93 165.96 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.32 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -121.59 -36.84 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.01 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.506 ' CB ' ' HD2' ' C' ' 12' ' ' PRO . . . -67.93 172.02 4.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' C' ' 11' ' ' ALA . 18.8 Cg_endo -59.31 -16.11 32.83 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.675 2.25 . . . . 0.0 112.899 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.24 151.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.977 0.418 . . . . 0.0 111.304 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.69 120.76 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.002 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mm -133.54 15.81 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.042 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.81 -146.14 4.73 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.001 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . 0.45 ' HA ' ' CG ' ' B' ' 104' ' ' PHE . 94.1 Cg_endo -87.37 44.51 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 112.917 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.23 154.55 17.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.026 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.87 169.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.36 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.02 -53.38 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.6 -177.19 2.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 m -142.24 132.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -103.48 104.98 15.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.47 -16.35 54.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.0 -104.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.27 -29.59 33.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.22 140.64 45.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.575 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.441 ' CG1' ' CB ' ' C' ' 127' ' ' ALA . 9.9 p -120.04 160.84 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.4 ' HB3' ' NZ ' ' B' ' 74' ' ' LYS . 2.9 mp -145.85 127.45 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 p -106.6 136.31 46.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 t -59.62 179.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.13 95.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.25 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.431 ' HG2' ' CG2' ' C' ' 58' ' ' VAL . 2.9 mp0 -62.06 138.17 58.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.259 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.49 ' HB ' ' HD2' ' C' ' 35' ' ' PRO . 0.7 OUTLIER -146.0 170.23 8.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.654 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' C' ' 34' ' ' ILE . 52.4 Cg_exo -54.36 -137.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.063 2.509 . . . . 0.0 112.29 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.427 -178.928 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.762 0.315 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.88 140.74 81.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.637 2.225 . . . . 0.0 112.358 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.45 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.083 0.468 . . . . 0.0 110.913 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 93.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 28.7 mm -39.01 -33.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.447 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.711 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -54.96 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.474 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.07 -44.36 63.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.36 -51.5 65.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.24 72.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.354 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' C' ' 57' ' ' ASN . 1.3 m -68.35 -46.4 70.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.58 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.32 -26.36 68.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -58.01 4.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.8 OUTLIER -54.9 -30.36 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.984 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.431 ' CG2' ' HG2' ' C' ' 33' ' ' GLN . 39.6 t -62.07 -34.62 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -80.86 -31.79 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.52 89.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -70.95 -46.31 68.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.733 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.89 -32.54 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.33 -38.39 60.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.093 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.31 65.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.139 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.1 21.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.87 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.445 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -158.9 139.23 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.036 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.0 p -96.16 145.01 25.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.21 -31.81 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.598 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.482 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -59.74 -18.28 41.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.477 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -88.78 -21.16 23.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 110.896 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 64.2 mt -59.39 109.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.426 ' CG1' HG22 ' C' ' 128' ' ' VAL . 2.8 m -81.04 -36.88 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.933 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . 0.444 ' HB3' ' CD ' ' C' ' 107' ' ' ARG . 8.6 mtmt -130.6 175.25 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.369 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' THR . . . . . 0.525 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 13.4 t 177.72 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.313 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.48 ' N ' ' HG2' ' C' ' 107' ' ' ARG . 0.0 OUTLIER -70.23 130.2 41.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 t -115.43 91.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' C' ' 76' ' ' THR . 5.3 m-85 -91.64 143.8 26.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.143 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 34.8 m -139.35 149.98 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 111.691 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.99 -4.23 56.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.816 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.1 109.04 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.305 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -17.19 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.0 -24.62 59.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.297 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.5 -15.28 58.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.827 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 0.3 OUTLIER -55.53 -23.04 24.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.261 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.63 84.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.01 -33.32 19.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.969 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.06 -49.66 54.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . 0.428 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 36.4 t-20 -63.12 -35.99 82.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.337 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.22 -42.14 94.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.973 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.68 -31.16 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.567 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.457 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 48.7 t80 -57.64 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . 0.414 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 7.7 tt0 -73.36 -27.37 61.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -25.19 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.77 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -79.32 -41.03 28.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 95' ' ' PHE . 56.7 m-85 -56.38 -50.4 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.781 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -28.72 69.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.954 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.91 -3.78 58.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.362 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.91 14.79 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 11.7 m-20 89.79 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.822 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.482 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.0 t-160 -127.55 72.17 77.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.705 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.03 -10.97 16.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.495 2.13 . . . . 0.0 112.146 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.998 0.428 . . . . 0.0 110.429 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.451 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 92.8 m-85 70.91 144.1 0.1 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.453 ' HG2' HG22 ' C' ' 75' ' ' THR . 2.0 Cg_endo -83.05 165.85 14.87 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.028 2.485 . . . . 0.0 111.948 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.29 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.525 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -169.22 -163.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.4 p -111.36 107.48 16.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.589 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -95.21 129.18 42.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.788 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 m -157.82 165.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' C' ' 79' ' ' VAL . 9.4 tt0 -99.76 102.86 14.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.75 162.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.08 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.83 168.09 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mt -144.21 161.82 43.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.52 135.99 68.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.608 2.205 . . . . 0.0 112.221 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.51 18.29 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 61.8 17.55 8.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 m -55.18 172.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.79 14.08 19.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.988 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 pp -176.62 148.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.489 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -150.83 137.93 19.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -144.74 138.35 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.11 0.481 . . . . 0.0 112.142 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.3 149.82 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.648 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.98 126.13 33.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 112.004 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.41 132.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.441 ' CB ' ' CG1' ' C' ' 28' ' ' VAL . . . -121.76 153.11 38.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.082 0.468 . . . . 0.0 112.029 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . 0.426 HG22 ' CG1' ' C' ' 73' ' ' VAL . 34.6 m -124.15 116.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.27 56.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.99 0.424 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.771 0.319 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.83 107.65 13.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 tp -54.31 125.88 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.311 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.4 mm -83.67 137.49 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.46 92.4 1.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -115.24 163.65 15.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.08 29.06 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.94 -41.78 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.807 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.438 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -72.34 178.16 1.49 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 32.3 Cg_exo -57.56 -13.83 14.98 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.808 2.339 . . . . 0.0 113.006 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.39 163.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 0.0 111.075 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -117.17 125.0 50.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.407 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 mp -144.89 18.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.025 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.1 -137.25 3.45 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.429 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.411 ' HB2' ' CD1' ' C' ' 92' ' ' TYR . 89.8 Cg_endo -88.82 32.42 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.795 2.33 . . . . 0.0 113.23 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.49 -178.03 6.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.392 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.412 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 10.3 m -136.68 179.79 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -68.86 -49.58 57.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -174.48 -177.42 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.88 141.58 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -117.97 91.01 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.95 -20.97 66.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.073 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.06 -108.85 0.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.846 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -57.85 -30.17 65.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.096 0.474 . . . . 0.0 110.229 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.71 124.55 42.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.736 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.54 171.61 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.097 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.7 164.81 29.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.751 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 p -138.47 143.9 39.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.911 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.4 p -72.47 179.55 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.27 95.43 0.96 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.377 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -66.93 165.13 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.342 . . . . 0.0 111.015 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 pt -159.5 157.59 26.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.294 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 35.5 Cg_exo -58.35 -15.05 22.51 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.075 2.517 . . . . 0.0 113.024 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 0.0 111.181 179.917 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' A' ' 35' ' ' PRO . 14.7 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.84 0.353 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 43' ' ' VAL . 51.8 Cg_exo -54.33 153.04 23.55 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.652 2.235 . . . . 0.0 112.414 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.74 60.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.02 95.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.868 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 tp -40.34 -32.98 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.797 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.62 -48.14 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.83 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.48 -48.51 80.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.827 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -65.97 -33.78 76.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.481 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.89 -35.88 69.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.008 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.61 -45.67 78.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.681 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -39.39 85.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.656 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t -69.75 -32.16 70.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.656 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.94 -44.97 65.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.53 -42.27 96.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.824 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -58.95 -38.16 78.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.56 -38.0 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -31.02 36.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.763 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.0 85.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.4 mt -71.54 -42.17 72.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.615 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -68.48 -33.05 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.583 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.5 -42.82 67.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.224 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -21.36 63.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.404 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.39 -28.85 19.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.703 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.99 52.82 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.61 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mt -161.28 -172.69 3.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 0.0 110.731 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -141.75 165.09 28.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.779 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.505 ' CB ' ' CE1' ' A' ' 101' ' ' HIS . . . -59.69 -32.33 70.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.876 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -56.67 -26.49 56.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.67 -22.64 34.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.22 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.412 ' CG2' ' HB1' ' A' ' 125' ' ' ALA . 89.7 mt -53.59 110.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.921 0.391 . . . . 0.0 111.243 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.4 m -78.65 -46.08 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.838 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.487 ' HB3' ' HG2' ' A' ' 107' ' ' ARG . 7.5 mttt -119.55 154.36 34.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.345 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.457 ' C ' ' HG3' ' A' ' 107' ' ' ARG . 76.1 p -153.77 102.37 2.53 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.428 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -69.38 124.32 23.56 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -111.07 111.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.428 ' CZ ' HG21 ' A' ' 76' ' ' THR . 13.7 m-30 -109.88 133.41 53.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.995 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 3.1 m -130.34 150.43 34.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.1 0.476 . . . . 0.0 111.858 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.6 -1.38 58.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.889 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.31 118.95 0.31 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 111' ' ' GLU . 51.6 mt -62.29 -14.55 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.23 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -74.14 -21.83 59.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.301 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -87.0 -18.71 30.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.991 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -53.48 -30.98 43.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.161 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.8 -34.91 72.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.287 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.76 -42.78 13.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.324 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.1 -45.84 79.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -63.0 -38.57 91.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.081 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.21 73.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.499 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -15.08 32.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.545 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.49 ' CE1' ' CE1' ' A' ' 96' ' ' PHE . 12.2 t80 -81.05 -38.39 27.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 111.338 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.419 ' HG3' ' CE1' ' A' ' 104' ' ' PHE . 2.4 tt0 -83.2 -27.97 29.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.516 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.83 -24.39 55.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.773 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.521 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -85.31 -37.44 19.96 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.719 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.521 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 3.9 m-85 -55.76 -55.19 35.32 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.168 0.509 . . . . 0.0 109.998 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -32.66 72.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.27 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.01 -6.72 57.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.385 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.712 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 1.5 t-20 -111.91 -4.62 14.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.494 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 15.6 m120 84.47 32.21 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.772 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' A' ' 99' ' ' ASN . 3.4 m170 -115.81 53.16 0.93 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.605 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 58.4 Cg_endo -70.56 -22.27 28.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.539 2.159 . . . . 0.0 112.47 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -50.14 -33.07 17.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.897 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CE1' ' HG3' ' A' ' 93' ' ' GLU . 13.2 m-85 64.54 131.01 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.193 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.441 ' CB ' ' CG2' ' A' ' 75' ' ' THR . 94.2 Cg_endo -88.51 133.58 2.72 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.978 2.452 . . . . 0.0 112.615 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -97.87 129.09 44.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.058 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.487 ' HG2' ' HB3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -162.73 -164.37 0.99 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.996 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.69 114.13 24.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.113 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 14.6 m -92.85 138.36 31.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.219 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.1 m -156.73 158.38 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.986 0.422 . . . . 0.0 111.634 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 3.6 tt0 -98.99 86.29 3.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.655 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.0 m -57.14 156.91 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.233 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.14 82.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.04 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.53 -178.25 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.735 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 mt -148.83 152.42 37.13 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.837 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.12 137.72 68.23 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.504 2.136 . . . . 0.0 112.162 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 tptt 75.17 14.1 3.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.272 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.29 13.62 8.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.188 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.0 m -58.1 156.72 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.727 0.299 . . . . 0.0 110.947 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.38 10.06 65.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.999 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 pp -177.26 148.26 0.59 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.085 0.469 . . . . 0.0 111.372 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -126.41 150.3 48.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.087 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.446 HD13 HG23 ' A' ' 123' ' ' ILE . 29.5 mt -128.92 121.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.146 0.498 . . . . 0.0 112.277 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -130.88 144.77 51.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 75' ' ' THR . . . -168.8 167.42 11.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.4 mt -123.9 145.21 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.645 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -123.87 148.03 47.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.115 0.483 . . . . 0.0 111.868 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.87 142.88 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.859 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.939 -179.9 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.818 0.342 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.83 107.64 13.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 tp -54.35 125.87 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.221 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 22.1 mm -83.58 137.55 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.48 92.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -115.21 163.7 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.13 29.04 3.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 -41.92 3.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.451 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -71.94 178.15 1.43 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 32.3 Cg_exo -57.63 -13.8 15.14 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.787 2.325 . . . . 0.0 113.008 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.39 163.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.896 0.379 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -117.18 125.06 50.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.377 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 mp -144.94 18.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.993 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.06 -137.23 3.45 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.44 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -88.81 32.4 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.844 2.363 . . . . 0.0 113.269 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -152.49 -178.09 6.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.427 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.411 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 10.5 m -136.64 179.7 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.21 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -68.82 -49.75 55.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.944 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -174.6 -177.42 1.18 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.219 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.99 141.59 38.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -117.94 91.05 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.975 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.04 -20.94 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.01 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.05 -108.83 0.78 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.881 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -57.82 -30.26 65.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.048 0.452 . . . . 0.0 110.194 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.65 124.54 42.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.726 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.46 171.62 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.69 164.8 29.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.75 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.7 p -138.46 143.87 39.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.3 p -71.93 179.67 3.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.801 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.31 95.49 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.369 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -66.95 165.09 16.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 111.004 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 8.7 pt -159.48 157.64 27.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.301 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.472 ' HB2' ' HA ' ' B' ' 43' ' ' VAL . 36.5 Cg_exo -58.41 -15.05 22.79 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.094 2.529 . . . . 0.0 113.045 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.397 . . . . 0.0 111.17 179.904 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' B' ' 35' ' ' PRO . 14.6 t . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.852 0.358 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' B' ' 43' ' ' VAL . 51.8 Cg_exo -54.32 153.09 23.37 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.586 2.191 . . . . 0.0 112.424 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.8 60.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.838 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.04 95.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 tp -40.34 -32.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.86 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.57 -48.12 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -48.55 80.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.86 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -65.86 -33.9 76.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.542 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.75 -35.88 70.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.912 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.6 -45.71 78.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.687 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -39.32 85.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.714 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 4.8 t -69.74 -32.23 70.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.648 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.417 HD13 ' CE2' ' B' ' 95' ' ' PHE . 17.3 mt -70.93 -44.97 65.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.59 -42.23 96.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.804 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -58.95 -38.11 78.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.854 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 12.3 t -61.6 -38.01 79.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -30.99 36.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.799 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.58 -41.02 84.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.94 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.51 -42.04 72.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.551 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 17.0 mt -68.41 -33.13 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.48 -42.76 67.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.258 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -21.36 63.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.366 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.39 -28.83 19.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.71 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.99 52.71 0.38 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.619 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mt -161.27 -172.73 3.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.689 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 22.5 p -141.69 165.05 28.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.765 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.513 ' CB ' ' CE1' ' B' ' 101' ' ' HIS . . . -59.68 -32.37 70.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.856 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.517 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -56.63 -26.56 56.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.42 -22.72 35.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.174 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.406 ' CG2' ' HB1' ' B' ' 125' ' ' ALA . 89.7 mt -53.61 110.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 111.24 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.4 m -78.66 -46.11 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.89 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.476 ' HB3' ' HG2' ' B' ' 107' ' ' ARG . 7.5 mttt -119.56 154.4 33.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.316 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.467 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 75.8 p -153.78 102.32 2.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.425 HG21 ' CZ ' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -69.28 124.29 23.45 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -111.04 111.84 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.425 ' CZ ' HG21 ' B' ' 76' ' ' THR . 13.6 m-30 -109.85 133.36 53.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.998 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 3.2 m -130.33 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.14 0.495 . . . . 0.0 111.866 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.69 -1.41 58.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.849 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.27 118.91 0.31 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.488 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' B' ' 111' ' ' GLU . 52.4 mt -62.25 -14.56 39.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.263 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -74.07 -21.89 59.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.91 0.386 . . . . 0.0 110.314 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -87.02 -18.71 29.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.976 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -53.44 -31.0 43.42 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.133 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.95 72.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.278 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.67 -42.81 13.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.338 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.5 t -69.08 -45.83 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.212 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -62.99 -38.51 91.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.09 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.2 73.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.503 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.94 -14.96 33.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.561 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' B' ' 96' ' ' PHE . 12.3 t80 -81.16 -38.36 27.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 111.264 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.421 ' HG3' ' CE1' ' B' ' 104' ' ' PHE . 2.4 tt0 -83.21 -27.89 29.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.545 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.87 -24.31 55.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.794 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.521 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -85.44 -37.35 19.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.672 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.521 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 3.9 m-85 -55.85 -55.18 35.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.172 0.51 . . . . 0.0 109.954 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -32.71 72.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.254 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.92 -6.82 57.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.385 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.716 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 1.5 t-20 -111.84 -4.63 14.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.499 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 15.6 m120 84.38 32.24 0.05 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.786 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.716 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 3.5 m170 -115.82 53.13 0.93 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.618 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 58.5 Cg_endo -70.54 -22.33 28.65 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.565 2.177 . . . . 0.0 112.428 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -50.09 -33.18 17.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.93 0.395 . . . . 0.0 110.865 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.421 ' CE1' ' HG3' ' B' ' 93' ' ' GLU . 13.1 m-85 64.64 130.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.2 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.439 ' HB2' HG21 ' B' ' 75' ' ' THR . 94.0 Cg_endo -88.48 133.64 2.74 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.004 2.469 . . . . 0.0 112.579 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -97.91 128.98 44.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.476 ' HG2' ' HB3' ' B' ' 74' ' ' LYS . 0.0 OUTLIER -162.61 -164.33 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.958 179.325 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.73 114.13 24.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.076 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 14.5 m -92.84 138.42 31.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.21 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 23.0 m -156.74 158.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.985 0.421 . . . . 0.0 111.659 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' B' ' 79' ' ' VAL . 3.6 tt0 -99.05 86.31 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.648 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 29.3 m -57.14 156.93 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.18 82.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.5 -178.22 7.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.728 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 mt -148.84 152.43 37.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.819 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.1 137.73 68.39 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.509 2.139 . . . . 0.0 112.18 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 tptt 75.13 14.12 3.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.249 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.28 13.64 8.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.142 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 23.0 m -58.08 156.84 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.55 9.8 64.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.019 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 pp -176.87 148.18 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.02 0.438 . . . . 0.0 111.39 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -126.34 150.28 48.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.082 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.417 HG23 HD13 ' B' ' 123' ' ' ILE . 29.6 mt -128.96 121.34 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 112.31 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' B' ' 76' ' ' THR . 4.3 tp10 -130.77 144.82 51.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' B' ' 75' ' ' THR . . . -168.8 167.48 11.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 1.4 mt -123.89 145.2 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.661 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -123.86 147.94 47.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.111 0.481 . . . . 0.0 111.867 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 28.9 m -114.75 142.8 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.887 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.85 107.65 13.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 tp -54.37 125.93 10.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.237 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 22.2 mm -83.6 137.51 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.44 92.41 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -115.22 163.68 15.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.13 29.12 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -41.73 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.84 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.439 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -72.4 178.18 1.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.899 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 32.3 Cg_exo -57.56 -13.78 14.85 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.801 2.334 . . . . 0.0 113.003 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.35 163.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.114 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -117.09 125.04 50.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.469 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 mp -144.93 18.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.007 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.09 -137.28 3.45 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.439 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . 0.418 ' HB2' ' CD1' ' B' ' 92' ' ' TYR . 88.0 Cg_endo -88.74 32.36 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.782 2.322 . . . . 0.0 113.254 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.48 -178.03 6.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.868 0.366 . . . . 0.0 111.354 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 10.4 m -136.71 179.72 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.193 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -68.87 -49.62 56.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -174.42 -177.47 1.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.142 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.92 141.56 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.157 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -117.95 91.04 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.96 -21.0 66.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.06 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.1 -108.82 0.78 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.893 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -57.9 -30.2 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.015 0.436 . . . . 0.0 110.189 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.67 124.57 42.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.745 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 m -105.53 171.64 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.076 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.72 164.79 29.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 15.3 p -138.44 143.76 39.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.4 p -72.18 179.54 3.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.27 95.47 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.359 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -66.96 165.19 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 8.7 pt -159.56 157.57 26.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.292 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.479 ' HB2' ' HA ' ' C' ' 43' ' ' VAL . 36.2 Cg_exo -58.4 -15.03 22.68 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.066 2.511 . . . . 0.0 112.997 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.39 . . . . 0.0 111.186 179.872 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' C' ' 35' ' ' PRO . 14.7 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.788 0.328 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.39 153.12 23.62 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.608 2.206 . . . . 0.0 112.404 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.64 60.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.01 95.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.888 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 tp -40.35 -32.94 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.63 -48.17 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.51 80.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.849 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -65.99 -33.9 76.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.45 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.84 -35.93 70.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.996 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.64 -45.63 78.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.696 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -39.33 85.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.682 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 4.8 t -69.74 -32.2 70.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.641 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.99 -44.94 64.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.741 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.58 -42.26 96.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -58.94 -38.15 78.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 12.3 t -61.58 -37.97 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -31.02 36.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.784 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.07 85.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.4 -42.17 73.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.507 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mt -68.38 -33.22 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.593 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.37 -42.83 67.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.291 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.25 -21.3 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.409 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.45 -28.81 19.45 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.714 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.04 52.72 0.37 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.579 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mt -161.26 -172.65 3.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 110.73 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -141.77 165.05 28.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.507 ' CB ' ' CE1' ' C' ' 101' ' ' HIS . . . -59.71 -32.29 70.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.903 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.519 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -56.72 -26.47 57.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.59 -22.67 34.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 90.0 mt -53.62 110.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.191 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.4 m -78.66 -46.05 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.9 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . 0.483 ' HB3' ' HG2' ' C' ' 107' ' ' ARG . 7.5 mttt -119.61 154.38 34.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.295 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' THR . . . . . 0.462 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 76.7 p -153.75 102.33 2.53 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.424 HG21 ' CZ ' ' C' ' 78' ' ' PHE . 0.2 OUTLIER -69.35 124.32 23.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 11.0 t -111.03 111.78 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.424 ' CZ ' HG21 ' C' ' 76' ' ' THR . 13.6 m-30 -109.83 133.45 53.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.989 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 3.1 m -130.38 150.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.132 0.492 . . . . 0.0 111.831 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.64 -1.28 57.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.946 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.32 118.86 0.31 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.431 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' C' ' 111' ' ' GLU . 52.1 mt -62.17 -14.6 39.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.3 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -74.09 -21.84 59.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.868 0.366 . . . . 0.0 110.286 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -87.06 -18.69 29.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.973 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -53.49 -30.94 43.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.141 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.95 72.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.257 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.67 -42.83 13.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.358 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -69.11 -45.76 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.209 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -63.05 -38.51 91.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.044 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.32 -35.3 73.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.487 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.83 -14.99 33.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.511 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.49 ' CE1' ' CE1' ' C' ' 96' ' ' PHE . 12.3 t80 -81.14 -38.36 27.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.0 111.286 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' C' ' 104' ' ' PHE . 2.4 tt0 -83.2 -27.94 29.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.508 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.88 -24.36 55.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.752 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -85.37 -37.36 19.97 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.713 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.523 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 3.9 m-85 -55.83 -55.17 35.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.132 0.492 . . . . 0.0 109.984 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -32.65 72.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.214 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -6.72 56.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.424 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.721 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 1.5 t-20 -111.86 -4.65 14.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.548 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 15.5 m120 84.4 32.17 0.05 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.81 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.721 ' CE1' ' HB3' ' C' ' 99' ' ' ASN . 3.5 m170 -115.79 53.18 0.93 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.587 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 58.5 Cg_endo -70.57 -22.22 28.64 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.519 2.146 . . . . 0.0 112.483 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -50.18 -33.11 18.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 110.879 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' C' ' 93' ' ' GLU . 13.1 m-85 64.59 131.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.184 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.447 ' CB ' ' CG2' ' C' ' 75' ' ' THR . 94.1 Cg_endo -88.5 133.62 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.962 2.442 . . . . 0.0 112.638 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -97.94 129.01 44.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.031 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.483 ' HG2' ' HB3' ' C' ' 74' ' ' LYS . 0.0 OUTLIER -162.61 -164.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 179.298 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.68 114.11 24.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 14.6 m -92.85 138.4 31.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.297 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 23.1 m -156.69 158.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.97 0.414 . . . . 0.0 111.682 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' C' ' 79' ' ' VAL . 3.6 tt0 -99.0 86.32 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.644 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -57.12 156.88 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.219 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.21 82.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.51 -178.2 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.767 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 27.8 mt -148.85 152.42 37.07 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.825 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.13 137.71 68.12 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.523 2.149 . . . . 0.0 112.151 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 tptt 75.16 14.12 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.219 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.25 13.63 8.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.152 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 23.3 m -58.06 156.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.771 0.32 . . . . 0.0 110.965 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.48 10.16 64.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.044 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 pp -177.33 148.18 0.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.063 0.459 . . . . 0.0 111.388 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -126.3 150.34 48.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.096 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . 0.4 HD13 HG23 ' C' ' 123' ' ' ILE . 29.3 mt -128.98 121.31 54.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.502 . . . . 0.0 112.322 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' C' ' 76' ' ' THR . 4.3 tp10 -130.79 144.75 51.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' C' ' 75' ' ' THR . . . -168.75 167.5 11.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . 0.407 HD13 HG22 ' C' ' 126' ' ' ILE . 1.4 mt -123.96 145.27 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.624 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -123.89 147.95 47.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.125 0.488 . . . . 0.0 111.848 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.76 142.87 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.853 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -123.07 47.54 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.926 0.393 . . . . 0.0 110.974 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 4' ' ' GLN . 90.1 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.961 0.41 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.51 ' O ' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 60.57 -173.31 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.873 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 4' ' ' GLN . 1.1 tp 57.67 120.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.907 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.422 HG12 ' HB2' ' A' ' 23' ' ' ASP . 13.7 mt -148.67 134.93 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.252 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.8 138.81 48.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 0.0 111.238 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.07 148.03 42.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.838 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.01 37.16 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -137.88 -45.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.992 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.7 110.95 7.43 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.33 -14.68 45.4 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.517 2.145 . . . . 0.0 112.36 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.77 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.198 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.535 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 61.22 -165.19 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.358 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.8 mt 77.38 17.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.252 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.02 -135.2 3.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.009 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.84 43.13 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.658 2.239 . . . . 0.0 112.568 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -177.33 -176.3 0.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.859 0.362 . . . . 0.0 110.983 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' C' ' 104' ' ' PHE . 16.6 m -115.26 165.25 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.439 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -56.38 -48.25 77.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 110.63 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -161.41 -175.96 5.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.523 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.09 131.47 61.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.975 0.417 . . . . 0.0 111.42 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.422 ' HB2' HG12 ' A' ' 6' ' ' ILE . 61.7 t0 -105.85 86.83 2.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.056 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.7 mt -60.79 -19.58 59.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.154 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.52 -108.49 0.88 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.669 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -57.63 -30.22 65.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.182 0.515 . . . . 0.0 109.948 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 27' ' ' LEU . 3.2 mp -124.16 136.62 54.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.506 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 ' CB ' ' A' ' 127' ' ' ALA . 0.7 OUTLIER -104.7 177.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.253 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.15 133.6 9.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.4 p -110.08 138.78 45.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 0.0 111.118 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.79 175.66 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.84 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.85 84.09 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.298 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.11 152.81 12.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 0.0 111.167 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 pt -132.07 142.1 43.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.023 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.406 ' CB ' ' CG ' ' A' ' 50' ' ' GLN . 90.7 Cg_endo -79.9 53.97 4.99 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.95 2.433 . . . . 0.0 112.975 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.167 0.508 . . . . 0.0 110.575 179.362 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 7.3 p . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.45 0.167 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -50.97 139.61 41.15 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.345 2.03 . . . . 0.0 112.174 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.39 72.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.046 0.451 . . . . 0.0 111.009 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.38 91.66 1.02 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.853 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.0 mm -41.42 -35.05 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.155 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.78 -45.49 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.434 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.81 95.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.408 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.406 ' CG ' ' CB ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -68.39 -32.11 71.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.189 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.56 -38.45 74.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.004 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -70.83 -48.96 51.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.51 -28.18 68.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.779 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -45.61 77.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.795 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.25 -22.28 64.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.9 -54.59 8.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.417 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 58' ' ' VAL . 29.1 p30 -55.72 -30.92 61.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.285 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.407 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 40.3 t -69.32 -50.36 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.929 0.395 . . . . 0.0 110.721 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -67.39 -33.78 75.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.694 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.56 -40.92 84.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.963 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.99 -56.56 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.653 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.429 ' CD1' ' CB ' ' A' ' 127' ' ' ALA . 5.2 tt -64.43 -26.32 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.812 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.44 -41.04 33.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 110.376 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -15.49 63.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.723 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.22 -26.99 17.93 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.954 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.09 44.32 0.49 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.381 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' CB ' HG12 ' A' ' 62' ' ' ILE . 4.5 mt -157.2 139.58 14.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.878 0.371 . . . . 0.0 110.851 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 p -92.73 159.32 15.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.538 ' CB ' ' CE1' ' A' ' 101' ' ' HIS . . . -57.31 -34.79 69.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.515 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -49.71 -27.39 4.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.35 -28.05 47.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.081 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 78.8 mt -44.48 118.47 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.925 0.393 . . . . 0.0 110.984 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.421 ' CB ' ' HG3' ' B' ' 4' ' ' GLN . 10.3 m -83.62 -46.3 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.134 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.424 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 6.8 tttm -141.67 147.73 37.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.604 0.24 . . . . 0.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.42 ' N ' ' HG2' ' A' ' 74' ' ' LYS . 2.3 t -141.59 117.51 10.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.396 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.98 162.57 18.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.4 t -150.8 103.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.932 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.401 ' CD2' HG13 ' C' ' 110' ' ' VAL . 9.5 m-85 -94.06 96.24 9.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.214 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.23 148.48 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.662 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -79.96 -5.06 54.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.017 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.97 143.05 9.17 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.468 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.82 2.13 46.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.24 -19.98 26.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.584 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.91 -29.99 16.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.903 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 35.2 t80 -57.18 -26.31 60.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.05 -35.8 69.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.246 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.95 -33.15 18.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.25 -42.31 66.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 32.2 t30 -67.73 -39.45 84.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.59 -30.46 69.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.28 -32.55 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -58.55 -47.71 83.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.55 -20.87 58.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.282 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 0.1 OUTLIER -77.3 -32.01 55.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.447 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -89.48 -33.34 16.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.116 0.484 . . . . 0.0 110.737 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.502 ' CE2' ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -58.05 -53.68 55.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.893 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -32.09 70.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 94' ' ' ARG . 3.8 pt-20 -72.76 -12.61 61.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.67 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.535 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 6.4 m-80 -102.88 -13.94 16.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.103 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 58.9 m-20 97.48 41.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.986 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.538 ' CE1' ' CB ' ' A' ' 69' ' ' ALA . 3.9 m170 -120.14 52.02 2.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.705 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 74.0 Cg_endo -74.11 -3.74 14.28 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.523 2.149 . . . . 0.0 113.077 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -30.75 69.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.46 ' HB2' ' CG1' ' B' ' 19' ' ' VAL . 15.4 m-85 65.23 113.08 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.59 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.502 ' HD3' ' CE2' ' A' ' 96' ' ' PHE . 78.2 Cg_endo -96.54 151.37 1.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.375 2.717 . . . . 0.0 112.671 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.413 ' CB ' ' HG3' ' A' ' 74' ' ' LYS . . . -60.01 163.36 4.79 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 137.72 10.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.176 0.513 . . . . 0.0 112.03 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.16 84.42 2.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.007 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 52.7 t -90.57 145.23 25.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.208 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.8 m -152.97 132.99 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.088 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -67.22 82.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -67.03 161.71 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.91 -44.21 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.61 164.62 33.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.817 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mt -139.79 159.95 62.87 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.762 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.52 134.64 39.75 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.478 2.119 . . . . 0.0 112.259 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.43 14.31 9.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.41 17.89 8.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.84 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.1 m -53.83 164.77 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.167 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -87.91 -24.38 35.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.646 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -153.25 147.35 25.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.163 0.506 . . . . 0.0 111.27 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.4 ' OE1' ' CD2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -132.39 138.62 47.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.779 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.8 138.02 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.384 0.611 . . . . 0.0 112.324 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.61 107.92 4.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.185 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -121.86 161.63 22.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.3 mp -111.71 155.51 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.027 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.429 ' CB ' ' CD1' ' A' ' 62' ' ' ILE . . . -142.42 149.99 40.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.01 0.433 . . . . 0.0 111.475 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.04 179.64 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.061 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 179.929 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.416 HG21 ' N ' ' B' ' 4' ' ' GLN . 90.1 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.98 0.419 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.507 ' O ' HG23 ' B' ' 5' ' ' ILE . 0.0 OUTLIER 60.39 -173.34 0.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.88 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.507 HG23 ' O ' ' B' ' 4' ' ' GLN . 1.1 tp 57.77 120.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.921 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' B' ' 23' ' ' ASP . 13.6 mt -148.67 134.93 12.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.245 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.81 138.93 48.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 111.171 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.12 148.01 42.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.778 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.09 37.17 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -137.79 -45.37 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.99 110.96 7.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.42 -14.56 44.91 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.453 2.102 . . . . 0.0 112.392 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.81 -167.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.182 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.531 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 61.26 -165.17 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.381 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 21.6 mt 77.33 17.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.253 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.11 -135.24 3.46 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.967 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.83 43.22 1.26 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.619 2.212 . . . . 0.0 112.535 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -177.47 -176.3 0.61 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.923 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.46 ' CG1' ' HB2' ' A' ' 104' ' ' PHE . 16.6 m -115.25 165.27 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . 0.442 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -56.45 -48.42 77.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.032 0.444 . . . . 0.0 110.607 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -161.16 -175.95 5.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.477 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.15 131.45 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.011 0.434 . . . . 0.0 111.369 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' B' ' 6' ' ' ILE . 61.6 t0 -105.82 86.76 2.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.06 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.78 -19.54 59.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.198 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.53 -108.52 0.88 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.669 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -57.66 -30.16 65.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.14 0.495 . . . . 0.0 109.906 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' B' ' 27' ' ' LEU . 3.2 mp -124.21 136.68 54.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.496 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.413 HG21 ' CB ' ' B' ' 127' ' ' ALA . 0.7 OUTLIER -104.72 177.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.173 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.22 133.63 9.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.776 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 81.7 p -110.09 139.28 45.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.884 0.373 . . . . 0.0 111.194 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.86 175.68 10.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.915 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.89 84.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.09 152.81 12.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.899 0.38 . . . . 0.0 111.198 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.405 ' CD1' ' CG2' ' B' ' 36' ' ' VAL . 10.3 pt -132.06 142.14 44.02 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.998 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.409 ' CB ' ' CG ' ' B' ' 50' ' ' GLN . 91.6 Cg_endo -79.92 53.91 4.96 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.931 2.421 . . . . 0.0 112.986 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.405 ' CG2' ' CD1' ' B' ' 34' ' ' ILE . 45.4 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.51 . . . . 0.0 110.586 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 7.4 p . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.537 0.208 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -50.95 139.64 40.9 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.366 2.044 . . . . 0.0 112.144 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.46 72.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.067 0.46 . . . . 0.0 111.031 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.36 91.67 1.01 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.828 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 24.0 mm -41.44 -35.01 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.158 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.86 -45.44 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.397 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.8 95.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.432 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.409 ' CG ' ' CB ' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -68.31 -31.68 71.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.163 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.53 -38.5 74.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.027 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -70.79 -48.91 51.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -60.58 -28.18 68.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.774 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -45.54 78.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.3 -22.28 64.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.88 -54.61 8.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.401 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -55.71 -30.86 61.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.38 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.38 -50.36 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 110.691 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.403 ' HA ' HG21 ' B' ' 62' ' ' ILE . 2.8 ptmm? -67.31 -33.8 76.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.71 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.5 -40.72 83.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.998 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 5.3 mt -65.07 -56.53 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.667 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.431 ' CD1' ' CB ' ' B' ' 127' ' ' ALA . 5.2 tt -64.45 -26.26 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.44 -41.0 34.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.968 0.413 . . . . 0.0 110.423 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -15.5 63.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.74 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.17 -27.0 17.97 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.961 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.08 44.32 0.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.399 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.404 ' CB ' HG12 ' B' ' 62' ' ' ILE . 4.5 mt -157.23 139.6 14.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.807 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 27.2 p -92.73 159.36 15.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.534 ' CB ' ' CE1' ' B' ' 101' ' ' HIS . . . -57.32 -34.79 69.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.499 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -49.71 -27.23 4.53 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.999 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.65 -27.94 45.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 78.8 mt -44.5 118.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 120.897 0.38 . . . . 0.0 111.003 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.411 ' CB ' ' HG3' ' C' ' 4' ' ' GLN . 10.4 m -83.65 -46.24 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.13 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.431 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 6.8 tttm -141.72 147.7 37.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.645 0.26 . . . . 0.0 110.892 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.423 ' N ' ' HG2' ' B' ' 74' ' ' LYS . 2.3 t -141.57 117.42 10.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.43 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.85 162.6 18.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.332 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -150.82 103.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.879 0.371 . . . . 0.0 111.931 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -94.03 96.28 9.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.227 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.24 148.44 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.705 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -80.0 -5.01 54.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.014 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.84 143.09 9.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.458 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.85 2.09 47.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.26 -19.98 26.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.613 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.95 -29.98 16.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' B' ' 89' ' ' ASN . 35.2 t80 -57.2 -26.27 60.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.169 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.85 69.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.324 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.93 -33.18 18.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.27 -42.39 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 32.0 t30 -67.66 -39.49 84.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.65 -30.52 69.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.26 -32.49 22.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -58.48 -47.71 83.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.56 -20.9 58.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.295 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' B' ' 98' ' ' GLU . 0.1 OUTLIER -77.3 -31.95 55.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.493 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.2 OUTLIER -89.51 -33.35 16.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.455 . . . . 0.0 110.741 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.5 ' CE2' ' HD3' ' B' ' 105' ' ' PRO . 0.1 OUTLIER -57.97 -53.7 55.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -32.04 70.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.961 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' B' ' 94' ' ' ARG . 3.8 pt-20 -72.72 -12.62 61.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 0.0 110.625 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.54 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 6.4 m-80 -102.96 -13.93 16.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.099 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 59.2 m-20 97.5 41.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.964 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 4.0 m170 -120.01 52.07 2.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.757 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 74.2 Cg_endo -74.14 -3.76 14.32 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.566 2.178 . . . . 0.0 113.087 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -30.7 69.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.49 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 15.3 m-85 65.16 113.14 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.594 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.5 ' HD3' ' CE2' ' B' ' 96' ' ' PHE . 80.2 Cg_endo -96.67 151.37 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.357 2.705 . . . . 0.0 112.675 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.41 ' CB ' ' HG3' ' B' ' 74' ' ' LYS . . . -59.96 163.34 4.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.6 137.76 10.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.203 0.525 . . . . 0.0 112.017 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.15 84.34 2.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.055 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 52.7 t -90.43 145.27 25.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.265 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' C' ' 78' ' ' PHE . 32.7 m -153.11 133.29 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -67.49 82.05 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -67.02 161.7 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.93 -44.19 20.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.081 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.56 164.66 33.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.805 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mt -139.81 159.96 62.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.783 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.5 134.61 39.59 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.521 2.147 . . . . 0.0 112.254 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.41 14.33 9.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.208 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.38 17.91 8.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.819 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -53.81 164.79 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.14 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -87.89 -24.27 35.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.652 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -153.45 147.41 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.111 0.482 . . . . 0.0 111.238 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.34 138.64 47.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.795 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.8 137.98 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.324 0.583 . . . . 0.0 112.348 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.59 107.91 4.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.214 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -121.91 161.71 22.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.297 0.57 . . . . 0.0 112.507 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 2.3 mp -111.79 155.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.977 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.431 ' CB ' ' CD1' ' B' ' 62' ' ' ILE . . . -142.34 150.06 40.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.403 . . . . 0.0 111.527 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.1 179.67 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.977 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.948 179.888 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 3' ' ' THR . . . . . 0.414 HG21 ' N ' ' C' ' 4' ' ' GLN . 90.1 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.934 0.397 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . 0.514 ' O ' HG23 ' C' ' 5' ' ' ILE . 0.0 OUTLIER 60.56 -173.35 0.12 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.824 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . 0.514 HG23 ' O ' ' C' ' 4' ' ' GLN . 1.1 tp 57.67 120.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.916 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.411 HG12 ' HB2' ' C' ' 23' ' ' ASP . 13.5 mt -148.66 134.95 12.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.247 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -131.85 138.86 48.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 111.205 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.12 148.01 42.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.835 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.06 37.11 1.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -137.91 -45.97 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.4 111.0 7.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.092 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.41 -14.62 45.23 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.496 2.131 . . . . 0.0 112.396 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.78 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.2 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.536 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 61.2 -165.16 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.385 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 21.9 mt 77.33 17.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.262 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.01 -135.2 3.46 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.029 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.85 43.15 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 112.561 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.536 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -177.34 -176.29 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.986 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.49 ' CG1' ' HB2' ' B' ' 104' ' ' PHE . 16.5 m -115.25 165.32 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . 0.443 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -56.38 -47.87 78.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.099 0.476 . . . . 0.0 110.519 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.02 -175.78 4.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.514 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.08 131.42 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.409 . . . . 0.0 111.351 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . 0.411 ' HB2' HG12 ' C' ' 6' ' ' ILE . 61.6 t0 -105.85 86.88 2.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.093 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 31.5 mt -60.82 -19.61 60.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.154 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.54 -108.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.693 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -57.62 -30.21 65.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.159 0.504 . . . . 0.0 109.917 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 mp -124.22 136.62 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.482 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.416 HG21 ' CB ' ' C' ' 127' ' ' ALA . 0.7 OUTLIER -104.7 177.17 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.249 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.2 133.54 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 81.3 p -109.94 138.16 46.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.83 0.348 . . . . 0.0 110.971 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.42 175.37 10.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.84 84.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.284 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.06 152.81 12.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 111.191 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' C' ' 36' ' ' VAL . 10.3 pt -132.05 142.17 44.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.422 ' CB ' ' CG ' ' C' ' 50' ' ' GLN . 91.8 Cg_endo -80.0 53.93 4.97 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.964 2.443 . . . . 0.0 112.975 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . 0.407 ' CG2' ' CD1' ' C' ' 34' ' ' ILE . 45.7 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.134 0.492 . . . . 0.0 110.537 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 7.4 p . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.407 0.146 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -50.97 139.64 41.05 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.318 2.012 . . . . 0.0 112.161 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.44 72.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.026 0.441 . . . . 0.0 111.001 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.46 91.7 1.05 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 24.1 mm -41.33 -35.13 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.192 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.79 -45.41 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.467 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.76 95.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.438 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . 0.422 ' CG ' ' CB ' ' C' ' 35' ' ' PRO . 0.0 OUTLIER -68.7 -32.44 72.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.214 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.88 -38.5 73.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.116 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -70.76 -48.9 51.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.55 -28.12 68.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.799 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -45.6 77.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 mt -68.38 -22.2 64.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.94 -54.53 8.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.417 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' C' ' 58' ' ' VAL . 29.2 p30 -55.8 -30.9 62.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.304 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.403 ' N ' ' OD1' ' C' ' 57' ' ' ASN . 40.3 t -69.31 -50.33 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 110.744 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.403 ' HA ' HG21 ' C' ' 62' ' ' ILE . 2.8 ptmm? -67.36 -33.84 76.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.753 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.52 -41.08 84.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.057 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 5.3 mt -65.17 -56.47 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.748 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . 0.417 ' CD1' ' CB ' ' C' ' 127' ' ' ALA . 5.2 tt -64.52 -26.19 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.826 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.53 -41.01 33.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.873 0.368 . . . . 0.0 110.335 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -15.48 63.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.724 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.12 -27.01 18.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.856 0.36 . . . . 0.0 111.003 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.15 44.24 0.49 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.36 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . 0.405 ' CB ' HG12 ' C' ' 62' ' ' ILE . 4.5 mt -157.21 139.59 14.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.385 . . . . 0.0 110.828 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 27.1 p -92.75 159.38 15.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.782 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.534 ' CB ' ' CE1' ' C' ' 101' ' ' HIS . . . -57.34 -34.76 69.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.8 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.513 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -49.77 -27.4 4.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.909 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.07 -27.99 48.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.046 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 78.8 mt -44.47 118.42 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.901 0.381 . . . . 0.0 111.003 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.427 ' CB ' ' HG3' ' A' ' 4' ' ' GLN . 10.3 m -83.58 -46.26 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.196 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . 0.43 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 6.8 tttm -141.7 147.7 37.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.626 0.25 . . . . 0.0 110.966 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' THR . . . . . 0.426 ' N ' ' HG2' ' C' ' 74' ' ' LYS . 2.3 t -141.52 117.5 10.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.41 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.98 162.56 18.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.309 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.4 t -150.81 103.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.366 . . . . 0.0 111.929 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.422 ' CD2' HG13 ' B' ' 110' ' ' VAL . 9.5 m-85 -94.04 96.32 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.187 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.27 148.46 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.652 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -79.98 -5.21 55.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.027 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.87 143.06 9.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.454 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.87 2.11 47.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.27 -19.94 26.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.571 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.93 -29.99 16.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 35.1 t80 -57.24 -26.24 60.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.129 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.84 69.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.248 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.98 -33.11 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.23 -42.35 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 31.9 t30 -67.68 -39.52 84.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.43 -30.4 69.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.063 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.41 -32.48 22.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -58.58 -47.71 83.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -75.57 -20.84 58.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.281 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' C' ' 98' ' ' GLU . 0.1 OUTLIER -77.39 -31.87 54.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.453 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.2 OUTLIER -89.53 -33.37 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 110.672 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.507 ' CG ' ' HB2' ' C' ' 101' ' ' HIS . 0.1 OUTLIER -57.94 -53.78 54.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.866 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -32.09 70.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.934 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' C' ' 94' ' ' ARG . 3.8 pt-20 -72.73 -12.6 61.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.652 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.537 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 6.5 m-80 -102.9 -13.97 16.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.089 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 59.1 m-20 97.49 41.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.974 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.537 ' CE1' ' HB3' ' C' ' 99' ' ' ASN . 3.9 m170 -119.95 51.99 2.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.76 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 74.0 Cg_endo -74.12 -3.77 14.33 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.549 2.166 . . . . 0.0 113.086 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -30.69 69.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.846 0.355 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.47 ' HB2' ' CG1' ' A' ' 19' ' ' VAL . 15.4 m-85 65.18 113.1 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.638 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.486 ' HD3' ' CE2' ' C' ' 96' ' ' PHE . 79.1 Cg_endo -96.61 151.3 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.388 2.725 . . . . 0.0 112.691 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . 0.407 ' CB ' ' HG3' ' C' ' 74' ' ' LYS . . . -59.92 163.39 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.68 137.73 10.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.21 0.528 . . . . 0.0 112.067 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.19 84.45 2.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.975 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 52.6 t -90.6 145.21 25.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . 0.401 HG13 ' CD2' ' A' ' 78' ' ' PHE . 32.8 m -152.97 132.82 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.051 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -67.17 82.04 0.13 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.1 161.71 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.93 -44.17 20.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.63 164.65 33.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mt -139.76 159.98 62.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.57 134.61 40.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.471 2.114 . . . . 0.0 112.283 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.44 14.37 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.174 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.35 17.97 8.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.793 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -53.84 164.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.115 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.14 -24.47 34.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.592 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -153.27 147.33 25.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.13 0.491 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.39 138.62 47.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.773 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.78 138.02 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.371 0.605 . . . . 0.0 112.286 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.56 107.94 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.19 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -121.95 161.74 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.34 0.591 . . . . 0.0 112.486 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 2.3 mp -111.78 155.45 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.998 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.417 ' CB ' ' CD1' ' C' ' 62' ' ' ILE . . . -142.4 150.04 40.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.027 0.442 . . . . 0.0 111.47 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.03 179.71 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.042 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -162.23 45.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.921 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.787 0.327 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.59 121.0 7.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -56.3 141.66 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.172 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 mt -92.58 146.42 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.271 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.416 ' CD2' ' HG3' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -151.28 117.32 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.699 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 t -129.29 161.58 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.031 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.68 24.85 6.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 -51.95 3.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.63 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.06 112.82 38.66 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.018 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -60.66 -16.16 41.55 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.446 2.097 . . . . 0.0 112.531 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.76 -168.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.293 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.592 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 63.65 -167.48 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.341 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.4 mm 78.26 16.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.239 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.21 -134.69 3.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.141 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.91 23.17 0.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.657 2.238 . . . . 0.0 112.868 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.592 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -154.18 -168.73 3.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.764 0.316 . . . . 0.0 110.822 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.86 172.23 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.264 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.416 ' HG3' ' CD2' ' A' ' 7' ' ' HIS . 0.3 OUTLIER -67.59 -55.09 14.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.866 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.78 178.5 10.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.038 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.96 134.31 65.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -117.77 96.3 5.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.839 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.35 -20.39 57.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.984 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.89 -106.02 0.73 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.825 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -59.58 -29.59 68.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 110.148 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.15 120.12 32.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.866 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.1 m -111.13 167.51 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.992 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.84 155.33 38.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.838 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -117.51 136.03 53.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.945 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 55.7 m -68.74 167.04 16.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.11 82.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.323 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -76.38 145.95 39.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.097 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 8.3 pt -128.49 160.31 63.2 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.436 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 84.7 Cg_exo -43.3 -47.85 8.6 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.721 2.281 . . . . 0.0 111.778 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.751 178.908 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 8.2 p . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 120.356 0.122 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 14.2 Cg_exo -69.97 143.57 50.22 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.606 2.204 . . . . 0.0 112.226 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.65 63.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.079 0.466 . . . . 0.0 110.957 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.3 96.05 0.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.617 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.01 -32.16 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.629 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.07 -52.45 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.592 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.33 -28.49 70.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.478 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.436 ' HG2' ' CG ' ' A' ' 35' ' ' PRO . 0.9 OUTLIER -79.75 -28.68 40.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.458 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.49 58.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.031 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -74.42 -41.74 60.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.083 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.21 -43.81 87.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.026 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.6 m -59.51 -43.62 93.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -66.4 -35.41 80.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.988 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.88 -38.27 82.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.011 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.64 -36.41 84.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 t -69.82 -46.94 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.947 0.403 . . . . 0.0 110.943 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -31.37 65.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.827 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.77 91.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 mt -65.44 -56.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.413 ' CD1' ' CB ' ' A' ' 127' ' ' ALA . 4.9 tt -63.83 -26.22 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.742 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 -40.12 60.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.374 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -10.78 59.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.788 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.84 -29.62 18.48 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.875 0.369 . . . . 0.0 110.905 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.61 52.42 0.33 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.52 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mt -147.88 -169.89 3.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.09 160.09 41.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.99 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.56 72.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.119 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.534 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -62.82 -17.18 60.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.461 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.28 -24.57 27.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.814 0.34 . . . . 0.0 110.829 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 47.0 mt -53.71 118.55 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.128 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.4 m -89.28 -37.19 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.707 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -141.25 149.33 41.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.705 0.288 . . . . 0.0 110.774 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' A' ' 74' ' ' LYS . 89.3 m -144.96 110.36 5.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.95 0.405 . . . . 0.0 111.323 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.8 m -95.22 157.81 15.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.246 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 3.3 m -159.1 142.46 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.084 0.468 . . . . 0.0 111.761 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.434 ' CD2' HG11 ' C' ' 110' ' ' VAL . 3.5 m-85 -114.0 119.09 36.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.283 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.409 HG11 ' CD1' ' A' ' 85' ' ' PHE . 33.2 m -107.34 152.23 9.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.114 0.483 . . . . 0.0 111.735 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.51 0.17 39.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.821 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -163.28 107.5 1.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.566 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.87 -13.89 60.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.222 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -79.66 -27.79 40.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.909 0.385 . . . . 0.0 110.493 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.32 -12.18 55.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.831 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.409 ' CD1' HG11 ' A' ' 79' ' ' VAL . 1.6 t80 -58.63 -24.52 61.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.82 -56.52 11.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.352 . . . . 0.0 111.38 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.48 -36.83 83.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 t -64.8 -42.07 93.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.16 -42.32 89.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.481 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.81 75.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.895 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -88.69 -30.01 19.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.693 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.428 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 58.7 t80 -57.72 -49.7 75.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.014 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.44 -17.49 45.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -75.12 -27.92 60.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.658 0.265 . . . . 0.0 111.38 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -86.19 -33.35 20.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.38 . . . . 0.0 110.525 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.471 ' CZ ' ' CD ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -56.27 -55.7 30.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.334 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.62 -28.81 70.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.889 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.47 -6.22 59.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.35 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 1.5 m120 -111.47 -5.13 14.62 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.56 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.0 m120 85.42 33.31 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.803 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.534 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 20.1 t-160 -128.88 67.3 77.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.529 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.416 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 4.5 Cg_exo -75.48 -20.24 16.13 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.602 2.202 . . . . 0.0 112.525 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.15 -36.69 77.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.063 0.459 . . . . 0.0 110.344 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' A' ' 102' ' ' PRO . 15.8 m-85 74.06 142.56 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.427 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.471 ' CD ' ' CZ ' ' A' ' 96' ' ' PHE . 73.2 Cg_endo -90.07 165.88 4.71 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.209 2.606 . . . . 0.0 111.956 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.1 154.11 1.24 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.421 ' CB ' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -119.02 140.98 49.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.227 0.537 . . . . 0.0 112.048 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.6 t -144.28 45.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.986 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 28.7 p -81.37 135.08 35.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.249 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.448 HG11 ' CD2' ' B' ' 78' ' ' PHE . 23.0 m -153.85 149.34 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.203 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.418 ' HB3' ' CB ' ' B' ' 114' ' ' ARG . 0.0 OUTLIER -84.4 91.04 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.771 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.15 177.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.188 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.83 -45.95 14.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.005 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.72 -179.72 7.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.788 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 mt -149.2 155.6 39.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.704 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 9.2 Cg_endo -52.33 139.23 55.06 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.523 2.149 . . . . 0.0 111.977 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 7.9 mmtm 66.46 17.72 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.278 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 61.63 17.45 8.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.025 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.1 m -55.76 167.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.073 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.03 8.49 42.24 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.918 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.58 154.6 3.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.086 0.469 . . . . 0.0 111.226 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.2 159.01 43.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.002 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.9 mt -144.25 145.75 21.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.38 0.609 . . . . 0.0 112.301 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.16 101.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.322 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 75' ' ' THR . . . -119.07 163.59 16.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.171 0.51 . . . . 0.0 112.194 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 126' ' ' ILE . 5.7 mt -114.43 151.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.133 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.413 ' CB ' ' CD1' ' A' ' 62' ' ' ILE . . . -136.06 148.39 48.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.034 0.445 . . . . 0.0 111.574 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.92 151.44 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.122 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.819 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.811 0.338 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.58 120.97 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -56.26 141.66 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mt -92.61 146.33 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.318 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.2 117.41 5.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.718 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 14.3 t -129.32 161.6 29.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.036 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.69 24.85 6.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.807 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.5 -52.47 3.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.677 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.5 112.93 38.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.7 -16.16 41.84 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.436 2.09 . . . . 0.0 112.473 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.75 -168.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.252 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.601 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 63.73 -167.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.315 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 19.4 mm 78.23 16.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.288 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.26 -134.73 3.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.163 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.84 23.18 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.685 2.256 . . . . 0.0 112.926 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.601 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -154.13 -168.71 3.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.755 0.312 . . . . 0.0 110.829 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 104' ' ' PHE . 15.5 m -124.88 172.31 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.362 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.71 -55.16 14.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.802 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.13 178.44 10.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.995 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 m -127.88 134.27 65.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.082 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -117.67 96.23 5.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.34 -20.42 57.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.002 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.97 -106.03 0.73 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.83 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -59.62 -29.51 68.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.038 0.447 . . . . 0.0 110.152 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.19 120.07 32.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.872 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 5.1 m -111.07 167.54 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.01 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.91 155.31 38.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -117.38 135.8 53.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 56.5 m -68.89 166.97 16.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.13 82.13 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.307 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -76.39 145.89 39.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.357 . . . . 0.0 111.15 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' B' ' 35' ' ' PRO . 8.2 pt -128.48 160.3 63.23 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.545 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.437 ' CG ' ' HG2' ' B' ' 50' ' ' GLN . 84.5 Cg_exo -43.2 -47.93 8.38 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.755 2.303 . . . . 0.0 111.753 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.717 178.957 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 8.2 p . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 120.368 0.128 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 43' ' ' VAL . 14.2 Cg_exo -69.96 143.6 50.38 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.636 2.224 . . . . 0.0 112.214 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.65 63.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.995 0.426 . . . . 0.0 110.896 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.22 96.05 0.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.677 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.0 -32.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.589 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.95 -52.51 15.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.64 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.35 -28.43 69.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.469 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.437 ' HG2' ' CG ' ' B' ' 35' ' ' PRO . 0.9 OUTLIER -79.76 -28.61 40.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.485 179.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.51 -35.45 58.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -74.38 -41.76 60.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.23 -43.75 87.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -59.47 -43.62 93.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.034 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 75.2 mt -66.44 -35.34 80.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.89 -38.35 82.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.6 -36.35 83.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.06 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 t -69.85 -46.91 72.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 0.0 110.956 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.4 ' HA ' HG22 ' B' ' 62' ' ' ILE . 0.0 OUTLIER -72.6 -31.29 65.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.812 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.24 -40.85 91.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.932 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 mt -65.48 -56.86 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.419 ' CD1' ' CB ' ' B' ' 127' ' ' ALA . 5.0 tt -63.83 -26.2 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.725 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -40.07 60.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.924 0.393 . . . . 0.0 110.446 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -10.84 59.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.812 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.78 -29.72 18.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.69 52.42 0.32 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mt -147.94 -169.94 3.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 110.577 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.08 160.14 40.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.982 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.98 -33.52 72.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.05 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.535 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -62.83 -17.17 60.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.448 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.16 -24.64 27.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 110.805 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.69 118.53 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.095 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 12.5 m -89.23 -37.22 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.73 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -141.21 149.37 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.708 0.29 . . . . 0.0 110.78 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' B' ' 74' ' ' LYS . 89.2 m -144.99 110.29 5.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 87.8 m -95.09 157.75 15.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.242 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' B' ' 109' ' ' CYS . 3.2 m -159.05 142.5 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.758 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.448 ' CD2' HG11 ' A' ' 110' ' ' VAL . 3.5 m-85 -114.01 119.09 36.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.248 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' B' ' 85' ' ' PHE . 33.9 m -107.33 152.18 9.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.125 0.488 . . . . 0.0 111.765 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.53 -0.14 38.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.817 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.85 107.51 1.11 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.578 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.99 -13.78 60.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.215 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -79.67 -27.85 40.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 0.0 110.484 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.27 -12.17 55.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.864 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.411 ' CD1' HG11 ' B' ' 79' ' ' VAL . 1.6 t80 -58.68 -24.43 61.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.007 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.87 -56.52 11.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 111.331 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.83 83.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 34.3 t -64.83 -42.06 93.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.715 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.18 -42.2 89.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.5 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.04 -36.09 76.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.938 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -88.45 -29.96 19.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.724 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.419 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 58.6 t80 -57.75 -49.66 75.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.028 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.47 -17.46 45.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.504 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -75.09 -27.94 60.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.699 0.285 . . . . 0.0 111.414 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.449 ' C ' ' CD1' ' B' ' 95' ' ' PHE . 0.9 OUTLIER -86.15 -33.48 20.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.499 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' B' ' 101' ' ' HIS . 0.9 OUTLIER -56.19 -55.76 29.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.344 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.54 -28.9 70.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.914 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -6.24 59.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.397 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 1.5 m120 -111.41 -5.15 14.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 6.9 m120 85.44 33.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.894 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.535 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.1 t-160 -128.81 67.42 77.46 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.534 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.416 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 4.6 Cg_exo -75.48 -20.25 16.12 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.621 2.214 . . . . 0.0 112.519 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -36.68 77.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.307 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.427 ' O ' HG11 ' C' ' 19' ' ' VAL . 15.8 m-85 74.07 142.52 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.453 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.462 ' CD ' ' CZ ' ' B' ' 96' ' ' PHE . 72.2 Cg_endo -90.09 165.86 4.69 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.107 2.538 . . . . 0.0 111.98 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.409 ' CB ' ' HG3' ' B' ' 74' ' ' LYS . . . -50.02 154.18 1.19 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.451 ' CB ' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -119.1 141.0 49.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.215 0.531 . . . . 0.0 112.068 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 30.8 t -144.26 45.83 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.954 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 77' ' ' VAL . 28.7 p -81.44 135.02 35.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.277 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' C' ' 78' ' ' PHE . 23.4 m -153.7 149.06 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.149 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.49 91.04 7.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.822 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.15 177.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.206 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.79 -45.92 14.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.418 ' CB ' ' HB3' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -151.7 -179.53 7.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.753 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 59.5 mt -149.33 155.56 39.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.669 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' B' ' 117' ' ' LYS . 9.3 Cg_endo -52.35 139.25 55.23 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.537 2.158 . . . . 0.0 111.987 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 8.0 mmtm 66.38 17.81 10.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.253 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 61.53 17.52 8.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.065 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 30.3 m -55.8 167.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.062 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.11 8.12 41.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.888 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.47 154.5 3.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.165 0.507 . . . . 0.0 111.296 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.12 158.95 43.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.025 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 28.2 mt -144.21 145.75 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.309 0.576 . . . . 0.0 112.309 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.17 101.48 1.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.344 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' B' ' 75' ' ' THR . . . -119.02 163.56 16.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.198 0.523 . . . . 0.0 112.245 -178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.429 HG23 HD11 ' B' ' 126' ' ' ILE . 5.7 mt -114.41 151.9 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.114 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.419 ' CB ' ' CD1' ' B' ' 62' ' ' ILE . . . -136.06 148.32 48.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.993 0.425 . . . . 0.0 111.618 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.82 151.38 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.84 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.84 0.352 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.56 121.02 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -56.31 141.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 32.0 mt -92.61 146.37 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.234 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . 0.409 ' CD2' ' HG3' ' C' ' 20' ' ' GLN . 0.1 OUTLIER -151.24 117.37 5.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.705 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 14.3 t -129.3 161.61 29.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.037 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.72 24.89 6.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 -52.34 3.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.751 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.62 112.86 37.78 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.05 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.65 -16.13 41.34 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.436 2.09 . . . . 0.0 112.525 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.8 -168.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.249 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.608 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 63.69 -167.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.332 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 19.4 mm 78.26 16.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.215 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.21 -134.78 3.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.14 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.8 23.16 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.609 2.206 . . . . 0.0 112.9 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.608 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -154.1 -168.61 3.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.738 0.304 . . . . 0.0 110.855 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.427 HG11 ' O ' ' B' ' 104' ' ' PHE . 15.4 m -124.97 172.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.29 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . 0.409 ' HG3' ' CD2' ' C' ' 7' ' ' HIS . 0.3 OUTLIER -67.61 -55.01 15.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.936 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.95 178.57 10.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.026 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 m -127.92 134.21 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -117.73 96.32 5.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.37 -20.36 57.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.0 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.92 -106.03 0.73 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.839 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.62 -29.55 68.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.119 0.485 . . . . 0.0 110.186 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.2 120.08 32.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 m -111.06 167.52 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.83 155.35 39.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.2 p -117.52 135.91 53.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.862 0.363 . . . . 0.0 110.914 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 56.3 m -68.55 166.99 15.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.818 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.03 82.14 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.341 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -76.43 145.92 38.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 111.178 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.419 ' HB ' ' HD2' ' C' ' 35' ' ' PRO . 8.3 pt -128.47 160.32 63.08 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.574 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.442 ' CG ' ' HG2' ' C' ' 50' ' ' GLN . 85.6 Cg_exo -43.22 -47.92 8.43 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.73 2.286 . . . . 0.0 111.757 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' C' ' 35' ' ' PRO . 9.8 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.769 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' C' ' 44' ' ' PRO . 8.2 p . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.41 0.148 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' C' ' 43' ' ' VAL . 14.2 Cg_exo -69.97 143.63 50.4 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.616 2.21 . . . . 0.0 112.235 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.62 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.044 0.45 . . . . 0.0 110.897 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.29 96.06 0.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.602 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.03 -32.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.605 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.95 -52.53 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.623 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.36 -28.45 70.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.492 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . 0.442 ' HG2' ' CG ' ' C' ' 35' ' ' PRO . 0.9 OUTLIER -79.69 -28.52 40.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.452 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.54 58.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -74.23 -41.87 60.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.24 -43.72 87.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -59.47 -43.71 93.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.38 -35.38 80.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.003 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.86 -38.3 82.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.014 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.63 -36.34 83.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.9 -46.93 72.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.923 0.392 . . . . 0.0 110.936 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -31.47 65.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.764 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.8 90.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.907 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 mt -65.39 -56.78 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.71 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . 0.418 ' CD1' ' CB ' ' C' ' 127' ' ' ALA . 4.9 tt -63.89 -26.19 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.746 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -40.03 60.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.921 0.391 . . . . 0.0 110.431 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -10.75 59.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.8 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.89 -29.64 18.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.837 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.63 52.42 0.33 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.485 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mt -147.91 -169.89 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 110.585 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.12 160.15 40.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.032 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.5 72.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.53 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -62.92 -17.31 61.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.42 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.18 -24.43 27.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.784 0.326 . . . . 0.0 110.786 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 47.1 mt -53.79 118.62 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.08 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 12.5 m -89.32 -37.16 9.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.693 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -141.26 149.36 41.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.782 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' THR . . . . . 0.43 ' N ' ' HG2' ' C' ' 74' ' ' LYS . 89.5 m -145.0 110.31 5.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.92 0.391 . . . . 0.0 111.343 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 87.8 m -95.14 157.82 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.217 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' C' ' 109' ' ' CYS . 3.3 m -159.15 142.47 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.081 0.467 . . . . 0.0 111.774 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.43 ' CD2' HG11 ' B' ' 110' ' ' VAL . 3.5 m-85 -114.0 119.07 35.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.283 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . 0.407 HG11 ' CD1' ' C' ' 85' ' ' PHE . 33.5 m -107.31 152.23 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.102 0.477 . . . . 0.0 111.744 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.55 -0.15 38.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.806 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.85 107.45 1.11 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.572 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.89 -13.82 60.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.213 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -79.69 -27.78 40.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.482 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.29 -12.17 55.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.83 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.407 ' CD1' HG11 ' C' ' 79' ' ' VAL . 1.6 t80 -58.7 -24.45 61.43 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.996 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.86 -56.51 11.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.338 . . . . 0.0 111.353 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.82 83.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 t -64.84 -42.07 93.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.72 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.13 -42.35 89.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.483 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.97 76.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.865 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -88.63 -29.88 19.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.7 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.424 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 59.0 t80 -57.77 -49.68 75.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.011 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.46 -17.46 45.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.496 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -75.1 -27.91 60.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.711 0.291 . . . . 0.0 111.381 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.9 OUTLIER -86.19 -33.45 20.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 110.493 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.461 ' CZ ' ' CD ' ' C' ' 105' ' ' PRO . 0.9 OUTLIER -56.2 -55.79 28.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.329 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.53 -28.91 70.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.882 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.39 -6.24 59.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.381 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 1.5 m120 -111.43 -5.14 14.64 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.588 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 6.9 m120 85.45 33.18 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.851 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.53 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.1 t-160 -128.89 67.38 77.73 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.481 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 4.5 Cg_exo -75.42 -20.32 16.16 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.667 2.244 . . . . 0.0 112.528 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -36.77 77.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.452 . . . . 0.0 110.336 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.417 ' CE2' ' O ' ' C' ' 102' ' ' PRO . 15.8 m-85 74.1 142.56 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.404 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.461 ' CD ' ' CZ ' ' C' ' 96' ' ' PHE . 73.5 Cg_endo -90.12 165.85 4.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.176 2.584 . . . . 0.0 111.929 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . 0.4 ' CB ' ' HG3' ' C' ' 74' ' ' LYS . . . -49.99 154.03 1.22 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.448 ' CB ' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -119.0 140.98 49.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.275 0.559 . . . . 0.0 112.086 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 30.5 t -144.28 45.87 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.963 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' C' ' 77' ' ' VAL . 28.8 p -81.44 135.01 35.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.312 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . 0.434 HG11 ' CD2' ' A' ' 78' ' ' PHE . 23.1 m -153.82 149.23 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.19 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.24 91.0 7.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.72 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.16 177.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.246 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.8 -46.0 14.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.999 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.71 -179.79 7.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 59.7 mt -149.14 155.58 40.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.727 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' C' ' 117' ' ' LYS . 9.2 Cg_endo -52.31 139.22 54.9 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.536 2.157 . . . . 0.0 111.992 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 8.0 mmtm 66.45 17.73 10.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.212 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 61.64 17.43 8.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.042 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -55.71 167.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.106 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -105.86 8.35 42.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.914 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.37 154.46 3.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.069 0.461 . . . . 0.0 111.22 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.12 159.0 43.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.027 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 27.8 mt -144.26 145.75 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.359 0.599 . . . . 0.0 112.334 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.17 101.49 1.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.333 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' C' ' 75' ' ' THR . . . -119.04 163.57 16.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.203 0.525 . . . . 0.0 112.185 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . 0.42 HG23 HD11 ' C' ' 126' ' ' ILE . 5.7 mt -114.4 151.87 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.099 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.418 ' CB ' ' CD1' ' C' ' 62' ' ' ILE . . . -136.03 148.39 48.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 0.0 111.629 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.89 151.42 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.12 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.09 70.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.811 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -171.06 125.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -56.54 141.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.9 mt -98.01 149.84 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.24 26.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.27 171.11 20.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.3 28.44 8.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.033 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -120.5 -44.96 2.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.712 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.485 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . . . -66.55 171.48 4.23 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.868 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 11' ' ' ALA . 29.6 Cg_endo -63.6 -12.68 32.33 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.572 2.181 . . . . 0.0 112.523 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.44 147.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.492 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . . . -126.28 120.95 31.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.838 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.23 17.1 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.073 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.92 -118.88 2.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.382 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.81 14.92 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.675 2.25 . . . . 0.0 113.316 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -147.04 -174.06 4.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.994 0.426 . . . . 0.0 111.517 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 18.0 m -138.61 169.34 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.798 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -49.09 79.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.602 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.02 -178.07 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.962 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 m -141.48 133.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HA ' HG23 ' A' ' 28' ' ' VAL . 37.6 t70 -110.8 115.39 29.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.839 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mt -90.98 -16.03 28.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -99.3 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.755 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -56.91 -29.12 62.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.183 0.516 . . . . 0.0 110.072 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.21 135.19 38.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.774 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.413 ' CG1' ' CB ' ' A' ' 127' ' ' ALA . 4.8 p -109.51 164.55 5.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.871 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.6 131.28 22.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.835 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.3 p -104.71 144.9 31.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.2 p -82.98 178.88 7.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.4 89.73 0.82 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.195 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -56.22 144.25 30.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.5 tt -125.51 132.89 24.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.702 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.528 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 21.9 Cg_exo -65.02 65.24 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.666 2.244 . . . . 0.0 112.56 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 121.122 0.487 . . . . 0.0 110.625 179.41 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 7.2 p . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.509 0.195 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.29 138.98 23.02 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.354 2.036 . . . . 0.0 112.191 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.73 -31.08 71.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.061 0.458 . . . . 0.0 110.902 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 94.9 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.904 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.5 mm -44.26 -31.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.878 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.78 -38.8 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.576 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.75 -54.34 36.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.47 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.38 -26.4 68.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.341 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.88 -40.77 72.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.4 -48.82 16.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.789 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.53 -46.73 88.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.745 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.422 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 89.2 p -60.05 -37.25 79.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD23 ' CD2' ' A' ' 92' ' ' TYR . 22.0 mt -76.54 -23.41 53.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.043 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -52.14 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.7 OUTLIER -58.08 -29.19 65.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.982 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.403 HG21 ' ND2' ' A' ' 57' ' ' ASN . 54.4 t -65.06 -46.39 91.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.984 0.421 . . . . 0.0 110.643 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -28.96 61.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.844 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.74 93.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.025 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.8 mt -73.59 -41.77 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 mt -69.48 -31.24 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.553 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.61 -37.33 59.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.034 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -22.41 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.272 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.87 -28.82 20.1 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.787 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.97 50.51 0.63 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.591 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -146.66 -176.56 5.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.409 . . . . 0.0 110.716 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.77 163.83 31.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.778 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.459 ' O ' ' CD2' ' A' ' 101' ' ' HIS . . . -50.26 -34.57 23.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.031 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -67.49 -24.78 65.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.359 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -80.46 -6.58 58.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.717 0.294 . . . . 0.0 110.959 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 24.2 mt -83.81 116.1 27.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.249 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.58 -46.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.041 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -118.41 -177.6 3.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.59 0.233 . . . . 0.0 111.093 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.519 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 11.1 t -179.99 101.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.895 0.378 . . . . 0.0 111.496 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.437 HG21 ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -71.21 126.72 30.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.198 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.8 t -114.71 98.88 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.437 ' CE1' HG21 ' A' ' 76' ' ' THR . 17.2 m-85 -98.17 147.49 24.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.951 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -144.76 151.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.09 0.471 . . . . 0.0 111.899 -179.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.0 -2.6 56.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.764 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.29 110.31 0.57 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.416 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.0 mt -56.81 -18.6 13.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.322 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -75.86 -23.47 55.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.844 0.354 . . . . 0.0 110.583 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -77.97 -12.77 60.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -27.21 59.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.252 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.46 71.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.779 0.323 . . . . 0.0 111.415 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.88 -29.45 20.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.287 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.2 t -73.84 -47.1 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.153 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -64.86 -39.32 93.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.47 -37.27 85.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -33.34 19.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.621 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 96' ' ' PHE . 35.3 t80 -61.16 -56.47 20.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.346 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -70.19 -15.29 62.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.333 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -40.06 66.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -84.95 -38.78 18.91 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.342 -179.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.493 ' CE1' ' CE1' ' A' ' 92' ' ' TYR . 11.1 m-85 -53.92 -50.63 65.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 110.32 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.94 -32.36 74.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.875 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.65 -1.9 54.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.432 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -110.4 -8.6 14.67 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.66 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.7 t-20 97.08 19.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.796 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.523 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.3 t60 -118.77 59.93 4.32 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.858 0.361 . . . . 0.0 110.927 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.403 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 43.9 Cg_endo -68.19 -17.78 45.16 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.493 2.129 . . . . 0.0 112.175 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -34.2 61.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.7 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 33.2 m-85 72.26 140.19 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.103 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 104' ' ' PHE . 7.2 Cg_exo -71.83 166.77 28.51 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.747 2.298 . . . . 0.0 112.138 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.52 131.01 54.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.726 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.519 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -167.48 -165.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.089 0.471 . . . . 0.0 111.303 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -116.24 114.93 25.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.209 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 16.0 m -95.69 131.47 41.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.275 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 m -158.96 170.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.494 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 6.9 tt0 -110.6 95.34 5.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.804 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.3 m -60.46 157.3 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.89 -45.73 93.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.992 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -151.87 173.99 14.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.688 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.66 156.26 59.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.69 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 12.4 Cg_endo -55.93 137.75 79.91 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.489 2.126 . . . . 0.0 111.988 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 10.3 mttt 68.18 16.03 9.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.328 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.97 15.58 9.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.3 m -51.79 169.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.713 0.292 . . . . 0.0 111.075 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.67 17.02 13.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.027 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.17 153.44 1.59 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.102 0.477 . . . . 0.0 111.397 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -142.5 140.22 31.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.884 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.1 mm -121.79 127.01 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 112.141 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 76' ' ' THR . 1.0 OUTLIER -140.21 146.23 38.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.08 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.4 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . . . -170.05 174.22 5.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.267 0.555 . . . . 0.0 112.275 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.2 mt -132.28 151.28 34.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.188 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -132.48 150.78 52.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.15 0.5 . . . . 0.0 111.756 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.0 m -110.64 116.23 51.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.874 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.933 -179.861 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.783 0.325 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -170.98 125.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -56.5 141.38 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 21.8 mt -97.97 149.85 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.209 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.25 26.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.3 171.14 20.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.36 28.48 8.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.99 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -120.64 -44.5 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.747 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.484 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . . . -66.68 171.3 4.53 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.971 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' B' ' 11' ' ' ALA . 29.7 Cg_endo -63.67 -12.72 32.73 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.563 2.176 . . . . 0.0 112.488 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.52 147.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.474 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.442 ' HB2' ' CE2' ' B' ' 18' ' ' TYR . . . -126.32 120.94 31.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.795 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.21 17.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.162 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.91 -118.96 2.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.39 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -89.64 14.72 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.787 2.325 . . . . 0.0 113.306 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.442 ' CE2' ' HB2' ' B' ' 14' ' ' ALA . 0.7 OUTLIER -146.99 -174.04 4.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 0.0 111.506 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.404 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 18.1 m -138.55 169.34 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.823 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -49.17 78.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 110.636 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.14 -177.93 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 m -141.51 133.29 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.151 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.409 ' HA ' HG23 ' B' ' 28' ' ' VAL . 37.6 t70 -110.77 115.36 29.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mt -90.88 -16.01 28.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.231 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.65 -99.29 0.81 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.767 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -56.93 -29.05 62.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.171 0.51 . . . . 0.0 110.111 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.18 135.18 38.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.717 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.42 ' CG1' ' CB ' ' B' ' 127' ' ' ALA . 4.8 p -109.54 164.48 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.923 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.49 131.32 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 41.1 p -104.71 144.85 31.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.972 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 10.3 p -83.32 179.17 7.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.013 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.43 89.75 0.82 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.199 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -56.18 144.16 30.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.936 0.398 . . . . 0.0 111.275 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 9.6 tt -125.45 132.87 24.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.703 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.536 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 21.9 Cg_exo -64.98 65.2 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.69 2.26 . . . . 0.0 112.59 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 63.7 t . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.12 0.486 . . . . 0.0 110.584 179.439 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 7.2 p . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.539 0.209 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.16 138.91 23.25 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.399 2.066 . . . . 0.0 112.283 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.68 -31.13 71.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 110.892 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.84 94.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 21.4 mm -44.27 -31.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.879 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.4 t -79.72 -38.8 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.78 -54.26 38.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.451 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.48 -26.74 68.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.344 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.68 -40.69 72.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.01 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.45 -48.71 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -59.6 -46.71 88.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.712 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' SER . . . . . 0.419 ' HA ' ' OD1' ' B' ' 57' ' ' ASN . 89.9 p -60.06 -37.25 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.859 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.413 HD23 ' CD2' ' B' ' 92' ' ' TYR . 21.9 mt -76.6 -23.3 53.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -52.07 12.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.169 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . 0.419 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.7 OUTLIER -58.01 -29.32 65.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.41 HG21 ' ND2' ' B' ' 57' ' ' ASN . 54.0 t -65.02 -46.39 91.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.921 0.391 . . . . 0.0 110.6 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.09 -28.94 61.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.91 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.01 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -73.21 -41.64 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.506 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 18.0 mt -69.51 -31.31 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.535 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.51 -37.39 60.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.1 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -22.38 66.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.276 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.83 -28.9 20.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.04 50.58 0.63 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.516 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -146.73 -176.68 5.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.988 0.423 . . . . 0.0 110.672 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.68 163.92 31.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.751 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' B' ' 101' ' ' HIS . . . -50.31 -34.62 24.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.043 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.532 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -67.49 -24.86 65.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.315 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -80.38 -6.6 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.929 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 24.4 mt -83.82 116.11 27.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.221 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.52 -47.03 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.05 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . 0.405 ' HB3' ' HD3' ' B' ' 107' ' ' ARG . 10.8 mtpt -118.35 -177.58 3.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.569 0.223 . . . . 0.0 111.153 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.521 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 11.2 t 179.98 101.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 111.539 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.446 HG21 ' CE1' ' B' ' 78' ' ' PHE . 0.0 OUTLIER -71.18 126.76 30.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.18 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.73 98.92 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.446 ' CE1' HG21 ' B' ' 76' ' ' THR . 17.1 m-85 -98.21 147.36 24.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.991 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 0.9 OUTLIER -144.68 151.76 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.173 0.511 . . . . 0.0 111.927 -179.252 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.03 -2.85 56.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.732 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.13 110.37 0.59 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.402 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.0 mt -56.92 -18.59 13.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.305 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -75.76 -23.58 55.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -77.91 -12.78 60.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -27.18 59.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.293 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.54 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.351 . . . . 0.0 111.408 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.87 -29.38 20.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.277 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.2 t -73.87 -47.09 44.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.128 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -64.9 -39.26 93.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.59 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.34 85.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.011 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.83 -33.34 19.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.646 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.498 ' CE1' ' CE1' ' B' ' 96' ' ' PHE . 35.4 t80 -61.23 -56.39 21.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.351 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -15.21 62.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.268 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -40.04 66.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.48 ' CE2' ' CE1' ' B' ' 96' ' ' PHE . 0.0 OUTLIER -84.95 -38.81 18.86 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.378 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.498 ' CE1' ' CE1' ' B' ' 92' ' ' TYR . 11.2 m-85 -53.86 -50.68 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.042 0.449 . . . . 0.0 110.328 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.96 -32.31 73.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.877 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.63 -1.93 55.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.463 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 1.0 OUTLIER -110.39 -8.63 14.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.637 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 2.7 t-20 97.09 19.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.761 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.532 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.3 t60 -118.53 59.86 4.01 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.961 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.411 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 44.0 Cg_endo -68.18 -17.79 45.23 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.457 2.105 . . . . 0.0 112.181 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -34.22 61.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.411 ' CE2' ' O ' ' B' ' 102' ' ' PRO . 33.0 m-85 72.26 140.19 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.425 ' HD3' ' CE2' ' B' ' 96' ' ' PHE . 7.2 Cg_exo -71.87 166.74 28.61 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.724 2.283 . . . . 0.0 112.113 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.45 131.02 54.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.761 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.521 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -167.51 -165.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.049 0.452 . . . . 0.0 111.33 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -116.16 114.93 25.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.224 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 16.0 m -95.69 131.52 41.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.207 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 m -158.96 170.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 111.413 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' B' ' 79' ' ' VAL . 6.9 tt0 -110.2 95.4 5.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.676 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -60.62 157.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.065 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.77 -45.67 93.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.041 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -151.94 173.98 14.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.733 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.66 156.31 59.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.7 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' B' ' 117' ' ' LYS . 12.4 Cg_endo -55.98 137.76 80.12 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.449 2.1 . . . . 0.0 112.052 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 10.3 mttt 68.23 15.97 9.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.356 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.99 15.62 9.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.088 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 29.2 m -51.84 169.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.057 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.67 16.81 13.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.016 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.11 153.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.109 0.481 . . . . 0.0 111.433 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -142.43 140.25 31.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.903 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 28.2 mm -121.81 127.05 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.146 0.498 . . . . 0.0 112.12 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' B' ' 76' ' ' THR . 1.0 OUTLIER -140.29 146.21 38.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.051 179.146 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' B' ' 124' ' ' GLU . . . -170.01 174.24 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.286 0.565 . . . . 0.0 112.269 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.2 mt -132.35 151.2 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.172 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -132.45 150.82 52.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.053 0.454 . . . . 0.0 111.731 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 13.2 m -110.67 116.21 51.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.891 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.975 -179.867 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.784 0.326 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -171.06 125.28 0.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -56.42 141.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 22.0 mt -98.05 149.88 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.24 26.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.28 171.15 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.34 28.42 8.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.023 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -120.65 -44.6 2.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.74 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.492 ' CB ' ' HD2' ' C' ' 12' ' ' PRO . . . -66.79 171.22 4.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.042 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' C' ' 11' ' ' ALA . 29.6 Cg_endo -63.61 -12.71 32.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.533 2.155 . . . . 0.0 112.506 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.45 147.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.488 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' C' ' 18' ' ' TYR . . . -126.35 120.99 31.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.756 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.24 17.14 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.11 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.95 -118.88 2.91 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.418 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.75 14.81 2.07 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.784 2.323 . . . . 0.0 113.306 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' C' ' 14' ' ' ALA . 0.7 OUTLIER -147.07 -174.06 4.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.948 0.404 . . . . 0.0 111.495 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.406 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 17.8 m -138.55 169.35 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.75 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -48.89 79.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 110.592 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.4 -177.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.898 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 m -141.47 133.34 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.05 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -110.77 115.4 29.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mt -91.01 -16.07 28.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.143 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.67 -99.27 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.762 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -56.99 -29.0 62.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.159 0.504 . . . . 0.0 110.081 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.17 135.22 38.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.42 ' CG1' ' CB ' ' C' ' 127' ' ' ALA . 4.8 p -109.59 164.49 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.847 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.55 131.3 22.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.887 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 40.9 p -104.63 144.35 31.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 10.1 p -83.03 179.1 7.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.51 89.74 0.83 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.177 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.415 ' HB3' ' ND2' ' C' ' 57' ' ' ASN . 88.3 mm-40 -56.12 144.17 30.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.286 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -125.49 132.9 24.44 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.691 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 21.9 Cg_exo -64.93 65.25 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.657 2.238 . . . . 0.0 112.574 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 63.5 t . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.59 179.437 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 7.3 p . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.504 0.192 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.24 138.92 23.09 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.407 2.072 . . . . 0.0 112.242 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.72 -31.07 71.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 94.96 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.887 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 21.5 mm -44.32 -31.0 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.933 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.79 -38.73 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.6 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.79 -54.28 37.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.478 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.52 -26.82 68.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.332 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.65 72.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.1 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.44 -48.7 16.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.763 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.62 -46.65 88.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.767 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.421 ' HA ' ' OD1' ' C' ' 57' ' ' ASN . 90.3 p -60.04 -37.29 79.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.405 HD23 ' CD2' ' C' ' 92' ' ' TYR . 21.9 mt -76.56 -23.35 53.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.094 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.69 -52.08 12.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.203 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . 0.421 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.6 OUTLIER -58.09 -29.2 65.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.939 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.413 HG21 ' ND2' ' C' ' 57' ' ' ASN . 54.3 t -65.16 -46.25 91.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.905 0.383 . . . . 0.0 110.602 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -28.87 61.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.88 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.03 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -73.13 -41.69 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.518 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mt -69.5 -31.38 48.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.485 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.47 -37.33 60.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.106 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -22.43 66.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.276 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.88 -28.81 20.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.824 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.99 50.51 0.63 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.568 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -146.67 -176.66 5.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 110.68 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.68 163.85 31.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.47 ' O ' ' CD2' ' C' ' 101' ' ' HIS . . . -50.21 -34.74 23.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.539 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -67.38 -24.72 65.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.324 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -80.67 -6.52 58.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.934 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 24.7 mt -83.88 116.08 27.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.188 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.57 -46.93 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.014 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -118.4 -177.7 3.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.591 0.234 . . . . 0.0 111.158 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' THR . . . . . 0.528 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 11.1 t -179.94 101.04 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.84 0.352 . . . . 0.0 111.509 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.445 HG21 ' CE1' ' C' ' 78' ' ' PHE . 0.0 OUTLIER -71.18 126.72 30.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.233 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.67 98.89 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.445 ' CE1' HG21 ' C' ' 76' ' ' THR . 17.1 m-85 -98.21 147.38 24.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.957 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 0.9 OUTLIER -144.68 151.79 15.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.479 . . . . 0.0 111.959 -179.274 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.05 -2.91 56.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.727 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.09 110.28 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.327 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 8.0 mt -56.89 -18.57 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -75.79 -23.57 55.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.617 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -77.88 -12.79 60.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -27.11 60.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.27 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.59 -42.54 71.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.815 0.34 . . . . 0.0 111.381 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.84 -29.45 20.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.275 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -73.82 -47.16 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -64.82 -39.32 93.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.596 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.42 -37.28 85.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.051 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.8 -33.33 19.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.594 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . 0.495 ' CE1' ' CE1' ' C' ' 96' ' ' PHE . 35.5 t80 -61.23 -56.43 20.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.36 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . 0.402 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 0.2 OUTLIER -70.22 -15.22 62.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.302 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -40.1 66.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.483 ' CE2' ' CE1' ' C' ' 96' ' ' PHE . 0.0 OUTLIER -84.91 -38.85 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.343 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.495 ' CE1' ' CE1' ' C' ' 92' ' ' TYR . 11.2 m-85 -53.86 -50.65 65.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 110.371 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.96 -32.24 73.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.911 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -83.76 -1.81 54.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.432 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 1.0 OUTLIER -110.39 -8.69 14.66 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.667 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 2.8 t-20 97.09 19.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.795 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.539 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.3 t60 -118.57 59.88 4.07 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.859 0.362 . . . . 0.0 110.91 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CE2' ' C' ' 104' ' ' PHE . 43.4 Cg_endo -68.16 -17.85 45.35 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.486 2.124 . . . . 0.0 112.15 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -34.16 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.694 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' C' ' 105' ' ' PRO . 33.2 m-85 72.24 140.14 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.08 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . 0.438 ' HD3' ' CE2' ' C' ' 96' ' ' PHE . 7.2 Cg_exo -71.71 166.72 28.59 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.777 2.318 . . . . 0.0 112.113 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.54 130.91 54.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.792 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.528 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -167.41 -165.53 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.0 111.324 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 3.1 p -116.2 114.84 24.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.256 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 15.8 m -95.67 131.49 41.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.265 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 m -158.97 170.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.947 0.403 . . . . 0.0 111.478 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' C' ' 79' ' ' VAL . 6.9 tt0 -110.26 95.36 5.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 29.9 m -60.51 157.27 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.63 93.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.011 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -151.93 173.94 14.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.727 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.65 156.25 59.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.71 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' C' ' 117' ' ' LYS . 12.4 Cg_endo -55.89 137.7 79.65 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.472 2.114 . . . . 0.0 112.069 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 10.3 mttt 68.21 16.02 9.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.392 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.89 15.69 9.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 29.3 m -51.83 169.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.736 0.303 . . . . 0.0 111.034 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.67 16.97 13.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.045 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.22 153.44 1.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.173 0.511 . . . . 0.0 111.367 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -142.46 140.26 31.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.89 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 28.3 mm -121.78 127.01 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.094 0.474 . . . . 0.0 112.162 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' C' ' 76' ' ' THR . 1.0 OUTLIER -140.19 146.19 38.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.071 179.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' C' ' 124' ' ' GLU . . . -169.99 174.33 5.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.214 0.531 . . . . 0.0 112.332 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 5.2 mt -132.41 151.21 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.214 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -132.45 150.73 52.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.08 0.467 . . . . 0.0 111.739 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 13.0 m -110.62 116.33 52.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -122.74 75.92 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.897 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.006 0.431 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.542 ' HA ' ' N ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 6' ' ' ILE . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' C' ' 107' ' ' ARG . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.45 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.542 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.0 m120 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.9 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 9.2 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.607 0.241 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 21' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' CB ' ' CE1' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.519 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' HG13 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.42 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.513 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CE1' ' CB ' ' A' ' 69' ' ' ALA . 3.3 m170 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' B' ' 17' ' ' PRO . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.439 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.425 HG13 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 123' ' ' ILE . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.977 0.417 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.538 ' HA ' ' N ' ' B' ' 23' ' ' ASP . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.449 HG23 HD12 ' B' ' 6' ' ' ILE . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.45 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.538 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' B' ' 35' ' ' PRO . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 9.3 p . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.595 0.236 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' B' ' 21' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.521 ' CB ' ' CE1' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.484 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' B' ' 69' ' ' ALA . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.516 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' PHE . . . . . 0.425 ' CD2' HG13 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.514 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . 0.521 ' CE1' ' CB ' ' B' ' 69' ' ' ALA . 3.4 m170 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.416 ' CD1' ' HA ' ' C' ' 17' ' ' PRO . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.425 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' VAL . . . . . 0.429 HG13 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.451 HG21 HD13 ' B' ' 123' ' ' ILE . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 4' ' ' GLN . . . . . 0.537 ' HA ' ' N ' ' C' ' 23' ' ' ASP . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . 0.451 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' PRO . . . . . 0.416 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' B' ' 107' ' ' ARG . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.452 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' VAL . . . . . 0.486 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.401 HG23 ' CB ' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 32.8 t . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 9.3 p . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.582 0.229 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.404 HD21 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' C' ' 21' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.518 ' CB ' ' CE1' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.476 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.515 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' PHE . . . . . 0.429 ' CD2' HG13 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' C' ' 95' ' ' PHE . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 101' ' ' HIS . . . . . 0.521 ' NE2' ' HB3' ' C' ' 99' ' ' ASN . 3.3 m170 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 17' ' ' PRO . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 105' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 107' ' ' ARG . . . . . 0.418 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 110' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 123' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 123' ' ' ILE . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 127' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.869 0.366 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.23 168.49 19.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.8 m -165.16 116.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.542 ' HA ' ' N ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 6' ' ' ILE . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' C' ' 107' ' ' ARG . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.45 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.542 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.0 m120 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.9 t -63.02 85.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 41' ' ' GLY . 36.7 t-20 -35.11 129.88 0.5 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.989 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.53 -10.59 29.14 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 112.178 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.5 -21.36 8.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.68 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 m -114.75 -25.2 8.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 63.67 56.06 21.4 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.323 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.27 -81.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.704 0.288 . . . . 0.0 111.625 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 9.2 p -173.89 106.83 0.3 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 21' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' CB ' ' CE1' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.519 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' HG13 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.42 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.513 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CE1' ' CB ' ' A' ' 69' ' ' ALA . 3.3 m170 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' B' ' 17' ' ' PRO . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.439 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.425 HG13 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 123' ' ' ILE . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -164.77 46.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.832 0.349 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.24 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 19.0 m -165.18 116.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.538 ' HA ' ' N ' ' B' ' 23' ' ' ASP . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.449 HG23 HD12 ' B' ' 6' ' ' ILE . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.45 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.538 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' B' ' 35' ' ' PRO . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 t -63.01 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' B' ' 41' ' ' GLY . 36.6 t-20 -35.14 129.93 0.51 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.935 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.58 -10.63 29.2 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.023 . . . . 0.0 112.192 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.4 -21.41 8.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.78 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 3.5 m -114.77 -25.32 8.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 63.81 56.13 20.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.36 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.623 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 9.3 p -173.94 106.72 0.3 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' B' ' 21' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.521 ' CB ' ' CE1' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.484 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' B' ' 69' ' ' ALA . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.516 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.425 ' CD2' HG13 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.514 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.521 ' CE1' ' CB ' ' B' ' 69' ' ' ALA . 3.4 m170 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.416 ' CD1' ' HA ' ' C' ' 17' ' ' PRO . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.425 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . 0.429 HG13 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.451 HG21 HD13 ' B' ' 123' ' ' ILE . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -164.83 46.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.951 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.21 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 19.0 m -165.22 116.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.537 ' HA ' ' N ' ' C' ' 23' ' ' ASP . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.451 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . 0.416 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' B' ' 107' ' ' ARG . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.452 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . 0.486 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.401 HG23 ' CB ' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 32.8 t -63.06 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' C' ' 41' ' ' GLY . 36.7 t-20 -35.13 129.94 0.51 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.56 -10.6 29.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.31 2.007 . . . . 0.0 112.18 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.44 -21.43 8.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.729 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 3.5 m -114.8 -25.24 8.32 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 63.64 56.1 21.27 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.395 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.26 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.61 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 9.3 p -173.93 106.74 0.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.365 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.404 HD21 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' C' ' 21' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.518 ' CB ' ' CE1' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.476 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.515 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.429 ' CD2' HG13 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' C' ' 95' ' ' PHE . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.521 ' NE2' ' HB3' ' C' ' 99' ' ' ASN . 3.3 m170 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 17' ' ' PRO . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.418 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 123' ' ' ILE . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.827 0.346 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.8 -175.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 21.8 m 63.58 128.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.924 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.491 ' HA ' ' N ' ' A' ' 23' ' ' ASP . 12.3 pt20 43.77 -165.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.743 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.466 HG12 ' HG3' ' A' ' 4' ' ' GLN . 34.3 mm 68.69 116.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.959 0.409 . . . . 0.0 111.633 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.412 HG12 ' HB2' ' A' ' 23' ' ' ASP . 36.3 mt -142.11 91.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.77 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -102.22 128.98 48.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.991 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 t -144.86 153.74 41.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 30.7 3.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -117.6 -36.82 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . -99.88 122.47 50.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.273 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 7.5 Cg_exo -72.93 3.07 4.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.67 2.247 . . . . 0.0 112.829 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.32 -178.17 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.998 0.428 . . . . 0.0 111.809 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 18' ' ' TYR . . . 64.05 118.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.048 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -146.79 17.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.342 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.92 -148.64 4.79 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.449 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.401 ' HA ' ' CE2' ' C' ' 104' ' ' PHE . 84.8 Cg_endo -87.57 34.33 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.859 2.373 . . . . 0.0 112.957 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.434 ' CD2' ' HB2' ' C' ' 107' ' ' ARG . 9.9 p90 -130.39 164.97 23.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.776 0.322 . . . . 0.0 110.821 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG13 ' O ' ' C' ' 104' ' ' PHE . 19.9 m -91.54 147.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -46.11 -48.85 17.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.44 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.58 -175.28 5.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.1 m -136.23 129.26 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.114 0.483 . . . . 0.0 111.922 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.491 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 44.1 t0 -113.14 103.97 11.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.803 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.6 mt -84.04 -18.69 36.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.105 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.05 -108.68 0.91 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.827 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.6 -30.19 62.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 110.065 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.92 127.88 50.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.581 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -105.75 179.4 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.243 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.9 146.83 16.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.0 p -121.1 142.25 50.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.8 m -79.03 165.99 22.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.26 74.4 0.28 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.987 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -66.46 165.21 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.031 0.444 . . . . 0.0 111.352 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 3.4 pt -138.99 159.07 68.44 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.243 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 85.5 Cg_exo -42.28 -45.39 7.74 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.64 2.227 . . . . 0.0 111.932 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.404 ' CG2' ' HA2' ' A' ' 41' ' ' GLY . 8.5 p 44.04 25.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.565 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 56.12 159.92 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 0.0 111.354 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.68 -26.02 7.35 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.549 2.166 . . . . 0.0 112.031 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.91 19.68 0.26 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.341 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.92 -27.24 8.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 110.575 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' HA2' ' CG2' ' A' ' 36' ' ' VAL . . . 71.41 45.11 49.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.925 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 6.4 mm-40 -146.47 -77.19 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.721 0.261 . . . . 0.0 110.789 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 42' ' ' GLU . 7.1 p 172.07 128.29 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.877 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 4.9 Cg_exo -76.58 153.12 34.23 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.684 2.256 . . . . 0.0 112.091 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.1 -30.85 55.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.074 0.464 . . . . 0.0 110.741 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.48 94.24 0.55 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.885 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.9 mm -40.32 -33.3 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.34 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.12 -46.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.699 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.37 -36.19 79.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.706 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 10.4 pt20 -77.61 -28.39 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.608 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.11 -31.55 25.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.248 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -38.35 29.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.17 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.55 -31.06 66.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.871 0.367 . . . . 0.0 110.823 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -30.85 68.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.4 mt -74.6 -33.85 62.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.38 -48.69 64.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.999 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -57.6 -48.2 80.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.092 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 t -59.63 -29.97 43.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.033 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -79.15 -39.83 32.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.043 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.04 -36.41 81.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.976 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' CG1' ' CB ' ' A' ' 11' ' ' ALA . 8.1 mt -70.21 -51.87 35.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 127' ' ' ALA . 3.7 tt -65.26 -22.43 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.076 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -82.95 -37.74 23.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.891 0.377 . . . . 0.0 110.31 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -11.15 60.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.97 -29.93 35.22 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.925 0.393 . . . . 0.0 110.335 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.3 28.5 1.0 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.141 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.405 ' CD1' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -146.84 -166.97 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.329 . . . . 0.0 110.69 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.58 153.73 49.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB1' ' CD2' ' A' ' 101' ' ' HIS . . . -57.25 -38.92 74.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.19 -29.86 15.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.06 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.74 -22.4 58.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 76.6 mt -47.76 114.88 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.97 0.414 . . . . 0.0 110.97 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.417 ' CG1' ' CG1' ' A' ' 128' ' ' VAL . 32.8 m -89.62 -31.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.702 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -134.44 163.0 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 111.055 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -158.75 139.56 12.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.303 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.427 HG23 ' CE1' ' A' ' 78' ' ' PHE . 96.7 m -123.63 147.41 47.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.176 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.9 t -149.22 109.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 111.697 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.427 ' CE1' HG23 ' A' ' 76' ' ' THR . 8.6 m-85 -89.0 110.23 20.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.47 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.38 144.89 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -85.03 -1.55 56.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.221 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.2 127.22 1.46 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.512 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.15 -11.92 52.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.65 -20.82 45.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.361 . . . . 0.0 110.693 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.6 -27.25 20.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 44.3 t80 -57.68 -28.77 64.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.13 -32.28 67.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.263 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.49 -34.95 18.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.221 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.7 -39.71 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 32.8 t30 -68.89 -36.55 78.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.51 -32.39 66.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.61 -30.35 19.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.088 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -58.43 -43.93 88.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.91 -29.36 35.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.18 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.48 75.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.036 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -89.32 -36.54 15.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.636 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.48 ' CG ' ' HB2' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -54.99 -53.59 53.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.807 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -72.82 -26.43 61.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.387 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -76.47 -13.32 60.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 12.6 m-80 -101.4 -17.29 16.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.011 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 5.2 p-10 103.5 35.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.154 0.909 . . . . 0.0 110.396 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.531 ' CE1' ' HB3' ' A' ' 99' ' ' ASN . 2.0 m-70 -114.97 55.27 0.87 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.376 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 88.8 Cg_endo -79.12 2.74 8.04 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.661 2.241 . . . . 0.0 113.112 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 2.0 t30 -64.48 -30.08 71.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.765 0.317 . . . . 0.0 111.477 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 2.5 m-85 70.91 110.21 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.547 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.448 ' HG3' ' CZ ' ' A' ' 96' ' ' PHE . 66.2 Cg_endo -96.03 153.39 1.4 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.064 2.509 . . . . 0.0 112.443 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.27 163.09 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.236 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.422 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -134.49 143.43 47.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.147 0.499 . . . . 0.0 111.607 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.73 63.81 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.305 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.09 134.69 40.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.025 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.22 138.49 29.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.26 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -68.23 83.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.686 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.21 163.91 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.233 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.55 -38.16 62.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.982 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.62 -177.65 6.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.761 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 77.8 mt -151.82 156.37 34.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.756 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.31 137.96 78.46 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.59 2.194 . . . . 0.0 112.099 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 74.74 14.21 3.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.244 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.76 16.88 8.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.07 175.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.831 0.348 . . . . 0.0 111.079 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.54 12.79 15.69 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.676 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 pp -176.75 148.17 0.67 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.025 0.441 . . . . 0.0 111.298 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.74 161.05 28.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.037 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -143.54 129.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.115 0.484 . . . . 0.0 112.012 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.09 109.51 2.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.895 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -126.73 174.61 8.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.137 0.494 . . . . 0.0 112.039 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.3 mt -125.63 156.41 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.422 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -146.34 151.07 36.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.551 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' A' ' 129' ' ' ARG . 5.1 p -147.99 159.95 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.128 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.436 ' N ' ' CG2' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -148.44 58.86 1.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.81 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.787 0.327 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.83 -175.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.973 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.421 ' O ' ' HG3' ' B' ' 4' ' ' GLN . 22.1 m 63.58 128.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.486 ' HA ' ' N ' ' B' ' 23' ' ' ASP . 12.3 pt20 43.82 -165.68 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.636 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.457 HG12 ' HG3' ' B' ' 4' ' ' GLN . 34.2 mm 68.65 116.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.023 0.439 . . . . 0.0 111.6 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.43 HG23 HD13 ' B' ' 6' ' ' ILE . 36.4 mt -142.12 91.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.782 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -102.15 129.02 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.949 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.7 t -144.87 153.74 41.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.05 30.67 3.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -117.55 -36.78 3.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -99.9 122.3 51.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.214 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 7.4 Cg_exo -72.87 3.05 4.73 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.68 2.254 . . . . 0.0 112.84 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.24 -178.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.005 0.431 . . . . 0.0 111.796 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.432 ' HA ' ' CZ ' ' B' ' 18' ' ' TYR . . . 64.01 118.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -146.78 17.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.341 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.9 -148.71 4.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.422 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.401 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 84.1 Cg_endo -87.49 34.26 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.869 2.379 . . . . 0.0 113.005 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.432 ' CZ ' ' HA ' ' B' ' 14' ' ' ALA . 10.0 p90 -130.4 164.95 23.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 110.835 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 104' ' ' PHE . 20.2 m -91.46 147.76 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -46.18 -48.97 17.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.414 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.39 -175.35 5.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.71 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 29.2 m -136.25 129.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.09 0.471 . . . . 0.0 111.941 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.486 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 44.1 t0 -113.11 103.92 11.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.834 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.2 mt -83.97 -18.71 36.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.109 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.03 -108.75 0.91 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.792 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.55 -30.21 62.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.093 0.473 . . . . 0.0 110.068 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.87 127.93 51.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.603 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' B' ' 127' ' ' ALA . 0.3 OUTLIER -105.81 179.4 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.94 146.84 16.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 35.9 p -121.11 141.98 50.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.89 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 17.6 m -78.68 165.97 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.25 74.36 0.28 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.968 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.408 ' HB2' HG12 ' B' ' 123' ' ' ILE . 17.2 mm-40 -66.42 165.32 14.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 111.374 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.4 ' HB ' ' HD2' ' B' ' 35' ' ' PRO . 3.4 pt -139.08 159.05 68.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.199 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 85.6 Cg_exo -42.28 -45.46 7.72 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.635 2.224 . . . . 0.0 111.87 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.404 ' CG2' ' HA2' ' B' ' 41' ' ' GLY . 8.5 p 44.1 25.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.508 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 56.05 159.97 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.954 0.407 . . . . 0.0 111.406 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.71 -26.02 7.33 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.547 2.164 . . . . 0.0 112.049 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.92 19.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.269 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 -27.33 8.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.0 110.578 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.404 ' HA2' ' CG2' ' B' ' 36' ' ' VAL . . . 71.55 45.1 47.9 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.932 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 6.4 mm-40 -146.43 -77.26 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.708 0.254 . . . . 0.0 110.755 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' B' ' 42' ' ' GLU . 7.1 p 172.15 128.32 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.854 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' B' ' 50' ' ' GLN . 5.0 Cg_exo -76.59 153.09 34.14 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.699 2.266 . . . . 0.0 112.115 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.11 -30.79 55.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.453 . . . . 0.0 110.715 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.55 94.24 0.56 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.864 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.2 mm -40.23 -33.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.387 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.08 -46.46 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.684 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.19 79.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.742 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.41 ' CB ' ' HD2' ' B' ' 44' ' ' PRO . 10.4 pt20 -77.57 -28.33 51.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.575 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.19 -31.56 25.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.271 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -38.31 30.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.254 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.6 -31.08 66.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.772 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.97 -30.88 68.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.801 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' B' ' 95' ' ' PHE . 57.3 mt -74.58 -33.88 62.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.46 -48.59 64.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.994 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -57.67 -48.16 80.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 t -59.64 -29.92 43.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.052 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -79.26 -39.78 32.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.01 -36.47 81.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.975 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -70.09 -51.89 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.998 0.428 . . . . 0.0 110.737 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.415 ' CD1' ' HB3' ' B' ' 127' ' ' ALA . 3.8 tt -65.23 -22.45 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.0 -37.73 23.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 110.3 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -11.1 60.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.737 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.93 -29.96 35.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.0 110.367 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.29 28.49 1.0 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.153 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.83 -167.02 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.7 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.52 153.76 49.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' B' ' 101' ' ' HIS . . . -57.34 -38.85 74.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.26 -29.92 16.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.76 -22.48 58.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.96 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 76.5 mt -47.72 114.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.893 0.377 . . . . 0.0 110.995 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.404 ' CG1' ' CG1' ' B' ' 128' ' ' VAL . 32.9 m -89.66 -31.57 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.66 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -134.39 163.08 30.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.017 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -158.76 139.6 12.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.297 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.418 HG23 ' CE1' ' B' ' 78' ' ' PHE . 96.8 m -123.68 147.41 47.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.172 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.8 t -149.22 109.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.863 0.363 . . . . 0.0 111.746 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.418 ' CE1' HG23 ' B' ' 76' ' ' THR . 8.6 m-85 -88.97 110.22 20.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.424 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.37 144.86 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.447 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -85.03 -1.68 57.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.145 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.12 127.14 1.48 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.507 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.01 -12.04 52.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.68 -20.74 45.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.789 0.328 . . . . 0.0 110.653 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.69 -27.16 20.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' B' ' 89' ' ' ASN . 44.5 t80 -57.74 -28.76 64.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.29 67.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.303 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.53 -34.96 18.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.16 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.79 -39.56 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.153 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 32.7 t30 -69.0 -36.45 77.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.47 -32.46 66.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.42 -30.43 19.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.418 ' CD2' HD23 ' B' ' 55' ' ' LEU . 9.8 t80 -58.36 -43.98 88.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.94 -29.35 35.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.54 75.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.069 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.421 ' CD2' HD13 ' B' ' 55' ' ' LEU . 0.9 OUTLIER -89.2 -36.64 15.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.646 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.483 ' CG ' ' HB2' ' B' ' 101' ' ' HIS . 0.2 OUTLIER -54.88 -53.63 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.863 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -72.77 -26.49 61.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.436 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -76.48 -13.29 60.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.568 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.543 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 12.6 m-80 -101.39 -17.35 16.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.01 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 5.3 p-10 103.6 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.148 0.905 . . . . 0.0 110.328 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 2.0 m-70 -115.06 55.25 0.89 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.387 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 89.3 Cg_endo -79.09 2.77 8.01 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.626 2.217 . . . . 0.0 113.141 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 2.0 t30 -64.4 -30.21 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 111.512 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 2.5 m-85 70.97 110.2 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.505 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.454 ' HG3' ' CZ ' ' B' ' 96' ' ' PHE . 66.0 Cg_endo -95.98 153.44 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.141 2.561 . . . . 0.0 112.438 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.37 163.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.292 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.444 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -134.4 143.44 47.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 111.607 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.77 63.88 0.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.283 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.05 134.74 40.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.04 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.32 139.3 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.294 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.67 84.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.78 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 m -67.4 163.95 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.133 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.55 -38.11 62.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.987 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.63 -177.74 6.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 77.7 mt -151.72 156.41 34.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.772 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.37 137.92 78.59 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.577 2.185 . . . . 0.0 112.093 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 74.8 14.2 3.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.26 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.78 16.89 8.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.069 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 29.6 m -57.18 175.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.83 0.347 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.34 13.04 16.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.71 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 pp -176.83 148.19 0.65 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 111.275 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.79 161.0 28.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.021 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.469 ' N ' HD13 ' B' ' 123' ' ' ILE . 0.0 OUTLIER -143.43 129.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 112.109 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 109.48 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.888 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -126.74 174.63 8.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.134 0.493 . . . . 0.0 111.985 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 15.2 mt -125.64 156.34 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.444 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -146.28 150.97 36.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.57 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' B' ' 129' ' ' ARG . 5.1 p -147.83 159.99 7.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.435 ' N ' ' CG2' ' B' ' 128' ' ' VAL . 0.0 OUTLIER -148.45 58.8 1.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.881 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.75 -174.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.993 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' THR . . . . . 0.417 ' O ' ' HG3' ' C' ' 4' ' ' GLN . 21.9 m 63.51 128.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.954 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.492 ' HA ' ' N ' ' C' ' 23' ' ' ASP . 12.3 pt20 43.79 -165.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.691 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . 0.467 HG12 ' HG3' ' C' ' 4' ' ' GLN . 34.4 mm 68.76 116.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.005 0.431 . . . . 0.0 111.628 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.465 HG23 HD13 ' C' ' 6' ' ' ILE . 36.6 mt -142.11 91.74 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.767 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -102.24 128.95 48.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 12.7 t -144.76 153.75 41.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.1 30.75 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -117.6 -37.08 3.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.016 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.406 ' CB ' ' CG1' ' C' ' 61' ' ' ILE . . . -99.59 122.48 51.29 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.186 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.84 2.94 4.82 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.731 2.288 . . . . 0.0 112.823 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.2 -178.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.966 0.412 . . . . 0.0 111.812 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.431 ' HA ' ' CZ ' ' C' ' 18' ' ' TYR . . . 63.97 118.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.096 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -146.74 17.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.364 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.9 -148.65 4.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.415 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -87.48 34.26 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.849 2.366 . . . . 0.0 113.037 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.444 ' CD2' ' HB2' ' B' ' 107' ' ' ARG . 9.9 p90 -130.41 164.91 23.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.775 0.322 . . . . 0.0 110.829 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.438 HG13 ' O ' ' B' ' 104' ' ' PHE . 20.4 m -91.44 147.8 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.947 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -46.18 -48.73 17.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.47 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.43 -175.26 5.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.677 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.27 129.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.062 0.458 . . . . 0.0 111.902 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . 0.492 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 44.2 t0 -113.18 103.9 11.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.819 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.97 -18.73 36.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.108 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.05 -108.7 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.811 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.6 -30.14 62.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.146 0.498 . . . . 0.0 110.118 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.91 127.9 50.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.624 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.409 HG23 ' CD1' ' C' ' 67' ' ' LEU . 0.3 OUTLIER -105.78 179.3 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.216 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.86 146.82 16.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.833 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 35.7 p -121.07 142.33 49.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 18.1 m -78.99 165.78 23.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.3 74.41 0.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.991 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.402 ' HB2' HG12 ' C' ' 123' ' ' ILE . 17.3 mm-40 -66.43 165.28 14.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.021 0.438 . . . . 0.0 111.325 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -139.04 159.1 68.2 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.232 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -42.36 -45.41 7.89 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.623 2.216 . . . . 0.0 111.867 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' C' ' 41' ' ' GLY . 8.6 p 44.07 25.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.556 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 56.06 159.96 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 120.98 0.419 . . . . 0.0 111.359 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.59 -26.12 7.39 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.58 2.187 . . . . 0.0 112.05 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.89 19.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.286 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.99 -27.37 8.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.36 . . . . 0.0 110.563 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' C' ' 36' ' ' VAL . . . 71.68 45.09 46.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.953 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . 0.444 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 6.4 mm-40 -146.48 -77.24 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.713 0.256 . . . . 0.0 110.763 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' C' ' 42' ' ' GLU . 7.1 p 172.17 128.33 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.914 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' C' ' 43' ' ' VAL . 4.8 Cg_exo -76.68 153.14 33.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.664 2.243 . . . . 0.0 112.067 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.16 -30.76 55.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.091 0.472 . . . . 0.0 110.738 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.54 94.31 0.56 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.888 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 29.2 mm -40.31 -33.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.397 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.13 -46.48 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.665 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.28 79.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.766 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.407 ' CB ' ' HD2' ' C' ' 44' ' ' PRO . 10.4 pt20 -77.63 -28.11 51.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.594 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.4 -31.59 24.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.337 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -38.38 30.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.55 -31.12 66.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.807 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -30.87 68.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.81 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.405 HD23 ' CD2' ' C' ' 92' ' ' TYR . 57.4 mt -74.48 -33.94 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.37 -48.66 64.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.02 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -57.56 -48.24 79.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 t -59.59 -29.93 43.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -79.21 -39.81 32.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.996 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.23 81.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.078 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . 0.406 ' CG1' ' CB ' ' C' ' 11' ' ' ALA . 8.1 mt -70.33 -51.9 34.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' C' ' 127' ' ' ALA . 3.8 tt -65.23 -22.42 31.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.094 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.02 -37.71 23.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.917 0.389 . . . . 0.0 110.287 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -11.08 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.713 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.99 35.06 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.964 0.412 . . . . 0.0 110.327 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.29 28.51 1.0 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.165 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.409 ' CD1' HG23 ' C' ' 28' ' ' VAL . 0.2 OUTLIER -146.88 -167.02 2.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.638 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.49 153.73 50.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.478 ' HB1' ' CD2' ' C' ' 101' ' ' HIS . . . -57.43 -38.71 74.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.16 -29.76 14.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.073 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.85 -22.56 58.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 76.3 mt -47.66 114.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 111.013 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.411 ' CG1' ' CG1' ' C' ' 128' ' ' VAL . 32.8 m -89.66 -31.47 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.696 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -134.5 162.99 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.752 0.311 . . . . 0.0 111.01 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 30.5 m -158.75 139.58 12.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.424 . . . . 0.0 111.302 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.43 HG23 ' CE1' ' C' ' 78' ' ' PHE . 96.8 m -123.64 147.44 47.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.197 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.7 t -149.27 109.27 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.745 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.43 ' CE1' HG23 ' C' ' 76' ' ' THR . 8.5 m-85 -88.95 110.19 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.476 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -101.4 144.87 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.461 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -85.02 -1.77 57.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.175 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.0 127.05 1.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.517 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.07 -11.98 52.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.63 -20.79 45.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.803 0.335 . . . . 0.0 110.673 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.63 -27.23 20.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' C' ' 89' ' ' ASN . 44.5 t80 -57.68 -28.83 64.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.102 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.29 67.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.255 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.46 -35.06 18.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.7 -39.62 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.152 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . 0.423 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 32.8 t30 -68.94 -36.5 78.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.49 -32.47 66.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -30.47 19.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.022 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.405 ' CD2' HD23 ' C' ' 55' ' ' LEU . 10.0 t80 -58.29 -44.01 88.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.89 -29.35 35.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.178 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.51 75.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.055 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.9 OUTLIER -89.27 -36.59 15.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 110.647 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.483 ' CG ' ' HB2' ' C' ' 101' ' ' HIS . 0.2 OUTLIER -54.95 -53.56 54.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.876 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -72.82 -26.48 61.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -76.48 -13.24 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.608 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.542 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 12.6 m-80 -101.46 -17.29 16.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.988 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 5.2 p-10 103.49 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.138 0.899 . . . . 0.0 110.372 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' C' ' 99' ' ' ASN . 2.0 m-70 -115.04 55.35 0.89 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.352 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 88.4 Cg_endo -79.2 2.82 7.98 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.628 2.219 . . . . 0.0 113.115 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 2.0 t30 -64.51 -30.06 71.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 111.534 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 2.5 m-85 70.93 110.21 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.543 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.45 ' HG3' ' CZ ' ' C' ' 96' ' ' PHE . 65.9 Cg_endo -96.03 153.38 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.116 2.544 . . . . 0.0 112.434 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.31 163.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.278 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.434 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -134.44 143.45 47.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.13 0.49 . . . . 0.0 111.563 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.76 63.82 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.332 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.05 134.76 40.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.034 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . 0.419 HG13 ' CD2' ' A' ' 78' ' ' PHE . 26.8 m -142.4 139.24 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.317 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.7 83.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.749 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.11 164.04 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.196 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.65 -38.19 62.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.975 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.59 -177.6 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.775 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 77.3 mt -151.76 156.42 34.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.755 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.48 137.95 79.01 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.588 2.192 . . . . 0.0 112.057 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 74.8 14.2 3.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.79 16.9 8.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.073 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 29.3 m -57.08 175.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.818 0.342 . . . . 0.0 111.123 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.36 13.25 16.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.766 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 pp -177.36 148.25 0.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.976 0.417 . . . . 0.0 111.249 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.69 161.02 28.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.054 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . 0.474 HD13 ' N ' ' C' ' 123' ' ' ILE . 0.0 OUTLIER -143.49 129.19 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.142 0.496 . . . . 0.0 112.039 -179.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.04 109.52 2.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.9 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -126.8 174.63 8.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.115 0.483 . . . . 0.0 112.026 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 15.3 mt -125.68 156.36 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.435 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -146.36 151.02 36.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 111.503 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' C' ' 129' ' ' ARG . 5.0 p -147.84 159.92 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . 0.431 ' N ' ' CG2' ' C' ' 128' ' ' VAL . 0.0 OUTLIER -148.41 58.89 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.817 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.855 0.359 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -172.57 4.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 61.7 113.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 132.97 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -55.2 152.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mt -103.43 139.26 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.137 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.58 117.18 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.7 t -133.88 165.99 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.33 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -121.62 -36.89 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.032 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.516 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . . . -67.82 172.05 4.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 11' ' ' ALA . 18.9 Cg_endo -59.39 -16.05 33.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.695 2.263 . . . . 0.0 112.85 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.24 151.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 111.317 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.67 120.71 41.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -133.51 15.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.072 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.85 -146.17 4.73 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.987 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' C' ' 104' ' ' PHE . 93.9 Cg_endo -87.39 44.53 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.536 2.158 . . . . 0.0 112.901 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.19 154.59 17.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.867 0.365 . . . . 0.0 111.033 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -110.91 169.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.284 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -58.96 -53.53 57.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.69 -177.09 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 m -142.33 132.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.166 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -103.47 105.01 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.51 -16.36 54.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.371 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.05 -104.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.28 -29.62 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.166 0.508 . . . . 0.0 110.21 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.2 140.65 45.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.435 ' CG1' ' CB ' ' A' ' 127' ' ' ALA . 9.9 p -120.04 160.88 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.123 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mp -145.87 127.37 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 p -106.5 136.11 46.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.983 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 t -59.36 179.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.07 95.55 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.244 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.433 ' HG2' ' CG2' ' A' ' 58' ' ' VAL . 2.9 mp0 -62.07 138.14 58.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.275 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.5 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -146.04 170.18 8.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.679 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -54.26 -137.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.313 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t 74.12 73.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.411 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 41' ' ' GLY . 2.1 t-20 -34.93 115.62 0.52 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.978 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.65 -13.68 11.46 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.339 2.026 . . . . 0.0 112.144 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.81 27.87 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.086 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.0 t -161.6 -33.37 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.908 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 96.92 66.2 0.92 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.847 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.73 -53.38 5.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.369 . . . . 0.0 111.276 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t 68.96 72.52 0.34 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.81 140.71 81.58 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.592 2.195 . . . . 0.0 112.433 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.37 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.4 93.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.791 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.9 mm -38.93 -33.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.5 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.08 -48.07 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.696 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.82 -55.04 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.498 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.93 -44.36 63.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -63.33 -51.54 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.79 -31.18 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.445 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 1.3 m -68.31 -46.48 70.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.29 -26.36 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.971 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -57.95 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.108 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.8 OUTLIER -54.88 -30.36 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.985 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.433 ' CG2' ' HG2' ' A' ' 33' ' ' GLN . 39.6 t -62.1 -34.54 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 110.517 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.99 -31.75 34.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.755 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.55 89.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.1 mt -70.93 -46.2 69.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.667 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.8 -32.62 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.28 -38.4 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.9 -24.33 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.145 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.71 -22.11 21.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.914 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.43 64.8 0.83 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -158.9 139.2 12.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.028 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 44.0 p -96.12 145.0 25.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.29 -31.75 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.518 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -59.77 -18.48 43.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 68' ' ' THR . 3.2 p-10 -88.58 -21.27 24.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 64.3 mt -59.35 109.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.414 ' CG1' HG22 ' A' ' 128' ' ' VAL . 2.8 m -81.11 -36.84 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.971 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.452 ' HB3' ' CD ' ' A' ' 107' ' ' ARG . 8.6 mtmt -130.55 175.23 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.319 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.539 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 13.4 t 177.71 110.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 111.36 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.489 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -70.18 130.1 41.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.33 91.6 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CZ ' ' HB ' ' A' ' 76' ' ' THR . 5.3 m-85 -91.7 143.77 26.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.089 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 35.3 m -139.31 150.0 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.023 0.44 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.95 -4.31 56.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.796 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.04 108.99 0.46 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -17.25 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.97 -24.64 59.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 110.282 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.46 -15.34 58.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.832 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 0.3 OUTLIER -55.52 -22.98 23.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.01 -46.63 84.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 -33.22 19.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.6 t -70.08 -49.66 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.673 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.417 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 36.4 t-20 -63.09 -35.99 82.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.14 94.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.016 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.62 -31.1 19.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.448 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 48.7 t80 -57.67 -51.35 69.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.727 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 7.7 tt0 -73.32 -27.34 61.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -25.11 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.765 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -79.31 -41.02 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.934 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 95' ' ' PHE . 57.1 m-85 -56.45 -50.43 71.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.8 69.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.77 58.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.402 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -110.54 -6.88 14.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 11.7 m-20 89.68 30.9 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 19.9 t-160 -127.57 72.17 77.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.96 -11.04 16.65 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.539 2.159 . . . . 0.0 112.153 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -79.14 -35.03 42.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.447 . . . . 0.0 110.439 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.453 ' CG ' ' HA ' ' B' ' 17' ' ' PRO . 92.7 m-85 70.99 144.0 0.1 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.515 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HG2' HG22 ' A' ' 75' ' ' THR . 2.0 Cg_endo -82.96 165.82 15.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.057 2.504 . . . . 0.0 112.0 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.28 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.779 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.539 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -169.27 -163.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.944 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.36 107.57 16.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.3 m -95.25 129.16 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.798 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -157.79 165.71 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.949 0.405 . . . . 0.0 111.666 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 9.4 tt0 -99.75 102.87 14.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.777 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.82 162.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.07 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.81 168.08 20.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.722 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mt -144.19 161.9 42.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.7 135.94 67.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.649 2.233 . . . . 0.0 112.183 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.58 18.28 7.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.87 17.47 8.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 m -55.18 172.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.61 14.08 20.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.011 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -176.64 149.0 0.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.123 0.487 . . . . 0.0 111.508 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -150.86 137.85 19.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.918 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -144.67 138.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 112.101 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.36 149.91 28.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.03 125.99 32.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.414 . . . . 0.0 112.027 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.42 132.16 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.876 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -121.74 153.14 38.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.063 0.459 . . . . 0.0 112.038 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.414 HG22 ' CG1' ' A' ' 73' ' ' VAL . 34.6 m -124.13 116.37 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.3 57.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.971 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.849 0.357 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.6 -172.5 4.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 61.63 113.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.72 132.95 5.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -55.2 152.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mt -103.43 139.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.07 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.59 117.19 9.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.6 t -133.86 165.97 23.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.804 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 26.32 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -121.6 -36.61 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.982 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . . . -68.18 172.03 4.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' B' ' 11' ' ' ALA . 18.7 Cg_endo -59.33 -16.06 32.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.632 2.221 . . . . 0.0 112.905 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.23 151.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.411 . . . . 0.0 111.281 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.006 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -133.53 15.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.79 -146.1 4.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.453 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . 94.4 Cg_endo -87.38 44.49 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.637 2.224 . . . . 0.0 112.916 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.26 154.53 17.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.915 0.388 . . . . 0.0 110.991 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.83 169.25 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.304 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -59.04 -53.58 56.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.46 -177.16 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 m -142.31 132.63 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.147 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -103.51 104.94 15.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.777 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.44 -16.4 54.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -103.96 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.972 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.3 -29.56 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.082 0.468 . . . . 0.0 110.189 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.3 140.65 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.52 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.444 ' CG1' ' CB ' ' B' ' 127' ' ' ALA . 9.9 p -120.07 160.84 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mp -145.87 127.42 15.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.68 136.36 46.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.06 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.1 t -59.69 179.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.961 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.01 95.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.435 ' HG2' ' CG2' ' B' ' 58' ' ' VAL . 2.9 mp0 -61.92 138.09 58.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.479 ' HB ' ' HD2' ' B' ' 35' ' ' PRO . 0.7 OUTLIER -145.98 170.19 8.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.665 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 52.2 Cg_exo -54.34 -137.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.069 2.513 . . . . 0.0 112.319 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t 74.21 73.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' B' ' 41' ' ' GLY . 2.1 t-20 -34.86 115.66 0.52 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.964 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.65 -13.71 11.53 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.4 2.067 . . . . 0.0 112.11 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.54 -26.78 27.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 8.0 t -161.65 -33.23 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 97.1 66.02 0.92 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.791 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -82.77 -53.36 5.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.371 . . . . 0.0 111.292 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t 68.91 72.59 0.34 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.83 140.7 81.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.662 2.242 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.39 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.35 93.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 28.9 mm -38.94 -33.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.443 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.02 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.91 -54.98 38.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.1 -26.16 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.522 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.18 -44.2 63.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.901 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.33 -51.54 65.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.22 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' SER . . . . . 0.448 ' HA ' ' OD1' ' B' ' 57' ' ' ASN . 1.3 m -68.4 -46.37 70.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.32 -26.38 68.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.963 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -57.99 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.163 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.8 OUTLIER -54.86 -30.39 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.931 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.435 ' CG2' ' HG2' ' B' ' 33' ' ' GLN . 39.7 t -62.13 -34.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.95 -31.77 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.49 89.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -71.25 -46.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.83 -32.53 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.656 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.31 -38.49 60.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.34 65.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.136 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 -22.06 21.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.919 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 64.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -158.91 139.2 12.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.022 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' B' ' 71' ' ' ASP . 43.8 p -96.1 144.99 25.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.26 -31.79 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.574 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.486 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -59.83 -18.27 42.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.425 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 68' ' ' THR . 3.3 p-10 -88.65 -21.23 24.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.714 0.292 . . . . 0.0 110.87 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 64.4 mt -59.4 109.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.874 0.369 . . . . 0.0 110.839 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.423 ' CG1' HG22 ' B' ' 128' ' ' VAL . 2.8 m -81.12 -36.88 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.969 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.443 ' HB3' ' CD ' ' B' ' 107' ' ' ARG . 8.6 mtmt -130.56 175.22 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.302 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.541 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 13.4 t 177.67 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 111.337 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.481 ' N ' ' HG2' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -70.15 130.12 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.325 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.43 91.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' B' ' 76' ' ' THR . 5.3 m-85 -91.66 143.72 26.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.151 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 35.1 m -139.32 150.01 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.072 0.463 . . . . 0.0 111.718 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.94 -4.12 56.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.839 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -169.23 109.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.321 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -17.32 20.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.228 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.94 -24.63 59.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.275 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -15.37 58.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.422 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 0.3 OUTLIER -55.46 -23.03 23.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.267 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.99 -46.62 84.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.09 -33.23 19.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 t -70.09 -49.59 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.721 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 36.4 t-20 -63.21 -35.96 82.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.04 94.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.67 -31.19 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 48.8 t80 -57.62 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.423 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 7.7 tt0 -73.41 -27.32 61.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.462 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -25.19 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.786 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -79.25 -41.09 28.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.97 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 95' ' ' PHE . 57.2 m-85 -56.36 -50.45 71.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.818 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.82 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.945 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.8 58.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.98 14.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.505 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 11.7 m-20 89.78 30.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.0 t-160 -127.48 72.19 77.52 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.98 -11.02 16.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.537 2.158 . . . . 0.0 112.153 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.03 0.443 . . . . 0.0 110.445 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.45 ' CG ' ' HA ' ' C' ' 17' ' ' PRO . 92.7 m-85 70.89 144.04 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.494 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.457 ' HG2' HG22 ' B' ' 75' ' ' THR . 2.0 Cg_endo -83.02 165.85 14.91 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.016 2.477 . . . . 0.0 111.917 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.27 137.95 51.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.541 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -169.23 -163.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.38 107.56 16.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.571 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -95.21 129.11 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.845 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -157.71 165.59 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.409 . . . . 0.0 111.632 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' B' ' 79' ' ' VAL . 9.3 tt0 -99.57 102.86 14.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.785 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.73 162.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.05 -46.27 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.82 168.11 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mt -144.21 161.87 42.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.62 135.97 67.82 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.157 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.53 18.29 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.88 17.46 8.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 m -55.18 172.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.082 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.63 13.95 20.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.025 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 pp -176.62 148.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -150.78 137.88 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.935 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -144.68 138.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 112.14 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.33 149.81 28.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.627 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.94 126.01 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.956 0.408 . . . . 0.0 112.041 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.33 132.14 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.947 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.444 ' CB ' ' CG1' ' B' ' 28' ' ' VAL . . . -121.75 153.2 38.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.096 0.474 . . . . 0.0 111.994 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.423 HG22 ' CG1' ' B' ' 73' ' ' VAL . 34.7 m -124.26 116.32 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.23 57.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.015 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.851 0.358 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 -172.51 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 61.67 113.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.68 132.97 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -55.18 152.35 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mt -103.46 139.23 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -143.59 117.2 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 11.7 t -133.93 165.96 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.32 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -121.59 -36.84 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.01 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.506 ' CB ' ' HD2' ' C' ' 12' ' ' PRO . . . -67.93 172.02 4.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' C' ' 11' ' ' ALA . 18.8 Cg_endo -59.31 -16.11 32.83 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.675 2.25 . . . . 0.0 112.899 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.24 151.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.977 0.418 . . . . 0.0 111.304 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.69 120.76 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.002 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mm -133.54 15.81 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.042 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.81 -146.14 4.73 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.001 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . 0.45 ' HA ' ' CG ' ' B' ' 104' ' ' PHE . 94.1 Cg_endo -87.37 44.51 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 112.917 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.23 154.55 17.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.026 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.87 169.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.36 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.02 -53.38 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.6 -177.19 2.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 m -142.24 132.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -103.48 104.98 15.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.47 -16.35 54.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.0 -104.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.27 -29.59 33.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.22 140.64 45.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.575 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.441 ' CG1' ' CB ' ' C' ' 127' ' ' ALA . 9.9 p -120.04 160.84 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.4 ' HB3' ' NZ ' ' B' ' 74' ' ' LYS . 2.9 mp -145.85 127.45 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 p -106.6 136.31 46.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 t -59.62 179.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.13 95.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.25 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.431 ' HG2' ' CG2' ' C' ' 58' ' ' VAL . 2.9 mp0 -62.06 138.17 58.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.259 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.49 ' HB ' ' HD2' ' C' ' 35' ' ' PRO . 0.7 OUTLIER -146.0 170.23 8.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.654 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' C' ' 34' ' ' ILE . 52.4 Cg_exo -54.36 -137.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.063 2.509 . . . . 0.0 112.29 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t 74.17 73.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.427 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' C' ' 41' ' ' GLY . 2.1 t-20 -34.93 115.67 0.52 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.967 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.61 -13.76 11.54 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.36 2.04 . . . . 0.0 112.088 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.56 -26.65 27.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.133 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 8.0 t -161.62 -33.31 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.928 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 96.98 66.09 0.92 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.79 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -82.74 -53.36 5.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.886 0.374 . . . . 0.0 111.287 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 t 68.96 72.52 0.34 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.931 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.88 140.74 81.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.637 2.225 . . . . 0.0 112.358 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.45 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.083 0.468 . . . . 0.0 110.913 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 93.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 28.7 mm -39.01 -33.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.447 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.711 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -54.96 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.474 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.07 -44.36 63.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.36 -51.5 65.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.24 72.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.354 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' C' ' 57' ' ' ASN . 1.3 m -68.35 -46.4 70.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.58 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.32 -26.36 68.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -58.01 4.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.8 OUTLIER -54.9 -30.36 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.984 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.431 ' CG2' ' HG2' ' C' ' 33' ' ' GLN . 39.6 t -62.07 -34.62 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -80.86 -31.79 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.52 89.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -70.95 -46.31 68.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.733 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.89 -32.54 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.33 -38.39 60.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.093 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.31 65.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.139 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.1 21.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.87 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.445 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -158.9 139.23 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.036 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.0 p -96.16 145.01 25.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.21 -31.81 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.598 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.482 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -59.74 -18.28 41.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.477 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -88.78 -21.16 23.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 110.896 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 64.2 mt -59.39 109.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.426 ' CG1' HG22 ' C' ' 128' ' ' VAL . 2.8 m -81.04 -36.88 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.933 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . 0.444 ' HB3' ' CD ' ' C' ' 107' ' ' ARG . 8.6 mtmt -130.6 175.25 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.369 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' THR . . . . . 0.525 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 13.4 t 177.72 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.313 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.48 ' N ' ' HG2' ' C' ' 107' ' ' ARG . 0.0 OUTLIER -70.23 130.2 41.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 t -115.43 91.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' C' ' 76' ' ' THR . 5.3 m-85 -91.64 143.8 26.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.143 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 34.8 m -139.35 149.98 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 111.691 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.99 -4.23 56.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.816 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.1 109.04 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.305 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -17.19 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.0 -24.62 59.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.297 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.5 -15.28 58.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.827 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 0.3 OUTLIER -55.53 -23.04 24.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.261 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.63 84.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.01 -33.32 19.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.969 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.06 -49.66 54.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . 0.428 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 36.4 t-20 -63.12 -35.99 82.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.337 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.22 -42.14 94.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.973 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.68 -31.16 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.567 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.457 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 48.7 t80 -57.64 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . 0.414 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 7.7 tt0 -73.36 -27.37 61.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -25.19 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.77 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -79.32 -41.03 28.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 95' ' ' PHE . 56.7 m-85 -56.38 -50.4 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.781 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -28.72 69.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.954 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.91 -3.78 58.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.362 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.91 14.79 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 11.7 m-20 89.79 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.822 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.482 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.0 t-160 -127.55 72.17 77.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.705 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.03 -10.97 16.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.495 2.13 . . . . 0.0 112.146 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.998 0.428 . . . . 0.0 110.429 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.451 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 92.8 m-85 70.91 144.1 0.1 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.453 ' HG2' HG22 ' C' ' 75' ' ' THR . 2.0 Cg_endo -83.05 165.85 14.87 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.028 2.485 . . . . 0.0 111.948 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.29 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.525 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -169.22 -163.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.4 p -111.36 107.48 16.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.589 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -95.21 129.18 42.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.788 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 m -157.82 165.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' C' ' 79' ' ' VAL . 9.4 tt0 -99.76 102.86 14.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.75 162.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.08 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.83 168.09 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mt -144.21 161.82 43.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.52 135.99 68.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.608 2.205 . . . . 0.0 112.221 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.51 18.29 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 61.8 17.55 8.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 m -55.18 172.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.79 14.08 19.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.988 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 pp -176.62 148.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.489 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -150.83 137.93 19.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -144.74 138.35 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.11 0.481 . . . . 0.0 112.142 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.3 149.82 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.648 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.98 126.13 33.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 112.004 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.41 132.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.441 ' CB ' ' CG1' ' C' ' 28' ' ' VAL . . . -121.76 153.11 38.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.082 0.468 . . . . 0.0 112.029 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . 0.426 HG22 ' CG1' ' C' ' 73' ' ' VAL . 34.6 m -124.15 116.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.27 56.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.99 0.424 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.815 0.341 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.9 tpp -107.77 162.2 14.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.6 m 63.54 131.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -173.58 122.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.023 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.404 ' CD1' ' ND2' ' C' ' 103' ' ' ASN . 2.0 mp -57.27 153.16 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.6 mt -114.16 154.75 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -153.69 126.15 8.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.725 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -130.46 151.73 50.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.037 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -98.22 30.11 3.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.76 -39.33 5.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.745 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.64 120.68 67.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.162 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.26 -11.59 23.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.491 2.127 . . . . 0.0 112.587 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.33 -169.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 0.0 111.396 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 58.37 -164.75 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.189 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.8 mm 80.32 16.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.107 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.69 -138.67 4.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.958 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -84.03 46.13 1.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.569 2.179 . . . . 0.0 112.624 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.517 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -176.11 -169.07 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.939 0.399 . . . . 0.0 111.051 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.407 HG11 ' O ' ' C' ' 104' ' ' PHE . 14.8 m -120.65 -179.64 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.804 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -71.16 -52.5 18.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.18 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -159.48 -178.52 7.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -137.54 134.18 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.165 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -113.89 93.3 4.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 mt -62.6 -20.44 64.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.043 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.93 -109.57 0.81 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.922 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.31 -30.37 64.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.058 0.456 . . . . 0.0 110.19 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.6 128.03 53.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.787 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.59 175.11 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.044 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.84 146.11 5.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -109.44 147.49 32.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.044 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.9 t -81.86 162.33 22.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.008 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.73 92.96 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.621 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -65.64 151.82 45.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.842 0.353 . . . . 0.0 111.093 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 34' ' ' ILE . 4.6 mp -126.58 134.01 25.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.634 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 61.2 Cg_endo -73.91 72.63 3.86 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.891 2.394 . . . . 0.0 112.321 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.35 87.92 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -33.09 126.44 0.4 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.998 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.77 -5.64 17.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.269 1.98 . . . . 0.0 112.097 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.46 -23.67 11.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.653 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.426 ' CG2' ' HB3' ' A' ' 37' ' ' ASN . 15.2 t -129.3 -28.98 2.28 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.762 0.315 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 77.46 52.36 5.6 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.156 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.461 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 9.6 mm-40 -147.25 -74.33 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.697 0.284 . . . . 0.0 111.245 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 11.2 p 172.63 115.0 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.047 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.1 140.38 60.41 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.396 2.064 . . . . 0.0 112.126 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.0 -31.44 70.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.061 0.458 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.86 95.87 2.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.736 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.73 -31.28 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.321 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.97 -51.45 20.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.385 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.64 87.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.227 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.407 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -69.14 -28.07 66.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.298 179.305 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.23 -34.95 36.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.902 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -69.03 -42.28 76.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.794 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.53 82.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m -71.07 -36.88 72.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -68.02 -40.45 82.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.752 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.73 -38.58 86.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.741 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.17 -43.69 97.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.8 t -61.15 -35.99 69.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.65 -32.76 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.698 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.9 89.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.81 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mt -69.23 -46.57 77.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.689 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mt -67.45 -32.67 58.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.492 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.6 -41.08 66.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.196 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -61.3 -21.95 64.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.344 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.54 -28.45 21.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.651 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.35 47.15 0.55 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.594 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -156.56 138.02 13.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.859 0.361 . . . . 0.0 110.95 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.6 m -93.27 159.4 15.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.798 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.476 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -57.32 -34.09 68.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.908 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 101' ' ' HIS . . . -51.93 -28.27 15.87 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.883 0.373 . . . . 0.0 110.711 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.68 -26.69 60.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.395 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 71.4 mt -47.61 118.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.5 m -92.14 -30.73 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.112 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -138.32 160.12 40.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.567 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.8 m -153.31 137.97 16.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.989 0.423 . . . . 0.0 111.49 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 58.5 m -126.98 140.65 52.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.043 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.26 115.61 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 111.617 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -89.35 112.08 23.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.482 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -97.46 148.34 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.575 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 -5.62 29.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.97 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 97.4 2.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.481 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mt -57.61 -18.11 18.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.226 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.45 -25.3 54.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.928 0.394 . . . . 0.0 110.49 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -87.13 -19.53 28.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.83 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -56.8 -22.48 36.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.09 -36.15 67.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 0.0 111.185 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.46 -44.66 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.54 -38.16 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.777 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -66.28 -41.91 89.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.81 84.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.208 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.29 -30.84 25.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.415 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 84.2 t80 -53.71 -44.36 69.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.893 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -85.86 -21.97 27.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.284 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.13 -21.27 59.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.429 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.2 p90 -91.78 -35.04 14.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.713 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 101' ' ' HIS . 0.8 OUTLIER -56.14 -60.2 3.84 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.145 0.498 . . . . 0.0 110.093 179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -28.85 70.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.576 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -77.33 -9.97 59.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.711 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 57.5 m-20 -113.46 -6.01 13.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.461 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.1 m120 88.04 34.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.169 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.476 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 1.6 m-70 -116.6 53.35 1.13 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.67 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 73.6 Cg_endo -73.62 -19.26 21.66 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.739 2.293 . . . . 0.0 112.907 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -46.16 -35.64 5.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.873 0.368 . . . . 0.0 111.399 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 13.4 m-85 68.18 106.36 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.372 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 98.6 Cg_endo -85.08 160.43 11.57 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.747 2.298 . . . . 0.0 112.319 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.97 154.45 5.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.575 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.413 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -113.73 150.39 33.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.0 111.315 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.07 53.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.447 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.93 146.78 27.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.019 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' B' ' 78' ' ' PHE . 29.7 m -153.23 156.23 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.303 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.99 95.36 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.8 m -83.21 148.45 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.65 -46.33 90.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.996 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -155.16 171.32 20.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.728 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.31 160.14 52.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -46.72 136.74 16.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.443 2.095 . . . . 0.0 112.236 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.85 17.86 7.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 61.67 17.14 8.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.034 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.16 154.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.055 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.8 26.49 24.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.666 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.91 158.01 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.113 0.482 . . . . 0.0 111.154 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -152.49 148.32 27.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.179 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.5 mm -122.94 146.13 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 111.766 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 99.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.101 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.03 166.8 15.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 111.877 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.0 mm -114.51 154.05 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.404 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -141.09 151.5 44.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.97 0.414 . . . . 0.0 111.573 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -105.88 -179.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.942 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.75 48.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.834 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 tttp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.266 -0.874 . . . . 0.0 110.878 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.843 0.354 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 6.9 tpp -107.82 162.18 14.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 51.0 m 63.56 131.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -173.52 122.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.418 ' CD1' ' ND2' ' A' ' 103' ' ' ASN . 2.0 mp -57.32 153.21 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 29.5 mt -114.22 154.67 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.201 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -153.63 126.08 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.75 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -130.46 151.77 50.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.99 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -98.19 30.18 3.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.894 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -39.76 4.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.33 120.74 67.43 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.168 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.25 -11.65 23.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.48 2.12 . . . . 0.0 112.613 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.29 -169.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.011 0.434 . . . . 0.0 111.391 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.518 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 58.36 -164.75 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.266 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' B' ' 14' ' ' ALA . 23.7 mm 80.34 16.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.126 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.74 -138.69 4.33 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.91 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -84.03 46.15 1.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.583 2.189 . . . . 0.0 112.653 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.518 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -176.16 -169.15 0.3 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 111.058 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 104' ' ' PHE . 14.5 m -120.55 -179.67 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.771 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -70.95 -51.33 26.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 0.0 111.038 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -161.19 -178.17 6.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.059 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.54 134.13 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.159 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -113.87 93.25 4.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.58 -20.34 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.046 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.87 -109.59 0.81 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.99 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.32 -30.38 64.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.462 . . . . 0.0 110.175 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.62 127.98 53.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.797 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.53 175.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.026 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -166.88 146.05 5.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 17.3 p -109.35 147.25 33.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 16.9 t -81.64 162.36 23.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.68 92.87 0.01 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.614 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -65.61 151.75 45.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 111.117 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.415 ' N ' HD13 ' B' ' 34' ' ' ILE . 4.6 mp -126.56 134.1 25.68 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.627 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 61.1 Cg_endo -74.0 72.73 3.89 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.88 2.387 . . . . 0.0 112.231 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t -87.42 87.88 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.623 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' B' ' 41' ' ' GLY . 0.9 OUTLIER -33.06 126.44 0.4 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.012 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.84 -5.52 17.34 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.236 1.957 . . . . 0.0 112.096 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.49 -23.73 11.72 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.653 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' THR . . . . . 0.427 ' CG2' ' HB3' ' B' ' 37' ' ' ASN . 15.2 t -129.37 -28.94 2.26 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.356 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 77.52 52.35 5.57 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.127 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 9.6 mm-40 -147.23 -74.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.683 0.278 . . . . 0.0 111.221 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 11.2 p 172.62 114.99 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.13 140.37 60.74 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.347 2.032 . . . . 0.0 112.158 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.96 -31.48 70.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.89 95.92 2.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.743 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.71 -31.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.313 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.3 t -76.03 -51.4 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.387 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.63 87.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.254 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.408 ' HG3' ' CG2' ' B' ' 43' ' ' VAL . 0.9 OUTLIER -69.14 -28.05 66.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.337 179.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.38 -34.97 35.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.927 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -68.99 -42.28 76.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.775 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -39.51 82.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.622 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m -71.04 -36.97 72.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.717 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.401 HD22 ' CE2' ' B' ' 95' ' ' PHE . 13.2 mt -67.97 -40.54 83.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.62 -38.64 87.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.758 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.09 -43.77 97.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.72 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.15 -36.05 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.792 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.48 -32.87 42.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.687 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.88 89.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mt -69.45 -46.66 75.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mt -67.48 -32.57 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.566 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.7 -41.05 65.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.183 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -61.26 -21.98 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.358 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.55 -28.41 21.98 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.35 47.16 0.55 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.616 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -156.54 137.98 13.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.975 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 9.4 m -93.27 159.4 15.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.819 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.468 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -57.29 -34.07 68.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' B' ' 101' ' ' HIS . . . -51.88 -28.12 15.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.975 0.417 . . . . 0.0 110.666 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.74 -26.62 60.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.416 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 71.4 mt -47.66 118.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.026 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 26.0 m -92.21 -30.55 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.08 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -138.43 160.02 40.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.596 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 42.0 m -153.27 137.97 16.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 0.0 111.461 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 58.5 m -126.98 140.65 52.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.08 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.26 115.58 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 111.551 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.409 ' CD2' HG11 ' A' ' 110' ' ' VAL . 9.1 m-85 -89.29 112.13 23.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.485 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -97.51 148.3 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.647 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 -5.73 29.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.95 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.67 97.43 2.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.508 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mt -57.63 -18.13 18.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.203 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.42 -25.33 54.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -87.08 -19.51 28.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.894 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -56.8 -22.52 36.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.204 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.18 67.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 111.214 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.53 -44.65 14.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.03 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.52 -38.15 81.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.818 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.23 -41.95 89.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.834 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.99 85.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.221 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.27 -31.0 25.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.415 ' O ' ' CE2' ' B' ' 95' ' ' PHE . 84.1 t80 -53.66 -44.46 69.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -85.8 -21.99 27.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.287 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.11 -21.27 59.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.438 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' B' ' 95' ' ' PHE . 1.2 p90 -91.83 -35.0 14.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.759 0.314 . . . . 0.0 110.695 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.414 ' CD1' ' HB2' ' B' ' 101' ' ' HIS . 0.8 OUTLIER -56.29 -60.12 3.97 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.174 0.512 . . . . 0.0 110.101 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -28.74 70.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.545 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -77.47 -9.91 59.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 110.658 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 57.1 m-20 -113.44 -6.02 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.482 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.1 m120 88.13 34.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.189 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' B' ' 69' ' ' ALA . 1.6 m-70 -116.47 53.38 1.1 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.701 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 73.5 Cg_endo -73.78 -19.21 21.3 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.771 2.314 . . . . 0.0 112.895 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 0.1 OUTLIER -46.12 -35.64 5.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.937 0.399 . . . . 0.0 111.409 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 13.5 m-85 68.15 106.37 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.36 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 97.0 Cg_endo -85.08 160.38 11.57 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.711 2.274 . . . . 0.0 112.327 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.88 154.53 5.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.615 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.468 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -113.78 150.46 33.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.015 0.436 . . . . 0.0 111.351 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.06 53.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.508 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.99 146.65 28.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.997 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' C' ' 78' ' ' PHE . 30.0 m -153.06 155.65 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.244 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.77 95.29 4.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.843 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 9.9 m -83.18 148.44 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.127 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.7 -46.34 90.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -155.16 171.26 20.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.719 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.29 160.19 52.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.706 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.75 136.75 16.45 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.459 2.106 . . . . 0.0 112.255 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.89 17.76 7.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 61.69 17.17 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.059 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.2 154.66 6.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.004 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.07 26.28 25.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.708 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.89 158.06 0.93 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.12 0.486 . . . . 0.0 111.191 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -152.48 148.25 27.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.23 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 23.5 mm -122.92 146.06 28.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.065 0.46 . . . . 0.0 111.799 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.88 99.82 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.144 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.05 166.7 15.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.877 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -114.47 154.0 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.422 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -141.03 151.58 44.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.914 0.388 . . . . 0.0 111.557 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.0 -179.42 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.894 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.71 48.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.947 0.403 . . . . 0.0 110.934 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 tttp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.849 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.817 0.342 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 6.9 tpp -107.82 162.11 14.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 51.2 m 63.57 131.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -173.53 122.4 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.29 153.21 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.834 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 29.0 mt -114.17 154.71 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.2 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -153.71 126.06 8.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.728 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -130.38 151.77 50.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.018 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -98.27 30.12 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.84 -39.33 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.72 120.72 67.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.18 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.31 -11.58 23.23 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.486 2.124 . . . . 0.0 112.593 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.32 -169.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.0 111.415 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.51 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 58.39 -164.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.231 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . 0.402 ' HB ' ' O ' ' C' ' 14' ' ' ALA . 23.8 mm 80.32 16.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.107 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.68 -138.61 4.33 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.0 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.08 46.17 1.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.621 2.214 . . . . 0.0 112.67 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.51 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -176.18 -169.12 0.3 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.92 0.391 . . . . 0.0 111.082 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.431 HG11 ' O ' ' B' ' 104' ' ' PHE . 14.6 m -120.58 -179.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.769 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -71.21 -52.52 18.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.271 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -159.65 -178.44 7.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.54 134.27 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -113.95 93.36 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 17.5 mt -62.68 -20.45 64.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.004 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.01 -109.57 0.81 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.926 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.33 -30.37 64.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.052 0.453 . . . . 0.0 110.187 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.6 128.02 53.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.776 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.55 175.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -166.83 146.1 5.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 17.4 p -109.61 147.62 32.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.915 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 16.9 t -81.76 162.24 22.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.002 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.61 92.9 0.01 OUTLIER Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.654 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -65.6 151.8 45.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 0.0 111.107 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.42 ' N ' HD13 ' C' ' 34' ' ' ILE . 4.6 mp -126.57 133.98 25.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.619 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 61.2 Cg_endo -73.88 72.61 3.84 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.888 2.392 . . . . 0.0 112.292 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t -87.31 87.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.68 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' C' ' 41' ' ' GLY . 0.9 OUTLIER -33.18 126.47 0.41 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.993 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.8 -5.55 17.4 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.215 1.943 . . . . 0.0 112.11 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.5 -23.69 11.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.638 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' C' ' 37' ' ' ASN . 15.2 t -129.31 -28.79 2.29 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.78 0.324 . . . . 0.0 111.405 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 77.21 52.31 5.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.13 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 9.6 mm-40 -147.23 -74.38 0.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.714 0.292 . . . . 0.0 111.182 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 11.1 p 172.66 115.02 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.049 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.07 140.4 60.14 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.327 2.018 . . . . 0.0 112.155 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.04 -31.38 70.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.008 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.94 95.97 2.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.684 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.79 -31.31 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.231 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.95 -51.47 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.383 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.6 87.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.246 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.41 ' HG3' ' CG2' ' C' ' 43' ' ' VAL . 0.9 OUTLIER -69.17 -27.91 65.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.301 179.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.52 -34.96 35.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.951 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -69.07 -42.29 76.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -39.49 82.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.698 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 1.3 m -71.03 -36.98 72.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.689 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -67.96 -40.52 83.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.728 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.68 -38.66 87.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.71 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.05 -43.8 97.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.717 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 24.8 t -61.12 -36.08 70.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.786 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.49 -32.77 42.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.676 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.0 90.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.799 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mt -69.18 -46.65 77.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.655 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 22.0 mt -67.43 -32.65 58.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.532 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.65 -41.03 65.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.18 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -61.3 -21.89 64.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.41 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.63 -28.41 21.89 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.623 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.32 47.14 0.55 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.613 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -156.52 138.0 13.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.853 0.358 . . . . 0.0 110.963 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 9.4 m -93.19 159.39 15.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.857 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.476 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -57.3 -34.19 68.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' C' ' 101' ' ' HIS . . . -51.9 -28.33 15.9 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.91 0.386 . . . . 0.0 110.712 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.55 -26.64 60.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.435 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 71.4 mt -47.66 118.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.033 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 26.4 m -92.09 -30.7 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.093 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -138.34 160.12 40.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 40.6 m -153.29 137.9 16.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.043 0.449 . . . . 0.0 111.517 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 58.8 m -126.94 140.61 52.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -146.22 115.66 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.616 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.421 ' CD2' HG11 ' B' ' 110' ' ' VAL . 9.1 m-85 -89.33 112.07 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.494 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -97.44 148.37 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.115 0.483 . . . . 0.0 111.575 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 -5.59 29.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.995 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.69 97.4 2.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.53 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mt -57.64 -18.15 18.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.38 -25.33 54.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.48 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -87.12 -19.51 28.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.888 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -56.73 -22.54 36.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.06 -36.11 67.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.55 -44.65 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.983 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.53 -38.18 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.31 -41.89 89.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.837 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.82 84.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.201 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.41 -30.97 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.418 ' O ' ' CE2' ' C' ' 95' ' ' PHE . 84.2 t80 -53.61 -44.47 69.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -85.82 -22.01 27.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.281 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -21.25 60.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.456 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 1.2 p90 -91.8 -35.13 14.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' C' ' 101' ' ' HIS . 0.8 OUTLIER -56.17 -60.21 3.82 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.117 0.484 . . . . 0.0 110.084 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -28.84 70.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.539 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.36 -9.96 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 0.0 110.681 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 57.2 m-20 -113.43 -6.01 13.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.491 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 11.9 m120 88.02 34.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.181 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.476 ' CD2' ' HB2' ' C' ' 69' ' ' ALA . 1.6 m-70 -116.56 53.35 1.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.664 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 73.5 Cg_endo -73.67 -19.29 21.51 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.797 2.332 . . . . 0.0 112.907 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 0.1 OUTLIER -46.18 -35.58 5.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.88 0.371 . . . . 0.0 111.388 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 13.5 m-85 68.12 106.39 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.36 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.421 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 96.7 Cg_endo -85.14 160.42 11.49 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.711 2.274 . . . . 0.0 112.353 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.9 154.46 5.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.556 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.464 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -113.75 150.46 33.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.998 0.428 . . . . 0.0 111.297 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.1 53.96 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.425 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.92 146.75 27.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.959 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 30.0 m -153.11 155.34 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.288 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 95.38 4.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.721 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 10.0 m -83.2 148.45 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.31 90.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -155.17 171.35 19.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.36 160.17 52.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.661 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.76 136.73 16.52 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.496 2.131 . . . . 0.0 112.243 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.95 17.79 7.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.7 17.08 8.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.049 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 35.7 m -63.17 154.6 6.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.044 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.77 26.41 24.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.652 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.76 157.98 0.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.08 0.467 . . . . 0.0 111.173 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.403 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 4.4 tt0 -152.46 148.28 27.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.226 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 23.2 mm -122.93 146.05 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.057 0.455 . . . . 0.0 111.81 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 99.84 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.068 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.08 166.86 15.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.037 0.446 . . . . 0.0 111.828 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 8.8 mm -114.52 154.0 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.463 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -141.1 151.46 43.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.898 0.38 . . . . 0.0 111.576 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.9 -179.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.884 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.71 48.1 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 tttp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.926 179.937 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.7 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.819 0.342 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -140.84 164.13 31.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.81 131.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.8 136.84 3.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -58.55 158.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.244 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 mt -115.13 160.58 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.043 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -160.73 124.48 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.997 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -127.65 165.52 19.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.973 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.76 51.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.25 -50.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.757 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . . . -66.41 172.34 3.25 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.03 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 11' ' ' ALA . 32.1 Cg_endo -64.37 -11.95 30.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.586 2.19 . . . . 0.0 112.714 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.27 171.61 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.987 0.423 . . . . 0.0 111.352 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.427 ' HB1' ' CZ ' ' A' ' 18' ' ' TYR . . . -166.98 122.75 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.799 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mm -141.42 17.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.377 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.58 -103.85 2.44 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.274 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.17 4.88 6.65 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.536 2.157 . . . . 0.0 112.788 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.427 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -160.74 177.21 10.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.448 HG12 ' O ' ' C' ' 103' ' ' ASN . 28.4 m -132.32 166.37 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.051 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -52.82 -46.43 67.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.21 176.79 1.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.997 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.19 133.89 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -97.26 139.69 32.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.654 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -112.94 -15.86 12.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.34 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 97.01 104.45 2.23 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.294 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 15.6 m-80 84.05 -35.72 0.06 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.2 101.5 6.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.771 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 127' ' ' ALA . 3.4 m -94.89 170.34 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.377 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mp -152.77 148.92 27.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 p -125.97 149.1 49.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 t -75.26 170.7 15.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.03 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.92 77.21 0.41 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.062 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.14 162.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.964 0.411 . . . . 0.0 111.536 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 7.5 pt -146.91 154.21 46.87 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.773 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.453 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 72.2 Cg_endo -77.11 48.79 2.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.925 2.416 . . . . 0.0 113.292 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.412 HG12 ' HA2' ' A' ' 41' ' ' GLY . 45.9 t -64.02 86.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.229 0.537 . . . . 0.0 110.473 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 41' ' ' GLY . 3.7 t30 -38.23 130.09 1.02 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.039 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.22 -6.98 19.22 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.228 1.952 . . . . 0.0 111.663 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.92 -28.3 12.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.552 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 37' ' ' ASN . 8.1 t -125.5 -33.63 2.77 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.967 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 85.24 62.22 1.67 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.731 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.25 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.694 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 9.9 p -170.59 125.74 0.66 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.309 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 50' ' ' GLN . 52.7 Cg_exo -54.4 141.77 71.38 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.453 2.102 . . . . 0.0 112.235 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.01 70.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 93.87 1.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.774 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.4 tp -42.25 -33.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.638 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.56 -46.38 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.15 -46.99 88.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.64 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.414 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 3.5 pt20 -64.89 -28.89 69.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.52 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.8 -40.87 54.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.859 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -67.81 -52.31 38.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.62 -27.97 63.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.622 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.86 -42.41 99.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.629 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.416 HD22 ' CD2' ' A' ' 92' ' ' TYR . 7.5 mt -74.98 -30.0 61.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.5 -36.16 83.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.086 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.418 ' OD1' HG21 ' A' ' 58' ' ' VAL . 22.4 p30 -72.43 -27.8 62.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.793 0.33 . . . . 0.0 110.598 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.418 HG21 ' OD1' ' A' ' 57' ' ' ASN . 35.2 t -67.63 -45.86 84.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -28.24 57.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.18 94.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mt -72.83 -40.9 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.584 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 mt -70.07 -33.07 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.68 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.53 -40.98 63.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.274 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -21.8 65.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.349 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.3 -28.41 17.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.734 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.24 56.65 0.26 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.606 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -172.77 144.17 1.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.0 p -99.43 166.06 11.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.763 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.512 ' HB1' ' CE1' ' A' ' 101' ' ' HIS . . . -62.48 -31.05 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.837 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -52.59 -26.85 14.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.911 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.15 -24.5 35.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.898 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.9 108.31 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.922 0.392 . . . . 0.0 110.954 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -74.31 -45.29 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.816 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.479 ' HB3' ' HG2' ' A' ' 107' ' ' ARG . 5.9 mttp -125.06 163.72 21.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.626 0.25 . . . . 0.0 111.263 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.5 ' N ' ' HG3' ' A' ' 107' ' ' ARG . 31.7 p -157.8 102.4 1.84 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.831 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.422 HG23 ' CZ ' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -70.03 124.64 24.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -116.28 110.36 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CZ ' HG23 ' A' ' 76' ' ' THR . 15.8 m-30 -107.88 119.92 40.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.973 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -114.26 152.21 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.13 0.491 . . . . 0.0 111.777 -179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.99 1.05 57.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.846 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.3 108.56 0.28 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.546 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 mt -57.84 -17.31 15.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.274 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.23 -22.18 60.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 0.0 110.458 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -87.05 -15.49 38.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.017 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.408 ' CE2' ' OD1' ' A' ' 89' ' ' ASN . 0.2 OUTLIER -57.35 -29.67 64.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.193 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.01 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.325 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.91 -28.84 22.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.322 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.76 -41.65 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.287 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.408 ' OD1' ' CE2' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -68.17 -36.56 79.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.91 75.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.321 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.59 -32.48 18.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.052 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.416 ' CD2' HD22 ' A' ' 55' ' ' LEU . 17.2 t80 -61.25 -49.89 75.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.041 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.52 -21.53 57.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.468 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -27.29 50.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.554 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.516 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -85.67 -39.07 17.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 110.752 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 4.3 m-85 -55.15 -54.5 42.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.154 0.502 . . . . 0.0 110.209 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -31.93 71.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.23 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.72 -4.18 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.713 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 4.1 t-20 -112.5 -5.54 14.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.535 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 5.6 m120 86.29 30.69 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.62 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.713 ' CE1' ' HB3' ' A' ' 99' ' ' ASN . 2.9 m170 -117.35 54.55 1.56 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.6 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.411 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 63.4 Cg_endo -72.09 -10.05 25.4 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.704 2.269 . . . . 0.0 113.362 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.452 ' O ' HG12 ' B' ' 19' ' ' VAL . 7.7 m-20 -56.7 -40.74 76.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.794 0.331 . . . . 0.0 110.921 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 102' ' ' PRO . 26.8 m-85 72.37 90.36 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.988 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.48 ' CB ' HG23 ' A' ' 75' ' ' THR . 77.0 Cg_exo -49.27 162.06 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.557 2.172 . . . . 0.0 112.322 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' B' ' 31' ' ' SER . . . -125.4 131.18 52.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.534 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -163.73 -166.47 1.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.57 114.93 28.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.219 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 14.3 m -96.94 130.37 44.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.127 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.4 m -148.74 167.64 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.924 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 30.7 tt0 -102.28 92.34 4.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.71 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.5 m -62.6 157.94 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.203 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.32 -51.44 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.17 178.45 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.718 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.3 mt -150.85 153.99 34.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.749 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.39 137.48 51.29 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.483 2.122 . . . . 0.0 112.21 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.66 14.84 2.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.303 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.58 14.48 9.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.095 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.3 m -58.78 160.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 111.027 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.48 21.75 21.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.782 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -178.86 154.9 0.74 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 0.0 111.208 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.55 150.59 43.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.044 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 20.8 mm -136.8 119.67 21.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -138.4 115.87 11.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.11 168.67 17.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.0 mm -116.55 146.03 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.488 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.413 ' CB ' HG22 ' A' ' 28' ' ' VAL . . . -132.63 148.48 52.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.171 0.51 . . . . 0.0 111.944 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.8 m -132.14 162.81 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.883 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -157.03 65.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.98 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.4 pttt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.459 179.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 40.6 mtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.813 0.34 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -140.83 164.16 30.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.8 131.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.83 136.88 3.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.026 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -58.61 158.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.242 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 mt -115.1 160.59 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -160.75 124.47 3.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.949 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -127.69 165.57 19.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.967 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.8 51.28 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.19 -49.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.512 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . . . -66.79 172.41 3.41 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.073 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' B' ' 11' ' ' ALA . 32.2 Cg_endo -64.37 -11.93 30.6 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.651 2.234 . . . . 0.0 112.758 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.26 171.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.422 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.434 ' HB1' ' CZ ' ' B' ' 18' ' ' TYR . . . -167.04 122.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.827 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 17.6 mm -141.41 17.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.399 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.49 -103.89 2.45 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.308 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.11 4.83 6.69 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.567 2.178 . . . . 0.0 112.843 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.434 ' CZ ' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -160.79 177.18 10.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.911 0.386 . . . . 0.0 111.291 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 103' ' ' ASN . 28.3 m -132.27 166.41 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.06 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -52.89 -46.44 67.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.806 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.47 176.84 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.875 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.27 133.84 34.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.122 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -97.2 139.75 32.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -112.98 -15.91 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 97.01 104.45 2.23 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.297 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 15.7 m-80 84.07 -35.74 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.19 101.52 6.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.791 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.412 HG22 ' CB ' ' B' ' 127' ' ' ALA . 3.4 m -94.91 170.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.392 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mp -152.85 148.81 27.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.4 p -125.79 148.08 49.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.755 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 106' ' ' ALA . 4.3 t -74.59 170.06 16.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.842 0.354 . . . . 0.0 110.953 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.87 77.14 0.41 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.026 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.15 162.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 111.448 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.405 ' CD1' ' CG2' ' B' ' 36' ' ' VAL . 7.5 pt -146.84 154.2 47.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 72.6 Cg_endo -77.23 48.85 2.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.903 2.402 . . . . 0.0 113.248 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.409 HG12 ' HA2' ' B' ' 41' ' ' GLY . 45.8 t -63.98 86.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.238 0.542 . . . . 0.0 110.545 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.449 ' HB3' ' CG2' ' B' ' 40' ' ' THR . 3.7 t30 -38.09 130.03 0.99 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.037 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.26 -6.95 19.15 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.171 1.914 . . . . 0.0 111.618 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.95 -28.2 12.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.545 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' B' ' 37' ' ' ASN . 8.0 t -125.66 -33.73 2.72 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.979 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 85.47 62.34 1.64 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.64 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.17 -84.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.669 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 9.8 p -170.53 125.78 0.67 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.308 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.8 Cg_exo -54.39 141.78 71.23 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.52 2.147 . . . . 0.0 112.21 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.77 -31.03 70.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.983 0.42 . . . . 0.0 110.941 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.13 93.77 1.86 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.817 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.4 tp -42.15 -33.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.714 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.59 -46.46 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.682 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.99 88.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.701 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.415 ' CB ' ' HD2' ' B' ' 44' ' ' PRO . 3.5 pt20 -65.11 -28.9 69.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.536 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.2 -41.11 42.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.319 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -67.69 -52.27 39.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.813 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.69 -27.92 63.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.88 -42.44 99.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.602 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mt -74.87 -30.03 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.019 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.51 -36.2 83.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.069 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . 0.403 ' OD1' HG21 ' B' ' 58' ' ' VAL . 22.2 p30 -72.37 -27.83 62.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.883 0.373 . . . . 0.0 110.59 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.403 HG21 ' OD1' ' B' ' 57' ' ' ASN . 35.1 t -67.7 -45.81 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -28.3 57.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.991 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.28 94.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.984 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 15.9 mt -72.95 -41.05 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.565 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 mt -70.0 -33.14 54.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.663 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.45 -41.0 63.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.286 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.48 -21.76 65.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.392 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.36 -28.37 17.76 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.751 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.27 56.57 0.26 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.583 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -172.8 144.12 1.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.355 . . . . 0.0 111.126 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -99.39 166.1 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.772 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.509 ' HB1' ' CE1' ' B' ' 101' ' ' HIS . . . -62.54 -31.0 71.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.788 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.54 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -52.49 -26.61 13.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.897 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.13 -24.59 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.88 108.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.008 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -74.29 -45.23 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.841 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.471 ' C ' HG23 ' B' ' 75' ' ' THR . 5.9 mttp -125.05 163.77 21.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.289 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.506 ' N ' ' HG3' ' B' ' 107' ' ' ARG . 31.8 p -157.83 102.5 1.84 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.787 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.423 HG23 ' CZ ' ' B' ' 78' ' ' PHE . 0.1 OUTLIER -70.12 124.69 24.72 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.38 110.37 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.423 ' CZ ' HG23 ' B' ' 76' ' ' THR . 15.7 m-30 -107.85 119.96 40.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.989 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 0.7 OUTLIER -114.29 152.2 15.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.154 0.502 . . . . 0.0 111.752 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.9 0.94 57.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.849 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.26 108.55 0.28 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.507 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 mt -57.8 -17.26 14.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.302 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.23 -22.26 60.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.834 0.35 . . . . 0.0 110.397 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -86.98 -15.52 38.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.031 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.413 ' CE2' ' OD1' ' B' ' 89' ' ' ASN . 0.2 OUTLIER -57.28 -29.69 64.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.232 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.94 68.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.32 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.96 -28.85 22.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.301 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.77 -41.57 28.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.295 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.413 ' OD1' ' CE2' ' B' ' 85' ' ' PHE . 0.3 OUTLIER -68.28 -36.53 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.828 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.57 -36.0 75.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.308 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.53 -32.48 18.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -61.29 -49.9 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.017 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.48 -21.6 57.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.457 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -27.27 50.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.591 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.52 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -85.68 -39.01 17.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.704 0.288 . . . . 0.0 110.765 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.52 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 4.3 m-85 -55.18 -54.5 42.54 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.136 0.493 . . . . 0.0 110.187 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -31.91 71.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.267 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.71 -4.18 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.584 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.713 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 4.1 t-20 -112.53 -5.51 14.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.547 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 5.6 m120 86.32 30.79 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.621 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.713 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 2.9 m170 -117.35 54.56 1.56 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.679 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 63.9 Cg_endo -72.08 -10.13 25.54 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.74 2.293 . . . . 0.0 113.359 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.449 ' O ' HG12 ' C' ' 19' ' ' VAL . 7.7 m-20 -56.6 -40.78 75.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.914 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' B' ' 102' ' ' PRO . 26.8 m-85 72.21 90.52 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.969 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.478 ' CB ' HG23 ' B' ' 75' ' ' THR . 78.1 Cg_exo -49.37 162.11 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.594 2.196 . . . . 0.0 112.274 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.5 131.1 52.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.505 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.506 ' HG3' ' N ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -163.57 -166.4 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.6 114.98 28.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.176 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 14.4 m -96.9 130.38 44.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.138 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 29.8 m -148.81 167.9 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.987 0.423 . . . . 0.0 111.982 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 79' ' ' VAL . 30.4 tt0 -102.42 92.46 4.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.708 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 24.1 m -62.76 158.05 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.37 -51.41 29.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.067 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.19 178.5 7.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.685 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 73.3 mt -150.88 153.99 34.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.769 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.37 137.56 51.73 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.428 2.085 . . . . 0.0 112.201 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.6 14.84 2.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.339 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.53 14.54 9.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.085 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 m -58.87 160.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.762 0.315 . . . . 0.0 110.99 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.5 21.68 21.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.682 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -178.88 154.86 0.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.077 0.465 . . . . 0.0 111.204 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.61 150.57 43.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.083 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 21.0 mm -136.85 119.55 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . 0.423 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.0 OUTLIER -138.32 115.87 11.3 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -132.12 168.68 17.56 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.0 mm -116.56 146.06 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.511 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' B' ' 28' ' ' VAL . . . -132.69 148.47 52.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.163 0.506 . . . . 0.0 111.937 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.09 162.78 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.945 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -157.02 65.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.004 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 6.4 pttt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.424 179.897 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 40.6 mtt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.867 0.365 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -140.84 164.13 31.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.83 131.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.967 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.75 136.87 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.054 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -58.54 158.24 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.181 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 mt -115.02 160.68 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.029 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -160.76 124.45 3.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.964 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -127.7 165.47 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.953 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.78 51.29 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.09 -49.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.704 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.502 ' CB ' ' HD2' ' C' ' 12' ' ' PRO . . . -67.43 172.3 3.98 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' C' ' 11' ' ' ALA . 32.1 Cg_endo -64.42 -11.95 30.84 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.598 2.199 . . . . 0.0 112.713 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.32 171.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.948 0.404 . . . . 0.0 111.365 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.443 ' HB1' ' CZ ' ' C' ' 18' ' ' TYR . . . -166.98 122.82 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.798 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mm -141.47 17.53 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.377 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.47 -103.89 2.45 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.296 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.14 4.83 6.68 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.565 2.177 . . . . 0.0 112.805 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.443 ' CZ ' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -160.72 177.18 10.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.897 0.38 . . . . 0.0 111.259 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.449 HG12 ' O ' ' B' ' 103' ' ' ASN . 28.1 m -132.28 166.39 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.054 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -52.86 -46.55 67.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -175.62 176.44 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.004 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.2 133.86 35.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -97.19 139.71 32.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.92 -15.87 12.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.352 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 97.03 104.41 2.23 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.344 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 16.0 m-80 84.1 -35.77 0.06 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.16 101.63 6.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.792 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' C' ' 127' ' ' ALA . 3.4 m -95.0 170.4 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.315 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.414 ' CD2' ' HD2' ' B' ' 74' ' ' LYS . 3.6 mp -152.78 148.89 27.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.962 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.4 p -125.91 148.95 49.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 4.4 t -75.36 170.27 16.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.82 77.16 0.4 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.033 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.21 162.95 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.008 0.432 . . . . 0.0 111.412 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 pt -146.9 154.29 46.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.681 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 72.5 Cg_endo -77.21 48.81 2.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.911 2.407 . . . . 0.0 113.23 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . 0.403 HG12 ' HA2' ' C' ' 41' ' ' GLY . 45.9 t -63.94 86.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.178 0.513 . . . . 0.0 110.469 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.453 ' HB3' ' CG2' ' C' ' 40' ' ' THR . 3.7 t30 -38.16 130.07 1.0 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.072 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.27 -6.94 19.14 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.186 1.924 . . . . 0.0 111.635 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.89 -28.25 12.51 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.594 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' C' ' 37' ' ' ASN . 8.1 t -125.62 -33.73 2.73 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.967 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 85.46 62.21 1.65 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.682 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.2 -84.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.669 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 10.0 p -170.57 125.77 0.66 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.335 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' C' ' 50' ' ' GLN . 52.7 Cg_exo -54.46 141.82 71.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.443 2.095 . . . . 0.0 112.224 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.0 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.059 0.457 . . . . 0.0 110.994 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.15 93.75 1.86 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.803 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 7.4 tp -42.11 -33.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.677 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.53 -46.41 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.705 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.99 88.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.688 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.41 ' CB ' ' HD2' ' C' ' 44' ' ' PRO . 3.5 pt20 -65.05 -28.8 69.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.453 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.29 -40.86 50.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.051 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -67.82 -52.22 39.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.79 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -27.98 63.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.644 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.82 -42.41 98.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' C' ' 92' ' ' TYR . 7.5 mt -74.94 -30.0 61.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.008 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.48 -36.15 83.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.149 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . 0.42 ' OD1' HG21 ' C' ' 58' ' ' VAL . 22.3 p30 -72.43 -27.82 62.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.42 HG21 ' OD1' ' C' ' 57' ' ' ASN . 34.5 t -67.65 -45.78 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -28.34 57.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.17 93.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.969 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 mt -73.06 -41.2 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.629 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 mt -69.9 -33.17 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.712 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.51 -40.96 63.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.229 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -21.83 65.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.325 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.29 -28.4 17.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.3 56.65 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.545 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -172.86 144.16 1.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.893 0.377 . . . . 0.0 111.063 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -99.41 166.08 11.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.764 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.513 ' HB1' ' CE1' ' C' ' 101' ' ' HIS . . . -62.44 -31.08 71.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.843 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.543 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -52.4 -26.62 13.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.973 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.47 -24.51 34.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.84 108.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.989 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -74.29 -45.26 47.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.818 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . 0.472 ' C ' HG23 ' C' ' 75' ' ' THR . 5.8 mttp -125.09 163.68 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.662 0.268 . . . . 0.0 111.248 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 31.8 p -157.74 102.44 1.86 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.788 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.43 HG23 ' CZ ' ' C' ' 78' ' ' PHE . 0.1 OUTLIER -70.04 124.63 24.54 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.33 110.39 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' C' ' 76' ' ' THR . 15.8 m-30 -107.86 119.97 40.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.94 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 0.8 OUTLIER -114.3 152.18 15.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.103 0.477 . . . . 0.0 111.773 -179.224 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.89 0.85 57.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.866 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.13 108.49 0.29 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.51 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 mt -57.76 -17.3 14.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -73.3 -22.19 60.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.384 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -87.01 -15.51 38.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.021 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.415 ' CE2' ' OD1' ' C' ' 89' ' ' ASN . 0.2 OUTLIER -57.33 -29.64 64.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.218 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.98 68.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.292 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.93 -28.89 22.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.273 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.72 -41.61 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.313 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . 0.415 ' OD1' ' CE2' ' C' ' 85' ' ' PHE . 0.3 OUTLIER -68.2 -36.6 79.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.881 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.95 75.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.274 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.51 -32.43 18.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.422 ' CD2' HD22 ' C' ' 55' ' ' LEU . 17.2 t80 -61.28 -49.86 75.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.084 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.5 -21.57 57.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.501 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -27.26 50.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.57 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.52 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -85.7 -39.02 17.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.703 0.287 . . . . 0.0 110.778 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.52 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 4.3 m-85 -55.12 -54.5 42.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.193 0.521 . . . . 0.0 110.231 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -31.9 71.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.264 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.73 -4.17 55.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.592 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.712 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 4.1 t-20 -112.54 -5.5 14.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.583 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 5.6 m120 86.29 30.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.631 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' C' ' 99' ' ' ASN . 2.9 m170 -117.25 54.58 1.51 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.626 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . 0.419 ' O ' ' CD2' ' C' ' 104' ' ' PHE . 63.4 Cg_endo -72.1 -10.04 25.37 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.744 2.296 . . . . 0.0 113.344 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . 0.448 ' O ' HG12 ' A' ' 19' ' ' VAL . 7.7 m-20 -56.75 -40.73 76.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.421 ' O ' HG12 ' A' ' 19' ' ' VAL . 26.7 m-85 72.34 90.39 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.965 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.48 ' CB ' HG23 ' C' ' 75' ' ' THR . 77.2 Cg_exo -49.31 162.1 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.569 2.179 . . . . 0.0 112.303 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.51 131.07 52.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.488 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.495 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -163.52 -166.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.64 114.99 28.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.195 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 14.2 m -96.9 130.33 44.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.163 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 30.2 m -148.88 168.12 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.906 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' C' ' 79' ' ' VAL . 30.6 tt0 -102.48 92.33 4.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 24.4 m -62.52 158.01 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.37 -51.44 29.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.18 178.51 7.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.706 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 73.3 mt -150.89 153.98 33.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.786 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.36 137.47 51.4 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.513 2.142 . . . . 0.0 112.184 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.62 14.9 2.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.307 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.52 14.52 8.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.84 160.86 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.323 . . . . 0.0 110.969 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.45 22.05 20.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.75 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.19 155.05 0.7 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.122 0.487 . . . . 0.0 111.144 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -140.63 150.62 43.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.036 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 20.8 mm -136.88 119.55 20.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.132 0.491 . . . . 0.0 112.286 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' C' ' 78' ' ' PHE . 0.0 OUTLIER -138.33 115.89 11.31 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -132.17 168.66 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . 0.408 ' CG2' ' HG ' ' C' ' 29' ' ' LEU . 4.0 mm -116.5 146.05 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.527 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' C' ' 28' ' ' VAL . . . -132.65 148.45 52.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.186 0.517 . . . . 0.0 111.895 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.09 162.82 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.932 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -157.05 65.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.984 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.4 pttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.449 179.924 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.767 0.318 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -177.28 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.4 m 63.33 141.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.849 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.89 127.17 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -56.47 153.7 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.177 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.9 mt -109.85 157.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -159.46 134.84 8.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -147.78 160.75 42.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.93 21.01 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.042 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -116.59 -35.91 4.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.913 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -52.7 177.79 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.343 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 17.1 Cg_exo -67.13 -8.28 21.37 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.831 2.354 . . . . 0.0 112.705 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.45 147.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 110.953 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.81 121.02 39.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.199 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.36 16.52 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.971 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.8 -148.87 4.85 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.307 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.73 38.75 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.869 2.379 . . . . 0.0 113.047 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.06 164.26 28.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.884 0.374 . . . . 0.0 111.05 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.6 m -113.32 175.4 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.963 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -48.22 81.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.936 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -175.53 178.97 1.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.922 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.17 132.95 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -111.25 118.42 35.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mt -94.1 -16.96 23.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.218 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.33 -99.99 0.9 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -59.08 -29.16 67.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.193 0.52 . . . . 0.0 109.717 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.55 139.52 51.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.547 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.413 ' CG1' ' CB ' ' A' ' 127' ' ' ALA . 4.2 p -127.92 151.34 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.009 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.66 135.46 42.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.743 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.3 p -108.85 136.18 48.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.066 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -63.94 143.23 58.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.827 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.55 92.17 0.01 OUTLIER Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.365 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -74.55 163.75 27.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.47 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.436 HG23 HD11 ' A' ' 34' ' ' ILE . 2.1 pt -146.27 160.26 43.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.672 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.542 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 17.6 Cg_exo -66.82 54.23 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.052 2.501 . . . . 0.0 113.262 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -65.21 86.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.168 0.509 . . . . 0.0 110.384 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' GLY . 24.4 t-20 -36.79 133.09 0.67 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.977 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.53 -12.7 31.85 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.316 2.01 . . . . 0.0 112.109 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.9 -20.66 9.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.739 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 m -115.46 -23.02 9.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.848 0.356 . . . . 0.0 110.95 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 58.86 56.89 22.82 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.36 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.5 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 9.2 p -175.13 108.43 0.26 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.35 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.46 140.98 74.06 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.353 2.035 . . . . 0.0 112.118 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.29 -31.55 71.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.068 0.461 . . . . 0.0 110.901 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.48 91.47 0.57 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.781 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mm -41.1 -32.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.542 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.9 -42.66 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.29 -36.51 77.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.766 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -20.66 50.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.605 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.94 -36.76 23.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.291 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -33.2 58.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.931 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.02 -26.68 59.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.696 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.7 p -70.57 -35.35 73.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.421 HD13 ' CE2' ' A' ' 95' ' ' PHE . 8.7 mt -77.38 -33.6 55.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.074 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -51.59 69.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.977 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -59.45 -39.85 84.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.947 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.5 t -61.76 -35.76 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.851 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -31.53 43.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.17 92.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.47 -46.25 76.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.789 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mt -65.33 -31.44 53.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.765 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -41.36 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.401 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -63.2 -20.44 65.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.512 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.77 -21.51 20.66 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.064 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.03 53.19 0.8 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.383 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -155.65 137.1 14.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 157.16 16.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.754 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.13 -36.76 31.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -58.47 -21.24 50.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.363 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.88 -26.45 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.884 0.373 . . . . 0.0 110.588 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 35.5 mt -59.35 114.21 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 m -84.39 -33.14 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.72 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.404 ' CG ' ' CB ' ' A' ' 106' ' ' ALA . 0.6 OUTLIER -139.86 152.68 46.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.693 0.283 . . . . 0.0 111.009 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.8 p -141.9 135.0 29.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 111.336 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.5 m -114.82 150.85 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.213 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.3 t -148.87 112.94 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 111.613 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -92.7 107.85 19.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.549 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 m -102.42 146.43 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.413 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.69 -3.07 58.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.031 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.85 125.89 2.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.25 -11.11 56.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.164 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.07 -20.52 52.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 110.632 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -95.24 7.01 47.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.291 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -84.24 -27.96 27.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.768 0.318 . . . . 0.0 111.124 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.88 77.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.176 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.7 -33.89 27.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 t -77.97 -43.29 28.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.029 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -61.72 -33.07 73.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.027 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.35 -48.63 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.299 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.47 -29.85 59.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.186 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.524 ' CE1' ' CE1' ' A' ' 96' ' ' PHE . 11.5 t80 -63.99 -37.51 87.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.148 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.47 -27.33 29.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.191 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -33.72 76.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.187 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.467 ' CZ ' ' CD1' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -85.7 -34.63 21.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.553 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.524 ' CE1' ' CE1' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -57.8 -55.05 39.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.287 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -32.74 71.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.049 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -85.8 -0.86 56.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.407 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 2.6 m-20 -98.88 -18.38 17.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.189 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 20.2 m-20 104.89 25.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.11 0.881 . . . . 0.0 110.948 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.46 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.1 t-80 -123.95 66.67 40.46 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.05 -16.87 22.58 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.533 2.155 . . . . 0.0 112.393 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.13 -35.21 77.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.793 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 76.2 120.44 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.3 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 93.9 Cg_endo -82.41 168.87 14.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.848 2.365 . . . . 0.0 112.218 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.404 ' CB ' ' CG ' ' A' ' 74' ' ' LYS . . . -56.35 159.47 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.406 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -127.97 142.77 51.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.033 0.444 . . . . 0.0 111.528 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 t -150.43 66.6 0.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.453 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 11.8 m -96.75 138.76 33.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.033 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.6 m -145.5 139.56 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.303 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' B' ' 114' ' ' ARG . 1.0 OUTLIER -70.87 86.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.822 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.7 m -71.18 155.94 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.238 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.87 -46.82 70.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 0.0 OUTLIER -153.79 176.96 11.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.799 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.0 mt -147.48 155.38 45.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.814 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.97 136.97 77.51 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.593 2.196 . . . . 0.0 112.045 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 74.88 13.91 3.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.244 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.98 15.95 8.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.109 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.1 m -55.56 146.31 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.185 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.45 -15.1 64.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.9 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.2 mt -151.18 147.6 27.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.085 0.469 . . . . 0.0 111.016 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -122.53 155.32 36.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.211 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 30.3 mm -130.88 133.57 62.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 0.0 111.767 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -152.42 155.88 38.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.007 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -177.45 165.07 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.081 0.467 . . . . 0.0 111.833 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.52 143.66 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.393 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -129.76 157.99 40.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.0 0.429 . . . . 0.0 111.775 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -115.95 155.0 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.956 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.72 47.04 2.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.826 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.993 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.871 0.367 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -177.3 4.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.814 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 10.5 m 63.37 141.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.86 127.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.004 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -56.49 153.73 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.207 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 31.7 mt -109.89 157.1 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.122 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -159.48 134.78 8.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -147.72 160.76 42.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.94 21.06 10.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.962 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -116.68 -35.83 4.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.439 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -52.77 177.77 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.424 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 17.1 Cg_exo -67.05 -8.38 21.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.9 2.4 . . . . 0.0 112.689 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.51 147.76 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 111.002 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.81 120.93 39.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.206 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.27 16.6 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.984 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.81 -148.88 4.85 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.308 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.72 38.78 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.853 2.369 . . . . 0.0 113.063 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.07 164.34 28.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 111.05 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 25.6 m -113.43 175.4 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -48.3 81.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.981 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -175.62 178.98 1.49 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 m -134.09 132.95 56.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.131 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -111.3 118.46 35.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mt -94.07 -16.98 23.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.249 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.37 -100.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.468 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -59.05 -29.19 67.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.719 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.57 139.47 51.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.564 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.416 ' CG1' ' CB ' ' B' ' 127' ' ' ALA . 4.2 p -127.99 151.39 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.964 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.62 135.45 42.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.76 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -108.99 136.24 48.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.028 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.15 143.35 57.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.55 92.1 0.01 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.358 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -74.53 163.76 27.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.429 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.439 HD11 HG23 ' B' ' 34' ' ' ILE . 2.2 pt -146.28 160.29 42.89 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.625 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.552 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 18.0 Cg_exo -66.96 54.35 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.058 2.505 . . . . 0.0 113.205 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 t -65.27 86.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.167 0.508 . . . . 0.0 110.361 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' B' ' 41' ' ' GLY . 24.4 t-20 -36.83 133.13 0.67 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.992 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.55 -12.66 31.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.29 1.993 . . . . 0.0 112.159 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.92 -20.66 9.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.784 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.6 m -115.49 -22.96 9.03 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.779 0.323 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 58.86 56.94 22.51 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.362 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.55 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.798 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 9.1 p -175.08 108.43 0.27 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.336 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.43 140.89 73.79 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.355 2.037 . . . . 0.0 112.183 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.18 -31.56 71.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.44 91.48 0.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.782 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mm -41.16 -32.75 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.514 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.82 -42.65 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.906 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.29 -36.55 77.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.768 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -20.85 49.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.614 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.8 -36.8 23.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.295 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 -33.1 58.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.01 -26.83 59.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' SER . . . . . 0.403 ' HA ' ' ND2' ' B' ' 57' ' ' ASN . 90.3 p -70.53 -35.25 73.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.42 HD13 ' CD2' ' B' ' 95' ' ' PHE . 8.7 mt -77.41 -33.6 54.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -51.6 69.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' B' ' 54' ' ' SER . 10.3 p30 -59.47 -39.85 85.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 31.5 t -61.77 -35.79 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.824 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -31.53 43.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.874 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.29 93.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.46 -46.21 76.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.77 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.25 -31.49 54.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -41.37 60.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.327 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -63.17 -20.43 65.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.556 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.83 -21.47 20.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.049 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.02 53.16 0.81 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.363 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -155.59 137.05 14.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.71 157.12 16.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.1 -36.77 30.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.445 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -58.61 -21.2 52.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.364 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.74 -26.49 49.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 110.583 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.505 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 35.2 mt -59.39 114.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 m -84.34 -33.13 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.745 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.91 152.68 46.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.747 0.308 . . . . 0.0 110.953 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 40.7 p -141.86 135.02 29.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.997 0.427 . . . . 0.0 111.353 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 4.4 m -114.8 150.86 34.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.19 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.2 t -148.83 112.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 111.637 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -92.74 107.88 19.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.543 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.41 146.42 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.467 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -3.13 59.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.028 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.8 125.9 2.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.581 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.19 -11.09 56.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.202 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.06 -20.58 52.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.831 0.348 . . . . 0.0 110.615 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -95.25 7.0 47.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -84.25 -27.95 27.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.145 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.26 -34.92 77.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.264 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.63 -34.01 27.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 t -77.95 -43.28 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.061 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -61.67 -33.19 73.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.008 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.29 -48.55 33.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.332 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.61 -29.93 59.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.524 ' CE1' ' CE1' ' B' ' 96' ' ' PHE . 11.4 t80 -63.94 -37.63 88.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.37 -27.39 29.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.213 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -33.79 76.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.132 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.468 ' CZ ' ' CD1' ' B' ' 96' ' ' PHE . 0.3 OUTLIER -85.7 -34.59 21.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 0.0 110.578 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.524 ' CE1' ' CE1' ' B' ' 92' ' ' TYR . 0.4 OUTLIER -57.83 -55.1 39.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.258 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -32.77 71.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.033 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -85.76 -1.0 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.381 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.547 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 2.6 m-20 -98.77 -18.42 17.99 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.192 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 20.4 m-20 104.98 25.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.117 0.885 . . . . 0.0 110.921 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.445 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.1 t-80 -124.15 66.62 42.3 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.01 -16.8 22.73 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.477 2.118 . . . . 0.0 112.393 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -35.11 77.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.851 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 76.14 120.4 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.287 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 92.8 Cg_endo -82.36 168.9 14.5 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.798 2.332 . . . . 0.0 112.266 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.31 159.54 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.404 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -128.0 142.79 51.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.082 0.468 . . . . 0.0 111.535 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 27.8 t -150.46 66.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.426 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 11.8 m -96.78 138.78 33.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 34.6 m -145.44 139.32 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.388 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.58 86.89 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.698 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m -71.29 155.8 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.74 -46.89 70.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -153.79 176.92 11.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 30.5 mt -147.43 155.32 45.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.809 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.93 136.97 77.4 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.161 . . . . 0.0 112.099 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 74.91 13.86 3.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.287 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 63.05 15.93 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.058 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 13.9 m -55.63 146.35 4.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.875 0.369 . . . . 0.0 111.177 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.44 -15.19 64.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.868 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 37.1 mt -151.1 147.41 27.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.07 0.462 . . . . 0.0 111.045 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -122.52 155.28 36.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.246 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 30.3 mm -130.83 133.6 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.424 . . . . 0.0 111.76 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -152.5 155.87 38.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.93 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -177.44 165.04 2.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 111.814 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.53 143.67 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.367 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -129.74 158.0 40.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.999 0.428 . . . . 0.0 111.756 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.91 155.03 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.982 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.83 47.0 2.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.854 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.959 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.798 0.332 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.46 -177.27 4.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 10.3 m 63.3 141.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.84 127.13 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.013 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -56.48 153.7 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 31.4 mt -109.8 157.18 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -159.57 134.76 8.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -147.71 160.7 42.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.9 21.05 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.041 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -116.62 -35.99 4.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.863 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.447 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -52.76 177.85 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.313 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 17.1 Cg_exo -67.09 -8.38 21.64 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.868 2.379 . . . . 0.0 112.653 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.56 147.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.898 0.38 . . . . 0.0 110.967 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.77 120.94 39.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.36 16.63 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.84 -148.84 4.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.269 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -88.72 38.76 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.827 2.351 . . . . 0.0 113.071 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.01 164.28 28.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.823 0.344 . . . . 0.0 111.055 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 25.0 m -113.36 175.41 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.907 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -48.24 81.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -175.67 178.98 1.47 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.932 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 m -134.12 132.91 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -111.2 118.43 35.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.723 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mt -94.04 -17.02 23.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.256 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.32 -100.01 0.9 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.489 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -59.04 -29.17 67.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.223 0.535 . . . . 0.0 109.755 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.59 139.55 51.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.522 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.417 ' CG1' ' CB ' ' C' ' 127' ' ' ALA . 4.2 p -127.96 151.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.61 135.5 42.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.767 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 32.9 p -108.9 136.34 48.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.103 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -64.01 143.24 58.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.77 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.5 92.12 0.01 OUTLIER Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.325 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -74.53 163.77 27.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.036 0.446 . . . . 0.0 111.432 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.406 HD11 HG23 ' C' ' 34' ' ' ILE . 2.1 pt -146.33 160.27 42.79 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.618 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.548 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 17.9 Cg_exo -66.84 54.24 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.113 2.542 . . . . 0.0 113.184 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 t -65.29 86.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 110.355 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' C' ' 41' ' ' GLY . 24.4 t-20 -36.78 133.13 0.67 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.969 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.57 -12.65 31.69 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.269 1.98 . . . . 0.0 112.165 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.92 -20.64 9.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.73 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 2.6 m -115.48 -23.04 9.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.854 0.359 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 58.88 56.95 22.47 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.343 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.45 -81.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.847 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 9.2 p -175.05 108.47 0.27 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.329 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.49 140.94 74.44 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.326 2.017 . . . . 0.0 112.19 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.54 71.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.49 91.5 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.78 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 mm -41.15 -32.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.471 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.88 -42.58 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.925 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.31 -36.6 77.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.704 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -20.74 50.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.88 -36.69 23.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.286 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.72 -33.12 58.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.935 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -74.99 -26.82 59.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.682 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.401 ' HA ' ' ND2' ' C' ' 57' ' ' ASN . 90.8 p -70.45 -35.38 73.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.418 HD13 ' CD2' ' C' ' 95' ' ' PHE . 8.6 mt -77.32 -33.64 55.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -51.56 69.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.993 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' C' ' 54' ' ' SER . 10.3 p30 -59.5 -39.85 85.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.929 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 31.5 t -61.77 -35.81 69.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.831 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -31.63 44.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.13 92.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.64 -46.28 75.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -65.34 -31.42 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -41.42 60.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.368 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -63.14 -20.46 65.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.521 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.79 -21.51 20.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.002 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.04 53.14 0.81 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.373 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -155.63 137.09 14.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 110.978 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 157.13 16.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.738 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.11 -36.71 30.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.451 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -58.63 -21.24 53.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.322 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.72 -26.49 50.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.551 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 35.3 mt -59.38 114.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -84.35 -33.19 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.729 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . 0.402 ' CG ' ' CB ' ' C' ' 106' ' ' ALA . 0.6 OUTLIER -139.87 152.66 46.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.771 0.319 . . . . 0.0 110.942 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 40.8 p -141.9 135.0 29.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.991 0.424 . . . . 0.0 111.381 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 4.5 m -114.83 150.78 34.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.185 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -148.73 112.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 0.0 111.622 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -92.68 107.83 19.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.616 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 m -102.44 146.49 10.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.391 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -2.81 58.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.058 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.15 125.94 1.96 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.624 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.28 -11.05 56.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.09 -20.53 52.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.836 0.35 . . . . 0.0 110.606 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -95.31 7.04 47.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.263 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -84.25 -28.0 27.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.728 0.299 . . . . 0.0 111.096 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.25 -35.0 77.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.197 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.6 -33.92 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.201 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.89 -43.3 28.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.099 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -61.66 -33.15 73.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.011 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.37 -48.45 34.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.337 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -29.83 59.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.14 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.522 ' CE1' ' CE1' ' C' ' 96' ' ' PHE . 11.6 t80 -63.94 -37.65 88.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.071 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.42 -27.36 29.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.167 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -33.7 76.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.151 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.459 ' CZ ' ' CD1' ' C' ' 96' ' ' PHE . 0.3 OUTLIER -85.76 -34.59 21.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 110.544 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.522 ' CE1' ' CE1' ' C' ' 92' ' ' TYR . 0.4 OUTLIER -57.81 -55.13 38.87 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.232 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -32.77 71.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.022 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -85.71 -0.98 56.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.43 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 2.6 m-20 -98.88 -18.33 17.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.179 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 20.3 m-20 104.8 25.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.869 0.868 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.451 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.1 t-80 -124.07 66.67 41.69 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.846 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.05 -16.8 22.61 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.483 2.122 . . . . 0.0 112.476 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.21 -35.14 77.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.852 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 76.18 120.49 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.264 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 94.2 Cg_endo -82.4 168.93 14.41 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.831 2.354 . . . . 0.0 112.206 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . 0.402 ' CB ' ' CG ' ' C' ' 74' ' ' LYS . . . -56.42 159.6 3.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.393 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -128.1 142.79 51.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.083 0.468 . . . . 0.0 111.471 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 27.7 t -150.47 66.68 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.387 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 11.7 m -96.76 138.78 33.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.068 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 34.6 m -145.54 139.53 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.372 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 1.0 OUTLIER -70.63 87.01 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 21.6 m -71.33 156.03 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.97 -46.81 70.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.75 176.92 11.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 30.5 mt -147.44 155.35 45.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.03 137.03 77.86 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.572 2.182 . . . . 0.0 112.058 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 74.91 13.88 3.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 20.1 t70 63.0 15.96 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 14.1 m -55.61 146.38 4.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.856 0.36 . . . . 0.0 111.217 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.41 -15.12 64.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.878 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 37.0 mt -150.81 147.46 27.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.0 0.429 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -122.6 155.27 36.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.249 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 30.2 mm -130.78 133.6 63.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.004 0.43 . . . . 0.0 111.771 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -152.47 155.87 38.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.981 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -177.42 165.04 2.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.834 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.49 143.65 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.372 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -129.74 157.99 40.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.962 0.41 . . . . 0.0 111.787 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.94 154.94 17.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.005 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.7 46.99 2.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.899 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.963 -179.961 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.82 0.343 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.26 42.07 15.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.838 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 23' ' ' ASP . 5.9 m -78.24 152.97 32.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -177.96 132.51 0.15 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.008 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -57.51 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.1 mt -113.55 150.64 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.203 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -147.84 134.25 19.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.83 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.7 t -148.14 163.27 37.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.93 28.67 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -110.31 -49.88 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.776 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.46 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -67.85 179.3 0.62 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.981 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 31.4 Cg_exo -59.08 -15.57 28.69 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.74 2.293 . . . . 0.0 112.614 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.78 153.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -110.37 119.94 40.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.201 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.22 16.23 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.833 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.38 -137.96 4.61 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.417 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HB2' ' CE1' ' C' ' 92' ' ' TYR . 87.1 Cg_endo -84.33 16.61 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.755 2.303 . . . . 0.0 113.641 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -137.41 177.85 7.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.454 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' C' ' 103' ' ' ASN . 10.6 m -128.82 169.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.047 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -59.54 -55.85 29.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.006 0.431 . . . . 0.0 110.458 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.99 178.04 4.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.596 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 m -144.58 131.51 16.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.954 0.407 . . . . 0.0 111.164 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 3' ' ' THR . 3.6 t70 -98.98 110.55 23.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.439 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.48 -11.52 60.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.504 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.51 -102.86 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.669 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.11 -30.05 64.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.176 0.512 . . . . 0.0 109.979 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.58 167.54 18.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.55 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.5 160.83 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.83 122.78 20.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.28 137.71 41.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.046 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 t -71.25 172.67 8.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.32 82.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.074 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.38 147.51 21.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 0.0 111.385 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 5.0 pt -142.3 149.75 52.66 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.576 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 34' ' ' ILE . 1.6 Cg_endo -83.17 51.09 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.921 2.414 . . . . 0.0 112.481 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 86.0 t -94.27 82.47 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.185 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.481 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 0.5 OUTLIER 157.47 -44.69 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.018 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 37' ' ' ASN . 79.9 Cg_exo -42.6 -24.39 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.285 1.99 . . . . 0.0 112.732 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 40' ' ' THR . . . -90.42 -30.14 17.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.047 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 37' ' ' ASN . 1.0 OUTLIER 158.26 -11.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.814 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 37' ' ' ASN . . . 131.7 58.37 0.09 OUTLIER Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.088 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -178.8 -65.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.624 0.249 . . . . 0.0 111.283 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 42' ' ' GLU . 5.4 p 164.67 115.87 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.7 147.51 91.75 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.514 2.143 . . . . 0.0 112.1 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.39 -31.0 57.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 110.943 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.65 95.79 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.28 -32.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.835 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 t -83.26 -43.23 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.11 96.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.794 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -74.27 -30.09 61.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.266 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.95 -33.37 59.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.369 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -30.16 29.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.12 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.21 -33.33 59.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -69.43 -35.74 76.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.573 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 92' ' ' TYR . 68.5 mt -63.0 -39.71 95.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.531 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -72.22 -40.56 67.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.673 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -57.82 -41.07 81.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.4 t -60.11 -40.76 84.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.792 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -32.41 59.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.769 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.46 86.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.9 -41.65 82.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.722 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.3 mt -69.28 -36.58 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.588 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -40.3 72.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -65.32 -19.04 65.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.539 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.33 -34.17 17.73 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.73 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.48 44.84 0.3 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.812 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.0 -170.54 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.716 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.78 157.25 44.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.441 ' O ' ' CD2' ' A' ' 101' ' ' HIS . . . -58.12 -36.58 73.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.03 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -57.49 -26.09 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.319 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -76.29 -24.48 54.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.879 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.3 mm -54.14 118.27 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.977 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.4 ' CG1' HG22 ' A' ' 128' ' ' VAL . 5.2 m -90.85 -32.86 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.929 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -143.25 163.97 31.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.658 0.266 . . . . 0.0 111.198 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.423 ' CB ' ' HB3' ' A' ' 125' ' ' ALA . 3.4 t -162.15 112.52 1.56 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.376 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -92.87 160.17 15.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.318 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.6 t -150.54 142.73 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.041 0.448 . . . . 0.0 111.945 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.428 ' CD2' HG12 ' C' ' 110' ' ' VAL . 3.2 m-85 -121.15 102.56 8.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.189 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 m -100.55 150.28 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.701 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.08 -1.86 58.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.839 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.59 124.5 1.38 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.477 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.79 -10.67 58.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.196 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.97 -22.81 42.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.827 0.346 . . . . 0.0 110.574 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -88.16 -20.27 25.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -57.52 -22.25 43.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.358 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.49 -60.41 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.57 79.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.3 t -61.67 -37.4 77.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.915 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.574 ' HA ' ' CE2' ' A' ' 92' ' ' TYR . 36.0 t-20 -62.28 -41.94 98.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.77 -23.46 42.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.351 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.16 -42.33 19.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.77 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.574 ' CE2' ' HA ' ' A' ' 89' ' ' ASN . 0.3 OUTLIER -77.34 -28.7 53.15 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.083 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.88 -33.72 39.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.966 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -72.63 -29.75 63.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.178 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -74.26 -41.65 60.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.782 0.325 . . . . 0.0 110.508 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.477 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 6.9 m-85 -52.04 -50.84 60.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.088 0.47 . . . . 0.0 110.377 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.04 -28.9 69.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.135 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.88 2.73 55.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.42 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -119.25 -1.52 10.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.3 t30 85.75 28.73 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.189 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.471 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -121.52 53.63 4.02 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.617 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 45.5 Cg_endo -68.3 -20.49 42.7 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.56 2.173 . . . . 0.0 112.676 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 2.1 m-20 -60.85 -40.34 92.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.942 0.401 . . . . 0.0 110.501 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 27.6 m-85 77.36 120.98 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.833 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HD3' ' NE2' ' A' ' 101' ' ' HIS . 84.7 Cg_endo -83.99 162.03 13.76 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.844 2.363 . . . . 0.0 112.303 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.32 163.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.447 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.463 ' CZ ' ' CZ ' ' A' ' 92' ' ' TYR . 13.7 ttm-85 -146.59 144.52 29.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.159 0.504 . . . . 0.0 111.876 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.14 63.31 1.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.996 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 19.8 p -79.92 134.78 36.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.278 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.438 HG12 ' CD2' ' B' ' 78' ' ' PHE . 33.9 m -146.25 146.62 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.193 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.42 88.05 5.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.7 m -71.75 155.4 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.88 -44.01 64.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.1 174.71 13.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.0 mt -147.16 156.01 46.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.23 136.33 67.88 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.595 2.197 . . . . 0.0 112.169 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt 74.7 14.1 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.232 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.48 17.8 8.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 m -52.1 162.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.845 0.355 . . . . 0.0 111.188 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.42 -25.55 13.66 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.737 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -157.51 148.87 21.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.164 0.507 . . . . 0.0 111.127 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.43 155.98 33.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.199 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mp -144.06 119.99 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.071 0.462 . . . . 0.0 112.016 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 149.01 50.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.437 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HB3' ' CB ' ' A' ' 75' ' ' THR . . . -163.83 161.18 23.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.313 0.578 . . . . 0.0 112.455 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.0 mt -118.0 152.44 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.058 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -133.3 149.9 51.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.139 0.495 . . . . 0.0 111.9 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.4 HG22 ' CG1' ' A' ' 73' ' ' VAL . 36.0 m -122.65 139.4 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.815 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -135.47 52.3 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.976 179.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.3 42.01 15.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' B' ' 23' ' ' ASP . 5.9 m -78.21 152.97 32.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.065 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -177.95 132.5 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.084 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -57.54 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.2 mt -113.53 150.57 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -147.82 134.24 19.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 2.7 t -148.17 163.24 37.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.85 28.67 7.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -110.26 -49.84 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.782 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.466 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -67.98 179.29 0.63 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 31.5 Cg_exo -59.01 -15.59 28.38 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.742 2.295 . . . . 0.0 112.627 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.77 153.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -110.38 119.93 40.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.23 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.2 16.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.826 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.44 -137.96 4.6 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.429 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.409 ' HB2' ' CE1' ' A' ' 92' ' ' TYR . 88.9 Cg_endo -84.32 16.52 1.92 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.75 2.3 . . . . 0.0 113.653 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -137.37 177.84 7.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.962 0.411 . . . . 0.0 111.456 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 103' ' ' ASN . 10.5 m -128.75 169.45 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.028 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -59.76 -55.74 30.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 110.466 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.94 178.12 4.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.594 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 m -144.62 131.54 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.954 0.407 . . . . 0.0 111.191 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' B' ' 3' ' ' THR . 3.6 t70 -98.96 110.65 23.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.405 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.55 -11.54 60.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.503 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.58 -102.87 0.68 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.668 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.19 -29.98 64.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.146 0.498 . . . . 0.0 109.972 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.59 167.53 18.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.523 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' B' ' 127' ' ' ALA . 7.1 p -129.52 160.78 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.057 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.8 122.76 20.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.736 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.24 137.82 40.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.041 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 16.6 t -71.27 172.54 9.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.96 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.21 82.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.113 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.4 147.49 21.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.022 0.439 . . . . 0.0 111.352 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.3 149.69 52.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.552 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 1.6 Cg_endo -83.12 51.04 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.956 2.437 . . . . 0.0 112.483 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.459 ' O ' ' CB ' ' B' ' 37' ' ' ASN . 86.7 t -94.26 82.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.188 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.478 ' N ' ' CD ' ' B' ' 38' ' ' PRO . 0.5 OUTLIER 157.4 -44.68 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.965 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' B' ' 37' ' ' ASN . 81.1 Cg_exo -42.51 -24.49 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.332 2.021 . . . . 0.0 112.726 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . 0.457 ' O ' ' CB ' ' B' ' 40' ' ' THR . . . -90.38 -30.18 17.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.048 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' THR . . . . . 0.463 ' N ' ' O ' ' B' ' 37' ' ' ASN . 1.0 OUTLIER 158.28 -11.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.795 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 37' ' ' ASN . . . 131.82 58.26 0.09 OUTLIER Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.142 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.506 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 0.0 OUTLIER -178.76 -65.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.607 0.241 . . . . 0.0 111.307 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' B' ' 42' ' ' GLU . 5.4 p 164.64 115.88 0.02 OUTLIER Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.074 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.76 147.61 91.53 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.458 2.105 . . . . 0.0 112.073 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.51 -30.99 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.438 . . . . 0.0 110.912 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.6 95.73 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.862 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.22 -32.41 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.806 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -83.25 -43.22 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.61 -44.17 96.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.787 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -74.13 -29.15 61.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.228 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.58 -33.46 58.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.429 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' B' ' 53' ' ' GLN . 0.0 OUTLIER -82.53 -30.23 29.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.123 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.4 ' N ' ' HG3' ' B' ' 52' ' ' ARG . 3.3 mm-40 -76.11 -33.3 59.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.787 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -69.54 -35.66 75.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.565 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' B' ' 92' ' ' TYR . 68.4 mt -62.97 -39.78 95.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.504 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -72.11 -40.66 68.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.717 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.75 -41.12 81.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 t -60.09 -40.74 84.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.783 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -32.53 59.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.747 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.33 -40.59 86.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.99 -41.56 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.753 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 12.3 mt -69.33 -36.58 72.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.536 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -40.21 72.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.229 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.33 -19.06 65.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.533 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.32 -34.16 17.75 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.748 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.49 44.82 0.3 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.769 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 mt -142.99 -170.47 3.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 110.702 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.79 157.28 44.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' B' ' 101' ' ' HIS . . . -58.19 -36.57 73.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.991 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.473 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -57.31 -25.8 59.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.294 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -76.7 -24.37 53.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.924 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 39.4 mm -54.21 118.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 5.2 m -90.79 -32.87 5.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.958 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -143.28 163.98 31.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.695 0.283 . . . . 0.0 111.164 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.428 ' CB ' ' HB3' ' B' ' 125' ' ' ALA . 3.3 t -162.23 112.46 1.53 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.321 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 27.6 m -92.8 160.16 15.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.301 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 13.6 t -150.52 142.74 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.098 0.475 . . . . 0.0 111.941 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.438 ' CD2' HG12 ' A' ' 110' ' ' VAL . 3.2 m-85 -121.11 102.58 8.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.181 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 m -100.58 150.33 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.069 0.461 . . . . 0.0 111.671 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.08 -2.11 58.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.846 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.16 124.33 1.48 Allowed 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.509 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.86 -10.69 58.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.165 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.95 -22.76 42.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.799 0.333 . . . . 0.0 110.578 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -88.22 -20.24 25.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -57.53 -22.33 43.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.32 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.34 -60.46 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 0.0 111.267 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.56 79.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 19.1 t -61.64 -37.46 78.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.894 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.579 ' HA ' ' CE2' ' B' ' 92' ' ' TYR . 36.0 t-20 -62.25 -41.99 98.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.799 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.79 -23.5 42.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.34 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.04 -42.32 19.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.817 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' B' ' 89' ' ' ASN . 0.3 OUTLIER -77.35 -28.71 53.12 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.094 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.92 -33.66 39.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -72.62 -29.79 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.14 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -74.23 -41.69 60.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.736 0.303 . . . . 0.0 110.473 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 6.9 m-85 -52.08 -50.78 60.91 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.071 0.462 . . . . 0.0 110.372 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' B' ' 98' ' ' GLU . 0.4 OUTLIER -62.12 -28.85 69.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.116 179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . 0.401 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 0.4 OUTLIER -90.93 2.76 55.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.433 178.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.1 OUTLIER -119.22 -1.58 10.82 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 7.3 t30 85.76 28.61 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.244 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.473 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 0.8 OUTLIER -121.36 53.65 3.87 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.593 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 45.7 Cg_endo -68.32 -20.44 42.6 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.617 2.211 . . . . 0.0 112.694 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 2.1 m-20 -60.92 -40.31 92.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 0.0 110.492 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 27.6 m-85 77.28 121.03 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.825 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.418 ' HD3' ' NE2' ' B' ' 101' ' ' HIS . 84.2 Cg_endo -83.98 162.06 13.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.83 2.354 . . . . 0.0 112.303 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' C' ' 31' ' ' SER . . . -52.46 163.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.445 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.467 ' CZ ' ' CZ ' ' B' ' 92' ' ' TYR . 13.6 ttm-85 -146.57 144.58 29.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.163 0.506 . . . . 0.0 111.836 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.14 63.11 1.49 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.966 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 20.1 p -79.7 134.8 36.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.37 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' C' ' 78' ' ' PHE . 33.9 m -146.43 147.1 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.236 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.92 88.07 5.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 5.7 m -71.78 155.47 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.145 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.91 -44.01 64.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.13 174.71 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.925 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 14.0 mt -147.15 156.04 46.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.38 136.36 67.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.608 2.205 . . . . 0.0 112.135 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt 74.64 14.13 3.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.293 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.52 17.76 8.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.961 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 m -52.16 162.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.216 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.24 -25.06 14.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.697 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' B' ' 121' ' ' LEU . 0.0 OUTLIER -158.2 149.06 20.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.109 0.48 . . . . 0.0 111.099 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.39 156.01 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.188 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mp -144.07 119.97 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.097 0.475 . . . . 0.0 111.994 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.88 148.97 50.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.434 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' B' ' 75' ' ' THR . . . -163.78 161.22 23.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.297 0.57 . . . . 0.0 112.449 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.01 152.43 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.044 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.41 ' HB2' ' CG1' ' B' ' 28' ' ' VAL . . . -133.23 149.98 51.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.129 0.49 . . . . 0.0 111.96 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.62 139.4 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.861 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -135.55 52.42 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 111.022 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.055 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.787 0.327 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.38 41.91 15.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.851 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' C' ' 23' ' ' ASP . 5.9 m -78.2 153.03 32.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.103 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -178.02 132.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.057 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -57.54 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.45 HD12 HG22 ' C' ' 6' ' ' ILE . 32.3 mt -113.49 150.54 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.243 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -147.75 134.26 19.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.7 t -148.15 163.28 37.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.94 28.63 8.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -110.2 -49.69 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.752 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.457 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -68.1 179.27 0.65 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.984 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 31.7 Cg_exo -59.08 -15.58 28.74 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.755 2.303 . . . . 0.0 112.645 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.79 154.0 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -110.38 119.96 40.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.228 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.29 16.23 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.764 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 -137.97 4.61 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.429 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . 0.419 ' HB2' ' CE1' ' B' ' 92' ' ' TYR . 88.4 Cg_endo -84.32 16.58 1.9 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.692 2.261 . . . . 0.0 113.657 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -137.36 177.88 7.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.975 0.416 . . . . 0.0 111.435 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' B' ' 103' ' ' ASN . 10.6 m -128.78 169.41 20.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -59.63 -55.51 33.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.457 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.61 178.2 4.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.537 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 m -144.53 131.5 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.888 0.375 . . . . 0.0 111.179 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' C' ' 3' ' ' THR . 3.6 t70 -99.0 110.63 23.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.447 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.57 -11.48 60.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.51 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.53 -102.89 0.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.627 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.12 -30.06 64.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.173 0.511 . . . . 0.0 109.975 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.53 167.48 18.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' C' ' 127' ' ' ALA . 7.1 p -129.5 160.77 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.1 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.74 122.79 20.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.741 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.25 137.71 41.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.958 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' SER . . . . . 0.419 ' HB2' ' CB ' ' B' ' 106' ' ' ALA . 16.6 t -71.76 172.78 9.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.034 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.33 82.74 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.11 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.36 147.48 21.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.039 0.447 . . . . 0.0 111.34 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 5.0 pt -142.3 149.73 52.58 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.554 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' C' ' 34' ' ' ILE . 1.6 Cg_endo -83.2 51.08 3.5 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.938 2.425 . . . . 0.0 112.469 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' C' ' 37' ' ' ASN . 87.2 t -94.23 82.48 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.157 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' C' ' 36' ' ' VAL . 0.5 OUTLIER 157.43 -44.65 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.999 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' C' ' 37' ' ' ASN . 79.3 Cg_exo -42.53 -24.53 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.376 2.051 . . . . 0.0 112.714 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' C' ' 40' ' ' THR . . . -90.31 -30.13 17.67 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.107 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' THR . . . . . 0.465 ' CB ' ' O ' ' C' ' 39' ' ' ALA . 1.0 OUTLIER 158.26 -11.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.798 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' C' ' 37' ' ' ASN . . . 131.71 58.41 0.09 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.114 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . 0.504 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 0.0 OUTLIER -178.81 -65.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.58 0.229 . . . . 0.0 111.283 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' C' ' 42' ' ' GLU . 5.4 p 164.65 115.87 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.083 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.74 147.62 91.44 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.478 2.119 . . . . 0.0 112.088 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.45 -31.03 57.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.439 . . . . 0.0 110.91 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.64 95.69 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.27 -32.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.826 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -83.24 -43.26 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -44.17 96.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.781 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -74.14 -29.65 61.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.319 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.18 -33.47 59.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.327 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -30.21 29.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.135 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.11 -33.32 59.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -69.45 -35.76 75.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.575 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.433 HD13 ' HB3' ' C' ' 92' ' ' TYR . 68.5 mt -62.94 -39.81 95.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.495 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -72.12 -40.65 67.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.703 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.73 -41.14 81.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.843 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 t -60.04 -40.78 84.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -32.51 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.713 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.57 87.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mt -68.67 -41.58 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.72 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 12.2 mt -69.27 -36.59 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.628 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -40.27 72.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.294 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.26 -19.16 65.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.526 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.29 -34.13 17.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.734 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.44 44.88 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.788 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.02 -170.55 3.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.728 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.74 157.28 44.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.432 ' O ' ' CD2' ' C' ' 101' ' ' HIS . . . -58.1 -36.56 73.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.459 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -57.51 -25.87 60.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.258 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -76.35 -24.45 54.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.996 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 39.4 mm -54.15 118.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.83 -32.87 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.908 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -143.23 163.98 31.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.662 0.268 . . . . 0.0 111.188 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' THR . . . . . 0.423 ' CB ' ' HB3' ' C' ' 125' ' ' ALA . 3.4 t -162.16 112.46 1.55 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -92.8 160.17 15.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.305 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.402 HG13 ' N ' ' C' ' 78' ' ' PHE . 13.6 t -150.52 142.76 17.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.102 0.477 . . . . 0.0 111.918 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.462 ' CD2' HG12 ' B' ' 110' ' ' VAL . 3.2 m-85 -121.09 102.49 8.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.206 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 m -100.57 150.26 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.008 0.433 . . . . 0.0 111.715 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.05 -1.7 58.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.893 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.92 124.59 1.29 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.458 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.76 -10.78 58.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.148 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.88 -22.83 42.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.796 0.332 . . . . 0.0 110.598 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -88.18 -20.3 25.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -57.54 -22.26 43.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.322 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.4 -60.47 3.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 111.28 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.69 -48.59 79.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 t -61.7 -37.4 77.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.944 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . 0.579 ' HA ' ' CE2' ' C' ' 92' ' ' TYR . 36.0 t-20 -62.32 -41.91 98.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.774 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.76 -23.33 42.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.347 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.31 -42.34 18.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.778 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' C' ' 89' ' ' ASN . 0.3 OUTLIER -77.41 -28.68 52.72 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.071 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.92 -33.78 39.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -72.48 -29.85 64.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.198 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.478 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -74.18 -41.71 61.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.478 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 7.0 m-85 -52.08 -50.8 60.87 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.358 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -28.88 69.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.145 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.89 2.76 55.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.437 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.1 OUTLIER -119.22 -1.63 10.81 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 7.3 t30 85.84 28.69 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.172 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.459 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 0.8 OUTLIER -121.34 53.63 3.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.627 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 45.9 Cg_endo -68.37 -20.39 42.35 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 112.675 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 2.2 m-20 -61.01 -40.17 92.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.882 0.372 . . . . 0.0 110.482 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 27.6 m-85 77.21 121.02 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.805 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.421 ' HD3' ' NE2' ' C' ' 101' ' ' HIS . 85.0 Cg_endo -83.99 161.98 13.74 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.854 2.369 . . . . 0.0 112.288 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.28 163.61 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.434 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.47 ' CZ ' ' CZ ' ' C' ' 92' ' ' TYR . 13.6 ttm-85 -146.62 144.5 29.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.199 0.524 . . . . 0.0 111.898 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.11 63.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.988 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 20.0 p -79.91 134.75 36.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.339 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 78' ' ' PHE . 33.9 m -146.07 145.89 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.96 88.2 4.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.761 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 5.8 m -71.84 155.45 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.129 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.9 -44.01 64.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.13 174.69 13.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.874 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 13.9 mt -147.13 155.99 46.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.942 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.21 136.38 68.22 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.621 2.214 . . . . 0.0 112.156 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt 74.59 14.13 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.309 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.54 17.75 8.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 23.2 m -52.15 162.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.48 -25.36 13.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.726 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' C' ' 121' ' ' LEU . 0.0 OUTLIER -157.81 148.96 21.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.146 0.498 . . . . 0.0 111.191 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.42 156.03 33.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.187 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mp -144.05 120.05 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.062 0.458 . . . . 0.0 112.056 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.97 148.93 50.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.429 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . 0.423 ' HB3' ' CB ' ' C' ' 75' ' ' THR . . . -163.8 161.2 23.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.28 0.562 . . . . 0.0 112.429 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mt -118.03 152.36 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.053 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.41 ' HB2' ' CG1' ' C' ' 28' ' ' VAL . . . -133.25 150.01 51.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.093 0.473 . . . . 0.0 111.946 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 35.2 m -122.69 139.39 49.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.803 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -135.51 52.48 2.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.987 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.031 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 ttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.822 0.344 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.8 mtm -141.15 159.83 41.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.91 109.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.57 122.74 7.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 mm -55.67 144.39 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.8 mt -109.49 143.51 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -146.99 141.8 26.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.1 159.34 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.1 28.54 4.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.007 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -122.39 -44.16 2.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.778 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . . . -67.22 171.64 4.59 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.114 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 11' ' ' ALA . 30.4 Cg_endo -63.86 -12.68 33.0 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.538 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.82 147.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.009 0.433 . . . . 0.0 111.336 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -106.15 123.23 47.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.011 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.6 mm -131.9 16.96 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.861 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.24 -128.05 3.19 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.385 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -90.02 24.61 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.782 2.322 . . . . 0.0 113.484 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.419 ' HB3' ' HB2' ' C' ' 107' ' ' ARG . 0.7 OUTLIER -152.1 174.53 13.58 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.752 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.41 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 15.8 m -123.12 173.24 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.826 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -40.41 87.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.399 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 175.62 175.22 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.803 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 m -140.22 134.87 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.35 108.86 15.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.18 -16.93 41.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.165 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.0 -105.75 0.86 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.993 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -53.83 -30.13 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.066 0.46 . . . . 0.0 110.298 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.9 132.8 52.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.843 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -131.3 151.99 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.659 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.15 140.01 29.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.809 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.3 p -106.28 142.44 35.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.6 p -69.67 155.89 39.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.142 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.02 94.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.518 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -78.23 156.22 29.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.992 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.0 pt -136.02 146.65 57.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 53.3 Cg_endo -69.36 61.56 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.863 2.375 . . . . 0.0 112.729 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 37' ' ' ASN . 59.7 t -68.07 85.97 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.085 0.469 . . . . 0.0 110.584 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 41' ' ' GLY . 9.0 t-20 -29.46 121.22 0.29 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.242 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.58 -15.09 43.76 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.377 2.051 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.59 -15.77 10.8 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.3 -30.16 7.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.849 0.357 . . . . 0.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 72.49 52.66 9.83 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.413 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.65 -76.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 111.208 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 11.3 p -174.27 123.23 0.39 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.65 140.48 51.72 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.272 1.982 . . . . 0.0 112.055 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.12 -30.96 60.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.121 0.486 . . . . 0.0 111.077 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.02 95.68 0.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.64 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.4 tp -45.05 -30.54 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.307 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.77 -38.68 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.485 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.98 -53.94 51.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.307 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -62.81 -29.43 70.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.104 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.18 -35.01 71.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.893 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -80.79 -41.23 23.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.808 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -40.54 96.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.403 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 13.1 p -64.29 -29.92 70.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.761 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.418 HD22 ' CD2' ' A' ' 92' ' ' TYR . 8.8 mt -82.04 -18.84 41.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.807 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.49 -49.04 9.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.453 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 54' ' ' SER . 24.4 p30 -62.79 -33.18 74.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.278 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.16 -40.84 58.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.508 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -73.05 -33.38 65.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.581 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.44 91.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.76 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.2 mt -68.6 -41.78 83.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.8 mt -67.37 -38.83 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.696 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.8 -37.43 67.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.292 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.59 -20.2 66.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.514 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.15 19.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.985 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.15 47.89 0.79 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.429 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.416 ' CD1' HG11 ' A' ' 28' ' ' VAL . 26.3 mt -149.05 136.09 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -87.91 163.25 16.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.161 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 72' ' ' ILE . . . -54.71 -30.24 55.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.119 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -67.93 -22.16 65.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.249 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.04 -30.8 69.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 110.213 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 4.0 mp -67.21 108.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.623 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.6 m -78.88 -32.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.828 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -131.85 156.61 45.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.769 0.319 . . . . 0.0 110.918 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -146.8 117.4 7.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.327 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -105.34 144.89 31.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.208 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.8 t -151.57 121.21 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 0.0 111.666 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.403 ' CD2' HG13 ' C' ' 110' ' ' VAL . 6.6 m-85 -95.85 118.88 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.274 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.5 m -110.54 151.98 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.187 0.518 . . . . 0.0 111.757 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -6.6 31.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.785 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.48 94.18 2.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.364 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.61 -13.93 46.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.271 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.3 -27.94 53.12 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.84 -17.5 25.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.503 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 22.4 t80 -57.95 -24.53 58.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.93 -41.96 35.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.841 0.353 . . . . 0.0 111.378 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.2 -33.57 20.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.441 ' O ' ' CD1' ' A' ' 92' ' ' TYR . 28.8 t -65.8 -54.52 26.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.665 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 17.1 t-20 -56.62 -43.95 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.972 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.96 70.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.786 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -34.91 77.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 88' ' ' VAL . 53.3 m-85 -67.36 -45.9 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 0.0 110.156 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -25.36 66.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.335 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -77.0 -38.2 53.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.231 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -37.94 24.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.851 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 7.5 m-85 -53.36 -52.02 60.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.168 0.508 . . . . 0.0 110.225 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -30.33 70.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.318 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.66 3.22 53.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.642 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -116.34 -6.25 11.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.877 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER 89.13 26.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.303 0.573 . . . . 0.0 110.505 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.561 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 12.9 t-160 -118.87 54.52 2.3 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.532 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.68 -18.64 32.57 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.702 2.268 . . . . 0.0 112.862 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.416 ' O ' ' CG1' ' B' ' 19' ' ' VAL . 1.9 m-20 -57.78 -39.26 77.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.85 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 81.07 123.36 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.427 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' A' ' 101' ' ' HIS . 97.1 Cg_endo -86.74 162.41 9.2 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.748 2.298 . . . . 0.0 112.707 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.45 140.74 44.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.533 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.424 ' HB2' ' HB3' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -102.07 138.45 39.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.032 0.444 . . . . 0.0 111.553 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.0 t -148.17 55.14 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.1 m -103.0 151.34 22.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.193 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.421 HG13 ' CD2' ' B' ' 78' ' ' PHE . 29.4 m -156.89 160.53 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -86.98 94.21 9.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.87 171.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.216 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.41 -50.01 8.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.991 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.13 171.36 15.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.731 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.49 160.05 52.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.859 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -50.83 135.93 42.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.506 2.137 . . . . 0.0 112.159 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.28 15.96 8.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.159 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 62.78 16.6 9.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.6 m -53.13 170.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.832 0.349 . . . . 0.0 111.147 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -101.9 -2.93 52.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.964 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 pp -175.92 148.49 0.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.899 0.381 . . . . 0.0 111.286 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.93 163.63 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.302 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.6 mm -139.75 129.93 30.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 111.862 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.86 119.04 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.082 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -133.88 161.95 33.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.03 0.443 . . . . 0.0 111.852 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.8 mm -111.93 150.65 14.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.474 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -127.43 157.86 38.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.038 0.447 . . . . 0.0 111.783 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.04 116.25 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.891 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -120.06 70.87 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.899 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ttt . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.781 0.324 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 3.8 mtm -141.14 159.91 41.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.989 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.85 109.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.974 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.53 122.69 7.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 mm -55.56 144.39 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.217 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.0 mt -109.44 143.41 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.156 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -146.98 141.76 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.09 159.35 43.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.16 28.48 4.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.977 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.18 -44.09 2.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.495 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . . . -67.34 171.73 4.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.931 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' B' ' 11' ' ' ALA . 30.7 Cg_endo -63.81 -12.71 33.03 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.544 2.162 . . . . 0.0 112.612 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.82 147.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.378 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.404 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -106.14 123.19 47.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 17.6 mm -131.92 17.01 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.834 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.25 -128.06 3.19 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.441 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.99 24.59 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.769 2.312 . . . . 0.0 113.494 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -152.08 174.48 13.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.038 0.447 . . . . 0.0 111.758 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 103' ' ' ASN . 15.8 m -123.14 173.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -40.37 86.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.016 0.436 . . . . 0.0 110.505 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 174.86 175.35 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.854 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.32 134.84 35.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.37 108.87 15.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.31 -16.86 41.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.095 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.01 -105.75 0.86 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -53.84 -30.16 44.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.076 0.465 . . . . 0.0 110.288 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.86 132.87 52.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.812 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.434 ' CG1' ' CB ' ' B' ' 127' ' ' ALA . 0.1 OUTLIER -131.37 151.97 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.66 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.2 139.98 29.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.812 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.3 p -106.09 141.36 37.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 79.1 p -69.3 156.1 39.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.087 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.97 94.05 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.521 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -78.15 156.2 30.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 7.0 pt -136.06 146.64 57.4 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.447 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 53.5 Cg_endo -69.31 61.49 1.49 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.868 2.379 . . . . 0.0 112.733 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 37' ' ' ASN . 60.0 t -68.07 85.97 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.105 0.478 . . . . 0.0 110.612 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' B' ' 36' ' ' VAL . 9.0 t-20 -29.46 121.2 0.29 Allowed Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.278 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.48 -15.14 43.62 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.344 2.029 . . . . 0.0 112.4 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.53 -15.87 10.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.21 -30.28 7.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.885 0.374 . . . . 0.0 110.964 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.64 52.63 9.57 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.449 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.62 -76.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 11.3 p -174.29 123.22 0.39 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.08 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.61 140.46 51.85 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.294 1.996 . . . . 0.0 112.077 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.2 -30.9 60.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 111.046 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.98 95.59 0.39 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.732 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 tp -45.06 -30.48 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.305 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.85 -38.68 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.452 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.88 -54.09 49.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.313 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -62.66 -29.55 70.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.072 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.07 -34.94 71.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.802 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -80.83 -41.23 23.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.786 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -40.53 96.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.689 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 13.0 p -64.24 -30.0 71.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.759 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.432 HD22 ' CD2' ' B' ' 92' ' ' TYR . 8.8 mt -82.05 -18.76 42.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.51 -49.1 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.409 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -62.66 -33.27 74.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.289 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.07 -40.87 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.967 0.413 . . . . 0.0 110.535 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -73.11 -33.31 65.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.573 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.43 91.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.71 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -68.61 -41.75 83.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.698 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 13.0 mt -67.36 -38.86 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.81 -37.45 67.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.281 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.53 -20.13 66.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.563 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.01 -25.1 18.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.971 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.14 47.87 0.8 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.417 ' CD1' HG11 ' B' ' 28' ' ' VAL . 26.4 mt -149.06 136.2 19.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.365 . . . . 0.0 110.813 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -88.05 163.27 16.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.151 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' B' ' 72' ' ' ILE . . . -54.73 -30.29 55.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.069 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.548 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -67.84 -22.12 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.285 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.21 -30.75 68.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 110.228 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 4.0 mp -67.23 108.58 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.705 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.402 ' CG1' HG21 ' B' ' 128' ' ' VAL . 6.5 m -78.94 -31.96 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.834 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -131.91 156.6 45.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.735 0.302 . . . . 0.0 110.96 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -146.81 117.4 7.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.309 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 86.7 m -105.38 144.88 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.235 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 38.8 t -151.5 121.22 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.946 0.403 . . . . 0.0 111.735 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.421 ' CD2' HG13 ' A' ' 110' ' ' VAL . 6.5 m-85 -95.84 118.84 33.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.25 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 13.5 m -110.52 152.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 0.0 111.78 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -6.58 31.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.715 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -149.66 94.25 2.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.347 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mt -63.57 -13.97 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.31 -27.9 53.1 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.79 -17.55 25.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.519 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' B' ' 89' ' ' ASN . 22.2 t80 -57.96 -24.43 57.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.222 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.03 -41.96 36.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.799 0.333 . . . . 0.0 111.354 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.17 -33.52 20.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . 0.45 ' O ' ' CD1' ' B' ' 92' ' ' TYR . 28.4 t -65.84 -54.59 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 17.1 t-20 -56.62 -43.91 80.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.998 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.96 70.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.729 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -34.9 77.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' B' ' 88' ' ' VAL . 52.9 m-85 -67.38 -45.92 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.147 0.499 . . . . 0.0 110.119 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -25.41 66.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.403 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -76.96 -38.25 53.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.228 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.1 OUTLIER -82.56 -37.99 24.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.812 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' B' ' 92' ' ' TYR . 7.5 m-85 -53.32 -52.03 60.46 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.185 0.517 . . . . 0.0 110.265 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -30.27 70.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.337 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.58 3.19 53.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.488 ' O ' ' ND2' ' B' ' 100' ' ' ASN . 0.6 OUTLIER -116.39 -6.17 11.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.871 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 99' ' ' ASN . 0.0 OUTLIER 89.08 25.82 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.326 0.584 . . . . 0.0 110.495 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.548 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 12.8 t-160 -118.63 54.52 2.18 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.492 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CZ ' ' B' ' 104' ' ' PHE . 58.1 Cg_endo -70.65 -18.65 32.68 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.687 2.258 . . . . 0.0 112.862 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.42 ' O ' ' CG1' ' C' ' 19' ' ' VAL . 1.9 m-20 -57.77 -39.24 76.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.773 0.32 . . . . 0.0 110.819 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.408 ' CZ ' ' O ' ' B' ' 102' ' ' PRO . 8.1 m-85 81.02 123.27 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.494 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.455 ' HD3' ' CE1' ' B' ' 101' ' ' HIS . 97.1 Cg_endo -86.72 162.37 9.22 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.746 2.297 . . . . 0.0 112.648 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.37 140.71 44.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.553 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.403 ' HB2' ' HB3' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -102.07 138.45 39.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.08 0.467 . . . . 0.0 111.503 -179.409 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 12.0 t -148.2 55.16 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.009 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 5.1 m -102.99 151.37 22.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.187 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . 0.412 HG13 ' CD2' ' C' ' 78' ' ' PHE . 29.5 m -156.89 160.75 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.102 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -87.14 94.3 9.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.94 171.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.253 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.34 -50.14 8.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.02 171.39 14.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.742 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.57 160.01 52.44 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.812 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.78 135.89 42.6 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.558 2.172 . . . . 0.0 112.137 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.31 15.98 8.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.064 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 62.82 16.54 9.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.021 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 15.6 m -53.13 170.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.832 0.349 . . . . 0.0 111.177 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -101.98 -3.1 51.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.988 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 pp -175.76 148.37 0.87 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 111.255 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.86 163.69 17.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.326 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 15.7 mm -139.77 129.89 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 111.881 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.87 118.99 5.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.074 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -133.84 161.91 33.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.979 0.419 . . . . 0.0 111.884 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.8 mm -111.86 150.6 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.515 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -127.4 157.85 38.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 111.764 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.402 HG21 ' CG1' ' B' ' 73' ' ' VAL . 34.1 m -130.0 116.24 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.837 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -120.06 70.88 0.88 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.999 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.89 179.968 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 16.4 ttt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.793 0.33 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 3.8 mtm -141.17 159.8 41.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.91 109.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.6 122.73 7.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 39.1 mm -55.65 144.42 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.176 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mt -109.52 143.46 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -146.99 141.73 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.0 159.39 43.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.15 28.5 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.33 -44.18 2.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.712 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.498 ' CB ' ' HD2' ' C' ' 12' ' ' PRO . . . -67.26 171.74 4.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.036 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' C' ' 11' ' ' ALA . 30.7 Cg_endo -63.8 -12.74 33.12 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.567 2.178 . . . . 0.0 112.615 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.88 147.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.322 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -106.14 123.22 47.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.053 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 17.6 mm -131.94 17.03 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.857 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.24 -128.05 3.19 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.399 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -90.1 24.63 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.769 2.313 . . . . 0.0 113.444 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' B' ' 107' ' ' ARG . 0.7 OUTLIER -152.06 174.52 13.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.093 0.473 . . . . 0.0 111.727 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' B' ' 103' ' ' ASN . 15.8 m -123.12 173.28 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.802 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -39.94 85.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 110.374 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 174.75 175.44 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.852 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.33 134.79 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.32 108.9 15.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.27 -16.9 41.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.96 -105.74 0.86 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.0 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -53.88 -30.13 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.082 0.468 . . . . 0.0 110.253 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.94 132.8 52.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.858 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.438 ' CG1' ' CB ' ' C' ' 127' ' ' ALA . 0.1 OUTLIER -131.29 152.06 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.656 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.22 139.95 28.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.838 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 25.5 p -106.15 141.46 37.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.773 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 79.6 p -69.17 155.82 39.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.97 94.08 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.481 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -78.17 156.07 30.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 7.0 pt -135.94 146.69 57.87 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.001 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.454 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 53.1 Cg_endo -69.37 61.51 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.821 2.347 . . . . 0.0 112.756 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' C' ' 37' ' ' ASN . 59.8 t -68.03 85.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 0.0 110.602 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' C' ' 36' ' ' VAL . 9.1 t-20 -29.48 121.22 0.29 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.201 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.53 -15.12 43.69 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.338 2.025 . . . . 0.0 112.374 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.56 -15.83 10.81 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.29 -30.13 7.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.818 0.342 . . . . 0.0 110.979 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 72.54 52.65 9.75 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.381 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.59 -76.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.784 0.326 . . . . 0.0 111.215 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 11.3 p -174.28 123.19 0.39 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.55 140.42 52.02 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.315 2.01 . . . . 0.0 112.077 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.14 -30.98 60.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.019 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.95 95.6 0.38 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.698 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 tp -45.02 -30.52 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.29 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.86 -38.62 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.496 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.96 -53.93 51.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.292 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -62.97 -29.53 70.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.052 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.34 -35.06 71.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.959 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -80.81 -41.19 23.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.754 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -40.47 96.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.662 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' C' ' 57' ' ' ASN . 13.3 p -64.27 -30.06 71.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' C' ' 92' ' ' TYR . 8.8 mt -81.98 -18.81 42.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.53 -49.02 9.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.424 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' C' ' 54' ' ' SER . 24.4 p30 -62.75 -33.24 74.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.263 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 91.6 t -73.1 -40.88 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.381 . . . . 0.0 110.54 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -73.05 -33.28 65.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.639 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.55 92.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.775 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -68.63 -41.78 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.742 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 12.9 mt -67.41 -38.8 81.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.734 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.86 -37.39 67.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.275 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.52 -20.21 66.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.589 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.18 19.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.2 47.91 0.79 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.41 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.409 ' CD1' HG11 ' C' ' 28' ' ' VAL . 26.3 mt -149.08 136.15 19.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 110.846 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -88.02 163.23 16.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.157 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' C' ' 72' ' ' ILE . . . -54.7 -30.2 55.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.137 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.561 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -67.8 -22.14 65.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.244 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.13 -30.77 69.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.985 0.422 . . . . 0.0 110.181 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 4.0 mp -67.25 108.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.684 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 6.5 m -79.04 -31.92 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.826 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -131.91 156.54 45.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -146.76 117.44 7.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.306 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 86.4 m -105.35 144.95 31.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.219 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 38.8 t -151.59 121.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.391 . . . . 0.0 111.714 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.412 ' CD2' HG13 ' B' ' 110' ' ' VAL . 6.4 m-85 -95.74 118.81 33.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.323 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 13.4 m -110.56 151.96 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.148 0.499 . . . . 0.0 111.737 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.12 -6.74 30.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.758 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.41 94.24 2.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.342 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.61 -14.01 47.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.247 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.34 -27.91 52.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.74 -17.57 25.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.526 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' C' ' 89' ' ' ASN . 22.3 t80 -58.02 -24.38 58.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.198 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.02 -41.94 36.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.841 0.353 . . . . 0.0 111.393 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.15 -33.59 20.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.766 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . 0.443 ' O ' ' CD1' ' C' ' 92' ' ' TYR . 29.4 t -65.88 -54.54 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.571 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . 0.419 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 17.1 t-20 -56.58 -43.96 80.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.976 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.06 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.795 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.63 -34.89 77.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.443 ' CD1' ' O ' ' C' ' 88' ' ' VAL . 53.4 m-85 -67.35 -45.92 74.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.154 0.502 . . . . 0.0 110.112 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.83 -25.45 66.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.378 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -76.98 -38.24 53.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.235 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.1 OUTLIER -82.54 -37.96 24.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.819 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.426 ' CD2' ' O ' ' C' ' 92' ' ' TYR . 7.5 m-85 -53.35 -52.01 60.6 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.201 0.524 . . . . 0.0 110.247 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -30.3 70.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.298 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.6 3.1 53.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.666 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' C' ' 100' ' ' ASN . 0.6 OUTLIER -116.3 -6.23 11.81 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.889 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' C' ' 99' ' ' ASN . 0.0 OUTLIER 89.16 26.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.305 0.574 . . . . 0.0 110.516 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.561 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 12.9 t-160 -118.82 54.62 2.31 Favored Pre-proline 0 CA--C 1.529 0.154 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.529 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . 0.403 ' O ' ' CE1' ' C' ' 104' ' ' PHE . 58.4 Cg_endo -70.69 -18.69 32.47 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.726 2.284 . . . . 0.0 112.868 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . 0.409 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 1.9 m-20 -57.77 -39.2 76.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.76 0.314 . . . . 0.0 110.849 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.403 ' CE1' ' O ' ' C' ' 102' ' ' PRO . 8.1 m-85 81.05 123.26 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.463 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.447 ' HD3' ' CE1' ' C' ' 101' ' ' HIS . 98.1 Cg_endo -86.7 162.3 9.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.779 2.319 . . . . 0.0 112.713 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.35 140.81 44.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.565 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -102.15 138.37 39.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.057 0.456 . . . . 0.0 111.502 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 12.0 t -148.14 55.26 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.058 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -103.09 151.35 22.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.17 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . 0.403 HG13 ' CD2' ' A' ' 78' ' ' PHE . 29.3 m -156.98 160.74 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.123 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -87.04 94.17 9.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.8 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.88 171.19 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.237 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.4 -49.99 8.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.029 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.14 171.35 15.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.51 160.02 52.6 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.833 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -50.92 135.9 43.63 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.477 2.118 . . . . 0.0 112.149 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.32 16.01 8.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.103 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 62.8 16.58 9.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.987 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.16 170.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.819 0.342 . . . . 0.0 111.163 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -101.88 -3.23 52.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.997 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 pp -175.72 148.29 0.87 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.219 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.87 163.65 17.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.278 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 15.6 mm -139.78 129.87 30.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.894 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.82 118.98 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.172 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -133.77 161.99 33.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 0.0 111.871 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 5.8 mm -111.97 150.65 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.471 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -127.42 157.89 38.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.043 0.449 . . . . 0.0 111.804 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.09 116.26 36.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.866 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -120.07 70.89 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.978 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.887 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mtp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.87 0.367 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.16 175.47 6.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.1 m 61.32 114.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.57 ' NE2' ' HB ' ' C' ' 73' ' ' VAL . 3.0 mm100 63.2 -165.74 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.258 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 1.2 mp 70.25 118.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.671 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 23' ' ' ASP . 22.3 mt -152.99 74.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.678 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -84.76 145.49 27.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.411 ' N ' ' OE1' ' A' ' 20' ' ' GLN . 1.7 t -149.83 153.46 36.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.71 35.83 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -121.13 -38.07 2.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.095 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.74 110.65 46.78 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.192 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.28 -16.41 46.56 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.516 2.144 . . . . 0.0 112.469 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.15 -167.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.221 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.49 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 64.87 -165.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.435 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mt 79.61 17.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.119 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.91 -134.64 4.22 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.223 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.64 28.59 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.724 2.283 . . . . 0.0 113.098 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -162.3 177.28 9.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' C' ' 104' ' ' PHE . 33.6 m -106.07 162.3 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.22 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.42 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 3.6 mt-30 -55.65 -52.8 62.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.135 0.493 . . . . 0.0 110.442 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.44 -172.75 3.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.166 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' GLN . 27.6 m -145.51 130.36 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.025 0.44 . . . . 0.0 111.851 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 48.0 t0 -108.69 102.88 11.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.3 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -14.17 62.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 111.188 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.02 -93.08 0.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -61.26 -28.82 69.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.249 0.547 . . . . 0.0 109.593 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.97 140.49 47.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.417 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 ' CB ' ' A' ' 127' ' ' ALA . 2.8 m -105.05 -179.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.197 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.89 136.78 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -108.64 135.78 49.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.744 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.2 p -81.07 177.16 9.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.49 95.67 0.1 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.544 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.67 150.95 47.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.906 0.384 . . . . 0.0 111.053 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.06 121.91 20.96 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.869 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.4 Cg_exo -67.76 58.96 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.695 2.263 . . . . 0.0 113.094 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.418 HG13 ' HA2' ' A' ' 41' ' ' GLY . 93.0 t -69.9 85.58 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.322 0.582 . . . . 0.0 110.639 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 41' ' ' GLY . 52.4 t30 -43.84 129.89 4.14 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.805 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.89 -9.64 26.1 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.988 1.792 . . . . 0.0 111.558 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.44 -32.97 11.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.625 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 37' ' ' ASN . 11.6 t -117.71 -27.83 6.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.834 0.35 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 78.56 60.29 2.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.704 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.23 -76.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.756 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 11.2 p -160.96 118.44 1.44 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.234 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.56 140.96 94.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.415 2.077 . . . . 0.0 112.251 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.8 -31.1 72.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 0.0 110.929 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.5 93.1 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.8 mm -42.49 -31.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.114 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.37 -42.52 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.788 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.98 -44.72 84.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.551 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.78 67.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.449 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.28 -40.84 67.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.86 -32.59 57.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.36 -41.14 76.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -64.27 -38.91 92.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.76 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.32 -41.18 77.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.34 -44.06 92.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -60.77 -37.26 81.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.8 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.0 -45.97 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.426 ' HE2' ' CD1' ' A' ' 95' ' ' PHE . 7.5 mttt -71.97 -32.62 67.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.782 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.51 87.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.04 -40.76 78.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.873 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 mt -70.5 -34.6 58.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.421 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -69.99 -42.61 72.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.402 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -15.73 63.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.595 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.99 -33.64 18.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.942 0.401 . . . . 0.0 110.627 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.24 41.42 0.36 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.793 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.9 mt -150.25 -177.55 6.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.733 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.08 164.88 28.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.799 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.75 -35.02 55.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.491 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -60.86 -22.35 64.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.216 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.03 -18.49 46.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.767 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.401 ' O ' ' CE1' ' A' ' 101' ' ' HIS . 28.2 mm -58.44 123.61 10.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.543 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 34.8 m -92.63 -27.4 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.382 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 36.8 tttm -150.49 164.69 35.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -156.4 113.27 3.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.777 0.322 . . . . 0.0 111.526 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -100.02 152.41 20.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.303 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.74 127.36 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.821 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CE2' ' OE1' ' A' ' 124' ' ' GLU . 10.6 m-85 -105.39 115.54 30.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.328 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.414 HG11 ' CD2' ' A' ' 85' ' ' PHE . 4.8 m -105.49 148.57 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.638 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.76 -4.52 56.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.051 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -164.59 134.23 3.8 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.549 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -8.89 56.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.274 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.35 -24.23 23.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.791 0.329 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -75.44 -22.3 57.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.084 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 109' ' ' CYS . 0.2 OUTLIER -61.68 -18.2 58.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.448 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.13 -41.12 68.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.852 0.358 . . . . 0.0 111.271 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -27.8 22.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.983 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.3 t -73.71 -47.07 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.25 -40.08 95.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.407 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.16 84.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.947 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -87.89 -28.25 21.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.554 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.406 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 81.0 t80 -53.39 -44.74 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.945 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -86.9 -25.26 24.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -21.36 60.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.473 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.446 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -91.13 -33.62 15.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.863 0.363 . . . . 0.0 110.613 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.457 ' CZ ' ' CG ' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -56.45 -58.01 9.85 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.316 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -64.58 -30.74 71.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.006 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -78.16 -9.23 59.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.233 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 3.5 m120 -109.82 -5.01 15.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.393 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 21.9 m-80 84.5 38.58 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.759 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.491 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 17.2 t-160 -130.69 68.86 82.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.337 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.35 -17.46 7.67 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.971 2.447 . . . . 0.0 112.824 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.532 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -59.27 -36.78 76.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.878 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 27.9 m-85 78.76 114.77 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.395 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' CG ' ' CZ ' ' A' ' 96' ' ' PHE . 62.3 Cg_endo -87.2 163.12 8.53 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.164 2.576 . . . . 0.0 112.147 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.46 175.6 0.23 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -173.0 163.48 4.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.331 0.586 . . . . 0.0 112.049 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.89 83.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.032 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.436 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 14.1 p -89.4 123.63 33.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.6 m -142.89 148.68 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.297 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.69 97.34 7.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.824 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.46 160.43 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.152 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.61 -45.65 68.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.023 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -156.89 176.98 12.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.8 mt -145.27 160.65 44.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.811 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -51.04 135.75 44.46 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.545 2.163 . . . . 0.0 112.218 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.3 14.45 5.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.226 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.24 14.24 9.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.212 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.57 171.22 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.865 0.364 . . . . 0.0 111.162 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.21 21.96 16.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.37 156.91 1.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.12 0.486 . . . . 0.0 111.213 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -149.89 156.34 41.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mm -133.41 136.73 54.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.153 0.502 . . . . 0.0 112.109 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 6.6 pt-20 -155.48 106.6 2.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.298 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 74' ' ' LYS . . . -129.05 175.28 8.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.258 0.552 . . . . 0.0 112.374 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.71 157.81 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.1 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.412 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -148.8 149.11 30.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.97 0.414 . . . . 0.0 111.459 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 m -96.96 156.43 3.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.077 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -151.43 51.58 0.83 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.887 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mtp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.885 0.374 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.14 175.4 6.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 11.1 m 61.36 114.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.543 ' NE2' ' HB ' ' A' ' 73' ' ' VAL . 2.9 mm100 63.27 -165.77 0.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.258 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' B' ' 5' ' ' ILE . 1.2 mp 70.29 118.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.644 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.409 HD13 ' HB2' ' B' ' 23' ' ' ASP . 22.3 mt -153.02 74.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.648 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -84.67 145.48 27.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.7 t -149.85 153.4 36.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.65 35.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -121.18 -38.05 2.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.73 110.71 47.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.193 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.27 -16.5 47.06 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.511 2.14 . . . . 0.0 112.447 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.08 -167.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.262 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.486 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 64.89 -165.09 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.369 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mt 79.65 17.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.102 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.91 -134.59 4.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.201 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -87.7 28.6 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.712 2.275 . . . . 0.0 113.089 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -162.28 177.37 9.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 111.201 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 104' ' ' PHE . 33.7 m -106.11 162.33 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.18 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.428 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 3.6 mt-30 -55.55 -52.65 63.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.221 0.534 . . . . 0.0 110.453 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.65 -172.72 3.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.189 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' B' ' 4' ' ' GLN . 27.7 m -145.53 130.41 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.059 0.457 . . . . 0.0 111.745 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.459 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 47.9 t0 -108.76 102.84 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.278 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -14.12 62.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.17 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.01 -93.05 0.59 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -61.27 -28.82 69.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 140.45 47.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.426 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.401 HG21 ' CB ' ' B' ' 127' ' ' ALA . 2.8 m -105.08 -179.25 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.183 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.82 136.78 3.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 66.7 p -108.68 135.64 49.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 42.8 p -80.88 177.25 9.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.48 95.62 0.1 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.537 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.65 150.94 47.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.908 0.385 . . . . 0.0 111.086 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -129.12 121.97 20.94 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.823 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.81 58.93 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.719 2.28 . . . . 0.0 113.037 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.404 HG13 ' HA2' ' B' ' 41' ' ' GLY . 93.3 t -69.88 85.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.281 0.562 . . . . 0.0 110.576 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 41' ' ' GLY . 52.2 t30 -43.83 129.82 4.14 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.807 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.82 -9.68 26.22 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 121.969 1.779 . . . . 0.0 111.542 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.42 -33.02 11.56 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.647 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' THR . . . . . 0.445 ' CG2' ' HB3' ' B' ' 37' ' ' ASN . 11.6 t -117.67 -27.95 6.14 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.866 0.365 . . . . 0.0 111.041 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 78.83 60.27 2.63 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.755 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 179.22 -76.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.723 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 11.2 p -161.01 118.49 1.44 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.173 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.68 141.07 95.37 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.364 2.043 . . . . 0.0 112.188 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.79 -31.21 72.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.43 93.09 1.92 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mm -42.48 -31.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.125 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.47 -42.5 21.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.723 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.72 84.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.565 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.71 67.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.526 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.88 67.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.82 -32.64 57.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.32 -41.17 77.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.748 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -64.23 -38.9 92.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.788 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.33 -41.2 76.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.36 -43.99 92.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -60.79 -37.29 81.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.758 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 26.5 t -63.04 -46.01 97.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.406 ' HE2' ' CD1' ' B' ' 95' ' ' PHE . 7.4 mttt -71.92 -32.64 67.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.808 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.42 -39.53 87.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.18 -40.77 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.839 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 mt -70.54 -34.59 58.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.391 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -69.98 -42.68 72.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.362 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -15.82 63.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.677 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.96 -33.62 18.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.632 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.28 41.39 0.36 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.812 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 64.2 mt -150.32 -177.57 6.02 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.004 0.43 . . . . 0.0 110.714 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.04 164.89 28.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.8 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.74 -35.11 55.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.941 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.494 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -60.79 -22.24 63.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.208 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.09 -18.43 46.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.787 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.403 ' O ' ' CE1' ' B' ' 101' ' ' HIS . 28.2 mm -58.53 123.65 10.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.564 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 34.9 m -92.69 -27.37 4.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.368 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' B' ' 125' ' ' ALA . 36.7 tttm -150.45 164.73 35.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' B' ' 107' ' ' ARG . 0.2 OUTLIER -156.48 113.23 3.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.727 0.299 . . . . 0.0 111.481 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -99.97 152.44 20.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.77 127.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.984 0.421 . . . . 0.0 111.801 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.403 ' CE2' ' OE1' ' B' ' 124' ' ' GLU . 10.5 m-85 -105.39 115.54 30.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.279 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.403 HG11 ' CD2' ' B' ' 85' ' ' PHE . 4.9 m -105.51 148.52 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.634 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.7 -4.63 56.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.978 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -164.65 134.18 3.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.609 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.87 -8.89 56.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.248 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.29 -24.28 23.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.804 0.335 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -75.42 -22.25 57.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' B' ' 109' ' ' CYS . 0.3 OUTLIER -61.7 -18.2 58.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.406 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.21 -41.09 68.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.804 0.335 . . . . 0.0 111.27 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -27.84 22.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' B' ' 92' ' ' TYR . 27.5 t -73.67 -47.11 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.941 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.15 -40.18 95.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.426 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.97 -40.21 84.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.945 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.09 -28.18 21.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.538 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 81.3 t80 -53.4 -44.79 68.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.9 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -86.9 -25.17 24.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.052 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -21.37 60.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.455 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.459 ' C ' ' CD1' ' B' ' 95' ' ' PHE . 1.0 OUTLIER -91.1 -33.69 15.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 110.623 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.444 ' CZ ' ' CG ' ' B' ' 105' ' ' PRO . 0.8 OUTLIER -56.39 -58.09 9.51 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.317 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -64.5 -30.72 71.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.051 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -78.17 -9.31 59.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.209 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' B' ' 100' ' ' ASN . 3.5 m120 -109.83 -4.97 15.7 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.389 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 21.9 m-80 84.53 38.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.812 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.494 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 17.2 t-160 -130.68 68.92 82.17 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.343 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.33 -17.48 7.69 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.006 2.471 . . . . 0.0 112.857 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 0.1 OUTLIER -59.25 -36.84 76.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 0.0 110.867 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 28.0 m-85 78.75 114.73 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.475 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' B' ' 101' ' ' HIS . 62.4 Cg_endo -87.22 163.04 8.51 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.167 2.578 . . . . 0.0 112.108 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.38 175.59 0.23 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' B' ' 75' ' ' THR . 0.9 OUTLIER -173.02 163.55 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.317 0.58 . . . . 0.0 112.078 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.94 83.87 1.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.089 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . 0.418 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 14.5 p -89.38 123.68 33.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.081 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 35.6 m -143.12 149.19 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.379 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.85 97.15 7.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.644 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.35 160.34 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.6 -45.58 68.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.026 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -156.94 176.92 12.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 12.7 mt -145.24 160.64 45.03 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.86 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -51.07 135.76 44.68 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.511 2.141 . . . . 0.0 112.249 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.23 14.51 5.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.223 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.26 14.24 9.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.145 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.56 171.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.879 0.371 . . . . 0.0 111.13 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.05 22.08 16.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.568 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.26 156.78 1.67 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.107 0.48 . . . . 0.0 111.151 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -149.84 156.39 41.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.104 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 22.7 mm -133.4 136.69 54.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.194 0.521 . . . . 0.0 112.091 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . 0.403 ' OE1' ' CE2' ' B' ' 78' ' ' PHE . 6.6 pt-20 -155.5 106.55 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.329 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' B' ' 74' ' ' LYS . . . -128.99 175.31 8.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.307 0.575 . . . . 0.0 112.37 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.68 157.89 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.134 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' B' ' 28' ' ' VAL . . . -148.97 149.08 30.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.0 0.429 . . . . 0.0 111.424 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 m -96.96 156.4 3.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.049 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -151.35 51.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.86 0.362 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.16 175.48 6.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 11.1 m 61.35 114.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.564 ' NE2' ' HB ' ' B' ' 73' ' ' VAL . 3.0 mm100 63.24 -165.76 0.23 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.292 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' C' ' 4' ' ' GLN . 1.2 mp 70.26 118.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.613 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.417 HD13 ' HB2' ' C' ' 23' ' ' ASP . 22.3 mt -153.05 74.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.674 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -84.67 145.56 27.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.216 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.42 ' N ' ' OE1' ' C' ' 20' ' ' GLN . 1.7 t -149.91 153.38 36.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.69 35.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -121.09 -38.06 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.87 110.79 47.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.147 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.33 -16.39 46.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.506 2.137 . . . . 0.0 112.444 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.15 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.243 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.488 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 64.78 -165.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.38 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mt 79.72 17.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.034 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.89 -134.6 4.22 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.3 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -87.64 28.61 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.784 2.323 . . . . 0.0 113.14 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.488 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -162.35 177.35 9.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 111.23 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' B' ' 104' ' ' PHE . 33.7 m -106.08 162.35 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.425 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 3.6 mt-30 -55.66 -52.92 62.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.144 0.497 . . . . 0.0 110.516 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.14 -172.77 4.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.152 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' C' ' 4' ' ' GLN . 27.6 m -145.53 130.41 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.043 0.449 . . . . 0.0 111.855 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . 0.457 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 48.2 t0 -108.75 102.88 11.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.244 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.75 -14.14 62.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.214 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.08 -93.13 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -61.27 -28.79 69.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.232 0.539 . . . . 0.0 109.574 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 140.47 47.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.397 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.405 ' CG2' ' CB ' ' C' ' 127' ' ' ALA . 2.8 m -105.05 -179.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.246 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.8 136.86 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.824 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -108.85 136.27 48.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.842 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 41.9 p -81.07 177.26 9.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.57 95.67 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.66 151.02 47.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 111.061 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 0.6 OUTLIER -129.18 121.96 20.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.85 58.9 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.715 2.277 . . . . 0.0 113.068 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . 0.409 HG13 ' HA2' ' C' ' 41' ' ' GLY . 93.0 t -69.82 85.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 0.0 110.593 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' C' ' 41' ' ' GLY . 52.5 t30 -43.87 129.89 4.17 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.816 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.86 -9.67 26.18 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 121.995 1.797 . . . . 0.0 111.569 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.46 -32.96 11.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.661 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' THR . . . . . 0.448 ' CG2' ' HB3' ' C' ' 37' ' ' ASN . 11.6 t -117.69 -27.88 6.15 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.864 0.364 . . . . 0.0 111.054 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 78.78 60.21 2.65 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.803 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.23 -76.76 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.875 0.337 . . . . 0.0 111.731 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 11.2 p -161.04 118.46 1.43 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.16 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.57 141.01 95.14 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.376 2.051 . . . . 0.0 112.23 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.83 -31.17 72.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.034 0.445 . . . . 0.0 110.91 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.4 93.11 1.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.935 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mm -42.45 -31.76 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.157 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.47 -42.43 21.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.756 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -44.71 83.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.506 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -27.6 67.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.46 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.95 68.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.986 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.79 -32.63 57.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -41.12 77.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -64.23 -38.95 92.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.777 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 18.6 mt -69.33 -41.18 76.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.839 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.27 -44.09 92.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -60.8 -37.26 81.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.755 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -62.96 -46.08 97.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.835 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.425 ' HE2' ' CD1' ' C' ' 95' ' ' PHE . 7.4 mttt -71.92 -32.62 67.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.809 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.16 -39.58 86.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.29 -40.75 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.839 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 mt -70.52 -34.56 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.433 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -69.98 -42.69 72.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -15.77 63.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.653 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.0 -33.69 18.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.548 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.29 41.32 0.37 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.841 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 64.0 mt -150.27 -177.58 6.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.936 0.398 . . . . 0.0 110.723 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.07 164.85 28.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.795 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.69 -35.1 54.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.493 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -60.9 -22.4 64.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.186 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.0 -18.42 46.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.788 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.47 123.64 10.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.57 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 34.7 m -92.7 -27.33 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.397 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' C' ' 125' ' ' ALA . 36.7 tttm -150.47 164.76 35.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.304 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' C' ' 107' ' ' ARG . 0.2 OUTLIER -156.45 113.32 3.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.732 0.301 . . . . 0.0 111.479 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 94.2 m -99.97 152.44 20.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.261 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.78 127.31 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.982 0.42 . . . . 0.0 111.83 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.407 ' CE2' ' OE1' ' C' ' 124' ' ' GLU . 10.6 m-85 -105.32 115.56 30.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.3 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' C' ' 85' ' ' PHE . 4.8 m -105.55 148.61 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.591 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.62 -4.21 55.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.082 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -165.03 134.31 3.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.549 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -8.94 56.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.236 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.22 -24.28 23.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.79 0.329 . . . . 0.0 110.888 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -75.38 -22.35 57.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' C' ' 109' ' ' CYS . 0.2 OUTLIER -61.66 -18.2 58.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.416 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.18 -41.16 68.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.34 . . . . 0.0 111.229 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.5 -27.82 22.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.974 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 28.0 t -73.76 -47.03 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.18 -40.17 95.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.457 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.07 83.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.937 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.05 -28.18 21.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.571 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 81.2 t80 -53.38 -44.82 68.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.904 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.84 -25.2 24.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.076 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.34 -21.37 60.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.441 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.46 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 1.0 OUTLIER -91.14 -33.72 15.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 110.576 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.454 ' CZ ' ' CG ' ' C' ' 105' ' ' PRO . 0.7 OUTLIER -56.36 -58.07 9.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.126 0.488 . . . . 0.0 110.285 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -64.56 -30.77 71.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.994 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -78.19 -9.21 59.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.248 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' C' ' 100' ' ' ASN . 3.5 m120 -109.87 -4.98 15.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.439 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 22.1 m-80 84.48 38.55 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.77 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.493 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 17.2 t-160 -130.8 68.87 82.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.35 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.27 -17.51 7.75 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.974 2.449 . . . . 0.0 112.828 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . 0.554 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 0.1 OUTLIER -59.28 -36.81 76.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 110.828 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.554 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 27.9 m-85 78.73 114.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.469 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.454 ' CG ' ' CZ ' ' C' ' 96' ' ' PHE . 62.3 Cg_endo -87.18 163.13 8.55 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.181 2.587 . . . . 0.0 112.094 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.44 175.59 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' C' ' 75' ' ' THR . 0.9 OUTLIER -173.04 163.44 4.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.263 0.554 . . . . 0.0 112.074 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.81 83.91 1.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.061 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . 0.441 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 13.8 p -89.42 123.65 33.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 35.6 m -143.06 149.53 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.351 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.02 97.26 8.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.46 160.52 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.211 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.65 -45.67 67.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.061 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -156.89 176.99 12.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 mt -145.28 160.6 45.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -50.96 135.72 43.81 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.513 2.142 . . . . 0.0 112.289 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.21 14.57 5.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.238 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.2 14.2 9.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.184 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.5 171.18 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 111.206 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.99 22.12 16.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.538 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.16 156.88 1.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.098 0.475 . . . . 0.0 111.158 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -149.95 156.41 41.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.054 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mm -133.42 136.75 54.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.163 0.506 . . . . 0.0 112.093 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 6.6 pt-20 -155.51 106.66 2.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.346 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' C' ' 74' ' ' LYS . . . -129.11 175.31 8.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.292 0.567 . . . . 0.0 112.368 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.69 157.85 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.127 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.405 ' CB ' ' CG2' ' C' ' 28' ' ' VAL . . . -148.91 149.05 30.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.995 0.426 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 m -96.93 156.35 3.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.035 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 54.1 ttt-85 -151.36 51.62 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.796 0.331 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.97 144.03 54.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.791 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.43 113.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.58 114.65 15.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tp -53.34 132.64 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.312 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 mm -98.59 143.32 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -168.08 106.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.81 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.7 t -124.99 169.34 12.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.86 29.85 3.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.2 -40.68 2.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.438 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -72.38 177.37 1.82 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.173 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 22.0 Cg_exo -65.01 -10.92 27.38 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.865 2.377 . . . . 0.0 112.728 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.73 151.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.021 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -114.35 122.47 46.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.187 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.4 mm -123.1 17.13 5.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.8 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.33 -132.0 3.64 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.355 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -89.95 20.73 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.793 2.329 . . . . 0.0 113.355 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -140.54 178.58 7.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.951 0.405 . . . . 0.0 111.462 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.424 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 15.7 m -132.87 -179.26 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.861 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -48.9 79.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.72 -172.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.825 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -142.19 132.63 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -113.94 109.77 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.816 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 mt -81.05 -14.65 57.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.269 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.82 -100.09 0.71 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.53 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -57.62 -29.77 64.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.162 0.506 . . . . 0.0 109.775 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.05 141.85 50.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.512 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 p -125.49 144.66 34.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.18 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.435 ' CD2' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -118.1 146.98 43.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.79 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 p -124.16 155.22 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.83 167.2 12.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.93 94.62 0.15 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.342 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -58.83 150.06 24.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.363 . . . . 0.0 111.171 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 22.3 mm -133.42 134.91 24.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.49 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.0 Cg_exo -68.02 56.16 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.898 2.399 . . . . 0.0 112.803 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.52 86.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.332 0.587 . . . . 0.0 110.654 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 41' ' ' GLY . 13.0 t30 -37.99 128.44 0.99 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.066 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -68.68 -10.61 29.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.213 1.942 . . . . 0.0 111.902 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.4 -30.33 10.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.958 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.41 ' CG2' ' HB3' ' A' ' 37' ' ' ASN . 11.8 t -123.3 -26.02 4.35 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.427 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 70.66 58.9 5.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.215 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -154.36 -73.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.3 . . . . 0.0 111.435 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' A' ' 119' ' ' VAL . 7.4 p 175.44 117.66 0.12 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.94 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.04 140.27 50.12 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.315 2.01 . . . . 0.0 112.165 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.64 -30.99 69.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.46 94.95 3.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.799 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.7 tp -43.4 -31.88 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.601 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.62 -45.5 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.669 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.23 -48.13 79.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.569 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -61.41 -29.53 69.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.392 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.75 -39.61 61.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.927 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -62.42 -48.47 79.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.06 -34.63 78.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -31.15 71.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.726 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.415 HD13 ' CE2' ' A' ' 95' ' ' PHE . 75.6 mt -69.69 -49.84 49.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -40.83 84.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.83 -38.45 70.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.26 -25.86 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.88 -39.15 20.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.806 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.27 -39.68 79.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.91 -53.05 28.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.917 0.389 . . . . 0.0 110.729 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.66 -28.89 45.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.708 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.45 -42.54 53.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.53 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -16.07 63.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.45 -28.68 20.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.59 43.65 0.63 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.587 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -149.78 -167.15 2.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.0 110.837 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.17 154.86 38.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.66 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.512 ' CB ' ' CE1' ' A' ' 101' ' ' HIS . . . -58.12 -36.7 73.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.943 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 100' ' ' ASN . . . -50.1 -26.3 4.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.251 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.73 -23.63 33.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.414 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.442 HG13 ' HA ' ' A' ' 69' ' ' ALA . 88.5 mt -44.39 120.44 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.917 0.389 . . . . 0.0 111.415 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.3 m -90.31 -38.02 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.651 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.72 155.45 49.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.599 0.238 . . . . 0.0 110.974 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 125' ' ' ALA . 17.3 p -143.43 152.07 41.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.027 0.441 . . . . 0.0 111.51 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.422 HG21 ' CE1' ' A' ' 78' ' ' PHE . 5.2 m -133.74 142.32 47.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.064 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -143.02 105.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 111.811 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.427 ' CD2' HG13 ' C' ' 110' ' ' VAL . 7.8 m-85 -86.98 106.28 17.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.469 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.71 152.59 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.549 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.13 -2.61 46.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.844 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.36 113.51 3.7 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.585 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.1 mt -65.27 -13.57 58.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.056 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -81.94 -23.2 36.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.875 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.84 -23.72 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.403 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 2.0 t80 -56.26 -23.88 39.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.382 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.92 74.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.199 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.44 -38.71 17.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.29 -36.06 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.6 t30 -69.31 -43.1 74.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.82 74.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.026 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -86.08 -23.26 26.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.2 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 10.3 t80 -77.82 -27.55 50.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.565 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.1 -39.42 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -67.25 -23.13 65.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -90.85 -32.8 15.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.553 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 1.7 m-85 -60.15 -58.85 6.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.3 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -63.55 -28.17 69.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.159 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -77.79 -10.89 59.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.54 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 2.2 m-80 -111.15 -5.92 14.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.379 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.5 OUTLIER 94.52 37.32 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.871 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.512 ' CE1' ' CB ' ' A' ' 69' ' ' ALA . 1.8 m170 -117.9 51.98 1.33 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 65.1 Cg_endo -71.91 -21.67 24.25 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.453 2.102 . . . . 0.0 112.56 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.411 ' O ' HG12 ' B' ' 19' ' ' VAL . 7.6 t30 -53.34 -32.98 51.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.728 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.43 ' O ' HG12 ' B' ' 19' ' ' VAL . 15.6 m-85 60.98 83.67 0.21 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.131 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 17.1 Cg_endo -58.15 159.42 18.78 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.44 2.093 . . . . 0.0 112.018 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.19 169.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.783 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.4 146.42 51.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.018 0.437 . . . . 0.0 111.308 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 p -152.56 58.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.411 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 25.4 p -96.01 142.85 27.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.431 HG13 ' CD2' ' B' ' 78' ' ' PHE . 33.9 m -147.6 153.92 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.93 83.63 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.78 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.5 m -71.99 160.82 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.111 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.56 -53.57 27.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.243 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -151.25 -178.59 6.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.964 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 122' ' ' GLU . 2.1 mp -153.55 159.37 32.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.572 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 9.6 Cg_endo -52.16 140.19 51.45 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.578 2.185 . . . . 0.0 112.21 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 66.84 14.0 9.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.559 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.71 19.23 5.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.069 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.501 ' HA ' HG22 ' A' ' 43' ' ' VAL . 3.0 p -52.33 -49.36 42.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.31 -7.37 81.61 Favored Glycine 0 C--N 1.308 -0.978 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.293 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.428 ' O ' HG21 ' A' ' 119' ' ' VAL . 16.7 mt -140.37 146.75 38.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.237 0.542 . . . . 0.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 115' ' ' LEU . 26.1 tt0 -147.67 152.42 37.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.941 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 26.9 mt -138.07 127.41 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.192 0.52 . . . . 0.0 112.229 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.45 132.18 18.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.391 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 75' ' ' THR . . . -149.39 159.42 44.3 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.8 mm -105.24 153.57 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.893 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.2 152.57 50.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.013 0.435 . . . . 0.0 111.828 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.98 178.09 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.804 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -167.75 59.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.873 0.368 . . . . 0.0 111.039 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.932 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.818 0.342 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.01 144.06 54.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.796 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.39 113.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.6 114.63 15.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tp -53.3 132.69 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.33 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 mm -98.57 143.34 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.402 ' CD2' ' OE1' ' B' ' 20' ' ' GLN . 1.1 m80 -168.15 106.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 3.8 t -124.97 169.3 12.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.009 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.85 29.89 3.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.34 -40.9 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.441 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -72.01 177.26 1.79 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.11 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 22.2 Cg_exo -65.01 -10.87 27.2 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.892 2.395 . . . . 0.0 112.677 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.66 151.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 111.083 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -114.27 122.43 46.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.202 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 26.5 mm -123.08 17.13 5.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.765 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.29 -131.98 3.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.422 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -89.93 20.66 1.0 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.809 2.339 . . . . 0.0 113.392 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -140.44 178.6 7.19 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.507 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 104' ' ' PHE . 15.6 m -132.92 -179.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.867 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.402 ' OE1' ' CD2' ' B' ' 7' ' ' HIS . 0.1 OUTLIER -58.92 -48.7 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.953 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -178.07 -172.71 0.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 m -142.2 132.67 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.145 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -113.95 109.76 19.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 mt -81.07 -14.71 57.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.265 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.86 -100.05 0.7 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.548 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -57.61 -29.77 64.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.177 0.513 . . . . 0.0 109.81 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.0 141.88 50.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.537 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.4 HG12 ' CB ' ' B' ' 127' ' ' ALA . 4.7 p -125.57 144.68 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.145 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' B' ' 29' ' ' LEU . 0.0 OUTLIER -118.06 146.94 43.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.83 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 16.1 p -124.18 155.03 39.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.832 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.99 167.11 12.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.91 94.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.329 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -58.82 150.07 24.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.376 . . . . 0.0 111.153 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' B' ' 35' ' ' PRO . 22.2 mm -133.42 134.88 24.36 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.096 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.492 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.0 Cg_exo -68.03 56.2 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.836 2.358 . . . . 0.0 112.79 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -63.52 86.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.366 0.603 . . . . 0.0 110.623 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' B' ' 41' ' ' GLY . 13.0 t30 -38.01 128.44 0.99 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.092 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.62 -10.68 29.76 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.235 1.957 . . . . 0.0 111.921 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.37 -30.28 10.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.015 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' THR . . . . . 0.411 ' CG2' ' HB3' ' B' ' 37' ' ' ASN . 11.6 t -123.25 -26.06 4.37 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.815 0.34 . . . . 0.0 111.477 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 70.76 58.96 5.45 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.215 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -154.35 -74.03 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.774 0.321 . . . . 0.0 111.398 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' B' ' 119' ' ' VAL . 7.4 p 175.49 117.59 0.12 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.992 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.12 140.29 50.91 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.249 1.966 . . . . 0.0 112.189 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.95 69.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.032 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.41 94.95 3.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.818 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 2.7 tp -43.39 -31.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.61 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.62 -45.51 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.04 79.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -61.56 -29.6 70.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.371 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.97 -39.6 61.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.999 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -62.37 -48.48 79.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.818 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.12 -34.58 78.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.708 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.09 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.733 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 75.6 mt -69.75 -49.81 49.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.83 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -40.86 84.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.85 -38.48 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.64 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -65.23 -25.88 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.66 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.86 -39.21 20.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.91 80.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 50.6 mt -68.67 -53.01 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.733 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.7 -28.82 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.47 -42.54 52.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.546 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -16.09 63.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.643 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.42 -28.64 20.77 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.706 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.58 43.67 0.63 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.523 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -149.83 -167.14 2.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 110.775 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 154.85 38.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.693 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.522 ' CB ' ' CE1' ' B' ' 101' ' ' HIS . . . -58.12 -36.66 73.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' B' ' 100' ' ' ASN . . . -50.18 -26.36 4.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.281 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -23.67 34.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.404 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.454 HG13 ' HA ' ' B' ' 69' ' ' ALA . 88.8 mt -44.44 120.36 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-O 120.923 0.392 . . . . 0.0 111.438 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.2 -38.02 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.66 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 155.47 48.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.625 0.25 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 17.3 p -143.38 152.1 41.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 111.543 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.43 HG21 ' CE1' ' B' ' 78' ' ' PHE . 5.2 m -133.8 142.32 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.026 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.4 t -143.0 105.82 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 111.838 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.431 ' CD2' HG13 ' A' ' 110' ' ' VAL . 7.7 m-85 -86.98 106.29 17.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.69 152.6 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.576 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.19 -2.51 46.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.808 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.62 113.54 3.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 6.1 mt -65.19 -13.5 58.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.095 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.96 -23.26 36.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.883 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.82 -23.67 39.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.192 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.408 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 2.0 t80 -56.3 -23.9 39.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.336 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.33 -36.91 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 0.0 111.209 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.48 -38.7 17.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.18 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.28 -36.07 65.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.408 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.6 t30 -69.34 -43.04 74.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.06 74.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.08 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . 0.527 ' HA ' ' HG2' ' B' ' 94' ' ' ARG . 0.1 OUTLIER -85.95 -23.3 26.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.482 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 10.3 t80 -77.8 -27.54 50.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.541 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.19 -39.41 12.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.527 ' HG2' ' HA ' ' B' ' 91' ' ' GLU . 0.0 OUTLIER -67.35 -23.02 65.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -90.82 -32.85 15.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.835 0.35 . . . . 0.0 110.57 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 1.6 m-85 -60.12 -58.79 7.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.309 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -63.53 -28.24 69.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.162 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -77.78 -10.85 59.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 2.2 m-80 -111.22 -5.87 14.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.349 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 0.5 OUTLIER 94.5 37.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.873 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.522 ' CE1' ' CB ' ' B' ' 69' ' ' ALA . 1.8 m170 -117.92 52.02 1.34 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.706 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 64.2 Cg_endo -72.05 -21.58 23.9 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.449 2.099 . . . . 0.0 112.536 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.41 ' O ' HG12 ' C' ' 19' ' ' VAL . 7.6 t30 -53.34 -33.02 51.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.894 0.378 . . . . 0.0 110.723 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.415 ' O ' HG12 ' C' ' 19' ' ' VAL . 15.6 m-85 61.05 83.67 0.21 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.122 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 16.9 Cg_endo -58.12 159.42 18.65 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.463 2.109 . . . . 0.0 112.025 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.17 169.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.805 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.46 146.45 51.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.994 0.426 . . . . 0.0 111.286 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 1.7 p -152.61 58.43 0.81 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.42 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 25.3 p -96.04 142.78 27.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.129 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . 0.425 HG13 ' CD2' ' C' ' 78' ' ' PHE . 33.9 m -147.44 153.52 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.153 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.7 83.64 6.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 9.7 m -71.87 160.8 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.59 -53.54 27.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.235 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -151.28 -178.52 6.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.402 ' CD2' ' HB2' ' B' ' 122' ' ' GLU . 2.2 mp -153.57 159.29 32.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.577 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' B' ' 117' ' ' LYS . 9.5 Cg_endo -52.15 140.19 51.38 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.573 2.182 . . . . 0.0 112.195 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 0.0 OUTLIER 66.86 13.97 9.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.537 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.76 19.16 5.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.078 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . 0.501 ' HA ' HG22 ' B' ' 43' ' ' VAL . 3.1 p -52.28 -49.38 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 121.655 0.741 . . . . 0.0 111.194 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.23 -7.47 81.48 Favored Glycine 0 C--N 1.308 -1.012 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.338 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.421 ' O ' HG21 ' B' ' 119' ' ' VAL . 16.7 mt -140.12 146.7 39.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.213 0.53 . . . . 0.0 111.128 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . 0.402 ' HB2' ' CD2' ' B' ' 115' ' ' LEU . 26.1 tt0 -147.56 152.42 37.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.976 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 26.7 mt -138.1 127.39 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.258 0.552 . . . . 0.0 112.237 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.43 132.19 18.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.417 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.43 159.4 44.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 14.8 mm -105.28 153.43 6.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.889 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -137.09 152.63 50.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.012 0.434 . . . . 0.0 111.845 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.06 178.05 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.834 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -167.68 59.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.887 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.85 0.357 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.11 144.12 54.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.818 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.4 113.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.57 114.64 15.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tp -53.3 132.71 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.3 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 12.4 mm -98.67 143.4 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -168.16 106.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.789 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 3.7 t -124.97 169.31 12.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.8 29.87 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.21 -40.76 2.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.434 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -72.21 177.24 1.84 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.213 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 22.2 Cg_exo -65.04 -10.89 27.33 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.947 2.432 . . . . 0.0 112.682 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.68 151.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.064 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -114.35 122.48 46.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.114 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -123.1 17.09 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.833 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.3 -131.92 3.63 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.36 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -90.03 20.77 0.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.759 2.306 . . . . 0.0 113.337 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -140.48 178.62 7.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.964 0.411 . . . . 0.0 111.516 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.421 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 15.7 m -132.92 -179.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.84 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -49.01 79.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.58 -172.78 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.825 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -142.24 132.64 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.161 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -113.97 109.83 19.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.81 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 mt -81.09 -14.72 57.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.231 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.88 -100.1 0.7 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.53 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -57.6 -29.79 64.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.194 0.521 . . . . 0.0 109.839 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.03 141.92 50.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.527 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' C' ' 127' ' ' ALA . 4.7 p -125.55 144.71 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.2 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.436 ' CD2' ' N ' ' C' ' 29' ' ' LEU . 0.0 OUTLIER -118.08 147.01 43.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 16.2 p -124.15 155.18 38.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.96 167.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.958 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.89 94.6 0.14 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.314 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -58.83 150.04 25.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 111.206 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -133.4 134.97 24.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.108 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.494 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.0 Cg_exo -68.09 56.2 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.874 2.383 . . . . 0.0 112.789 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.5 86.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.295 0.569 . . . . 0.0 110.595 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' C' ' 41' ' ' GLY . 13.1 t30 -38.08 128.44 1.0 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.093 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' C' ' 37' ' ' ASN . 13.9 Cg_exo -68.61 -10.71 29.85 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.232 1.955 . . . . 0.0 111.91 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.29 -30.3 10.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 112.073 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' THR . . . . . 0.418 ' CG2' ' HB3' ' C' ' 37' ' ' ASN . 11.8 t -123.29 -26.0 4.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.834 0.35 . . . . 0.0 111.474 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 70.65 58.96 5.5 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.227 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -154.38 -74.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.714 0.292 . . . . 0.0 111.404 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 7.4 p 175.51 117.59 0.12 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.98 140.26 49.6 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.297 1.998 . . . . 0.0 112.204 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.67 -31.0 69.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.009 0.433 . . . . 0.0 111.065 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.44 94.91 3.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 2.7 tp -43.38 -31.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.636 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 32.2 t -79.66 -45.51 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.646 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.09 79.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.587 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -61.53 -29.47 70.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.359 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.91 -39.61 61.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.964 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -62.38 -48.48 79.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.794 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.04 -34.62 78.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.17 -31.1 71.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.409 HD13 ' CE2' ' C' ' 95' ' ' PHE . 75.5 mt -69.72 -49.89 48.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -40.82 84.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.87 -38.51 70.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.671 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 38.9 t -65.15 -25.97 38.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.678 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.79 -39.22 20.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.755 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.26 -39.84 80.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . 0.401 HD13 HG22 ' C' ' 61' ' ' ILE . 50.3 mt -68.69 -53.07 29.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 50.9 mt -64.65 -28.87 45.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.731 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.49 -42.53 52.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.558 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -16.2 64.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.615 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.34 -28.74 20.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.929 0.395 . . . . 0.0 110.741 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.62 43.66 0.62 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.545 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -149.74 -167.13 2.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.939 0.4 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.16 154.91 38.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.71 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.522 ' CB ' ' CE1' ' C' ' 101' ' ' HIS . . . -58.16 -36.68 73.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.371 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' C' ' 100' ' ' ASN . . . -50.09 -26.35 4.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.285 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -23.75 34.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.381 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.443 HG13 ' HA ' ' C' ' 69' ' ' ALA . 88.8 mt -44.34 120.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.883 0.373 . . . . 0.0 111.416 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.17 -38.02 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.716 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 155.5 48.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 17.4 p -143.37 152.03 41.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.034 0.445 . . . . 0.0 111.579 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.429 HG21 ' CE1' ' C' ' 78' ' ' PHE . 5.3 m -133.72 142.31 47.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.007 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -143.03 105.88 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 111.787 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.429 ' CE1' HG21 ' C' ' 76' ' ' THR . 7.7 m-85 -86.96 106.21 17.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.544 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.66 152.59 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.624 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.08 -2.58 46.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.802 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -154.45 113.44 3.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.635 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 6.1 mt -65.2 -13.56 58.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.044 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.95 -23.17 36.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.88 -23.69 38.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.156 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.405 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 2.0 t80 -56.25 -23.92 39.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.384 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.85 74.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.214 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.46 -38.68 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.242 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.37 -36.04 65.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . 0.405 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.6 t30 -69.24 -43.22 74.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.12 -32.9 74.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.08 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . 0.552 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 0.1 OUTLIER -86.0 -23.2 26.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.156 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.484 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 10.3 t80 -77.94 -27.5 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.538 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.1 -39.52 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . 0.552 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 0.0 OUTLIER -67.25 -23.12 65.67 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.497 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -90.88 -32.75 15.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.784 0.326 . . . . 0.0 110.529 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.497 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 1.6 m-85 -60.2 -58.81 6.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.059 0.457 . . . . 0.0 110.259 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -63.53 -28.22 69.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.141 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -77.75 -10.9 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.566 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 2.2 m-80 -111.17 -5.85 14.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.397 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 0.5 OUTLIER 94.5 37.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.86 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.522 ' CE1' ' CB ' ' C' ' 69' ' ' ALA . 1.8 m170 -117.93 51.99 1.34 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.723 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 64.3 Cg_endo -72.0 -21.57 24.07 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.442 2.095 . . . . 0.0 112.574 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . 0.408 ' O ' HG12 ' A' ' 19' ' ' VAL . 7.6 t30 -53.36 -33.01 51.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.936 0.398 . . . . 0.0 110.718 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.422 ' O ' HG12 ' A' ' 19' ' ' VAL . 15.5 m-85 60.98 83.75 0.2 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.074 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 17.1 Cg_endo -58.17 159.46 18.72 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.45 2.1 . . . . 0.0 112.005 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.26 169.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.779 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.31 146.44 51.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.0 0.429 . . . . 0.0 111.341 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 1.7 p -152.59 58.5 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.457 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 25.4 p -96.05 142.85 27.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.093 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 78' ' ' PHE . 33.9 m -147.62 153.93 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.85 83.63 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 9.6 m -71.95 160.81 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.55 -53.57 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.22 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -151.25 -178.6 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.987 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . 0.404 ' CD2' ' HB2' ' C' ' 122' ' ' GLU . 2.1 mp -153.56 159.39 32.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . 0.437 ' O ' ' HB2' ' C' ' 117' ' ' LYS . 9.6 Cg_endo -52.18 140.17 51.75 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.598 2.199 . . . . 0.0 112.195 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 0.0 OUTLIER 66.89 13.99 9.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.515 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.72 19.21 5.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . 0.472 HG22 ' CG2' ' C' ' 43' ' ' VAL . 3.1 p -52.34 -49.34 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.658 0.742 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.3 -7.49 81.41 Favored Glycine 0 C--N 1.308 -0.984 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.333 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . 0.419 ' O ' HG21 ' C' ' 119' ' ' VAL . 16.7 mt -140.16 146.72 39.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.246 0.546 . . . . 0.0 111.134 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.404 ' HB2' ' CD2' ' C' ' 115' ' ' LEU . 26.1 tt0 -147.67 152.39 37.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.953 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 26.7 mt -138.05 127.47 33.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.229 0.538 . . . . 0.0 112.189 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.48 132.13 18.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.431 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.37 159.39 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.211 0.529 . . . . 0.0 112.412 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 14.7 mm -105.22 153.43 6.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.917 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -137.11 152.56 50.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.031 0.443 . . . . 0.0 111.79 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.99 178.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.842 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -167.74 59.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 111.035 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.916 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.848 0.356 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.6 mtt -89.47 87.97 7.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.63 118.21 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -157.82 118.17 3.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -58.25 138.3 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.081 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.9 mt -94.83 138.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.158 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -150.97 136.94 18.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.51 162.81 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.75 26.61 5.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -118.03 -40.57 2.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.64 119.65 72.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.171 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.05 -10.84 28.61 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.42 2.08 . . . . 0.0 112.596 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.45 172.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.928 0.394 . . . . 0.0 111.464 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.468 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 62.84 130.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.187 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.94 -36.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.504 0.669 . . . . 0.0 110.768 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.03 -145.11 11.19 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.368 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.69 57.97 5.78 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.731 2.287 . . . . 0.0 112.873 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -168.46 -177.3 3.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 111.08 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.8 -178.45 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.297 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -80.2 -50.94 9.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.982 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -156.95 179.8 8.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.268 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 m -139.57 147.3 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.082 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -123.23 94.32 4.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mt -69.96 -17.37 63.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.268 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.62 -105.42 0.95 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.146 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -52.6 -29.99 28.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.054 0.454 . . . . 0.0 110.525 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.24 134.16 35.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.773 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.405 HG23 ' CD1' ' A' ' 67' ' ' LEU . 3.0 m -113.07 172.32 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.218 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.67 165.71 27.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.3 p -130.13 135.98 48.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m -69.23 154.54 41.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.97 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.26 93.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.631 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -67.65 173.7 4.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.776 0.322 . . . . 0.0 111.009 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.6 pt -159.38 152.54 18.48 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.441 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.661 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 43.8 Cg_endo -68.09 74.8 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.05 2.5 . . . . 0.0 112.325 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.5 t -90.96 88.23 2.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.587 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -36.18 129.18 0.65 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.886 -179.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.12 -7.91 21.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.288 1.992 . . . . 0.0 112.081 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.95 -22.56 12.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.601 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.4 t -132.69 -39.0 1.0 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.878 0.37 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 85.79 56.92 2.25 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.305 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 12.9 mm-40 -145.12 -71.22 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 111.411 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 7.1 p 172.91 112.51 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -55.58 140.62 83.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.296 1.998 . . . . 0.0 112.144 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.06 71.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.044 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.75 94.93 3.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.4 tp -44.5 -31.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.427 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -38.29 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.713 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.24 -39.97 78.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.497 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.44 -21.88 57.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.223 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.5 -41.5 27.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.161 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.24 -34.45 63.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.76 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.15 -31.59 64.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.529 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.41 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 68.7 p -67.31 -30.79 70.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.703 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.436 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 34.2 mt -79.39 -30.72 42.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.802 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.55 -55.91 20.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.985 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 9.3 p-10 -55.79 -44.99 78.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.25 -31.02 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -79.2 -38.42 35.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.766 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.27 81.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.06 -51.26 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.771 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.8 mt -63.21 -32.63 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.592 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.68 -40.71 63.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.241 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.52 -21.0 65.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.94 -25.66 20.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.812 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 47.91 0.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.482 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.405 ' CD1' HG23 ' A' ' 28' ' ' VAL . 7.2 mt -156.68 -171.62 3.74 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.724 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.6 p -142.82 -179.58 6.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.981 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -78.63 -24.89 45.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.58 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -59.81 -36.54 76.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.981 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.01 -26.51 63.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.072 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 88.3 mt -46.76 115.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.83 0.348 . . . . 0.0 110.933 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.26 -26.01 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.766 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -138.03 164.46 29.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.735 0.302 . . . . 0.0 110.899 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.9 m -163.63 126.58 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.045 0.45 . . . . 0.0 111.492 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.423 HG22 ' CE1' ' A' ' 78' ' ' PHE . 2.8 m -109.25 144.8 36.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.881 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.08 108.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 111.782 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 76' ' ' THR . 6.6 m-85 -91.47 107.11 18.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.278 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' A' ' 85' ' ' PHE . 30.0 m -102.21 149.95 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.201 0.524 . . . . 0.0 111.804 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.74 -6.18 49.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.818 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.44 111.99 3.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.54 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.28 -15.18 32.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.241 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -78.32 -19.45 53.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.758 0.313 . . . . 0.0 110.869 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -90.65 7.18 40.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.411 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.431 ' CD1' HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -82.18 -27.46 32.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 111.172 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -36.76 76.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.123 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.38 -36.6 29.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 t -75.6 -30.52 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 85' ' ' PHE . 9.9 m120 -67.19 -48.88 66.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.02 -39.18 90.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.177 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.89 -23.94 55.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.196 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -81.73 -33.29 31.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.401 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.65 -29.76 18.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.696 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -75.86 -21.59 57.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.663 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.503 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -92.01 -33.13 14.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 0.0 110.671 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.503 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 2.6 m-85 -58.98 -59.13 5.96 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.063 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -31.5 72.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.246 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.57 -11.5 60.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.419 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 4.9 m-20 -110.91 -6.53 14.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.336 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 8.1 t-20 90.11 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.548 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.469 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 1.6 m-70 -115.21 53.41 0.81 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.025 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.1 Cg_endo -74.63 -14.51 22.07 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.51 2.14 . . . . 0.0 112.55 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -51.68 -33.28 33.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.093 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 61.47 96.46 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.031 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 59.9 Cg_endo -73.33 159.09 47.53 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.443 2.095 . . . . 0.0 112.258 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.71 147.69 18.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.445 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.64 142.52 45.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.005 0.431 . . . . 0.0 111.442 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t -149.58 62.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.376 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.5 p -94.64 145.38 24.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.9 m -153.28 135.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.212 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.76 91.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.802 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.4 m -76.26 164.43 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.66 -44.8 14.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.54 158.62 34.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.734 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 0.9 OUTLIER -141.34 168.99 12.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.485 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 115' ' ' LEU . 74.4 Cg_exo -50.18 136.87 38.28 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.351 2.034 . . . . 0.0 112.362 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.13 14.31 9.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.359 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.53 20.11 5.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.021 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -53.12 149.75 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.244 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.52 -15.01 77.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.754 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.1 mt -152.3 148.65 27.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 110.848 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -129.8 146.71 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.21 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 123' ' ' ILE . 29.0 mm -120.1 150.27 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.035 0.445 . . . . 0.0 111.763 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.22 147.45 6.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.694 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -173.83 164.34 4.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.098 0.475 . . . . 0.0 112.129 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.6 mm -117.59 151.83 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.362 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -131.49 147.53 52.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.976 0.417 . . . . 0.0 111.739 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.6 152.01 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.055 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -173.18 73.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.78 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.86 0.362 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 3.6 mtt -89.48 87.99 7.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.58 118.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -157.81 118.18 3.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.009 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -58.22 138.26 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.83 138.11 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -150.94 136.92 18.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.52 162.77 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.72 26.67 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -118.11 -40.86 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.24 119.68 72.61 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.03 -10.88 28.71 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.424 2.083 . . . . 0.0 112.572 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.43 172.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.525 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 62.86 130.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.207 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.95 -36.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.509 0.671 . . . . 0.0 110.773 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.04 -145.18 11.29 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.313 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.64 58.01 5.82 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.715 2.276 . . . . 0.0 112.896 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.471 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -168.54 -177.29 3.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 111.067 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.77 -178.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.298 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -80.3 -51.05 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -156.59 179.75 8.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.272 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.56 147.32 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.076 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -123.24 94.39 4.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mt -70.02 -17.42 63.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.61 -105.32 0.95 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.12 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -52.66 -29.97 29.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.472 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.29 134.17 35.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.776 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' B' ' 67' ' ' LEU . 3.0 m -113.03 172.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.7 165.69 28.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.672 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 44.2 p -130.13 136.0 48.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 48.6 m -69.34 154.41 42.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' B' ' 123' ' ' ILE . . . -55.21 93.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.608 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -67.66 173.66 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.734 0.302 . . . . 0.0 111.004 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 pt -159.37 152.59 18.55 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.004 0.43 . . . . 0.0 111.467 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.645 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 44.0 Cg_endo -68.14 74.81 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.108 2.538 . . . . 0.0 112.338 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 22.6 t -91.01 88.15 2.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.55 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' B' ' 41' ' ' GLY . 0.3 OUTLIER -36.1 129.16 0.64 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.922 -179.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.12 -7.85 21.77 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.261 1.974 . . . . 0.0 112.108 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.99 -22.53 12.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.577 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 4.5 t -132.76 -38.94 0.99 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.909 0.385 . . . . 0.0 111.002 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 85.77 56.86 2.27 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.32 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.435 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 12.9 mm-40 -145.08 -71.13 0.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.682 0.277 . . . . 0.0 111.441 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 7.1 p 172.89 112.54 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -55.63 140.64 84.07 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.331 2.021 . . . . 0.0 112.153 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.1 71.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.74 94.91 3.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 tp -44.43 -31.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.408 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.19 -38.27 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.733 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.28 -39.99 78.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.463 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.52 -21.83 57.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.239 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.6 -41.49 26.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.213 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.26 -34.47 63.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.15 -31.51 64.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.57 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' SER . . . . . 0.421 ' HA ' ' OD1' ' B' ' 57' ' ' ASN . 68.9 p -67.31 -30.82 70.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.402 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 34.4 mt -79.38 -30.7 42.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.6 -55.9 20.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . 0.421 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 9.3 p-10 -55.76 -45.03 78.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.27 -30.94 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.768 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -79.22 -38.47 35.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.16 81.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.02 -51.41 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.792 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 45.8 mt -63.19 -32.64 57.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.598 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.64 -40.69 63.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.266 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.56 -21.0 65.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.485 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.89 -25.68 20.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.1 47.96 0.54 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.461 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.419 ' CD1' HG23 ' B' ' 28' ' ' VAL . 7.2 mt -156.75 -171.65 3.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.764 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 76.8 p -142.82 -179.65 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -78.59 -24.93 45.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.577 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -59.79 -36.47 76.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.029 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.06 -26.51 63.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.055 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' B' ' 105' ' ' PRO . 88.3 mt -46.8 115.63 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.21 -25.95 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.762 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -138.11 164.42 29.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 91.7 m -163.58 126.63 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.048 0.451 . . . . 0.0 111.484 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.417 HG22 ' CE1' ' B' ' 78' ' ' PHE . 2.8 m -109.28 144.78 36.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.03 108.4 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.914 0.388 . . . . 0.0 111.828 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.417 ' CE1' HG22 ' B' ' 76' ' ' THR . 6.6 m-85 -91.46 107.16 19.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.24 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.42 HG12 ' CD1' ' B' ' 85' ' ' PHE . 30.2 m -102.22 149.97 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.158 0.504 . . . . 0.0 111.838 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.89 -6.14 49.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.747 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.45 111.96 3.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.516 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.15 -15.24 31.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.242 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -78.31 -19.52 53.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -90.62 7.26 40.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.448 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.42 ' CD1' HG12 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -82.25 -27.48 32.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.749 0.309 . . . . 0.0 111.114 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.19 -36.8 75.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.157 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.36 -36.63 29.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 28.8 t -75.63 -30.48 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' B' ' 85' ' ' PHE . 9.9 m120 -67.21 -48.93 66.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.94 -39.32 90.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.78 -23.98 55.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -81.78 -33.29 30.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.399 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.71 -29.68 18.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.657 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -75.88 -21.57 57.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.668 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.495 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -92.04 -33.13 14.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 110.671 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.495 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 2.6 m-85 -58.95 -59.11 5.99 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.09 0.472 . . . . 0.0 110.138 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -31.46 72.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.297 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.49 -11.6 60.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.436 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 4.9 m-20 -110.88 -6.44 14.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.336 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 8.1 t-20 90.11 35.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.619 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 1.6 m-70 -115.3 53.43 0.83 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.959 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.41 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 71.8 Cg_endo -74.56 -14.61 22.21 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.541 2.161 . . . . 0.0 112.577 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -51.59 -33.33 32.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.135 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 61.49 96.48 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.997 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.426 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 59.9 Cg_endo -73.34 159.05 47.56 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.404 2.069 . . . . 0.0 112.255 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.59 147.72 17.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.458 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.76 142.49 45.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.032 0.444 . . . . 0.0 111.471 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 31.2 t -149.52 62.87 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.352 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 18.8 p -94.62 145.41 24.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.233 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . 0.404 HG11 ' CD2' ' C' ' 78' ' ' PHE . 35.9 m -153.33 135.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.244 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' C' ' 114' ' ' ARG . 0.0 OUTLIER -64.78 91.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.77 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 m -76.35 164.45 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.236 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.6 -44.88 14.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.51 158.68 34.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.706 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.44 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.9 OUTLIER -141.4 168.95 12.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.495 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' B' ' 115' ' ' LEU . 74.5 Cg_exo -50.16 136.89 38.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.352 2.035 . . . . 0.0 112.325 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.11 14.28 9.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.398 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.56 20.07 5.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.041 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -53.1 149.77 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.198 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.56 -15.15 76.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.769 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 42.5 mt -152.21 148.63 27.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.959 0.409 . . . . 0.0 110.848 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -129.68 146.63 51.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.284 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.409 ' O ' ' HA2' ' B' ' 32' ' ' GLY . 29.3 mm -120.11 150.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 111.748 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.16 147.48 6.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.69 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -173.87 164.4 4.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 112.133 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.6 mm -117.74 151.85 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.334 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -131.45 147.54 52.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 111.781 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.62 151.93 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.086 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -173.09 73.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.79 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.94 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.844 0.354 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 3.6 mtt -89.51 87.93 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.57 118.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.742 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -157.87 118.22 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -58.19 138.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.092 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 31.6 mt -94.73 138.08 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.169 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -151.0 136.91 18.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.49 162.77 34.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.71 26.65 5.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -118.06 -40.69 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.791 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' C' ' 12' ' ' PRO . . . -85.5 119.67 72.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.124 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' C' ' 11' ' ' ALA . 17.8 Cg_exo -66.03 -10.88 28.73 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.496 2.131 . . . . 0.0 112.601 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.5 172.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.472 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.468 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 62.94 130.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.16 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.91 -36.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.495 0.664 . . . . 0.0 110.741 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.06 -145.12 11.23 Favored Glycine 0 C--N 1.315 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.364 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.68 57.95 5.78 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.702 2.268 . . . . 0.0 112.901 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -168.45 -177.37 3.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.086 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.73 -178.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.328 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -80.31 -51.2 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.05 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -156.41 179.68 9.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.282 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.5 147.37 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -123.25 94.36 4.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mt -69.99 -17.4 63.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.232 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.62 -105.37 0.95 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.178 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -52.53 -30.07 28.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.038 0.447 . . . . 0.0 110.517 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.21 134.14 35.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.824 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.407 HG23 ' CD1' ' C' ' 67' ' ' LEU . 3.0 m -113.0 172.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.256 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.68 165.65 28.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.69 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 44.1 p -130.14 135.96 48.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -69.43 154.44 42.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.032 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.26 93.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.647 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -67.58 173.7 4.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.742 0.306 . . . . 0.0 110.991 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 pt -159.37 152.52 18.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.484 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.651 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 43.7 Cg_endo -68.14 74.84 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.112 2.541 . . . . 0.0 112.304 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 22.5 t -90.99 88.14 2.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.589 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' C' ' 41' ' ' GLY . 0.3 OUTLIER -36.13 129.16 0.64 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.939 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.1 -7.84 21.75 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.339 2.026 . . . . 0.0 112.084 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.02 -22.54 12.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.582 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 4.5 t -132.73 -39.0 0.99 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.869 0.366 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 85.77 56.92 2.26 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.275 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . 0.44 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 13.0 mm-40 -145.09 -71.19 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.389 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 7.2 p 172.92 112.56 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.67 140.65 84.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.304 2.002 . . . . 0.0 112.151 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.13 71.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.979 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.76 94.9 3.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.822 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 tp -44.43 -31.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.39 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.25 -38.21 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.723 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.25 -40.05 78.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.46 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.5 -21.95 57.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.241 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.69 -41.59 26.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.181 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.28 -34.36 63.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.786 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.16 -31.56 64.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.556 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.414 ' HA ' ' OD1' ' C' ' 57' ' ' ASN . 69.0 p -67.28 -30.87 70.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.696 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 34.4 mt -79.34 -30.71 42.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.53 -55.89 20.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.031 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . 0.414 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 9.3 p-10 -55.77 -45.06 78.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 45.1 t -59.19 -31.03 45.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -79.24 -38.5 35.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.701 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.9 80.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.32 -51.52 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.826 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 mt -63.18 -32.69 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.6 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.66 -40.66 63.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.28 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.58 -20.96 65.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.485 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.9 -25.67 20.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.858 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.11 47.91 0.54 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.453 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.407 ' CD1' HG23 ' C' ' 28' ' ' VAL . 7.2 mt -156.71 -171.64 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.712 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 77.7 p -142.77 -179.6 6.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.468 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -78.64 -24.95 44.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.52 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -59.82 -36.54 77.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.11 -26.34 62.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.062 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' C' ' 105' ' ' PRO . 88.4 mt -46.81 115.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.87 0.367 . . . . 0.0 110.953 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.2 -26.0 5.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.78 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -138.08 164.45 29.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.704 0.288 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -163.54 126.62 2.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.994 0.426 . . . . 0.0 111.502 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.41 HG22 ' CE1' ' C' ' 78' ' ' PHE . 2.8 m -109.34 144.79 37.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.845 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.01 108.39 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 111.844 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.41 ' CE1' HG22 ' C' ' 76' ' ' THR . 6.6 m-85 -91.44 107.11 18.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.332 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' C' ' 85' ' ' PHE . 29.9 m -102.14 149.94 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.137 0.494 . . . . 0.0 111.837 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.81 -6.36 49.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.858 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.13 111.91 3.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.488 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.22 -15.21 32.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.282 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -78.33 -19.51 53.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.767 0.318 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -90.64 7.26 40.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.372 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.431 ' CD1' HG12 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -82.32 -27.41 32.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 111.117 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.31 -36.67 76.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.162 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.41 -36.66 29.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.63 -30.47 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' C' ' 85' ' ' PHE . 9.9 m120 -67.16 -48.95 66.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.1 90.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.91 -23.91 55.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.248 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -81.71 -33.32 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.378 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.69 -29.72 18.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.651 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -75.88 -21.54 57.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.686 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -92.02 -33.18 14.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.795 0.331 . . . . 0.0 110.669 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 2.6 m-85 -59.03 -59.05 6.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.032 0.444 . . . . 0.0 110.124 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -31.5 72.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.279 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.53 -11.5 60.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.436 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 4.9 m-20 -110.93 -6.49 14.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.302 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 8.1 t-20 90.21 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.539 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' C' ' 69' ' ' ALA . 1.6 m-70 -115.37 53.38 0.84 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.0 Cg_endo -74.57 -14.61 22.2 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.514 2.143 . . . . 0.0 112.563 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -51.61 -33.27 32.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.125 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 61.5 96.45 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.016 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 60.2 Cg_endo -73.26 159.17 47.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.389 2.059 . . . . 0.0 112.293 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.77 147.64 18.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.65 142.47 45.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.034 0.445 . . . . 0.0 111.476 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 31.0 t -149.49 62.84 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.346 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 18.5 p -94.59 145.36 24.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.221 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 35.8 m -153.24 134.88 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.195 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 91.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.761 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 8.4 m -76.28 164.41 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.286 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.68 -44.81 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' B' ' 111' ' ' GLU . 0.1 OUTLIER -158.56 158.61 34.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.746 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . 0.438 ' HB3' ' HD2' ' C' ' 116' ' ' PRO . 0.9 OUTLIER -141.37 168.98 12.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.501 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' C' ' 115' ' ' LEU . 74.1 Cg_exo -50.19 136.88 38.37 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.37 2.047 . . . . 0.0 112.275 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.11 14.35 9.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.366 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.54 20.14 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.009 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -53.21 149.81 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.72 -15.13 76.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.794 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 41.9 mt -152.16 148.53 27.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -129.68 146.68 51.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.26 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 29.3 mm -120.18 150.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.064 0.459 . . . . 0.0 111.742 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.09 147.46 6.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.65 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -173.83 164.38 4.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.111 0.482 . . . . 0.0 112.119 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 5.6 mm -117.67 151.85 19.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.303 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.46 147.58 52.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 111.771 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.66 151.97 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.062 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' C' ' 67' ' ' LEU . 11.7 ttp180 -173.09 73.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.759 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.76 0.314 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.4 tpp -137.2 166.65 23.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.1 101.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.12 110.6 17.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 tp -54.99 129.66 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.192 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.1 mt -90.53 151.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.412 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.78 108.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.818 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.09 170.28 10.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.69 22.27 10.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.926 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.5 -37.96 6.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.638 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.407 ' CB ' ' CG1' ' A' ' 61' ' ' ILE . . . -100.46 127.87 31.73 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.058 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 7.8 Cg_exo -72.1 -1.67 10.41 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.668 2.246 . . . . 0.0 112.701 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.92 170.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.862 0.363 . . . . 0.0 111.586 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.27 119.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.115 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.4 HG22 HD12 ' A' ' 15' ' ' ILE . 13.5 mt -154.79 15.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.858 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.36 -114.64 0.5 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.974 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.434 ' HB2' ' CD1' ' C' ' 92' ' ' TYR . 92.8 Cg_endo -81.01 50.98 3.76 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.664 2.242 . . . . 0.0 112.981 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.472 ' CG ' ' HB2' ' C' ' 107' ' ' ARG . 1.7 p90 -178.7 156.84 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.0 111.002 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.435 HG11 ' O ' ' C' ' 103' ' ' ASN . 31.2 m -106.69 -174.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.174 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.68 -43.8 58.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.93 177.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.38 133.75 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -103.86 102.8 12.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.07 -17.88 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.16 -103.57 0.9 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.954 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.35 -29.11 63.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.086 0.47 . . . . 0.0 110.286 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.18 122.98 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.923 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.429 ' CG1' ' HB1' ' A' ' 127' ' ' ALA . 4.2 p -109.28 145.75 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.98 139.53 53.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.9 p -112.93 161.84 16.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.771 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.6 p -95.65 165.55 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.099 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.53 94.34 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.342 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.19 146.14 54.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.248 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 9.5 pt -134.46 142.08 41.44 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.794 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.51 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 7.8 Cg_exo -72.56 55.16 2.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.961 2.441 . . . . 0.0 113.138 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.418 ' HB ' ' CB ' ' A' ' 12' ' ' PRO . 20.5 t -62.05 85.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.241 0.544 . . . . 0.0 110.554 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 41' ' ' GLY . 12.6 t-20 -35.52 125.58 0.61 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.098 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.78 -7.75 21.73 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.108 1.872 . . . . 0.0 111.672 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.84 -28.09 13.3 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.653 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.445 ' CG2' ' HB3' ' A' ' 37' ' ' ASN . 4.7 t -128.84 -30.57 2.25 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.398 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 83.08 62.13 1.85 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.536 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.4 -81.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.674 0.273 . . . . 0.0 111.418 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 11.4 p -177.15 110.31 0.23 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.379 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.53 140.44 54.62 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.477 2.118 . . . . 0.0 112.422 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.64 -32.05 70.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 92.69 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.615 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mm -40.12 -32.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.373 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.87 -56.46 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.08 -28.74 70.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.772 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.407 ' HG3' HG21 ' A' ' 43' ' ' VAL . 3.0 tt0 -80.59 -28.83 37.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.675 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.28 -34.8 42.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.538 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -28.79 52.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.179 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.25 -48.17 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 110.838 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.65 -35.74 75.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.759 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -64.3 -54.76 28.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.15 -31.44 68.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -67.96 -33.84 75.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.791 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.95 -49.44 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -29.67 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.988 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.42 95.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.407 ' CG1' ' CB ' ' A' ' 11' ' ' ALA . 5.3 mt -72.39 -42.57 64.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.536 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.1 mt -69.15 -30.85 47.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.822 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.11 -40.79 59.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.328 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.73 -19.49 65.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.602 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.54 -26.81 19.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.47 41.59 0.67 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.529 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -155.28 147.11 23.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 110.669 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -101.49 -179.65 4.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.747 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB1' ' CE1' ' A' ' 101' ' ' HIS . . . -78.8 -23.07 45.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -62.98 -33.52 75.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' OD1' ' HB2' ' A' ' 127' ' ' ALA . 10.7 p30 -75.47 -21.76 57.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.71 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 26.4 mm -52.44 121.02 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.86 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 m -89.55 -32.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.013 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.11 165.67 21.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.571 0.224 . . . . 0.0 110.937 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.1 p -162.47 105.91 1.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.831 0.348 . . . . 0.0 111.544 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.423 HG22 ' CE1' ' A' ' 78' ' ' PHE . 4.6 m -91.92 155.34 18.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.158 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.93 103.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.911 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 76' ' ' THR . 10.8 m-85 -89.7 99.73 12.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.358 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 m -98.41 147.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.588 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.21 -3.71 50.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.231 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -160.98 142.24 11.78 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.627 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 mt -82.91 1.55 38.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.26 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -98.67 -24.3 15.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.824 0.345 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.81 -27.01 60.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.01 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -59.31 -18.65 39.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.58 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.28 -57.78 10.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 111.382 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.93 71.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 t -70.73 -41.27 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.981 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.11 -47.36 80.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.726 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.49 75.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -92.31 -15.95 26.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.685 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.428 ' CD1' ' HB2' ' B' ' 17' ' ' PRO . 12.4 t80 -81.66 -38.33 26.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.729 0.299 . . . . 0.0 111.281 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.0 -28.71 22.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.346 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.21 -21.81 59.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.649 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.505 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -92.07 -34.39 14.4 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.983 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.505 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 3.1 m-85 -57.3 -57.79 11.1 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.091 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.28 -29.81 70.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.097 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.92 -10.17 59.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.49 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.709 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 1.7 t-20 -108.57 -8.83 15.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.311 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 4.3 t30 88.96 33.24 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.445 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.709 ' CE1' ' HB3' ' A' ' 99' ' ' ASN . 4.2 m170 -116.83 54.35 1.31 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.842 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.22 -11.59 21.08 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.618 2.212 . . . . 0.0 112.823 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.431 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -47.96 -37.55 14.78 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 63.96 83.89 0.19 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.387 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.76 156.16 63.23 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.611 2.207 . . . . 0.0 112.018 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.38 162.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.572 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.469 ' HB2' ' CG ' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -133.01 143.74 49.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.22 0.534 . . . . 0.0 111.734 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 t -143.64 65.23 1.32 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.802 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.91 140.26 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.275 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' B' ' 78' ' ' PHE . 35.7 m -149.94 132.48 6.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.018 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.73 86.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.923 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.57 161.22 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.115 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.17 -45.81 25.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.57 168.08 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mp -142.7 160.62 52.95 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.708 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.75 136.03 27.89 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.486 2.124 . . . . 0.0 112.228 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm 64.39 16.73 10.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.319 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.72 17.76 9.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.913 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.2 m -53.31 122.52 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.302 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.32 -21.45 26.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.909 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mp -152.77 147.67 26.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.278 0.561 . . . . 0.0 111.53 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -139.21 151.48 46.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.407 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.8 pt -150.29 139.28 15.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.4 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 1.1 pm0 -138.74 142.94 38.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.053 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.62 172.6 14.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.4 mt -125.68 153.96 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.064 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.505 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . . . -135.4 152.96 51.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.035 0.445 . . . . 0.0 111.797 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.98 164.15 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.999 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -164.06 64.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.815 0.34 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 1.4 tpp -137.17 166.64 23.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.1 101.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.13 110.63 17.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.946 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 tp -55.02 129.66 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.22 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 31.4 mt -90.43 151.53 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.413 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.81 108.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.06 170.32 10.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.981 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.73 22.24 10.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.55 -38.05 6.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.645 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -100.32 127.88 31.91 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.05 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 7.7 Cg_exo -72.11 -1.67 10.42 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.618 2.212 . . . . 0.0 112.751 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.88 170.17 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.867 0.365 . . . . 0.0 111.544 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.18 119.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.053 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 13.3 mt -154.73 15.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.908 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.33 -114.66 0.5 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.977 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.428 ' HB2' ' CD1' ' A' ' 92' ' ' TYR . 92.5 Cg_endo -80.95 50.93 3.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.7 2.267 . . . . 0.0 112.992 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.469 ' CG ' ' HB2' ' A' ' 107' ' ' ARG . 1.7 p90 -178.69 156.81 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.9 0.381 . . . . 0.0 110.996 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 103' ' ' ASN . 30.8 m -106.69 -174.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.17 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.53 -43.54 59.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.06 177.46 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.37 133.78 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.146 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -103.93 102.84 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 11.9 mt -81.08 -17.93 48.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.2 -103.6 0.9 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.895 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.32 -29.1 63.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.088 0.471 . . . . 0.0 110.287 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.21 122.96 26.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.44 ' CG1' ' HB1' ' B' ' 127' ' ' ALA . 4.2 p -109.29 145.8 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.844 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.95 139.52 53.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.993 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 77.3 p -112.97 161.89 16.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.745 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 27.6 p -95.6 165.59 12.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.51 94.27 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.335 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.21 146.18 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' B' ' 35' ' ' PRO . 9.4 pt -134.5 142.06 41.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.815 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.501 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 7.9 Cg_exo -72.58 55.18 2.58 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.964 2.443 . . . . 0.0 113.146 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.419 ' HB ' ' CB ' ' B' ' 12' ' ' PRO . 20.5 t -61.99 85.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.585 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' B' ' 41' ' ' GLY . 12.6 t-20 -35.44 125.62 0.6 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.052 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.78 -7.8 21.84 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.148 1.898 . . . . 0.0 111.703 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.84 -28.04 13.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.703 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' THR . . . . . 0.446 ' CG2' ' HB3' ' B' ' 37' ' ' ASN . 4.7 t -128.86 -30.42 2.25 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.306 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 82.78 62.25 1.87 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.509 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.46 -81.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 0.0 111.435 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 11.5 p -177.15 110.36 0.23 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.341 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.65 140.45 55.82 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.46 2.107 . . . . 0.0 112.407 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.0 70.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.2 92.7 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.613 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 22.4 mm -40.16 -32.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.35 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.87 -56.43 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.749 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.05 -28.79 70.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.752 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.402 ' HG3' HG21 ' B' ' 43' ' ' VAL . 3.0 tt0 -80.4 -28.3 37.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.634 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.43 -34.86 41.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.535 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -28.84 52.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.169 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.24 -48.11 65.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.82 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -35.79 75.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.411 HD11 ' CE2' ' B' ' 95' ' ' PHE . 9.8 mt -64.24 -54.8 27.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.24 -31.31 68.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -68.04 -33.71 75.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.2 t -70.0 -49.39 56.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -29.7 65.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.937 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.49 95.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.822 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.41 ' CG1' ' CB ' ' B' ' 11' ' ' ALA . 5.3 mt -72.29 -42.51 65.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.532 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 21.1 mt -69.1 -30.92 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.815 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -75.16 -40.7 59.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.337 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.78 -19.51 65.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.56 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.49 -26.85 19.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.47 41.69 0.67 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.469 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -155.28 147.16 23.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 110.695 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -101.58 -179.73 4.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.719 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.554 ' HB1' ' CE1' ' B' ' 101' ' ' HIS . . . -78.75 -23.1 45.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 110.465 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.522 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -62.86 -33.55 75.52 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' B' ' 127' ' ' ALA . 10.6 p30 -75.35 -21.81 58.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.702 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 26.6 mm -52.54 121.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.79 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 m -89.61 -32.72 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.019 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.19 165.65 21.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.567 0.222 . . . . 0.0 110.916 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 6.1 p -162.43 105.9 1.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 111.523 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.423 HG22 ' CE1' ' B' ' 78' ' ' PHE . 4.6 m -91.89 155.4 18.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.219 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.97 103.15 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.834 0.349 . . . . 0.0 111.908 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' B' ' 76' ' ' THR . 10.9 m-85 -89.84 99.86 12.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.247 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 19.0 m -98.52 147.71 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.58 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.27 -3.7 50.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.222 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -161.03 142.26 11.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.646 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 mt -82.97 1.58 39.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.256 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -98.68 -24.21 15.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.85 -26.96 60.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -59.3 -18.73 40.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.586 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.23 -57.82 10.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.36 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.96 71.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.158 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.3 t -70.72 -41.29 77.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.99 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.16 -47.32 80.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.733 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.52 75.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -92.2 -15.98 26.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.667 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.433 ' CD1' ' HB2' ' C' ' 17' ' ' PRO . 12.5 t80 -81.65 -38.29 26.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.771 0.32 . . . . 0.0 111.314 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.02 -28.78 22.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.329 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.15 -21.81 59.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.695 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.489 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -92.07 -34.47 14.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.941 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.489 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 3.1 m-85 -57.31 -57.76 11.22 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.07 0.462 . . . . 0.0 110.092 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.29 -29.78 70.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.121 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.96 -10.16 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.476 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.712 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 1.7 t-20 -108.58 -8.79 15.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.34 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 4.3 t30 88.97 33.13 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.457 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 4.2 m170 -116.73 54.45 1.29 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.859 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.3 -11.62 20.95 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.68 2.253 . . . . 0.0 112.777 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.425 ' O ' HG11 ' C' ' 19' ' ' VAL . 0.1 OUTLIER -47.91 -37.59 14.56 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.941 0.4 . . . . 0.0 111.035 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 64.01 83.84 0.19 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.396 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.75 156.17 63.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.604 2.203 . . . . 0.0 112.022 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.36 162.55 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.519 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.463 ' HB2' ' CG ' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -133.07 143.71 49.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.178 0.513 . . . . 0.0 111.689 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.6 t -143.66 65.29 1.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.759 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.99 140.25 30.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.245 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . 0.408 HG12 ' CD2' ' C' ' 78' ' ' PHE . 35.8 m -150.01 132.54 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.984 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.71 86.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.84 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 6.8 m -72.43 161.2 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.18 -45.85 25.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.58 168.03 27.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mp -142.64 160.63 53.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.711 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.74 136.02 27.85 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.443 2.096 . . . . 0.0 112.259 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm 64.45 16.66 10.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.331 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.81 17.76 9.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.875 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 30.6 m -53.4 122.63 3.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.265 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.28 -21.71 27.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.894 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mp -152.6 147.58 26.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.268 0.556 . . . . 0.0 111.496 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -139.18 151.52 46.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.407 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 5.8 pt -150.29 139.23 15.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -138.73 142.98 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.041 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.61 172.62 14.74 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.69 154.04 34.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.008 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.502 ' HB2' ' OD1' ' B' ' 71' ' ' ASP . . . -135.39 153.03 51.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.016 0.436 . . . . 0.0 111.849 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.02 164.09 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -164.03 64.98 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.908 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.869 0.366 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 1.4 tpp -137.13 166.7 23.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.07 101.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.1 110.64 17.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 tp -55.01 129.66 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 31.2 mt -90.51 151.59 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.4 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.81 108.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.801 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.11 170.27 10.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.69 22.32 10.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.83 -38.3 6.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' C' ' 12' ' ' PRO . . . -99.92 127.96 32.25 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.115 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' C' ' 11' ' ' ALA . 7.8 Cg_exo -72.11 -1.75 10.53 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.653 2.235 . . . . 0.0 112.731 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.83 170.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.864 0.364 . . . . 0.0 111.592 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.18 119.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.088 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 mt -154.73 15.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.881 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.42 -114.73 0.51 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.929 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . 0.433 ' HB2' ' CD1' ' B' ' 92' ' ' TYR . 93.3 Cg_endo -80.97 51.0 3.76 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.647 2.231 . . . . 0.0 113.018 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.463 ' CG ' ' HB2' ' B' ' 107' ' ' ARG . 1.7 p90 -178.65 156.84 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.952 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.425 HG11 ' O ' ' B' ' 103' ' ' ASN . 30.9 m -106.72 -174.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.15 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.6 -43.49 59.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.956 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.95 177.6 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.088 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.42 133.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.149 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -103.97 102.68 12.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 mt -80.91 -17.94 48.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.109 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.22 -103.57 0.9 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.915 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.38 -29.04 63.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.084 0.468 . . . . 0.0 110.279 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.23 122.87 25.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.431 ' CG1' ' HB1' ' C' ' 127' ' ' ALA . 4.2 p -109.22 145.77 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.893 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.89 139.63 53.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 0.0 110.979 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 76.2 p -113.17 162.2 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.747 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 27.5 p -95.94 165.57 12.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.111 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.55 94.3 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.325 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.19 146.16 54.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 9.5 pt -134.47 142.06 41.37 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.847 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.508 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 7.9 Cg_exo -72.54 55.2 2.56 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.939 2.426 . . . . 0.0 113.138 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' C' ' 34' ' ' ILE . 20.6 t -62.03 85.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.194 0.521 . . . . 0.0 110.513 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' C' ' 41' ' ' GLY . 12.6 t-20 -35.47 125.53 0.61 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.1 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.74 -7.83 21.91 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.141 1.894 . . . . 0.0 111.626 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.82 -28.07 13.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.678 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' THR . . . . . 0.45 ' CG2' ' HB3' ' C' ' 37' ' ' ASN . 4.7 t -128.95 -30.69 2.21 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.342 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 83.25 62.19 1.83 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.569 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.47 -81.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.685 0.278 . . . . 0.0 111.4 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 11.4 p -177.12 110.37 0.23 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.324 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.59 140.45 55.26 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.488 2.125 . . . . 0.0 112.443 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.74 -32.01 70.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 92.77 0.12 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.635 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mm -40.23 -32.4 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.351 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.86 -56.45 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.71 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.1 -28.71 70.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.773 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.418 ' HG3' HG21 ' C' ' 43' ' ' VAL . 3.0 tt0 -80.54 -28.77 37.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.626 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.19 -34.82 42.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.581 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -28.86 52.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.181 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.24 -48.11 65.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.836 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -35.72 75.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.28 -54.79 27.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.925 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.19 -31.4 68.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -67.97 -33.8 75.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.828 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.91 -49.47 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -29.8 65.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.67 -41.25 94.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 5.3 mt -72.51 -42.58 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.574 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 21.0 mt -69.13 -30.85 47.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.852 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.19 -40.67 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.923 0.392 . . . . 0.0 110.335 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -19.44 65.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.531 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.52 -26.86 19.54 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.907 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.49 41.64 0.67 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.512 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 18.5 mt -155.29 147.1 23.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.661 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -101.47 -179.74 4.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.556 ' HB1' ' CE1' ' C' ' 101' ' ' HIS . . . -78.72 -23.06 45.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.789 0.328 . . . . 0.0 110.49 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.523 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -62.98 -33.37 75.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' C' ' 127' ' ' ALA . 10.7 p30 -75.81 -21.64 57.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 26.4 mm -52.53 121.12 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.848 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 m -89.68 -32.7 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.013 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.25 165.62 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.576 0.227 . . . . 0.0 110.888 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 6.1 p -162.44 105.84 1.13 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.811 0.338 . . . . 0.0 111.559 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.427 HG22 ' CE1' ' C' ' 78' ' ' PHE . 4.6 m -91.87 155.39 18.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.177 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 21.1 t -151.02 103.12 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.909 0.385 . . . . 0.0 111.935 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' C' ' 76' ' ' THR . 10.9 m-85 -89.78 99.82 12.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.301 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 19.0 m -98.49 147.72 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.527 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.21 -3.43 49.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.176 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -161.27 142.17 11.29 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.639 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 mt -82.92 1.61 38.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.233 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -98.66 -24.21 15.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.768 0.318 . . . . 0.0 110.9 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.86 -27.01 60.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.034 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -59.35 -18.6 39.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.619 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.35 -57.81 10.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 111.338 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.0 71.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 t -70.77 -41.19 77.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.17 -47.36 80.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.704 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.42 75.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.298 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -92.28 -15.88 26.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.721 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.434 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 12.5 t80 -81.71 -38.33 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.307 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.05 -28.68 22.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.333 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.15 -21.89 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.69 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.497 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.98 -34.49 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.972 -179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.497 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 3.1 m-85 -57.23 -57.79 11.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 110.13 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.25 -29.83 70.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.128 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.98 -10.09 59.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.489 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.717 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 1.7 t-20 -108.67 -8.8 15.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.29 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 4.3 t30 89.0 33.3 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.454 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.717 ' CE1' ' HB3' ' C' ' 99' ' ' ASN . 4.2 m170 -116.97 54.48 1.37 Allowed Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.84 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -75.32 -11.62 20.91 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.646 2.23 . . . . 0.0 112.761 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . 0.435 ' O ' HG11 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -47.91 -37.52 14.44 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.876 0.37 . . . . 0.0 111.089 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 63.93 83.84 0.19 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.41 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 33.8 Cg_endo -64.64 156.15 62.82 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.618 2.212 . . . . 0.0 112.076 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.44 162.6 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.567 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.472 ' HB2' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -133.14 143.74 49.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.185 0.516 . . . . 0.0 111.681 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.6 t -143.63 65.23 1.32 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.787 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.88 140.29 29.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.306 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 35.7 m -150.11 132.55 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.044 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.59 86.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.48 161.21 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.188 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.2 -45.79 25.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.114 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.61 168.12 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mp -142.73 160.62 52.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.693 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.76 136.06 27.92 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.41 2.073 . . . . 0.0 112.273 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm 64.46 16.65 10.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.286 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.74 17.85 9.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.879 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -53.41 122.54 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.264 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.14 -21.53 25.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.905 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mp -152.56 147.58 26.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.321 0.582 . . . . 0.0 111.489 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -139.23 151.5 46.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.394 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 5.8 pt -150.28 139.22 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 1.1 pm0 -138.72 142.98 38.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.06 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.6 172.62 14.74 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 9.4 mt -125.69 154.05 34.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.046 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.503 ' HB2' ' OD1' ' C' ' 71' ' ' ASP . . . -135.46 153.16 51.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.001 0.429 . . . . 0.0 111.834 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.12 164.16 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.0 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -164.07 64.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.785 0.326 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.2 mtm -123.02 55.15 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.34 135.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.41 131.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -59.0 155.13 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.444 HD13 HG23 ' A' ' 6' ' ' ILE . 31.3 mt -121.13 133.61 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.33 149.19 28.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.3 t -150.84 165.59 33.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.946 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.89 25.56 5.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -110.06 -50.97 2.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.13 114.03 50.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.58 -12.53 36.19 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.358 2.038 . . . . 0.0 112.621 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.83 -169.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.527 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 62.18 -169.42 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.25 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 mt 77.17 17.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.228 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.11 -127.96 2.92 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.245 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -87.44 33.91 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.759 2.306 . . . . 0.0 112.861 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.527 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -175.87 156.8 1.85 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.025 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -92.26 152.6 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.06 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.93 -36.51 70.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.409 . . . . 0.0 110.451 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.31 163.13 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.941 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.15 136.88 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.878 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -110.25 120.43 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.231 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.53 -20.68 22.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.916 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.12 -108.66 0.77 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.672 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -60.38 -29.2 68.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.126 0.489 . . . . 0.0 110.067 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -126.44 115.2 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.811 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -105.37 176.24 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.197 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 mp -150.53 161.66 42.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.4 p -126.16 159.21 33.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.074 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -95.06 168.07 10.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.196 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.09 94.74 0.1 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.263 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -73.6 165.73 24.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.909 0.385 . . . . 0.0 111.19 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 pt -149.93 143.05 16.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.015 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 73.7 Cg_endo -75.05 59.38 5.21 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.794 2.33 . . . . 0.0 112.875 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG13 ' HA2' ' A' ' 41' ' ' GLY . 46.3 t -65.04 84.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.263 0.554 . . . . 0.0 110.643 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 41' ' ' GLY . 28.3 t30 -41.01 135.53 1.67 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.994 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.04 -5.91 16.81 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.222 1.948 . . . . 0.0 111.822 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.12 -28.45 9.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.349 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 37' ' ' ASN . 65.6 p -115.81 -29.26 6.45 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.865 0.364 . . . . 0.0 110.829 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 75.76 55.77 4.81 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.543 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.28 -79.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.639 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 11.2 p -159.16 123.32 2.12 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.412 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 31.8 Cg_exo -58.26 150.18 68.27 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.388 2.059 . . . . 0.0 112.035 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.47 -30.79 68.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.978 0.418 . . . . 0.0 110.893 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.51 97.45 1.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.2 tp -42.14 -32.22 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.767 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -48.62 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.04 93.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.752 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.401 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -70.01 -30.85 68.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.583 179.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.34 -37.49 71.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.196 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -78.95 -35.62 42.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.92 -36.08 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.81 -31.67 61.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.752 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.6 mt -72.74 -36.28 67.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.8 -44.31 73.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -58.68 -46.57 86.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.72 -31.85 50.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.96 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -80.61 -32.51 36.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.14 -35.98 80.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 mt -69.7 -45.24 78.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.485 ' CG2' ' HB3' ' A' ' 67' ' ' LEU . 11.0 mt -65.75 -35.28 74.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.458 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.94 75.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.327 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -21.42 63.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.422 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.45 -28.31 20.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.71 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.92 54.44 0.35 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.615 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 158.01 23.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.878 0.37 . . . . 0.0 110.671 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -115.33 156.85 24.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.161 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 72' ' ' ILE . . . -57.97 -35.91 71.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.057 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.64 -26.74 5.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.455 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' HB2' HD21 ' A' ' 67' ' ' LEU . 4.7 m-20 -85.5 -18.67 32.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.297 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -54.5 117.89 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.506 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.13 -33.73 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.92 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 125' ' ' ALA . 4.2 tttm -128.32 169.77 13.84 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -169.93 112.97 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.875 0.369 . . . . 0.0 111.409 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.7 m -99.96 151.77 20.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.173 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.0 m -146.48 128.85 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 111.929 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -107.6 129.68 54.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.144 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.8 149.5 27.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.463 . . . . 0.0 111.721 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -88.41 -4.2 58.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.781 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -160.57 115.55 2.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.384 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.38 -11.23 50.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.088 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -80.83 -19.06 45.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.779 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -87.02 -19.53 28.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.07 -20.93 43.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.31 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.73 -39.2 65.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 111.283 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.54 -29.25 21.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.0 t -72.39 -44.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.31 -42.36 93.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.615 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.4 73.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -27.52 19.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.515 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.43 ' O ' ' CD2' ' A' ' 96' ' ' PHE . 68.6 t80 -54.08 -49.03 69.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.891 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.6 -27.44 25.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.54 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.23 -20.24 60.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.619 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.3 OUTLIER -90.14 -38.84 13.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.933 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.452 ' HB3' ' O ' ' A' ' 101' ' ' HIS . 14.6 m-85 -55.61 -58.81 6.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.604 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -64.74 -28.15 69.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.704 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -72.88 -13.58 61.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.317 . . . . 0.0 110.883 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 58.7 m-80 -111.18 -10.75 14.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.472 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.4 p-10 99.56 33.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.907 0.754 . . . . 0.0 111.004 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.493 ' CE1' ' HB3' ' A' ' 99' ' ' ASN . 1.2 m-70 -115.11 56.43 0.98 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.552 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 54.4 Cg_endo -68.64 -15.14 40.84 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.659 2.239 . . . . 0.0 113.363 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 3.1 m-20 -53.86 -43.19 69.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.913 0.387 . . . . 0.0 110.606 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 30.4 m-85 71.85 84.13 0.13 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.959 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 19.1 Cg_endo -59.25 155.67 39.14 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.772 2.314 . . . . 0.0 112.327 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.39 158.16 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.234 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.415 ' NH1' ' CG ' ' B' ' 18' ' ' TYR . 2.9 ttp-105 -134.66 141.38 46.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.131 0.491 . . . . 0.0 111.854 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.42 66.12 1.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.064 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 28.0 p -79.49 130.88 35.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.188 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.5 m -148.82 144.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.981 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -86.68 94.6 9.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.817 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 36.0 m -73.49 159.9 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.94 -37.13 72.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.406 ' CB ' ' HB3' ' C' ' 111' ' ' GLU . 0.0 OUTLIER -160.84 166.96 27.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.976 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 mt -143.39 155.71 60.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.673 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.34 135.85 70.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.563 2.175 . . . . 0.0 112.018 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? 69.62 20.36 7.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.18 26.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.118 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.1 m -55.66 174.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.206 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.04 -15.13 43.14 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.569 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -172.49 148.88 2.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.046 0.45 . . . . 0.0 111.168 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -116.4 167.25 11.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.322 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.9 mm -141.88 131.87 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.206 0.527 . . . . 0.0 112.196 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.53 117.75 4.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.204 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 74' ' ' LYS . . . -140.3 176.03 9.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.7 mt -119.88 154.69 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.038 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.447 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -139.37 150.75 45.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.908 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.1 126.67 71.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.402 ' CB ' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -94.93 43.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.042 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.928 179.876 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.815 0.34 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 3.2 mtm -122.98 55.25 1.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.809 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.4 135.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.49 131.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -58.96 155.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.414 HG23 HD13 ' B' ' 6' ' ' ILE . 31.6 mt -121.23 133.67 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.34 149.19 28.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.789 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.3 t -150.85 165.56 33.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.92 25.62 5.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.014 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -110.13 -50.88 2.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.677 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.16 114.04 50.14 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.966 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.66 -12.5 36.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.35 2.034 . . . . 0.0 112.595 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.74 -169.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.534 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 62.18 -169.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.196 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 mt 77.19 17.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.22 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.06 -127.91 2.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.225 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.51 33.94 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 112.892 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.534 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -175.85 156.78 1.85 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.85 0.357 . . . . 0.0 110.999 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -92.27 152.59 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.064 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.88 -36.52 70.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 110.492 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.58 163.15 2.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.037 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.13 136.95 58.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.835 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -110.3 120.48 42.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.219 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.5 -20.77 22.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.18 -108.79 0.78 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.64 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -60.26 -29.32 68.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.04 0.448 . . . . 0.0 109.998 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 7.3 mp -126.37 115.15 19.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.795 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' B' ' 127' ' ' ALA . 0.9 OUTLIER -105.28 176.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.198 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 mp -150.48 161.68 42.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.933 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.8 p -126.1 158.89 34.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.033 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.6 m -94.6 168.14 11.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.037 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.13 94.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.293 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -73.59 165.81 24.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 111.16 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 pt -150.03 143.03 16.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.992 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 73.7 Cg_endo -75.03 59.38 5.19 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.755 2.304 . . . . 0.0 112.898 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.416 HG13 ' HA2' ' B' ' 41' ' ' GLY . 46.3 t -65.03 84.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.297 0.57 . . . . 0.0 110.627 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' B' ' 40' ' ' THR . 28.3 t30 -40.99 135.54 1.66 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.997 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.04 -5.96 16.85 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.244 1.963 . . . . 0.0 111.823 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.1 -28.35 9.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.36 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' B' ' 37' ' ' ASN . 66.5 p -115.96 -29.41 6.35 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.827 0.346 . . . . 0.0 110.788 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 75.88 55.79 4.75 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.61 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.21 -79.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.687 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 11.1 p -159.1 123.36 2.14 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.388 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' B' ' 50' ' ' GLN . 31.3 Cg_exo -58.34 150.18 68.94 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.373 2.049 . . . . 0.0 112.036 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.5 -30.69 68.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.026 0.441 . . . . 0.0 110.921 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.55 97.43 1.68 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.829 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 9.1 tp -42.02 -32.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.756 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.22 -48.67 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.827 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.11 93.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.768 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.403 ' CB ' ' HD2' ' B' ' 44' ' ' PRO . 0.9 OUTLIER -69.97 -30.91 68.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.562 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.41 -37.57 71.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.257 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -79.01 -35.7 42.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -36.16 73.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.78 -31.78 61.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 34.9 mt -72.69 -36.24 67.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.86 -44.25 73.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -58.71 -46.56 87.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.73 -31.87 50.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.949 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -80.66 -32.48 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.95 -35.95 81.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 mt -69.77 -45.21 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.838 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.48 ' CG2' ' HB3' ' B' ' 67' ' ' LEU . 11.0 mt -65.75 -35.34 74.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.47 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 -42.94 76.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.303 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -21.47 63.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.403 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.51 -28.2 20.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.698 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.85 54.42 0.36 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.649 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.48 ' HB3' ' CG2' ' B' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 157.96 23.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.84 0.353 . . . . 0.0 110.672 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -115.29 156.92 24.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.222 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.507 ' HA ' HD12 ' B' ' 72' ' ' ILE . . . -58.06 -35.86 71.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.051 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -26.75 5.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.413 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.417 ' HB3' HD23 ' B' ' 67' ' ' LEU . 4.7 m-20 -85.49 -18.68 32.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.361 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' B' ' 69' ' ' ALA . 0.5 OUTLIER -54.51 117.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 110.556 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 28.7 m -88.17 -33.7 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.876 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' B' ' 125' ' ' ALA . 4.2 tttm -128.32 169.83 13.78 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.79 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -170.02 112.86 0.47 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.86 0.362 . . . . 0.0 111.378 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -99.9 151.84 20.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.147 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 m -146.57 128.85 7.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.017 0.437 . . . . 0.0 111.901 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -107.58 129.68 54.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.125 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.8 149.49 27.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.065 0.46 . . . . 0.0 111.774 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -88.45 -4.4 58.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.735 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.48 115.51 2.24 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.387 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mt -66.33 -11.28 50.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -80.8 -19.08 45.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -86.98 -19.57 28.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.172 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.08 -20.9 43.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.339 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.27 65.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.817 0.341 . . . . 0.0 111.289 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.51 -29.19 21.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 28.5 t -72.37 -44.94 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.36 -42.35 92.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.559 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.41 73.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -27.52 18.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.517 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.433 ' O ' ' CD2' ' B' ' 96' ' ' PHE . 68.6 t80 -54.06 -49.13 69.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.885 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.54 -27.45 25.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.54 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.16 -20.26 60.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.648 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.498 ' C ' ' CD1' ' B' ' 95' ' ' PHE . 0.3 OUTLIER -90.13 -38.86 13.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.0 110.932 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' B' ' 101' ' ' HIS . 14.8 m-85 -55.55 -58.88 5.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.584 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -64.75 -28.11 69.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.743 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -72.87 -13.59 61.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 110.919 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 58.8 m-80 -111.13 -10.83 14.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.482 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 2.3 p-10 99.57 33.26 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.832 0.707 . . . . 0.0 110.99 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.5 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 1.2 m-70 -115.01 56.36 0.94 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.553 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.401 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 53.8 Cg_endo -68.65 -15.17 40.85 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 113.335 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 3.1 m-20 -53.91 -43.08 69.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.62 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 30.3 m-85 71.77 84.15 0.13 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.966 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 19.1 Cg_endo -59.22 155.67 39.0 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.749 2.299 . . . . 0.0 112.358 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.32 158.34 0.84 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.291 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.424 ' NH1' ' CG ' ' C' ' 18' ' ' TYR . 2.9 ttp-105 -134.84 141.31 46.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.13 0.491 . . . . 0.0 111.838 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.39 66.03 1.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.11 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 28.0 p -79.42 130.89 35.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.18 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 20.9 m -148.79 143.91 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.982 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -86.45 94.33 9.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.744 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 35.8 m -73.29 159.87 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.12 72.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.87 166.91 27.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.004 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 mt -143.33 155.73 61.08 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.41 135.83 70.94 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.578 2.186 . . . . 0.0 112.031 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? 69.69 20.31 6.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.975 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.19 26.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 m -55.78 174.49 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.08 -15.58 41.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.554 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' B' ' 121' ' ' LEU . 0.0 OUTLIER -172.09 148.74 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 111.184 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -116.4 167.23 11.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.264 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 22.6 mm -141.91 131.85 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.188 0.518 . . . . 0.0 112.219 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.57 117.69 4.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.166 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' B' ' 74' ' ' LYS . . . -140.22 176.05 9.08 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 6.7 mt -119.86 154.68 22.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.072 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.443 ' HB3' HG21 ' B' ' 28' ' ' VAL . . . -139.36 150.82 45.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.833 0.349 . . . . 0.0 111.902 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.22 126.66 71.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.85 43.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.07 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.922 179.867 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 3.2 mtm -122.99 55.13 1.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.37 135.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.42 131.19 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mm -58.94 155.15 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.479 HD13 HG23 ' C' ' 6' ' ' ILE . 31.3 mt -121.25 133.55 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.25 149.17 28.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.84 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 11.3 t -150.83 165.6 33.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.951 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.93 25.62 5.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.028 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -110.11 -51.18 2.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.662 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.84 114.15 50.27 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.902 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.53 -12.57 36.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.369 2.046 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -169.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.533 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 62.24 -169.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.186 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 mt 77.2 17.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.191 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.09 -128.0 2.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.23 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.4 33.88 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.728 2.285 . . . . 0.0 112.918 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.533 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -175.82 156.83 1.87 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.91 0.386 . . . . 0.0 110.987 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -92.29 152.59 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.048 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -36.54 70.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.439 . . . . 0.0 110.573 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.26 163.09 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.934 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.07 136.92 58.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -110.31 120.49 42.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.201 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.57 -20.66 22.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.1 -108.67 0.77 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.664 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -60.42 -29.22 68.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.147 0.498 . . . . 0.0 110.072 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 7.3 mp -126.42 115.15 19.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.795 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' C' ' 127' ' ' ALA . 0.9 OUTLIER -105.31 176.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.203 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 mp -150.56 161.64 42.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.3 p -126.22 158.99 34.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.006 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -94.64 167.99 11.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.1 94.8 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.251 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -73.59 165.78 24.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.204 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 pt -149.98 143.06 16.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.993 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.415 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 73.6 Cg_endo -75.01 59.31 5.16 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.782 2.321 . . . . 0.0 112.941 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . 0.404 HG13 ' HA2' ' C' ' 41' ' ' GLY . 46.4 t -64.98 84.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.222 0.534 . . . . 0.0 110.612 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.45 ' HB3' ' OG1' ' C' ' 40' ' ' THR . 28.2 t30 -40.99 135.5 1.66 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.989 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.99 -5.95 16.88 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.255 1.97 . . . . 0.0 111.816 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.17 -28.29 9.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.347 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' C' ' 37' ' ' ASN . 65.7 p -115.94 -29.37 6.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.87 0.367 . . . . 0.0 110.85 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 75.88 55.78 4.75 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.599 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.29 -79.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.644 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 11.3 p -159.12 123.38 2.14 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.464 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' C' ' 35' ' ' PRO . 31.2 Cg_exo -58.42 150.21 69.42 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.355 2.037 . . . . 0.0 112.016 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.5 -30.7 68.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.034 0.445 . . . . 0.0 110.9 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.51 97.41 1.66 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 9.2 tp -42.17 -32.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.754 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -48.68 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.791 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.09 93.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.789 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -30.88 68.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.627 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.54 -37.63 71.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.192 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -79.0 -35.6 42.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -36.13 73.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.89 -31.68 61.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.694 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 34.8 mt -72.74 -36.3 67.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.789 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.75 -44.27 74.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.951 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -58.71 -46.56 87.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.72 -31.93 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -80.61 -32.44 36.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.02 -35.94 81.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.023 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.7 -45.32 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . 0.486 ' CG2' ' HB3' ' C' ' 67' ' ' LEU . 10.9 mt -65.66 -35.32 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.9 75.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -21.54 63.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.409 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.43 -28.26 21.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.692 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.9 54.43 0.35 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.578 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.486 ' HB3' ' CG2' ' C' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 157.96 23.84 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.632 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -115.37 156.88 24.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.188 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' C' ' 72' ' ' ILE . . . -58.05 -35.84 71.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.065 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -26.62 5.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.448 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . 0.423 ' HB2' HD21 ' C' ' 67' ' ' LEU . 4.7 m-20 -85.64 -18.69 32.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.323 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' C' ' 69' ' ' ALA . 0.5 OUTLIER -54.49 117.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.521 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 28.4 m -88.16 -33.73 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.874 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' C' ' 125' ' ' ALA . 4.2 tttm -128.27 169.75 13.84 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.811 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -169.95 112.94 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.852 0.358 . . . . 0.0 111.442 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -99.96 151.83 20.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.159 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 5.0 m -146.49 128.86 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.935 0.398 . . . . 0.0 112.004 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -107.65 129.64 54.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.143 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.83 149.5 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.026 0.441 . . . . 0.0 111.772 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -88.46 -4.53 58.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.773 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.21 115.44 2.31 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.384 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.35 -11.25 50.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.126 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -80.79 -19.1 45.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.817 0.342 . . . . 0.0 110.83 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -86.98 -19.55 28.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.223 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.07 -20.91 43.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.342 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.72 -39.2 65.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.837 0.351 . . . . 0.0 111.315 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -29.2 21.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.962 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 29.3 t -72.39 -45.01 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.32 -42.37 93.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.561 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.52 73.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.974 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -27.49 19.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.494 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.427 ' O ' ' CD2' ' C' ' 96' ' ' PHE . 68.8 t80 -54.08 -49.04 69.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.892 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.6 -27.47 25.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.542 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.16 -20.29 60.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.604 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.501 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 0.3 OUTLIER -90.19 -38.77 13.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.826 0.346 . . . . 0.0 110.954 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' C' ' 101' ' ' HIS . 14.7 m-85 -55.58 -58.85 6.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -64.7 -28.22 69.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.684 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -72.86 -13.54 61.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.783 0.325 . . . . 0.0 110.94 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.511 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 58.9 m-80 -111.11 -10.93 14.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.476 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 2.4 p-10 99.66 33.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.524 0.73 . . . . 0.0 110.95 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.498 ' CE1' ' HB3' ' C' ' 99' ' ' ASN . 1.2 m-70 -115.13 56.3 0.98 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.581 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . 0.404 ' O ' ' CD2' ' C' ' 104' ' ' PHE . 53.9 Cg_endo -68.6 -15.21 41.06 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.659 2.239 . . . . 0.0 113.35 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 3.1 m-20 -53.81 -43.14 69.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 110.601 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 30.4 m-85 71.8 84.12 0.13 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.988 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 19.0 Cg_endo -59.23 155.72 38.78 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.768 2.312 . . . . 0.0 112.298 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.4 158.1 0.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.253 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.428 ' NH1' ' CG ' ' A' ' 18' ' ' TYR . 2.9 ttp-105 -134.65 141.37 46.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.107 0.479 . . . . 0.0 111.827 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.42 66.11 1.47 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.063 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 28.0 p -79.45 130.87 35.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.18 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 20.6 m -148.9 144.74 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.053 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . 0.406 ' HB3' ' CB ' ' A' ' 114' ' ' ARG . 2.3 tt0 -87.02 94.51 9.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.76 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 36.0 m -73.43 159.89 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.171 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.97 -37.08 72.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.069 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.88 166.9 27.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.036 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 mt -143.35 155.72 61.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.743 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.39 135.91 71.26 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.577 2.184 . . . . 0.0 111.979 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? 69.6 20.38 7.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.938 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.16 26.31 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.095 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.9 m -55.67 174.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.246 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.12 -15.22 42.55 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.537 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' C' ' 121' ' ' LEU . 0.0 OUTLIER -172.18 148.74 2.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.993 0.425 . . . . 0.0 111.204 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -116.33 167.31 11.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.289 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mm -141.99 131.8 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.208 0.527 . . . . 0.0 112.177 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.52 117.75 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.166 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' C' ' 74' ' ' LYS . . . -140.28 176.03 9.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 6.7 mt -119.85 154.67 22.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.038 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.435 ' HB3' HG21 ' C' ' 28' ' ' VAL . . . -139.4 150.79 45.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.839 0.352 . . . . 0.0 111.884 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.14 126.69 71.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.092 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . 0.401 ' CB ' HD12 ' C' ' 67' ' ' LEU . 0.4 OUTLIER -94.89 43.5 1.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.095 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.935 179.867 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.869 0.366 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.23 168.49 19.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.8 m -165.16 116.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.542 ' HA ' ' N ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 6' ' ' ILE . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' C' ' 107' ' ' ARG . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.45 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.542 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.0 m120 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.9 t -63.02 85.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 41' ' ' GLY . 36.7 t-20 -35.11 129.88 0.5 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.989 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.53 -10.59 29.14 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 112.178 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.5 -21.36 8.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.68 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 m -114.75 -25.2 8.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 63.67 56.06 21.4 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.323 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.27 -81.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.704 0.288 . . . . 0.0 111.625 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 9.2 p -173.89 106.83 0.3 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 21' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' CB ' ' CE1' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.519 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' HG13 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.42 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.513 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CE1' ' CB ' ' A' ' 69' ' ' ALA . 3.3 m170 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' B' ' 17' ' ' PRO . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.439 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.425 HG13 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 123' ' ' ILE . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -164.77 46.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.832 0.349 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.24 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 19.0 m -165.18 116.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.538 ' HA ' ' N ' ' B' ' 23' ' ' ASP . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.449 HG23 HD12 ' B' ' 6' ' ' ILE . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.45 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.538 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' B' ' 35' ' ' PRO . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 t -63.01 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' B' ' 41' ' ' GLY . 36.6 t-20 -35.14 129.93 0.51 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.935 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.58 -10.63 29.2 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.023 . . . . 0.0 112.192 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.4 -21.41 8.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.78 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 3.5 m -114.77 -25.32 8.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 63.81 56.13 20.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.357 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.36 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.623 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 9.3 p -173.94 106.72 0.3 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' B' ' 21' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.521 ' CB ' ' CE1' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.484 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' B' ' 69' ' ' ALA . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.516 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.425 ' CD2' HG13 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.514 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.521 ' CE1' ' CB ' ' B' ' 69' ' ' ALA . 3.4 m170 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.416 ' CD1' ' HA ' ' C' ' 17' ' ' PRO . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.425 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . 0.429 HG13 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.451 HG21 HD13 ' B' ' 123' ' ' ILE . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -164.83 46.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.951 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.21 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 19.0 m -165.22 116.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.537 ' HA ' ' N ' ' C' ' 23' ' ' ASP . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.451 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . 0.416 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' B' ' 107' ' ' ARG . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.452 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . 0.486 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.401 HG23 ' CB ' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 32.8 t -63.06 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' C' ' 41' ' ' GLY . 36.7 t-20 -35.13 129.94 0.51 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.56 -10.6 29.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.31 2.007 . . . . 0.0 112.18 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.44 -21.43 8.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.729 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 3.5 m -114.8 -25.24 8.32 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 63.64 56.1 21.27 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.395 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.26 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.61 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 9.3 p -173.93 106.74 0.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.365 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.404 HD21 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' C' ' 21' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.518 ' CB ' ' CE1' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.476 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.515 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.429 ' CD2' HG13 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' C' ' 95' ' ' PHE . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.521 ' NE2' ' HB3' ' C' ' 99' ' ' ASN . 3.3 m170 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 17' ' ' PRO . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.418 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 123' ' ' ILE . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.855 0.359 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -172.57 4.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 61.7 113.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 132.97 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -55.2 152.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mt -103.43 139.26 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.137 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.58 117.18 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.7 t -133.88 165.99 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.33 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -121.62 -36.89 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.032 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.516 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . . . -67.82 172.05 4.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 11' ' ' ALA . 18.9 Cg_endo -59.39 -16.05 33.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.695 2.263 . . . . 0.0 112.85 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.24 151.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 111.317 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.67 120.71 41.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -133.51 15.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.072 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.85 -146.17 4.73 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.987 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' C' ' 104' ' ' PHE . 93.9 Cg_endo -87.39 44.53 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.536 2.158 . . . . 0.0 112.901 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.19 154.59 17.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.867 0.365 . . . . 0.0 111.033 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -110.91 169.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.284 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -58.96 -53.53 57.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.69 -177.09 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 m -142.33 132.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.166 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -103.47 105.01 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.51 -16.36 54.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.371 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.05 -104.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.28 -29.62 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.166 0.508 . . . . 0.0 110.21 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.2 140.65 45.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.435 ' CG1' ' CB ' ' A' ' 127' ' ' ALA . 9.9 p -120.04 160.88 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.123 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mp -145.87 127.37 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 p -106.5 136.11 46.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.983 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 t -59.36 179.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.07 95.55 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.244 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.433 ' HG2' ' CG2' ' A' ' 58' ' ' VAL . 2.9 mp0 -62.07 138.14 58.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.275 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.5 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -146.04 170.18 8.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.679 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -54.26 -137.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.313 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t 74.12 73.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.411 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 41' ' ' GLY . 2.1 t-20 -34.93 115.62 0.52 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.978 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.65 -13.68 11.46 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.339 2.026 . . . . 0.0 112.144 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.81 27.87 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.086 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.0 t -161.6 -33.37 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.908 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 96.92 66.2 0.92 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.847 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.73 -53.38 5.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.369 . . . . 0.0 111.276 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t 68.96 72.52 0.34 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.81 140.71 81.58 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.592 2.195 . . . . 0.0 112.433 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.37 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.4 93.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.791 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.9 mm -38.93 -33.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.5 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.08 -48.07 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.696 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.82 -55.04 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.498 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.93 -44.36 63.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -63.33 -51.54 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.79 -31.18 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.445 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 1.3 m -68.31 -46.48 70.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.29 -26.36 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.971 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -57.95 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.108 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.8 OUTLIER -54.88 -30.36 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.985 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.433 ' CG2' ' HG2' ' A' ' 33' ' ' GLN . 39.6 t -62.1 -34.54 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 110.517 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.99 -31.75 34.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.755 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.55 89.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.1 mt -70.93 -46.2 69.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.667 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.8 -32.62 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.28 -38.4 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.9 -24.33 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.145 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.71 -22.11 21.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.914 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.43 64.8 0.83 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -158.9 139.2 12.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.028 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 44.0 p -96.12 145.0 25.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.29 -31.75 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.518 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -59.77 -18.48 43.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 68' ' ' THR . 3.2 p-10 -88.58 -21.27 24.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 64.3 mt -59.35 109.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.414 ' CG1' HG22 ' A' ' 128' ' ' VAL . 2.8 m -81.11 -36.84 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.971 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.452 ' HB3' ' CD ' ' A' ' 107' ' ' ARG . 8.6 mtmt -130.55 175.23 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.319 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.539 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 13.4 t 177.71 110.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 111.36 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.489 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -70.18 130.1 41.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.33 91.6 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CZ ' ' HB ' ' A' ' 76' ' ' THR . 5.3 m-85 -91.7 143.77 26.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.089 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 35.3 m -139.31 150.0 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.023 0.44 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.95 -4.31 56.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.796 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.04 108.99 0.46 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -17.25 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.97 -24.64 59.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 110.282 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.46 -15.34 58.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.832 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 0.3 OUTLIER -55.52 -22.98 23.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.01 -46.63 84.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 -33.22 19.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.6 t -70.08 -49.66 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.673 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.417 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 36.4 t-20 -63.09 -35.99 82.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.14 94.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.016 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.62 -31.1 19.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.448 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 48.7 t80 -57.67 -51.35 69.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.727 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 7.7 tt0 -73.32 -27.34 61.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -25.11 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.765 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -79.31 -41.02 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.934 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 95' ' ' PHE . 57.1 m-85 -56.45 -50.43 71.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.8 69.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.77 58.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.402 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -110.54 -6.88 14.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 11.7 m-20 89.68 30.9 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 19.9 t-160 -127.57 72.17 77.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.96 -11.04 16.65 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.539 2.159 . . . . 0.0 112.153 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -79.14 -35.03 42.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.447 . . . . 0.0 110.439 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.453 ' CG ' ' HA ' ' B' ' 17' ' ' PRO . 92.7 m-85 70.99 144.0 0.1 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.515 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HG2' HG22 ' A' ' 75' ' ' THR . 2.0 Cg_endo -82.96 165.82 15.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.057 2.504 . . . . 0.0 112.0 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.28 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.779 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.539 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -169.27 -163.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.944 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.36 107.57 16.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.3 m -95.25 129.16 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.798 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -157.79 165.71 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.949 0.405 . . . . 0.0 111.666 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 9.4 tt0 -99.75 102.87 14.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.777 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.82 162.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.07 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.81 168.08 20.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.722 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mt -144.19 161.9 42.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.7 135.94 67.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.649 2.233 . . . . 0.0 112.183 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.58 18.28 7.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.87 17.47 8.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 m -55.18 172.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.61 14.08 20.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.011 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -176.64 149.0 0.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.123 0.487 . . . . 0.0 111.508 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -150.86 137.85 19.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.918 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -144.67 138.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 112.101 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.36 149.91 28.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.03 125.99 32.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.414 . . . . 0.0 112.027 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.42 132.16 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.876 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -121.74 153.14 38.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.063 0.459 . . . . 0.0 112.038 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.414 HG22 ' CG1' ' A' ' 73' ' ' VAL . 34.6 m -124.13 116.37 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.3 57.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.971 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.849 0.357 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.6 -172.5 4.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 61.63 113.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.72 132.95 5.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -55.2 152.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mt -103.43 139.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.07 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.59 117.19 9.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.6 t -133.86 165.97 23.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.804 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 26.32 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -121.6 -36.61 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.982 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . . . -68.18 172.03 4.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' B' ' 11' ' ' ALA . 18.7 Cg_endo -59.33 -16.06 32.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.632 2.221 . . . . 0.0 112.905 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.23 151.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.411 . . . . 0.0 111.281 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.006 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -133.53 15.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.79 -146.1 4.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.453 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . 94.4 Cg_endo -87.38 44.49 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.637 2.224 . . . . 0.0 112.916 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.26 154.53 17.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.915 0.388 . . . . 0.0 110.991 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.83 169.25 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.304 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -59.04 -53.58 56.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.46 -177.16 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 m -142.31 132.63 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.147 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -103.51 104.94 15.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.777 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.44 -16.4 54.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -103.96 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.972 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.3 -29.56 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.082 0.468 . . . . 0.0 110.189 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.3 140.65 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.52 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.444 ' CG1' ' CB ' ' B' ' 127' ' ' ALA . 9.9 p -120.07 160.84 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mp -145.87 127.42 15.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.68 136.36 46.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.06 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.1 t -59.69 179.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.961 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.01 95.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.435 ' HG2' ' CG2' ' B' ' 58' ' ' VAL . 2.9 mp0 -61.92 138.09 58.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.479 ' HB ' ' HD2' ' B' ' 35' ' ' PRO . 0.7 OUTLIER -145.98 170.19 8.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.665 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 52.2 Cg_exo -54.34 -137.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.069 2.513 . . . . 0.0 112.319 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t 74.21 73.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' B' ' 41' ' ' GLY . 2.1 t-20 -34.86 115.66 0.52 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.964 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.65 -13.71 11.53 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.4 2.067 . . . . 0.0 112.11 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.54 -26.78 27.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 8.0 t -161.65 -33.23 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 97.1 66.02 0.92 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.791 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -82.77 -53.36 5.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.371 . . . . 0.0 111.292 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t 68.91 72.59 0.34 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.83 140.7 81.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.662 2.242 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.39 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.35 93.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 28.9 mm -38.94 -33.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.443 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.02 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.91 -54.98 38.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.1 -26.16 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.522 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.18 -44.2 63.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.901 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.33 -51.54 65.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.22 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' SER . . . . . 0.448 ' HA ' ' OD1' ' B' ' 57' ' ' ASN . 1.3 m -68.4 -46.37 70.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.32 -26.38 68.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.963 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -57.99 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.163 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.8 OUTLIER -54.86 -30.39 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.931 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.435 ' CG2' ' HG2' ' B' ' 33' ' ' GLN . 39.7 t -62.13 -34.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.95 -31.77 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.49 89.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -71.25 -46.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.83 -32.53 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.656 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.31 -38.49 60.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.34 65.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.136 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 -22.06 21.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.919 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 64.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -158.91 139.2 12.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.022 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' B' ' 71' ' ' ASP . 43.8 p -96.1 144.99 25.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.26 -31.79 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.574 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.486 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -59.83 -18.27 42.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.425 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 68' ' ' THR . 3.3 p-10 -88.65 -21.23 24.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.714 0.292 . . . . 0.0 110.87 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 64.4 mt -59.4 109.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.874 0.369 . . . . 0.0 110.839 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.423 ' CG1' HG22 ' B' ' 128' ' ' VAL . 2.8 m -81.12 -36.88 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.969 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.443 ' HB3' ' CD ' ' B' ' 107' ' ' ARG . 8.6 mtmt -130.56 175.22 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.302 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.541 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 13.4 t 177.67 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 111.337 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.481 ' N ' ' HG2' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -70.15 130.12 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.325 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.43 91.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' B' ' 76' ' ' THR . 5.3 m-85 -91.66 143.72 26.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.151 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 35.1 m -139.32 150.01 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.072 0.463 . . . . 0.0 111.718 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.94 -4.12 56.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.839 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -169.23 109.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.321 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -17.32 20.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.228 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.94 -24.63 59.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.275 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -15.37 58.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.422 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 0.3 OUTLIER -55.46 -23.03 23.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.267 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.99 -46.62 84.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.09 -33.23 19.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 t -70.09 -49.59 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.721 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 36.4 t-20 -63.21 -35.96 82.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.04 94.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.67 -31.19 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 48.8 t80 -57.62 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.423 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 7.7 tt0 -73.41 -27.32 61.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.462 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -25.19 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.786 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -79.25 -41.09 28.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.97 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 95' ' ' PHE . 57.2 m-85 -56.36 -50.45 71.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.818 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.82 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.945 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.8 58.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.98 14.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.505 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 11.7 m-20 89.78 30.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.0 t-160 -127.48 72.19 77.52 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.98 -11.02 16.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.537 2.158 . . . . 0.0 112.153 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.03 0.443 . . . . 0.0 110.445 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.45 ' CG ' ' HA ' ' C' ' 17' ' ' PRO . 92.7 m-85 70.89 144.04 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.494 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.457 ' HG2' HG22 ' B' ' 75' ' ' THR . 2.0 Cg_endo -83.02 165.85 14.91 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.016 2.477 . . . . 0.0 111.917 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.27 137.95 51.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.541 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -169.23 -163.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.38 107.56 16.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.571 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -95.21 129.11 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.845 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -157.71 165.59 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.409 . . . . 0.0 111.632 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' B' ' 79' ' ' VAL . 9.3 tt0 -99.57 102.86 14.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.785 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.73 162.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.05 -46.27 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.82 168.11 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mt -144.21 161.87 42.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.62 135.97 67.82 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.157 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.53 18.29 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.88 17.46 8.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 m -55.18 172.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.082 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.63 13.95 20.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.025 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 pp -176.62 148.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -150.78 137.88 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.935 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -144.68 138.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 112.14 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.33 149.81 28.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.627 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.94 126.01 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.956 0.408 . . . . 0.0 112.041 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.33 132.14 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.947 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.444 ' CB ' ' CG1' ' B' ' 28' ' ' VAL . . . -121.75 153.2 38.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.096 0.474 . . . . 0.0 111.994 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.423 HG22 ' CG1' ' B' ' 73' ' ' VAL . 34.7 m -124.26 116.32 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.23 57.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.015 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.851 0.358 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 -172.51 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 61.67 113.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.68 132.97 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -55.18 152.35 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mt -103.46 139.23 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -143.59 117.2 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 11.7 t -133.93 165.96 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.32 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -121.59 -36.84 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.01 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.506 ' CB ' ' HD2' ' C' ' 12' ' ' PRO . . . -67.93 172.02 4.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' C' ' 11' ' ' ALA . 18.8 Cg_endo -59.31 -16.11 32.83 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.675 2.25 . . . . 0.0 112.899 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.24 151.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.977 0.418 . . . . 0.0 111.304 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.69 120.76 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.002 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mm -133.54 15.81 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.042 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.81 -146.14 4.73 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.001 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . 0.45 ' HA ' ' CG ' ' B' ' 104' ' ' PHE . 94.1 Cg_endo -87.37 44.51 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 112.917 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.23 154.55 17.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.026 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.87 169.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.36 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.02 -53.38 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.6 -177.19 2.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 m -142.24 132.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -103.48 104.98 15.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.47 -16.35 54.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.0 -104.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.27 -29.59 33.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.22 140.64 45.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.575 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.441 ' CG1' ' CB ' ' C' ' 127' ' ' ALA . 9.9 p -120.04 160.84 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.4 ' HB3' ' NZ ' ' B' ' 74' ' ' LYS . 2.9 mp -145.85 127.45 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 p -106.6 136.31 46.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 t -59.62 179.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.13 95.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.25 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.431 ' HG2' ' CG2' ' C' ' 58' ' ' VAL . 2.9 mp0 -62.06 138.17 58.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.259 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.49 ' HB ' ' HD2' ' C' ' 35' ' ' PRO . 0.7 OUTLIER -146.0 170.23 8.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.654 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' C' ' 34' ' ' ILE . 52.4 Cg_exo -54.36 -137.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.063 2.509 . . . . 0.0 112.29 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t 74.17 73.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.427 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' C' ' 41' ' ' GLY . 2.1 t-20 -34.93 115.67 0.52 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.967 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.61 -13.76 11.54 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.36 2.04 . . . . 0.0 112.088 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.56 -26.65 27.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.133 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 8.0 t -161.62 -33.31 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.928 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 96.98 66.09 0.92 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.79 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -82.74 -53.36 5.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.886 0.374 . . . . 0.0 111.287 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 t 68.96 72.52 0.34 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.931 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.88 140.74 81.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.637 2.225 . . . . 0.0 112.358 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.45 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.083 0.468 . . . . 0.0 110.913 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 93.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 28.7 mm -39.01 -33.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.447 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.711 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -54.96 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.474 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.07 -44.36 63.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.36 -51.5 65.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.24 72.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.354 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' C' ' 57' ' ' ASN . 1.3 m -68.35 -46.4 70.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.58 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.32 -26.36 68.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -58.01 4.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.8 OUTLIER -54.9 -30.36 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.984 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.431 ' CG2' ' HG2' ' C' ' 33' ' ' GLN . 39.6 t -62.07 -34.62 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -80.86 -31.79 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.52 89.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -70.95 -46.31 68.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.733 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.89 -32.54 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.33 -38.39 60.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.093 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.31 65.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.139 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.1 21.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.87 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.445 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -158.9 139.23 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.036 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.0 p -96.16 145.01 25.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.21 -31.81 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.598 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.482 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -59.74 -18.28 41.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.477 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -88.78 -21.16 23.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 110.896 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 64.2 mt -59.39 109.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.426 ' CG1' HG22 ' C' ' 128' ' ' VAL . 2.8 m -81.04 -36.88 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.933 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . 0.444 ' HB3' ' CD ' ' C' ' 107' ' ' ARG . 8.6 mtmt -130.6 175.25 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.369 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' THR . . . . . 0.525 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 13.4 t 177.72 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.313 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.48 ' N ' ' HG2' ' C' ' 107' ' ' ARG . 0.0 OUTLIER -70.23 130.2 41.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 t -115.43 91.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' C' ' 76' ' ' THR . 5.3 m-85 -91.64 143.8 26.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.143 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 34.8 m -139.35 149.98 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 111.691 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.99 -4.23 56.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.816 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.1 109.04 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.305 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -17.19 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.0 -24.62 59.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.297 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.5 -15.28 58.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.827 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 0.3 OUTLIER -55.53 -23.04 24.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.261 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.63 84.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.01 -33.32 19.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.969 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.06 -49.66 54.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . 0.428 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 36.4 t-20 -63.12 -35.99 82.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.337 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.22 -42.14 94.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.973 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.68 -31.16 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.567 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.457 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 48.7 t80 -57.64 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . 0.414 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 7.7 tt0 -73.36 -27.37 61.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -25.19 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.77 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -79.32 -41.03 28.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 95' ' ' PHE . 56.7 m-85 -56.38 -50.4 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.781 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -28.72 69.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.954 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.91 -3.78 58.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.362 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.91 14.79 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 11.7 m-20 89.79 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.822 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.482 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.0 t-160 -127.55 72.17 77.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.705 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.03 -10.97 16.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.495 2.13 . . . . 0.0 112.146 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.998 0.428 . . . . 0.0 110.429 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.451 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 92.8 m-85 70.91 144.1 0.1 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.453 ' HG2' HG22 ' C' ' 75' ' ' THR . 2.0 Cg_endo -83.05 165.85 14.87 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.028 2.485 . . . . 0.0 111.948 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.29 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.525 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -169.22 -163.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.4 p -111.36 107.48 16.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.589 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -95.21 129.18 42.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.788 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 m -157.82 165.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' C' ' 79' ' ' VAL . 9.4 tt0 -99.76 102.86 14.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.75 162.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.08 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.83 168.09 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mt -144.21 161.82 43.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.52 135.99 68.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.608 2.205 . . . . 0.0 112.221 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.51 18.29 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 61.8 17.55 8.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 m -55.18 172.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.79 14.08 19.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.988 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 pp -176.62 148.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.489 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -150.83 137.93 19.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -144.74 138.35 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.11 0.481 . . . . 0.0 112.142 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.3 149.82 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.648 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.98 126.13 33.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 112.004 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.41 132.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.441 ' CB ' ' CG1' ' C' ' 28' ' ' VAL . . . -121.76 153.11 38.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.082 0.468 . . . . 0.0 112.029 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . 0.426 HG22 ' CG1' ' C' ' 73' ' ' VAL . 34.6 m -124.15 116.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.27 56.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.99 0.424 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.894 0.378 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mtt -95.93 -170.65 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.99 106.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.83 107.65 13.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 tp -54.31 125.88 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.311 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.4 mm -83.67 137.49 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.46 92.4 1.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -115.24 163.65 15.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.08 29.06 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.94 -41.78 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.807 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.438 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -72.34 178.16 1.49 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 32.3 Cg_exo -57.56 -13.83 14.98 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.808 2.339 . . . . 0.0 113.006 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.39 163.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 0.0 111.075 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -117.17 125.0 50.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.407 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 mp -144.89 18.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.025 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.1 -137.25 3.45 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.429 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.411 ' HB2' ' CD1' ' C' ' 92' ' ' TYR . 89.8 Cg_endo -88.82 32.42 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.795 2.33 . . . . 0.0 113.23 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.49 -178.03 6.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.392 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.412 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 10.3 m -136.68 179.79 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -68.86 -49.58 57.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -174.48 -177.42 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.88 141.58 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -117.97 91.01 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.95 -20.97 66.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.073 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.06 -108.85 0.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.846 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -57.85 -30.17 65.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.096 0.474 . . . . 0.0 110.229 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.71 124.55 42.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.736 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.54 171.61 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.097 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.7 164.81 29.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.751 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 p -138.47 143.9 39.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.911 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.4 p -72.47 179.55 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.27 95.43 0.96 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.377 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -66.93 165.13 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.342 . . . . 0.0 111.015 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 pt -159.5 157.59 26.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.294 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 35.5 Cg_exo -58.35 -15.05 22.51 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.075 2.517 . . . . 0.0 113.024 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.414 HG11 ' HA2' ' A' ' 41' ' ' GLY . 44.0 t -50.03 89.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -43.86 117.35 2.62 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.576 -179.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HG3' ' HA ' ' A' ' 12' ' ' PRO . 31.3 Cg_exo -58.28 -14.19 19.03 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.292 1.994 . . . . 0.0 112.249 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.78 -26.92 25.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.305 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.2 t -158.77 -32.82 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.991 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 92.68 66.73 1.1 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.408 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -77.55 -65.17 1.0 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.962 0.411 . . . . 0.0 111.104 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' A' ' 35' ' ' PRO . 14.7 t 69.52 62.44 0.55 Allowed Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.966 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 43' ' ' VAL . 51.8 Cg_exo -54.33 153.04 23.55 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.652 2.235 . . . . 0.0 112.414 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.74 60.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.02 95.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.868 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 tp -40.34 -32.98 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.797 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.62 -48.14 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.83 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.48 -48.51 80.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.827 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -65.97 -33.78 76.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.481 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.89 -35.88 69.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.008 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.61 -45.67 78.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.681 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -39.39 85.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.656 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t -69.75 -32.16 70.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.656 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.94 -44.97 65.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.53 -42.27 96.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.824 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -58.95 -38.16 78.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.56 -38.0 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -31.02 36.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.763 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.0 85.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.4 mt -71.54 -42.17 72.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.615 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -68.48 -33.05 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.583 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.5 -42.82 67.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.224 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -21.36 63.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.404 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.39 -28.85 19.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.703 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.99 52.82 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.61 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mt -161.28 -172.69 3.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 0.0 110.731 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -141.75 165.09 28.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.779 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.505 ' CB ' ' CE1' ' A' ' 101' ' ' HIS . . . -59.69 -32.33 70.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.876 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -56.67 -26.49 56.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.67 -22.64 34.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.22 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.412 ' CG2' ' HB1' ' A' ' 125' ' ' ALA . 89.7 mt -53.59 110.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.921 0.391 . . . . 0.0 111.243 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.4 m -78.65 -46.08 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.838 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.487 ' HB3' ' HG2' ' A' ' 107' ' ' ARG . 7.5 mttt -119.55 154.36 34.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.345 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.457 ' C ' ' HG3' ' A' ' 107' ' ' ARG . 76.1 p -153.77 102.37 2.53 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.428 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -69.38 124.32 23.56 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -111.07 111.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.428 ' CZ ' HG21 ' A' ' 76' ' ' THR . 13.7 m-30 -109.88 133.41 53.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.995 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 3.1 m -130.34 150.43 34.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.1 0.476 . . . . 0.0 111.858 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.6 -1.38 58.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.889 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.31 118.95 0.31 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 111' ' ' GLU . 51.6 mt -62.29 -14.55 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.23 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -74.14 -21.83 59.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.301 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -87.0 -18.71 30.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.991 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -53.48 -30.98 43.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.161 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.8 -34.91 72.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.287 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.76 -42.78 13.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.324 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.1 -45.84 79.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -63.0 -38.57 91.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.081 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.21 73.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.499 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -15.08 32.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.545 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.49 ' CE1' ' CE1' ' A' ' 96' ' ' PHE . 12.2 t80 -81.05 -38.39 27.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 111.338 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.419 ' HG3' ' CE1' ' A' ' 104' ' ' PHE . 2.4 tt0 -83.2 -27.97 29.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.516 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.83 -24.39 55.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.773 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.521 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -85.31 -37.44 19.96 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.719 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.521 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 3.9 m-85 -55.76 -55.19 35.32 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.168 0.509 . . . . 0.0 109.998 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -32.66 72.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.27 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.01 -6.72 57.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.385 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.712 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 1.5 t-20 -111.91 -4.62 14.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.494 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 15.6 m120 84.47 32.21 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.772 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.712 ' CE1' ' HB3' ' A' ' 99' ' ' ASN . 3.4 m170 -115.81 53.16 0.93 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.605 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 58.4 Cg_endo -70.56 -22.27 28.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.539 2.159 . . . . 0.0 112.47 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -50.14 -33.07 17.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.897 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CE1' ' HG3' ' A' ' 93' ' ' GLU . 13.2 m-85 64.54 131.01 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.193 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.441 ' CB ' ' CG2' ' A' ' 75' ' ' THR . 94.2 Cg_endo -88.51 133.58 2.72 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.978 2.452 . . . . 0.0 112.615 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -97.87 129.09 44.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.058 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.487 ' HG2' ' HB3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -162.73 -164.37 0.99 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.996 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.69 114.13 24.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.113 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 14.6 m -92.85 138.36 31.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.219 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.1 m -156.73 158.38 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.986 0.422 . . . . 0.0 111.634 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 3.6 tt0 -98.99 86.29 3.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.655 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.0 m -57.14 156.91 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.233 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.14 82.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.04 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.53 -178.25 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.735 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 mt -148.83 152.42 37.13 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.837 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.12 137.72 68.23 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.504 2.136 . . . . 0.0 112.162 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 tptt 75.17 14.1 3.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.272 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.29 13.62 8.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.188 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.0 m -58.1 156.72 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.727 0.299 . . . . 0.0 110.947 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.38 10.06 65.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.999 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 pp -177.26 148.26 0.59 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.085 0.469 . . . . 0.0 111.372 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -126.41 150.3 48.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.087 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.446 HD13 HG23 ' A' ' 123' ' ' ILE . 29.5 mt -128.92 121.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.146 0.498 . . . . 0.0 112.277 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -130.88 144.77 51.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 75' ' ' THR . . . -168.8 167.42 11.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.4 mt -123.9 145.21 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.645 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -123.87 148.03 47.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.115 0.483 . . . . 0.0 111.868 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.87 142.88 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.859 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -123.09 47.55 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.939 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.918 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.802 0.334 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mtt -95.89 -170.7 2.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.04 106.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.83 107.64 13.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 tp -54.35 125.87 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.221 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 22.1 mm -83.58 137.55 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.48 92.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -115.21 163.7 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.13 29.04 3.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 -41.92 3.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.451 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -71.94 178.15 1.43 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 32.3 Cg_exo -57.63 -13.8 15.14 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.787 2.325 . . . . 0.0 113.008 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.39 163.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.896 0.379 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -117.18 125.06 50.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.377 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 mp -144.94 18.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.993 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.06 -137.23 3.45 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.44 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -88.81 32.4 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.844 2.363 . . . . 0.0 113.269 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -152.49 -178.09 6.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.427 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.411 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 10.5 m -136.64 179.7 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.21 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -68.82 -49.75 55.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.944 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -174.6 -177.42 1.18 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.219 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.99 141.59 38.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -117.94 91.05 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.975 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.04 -20.94 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.01 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.05 -108.83 0.78 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.881 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -57.82 -30.26 65.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.048 0.452 . . . . 0.0 110.194 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.65 124.54 42.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.726 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.46 171.62 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.69 164.8 29.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.75 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.7 p -138.46 143.87 39.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.3 p -71.93 179.67 3.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.801 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.31 95.49 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.369 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -66.95 165.09 16.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 111.004 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 8.7 pt -159.48 157.64 27.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.301 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.472 ' HB2' ' HA ' ' B' ' 43' ' ' VAL . 36.5 Cg_exo -58.41 -15.05 22.79 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.094 2.529 . . . . 0.0 113.045 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.404 HG11 ' HA2' ' B' ' 41' ' ' GLY . 44.1 t -50.01 89.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.397 . . . . 0.0 111.17 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' B' ' 41' ' ' GLY . 0.8 OUTLIER -43.89 117.39 2.64 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.558 -179.733 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.35 -14.16 19.21 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.272 1.981 . . . . 0.0 112.191 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.75 -26.96 25.54 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.311 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 12.2 t -158.71 -33.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.972 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 92.7 66.86 1.1 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.418 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -77.56 -65.18 0.99 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.978 0.418 . . . . 0.0 111.116 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' B' ' 35' ' ' PRO . 14.6 t 69.58 62.34 0.55 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.982 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' B' ' 43' ' ' VAL . 51.8 Cg_exo -54.32 153.09 23.37 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.586 2.191 . . . . 0.0 112.424 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.8 60.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.838 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.04 95.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 tp -40.34 -32.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.86 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.57 -48.12 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -48.55 80.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.86 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -65.86 -33.9 76.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.542 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.75 -35.88 70.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.912 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.6 -45.71 78.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.687 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -39.32 85.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.714 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 4.8 t -69.74 -32.23 70.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.648 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.417 HD13 ' CE2' ' B' ' 95' ' ' PHE . 17.3 mt -70.93 -44.97 65.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.59 -42.23 96.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.804 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -58.95 -38.11 78.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.854 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 12.3 t -61.6 -38.01 79.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -30.99 36.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.799 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.58 -41.02 84.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.94 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.51 -42.04 72.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.551 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 17.0 mt -68.41 -33.13 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.48 -42.76 67.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.258 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -21.36 63.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.366 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.39 -28.83 19.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.71 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.99 52.71 0.38 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.619 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mt -161.27 -172.73 3.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.689 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 22.5 p -141.69 165.05 28.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.765 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.513 ' CB ' ' CE1' ' B' ' 101' ' ' HIS . . . -59.68 -32.37 70.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.856 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.517 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -56.63 -26.56 56.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.42 -22.72 35.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.174 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.406 ' CG2' ' HB1' ' B' ' 125' ' ' ALA . 89.7 mt -53.61 110.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 111.24 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.4 m -78.66 -46.11 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.89 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.476 ' HB3' ' HG2' ' B' ' 107' ' ' ARG . 7.5 mttt -119.56 154.4 33.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.316 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.467 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 75.8 p -153.78 102.32 2.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.425 HG21 ' CZ ' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -69.28 124.29 23.45 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -111.04 111.84 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.425 ' CZ ' HG21 ' B' ' 76' ' ' THR . 13.6 m-30 -109.85 133.36 53.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.998 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 3.2 m -130.33 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.14 0.495 . . . . 0.0 111.866 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.69 -1.41 58.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.849 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.27 118.91 0.31 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.488 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' B' ' 111' ' ' GLU . 52.4 mt -62.25 -14.56 39.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.263 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -74.07 -21.89 59.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.91 0.386 . . . . 0.0 110.314 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -87.02 -18.71 29.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.976 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -53.44 -31.0 43.42 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.133 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.95 72.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.278 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.67 -42.81 13.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.338 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.5 t -69.08 -45.83 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.212 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -62.99 -38.51 91.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.09 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.2 73.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.503 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.94 -14.96 33.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.561 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' B' ' 96' ' ' PHE . 12.3 t80 -81.16 -38.36 27.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 111.264 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.421 ' HG3' ' CE1' ' B' ' 104' ' ' PHE . 2.4 tt0 -83.21 -27.89 29.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.545 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.87 -24.31 55.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.794 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.521 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -85.44 -37.35 19.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.672 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.521 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 3.9 m-85 -55.85 -55.18 35.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.172 0.51 . . . . 0.0 109.954 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -32.71 72.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.254 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.92 -6.82 57.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.385 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.716 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 1.5 t-20 -111.84 -4.63 14.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.499 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 15.6 m120 84.38 32.24 0.05 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.786 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.716 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 3.5 m170 -115.82 53.13 0.93 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.618 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 58.5 Cg_endo -70.54 -22.33 28.65 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.565 2.177 . . . . 0.0 112.428 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -50.09 -33.18 17.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.93 0.395 . . . . 0.0 110.865 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.421 ' CE1' ' HG3' ' B' ' 93' ' ' GLU . 13.1 m-85 64.64 130.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.2 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.439 ' HB2' HG21 ' B' ' 75' ' ' THR . 94.0 Cg_endo -88.48 133.64 2.74 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.004 2.469 . . . . 0.0 112.579 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -97.91 128.98 44.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.476 ' HG2' ' HB3' ' B' ' 74' ' ' LYS . 0.0 OUTLIER -162.61 -164.33 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.958 179.325 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.73 114.13 24.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.076 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 14.5 m -92.84 138.42 31.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.21 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 23.0 m -156.74 158.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.985 0.421 . . . . 0.0 111.659 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' B' ' 79' ' ' VAL . 3.6 tt0 -99.05 86.31 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.648 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 29.3 m -57.14 156.93 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.18 82.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.5 -178.22 7.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.728 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 mt -148.84 152.43 37.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.819 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.1 137.73 68.39 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.509 2.139 . . . . 0.0 112.18 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 tptt 75.13 14.12 3.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.249 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.28 13.64 8.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.142 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 23.0 m -58.08 156.84 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.55 9.8 64.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.019 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 pp -176.87 148.18 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.02 0.438 . . . . 0.0 111.39 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -126.34 150.28 48.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.082 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.417 HG23 HD13 ' B' ' 123' ' ' ILE . 29.6 mt -128.96 121.34 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 112.31 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' B' ' 76' ' ' THR . 4.3 tp10 -130.77 144.82 51.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' B' ' 75' ' ' THR . . . -168.8 167.48 11.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 1.4 mt -123.89 145.2 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.661 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -123.86 147.94 47.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.111 0.481 . . . . 0.0 111.867 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 28.9 m -114.75 142.8 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.887 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -122.98 47.49 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.951 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.861 0.363 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mtt -95.92 -170.69 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.98 106.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.901 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.85 107.65 13.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 tp -54.37 125.93 10.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.237 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 22.2 mm -83.6 137.51 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.44 92.41 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -115.22 163.68 15.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.13 29.12 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -41.73 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.84 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.439 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -72.4 178.18 1.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.899 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 32.3 Cg_exo -57.56 -13.78 14.85 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.801 2.334 . . . . 0.0 113.003 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 77.35 163.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.114 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -117.09 125.04 50.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.469 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 mp -144.93 18.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.007 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.09 -137.28 3.45 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.439 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . 0.418 ' HB2' ' CD1' ' B' ' 92' ' ' TYR . 88.0 Cg_endo -88.74 32.36 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.782 2.322 . . . . 0.0 113.254 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.48 -178.03 6.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.868 0.366 . . . . 0.0 111.354 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 10.4 m -136.71 179.72 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.193 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -68.87 -49.62 56.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -174.42 -177.47 1.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.142 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.92 141.56 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.157 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -117.95 91.04 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.96 -21.0 66.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.06 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.1 -108.82 0.78 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.893 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -57.9 -30.2 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.015 0.436 . . . . 0.0 110.189 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.67 124.57 42.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.745 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 m -105.53 171.64 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.076 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.72 164.79 29.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 15.3 p -138.44 143.76 39.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.4 p -72.18 179.54 3.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.27 95.47 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.359 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -66.96 165.19 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 8.7 pt -159.56 157.57 26.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.292 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.479 ' HB2' ' HA ' ' C' ' 43' ' ' VAL . 36.2 Cg_exo -58.4 -15.03 22.68 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.066 2.511 . . . . 0.0 112.997 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . 0.408 HG11 ' HA2' ' C' ' 41' ' ' GLY . 43.9 t -49.97 89.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.39 . . . . 0.0 111.186 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' C' ' 41' ' ' GLY . 0.8 OUTLIER -43.92 117.41 2.66 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.579 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.32 -14.14 19.04 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.297 1.998 . . . . 0.0 112.239 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.79 -26.94 25.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.288 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 12.2 t -158.75 -32.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.02 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 92.79 66.72 1.09 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.397 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -77.58 -65.15 1.0 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.992 0.425 . . . . 0.0 111.107 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' C' ' 35' ' ' PRO . 14.7 t 69.55 62.4 0.55 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.964 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.39 153.12 23.62 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.608 2.206 . . . . 0.0 112.404 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.64 60.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.01 95.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.888 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 tp -40.35 -32.94 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.63 -48.17 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.51 80.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.849 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -65.99 -33.9 76.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.45 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.84 -35.93 70.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.996 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.64 -45.63 78.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.696 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -39.33 85.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.682 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 4.8 t -69.74 -32.2 70.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.641 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.99 -44.94 64.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.741 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.58 -42.26 96.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -58.94 -38.15 78.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 12.3 t -61.58 -37.97 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -31.02 36.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.784 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.07 85.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.4 -42.17 73.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.507 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mt -68.38 -33.22 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.593 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.37 -42.83 67.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.291 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.25 -21.3 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.409 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.45 -28.81 19.45 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.714 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.04 52.72 0.37 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.579 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mt -161.26 -172.65 3.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 110.73 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -141.77 165.05 28.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.507 ' CB ' ' CE1' ' C' ' 101' ' ' HIS . . . -59.71 -32.29 70.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.903 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.519 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -56.72 -26.47 57.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.59 -22.67 34.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 90.0 mt -53.62 110.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.191 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.4 m -78.66 -46.05 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.9 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . 0.483 ' HB3' ' HG2' ' C' ' 107' ' ' ARG . 7.5 mttt -119.61 154.38 34.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.295 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' THR . . . . . 0.462 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 76.7 p -153.75 102.33 2.53 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.424 HG21 ' CZ ' ' C' ' 78' ' ' PHE . 0.2 OUTLIER -69.35 124.32 23.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 11.0 t -111.03 111.78 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.424 ' CZ ' HG21 ' C' ' 76' ' ' THR . 13.6 m-30 -109.83 133.45 53.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.989 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 3.1 m -130.38 150.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.132 0.492 . . . . 0.0 111.831 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.64 -1.28 57.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.946 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.32 118.86 0.31 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.431 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' C' ' 111' ' ' GLU . 52.1 mt -62.17 -14.6 39.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.3 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -74.09 -21.84 59.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.868 0.366 . . . . 0.0 110.286 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -87.06 -18.69 29.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.973 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -53.49 -30.94 43.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.141 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.95 72.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.257 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.67 -42.83 13.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.358 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -69.11 -45.76 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.209 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -63.05 -38.51 91.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.044 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.32 -35.3 73.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.487 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.83 -14.99 33.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.511 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.49 ' CE1' ' CE1' ' C' ' 96' ' ' PHE . 12.3 t80 -81.14 -38.36 27.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.0 111.286 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' C' ' 104' ' ' PHE . 2.4 tt0 -83.2 -27.94 29.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.508 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.88 -24.36 55.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.752 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.523 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -85.37 -37.36 19.97 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.713 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.523 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 3.9 m-85 -55.83 -55.17 35.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.132 0.492 . . . . 0.0 109.984 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -32.65 72.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.214 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -6.72 56.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.424 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.721 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 1.5 t-20 -111.86 -4.65 14.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.548 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 15.5 m120 84.4 32.17 0.05 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.81 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.721 ' CE1' ' HB3' ' C' ' 99' ' ' ASN . 3.5 m170 -115.79 53.18 0.93 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.587 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 58.5 Cg_endo -70.57 -22.22 28.64 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.519 2.146 . . . . 0.0 112.483 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -50.18 -33.11 18.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 110.879 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' C' ' 93' ' ' GLU . 13.1 m-85 64.59 131.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.184 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.447 ' CB ' ' CG2' ' C' ' 75' ' ' THR . 94.1 Cg_endo -88.5 133.62 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.962 2.442 . . . . 0.0 112.638 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -97.94 129.01 44.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.031 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.483 ' HG2' ' HB3' ' C' ' 74' ' ' LYS . 0.0 OUTLIER -162.61 -164.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 179.298 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.68 114.11 24.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 14.6 m -92.85 138.4 31.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.297 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 23.1 m -156.69 158.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.97 0.414 . . . . 0.0 111.682 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' C' ' 79' ' ' VAL . 3.6 tt0 -99.0 86.32 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.644 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -57.12 156.88 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.219 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.21 82.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.51 -178.2 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.767 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 27.8 mt -148.85 152.42 37.07 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.825 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.13 137.71 68.12 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.523 2.149 . . . . 0.0 112.151 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 tptt 75.16 14.12 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.219 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.25 13.63 8.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.152 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 23.3 m -58.06 156.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.771 0.32 . . . . 0.0 110.965 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.48 10.16 64.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.044 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 pp -177.33 148.18 0.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.063 0.459 . . . . 0.0 111.388 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -126.3 150.34 48.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.096 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . 0.4 HD13 HG23 ' C' ' 123' ' ' ILE . 29.3 mt -128.98 121.31 54.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.502 . . . . 0.0 112.322 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' C' ' 76' ' ' THR . 4.3 tp10 -130.79 144.75 51.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' C' ' 75' ' ' THR . . . -168.75 167.5 11.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . 0.407 HD13 HG22 ' C' ' 126' ' ' ILE . 1.4 mt -123.96 145.27 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.624 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -123.89 147.95 47.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.125 0.488 . . . . 0.0 111.848 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.76 142.87 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.853 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -123.07 47.54 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.926 0.393 . . . . 0.0 110.974 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.814 0.34 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.3 ttt 59.5 -172.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.806 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 4' ' ' GLN . 90.1 m 62.39 149.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.977 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.51 ' O ' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 60.57 -173.31 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.873 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 4' ' ' GLN . 1.1 tp 57.67 120.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.907 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.422 HG12 ' HB2' ' A' ' 23' ' ' ASP . 13.7 mt -148.67 134.93 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.252 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.8 138.81 48.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 0.0 111.238 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.07 148.03 42.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.838 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.01 37.16 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -137.88 -45.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.992 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.7 110.95 7.43 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.33 -14.68 45.4 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.517 2.145 . . . . 0.0 112.36 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.77 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.198 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.535 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 61.22 -165.19 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.358 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.8 mt 77.38 17.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.252 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.02 -135.2 3.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.009 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.84 43.13 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.658 2.239 . . . . 0.0 112.568 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -177.33 -176.3 0.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.859 0.362 . . . . 0.0 110.983 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' C' ' 104' ' ' PHE . 16.6 m -115.26 165.25 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.439 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -56.38 -48.25 77.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 110.63 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -161.41 -175.96 5.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.523 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.09 131.47 61.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.975 0.417 . . . . 0.0 111.42 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.422 ' HB2' HG12 ' A' ' 6' ' ' ILE . 61.7 t0 -105.85 86.83 2.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.056 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.7 mt -60.79 -19.58 59.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.154 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.52 -108.49 0.88 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.669 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -57.63 -30.22 65.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.182 0.515 . . . . 0.0 109.948 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 27' ' ' LEU . 3.2 mp -124.16 136.62 54.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.506 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 ' CB ' ' A' ' 127' ' ' ALA . 0.7 OUTLIER -104.7 177.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.253 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.15 133.6 9.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.4 p -110.08 138.78 45.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 0.0 111.118 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.79 175.66 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.84 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.85 84.09 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.298 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.11 152.81 12.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 0.0 111.167 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 pt -132.07 142.1 43.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.023 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.406 ' CB ' ' CG ' ' A' ' 50' ' ' GLN . 90.7 Cg_endo -79.9 53.97 4.99 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.95 2.433 . . . . 0.0 112.975 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -63.01 85.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.167 0.508 . . . . 0.0 110.575 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 41' ' ' GLY . 28.0 t-20 -35.76 131.72 0.56 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.953 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.62 -13.46 32.53 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.256 1.97 . . . . 0.0 112.077 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.64 -19.96 10.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.576 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.96 -29.99 7.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.924 0.392 . . . . 0.0 110.664 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 69.72 51.83 23.18 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.518 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -171.06 -80.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.772 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 7.3 p -166.04 112.72 0.75 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.173 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -50.97 139.61 41.15 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.345 2.03 . . . . 0.0 112.174 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.39 72.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.046 0.451 . . . . 0.0 111.009 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.38 91.66 1.02 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.853 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.0 mm -41.42 -35.05 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.155 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.78 -45.49 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.434 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.81 95.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.408 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.406 ' CG ' ' CB ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -68.39 -32.11 71.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.189 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.56 -38.45 74.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.004 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -70.83 -48.96 51.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.51 -28.18 68.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.779 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -45.61 77.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.795 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.25 -22.28 64.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.9 -54.59 8.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.417 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 58' ' ' VAL . 29.1 p30 -55.72 -30.92 61.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.285 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.407 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 40.3 t -69.32 -50.36 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.929 0.395 . . . . 0.0 110.721 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -67.39 -33.78 75.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.694 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.56 -40.92 84.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.963 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.99 -56.56 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.653 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.429 ' CD1' ' CB ' ' A' ' 127' ' ' ALA . 5.2 tt -64.43 -26.32 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.812 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.44 -41.04 33.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 110.376 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -15.49 63.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.723 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.22 -26.99 17.93 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.954 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.09 44.32 0.49 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.381 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' CB ' HG12 ' A' ' 62' ' ' ILE . 4.5 mt -157.2 139.58 14.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.878 0.371 . . . . 0.0 110.851 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 p -92.73 159.32 15.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.538 ' CB ' ' CE1' ' A' ' 101' ' ' HIS . . . -57.31 -34.79 69.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.515 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -49.71 -27.39 4.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.35 -28.05 47.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.081 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 78.8 mt -44.48 118.47 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.925 0.393 . . . . 0.0 110.984 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.421 ' CB ' ' HG3' ' B' ' 4' ' ' GLN . 10.3 m -83.62 -46.3 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.134 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.424 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 6.8 tttm -141.67 147.73 37.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.604 0.24 . . . . 0.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.42 ' N ' ' HG2' ' A' ' 74' ' ' LYS . 2.3 t -141.59 117.51 10.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.396 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.98 162.57 18.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.4 t -150.8 103.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.932 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.401 ' CD2' HG13 ' C' ' 110' ' ' VAL . 9.5 m-85 -94.06 96.24 9.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.214 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.23 148.48 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.662 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -79.96 -5.06 54.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.017 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.97 143.05 9.17 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.468 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.82 2.13 46.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.24 -19.98 26.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.584 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.91 -29.99 16.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.903 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 35.2 t80 -57.18 -26.31 60.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.05 -35.8 69.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.246 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.95 -33.15 18.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.25 -42.31 66.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 32.2 t30 -67.73 -39.45 84.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.59 -30.46 69.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.28 -32.55 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -58.55 -47.71 83.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.55 -20.87 58.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.282 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 0.1 OUTLIER -77.3 -32.01 55.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.447 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -89.48 -33.34 16.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.116 0.484 . . . . 0.0 110.737 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.502 ' CE2' ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -58.05 -53.68 55.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.893 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -32.09 70.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 94' ' ' ARG . 3.8 pt-20 -72.76 -12.61 61.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.67 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.535 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 6.4 m-80 -102.88 -13.94 16.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.103 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 58.9 m-20 97.48 41.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.986 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.538 ' CE1' ' CB ' ' A' ' 69' ' ' ALA . 3.9 m170 -120.14 52.02 2.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.705 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 74.0 Cg_endo -74.11 -3.74 14.28 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.523 2.149 . . . . 0.0 113.077 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -30.75 69.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.46 ' HB2' ' CG1' ' B' ' 19' ' ' VAL . 15.4 m-85 65.23 113.08 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.59 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.502 ' HD3' ' CE2' ' A' ' 96' ' ' PHE . 78.2 Cg_endo -96.54 151.37 1.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.375 2.717 . . . . 0.0 112.671 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.413 ' CB ' ' HG3' ' A' ' 74' ' ' LYS . . . -60.01 163.36 4.79 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 137.72 10.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.176 0.513 . . . . 0.0 112.03 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.16 84.42 2.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.007 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 52.7 t -90.57 145.23 25.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.208 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.8 m -152.97 132.99 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.088 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -67.22 82.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -67.03 161.71 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.91 -44.21 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.61 164.62 33.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.817 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mt -139.79 159.95 62.87 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.762 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.52 134.64 39.75 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.478 2.119 . . . . 0.0 112.259 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.43 14.31 9.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.41 17.89 8.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.84 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.1 m -53.83 164.77 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.167 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -87.91 -24.38 35.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.646 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -153.25 147.35 25.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.163 0.506 . . . . 0.0 111.27 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.4 ' OE1' ' CD2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -132.39 138.62 47.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.779 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.8 138.02 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.384 0.611 . . . . 0.0 112.324 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.61 107.92 4.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.185 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -121.86 161.63 22.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.3 mp -111.71 155.51 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.027 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.429 ' CB ' ' CD1' ' A' ' 62' ' ' ILE . . . -142.42 149.99 40.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.01 0.433 . . . . 0.0 111.475 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.04 179.64 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.061 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -162.2 45.59 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.925 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.819 0.342 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 1.3 ttt 59.46 -172.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.416 HG21 ' N ' ' B' ' 4' ' ' GLN . 90.1 m 62.43 149.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.03 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.507 ' O ' HG23 ' B' ' 5' ' ' ILE . 0.0 OUTLIER 60.39 -173.34 0.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.88 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.507 HG23 ' O ' ' B' ' 4' ' ' GLN . 1.1 tp 57.77 120.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.921 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' B' ' 23' ' ' ASP . 13.6 mt -148.67 134.93 12.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.245 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.81 138.93 48.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 111.171 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.12 148.01 42.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.778 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.09 37.17 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -137.79 -45.37 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.99 110.96 7.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.42 -14.56 44.91 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.453 2.102 . . . . 0.0 112.392 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.81 -167.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.182 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.531 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 61.26 -165.17 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.381 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 21.6 mt 77.33 17.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.253 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.11 -135.24 3.46 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.967 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.83 43.22 1.26 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.619 2.212 . . . . 0.0 112.535 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -177.47 -176.3 0.61 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.923 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.46 ' CG1' ' HB2' ' A' ' 104' ' ' PHE . 16.6 m -115.25 165.27 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.442 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -56.45 -48.42 77.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.032 0.444 . . . . 0.0 110.607 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -161.16 -175.95 5.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.477 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.15 131.45 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.011 0.434 . . . . 0.0 111.369 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' B' ' 6' ' ' ILE . 61.6 t0 -105.82 86.76 2.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.06 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.78 -19.54 59.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.198 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.53 -108.52 0.88 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.669 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -57.66 -30.16 65.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.14 0.495 . . . . 0.0 109.906 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' B' ' 27' ' ' LEU . 3.2 mp -124.21 136.68 54.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.496 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.413 HG21 ' CB ' ' B' ' 127' ' ' ALA . 0.7 OUTLIER -104.72 177.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.173 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.22 133.63 9.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.776 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 81.7 p -110.09 139.28 45.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.884 0.373 . . . . 0.0 111.194 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.86 175.68 10.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.915 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.89 84.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.09 152.81 12.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.899 0.38 . . . . 0.0 111.198 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.405 ' CD1' ' CG2' ' B' ' 36' ' ' VAL . 10.3 pt -132.06 142.14 44.02 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.998 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.409 ' CB ' ' CG ' ' B' ' 50' ' ' GLN . 91.6 Cg_endo -79.92 53.91 4.96 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.931 2.421 . . . . 0.0 112.986 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.405 ' CG2' ' CD1' ' B' ' 34' ' ' ILE . 45.4 t -62.93 85.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.51 . . . . 0.0 110.586 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 41' ' ' GLY . 28.0 t-20 -35.75 131.69 0.56 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.011 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.66 -13.41 32.38 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.259 1.972 . . . . 0.0 112.031 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.6 -20.02 10.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.562 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.89 -30.01 7.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.045 0.45 . . . . 0.0 110.654 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 69.65 51.82 23.6 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.56 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -171.09 -80.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.796 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 7.4 p -166.06 112.75 0.75 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.127 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -50.95 139.64 40.9 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.366 2.044 . . . . 0.0 112.144 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.46 72.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.067 0.46 . . . . 0.0 111.031 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.36 91.67 1.01 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.828 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 24.0 mm -41.44 -35.01 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.158 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.86 -45.44 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.397 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.8 95.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.432 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.409 ' CG ' ' CB ' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -68.31 -31.68 71.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.163 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.53 -38.5 74.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.027 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -70.79 -48.91 51.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -60.58 -28.18 68.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.774 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -45.54 78.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.3 -22.28 64.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.88 -54.61 8.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.401 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -55.71 -30.86 61.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.38 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.38 -50.36 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 110.691 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.403 ' HA ' HG21 ' B' ' 62' ' ' ILE . 2.8 ptmm? -67.31 -33.8 76.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.71 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.5 -40.72 83.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.998 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 5.3 mt -65.07 -56.53 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.667 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.431 ' CD1' ' CB ' ' B' ' 127' ' ' ALA . 5.2 tt -64.45 -26.26 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.44 -41.0 34.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.968 0.413 . . . . 0.0 110.423 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -15.5 63.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.74 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.17 -27.0 17.97 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.961 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.08 44.32 0.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.399 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.404 ' CB ' HG12 ' B' ' 62' ' ' ILE . 4.5 mt -157.23 139.6 14.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.807 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 27.2 p -92.73 159.36 15.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.534 ' CB ' ' CE1' ' B' ' 101' ' ' HIS . . . -57.32 -34.79 69.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.499 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -49.71 -27.23 4.53 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.999 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.65 -27.94 45.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 78.8 mt -44.5 118.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 120.897 0.38 . . . . 0.0 111.003 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.411 ' CB ' ' HG3' ' C' ' 4' ' ' GLN . 10.4 m -83.65 -46.24 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.13 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.431 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 6.8 tttm -141.72 147.7 37.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.645 0.26 . . . . 0.0 110.892 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.423 ' N ' ' HG2' ' B' ' 74' ' ' LYS . 2.3 t -141.57 117.42 10.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.43 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.85 162.6 18.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.332 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -150.82 103.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.879 0.371 . . . . 0.0 111.931 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -94.03 96.28 9.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.227 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.24 148.44 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.705 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -80.0 -5.01 54.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.014 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.84 143.09 9.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.458 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.85 2.09 47.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.26 -19.98 26.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.613 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.95 -29.98 16.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' B' ' 89' ' ' ASN . 35.2 t80 -57.2 -26.27 60.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.169 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.85 69.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.324 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.93 -33.18 18.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.27 -42.39 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.422 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 32.0 t30 -67.66 -39.49 84.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.65 -30.52 69.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.26 -32.49 22.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -58.48 -47.71 83.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.56 -20.9 58.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.295 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' B' ' 98' ' ' GLU . 0.1 OUTLIER -77.3 -31.95 55.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.493 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.2 OUTLIER -89.51 -33.35 16.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.455 . . . . 0.0 110.741 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.5 ' CE2' ' HD3' ' B' ' 105' ' ' PRO . 0.1 OUTLIER -57.97 -53.7 55.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -32.04 70.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.961 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' B' ' 94' ' ' ARG . 3.8 pt-20 -72.72 -12.62 61.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 0.0 110.625 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.54 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 6.4 m-80 -102.96 -13.93 16.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.099 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 59.2 m-20 97.5 41.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.964 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' B' ' 99' ' ' ASN . 4.0 m170 -120.01 52.07 2.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.757 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 74.2 Cg_endo -74.14 -3.76 14.32 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.566 2.178 . . . . 0.0 113.087 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -30.7 69.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.49 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 15.3 m-85 65.16 113.14 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.594 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.5 ' HD3' ' CE2' ' B' ' 96' ' ' PHE . 80.2 Cg_endo -96.67 151.37 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.357 2.705 . . . . 0.0 112.675 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.41 ' CB ' ' HG3' ' B' ' 74' ' ' LYS . . . -59.96 163.34 4.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.6 137.76 10.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.203 0.525 . . . . 0.0 112.017 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.15 84.34 2.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.055 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 52.7 t -90.43 145.27 25.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.265 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' C' ' 78' ' ' PHE . 32.7 m -153.11 133.29 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -67.49 82.05 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -67.02 161.7 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.93 -44.19 20.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.081 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.56 164.66 33.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.805 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mt -139.81 159.96 62.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.783 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.5 134.61 39.59 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.521 2.147 . . . . 0.0 112.254 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.41 14.33 9.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.208 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.38 17.91 8.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.819 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -53.81 164.79 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.14 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -87.89 -24.27 35.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.652 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -153.45 147.41 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.111 0.482 . . . . 0.0 111.238 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.34 138.64 47.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.795 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.8 137.98 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.324 0.583 . . . . 0.0 112.348 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.59 107.91 4.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.214 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -121.91 161.71 22.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.297 0.57 . . . . 0.0 112.507 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 2.3 mp -111.79 155.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.977 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.431 ' CB ' ' CD1' ' B' ' 62' ' ' ILE . . . -142.34 150.06 40.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.403 . . . . 0.0 111.527 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.1 179.67 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.977 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -162.21 45.62 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.948 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.838 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.78 0.324 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 1.3 ttt 59.52 -172.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' THR . . . . . 0.414 HG21 ' N ' ' C' ' 4' ' ' GLN . 90.1 m 62.42 149.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.514 ' O ' HG23 ' C' ' 5' ' ' ILE . 0.0 OUTLIER 60.56 -173.35 0.12 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.824 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . 0.514 HG23 ' O ' ' C' ' 4' ' ' GLN . 1.1 tp 57.67 120.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.916 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.411 HG12 ' HB2' ' C' ' 23' ' ' ASP . 13.5 mt -148.66 134.95 12.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.247 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -131.85 138.86 48.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 111.205 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.12 148.01 42.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.835 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.06 37.11 1.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -137.91 -45.97 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.4 111.0 7.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.092 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.41 -14.62 45.23 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.496 2.131 . . . . 0.0 112.396 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.78 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.2 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.536 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 61.2 -165.16 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.385 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 21.9 mt 77.33 17.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.262 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.01 -135.2 3.46 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.029 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.85 43.15 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 112.561 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.536 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -177.34 -176.29 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.986 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.49 ' CG1' ' HB2' ' B' ' 104' ' ' PHE . 16.5 m -115.25 165.32 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.443 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -56.38 -47.87 78.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.099 0.476 . . . . 0.0 110.519 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.02 -175.78 4.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.514 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.08 131.42 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.409 . . . . 0.0 111.351 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . 0.411 ' HB2' HG12 ' C' ' 6' ' ' ILE . 61.6 t0 -105.85 86.88 2.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.093 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 31.5 mt -60.82 -19.61 60.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.154 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.54 -108.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.693 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -57.62 -30.21 65.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.159 0.504 . . . . 0.0 109.917 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 mp -124.22 136.62 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.482 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.416 HG21 ' CB ' ' C' ' 127' ' ' ALA . 0.7 OUTLIER -104.7 177.17 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.249 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.2 133.54 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 81.3 p -109.94 138.16 46.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.83 0.348 . . . . 0.0 110.971 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.42 175.37 10.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.84 84.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.284 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.06 152.81 12.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 111.191 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' C' ' 36' ' ' VAL . 10.3 pt -132.05 142.17 44.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.422 ' CB ' ' CG ' ' C' ' 50' ' ' GLN . 91.8 Cg_endo -80.0 53.93 4.97 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.964 2.443 . . . . 0.0 112.975 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . 0.41 HG13 ' HA2' ' C' ' 41' ' ' GLY . 45.7 t -63.0 85.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.134 0.492 . . . . 0.0 110.537 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' C' ' 41' ' ' GLY . 27.9 t-20 -35.74 131.67 0.56 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.015 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.64 -13.42 32.44 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.318 2.012 . . . . 0.0 112.008 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.66 -20.0 10.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.548 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.02 -30.16 7.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.988 0.423 . . . . 0.0 110.634 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 69.77 51.98 22.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.484 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -170.98 -80.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.724 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 7.4 p -165.99 112.71 0.76 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.169 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -50.97 139.64 41.05 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.318 2.012 . . . . 0.0 112.161 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.44 72.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.026 0.441 . . . . 0.0 111.001 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.46 91.7 1.05 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 24.1 mm -41.33 -35.13 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.192 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.79 -45.41 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.467 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.76 95.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.438 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.422 ' CG ' ' CB ' ' C' ' 35' ' ' PRO . 0.0 OUTLIER -68.7 -32.44 72.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.214 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.88 -38.5 73.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.116 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -70.76 -48.9 51.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.55 -28.12 68.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.799 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -45.6 77.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 mt -68.38 -22.2 64.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.94 -54.53 8.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.417 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' C' ' 58' ' ' VAL . 29.2 p30 -55.8 -30.9 62.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.304 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.403 ' N ' ' OD1' ' C' ' 57' ' ' ASN . 40.3 t -69.31 -50.33 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 110.744 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.403 ' HA ' HG21 ' C' ' 62' ' ' ILE . 2.8 ptmm? -67.36 -33.84 76.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.753 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.52 -41.08 84.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.057 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 5.3 mt -65.17 -56.47 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.748 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . 0.417 ' CD1' ' CB ' ' C' ' 127' ' ' ALA . 5.2 tt -64.52 -26.19 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.826 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.53 -41.01 33.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.873 0.368 . . . . 0.0 110.335 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -15.48 63.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.724 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.12 -27.01 18.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.856 0.36 . . . . 0.0 111.003 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.15 44.24 0.49 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.36 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . 0.405 ' CB ' HG12 ' C' ' 62' ' ' ILE . 4.5 mt -157.21 139.59 14.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.385 . . . . 0.0 110.828 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 27.1 p -92.75 159.38 15.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.782 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.534 ' CB ' ' CE1' ' C' ' 101' ' ' HIS . . . -57.34 -34.76 69.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.8 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.513 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -49.77 -27.4 4.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.909 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.07 -27.99 48.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.046 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 78.8 mt -44.47 118.42 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.901 0.381 . . . . 0.0 111.003 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.427 ' CB ' ' HG3' ' A' ' 4' ' ' GLN . 10.3 m -83.58 -46.26 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.196 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . 0.43 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 6.8 tttm -141.7 147.7 37.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.626 0.25 . . . . 0.0 110.966 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' THR . . . . . 0.426 ' N ' ' HG2' ' C' ' 74' ' ' LYS . 2.3 t -141.52 117.5 10.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.41 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.98 162.56 18.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.309 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.4 t -150.81 103.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.366 . . . . 0.0 111.929 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.422 ' CD2' HG13 ' B' ' 110' ' ' VAL . 9.5 m-85 -94.04 96.32 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.187 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.27 148.46 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.652 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -79.98 -5.21 55.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.027 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.87 143.06 9.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.454 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.87 2.11 47.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.27 -19.94 26.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.571 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.93 -29.99 16.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 35.1 t80 -57.24 -26.24 60.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.129 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.84 69.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.248 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.98 -33.11 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.23 -42.35 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 31.9 t30 -67.68 -39.52 84.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.43 -30.4 69.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.063 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.41 -32.48 22.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -58.58 -47.71 83.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -75.57 -20.84 58.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.281 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' C' ' 98' ' ' GLU . 0.1 OUTLIER -77.39 -31.87 54.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.453 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.2 OUTLIER -89.53 -33.37 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 110.672 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.507 ' CG ' ' HB2' ' C' ' 101' ' ' HIS . 0.1 OUTLIER -57.94 -53.78 54.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.866 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -32.09 70.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.934 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' C' ' 94' ' ' ARG . 3.8 pt-20 -72.73 -12.6 61.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.652 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.537 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 6.5 m-80 -102.9 -13.97 16.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.089 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 59.1 m-20 97.49 41.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.974 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.537 ' CE1' ' HB3' ' C' ' 99' ' ' ASN . 3.9 m170 -119.95 51.99 2.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.76 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 74.0 Cg_endo -74.12 -3.77 14.33 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.549 2.166 . . . . 0.0 113.086 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -30.69 69.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.846 0.355 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.47 ' HB2' ' CG1' ' A' ' 19' ' ' VAL . 15.4 m-85 65.18 113.1 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.638 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.486 ' HD3' ' CE2' ' C' ' 96' ' ' PHE . 79.1 Cg_endo -96.61 151.3 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.388 2.725 . . . . 0.0 112.691 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . 0.407 ' CB ' ' HG3' ' C' ' 74' ' ' LYS . . . -59.92 163.39 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.68 137.73 10.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.21 0.528 . . . . 0.0 112.067 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.19 84.45 2.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.975 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 52.6 t -90.6 145.21 25.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . 0.401 HG13 ' CD2' ' A' ' 78' ' ' PHE . 32.8 m -152.97 132.82 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.051 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -67.17 82.04 0.13 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.1 161.71 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.93 -44.17 20.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.63 164.65 33.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mt -139.76 159.98 62.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.57 134.61 40.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.471 2.114 . . . . 0.0 112.283 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.44 14.37 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.174 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.35 17.97 8.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.793 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -53.84 164.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.115 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.14 -24.47 34.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.592 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -153.27 147.33 25.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.13 0.491 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.39 138.62 47.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.773 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.78 138.02 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.371 0.605 . . . . 0.0 112.286 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.56 107.94 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.19 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -121.95 161.74 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.34 0.591 . . . . 0.0 112.486 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 2.3 mp -111.78 155.45 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.998 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.417 ' CB ' ' CD1' ' C' ' 62' ' ' ILE . . . -142.4 150.04 40.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.027 0.442 . . . . 0.0 111.47 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.03 179.71 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.042 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -162.23 45.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.921 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mmm . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.807 0.337 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.81 175.19 10.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 62.15 117.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.59 121.0 7.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -56.3 141.66 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.172 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 mt -92.58 146.42 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.271 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.416 ' CD2' ' HG3' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -151.28 117.32 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.699 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 t -129.29 161.58 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.031 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.68 24.85 6.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 -51.95 3.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.63 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.06 112.82 38.66 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.018 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -60.66 -16.16 41.55 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.446 2.097 . . . . 0.0 112.531 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.76 -168.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.293 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.592 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 63.65 -167.48 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.341 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.4 mm 78.26 16.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.239 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.21 -134.69 3.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.141 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.91 23.17 0.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.657 2.238 . . . . 0.0 112.868 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.592 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -154.18 -168.73 3.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.764 0.316 . . . . 0.0 110.822 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.86 172.23 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.264 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.416 ' HG3' ' CD2' ' A' ' 7' ' ' HIS . 0.3 OUTLIER -67.59 -55.09 14.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.866 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.78 178.5 10.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.038 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.96 134.31 65.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -117.77 96.3 5.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.839 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.35 -20.39 57.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.984 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.89 -106.02 0.73 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.825 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -59.58 -29.59 68.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 110.148 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.15 120.12 32.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.866 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.1 m -111.13 167.51 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.992 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.84 155.33 38.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.838 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -117.51 136.03 53.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.945 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 55.7 m -68.74 167.04 16.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.11 82.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.323 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -76.38 145.95 39.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.097 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 8.3 pt -128.49 160.31 63.2 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.436 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 84.7 Cg_exo -43.3 -47.85 8.6 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.721 2.281 . . . . 0.0 111.778 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 37' ' ' ASN . 9.8 p 46.91 21.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.751 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 36' ' ' VAL . 7.2 t-20 58.7 138.7 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.881 0.372 . . . . 0.0 111.45 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.71 -34.02 20.11 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.009 2.473 . . . . 0.0 113.258 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.63 17.75 0.13 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -107.22 -17.69 14.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.366 . . . . 0.0 110.428 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 36' ' ' VAL . . . 70.09 43.18 65.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.887 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -143.34 -83.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.567 0.222 . . . . 0.0 110.791 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 42' ' ' GLU . 8.2 p 174.11 128.06 0.11 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.943 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 14.2 Cg_exo -69.97 143.57 50.22 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.606 2.204 . . . . 0.0 112.226 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.65 63.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.079 0.466 . . . . 0.0 110.957 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.3 96.05 0.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.617 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.01 -32.16 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.629 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.07 -52.45 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.592 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.33 -28.49 70.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.478 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.436 ' HG2' ' CG ' ' A' ' 35' ' ' PRO . 0.9 OUTLIER -79.75 -28.68 40.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.458 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.49 58.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.031 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -74.42 -41.74 60.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.083 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.21 -43.81 87.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.026 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.6 m -59.51 -43.62 93.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -66.4 -35.41 80.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.988 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.88 -38.27 82.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.011 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.64 -36.41 84.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 t -69.82 -46.94 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.947 0.403 . . . . 0.0 110.943 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -31.37 65.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.827 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.77 91.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 mt -65.44 -56.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.413 ' CD1' ' CB ' ' A' ' 127' ' ' ALA . 4.9 tt -63.83 -26.22 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.742 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 -40.12 60.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.374 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -10.78 59.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.788 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.84 -29.62 18.48 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.875 0.369 . . . . 0.0 110.905 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.61 52.42 0.33 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.52 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mt -147.88 -169.89 3.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.09 160.09 41.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.99 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.56 72.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.119 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.534 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -62.82 -17.18 60.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.461 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.28 -24.57 27.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.814 0.34 . . . . 0.0 110.829 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 47.0 mt -53.71 118.55 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.128 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.4 m -89.28 -37.19 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.707 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -141.25 149.33 41.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.705 0.288 . . . . 0.0 110.774 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' A' ' 74' ' ' LYS . 89.3 m -144.96 110.36 5.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.95 0.405 . . . . 0.0 111.323 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.8 m -95.22 157.81 15.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.246 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 3.3 m -159.1 142.46 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.084 0.468 . . . . 0.0 111.761 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.434 ' CD2' HG11 ' C' ' 110' ' ' VAL . 3.5 m-85 -114.0 119.09 36.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.283 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.409 HG11 ' CD1' ' A' ' 85' ' ' PHE . 33.2 m -107.34 152.23 9.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.114 0.483 . . . . 0.0 111.735 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.51 0.17 39.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.821 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -163.28 107.5 1.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.566 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.87 -13.89 60.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.222 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -79.66 -27.79 40.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.909 0.385 . . . . 0.0 110.493 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.32 -12.18 55.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.831 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.409 ' CD1' HG11 ' A' ' 79' ' ' VAL . 1.6 t80 -58.63 -24.52 61.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.82 -56.52 11.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.352 . . . . 0.0 111.38 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.48 -36.83 83.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 t -64.8 -42.07 93.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.16 -42.32 89.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.481 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.81 75.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.895 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -88.69 -30.01 19.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.693 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.428 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 58.7 t80 -57.72 -49.7 75.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.014 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.44 -17.49 45.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -75.12 -27.92 60.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.658 0.265 . . . . 0.0 111.38 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -86.19 -33.35 20.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.38 . . . . 0.0 110.525 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.471 ' CZ ' ' CD ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -56.27 -55.7 30.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.334 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.62 -28.81 70.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.889 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.47 -6.22 59.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.35 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 1.5 m120 -111.47 -5.13 14.62 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.56 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.0 m120 85.42 33.31 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.803 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.534 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 20.1 t-160 -128.88 67.3 77.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.529 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.416 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 4.5 Cg_exo -75.48 -20.24 16.13 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.602 2.202 . . . . 0.0 112.525 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.15 -36.69 77.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.063 0.459 . . . . 0.0 110.344 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' A' ' 102' ' ' PRO . 15.8 m-85 74.06 142.56 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.427 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.471 ' CD ' ' CZ ' ' A' ' 96' ' ' PHE . 73.2 Cg_endo -90.07 165.88 4.71 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.209 2.606 . . . . 0.0 111.956 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.1 154.11 1.24 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.421 ' CB ' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -119.02 140.98 49.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.227 0.537 . . . . 0.0 112.048 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.6 t -144.28 45.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.986 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 28.7 p -81.37 135.08 35.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.249 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.448 HG11 ' CD2' ' B' ' 78' ' ' PHE . 23.0 m -153.85 149.34 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.203 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.418 ' HB3' ' CB ' ' B' ' 114' ' ' ARG . 0.0 OUTLIER -84.4 91.04 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.771 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.15 177.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.188 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.83 -45.95 14.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.005 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.72 -179.72 7.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.788 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 mt -149.2 155.6 39.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.704 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 9.2 Cg_endo -52.33 139.23 55.06 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.523 2.149 . . . . 0.0 111.977 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 7.9 mmtm 66.46 17.72 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.278 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 61.63 17.45 8.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.025 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.1 m -55.76 167.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.073 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.03 8.49 42.24 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.918 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.58 154.6 3.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.086 0.469 . . . . 0.0 111.226 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.2 159.01 43.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.002 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.9 mt -144.25 145.75 21.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.38 0.609 . . . . 0.0 112.301 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.16 101.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.322 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 75' ' ' THR . . . -119.07 163.59 16.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.171 0.51 . . . . 0.0 112.194 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 126' ' ' ILE . 5.7 mt -114.43 151.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.133 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.413 ' CB ' ' CD1' ' A' ' 62' ' ' ILE . . . -136.06 148.39 48.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.034 0.445 . . . . 0.0 111.574 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.92 151.44 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.122 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.08 70.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.819 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.884 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 71.2 mmm . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.821 0.343 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.87 175.14 10.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 62.16 117.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.58 120.97 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -56.26 141.66 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mt -92.61 146.33 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.318 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.2 117.41 5.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.718 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 14.3 t -129.32 161.6 29.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.036 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.69 24.85 6.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.807 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.5 -52.47 3.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.677 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.5 112.93 38.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.7 -16.16 41.84 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.436 2.09 . . . . 0.0 112.473 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.75 -168.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.252 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.601 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 63.73 -167.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.315 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 19.4 mm 78.23 16.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.288 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.26 -134.73 3.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.163 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.84 23.18 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.685 2.256 . . . . 0.0 112.926 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.601 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -154.13 -168.71 3.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.755 0.312 . . . . 0.0 110.829 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 104' ' ' PHE . 15.5 m -124.88 172.31 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.362 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.71 -55.16 14.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.802 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.13 178.44 10.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.995 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 m -127.88 134.27 65.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.082 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -117.67 96.23 5.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.34 -20.42 57.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.002 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.97 -106.03 0.73 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.83 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -59.62 -29.51 68.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.038 0.447 . . . . 0.0 110.152 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.19 120.07 32.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.872 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 5.1 m -111.07 167.54 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.01 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.91 155.31 38.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -117.38 135.8 53.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 56.5 m -68.89 166.97 16.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.13 82.13 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.307 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -76.39 145.89 39.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.357 . . . . 0.0 111.15 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' B' ' 35' ' ' PRO . 8.2 pt -128.48 160.3 63.23 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.545 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.437 ' CG ' ' HG2' ' B' ' 50' ' ' GLN . 84.5 Cg_exo -43.2 -47.93 8.38 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.755 2.303 . . . . 0.0 111.753 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' B' ' 37' ' ' ASN . 9.8 p 46.91 21.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.717 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.412 ' O ' ' O ' ' B' ' 36' ' ' VAL . 7.2 t-20 58.72 138.69 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.895 0.378 . . . . 0.0 111.455 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.75 -34.01 20.38 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.042 2.495 . . . . 0.0 113.207 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.63 17.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -107.35 -17.79 14.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 110.445 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.412 ' HA2' ' CG2' ' B' ' 36' ' ' VAL . . . 70.14 43.36 64.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.89 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 0.0 OUTLIER -143.37 -83.31 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.602 0.239 . . . . 0.0 110.833 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 8.2 p 174.08 128.05 0.11 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.927 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 43' ' ' VAL . 14.2 Cg_exo -69.96 143.6 50.38 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.636 2.224 . . . . 0.0 112.214 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.65 63.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.995 0.426 . . . . 0.0 110.896 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.22 96.05 0.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.677 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.0 -32.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.589 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.95 -52.51 15.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.64 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.35 -28.43 69.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.469 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.437 ' HG2' ' CG ' ' B' ' 35' ' ' PRO . 0.9 OUTLIER -79.76 -28.61 40.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.485 179.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.51 -35.45 58.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -74.38 -41.76 60.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.23 -43.75 87.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -59.47 -43.62 93.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.034 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 75.2 mt -66.44 -35.34 80.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.89 -38.35 82.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.6 -36.35 83.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.06 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 t -69.85 -46.91 72.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 0.0 110.956 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.4 ' HA ' HG22 ' B' ' 62' ' ' ILE . 0.0 OUTLIER -72.6 -31.29 65.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.812 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.24 -40.85 91.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.932 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 mt -65.48 -56.86 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.419 ' CD1' ' CB ' ' B' ' 127' ' ' ALA . 5.0 tt -63.83 -26.2 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.725 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -40.07 60.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.924 0.393 . . . . 0.0 110.446 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -10.84 59.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.812 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.78 -29.72 18.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.69 52.42 0.32 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mt -147.94 -169.94 3.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 110.577 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.08 160.14 40.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.982 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.98 -33.52 72.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.05 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.535 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -62.83 -17.17 60.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.448 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.16 -24.64 27.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 110.805 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.69 118.53 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.095 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 12.5 m -89.23 -37.22 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.73 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -141.21 149.37 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.708 0.29 . . . . 0.0 110.78 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' B' ' 74' ' ' LYS . 89.2 m -144.99 110.29 5.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 87.8 m -95.09 157.75 15.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.242 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' B' ' 109' ' ' CYS . 3.2 m -159.05 142.5 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.758 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.448 ' CD2' HG11 ' A' ' 110' ' ' VAL . 3.5 m-85 -114.01 119.09 36.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.248 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' B' ' 85' ' ' PHE . 33.9 m -107.33 152.18 9.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.125 0.488 . . . . 0.0 111.765 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.53 -0.14 38.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.817 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.85 107.51 1.11 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.578 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.99 -13.78 60.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.215 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -79.67 -27.85 40.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 0.0 110.484 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.27 -12.17 55.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.864 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.411 ' CD1' HG11 ' B' ' 79' ' ' VAL . 1.6 t80 -58.68 -24.43 61.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.007 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.87 -56.52 11.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 111.331 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.83 83.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 34.3 t -64.83 -42.06 93.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.715 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.18 -42.2 89.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.5 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.04 -36.09 76.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.938 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -88.45 -29.96 19.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.724 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.419 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 58.6 t80 -57.75 -49.66 75.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.028 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.47 -17.46 45.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.504 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -75.09 -27.94 60.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.699 0.285 . . . . 0.0 111.414 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.449 ' C ' ' CD1' ' B' ' 95' ' ' PHE . 0.9 OUTLIER -86.15 -33.48 20.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.499 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' B' ' 101' ' ' HIS . 0.9 OUTLIER -56.19 -55.76 29.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.344 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.54 -28.9 70.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.914 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -6.24 59.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.397 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 1.5 m120 -111.41 -5.15 14.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 6.9 m120 85.44 33.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.894 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.535 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.1 t-160 -128.81 67.42 77.46 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.534 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.416 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 4.6 Cg_exo -75.48 -20.25 16.12 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.621 2.214 . . . . 0.0 112.519 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -36.68 77.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.307 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.427 ' O ' HG11 ' C' ' 19' ' ' VAL . 15.8 m-85 74.07 142.52 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.453 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.462 ' CD ' ' CZ ' ' B' ' 96' ' ' PHE . 72.2 Cg_endo -90.09 165.86 4.69 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.107 2.538 . . . . 0.0 111.98 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.409 ' CB ' ' HG3' ' B' ' 74' ' ' LYS . . . -50.02 154.18 1.19 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.451 ' CB ' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -119.1 141.0 49.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.215 0.531 . . . . 0.0 112.068 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 30.8 t -144.26 45.83 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.954 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 77' ' ' VAL . 28.7 p -81.44 135.02 35.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.277 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' C' ' 78' ' ' PHE . 23.4 m -153.7 149.06 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.149 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.49 91.04 7.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.822 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.15 177.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.206 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.79 -45.92 14.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.418 ' CB ' ' HB3' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -151.7 -179.53 7.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.753 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 59.5 mt -149.33 155.56 39.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.669 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' B' ' 117' ' ' LYS . 9.3 Cg_endo -52.35 139.25 55.23 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.537 2.158 . . . . 0.0 111.987 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 8.0 mmtm 66.38 17.81 10.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.253 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 61.53 17.52 8.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.065 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 30.3 m -55.8 167.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.062 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.11 8.12 41.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.888 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.47 154.5 3.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.165 0.507 . . . . 0.0 111.296 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.12 158.95 43.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.025 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 28.2 mt -144.21 145.75 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.309 0.576 . . . . 0.0 112.309 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.17 101.48 1.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.344 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' B' ' 75' ' ' THR . . . -119.02 163.56 16.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.198 0.523 . . . . 0.0 112.245 -178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.429 HG23 HD11 ' B' ' 126' ' ' ILE . 5.7 mt -114.41 151.9 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.114 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.419 ' CB ' ' CD1' ' B' ' 62' ' ' ILE . . . -136.06 148.32 48.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.993 0.425 . . . . 0.0 111.618 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.82 151.38 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.06 70.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.84 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mmm . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.792 0.33 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.83 175.15 10.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 62.15 117.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.56 121.02 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -56.31 141.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 32.0 mt -92.61 146.37 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.234 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . 0.409 ' CD2' ' HG3' ' C' ' 20' ' ' GLN . 0.1 OUTLIER -151.24 117.37 5.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.705 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 14.3 t -129.3 161.61 29.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.037 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.72 24.89 6.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 -52.34 3.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.751 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.62 112.86 37.78 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.05 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.65 -16.13 41.34 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.436 2.09 . . . . 0.0 112.525 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.8 -168.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.249 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.608 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 63.69 -167.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.332 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 19.4 mm 78.26 16.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.215 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.21 -134.78 3.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.14 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.8 23.16 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.609 2.206 . . . . 0.0 112.9 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.608 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -154.1 -168.61 3.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.738 0.304 . . . . 0.0 110.855 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.427 HG11 ' O ' ' B' ' 104' ' ' PHE . 15.4 m -124.97 172.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.29 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . 0.409 ' HG3' ' CD2' ' C' ' 7' ' ' HIS . 0.3 OUTLIER -67.61 -55.01 15.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.936 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.95 178.57 10.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.026 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 m -127.92 134.21 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -117.73 96.32 5.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.37 -20.36 57.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.0 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.92 -106.03 0.73 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.839 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.62 -29.55 68.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.119 0.485 . . . . 0.0 110.186 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.2 120.08 32.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 m -111.06 167.52 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.83 155.35 39.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.2 p -117.52 135.91 53.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.862 0.363 . . . . 0.0 110.914 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 56.3 m -68.55 166.99 15.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.818 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.03 82.14 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.341 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -76.43 145.92 38.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 111.178 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.419 ' HB ' ' HD2' ' C' ' 35' ' ' PRO . 8.3 pt -128.47 160.32 63.08 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.574 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.442 ' CG ' ' HG2' ' C' ' 50' ' ' GLN . 85.6 Cg_exo -43.22 -47.92 8.43 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.73 2.286 . . . . 0.0 111.757 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' C' ' 37' ' ' ASN . 9.8 p 46.94 21.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.769 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' C' ' 36' ' ' VAL . 7.1 t-20 58.73 138.71 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.902 0.382 . . . . 0.0 111.496 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.78 -33.99 20.53 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.058 2.505 . . . . 0.0 113.215 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.64 17.71 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -107.16 -17.59 14.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 110.46 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' C' ' 36' ' ' VAL . . . 69.95 43.19 66.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.894 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . 0.438 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 0.0 OUTLIER -143.32 -83.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.61 0.243 . . . . 0.0 110.842 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' C' ' 42' ' ' GLU . 8.2 p 174.06 128.05 0.11 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.936 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' C' ' 43' ' ' VAL . 14.2 Cg_exo -69.97 143.63 50.4 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.616 2.21 . . . . 0.0 112.235 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.62 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.044 0.45 . . . . 0.0 110.897 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.29 96.06 0.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.602 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.03 -32.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.605 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.95 -52.53 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.623 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.36 -28.45 70.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.492 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.442 ' HG2' ' CG ' ' C' ' 35' ' ' PRO . 0.9 OUTLIER -79.69 -28.52 40.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.452 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.54 58.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -74.23 -41.87 60.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.24 -43.72 87.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -59.47 -43.71 93.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.38 -35.38 80.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.003 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.86 -38.3 82.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.014 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.63 -36.34 83.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.9 -46.93 72.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.923 0.392 . . . . 0.0 110.936 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -31.47 65.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.764 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.8 90.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.907 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 mt -65.39 -56.78 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.71 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . 0.418 ' CD1' ' CB ' ' C' ' 127' ' ' ALA . 4.9 tt -63.89 -26.19 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.746 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -40.03 60.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.921 0.391 . . . . 0.0 110.431 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -10.75 59.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.8 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.89 -29.64 18.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.837 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.63 52.42 0.33 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.485 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mt -147.91 -169.89 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 110.585 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.12 160.15 40.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.032 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.5 72.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.53 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -62.92 -17.31 61.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.42 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.18 -24.43 27.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.784 0.326 . . . . 0.0 110.786 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 47.1 mt -53.79 118.62 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.08 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 12.5 m -89.32 -37.16 9.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.693 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -141.26 149.36 41.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.782 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' THR . . . . . 0.43 ' N ' ' HG2' ' C' ' 74' ' ' LYS . 89.5 m -145.0 110.31 5.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.92 0.391 . . . . 0.0 111.343 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 87.8 m -95.14 157.82 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.217 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' C' ' 109' ' ' CYS . 3.3 m -159.15 142.47 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.081 0.467 . . . . 0.0 111.774 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.43 ' CD2' HG11 ' B' ' 110' ' ' VAL . 3.5 m-85 -114.0 119.07 35.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.283 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . 0.407 HG11 ' CD1' ' C' ' 85' ' ' PHE . 33.5 m -107.31 152.23 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.102 0.477 . . . . 0.0 111.744 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.55 -0.15 38.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.806 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.85 107.45 1.11 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.572 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.89 -13.82 60.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.213 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -79.69 -27.78 40.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.482 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.29 -12.17 55.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.83 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.407 ' CD1' HG11 ' C' ' 79' ' ' VAL . 1.6 t80 -58.7 -24.45 61.43 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.996 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.86 -56.51 11.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.338 . . . . 0.0 111.353 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.82 83.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 t -64.84 -42.07 93.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.72 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.13 -42.35 89.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.483 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.97 76.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.865 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -88.63 -29.88 19.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.7 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.424 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 59.0 t80 -57.77 -49.68 75.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.011 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.46 -17.46 45.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.496 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -75.1 -27.91 60.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.711 0.291 . . . . 0.0 111.381 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.9 OUTLIER -86.19 -33.45 20.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 110.493 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.461 ' CZ ' ' CD ' ' C' ' 105' ' ' PRO . 0.9 OUTLIER -56.2 -55.79 28.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.329 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.53 -28.91 70.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.882 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.39 -6.24 59.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.381 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 1.5 m120 -111.43 -5.14 14.64 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.588 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 6.9 m120 85.45 33.18 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.851 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.53 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.1 t-160 -128.89 67.38 77.73 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.481 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 4.5 Cg_exo -75.42 -20.32 16.16 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.667 2.244 . . . . 0.0 112.528 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -36.77 77.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.452 . . . . 0.0 110.336 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.417 ' CE2' ' O ' ' C' ' 102' ' ' PRO . 15.8 m-85 74.1 142.56 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.404 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.461 ' CD ' ' CZ ' ' C' ' 96' ' ' PHE . 73.5 Cg_endo -90.12 165.85 4.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.176 2.584 . . . . 0.0 111.929 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . 0.4 ' CB ' ' HG3' ' C' ' 74' ' ' LYS . . . -49.99 154.03 1.22 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.448 ' CB ' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -119.0 140.98 49.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.275 0.559 . . . . 0.0 112.086 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 30.5 t -144.28 45.87 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.963 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' C' ' 77' ' ' VAL . 28.8 p -81.44 135.01 35.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.312 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . 0.434 HG11 ' CD2' ' A' ' 78' ' ' PHE . 23.1 m -153.82 149.23 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.19 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.24 91.0 7.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.72 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.16 177.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.246 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -81.8 -46.0 14.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.999 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.71 -179.79 7.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 59.7 mt -149.14 155.58 40.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.727 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' C' ' 117' ' ' LYS . 9.2 Cg_endo -52.31 139.22 54.9 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.536 2.157 . . . . 0.0 111.992 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 8.0 mmtm 66.45 17.73 10.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.212 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 61.64 17.43 8.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.042 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 30.5 m -55.71 167.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.106 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -105.86 8.35 42.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.914 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.37 154.46 3.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.069 0.461 . . . . 0.0 111.22 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.12 159.0 43.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.027 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 27.8 mt -144.26 145.75 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.359 0.599 . . . . 0.0 112.334 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.17 101.49 1.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.333 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' C' ' 75' ' ' THR . . . -119.04 163.57 16.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.203 0.525 . . . . 0.0 112.185 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . 0.42 HG23 HD11 ' C' ' 126' ' ' ILE . 5.7 mt -114.4 151.87 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.099 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.418 ' CB ' ' CD1' ' C' ' 62' ' ' ILE . . . -136.03 148.39 48.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 0.0 111.629 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.89 151.42 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.12 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.09 70.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.811 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.774 0.321 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.03 111.98 23.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.1 m 61.68 114.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -171.06 125.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -56.54 141.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.9 mt -98.01 149.84 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.24 26.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.27 171.11 20.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.3 28.44 8.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.033 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -120.5 -44.96 2.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.712 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.485 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . . . -66.55 171.48 4.23 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.868 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 11' ' ' ALA . 29.6 Cg_endo -63.6 -12.68 32.33 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.572 2.181 . . . . 0.0 112.523 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.44 147.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.492 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . . . -126.28 120.95 31.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.838 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.23 17.1 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.073 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.92 -118.88 2.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.382 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.81 14.92 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.675 2.25 . . . . 0.0 113.316 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -147.04 -174.06 4.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.994 0.426 . . . . 0.0 111.517 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 18.0 m -138.61 169.34 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.798 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -49.09 79.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.602 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.02 -178.07 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.962 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 m -141.48 133.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HA ' HG23 ' A' ' 28' ' ' VAL . 37.6 t70 -110.8 115.39 29.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.839 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mt -90.98 -16.03 28.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -99.3 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.755 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -56.91 -29.12 62.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.183 0.516 . . . . 0.0 110.072 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.21 135.19 38.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.774 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.413 ' CG1' ' CB ' ' A' ' 127' ' ' ALA . 4.8 p -109.51 164.55 5.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.871 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.6 131.28 22.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.835 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.3 p -104.71 144.9 31.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.2 p -82.98 178.88 7.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.4 89.73 0.82 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.195 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -56.22 144.25 30.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.5 tt -125.51 132.89 24.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.702 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.528 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 21.9 Cg_exo -65.02 65.24 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.666 2.244 . . . . 0.0 112.56 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.3 t -84.8 88.21 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.122 0.487 . . . . 0.0 110.625 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' A' ' 41' ' ' GLY . 1.8 m-20 -33.86 134.48 0.35 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.893 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.27 -20.79 20.84 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.489 2.126 . . . . 0.0 112.277 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.35 -3.59 14.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.601 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.7 m -126.22 -30.26 2.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.829 0.347 . . . . 0.0 110.83 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 65.99 53.44 30.27 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.325 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -165.59 -82.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.507 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 7.2 p 175.55 125.17 0.14 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.074 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.29 138.98 23.02 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.354 2.036 . . . . 0.0 112.191 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.73 -31.08 71.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.061 0.458 . . . . 0.0 110.902 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 94.9 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.904 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.5 mm -44.26 -31.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.878 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.78 -38.8 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.576 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.75 -54.34 36.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.47 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.38 -26.4 68.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.341 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.88 -40.77 72.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.4 -48.82 16.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.789 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.53 -46.73 88.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.745 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.422 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 89.2 p -60.05 -37.25 79.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD23 ' CD2' ' A' ' 92' ' ' TYR . 22.0 mt -76.54 -23.41 53.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.043 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -52.14 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.7 OUTLIER -58.08 -29.19 65.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.982 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.403 HG21 ' ND2' ' A' ' 57' ' ' ASN . 54.4 t -65.06 -46.39 91.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.984 0.421 . . . . 0.0 110.643 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -28.96 61.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.844 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.74 93.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.025 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.8 mt -73.59 -41.77 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 mt -69.48 -31.24 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.553 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.61 -37.33 59.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.034 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -22.41 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.272 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.87 -28.82 20.1 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.787 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.97 50.51 0.63 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.591 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -146.66 -176.56 5.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.409 . . . . 0.0 110.716 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.77 163.83 31.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.778 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.459 ' O ' ' CD2' ' A' ' 101' ' ' HIS . . . -50.26 -34.57 23.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.031 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -67.49 -24.78 65.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.359 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -80.46 -6.58 58.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.717 0.294 . . . . 0.0 110.959 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 24.2 mt -83.81 116.1 27.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.249 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.58 -46.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.041 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -118.41 -177.6 3.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.59 0.233 . . . . 0.0 111.093 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.519 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 11.1 t -179.99 101.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.895 0.378 . . . . 0.0 111.496 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.437 HG21 ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -71.21 126.72 30.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.198 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.8 t -114.71 98.88 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.437 ' CE1' HG21 ' A' ' 76' ' ' THR . 17.2 m-85 -98.17 147.49 24.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.951 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -144.76 151.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.09 0.471 . . . . 0.0 111.899 -179.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.0 -2.6 56.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.764 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.29 110.31 0.57 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.416 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.0 mt -56.81 -18.6 13.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.322 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -75.86 -23.47 55.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.844 0.354 . . . . 0.0 110.583 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -77.97 -12.77 60.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -27.21 59.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.252 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.46 71.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.779 0.323 . . . . 0.0 111.415 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.88 -29.45 20.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.287 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.2 t -73.84 -47.1 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.153 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -64.86 -39.32 93.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.47 -37.27 85.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -33.34 19.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.621 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 96' ' ' PHE . 35.3 t80 -61.16 -56.47 20.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.346 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -70.19 -15.29 62.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.333 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -40.06 66.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -84.95 -38.78 18.91 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.342 -179.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.493 ' CE1' ' CE1' ' A' ' 92' ' ' TYR . 11.1 m-85 -53.92 -50.63 65.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 110.32 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.94 -32.36 74.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.875 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.65 -1.9 54.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.432 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -110.4 -8.6 14.67 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.66 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.7 t-20 97.08 19.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.796 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.523 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.3 t60 -118.77 59.93 4.32 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.858 0.361 . . . . 0.0 110.927 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.403 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 43.9 Cg_endo -68.19 -17.78 45.16 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.493 2.129 . . . . 0.0 112.175 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -34.2 61.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.7 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 33.2 m-85 72.26 140.19 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.103 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 104' ' ' PHE . 7.2 Cg_exo -71.83 166.77 28.51 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.747 2.298 . . . . 0.0 112.138 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.52 131.01 54.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.726 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.519 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -167.48 -165.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.089 0.471 . . . . 0.0 111.303 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -116.24 114.93 25.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.209 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 16.0 m -95.69 131.47 41.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.275 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 m -158.96 170.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.494 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 6.9 tt0 -110.6 95.34 5.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.804 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.3 m -60.46 157.3 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.89 -45.73 93.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.992 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -151.87 173.99 14.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.688 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.66 156.26 59.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.69 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 12.4 Cg_endo -55.93 137.75 79.91 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.489 2.126 . . . . 0.0 111.988 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 10.3 mttt 68.18 16.03 9.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.328 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.97 15.58 9.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.3 m -51.79 169.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.713 0.292 . . . . 0.0 111.075 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.67 17.02 13.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.027 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.17 153.44 1.59 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.102 0.477 . . . . 0.0 111.397 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -142.5 140.22 31.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.884 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.1 mm -121.79 127.01 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 112.141 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 76' ' ' THR . 1.0 OUTLIER -140.21 146.23 38.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.08 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.4 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . . . -170.05 174.22 5.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.267 0.555 . . . . 0.0 112.275 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.2 mt -132.28 151.28 34.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.188 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -132.48 150.78 52.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.15 0.5 . . . . 0.0 111.756 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.0 m -110.64 116.23 51.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.874 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -122.67 75.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.933 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.866 179.928 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.841 0.353 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.01 112.04 23.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 3.1 m 61.6 114.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -170.98 125.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -56.5 141.38 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 21.8 mt -97.97 149.85 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.209 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.25 26.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.3 171.14 20.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.36 28.48 8.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.99 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -120.64 -44.5 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.747 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.484 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . . . -66.68 171.3 4.53 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.971 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' B' ' 11' ' ' ALA . 29.7 Cg_endo -63.67 -12.72 32.73 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.563 2.176 . . . . 0.0 112.488 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.52 147.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.474 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.442 ' HB2' ' CE2' ' B' ' 18' ' ' TYR . . . -126.32 120.94 31.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.795 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.21 17.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.162 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.91 -118.96 2.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.39 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -89.64 14.72 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.787 2.325 . . . . 0.0 113.306 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.442 ' CE2' ' HB2' ' B' ' 14' ' ' ALA . 0.7 OUTLIER -146.99 -174.04 4.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 0.0 111.506 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.404 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 18.1 m -138.55 169.34 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.823 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -49.17 78.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 110.636 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.14 -177.93 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 m -141.51 133.29 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.151 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.409 ' HA ' HG23 ' B' ' 28' ' ' VAL . 37.6 t70 -110.77 115.36 29.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mt -90.88 -16.01 28.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.231 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.65 -99.29 0.81 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.767 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -56.93 -29.05 62.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.171 0.51 . . . . 0.0 110.111 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.18 135.18 38.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.717 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.42 ' CG1' ' CB ' ' B' ' 127' ' ' ALA . 4.8 p -109.54 164.48 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.923 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.49 131.32 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 41.1 p -104.71 144.85 31.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.972 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 10.3 p -83.32 179.17 7.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.013 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.43 89.75 0.82 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.199 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -56.18 144.16 30.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.936 0.398 . . . . 0.0 111.275 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 9.6 tt -125.45 132.87 24.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.703 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.536 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 21.9 Cg_exo -64.98 65.2 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.69 2.26 . . . . 0.0 112.59 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 63.7 t -84.85 88.25 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.12 0.486 . . . . 0.0 110.584 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -33.82 134.48 0.35 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.849 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.28 -20.82 20.78 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.443 2.095 . . . . 0.0 112.232 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.25 -3.76 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.61 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 3.7 m -126.16 -30.17 2.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.851 0.358 . . . . 0.0 110.793 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.85 53.44 30.8 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.232 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 0.0 OUTLIER -165.55 -82.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.49 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 7.2 p 175.6 125.17 0.14 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.053 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.16 138.91 23.25 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.399 2.066 . . . . 0.0 112.283 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.68 -31.13 71.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 110.892 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.84 94.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 21.4 mm -44.27 -31.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.879 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.4 t -79.72 -38.8 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.78 -54.26 38.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.451 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.48 -26.74 68.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.344 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.68 -40.69 72.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.01 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.45 -48.71 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -59.6 -46.71 88.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.712 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' SER . . . . . 0.419 ' HA ' ' OD1' ' B' ' 57' ' ' ASN . 89.9 p -60.06 -37.25 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.859 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.413 HD23 ' CD2' ' B' ' 92' ' ' TYR . 21.9 mt -76.6 -23.3 53.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -52.07 12.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.169 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . 0.419 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.7 OUTLIER -58.01 -29.32 65.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.41 HG21 ' ND2' ' B' ' 57' ' ' ASN . 54.0 t -65.02 -46.39 91.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.921 0.391 . . . . 0.0 110.6 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.09 -28.94 61.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.91 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.01 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -73.21 -41.64 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.506 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 18.0 mt -69.51 -31.31 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.535 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.51 -37.39 60.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.1 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -22.38 66.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.276 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.83 -28.9 20.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.04 50.58 0.63 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.516 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -146.73 -176.68 5.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.988 0.423 . . . . 0.0 110.672 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.68 163.92 31.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.751 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' B' ' 101' ' ' HIS . . . -50.31 -34.62 24.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.043 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.532 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -67.49 -24.86 65.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.315 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -80.38 -6.6 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.929 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 24.4 mt -83.82 116.11 27.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.221 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.52 -47.03 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.05 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . 0.405 ' HB3' ' HD3' ' B' ' 107' ' ' ARG . 10.8 mtpt -118.35 -177.58 3.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.569 0.223 . . . . 0.0 111.153 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.521 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 11.2 t 179.98 101.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 111.539 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.446 HG21 ' CE1' ' B' ' 78' ' ' PHE . 0.0 OUTLIER -71.18 126.76 30.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.18 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.73 98.92 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.446 ' CE1' HG21 ' B' ' 76' ' ' THR . 17.1 m-85 -98.21 147.36 24.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.991 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 0.9 OUTLIER -144.68 151.76 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.173 0.511 . . . . 0.0 111.927 -179.252 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.03 -2.85 56.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.732 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.13 110.37 0.59 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.402 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.0 mt -56.92 -18.59 13.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.305 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -75.76 -23.58 55.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -77.91 -12.78 60.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -27.18 59.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.293 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.54 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.351 . . . . 0.0 111.408 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.87 -29.38 20.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.277 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.2 t -73.87 -47.09 44.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.128 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -64.9 -39.26 93.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.59 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.34 85.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.011 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.83 -33.34 19.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.646 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.498 ' CE1' ' CE1' ' B' ' 96' ' ' PHE . 35.4 t80 -61.23 -56.39 21.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.351 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -15.21 62.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.268 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -40.04 66.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.48 ' CE2' ' CE1' ' B' ' 96' ' ' PHE . 0.0 OUTLIER -84.95 -38.81 18.86 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.378 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.498 ' CE1' ' CE1' ' B' ' 92' ' ' TYR . 11.2 m-85 -53.86 -50.68 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.042 0.449 . . . . 0.0 110.328 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.96 -32.31 73.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.877 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.63 -1.93 55.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.463 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 1.0 OUTLIER -110.39 -8.63 14.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.637 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 2.7 t-20 97.09 19.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.761 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.532 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.3 t60 -118.53 59.86 4.01 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.961 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.411 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 44.0 Cg_endo -68.18 -17.79 45.23 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.457 2.105 . . . . 0.0 112.181 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -34.22 61.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.411 ' CE2' ' O ' ' B' ' 102' ' ' PRO . 33.0 m-85 72.26 140.19 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.425 ' HD3' ' CE2' ' B' ' 96' ' ' PHE . 7.2 Cg_exo -71.87 166.74 28.61 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.724 2.283 . . . . 0.0 112.113 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.45 131.02 54.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.761 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.521 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -167.51 -165.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.049 0.452 . . . . 0.0 111.33 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -116.16 114.93 25.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.224 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 16.0 m -95.69 131.52 41.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.207 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 m -158.96 170.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 111.413 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' B' ' 79' ' ' VAL . 6.9 tt0 -110.2 95.4 5.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.676 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -60.62 157.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.065 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.77 -45.67 93.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.041 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -151.94 173.98 14.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.733 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.66 156.31 59.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.7 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' B' ' 117' ' ' LYS . 12.4 Cg_endo -55.98 137.76 80.12 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.449 2.1 . . . . 0.0 112.052 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 10.3 mttt 68.23 15.97 9.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.356 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.99 15.62 9.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.088 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 29.2 m -51.84 169.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.057 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.67 16.81 13.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.016 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.11 153.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.109 0.481 . . . . 0.0 111.433 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -142.43 140.25 31.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.903 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 28.2 mm -121.81 127.05 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.146 0.498 . . . . 0.0 112.12 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' B' ' 76' ' ' THR . 1.0 OUTLIER -140.29 146.21 38.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.051 179.146 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' B' ' 124' ' ' GLU . . . -170.01 174.24 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.286 0.565 . . . . 0.0 112.269 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.2 mt -132.35 151.2 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.172 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' B' ' 72' ' ' ILE . . . -132.45 150.82 52.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.053 0.454 . . . . 0.0 111.731 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 13.2 m -110.67 116.21 51.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.891 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -122.66 75.88 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.975 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.915 179.931 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.812 0.339 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.0 112.0 23.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 3.1 m 61.6 114.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -171.06 125.28 0.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -56.42 141.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 22.0 mt -98.05 149.88 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.24 26.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.28 171.15 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.34 28.42 8.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.023 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -120.65 -44.6 2.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.74 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.492 ' CB ' ' HD2' ' C' ' 12' ' ' PRO . . . -66.79 171.22 4.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.042 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' C' ' 11' ' ' ALA . 29.6 Cg_endo -63.61 -12.71 32.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.533 2.155 . . . . 0.0 112.506 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.45 147.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.488 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' C' ' 18' ' ' TYR . . . -126.35 120.99 31.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.756 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.24 17.14 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.11 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.95 -118.88 2.91 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.418 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.75 14.81 2.07 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.784 2.323 . . . . 0.0 113.306 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' C' ' 14' ' ' ALA . 0.7 OUTLIER -147.07 -174.06 4.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.948 0.404 . . . . 0.0 111.495 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.406 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 17.8 m -138.55 169.35 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.75 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -48.89 79.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 110.592 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.4 -177.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.898 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 m -141.47 133.34 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.05 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -110.77 115.4 29.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mt -91.01 -16.07 28.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.143 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.67 -99.27 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.762 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -56.99 -29.0 62.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.159 0.504 . . . . 0.0 110.081 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.17 135.22 38.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.42 ' CG1' ' CB ' ' C' ' 127' ' ' ALA . 4.8 p -109.59 164.49 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.847 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.55 131.3 22.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.887 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 40.9 p -104.63 144.35 31.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 10.1 p -83.03 179.1 7.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.51 89.74 0.83 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.177 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.415 ' HB3' ' ND2' ' C' ' 57' ' ' ASN . 88.3 mm-40 -56.12 144.17 30.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.286 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -125.49 132.9 24.44 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.691 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 21.9 Cg_exo -64.93 65.25 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.657 2.238 . . . . 0.0 112.574 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . 0.403 HG11 ' HA2' ' C' ' 41' ' ' GLY . 63.5 t -84.9 88.24 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.59 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -33.83 134.47 0.35 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.867 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.25 -20.84 20.83 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.445 2.097 . . . . 0.0 112.249 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.27 -3.64 14.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.619 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 3.7 m -126.25 -30.21 2.93 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.403 ' HA2' HG11 ' C' ' 36' ' ' VAL . . . 65.9 53.49 30.32 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.306 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . 0.402 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 0.0 OUTLIER -165.52 -82.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.486 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 7.3 p 175.62 125.14 0.14 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.102 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.24 138.92 23.09 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.407 2.072 . . . . 0.0 112.242 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.72 -31.07 71.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 94.96 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.887 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 21.5 mm -44.32 -31.0 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.933 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.79 -38.73 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.6 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.79 -54.28 37.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.478 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.52 -26.82 68.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.332 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.65 72.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.1 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.44 -48.7 16.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.763 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.62 -46.65 88.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.767 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.421 ' HA ' ' OD1' ' C' ' 57' ' ' ASN . 90.3 p -60.04 -37.29 79.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.405 HD23 ' CD2' ' C' ' 92' ' ' TYR . 21.9 mt -76.56 -23.35 53.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.094 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.69 -52.08 12.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.203 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . 0.421 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.6 OUTLIER -58.09 -29.2 65.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.939 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.413 HG21 ' ND2' ' C' ' 57' ' ' ASN . 54.3 t -65.16 -46.25 91.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.905 0.383 . . . . 0.0 110.602 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -28.87 61.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.88 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.03 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -73.13 -41.69 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.518 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mt -69.5 -31.38 48.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.485 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.47 -37.33 60.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.106 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -22.43 66.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.276 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.88 -28.81 20.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.824 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.99 50.51 0.63 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.568 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -146.67 -176.66 5.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 110.68 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.68 163.85 31.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.47 ' O ' ' CD2' ' C' ' 101' ' ' HIS . . . -50.21 -34.74 23.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.539 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -67.38 -24.72 65.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.324 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -80.67 -6.52 58.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.934 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 24.7 mt -83.88 116.08 27.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.188 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.57 -46.93 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.014 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -118.4 -177.7 3.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.591 0.234 . . . . 0.0 111.158 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' THR . . . . . 0.528 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 11.1 t -179.94 101.04 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.84 0.352 . . . . 0.0 111.509 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.445 HG21 ' CE1' ' C' ' 78' ' ' PHE . 0.0 OUTLIER -71.18 126.72 30.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.233 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.67 98.89 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.445 ' CE1' HG21 ' C' ' 76' ' ' THR . 17.1 m-85 -98.21 147.38 24.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.957 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 0.9 OUTLIER -144.68 151.79 15.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.479 . . . . 0.0 111.959 -179.274 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.05 -2.91 56.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.727 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.09 110.28 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.327 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 8.0 mt -56.89 -18.57 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -75.79 -23.57 55.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.617 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -77.88 -12.79 60.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -27.11 60.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.27 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.59 -42.54 71.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.815 0.34 . . . . 0.0 111.381 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.84 -29.45 20.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.275 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -73.82 -47.16 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -64.82 -39.32 93.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.596 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.42 -37.28 85.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.051 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.8 -33.33 19.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.594 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . 0.495 ' CE1' ' CE1' ' C' ' 96' ' ' PHE . 35.5 t80 -61.23 -56.43 20.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.36 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . 0.402 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 0.2 OUTLIER -70.22 -15.22 62.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.302 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -40.1 66.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.483 ' CE2' ' CE1' ' C' ' 96' ' ' PHE . 0.0 OUTLIER -84.91 -38.85 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.343 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.495 ' CE1' ' CE1' ' C' ' 92' ' ' TYR . 11.2 m-85 -53.86 -50.65 65.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 110.371 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.96 -32.24 73.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.911 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -83.76 -1.81 54.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.432 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 1.0 OUTLIER -110.39 -8.69 14.66 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.667 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 2.8 t-20 97.09 19.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.795 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.539 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.3 t60 -118.57 59.88 4.07 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.859 0.362 . . . . 0.0 110.91 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CE2' ' C' ' 104' ' ' PHE . 43.4 Cg_endo -68.16 -17.85 45.35 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.486 2.124 . . . . 0.0 112.15 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -34.16 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.694 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' C' ' 105' ' ' PRO . 33.2 m-85 72.24 140.14 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.08 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . 0.438 ' HD3' ' CE2' ' C' ' 96' ' ' PHE . 7.2 Cg_exo -71.71 166.72 28.59 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.777 2.318 . . . . 0.0 112.113 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.54 130.91 54.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.792 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.528 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -167.41 -165.53 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.0 111.324 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 3.1 p -116.2 114.84 24.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.256 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 15.8 m -95.67 131.49 41.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.265 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 m -158.97 170.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.947 0.403 . . . . 0.0 111.478 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' C' ' 79' ' ' VAL . 6.9 tt0 -110.26 95.36 5.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 29.9 m -60.51 157.27 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.63 93.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.011 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -151.93 173.94 14.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.727 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.65 156.25 59.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.71 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' C' ' 117' ' ' LYS . 12.4 Cg_endo -55.89 137.7 79.65 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.472 2.114 . . . . 0.0 112.069 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 10.3 mttt 68.21 16.02 9.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.392 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.89 15.69 9.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 29.3 m -51.83 169.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.736 0.303 . . . . 0.0 111.034 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.67 16.97 13.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.045 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.22 153.44 1.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.173 0.511 . . . . 0.0 111.367 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -142.46 140.26 31.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.89 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 28.3 mm -121.78 127.01 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.094 0.474 . . . . 0.0 112.162 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' C' ' 76' ' ' THR . 1.0 OUTLIER -140.19 146.19 38.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.071 179.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' C' ' 124' ' ' GLU . . . -169.99 174.33 5.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.214 0.531 . . . . 0.0 112.332 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 5.2 mt -132.41 151.21 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.214 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -132.45 150.73 52.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.08 0.467 . . . . 0.0 111.739 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 13.0 m -110.62 116.33 52.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -122.74 75.92 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.897 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.869 0.366 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.23 168.49 19.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.8 m -165.16 116.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.542 ' HA ' ' N ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 6' ' ' ILE . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' C' ' 107' ' ' ARG . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.45 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.542 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.0 m120 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.517 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.9 t -63.02 85.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 41' ' ' GLY . 36.7 t-20 -35.11 129.88 0.5 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.989 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.53 -10.59 29.14 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 112.178 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.5 -21.36 8.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.68 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 m -114.75 -25.2 8.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 63.67 56.06 21.4 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.323 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.27 -81.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.704 0.288 . . . . 0.0 111.625 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 9.2 p -173.89 106.83 0.3 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 21' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' CB ' ' CE1' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.519 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' HG13 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.42 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.513 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CE1' ' CB ' ' A' ' 69' ' ' ALA . 3.3 m170 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' B' ' 17' ' ' PRO . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.439 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.425 HG13 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 123' ' ' ILE . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -164.77 46.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.832 0.349 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.24 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 19.0 m -165.18 116.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.538 ' HA ' ' N ' ' B' ' 23' ' ' ASP . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.449 HG23 HD12 ' B' ' 6' ' ' ILE . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.45 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' B' ' 19' ' ' VAL . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' B' ' 4' ' ' GLN . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.538 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' B' ' 35' ' ' PRO . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 t -63.01 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' B' ' 41' ' ' GLY . 36.6 t-20 -35.14 129.93 0.51 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.935 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.58 -10.63 29.2 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.023 . . . . 0.0 112.192 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.4 -21.41 8.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.78 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 3.5 m -114.77 -25.32 8.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 63.81 56.13 20.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.357 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.36 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.623 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 9.3 p -173.94 106.72 0.3 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' B' ' 21' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.521 ' CB ' ' CE1' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.484 ' CB ' ' CD2' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' B' ' 69' ' ' ALA . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.516 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.425 ' CD2' HG13 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.514 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . 0.521 ' CE1' ' CB ' ' B' ' 69' ' ' ALA . 3.4 m170 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.416 ' CD1' ' HA ' ' C' ' 17' ' ' PRO . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.425 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . 0.429 HG13 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.451 HG21 HD13 ' B' ' 123' ' ' ILE . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -164.83 46.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.951 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.21 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 19.0 m -165.22 116.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.537 ' HA ' ' N ' ' C' ' 23' ' ' ASP . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' ILE . . . . . . . . . . . . . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . 0.451 ' CB ' ' CD ' ' C' ' 12' ' ' PRO . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' PRO . . . . . 0.416 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' B' ' 107' ' ' ARG . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.452 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' VAL . . . . . 0.486 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.401 HG23 ' CB ' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 32.8 t -63.06 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' C' ' 41' ' ' GLY . 36.7 t-20 -35.13 129.94 0.51 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.56 -10.6 29.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.31 2.007 . . . . 0.0 112.18 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.44 -21.43 8.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.729 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 3.5 m -114.8 -25.24 8.32 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 63.64 56.1 21.27 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.395 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.26 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.61 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 9.3 p -173.93 106.74 0.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.365 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.404 HD21 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' C' ' 21' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.518 ' CB ' ' CE1' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.476 ' CB ' ' CD2' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.515 ' HB ' ' NE2' ' A' ' 4' ' ' GLN . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.429 ' CD2' HG13 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' C' ' 95' ' ' PHE . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' HIS . . . . . 0.521 ' NE2' ' HB3' ' C' ' 99' ' ' ASN . 3.3 m170 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 17' ' ' PRO . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 105' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 107' ' ' ARG . . . . . 0.418 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 123' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 123' ' ' ILE . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 126' ' ' ILE . . . . . . . . . . . . . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 127' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' C' ' 72' ' ' ILE . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 128' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.486 HG23 ' CD2' ' A' ' 24' ' ' LEU . 18.8 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.006 0.431 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HD23 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.694 HD11 ' OD1' ' C' ' 103' ' ' ASN . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.719 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 14' ' ' ALA . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.843 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' C' ' 104' ' ' PHE . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 29' ' ' LEU . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.565 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.916 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.446 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 25' ' ' GLY . 9.1 m-80 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 128' ' ' VAL . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.959 HG23 ' HB3' ' A' ' 127' ' ' ALA . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 62' ' ' ILE . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.693 ' HB ' HG11 ' A' ' 119' ' ' VAL . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 34' ' ' ILE . 32.9 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.607 0.241 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.406 ' OE1' HD13 ' A' ' 47' ' ' ILE . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.782 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 54' ' ' SER . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.719 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 30' ' ' THR . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.844 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 126' ' ' ILE . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 128' ' ' VAL . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 125' ' ' ALA . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 108' ' ' SER . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 122' ' ' GLU . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.712 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 85' ' ' PHE . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' A' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.475 ' OH ' HG21 ' A' ' 75' ' ' THR . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.743 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.844 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 m-70 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.691 ' CG ' HD11 ' B' ' 5' ' ' ILE . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.731 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 72' ' ' ILE . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 76' ' ' THR . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.596 ' HB3' HD12 ' C' ' 82' ' ' LEU . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 78' ' ' PHE . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 34' ' ' ILE . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.795 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' ' 35' ' ' PRO . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.725 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' ILE . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.959 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 73' ' ' VAL . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB3' HD21 ' A' ' 67' ' ' LEU . 14.1 ptm180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.481 HG23 ' CD2' ' B' ' 24' ' ' LEU . 19.0 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.977 0.417 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.568 ' OE1' HD23 ' B' ' 24' ' ' LEU . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.691 HD11 ' CG ' ' A' ' 103' ' ' ASN . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.722 ' HB2' ' CG1' ' B' ' 61' ' ' ILE . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.786 HD13 ' O ' ' B' ' 14' ' ' ALA . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.84 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 104' ' ' PHE . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 11' ' ' ALA . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.53 HG23 HD13 ' B' ' 29' ' ' LEU . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.562 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.515 HD13 HG12 ' B' ' 128' ' ' VAL . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' B' ' 127' ' ' ALA . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.631 HD12 ' N ' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.737 HG21 HD11 ' B' ' 62' ' ' ILE . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.484 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.716 ' HB ' HG11 ' B' ' 119' ' ' VAL . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.565 HG23 HG13 ' B' ' 34' ' ' ILE . 33.3 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.791 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.3 p . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.595 0.236 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' B' ' 47' ' ' ILE . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' B' ' 95' ' ' PHE . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' B' ' 54' ' ' SER . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.722 ' CG1' ' HB2' ' B' ' 11' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.737 HD11 HG21 ' B' ' 30' ' ' THR . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.697 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.477 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 126' ' ' ILE . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.635 HG13 HG22 ' B' ' 128' ' ' VAL . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.681 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.727 HG23 ' HB2' ' B' ' 125' ' ' ALA . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 108' ' ' SER . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.702 HG13 ' O ' ' B' ' 122' ' ' GLU . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.507 HG11 ' HD1' ' B' ' 85' ' ' PHE . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.507 ' HD1' HG11 ' B' ' 79' ' ' VAL . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' B' ' 75' ' ' THR . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.742 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.851 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.8 m-70 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.7 ' CG ' HD11 ' C' ' 5' ' ' ILE . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.72 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' B' ' 72' ' ' ILE . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.431 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.845 ' O ' HG23 ' B' ' 76' ' ' THR . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.729 HG11 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.543 ' HB3' HD12 ' A' ' 82' ' ' LEU . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HB2' ' B' ' 78' ' ' PHE . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.482 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.716 HG11 ' HB ' ' B' ' 34' ' ' ILE . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' GLY . . . . . 0.791 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.468 HD11 ' HG3' ' B' ' 35' ' ' PRO . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.702 ' O ' HG13 ' B' ' 77' ' ' VAL . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.56 ' CG2' HG21 ' B' ' 58' ' ' VAL . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 72' ' ' ILE . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.997 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.635 HG22 HG13 ' B' ' 73' ' ' VAL . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' B' ' 67' ' ' LEU . 14.1 ptm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.48 HG23 ' CD2' ' C' ' 24' ' ' LEU . 19.0 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 4' ' ' GLN . . . . . 0.562 ' OE1' HD23 ' C' ' 24' ' ' LEU . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.7 HD11 ' CG ' ' B' ' 103' ' ' ASN . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.497 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.721 ' HB2' ' CG1' ' C' ' 61' ' ' ILE . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.67 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.779 HD13 ' O ' ' C' ' 14' ' ' ALA . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.826 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' B' ' 104' ' ' PHE . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.535 HG23 HD13 ' C' ' 29' ' ' LEU . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.559 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.898 HD13 ' O ' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.482 HD13 HG12 ' C' ' 128' ' ' VAL . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.63 ' N ' HD12 ' C' ' 29' ' ' LEU . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.711 HG21 HD11 ' C' ' 62' ' ' ILE . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.691 ' HB ' HG11 ' C' ' 119' ' ' VAL . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.561 HG23 HG13 ' C' ' 34' ' ' ILE . 32.8 t . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.789 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.3 p . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.582 0.229 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' C' ' 51' ' ' ALA . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.401 ' OE1' HD13 ' C' ' 47' ' ' ILE . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 54' ' ' SER . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.721 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.711 HD11 HG21 ' C' ' 30' ' ' THR . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.694 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.464 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.484 HG23 ' O ' ' C' ' 126' ' ' ILE . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.636 HG13 HG22 ' C' ' 128' ' ' VAL . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' ALA . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.847 HG23 ' O ' ' C' ' 108' ' ' SER . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.714 HG13 ' O ' ' C' ' 122' ' ' GLU . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.729 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' C' ' 85' ' ' PHE . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' C' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.479 ' OH ' HG21 ' C' ' 75' ' ' THR . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.749 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.851 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.8 m-70 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.694 ' OD1' HD11 ' A' ' 5' ' ' ILE . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.704 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' C' ' 72' ' ' ILE . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 108' ' ' SER . . . . . 0.847 ' O ' HG23 ' C' ' 76' ' ' THR . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.712 HG11 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.731 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.581 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' C' ' 78' ' ' PHE . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.582 ' O ' HG22 ' C' ' 119' ' ' VAL . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.484 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' C' ' 34' ' ' ILE . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 120' ' ' GLY . . . . . 0.789 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' C' ' 35' ' ' PRO . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 77' ' ' VAL . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' HB ' ' C' ' 76' ' ' THR . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.705 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' ILE . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.956 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.636 HG22 HG13 ' C' ' 73' ' ' VAL . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' C' ' 67' ' ' LEU . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 21.8 m . . . . . 0 N--CA 1.46 0.051 0 CA-C-O 120.813 0.34 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.511 ' HA ' ' N ' ' A' ' 23' ' ' ASP . 12.3 pt20 43.77 -165.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.743 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.638 HD11 ' O ' ' C' ' 103' ' ' ASN . 34.3 mm 68.69 116.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.959 0.409 . . . . 0.0 111.633 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 36.3 mt -142.11 91.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.77 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -102.22 128.98 48.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.991 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 t -144.86 153.74 41.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 30.7 3.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.458 ' HG2' ' HB1' ' A' ' 60' ' ' ALA . 4.6 tptm -117.6 -36.82 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . -99.88 122.47 50.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.273 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 7.5 Cg_exo -72.93 3.07 4.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.67 2.247 . . . . 0.0 112.829 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.636 ' HB1' ' OE1' ' A' ' 33' ' ' GLN . . . -50.32 -178.17 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.998 0.428 . . . . 0.0 111.809 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.58 ' C ' HD12 ' A' ' 15' ' ' ILE . . . 64.05 118.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.048 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.9 mp -146.79 17.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.342 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.92 -148.64 4.79 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.449 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.48 ' HA ' ' CE2' ' C' ' 104' ' ' PHE . 84.8 Cg_endo -87.57 34.33 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.859 2.373 . . . . 0.0 112.957 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.456 ' CD2' ' HB2' ' C' ' 107' ' ' ARG . 9.9 p90 -130.39 164.97 23.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.776 0.322 . . . . 0.0 110.821 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.956 HG13 ' HB3' ' C' ' 104' ' ' PHE . 19.9 m -91.54 147.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.437 ' HG2' ' HB2' ' A' ' 14' ' ' ALA . 15.4 mt-30 -46.11 -48.85 17.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.44 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.627 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -157.58 -175.28 5.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.451 ' C ' HD11 ' A' ' 6' ' ' ILE . 29.1 m -136.23 129.26 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.114 0.483 . . . . 0.0 111.922 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.511 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 44.1 t0 -113.14 103.97 11.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.803 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 4' ' ' GLN . 33.6 mt -84.04 -18.69 36.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.105 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.05 -108.68 0.91 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.827 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.6 -30.19 62.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 110.065 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HG ' HG23 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -121.92 127.88 50.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.581 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.938 HG23 ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -105.75 179.4 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.243 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -159.9 146.83 16.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.0 p -121.1 142.25 50.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.8 m -79.03 165.99 22.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.26 74.4 0.28 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.987 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.636 ' OE1' ' HB1' ' A' ' 13' ' ' ALA . 17.3 mm-40 -66.46 165.21 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.031 0.444 . . . . 0.0 111.352 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.8 ' HB ' HG11 ' A' ' 119' ' ' VAL . 3.4 pt -138.99 159.07 68.44 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.243 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.531 ' O ' HG12 ' A' ' 36' ' ' VAL . 85.5 Cg_exo -42.28 -45.39 7.74 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.64 2.227 . . . . 0.0 111.932 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 35' ' ' PRO . 8.5 p . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.565 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.731 ' HB ' HG12 ' A' ' 119' ' ' VAL . 7.1 p . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 120.347 0.118 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 4.9 Cg_exo -76.58 153.12 34.23 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.684 2.256 . . . . 0.0 112.091 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.1 -30.85 55.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.074 0.464 . . . . 0.0 110.741 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -68.48 94.24 0.55 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.885 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.624 HD13 ' NE2' ' A' ' 50' ' ' GLN . 28.9 mm -40.32 -33.3 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.34 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.12 -46.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.699 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' A' ' 46' ' ' ASP . . . -61.37 -36.19 79.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.706 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.66 ' HG3' HD21 ' A' ' 121' ' ' LEU . 10.4 pt20 -77.61 -28.39 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.608 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.11 -31.55 25.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.248 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -38.35 29.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.17 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.55 -31.06 66.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.871 0.367 . . . . 0.0 110.823 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.839 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -70.03 -30.85 68.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.748 HD13 ' CE2' ' A' ' 95' ' ' PHE . 57.4 mt -74.6 -33.85 62.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.38 -48.69 64.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.999 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -57.6 -48.2 80.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.092 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 54' ' ' SER . 27.2 t -59.63 -29.97 43.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 1.9 ttpp -79.15 -39.83 32.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.043 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 10' ' ' LYS . . . -62.04 -36.41 81.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.976 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 58' ' ' VAL . 8.1 mt -70.21 -51.87 35.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 127' ' ' ALA . 3.7 tt -65.26 -22.43 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.076 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -82.95 -37.74 23.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.891 0.377 . . . . 0.0 110.31 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -11.15 60.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.97 -29.93 35.22 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.925 0.393 . . . . 0.0 110.335 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.3 28.5 1.0 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.141 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -146.84 -166.97 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.329 . . . . 0.0 110.69 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.58 153.73 49.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.852 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -57.25 -38.92 74.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -51.19 -29.86 15.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.06 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.74 -22.4 58.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.627 HG23 ' O ' ' A' ' 126' ' ' ILE . 76.6 mt -47.76 114.88 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.97 0.414 . . . . 0.0 110.97 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.622 ' CG1' HG12 ' A' ' 128' ' ' VAL . 32.8 m -89.62 -31.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.702 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.771 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 78.1 tttt -134.44 163.0 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 111.055 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.739 HG23 ' HB2' ' A' ' 125' ' ' ALA . 30.4 m -158.75 139.56 12.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.303 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 108' ' ' SER . 96.7 m -123.63 147.41 47.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.176 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.9 t -149.22 109.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 111.697 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.709 ' CD2' HG11 ' C' ' 110' ' ' VAL . 8.6 m-85 -89.0 110.23 20.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.47 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.408 HG11 ' HD1' ' A' ' 85' ' ' PHE . 31.3 m -101.38 144.89 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -85.03 -1.55 56.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.221 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.2 127.22 1.46 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.512 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.15 -11.92 52.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.65 -20.82 45.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.361 . . . . 0.0 110.693 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.6 -27.25 20.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 44.3 t80 -57.68 -28.77 64.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.13 -32.28 67.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.263 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.49 -34.95 18.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.221 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.7 -39.71 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.413 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 32.8 t30 -68.89 -36.55 78.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.51 -32.39 66.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.61 -30.35 19.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.088 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.716 ' OH ' HG21 ' A' ' 75' ' ' THR . 10.0 t80 -58.43 -43.93 88.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.91 -29.36 35.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.18 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.48 75.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.036 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.748 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -89.32 -36.54 15.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.636 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.509 ' CD2' ' HB2' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -54.99 -53.59 53.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.807 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -72.82 -26.43 61.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.387 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 95' ' ' PHE . 2.4 mm-40 -76.47 -13.32 60.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.553 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 12.6 m-80 -101.4 -17.29 16.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.011 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 5.2 p-10 103.5 35.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.154 0.909 . . . . 0.0 110.396 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.852 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 2.0 m-70 -114.97 55.27 0.87 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.376 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.491 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 88.8 Cg_endo -79.12 2.74 8.04 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.661 2.241 . . . . 0.0 113.112 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.63 ' O ' HD11 ' B' ' 5' ' ' ILE . 2.2 t-20 -64.48 -30.08 71.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.765 0.317 . . . . 0.0 111.477 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.973 ' HB3' HG13 ' B' ' 19' ' ' VAL . 2.5 m-85 70.91 110.21 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.547 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 96' ' ' PHE . 66.2 Cg_endo -96.03 153.39 1.4 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.064 2.509 . . . . 0.0 112.443 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.771 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -50.27 163.09 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.236 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.441 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -134.49 143.43 47.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.147 0.499 . . . . 0.0 111.607 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 76' ' ' THR . 0.8 OUTLIER -150.73 63.81 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.305 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.09 134.69 40.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.025 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.661 HG11 ' CD2' ' B' ' 78' ' ' PHE . 26.8 m -142.22 138.49 29.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.26 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.785 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 2.9 tm-20 -68.23 83.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.686 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.21 163.91 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.233 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -74.55 -38.16 62.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.982 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.404 ' CB ' ' HB3' ' C' ' 111' ' ' GLU . 0.4 OUTLIER -161.62 -177.65 6.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.761 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.48 HD11 ' O ' ' A' ' 78' ' ' PHE . 77.8 mt -151.82 156.37 34.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.756 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.31 137.96 78.46 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.59 2.194 . . . . 0.0 112.099 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.682 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.9 OUTLIER 74.74 14.21 3.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.244 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.76 16.88 8.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.8 HG11 ' HB ' ' A' ' 34' ' ' ILE . 29.5 m -57.07 175.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.831 0.348 . . . . 0.0 111.079 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.54 12.79 15.69 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.676 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 50' ' ' GLN . 4.3 pp -176.75 148.17 0.67 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.025 0.441 . . . . 0.0 111.298 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.408 ' C ' HD13 ' A' ' 123' ' ' ILE . 1.2 tt0 -125.74 161.05 28.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.037 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' A' ' 54' ' ' SER . 0.0 OUTLIER -143.54 129.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.115 0.484 . . . . 0.0 112.012 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.09 109.51 2.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.895 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.739 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -126.73 174.61 8.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.137 0.494 . . . . 0.0 112.039 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 72' ' ' ILE . 15.3 mt -125.63 156.41 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.422 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.938 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -146.34 151.07 36.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.551 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.622 HG12 ' CG1' ' A' ' 73' ' ' VAL . 5.1 p -147.99 159.95 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.128 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.763 ' HB3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.81 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' B' ' 4' ' ' GLN . 22.1 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.794 0.33 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.507 ' HA ' ' N ' ' B' ' 23' ' ' ASP . 12.3 pt20 43.82 -165.68 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.636 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.63 HD11 ' O ' ' A' ' 103' ' ' ASN . 34.2 mm 68.65 116.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.023 0.439 . . . . 0.0 111.6 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 36.4 mt -142.12 91.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.782 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -102.15 129.02 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.949 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.7 t -144.87 153.74 41.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.05 30.67 3.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.44 ' HG2' ' HB1' ' B' ' 60' ' ' ALA . 4.6 tptm -117.55 -36.78 3.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -99.9 122.3 51.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.214 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 7.4 Cg_exo -72.87 3.05 4.73 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.68 2.254 . . . . 0.0 112.84 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.664 ' HB1' ' OE1' ' B' ' 33' ' ' GLN . . . -50.24 -178.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.005 0.431 . . . . 0.0 111.796 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.593 ' C ' HD12 ' B' ' 15' ' ' ILE . . . 64.01 118.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.605 HG22 ' O ' ' B' ' 15' ' ' ILE . 2.9 mp -146.78 17.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.341 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.9 -148.71 4.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.422 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.482 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 84.1 Cg_endo -87.49 34.26 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.869 2.379 . . . . 0.0 113.005 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.444 ' CZ ' ' HA ' ' B' ' 14' ' ' ALA . 10.0 p90 -130.4 164.95 23.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 110.835 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.973 HG13 ' HB3' ' A' ' 104' ' ' PHE . 20.2 m -91.46 147.76 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.424 ' HG2' ' HB2' ' B' ' 14' ' ' ALA . 15.5 mt-30 -46.18 -48.97 17.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.414 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.655 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -157.39 -175.35 5.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.71 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.45 ' C ' HD11 ' B' ' 6' ' ' ILE . 29.2 m -136.25 129.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.09 0.471 . . . . 0.0 111.941 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.507 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 44.1 t0 -113.11 103.92 11.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.834 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.4 HD23 ' H ' ' B' ' 4' ' ' GLN . 33.2 mt -83.97 -18.71 36.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.109 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.03 -108.75 0.91 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.792 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.55 -30.21 62.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.093 0.473 . . . . 0.0 110.068 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.422 ' HG ' HG23 ' B' ' 128' ' ' VAL . 0.7 OUTLIER -121.87 127.93 51.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.603 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.909 HG23 ' HB3' ' B' ' 127' ' ' ALA . 0.3 OUTLIER -105.81 179.4 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.478 HD12 ' O ' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -159.94 146.84 16.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 35.9 p -121.11 141.98 50.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.89 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 17.6 m -78.68 165.97 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.25 74.36 0.28 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.968 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.664 ' OE1' ' HB1' ' B' ' 13' ' ' ALA . 17.2 mm-40 -66.42 165.32 14.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 111.374 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.842 ' HB ' HG11 ' B' ' 119' ' ' VAL . 3.4 pt -139.08 159.05 68.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.199 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.536 ' O ' HG12 ' B' ' 36' ' ' VAL . 85.6 Cg_exo -42.28 -45.46 7.72 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.635 2.224 . . . . 0.0 111.87 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.536 HG12 ' O ' ' B' ' 35' ' ' PRO . 8.5 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.508 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.717 ' HB ' HG12 ' B' ' 119' ' ' VAL . 7.1 p . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.365 0.126 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' B' ' 35' ' ' PRO . 5.0 Cg_exo -76.59 153.09 34.14 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.699 2.266 . . . . 0.0 112.115 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.11 -30.79 55.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.453 . . . . 0.0 110.715 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' B' ' 49' ' ' ALA . 0.4 OUTLIER -68.55 94.24 0.56 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.864 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.62 HD13 ' NE2' ' B' ' 50' ' ' GLN . 29.2 mm -40.23 -33.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.387 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.08 -46.46 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.684 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.427 ' H ' ' HB3' ' B' ' 46' ' ' ASP . . . -61.34 -36.19 79.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.742 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.669 ' HG3' HD21 ' B' ' 121' ' ' LEU . 10.4 pt20 -77.57 -28.33 51.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.575 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.19 -31.56 25.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.271 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -38.31 30.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.254 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.6 -31.08 66.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.772 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.84 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.4 OUTLIER -69.97 -30.88 68.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.801 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.792 HD13 ' CE2' ' B' ' 95' ' ' PHE . 57.3 mt -74.58 -33.88 62.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.46 -48.59 64.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.994 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -57.67 -48.16 80.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.84 HG23 ' O ' ' B' ' 54' ' ' SER . 27.1 t -59.64 -29.92 43.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.052 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 1.9 ttpp -79.26 -39.78 32.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.44 ' HB1' ' HG2' ' B' ' 10' ' ' LYS . . . -62.01 -36.47 81.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.548 HG22 HG21 ' B' ' 6' ' ' ILE . 8.2 mt -70.09 -51.89 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.998 0.428 . . . . 0.0 110.737 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' B' ' 127' ' ' ALA . 3.8 tt -65.23 -22.45 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.0 -37.73 23.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 110.3 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -11.1 60.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.737 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.93 -29.96 35.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.0 110.367 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.29 28.49 1.0 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.153 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' B' ' 129' ' ' ARG . 0.2 OUTLIER -146.83 -167.02 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.7 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.52 153.76 49.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.86 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -57.34 -38.85 74.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.652 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -51.26 -29.92 16.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.76 -22.48 58.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.96 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.629 HG23 ' O ' ' B' ' 126' ' ' ILE . 76.5 mt -47.72 114.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.893 0.377 . . . . 0.0 110.995 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.605 ' CG1' HG12 ' B' ' 128' ' ' VAL . 32.9 m -89.66 -31.57 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.66 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.751 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 78.1 tttt -134.39 163.08 30.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.017 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.73 HG23 ' HB2' ' B' ' 125' ' ' ALA . 30.4 m -158.76 139.6 12.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.297 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.626 HG23 ' O ' ' B' ' 108' ' ' SER . 96.8 m -123.68 147.41 47.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.172 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.8 t -149.22 109.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.863 0.363 . . . . 0.0 111.746 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.661 ' CD2' HG11 ' A' ' 110' ' ' VAL . 8.6 m-85 -88.97 110.22 20.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.424 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.415 HG11 ' HD1' ' B' ' 85' ' ' PHE . 31.3 m -101.37 144.86 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.447 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -85.03 -1.68 57.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.145 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.12 127.14 1.48 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.507 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' B' ' 82' ' ' LEU . 12.0 mt -66.01 -12.04 52.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.68 -20.74 45.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.789 0.328 . . . . 0.0 110.653 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.69 -27.16 20.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' B' ' 89' ' ' ASN . 44.5 t80 -57.74 -28.76 64.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.29 67.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.303 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.53 -34.96 18.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.16 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.79 -39.56 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.153 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 32.7 t30 -69.0 -36.45 77.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.47 -32.46 66.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.42 -30.43 19.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.706 ' OH ' HG21 ' B' ' 75' ' ' THR . 9.8 t80 -58.36 -43.98 88.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.94 -29.35 35.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.54 75.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.069 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.792 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.9 OUTLIER -89.2 -36.64 15.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.646 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.511 ' CD2' ' HB2' ' B' ' 101' ' ' HIS . 0.2 OUTLIER -54.88 -53.63 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.863 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -72.77 -26.49 61.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.436 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' GLU . . . . . 0.412 ' HB2' ' HA ' ' B' ' 95' ' ' PHE . 2.4 mm-40 -76.48 -13.29 60.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.568 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.567 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 12.6 m-80 -101.39 -17.35 16.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.01 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 5.3 p-10 103.6 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.148 0.905 . . . . 0.0 110.328 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.86 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 2.0 m-70 -115.06 55.25 0.89 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.387 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.487 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 89.3 Cg_endo -79.09 2.77 8.01 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.626 2.217 . . . . 0.0 113.141 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.664 ' O ' HD11 ' C' ' 5' ' ' ILE . 2.1 t-20 -64.4 -30.21 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 111.512 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.929 ' HB3' HG13 ' C' ' 19' ' ' VAL . 2.5 m-85 70.97 110.2 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.505 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' B' ' 96' ' ' PHE . 66.0 Cg_endo -95.98 153.44 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.141 2.561 . . . . 0.0 112.438 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.751 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -50.37 163.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.292 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.465 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -134.4 143.44 47.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 111.607 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.626 ' O ' HG23 ' B' ' 76' ' ' THR . 0.8 OUTLIER -150.77 63.88 0.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.283 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.05 134.74 40.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.04 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' C' ' 78' ' ' PHE . 26.9 m -142.32 139.3 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.294 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.728 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 2.8 tm-20 -68.67 84.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.78 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 m -67.4 163.95 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.133 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -74.55 -38.11 62.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.63 -177.74 6.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.484 HD11 ' O ' ' B' ' 78' ' ' PHE . 77.7 mt -151.72 156.41 34.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.772 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.37 137.92 78.59 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.577 2.185 . . . . 0.0 112.093 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.678 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.9 OUTLIER 74.8 14.2 3.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.26 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.78 16.89 8.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.069 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.842 HG11 ' HB ' ' B' ' 34' ' ' ILE . 29.6 m -57.18 175.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.83 0.347 . . . . 0.0 111.075 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.34 13.04 16.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.71 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.669 HD21 ' HG3' ' B' ' 50' ' ' GLN . 4.3 pp -176.83 148.19 0.65 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 111.275 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.79 161.0 28.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.021 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' B' ' 54' ' ' SER . 0.0 OUTLIER -143.43 129.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 112.109 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 109.48 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.888 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -126.74 174.63 8.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.134 0.493 . . . . 0.0 111.985 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.629 ' O ' HG23 ' B' ' 72' ' ' ILE . 15.2 mt -125.64 156.34 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.444 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.909 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -146.28 150.97 36.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.57 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.605 HG12 ' CG1' ' B' ' 73' ' ' VAL . 5.1 p -147.83 159.99 7.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.774 ' HB3' HD21 ' B' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.881 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' C' ' 4' ' ' GLN . 21.9 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.808 0.337 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 4' ' ' GLN . . . . . 0.513 ' HA ' ' N ' ' C' ' 23' ' ' ASP . 12.3 pt20 43.79 -165.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.691 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.664 HD11 ' O ' ' B' ' 103' ' ' ASN . 34.4 mm 68.76 116.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.005 0.431 . . . . 0.0 111.628 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.662 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 36.6 mt -142.11 91.74 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.767 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -102.24 128.95 48.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 12.7 t -144.76 153.75 41.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.1 30.75 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.46 ' HG2' ' HB1' ' C' ' 60' ' ' ALA . 4.7 tptm -117.6 -37.08 3.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.016 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.413 ' HB2' HG13 ' C' ' 61' ' ' ILE . . . -99.59 122.48 51.29 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.186 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.84 2.94 4.82 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.731 2.288 . . . . 0.0 112.823 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.634 ' HB1' ' OE1' ' C' ' 33' ' ' GLN . . . -50.2 -178.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.966 0.412 . . . . 0.0 111.812 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.577 ' C ' HD12 ' C' ' 15' ' ' ILE . . . 63.97 118.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.096 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.598 HG22 ' O ' ' C' ' 15' ' ' ILE . 2.9 mp -146.74 17.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.364 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.9 -148.65 4.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.415 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' PRO . . . . . 0.466 ' HA ' ' CE2' ' B' ' 104' ' ' PHE . 83.3 Cg_endo -87.48 34.26 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.849 2.366 . . . . 0.0 113.037 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.465 ' CD2' ' HB2' ' B' ' 107' ' ' ARG . 9.9 p90 -130.41 164.91 23.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.775 0.322 . . . . 0.0 110.829 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.929 HG13 ' HB3' ' B' ' 104' ' ' PHE . 20.4 m -91.44 147.8 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.947 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.435 ' HG2' ' HB2' ' C' ' 14' ' ' ALA . 15.5 mt-30 -46.18 -48.73 17.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.47 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.662 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -157.43 -175.26 5.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.677 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.491 HG11 ' O ' ' B' ' 73' ' ' VAL . 29.5 m -136.27 129.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.062 0.458 . . . . 0.0 111.902 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.513 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 44.2 t0 -113.18 103.9 11.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.819 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.421 HD23 ' H ' ' C' ' 4' ' ' GLN . 33.3 mt -83.97 -18.73 36.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.108 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.05 -108.7 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.811 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.6 -30.14 62.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.146 0.498 . . . . 0.0 110.118 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.491 ' HG ' HG23 ' C' ' 128' ' ' VAL . 0.7 OUTLIER -121.91 127.9 50.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.624 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.968 HG23 ' HB3' ' C' ' 127' ' ' ALA . 0.3 OUTLIER -105.78 179.3 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.216 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.476 HD12 ' O ' ' C' ' 28' ' ' VAL . 0.1 OUTLIER -159.86 146.82 16.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.833 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.406 HG23 HD12 ' C' ' 62' ' ' ILE . 35.7 p -121.07 142.33 49.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.833 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 18.1 m -78.99 165.78 23.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.3 74.41 0.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.991 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.634 ' OE1' ' HB1' ' C' ' 13' ' ' ALA . 17.3 mm-40 -66.43 165.28 14.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.021 0.438 . . . . 0.0 111.325 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.82 ' HB ' HG11 ' C' ' 119' ' ' VAL . 3.4 pt -139.04 159.1 68.2 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.232 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.533 ' O ' HG12 ' C' ' 36' ' ' VAL . 85.3 Cg_exo -42.36 -45.41 7.89 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.623 2.216 . . . . 0.0 111.867 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.533 HG12 ' O ' ' C' ' 35' ' ' PRO . 8.6 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.556 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.763 ' HB ' HG12 ' C' ' 119' ' ' VAL . 7.1 p . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 120.351 0.119 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 43' ' ' VAL . 4.8 Cg_exo -76.68 153.14 33.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.664 2.243 . . . . 0.0 112.067 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.16 -30.76 55.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.091 0.472 . . . . 0.0 110.738 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' C' ' 49' ' ' ALA . 0.4 OUTLIER -68.54 94.31 0.56 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.888 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.623 HD13 ' NE2' ' C' ' 50' ' ' GLN . 29.2 mm -40.31 -33.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.397 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.13 -46.48 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.665 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' C' ' 46' ' ' ASP . . . -61.23 -36.28 79.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.766 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.65 ' HG3' HD21 ' C' ' 121' ' ' LEU . 10.4 pt20 -77.63 -28.11 51.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.594 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.4 -31.59 24.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.337 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -38.38 30.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.55 -31.12 66.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.807 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.822 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.4 OUTLIER -69.98 -30.87 68.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.81 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.743 HD13 ' CE2' ' C' ' 95' ' ' PHE . 57.4 mt -74.48 -33.94 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.37 -48.66 64.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.02 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -57.56 -48.24 79.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.822 HG23 ' O ' ' C' ' 54' ' ' SER . 27.2 t -59.59 -29.93 43.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.446 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 1.9 ttpp -79.21 -39.81 32.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.996 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' C' ' 10' ' ' LYS . . . -62.08 -36.23 81.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.078 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' C' ' 58' ' ' VAL . 8.1 mt -70.33 -51.9 34.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' C' ' 127' ' ' ALA . 3.8 tt -65.23 -22.42 31.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.094 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.02 -37.71 23.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.917 0.389 . . . . 0.0 110.287 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -11.08 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.713 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.99 35.06 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.964 0.412 . . . . 0.0 110.327 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.29 28.51 1.0 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.165 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.762 HD21 ' HB3' ' C' ' 129' ' ' ARG . 0.2 OUTLIER -146.88 -167.02 2.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.638 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.49 153.73 50.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.867 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -57.43 -38.71 74.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.656 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -51.16 -29.76 14.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.073 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.85 -22.56 58.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.642 HG23 ' O ' ' C' ' 126' ' ' ILE . 76.3 mt -47.66 114.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 111.013 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.628 ' CG1' HG12 ' C' ' 128' ' ' VAL . 32.8 m -89.66 -31.47 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.696 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.743 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 78.0 tttt -134.5 162.99 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.752 0.311 . . . . 0.0 111.01 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.734 HG23 ' HB2' ' C' ' 125' ' ' ALA . 30.5 m -158.75 139.58 12.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.424 . . . . 0.0 111.302 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.626 HG23 ' O ' ' C' ' 108' ' ' SER . 96.8 m -123.64 147.44 47.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.197 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.7 t -149.27 109.27 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.745 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.709 ' CD2' HG11 ' B' ' 110' ' ' VAL . 8.5 m-85 -88.95 110.19 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.476 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.409 HG11 ' HD1' ' C' ' 85' ' ' PHE . 31.6 m -101.4 144.87 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.461 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -85.02 -1.77 57.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.175 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.0 127.05 1.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.517 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 115' ' ' LEU . 12.0 mt -66.07 -11.98 52.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.63 -20.79 45.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.803 0.335 . . . . 0.0 110.673 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.63 -27.23 20.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' C' ' 89' ' ' ASN . 44.5 t80 -57.68 -28.83 64.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.102 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.29 67.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.255 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.46 -35.06 18.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.7 -39.62 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.152 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' ASN . . . . . 0.413 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 32.8 t30 -68.94 -36.5 78.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.49 -32.47 66.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -30.47 19.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.022 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.692 ' OH ' HG21 ' C' ' 75' ' ' THR . 10.0 t80 -58.29 -44.01 88.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.89 -29.35 35.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.178 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.51 75.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.055 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.743 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.9 OUTLIER -89.27 -36.59 15.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 110.647 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 0.2 OUTLIER -54.95 -53.56 54.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.876 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -72.82 -26.48 61.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 98' ' ' GLU . . . . . 0.41 ' HB2' ' HA ' ' C' ' 95' ' ' PHE . 2.4 mm-40 -76.48 -13.24 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.608 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.566 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 12.6 m-80 -101.46 -17.29 16.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.988 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 5.2 p-10 103.49 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.138 0.899 . . . . 0.0 110.372 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.867 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 2.0 m-70 -115.04 55.35 0.89 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.352 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 88.4 Cg_endo -79.2 2.82 7.98 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.628 2.219 . . . . 0.0 113.115 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.638 ' O ' HD11 ' A' ' 5' ' ' ILE . 2.2 t-20 -64.51 -30.06 71.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 111.534 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.956 ' HB3' HG13 ' A' ' 19' ' ' VAL . 2.5 m-85 70.93 110.21 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.543 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.457 ' HG3' ' CZ ' ' C' ' 96' ' ' PHE . 65.9 Cg_endo -96.03 153.38 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.116 2.544 . . . . 0.0 112.434 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.743 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -50.31 163.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.278 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.456 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -134.44 143.45 47.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.13 0.49 . . . . 0.0 111.563 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 108' ' ' SER . . . . . 0.626 ' O ' HG23 ' C' ' 76' ' ' THR . 0.8 OUTLIER -150.76 63.82 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.332 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.05 134.76 40.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.034 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' A' ' 78' ' ' PHE . 26.8 m -142.4 139.24 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.317 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.778 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.8 tm-20 -68.7 83.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.749 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.11 164.04 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.196 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -74.65 -38.19 62.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.975 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.409 ' CB ' ' HB3' ' B' ' 111' ' ' GLU . 0.4 OUTLIER -161.59 -177.6 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.775 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.478 HD11 ' O ' ' C' ' 78' ' ' PHE . 77.3 mt -151.76 156.42 34.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.755 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.48 137.95 79.01 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.588 2.192 . . . . 0.0 112.057 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.654 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.9 OUTLIER 74.8 14.2 3.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.275 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.79 16.9 8.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.073 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.82 HG11 ' HB ' ' C' ' 34' ' ' ILE . 29.3 m -57.08 175.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.818 0.342 . . . . 0.0 111.123 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.36 13.25 16.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.766 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' C' ' 50' ' ' GLN . 4.3 pp -177.36 148.25 0.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.976 0.417 . . . . 0.0 111.249 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.403 ' C ' HD13 ' C' ' 123' ' ' ILE . 1.2 tt0 -125.69 161.02 28.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.054 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' C' ' 54' ' ' SER . 0.0 OUTLIER -143.49 129.19 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.142 0.496 . . . . 0.0 112.039 -179.454 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.04 109.52 2.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.9 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.734 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -126.8 174.63 8.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.115 0.483 . . . . 0.0 112.026 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.642 ' O ' HG23 ' C' ' 72' ' ' ILE . 15.3 mt -125.68 156.36 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.435 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.968 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -146.36 151.02 36.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 111.503 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.628 HG12 ' CG1' ' C' ' 73' ' ' VAL . 5.0 p -147.84 159.92 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.762 ' HB3' HD21 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -148.41 58.89 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.817 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.044 HG21 HG21 ' C' ' 128' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.817 0.341 . . . . 0.0 110.954 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 132.97 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.82 HD13 ' OD1' ' C' ' 103' ' ' ASN . 4.3 mp -55.2 152.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 21' ' ' ALA . 32.7 mt -103.43 139.26 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.58 117.18 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.58 HG22 ' OE1' ' A' ' 20' ' ' GLN . 11.7 t -133.88 165.99 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.33 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.52 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 7.6 mmtp -121.62 -36.89 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.032 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.872 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.82 172.05 4.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 18.9 Cg_endo -59.39 -16.05 33.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.695 2.263 . . . . 0.0 112.85 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 77.24 151.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 111.317 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.603 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -104.67 120.71 41.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 14' ' ' ALA . 22.1 mm -133.51 15.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.072 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.85 -146.17 4.73 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.987 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' C' ' 104' ' ' PHE . 93.9 Cg_endo -87.39 44.53 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.536 2.158 . . . . 0.0 112.901 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.541 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -163.19 154.59 17.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.867 0.365 . . . . 0.0 111.033 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.465 HG13 ' O ' ' C' ' 103' ' ' ASN . 27.3 m -110.91 169.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.58 ' OE1' HG22 ' A' ' 8' ' ' THR . 56.2 mt-30 -58.96 -53.53 57.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' A' ' 6' ' ' ILE . . . -170.69 -177.09 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG21 ' HB ' ' C' ' 73' ' ' VAL . 9.3 m -142.33 132.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.166 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.645 ' HA ' HG23 ' A' ' 28' ' ' VAL . 20.8 t70 -103.47 105.01 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.567 ' CD2' HG23 ' A' ' 3' ' ' THR . 19.5 mt -80.51 -16.36 54.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.371 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.05 -104.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.28 -29.62 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.166 0.508 . . . . 0.0 110.21 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 28' ' ' VAL . 5.0 tt -135.2 140.65 45.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.95 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 9.9 p -120.04 160.88 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.123 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' HE2' ' C' ' 74' ' ' LYS . 2.9 mp -145.87 127.37 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 p -106.5 136.11 46.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.983 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.812 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 1.1 t -59.36 179.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.07 95.55 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.244 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.805 ' HG2' HG22 ' A' ' 58' ' ' VAL . 2.0 mp0 -62.07 138.14 58.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.275 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.524 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -146.04 170.18 8.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.679 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -54.26 -137.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.313 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.411 -178.926 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.81 140.71 81.58 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.592 2.195 . . . . 0.0 112.433 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.37 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.4 93.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.791 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.616 HD13 ' NE2' ' A' ' 50' ' ' GLN . 28.9 mm -38.93 -33.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.5 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.08 -48.07 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.696 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.82 -55.04 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.616 ' NE2' HD13 ' A' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.498 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -71.93 -44.36 63.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -63.33 -51.54 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.79 -31.18 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.871 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.3 m -68.31 -46.48 70.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.29 -26.36 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.971 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -57.95 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.108 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.8 OUTLIER -54.88 -30.36 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.985 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 54' ' ' SER . 39.6 t -62.1 -34.54 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 110.517 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.99 -31.75 34.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.755 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -62.23 -38.55 89.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 11' ' ' ALA . 6.1 mt -70.93 -46.2 69.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.667 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.8 -32.62 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.28 -38.4 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.9 -24.33 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.145 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.71 -22.11 21.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.914 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.43 64.8 0.83 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' OD2' ' A' ' 71' ' ' ASP . 14.7 mt -158.9 139.2 12.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 44.0 p -96.12 145.0 25.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -46.29 -31.75 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.518 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -59.77 -18.48 43.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.715 ' OD2' HD22 ' A' ' 67' ' ' LEU . 3.2 p-10 -88.58 -21.27 24.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 126' ' ' ILE . 64.3 mt -59.35 109.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.528 ' HB ' HG21 ' B' ' 22' ' ' VAL . 2.8 m -81.11 -36.84 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.971 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HE2' HD22 ' B' ' 29' ' ' LEU . 8.6 mtmt -130.55 175.23 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.319 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.61 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 13.4 t 177.71 110.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 111.36 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.18 130.1 41.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.33 91.6 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 76' ' ' THR . 5.3 m-85 -91.7 143.77 26.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.089 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.514 HG11 ' CD1' ' A' ' 85' ' ' PHE . 35.3 m -139.31 150.0 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.023 0.44 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.57 ' HE2' HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -90.95 -4.31 56.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.796 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.04 108.99 0.46 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.687 HD12 ' HB3' ' B' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.25 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.97 -24.64 59.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 110.282 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -78.46 -15.34 58.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.832 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.514 ' CD1' HG11 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -55.52 -22.98 23.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.01 -46.63 84.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 -33.22 19.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 84' ' ' ASP . 32.6 t -70.08 -49.66 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.673 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 36.4 t-20 -63.09 -35.99 82.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.14 94.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.016 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.62 -31.1 19.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.448 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 48.7 t80 -57.67 -51.35 69.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.727 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 7.7 tt0 -73.32 -27.34 61.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -25.11 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.765 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -79.31 -41.02 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.934 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 95' ' ' PHE . 57.1 m-85 -56.45 -50.43 71.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.8 69.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.77 58.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.402 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -110.54 -6.88 14.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.7 m-20 89.68 30.9 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.8 t60 -127.57 72.17 77.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.96 -11.04 16.65 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.539 2.159 . . . . 0.0 112.153 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.844 ' OD1' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.03 42.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.447 . . . . 0.0 110.439 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CG ' ' HA ' ' B' ' 17' ' ' PRO . 92.7 m-85 70.99 144.0 0.1 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.515 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 104' ' ' PHE . 2.0 Cg_endo -82.96 165.82 15.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.057 2.504 . . . . 0.0 112.0 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' B' ' 31' ' ' SER . . . -115.28 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.779 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.61 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -169.27 -163.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.944 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.36 107.57 16.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.493 ' O ' HG13 ' A' ' 110' ' ' VAL . 5.3 m -95.25 129.16 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.798 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.519 HG12 HD23 ' B' ' 115' ' ' LEU . 7.0 m -157.79 165.71 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.949 0.405 . . . . 0.0 111.666 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 9.4 tt0 -99.75 102.87 14.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.777 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.82 162.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -79.07 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.685 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -140.81 168.08 20.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.722 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.622 HD22 ' HB2' ' A' ' 122' ' ' GLU . 3.0 mt -144.19 161.9 42.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 119' ' ' VAL . 32.7 Cg_exo -59.7 135.94 67.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.649 2.233 . . . . 0.0 112.183 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.58 18.28 7.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.87 17.47 8.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 116' ' ' PRO . 21.2 m -55.18 172.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.61 14.08 20.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.011 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 121' ' ' LEU . 4.5 pp -176.64 149.0 0.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.123 0.487 . . . . 0.0 111.508 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.622 ' HB2' HD22 ' A' ' 115' ' ' LEU . 44.5 tt0 -150.86 137.85 19.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.918 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 76' ' ' THR . 3.4 mp -144.67 138.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 112.101 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.36 149.91 28.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.569 ' C ' HD13 ' A' ' 126' ' ' ILE . . . -132.03 125.99 32.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.414 . . . . 0.0 112.027 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.569 HD13 ' C ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -114.42 132.16 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.876 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.95 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -121.74 153.14 38.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.063 0.459 . . . . 0.0 112.038 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.111 HG21 HG21 ' B' ' 3' ' ' THR . 34.6 m -124.13 116.37 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.464 ' CD ' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' THR . . . . . 1.111 HG21 HG21 ' A' ' 128' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.72 132.95 5.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.844 HD13 ' OD1' ' A' ' 103' ' ' ASN . 4.4 mp -55.2 152.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' B' ' 21' ' ' ALA . 32.7 mt -103.43 139.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.59 117.19 9.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.575 HG23 ' H ' ' B' ' 11' ' ' ALA . 11.6 t -133.86 165.97 23.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.804 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 26.32 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.58 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 7.6 mmtt -121.6 -36.61 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -68.18 172.03 4.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 18.7 Cg_endo -59.33 -16.06 32.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.632 2.221 . . . . 0.0 112.905 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 77.23 151.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.411 . . . . 0.0 111.281 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.586 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.597 HG22 ' O ' ' B' ' 15' ' ' ILE . 22.1 mm -133.53 15.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.79 -146.1 4.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.509 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . 94.4 Cg_endo -87.38 44.49 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.637 2.224 . . . . 0.0 112.916 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -163.26 154.53 17.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.915 0.388 . . . . 0.0 110.991 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 103' ' ' ASN . 27.2 m -110.83 169.25 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.304 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.575 ' OE1' HG22 ' B' ' 8' ' ' THR . 56.3 mt-30 -59.04 -53.58 56.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -170.46 -177.16 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.528 HG21 ' HB ' ' A' ' 73' ' ' VAL . 9.2 m -142.31 132.63 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.636 ' HA ' HG23 ' B' ' 28' ' ' VAL . 20.8 t70 -103.51 104.94 15.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.554 ' CD2' HG23 ' B' ' 3' ' ' THR . 19.5 mt -80.44 -16.4 54.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -103.96 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.972 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.3 -29.56 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.082 0.468 . . . . 0.0 110.189 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.644 HD23 ' N ' ' B' ' 28' ' ' VAL . 5.0 tt -135.3 140.65 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.52 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.945 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 9.9 p -120.07 160.84 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.657 HD22 ' HE2' ' A' ' 74' ' ' LYS . 2.9 mp -145.87 127.42 15.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.68 136.36 46.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.06 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.843 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 1.1 t -59.69 179.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.01 95.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.834 ' HG2' HG22 ' B' ' 58' ' ' VAL . 2.0 mp0 -61.92 138.09 58.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.553 HG22 ' O ' ' B' ' 121' ' ' LEU . 0.7 OUTLIER -145.98 170.19 8.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.665 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 52.2 Cg_exo -54.34 -137.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.069 2.513 . . . . 0.0 112.319 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -178.922 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.83 140.7 81.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.662 2.242 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.39 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.35 93.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.618 HD13 ' NE2' ' B' ' 50' ' ' GLN . 28.9 mm -38.94 -33.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.443 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.02 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.91 -54.98 38.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.618 ' NE2' HD13 ' B' ' 47' ' ' ILE . 15.8 pt20 -61.1 -26.16 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.522 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -72.18 -44.2 63.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.901 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.33 -51.54 65.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.22 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.9 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.3 m -68.4 -46.37 70.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.32 -26.38 68.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.963 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -57.99 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.163 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.8 OUTLIER -54.86 -30.39 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.931 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.9 HG23 ' O ' ' B' ' 54' ' ' SER . 39.7 t -62.13 -34.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.95 -31.77 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -62.21 -38.49 89.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.571 HG12 ' HB2' ' B' ' 11' ' ' ALA . 6.0 mt -71.25 -46.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.83 -32.53 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.656 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.31 -38.49 60.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.34 65.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.136 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 -22.06 21.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.919 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 64.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.711 HD22 ' OD2' ' B' ' 71' ' ' ASP . 14.7 mt -158.91 139.2 12.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.022 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' B' ' 71' ' ' ASP . 43.8 p -96.1 144.99 25.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -46.26 -31.79 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.574 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -59.83 -18.27 42.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.425 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.711 ' OD2' HD22 ' B' ' 67' ' ' LEU . 3.3 p-10 -88.65 -21.23 24.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.714 0.292 . . . . 0.0 110.87 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.512 HG23 ' O ' ' B' ' 126' ' ' ILE . 64.4 mt -59.4 109.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.874 0.369 . . . . 0.0 110.839 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' C' ' 22' ' ' VAL . 2.8 m -81.12 -36.88 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.969 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.667 ' HE2' HD22 ' C' ' 29' ' ' LEU . 8.6 mtmt -130.56 175.22 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.302 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.612 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 13.4 t 177.67 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 111.337 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.753 ' O ' HG23 ' B' ' 123' ' ' ILE . 0.0 OUTLIER -70.15 130.12 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.325 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.43 91.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.404 ' CZ ' ' HB ' ' B' ' 76' ' ' THR . 5.3 m-85 -91.66 143.72 26.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.151 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' B' ' 85' ' ' PHE . 35.1 m -139.32 150.01 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.072 0.463 . . . . 0.0 111.718 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' B' ' 47' ' ' ILE . 0.3 OUTLIER -90.94 -4.12 56.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.839 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -169.23 109.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.321 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' C' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.32 20.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.228 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.94 -24.63 59.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.275 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.547 ' O ' HG23 ' B' ' 88' ' ' VAL . 0.6 OUTLIER -78.52 -15.37 58.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.51 ' CD1' HG11 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -55.46 -23.03 23.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.267 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.99 -46.62 84.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.09 -33.23 19.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 84' ' ' ASP . 33.0 t -70.09 -49.59 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.721 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 36.4 t-20 -63.21 -35.96 82.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.04 94.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.67 -31.19 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 48.8 t80 -57.62 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 7.7 tt0 -73.41 -27.32 61.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.462 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -25.19 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.786 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -79.25 -41.09 28.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.97 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 95' ' ' PHE . 57.2 m-85 -56.36 -50.45 71.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.818 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.82 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.945 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.8 58.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.98 14.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.505 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 11.7 m-20 89.78 30.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.502 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.8 t60 -127.48 72.19 77.52 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.98 -11.02 16.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.537 2.158 . . . . 0.0 112.153 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.98 ' ND2' HD13 ' C' ' 5' ' ' ILE . 2.9 t-20 -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.03 0.443 . . . . 0.0 110.445 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.506 ' CG ' ' HA ' ' C' ' 17' ' ' PRO . 92.7 m-85 70.89 144.04 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.494 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 104' ' ' PHE . 2.0 Cg_endo -83.02 165.85 14.91 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.016 2.477 . . . . 0.0 111.917 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.835 ' HB1' ' HB2' ' C' ' 31' ' ' SER . . . -115.27 137.95 51.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.612 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -169.23 -163.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.38 107.56 16.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.571 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' CYS . . . . . 0.504 ' O ' HG13 ' B' ' 110' ' ' VAL . 5.2 m -95.21 129.11 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.845 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.533 HG12 HD23 ' C' ' 115' ' ' LEU . 7.0 m -157.71 165.59 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.409 . . . . 0.0 111.632 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 9.3 tt0 -99.57 102.86 14.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.785 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.73 162.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -79.05 -46.27 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -140.82 168.11 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' B' ' 122' ' ' GLU . 3.0 mt -144.21 161.87 42.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.549 ' O ' HG22 ' B' ' 119' ' ' VAL . 33.1 Cg_exo -59.62 135.97 67.82 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.157 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.53 18.29 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.88 17.46 8.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.549 HG22 ' O ' ' B' ' 116' ' ' PRO . 21.5 m -55.18 172.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.082 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.63 13.95 20.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.025 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.553 ' O ' HG22 ' B' ' 34' ' ' ILE . 4.6 pp -176.62 148.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.615 ' HB2' HD22 ' B' ' 115' ' ' LEU . 44.5 tt0 -150.78 137.88 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.935 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.753 HG23 ' O ' ' B' ' 76' ' ' THR . 3.4 mp -144.68 138.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 112.14 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.33 149.81 28.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.627 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.572 ' C ' HD13 ' B' ' 126' ' ' ILE . . . -131.94 126.01 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.956 0.408 . . . . 0.0 112.041 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.572 HD13 ' C ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -114.33 132.14 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.947 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.945 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -121.75 153.2 38.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.096 0.474 . . . . 0.0 111.994 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 1.04 HG21 HG21 ' C' ' 3' ' ' THR . 34.7 m -124.26 116.32 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.474 ' CD ' HD21 ' B' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 3' ' ' THR . . . . . 1.04 HG21 HG21 ' B' ' 128' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.842 0.353 . . . . 0.0 110.947 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.68 132.97 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.98 HD13 ' ND2' ' B' ' 103' ' ' ASN . 4.4 mp -55.18 152.35 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' C' ' 21' ' ' ALA . 32.5 mt -103.46 139.23 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -143.59 117.2 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.572 HG22 ' OE1' ' C' ' 20' ' ' GLN . 11.7 t -133.93 165.96 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.32 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.542 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 7.6 mmtp -121.59 -36.84 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.01 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.885 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.93 172.02 4.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.885 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 18.8 Cg_endo -59.31 -16.11 32.83 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.675 2.25 . . . . 0.0 112.899 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 77.24 151.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.977 0.418 . . . . 0.0 111.304 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.591 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -104.69 120.76 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.002 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.591 HD13 ' O ' ' C' ' 14' ' ' ALA . 22.5 mm -133.54 15.81 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.81 -146.14 4.73 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.001 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' B' ' 104' ' ' PHE . 94.1 Cg_endo -87.37 44.51 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 112.917 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.532 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -163.23 154.55 17.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.026 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' B' ' 103' ' ' ASN . 27.2 m -110.87 169.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.36 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.572 ' OE1' HG22 ' C' ' 8' ' ' THR . 56.2 mt-30 -59.02 -53.38 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' C' ' 6' ' ' ILE . . . -170.6 -177.19 2.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' B' ' 73' ' ' VAL . 9.2 m -142.24 132.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.64 ' HA ' HG23 ' C' ' 28' ' ' VAL . 20.8 t70 -103.48 104.98 15.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.549 ' CD2' HG23 ' C' ' 3' ' ' THR . 19.5 mt -80.47 -16.35 54.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.0 -104.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.27 -29.59 33.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.648 HD23 ' N ' ' C' ' 28' ' ' VAL . 5.0 tt -135.22 140.64 45.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.575 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.947 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 9.9 p -120.04 160.84 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.667 HD22 ' HE2' ' B' ' 74' ' ' LYS . 2.9 mp -145.85 127.45 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 p -106.6 136.31 46.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' SER . . . . . 0.835 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 1.1 t -59.62 179.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.13 95.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.25 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.821 ' HG2' HG22 ' C' ' 58' ' ' VAL . 2.0 mp0 -62.06 138.17 58.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.259 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.528 HG22 ' O ' ' C' ' 121' ' ' LEU . 0.7 OUTLIER -146.0 170.23 8.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.654 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' C' ' 34' ' ' ILE . 52.4 Cg_exo -54.36 -137.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.063 2.509 . . . . 0.0 112.29 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.427 -178.928 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.762 0.315 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.88 140.74 81.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.637 2.225 . . . . 0.0 112.358 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.45 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.083 0.468 . . . . 0.0 110.913 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 93.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.621 HD13 ' NE2' ' C' ' 50' ' ' GLN . 28.7 mm -39.01 -33.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.447 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.711 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -54.96 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.621 ' NE2' HD13 ' C' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.474 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -72.07 -44.36 63.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.36 -51.5 65.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.24 72.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.354 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.903 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.3 m -68.35 -46.4 70.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.58 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.32 -26.36 68.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -58.01 4.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.8 OUTLIER -54.9 -30.36 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.984 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.903 HG23 ' O ' ' C' ' 54' ' ' SER . 39.6 t -62.07 -34.62 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -80.86 -31.79 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -62.26 -38.52 89.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' C' ' 11' ' ' ALA . 6.0 mt -70.95 -46.31 68.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.89 -32.54 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.33 -38.39 60.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.093 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.31 65.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.139 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.1 21.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.87 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.445 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.712 HD22 ' OD2' ' C' ' 71' ' ' ASP . 14.7 mt -158.9 139.23 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.036 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.0 p -96.16 145.01 25.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -46.21 -31.81 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.598 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -59.74 -18.28 41.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.477 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.712 ' OD2' HD22 ' C' ' 67' ' ' LEU . 3.3 p-10 -88.78 -21.16 23.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 110.896 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.503 HG23 ' O ' ' C' ' 126' ' ' ILE . 64.2 mt -59.39 109.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.496 ' HB ' HG21 ' A' ' 22' ' ' VAL . 2.8 m -81.04 -36.88 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.933 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.646 ' HE2' HD22 ' A' ' 29' ' ' LEU . 8.6 mtmt -130.6 175.25 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.369 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 13.4 t 177.72 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.313 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.754 ' O ' HG23 ' C' ' 123' ' ' ILE . 0.0 OUTLIER -70.23 130.2 41.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 t -115.43 91.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' C' ' 76' ' ' THR . 5.3 m-85 -91.64 143.8 26.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.143 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' C' ' 85' ' ' PHE . 34.8 m -139.35 149.98 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 111.691 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' C' ' 47' ' ' ILE . 0.3 OUTLIER -90.99 -4.23 56.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.816 178.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.1 109.04 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.305 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.685 HD12 ' HB3' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -58.58 -17.19 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.0 -24.62 59.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.297 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.546 ' O ' HG23 ' C' ' 88' ' ' VAL . 0.6 OUTLIER -78.5 -15.28 58.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.827 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.513 ' CD1' HG11 ' C' ' 79' ' ' VAL . 0.3 OUTLIER -55.53 -23.04 24.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.261 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.63 84.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.01 -33.32 19.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.969 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.546 HG23 ' O ' ' C' ' 84' ' ' ASP . 32.8 t -70.06 -49.66 54.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 89' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 36.4 t-20 -63.12 -35.99 82.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.337 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.22 -42.14 94.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.973 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.68 -31.16 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.567 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.457 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 48.7 t80 -57.64 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 7.7 tt0 -73.36 -27.37 61.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -25.19 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.77 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -79.32 -41.03 28.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 95' ' ' PHE . 56.7 m-85 -56.38 -50.4 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.781 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -28.72 69.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.954 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.91 -3.78 58.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.362 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.91 14.79 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 11.7 m-20 89.79 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.822 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.499 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.8 t60 -127.55 72.17 77.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.705 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.03 -10.97 16.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.495 2.13 . . . . 0.0 112.146 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.82 ' OD1' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.998 0.428 . . . . 0.0 110.429 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.512 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 92.8 m-85 70.91 144.1 0.1 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.42 ' HB2' HG22 ' C' ' 75' ' ' THR . 2.0 Cg_endo -83.05 165.85 14.87 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.028 2.485 . . . . 0.0 111.948 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.812 ' HB1' ' HB2' ' A' ' 31' ' ' SER . . . -115.29 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.6 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -169.22 -163.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.4 p -111.36 107.48 16.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.589 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 109' ' ' CYS . . . . . 0.502 ' O ' HG13 ' C' ' 110' ' ' VAL . 5.2 m -95.21 129.18 42.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.788 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.514 HG12 HD23 ' A' ' 115' ' ' LEU . 7.1 m -157.82 165.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 9.4 tt0 -99.76 102.86 14.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.75 162.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -79.08 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.671 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -140.83 168.09 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' C' ' 122' ' ' GLU . 3.0 mt -144.21 161.82 43.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.913 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.544 ' O ' HG22 ' C' ' 119' ' ' VAL . 33.7 Cg_exo -59.52 135.99 68.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.608 2.205 . . . . 0.0 112.221 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.51 18.29 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 61.8 17.55 8.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.544 HG22 ' O ' ' C' ' 116' ' ' PRO . 21.2 m -55.18 172.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.065 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.79 14.08 19.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.988 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.534 ' O ' HD12 ' C' ' 121' ' ' LEU . 4.6 pp -176.62 148.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.489 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.619 ' HB2' HD22 ' C' ' 115' ' ' LEU . 44.4 tt0 -150.83 137.93 19.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.754 HG23 ' O ' ' C' ' 76' ' ' THR . 3.4 mp -144.74 138.35 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.11 0.481 . . . . 0.0 112.142 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.3 149.82 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.648 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.573 ' C ' HD13 ' C' ' 126' ' ' ILE . . . -131.98 126.13 33.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 112.004 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.573 HD13 ' C ' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -114.41 132.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 178.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.947 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -121.76 153.11 38.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.082 0.468 . . . . 0.0 112.029 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 3' ' ' THR . 34.6 m -124.15 116.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.47 ' CD ' HD21 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -106.27 56.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.99 0.424 . . . . 0.0 110.892 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.85 HG21 HG21 ' C' ' 128' ' ' VAL . 50.6 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.797 0.332 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -173.58 122.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.023 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.643 HD13 ' OD1' ' C' ' 103' ' ' ASN . 2.0 mp -57.27 153.16 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 23' ' ' ASP . 29.6 mt -114.16 154.75 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.421 ' N ' HG22 ' A' ' 6' ' ' ILE . 21.0 t60 -153.69 126.15 8.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.725 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -130.46 151.73 50.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.037 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -98.22 30.11 3.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.479 ' HE3' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -109.76 -39.33 5.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.745 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . -92.64 120.68 67.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.162 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 26.0 Cg_exo -62.26 -11.59 23.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.491 2.127 . . . . 0.0 112.587 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.33 -169.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 0.0 111.396 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.535 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 58.37 -164.75 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.189 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 15' ' ' ILE . 23.8 mm 80.32 16.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.107 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.69 -138.67 4.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.958 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.401 ' HB3' ' HB2' ' C' ' 93' ' ' GLU . 86.1 Cg_endo -84.03 46.13 1.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.569 2.179 . . . . 0.0 112.624 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -176.11 -169.07 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.939 0.399 . . . . 0.0 111.051 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.757 HG13 ' HB2' ' C' ' 104' ' ' PHE . 14.8 m -120.65 -179.64 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.804 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -71.16 -52.5 18.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.18 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -159.48 -178.52 7.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.795 HG11 ' O ' ' C' ' 73' ' ' VAL . 14.8 m -137.54 134.18 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.165 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.617 ' HB2' HD11 ' A' ' 6' ' ' ILE . 17.9 t0 -113.89 93.3 4.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.82 HD21 HG21 ' C' ' 73' ' ' VAL . 17.2 mt -62.6 -20.44 64.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.043 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.93 -109.57 0.81 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.922 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.31 -30.37 64.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.058 0.456 . . . . 0.0 110.19 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.49 HD21 HD22 ' B' ' 24' ' ' LEU . 0.1 OUTLIER -119.6 128.03 53.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.787 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.929 HG23 ' HB3' ' A' ' 127' ' ' ALA . 2.4 m -106.59 175.11 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.044 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.575 ' HG ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -166.84 146.11 5.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.51 HG21 HD11 ' A' ' 62' ' ' ILE . 17.5 p -109.44 147.49 32.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.044 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.527 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 16.9 t -81.86 162.33 22.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.008 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -52.73 92.96 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.621 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.632 ' HG3' HG22 ' A' ' 58' ' ' VAL . 16.4 mm-40 -65.64 151.82 45.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.842 0.353 . . . . 0.0 111.093 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.745 HG23 HG11 ' A' ' 119' ' ' VAL . 4.6 mp -126.58 134.01 25.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.65 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 61.2 Cg_endo -73.91 72.63 3.86 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.891 2.394 . . . . 0.0 112.321 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 179.57 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.693 ' HB ' HG12 ' A' ' 119' ' ' VAL . 11.2 p . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.509 0.195 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.1 140.38 60.41 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.396 2.064 . . . . 0.0 112.126 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.0 -31.44 70.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.061 0.458 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -72.86 95.87 2.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.736 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.73 -31.28 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.321 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.449 HG22 ' HB1' ' A' ' 87' ' ' ALA . 22.1 t -75.97 -51.45 20.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.385 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -62.7 -37.64 87.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.227 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -69.14 -28.07 66.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.298 179.305 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.23 -34.95 36.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.902 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -69.03 -42.28 76.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.794 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.53 82.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.799 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.3 m -71.07 -36.88 72.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -68.02 -40.45 82.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.752 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.73 -38.58 86.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.741 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.17 -43.69 97.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.978 HG21 HG21 ' A' ' 123' ' ' ILE . 24.8 t -61.15 -35.99 69.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.65 -32.76 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.698 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . . . -60.63 -39.9 89.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.81 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 58' ' ' VAL . 3.0 mt -69.23 -46.57 77.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.689 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.51 HD11 HG21 ' A' ' 30' ' ' THR . 22.1 mt -67.45 -32.67 58.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.492 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.6 -41.08 66.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.196 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -61.3 -21.95 64.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.344 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.54 -28.45 21.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.651 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.35 47.15 0.55 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.594 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 129' ' ' ARG . 5.4 mt -156.56 138.02 13.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.859 0.361 . . . . 0.0 110.95 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.6 m -93.27 159.4 15.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.798 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.864 ' HB3' ' CD2' ' A' ' 101' ' ' HIS . . . -57.32 -34.09 68.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.908 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.82 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -51.93 -28.27 15.87 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.883 0.373 . . . . 0.0 110.711 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.68 -26.69 60.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.395 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 126' ' ' ILE . 71.4 mt -47.61 118.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.763 HG21 HD21 ' B' ' 24' ' ' LEU . 26.5 m -92.14 -30.73 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.741 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 22.8 tttm -138.32 160.12 40.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.567 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.703 HG23 ' HB2' ' A' ' 125' ' ' ALA . 41.8 m -153.31 137.97 16.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.989 0.423 . . . . 0.0 111.49 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.903 HG23 ' O ' ' A' ' 108' ' ' SER . 58.5 m -126.98 140.65 52.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.043 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.651 HG13 HD13 ' A' ' 123' ' ' ILE . 21.3 t -146.26 115.61 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 111.617 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.694 ' HB2' HD21 ' A' ' 115' ' ' LEU . 9.2 m-85 -89.35 112.08 23.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.482 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.614 HG12 HD21 ' A' ' 121' ' ' LEU . 34.4 m -97.46 148.34 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.575 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 -5.62 29.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.97 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 97.4 2.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.481 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' B' ' 114' ' ' ARG . 1.9 mt -57.61 -18.11 18.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.226 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.45 -25.3 54.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.928 0.394 . . . . 0.0 110.49 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -87.13 -19.53 28.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.83 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.4 ' CD1' HG11 ' A' ' 79' ' ' VAL . 35.2 t80 -56.8 -22.48 36.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.09 -36.15 67.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 0.0 111.185 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.449 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -83.46 -44.66 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.54 -38.16 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.777 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -66.28 -41.91 89.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.81 84.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.208 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.29 -30.84 25.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.415 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 84.2 t80 -53.71 -44.36 69.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.893 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' B' ' 17' ' ' PRO . 1.5 tt0 -85.86 -21.97 27.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.284 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.13 -21.27 59.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.429 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.2 p90 -91.78 -35.04 14.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.713 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 101' ' ' HIS . 0.8 OUTLIER -56.14 -60.2 3.84 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.145 0.498 . . . . 0.0 110.093 179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -28.85 70.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.576 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -77.33 -9.97 59.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.711 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.466 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . 57.5 m-20 -113.46 -6.01 13.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.461 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.1 m120 88.04 34.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.169 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.864 ' CD2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 m-70 -116.6 53.35 1.13 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.67 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 73.6 Cg_endo -73.62 -19.26 21.66 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.739 2.293 . . . . 0.0 112.907 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.645 ' OD1' HD13 ' B' ' 5' ' ' ILE . 2.1 t-20 -46.16 -35.64 5.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.873 0.368 . . . . 0.0 111.399 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.766 ' HB2' HG13 ' B' ' 19' ' ' VAL . 13.4 m-85 68.18 106.36 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.372 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 98.6 Cg_endo -85.08 160.43 11.57 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.747 2.298 . . . . 0.0 112.319 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.741 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -54.97 154.45 5.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.575 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -113.73 150.39 33.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.0 111.315 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.903 ' O ' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -160.07 53.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.447 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.93 146.78 27.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.019 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.596 HG12 HD23 ' B' ' 115' ' ' LEU . 29.7 m -153.23 156.23 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.303 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.434 ' HA ' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -77.99 95.36 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.435 HG21 HD21 ' A' ' 115' ' ' LEU . 9.8 m -83.21 148.45 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -60.65 -46.33 90.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.996 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.449 ' HB3' HD12 ' C' ' 82' ' ' LEU . 19.5 mtt180 -155.16 171.32 20.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.728 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 122' ' ' GLU . 1.6 mt -143.31 160.14 52.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 119' ' ' VAL . 89.4 Cg_exo -46.72 136.74 16.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.443 2.095 . . . . 0.0 112.236 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.85 17.86 7.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 61.67 17.14 8.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.034 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.745 HG11 HG23 ' A' ' 34' ' ' ILE . 35.8 m -63.16 154.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.055 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.8 26.49 24.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.666 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.614 HD21 HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -178.91 158.01 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.113 0.482 . . . . 0.0 111.154 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' A' ' 115' ' ' LEU . 4.4 tt0 -152.49 148.32 27.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.179 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.978 HG21 HG21 ' A' ' 58' ' ' VAL . 23.5 mm -122.94 146.13 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 111.766 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 99.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.101 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.703 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -124.03 166.8 15.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 111.877 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 72' ' ' ILE . 9.0 mm -114.51 154.05 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.404 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.929 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -141.09 151.5 44.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.97 0.414 . . . . 0.0 111.573 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.767 HG21 HG21 ' B' ' 3' ' ' THR . 28.0 m -105.88 -179.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.942 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.771 ' HB2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.834 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.767 HG21 HG21 ' A' ' 128' ' ' VAL . 51.0 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -173.52 122.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.645 HD13 ' OD1' ' A' ' 103' ' ' ASN . 2.0 mp -57.32 153.21 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' B' ' 23' ' ' ASP . 29.5 mt -114.22 154.67 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.201 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.409 ' N ' HG22 ' B' ' 6' ' ' ILE . 21.0 t60 -153.63 126.08 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.75 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -130.46 151.77 50.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.99 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -98.19 30.18 3.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.894 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -39.76 4.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.33 120.74 67.43 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.168 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.25 -11.65 23.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.48 2.12 . . . . 0.0 112.613 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.29 -169.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.011 0.434 . . . . 0.0 111.391 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.536 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 58.36 -164.75 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.266 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.617 HG22 ' O ' ' B' ' 15' ' ' ILE . 23.7 mm 80.34 16.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.126 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.74 -138.69 4.33 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.91 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 86.2 Cg_endo -84.03 46.15 1.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.583 2.189 . . . . 0.0 112.653 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.536 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -176.16 -169.15 0.3 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 111.058 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.766 HG13 ' HB2' ' A' ' 104' ' ' PHE . 14.5 m -120.55 -179.67 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.771 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -70.95 -51.33 26.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 0.0 111.038 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -161.19 -178.17 6.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.059 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.743 HG11 ' O ' ' A' ' 73' ' ' VAL . 14.9 m -137.54 134.13 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.159 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.62 ' HB2' HD11 ' B' ' 6' ' ' ILE . 17.9 t0 -113.87 93.25 4.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.763 HD21 HG21 ' A' ' 73' ' ' VAL . 17.4 mt -62.58 -20.34 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.046 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.87 -109.59 0.81 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.99 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.32 -30.38 64.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.462 . . . . 0.0 110.175 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.695 HD21 HD22 ' C' ' 24' ' ' LEU . 0.1 OUTLIER -119.62 127.98 53.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.797 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.937 HG23 ' HB3' ' B' ' 127' ' ' ALA . 2.4 m -106.53 175.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.026 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.582 ' HG ' HG23 ' B' ' 22' ' ' VAL . 0.6 OUTLIER -166.88 146.05 5.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.575 HG21 HD11 ' B' ' 62' ' ' ILE . 17.3 p -109.35 147.25 33.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.519 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 16.9 t -81.64 162.36 23.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.438 ' O ' HD12 ' B' ' 34' ' ' ILE . . . -52.68 92.87 0.01 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.614 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.651 ' HG3' HG22 ' B' ' 58' ' ' VAL . 16.3 mm-40 -65.61 151.75 45.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 111.117 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.697 HG23 HG11 ' B' ' 119' ' ' VAL . 4.6 mp -126.56 134.1 25.68 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.644 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 61.1 Cg_endo -74.0 72.73 3.89 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.88 2.387 . . . . 0.0 112.231 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.623 179.563 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.722 ' HB ' HG12 ' B' ' 119' ' ' VAL . 11.2 p . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.521 0.2 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.13 140.37 60.74 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.347 2.032 . . . . 0.0 112.158 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.96 -31.48 70.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.2 OUTLIER -72.89 95.92 2.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.743 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.71 -31.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.313 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.431 HG22 ' HB1' ' B' ' 87' ' ' ALA . 22.3 t -76.03 -51.4 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.387 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -62.7 -37.63 87.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.254 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.419 ' HG3' ' CG2' ' B' ' 43' ' ' VAL . 0.9 OUTLIER -69.14 -28.05 66.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.337 179.26 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.38 -34.97 35.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.927 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -68.99 -42.28 76.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.775 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -39.51 82.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.622 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.823 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.3 m -71.04 -36.97 72.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.717 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -67.97 -40.54 83.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.62 -38.64 87.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.758 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.09 -43.77 97.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.72 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.985 HG21 HG21 ' B' ' 123' ' ' ILE . 24.7 t -61.15 -36.05 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.792 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.48 -32.87 42.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.687 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.88 89.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' B' ' 58' ' ' VAL . 3.0 mt -69.45 -46.66 75.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.575 HD11 HG21 ' B' ' 30' ' ' THR . 22.1 mt -67.48 -32.57 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.566 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.7 -41.05 65.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.183 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -61.26 -21.98 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.358 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.55 -28.41 21.98 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.35 47.16 0.55 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.616 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.823 HD11 ' HB2' ' B' ' 129' ' ' ARG . 5.4 mt -156.54 137.98 13.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.975 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 9.4 m -93.27 159.4 15.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.819 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.85 ' HB3' ' CD2' ' B' ' 101' ' ' HIS . . . -57.29 -34.07 68.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.819 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -51.88 -28.12 15.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.975 0.417 . . . . 0.0 110.666 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.74 -26.62 60.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.416 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.558 HG23 ' O ' ' B' ' 126' ' ' ILE . 71.4 mt -47.66 118.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.026 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.78 ' O ' HG11 ' C' ' 22' ' ' VAL . 26.0 m -92.21 -30.55 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.08 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.768 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 22.8 tttm -138.43 160.02 40.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.596 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.717 HG23 ' HB2' ' B' ' 125' ' ' ALA . 42.0 m -153.27 137.97 16.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 0.0 111.461 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.924 HG23 ' O ' ' B' ' 108' ' ' SER . 58.5 m -126.98 140.65 52.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.08 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.664 HG13 HD13 ' B' ' 123' ' ' ILE . 21.3 t -146.26 115.58 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 111.551 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.659 ' HB2' HD21 ' B' ' 115' ' ' LEU . 9.1 m-85 -89.29 112.13 23.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.485 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.621 HG12 HD21 ' B' ' 121' ' ' LEU . 34.3 m -97.51 148.3 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.647 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 -5.73 29.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.95 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.67 97.43 2.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.508 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' C' ' 114' ' ' ARG . 1.9 mt -57.63 -18.13 18.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.203 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.42 -25.33 54.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -87.08 -19.51 28.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.894 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.4 ' CD1' HG11 ' B' ' 79' ' ' VAL . 35.0 t80 -56.8 -22.52 36.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.204 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.18 67.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 111.214 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.431 ' HB1' HG22 ' B' ' 48' ' ' VAL . . . -83.53 -44.65 14.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.52 -38.15 81.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.818 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.23 -41.95 89.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.834 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.99 85.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.221 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.27 -31.0 25.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.415 ' O ' ' CE2' ' B' ' 95' ' ' PHE . 84.1 t80 -53.66 -44.46 69.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' C' ' 17' ' ' PRO . 1.5 tt0 -85.8 -21.99 27.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.287 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.11 -21.27 59.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.438 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 1.2 p90 -91.83 -35.0 14.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.759 0.314 . . . . 0.0 110.695 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' B' ' 101' ' ' HIS . 0.8 OUTLIER -56.29 -60.12 3.97 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.174 0.512 . . . . 0.0 110.101 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -28.74 70.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.545 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -77.47 -9.91 59.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 110.658 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.465 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . 57.1 m-20 -113.44 -6.02 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.482 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.1 m120 88.13 34.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.189 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.85 ' CD2' ' HB3' ' B' ' 69' ' ' ALA . 1.6 m-70 -116.47 53.38 1.1 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.701 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 73.5 Cg_endo -73.78 -19.21 21.3 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.771 2.314 . . . . 0.0 112.895 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.63 ' OD1' HD13 ' C' ' 5' ' ' ILE . 2.1 t-20 -46.12 -35.64 5.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.937 0.399 . . . . 0.0 111.409 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.759 ' HB2' HG13 ' C' ' 19' ' ' VAL . 13.5 m-85 68.15 106.37 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.36 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 97.0 Cg_endo -85.08 160.38 11.57 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.711 2.274 . . . . 0.0 112.327 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.768 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -54.88 154.53 5.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.615 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.473 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -113.78 150.46 33.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.015 0.436 . . . . 0.0 111.351 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.924 ' O ' HG23 ' B' ' 76' ' ' THR . 0.4 OUTLIER -160.06 53.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.508 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.99 146.65 28.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.997 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' C' ' 78' ' ' PHE . 30.0 m -153.06 155.65 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.244 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -77.77 95.29 4.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.843 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.428 HG21 HD21 ' B' ' 115' ' ' LEU . 9.9 m -83.18 148.44 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.127 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -60.7 -46.34 90.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.477 ' HB3' HD12 ' A' ' 82' ' ' LEU . 19.4 mtt180 -155.16 171.26 20.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.719 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' B' ' 122' ' ' GLU . 1.6 mt -143.29 160.19 52.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.706 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.607 ' O ' HG22 ' B' ' 119' ' ' VAL . 89.1 Cg_exo -46.75 136.75 16.45 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.459 2.106 . . . . 0.0 112.255 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.89 17.76 7.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 61.69 17.17 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.059 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.722 HG12 ' HB ' ' B' ' 43' ' ' VAL . 35.5 m -63.2 154.66 6.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.004 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.07 26.28 25.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.708 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.621 HD21 HG12 ' B' ' 79' ' ' VAL . 0.4 OUTLIER -178.89 158.06 0.93 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.12 0.486 . . . . 0.0 111.191 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.776 ' HB2' HD22 ' B' ' 115' ' ' LEU . 4.4 tt0 -152.48 148.25 27.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.23 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.985 HG21 HG21 ' B' ' 58' ' ' VAL . 23.5 mm -122.92 146.06 28.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.065 0.46 . . . . 0.0 111.799 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.88 99.82 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.144 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.717 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -124.05 166.7 15.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.877 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.558 ' O ' HG23 ' B' ' 72' ' ' ILE . 8.9 mm -114.47 154.0 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.422 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.937 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -141.03 151.58 44.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.914 0.388 . . . . 0.0 111.557 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.814 HG21 HG21 ' C' ' 3' ' ' THR . 27.6 m -106.0 -179.42 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.894 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.823 ' HB2' HD11 ' B' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.947 0.403 . . . . 0.0 110.934 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.814 HG21 HG21 ' B' ' 128' ' ' VAL . 51.2 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.844 0.354 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -173.53 122.4 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.63 HD13 ' OD1' ' B' ' 103' ' ' ASN . 2.1 mp -57.29 153.21 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.834 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' C' ' 23' ' ' ASP . 29.0 mt -114.17 154.71 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.2 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 7' ' ' HIS . . . . . 0.408 ' N ' HG22 ' C' ' 6' ' ' ILE . 21.0 t60 -153.71 126.06 8.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.728 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -130.38 151.77 50.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.018 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -98.27 30.12 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.474 ' HE3' ' HB2' ' C' ' 60' ' ' ALA . 0.0 OUTLIER -109.84 -39.33 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.72 120.72 67.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.18 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.31 -11.58 23.23 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.486 2.124 . . . . 0.0 112.593 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.32 -169.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.0 111.415 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.528 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 58.39 -164.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.231 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.6 HG22 ' O ' ' C' ' 15' ' ' ILE . 23.8 mm 80.32 16.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.107 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.68 -138.61 4.33 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.0 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' PRO . . . . . 0.41 ' HB3' ' HB2' ' B' ' 93' ' ' GLU . 84.4 Cg_endo -84.08 46.17 1.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.621 2.214 . . . . 0.0 112.67 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.528 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -176.18 -169.12 0.3 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.92 0.391 . . . . 0.0 111.082 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.759 HG13 ' HB2' ' B' ' 104' ' ' PHE . 14.6 m -120.58 -179.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.769 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -71.21 -52.52 18.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.271 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -159.65 -178.44 7.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.78 HG11 ' O ' ' B' ' 73' ' ' VAL . 14.9 m -137.54 134.27 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.634 ' HB2' HD11 ' C' ' 6' ' ' ILE . 18.0 t0 -113.95 93.36 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.731 HD21 HG21 ' B' ' 73' ' ' VAL . 17.5 mt -62.68 -20.45 64.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.004 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.01 -109.57 0.81 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.926 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.33 -30.37 64.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.052 0.453 . . . . 0.0 110.187 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.57 HD21 HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -119.6 128.02 53.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.776 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.94 HG23 ' HB3' ' C' ' 127' ' ' ALA . 2.4 m -106.55 175.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.041 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.593 ' HG ' HG23 ' C' ' 22' ' ' VAL . 0.6 OUTLIER -166.83 146.1 5.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.807 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.491 HG21 HD11 ' C' ' 62' ' ' ILE . 17.4 p -109.61 147.62 32.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' SER . . . . . 0.529 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 16.9 t -81.76 162.24 22.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.002 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' GLY . . . . . 0.442 ' O ' HD12 ' C' ' 34' ' ' ILE . . . -52.61 92.9 0.01 OUTLIER Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.654 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.621 ' HG3' HG22 ' C' ' 58' ' ' VAL . 16.4 mm-40 -65.6 151.8 45.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 0.0 111.107 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.715 HG23 HG11 ' C' ' 119' ' ' VAL . 4.6 mp -126.57 133.98 25.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.636 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 61.2 Cg_endo -73.88 72.61 3.84 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.888 2.392 . . . . 0.0 112.292 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.68 179.543 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.694 ' HB ' HG12 ' C' ' 119' ' ' VAL . 11.1 p . . . . . 0 CA--C 1.53 0.183 0 CA-C-O 120.499 0.19 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.07 140.4 60.14 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.327 2.018 . . . . 0.0 112.155 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.04 -31.38 70.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.008 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -72.94 95.97 2.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.684 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.79 -31.31 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.231 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' VAL . . . . . 0.403 HG22 ' HB1' ' C' ' 87' ' ' ALA . 22.1 t -75.95 -51.47 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.383 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -62.75 -37.6 87.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.246 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.42 ' HG3' ' CG2' ' C' ' 43' ' ' VAL . 0.9 OUTLIER -69.17 -27.91 65.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.301 179.273 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.52 -34.96 35.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.951 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -69.07 -42.29 76.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -39.49 82.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.698 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.825 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.3 m -71.03 -36.98 72.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.689 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -67.96 -40.52 83.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.728 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.68 -38.66 87.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.71 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.05 -43.8 97.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.717 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 1.007 HG21 HG21 ' C' ' 123' ' ' ILE . 24.8 t -61.12 -36.08 70.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.786 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.49 -32.77 42.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.676 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.474 ' HB2' ' HE3' ' C' ' 10' ' ' LYS . . . -60.65 -40.0 90.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.799 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' C' ' 58' ' ' VAL . 3.0 mt -69.18 -46.65 77.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.655 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.491 HD11 HG21 ' C' ' 30' ' ' THR . 22.0 mt -67.43 -32.65 58.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.532 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.65 -41.03 65.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.18 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -61.3 -21.89 64.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.41 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.63 -28.41 21.89 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.623 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.32 47.14 0.55 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.613 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.812 HD11 ' HB2' ' C' ' 129' ' ' ARG . 5.4 mt -156.52 138.0 13.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.853 0.358 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 9.4 m -93.19 159.39 15.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.857 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' CD2' ' C' ' 101' ' ' HIS . . . -57.3 -34.19 68.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.815 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -51.9 -28.33 15.9 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.91 0.386 . . . . 0.0 110.712 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.55 -26.64 60.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.435 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.548 HG23 ' O ' ' C' ' 126' ' ' ILE . 71.4 mt -47.66 118.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.033 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.82 HG21 HD21 ' A' ' 24' ' ' LEU . 26.4 m -92.09 -30.7 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.093 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.742 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 22.8 tttm -138.34 160.12 40.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.576 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.69 HG23 ' HB2' ' C' ' 125' ' ' ALA . 40.6 m -153.29 137.9 16.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.043 0.449 . . . . 0.0 111.517 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.932 HG23 ' O ' ' C' ' 108' ' ' SER . 58.8 m -126.94 140.61 52.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.098 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.65 HG13 HD13 ' C' ' 123' ' ' ILE . 21.4 t -146.22 115.66 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.616 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.679 ' HB2' HD21 ' C' ' 115' ' ' LEU . 9.1 m-85 -89.33 112.07 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.494 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.586 HG12 HD21 ' C' ' 121' ' ' LEU . 34.4 m -97.44 148.37 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.115 0.483 . . . . 0.0 111.575 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 -5.59 29.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.995 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.69 97.4 2.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.53 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 114' ' ' ARG . 1.9 mt -57.64 -18.15 18.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.127 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.38 -25.33 54.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.48 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -87.12 -19.51 28.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.888 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -56.73 -22.54 36.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.06 -36.11 67.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.403 ' HB1' HG22 ' C' ' 48' ' ' VAL . . . -83.55 -44.65 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.53 -38.18 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.31 -41.89 89.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.837 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.82 84.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.201 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.41 -30.97 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.418 ' O ' ' CE2' ' C' ' 95' ' ' PHE . 84.2 t80 -53.61 -44.47 69.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 93' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 1.5 tt0 -85.82 -22.01 27.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.281 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -21.25 60.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.456 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 1.2 p90 -91.8 -35.13 14.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' C' ' 101' ' ' HIS . 0.8 OUTLIER -56.17 -60.21 3.82 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.117 0.484 . . . . 0.0 110.084 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -28.84 70.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.539 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.36 -9.96 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 0.0 110.681 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 57.2 m-20 -113.43 -6.01 13.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.491 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 11.9 m120 88.02 34.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.181 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.851 ' CD2' ' HB3' ' C' ' 69' ' ' ALA . 1.6 m-70 -116.56 53.35 1.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.664 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 73.5 Cg_endo -73.67 -19.29 21.51 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.797 2.332 . . . . 0.0 112.907 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.643 ' OD1' HD13 ' A' ' 5' ' ' ILE . 2.1 t-20 -46.18 -35.58 5.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.88 0.371 . . . . 0.0 111.388 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.757 ' HB2' HG13 ' A' ' 19' ' ' VAL . 13.5 m-85 68.12 106.39 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.36 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.431 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 96.7 Cg_endo -85.14 160.42 11.49 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.711 2.274 . . . . 0.0 112.353 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.742 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -54.9 154.46 5.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.556 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.467 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -113.75 150.46 33.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.998 0.428 . . . . 0.0 111.297 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 108' ' ' SER . . . . . 0.932 ' O ' HG23 ' C' ' 76' ' ' THR . 0.4 OUTLIER -160.1 53.96 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.425 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.92 146.75 27.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.959 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.578 HG11 ' CD2' ' A' ' 78' ' ' PHE . 30.0 m -153.11 155.34 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.288 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -77.32 95.38 4.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.721 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.427 HG21 HD21 ' C' ' 115' ' ' LEU . 10.0 m -83.2 148.45 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -60.71 -46.31 90.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.485 ' HB3' HD12 ' B' ' 82' ' ' LEU . 19.4 mtt180 -155.17 171.35 19.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.823 HD22 ' HB2' ' C' ' 122' ' ' GLU . 1.6 mt -143.36 160.17 52.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.661 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.618 ' O ' HG22 ' C' ' 119' ' ' VAL . 89.3 Cg_exo -46.76 136.73 16.52 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.496 2.131 . . . . 0.0 112.243 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.95 17.79 7.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.7 17.08 8.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.049 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.715 HG11 HG23 ' C' ' 34' ' ' ILE . 35.7 m -63.17 154.6 6.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.77 26.41 24.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.652 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.586 HD21 HG12 ' C' ' 79' ' ' VAL . 0.4 OUTLIER -178.76 157.98 0.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.08 0.467 . . . . 0.0 111.173 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.823 ' HB2' HD22 ' C' ' 115' ' ' LEU . 4.4 tt0 -152.46 148.28 27.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.226 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 1.007 HG21 HG21 ' C' ' 58' ' ' VAL . 23.2 mm -122.93 146.05 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.057 0.455 . . . . 0.0 111.81 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 99.84 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.068 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.69 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -124.08 166.86 15.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.037 0.446 . . . . 0.0 111.828 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.548 ' O ' HG23 ' C' ' 72' ' ' ILE . 8.8 mm -114.52 154.0 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.463 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.94 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -141.1 151.46 43.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.898 0.38 . . . . 0.0 111.576 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.85 HG21 HG21 ' A' ' 3' ' ' THR . 27.2 m -105.9 -179.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.884 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.812 ' HB2' HD11 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -163.71 48.1 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.884 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 tttp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.926 179.937 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.557 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.8 136.84 3.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.637 HG23 HG21 ' A' ' 19' ' ' VAL . 4.8 mp -58.55 158.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.244 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' A' ' 21' ' ' ALA . 19.0 mt -115.13 160.58 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.043 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.475 ' N ' HG22 ' A' ' 6' ' ' ILE . 1.4 t-80 -160.73 124.48 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.997 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 61' ' ' ILE . 8.0 t -127.65 165.52 19.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.973 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.76 51.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.25 -50.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.757 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.921 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -66.41 172.34 3.25 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.03 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.921 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 32.1 Cg_endo -64.37 -11.95 30.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.586 2.19 . . . . 0.0 112.714 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 73.27 171.61 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.987 0.423 . . . . 0.0 111.352 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.768 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -166.98 122.75 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.799 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 14' ' ' ALA . 17.8 mm -141.42 17.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.377 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.58 -103.85 2.44 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.274 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.17 4.88 6.65 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.536 2.157 . . . . 0.0 112.788 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.498 ' CD1' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -160.74 177.21 10.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.673 HG13 ' HB2' ' C' ' 104' ' ' PHE . 28.4 m -132.32 166.37 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.051 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.772 ' OE1' ' HB3' ' A' ' 11' ' ' ALA . 3.9 mm-40 -52.82 -46.43 67.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . -176.21 176.79 1.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.997 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.661 HG21 ' HB ' ' C' ' 73' ' ' VAL . 3.1 m -140.19 133.89 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.458 ' CG ' HG12 ' A' ' 28' ' ' VAL . 6.9 t0 -97.26 139.69 32.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.654 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.846 HD11 HD13 ' A' ' 29' ' ' LEU . 6.6 mt -112.94 -15.86 12.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.34 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 97.01 104.45 2.23 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.294 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.2 m120 84.05 -35.72 0.06 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.783 ' HG ' HG12 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -127.2 101.5 6.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.771 179.042 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.095 HG23 ' HB3' ' A' ' 127' ' ' ALA . 3.4 m -94.89 170.34 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.377 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.909 ' HG ' HG23 ' A' ' 126' ' ' ILE . 3.6 mp -152.77 148.92 27.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.943 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 p -125.97 149.1 49.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.863 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 4.1 t -75.26 170.7 15.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.03 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.92 77.21 0.41 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.062 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -53.14 162.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.964 0.411 . . . . 0.0 111.536 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.713 HG13 HG23 ' A' ' 36' ' ' VAL . 7.5 pt -146.91 154.21 46.87 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.773 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.626 ' HG2' HG23 ' A' ' 43' ' ' VAL . 72.2 Cg_endo -77.11 48.79 2.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.925 2.416 . . . . 0.0 113.292 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.713 HG23 HG13 ' A' ' 34' ' ' ILE . 45.9 t . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 121.229 0.537 . . . . 0.0 110.473 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.626 HG23 ' HG2' ' A' ' 35' ' ' PRO . 9.9 p . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.551 0.215 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 35' ' ' PRO . 52.7 Cg_exo -54.4 141.77 71.38 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.453 2.102 . . . . 0.0 112.235 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.01 70.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 93.87 1.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.774 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' A' ' 47' ' ' ILE . 7.4 tp -42.25 -33.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.638 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.56 -46.38 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.15 -46.99 88.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.64 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.401 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 3.5 pt20 -64.89 -28.89 69.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.52 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.8 -40.87 54.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.859 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -67.81 -52.31 38.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.62 -27.97 63.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.622 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -61.86 -42.41 99.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.629 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.639 HD13 ' CE2' ' A' ' 95' ' ' PHE . 7.5 mt -74.98 -30.0 61.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 32.5 mt-10 -65.5 -36.16 83.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.086 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 54' ' ' SER . 22.4 p30 -72.43 -27.8 62.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.793 0.33 . . . . 0.0 110.598 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.864 HG21 HG21 ' A' ' 123' ' ' ILE . 35.2 t -67.63 -45.86 84.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -76.06 -28.24 57.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.18 94.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 8' ' ' THR . 16.1 mt -72.83 -40.9 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.584 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.516 ' CD1' HD11 ' A' ' 72' ' ' ILE . 18.4 mt -70.07 -33.07 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.68 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.53 -40.98 63.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.274 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -21.8 65.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.349 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.3 -28.41 17.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.734 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.24 56.65 0.26 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.606 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 129' ' ' ARG . 3.5 mt -172.77 144.17 1.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.0 p -99.43 166.06 11.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.763 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.938 ' HB3' ' CD2' ' A' ' 101' ' ' HIS . . . -62.48 -31.05 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.837 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.774 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -52.59 -26.85 14.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.911 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.463 ' CB ' HD22 ' A' ' 67' ' ' LEU . 1.2 m-20 -82.15 -24.5 35.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.898 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.566 HG21 HG22 ' A' ' 75' ' ' THR . 96.6 mt -52.9 108.31 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.922 0.392 . . . . 0.0 110.954 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.678 ' HB ' HG21 ' B' ' 22' ' ' VAL . 35.4 m -74.31 -45.29 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.816 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.599 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 5.9 mttp -125.06 163.72 21.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.626 0.25 . . . . 0.0 111.263 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.618 HG23 ' CB ' ' A' ' 105' ' ' PRO . 31.7 p -157.8 102.4 1.84 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.831 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.82 HG23 ' CD ' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -70.03 124.64 24.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.412 HG11 ' HE1' ' A' ' 85' ' ' PHE . 6.2 t -116.28 110.36 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.413 ' CE2' ' OE2' ' A' ' 124' ' ' GLU . 15.8 m-30 -107.88 119.92 40.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.973 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.602 HG12 HD21 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -114.26 152.21 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.13 0.491 . . . . 0.0 111.777 -179.198 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.99 1.05 57.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.846 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.3 108.56 0.28 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.546 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' B' ' 114' ' ' ARG . 3.0 mt -57.84 -17.31 15.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.274 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.23 -22.18 60.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 0.0 110.458 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 88' ' ' VAL . 75.3 m-20 -87.05 -15.49 38.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.017 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.562 ' CE2' ' ND2' ' A' ' 89' ' ' ASN . 0.2 OUTLIER -57.35 -29.67 64.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.193 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.01 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.325 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.91 -28.84 22.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.322 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 84' ' ' ASP . 21.4 t -77.76 -41.65 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.287 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.562 ' ND2' ' CE2' ' A' ' 85' ' ' PHE . 2.5 m-20 -68.17 -36.56 79.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.91 75.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.321 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.59 -32.48 18.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.052 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -61.25 -49.89 75.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.041 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.52 -21.53 57.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.468 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -27.29 50.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.554 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.639 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -85.67 -39.07 17.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 110.752 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 4.3 m-85 -55.15 -54.5 42.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.154 0.502 . . . . 0.0 110.209 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -31.93 71.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.23 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.72 -4.18 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.567 ' HB3' ' CD2' ' A' ' 101' ' ' HIS . 4.1 t-20 -112.5 -5.54 14.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.535 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 5.6 m120 86.29 30.69 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.62 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.938 ' CD2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 m-70 -117.35 54.55 1.56 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.6 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.411 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 63.4 Cg_endo -72.09 -10.05 25.4 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.704 2.269 . . . . 0.0 113.362 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.621 ' HB3' HD11 ' B' ' 5' ' ' ILE . 7.7 m-20 -56.7 -40.74 76.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.794 0.331 . . . . 0.0 110.921 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.672 ' HB2' HG13 ' B' ' 19' ' ' VAL . 26.8 m-85 72.37 90.36 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.988 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.618 ' CB ' HG23 ' A' ' 75' ' ' THR . 77.0 Cg_exo -49.27 162.06 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.557 2.172 . . . . 0.0 112.322 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.878 ' HB1' ' HB2' ' B' ' 31' ' ' SER . . . -125.4 131.18 52.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.534 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.82 ' CD ' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -163.73 -166.47 1.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.57 114.93 28.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.219 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 14.3 m -96.94 130.37 44.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.127 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.718 HG12 HD23 ' B' ' 115' ' ' LEU . 30.4 m -148.74 167.64 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.924 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.805 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 30.7 tt0 -102.28 92.34 4.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.71 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.872 HG21 HD21 ' A' ' 115' ' ' LEU . 24.5 m -62.6 157.94 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.203 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -70.32 -51.44 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.552 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.6 OUTLIER -143.17 178.45 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.718 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.872 HD21 HG21 ' A' ' 112' ' ' VAL . 73.3 mt -150.85 153.99 34.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.749 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.573 ' O ' HG22 ' A' ' 119' ' ' VAL . 36.3 Cg_endo -65.39 137.48 51.29 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.483 2.122 . . . . 0.0 112.21 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 76.66 14.84 2.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.303 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.58 14.48 9.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.095 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.638 HG11 ' HB ' ' A' ' 34' ' ' ILE . 17.3 m -58.78 160.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 111.027 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.48 21.75 21.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.782 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.602 HD21 HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -178.86 154.9 0.74 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 0.0 111.208 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HD13 ' A' ' 123' ' ' ILE . 4.3 tt0 -140.55 150.59 43.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.044 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.864 HG21 HG21 ' A' ' 58' ' ' VAL . 20.8 mm -136.8 119.67 21.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -138.4 115.87 11.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -132.11 168.67 17.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.909 HG23 ' HG ' ' A' ' 29' ' ' LEU . 4.0 mm -116.55 146.03 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.488 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 1.095 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -132.63 148.48 52.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.171 0.51 . . . . 0.0 111.944 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.783 HG12 ' HG ' ' A' ' 27' ' ' LEU . 30.8 m -132.14 162.81 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.883 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.625 ' HB3' HD21 ' A' ' 67' ' ' LEU . 9.9 ptt180 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.98 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.586 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.776 0.322 . . . . 0.0 110.953 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.83 136.88 3.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.026 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.638 HG23 HG21 ' B' ' 19' ' ' VAL . 4.8 mp -58.61 158.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.242 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.539 HD12 ' CB ' ' B' ' 21' ' ' ALA . 19.0 mt -115.1 160.59 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.009 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.475 ' N ' HG22 ' B' ' 6' ' ' ILE . 1.4 t-80 -160.75 124.47 3.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.464 HG22 HG12 ' B' ' 61' ' ' ILE . 8.0 t -127.69 165.57 19.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.967 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.8 51.28 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.402 ' HB3' ' CB ' ' B' ' 60' ' ' ALA . 0.7 OUTLIER -144.19 -49.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.914 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -66.79 172.41 3.41 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.073 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.914 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 32.2 Cg_endo -64.37 -11.93 30.6 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.651 2.234 . . . . 0.0 112.758 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 73.26 171.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.422 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.762 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -167.04 122.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.827 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.762 HD13 ' O ' ' B' ' 14' ' ' ALA . 17.6 mm -141.41 17.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.399 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.49 -103.89 2.45 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.308 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.11 4.83 6.69 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.567 2.178 . . . . 0.0 112.843 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.508 ' CD1' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -160.79 177.18 10.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.911 0.386 . . . . 0.0 111.291 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 104' ' ' PHE . 28.3 m -132.27 166.41 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.06 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.766 ' OE1' ' HB3' ' B' ' 11' ' ' ALA . 3.9 mm-40 -52.89 -46.44 67.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.806 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.539 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . -176.47 176.84 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.875 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.678 HG21 ' HB ' ' A' ' 73' ' ' VAL . 3.1 m -140.27 133.84 34.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.122 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.463 ' CG ' HG12 ' B' ' 28' ' ' VAL . 6.9 t0 -97.2 139.75 32.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.837 HD11 HD13 ' B' ' 29' ' ' LEU . 6.6 mt -112.98 -15.91 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.324 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 97.01 104.45 2.23 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.297 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 8.2 m120 84.07 -35.74 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.763 ' HG ' HG12 ' B' ' 128' ' ' VAL . 0.3 OUTLIER -127.19 101.52 6.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.791 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.122 HG23 ' HB3' ' B' ' 127' ' ' ALA . 3.4 m -94.91 170.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.392 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.914 ' HG ' HG23 ' B' ' 126' ' ' ILE . 3.6 mp -152.85 148.81 27.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.993 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.4 p -125.79 148.08 49.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.755 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.878 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 4.3 t -74.59 170.06 16.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.842 0.354 . . . . 0.0 110.953 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.87 77.14 0.41 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.026 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.15 162.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 111.448 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.721 ' HB ' HG11 ' B' ' 119' ' ' VAL . 7.5 pt -146.84 154.2 47.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.633 ' CG ' HG23 ' B' ' 43' ' ' VAL . 72.6 Cg_endo -77.23 48.85 2.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.903 2.402 . . . . 0.0 113.248 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.718 HG23 HG13 ' B' ' 34' ' ' ILE . 45.8 t . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.238 0.542 . . . . 0.0 110.545 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.633 HG23 ' CG ' ' B' ' 35' ' ' PRO . 9.8 p . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.566 0.222 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.8 Cg_exo -54.39 141.78 71.23 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.52 2.147 . . . . 0.0 112.21 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.77 -31.03 70.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.983 0.42 . . . . 0.0 110.941 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.13 93.77 1.86 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.817 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.4 tp -42.15 -33.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.714 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.49 HG12 ' HD2' ' B' ' 52' ' ' ARG . 22.1 t -78.59 -46.46 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.682 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.99 88.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.701 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.4 ' CB ' ' HD2' ' B' ' 44' ' ' PRO . 3.5 pt20 -65.11 -28.9 69.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.536 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.2 -41.11 42.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.319 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.49 ' HD2' HG12 ' B' ' 48' ' ' VAL . 24.3 mtp180 -67.69 -52.27 39.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.813 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.69 -27.92 63.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.575 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.6 OUTLIER -61.88 -42.44 99.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.602 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.613 HD13 ' CE2' ' B' ' 95' ' ' PHE . 7.5 mt -74.87 -30.03 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.019 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' B' ' 59' ' ' LYS . 32.5 mt-10 -65.51 -36.2 83.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.069 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' B' ' 54' ' ' SER . 22.2 p30 -72.37 -27.83 62.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.883 0.373 . . . . 0.0 110.59 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.841 HG21 HG21 ' B' ' 123' ' ' ILE . 35.1 t -67.7 -45.81 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -76.1 -28.3 57.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.991 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' B' ' 10' ' ' LYS . . . -60.64 -41.28 94.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.464 HG12 HG22 ' B' ' 8' ' ' THR . 15.9 mt -72.95 -41.05 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.565 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.493 ' CD1' HD11 ' B' ' 72' ' ' ILE . 18.3 mt -70.0 -33.14 54.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.663 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.45 -41.0 63.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.286 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.48 -21.76 65.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.392 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.36 -28.37 17.76 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.751 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.27 56.57 0.26 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.583 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.634 HD21 ' HB3' ' B' ' 129' ' ' ARG . 3.5 mt -172.8 144.12 1.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.355 . . . . 0.0 111.126 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -99.39 166.1 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.772 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.924 ' HB3' ' CD2' ' B' ' 101' ' ' HIS . . . -62.54 -31.0 71.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.788 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.769 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -52.49 -26.61 13.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.897 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.443 ' CB ' HD22 ' B' ' 67' ' ' LEU . 1.2 m-20 -82.13 -24.59 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.575 HG21 HG22 ' B' ' 75' ' ' THR . 96.7 mt -52.88 108.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.008 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.649 HG13 HG22 ' B' ' 128' ' ' VAL . 35.3 m -74.29 -45.23 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.841 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.589 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 5.9 mttp -125.05 163.77 21.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.289 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.607 HG23 ' CB ' ' B' ' 105' ' ' PRO . 31.8 p -157.83 102.5 1.84 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.787 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.829 HG23 ' CD ' ' B' ' 107' ' ' ARG . 0.1 OUTLIER -70.12 124.69 24.72 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.017 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.411 HG11 ' HE1' ' B' ' 85' ' ' PHE . 6.3 t -116.38 110.37 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.423 ' CE2' ' OE2' ' B' ' 124' ' ' GLU . 15.7 m-30 -107.85 119.96 40.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.989 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.613 HG12 HD21 ' B' ' 121' ' ' LEU . 0.7 OUTLIER -114.29 152.2 15.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.154 0.502 . . . . 0.0 111.752 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.9 0.94 57.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.849 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.26 108.55 0.28 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.507 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' C' ' 114' ' ' ARG . 3.0 mt -57.8 -17.26 14.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.302 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.23 -22.26 60.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.834 0.35 . . . . 0.0 110.397 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.413 ' O ' HG23 ' B' ' 88' ' ' VAL . 75.2 m-20 -86.98 -15.52 38.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.031 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.563 ' CE2' ' ND2' ' B' ' 89' ' ' ASN . 0.2 OUTLIER -57.28 -29.69 64.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.232 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.94 68.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.32 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.96 -28.85 22.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.301 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 84' ' ' ASP . 21.4 t -77.77 -41.57 28.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.295 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.563 ' ND2' ' CE2' ' B' ' 85' ' ' PHE . 2.5 m-20 -68.28 -36.53 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.828 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.57 -36.0 75.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.308 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.53 -32.48 18.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -61.29 -49.9 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.017 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.48 -21.6 57.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.457 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -27.27 50.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.591 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.613 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -85.68 -39.01 17.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.704 0.288 . . . . 0.0 110.765 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.52 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 4.3 m-85 -55.18 -54.5 42.54 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.136 0.493 . . . . 0.0 110.187 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -31.91 71.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.267 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.71 -4.18 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.584 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.562 ' HB3' ' CD2' ' B' ' 101' ' ' HIS . 4.1 t-20 -112.53 -5.51 14.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.547 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 5.6 m120 86.32 30.79 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.621 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.924 ' CD2' ' HB3' ' B' ' 69' ' ' ALA . 1.6 m-70 -117.35 54.56 1.56 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.679 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 63.9 Cg_endo -72.08 -10.13 25.54 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.74 2.293 . . . . 0.0 113.359 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.486 ' HB3' HD11 ' C' ' 5' ' ' ILE . 7.7 m-20 -56.6 -40.78 75.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.914 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.71 ' HB2' HG13 ' C' ' 19' ' ' VAL . 26.8 m-85 72.21 90.52 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.969 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.607 ' CB ' HG23 ' B' ' 75' ' ' THR . 78.1 Cg_exo -49.37 162.11 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.594 2.196 . . . . 0.0 112.274 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.862 ' HB1' ' HB2' ' C' ' 31' ' ' SER . . . -125.5 131.1 52.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.505 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.829 ' CD ' HG23 ' B' ' 76' ' ' THR . 0.0 OUTLIER -163.57 -166.4 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.6 114.98 28.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.176 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 14.4 m -96.9 130.38 44.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.138 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.729 HG12 HD23 ' C' ' 115' ' ' LEU . 29.8 m -148.81 167.9 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.987 0.423 . . . . 0.0 111.982 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.817 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 30.4 tt0 -102.42 92.46 4.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.708 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.871 HG21 HD21 ' B' ' 115' ' ' LEU . 24.1 m -62.76 158.05 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -70.37 -51.41 29.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.067 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.567 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -143.19 178.5 7.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.685 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.871 HD21 HG21 ' B' ' 112' ' ' VAL . 73.3 mt -150.88 153.99 34.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.769 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 36.4 Cg_endo -65.37 137.56 51.73 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.428 2.085 . . . . 0.0 112.201 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.538 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 76.6 14.84 2.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.339 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.53 14.54 9.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.085 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.721 HG11 ' HB ' ' B' ' 34' ' ' ILE . 17.1 m -58.87 160.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.762 0.315 . . . . 0.0 110.99 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.5 21.68 21.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.682 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.613 HD21 HG12 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -178.88 154.86 0.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.077 0.465 . . . . 0.0 111.204 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.704 ' O ' HD13 ' B' ' 123' ' ' ILE . 4.3 tt0 -140.61 150.57 43.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.083 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.841 HG21 HG21 ' B' ' 58' ' ' VAL . 21.0 mm -136.85 119.55 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' GLU . . . . . 0.423 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.0 OUTLIER -138.32 115.87 11.3 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -132.12 168.68 17.56 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.914 HG23 ' HG ' ' B' ' 29' ' ' LEU . 4.0 mm -116.56 146.06 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.511 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 1.122 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -132.69 148.47 52.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.163 0.506 . . . . 0.0 111.937 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.763 HG12 ' HG ' ' B' ' 27' ' ' LEU . 30.4 m -132.09 162.78 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.945 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.634 ' HB3' HD21 ' B' ' 67' ' ' LEU . 9.9 ptt180 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.004 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.815 0.34 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.75 136.87 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.054 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.653 HG23 HG21 ' C' ' 19' ' ' VAL . 4.8 mp -58.54 158.24 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.181 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' C' ' 21' ' ' ALA . 18.9 mt -115.02 160.68 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.029 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 7' ' ' HIS . . . . . 0.482 ' N ' HG22 ' C' ' 6' ' ' ILE . 1.4 t-80 -160.76 124.45 3.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.964 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.475 HG22 HG12 ' C' ' 61' ' ' ILE . 8.0 t -127.7 165.47 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.78 51.29 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.401 ' HB3' ' CB ' ' C' ' 60' ' ' ALA . 0.7 OUTLIER -144.09 -49.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.704 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.916 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.43 172.3 3.98 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.916 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 32.1 Cg_endo -64.42 -11.95 30.84 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.598 2.199 . . . . 0.0 112.713 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 73.32 171.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.948 0.404 . . . . 0.0 111.365 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.772 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -166.98 122.82 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.798 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.772 HD13 ' O ' ' C' ' 14' ' ' ALA . 17.9 mm -141.47 17.53 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.377 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.47 -103.89 2.45 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.296 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.14 4.83 6.68 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.565 2.177 . . . . 0.0 112.805 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.512 ' CD1' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -160.72 177.18 10.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.897 0.38 . . . . 0.0 111.259 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.71 HG13 ' HB2' ' B' ' 104' ' ' PHE . 28.1 m -132.28 166.39 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.054 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.766 ' OE1' ' HB3' ' C' ' 11' ' ' ALA . 3.9 mm-40 -52.86 -46.55 67.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . -175.62 176.44 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.004 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.593 HG21 ' HB ' ' B' ' 73' ' ' VAL . 3.1 m -140.2 133.86 35.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.464 ' CG ' HG12 ' C' ' 28' ' ' VAL . 6.9 t0 -97.19 139.71 32.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.684 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.818 HD11 HD13 ' C' ' 29' ' ' LEU . 6.5 mt -112.92 -15.87 12.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.352 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 97.03 104.41 2.23 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.344 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 26' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 8.3 m120 84.1 -35.77 0.06 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.769 ' HG ' HG12 ' C' ' 128' ' ' VAL . 0.3 OUTLIER -127.16 101.63 6.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.792 178.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 1.056 HG23 ' HB3' ' C' ' 127' ' ' ALA . 3.4 m -95.0 170.4 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.315 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.903 ' HG ' HG23 ' C' ' 126' ' ' ILE . 3.6 mp -152.78 148.89 27.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.962 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.4 p -125.91 148.95 49.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' SER . . . . . 0.862 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 4.4 t -75.36 170.27 16.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.82 77.16 0.4 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.033 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -53.21 162.95 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.008 0.432 . . . . 0.0 111.412 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.724 HG13 HG23 ' C' ' 36' ' ' VAL . 7.5 pt -146.9 154.29 46.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.681 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.627 ' HG2' HG23 ' C' ' 43' ' ' VAL . 72.5 Cg_endo -77.21 48.81 2.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.911 2.407 . . . . 0.0 113.23 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.724 HG23 HG13 ' C' ' 34' ' ' ILE . 45.9 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 121.178 0.513 . . . . 0.0 110.469 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.627 HG23 ' HG2' ' C' ' 35' ' ' PRO . 10.0 p . . . . . 0 CA--C 1.53 0.2 0 CA-C-O 120.496 0.189 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' C' ' 35' ' ' PRO . 52.7 Cg_exo -54.46 141.82 71.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.443 2.095 . . . . 0.0 112.224 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.0 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.059 0.457 . . . . 0.0 110.994 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -73.15 93.75 1.86 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.803 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' C' ' 47' ' ' ILE . 7.4 tp -42.11 -33.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.677 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 48' ' ' VAL . . . . . 0.427 HG12 ' HD2' ' C' ' 52' ' ' ARG . 22.0 t -78.53 -46.41 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.705 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -61.07 -46.99 88.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.688 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -65.05 -28.8 69.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.453 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.29 -40.86 50.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.051 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.427 ' HD2' HG12 ' C' ' 48' ' ' VAL . 24.2 mtp180 -67.82 -52.22 39.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.79 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -27.98 63.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.644 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.579 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.6 OUTLIER -61.82 -42.41 98.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.621 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.609 HD13 ' CE2' ' C' ' 95' ' ' PHE . 7.5 mt -74.94 -30.0 61.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.008 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' C' ' 59' ' ' LYS . 32.6 mt-10 -65.48 -36.15 83.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -72.43 -27.82 62.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.879 HG21 HG21 ' C' ' 123' ' ' ILE . 34.5 t -67.65 -45.78 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' C' ' 56' ' ' GLU . 0.0 OUTLIER -76.13 -28.34 57.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' C' ' 10' ' ' LYS . . . -60.53 -41.17 93.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.969 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.475 HG12 HG22 ' C' ' 8' ' ' THR . 15.7 mt -73.06 -41.2 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.629 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.53 ' CD1' HD11 ' C' ' 72' ' ' ILE . 18.3 mt -69.9 -33.17 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.712 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.51 -40.96 63.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.229 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -21.83 65.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.325 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.29 -28.4 17.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.3 56.65 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.545 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.622 HD21 ' HB3' ' C' ' 129' ' ' ARG . 3.5 mt -172.86 144.16 1.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.893 0.377 . . . . 0.0 111.063 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -99.41 166.08 11.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.764 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.94 ' HB3' ' CD2' ' C' ' 101' ' ' HIS . . . -62.44 -31.08 71.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.843 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.768 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -52.4 -26.62 13.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.973 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.429 ' CB ' HD22 ' C' ' 67' ' ' LEU . 1.2 m-20 -82.47 -24.51 34.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.582 HG21 HG22 ' C' ' 75' ' ' THR . 96.6 mt -52.84 108.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.989 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.661 ' HB ' HG21 ' A' ' 22' ' ' VAL . 35.4 m -74.29 -45.26 47.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.818 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.596 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 5.8 mttp -125.09 163.68 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.662 0.268 . . . . 0.0 111.248 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.621 HG23 ' CB ' ' C' ' 105' ' ' PRO . 31.8 p -157.74 102.44 1.86 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.788 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.821 HG23 ' CD ' ' C' ' 107' ' ' ARG . 0.1 OUTLIER -70.04 124.63 24.54 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.33 110.39 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.413 ' CE2' ' OE2' ' C' ' 124' ' ' GLU . 15.8 m-30 -107.86 119.97 40.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.94 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.589 HG12 HD21 ' C' ' 121' ' ' LEU . 0.8 OUTLIER -114.3 152.18 15.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.103 0.477 . . . . 0.0 111.773 -179.224 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.89 0.85 57.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.866 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.13 108.49 0.29 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.51 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.552 HD12 ' HB3' ' A' ' 114' ' ' ARG . 3.0 mt -57.76 -17.3 14.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -73.3 -22.19 60.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.384 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.418 ' O ' HG23 ' C' ' 88' ' ' VAL . 75.3 m-20 -87.01 -15.51 38.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.021 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.566 ' CE2' ' ND2' ' C' ' 89' ' ' ASN . 0.2 OUTLIER -57.33 -29.64 64.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.218 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.98 68.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.292 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.93 -28.89 22.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.273 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.418 HG23 ' O ' ' C' ' 84' ' ' ASP . 21.4 t -77.72 -41.61 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 89' ' ' ASN . . . . . 0.566 ' ND2' ' CE2' ' C' ' 85' ' ' PHE . 2.5 m-20 -68.2 -36.6 79.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.95 75.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.274 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.51 -32.43 18.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -61.28 -49.86 75.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.084 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.5 -21.57 57.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.501 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -27.26 50.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.57 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -85.7 -39.02 17.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.703 0.287 . . . . 0.0 110.778 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.52 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 4.3 m-85 -55.12 -54.5 42.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.193 0.521 . . . . 0.0 110.231 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -31.9 71.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.264 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.73 -4.17 55.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.592 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.566 ' HB3' ' CD2' ' C' ' 101' ' ' HIS . 4.1 t-20 -112.54 -5.5 14.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.583 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 5.6 m120 86.29 30.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.631 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.94 ' CD2' ' HB3' ' C' ' 69' ' ' ALA . 1.6 m-70 -117.25 54.58 1.51 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.626 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.419 ' O ' ' CD2' ' C' ' 104' ' ' PHE . 63.4 Cg_endo -72.1 -10.04 25.37 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.744 2.296 . . . . 0.0 113.344 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.568 ' HB3' HD11 ' A' ' 5' ' ' ILE . 7.7 m-20 -56.75 -40.73 76.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.673 ' HB2' HG13 ' A' ' 19' ' ' VAL . 26.7 m-85 72.34 90.39 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.965 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.621 ' CB ' HG23 ' C' ' 75' ' ' THR . 77.2 Cg_exo -49.31 162.1 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.569 2.179 . . . . 0.0 112.303 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.863 ' HB1' ' HB2' ' A' ' 31' ' ' SER . . . -125.51 131.07 52.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.488 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.821 ' CD ' HG23 ' C' ' 76' ' ' THR . 0.0 OUTLIER -163.52 -166.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.64 114.99 28.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.195 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 14.2 m -96.9 130.33 44.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.163 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.722 HG12 HD23 ' A' ' 115' ' ' LEU . 30.2 m -148.88 168.12 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.906 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.826 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 30.6 tt0 -102.48 92.33 4.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.902 HG21 HD21 ' C' ' 115' ' ' LEU . 24.4 m -62.52 158.01 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -70.37 -51.44 29.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.485 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.6 OUTLIER -143.18 178.51 7.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.706 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.902 HD21 HG21 ' C' ' 112' ' ' VAL . 73.3 mt -150.89 153.98 33.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.786 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.562 ' O ' HG22 ' C' ' 119' ' ' VAL . 36.4 Cg_endo -65.36 137.47 51.4 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.513 2.142 . . . . 0.0 112.184 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.546 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 76.62 14.9 2.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.307 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.52 14.52 8.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.72 HG11 ' HB ' ' C' ' 34' ' ' ILE . 17.2 m -58.84 160.86 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.323 . . . . 0.0 110.969 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.45 22.05 20.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.75 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.589 HD21 HG12 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -179.19 155.05 0.7 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.122 0.487 . . . . 0.0 111.144 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.702 ' O ' HD13 ' C' ' 123' ' ' ILE . 4.2 tt0 -140.63 150.62 43.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.036 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.879 HG21 HG21 ' C' ' 58' ' ' VAL . 20.8 mm -136.88 119.55 20.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.132 0.491 . . . . 0.0 112.286 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 124' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' C' ' 78' ' ' PHE . 0.0 OUTLIER -138.33 115.89 11.31 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -132.17 168.66 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.903 HG23 ' HG ' ' C' ' 29' ' ' LEU . 4.0 mm -116.5 146.05 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.527 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 1.056 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -132.65 148.45 52.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.186 0.517 . . . . 0.0 111.895 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.769 HG12 ' HG ' ' C' ' 27' ' ' LEU . 30.5 m -132.09 162.82 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.932 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.622 ' HB3' HD21 ' C' ' 67' ' ' LEU . 9.9 ptt180 -157.05 65.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.4 pttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.449 179.924 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.055 HG21 HG21 ' C' ' 128' ' ' VAL . 10.4 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.827 0.346 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.89 127.17 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.604 HD13 ' CG ' ' C' ' 103' ' ' ASN . 4.6 mp -56.47 153.7 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.177 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 7' ' ' HIS . 31.9 mt -109.85 157.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.459 ' N ' HG22 ' A' ' 6' ' ' ILE . 12.0 t60 -159.46 134.84 8.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.64 HG23 ' H ' ' A' ' 11' ' ' ALA . 8.9 t -147.78 160.75 42.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.93 21.01 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.042 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.508 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 3.8 mmmt -116.59 -35.91 4.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.913 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.704 ' HB2' HG12 ' A' ' 61' ' ' ILE . . . -52.7 177.79 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.343 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.675 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 17.1 Cg_exo -67.13 -8.28 21.37 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.831 2.354 . . . . 0.0 112.705 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 76.45 147.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 110.953 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.81 121.02 39.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.199 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 15' ' ' ILE . 3.1 mp -119.36 16.52 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.971 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.8 -148.87 4.85 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.307 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.73 38.75 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.869 2.379 . . . . 0.0 113.047 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.06 164.26 28.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.884 0.374 . . . . 0.0 111.05 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.588 HG21 HG23 ' A' ' 5' ' ' ILE . 25.6 m -113.32 175.4 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.963 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.542 ' NE2' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -58.51 -48.22 81.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.936 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 61' ' ' ILE . . . -175.53 178.97 1.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.632 HG11 ' O ' ' C' ' 73' ' ' VAL . 14.3 m -134.17 132.95 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.678 ' HA ' HG23 ' A' ' 28' ' ' VAL . 9.8 t70 -111.25 118.42 35.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.742 HD22 ' CG1' ' C' ' 128' ' ' VAL . 3.7 mt -94.1 -16.96 23.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.218 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.33 -99.99 0.9 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.416 ' O ' HD22 ' A' ' 27' ' ' LEU . 4.2 m120 -59.08 -29.16 67.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.193 0.52 . . . . 0.0 109.717 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.63 ' CD2' HG12 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -129.55 139.52 51.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.547 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.92 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 4.2 p -127.92 151.34 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.009 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.921 HD12 HG23 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -134.66 135.46 42.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.743 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.3 p -108.85 136.18 48.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.066 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -63.94 143.23 58.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.827 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.55 92.17 0.01 OUTLIER Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.365 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.511 ' CG ' HG22 ' A' ' 58' ' ' VAL . 32.1 mm-40 -74.55 163.75 27.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.47 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 119' ' ' VAL . 2.1 pt -146.27 160.26 43.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.672 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.564 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 17.6 Cg_exo -66.82 54.23 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.052 2.501 . . . . 0.0 113.262 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.465 HG23 HG13 ' A' ' 34' ' ' ILE . 34.4 t . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.168 0.509 . . . . 0.0 110.384 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.75 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.591 0.234 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.46 140.98 74.06 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.353 2.035 . . . . 0.0 112.118 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.29 -31.55 71.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.068 0.461 . . . . 0.0 110.901 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.48 91.47 0.57 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.781 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mm -41.1 -32.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.542 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.9 -42.66 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.29 -36.51 77.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.766 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.659 ' OE1' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -78.51 -20.66 50.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.605 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.94 -36.76 23.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.291 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -33.2 58.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.931 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.02 -26.68 59.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.696 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.838 ' O ' HG23 ' A' ' 58' ' ' VAL . 90.7 p -70.57 -35.35 73.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.908 HD13 ' CE2' ' A' ' 95' ' ' PHE . 8.7 mt -77.38 -33.6 55.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.074 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -51.59 69.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.977 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 54' ' ' SER . 10.3 p30 -59.45 -39.85 84.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 54' ' ' SER . 31.5 t -61.76 -35.76 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.851 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -31.53 43.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -62.62 -39.17 92.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.704 HG12 ' HB2' ' A' ' 11' ' ' ALA . 22.0 mt -69.47 -46.25 76.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.789 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mt -65.33 -31.44 53.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.765 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -41.36 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.401 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -63.2 -20.44 65.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.512 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.77 -21.51 20.66 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.064 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.03 53.19 0.8 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.383 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' A' ' 71' ' ' ASP . 11.8 mt -155.65 137.1 14.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.964 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 157.16 16.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.754 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -50.13 -36.76 31.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -58.47 -21.24 50.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.363 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.494 ' CB ' HD22 ' A' ' 67' ' ' LEU . 1.5 m-20 -77.88 -26.45 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.884 0.373 . . . . 0.0 110.588 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 35.5 mt -59.35 114.21 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.663 ' O ' HG11 ' B' ' 22' ' ' VAL . 3.4 m -84.39 -33.14 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.72 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.888 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 0.6 OUTLIER -139.86 152.68 46.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.693 0.283 . . . . 0.0 111.009 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.644 HG22 ' CB ' ' A' ' 125' ' ' ALA . 40.8 p -141.9 135.0 29.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 111.336 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 108' ' ' SER . 4.5 m -114.82 150.85 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.213 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 122' ' ' GLU . 20.3 t -148.87 112.94 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 111.613 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.431 ' HB3' HG11 ' A' ' 112' ' ' VAL . 5.5 m-85 -92.7 107.85 19.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.549 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.669 HG12 HD22 ' A' ' 121' ' ' LEU . 36.0 m -102.42 146.43 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.413 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.69 -3.07 58.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.031 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.85 125.89 2.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.25 -11.11 56.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.164 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.07 -20.52 52.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 110.632 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 88' ' ' VAL . 38.8 m-20 -95.24 7.01 47.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.291 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -84.24 -27.96 27.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.768 0.318 . . . . 0.0 111.124 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.88 77.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.176 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.7 -33.89 27.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 84' ' ' ASP . 26.7 t -77.97 -43.29 28.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.029 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -61.72 -33.07 73.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.027 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.35 -48.63 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.299 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.47 -29.85 59.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.186 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.597 ' OH ' HG21 ' A' ' 75' ' ' THR . 11.5 t80 -63.99 -37.51 87.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.148 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.47 -27.33 29.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.191 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -33.72 76.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.187 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.908 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -85.7 -34.63 21.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.553 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.524 ' CE1' ' CE1' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -57.8 -55.05 39.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.287 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -32.74 71.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.049 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -85.8 -0.86 56.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.407 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 2.6 m-20 -98.88 -18.38 17.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.189 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.603 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 20.2 m-20 104.89 25.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.11 0.881 . . . . 0.0 110.948 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.474 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.1 t-80 -123.95 66.67 40.46 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.05 -16.87 22.58 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.533 2.155 . . . . 0.0 112.393 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.578 ' CG ' HD13 ' B' ' 5' ' ' ILE . 1.8 t-20 -68.13 -35.21 77.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.793 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.569 ' O ' HG13 ' B' ' 19' ' ' VAL . 7.8 m-85 76.2 120.44 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.3 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 93.9 Cg_endo -82.41 168.87 14.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.848 2.365 . . . . 0.0 112.218 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.888 ' HB3' ' CG ' ' A' ' 74' ' ' LYS . . . -56.35 159.47 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.406 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -127.97 142.77 51.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.033 0.444 . . . . 0.0 111.528 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 76' ' ' THR . 27.9 t -150.43 66.6 0.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.453 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 11.8 m -96.75 138.76 33.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.033 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.405 HG12 HD23 ' B' ' 115' ' ' LEU . 34.6 m -145.5 139.56 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.303 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.859 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 1.0 OUTLIER -70.87 86.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.822 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.617 HG21 HD21 ' A' ' 115' ' ' LEU . 21.7 m -71.18 155.94 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.238 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.853 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -67.87 -46.82 70.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.076 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 0.0 OUTLIER -153.79 176.96 11.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.799 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.617 HD21 HG21 ' A' ' 112' ' ' VAL . 31.0 mt -147.48 155.38 45.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.814 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.542 ' O ' HG22 ' A' ' 119' ' ' VAL . 12.5 Cg_endo -55.97 136.97 77.51 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.593 2.196 . . . . 0.0 112.045 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.2 OUTLIER 74.88 13.91 3.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.244 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.98 15.95 8.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.109 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.937 HG21 HG21 ' A' ' 34' ' ' ILE . 14.1 m -55.56 146.31 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.185 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.75 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.45 -15.1 64.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.9 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.669 HD22 HG12 ' A' ' 79' ' ' VAL . 37.2 mt -151.18 147.6 27.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.085 0.469 . . . . 0.0 111.016 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.659 ' O ' HD13 ' A' ' 123' ' ' ILE . 5.3 tt0 -122.53 155.32 36.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.211 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.736 ' CG2' HG21 ' A' ' 58' ' ' VAL . 30.3 mm -130.88 133.57 62.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 0.0 111.767 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -152.42 155.88 38.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.007 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.779 ' C ' HD13 ' A' ' 126' ' ' ILE . . . -177.45 165.07 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.081 0.467 . . . . 0.0 111.833 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.921 HG23 HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -124.52 143.66 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.393 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.92 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -129.76 157.99 40.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.0 0.429 . . . . 0.0 111.775 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.012 HG21 HG21 ' B' ' 3' ' ' THR . 30.1 m -115.95 155.0 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.956 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.826 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' THR . . . . . 1.012 HG21 HG21 ' A' ' 128' ' ' VAL . 10.5 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.78 0.324 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.86 127.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.004 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.595 ' H ' HD12 ' B' ' 5' ' ' ILE . 4.6 mp -56.49 153.73 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.207 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.462 HG22 ' N ' ' B' ' 7' ' ' HIS . 31.7 mt -109.89 157.1 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.122 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.462 ' N ' HG22 ' B' ' 6' ' ' ILE . 11.9 t60 -159.48 134.78 8.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.642 HG23 ' H ' ' B' ' 11' ' ' ALA . 8.9 t -147.72 160.76 42.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.94 21.06 10.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.962 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.495 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 3.8 mmmt -116.68 -35.83 4.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 0.0 110.893 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.688 ' HB2' HG12 ' B' ' 61' ' ' ILE . . . -52.77 177.77 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.424 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.686 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 17.1 Cg_exo -67.05 -8.38 21.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.9 2.4 . . . . 0.0 112.689 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.51 147.76 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 111.002 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.81 120.93 39.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.206 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 15' ' ' ILE . 3.1 mp -119.27 16.6 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.984 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.81 -148.88 4.85 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.308 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.72 38.78 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.853 2.369 . . . . 0.0 113.063 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.07 164.34 28.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 111.05 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 104' ' ' PHE . 25.6 m -113.43 175.4 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.917 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.561 ' NE2' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -58.45 -48.3 81.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.981 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' B' ' 61' ' ' ILE . . . -175.62 178.98 1.49 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 73' ' ' VAL . 14.4 m -134.09 132.95 56.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.131 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.682 ' HA ' HG23 ' B' ' 28' ' ' VAL . 9.8 t70 -111.3 118.46 35.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.767 HD22 ' CG1' ' A' ' 128' ' ' VAL . 3.7 mt -94.07 -16.98 23.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.249 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.37 -100.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.468 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ASN . . . . . 0.421 ' O ' HD22 ' B' ' 27' ' ' LEU . 4.2 m120 -59.05 -29.19 67.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.719 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.625 ' CD2' HG12 ' B' ' 128' ' ' VAL . 1.0 OUTLIER -129.57 139.47 51.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.564 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.916 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 4.2 p -127.99 151.39 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.964 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.944 HD12 HG23 ' B' ' 126' ' ' ILE . 0.2 OUTLIER -134.62 135.45 42.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.76 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -108.99 136.24 48.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.028 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.15 143.35 57.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.55 92.1 0.01 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.358 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.516 ' CG ' HG22 ' B' ' 58' ' ' VAL . 32.1 mm-40 -74.53 163.76 27.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.429 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.963 HG21 HG21 ' B' ' 119' ' ' VAL . 2.2 pt -146.28 160.29 42.89 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.625 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.574 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 18.0 Cg_exo -66.96 54.35 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.058 2.505 . . . . 0.0 113.205 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.481 HG23 HG13 ' B' ' 34' ' ' ILE . 34.0 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 121.167 0.508 . . . . 0.0 110.361 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.704 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.1 p . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.589 0.233 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.43 140.89 73.79 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.355 2.037 . . . . 0.0 112.183 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.18 -31.56 71.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.44 91.48 0.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.782 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mm -41.16 -32.75 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.514 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.82 -42.65 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.906 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.29 -36.55 77.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.768 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.645 ' OE1' HD12 ' B' ' 121' ' ' LEU . 0.0 OUTLIER -78.52 -20.85 49.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.614 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.8 -36.8 23.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.295 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 -33.1 58.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.01 -26.83 59.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.809 ' O ' HG23 ' B' ' 58' ' ' VAL . 90.3 p -70.53 -35.25 73.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.904 HD13 ' CE2' ' B' ' 95' ' ' PHE . 8.7 mt -77.41 -33.6 54.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -51.6 69.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' B' ' 54' ' ' SER . 10.3 p30 -59.47 -39.85 85.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.809 HG23 ' O ' ' B' ' 54' ' ' SER . 31.5 t -61.77 -35.79 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.824 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -31.53 43.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.874 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -62.62 -39.29 93.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.688 HG12 ' HB2' ' B' ' 11' ' ' ALA . 22.0 mt -69.46 -46.21 76.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.77 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.25 -31.49 54.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -41.37 60.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.327 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -63.17 -20.43 65.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.556 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.83 -21.47 20.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.049 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.02 53.16 0.81 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.363 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.498 HD22 ' CB ' ' B' ' 71' ' ' ASP . 11.8 mt -155.59 137.05 14.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.71 157.12 16.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -50.1 -36.77 30.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -58.61 -21.2 52.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.364 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.498 ' CB ' HD22 ' B' ' 67' ' ' LEU . 1.5 m-20 -77.74 -26.49 49.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 110.583 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 35.2 mt -59.39 114.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.684 ' O ' HG11 ' C' ' 22' ' ' VAL . 3.4 m -84.34 -33.13 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.745 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.883 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 0.6 OUTLIER -139.91 152.68 46.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.747 0.308 . . . . 0.0 110.953 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.648 HG22 ' CB ' ' B' ' 125' ' ' ALA . 40.7 p -141.86 135.02 29.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.997 0.427 . . . . 0.0 111.353 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.64 HG23 ' O ' ' B' ' 108' ' ' SER . 4.4 m -114.8 150.86 34.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.19 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.405 HG13 ' O ' ' B' ' 122' ' ' GLU . 20.2 t -148.83 112.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 111.637 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.448 ' HB3' HG11 ' B' ' 112' ' ' VAL . 5.6 m-85 -92.74 107.88 19.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.543 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.676 HG12 HD22 ' B' ' 121' ' ' LEU . 35.9 m -102.41 146.42 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.467 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -3.13 59.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.028 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.8 125.9 2.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.581 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.19 -11.09 56.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.202 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.06 -20.58 52.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.831 0.348 . . . . 0.0 110.615 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.7 ' O ' HG23 ' B' ' 88' ' ' VAL . 38.7 m-20 -95.25 7.0 47.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -84.25 -27.95 27.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.145 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.26 -34.92 77.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.264 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.63 -34.01 27.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 84' ' ' ASP . 26.7 t -77.95 -43.28 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.061 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -61.67 -33.19 73.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.008 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.29 -48.55 33.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.332 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.61 -29.93 59.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.615 ' HH ' HG21 ' B' ' 75' ' ' THR . 11.4 t80 -63.94 -37.63 88.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.37 -27.39 29.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.213 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -33.79 76.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.132 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.904 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.3 OUTLIER -85.7 -34.59 21.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 0.0 110.578 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.524 ' CE1' ' CE1' ' B' ' 92' ' ' TYR . 0.4 OUTLIER -57.83 -55.1 39.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.258 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -32.77 71.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.033 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -85.76 -1.0 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.381 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.547 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 2.6 m-20 -98.77 -18.42 17.99 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.192 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.594 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 20.4 m-20 104.98 25.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.117 0.885 . . . . 0.0 110.921 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.464 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.1 t-80 -124.15 66.62 42.3 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.01 -16.8 22.73 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.477 2.118 . . . . 0.0 112.393 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.647 ' CG ' HD13 ' C' ' 5' ' ' ILE . 1.7 t-20 -68.19 -35.11 77.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.851 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.564 ' O ' HG13 ' C' ' 19' ' ' VAL . 7.7 m-85 76.14 120.4 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.287 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.43 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 92.8 Cg_endo -82.36 168.9 14.5 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.798 2.332 . . . . 0.0 112.266 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.883 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -56.31 159.54 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.404 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -128.0 142.79 51.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.082 0.468 . . . . 0.0 111.535 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.64 ' O ' HG23 ' B' ' 76' ' ' THR . 27.8 t -150.46 66.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.426 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 11.8 m -96.78 138.78 33.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 34.6 m -145.44 139.32 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.388 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.866 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 1.0 OUTLIER -70.58 86.89 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.698 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.621 HG21 HD21 ' B' ' 115' ' ' LEU . 21.8 m -71.29 155.8 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.859 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -67.74 -46.89 70.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.439 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -153.79 176.92 11.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.621 HD21 HG21 ' B' ' 112' ' ' VAL . 30.5 mt -147.43 155.32 45.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.809 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.55 ' O ' HG22 ' B' ' 119' ' ' VAL . 12.4 Cg_endo -55.93 136.97 77.4 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.161 . . . . 0.0 112.099 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.428 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.2 OUTLIER 74.91 13.86 3.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.287 -179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 63.05 15.93 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.058 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.963 HG21 HG21 ' B' ' 34' ' ' ILE . 13.9 m -55.63 146.35 4.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.875 0.369 . . . . 0.0 111.177 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' GLY . . . . . 0.704 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.44 -15.19 64.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.868 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.676 HD22 HG12 ' B' ' 79' ' ' VAL . 37.1 mt -151.1 147.41 27.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.07 0.462 . . . . 0.0 111.045 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.656 ' O ' HD13 ' B' ' 123' ' ' ILE . 5.3 tt0 -122.52 155.28 36.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.246 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.72 ' CG2' HG21 ' B' ' 58' ' ' VAL . 30.3 mm -130.83 133.6 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.424 . . . . 0.0 111.76 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -152.5 155.87 38.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.93 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.778 ' C ' HD13 ' B' ' 126' ' ' ILE . . . -177.44 165.04 2.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 111.814 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.944 HG23 HD12 ' B' ' 29' ' ' LEU . 0.7 OUTLIER -124.53 143.67 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.367 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.916 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -129.74 158.0 40.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.999 0.428 . . . . 0.0 111.756 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.987 HG21 HG21 ' C' ' 3' ' ' THR . 30.3 m -115.91 155.03 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.982 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.854 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.987 HG21 HG21 ' B' ' 128' ' ' VAL . 10.3 m . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.794 0.33 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.84 127.13 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.013 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.647 HD13 ' CG ' ' B' ' 103' ' ' ASN . 4.6 mp -56.48 153.7 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.46 HG22 ' N ' ' C' ' 7' ' ' HIS . 31.4 mt -109.8 157.18 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.158 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 7' ' ' HIS . . . . . 0.46 ' N ' HG22 ' C' ' 6' ' ' ILE . 11.9 t60 -159.57 134.76 8.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.644 HG23 ' H ' ' C' ' 11' ' ' ALA . 9.0 t -147.71 160.7 42.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.9 21.05 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.041 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.463 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 3.8 mmmt -116.62 -35.99 4.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.676 ' HB2' HG12 ' C' ' 61' ' ' ILE . . . -52.76 177.85 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.313 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.668 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 17.1 Cg_exo -67.09 -8.38 21.64 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.868 2.379 . . . . 0.0 112.653 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 76.56 147.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.898 0.38 . . . . 0.0 110.967 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.77 120.94 39.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.605 HG22 ' O ' ' C' ' 15' ' ' ILE . 3.1 mp -119.36 16.63 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.84 -148.84 4.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.269 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -88.72 38.76 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.827 2.351 . . . . 0.0 113.071 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.01 164.28 28.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.823 0.344 . . . . 0.0 111.055 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.593 HG21 HG23 ' C' ' 5' ' ' ILE . 25.0 m -113.36 175.41 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.907 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.547 ' NE2' ' HB3' ' C' ' 11' ' ' ALA . 0.0 OUTLIER -58.46 -48.24 81.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.947 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' C' ' 61' ' ' ILE . . . -175.67 178.98 1.47 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.932 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.684 HG11 ' O ' ' B' ' 73' ' ' VAL . 14.2 m -134.12 132.91 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.669 ' HA ' HG23 ' C' ' 28' ' ' VAL . 9.8 t70 -111.2 118.43 35.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.723 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.777 HD22 ' CG1' ' B' ' 128' ' ' VAL . 3.7 mt -94.04 -17.02 23.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.256 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.32 -100.01 0.9 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.489 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' ASN . . . . . 0.412 ' O ' HD22 ' C' ' 27' ' ' LEU . 4.2 m120 -59.04 -29.17 67.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.223 0.535 . . . . 0.0 109.755 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.656 ' CD2' HG12 ' C' ' 128' ' ' VAL . 1.0 OUTLIER -129.59 139.55 51.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.522 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.927 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 4.2 p -127.96 151.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.951 HD12 HG23 ' C' ' 126' ' ' ILE . 0.2 OUTLIER -134.61 135.5 42.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.767 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 32.9 p -108.9 136.34 48.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.103 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -64.01 143.24 58.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.77 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.5 92.12 0.01 OUTLIER Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.325 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.512 ' CG ' HG22 ' C' ' 58' ' ' VAL . 32.1 mm-40 -74.53 163.77 27.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.036 0.446 . . . . 0.0 111.432 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.954 HG21 HG21 ' C' ' 119' ' ' VAL . 2.1 pt -146.33 160.27 42.79 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.618 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.568 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 17.9 Cg_exo -66.84 54.24 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.113 2.542 . . . . 0.0 113.184 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.477 HG23 HG13 ' C' ' 34' ' ' ILE . 34.8 t . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 110.355 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.712 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.2 p . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.572 0.225 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' C' ' 35' ' ' PRO . 53.0 Cg_exo -54.49 140.94 74.44 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.326 2.017 . . . . 0.0 112.19 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.54 71.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.49 91.5 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.78 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 mm -41.15 -32.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.471 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.88 -42.58 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.925 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.31 -36.6 77.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.704 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.65 ' OE1' HD12 ' C' ' 121' ' ' LEU . 0.0 OUTLIER -78.51 -20.74 50.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.88 -36.69 23.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.286 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.72 -33.12 58.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.935 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -74.99 -26.82 59.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.682 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.839 ' O ' HG23 ' C' ' 58' ' ' VAL . 90.8 p -70.45 -35.38 73.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.915 HD13 ' CE2' ' C' ' 95' ' ' PHE . 8.6 mt -77.32 -33.64 55.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -51.56 69.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.993 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 57' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' C' ' 54' ' ' SER . 10.3 p30 -59.5 -39.85 85.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.929 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.839 HG23 ' O ' ' C' ' 54' ' ' SER . 31.5 t -61.77 -35.81 69.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.831 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -31.63 44.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -62.5 -39.13 92.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.676 HG12 ' HB2' ' C' ' 11' ' ' ALA . 22.0 mt -69.64 -46.28 75.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -65.34 -31.42 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -41.42 60.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.368 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -63.14 -20.46 65.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.521 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.79 -21.51 20.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.002 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.04 53.14 0.81 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.373 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.488 HD22 ' CB ' ' C' ' 71' ' ' ASP . 11.8 mt -155.63 137.09 14.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 110.978 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 157.13 16.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.738 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -50.11 -36.71 30.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -58.63 -21.24 53.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.322 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.488 ' CB ' HD22 ' C' ' 67' ' ' LEU . 1.5 m-20 -77.72 -26.49 50.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.551 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 35.3 mt -59.38 114.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.632 ' O ' HG11 ' A' ' 22' ' ' VAL . 3.5 m -84.35 -33.19 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.729 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.895 ' CG ' ' HB3' ' C' ' 106' ' ' ALA . 0.6 OUTLIER -139.87 152.66 46.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.771 0.319 . . . . 0.0 110.942 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.639 HG22 ' CB ' ' C' ' 125' ' ' ALA . 40.8 p -141.9 135.0 29.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.991 0.424 . . . . 0.0 111.381 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.651 HG23 ' O ' ' C' ' 108' ' ' SER . 4.5 m -114.83 150.78 34.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.185 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.41 HG13 ' O ' ' C' ' 122' ' ' GLU . 20.1 t -148.73 112.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 0.0 111.622 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.445 ' HB3' HG11 ' C' ' 112' ' ' VAL . 5.5 m-85 -92.68 107.83 19.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.616 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.685 HG12 HD22 ' C' ' 121' ' ' LEU . 36.0 m -102.44 146.49 10.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.391 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -2.81 58.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.058 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.15 125.94 1.96 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.624 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.28 -11.05 56.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.09 -20.53 52.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.836 0.35 . . . . 0.0 110.606 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.691 ' O ' HG23 ' C' ' 88' ' ' VAL . 38.7 m-20 -95.31 7.04 47.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.263 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -84.25 -28.0 27.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.728 0.299 . . . . 0.0 111.096 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.25 -35.0 77.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.197 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.6 -33.92 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.201 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.691 HG23 ' O ' ' C' ' 84' ' ' ASP . 26.4 t -77.89 -43.3 28.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.099 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -61.66 -33.15 73.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.011 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.37 -48.45 34.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.337 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -29.83 59.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.14 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.605 ' OH ' HG21 ' C' ' 75' ' ' THR . 11.6 t80 -63.94 -37.65 88.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.071 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.42 -27.36 29.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.167 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -33.7 76.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.151 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.915 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.3 OUTLIER -85.76 -34.59 21.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 110.544 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.522 ' CE1' ' CE1' ' C' ' 92' ' ' TYR . 0.4 OUTLIER -57.81 -55.13 38.87 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.232 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -32.77 71.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.022 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -85.71 -0.98 56.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.43 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 2.6 m-20 -98.88 -18.33 17.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.179 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 20.3 m-20 104.8 25.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.869 0.868 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.468 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.1 t-80 -124.07 66.67 41.69 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.846 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.05 -16.8 22.61 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.483 2.122 . . . . 0.0 112.476 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.604 ' CG ' HD13 ' A' ' 5' ' ' ILE . 1.7 t-20 -68.21 -35.14 77.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.852 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.56 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.8 m-85 76.18 120.49 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.264 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 94.2 Cg_endo -82.4 168.93 14.41 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.831 2.354 . . . . 0.0 112.206 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.895 ' HB3' ' CG ' ' C' ' 74' ' ' LYS . . . -56.42 159.6 3.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.393 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -128.1 142.79 51.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.083 0.468 . . . . 0.0 111.471 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 108' ' ' SER . . . . . 0.651 ' O ' HG23 ' C' ' 76' ' ' THR . 27.7 t -150.47 66.68 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.387 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 11.7 m -96.76 138.78 33.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.068 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.412 HG12 HD23 ' A' ' 115' ' ' LEU . 34.6 m -145.54 139.53 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.372 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.853 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -70.63 87.01 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.621 HG21 HD21 ' C' ' 115' ' ' LEU . 21.6 m -71.33 156.03 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -67.97 -46.81 70.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.993 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.75 176.92 11.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.621 HD21 HG21 ' C' ' 112' ' ' VAL . 30.5 mt -147.44 155.35 45.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.539 ' O ' HG22 ' C' ' 119' ' ' VAL . 12.3 Cg_endo -56.03 137.03 77.86 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.572 2.182 . . . . 0.0 112.058 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.2 OUTLIER 74.91 13.88 3.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 20.1 t70 63.0 15.96 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.954 HG21 HG21 ' C' ' 34' ' ' ILE . 14.1 m -55.61 146.38 4.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.856 0.36 . . . . 0.0 111.217 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 120' ' ' GLY . . . . . 0.712 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.41 -15.12 64.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.878 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.685 HD22 HG12 ' C' ' 79' ' ' VAL . 37.0 mt -150.81 147.46 27.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.0 0.429 . . . . 0.0 111.046 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.658 ' O ' HD13 ' C' ' 123' ' ' ILE . 5.3 tt0 -122.6 155.27 36.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.249 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.724 ' CG2' HG21 ' C' ' 58' ' ' VAL . 30.2 mm -130.78 133.6 63.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.004 0.43 . . . . 0.0 111.771 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -152.47 155.87 38.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.981 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.771 ' C ' HD13 ' C' ' 126' ' ' ILE . . . -177.42 165.04 2.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.834 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.951 HG23 HD12 ' C' ' 29' ' ' LEU . 0.7 OUTLIER -124.49 143.65 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.372 179.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.927 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -129.74 157.99 40.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.962 0.41 . . . . 0.0 111.787 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 1.055 HG21 HG21 ' A' ' 3' ' ' THR . 30.7 m -115.94 154.94 17.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.005 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.7 46.99 2.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.899 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.963 -179.961 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.13 HG21 HG21 ' C' ' 128' ' ' VAL . 5.9 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.762 0.315 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -177.96 132.51 0.15 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.008 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.576 ' HA ' HG12 ' A' ' 22' ' ' VAL . 4.3 mp -57.51 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.474 ' N ' HG22 ' A' ' 5' ' ' ILE . 32.1 mt -113.55 150.64 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.203 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -147.84 134.25 19.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.83 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.516 HG21 ' HA ' ' A' ' 61' ' ' ILE . 2.7 t -148.14 163.27 37.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.93 28.67 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -110.31 -49.88 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.776 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.717 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.85 179.3 0.62 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.981 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 31.4 Cg_exo -59.08 -15.57 28.69 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.74 2.293 . . . . 0.0 112.614 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 73.78 153.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -110.37 119.94 40.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.201 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 15' ' ' ILE . 1.9 mp -132.22 16.23 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.833 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.38 -137.96 4.61 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.417 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HB2' ' CE1' ' C' ' 92' ' ' TYR . 87.1 Cg_endo -84.33 16.61 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.755 2.303 . . . . 0.0 113.641 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.559 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 1.1 p90 -137.41 177.85 7.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.454 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 10.6 m -128.82 169.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.047 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.42 HE22 ' HB3' ' A' ' 11' ' ' ALA . 13.7 mm-40 -59.54 -55.85 29.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.006 0.431 . . . . 0.0 110.458 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.99 178.04 4.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.596 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.744 HG21 ' HB ' ' C' ' 73' ' ' VAL . 5.2 m -144.58 131.51 16.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.954 0.407 . . . . 0.0 111.164 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.512 ' HA ' HG23 ' A' ' 28' ' ' VAL . 3.6 t70 -98.98 110.55 23.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.439 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.95 HD22 HG11 ' C' ' 128' ' ' VAL . 17.2 mt -73.48 -11.52 60.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.504 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.51 -102.86 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.669 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.11 -30.05 64.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.176 0.512 . . . . 0.0 109.979 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.58 167.54 18.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.55 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.061 HG12 ' HB3' ' A' ' 127' ' ' ALA . 7.1 p -129.5 160.83 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.787 HD13 HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -136.83 122.78 20.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.28 137.71 41.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.046 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.486 ' CB ' ' HB1' ' C' ' 106' ' ' ALA . 16.8 t -71.25 172.67 8.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.32 82.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.074 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.559 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -56.38 147.51 21.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 0.0 111.385 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 5.0 pt -142.3 149.75 52.66 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.576 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 34' ' ' ILE . 1.6 Cg_endo -83.17 51.09 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.921 2.414 . . . . 0.0 112.481 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.731 HG21 ' HD2' ' A' ' 117' ' ' LYS . 86.0 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.185 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 43' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.556 0.217 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 37.8 Cg_exo -59.7 147.51 91.75 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.514 2.143 . . . . 0.0 112.1 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.39 -31.0 57.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 110.943 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -67.65 95.79 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.28 -32.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.835 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 t -83.26 -43.23 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . . . -60.62 -44.11 96.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.794 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -74.27 -30.09 61.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.266 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.628 ' HB1' HG22 ' A' ' 88' ' ' VAL . . . -75.95 -33.37 59.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.369 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -30.16 29.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.12 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.21 -33.33 59.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.88 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.0 p -69.43 -35.74 76.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.573 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD22 ' HB2' ' A' ' 92' ' ' TYR . 68.5 mt -63.0 -39.71 95.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.531 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -72.22 -40.56 67.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.673 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -57.82 -41.07 81.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 54' ' ' SER . 16.4 t -60.11 -40.76 84.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.792 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.513 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -76.02 -32.41 59.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.769 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.46 86.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.516 ' HA ' HG21 ' A' ' 8' ' ' THR . 17.3 mt -68.9 -41.65 82.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.722 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.997 HD13 HD11 ' A' ' 72' ' ' ILE . 12.3 mt -69.28 -36.58 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.588 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -40.3 72.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -65.32 -19.04 65.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.539 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 6' ' ' ILE . . . -88.33 -34.17 17.73 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.73 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.48 44.84 0.3 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.812 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 129' ' ' ARG . 1.3 mt -143.0 -170.54 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.716 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.78 157.25 44.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.513 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . . . -58.12 -36.58 73.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.03 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -57.49 -26.09 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.319 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.453 ' CB ' HD22 ' A' ' 67' ' ' LEU . 9.3 m-20 -76.29 -24.48 54.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.879 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 127' ' ' ALA . 39.3 mm -54.14 118.27 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.977 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.718 ' HB ' HG21 ' B' ' 22' ' ' VAL . 5.2 m -90.85 -32.86 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.929 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.668 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 14.3 tttt -143.25 163.97 31.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.658 0.266 . . . . 0.0 111.198 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.578 HG21 ' NH2' ' A' ' 107' ' ' ARG . 3.4 t -162.15 112.52 1.56 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.376 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.414 ' HB ' ' CG ' ' A' ' 124' ' ' GLU . 27.3 m -92.87 160.17 15.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.318 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 122' ' ' GLU . 13.6 t -150.54 142.73 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.041 0.448 . . . . 0.0 111.945 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.519 ' CD2' HG11 ' C' ' 110' ' ' VAL . 3.2 m-85 -121.15 102.56 8.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.189 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.479 HG11 ' HD1' ' A' ' 85' ' ' PHE . 5.8 m -100.55 150.28 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.701 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.08 -1.86 58.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.839 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.59 124.5 1.38 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.477 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.59 HD12 ' HD3' ' B' ' 114' ' ' ARG . 9.7 mt -68.79 -10.67 58.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.196 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.97 -22.81 42.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.827 0.346 . . . . 0.0 110.574 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -88.16 -20.27 25.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.479 ' HD1' HG11 ' A' ' 79' ' ' VAL . 14.4 t80 -57.52 -22.25 43.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.358 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.49 -60.41 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.57 79.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.628 HG22 ' HB1' ' A' ' 51' ' ' ALA . 19.3 t -61.67 -37.4 77.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.915 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.589 ' HA ' ' CE2' ' A' ' 92' ' ' TYR . 36.0 t-20 -62.28 -41.94 98.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.77 -23.46 42.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.351 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.16 -42.33 19.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.77 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.601 ' HB2' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -77.34 -28.7 53.15 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.083 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.88 -33.72 39.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.966 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -72.63 -29.75 63.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.178 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -74.26 -41.65 60.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.782 0.325 . . . . 0.0 110.508 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.477 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 6.9 m-85 -52.04 -50.84 60.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.088 0.47 . . . . 0.0 110.377 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HG3' ' N ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -62.04 -28.9 69.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.135 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -90.88 2.73 55.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.42 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -119.25 -1.52 10.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 7.3 t30 85.75 28.73 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.189 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -121.52 53.63 4.02 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.617 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 45.5 Cg_endo -68.3 -20.49 42.7 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.56 2.173 . . . . 0.0 112.676 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 2.1 m-20 -60.85 -40.34 92.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.942 0.401 . . . . 0.0 110.501 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 27.6 m-85 77.36 120.98 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.833 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.547 ' HG2' HG22 ' A' ' 75' ' ' THR . 84.7 Cg_endo -83.99 162.03 13.76 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.844 2.363 . . . . 0.0 112.303 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.668 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -52.32 163.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.447 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.578 ' NH2' HG21 ' A' ' 75' ' ' THR . 13.7 ttm-85 -146.59 144.52 29.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.159 0.504 . . . . 0.0 111.876 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.14 63.31 1.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.996 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 19.8 p -79.92 134.78 36.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.278 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.61 HG12 HD23 ' B' ' 115' ' ' LEU . 33.9 m -146.25 146.62 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.193 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.6 OUTLIER -79.42 88.05 5.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 78' ' ' PHE . 5.7 m -71.75 155.4 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -71.88 -44.01 64.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.614 ' HD3' HD12 ' C' ' 82' ' ' LEU . 0.5 OUTLIER -152.1 174.71 13.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.607 HD23 HG12 ' C' ' 110' ' ' VAL . 14.0 mt -147.16 156.01 46.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.23 136.33 67.88 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.595 2.197 . . . . 0.0 112.169 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.731 ' HD2' HG21 ' A' ' 36' ' ' VAL . 3.1 ttmt 74.7 14.1 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.232 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.48 17.8 8.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 117' ' ' LYS . 23.1 m -52.1 162.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.845 0.355 . . . . 0.0 111.188 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.698 ' C ' HD13 ' A' ' 121' ' ' LEU . . . -95.42 -25.55 13.66 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.737 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.698 HD13 ' C ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -157.51 148.87 21.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.164 0.507 . . . . 0.0 111.127 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.727 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -121.43 155.98 33.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.199 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.819 HD13 ' HB2' ' A' ' 54' ' ' SER . 4.1 mp -144.06 119.99 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.071 0.462 . . . . 0.0 112.016 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.414 ' CG ' ' HB ' ' A' ' 76' ' ' THR . 0.9 OUTLIER -128.88 149.01 50.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.437 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -163.83 161.18 23.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.313 0.578 . . . . 0.0 112.455 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 28' ' ' VAL . 6.0 mt -118.0 152.44 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.058 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 1.061 ' HB3' HG12 ' A' ' 28' ' ' VAL . . . -133.3 149.9 51.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.139 0.495 . . . . 0.0 111.9 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.065 HG21 HG21 ' B' ' 3' ' ' THR . 36.0 m -122.65 139.4 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.815 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.648 ' HB2' HD21 ' A' ' 67' ' ' LEU . 32.5 ttp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' THR . . . . . 1.065 HG21 HG21 ' A' ' 128' ' ' VAL . 5.9 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.829 0.347 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -177.95 132.5 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.084 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.582 ' HA ' HG12 ' B' ' 22' ' ' VAL . 4.3 mp -57.54 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.488 ' N ' HG22 ' B' ' 5' ' ' ILE . 32.2 mt -113.53 150.57 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.222 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -147.82 134.24 19.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.566 HG21 ' HA ' ' B' ' 61' ' ' ILE . 2.7 t -148.17 163.24 37.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.85 28.67 7.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -110.26 -49.84 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.782 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.714 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -67.98 179.29 0.63 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.714 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 31.5 Cg_exo -59.01 -15.59 28.38 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.742 2.295 . . . . 0.0 112.627 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 73.77 153.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -110.38 119.93 40.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.23 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.63 HG22 ' O ' ' B' ' 15' ' ' ILE . 1.9 mp -132.2 16.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.826 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.44 -137.96 4.6 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.429 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.428 ' HB2' ' CE1' ' A' ' 92' ' ' TYR . 88.9 Cg_endo -84.32 16.52 1.92 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.75 2.3 . . . . 0.0 113.653 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.553 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 1.1 p90 -137.37 177.84 7.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.962 0.411 . . . . 0.0 111.456 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.423 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 10.5 m -128.75 169.45 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.028 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.43 HE22 ' HB3' ' B' ' 11' ' ' ALA . 13.7 mm-40 -59.76 -55.74 30.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 110.466 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.94 178.12 4.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.594 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.718 HG21 ' HB ' ' A' ' 73' ' ' VAL . 5.2 m -144.62 131.54 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.954 0.407 . . . . 0.0 111.191 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.509 ' HA ' HG23 ' B' ' 28' ' ' VAL . 3.6 t70 -98.96 110.65 23.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.405 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.967 HD22 HG11 ' A' ' 128' ' ' VAL . 17.3 mt -73.55 -11.54 60.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.503 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.58 -102.87 0.68 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.668 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.19 -29.98 64.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.146 0.498 . . . . 0.0 109.972 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.59 167.53 18.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.523 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.071 HG12 ' HB3' ' B' ' 127' ' ' ALA . 7.1 p -129.52 160.78 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.057 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.764 HD13 HD11 ' B' ' 24' ' ' LEU . 0.1 OUTLIER -136.8 122.76 20.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.736 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.24 137.82 40.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.041 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.494 ' CB ' ' HB1' ' A' ' 106' ' ' ALA . 16.6 t -71.27 172.54 9.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.96 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.21 82.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.113 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.531 ' CB ' HG22 ' B' ' 58' ' ' VAL . 0.1 OUTLIER -56.4 147.49 21.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.022 0.439 . . . . 0.0 111.352 -179.558 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.3 149.69 52.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.552 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.415 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 1.6 Cg_endo -83.12 51.04 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.956 2.437 . . . . 0.0 112.483 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.768 HG21 ' HD2' ' B' ' 117' ' ' LYS . 86.7 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.188 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.458 HG13 ' O ' ' B' ' 43' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.465 0.304 0 CA-C-O 120.495 0.188 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.76 147.61 91.53 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.458 2.105 . . . . 0.0 112.073 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.51 -30.99 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.438 . . . . 0.0 110.912 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' B' ' 49' ' ' ALA . 0.7 OUTLIER -67.6 95.73 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.862 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.22 -32.41 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.806 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -83.25 -43.22 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' B' ' 46' ' ' ASP . . . -60.61 -44.17 96.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.787 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.419 ' HG3' HD11 ' B' ' 121' ' ' LEU . 20.3 pt20 -74.13 -29.15 61.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.228 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.633 ' HB1' HG22 ' B' ' 88' ' ' VAL . . . -76.58 -33.46 58.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.429 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -30.23 29.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.123 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.11 -33.3 59.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.787 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.878 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.0 p -69.54 -35.66 75.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.565 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' B' ' 92' ' ' TYR . 68.4 mt -62.97 -39.78 95.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.504 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -72.11 -40.66 68.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.717 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.75 -41.12 81.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.878 HG23 ' O ' ' B' ' 54' ' ' SER . 16.5 t -60.09 -40.74 84.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.783 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -76.02 -32.53 59.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.747 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.33 -40.59 86.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.566 ' HA ' HG21 ' B' ' 8' ' ' THR . 17.3 mt -68.99 -41.56 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.753 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.988 HD13 HD11 ' B' ' 72' ' ' ILE . 12.3 mt -69.33 -36.58 72.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.536 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -40.21 72.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.229 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.33 -19.06 65.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.533 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.32 -34.16 17.75 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.748 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.49 44.82 0.3 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.769 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.633 HD21 ' HB2' ' B' ' 129' ' ' ARG . 1.3 mt -142.99 -170.47 3.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 110.702 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.79 157.28 44.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.515 ' HB2' ' HG3' ' B' ' 59' ' ' LYS . . . -58.19 -36.57 73.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.991 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.486 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -57.31 -25.8 59.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.294 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.472 ' CB ' HD22 ' B' ' 67' ' ' LEU . 9.4 m-20 -76.7 -24.37 53.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.924 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 1.027 HD13 ' HB2' ' B' ' 127' ' ' ALA . 39.4 mm -54.21 118.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.937 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.764 ' HB ' HG21 ' C' ' 22' ' ' VAL . 5.2 m -90.79 -32.87 5.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.958 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.701 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 14.3 tttt -143.28 163.98 31.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.695 0.283 . . . . 0.0 111.164 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.568 HG21 ' NH2' ' B' ' 107' ' ' ARG . 3.3 t -162.23 112.46 1.53 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.321 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.421 ' HB ' ' CG ' ' B' ' 124' ' ' GLU . 27.6 m -92.8 160.16 15.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.301 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.705 HG13 ' O ' ' B' ' 122' ' ' GLU . 13.6 t -150.52 142.74 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.098 0.475 . . . . 0.0 111.941 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.532 ' CD2' HG11 ' A' ' 110' ' ' VAL . 3.2 m-85 -121.11 102.58 8.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.181 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.475 HG11 ' HD1' ' B' ' 85' ' ' PHE . 5.7 m -100.58 150.33 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.069 0.461 . . . . 0.0 111.671 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.08 -2.11 58.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.846 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.16 124.33 1.48 Allowed 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.509 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.618 HD12 ' HD3' ' C' ' 114' ' ' ARG . 9.7 mt -68.86 -10.69 58.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.165 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.95 -22.76 42.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.799 0.333 . . . . 0.0 110.578 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -88.22 -20.24 25.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.475 ' HD1' HG11 ' B' ' 79' ' ' VAL . 14.3 t80 -57.53 -22.33 43.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.32 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.34 -60.46 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 0.0 111.267 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.56 79.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.633 HG22 ' HB1' ' B' ' 51' ' ' ALA . 19.1 t -61.64 -37.46 78.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.894 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.595 ' HA ' ' CE2' ' B' ' 92' ' ' TYR . 36.0 t-20 -62.25 -41.99 98.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.799 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.79 -23.5 42.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.34 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.04 -42.32 19.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.817 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.595 ' CE2' ' HA ' ' B' ' 89' ' ' ASN . 0.3 OUTLIER -77.35 -28.71 53.12 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.094 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.92 -33.66 39.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -72.62 -29.79 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.14 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -74.23 -41.69 60.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.736 0.303 . . . . 0.0 110.473 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 6.9 m-85 -52.08 -50.78 60.91 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.071 0.462 . . . . 0.0 110.372 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' B' ' 98' ' ' GLU . 0.4 OUTLIER -62.12 -28.85 69.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.116 179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 98' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 0.4 OUTLIER -90.93 2.76 55.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.433 178.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.1 OUTLIER -119.22 -1.58 10.82 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 7.3 t30 85.76 28.61 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.244 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 0.8 OUTLIER -121.36 53.65 3.87 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.593 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 45.7 Cg_endo -68.32 -20.44 42.6 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.617 2.211 . . . . 0.0 112.694 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 2.1 m-20 -60.92 -40.31 92.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 0.0 110.492 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 27.6 m-85 77.28 121.03 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.825 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.525 ' HG2' HG22 ' B' ' 75' ' ' THR . 84.2 Cg_endo -83.98 162.06 13.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.83 2.354 . . . . 0.0 112.303 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.701 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -52.46 163.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.445 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.568 ' NH2' HG21 ' B' ' 75' ' ' THR . 13.6 ttm-85 -146.57 144.58 29.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.163 0.506 . . . . 0.0 111.836 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.14 63.11 1.49 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.966 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 20.1 p -79.7 134.8 36.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.37 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.611 HG12 HD23 ' C' ' 115' ' ' LEU . 33.9 m -146.43 147.1 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.236 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.6 OUTLIER -79.92 88.07 5.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' B' ' 78' ' ' PHE . 5.7 m -71.78 155.47 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.145 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -71.91 -44.01 64.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.59 ' HD3' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -152.13 174.71 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.925 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.61 HD23 HG12 ' A' ' 110' ' ' VAL . 14.0 mt -147.15 156.04 46.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.38 136.36 67.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.608 2.205 . . . . 0.0 112.135 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.768 ' HD2' HG21 ' B' ' 36' ' ' VAL . 3.1 ttmt 74.64 14.13 3.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.293 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.52 17.76 8.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.961 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 m -52.16 162.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.216 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' GLY . . . . . 0.715 ' C ' HD13 ' B' ' 121' ' ' LEU . . . -95.24 -25.06 14.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.697 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.715 HD13 ' C ' ' B' ' 120' ' ' GLY . 0.0 OUTLIER -158.2 149.06 20.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.109 0.48 . . . . 0.0 111.099 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.705 ' O ' HG13 ' B' ' 77' ' ' VAL . 0.4 OUTLIER -121.39 156.01 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.188 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' B' ' 54' ' ' SER . 4.1 mp -144.07 119.97 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.097 0.475 . . . . 0.0 111.994 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' GLU . . . . . 0.421 ' CG ' ' HB ' ' B' ' 76' ' ' THR . 1.0 OUTLIER -128.88 148.97 50.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.434 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -163.78 161.22 23.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.297 0.57 . . . . 0.0 112.449 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.419 HG23 ' O ' ' B' ' 28' ' ' VAL . 5.9 mt -118.01 152.43 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.044 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 1.071 ' HB3' HG12 ' B' ' 28' ' ' VAL . . . -133.23 149.98 51.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.129 0.49 . . . . 0.0 111.96 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 1.044 HG21 HG21 ' C' ' 3' ' ' THR . 35.9 m -122.62 139.4 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.861 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.633 ' HB2' HD21 ' B' ' 67' ' ' LEU . 32.5 ttp180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 111.022 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 3' ' ' THR . . . . . 1.044 HG21 HG21 ' B' ' 128' ' ' VAL . 5.9 m . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.826 0.346 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -178.02 132.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.057 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.591 ' HA ' HG12 ' C' ' 22' ' ' VAL . 4.3 mp -57.54 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.485 ' N ' HG22 ' C' ' 5' ' ' ILE . 32.3 mt -113.49 150.54 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.243 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -147.75 134.26 19.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.588 HG21 ' HA ' ' C' ' 61' ' ' ILE . 2.7 t -148.15 163.28 37.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.94 28.63 8.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.439 ' CB ' ' HB1' ' C' ' 60' ' ' ALA . 26.6 mmtt -110.2 -49.69 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.752 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -68.1 179.27 0.65 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.984 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 31.7 Cg_exo -59.08 -15.58 28.74 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.755 2.303 . . . . 0.0 112.645 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 73.79 154.0 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.056 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -110.38 119.96 40.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.228 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.611 HG22 ' O ' ' C' ' 15' ' ' ILE . 1.9 mp -132.29 16.23 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.764 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 -137.97 4.61 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.429 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' PRO . . . . . 0.441 ' HB2' ' CE1' ' B' ' 92' ' ' TYR . 88.4 Cg_endo -84.32 16.58 1.9 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.692 2.261 . . . . 0.0 113.657 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.553 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 1.1 p90 -137.36 177.88 7.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.975 0.416 . . . . 0.0 111.435 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.418 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 10.6 m -128.78 169.41 20.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.419 HE22 ' HB3' ' C' ' 11' ' ' ALA . 13.7 mm-40 -59.63 -55.51 33.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.457 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.61 178.2 4.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.537 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.764 HG21 ' HB ' ' B' ' 73' ' ' VAL . 5.2 m -144.53 131.5 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.888 0.375 . . . . 0.0 111.179 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.492 ' HA ' HG23 ' C' ' 28' ' ' VAL . 3.6 t70 -99.0 110.63 23.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.447 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.932 HD22 HG11 ' B' ' 128' ' ' VAL . 17.2 mt -73.57 -11.48 60.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.51 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.53 -102.89 0.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.627 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.12 -30.06 64.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.173 0.511 . . . . 0.0 109.975 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.53 167.48 18.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 1.021 HG12 ' HB3' ' C' ' 127' ' ' ALA . 7.1 p -129.5 160.77 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.1 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.776 HD13 HD11 ' C' ' 24' ' ' LEU . 0.1 OUTLIER -136.74 122.79 20.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.741 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.25 137.71 41.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.958 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' SER . . . . . 0.522 ' CB ' ' HB1' ' B' ' 106' ' ' ALA . 16.6 t -71.76 172.78 9.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.034 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.33 82.74 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.11 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.573 ' CB ' HG22 ' C' ' 58' ' ' VAL . 0.0 OUTLIER -56.36 147.48 21.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.039 0.447 . . . . 0.0 111.34 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 5.0 pt -142.3 149.73 52.58 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.554 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 1.6 Cg_endo -83.2 51.08 3.5 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.938 2.425 . . . . 0.0 112.469 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.777 HG21 ' HD2' ' C' ' 117' ' ' LYS . 87.2 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.157 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.462 ' O ' HG13 ' C' ' 43' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 120.539 0.209 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' C' ' 35' ' ' PRO . 37.8 Cg_exo -59.74 147.62 91.44 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.478 2.119 . . . . 0.0 112.088 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.45 -31.03 57.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.439 . . . . 0.0 110.91 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' C' ' 49' ' ' ALA . 0.7 OUTLIER -67.64 95.69 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.873 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.27 -32.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.826 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -83.24 -43.26 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' C' ' 46' ' ' ASP . . . -60.57 -44.17 96.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.781 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -74.14 -29.65 61.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.319 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.588 ' HB1' HG22 ' C' ' 88' ' ' VAL . . . -76.18 -33.47 59.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.327 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -30.21 29.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.135 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.11 -33.32 59.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.857 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.0 p -69.45 -35.76 75.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.575 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.568 HD22 ' HB2' ' C' ' 92' ' ' TYR . 68.5 mt -62.94 -39.81 95.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.495 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -72.12 -40.65 67.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.703 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.73 -41.14 81.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.843 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.857 HG23 ' O ' ' C' ' 54' ' ' SER . 16.5 t -60.04 -40.78 84.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.529 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -76.02 -32.51 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.713 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.439 ' HB1' ' CB ' ' C' ' 10' ' ' LYS . . . -59.44 -40.57 87.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.588 ' HA ' HG21 ' C' ' 8' ' ' THR . 17.4 mt -68.67 -41.58 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.72 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 1.04 HD13 HD11 ' C' ' 72' ' ' ILE . 12.2 mt -69.27 -36.59 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.628 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -40.27 72.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.294 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.26 -19.16 65.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.526 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' ALA . . . . . 0.428 ' HB2' HD13 ' C' ' 6' ' ' ILE . . . -88.29 -34.13 17.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.734 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.44 44.88 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.788 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' C' ' 129' ' ' ARG . 1.3 mt -143.02 -170.55 3.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.728 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.74 157.28 44.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.529 ' HB2' ' HG3' ' C' ' 59' ' ' LYS . . . -58.1 -36.56 73.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -57.51 -25.87 60.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.258 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.468 ' CB ' HD22 ' C' ' 67' ' ' LEU . 9.5 m-20 -76.35 -24.45 54.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.996 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 1.04 HD11 HD13 ' C' ' 62' ' ' ILE . 39.4 mm -54.15 118.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.744 ' HB ' HG21 ' A' ' 22' ' ' VAL . 5.1 m -90.83 -32.87 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.908 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 14.3 tttt -143.23 163.98 31.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.662 0.268 . . . . 0.0 111.188 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.576 HG21 ' NH2' ' C' ' 107' ' ' ARG . 3.4 t -162.16 112.46 1.55 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.418 ' HB ' ' CG ' ' C' ' 124' ' ' GLU . 27.3 m -92.8 160.17 15.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.305 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.723 HG13 ' O ' ' C' ' 122' ' ' GLU . 13.6 t -150.52 142.76 17.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.102 0.477 . . . . 0.0 111.918 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.557 ' CD2' HG11 ' B' ' 110' ' ' VAL . 3.2 m-85 -121.09 102.49 8.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.206 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.473 HG11 ' HD1' ' C' ' 85' ' ' PHE . 5.7 m -100.57 150.26 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.008 0.433 . . . . 0.0 111.715 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.05 -1.7 58.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.893 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.92 124.59 1.29 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.458 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.614 HD12 ' HD3' ' A' ' 114' ' ' ARG . 9.7 mt -68.76 -10.78 58.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.148 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.88 -22.83 42.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.796 0.332 . . . . 0.0 110.598 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -88.18 -20.3 25.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.473 ' HD1' HG11 ' C' ' 79' ' ' VAL . 14.3 t80 -57.54 -22.26 43.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.322 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.4 -60.47 3.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 111.28 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.69 -48.59 79.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.588 HG22 ' HB1' ' C' ' 51' ' ' ALA . 19.4 t -61.7 -37.4 77.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.944 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 89' ' ' ASN . . . . . 0.593 ' HA ' ' CE2' ' C' ' 92' ' ' TYR . 36.0 t-20 -62.32 -41.91 98.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.774 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.76 -23.33 42.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.347 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 1.2 tp10 -82.31 -42.34 18.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.778 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.593 ' CE2' ' HA ' ' C' ' 89' ' ' ASN . 0.3 OUTLIER -77.41 -28.68 52.72 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.071 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.92 -33.78 39.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 16.5 ptp180 -72.48 -29.85 64.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.198 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.478 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -74.18 -41.71 61.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.478 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 7.0 m-85 -52.08 -50.8 60.87 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.358 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -28.88 69.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.145 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.89 2.76 55.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.437 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.1 OUTLIER -119.22 -1.63 10.81 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 7.3 t30 85.84 28.69 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.172 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.474 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 0.8 OUTLIER -121.34 53.63 3.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.627 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 45.9 Cg_endo -68.37 -20.39 42.35 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 112.675 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 2.2 m-20 -61.01 -40.17 92.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.882 0.372 . . . . 0.0 110.482 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 27.6 m-85 77.21 121.02 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.805 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.551 ' HG2' HG22 ' C' ' 75' ' ' THR . 85.0 Cg_endo -83.99 161.98 13.74 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.854 2.369 . . . . 0.0 112.288 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -52.28 163.61 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.434 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.576 ' NH2' HG21 ' C' ' 75' ' ' THR . 13.6 ttm-85 -146.62 144.5 29.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.199 0.524 . . . . 0.0 111.898 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.11 63.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.988 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 20.0 p -79.91 134.75 36.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.339 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.607 HG12 HD23 ' A' ' 115' ' ' LEU . 33.9 m -146.07 145.89 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -78.96 88.2 4.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.761 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' C' ' 78' ' ' PHE . 5.8 m -71.84 155.45 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.129 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -71.9 -44.01 64.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.618 ' HD3' HD12 ' B' ' 82' ' ' LEU . 0.5 OUTLIER -152.13 174.69 13.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.874 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.611 HD23 HG12 ' B' ' 110' ' ' VAL . 13.9 mt -147.13 155.99 46.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.942 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.21 136.38 68.22 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.621 2.214 . . . . 0.0 112.156 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.777 ' HD2' HG21 ' C' ' 36' ' ' VAL . 3.1 ttmt 74.59 14.13 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.309 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.54 17.75 8.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.41 HG13 ' HB3' ' C' ' 117' ' ' LYS . 23.2 m -52.15 162.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 120' ' ' GLY . . . . . 0.703 ' C ' HD13 ' C' ' 121' ' ' LEU . . . -95.48 -25.36 13.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.726 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.703 HD13 ' C ' ' C' ' 120' ' ' GLY . 0.0 OUTLIER -157.81 148.96 21.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.146 0.498 . . . . 0.0 111.191 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.723 ' O ' HG13 ' C' ' 77' ' ' VAL . 0.4 OUTLIER -121.42 156.03 33.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.187 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.8 HD13 ' HB2' ' C' ' 54' ' ' SER . 4.1 mp -144.05 120.05 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.062 0.458 . . . . 0.0 112.056 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 124' ' ' GLU . . . . . 0.418 ' CG ' ' HB ' ' C' ' 76' ' ' THR . 1.0 OUTLIER -128.97 148.93 50.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.429 178.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -163.8 161.2 23.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.28 0.562 . . . . 0.0 112.429 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.414 HG23 ' O ' ' C' ' 28' ' ' VAL . 5.9 mt -118.03 152.36 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.053 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 1.021 ' HB3' HG12 ' C' ' 28' ' ' VAL . . . -133.25 150.01 51.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.093 0.473 . . . . 0.0 111.946 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 1.13 HG21 HG21 ' A' ' 3' ' ' THR . 35.2 m -122.69 139.39 49.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.803 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.618 ' HB2' HD21 ' C' ' 67' ' ' LEU . 32.6 ttp180 -135.51 52.48 2.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.987 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.031 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.509 ' CG2' HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.827 0.346 . . . . 0.0 110.924 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.57 122.74 7.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.486 HD13 HG12 ' A' ' 22' ' ' VAL . 39.2 mm -55.67 144.39 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.543 HD12 ' CB ' ' A' ' 21' ' ' ALA . 32.8 mt -109.49 143.51 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -146.99 141.8 26.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.1 159.34 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.1 28.54 4.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.007 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -122.39 -44.16 2.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.778 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.869 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.22 171.64 4.59 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.114 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.869 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 30.4 Cg_endo -63.86 -12.68 33.0 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.538 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 69.82 147.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.009 0.433 . . . . 0.0 111.336 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.801 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -106.15 123.23 47.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.011 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.801 HD13 ' O ' ' A' ' 14' ' ' ALA . 17.6 mm -131.9 16.96 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.861 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.24 -128.05 3.19 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.385 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -90.02 24.61 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.782 2.322 . . . . 0.0 113.484 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.734 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -152.1 174.53 13.58 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.752 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG13 ' HB2' ' C' ' 104' ' ' PHE . 15.8 m -123.12 173.24 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.826 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.466 HE21 ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -59.62 -40.41 87.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.399 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . 175.62 175.22 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.803 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' C' ' 73' ' ' VAL . 1.8 m -140.22 134.87 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.35 108.86 15.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.597 HD21 HG11 ' C' ' 73' ' ' VAL . 4.1 mm? -84.18 -16.93 41.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.0 -105.75 0.86 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.993 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -53.83 -30.13 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.066 0.46 . . . . 0.0 110.298 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.9 132.8 52.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.843 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.074 HG13 ' HB3' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -131.3 151.99 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.659 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.769 HD23 HD12 ' A' ' 126' ' ' ILE . 0.5 OUTLIER -144.15 140.01 29.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.809 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.3 p -106.28 142.44 35.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.6 p -69.67 155.89 39.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.142 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.02 94.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.518 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.665 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.5 mp0 -78.23 156.22 29.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.992 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.744 ' HB ' HG11 ' A' ' 119' ' ' VAL . 7.0 pt -136.02 146.65 57.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.982 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 53.3 Cg_endo -69.36 61.56 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.863 2.375 . . . . 0.0 112.729 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.568 HG23 HG13 ' A' ' 34' ' ' ILE . 59.7 t . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.085 0.469 . . . . 0.0 110.584 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG21 ' H ' ' A' ' 120' ' ' GLY . 11.3 p . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.52 0.2 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.65 140.48 51.72 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.272 1.982 . . . . 0.0 112.055 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.12 -30.96 60.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.121 0.486 . . . . 0.0 111.077 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -67.02 95.68 0.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.64 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 47' ' ' ILE . 6.4 tp -45.05 -30.54 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.307 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.77 -38.68 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.485 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 46' ' ' ASP . . . -60.98 -53.94 51.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.307 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.568 ' HG3' HD21 ' A' ' 121' ' ' LEU . 17.8 pt20 -62.81 -29.43 70.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.104 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.67 ' HB1' HG13 ' A' ' 88' ' ' VAL . . . -71.18 -35.01 71.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.893 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -80.79 -41.23 23.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.808 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -40.54 96.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 58' ' ' VAL . 13.1 p -64.29 -29.92 70.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.761 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.89 HD21 ' CD2' ' A' ' 92' ' ' TYR . 8.8 mt -82.04 -18.84 41.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.807 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.49 -49.04 9.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.453 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.443 ' OD1' HG23 ' A' ' 58' ' ' VAL . 24.4 p30 -62.79 -33.18 74.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.278 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.738 HG21 ' CG2' ' A' ' 123' ' ' ILE . 92.3 t -73.16 -40.84 58.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.508 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.535 ' HA ' HD12 ' A' ' 62' ' ' ILE . 8.4 tttm -73.05 -33.38 65.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.581 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.44 91.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.76 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.2 mt -68.6 -41.78 83.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.647 HG21 HD11 ' A' ' 72' ' ' ILE . 12.8 mt -67.37 -38.83 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.696 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.8 -37.43 67.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.292 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.59 -20.2 66.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.514 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.15 19.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.985 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.15 47.89 0.79 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.429 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 129' ' ' ARG . 26.3 mt -149.05 136.09 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -87.91 163.25 16.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.161 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.716 ' HA ' HD13 ' A' ' 72' ' ' ILE . . . -54.71 -30.24 55.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.119 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.569 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -67.93 -22.16 65.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.249 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.04 -30.8 69.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 110.213 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.716 HD13 ' HA ' ' A' ' 69' ' ' ALA . 4.0 mp -67.21 108.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.623 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.636 ' HB ' HG21 ' B' ' 22' ' ' VAL . 6.6 m -78.88 -32.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.828 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.675 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 49.7 tttt -131.85 156.61 45.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.769 0.319 . . . . 0.0 110.918 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 125' ' ' ALA . 1.3 m -146.8 117.4 7.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.327 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 108' ' ' SER . 86.6 m -105.34 144.89 31.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.208 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.655 HG13 HD13 ' A' ' 123' ' ' ILE . 38.8 t -151.57 121.21 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 0.0 111.666 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.55 ' HB2' HD21 ' A' ' 115' ' ' LEU . 6.6 m-85 -95.85 118.88 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.274 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.607 HG11 ' CD1' ' A' ' 85' ' ' PHE . 13.5 m -110.54 151.98 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.187 0.518 . . . . 0.0 111.757 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -6.6 31.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.785 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.48 94.18 2.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.364 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 82' ' ' LEU . 4.8 mt -63.61 -13.93 46.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.271 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -27.94 53.12 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.84 -17.5 25.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.503 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.607 ' CD1' HG11 ' A' ' 79' ' ' VAL . 22.4 t80 -57.95 -24.53 58.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.93 -41.96 35.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.841 0.353 . . . . 0.0 111.378 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.2 -33.57 20.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.702 HG12 ' HE1' ' A' ' 92' ' ' TYR . 28.8 t -65.8 -54.52 26.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.665 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 17.1 t-20 -56.62 -43.95 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.972 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.96 70.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.786 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -34.91 77.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.89 ' CD2' HD21 ' A' ' 55' ' ' LEU . 53.3 m-85 -67.36 -45.9 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 0.0 110.156 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -25.36 66.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.335 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -77.0 -38.2 53.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.231 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -37.94 24.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.851 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 7.5 m-85 -53.36 -52.02 60.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.168 0.508 . . . . 0.0 110.225 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -30.33 70.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.318 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.66 3.22 53.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.642 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -116.34 -6.25 11.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.877 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.442 ' O ' ' CG ' ' A' ' 100' ' ' ASN . 0.2 OUTLIER 89.13 26.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.303 0.573 . . . . 0.0 110.505 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.569 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 12.9 t-160 -118.87 54.52 2.3 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.532 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.68 -18.64 32.57 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.702 2.268 . . . . 0.0 112.862 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.416 ' O ' ' CG1' ' B' ' 19' ' ' VAL . 1.9 m-20 -57.78 -39.26 77.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.85 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' B' ' 19' ' ' VAL . 8.1 m-85 81.07 123.36 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.427 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' A' ' 101' ' ' HIS . 97.1 Cg_endo -86.74 162.41 9.2 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.748 2.298 . . . . 0.0 112.707 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.675 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -56.45 140.74 44.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.533 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.443 ' HB2' ' HB3' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -102.07 138.45 39.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.032 0.444 . . . . 0.0 111.553 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.885 ' O ' HG23 ' A' ' 76' ' ' THR . 12.0 t -148.17 55.14 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.1 m -103.0 151.34 22.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.193 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.551 HG11 ' CD2' ' B' ' 78' ' ' PHE . 29.4 m -156.89 160.53 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 5.9 tt0 -86.98 94.21 9.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.87 171.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.216 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -84.41 -50.01 8.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.991 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.402 ' HB3' ' CB ' ' C' ' 111' ' ' GLU . 0.1 OUTLIER -146.13 171.36 15.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.731 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 122' ' ' GLU . 3.2 mt -143.49 160.05 52.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.575 ' O ' HG22 ' A' ' 119' ' ' VAL . 68.2 Cg_exo -50.83 135.93 42.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.506 2.137 . . . . 0.0 112.159 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.28 15.96 8.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.159 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 62.78 16.6 9.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.744 HG11 ' HB ' ' A' ' 34' ' ' ILE . 15.6 m -53.13 170.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.832 0.349 . . . . 0.0 111.147 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.543 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -101.9 -2.93 52.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.964 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.568 HD21 ' HG3' ' A' ' 50' ' ' GLN . 4.2 pp -175.92 148.49 0.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.899 0.381 . . . . 0.0 111.286 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -119.93 163.63 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.302 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.738 ' CG2' HG21 ' A' ' 58' ' ' VAL . 15.6 mm -139.75 129.93 30.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 111.862 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.86 119.04 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.082 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.529 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -133.88 161.95 33.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.03 0.443 . . . . 0.0 111.852 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.769 HD12 HD23 ' A' ' 29' ' ' LEU . 5.8 mm -111.93 150.65 14.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.474 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 1.074 ' HB3' HG13 ' A' ' 28' ' ' VAL . . . -127.43 157.86 38.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.038 0.447 . . . . 0.0 111.783 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 73' ' ' VAL . 34.6 m -130.04 116.25 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.891 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.728 ' HB2' HD21 ' A' ' 67' ' ' LEU . 75.6 ttt-85 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.524 ' CG2' HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.821 0.343 . . . . 0.0 110.974 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.53 122.69 7.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.515 HD13 HG12 ' B' ' 22' ' ' VAL . 39.2 mm -55.56 144.39 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.217 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.491 HD12 ' CB ' ' B' ' 21' ' ' ALA . 32.0 mt -109.44 143.41 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.156 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -146.98 141.76 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.09 159.35 43.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.16 28.48 4.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.977 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.18 -44.09 2.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.865 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -67.34 171.73 4.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.931 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.865 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 30.7 Cg_endo -63.81 -12.71 33.03 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.544 2.162 . . . . 0.0 112.612 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 69.82 147.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.378 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.792 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -106.14 123.19 47.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.792 HD13 ' O ' ' B' ' 14' ' ' ALA . 17.6 mm -131.92 17.01 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.834 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.25 -128.06 3.19 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.441 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.99 24.59 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.769 2.312 . . . . 0.0 113.494 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.725 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.7 OUTLIER -152.08 174.48 13.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.038 0.447 . . . . 0.0 111.758 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 104' ' ' PHE . 15.8 m -123.14 173.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.458 HE21 ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -59.48 -40.37 86.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.016 0.436 . . . . 0.0 110.505 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.491 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . 174.86 175.35 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.854 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.636 HG21 ' HB ' ' A' ' 73' ' ' VAL . 1.9 m -140.32 134.84 35.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.37 108.87 15.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.621 HD21 HG11 ' A' ' 73' ' ' VAL . 4.1 mm? -84.31 -16.86 41.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.01 -105.75 0.86 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -53.84 -30.16 44.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.076 0.465 . . . . 0.0 110.288 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.86 132.87 52.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.812 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.051 HG13 ' HB3' ' B' ' 127' ' ' ALA . 0.1 OUTLIER -131.37 151.97 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.66 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.782 HD23 HD12 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -144.2 139.98 29.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.812 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.3 p -106.09 141.36 37.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.425 ' HA ' ' HB1' ' A' ' 106' ' ' ALA . 79.1 p -69.3 156.1 39.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.087 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.97 94.05 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.521 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.658 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.5 mp0 -78.15 156.2 30.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 110.999 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.737 ' HB ' HG11 ' B' ' 119' ' ' VAL . 7.0 pt -136.06 146.64 57.4 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.981 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 53.5 Cg_endo -69.31 61.49 1.49 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.868 2.379 . . . . 0.0 112.733 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.591 HG23 HG13 ' B' ' 34' ' ' ILE . 60.0 t . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.105 0.478 . . . . 0.0 110.612 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.53 HG21 ' H ' ' B' ' 120' ' ' GLY . 11.3 p . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.507 0.194 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.61 140.46 51.85 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.294 1.996 . . . . 0.0 112.077 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.2 -30.9 60.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 111.046 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' B' ' 49' ' ' ALA . 0.2 OUTLIER -66.98 95.59 0.39 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.732 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.425 ' HA ' HD12 ' B' ' 47' ' ' ILE . 6.3 tp -45.06 -30.48 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.305 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.85 -38.68 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.452 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' B' ' 46' ' ' ASP . . . -60.88 -54.09 49.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.313 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.546 ' HG3' HD21 ' B' ' 121' ' ' LEU . 17.9 pt20 -62.66 -29.55 70.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.072 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.686 ' HB1' HG13 ' B' ' 88' ' ' VAL . . . -71.07 -34.94 71.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.802 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -80.83 -41.23 23.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.786 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -40.53 96.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.689 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.583 ' O ' HG23 ' B' ' 58' ' ' VAL . 13.0 p -64.24 -30.0 71.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.759 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.902 HD21 ' CD2' ' B' ' 92' ' ' TYR . 8.8 mt -82.05 -18.76 42.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.51 -49.1 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.409 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.432 ' OD1' HG23 ' B' ' 58' ' ' VAL . 24.8 p30 -62.66 -33.27 74.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.289 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.747 HG21 ' CG2' ' B' ' 123' ' ' ILE . 91.2 t -73.07 -40.87 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.967 0.413 . . . . 0.0 110.535 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.533 ' HA ' HD12 ' B' ' 62' ' ' ILE . 8.4 tttm -73.11 -33.31 65.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.573 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.43 91.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.71 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -68.61 -41.75 83.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.698 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.656 HG21 HD11 ' B' ' 72' ' ' ILE . 13.0 mt -67.36 -38.86 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.81 -37.45 67.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.281 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.53 -20.13 66.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.563 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.01 -25.1 18.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.971 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.14 47.87 0.8 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.733 HD21 ' HB2' ' B' ' 129' ' ' ARG . 26.4 mt -149.06 136.2 19.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.365 . . . . 0.0 110.813 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -88.05 163.27 16.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.151 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.719 ' HA ' HD13 ' B' ' 72' ' ' ILE . . . -54.73 -30.29 55.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.069 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.557 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -67.84 -22.12 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.285 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.21 -30.75 68.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 110.228 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.719 HD13 ' HA ' ' B' ' 69' ' ' ALA . 4.0 mp -67.23 108.58 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.705 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.624 HG13 HG22 ' B' ' 128' ' ' VAL . 6.5 m -78.94 -31.96 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.834 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.649 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 49.7 tttt -131.91 156.6 45.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.735 0.302 . . . . 0.0 110.96 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.541 HG23 ' HB2' ' B' ' 125' ' ' ALA . 1.3 m -146.81 117.4 7.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.309 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.873 HG23 ' O ' ' B' ' 108' ' ' SER . 86.7 m -105.38 144.88 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.235 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.63 HG13 HD13 ' B' ' 123' ' ' ILE . 38.8 t -151.5 121.22 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.946 0.403 . . . . 0.0 111.735 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.551 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.5 m-85 -95.84 118.84 33.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.25 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.614 HG11 ' CD1' ' B' ' 85' ' ' PHE . 13.5 m -110.52 152.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 0.0 111.78 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -6.58 31.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.715 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -149.66 94.25 2.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.347 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' B' ' 82' ' ' LEU . 4.7 mt -63.57 -13.97 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.31 -27.9 53.1 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.79 -17.55 25.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.519 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' B' ' 79' ' ' VAL . 22.2 t80 -57.96 -24.43 57.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.222 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.03 -41.96 36.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.799 0.333 . . . . 0.0 111.354 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.17 -33.52 20.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.696 HG12 ' HE1' ' B' ' 92' ' ' TYR . 28.4 t -65.84 -54.59 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.41 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 17.1 t-20 -56.62 -43.91 80.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.998 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.96 70.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.729 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -34.9 77.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.902 ' CD2' HD21 ' B' ' 55' ' ' LEU . 52.9 m-85 -67.38 -45.92 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.147 0.499 . . . . 0.0 110.119 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -25.41 66.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.403 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -76.96 -38.25 53.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.228 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.1 OUTLIER -82.56 -37.99 24.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.812 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' B' ' 92' ' ' TYR . 7.5 m-85 -53.32 -52.03 60.46 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.185 0.517 . . . . 0.0 110.265 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -30.27 70.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.337 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.58 3.19 53.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.6 OUTLIER -116.39 -6.17 11.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.871 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 0.2 OUTLIER 89.08 25.82 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.326 0.584 . . . . 0.0 110.495 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.557 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 12.8 t-160 -118.63 54.52 2.18 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.492 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CZ ' ' B' ' 104' ' ' PHE . 58.1 Cg_endo -70.65 -18.65 32.68 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.687 2.258 . . . . 0.0 112.862 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.42 ' O ' ' CG1' ' C' ' 19' ' ' VAL . 1.9 m-20 -57.77 -39.24 76.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.773 0.32 . . . . 0.0 110.819 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.503 ' HB2' HG13 ' C' ' 19' ' ' VAL . 8.1 m-85 81.02 123.27 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.494 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' B' ' 101' ' ' HIS . 97.1 Cg_endo -86.72 162.37 9.22 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.746 2.297 . . . . 0.0 112.648 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.649 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -56.37 140.71 44.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.553 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -102.07 138.45 39.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.08 0.467 . . . . 0.0 111.503 -179.409 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.873 ' O ' HG23 ' B' ' 76' ' ' THR . 12.0 t -148.2 55.16 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.009 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 5.1 m -102.99 151.37 22.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.187 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.533 HG11 ' CD2' ' C' ' 78' ' ' PHE . 29.5 m -156.89 160.75 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.102 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 5.8 tt0 -87.14 94.3 9.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.94 171.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.253 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -84.34 -50.14 8.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.02 171.39 14.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.742 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.819 HD22 ' HB2' ' B' ' 122' ' ' GLU . 3.2 mt -143.57 160.01 52.44 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.812 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.579 ' O ' HG22 ' B' ' 119' ' ' VAL . 68.7 Cg_exo -50.78 135.89 42.6 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.558 2.172 . . . . 0.0 112.137 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.31 15.98 8.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.064 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 62.82 16.54 9.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.021 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.737 HG11 ' HB ' ' B' ' 34' ' ' ILE . 15.6 m -53.13 170.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.832 0.349 . . . . 0.0 111.177 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' GLY . . . . . 0.53 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -101.98 -3.1 51.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.988 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' B' ' 50' ' ' GLN . 4.2 pp -175.76 148.37 0.87 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 111.255 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.819 ' HB2' HD22 ' B' ' 115' ' ' LEU . 0.0 OUTLIER -119.86 163.69 17.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.326 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.747 ' CG2' HG21 ' B' ' 58' ' ' VAL . 15.7 mm -139.77 129.89 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 111.881 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.87 118.99 5.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.074 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -133.84 161.91 33.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.979 0.419 . . . . 0.0 111.884 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.782 HD12 HD23 ' B' ' 29' ' ' LEU . 5.8 mm -111.86 150.6 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.515 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 1.051 ' HB3' HG13 ' B' ' 28' ' ' VAL . . . -127.4 157.85 38.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 111.764 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.624 HG22 HG13 ' B' ' 73' ' ' VAL . 34.1 m -130.0 116.24 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.837 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.733 ' HB2' HD21 ' B' ' 67' ' ' LEU . 75.7 ttt-85 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.999 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.507 ' CG2' HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.79 0.329 . . . . 0.0 110.903 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.6 122.73 7.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.5 HD13 HG12 ' C' ' 22' ' ' VAL . 39.1 mm -55.65 144.42 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.176 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.534 HD12 ' CB ' ' C' ' 21' ' ' ALA . 32.5 mt -109.52 143.46 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -146.99 141.73 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.0 159.39 43.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.15 28.5 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.33 -44.18 2.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.712 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.87 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.26 171.74 4.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.036 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.87 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 30.7 Cg_endo -63.8 -12.74 33.12 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.567 2.178 . . . . 0.0 112.615 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 69.88 147.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.322 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.803 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -106.14 123.22 47.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.053 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.803 HD13 ' O ' ' C' ' 14' ' ' ALA . 17.6 mm -131.94 17.03 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.857 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.24 -128.05 3.19 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.399 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -90.1 24.63 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.769 2.313 . . . . 0.0 113.444 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.736 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.7 OUTLIER -152.06 174.52 13.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.093 0.473 . . . . 0.0 111.727 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' B' ' 104' ' ' PHE . 15.8 m -123.12 173.28 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.802 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.469 HE21 ' HB3' ' C' ' 11' ' ' ALA . 0.0 OUTLIER -59.52 -39.94 85.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 110.374 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . 174.75 175.44 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.852 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.615 HG21 ' HB ' ' B' ' 73' ' ' VAL . 1.9 m -140.33 134.79 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.32 108.9 15.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.62 HD21 HG11 ' B' ' 73' ' ' VAL . 4.1 mm? -84.27 -16.9 41.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.96 -105.74 0.86 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.0 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -53.88 -30.13 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.082 0.468 . . . . 0.0 110.253 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.94 132.8 52.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.858 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 1.031 HG13 ' HB3' ' C' ' 127' ' ' ALA . 0.1 OUTLIER -131.29 152.06 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.656 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.799 HD23 HD12 ' C' ' 126' ' ' ILE . 0.4 OUTLIER -144.22 139.95 28.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.838 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 25.5 p -106.15 141.46 37.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.773 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 79.6 p -69.17 155.82 39.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.97 94.08 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.481 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.643 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.5 mp0 -78.17 156.07 30.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 111.02 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.756 ' HB ' HG11 ' C' ' 119' ' ' VAL . 7.0 pt -135.94 146.69 57.87 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.467 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 53.1 Cg_endo -69.37 61.51 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.821 2.347 . . . . 0.0 112.756 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.589 HG23 HG13 ' C' ' 34' ' ' ILE . 59.8 t . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 0.0 110.602 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.574 HG21 ' H ' ' C' ' 120' ' ' GLY . 11.3 p . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.504 0.193 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.55 140.42 52.02 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.315 2.01 . . . . 0.0 112.077 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.14 -30.98 60.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.019 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -66.95 95.6 0.38 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.698 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' C' ' 47' ' ' ILE . 6.3 tp -45.02 -30.52 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.29 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.86 -38.62 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.496 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' C' ' 46' ' ' ASP . . . -60.96 -53.93 51.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.292 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' C' ' 121' ' ' LEU . 17.9 pt20 -62.97 -29.53 70.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.052 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' C' ' 88' ' ' VAL . . . -71.34 -35.06 71.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.959 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -80.81 -41.19 23.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.754 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -40.47 96.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.662 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.597 ' O ' HG23 ' C' ' 58' ' ' VAL . 13.3 p -64.27 -30.06 71.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.906 HD21 ' CD2' ' C' ' 92' ' ' TYR . 8.8 mt -81.98 -18.81 42.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.53 -49.02 9.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.424 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' ASN . . . . . 0.434 ' OD1' HG23 ' C' ' 58' ' ' VAL . 24.4 p30 -62.75 -33.24 74.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.263 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.748 HG21 ' CG2' ' C' ' 123' ' ' ILE . 91.6 t -73.1 -40.88 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.381 . . . . 0.0 110.54 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.531 ' HA ' HD12 ' C' ' 62' ' ' ILE . 8.3 tttm -73.05 -33.28 65.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.639 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.55 92.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.775 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -68.63 -41.78 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.742 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.646 HD13 HD11 ' C' ' 72' ' ' ILE . 12.9 mt -67.41 -38.8 81.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.734 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.86 -37.39 67.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.275 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.52 -20.21 66.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.589 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.18 19.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.2 47.91 0.79 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.41 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.734 HD13 HG11 ' C' ' 28' ' ' VAL . 26.3 mt -149.08 136.15 19.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 110.846 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -88.02 163.23 16.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.157 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.734 ' HA ' HD13 ' C' ' 72' ' ' ILE . . . -54.7 -30.2 55.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.137 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.568 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -67.8 -22.14 65.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.244 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.13 -30.77 69.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.985 0.422 . . . . 0.0 110.181 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.734 HD13 ' HA ' ' C' ' 69' ' ' ALA . 4.0 mp -67.25 108.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.684 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.62 HG13 HG22 ' C' ' 128' ' ' VAL . 6.5 m -79.04 -31.92 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.826 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.68 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 49.7 tttt -131.91 156.54 45.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.946 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.537 HG23 ' HB2' ' C' ' 125' ' ' ALA . 1.3 m -146.76 117.44 7.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.306 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.885 HG23 ' O ' ' C' ' 108' ' ' SER . 86.4 m -105.35 144.95 31.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.219 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.663 HG13 HD13 ' C' ' 123' ' ' ILE . 38.8 t -151.59 121.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.391 . . . . 0.0 111.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.549 ' HB2' HD21 ' C' ' 115' ' ' LEU . 6.4 m-85 -95.74 118.81 33.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.323 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' C' ' 85' ' ' PHE . 13.4 m -110.56 151.96 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.148 0.499 . . . . 0.0 111.737 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.12 -6.74 30.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.758 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.41 94.24 2.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.342 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' C' ' 82' ' ' LEU . 4.8 mt -63.61 -14.01 47.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.247 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.34 -27.91 52.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.74 -17.57 25.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.526 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.615 ' CD1' HG11 ' C' ' 79' ' ' VAL . 22.3 t80 -58.02 -24.38 58.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.198 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.02 -41.94 36.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.841 0.353 . . . . 0.0 111.393 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.15 -33.59 20.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.766 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.698 HG12 ' HE1' ' C' ' 92' ' ' TYR . 29.4 t -65.88 -54.54 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.571 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 89' ' ' ASN . . . . . 0.409 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 17.1 t-20 -56.58 -43.96 80.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.976 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.06 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.795 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.63 -34.89 77.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.906 ' CD2' HD21 ' C' ' 55' ' ' LEU . 53.4 m-85 -67.35 -45.92 74.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.154 0.502 . . . . 0.0 110.112 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.83 -25.45 66.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.378 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -76.98 -38.24 53.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.235 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.1 OUTLIER -82.54 -37.96 24.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.819 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' C' ' 92' ' ' TYR . 7.5 m-85 -53.35 -52.01 60.6 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.201 0.524 . . . . 0.0 110.247 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -30.3 70.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.298 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.6 3.1 53.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.666 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.6 OUTLIER -116.3 -6.23 11.81 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.889 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.435 ' O ' ' CG ' ' C' ' 100' ' ' ASN . 0.2 OUTLIER 89.16 26.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.305 0.574 . . . . 0.0 110.516 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.568 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 12.9 t-160 -118.82 54.62 2.31 Favored Pre-proline 0 CA--C 1.529 0.154 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.529 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.403 ' O ' ' CE1' ' C' ' 104' ' ' PHE . 58.4 Cg_endo -70.69 -18.69 32.47 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.726 2.284 . . . . 0.0 112.868 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.409 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 1.9 m-20 -57.77 -39.2 76.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.76 0.314 . . . . 0.0 110.849 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.502 ' HB2' HG13 ' A' ' 19' ' ' VAL . 8.1 m-85 81.05 123.26 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.463 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.426 ' HD3' ' CE1' ' C' ' 101' ' ' HIS . 98.1 Cg_endo -86.7 162.3 9.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.779 2.319 . . . . 0.0 112.713 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.68 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -56.35 140.81 44.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.565 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -102.15 138.37 39.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.057 0.456 . . . . 0.0 111.502 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 108' ' ' SER . . . . . 0.885 ' O ' HG23 ' C' ' 76' ' ' THR . 12.0 t -148.14 55.26 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.058 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -103.09 151.35 22.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.17 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.523 HG11 ' CD2' ' A' ' 78' ' ' PHE . 29.3 m -156.98 160.74 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.123 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 6.0 tt0 -87.04 94.17 9.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.8 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.88 171.19 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.237 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -84.4 -49.99 8.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.029 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.14 171.35 15.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.809 HD22 ' HB2' ' C' ' 122' ' ' GLU . 3.2 mt -143.51 160.02 52.6 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.833 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.579 ' O ' HG22 ' C' ' 119' ' ' VAL . 69.9 Cg_exo -50.92 135.9 43.63 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.477 2.118 . . . . 0.0 112.149 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.32 16.01 8.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.103 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 62.8 16.58 9.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.987 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.756 HG11 ' HB ' ' C' ' 34' ' ' ILE . 15.7 m -53.16 170.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.819 0.342 . . . . 0.0 111.163 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 120' ' ' GLY . . . . . 0.574 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -101.88 -3.23 52.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.997 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.557 HD21 ' HG3' ' C' ' 50' ' ' GLN . 4.2 pp -175.72 148.29 0.87 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.219 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.809 ' HB2' HD22 ' C' ' 115' ' ' LEU . 0.0 OUTLIER -119.87 163.65 17.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.278 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.748 ' CG2' HG21 ' C' ' 58' ' ' VAL . 15.6 mm -139.78 129.87 30.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.894 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.82 118.98 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.172 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.537 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -133.77 161.99 33.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 0.0 111.871 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.799 HD12 HD23 ' C' ' 29' ' ' LEU . 5.8 mm -111.97 150.65 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.471 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 1.031 ' HB3' HG13 ' C' ' 28' ' ' VAL . . . -127.42 157.89 38.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.043 0.449 . . . . 0.0 111.804 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.62 HG22 HG13 ' C' ' 73' ' ' VAL . 34.2 m -130.09 116.26 36.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.866 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.73 ' HB2' HD21 ' C' ' 67' ' ' LEU . 75.7 ttt-85 -120.07 70.89 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.978 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.887 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.524 HG21 HG21 ' C' ' 128' ' ' VAL . 11.1 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.934 0.397 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.581 ' NE2' ' HB ' ' C' ' 73' ' ' VAL . 3.0 mm100 63.2 -165.74 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.258 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.2 mp 70.25 118.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.671 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.785 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 22.3 mt -152.99 74.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.678 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -84.76 145.49 27.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 61' ' ' ILE . 1.7 t -149.83 153.46 36.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.71 35.83 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.412 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . 11.5 mmtt -121.13 -38.07 2.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.74 110.65 46.78 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.192 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.28 -16.41 46.56 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.516 2.144 . . . . 0.0 112.469 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.15 -167.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.221 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.502 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 64.87 -165.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.435 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.6 mt 79.61 17.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.119 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.91 -134.64 4.22 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.223 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.64 28.59 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.724 2.283 . . . . 0.0 113.098 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -162.3 177.28 9.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' C' ' 104' ' ' PHE . 33.6 m -106.07 162.3 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.22 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.426 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 3.6 mt-30 -55.65 -52.8 62.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.135 0.493 . . . . 0.0 110.442 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.785 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -158.44 -172.75 3.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.166 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 4' ' ' GLN . 27.6 m -145.51 130.36 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.025 0.44 . . . . 0.0 111.851 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.488 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 48.0 t0 -108.69 102.88 11.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.3 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.722 HD11 HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -66.74 -14.17 62.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 111.188 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.02 -93.08 0.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -61.26 -28.82 69.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.249 0.547 . . . . 0.0 109.593 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.97 140.49 47.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.417 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.899 HG23 ' HB3' ' A' ' 127' ' ' ALA . 2.8 m -105.05 -179.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.197 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.722 HD12 HD11 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -165.89 136.78 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -108.64 135.78 49.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.744 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.2 p -81.07 177.16 9.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.49 95.67 0.1 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.544 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.67 150.95 47.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.906 0.384 . . . . 0.0 111.053 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.748 HG23 HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -129.06 121.91 20.96 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.869 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.4 Cg_exo -67.76 58.96 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.695 2.263 . . . . 0.0 113.094 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.748 HG23 HG23 ' A' ' 34' ' ' ILE . 93.0 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 121.322 0.582 . . . . 0.0 110.639 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.78 ' HB ' HG12 ' A' ' 119' ' ' VAL . 11.2 p . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.522 0.201 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.56 140.96 94.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.415 2.077 . . . . 0.0 112.251 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.8 -31.1 72.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 0.0 110.929 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.54 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 1.3 m-20 -73.5 93.1 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.8 mm -42.49 -31.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.114 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.37 -42.52 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.788 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . . . -65.98 -44.72 84.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.551 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.78 67.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.449 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.28 -40.84 67.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.86 -32.59 57.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.36 -41.14 76.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.1 t -64.27 -38.91 92.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.32 -41.18 77.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.34 -44.06 92.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -60.77 -37.26 81.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.8 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.966 HG21 HG21 ' A' ' 123' ' ' ILE . 26.3 t -63.0 -45.97 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HA ' HD12 ' A' ' 62' ' ' ILE . 7.5 mttt -71.97 -32.62 67.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.782 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.412 ' HB1' ' CB ' ' A' ' 10' ' ' LYS . . . -60.44 -39.51 87.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.557 HG22 ' CG2' ' A' ' 6' ' ' ILE . 4.2 mt -70.04 -40.76 78.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.011 HD13 HD11 ' A' ' 72' ' ' ILE . 8.6 mt -70.5 -34.6 58.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.421 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -69.99 -42.61 72.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.402 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -15.73 63.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.595 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 6' ' ' ILE . . . -87.99 -33.64 18.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.942 0.401 . . . . 0.0 110.627 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.24 41.42 0.36 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.793 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.762 HD21 ' HG3' ' A' ' 129' ' ' ARG . 63.9 mt -150.25 -177.55 6.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.733 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.08 164.88 28.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.799 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -52.75 -35.02 55.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -60.86 -22.35 64.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.216 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 128' ' ' VAL . 6.9 m-20 -81.03 -18.49 46.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.767 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 62' ' ' ILE . 28.2 mm -58.44 123.61 10.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.868 HG11 HG13 ' A' ' 128' ' ' VAL . 34.8 m -92.63 -27.4 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.382 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.49 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 36.8 tttm -150.49 164.69 35.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -156.4 113.27 3.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.777 0.322 . . . . 0.0 111.526 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -100.02 152.41 20.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.303 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.422 HG13 HD13 ' A' ' 123' ' ' ILE . 21.2 t -151.74 127.36 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.821 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CE2' ' OE1' ' A' ' 124' ' ' GLU . 10.6 m-85 -105.39 115.54 30.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.328 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 85' ' ' PHE . 4.8 m -105.49 148.57 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.638 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.76 -4.52 56.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.051 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -164.59 134.23 3.8 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.549 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' B' ' 114' ' ' ARG . 1.0 OUTLIER -70.9 -8.89 56.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.274 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.35 -24.23 23.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.791 0.329 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -75.44 -22.3 57.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.084 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.576 ' CD2' HG11 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -61.68 -18.2 58.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.448 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.13 -41.12 68.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.852 0.358 . . . . 0.0 111.271 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -27.8 22.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.983 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.3 t -73.71 -47.07 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.25 -40.08 95.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.407 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.16 84.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.947 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -87.89 -28.25 21.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.554 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 95' ' ' PHE . 81.0 t80 -53.39 -44.74 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.945 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -86.9 -25.26 24.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -21.36 60.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.473 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.446 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -91.13 -33.62 15.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.863 0.363 . . . . 0.0 110.613 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.457 ' CZ ' ' CG ' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -56.45 -58.01 9.85 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.316 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -64.58 -30.74 71.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.006 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -78.16 -9.23 59.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.233 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.667 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 3.5 m120 -109.82 -5.01 15.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.393 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 21.9 m-80 84.5 38.58 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.759 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -130.69 68.86 82.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.337 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 1.4 Cg_endo -82.35 -17.46 7.67 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.971 2.447 . . . . 0.0 112.824 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 1.2 t-20 -59.27 -36.78 76.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.878 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 27.9 m-85 78.76 114.77 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.395 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' CG ' ' CZ ' ' A' ' 96' ' ' PHE . 62.3 Cg_endo -87.2 163.12 8.53 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.164 2.576 . . . . 0.0 112.147 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.46 175.6 0.23 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -173.0 163.48 4.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.331 0.586 . . . . 0.0 112.049 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.89 83.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.032 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.457 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 14.1 p -89.4 123.63 33.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.492 HG12 HD23 ' B' ' 115' ' ' LEU . 35.6 m -142.89 148.68 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.297 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.867 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.8 OUTLIER -81.69 97.34 7.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.824 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.46 160.43 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.152 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.861 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -69.61 -45.65 68.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.023 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.491 ' HB3' HD12 ' C' ' 82' ' ' LEU . 6.3 mtt-85 -156.89 176.98 12.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.824 HD22 ' HB2' ' A' ' 122' ' ' GLU . 12.8 mt -145.27 160.65 44.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.811 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.495 ' O ' HG22 ' A' ' 119' ' ' VAL . 69.2 Cg_exo -51.04 135.75 44.46 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.545 2.163 . . . . 0.0 112.218 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.607 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.1 OUTLIER 72.3 14.45 5.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.226 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.24 14.24 9.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.212 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.78 HG12 ' HB ' ' A' ' 43' ' ' VAL . 27.7 m -57.57 171.22 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.865 0.364 . . . . 0.0 111.162 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.21 21.96 16.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.474 HD21 HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -176.37 156.91 1.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.12 0.486 . . . . 0.0 111.213 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.824 ' HB2' HD22 ' A' ' 115' ' ' LEU . 6.2 tt0 -149.89 156.34 41.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.966 HG21 HG21 ' A' ' 58' ' ' VAL . 22.8 mm -133.41 136.73 54.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.153 0.502 . . . . 0.0 112.109 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 6.6 pt-20 -155.48 106.6 2.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.298 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.676 ' HB2' HG22 ' A' ' 75' ' ' THR . . . -129.05 175.28 8.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.258 0.552 . . . . 0.0 112.374 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.705 HG23 ' HG ' ' A' ' 29' ' ' LEU . 3.1 mt -125.71 157.81 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.1 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.994 ' HB2' HD13 ' A' ' 72' ' ' ILE . . . -148.8 149.11 30.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.97 0.414 . . . . 0.0 111.459 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.868 HG13 HG11 ' A' ' 73' ' ' VAL . 3.3 m -96.96 156.43 3.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.077 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.762 ' HG3' HD21 ' A' ' 67' ' ' LEU . 54.2 ttt-85 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.522 HG21 HG21 ' A' ' 128' ' ' VAL . 11.1 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.917 0.389 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.555 ' NE2' ' HB ' ' A' ' 73' ' ' VAL . 2.9 mm100 63.27 -165.77 0.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.258 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.474 ' N ' HD12 ' B' ' 5' ' ' ILE . 1.2 mp 70.29 118.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.644 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.77 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 22.3 mt -153.02 74.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.648 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -84.67 145.48 27.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.507 HG21 ' HA ' ' B' ' 61' ' ' ILE . 1.7 t -149.85 153.4 36.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.65 35.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.417 ' CB ' ' HB1' ' B' ' 60' ' ' ALA . 11.5 mmtt -121.18 -38.05 2.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.73 110.71 47.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.193 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.27 -16.5 47.06 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.511 2.14 . . . . 0.0 112.447 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.08 -167.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.262 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.501 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 64.89 -165.09 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.369 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.586 HG22 ' O ' ' B' ' 15' ' ' ILE . 2.6 mt 79.65 17.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.102 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.91 -134.59 4.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.201 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -87.7 28.6 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.712 2.275 . . . . 0.0 113.089 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -162.28 177.37 9.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 111.201 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 104' ' ' PHE . 33.7 m -106.11 162.33 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.18 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.437 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 3.6 mt-30 -55.55 -52.65 63.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.221 0.534 . . . . 0.0 110.453 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.77 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -158.65 -172.72 3.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.189 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' B' ' 4' ' ' GLN . 27.7 m -145.53 130.41 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.059 0.457 . . . . 0.0 111.745 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.482 ' CG ' HG12 ' B' ' 28' ' ' VAL . 47.9 t0 -108.76 102.84 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.278 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.708 HD11 HD12 ' B' ' 29' ' ' LEU . 0.5 OUTLIER -66.74 -14.12 62.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.17 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.01 -93.05 0.59 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -61.27 -28.82 69.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 140.45 47.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.426 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.887 HG23 ' HB3' ' B' ' 127' ' ' ALA . 2.8 m -105.08 -179.25 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.183 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.708 HD12 HD11 ' B' ' 24' ' ' LEU . 0.2 OUTLIER -165.82 136.78 3.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 66.7 p -108.68 135.64 49.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 42.8 p -80.88 177.25 9.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.48 95.62 0.1 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.537 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.65 150.94 47.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.908 0.385 . . . . 0.0 111.086 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.752 HG23 HG23 ' B' ' 36' ' ' VAL . 0.6 OUTLIER -129.12 121.97 20.94 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.823 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.81 58.93 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.719 2.28 . . . . 0.0 113.037 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.752 HG23 HG23 ' B' ' 34' ' ' ILE . 93.3 t . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 121.281 0.562 . . . . 0.0 110.576 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.758 ' HB ' HG12 ' B' ' 119' ' ' VAL . 11.2 p . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.525 0.202 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.68 141.07 95.37 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.364 2.043 . . . . 0.0 112.188 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.79 -31.21 72.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.554 ' HB2' ' HB3' ' B' ' 49' ' ' ALA . 1.3 m-20 -73.43 93.09 1.92 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mm -42.48 -31.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.125 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.47 -42.5 21.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.723 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' B' ' 46' ' ' ASP . . . -65.99 -44.72 84.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.565 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.71 67.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.526 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.88 67.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.82 -32.64 57.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.32 -41.17 77.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.748 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.739 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.1 t -64.23 -38.9 92.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.788 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.33 -41.2 76.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.36 -43.99 92.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -60.79 -37.29 81.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.758 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.984 HG21 HG21 ' B' ' 123' ' ' ILE . 26.5 t -63.04 -46.01 97.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' B' ' 62' ' ' ILE . 7.4 mttt -71.92 -32.64 67.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.808 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.417 ' HB1' ' CB ' ' B' ' 10' ' ' LYS . . . -60.42 -39.53 87.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.55 HG22 ' CG2' ' B' ' 6' ' ' ILE . 4.2 mt -70.18 -40.77 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.839 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.95 HD13 HD11 ' B' ' 72' ' ' ILE . 8.6 mt -70.54 -34.59 58.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.391 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -69.98 -42.68 72.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.362 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -15.82 63.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.677 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' B' ' 6' ' ' ILE . . . -87.96 -33.62 18.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.632 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.28 41.39 0.36 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.812 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.746 HD21 ' HG3' ' B' ' 129' ' ' ARG . 64.2 mt -150.32 -177.57 6.02 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.004 0.43 . . . . 0.0 110.714 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.04 164.89 28.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.8 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.635 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -52.74 -35.11 55.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.941 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -60.79 -22.24 63.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.208 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.512 ' O ' HG22 ' B' ' 128' ' ' VAL . 6.9 m-20 -81.09 -18.43 46.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.787 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 1.008 HD13 ' HB2' ' B' ' 127' ' ' ALA . 28.2 mm -58.53 123.65 10.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.857 HG11 HG13 ' B' ' 128' ' ' VAL . 34.9 m -92.69 -27.37 4.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.368 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.496 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 36.7 tttm -150.45 164.73 35.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.661 HG22 ' HB2' ' B' ' 125' ' ' ALA . 0.2 OUTLIER -156.48 113.23 3.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.727 0.299 . . . . 0.0 111.481 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -99.97 152.44 20.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.417 HG13 HD13 ' B' ' 123' ' ' ILE . 21.2 t -151.77 127.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.984 0.421 . . . . 0.0 111.801 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.403 ' CE2' ' OE1' ' B' ' 124' ' ' GLU . 10.5 m-85 -105.39 115.54 30.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.279 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.565 HG11 ' CD2' ' B' ' 85' ' ' PHE . 4.9 m -105.51 148.52 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.634 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.7 -4.63 56.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.978 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -164.65 134.18 3.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.609 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.87 -8.89 56.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.248 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.29 -24.28 23.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.804 0.335 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -75.42 -22.25 57.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.565 ' CD2' HG11 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -61.7 -18.2 58.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.406 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.21 -41.09 68.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.804 0.335 . . . . 0.0 111.27 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -27.84 22.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' B' ' 92' ' ' TYR . 27.5 t -73.67 -47.11 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.941 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.15 -40.18 95.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.426 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.97 -40.21 84.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.945 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.09 -28.18 21.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.538 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 81.3 t80 -53.4 -44.79 68.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.9 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -86.9 -25.17 24.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.052 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -21.37 60.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.455 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 1.0 OUTLIER -91.1 -33.69 15.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 110.623 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.444 ' CZ ' ' CG ' ' B' ' 105' ' ' PRO . 0.8 OUTLIER -56.39 -58.09 9.51 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.317 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -64.5 -30.72 71.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.051 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -78.17 -9.31 59.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.209 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' B' ' 69' ' ' ALA . 3.5 m120 -109.83 -4.97 15.7 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.389 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.685 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 21.9 m-80 84.53 38.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.812 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' B' ' 69' ' ' ALA . 0.8 OUTLIER -130.68 68.92 82.17 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.343 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.33 -17.48 7.69 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.006 2.471 . . . . 0.0 112.857 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 1.2 t-20 -59.25 -36.84 76.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 0.0 110.867 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.55 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 28.0 m-85 78.75 114.73 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.475 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.444 ' CG ' ' CZ ' ' B' ' 96' ' ' PHE . 62.4 Cg_endo -87.22 163.04 8.51 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.167 2.578 . . . . 0.0 112.108 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.38 175.59 0.23 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' B' ' 75' ' ' THR . 0.9 OUTLIER -173.02 163.55 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.317 0.58 . . . . 0.0 112.078 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.94 83.87 1.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.089 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' CYS . . . . . 0.442 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 14.5 p -89.38 123.68 33.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.081 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.445 HG12 HD23 ' C' ' 115' ' ' LEU . 35.6 m -143.12 149.19 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.379 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.838 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.8 OUTLIER -81.85 97.15 7.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.644 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.35 160.34 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.867 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -69.6 -45.58 68.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.026 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.514 ' HB3' HD12 ' A' ' 82' ' ' LEU . 6.3 mtt-85 -156.94 176.92 12.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' B' ' 122' ' ' GLU . 12.7 mt -145.24 160.64 45.03 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.86 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.495 ' O ' HG22 ' B' ' 119' ' ' VAL . 69.7 Cg_exo -51.07 135.76 44.68 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.511 2.141 . . . . 0.0 112.249 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.608 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.1 OUTLIER 72.23 14.51 5.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.223 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.26 14.24 9.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.145 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.758 HG12 ' HB ' ' B' ' 43' ' ' VAL . 27.7 m -57.56 171.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.879 0.371 . . . . 0.0 111.13 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.05 22.08 16.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.568 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.486 ' C ' HD13 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -176.26 156.78 1.67 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.107 0.48 . . . . 0.0 111.151 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' B' ' 115' ' ' LEU . 6.2 tt0 -149.84 156.39 41.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.104 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.984 HG21 HG21 ' B' ' 58' ' ' VAL . 22.7 mm -133.4 136.69 54.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.194 0.521 . . . . 0.0 112.091 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' GLU . . . . . 0.403 ' OE1' ' CE2' ' B' ' 78' ' ' PHE . 6.6 pt-20 -155.5 106.55 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.329 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.661 ' HB2' HG22 ' B' ' 75' ' ' THR . . . -128.99 175.31 8.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.307 0.575 . . . . 0.0 112.37 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.7 HG23 ' HG ' ' B' ' 29' ' ' LEU . 3.1 mt -125.68 157.89 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.134 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 1.008 ' HB2' HD13 ' B' ' 72' ' ' ILE . . . -148.97 149.08 30.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.0 0.429 . . . . 0.0 111.424 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.857 HG13 HG11 ' B' ' 73' ' ' VAL . 3.3 m -96.96 156.4 3.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.049 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.746 ' HG3' HD21 ' B' ' 67' ' ' LEU . 54.2 ttt-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.513 HG21 HG21 ' B' ' 128' ' ' VAL . 11.1 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.9 0.381 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 4' ' ' GLN . . . . . 0.578 ' NE2' ' HB ' ' B' ' 73' ' ' VAL . 3.0 mm100 63.24 -165.76 0.23 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.292 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.483 HD12 ' N ' ' C' ' 5' ' ' ILE . 1.2 mp 70.26 118.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.613 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.79 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 22.3 mt -153.05 74.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.674 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -84.67 145.56 27.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.216 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.514 HG21 ' HA ' ' C' ' 61' ' ' ILE . 1.7 t -149.91 153.38 36.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.69 35.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.422 ' CB ' ' HB1' ' C' ' 60' ' ' ALA . 11.5 mmtt -121.09 -38.06 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.87 110.79 47.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.147 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.33 -16.39 46.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.506 2.137 . . . . 0.0 112.444 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' C' ' 34' ' ' ILE . . . -57.15 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.243 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.502 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 64.78 -165.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.38 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.591 HG22 ' O ' ' C' ' 15' ' ' ILE . 2.6 mt 79.72 17.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.034 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.89 -134.6 4.22 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.3 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -87.64 28.61 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.784 2.323 . . . . 0.0 113.14 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -162.35 177.35 9.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 111.23 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.415 HG13 ' O ' ' B' ' 104' ' ' PHE . 33.7 m -106.08 162.35 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.434 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 3.6 mt-30 -55.66 -52.92 62.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.144 0.497 . . . . 0.0 110.516 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.79 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -158.14 -172.77 4.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.152 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.41 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 27.6 m -145.53 130.41 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.043 0.449 . . . . 0.0 111.855 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.481 ' CG ' HG12 ' C' ' 28' ' ' VAL . 48.2 t0 -108.75 102.88 11.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.244 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.725 HD11 HD12 ' C' ' 29' ' ' LEU . 0.5 OUTLIER -66.75 -14.14 62.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.214 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.08 -93.13 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -61.27 -28.79 69.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.232 0.539 . . . . 0.0 109.574 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 140.47 47.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.397 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.893 HG23 ' HB3' ' C' ' 127' ' ' ALA . 2.8 m -105.05 -179.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.246 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.725 HD12 HD11 ' C' ' 24' ' ' LEU . 0.2 OUTLIER -165.8 136.86 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.824 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -108.85 136.27 48.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.842 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 41.9 p -81.07 177.26 9.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.57 95.67 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.66 151.02 47.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 111.061 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.755 HG23 HG23 ' C' ' 36' ' ' VAL . 0.6 OUTLIER -129.18 121.96 20.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.85 58.9 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.715 2.277 . . . . 0.0 113.068 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.755 HG23 HG23 ' C' ' 34' ' ' ILE . 93.0 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 0.0 110.593 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.759 ' HB ' HG12 ' C' ' 119' ' ' VAL . 11.2 p . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.531 0.205 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.57 141.01 95.14 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.376 2.051 . . . . 0.0 112.23 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.83 -31.17 72.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.034 0.445 . . . . 0.0 110.91 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.544 ' HB2' ' HB3' ' C' ' 49' ' ' ALA . 1.3 m-20 -73.4 93.11 1.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.935 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mm -42.45 -31.76 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.157 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' VAL . . . . . 0.444 HG22 ' CB ' ' C' ' 87' ' ' ALA . 22.0 t -80.47 -42.43 21.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.756 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' C' ' 46' ' ' ASP . . . -66.04 -44.71 83.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.506 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -27.6 67.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.46 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.95 68.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.986 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.79 -32.63 57.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -41.12 77.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.743 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.1 t -64.23 -38.95 92.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.777 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 18.6 mt -69.33 -41.18 76.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.839 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.27 -44.09 92.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -60.8 -37.26 81.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.755 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 1.029 HG21 HG21 ' C' ' 123' ' ' ILE . 26.3 t -62.96 -46.08 97.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.556 ' HA ' HD12 ' C' ' 62' ' ' ILE . 7.4 mttt -71.92 -32.62 67.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.809 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.422 ' HB1' ' CB ' ' C' ' 10' ' ' LYS . . . -60.16 -39.58 86.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.549 HG22 ' CG2' ' C' ' 6' ' ' ILE . 4.2 mt -70.29 -40.75 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.839 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 1.036 HD13 HD11 ' C' ' 72' ' ' ILE . 8.6 mt -70.52 -34.56 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.433 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -69.98 -42.69 72.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -15.77 63.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.653 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 65' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' C' ' 6' ' ' ILE . . . -88.0 -33.69 18.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.548 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.29 41.32 0.37 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.841 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.763 HD21 ' HG3' ' C' ' 129' ' ' ARG . 64.0 mt -150.27 -177.58 6.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.936 0.398 . . . . 0.0 110.723 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.07 164.85 28.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.795 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -52.69 -35.1 54.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -60.9 -22.4 64.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.186 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.515 ' O ' HG22 ' C' ' 128' ' ' VAL . 6.9 m-20 -81.0 -18.42 46.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.788 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 1.036 HD11 HD13 ' C' ' 62' ' ' ILE . 28.2 mm -58.47 123.64 10.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.875 HG11 HG13 ' C' ' 128' ' ' VAL . 34.7 m -92.7 -27.33 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.397 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.488 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 36.7 tttm -150.47 164.76 35.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.304 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.666 HG22 ' HB2' ' C' ' 125' ' ' ALA . 0.2 OUTLIER -156.45 113.32 3.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.732 0.301 . . . . 0.0 111.479 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 94.2 m -99.97 152.44 20.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.261 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.429 HG13 HD13 ' C' ' 123' ' ' ILE . 21.2 t -151.78 127.31 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.982 0.42 . . . . 0.0 111.83 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.407 ' CE2' ' OE1' ' C' ' 124' ' ' GLU . 10.6 m-85 -105.32 115.56 30.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.3 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.569 HG11 ' CD2' ' C' ' 85' ' ' PHE . 4.8 m -105.55 148.61 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.591 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.62 -4.21 55.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.082 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -165.03 134.31 3.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.549 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 114' ' ' ARG . 1.0 OUTLIER -70.91 -8.94 56.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.236 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.22 -24.28 23.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.79 0.329 . . . . 0.0 110.888 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -75.38 -22.35 57.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.569 ' CD2' HG11 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -61.66 -18.2 58.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.416 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.18 -41.16 68.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.34 . . . . 0.0 111.229 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' C' ' 48' ' ' VAL . . . -87.5 -27.82 22.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.974 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 28.0 t -73.76 -47.03 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.18 -40.17 95.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.457 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.07 83.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.937 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.05 -28.18 21.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.571 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 81.2 t80 -53.38 -44.82 68.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.904 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.84 -25.2 24.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.076 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.34 -21.37 60.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.441 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.46 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 1.0 OUTLIER -91.14 -33.72 15.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 110.576 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.454 ' CZ ' ' CG ' ' C' ' 105' ' ' PRO . 0.7 OUTLIER -56.36 -58.07 9.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.126 0.488 . . . . 0.0 110.285 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -64.56 -30.77 71.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.994 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -78.19 -9.21 59.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.248 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.629 ' HB3' ' HB3' ' C' ' 69' ' ' ALA . 3.5 m120 -109.87 -4.98 15.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.439 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 22.1 m-80 84.48 38.55 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.77 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' C' ' 69' ' ' ALA . 0.8 OUTLIER -130.8 68.87 82.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.35 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.27 -17.51 7.75 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.974 2.449 . . . . 0.0 112.828 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 1.2 t-20 -59.28 -36.81 76.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 27.9 m-85 78.73 114.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.469 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.454 ' CG ' ' CZ ' ' C' ' 96' ' ' PHE . 62.3 Cg_endo -87.18 163.13 8.55 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.181 2.587 . . . . 0.0 112.094 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.44 175.59 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' C' ' 75' ' ' THR . 0.9 OUTLIER -173.04 163.44 4.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.263 0.554 . . . . 0.0 112.074 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.81 83.91 1.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.061 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 109' ' ' CYS . . . . . 0.464 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 13.8 p -89.42 123.65 33.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 115' ' ' LEU . 35.6 m -143.06 149.53 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.351 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.861 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -82.02 97.26 8.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.4 HG22 ' H ' ' C' ' 112' ' ' VAL . 8.1 m -78.46 160.52 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.211 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.838 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -69.65 -45.67 67.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.061 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -156.89 176.99 12.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.851 HD22 ' HB2' ' C' ' 122' ' ' GLU . 12.9 mt -145.28 160.6 45.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.497 ' O ' HG22 ' C' ' 119' ' ' VAL . 67.9 Cg_exo -50.96 135.72 43.81 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.513 2.142 . . . . 0.0 112.289 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.59 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.1 OUTLIER 72.21 14.57 5.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.238 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.2 14.2 9.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.184 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.759 HG12 ' HB ' ' C' ' 43' ' ' VAL . 27.6 m -57.5 171.18 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 111.206 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.99 22.12 16.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.538 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.494 ' C ' HD13 ' C' ' 115' ' ' LEU . 0.2 OUTLIER -176.16 156.88 1.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.098 0.475 . . . . 0.0 111.158 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.851 ' HB2' HD22 ' C' ' 115' ' ' LEU . 6.3 tt0 -149.95 156.41 41.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.054 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 1.029 HG21 HG21 ' C' ' 58' ' ' VAL . 22.8 mm -133.42 136.75 54.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.163 0.506 . . . . 0.0 112.093 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 6.6 pt-20 -155.51 106.66 2.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.346 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.666 ' HB2' HG22 ' C' ' 75' ' ' THR . . . -129.11 175.31 8.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.292 0.567 . . . . 0.0 112.368 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.693 HG23 ' HG ' ' C' ' 29' ' ' LEU . 3.1 mt -125.69 157.85 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.127 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 1.022 ' HB2' HD13 ' C' ' 72' ' ' ILE . . . -148.91 149.05 30.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.995 0.426 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.875 HG13 HG11 ' C' ' 73' ' ' VAL . 3.3 m -96.93 156.35 3.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.035 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.763 ' HG3' HD21 ' C' ' 67' ' ' LEU . 54.1 ttt-85 -151.36 51.62 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.688 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.82 0.343 . . . . 0.0 110.887 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.58 114.65 15.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.028 HD11 HG11 ' A' ' 19' ' ' VAL . 1.1 tp -53.34 132.64 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.312 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' A' ' 23' ' ' ASP . 12.5 mm -98.59 143.32 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -168.08 106.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.81 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.7 t -124.99 169.34 12.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.86 29.85 3.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.447 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -118.2 -40.68 2.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.682 ' HB1' ' CD ' ' A' ' 12' ' ' PRO . . . -72.38 177.37 1.82 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.173 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.682 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 22.0 Cg_exo -65.01 -10.92 27.38 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.865 2.377 . . . . 0.0 112.728 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.73 151.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.021 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.35 122.47 46.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.187 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 15' ' ' ILE . 26.4 mm -123.1 17.13 5.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.8 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.33 -132.0 3.64 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.355 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.446 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 79.9 Cg_endo -89.95 20.73 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.793 2.329 . . . . 0.0 113.355 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.576 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 1.5 p90 -140.54 178.58 7.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.951 0.405 . . . . 0.0 111.462 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.028 HG11 HD11 ' A' ' 5' ' ' ILE . 15.7 m -132.87 -179.26 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.861 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -48.9 79.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.72 -172.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.825 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.756 HG23 HD23 ' A' ' 29' ' ' LEU . 4.7 m -142.19 132.63 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.794 ' HA ' HG23 ' A' ' 28' ' ' VAL . 10.5 t0 -113.94 109.77 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.648 ' CD1' HD21 ' A' ' 29' ' ' LEU . 12.0 mt -81.05 -14.65 57.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.269 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.82 -100.09 0.71 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.53 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.727 ' C ' HD23 ' A' ' 27' ' ' LEU . 9.3 m-20 -57.62 -29.77 64.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.162 0.506 . . . . 0.0 109.775 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.917 HD22 HG12 ' A' ' 128' ' ' VAL . 1.4 mt -130.05 141.85 50.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.512 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.039 HG12 ' HB3' ' A' ' 127' ' ' ALA . 4.7 p -125.49 144.66 34.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.18 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.824 HD12 HD12 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -118.1 146.98 43.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.79 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.507 HG21 HD11 ' A' ' 62' ' ' ILE . 16.3 p -124.16 155.22 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.83 167.2 12.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.93 94.62 0.15 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.342 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.521 ' O ' HD13 ' A' ' 34' ' ' ILE . 23.2 mm-40 -58.83 150.06 24.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.363 . . . . 0.0 111.171 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 33' ' ' GLN . 22.3 mm -133.42 134.91 24.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.557 ' HD2' HG21 ' A' ' 119' ' ' VAL . 16.0 Cg_exo -68.02 56.16 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.898 2.399 . . . . 0.0 112.803 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 121.332 0.587 . . . . 0.0 110.654 179.45 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.726 HG11 ' HA ' ' A' ' 119' ' ' VAL . 7.4 p . . . . . 0 CA--C 1.53 0.183 0 CA-C-O 120.512 0.196 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 35' ' ' PRO . 52.2 Cg_exo -52.04 140.27 50.12 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.315 2.01 . . . . 0.0 112.165 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.64 -30.99 69.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -75.46 94.95 3.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.799 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.725 HG13 HD11 ' A' ' 121' ' ' LEU . 2.7 tp -43.4 -31.88 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.601 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.62 -45.5 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.669 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -63.23 -48.13 79.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.569 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.727 ' OE1' HD12 ' A' ' 121' ' ' LEU . 2.7 pt20 -61.41 -29.53 69.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.392 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.75 -39.61 61.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.927 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -62.42 -48.47 79.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.06 -34.63 78.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -66.11 -31.15 71.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.726 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.768 HD13 ' CE2' ' A' ' 95' ' ' PHE . 75.6 mt -69.69 -49.84 49.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -40.83 84.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.83 -38.45 70.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 54' ' ' SER . 39.2 t -65.26 -25.86 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.716 ' HD3' ' HB2' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -83.88 -39.15 20.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.806 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -58.27 -39.68 79.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.468 HD11 ' OE1' ' A' ' 33' ' ' GLN . 50.3 mt -68.91 -53.05 28.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.917 0.389 . . . . 0.0 110.729 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 30' ' ' THR . 51.0 mt -64.66 -28.89 45.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.708 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.45 -42.54 53.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.53 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -16.07 63.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.466 ' HB2' HD12 ' A' ' 6' ' ' ILE . . . -88.45 -28.68 20.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.59 43.65 0.63 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.587 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.443 ' HB3' HG22 ' A' ' 62' ' ' ILE . 1.5 mt -149.78 -167.15 2.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.0 110.837 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.17 154.86 38.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.66 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.733 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -58.12 -36.7 73.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.943 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.1 -26.3 4.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.251 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.73 -23.63 33.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.414 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 69' ' ' ALA . 88.5 mt -44.39 120.44 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.917 0.389 . . . . 0.0 111.415 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 128' ' ' VAL . 29.3 m -90.31 -38.02 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.651 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.53 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -137.72 155.45 49.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.599 0.238 . . . . 0.0 110.974 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.803 HG21 ' OH ' ' A' ' 92' ' ' TYR . 17.3 p -143.43 152.07 41.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.027 0.441 . . . . 0.0 111.51 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 108' ' ' SER . 5.2 m -133.74 142.32 47.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.064 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -143.02 105.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 111.811 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.5 ' HB2' HD21 ' A' ' 115' ' ' LEU . 7.8 m-85 -86.98 106.28 17.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.469 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.687 HG12 ' CD2' ' A' ' 121' ' ' LEU . 18.7 m -102.71 152.59 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.549 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.13 -2.61 46.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.844 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.36 113.51 3.7 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.585 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.602 HD11 ' C ' ' B' ' 115' ' ' LEU . 6.1 mt -65.27 -13.57 58.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.056 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -81.94 -23.2 36.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.875 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.406 ' OD1' HG21 ' A' ' 47' ' ' ILE . 6.7 m-20 -80.84 -23.72 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.138 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.601 ' HD1' HG11 ' A' ' 79' ' ' VAL . 2.0 t80 -56.26 -23.88 39.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.382 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.92 74.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.199 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.44 -38.71 17.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.29 -36.06 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.6 t30 -69.31 -43.1 74.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.82 74.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.026 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.582 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -86.08 -23.26 26.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.2 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.803 ' OH ' HG21 ' A' ' 75' ' ' THR . 10.3 t80 -77.82 -27.55 50.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.565 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.1 -39.42 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -67.25 -23.13 65.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.768 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -90.85 -32.8 15.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.553 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.582 ' HA ' ' CD2' ' A' ' 101' ' ' HIS . 1.7 m-85 -60.15 -58.85 6.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.3 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -63.55 -28.17 69.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.159 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -77.79 -10.89 59.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.54 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.681 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.15 -5.92 14.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.379 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.5 OUTLIER 94.52 37.32 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.871 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.733 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 1.6 m-70 -117.9 51.98 1.33 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 65.1 Cg_endo -71.91 -21.67 24.25 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.453 2.102 . . . . 0.0 112.56 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.34 -32.98 51.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.728 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.617 ' O ' HG22 ' B' ' 19' ' ' VAL . 15.6 m-85 60.98 83.67 0.21 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.131 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 17.1 Cg_endo -58.15 159.42 18.78 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.44 2.093 . . . . 0.0 112.018 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 74' ' ' LYS . . . -50.19 169.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.783 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' B' ' 18' ' ' TYR . 2.5 ttt85 -133.4 146.42 51.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.018 0.437 . . . . 0.0 111.308 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 76' ' ' THR . 1.7 p -152.56 58.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.411 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 25.4 p -96.01 142.85 27.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.435 HG11 ' CD2' ' B' ' 78' ' ' PHE . 33.9 m -147.6 153.92 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.856 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.7 OUTLIER -80.93 83.63 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.78 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.654 ' CG2' HD11 ' A' ' 115' ' ' LEU . 9.5 m -71.99 160.82 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.111 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.852 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -67.56 -53.57 27.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.243 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.4 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 1.5 mpt_? -151.25 -178.59 6.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.964 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.654 HD11 ' CG2' ' A' ' 112' ' ' VAL . 2.1 mp -153.55 159.37 32.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.572 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.528 ' O ' HG12 ' A' ' 119' ' ' VAL . 9.6 Cg_endo -52.16 140.19 51.45 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.578 2.185 . . . . 0.0 112.21 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 66.84 14.0 9.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.559 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.71 19.23 5.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.069 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.726 ' HA ' HG11 ' A' ' 43' ' ' VAL . 3.0 p -52.33 -49.36 42.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.543 ' C ' HD13 ' A' ' 115' ' ' LEU . . . 90.31 -7.37 81.61 Favored Glycine 0 C--N 1.308 -0.978 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.293 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.727 HD12 ' OE1' ' A' ' 50' ' ' GLN . 16.7 mt -140.37 146.75 38.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.237 0.542 . . . . 0.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.424 ' HB2' ' CD2' ' A' ' 115' ' ' LEU . 26.1 tt0 -147.67 152.42 37.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.941 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.55 HD13 HD23 ' A' ' 55' ' ' LEU . 26.9 mt -138.07 127.41 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.192 0.52 . . . . 0.0 112.229 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.4 ' HG3' ' HB ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.45 132.18 18.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.391 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.685 ' CB ' HG22 ' A' ' 75' ' ' THR . . . -149.39 159.42 44.3 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.824 HD12 HD12 ' A' ' 29' ' ' LEU . 14.8 mm -105.24 153.57 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.893 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 1.039 ' HB3' HG12 ' A' ' 28' ' ' VAL . . . -137.2 152.57 50.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.013 0.435 . . . . 0.0 111.828 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.917 HG12 HD22 ' A' ' 27' ' ' LEU . 27.0 m -119.98 178.09 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.804 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.873 0.368 . . . . 0.0 111.039 -179.885 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.717 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.828 0.347 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.6 114.63 15.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 1.032 HD11 HG11 ' B' ' 19' ' ' VAL . 1.1 tp -53.3 132.69 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.33 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.644 HD11 ' HB2' ' B' ' 23' ' ' ASP . 12.5 mm -98.57 143.34 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -168.15 106.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 3.8 t -124.97 169.3 12.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.009 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.85 29.89 3.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.449 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 0.4 OUTLIER -118.34 -40.9 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.676 ' HB1' ' CD ' ' B' ' 12' ' ' PRO . . . -72.01 177.26 1.79 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.11 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.676 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 22.2 Cg_exo -65.01 -10.87 27.2 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.892 2.395 . . . . 0.0 112.677 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.66 151.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 111.083 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.27 122.43 46.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.202 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 15' ' ' ILE . 26.5 mm -123.08 17.13 5.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.765 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.29 -131.98 3.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.422 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.459 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 78.3 Cg_endo -89.93 20.66 1.0 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.809 2.339 . . . . 0.0 113.392 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.586 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 1.5 p90 -140.44 178.6 7.19 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.507 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.032 HG11 HD11 ' B' ' 5' ' ' ILE . 15.6 m -132.92 -179.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.867 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -48.7 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.953 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.432 ' HB2' HG21 ' B' ' 61' ' ' ILE . . . -178.07 -172.71 0.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.76 HG23 HD23 ' B' ' 29' ' ' LEU . 4.6 m -142.2 132.67 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.145 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.802 ' HA ' HG23 ' B' ' 28' ' ' VAL . 10.5 t0 -113.95 109.76 19.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.65 ' CD1' HD21 ' B' ' 29' ' ' LEU . 12.0 mt -81.07 -14.71 57.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.265 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.86 -100.05 0.7 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.548 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ASN . . . . . 0.716 ' C ' HD23 ' B' ' 27' ' ' LEU . 9.2 m-20 -57.61 -29.77 64.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.177 0.513 . . . . 0.0 109.81 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.897 HD22 HG12 ' B' ' 128' ' ' VAL . 1.4 mt -130.0 141.88 50.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.537 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.045 HG12 ' HB3' ' B' ' 127' ' ' ALA . 4.7 p -125.57 144.68 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.145 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.827 HD12 HD12 ' B' ' 126' ' ' ILE . 0.0 OUTLIER -118.06 146.94 43.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.83 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.51 HG21 HD11 ' B' ' 62' ' ' ILE . 16.1 p -124.18 155.03 39.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.832 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.99 167.11 12.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.91 94.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.329 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.528 ' O ' HD13 ' B' ' 34' ' ' ILE . 23.3 mm-40 -58.82 150.07 24.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.376 . . . . 0.0 111.153 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.528 HD13 ' O ' ' B' ' 33' ' ' GLN . 22.2 mm -133.42 134.88 24.36 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.096 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.549 ' HD2' HG21 ' B' ' 119' ' ' VAL . 16.0 Cg_exo -68.03 56.2 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.836 2.358 . . . . 0.0 112.79 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 121.366 0.603 . . . . 0.0 110.623 179.442 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.717 HG11 ' HA ' ' B' ' 119' ' ' VAL . 7.4 p . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.391 0.139 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.2 Cg_exo -52.12 140.29 50.91 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.249 1.966 . . . . 0.0 112.189 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.95 69.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.032 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.435 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.1 OUTLIER -75.41 94.95 3.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.818 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.711 HG13 HD11 ' B' ' 121' ' ' LEU . 2.7 tp -43.39 -31.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.61 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.62 -45.51 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -63.27 -48.04 79.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.699 ' OE1' HD12 ' B' ' 121' ' ' LEU . 2.7 pt20 -61.56 -29.6 70.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.371 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.97 -39.6 61.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.999 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -62.37 -48.48 79.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.818 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.12 -34.58 78.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.708 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.607 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.7 OUTLIER -66.09 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.733 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.76 HD13 ' CE2' ' B' ' 95' ' ' PHE . 75.6 mt -69.75 -49.81 49.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.83 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -40.86 84.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.85 -38.48 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.64 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 54' ' ' SER . 39.0 t -65.23 -25.88 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.66 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.719 ' HD3' ' HB2' ' B' ' 69' ' ' ALA . 0.3 OUTLIER -83.86 -39.21 20.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -58.25 -39.91 80.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.456 HD11 ' OE1' ' B' ' 33' ' ' GLN . 50.6 mt -68.67 -53.01 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.733 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.51 HD11 HG21 ' B' ' 30' ' ' THR . 51.0 mt -64.7 -28.82 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.47 -42.54 52.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.546 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -16.09 63.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.643 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ALA . . . . . 0.511 ' HB2' HD12 ' B' ' 6' ' ' ILE . . . -88.42 -28.64 20.77 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.706 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.58 43.67 0.63 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.523 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.461 ' HB3' HG22 ' B' ' 62' ' ' ILE . 1.5 mt -149.83 -167.14 2.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 154.85 38.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.693 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.745 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -58.12 -36.66 73.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.18 -26.36 4.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.281 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -23.67 34.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.404 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.464 HG13 ' HA ' ' B' ' 69' ' ' ALA . 88.8 mt -44.44 120.36 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-O 120.923 0.392 . . . . 0.0 111.438 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.541 HG13 HG22 ' B' ' 128' ' ' VAL . 29.1 m -90.2 -38.02 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.66 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.528 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -137.79 155.47 48.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.625 0.25 . . . . 0.0 110.905 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.793 HG21 ' OH ' ' B' ' 92' ' ' TYR . 17.3 p -143.38 152.1 41.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 111.543 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.658 HG23 ' O ' ' B' ' 108' ' ' SER . 5.2 m -133.8 142.32 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.026 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.4 t -143.0 105.82 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 111.838 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.468 ' HB2' HD21 ' B' ' 115' ' ' LEU . 7.7 m-85 -86.98 106.29 17.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.687 HG12 ' CD2' ' B' ' 121' ' ' LEU . 18.7 m -102.69 152.6 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.576 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.19 -2.51 46.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.808 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.62 113.54 3.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.518 HD11 ' C ' ' C' ' 115' ' ' LEU . 6.1 mt -65.19 -13.5 58.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.96 -23.26 36.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.883 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.82 -23.67 39.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.192 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.614 ' HD1' HG11 ' B' ' 79' ' ' VAL . 2.0 t80 -56.3 -23.9 39.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.336 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.33 -36.91 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 0.0 111.209 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.48 -38.7 17.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.18 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.28 -36.07 65.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.6 t30 -69.34 -43.04 74.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.06 74.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.08 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' B' ' 94' ' ' ARG . 0.1 OUTLIER -85.95 -23.3 26.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.793 ' OH ' HG21 ' B' ' 75' ' ' THR . 10.3 t80 -77.8 -27.54 50.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.541 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.19 -39.41 12.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' B' ' 91' ' ' GLU . 0.0 OUTLIER -67.35 -23.02 65.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.76 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -90.82 -32.85 15.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.835 0.35 . . . . 0.0 110.57 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.584 ' HA ' ' CD2' ' B' ' 101' ' ' HIS . 1.6 m-85 -60.12 -58.79 7.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.309 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -63.53 -28.24 69.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.162 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -77.78 -10.85 59.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.691 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.22 -5.87 14.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.349 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 0.5 OUTLIER 94.5 37.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.873 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.745 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 1.6 m-70 -117.92 52.02 1.34 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.706 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 64.2 Cg_endo -72.05 -21.58 23.9 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.449 2.099 . . . . 0.0 112.536 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.34 -33.02 51.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.894 0.378 . . . . 0.0 110.723 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.635 ' O ' HG22 ' C' ' 19' ' ' VAL . 15.6 m-85 61.05 83.67 0.21 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.122 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 16.9 Cg_endo -58.12 159.42 18.65 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.463 2.109 . . . . 0.0 112.025 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' B' ' 74' ' ' LYS . . . -50.17 169.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.805 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.46 146.45 51.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.994 0.426 . . . . 0.0 111.286 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.658 ' O ' HG23 ' B' ' 76' ' ' THR . 1.7 p -152.61 58.43 0.81 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.42 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 25.3 p -96.04 142.78 27.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.129 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' C' ' 78' ' ' PHE . 33.9 m -147.44 153.52 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.153 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.837 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.7 OUTLIER -80.7 83.64 6.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.644 ' CG2' HD11 ' B' ' 115' ' ' LEU . 9.7 m -71.87 160.8 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.856 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -67.59 -53.54 27.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.235 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.417 ' HB3' HD12 ' A' ' 82' ' ' LEU . 1.5 mpt_? -151.28 -178.52 6.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.644 HD11 ' CG2' ' B' ' 112' ' ' VAL . 2.2 mp -153.57 159.29 32.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.577 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.525 ' O ' HG12 ' B' ' 119' ' ' VAL . 9.5 Cg_endo -52.15 140.19 51.38 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.573 2.182 . . . . 0.0 112.195 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 0.0 OUTLIER 66.86 13.97 9.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.537 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.76 19.16 5.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.078 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.717 ' HA ' HG11 ' B' ' 43' ' ' VAL . 3.1 p -52.28 -49.38 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 121.655 0.741 . . . . 0.0 111.194 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' GLY . . . . . 0.524 ' C ' HD13 ' B' ' 115' ' ' LEU . . . 90.23 -7.47 81.48 Favored Glycine 0 C--N 1.308 -1.012 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.338 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.711 HD11 HG13 ' B' ' 47' ' ' ILE . 16.7 mt -140.12 146.7 39.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.213 0.53 . . . . 0.0 111.128 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.426 ' HB2' ' CD2' ' B' ' 115' ' ' LEU . 26.1 tt0 -147.56 152.42 37.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.976 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.573 HD13 HD23 ' B' ' 55' ' ' LEU . 26.7 mt -138.1 127.39 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.258 0.552 . . . . 0.0 112.237 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.43 132.19 18.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.417 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.699 ' CB ' HG22 ' B' ' 75' ' ' THR . . . -149.43 159.4 44.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.827 HD12 HD12 ' B' ' 29' ' ' LEU . 14.8 mm -105.28 153.43 6.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.889 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 1.045 ' HB3' HG12 ' B' ' 28' ' ' VAL . . . -137.09 152.63 50.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.012 0.434 . . . . 0.0 111.845 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.897 HG12 HD22 ' B' ' 27' ' ' LEU . 27.0 m -120.06 178.05 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.834 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 -179.838 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.72 HG21 HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.819 0.342 . . . . 0.0 110.942 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.57 114.64 15.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 1.026 HD11 HG11 ' C' ' 19' ' ' VAL . 1.1 tp -53.3 132.71 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.3 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' C' ' 23' ' ' ASP . 12.4 mm -98.67 143.4 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -168.16 106.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.789 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 3.7 t -124.97 169.31 12.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.8 29.87 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.454 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 0.4 OUTLIER -118.21 -40.76 2.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.677 ' HB1' ' CD ' ' C' ' 12' ' ' PRO . . . -72.21 177.24 1.84 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.213 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 22.2 Cg_exo -65.04 -10.89 27.33 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.947 2.432 . . . . 0.0 112.682 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.68 151.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.064 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.35 122.48 46.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.114 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.616 HG22 ' O ' ' C' ' 15' ' ' ILE . 26.3 mm -123.1 17.09 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.833 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.3 -131.92 3.63 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.36 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' PRO . . . . . 0.456 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 80.2 Cg_endo -90.03 20.77 0.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.759 2.306 . . . . 0.0 113.337 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.588 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 1.5 p90 -140.48 178.62 7.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.964 0.411 . . . . 0.0 111.516 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 1.026 HG11 HD11 ' C' ' 5' ' ' ILE . 15.7 m -132.92 -179.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.84 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -49.01 79.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' C' ' 61' ' ' ILE . . . -177.58 -172.78 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.825 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.789 HG23 HD23 ' C' ' 29' ' ' LEU . 4.7 m -142.24 132.64 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.161 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.788 ' HA ' HG23 ' C' ' 28' ' ' VAL . 10.5 t0 -113.97 109.83 19.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.81 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.646 ' CD1' HD21 ' C' ' 29' ' ' LEU . 12.1 mt -81.09 -14.72 57.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.231 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.88 -100.1 0.7 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.53 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' ASN . . . . . 0.722 ' C ' HD23 ' C' ' 27' ' ' LEU . 9.2 m-20 -57.6 -29.79 64.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.194 0.521 . . . . 0.0 109.839 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.93 HD22 HG12 ' C' ' 128' ' ' VAL . 1.4 mt -130.03 141.92 50.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.998 HG12 ' HB3' ' C' ' 127' ' ' ALA . 4.7 p -125.55 144.71 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.2 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.81 HD12 HD12 ' C' ' 126' ' ' ILE . 0.0 OUTLIER -118.08 147.01 43.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.51 HG21 HD11 ' C' ' 62' ' ' ILE . 16.2 p -124.15 155.18 38.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.923 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.96 167.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.958 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.89 94.6 0.14 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.314 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.521 ' O ' HD13 ' C' ' 34' ' ' ILE . 23.2 mm-40 -58.83 150.04 25.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 111.206 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.521 HD13 ' O ' ' C' ' 33' ' ' GLN . 22.4 mm -133.4 134.97 24.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.108 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.563 ' HD2' HG21 ' C' ' 119' ' ' VAL . 16.0 Cg_exo -68.09 56.2 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.874 2.383 . . . . 0.0 112.789 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.411 HG21 ' HB3' ' C' ' 12' ' ' PRO . 41.4 t . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 121.295 0.569 . . . . 0.0 110.595 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' C' ' 119' ' ' VAL . 7.4 p . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.478 0.18 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' C' ' 35' ' ' PRO . 52.1 Cg_exo -51.98 140.26 49.6 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.297 1.998 . . . . 0.0 112.204 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.67 -31.0 69.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.009 0.433 . . . . 0.0 111.065 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.1 OUTLIER -75.44 94.91 3.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.869 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.698 HG13 HD11 ' C' ' 121' ' ' LEU . 2.7 tp -43.38 -31.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.636 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 32.2 t -79.66 -45.51 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.646 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -63.22 -48.09 79.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.587 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.728 ' OE1' HD12 ' C' ' 121' ' ' LEU . 2.7 pt20 -61.53 -29.47 70.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.359 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.91 -39.61 61.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.964 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -62.38 -48.48 79.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.794 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.04 -34.62 78.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.601 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.8 OUTLIER -66.17 -31.1 71.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.762 HD13 ' CE2' ' C' ' 95' ' ' PHE . 75.5 mt -69.72 -49.89 48.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -40.82 84.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.87 -38.51 70.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.671 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.601 HG23 ' O ' ' C' ' 54' ' ' SER . 38.9 t -65.15 -25.97 38.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.678 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.711 ' HD3' ' HB2' ' C' ' 69' ' ' ALA . 0.3 OUTLIER -83.79 -39.22 20.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.755 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -58.26 -39.84 80.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.455 HD11 ' OE1' ' C' ' 33' ' ' GLN . 50.3 mt -68.69 -53.07 29.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.51 HD11 HG21 ' C' ' 30' ' ' THR . 50.9 mt -64.65 -28.87 45.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.731 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.49 -42.53 52.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.558 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -16.2 64.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.615 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' ALA . . . . . 0.513 ' HB2' HD12 ' C' ' 6' ' ' ILE . . . -88.34 -28.74 20.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.929 0.395 . . . . 0.0 110.741 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.62 43.66 0.62 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.545 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.465 ' HB3' HG22 ' C' ' 62' ' ' ILE . 1.5 mt -149.74 -167.13 2.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.939 0.4 . . . . 0.0 110.849 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.16 154.91 38.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.71 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.741 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -58.16 -36.68 73.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.371 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.09 -26.35 4.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.285 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -23.75 34.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.381 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' C' ' 69' ' ' ALA . 88.8 mt -44.34 120.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.883 0.373 . . . . 0.0 111.416 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.565 HG13 HG22 ' C' ' 128' ' ' VAL . 29.1 m -90.17 -38.02 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.716 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.538 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -137.8 155.5 48.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.952 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.792 HG21 ' OH ' ' C' ' 92' ' ' TYR . 17.4 p -143.37 152.03 41.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.034 0.445 . . . . 0.0 111.579 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.656 HG23 ' O ' ' C' ' 108' ' ' SER . 5.3 m -133.72 142.31 47.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.007 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -143.03 105.88 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 111.787 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.488 ' HB2' HD21 ' C' ' 115' ' ' LEU . 7.7 m-85 -86.96 106.21 17.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.544 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.698 HG12 ' CD2' ' C' ' 121' ' ' LEU . 18.7 m -102.66 152.59 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.624 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.08 -2.58 46.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.802 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -154.45 113.44 3.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.635 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.56 HD11 ' C ' ' A' ' 115' ' ' LEU . 6.1 mt -65.2 -13.56 58.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.044 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.95 -23.17 36.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.443 ' OD1' HG21 ' C' ' 47' ' ' ILE . 6.6 m-20 -80.88 -23.69 38.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.156 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.615 ' HD1' HG11 ' C' ' 79' ' ' VAL . 2.0 t80 -56.25 -23.92 39.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.384 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.85 74.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.214 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.46 -38.68 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.242 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.37 -36.04 65.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.6 t30 -69.24 -43.22 74.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.12 -32.9 74.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.08 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' GLU . . . . . 0.588 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 0.1 OUTLIER -86.0 -23.2 26.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.156 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.792 ' OH ' HG21 ' C' ' 75' ' ' THR . 10.3 t80 -77.94 -27.5 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.538 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.1 -39.52 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' ARG . . . . . 0.588 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 0.0 OUTLIER -67.25 -23.12 65.67 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.762 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -90.88 -32.75 15.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.784 0.326 . . . . 0.0 110.529 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.588 ' HA ' ' CD2' ' C' ' 101' ' ' HIS . 1.6 m-85 -60.2 -58.81 6.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.059 0.457 . . . . 0.0 110.259 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -63.53 -28.22 69.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.141 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -77.75 -10.9 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.566 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.697 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.17 -5.85 14.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.397 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 0.5 OUTLIER 94.5 37.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.86 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.741 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 1.6 m-70 -117.93 51.99 1.34 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.723 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 64.3 Cg_endo -72.0 -21.57 24.07 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.442 2.095 . . . . 0.0 112.574 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.36 -33.01 51.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.936 0.398 . . . . 0.0 110.718 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.633 ' O ' HG22 ' A' ' 19' ' ' VAL . 15.5 m-85 60.98 83.75 0.2 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.074 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 17.1 Cg_endo -58.17 159.46 18.72 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.45 2.1 . . . . 0.0 112.005 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' C' ' 74' ' ' LYS . . . -50.26 169.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.779 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.31 146.44 51.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.0 0.429 . . . . 0.0 111.341 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 108' ' ' SER . . . . . 0.656 ' O ' HG23 ' C' ' 76' ' ' THR . 1.7 p -152.59 58.5 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.457 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 25.4 p -96.05 142.85 27.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.093 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.435 HG11 ' CD2' ' A' ' 78' ' ' PHE . 33.9 m -147.62 153.93 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.852 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -80.85 83.63 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.656 ' CG2' HD11 ' C' ' 115' ' ' LEU . 9.6 m -71.95 160.81 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.837 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -67.55 -53.57 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.22 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -151.25 -178.6 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.987 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.656 HD11 ' CG2' ' C' ' 112' ' ' VAL . 2.1 mp -153.56 159.39 32.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.526 ' O ' HG12 ' C' ' 119' ' ' VAL . 9.6 Cg_endo -52.18 140.17 51.75 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.598 2.199 . . . . 0.0 112.195 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 0.0 OUTLIER 66.89 13.99 9.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.515 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.72 19.21 5.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.728 ' HA ' HG11 ' C' ' 43' ' ' VAL . 3.1 p -52.34 -49.34 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.658 0.742 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 120' ' ' GLY . . . . . 0.54 ' C ' HD13 ' C' ' 115' ' ' LEU . . . 90.3 -7.49 81.41 Favored Glycine 0 C--N 1.308 -0.984 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.333 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.728 HD12 ' OE1' ' C' ' 50' ' ' GLN . 16.7 mt -140.16 146.72 39.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.246 0.546 . . . . 0.0 111.134 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.429 ' HB2' ' CD2' ' C' ' 115' ' ' LEU . 26.1 tt0 -147.67 152.39 37.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.953 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.558 HD13 HD23 ' C' ' 55' ' ' LEU . 26.7 mt -138.05 127.47 33.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.229 0.538 . . . . 0.0 112.189 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.48 132.13 18.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.431 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.699 ' CB ' HG22 ' C' ' 75' ' ' THR . . . -149.37 159.39 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.211 0.529 . . . . 0.0 112.412 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.81 HD12 HD12 ' C' ' 29' ' ' LEU . 14.7 mm -105.22 153.43 6.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.917 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.998 ' HB3' HG12 ' C' ' 28' ' ' VAL . . . -137.11 152.56 50.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.031 0.443 . . . . 0.0 111.79 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.93 HG12 HD22 ' C' ' 27' ' ' LEU . 27.0 m -119.99 178.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.842 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -167.74 59.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 111.035 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.916 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.977 HG21 HG21 ' C' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.798 0.332 . . . . 0.0 110.794 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -157.82 118.17 3.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.803 HD11 ' OD1' ' C' ' 103' ' ' ASN . 4.4 mp -58.25 138.3 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.081 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.863 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 31.9 mt -94.83 138.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.158 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -150.97 136.94 18.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.51 162.81 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.75 26.61 5.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -118.03 -40.57 2.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.64 119.65 72.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.171 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.05 -10.84 28.61 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.42 2.08 . . . . 0.0 112.596 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.45 172.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.928 0.394 . . . . 0.0 111.464 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 62.84 130.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.187 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.94 -36.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.504 0.669 . . . . 0.0 110.768 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.03 -145.11 11.19 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.368 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.69 57.97 5.78 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.731 2.287 . . . . 0.0 112.873 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.482 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -168.46 -177.3 3.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 111.08 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' C' ' 104' ' ' PHE . 27.0 m -112.8 -178.45 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.297 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.415 ' CG ' ' HB2' ' A' ' 14' ' ' ALA . 43.5 mt-30 -80.2 -50.94 9.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.982 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -156.95 179.8 8.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.268 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 m -139.57 147.3 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.082 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.908 ' HA ' HG12 ' A' ' 28' ' ' VAL . 20.3 t0 -123.23 94.32 4.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.736 HD22 HG11 ' C' ' 128' ' ' VAL . 11.0 mt -69.96 -17.37 63.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.268 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.62 -105.42 0.95 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.146 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.478 ' HB2' HD23 ' A' ' 27' ' ' LEU . 67.0 m-80 -52.6 -29.99 28.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.054 0.454 . . . . 0.0 110.525 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -137.24 134.16 35.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.773 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.01 HG23 ' HB3' ' A' ' 127' ' ' ALA . 3.0 m -113.07 172.32 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.218 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.761 HD23 HD12 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -145.67 165.71 27.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.431 HG21 HD11 ' A' ' 62' ' ' ILE . 44.3 p -130.13 135.98 48.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m -69.23 154.54 41.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.97 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 123' ' ' ILE . . . -55.26 93.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.631 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.767 ' HG2' HG22 ' A' ' 58' ' ' VAL . 1.6 mp0 -67.65 173.7 4.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.776 0.322 . . . . 0.0 111.009 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.677 ' HB ' HG11 ' A' ' 119' ' ' VAL . 7.6 pt -159.38 152.54 18.48 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.441 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.68 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 43.8 Cg_endo -68.09 74.8 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.05 2.5 . . . . 0.0 112.325 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.508 HG23 HG13 ' A' ' 34' ' ' ILE . 22.5 t . . . . . 0 C--N 1.32 -0.698 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.587 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 7.1 p . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.507 0.194 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -55.58 140.62 83.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.296 1.998 . . . . 0.0 112.144 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.06 71.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.044 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -75.75 94.93 3.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.858 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.502 HD12 ' NE2' ' A' ' 50' ' ' GLN . 6.4 tp -44.5 -31.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.427 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -38.29 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.713 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . . . -69.24 -39.97 78.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.497 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.502 ' NE2' HD12 ' A' ' 47' ' ' ILE . 6.8 pt20 -75.44 -21.88 57.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.223 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.5 -41.5 27.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.161 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.24 -34.45 63.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.76 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.15 -31.59 64.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.529 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.802 ' O ' HG23 ' A' ' 58' ' ' VAL . 68.7 p -67.31 -30.79 70.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.703 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.873 HD13 ' CE2' ' A' ' 95' ' ' PHE . 34.2 mt -79.39 -30.72 42.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.802 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.55 -55.91 20.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.985 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 9.3 p-10 -55.79 -44.99 78.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 54' ' ' SER . 45.0 t -59.25 -31.02 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -79.2 -38.42 35.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.766 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.27 81.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' A' ' 58' ' ' VAL . 6.5 mt -67.06 -51.26 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.771 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.431 HD11 HG21 ' A' ' 30' ' ' THR . 45.8 mt -63.21 -32.63 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.592 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.68 -40.71 63.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.241 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.52 -21.0 65.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.94 -25.66 20.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.812 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 47.91 0.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.482 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.808 HD22 ' OD2' ' A' ' 71' ' ' ASP . 7.2 mt -156.68 -171.62 3.74 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.724 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.6 p -142.82 -179.58 6.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.981 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.812 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -78.63 -24.89 45.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.58 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.565 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -59.81 -36.54 76.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.981 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.808 ' OD2' HD22 ' A' ' 67' ' ' LEU . 4.0 p30 -71.01 -26.51 63.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.072 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.443 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 88.3 mt -46.76 115.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.83 0.348 . . . . 0.0 110.933 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.46 HG21 HD21 ' B' ' 24' ' ' LEU . 27.3 m -91.26 -26.01 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.766 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.639 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 1.7 ttpm? -138.03 164.46 29.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.735 0.302 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 125' ' ' ALA . 91.9 m -163.63 126.58 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.045 0.45 . . . . 0.0 111.492 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 108' ' ' SER . 2.8 m -109.25 144.8 36.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.881 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.08 108.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 111.782 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.455 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.6 m-85 -91.47 107.11 18.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.278 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.757 HG12 HD22 ' A' ' 121' ' ' LEU . 30.0 m -102.21 149.95 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.201 0.524 . . . . 0.0 111.804 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.74 -6.18 49.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.818 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.44 111.99 3.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.54 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 82' ' ' LEU . 2.6 mt -61.28 -15.18 32.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -78.32 -19.45 53.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.758 0.313 . . . . 0.0 110.869 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 88' ' ' VAL . 19.2 m-20 -90.65 7.18 40.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.411 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.444 ' CD1' HG11 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -82.18 -27.46 32.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 111.172 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -36.76 76.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.123 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.38 -36.6 29.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 84' ' ' ASP . 27.9 t -75.6 -30.52 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 85' ' ' PHE . 9.9 m120 -67.19 -48.88 66.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.02 -39.18 90.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.177 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.412 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 0.6 OUTLIER -75.89 -23.94 55.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.196 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -81.73 -33.29 31.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.401 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' B' ' 17' ' ' PRO . 0.8 OUTLIER -89.65 -29.76 18.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.696 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.412 ' HG2' ' HA ' ' A' ' 91' ' ' GLU . 1.3 ppt_? -75.86 -21.59 57.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.663 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.873 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -92.01 -33.13 14.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 0.0 110.671 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.503 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 2.6 m-85 -58.98 -59.13 5.96 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.063 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -31.5 72.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.246 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.57 -11.5 60.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.419 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 4.9 m-20 -110.91 -6.53 14.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.336 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER 90.11 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.548 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.812 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 m-70 -115.21 53.41 0.81 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.025 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.1 Cg_endo -74.63 -14.51 22.07 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.51 2.14 . . . . 0.0 112.55 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.803 ' OD1' HD11 ' B' ' 5' ' ' ILE . 2.0 t30 -51.68 -33.28 33.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.093 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.751 ' CB ' HG13 ' B' ' 19' ' ' VAL . 3.6 m-85 61.47 96.46 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.031 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 59.9 Cg_endo -73.33 159.09 47.53 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.443 2.095 . . . . 0.0 112.258 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.639 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -55.71 147.69 18.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.445 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.64 142.52 45.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.005 0.431 . . . . 0.0 111.442 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.584 ' O ' HG23 ' A' ' 76' ' ' THR . 31.1 t -149.58 62.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.376 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.5 p -94.64 145.38 24.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.461 HG11 ' CD2' ' B' ' 78' ' ' PHE . 35.9 m -153.28 135.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.212 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.601 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -64.76 91.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.802 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.769 HG21 HD21 ' A' ' 115' ' ' LEU . 8.4 m -76.26 164.43 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -83.66 -44.8 14.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.411 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 0.1 OUTLIER -158.54 158.62 34.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.734 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.87 HD22 ' HB2' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -141.34 168.99 12.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.485 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 115' ' ' LEU . 74.4 Cg_exo -50.18 136.87 38.28 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.351 2.034 . . . . 0.0 112.362 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 67.13 14.31 9.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.359 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.53 20.11 5.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.021 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.677 HG11 ' HB ' ' A' ' 34' ' ' ILE . 16.0 m -53.12 149.75 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.244 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.581 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -81.52 -15.01 77.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.754 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.757 HD22 HG12 ' A' ' 79' ' ' VAL . 42.1 mt -152.3 148.65 27.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 110.848 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.87 ' HB2' HD22 ' A' ' 115' ' ' LEU . 27.2 tt0 -129.8 146.71 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.21 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.401 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 29.0 mm -120.1 150.27 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.035 0.445 . . . . 0.0 111.763 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.22 147.45 6.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.694 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -173.83 164.34 4.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.098 0.475 . . . . 0.0 112.129 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.761 HD12 HD23 ' A' ' 29' ' ' LEU . 5.6 mm -117.59 151.83 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.362 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 1.01 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -131.49 147.53 52.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.976 0.417 . . . . 0.0 111.739 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.969 HG21 HG21 ' B' ' 3' ' ' THR . 27.1 m -109.6 152.01 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.055 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.786 ' HB2' HD11 ' A' ' 67' ' ' LEU . 11.7 ttp180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.78 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.969 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.778 0.323 . . . . 0.0 110.809 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -157.81 118.18 3.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.009 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.803 HD11 ' OD1' ' A' ' 103' ' ' ASN . 4.4 mp -58.22 138.26 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.084 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.865 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 31.8 mt -94.83 138.11 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -150.94 136.92 18.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.52 162.77 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.72 26.67 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -118.11 -40.86 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -85.24 119.68 72.61 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 17.8 Cg_exo -66.03 -10.88 28.71 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.424 2.083 . . . . 0.0 112.572 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.43 172.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.525 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.487 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 62.86 130.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.207 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.95 -36.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.509 0.671 . . . . 0.0 110.773 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.04 -145.18 11.29 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.313 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 94.3 Cg_endo -83.64 58.01 5.82 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.715 2.276 . . . . 0.0 112.896 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -168.54 -177.29 3.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 111.067 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.751 HG13 ' CB ' ' A' ' 104' ' ' PHE . 27.0 m -112.77 -178.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.418 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 43.5 mt-30 -80.3 -51.05 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.044 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.865 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -156.59 179.75 8.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.272 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.56 147.32 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.076 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.916 ' HA ' HG12 ' B' ' 28' ' ' VAL . 20.4 t0 -123.24 94.39 4.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.786 HD22 HG11 ' A' ' 128' ' ' VAL . 11.0 mt -70.02 -17.42 63.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.61 -105.32 0.95 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.12 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ASN . . . . . 0.483 ' HB2' HD23 ' B' ' 27' ' ' LEU . 67.3 m-80 -52.66 -29.97 29.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.472 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' B' ' 26' ' ' ASN . 0.2 OUTLIER -137.29 134.17 35.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.776 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.017 HG23 ' HB3' ' B' ' 127' ' ' ALA . 3.0 m -113.03 172.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.737 HD23 HD12 ' B' ' 126' ' ' ILE . 1.0 OUTLIER -145.7 165.69 28.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.672 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.418 HG21 HD11 ' B' ' 62' ' ' ILE . 44.2 p -130.13 136.0 48.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 48.6 m -69.34 154.41 42.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' B' ' 123' ' ' ILE . . . -55.21 93.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.608 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.755 ' HG2' HG22 ' B' ' 58' ' ' VAL . 1.6 mp0 -67.66 173.66 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.734 0.302 . . . . 0.0 111.004 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.68 ' HB ' HG11 ' B' ' 119' ' ' VAL . 7.7 pt -159.37 152.59 18.55 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.004 0.43 . . . . 0.0 111.467 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.667 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 44.0 Cg_endo -68.14 74.81 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.108 2.538 . . . . 0.0 112.338 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.509 HG23 HG13 ' B' ' 34' ' ' ILE . 22.6 t . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.55 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 7.1 p . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.496 0.189 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -55.63 140.64 84.07 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.331 2.021 . . . . 0.0 112.153 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.1 71.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' B' ' 49' ' ' ALA . 1.0 OUTLIER -75.74 94.91 3.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.863 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.497 HD12 ' NE2' ' B' ' 50' ' ' GLN . 6.3 tp -44.43 -31.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.408 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.19 -38.27 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.733 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' B' ' 46' ' ' ASP . . . -69.28 -39.99 78.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.463 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.497 ' NE2' HD12 ' B' ' 47' ' ' ILE . 6.8 pt20 -75.52 -21.83 57.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.239 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.6 -41.49 26.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.213 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.26 -34.47 63.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.15 -31.51 64.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.57 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.795 ' O ' HG23 ' B' ' 58' ' ' VAL . 68.9 p -67.31 -30.82 70.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.84 HD13 ' CE2' ' B' ' 95' ' ' PHE . 34.4 mt -79.38 -30.7 42.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.6 -55.9 20.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 9.3 p-10 -55.76 -45.03 78.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.795 HG23 ' O ' ' B' ' 54' ' ' SER . 44.9 t -59.27 -30.94 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.768 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -79.22 -38.47 35.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.16 81.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' B' ' 58' ' ' VAL . 6.5 mt -67.02 -51.41 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.792 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.418 HD11 HG21 ' B' ' 30' ' ' THR . 45.8 mt -63.19 -32.64 57.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.598 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.64 -40.69 63.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.266 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.56 -21.0 65.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.485 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.89 -25.68 20.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.1 47.96 0.54 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.461 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.809 HD22 ' OD2' ' B' ' 71' ' ' ASP . 7.2 mt -156.75 -171.65 3.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.764 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 76.8 p -142.82 -179.65 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.809 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -78.59 -24.93 45.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.577 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.579 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -59.79 -36.47 76.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.029 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.809 ' OD2' HD22 ' B' ' 67' ' ' LEU . 4.0 p30 -71.06 -26.51 63.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.055 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 105' ' ' PRO . 88.3 mt -46.8 115.63 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.445 HG21 HD21 ' C' ' 24' ' ' LEU . 27.3 m -91.21 -25.95 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.762 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.636 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 1.7 ttpm? -138.11 164.42 29.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.0 110.936 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 125' ' ' ALA . 91.7 m -163.58 126.63 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.048 0.451 . . . . 0.0 111.484 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.587 HG23 ' O ' ' B' ' 108' ' ' SER . 2.8 m -109.28 144.78 36.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.03 108.4 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.914 0.388 . . . . 0.0 111.828 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.461 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.6 m-85 -91.46 107.16 19.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.24 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.753 HG12 HD22 ' B' ' 121' ' ' LEU . 30.2 m -102.22 149.97 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.158 0.504 . . . . 0.0 111.838 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.89 -6.14 49.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.747 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.45 111.96 3.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.516 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' B' ' 82' ' ' LEU . 2.6 mt -61.15 -15.24 31.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.242 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -78.31 -19.52 53.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.603 ' O ' HG23 ' B' ' 88' ' ' VAL . 19.2 m-20 -90.62 7.26 40.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.448 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.448 ' CD1' HG11 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -82.25 -27.48 32.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.749 0.309 . . . . 0.0 111.114 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.19 -36.8 75.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.157 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.36 -36.63 29.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.603 HG23 ' O ' ' B' ' 84' ' ' ASP . 28.8 t -75.63 -30.48 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' B' ' 85' ' ' PHE . 9.9 m120 -67.21 -48.93 66.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.94 -39.32 90.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.78 -23.98 55.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -81.78 -33.29 30.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.399 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.71 -29.68 18.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.657 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -75.88 -21.57 57.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.668 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.84 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -92.04 -33.13 14.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 110.671 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.495 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 2.6 m-85 -58.95 -59.11 5.99 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.09 0.472 . . . . 0.0 110.138 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -31.46 72.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.297 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.49 -11.6 60.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.436 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.49 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 4.9 m-20 -110.88 -6.44 14.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.336 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 0.9 OUTLIER 90.11 35.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.619 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.809 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.6 m-70 -115.3 53.43 0.83 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.959 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 71.8 Cg_endo -74.56 -14.61 22.21 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.541 2.161 . . . . 0.0 112.577 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.789 ' OD1' HD11 ' C' ' 5' ' ' ILE . 2.0 t30 -51.59 -33.33 32.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.135 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.727 ' CB ' HG13 ' C' ' 19' ' ' VAL . 3.6 m-85 61.49 96.48 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 59.9 Cg_endo -73.34 159.05 47.56 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.404 2.069 . . . . 0.0 112.255 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.636 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -55.59 147.72 17.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.458 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.76 142.49 45.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.032 0.444 . . . . 0.0 111.471 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.587 ' O ' HG23 ' B' ' 76' ' ' THR . 31.2 t -149.52 62.87 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.352 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 18.8 p -94.62 145.41 24.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.233 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.464 HG11 ' CD2' ' C' ' 78' ' ' PHE . 35.9 m -153.33 135.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.244 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -64.78 91.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.77 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.739 HG21 HD21 ' B' ' 115' ' ' LEU . 8.2 m -76.35 164.45 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.236 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -83.6 -44.88 14.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.106 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.425 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -158.51 158.68 34.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.706 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.863 HD22 ' HB2' ' B' ' 122' ' ' GLU . 0.9 OUTLIER -141.4 168.95 12.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.495 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' B' ' 115' ' ' LEU . 74.5 Cg_exo -50.16 136.89 38.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.352 2.035 . . . . 0.0 112.325 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.11 14.28 9.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.398 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.56 20.07 5.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.041 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.68 HG11 ' HB ' ' B' ' 34' ' ' ILE . 16.0 m -53.1 149.77 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.198 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 120' ' ' GLY . . . . . 0.581 ' O ' HD23 ' B' ' 121' ' ' LEU . . . -81.56 -15.15 76.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.769 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.753 HD22 HG12 ' B' ' 79' ' ' VAL . 42.5 mt -152.21 148.63 27.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.959 0.409 . . . . 0.0 110.848 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.863 ' HB2' HD22 ' B' ' 115' ' ' LEU . 27.0 tt0 -129.68 146.63 51.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.284 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.415 ' O ' ' HA2' ' B' ' 32' ' ' GLY . 29.3 mm -120.11 150.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 111.748 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.16 147.48 6.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.69 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.517 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -173.87 164.4 4.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 112.133 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.737 HD12 HD23 ' B' ' 29' ' ' LEU . 5.6 mm -117.74 151.85 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.334 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 1.017 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -131.45 147.54 52.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 111.781 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.945 HG21 HG21 ' C' ' 3' ' ' THR . 27.1 m -109.62 151.93 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.086 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.786 ' HB2' HD11 ' B' ' 67' ' ' LEU . 11.7 ttp180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.79 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.945 HG21 HG21 ' B' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.793 0.33 . . . . 0.0 110.742 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -157.87 118.22 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.789 HD11 ' OD1' ' B' ' 103' ' ' ASN . 4.4 mp -58.19 138.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.092 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.83 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 31.6 mt -94.73 138.08 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.169 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -151.0 136.91 18.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.49 162.77 34.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.71 26.65 5.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -118.06 -40.69 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.791 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' C' ' 12' ' ' PRO . . . -85.5 119.67 72.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.124 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' C' ' 11' ' ' ALA . 17.8 Cg_exo -66.03 -10.88 28.73 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.496 2.131 . . . . 0.0 112.601 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.5 172.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.472 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 62.94 130.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.16 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.91 -36.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.495 0.664 . . . . 0.0 110.741 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.06 -145.12 11.23 Favored Glycine 0 C--N 1.315 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.364 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.68 57.95 5.78 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.702 2.268 . . . . 0.0 112.901 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -168.45 -177.37 3.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.086 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.727 HG13 ' CB ' ' B' ' 104' ' ' PHE . 27.0 m -112.73 -178.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.328 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 43.4 mt-30 -80.31 -51.2 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.05 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.83 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -156.41 179.68 9.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.282 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.5 147.37 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.921 ' HA ' HG12 ' C' ' 28' ' ' VAL . 20.4 t0 -123.25 94.36 4.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.773 HD22 HG11 ' B' ' 128' ' ' VAL . 11.0 mt -69.99 -17.4 63.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.232 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.62 -105.37 0.95 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.178 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' ASN . . . . . 0.499 ' HB2' HD23 ' C' ' 27' ' ' LEU . 67.0 m-80 -52.53 -30.07 28.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.038 0.447 . . . . 0.0 110.517 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' C' ' 26' ' ' ASN . 0.2 OUTLIER -137.21 134.14 35.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.824 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.998 HG23 ' HB3' ' C' ' 127' ' ' ALA . 3.0 m -113.0 172.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.256 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.753 HD23 HD12 ' C' ' 126' ' ' ILE . 1.0 OUTLIER -145.68 165.65 28.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.69 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 44.1 p -130.14 135.96 48.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -69.43 154.44 42.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.032 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' C' ' 123' ' ' ILE . . . -55.26 93.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.647 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.746 ' HG2' HG22 ' C' ' 58' ' ' VAL . 1.6 mp0 -67.58 173.7 4.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.742 0.306 . . . . 0.0 110.991 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.671 ' HB ' HG11 ' C' ' 119' ' ' VAL . 7.7 pt -159.37 152.52 18.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.484 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.672 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 43.7 Cg_endo -68.14 74.84 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.112 2.541 . . . . 0.0 112.304 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.5 HG23 HG13 ' C' ' 34' ' ' ILE . 22.5 t . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.589 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 7.2 p . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.487 0.184 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.67 140.65 84.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.304 2.002 . . . . 0.0 112.151 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.13 71.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.979 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' C' ' 49' ' ' ALA . 1.0 OUTLIER -75.76 94.9 3.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.822 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 tp -44.43 -31.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.39 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.25 -38.21 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.723 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' C' ' 46' ' ' ASP . . . -69.25 -40.05 78.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.46 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -75.5 -21.95 57.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.241 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.69 -41.59 26.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.181 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.28 -34.36 63.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.786 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.16 -31.56 64.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.556 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.815 ' O ' HG23 ' C' ' 58' ' ' VAL . 69.0 p -67.28 -30.87 70.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.696 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.795 HD13 ' CE2' ' C' ' 95' ' ' PHE . 34.4 mt -79.34 -30.71 42.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.851 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.53 -55.89 20.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.031 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 9.3 p-10 -55.77 -45.06 78.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.815 HG23 ' O ' ' C' ' 54' ' ' SER . 45.1 t -59.19 -31.03 45.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -79.24 -38.5 35.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.701 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.9 80.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' C' ' 58' ' ' VAL . 6.5 mt -67.32 -51.52 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.826 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 mt -63.18 -32.69 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.6 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.66 -40.66 63.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.28 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.58 -20.96 65.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.485 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.9 -25.67 20.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.858 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.11 47.91 0.54 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.453 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.822 HD22 ' OD2' ' C' ' 71' ' ' ASP . 7.2 mt -156.71 -171.64 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.712 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 77.7 p -142.77 -179.6 6.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.804 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -78.64 -24.95 44.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.52 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.575 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -59.82 -36.54 77.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.822 ' OD2' HD22 ' C' ' 67' ' ' LEU . 4.0 p30 -71.11 -26.34 62.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.062 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' C' ' 105' ' ' PRO . 88.4 mt -46.81 115.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.87 0.367 . . . . 0.0 110.953 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.44 HG21 HD21 ' A' ' 24' ' ' LEU . 27.3 m -91.2 -26.0 5.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.78 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 1.7 ttpm? -138.08 164.45 29.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.704 0.288 . . . . 0.0 110.913 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.486 HG23 ' HB2' ' C' ' 125' ' ' ALA . 91.0 m -163.54 126.62 2.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.994 0.426 . . . . 0.0 111.502 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.6 HG23 ' O ' ' C' ' 108' ' ' SER . 2.8 m -109.34 144.79 37.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.845 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.01 108.39 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 111.844 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.464 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.6 m-85 -91.44 107.11 18.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.332 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.73 HG12 HD22 ' C' ' 121' ' ' LEU . 29.9 m -102.14 149.94 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.137 0.494 . . . . 0.0 111.837 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.81 -6.36 49.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.858 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.13 111.91 3.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.488 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.22 -15.21 32.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.282 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -78.33 -19.51 53.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.767 0.318 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.608 ' O ' HG23 ' C' ' 88' ' ' VAL . 19.2 m-20 -90.64 7.26 40.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.372 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.447 ' CD1' HG11 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -82.32 -27.41 32.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 111.117 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.31 -36.67 76.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.162 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.41 -36.66 29.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.608 HG23 ' O ' ' C' ' 84' ' ' ASP . 28.3 t -75.63 -30.47 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 89' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' C' ' 85' ' ' PHE . 9.9 m120 -67.16 -48.95 66.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.1 90.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 91' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 0.6 OUTLIER -75.91 -23.91 55.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.248 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -81.71 -33.32 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.378 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 93' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' C' ' 104' ' ' PHE . 0.8 OUTLIER -89.69 -29.72 18.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.651 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 94' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 1.3 ppt_? -75.88 -21.54 57.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.686 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.795 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -92.02 -33.18 14.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.795 0.331 . . . . 0.0 110.669 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 2.6 m-85 -59.03 -59.05 6.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.032 0.444 . . . . 0.0 110.124 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -31.5 72.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.279 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.53 -11.5 60.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.436 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 4.9 m-20 -110.93 -6.49 14.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.302 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 0.9 OUTLIER 90.21 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.539 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.804 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.6 m-70 -115.37 53.38 0.84 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.0 Cg_endo -74.57 -14.61 22.2 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.514 2.143 . . . . 0.0 112.563 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.803 ' OD1' HD11 ' A' ' 5' ' ' ILE . 2.0 t30 -51.61 -33.27 32.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.125 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.74 ' CB ' HG13 ' A' ' 19' ' ' VAL . 3.7 m-85 61.5 96.45 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.016 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 60.2 Cg_endo -73.26 159.17 47.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.389 2.059 . . . . 0.0 112.293 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.648 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -55.77 147.64 18.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.65 142.47 45.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.034 0.445 . . . . 0.0 111.476 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 108' ' ' SER . . . . . 0.6 ' O ' HG23 ' C' ' 76' ' ' THR . 31.0 t -149.49 62.84 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.346 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 18.5 p -94.59 145.36 24.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.221 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.455 HG11 ' CD2' ' A' ' 78' ' ' PHE . 35.8 m -153.24 134.88 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.195 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.636 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.51 91.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.761 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.753 HG21 HD21 ' C' ' 115' ' ' LEU . 8.4 m -76.28 164.41 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.286 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -83.68 -44.81 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.432 ' HB2' ' HB3' ' B' ' 111' ' ' GLU . 0.1 OUTLIER -158.56 158.61 34.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.746 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.86 HD22 ' HB2' ' C' ' 122' ' ' GLU . 0.9 OUTLIER -141.37 168.98 12.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.501 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' C' ' 115' ' ' LEU . 74.1 Cg_exo -50.19 136.88 38.37 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.37 2.047 . . . . 0.0 112.275 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.11 14.35 9.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.366 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.54 20.14 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.009 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.671 HG11 ' HB ' ' C' ' 34' ' ' ILE . 16.0 m -53.21 149.81 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 120' ' ' GLY . . . . . 0.595 ' O ' HD23 ' C' ' 121' ' ' LEU . . . -81.72 -15.13 76.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.794 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.73 HD22 HG12 ' C' ' 79' ' ' VAL . 41.9 mt -152.16 148.53 27.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.89 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.86 ' HB2' HD22 ' C' ' 115' ' ' LEU . 27.1 tt0 -129.68 146.68 51.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.26 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' C' ' 32' ' ' GLY . 29.3 mm -120.18 150.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.064 0.459 . . . . 0.0 111.742 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.09 147.46 6.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.65 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -173.83 164.38 4.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.111 0.482 . . . . 0.0 112.119 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.753 HD12 HD23 ' C' ' 29' ' ' LEU . 5.6 mm -117.67 151.85 19.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.303 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.998 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -131.46 147.58 52.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 111.771 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.977 HG21 HG21 ' A' ' 3' ' ' THR . 27.1 m -109.66 151.97 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.062 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.797 ' HB2' HD11 ' C' ' 67' ' ' LEU . 11.7 ttp180 -173.09 73.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.759 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.821 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.12 110.6 17.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.859 HD11 HG21 ' A' ' 19' ' ' VAL . 2.3 tp -54.99 129.66 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.192 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.634 HD12 ' CB ' ' A' ' 21' ' ' ALA . 32.1 mt -90.53 151.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.412 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.78 108.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.818 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.09 170.28 10.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.69 22.27 10.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.926 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.5 -37.96 6.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.638 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -100.46 127.87 31.73 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.058 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 7.8 Cg_exo -72.1 -1.67 10.41 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.668 2.246 . . . . 0.0 112.701 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' HE21 ' A' ' 20' ' ' GLN . . . -46.92 170.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.862 0.363 . . . . 0.0 111.586 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.27 119.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.115 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 15' ' ' ILE . 13.5 mt -154.79 15.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.858 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.36 -114.64 0.5 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.974 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HB2' ' CD1' ' C' ' 92' ' ' TYR . 92.8 Cg_endo -81.01 50.98 3.76 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.664 2.242 . . . . 0.0 112.981 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.484 ' CG ' ' HB2' ' C' ' 107' ' ' ARG . 1.7 p90 -178.7 156.84 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.0 111.002 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.859 HG21 HD11 ' A' ' 5' ' ' ILE . 31.2 m -106.69 -174.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.174 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.699 HE21 ' HB3' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -73.68 -43.8 58.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.634 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . -176.93 177.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.742 HG12 HD12 ' A' ' 5' ' ' ILE . 18.6 m -138.38 133.75 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.809 ' HA ' HG23 ' A' ' 28' ' ' VAL . 37.5 t70 -103.86 102.8 12.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.657 HD22 HG11 ' C' ' 128' ' ' VAL . 11.8 mt -81.07 -17.88 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.16 -103.57 0.9 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.954 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.35 -29.11 63.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.086 0.47 . . . . 0.0 110.286 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -132.18 122.98 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.923 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.029 HG12 ' HB3' ' A' ' 127' ' ' ALA . 4.2 p -109.28 145.75 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.98 139.53 53.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.9 p -112.93 161.84 16.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.771 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.6 p -95.65 165.55 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.099 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.53 94.34 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.342 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.19 146.14 54.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.248 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.784 ' HB ' HG11 ' A' ' 119' ' ' VAL . 9.5 pt -134.46 142.08 41.44 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.794 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 7.8 Cg_exo -72.56 55.16 2.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.961 2.441 . . . . 0.0 113.138 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.579 HG22 HD12 ' A' ' 34' ' ' ILE . 20.5 t . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.241 0.544 . . . . 0.0 110.554 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.617 HG21 ' H ' ' A' ' 120' ' ' GLY . 11.4 p . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 120.665 0.269 . . . . 0.0 111.379 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 35' ' ' PRO . 52.5 Cg_exo -52.53 140.44 54.62 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.477 2.118 . . . . 0.0 112.422 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.64 -32.05 70.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 92.69 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.615 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 47' ' ' ILE . 22.5 mm -40.12 -32.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.373 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.87 -56.46 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . . . -63.08 -28.74 70.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.772 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -80.59 -28.83 37.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.675 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' CB ' HG22 ' A' ' 88' ' ' VAL . . . -79.28 -34.8 42.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.538 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.52 -28.79 52.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.179 -179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.25 -48.17 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 110.838 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -59.65 -35.74 75.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.759 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.636 HD13 ' CE2' ' A' ' 95' ' ' PHE . 9.8 mt -64.3 -54.76 28.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.15 -31.44 68.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -67.96 -33.84 75.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.791 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 54' ' ' SER . 39.3 t -69.95 -49.44 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -29.67 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.988 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.42 95.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.61 HG22 HG21 ' A' ' 6' ' ' ILE . 5.3 mt -72.39 -42.57 64.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.536 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.981 HD13 HD11 ' A' ' 72' ' ' ILE . 21.1 mt -69.15 -30.85 47.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.822 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.11 -40.79 59.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.328 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.73 -19.49 65.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.602 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.54 -26.81 19.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.47 41.59 0.67 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.529 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.569 HD22 ' OD2' ' A' ' 71' ' ' ASP . 18.4 mt -155.28 147.11 23.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 110.669 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -101.49 -179.65 4.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.747 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.0 ' HB3' ' CD2' ' A' ' 101' ' ' HIS . . . -78.8 -23.07 45.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.773 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -62.98 -33.52 75.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.569 ' OD2' HD22 ' A' ' 67' ' ' LEU . 10.7 p30 -75.47 -21.76 57.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.71 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.063 HD13 ' HB2' ' A' ' 127' ' ' ALA . 26.4 mm -52.44 121.02 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.86 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' B' ' 22' ' ' VAL . 7.3 m -89.55 -32.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.013 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.825 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -130.11 165.67 21.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.571 0.224 . . . . 0.0 110.937 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 74' ' ' LYS . 6.1 p -162.47 105.91 1.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.831 0.348 . . . . 0.0 111.544 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 108' ' ' SER . 4.6 m -91.92 155.34 18.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.158 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.605 HG22 HG22 ' A' ' 123' ' ' ILE . 21.2 t -150.93 103.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.911 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.537 ' CD2' HG11 ' C' ' 110' ' ' VAL . 10.8 m-85 -89.7 99.73 12.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.358 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.863 HG12 HD23 ' A' ' 121' ' ' LEU . 19.1 m -98.41 147.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.588 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.21 -3.71 50.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.231 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -160.98 142.24 11.78 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.627 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.502 HD12 ' HB3' ' B' ' 114' ' ' ARG . 6.6 mt -82.91 1.55 38.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.26 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -98.67 -24.3 15.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.824 0.345 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.81 -27.01 60.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.01 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.546 ' HD2' HG11 ' A' ' 79' ' ' VAL . 1.8 t80 -59.31 -18.65 39.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.58 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.28 -57.78 10.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 111.382 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.93 71.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG22 ' CB ' ' A' ' 51' ' ' ALA . 26.7 t -70.73 -41.27 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.981 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.11 -47.36 80.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.726 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.49 75.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -92.31 -15.95 26.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.685 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.464 ' OH ' HG21 ' A' ' 75' ' ' THR . 12.4 t80 -81.66 -38.33 26.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.729 0.299 . . . . 0.0 111.281 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.0 -28.71 22.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.346 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.21 -21.81 59.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.649 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.636 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -92.07 -34.39 14.4 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.983 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.505 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 3.1 m-85 -57.3 -57.79 11.1 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.091 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.28 -29.81 70.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.097 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.92 -10.17 59.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.49 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.567 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 1.7 t-20 -108.57 -8.83 15.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.311 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 4.3 t30 88.96 33.24 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.445 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 1.0 ' CD2' ' HB3' ' A' ' 69' ' ' ALA . 2.0 m-70 -116.83 54.35 1.31 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.842 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 80.2 Cg_endo -75.22 -11.59 21.08 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.618 2.212 . . . . 0.0 112.823 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.612 ' OD1' HD13 ' B' ' 5' ' ' ILE . 2.2 t-20 -47.96 -37.55 14.78 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.763 ' O ' HG13 ' B' ' 19' ' ' VAL . 11.6 m-85 63.96 83.89 0.19 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.387 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.76 156.16 63.23 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.611 2.207 . . . . 0.0 112.018 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.825 ' HB3' ' CG ' ' A' ' 74' ' ' LYS . . . -53.38 162.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.572 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.484 ' HB2' ' CG ' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -133.01 143.74 49.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.22 0.534 . . . . 0.0 111.734 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 76' ' ' THR . 5.7 t -143.64 65.23 1.32 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.802 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.91 140.26 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.275 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' B' ' 78' ' ' PHE . 35.7 m -149.94 132.48 6.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.018 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.843 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 2.4 tt0 -63.73 86.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 78' ' ' PHE . 6.7 m -72.57 161.22 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.115 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -77.17 -45.81 25.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.501 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -153.57 168.08 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.637 HD22 ' CB ' ' A' ' 122' ' ' GLU . 1.3 mp -142.7 160.62 52.95 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.708 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' O ' HG22 ' A' ' 119' ' ' VAL . 71.5 Cg_exo -48.75 136.03 27.89 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.486 2.124 . . . . 0.0 112.228 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.475 ' HB2' HG13 ' A' ' 119' ' ' VAL . 6.0 mmtm 64.39 16.73 10.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.319 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.72 17.76 9.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.913 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.784 HG11 ' HB ' ' A' ' 34' ' ' ILE . 30.2 m -53.31 122.52 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.302 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -55.32 -21.45 26.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.909 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.863 HD23 HG12 ' A' ' 79' ' ' VAL . 1.6 mp -152.77 147.67 26.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.278 0.561 . . . . 0.0 111.53 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.637 ' CB ' HD22 ' A' ' 115' ' ' LEU . 11.8 tt0 -139.21 151.48 46.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.407 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 77' ' ' VAL . 5.8 pt -150.29 139.28 15.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.4 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 1.1 pm0 -138.74 142.94 38.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.053 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -149.62 172.6 14.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.496 ' O ' HG23 ' A' ' 72' ' ' ILE . 9.4 mt -125.68 153.96 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.064 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' A' ' 72' ' ' ILE . . . -135.4 152.96 51.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.035 0.445 . . . . 0.0 111.797 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.795 HG21 HG21 ' B' ' 3' ' ' THR . 30.0 m -115.98 164.15 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.999 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB2' HD21 ' A' ' 67' ' ' LEU . 28.2 ttt85 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.795 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.13 110.63 17.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.946 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.876 HD11 HG21 ' B' ' 19' ' ' VAL . 2.3 tp -55.02 129.66 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.22 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.639 HD12 ' CB ' ' B' ' 21' ' ' ALA . 31.4 mt -90.43 151.53 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.413 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.81 108.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.06 170.32 10.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.981 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.73 22.24 10.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.55 -38.05 6.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.645 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -100.32 127.88 31.91 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.05 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 7.7 Cg_exo -72.11 -1.67 10.42 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.618 2.212 . . . . 0.0 112.751 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.693 ' HB3' HE21 ' B' ' 20' ' ' GLN . . . -46.88 170.17 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.867 0.365 . . . . 0.0 111.544 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.18 119.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.053 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.607 HG22 ' O ' ' B' ' 15' ' ' ILE . 13.3 mt -154.73 15.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.908 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.33 -114.66 0.5 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.977 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.462 ' HB2' ' CD1' ' A' ' 92' ' ' TYR . 92.5 Cg_endo -80.95 50.93 3.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.7 2.267 . . . . 0.0 112.992 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.484 ' CG ' ' HB2' ' A' ' 107' ' ' ARG . 1.7 p90 -178.69 156.81 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.9 0.381 . . . . 0.0 110.996 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.876 HG21 HD11 ' B' ' 5' ' ' ILE . 30.8 m -106.69 -174.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.17 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.693 HE21 ' HB3' ' B' ' 13' ' ' ALA . 1.0 OUTLIER -73.53 -43.54 59.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.639 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . -177.06 177.46 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.719 HG12 HD12 ' B' ' 5' ' ' ILE . 18.6 m -138.37 133.78 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.146 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.829 ' HA ' HG23 ' B' ' 28' ' ' VAL . 37.5 t70 -103.93 102.84 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.684 HD22 HG11 ' A' ' 128' ' ' VAL . 11.9 mt -81.08 -17.93 48.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.2 -103.6 0.9 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.895 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.32 -29.1 63.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.088 0.471 . . . . 0.0 110.287 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.424 ' HG ' HG12 ' B' ' 128' ' ' VAL . 0.2 OUTLIER -132.21 122.96 26.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.884 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.053 HG12 ' HB3' ' B' ' 127' ' ' ALA . 4.2 p -109.29 145.8 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.844 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.403 HD23 ' HD2' ' A' ' 74' ' ' LYS . 5.2 mp -124.95 139.52 53.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.993 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 77.3 p -112.97 161.89 16.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.745 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 27.6 p -95.6 165.59 12.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.51 94.27 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.335 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.21 146.18 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.753 ' HB ' HG11 ' B' ' 119' ' ' VAL . 9.4 pt -134.5 142.06 41.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.815 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 7.9 Cg_exo -72.58 55.18 2.58 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.964 2.443 . . . . 0.0 113.146 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.574 HG22 HD12 ' B' ' 34' ' ' ILE . 20.5 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.585 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.616 HG13 ' O ' ' B' ' 43' ' ' VAL . 11.5 p . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 120.649 0.261 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.8 Cg_exo -52.65 140.45 55.82 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.46 2.107 . . . . 0.0 112.407 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.0 70.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.2 92.7 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.613 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' B' ' 47' ' ' ILE . 22.4 mm -40.16 -32.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.35 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.87 -56.43 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.749 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.43 ' HA ' ' HG2' ' B' ' 52' ' ' ARG . . . -63.05 -28.79 70.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.752 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -80.4 -28.3 37.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.634 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.492 ' CB ' HG22 ' B' ' 88' ' ' VAL . . . -79.43 -34.86 41.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.535 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' B' ' 49' ' ' ALA . 0.0 OUTLIER -77.48 -28.84 52.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.169 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.24 -48.11 65.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.82 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.765 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.5 OUTLIER -59.61 -35.79 75.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.66 HD13 ' CE2' ' B' ' 95' ' ' PHE . 9.8 mt -64.24 -54.8 27.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.24 -31.31 68.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.404 ' ND2' ' HD3' ' B' ' 12' ' ' PRO . 26.0 m120 -68.04 -33.71 75.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.765 HG23 ' O ' ' B' ' 54' ' ' SER . 39.2 t -70.0 -49.39 56.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -29.7 65.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.937 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.49 95.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.822 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.588 HG22 HG21 ' B' ' 6' ' ' ILE . 5.3 mt -72.29 -42.51 65.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.532 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 1.006 HD13 HD11 ' B' ' 72' ' ' ILE . 21.1 mt -69.1 -30.92 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.815 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -75.16 -40.7 59.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.337 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.78 -19.51 65.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.56 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.49 -26.85 19.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.47 41.69 0.67 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.469 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.568 HD22 ' OD2' ' B' ' 71' ' ' ASP . 18.4 mt -155.28 147.16 23.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 110.695 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -101.58 -179.73 4.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.719 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 1.01 ' HB3' ' CD2' ' B' ' 101' ' ' HIS . . . -78.75 -23.1 45.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 110.465 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.753 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -62.86 -33.55 75.52 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.568 ' OD2' HD22 ' B' ' 67' ' ' LEU . 10.6 p30 -75.35 -21.81 58.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.702 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 1.126 HD13 ' HB2' ' B' ' 127' ' ' ALA . 26.6 mm -52.54 121.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.79 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.639 ' HB ' HG21 ' C' ' 22' ' ' VAL . 7.2 m -89.61 -32.72 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.019 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.852 ' HG2' ' HB3' ' B' ' 106' ' ' ALA . 0.8 OUTLIER -130.19 165.65 21.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.567 0.222 . . . . 0.0 110.916 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.612 HG23 ' O ' ' B' ' 74' ' ' LYS . 6.1 p -162.43 105.9 1.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 111.523 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.536 HG23 ' O ' ' B' ' 108' ' ' SER . 4.6 m -91.89 155.4 18.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.219 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.602 HG22 HG22 ' B' ' 123' ' ' ILE . 21.2 t -150.97 103.15 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.834 0.349 . . . . 0.0 111.908 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.603 ' CD2' HG11 ' A' ' 110' ' ' VAL . 10.9 m-85 -89.84 99.86 12.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.247 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.857 HG12 HD23 ' B' ' 121' ' ' LEU . 19.0 m -98.52 147.71 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.58 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.27 -3.7 50.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.222 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -161.03 142.26 11.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.646 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.497 HD12 ' HB3' ' C' ' 114' ' ' ARG . 6.6 mt -82.97 1.58 39.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.256 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -98.68 -24.21 15.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.85 -26.96 60.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.549 ' HD2' HG11 ' B' ' 79' ' ' VAL . 1.8 t80 -59.3 -18.73 40.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.586 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.23 -57.82 10.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.36 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.96 71.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.158 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.492 HG22 ' CB ' ' B' ' 51' ' ' ALA . 26.3 t -70.72 -41.29 77.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.99 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.16 -47.32 80.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.733 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.52 75.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -92.2 -15.98 26.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.667 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' C' ' 17' ' ' PRO . 12.5 t80 -81.65 -38.29 26.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.771 0.32 . . . . 0.0 111.314 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.02 -28.78 22.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.329 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.15 -21.81 59.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.695 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.66 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -92.07 -34.47 14.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.941 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.489 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 3.1 m-85 -57.31 -57.76 11.22 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.07 0.462 . . . . 0.0 110.092 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.29 -29.78 70.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.121 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.96 -10.16 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.476 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.575 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 1.7 t-20 -108.58 -8.79 15.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.34 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 4.3 t30 88.97 33.13 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.457 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 1.01 ' CD2' ' HB3' ' B' ' 69' ' ' ALA . 2.0 m-70 -116.73 54.45 1.29 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.859 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 79.1 Cg_endo -75.3 -11.62 20.95 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.68 2.253 . . . . 0.0 112.777 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.594 ' OD1' HD13 ' C' ' 5' ' ' ILE . 2.2 t-20 -47.91 -37.59 14.56 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.941 0.4 . . . . 0.0 111.035 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.772 ' O ' HG13 ' C' ' 19' ' ' VAL . 11.6 m-85 64.01 83.84 0.19 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.396 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.75 156.17 63.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.604 2.203 . . . . 0.0 112.022 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.852 ' HB3' ' HG2' ' B' ' 74' ' ' LYS . . . -53.36 162.55 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.519 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.479 ' HB2' ' CG ' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -133.07 143.71 49.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.178 0.513 . . . . 0.0 111.689 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.536 ' O ' HG23 ' B' ' 76' ' ' THR . 5.6 t -143.66 65.29 1.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.759 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.99 140.25 30.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.245 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' C' ' 78' ' ' PHE . 35.8 m -150.01 132.54 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.984 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 2.4 tt0 -63.71 86.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.84 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' B' ' 78' ' ' PHE . 6.8 m -72.43 161.2 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -77.18 -45.85 25.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.502 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -153.58 168.03 27.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.623 HD22 ' CB ' ' B' ' 122' ' ' GLU . 1.3 mp -142.64 160.63 53.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.711 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.493 ' O ' HG22 ' B' ' 119' ' ' VAL . 71.6 Cg_exo -48.74 136.02 27.85 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.443 2.096 . . . . 0.0 112.259 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.476 ' HB2' HG13 ' B' ' 119' ' ' VAL . 6.0 mmtm 64.45 16.66 10.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.331 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.81 17.76 9.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.875 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.753 HG11 ' HB ' ' B' ' 34' ' ' ILE . 30.6 m -53.4 122.63 3.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.265 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 120' ' ' GLY . . . . . 0.584 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -55.28 -21.71 27.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.894 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.857 HD23 HG12 ' B' ' 79' ' ' VAL . 1.6 mp -152.6 147.58 26.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.268 0.556 . . . . 0.0 111.496 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.623 ' CB ' HD22 ' B' ' 115' ' ' LEU . 11.8 tt0 -139.18 151.52 46.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.407 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.602 HG22 HG22 ' B' ' 77' ' ' VAL . 5.8 pt -150.29 139.23 15.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -138.73 142.98 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.041 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -149.61 172.62 14.74 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.49 ' O ' HG23 ' B' ' 72' ' ' ILE . 9.5 mt -125.69 154.04 34.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.008 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 1.126 ' HB2' HD13 ' B' ' 72' ' ' ILE . . . -135.39 153.03 51.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.016 0.436 . . . . 0.0 111.849 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.834 HG21 HG21 ' C' ' 3' ' ' THR . 30.1 m -116.02 164.09 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.95 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.502 ' HB2' HD21 ' B' ' 67' ' ' LEU . 28.2 ttt85 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.908 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.834 HG21 HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.828 0.347 . . . . 0.0 110.88 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.1 110.64 17.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.89 HD11 HG21 ' C' ' 19' ' ' VAL . 2.3 tp -55.01 129.66 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.678 HD12 ' CB ' ' C' ' 21' ' ' ALA . 31.2 mt -90.51 151.59 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.4 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.81 108.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.801 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.11 170.27 10.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.69 22.32 10.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.83 -38.3 6.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' C' ' 12' ' ' PRO . . . -99.92 127.96 32.25 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.115 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' C' ' 11' ' ' ALA . 7.8 Cg_exo -72.11 -1.75 10.53 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.653 2.235 . . . . 0.0 112.731 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.689 ' HB3' HE21 ' C' ' 20' ' ' GLN . . . -46.83 170.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.864 0.364 . . . . 0.0 111.592 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.18 119.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.088 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.604 HG22 ' O ' ' C' ' 15' ' ' ILE . 13.5 mt -154.73 15.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.881 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.42 -114.73 0.51 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.929 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' PRO . . . . . 0.465 ' HB2' ' CD1' ' B' ' 92' ' ' TYR . 93.3 Cg_endo -80.97 51.0 3.76 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.647 2.231 . . . . 0.0 113.018 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' B' ' 107' ' ' ARG . 1.7 p90 -178.65 156.84 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.952 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.89 HG21 HD11 ' C' ' 5' ' ' ILE . 30.9 m -106.72 -174.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.15 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.689 HE21 ' HB3' ' C' ' 13' ' ' ALA . 1.0 OUTLIER -73.6 -43.49 59.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.956 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.678 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . -176.95 177.6 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.088 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.751 HG12 HD12 ' C' ' 5' ' ' ILE . 18.6 m -138.42 133.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.839 ' HA ' HG23 ' C' ' 28' ' ' VAL . 37.5 t70 -103.97 102.68 12.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.715 HD23 HG23 ' C' ' 3' ' ' THR . 11.8 mt -80.91 -17.94 48.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.109 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.22 -103.57 0.9 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.915 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.38 -29.04 63.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.084 0.468 . . . . 0.0 110.279 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.463 ' HG ' HG12 ' C' ' 128' ' ' VAL . 0.2 OUTLIER -132.23 122.87 25.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.905 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 1.0 HG12 ' HB3' ' C' ' 127' ' ' ALA . 4.2 p -109.22 145.77 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.893 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.89 139.63 53.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 0.0 110.979 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 76.2 p -113.17 162.2 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.747 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 27.5 p -95.94 165.57 12.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.111 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.55 94.3 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.325 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.19 146.16 54.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.767 ' HB ' HG11 ' C' ' 119' ' ' VAL . 9.5 pt -134.47 142.06 41.37 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.847 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.523 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 7.9 Cg_exo -72.54 55.2 2.56 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.939 2.426 . . . . 0.0 113.138 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.567 HG22 HD12 ' C' ' 34' ' ' ILE . 20.6 t . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.194 0.521 . . . . 0.0 110.513 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.61 ' O ' HG13 ' C' ' 43' ' ' VAL . 11.4 p . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 120.64 0.257 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' C' ' 35' ' ' PRO . 52.6 Cg_exo -52.59 140.45 55.26 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.488 2.125 . . . . 0.0 112.443 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.74 -32.01 70.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 92.77 0.12 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.635 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mm -40.23 -32.4 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.351 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.86 -56.45 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.71 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.422 ' HA ' ' HG2' ' C' ' 52' ' ' ARG . . . -63.1 -28.71 70.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.773 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -80.54 -28.77 37.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.626 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.411 ' CB ' HG22 ' C' ' 88' ' ' VAL . . . -79.19 -34.82 42.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.581 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' C' ' 49' ' ' ALA . 0.0 OUTLIER -77.51 -28.86 52.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.181 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.24 -48.11 65.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.836 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.775 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.5 OUTLIER -59.68 -35.72 75.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.611 HD13 ' CE2' ' C' ' 95' ' ' PHE . 9.7 mt -64.28 -54.79 27.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.925 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.19 -31.4 68.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -67.97 -33.8 75.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.828 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.775 HG23 ' O ' ' C' ' 54' ' ' SER . 39.1 t -69.91 -49.47 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -29.8 65.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.67 -41.25 94.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.616 HG22 HG21 ' C' ' 6' ' ' ILE . 5.3 mt -72.51 -42.58 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.574 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 1.003 HD13 HD11 ' C' ' 72' ' ' ILE . 21.0 mt -69.13 -30.85 47.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.852 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.19 -40.67 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.923 0.392 . . . . 0.0 110.335 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -19.44 65.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.531 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.52 -26.86 19.54 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.907 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.49 41.64 0.67 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.512 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.57 HD22 ' OD2' ' C' ' 71' ' ' ASP . 18.5 mt -155.29 147.1 23.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.661 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -101.47 -179.74 4.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.99 ' HB3' ' CD2' ' C' ' 101' ' ' HIS . . . -78.72 -23.06 45.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.789 0.328 . . . . 0.0 110.49 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.766 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -62.98 -33.37 75.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.57 ' OD2' HD22 ' C' ' 67' ' ' LEU . 10.7 p30 -75.81 -21.64 57.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 1.039 HD13 ' HB2' ' C' ' 127' ' ' ALA . 26.4 mm -52.53 121.12 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.848 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.619 ' HB ' HG21 ' A' ' 22' ' ' VAL . 7.1 m -89.68 -32.7 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.013 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.846 ' HG2' ' HB3' ' C' ' 106' ' ' ALA . 0.8 OUTLIER -130.25 165.62 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.576 0.227 . . . . 0.0 110.888 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.618 HG23 ' O ' ' C' ' 74' ' ' LYS . 6.1 p -162.44 105.84 1.13 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.811 0.338 . . . . 0.0 111.559 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.554 HG23 ' O ' ' C' ' 108' ' ' SER . 4.6 m -91.87 155.39 18.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.177 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.611 HG22 HG22 ' C' ' 123' ' ' ILE . 21.1 t -151.02 103.12 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.909 0.385 . . . . 0.0 111.935 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.586 ' CD2' HG11 ' B' ' 110' ' ' VAL . 10.9 m-85 -89.78 99.82 12.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.301 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.865 HG12 HD23 ' C' ' 121' ' ' LEU . 19.0 m -98.49 147.72 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.527 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.21 -3.43 49.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.176 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -161.27 142.17 11.29 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.639 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 114' ' ' ARG . 6.6 mt -82.92 1.61 38.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.233 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -98.66 -24.21 15.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.768 0.318 . . . . 0.0 110.9 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.86 -27.01 60.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.034 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.543 ' HD2' HG11 ' C' ' 79' ' ' VAL . 1.8 t80 -59.35 -18.6 39.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.619 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.35 -57.81 10.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 111.338 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.0 71.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.411 HG22 ' CB ' ' C' ' 51' ' ' ALA . 27.2 t -70.77 -41.19 77.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.17 -47.36 80.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.704 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.42 75.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.298 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -92.28 -15.88 26.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.721 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 12.5 t80 -81.71 -38.33 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.307 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.05 -28.68 22.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.333 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.15 -21.89 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.69 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.611 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -91.98 -34.49 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.972 -179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.497 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 3.1 m-85 -57.23 -57.79 11.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 110.13 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.25 -29.83 70.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.128 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.98 -10.09 59.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.489 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.559 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 1.7 t-20 -108.67 -8.8 15.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.29 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 4.3 t30 89.0 33.3 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.454 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.99 ' CD2' ' HB3' ' C' ' 69' ' ' ALA . 2.0 m-70 -116.97 54.48 1.37 Allowed Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.84 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 77.0 Cg_endo -75.32 -11.62 20.91 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.646 2.23 . . . . 0.0 112.761 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.615 ' OD1' HD13 ' A' ' 5' ' ' ILE . 2.2 t-20 -47.91 -37.52 14.44 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.876 0.37 . . . . 0.0 111.089 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.753 ' O ' HG13 ' A' ' 19' ' ' VAL . 11.5 m-85 63.93 83.84 0.19 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.41 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 33.8 Cg_endo -64.64 156.15 62.82 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.618 2.212 . . . . 0.0 112.076 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.846 ' HB3' ' HG2' ' C' ' 74' ' ' LYS . . . -53.44 162.6 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.567 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.484 ' HB2' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -133.14 143.74 49.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.185 0.516 . . . . 0.0 111.681 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 108' ' ' SER . . . . . 0.554 ' O ' HG23 ' C' ' 76' ' ' THR . 5.6 t -143.63 65.23 1.32 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.787 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.88 140.29 29.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.306 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.537 HG11 ' CD2' ' A' ' 78' ' ' PHE . 35.7 m -150.11 132.55 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.044 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.839 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.5 tt0 -63.59 86.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' C' ' 78' ' ' PHE . 6.7 m -72.48 161.21 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.188 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -77.2 -45.79 25.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.114 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.497 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -153.61 168.12 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.645 HD22 ' CB ' ' C' ' 122' ' ' GLU . 1.3 mp -142.73 160.62 52.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.693 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.485 ' O ' HG22 ' C' ' 119' ' ' VAL . 71.2 Cg_exo -48.76 136.06 27.92 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.41 2.073 . . . . 0.0 112.273 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.463 ' HB2' HG13 ' C' ' 119' ' ' VAL . 6.0 mmtm 64.46 16.65 10.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.286 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.74 17.85 9.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.879 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.767 HG11 ' HB ' ' C' ' 34' ' ' ILE . 30.5 m -53.41 122.54 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 120' ' ' GLY . . . . . 0.603 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -55.14 -21.53 25.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.905 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.865 HD23 HG12 ' C' ' 79' ' ' VAL . 1.6 mp -152.56 147.58 26.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.321 0.582 . . . . 0.0 111.489 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.645 ' CB ' HD22 ' C' ' 115' ' ' LEU . 11.8 tt0 -139.23 151.5 46.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.394 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.611 HG22 HG22 ' C' ' 77' ' ' VAL . 5.8 pt -150.28 139.22 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 1.1 pm0 -138.72 142.98 38.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.06 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -149.6 172.62 14.74 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' C' ' 72' ' ' ILE . 9.4 mt -125.69 154.05 34.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.046 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 1.039 ' HB2' HD13 ' C' ' 72' ' ' ILE . . . -135.46 153.16 51.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.001 0.429 . . . . 0.0 111.834 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.821 HG21 HG21 ' A' ' 3' ' ' THR . 30.2 m -116.12 164.16 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.0 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.537 ' HB2' HD21 ' C' ' 67' ' ' LEU . 28.2 ttt85 -164.07 64.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.737 HG21 HG21 ' C' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.779 0.323 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.41 131.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.712 HD12 HG11 ' A' ' 19' ' ' VAL . 39.0 mm -59.0 155.13 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' A' ' 21' ' ' ALA . 31.3 mt -121.13 133.61 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.33 149.19 28.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.686 HG22 ' OE1' ' A' ' 20' ' ' GLN . 11.3 t -150.84 165.59 33.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.946 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.89 25.56 5.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 5.5 mmtp -110.06 -50.97 2.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.655 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.13 114.03 50.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.58 -12.53 36.19 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.358 2.038 . . . . 0.0 112.621 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 15' ' ' ILE . . . -64.83 -169.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 62.18 -169.42 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.25 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.3 mt 77.17 17.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.228 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.11 -127.96 2.92 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.245 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -87.44 33.91 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.759 2.306 . . . . 0.0 112.861 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -175.87 156.8 1.85 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.025 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.712 HG11 HD12 ' A' ' 5' ' ' ILE . 35.0 m -92.26 152.6 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.06 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.686 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER -56.93 -36.51 70.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.409 . . . . 0.0 110.451 179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . -176.31 163.13 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.941 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -128.15 136.88 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.878 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.873 ' HA ' HG12 ' A' ' 28' ' ' VAL . 1.6 p30 -110.25 120.43 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.231 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.01 HD21 HG11 ' C' ' 128' ' ' VAL . 0.8 OUTLIER -90.53 -20.68 22.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.916 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.12 -108.66 0.77 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.672 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -60.38 -29.2 68.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.126 0.489 . . . . 0.0 110.067 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.724 ' HG ' HG12 ' A' ' 128' ' ' VAL . 7.4 mp -126.44 115.2 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.811 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.873 HG12 ' HA ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -105.37 176.24 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.197 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 28' ' ' VAL . 4.7 mp -150.53 161.66 42.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.408 HG21 HD11 ' A' ' 62' ' ' ILE . 23.4 p -126.16 159.21 33.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.074 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -95.06 168.07 10.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.196 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.09 94.74 0.1 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.263 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.451 ' CD ' HD11 ' A' ' 61' ' ' ILE . 47.0 mm-40 -73.6 165.73 24.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.909 0.385 . . . . 0.0 111.19 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.522 HG13 HG23 ' A' ' 36' ' ' VAL . 10.3 pt -149.93 143.05 16.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.015 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 43' ' ' VAL . 73.7 Cg_endo -75.05 59.38 5.21 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.794 2.33 . . . . 0.0 112.875 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.522 HG23 HG13 ' A' ' 34' ' ' ILE . 46.3 t . . . . . 0 C--N 1.326 -0.453 0 CA-C-O 121.263 0.554 . . . . 0.0 110.643 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.6 HG21 ' H ' ' A' ' 120' ' ' GLY . 11.2 p . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.543 0.211 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 31.8 Cg_exo -58.26 150.18 68.27 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.388 2.059 . . . . 0.0 112.035 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.47 -30.79 68.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.978 0.418 . . . . 0.0 110.893 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -71.51 97.45 1.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.829 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.439 HD12 ' NE2' ' A' ' 50' ' ' GLN . 9.2 tp -42.14 -32.22 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.767 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -48.62 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -60.58 -41.04 93.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.752 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' NE2' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -70.01 -30.85 68.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.583 179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.34 -37.49 71.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.196 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -78.95 -35.62 42.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.92 -36.08 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.854 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -74.81 -31.67 61.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.752 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.6 mt -72.74 -36.28 67.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.8 -44.31 73.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -58.68 -46.57 86.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.948 HG21 ' CG2' ' A' ' 123' ' ' ILE . 21.4 t -60.72 -31.85 50.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.96 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.592 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 3.3 tttt -80.61 -32.51 36.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -67.14 -35.98 80.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 58' ' ' VAL . 5.8 mt -69.7 -45.24 78.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.76 HG22 ' HB3' ' A' ' 67' ' ' LEU . 11.0 mt -65.75 -35.28 74.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.458 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.94 75.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.327 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -21.42 63.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.422 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.45 -28.31 20.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.71 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.92 54.44 0.35 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.615 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.76 ' HB3' HG22 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 158.01 23.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.878 0.37 . . . . 0.0 110.671 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.429 ' O ' HD23 ' A' ' 67' ' ' LEU . 2.1 p -115.33 156.85 24.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.161 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.798 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -57.97 -35.91 71.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.057 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -50.64 -26.74 5.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.455 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.561 ' CB ' HD21 ' A' ' 67' ' ' LEU . 4.7 m-20 -85.5 -18.67 32.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.297 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.495 HD12 ' CB ' ' A' ' 127' ' ' ALA . 0.5 OUTLIER -54.5 117.89 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.506 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.665 HG11 HD21 ' B' ' 24' ' ' LEU . 29.0 m -88.13 -33.73 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.92 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.698 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 4.2 tttm -128.32 169.77 13.84 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.454 HG22 ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -169.93 112.97 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.875 0.369 . . . . 0.0 111.409 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.7 m -99.96 151.77 20.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.173 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 109' ' ' CYS . 5.0 m -146.48 128.85 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 111.929 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.535 ' HB2' HD21 ' A' ' 115' ' ' LEU . 4.1 m-85 -107.6 129.68 54.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.144 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.8 149.5 27.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.463 . . . . 0.0 111.721 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 115' ' ' LEU . 12.3 mttt -88.41 -4.2 58.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.781 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -160.57 115.55 2.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.384 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' B' ' 114' ' ' ARG . 3.1 mt -66.38 -11.23 50.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.088 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -80.83 -19.06 45.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.779 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -87.02 -19.53 28.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.07 -20.93 43.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.31 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.73 -39.2 65.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 111.283 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.54 -29.25 21.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.0 t -72.39 -44.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.31 -42.36 93.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.615 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.4 73.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -27.52 19.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.515 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.43 ' O ' ' CD2' ' A' ' 96' ' ' PHE . 68.6 t80 -54.08 -49.03 69.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.891 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.6 -27.44 25.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.54 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.23 -20.24 60.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.619 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.3 OUTLIER -90.14 -38.84 13.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.933 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 101' ' ' HIS . 14.6 m-85 -55.61 -58.81 6.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.604 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -64.74 -28.15 69.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.704 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -72.88 -13.58 61.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.317 . . . . 0.0 110.883 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 58.7 m-80 -111.18 -10.75 14.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.472 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 2.4 p-10 99.56 33.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.907 0.754 . . . . 0.0 111.004 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.798 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.2 m-70 -115.11 56.43 0.98 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.552 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 54.4 Cg_endo -68.64 -15.14 40.84 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.659 2.239 . . . . 0.0 113.363 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.548 ' HB3' HD11 ' B' ' 5' ' ' ILE . 3.1 m-20 -53.86 -43.19 69.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.913 0.387 . . . . 0.0 110.606 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.684 ' O ' HG13 ' B' ' 19' ' ' VAL . 30.4 m-85 71.85 84.13 0.13 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.959 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 19.1 Cg_endo -59.25 155.67 39.14 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.772 2.314 . . . . 0.0 112.327 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.698 ' HB3' ' CG ' ' A' ' 74' ' ' LYS . . . -51.39 158.16 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.234 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.9 ttp-105 -134.66 141.38 46.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.131 0.491 . . . . 0.0 111.854 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.42 66.12 1.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.064 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.4 ' HA ' HG23 ' A' ' 77' ' ' VAL . 28.0 p -79.49 130.88 35.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.188 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.5 m -148.82 144.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.981 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.842 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 2.3 tt0 -86.68 94.6 9.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.817 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' A' ' 115' ' ' LEU . 36.0 m -73.49 159.9 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -70.94 -37.13 72.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.434 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -160.84 166.96 27.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.976 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.543 ' C ' HD11 ' C' ' 82' ' ' LEU . 1.4 mt -143.39 155.71 60.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.673 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.34 135.85 70.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.563 2.175 . . . . 0.0 112.018 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.681 ' HB3' HG13 ' A' ' 119' ' ' VAL . 1.4 tppt? 69.62 20.36 7.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.18 26.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.118 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 117' ' ' LYS . 22.1 m -55.66 174.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.206 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.6 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -96.04 -15.13 43.14 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.569 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.623 HD22 ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -172.49 148.88 2.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.046 0.45 . . . . 0.0 111.168 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.716 ' O ' HD13 ' A' ' 123' ' ' ILE . 4.6 mt-10 -116.4 167.25 11.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.322 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.948 ' CG2' HG21 ' A' ' 58' ' ' VAL . 22.9 mm -141.88 131.87 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.206 0.527 . . . . 0.0 112.196 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.53 117.75 4.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.204 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -140.3 176.03 9.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.467 HG23 ' HG ' ' A' ' 29' ' ' LEU . 6.7 mt -119.88 154.69 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.038 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.859 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -139.37 150.75 45.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.908 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.948 HG11 HD21 ' B' ' 24' ' ' LEU . 33.0 m -125.1 126.67 71.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.665 ' HG3' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.042 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.766 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.819 0.342 . . . . 0.0 110.87 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.49 131.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.67 HD12 HG11 ' B' ' 19' ' ' VAL . 39.0 mm -58.96 155.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.542 HD12 ' CB ' ' B' ' 21' ' ' ALA . 31.6 mt -121.23 133.67 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.34 149.19 28.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.789 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.665 HG22 ' OE1' ' B' ' 20' ' ' GLN . 11.3 t -150.85 165.56 33.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.92 25.62 5.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.014 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.44 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 5.5 mmtp -110.13 -50.88 2.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.677 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.16 114.04 50.14 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.966 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.66 -12.5 36.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.35 2.034 . . . . 0.0 112.595 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.74 -169.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.548 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 62.18 -169.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.196 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.583 HG22 ' O ' ' B' ' 15' ' ' ILE . 2.3 mt 77.19 17.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.22 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.06 -127.91 2.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.225 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.51 33.94 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 112.892 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -175.85 156.78 1.85 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.85 0.357 . . . . 0.0 110.999 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 104' ' ' PHE . 35.1 m -92.27 152.59 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.064 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.665 ' OE1' HG22 ' B' ' 8' ' ' THR . 0.8 OUTLIER -56.88 -36.52 70.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 110.492 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.542 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . -176.58 163.15 2.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.037 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.494 HG13 HG21 ' B' ' 19' ' ' VAL . 0.2 OUTLIER -128.13 136.95 58.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.835 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.867 ' HA ' HG12 ' B' ' 28' ' ' VAL . 1.6 p30 -110.3 120.48 42.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.219 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.948 HD21 HG11 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -90.5 -20.77 22.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.18 -108.79 0.78 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.64 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -60.26 -29.32 68.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.04 0.448 . . . . 0.0 109.998 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.718 ' HG ' HG12 ' B' ' 128' ' ' VAL . 7.3 mp -126.37 115.15 19.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.795 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.894 HG23 ' HB3' ' B' ' 127' ' ' ALA . 0.9 OUTLIER -105.28 176.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.198 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.581 HD12 ' C ' ' B' ' 28' ' ' VAL . 4.7 mp -150.48 161.68 42.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.933 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.41 HG21 HD11 ' B' ' 62' ' ' ILE . 23.8 p -126.1 158.89 34.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.033 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.6 m -94.6 168.14 11.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.037 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.13 94.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.293 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.468 ' CG ' HG22 ' B' ' 58' ' ' VAL . 47.2 mm-40 -73.59 165.81 24.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 111.16 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.513 HG13 HG23 ' B' ' 36' ' ' VAL . 10.2 pt -150.03 143.03 16.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.992 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.52 ' HG2' HG23 ' B' ' 43' ' ' VAL . 73.7 Cg_endo -75.03 59.38 5.19 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.755 2.304 . . . . 0.0 112.898 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.513 HG23 HG13 ' B' ' 34' ' ' ILE . 46.3 t . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 121.297 0.57 . . . . 0.0 110.627 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.568 HG21 ' H ' ' B' ' 120' ' ' GLY . 11.1 p . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.475 0.179 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' B' ' 35' ' ' PRO . 31.3 Cg_exo -58.34 150.18 68.94 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.373 2.049 . . . . 0.0 112.036 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.5 -30.69 68.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.026 0.441 . . . . 0.0 110.921 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.1 OUTLIER -71.55 97.43 1.68 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.829 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.442 HD12 ' NE2' ' B' ' 50' ' ' GLN . 9.1 tp -42.02 -32.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.756 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.22 -48.67 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.827 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -60.47 -41.11 93.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.768 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.443 ' NE2' HD12 ' B' ' 121' ' ' LEU . 0.9 OUTLIER -69.97 -30.91 68.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.562 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.41 -37.57 71.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.257 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -79.01 -35.7 42.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -36.16 73.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.854 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.1 OUTLIER -74.78 -31.78 61.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 34.9 mt -72.69 -36.24 67.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.86 -44.25 73.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -58.71 -46.56 87.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.949 HG21 ' CG2' ' B' ' 123' ' ' ILE . 21.5 t -60.73 -31.87 50.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.949 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.588 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 3.3 tttt -80.66 -32.48 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -66.95 -35.95 81.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' B' ' 58' ' ' VAL . 5.8 mt -69.77 -45.21 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.838 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.77 HG22 ' HB3' ' B' ' 67' ' ' LEU . 11.0 mt -65.75 -35.34 74.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.47 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 -42.94 76.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.303 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -21.47 63.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.403 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.51 -28.2 20.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.698 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.85 54.42 0.36 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.649 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.77 ' HB3' HG22 ' B' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 157.96 23.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.84 0.353 . . . . 0.0 110.672 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.428 ' O ' HD23 ' B' ' 67' ' ' LEU . 2.1 p -115.29 156.92 24.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.222 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.827 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -58.06 -35.86 71.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.051 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.581 ' HB2' ' OD1' ' B' ' 100' ' ' ASN . . . -50.67 -26.75 5.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.413 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.557 ' CB ' HD21 ' B' ' 67' ' ' LEU . 4.7 m-20 -85.49 -18.68 32.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.361 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' B' ' 69' ' ' ALA . 0.5 OUTLIER -54.51 117.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 110.556 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.648 HG11 HD21 ' C' ' 24' ' ' LEU . 28.7 m -88.17 -33.7 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.876 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.701 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 4.2 tttm -128.32 169.83 13.78 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.79 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.442 HG22 ' HB2' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -170.02 112.86 0.47 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.86 0.362 . . . . 0.0 111.378 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' B' ' 124' ' ' GLU . 24.6 m -99.9 151.84 20.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.147 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.404 HG23 ' HA ' ' B' ' 109' ' ' CYS . 4.9 m -146.57 128.85 7.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.017 0.437 . . . . 0.0 111.901 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.529 ' HB2' HD21 ' B' ' 115' ' ' LEU . 4.0 m-85 -107.58 129.68 54.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.125 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.8 149.49 27.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.065 0.46 . . . . 0.0 111.774 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' B' ' 115' ' ' LEU . 12.3 mttt -88.45 -4.4 58.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.735 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.48 115.51 2.24 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.387 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.476 HD11 ' C ' ' C' ' 115' ' ' LEU . 3.2 mt -66.33 -11.28 50.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -80.8 -19.08 45.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -86.98 -19.57 28.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.172 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.08 -20.9 43.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.339 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.27 65.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.817 0.341 . . . . 0.0 111.289 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.51 -29.19 21.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' B' ' 92' ' ' TYR . 28.5 t -72.37 -44.94 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.36 -42.35 92.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.559 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.41 73.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -27.52 18.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.517 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.433 ' O ' ' CD2' ' B' ' 96' ' ' PHE . 68.6 t80 -54.06 -49.13 69.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.885 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.54 -27.45 25.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.54 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.16 -20.26 60.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.648 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.3 OUTLIER -90.13 -38.86 13.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.0 110.932 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' B' ' 101' ' ' HIS . 14.8 m-85 -55.55 -58.88 5.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.584 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -64.75 -28.11 69.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.743 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -72.87 -13.59 61.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 110.919 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.525 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 58.8 m-80 -111.13 -10.83 14.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.482 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.581 ' OD1' ' HB2' ' B' ' 70' ' ' ALA . 2.3 p-10 99.57 33.26 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.832 0.707 . . . . 0.0 110.99 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.827 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.2 m-70 -115.01 56.36 0.94 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.553 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.401 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 53.8 Cg_endo -68.65 -15.17 40.85 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 113.335 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.543 ' HB3' HD11 ' C' ' 5' ' ' ILE . 3.1 m-20 -53.91 -43.08 69.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.62 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.693 ' O ' HG13 ' C' ' 19' ' ' VAL . 30.3 m-85 71.77 84.15 0.13 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.966 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 19.1 Cg_endo -59.22 155.67 39.0 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.749 2.299 . . . . 0.0 112.358 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.701 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.32 158.34 0.84 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.291 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.432 ' HB3' ' CD2' ' C' ' 18' ' ' TYR . 2.9 ttp-105 -134.84 141.31 46.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.13 0.491 . . . . 0.0 111.838 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.39 66.03 1.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.11 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' CYS . . . . . 0.404 ' HA ' HG23 ' B' ' 77' ' ' VAL . 28.0 p -79.42 130.89 35.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.18 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 20.9 m -148.79 143.91 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.982 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.839 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 2.3 tt0 -86.45 94.33 9.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' B' ' 115' ' ' LEU . 35.8 m -73.29 159.87 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.842 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -70.93 -37.12 72.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.57 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -160.87 166.91 27.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.004 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.545 ' C ' HD11 ' A' ' 82' ' ' LEU . 1.4 mt -143.33 155.73 61.08 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.41 135.83 70.94 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.578 2.186 . . . . 0.0 112.031 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.674 ' HB3' HG13 ' B' ' 119' ' ' VAL . 1.4 tppt? 69.69 20.31 6.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.975 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.19 26.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' B' ' 117' ' ' LYS . 21.6 m -55.78 174.49 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 120' ' ' GLY . . . . . 0.568 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -96.08 -15.58 41.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.554 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.61 ' C ' HD22 ' B' ' 121' ' ' LEU . 0.0 OUTLIER -172.09 148.74 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 111.184 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.715 ' O ' HD13 ' B' ' 123' ' ' ILE . 4.5 mt-10 -116.4 167.23 11.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.264 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.949 ' CG2' HG21 ' B' ' 58' ' ' VAL . 22.6 mm -141.91 131.85 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.188 0.518 . . . . 0.0 112.219 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 124' ' ' GLU . . . . . 0.401 ' HG3' ' HB ' ' B' ' 76' ' ' THR . 0.0 OUTLIER -153.57 117.69 4.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.166 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -140.22 176.05 9.08 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.469 HG23 ' HG ' ' B' ' 29' ' ' LEU . 6.7 mt -119.86 154.68 22.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.072 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.894 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -139.36 150.82 45.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.833 0.349 . . . . 0.0 111.902 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 1.027 HG11 HD21 ' C' ' 24' ' ' LEU . 33.0 m -125.22 126.66 71.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.678 ' HG3' HD12 ' B' ' 67' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.07 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.794 HG21 HG21 ' B' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.845 0.355 . . . . 0.0 110.9 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.42 131.19 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.672 HD12 HG11 ' C' ' 19' ' ' VAL . 38.9 mm -58.94 155.15 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.536 HD12 ' CB ' ' C' ' 21' ' ' ALA . 31.3 mt -121.25 133.55 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.25 149.17 28.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.84 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.689 HG22 ' OE1' ' C' ' 20' ' ' GLN . 11.3 t -150.83 165.6 33.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.93 25.62 5.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.028 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.448 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 5.5 mmtp -110.11 -51.18 2.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.662 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.84 114.15 50.27 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.902 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.53 -12.57 36.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.369 2.046 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.406 ' O ' HD12 ' C' ' 15' ' ' ILE . . . -64.82 -169.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.14 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.547 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 62.24 -169.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.186 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.577 HG22 ' O ' ' C' ' 15' ' ' ILE . 2.3 mt 77.2 17.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.191 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.09 -128.0 2.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.23 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.4 33.88 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.728 2.285 . . . . 0.0 112.918 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.547 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -175.82 156.83 1.87 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.91 0.386 . . . . 0.0 110.987 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.693 HG13 ' O ' ' B' ' 104' ' ' PHE . 35.1 m -92.29 152.59 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.048 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.689 ' OE1' HG22 ' C' ' 8' ' ' THR . 0.8 OUTLIER -56.87 -36.54 70.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.439 . . . . 0.0 110.573 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.536 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . -176.26 163.09 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.934 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.478 HG13 HG21 ' C' ' 19' ' ' VAL . 0.2 OUTLIER -128.07 136.92 58.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.866 ' HA ' HG12 ' C' ' 28' ' ' VAL . 1.6 p30 -110.31 120.49 42.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.201 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 1.027 HD21 HG11 ' B' ' 128' ' ' VAL . 0.8 OUTLIER -90.57 -20.66 22.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.1 -108.67 0.77 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.664 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -60.42 -29.22 68.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.147 0.498 . . . . 0.0 110.072 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.709 ' HG ' HG12 ' C' ' 128' ' ' VAL . 7.3 mp -126.42 115.15 19.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.795 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.889 HG23 ' HB3' ' C' ' 127' ' ' ALA . 0.9 OUTLIER -105.31 176.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.203 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.581 HD12 ' C ' ' C' ' 28' ' ' VAL . 4.7 mp -150.56 161.64 42.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.3 p -126.22 158.99 34.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.006 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -94.64 167.99 11.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.1 94.8 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.251 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.453 ' CG ' HG22 ' C' ' 58' ' ' VAL . 47.2 mm-40 -73.59 165.78 24.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.204 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.541 ' HB ' HG11 ' C' ' 119' ' ' VAL . 10.3 pt -149.98 143.06 16.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.993 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.493 ' HG2' HG23 ' C' ' 43' ' ' VAL . 73.6 Cg_endo -75.01 59.31 5.16 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.782 2.321 . . . . 0.0 112.941 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.509 HG23 HG13 ' C' ' 34' ' ' ILE . 46.4 t . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 121.222 0.534 . . . . 0.0 110.612 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.585 HG21 ' H ' ' C' ' 120' ' ' GLY . 11.3 p . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.528 0.204 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' C' ' 35' ' ' PRO . 31.2 Cg_exo -58.42 150.21 69.42 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.355 2.037 . . . . 0.0 112.016 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.5 -30.7 68.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.034 0.445 . . . . 0.0 110.9 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.1 OUTLIER -71.51 97.41 1.66 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.807 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.45 HD12 ' NE2' ' C' ' 50' ' ' GLN . 9.2 tp -42.17 -32.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.754 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -48.68 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.791 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -60.47 -41.09 93.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.789 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.45 ' NE2' HD12 ' C' ' 47' ' ' ILE . 0.9 OUTLIER -69.96 -30.88 68.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.627 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.54 -37.63 71.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.192 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' C' ' 49' ' ' ALA . 3.5 ptm180 -79.0 -35.6 42.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -36.13 73.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.846 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.1 OUTLIER -74.89 -31.68 61.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.694 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 34.8 mt -72.74 -36.3 67.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.789 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.75 -44.27 74.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.951 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -58.71 -46.56 87.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.951 HG21 ' CG2' ' C' ' 123' ' ' ILE . 21.4 t -60.72 -31.93 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.607 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 3.3 tttt -80.61 -32.44 36.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -67.02 -35.94 81.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.023 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' C' ' 58' ' ' VAL . 5.9 mt -69.7 -45.32 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.762 HG22 ' HB3' ' C' ' 67' ' ' LEU . 10.9 mt -65.66 -35.32 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.9 75.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -21.54 63.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.409 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.43 -28.26 21.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.692 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.9 54.43 0.35 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.578 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.762 ' HB3' HG22 ' C' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 157.96 23.84 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.632 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 68' ' ' THR . . . . . 0.426 ' O ' HD23 ' C' ' 67' ' ' LEU . 2.1 p -115.37 156.88 24.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.188 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.816 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -58.05 -35.84 71.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.065 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.579 ' HB2' ' OD1' ' C' ' 100' ' ' ASN . . . -50.67 -26.62 5.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.548 ' CB ' HD21 ' C' ' 67' ' ' LEU . 4.7 m-20 -85.64 -18.69 32.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.323 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' C' ' 69' ' ' ALA . 0.5 OUTLIER -54.49 117.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.521 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.702 HG11 HD21 ' A' ' 24' ' ' LEU . 28.4 m -88.16 -33.73 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.874 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.692 ' CG ' ' HB3' ' C' ' 106' ' ' ALA . 4.2 tttm -128.27 169.75 13.84 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.811 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.442 HG22 ' HB2' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -169.95 112.94 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.852 0.358 . . . . 0.0 111.442 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -99.96 151.83 20.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.159 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.409 HG23 ' HA ' ' C' ' 109' ' ' CYS . 5.0 m -146.49 128.86 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.935 0.398 . . . . 0.0 112.004 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.504 ' HB2' HD21 ' C' ' 115' ' ' LEU . 4.1 m-85 -107.65 129.64 54.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.143 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.83 149.5 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.026 0.441 . . . . 0.0 111.772 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 80' ' ' LYS . . . . . 0.43 ' HG3' HD12 ' C' ' 115' ' ' LEU . 12.3 mttt -88.46 -4.53 58.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.773 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.21 115.44 2.31 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.384 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.543 HD11 ' C ' ' A' ' 115' ' ' LEU . 3.1 mt -66.35 -11.25 50.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.126 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -80.79 -19.1 45.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.817 0.342 . . . . 0.0 110.83 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -86.98 -19.55 28.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.223 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.07 -20.91 43.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.342 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.72 -39.2 65.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.837 0.351 . . . . 0.0 111.315 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -29.2 21.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.962 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' C' ' 92' ' ' TYR . 29.3 t -72.39 -45.01 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.32 -42.37 93.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.561 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.52 73.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.974 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -27.49 19.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.494 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.427 ' O ' ' CD2' ' C' ' 96' ' ' PHE . 68.8 t80 -54.08 -49.04 69.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.892 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.6 -27.47 25.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.542 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.16 -20.29 60.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.604 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.501 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 0.3 OUTLIER -90.19 -38.77 13.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.826 0.346 . . . . 0.0 110.954 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' C' ' 101' ' ' HIS . 14.7 m-85 -55.58 -58.85 6.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -64.7 -28.22 69.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.684 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -72.86 -13.54 61.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.783 0.325 . . . . 0.0 110.94 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.524 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 58.9 m-80 -111.11 -10.93 14.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.476 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.579 ' OD1' ' HB2' ' C' ' 70' ' ' ALA . 2.4 p-10 99.66 33.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.524 0.73 . . . . 0.0 110.95 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.816 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.2 m-70 -115.13 56.3 0.98 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.581 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.404 ' O ' ' CD2' ' C' ' 104' ' ' PHE . 53.9 Cg_endo -68.6 -15.21 41.06 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.659 2.239 . . . . 0.0 113.35 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.525 ' HB3' HD11 ' A' ' 5' ' ' ILE . 3.1 m-20 -53.81 -43.14 69.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 110.601 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.691 ' O ' HG13 ' A' ' 19' ' ' VAL . 30.4 m-85 71.8 84.12 0.13 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.988 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 19.0 Cg_endo -59.23 155.72 38.78 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.768 2.312 . . . . 0.0 112.298 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.692 ' HB3' ' CG ' ' C' ' 74' ' ' LYS . . . -51.4 158.1 0.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.253 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' A' ' 18' ' ' TYR . 2.9 ttp-105 -134.65 141.37 46.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.107 0.479 . . . . 0.0 111.827 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.42 66.11 1.47 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.063 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 109' ' ' CYS . . . . . 0.409 ' HA ' HG23 ' C' ' 77' ' ' VAL . 28.0 p -79.45 130.87 35.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.18 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 20.6 m -148.9 144.74 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.053 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.804 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.3 tt0 -87.02 94.51 9.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.76 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.42 HG21 ' HG ' ' C' ' 115' ' ' LEU . 36.0 m -73.43 159.89 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -70.97 -37.08 72.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.069 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.446 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -160.88 166.9 27.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.036 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' C' ' 78' ' ' PHE . 1.4 mt -143.35 155.72 61.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.743 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.39 135.91 71.26 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.577 2.184 . . . . 0.0 111.979 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.696 ' HB3' HG13 ' C' ' 119' ' ' VAL . 1.4 tppt? 69.6 20.38 7.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.938 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.16 26.31 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.095 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.696 HG13 ' HB3' ' C' ' 117' ' ' LYS . 21.9 m -55.67 174.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.246 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 120' ' ' GLY . . . . . 0.585 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -96.12 -15.22 42.55 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.537 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.624 ' C ' HD22 ' C' ' 121' ' ' LEU . 0.0 OUTLIER -172.18 148.74 2.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.993 0.425 . . . . 0.0 111.204 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.719 ' O ' HD13 ' C' ' 123' ' ' ILE . 4.6 mt-10 -116.33 167.31 11.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.289 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.951 ' CG2' HG21 ' C' ' 58' ' ' VAL . 22.8 mm -141.99 131.8 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.208 0.527 . . . . 0.0 112.177 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.52 117.75 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.166 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -140.28 176.03 9.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.459 HG23 ' HG ' ' C' ' 29' ' ' LEU . 6.7 mt -119.85 154.67 22.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.038 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.889 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -139.4 150.79 45.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.839 0.352 . . . . 0.0 111.884 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 1.01 HG11 HD21 ' A' ' 24' ' ' LEU . 33.0 m -125.14 126.69 71.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.092 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.671 ' HG3' HD12 ' C' ' 67' ' ' LEU . 0.4 OUTLIER -94.89 43.5 1.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.095 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.935 179.867 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.486 HG23 ' CD2' ' A' ' 24' ' ' LEU . 18.8 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.006 0.431 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HD23 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.694 HD11 ' OD1' ' C' ' 103' ' ' ASN . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.719 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 14' ' ' ALA . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.843 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' C' ' 104' ' ' PHE . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 29' ' ' LEU . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.565 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.916 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.446 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 25' ' ' GLY . 9.1 m-80 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 128' ' ' VAL . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.959 HG23 ' HB3' ' A' ' 127' ' ' ALA . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 62' ' ' ILE . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.693 ' HB ' HG11 ' A' ' 119' ' ' VAL . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 34' ' ' ILE . 32.9 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.607 0.241 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.406 ' OE1' HD13 ' A' ' 47' ' ' ILE . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.782 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 54' ' ' SER . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.719 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 30' ' ' THR . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.844 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 126' ' ' ILE . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 128' ' ' VAL . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 125' ' ' ALA . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 108' ' ' SER . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 122' ' ' GLU . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.712 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 85' ' ' PHE . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' A' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.475 ' OH ' HG21 ' A' ' 75' ' ' THR . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.743 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.844 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 m-70 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.691 ' CG ' HD11 ' B' ' 5' ' ' ILE . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.731 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 72' ' ' ILE . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 76' ' ' THR . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.596 ' HB3' HD12 ' C' ' 82' ' ' LEU . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 78' ' ' PHE . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 34' ' ' ILE . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.795 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' ' 35' ' ' PRO . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.725 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' ILE . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.959 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 73' ' ' VAL . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB3' HD21 ' A' ' 67' ' ' LEU . 14.1 ptm180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.481 HG23 ' CD2' ' B' ' 24' ' ' LEU . 19.0 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.977 0.417 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.568 ' OE1' HD23 ' B' ' 24' ' ' LEU . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.691 HD11 ' CG ' ' A' ' 103' ' ' ASN . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.722 ' HB2' ' CG1' ' B' ' 61' ' ' ILE . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.786 HD13 ' O ' ' B' ' 14' ' ' ALA . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.84 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 104' ' ' PHE . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 11' ' ' ALA . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.53 HG23 HD13 ' B' ' 29' ' ' LEU . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.562 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.515 HD13 HG12 ' B' ' 128' ' ' VAL . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' B' ' 127' ' ' ALA . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.631 HD12 ' N ' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.737 HG21 HD11 ' B' ' 62' ' ' ILE . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.484 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.716 ' HB ' HG11 ' B' ' 119' ' ' VAL . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.565 HG23 HG13 ' B' ' 34' ' ' ILE . 33.3 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.791 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.3 p . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.595 0.236 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' B' ' 47' ' ' ILE . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' B' ' 95' ' ' PHE . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' B' ' 54' ' ' SER . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.722 ' CG1' ' HB2' ' B' ' 11' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.737 HD11 HG21 ' B' ' 30' ' ' THR . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.697 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.477 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 126' ' ' ILE . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.635 HG13 HG22 ' B' ' 128' ' ' VAL . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.681 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.727 HG23 ' HB2' ' B' ' 125' ' ' ALA . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 108' ' ' SER . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.702 HG13 ' O ' ' B' ' 122' ' ' GLU . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.507 HG11 ' HD1' ' B' ' 85' ' ' PHE . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.507 ' HD1' HG11 ' B' ' 79' ' ' VAL . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' B' ' 75' ' ' THR . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.742 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.851 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.8 m-70 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.7 ' CG ' HD11 ' C' ' 5' ' ' ILE . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.72 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' B' ' 72' ' ' ILE . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.431 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.845 ' O ' HG23 ' B' ' 76' ' ' THR . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.729 HG11 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.543 ' HB3' HD12 ' A' ' 82' ' ' LEU . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HB2' ' B' ' 78' ' ' PHE . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.482 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.716 HG11 ' HB ' ' B' ' 34' ' ' ILE . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 120' ' ' GLY . . . . . 0.791 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.468 HD11 ' HG3' ' B' ' 35' ' ' PRO . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.702 ' O ' HG13 ' B' ' 77' ' ' VAL . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.56 ' CG2' HG21 ' B' ' 58' ' ' VAL . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 72' ' ' ILE . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.997 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.635 HG22 HG13 ' B' ' 73' ' ' VAL . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' B' ' 67' ' ' LEU . 14.1 ptm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.48 HG23 ' CD2' ' C' ' 24' ' ' LEU . 19.0 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 4' ' ' GLN . . . . . 0.562 ' OE1' HD23 ' C' ' 24' ' ' LEU . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.7 HD11 ' CG ' ' B' ' 103' ' ' ASN . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.497 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.721 ' HB2' ' CG1' ' C' ' 61' ' ' ILE . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.67 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.779 HD13 ' O ' ' C' ' 14' ' ' ALA . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.826 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' B' ' 104' ' ' PHE . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.535 HG23 HD13 ' C' ' 29' ' ' LEU . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.559 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.898 HD13 ' O ' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.482 HD13 HG12 ' C' ' 128' ' ' VAL . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.63 ' N ' HD12 ' C' ' 29' ' ' LEU . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.711 HG21 HD11 ' C' ' 62' ' ' ILE . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.691 ' HB ' HG11 ' C' ' 119' ' ' VAL . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.561 HG23 HG13 ' C' ' 34' ' ' ILE . 32.8 t . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.789 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.3 p . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.582 0.229 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' C' ' 51' ' ' ALA . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.401 ' OE1' HD13 ' C' ' 47' ' ' ILE . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 54' ' ' SER . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.721 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.711 HD11 HG21 ' C' ' 30' ' ' THR . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.694 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.464 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.484 HG23 ' O ' ' C' ' 126' ' ' ILE . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.636 HG13 HG22 ' C' ' 128' ' ' VAL . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' ALA . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.847 HG23 ' O ' ' C' ' 108' ' ' SER . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.714 HG13 ' O ' ' C' ' 122' ' ' GLU . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.729 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' C' ' 85' ' ' PHE . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' C' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.479 ' OH ' HG21 ' C' ' 75' ' ' THR . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.749 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.851 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.8 m-70 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.694 ' OD1' HD11 ' A' ' 5' ' ' ILE . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.704 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' C' ' 72' ' ' ILE . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 108' ' ' SER . . . . . 0.847 ' O ' HG23 ' C' ' 76' ' ' THR . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.712 HG11 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.731 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.581 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' C' ' 78' ' ' PHE . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.582 ' O ' HG22 ' C' ' 119' ' ' VAL . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.484 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' C' ' 34' ' ' ILE . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 120' ' ' GLY . . . . . 0.789 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' C' ' 35' ' ' PRO . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 77' ' ' VAL . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' HB ' ' C' ' 76' ' ' THR . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.705 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' ILE . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.956 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.636 HG22 HG13 ' C' ' 73' ' ' VAL . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' C' ' 67' ' ' LEU . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.044 HG21 HG21 ' C' ' 128' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.817 0.341 . . . . 0.0 110.954 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 132.97 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.82 HD13 ' OD1' ' C' ' 103' ' ' ASN . 4.3 mp -55.2 152.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 21' ' ' ALA . 32.7 mt -103.43 139.26 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.58 117.18 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.58 HG22 ' OE1' ' A' ' 20' ' ' GLN . 11.7 t -133.88 165.99 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.33 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.52 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 7.6 mmtp -121.62 -36.89 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.032 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.872 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.82 172.05 4.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 18.9 Cg_endo -59.39 -16.05 33.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.695 2.263 . . . . 0.0 112.85 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 77.24 151.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 111.317 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.603 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -104.67 120.71 41.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 14' ' ' ALA . 22.1 mm -133.51 15.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.072 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.85 -146.17 4.73 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.987 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' C' ' 104' ' ' PHE . 93.9 Cg_endo -87.39 44.53 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.536 2.158 . . . . 0.0 112.901 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.541 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -163.19 154.59 17.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.867 0.365 . . . . 0.0 111.033 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.465 HG13 ' O ' ' C' ' 103' ' ' ASN . 27.3 m -110.91 169.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.58 ' OE1' HG22 ' A' ' 8' ' ' THR . 56.2 mt-30 -58.96 -53.53 57.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' A' ' 6' ' ' ILE . . . -170.69 -177.09 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG21 ' HB ' ' C' ' 73' ' ' VAL . 9.3 m -142.33 132.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.166 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.645 ' HA ' HG23 ' A' ' 28' ' ' VAL . 20.8 t70 -103.47 105.01 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.567 ' CD2' HG23 ' A' ' 3' ' ' THR . 19.5 mt -80.51 -16.36 54.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.371 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.05 -104.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.28 -29.62 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.166 0.508 . . . . 0.0 110.21 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 28' ' ' VAL . 5.0 tt -135.2 140.65 45.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.95 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 9.9 p -120.04 160.88 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.123 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' HE2' ' C' ' 74' ' ' LYS . 2.9 mp -145.87 127.37 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 p -106.5 136.11 46.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.983 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.812 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 1.1 t -59.36 179.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.07 95.55 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.244 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.805 ' HG2' HG22 ' A' ' 58' ' ' VAL . 2.0 mp0 -62.07 138.14 58.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.275 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.524 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -146.04 170.18 8.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.679 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -54.26 -137.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.313 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.411 -178.926 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.81 140.71 81.58 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.592 2.195 . . . . 0.0 112.433 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.37 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.4 93.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.791 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.616 HD13 ' NE2' ' A' ' 50' ' ' GLN . 28.9 mm -38.93 -33.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.5 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.08 -48.07 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.696 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.82 -55.04 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.616 ' NE2' HD13 ' A' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.498 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -71.93 -44.36 63.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -63.33 -51.54 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.79 -31.18 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.871 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.3 m -68.31 -46.48 70.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.29 -26.36 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.971 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -57.95 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.108 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.8 OUTLIER -54.88 -30.36 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.985 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 54' ' ' SER . 39.6 t -62.1 -34.54 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 110.517 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.99 -31.75 34.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.755 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -62.23 -38.55 89.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 11' ' ' ALA . 6.1 mt -70.93 -46.2 69.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.667 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.8 -32.62 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.28 -38.4 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.9 -24.33 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.145 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.71 -22.11 21.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.914 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.43 64.8 0.83 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' OD2' ' A' ' 71' ' ' ASP . 14.7 mt -158.9 139.2 12.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 44.0 p -96.12 145.0 25.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -46.29 -31.75 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.518 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -59.77 -18.48 43.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.715 ' OD2' HD22 ' A' ' 67' ' ' LEU . 3.2 p-10 -88.58 -21.27 24.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 126' ' ' ILE . 64.3 mt -59.35 109.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.528 ' HB ' HG21 ' B' ' 22' ' ' VAL . 2.8 m -81.11 -36.84 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.971 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HE2' HD22 ' B' ' 29' ' ' LEU . 8.6 mtmt -130.55 175.23 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.319 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.61 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 13.4 t 177.71 110.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 111.36 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.18 130.1 41.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.33 91.6 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 76' ' ' THR . 5.3 m-85 -91.7 143.77 26.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.089 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.514 HG11 ' CD1' ' A' ' 85' ' ' PHE . 35.3 m -139.31 150.0 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.023 0.44 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.57 ' HE2' HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -90.95 -4.31 56.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.796 178.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.04 108.99 0.46 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.687 HD12 ' HB3' ' B' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.25 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.97 -24.64 59.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 110.282 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -78.46 -15.34 58.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.832 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.514 ' CD1' HG11 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -55.52 -22.98 23.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.01 -46.63 84.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 -33.22 19.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 84' ' ' ASP . 32.6 t -70.08 -49.66 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.673 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 36.4 t-20 -63.09 -35.99 82.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.14 94.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.016 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.62 -31.1 19.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.448 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 48.7 t80 -57.67 -51.35 69.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.727 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 7.7 tt0 -73.32 -27.34 61.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -25.11 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.765 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -79.31 -41.02 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.934 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 95' ' ' PHE . 57.1 m-85 -56.45 -50.43 71.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.8 69.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.77 58.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.402 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -110.54 -6.88 14.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.7 m-20 89.68 30.9 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.8 t60 -127.57 72.17 77.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.96 -11.04 16.65 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.539 2.159 . . . . 0.0 112.153 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.844 ' OD1' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.03 42.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.447 . . . . 0.0 110.439 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CG ' ' HA ' ' B' ' 17' ' ' PRO . 92.7 m-85 70.99 144.0 0.1 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.515 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 104' ' ' PHE . 2.0 Cg_endo -82.96 165.82 15.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.057 2.504 . . . . 0.0 112.0 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' B' ' 31' ' ' SER . . . -115.28 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.779 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.61 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -169.27 -163.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.944 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.36 107.57 16.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.493 ' O ' HG13 ' A' ' 110' ' ' VAL . 5.3 m -95.25 129.16 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.798 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.519 HG12 HD23 ' B' ' 115' ' ' LEU . 7.0 m -157.79 165.71 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.949 0.405 . . . . 0.0 111.666 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 9.4 tt0 -99.75 102.87 14.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.777 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.82 162.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -79.07 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.685 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -140.81 168.08 20.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.722 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.622 HD22 ' HB2' ' A' ' 122' ' ' GLU . 3.0 mt -144.19 161.9 42.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 119' ' ' VAL . 32.7 Cg_exo -59.7 135.94 67.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.649 2.233 . . . . 0.0 112.183 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.58 18.28 7.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.87 17.47 8.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 116' ' ' PRO . 21.2 m -55.18 172.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.61 14.08 20.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.011 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 121' ' ' LEU . 4.5 pp -176.64 149.0 0.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.123 0.487 . . . . 0.0 111.508 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.622 ' HB2' HD22 ' A' ' 115' ' ' LEU . 44.5 tt0 -150.86 137.85 19.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.918 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 76' ' ' THR . 3.4 mp -144.67 138.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 112.101 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.36 149.91 28.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.569 ' C ' HD13 ' A' ' 126' ' ' ILE . . . -132.03 125.99 32.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.414 . . . . 0.0 112.027 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.569 HD13 ' C ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -114.42 132.16 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.876 178.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.95 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -121.74 153.14 38.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.063 0.459 . . . . 0.0 112.038 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.111 HG21 HG21 ' B' ' 3' ' ' THR . 34.6 m -124.13 116.37 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.464 ' CD ' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' THR . . . . . 1.111 HG21 HG21 ' A' ' 128' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.72 132.95 5.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.844 HD13 ' OD1' ' A' ' 103' ' ' ASN . 4.4 mp -55.2 152.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' B' ' 21' ' ' ALA . 32.7 mt -103.43 139.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.59 117.19 9.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.575 HG23 ' H ' ' B' ' 11' ' ' ALA . 11.6 t -133.86 165.97 23.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.804 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 26.32 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.58 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 7.6 mmtt -121.6 -36.61 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -68.18 172.03 4.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 18.7 Cg_endo -59.33 -16.06 32.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.632 2.221 . . . . 0.0 112.905 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 77.23 151.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.411 . . . . 0.0 111.281 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.586 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.597 HG22 ' O ' ' B' ' 15' ' ' ILE . 22.1 mm -133.53 15.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.79 -146.1 4.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.509 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . 94.4 Cg_endo -87.38 44.49 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.637 2.224 . . . . 0.0 112.916 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -163.26 154.53 17.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.915 0.388 . . . . 0.0 110.991 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 103' ' ' ASN . 27.2 m -110.83 169.25 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.304 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.575 ' OE1' HG22 ' B' ' 8' ' ' THR . 56.3 mt-30 -59.04 -53.58 56.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -170.46 -177.16 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.528 HG21 ' HB ' ' A' ' 73' ' ' VAL . 9.2 m -142.31 132.63 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.636 ' HA ' HG23 ' B' ' 28' ' ' VAL . 20.8 t70 -103.51 104.94 15.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.554 ' CD2' HG23 ' B' ' 3' ' ' THR . 19.5 mt -80.44 -16.4 54.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -103.96 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.972 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.3 -29.56 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.082 0.468 . . . . 0.0 110.189 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.644 HD23 ' N ' ' B' ' 28' ' ' VAL . 5.0 tt -135.3 140.65 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.52 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.945 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 9.9 p -120.07 160.84 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.657 HD22 ' HE2' ' A' ' 74' ' ' LYS . 2.9 mp -145.87 127.42 15.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.68 136.36 46.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.06 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.843 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 1.1 t -59.69 179.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.01 95.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.834 ' HG2' HG22 ' B' ' 58' ' ' VAL . 2.0 mp0 -61.92 138.09 58.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.553 HG22 ' O ' ' B' ' 121' ' ' LEU . 0.7 OUTLIER -145.98 170.19 8.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.665 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 52.2 Cg_exo -54.34 -137.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.069 2.513 . . . . 0.0 112.319 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -178.922 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.83 140.7 81.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.662 2.242 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.39 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.35 93.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.618 HD13 ' NE2' ' B' ' 50' ' ' GLN . 28.9 mm -38.94 -33.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.443 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.02 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.91 -54.98 38.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.618 ' NE2' HD13 ' B' ' 47' ' ' ILE . 15.8 pt20 -61.1 -26.16 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.522 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -72.18 -44.2 63.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.901 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.33 -51.54 65.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.22 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.9 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.3 m -68.4 -46.37 70.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.32 -26.38 68.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.963 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -57.99 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.163 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.8 OUTLIER -54.86 -30.39 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.931 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.9 HG23 ' O ' ' B' ' 54' ' ' SER . 39.7 t -62.13 -34.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.95 -31.77 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -62.21 -38.49 89.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.571 HG12 ' HB2' ' B' ' 11' ' ' ALA . 6.0 mt -71.25 -46.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.83 -32.53 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.656 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.31 -38.49 60.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.34 65.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.136 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 -22.06 21.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.919 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 64.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.711 HD22 ' OD2' ' B' ' 71' ' ' ASP . 14.7 mt -158.91 139.2 12.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.022 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' B' ' 71' ' ' ASP . 43.8 p -96.1 144.99 25.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -46.26 -31.79 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.574 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -59.83 -18.27 42.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.425 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.711 ' OD2' HD22 ' B' ' 67' ' ' LEU . 3.3 p-10 -88.65 -21.23 24.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.714 0.292 . . . . 0.0 110.87 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.512 HG23 ' O ' ' B' ' 126' ' ' ILE . 64.4 mt -59.4 109.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.874 0.369 . . . . 0.0 110.839 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' C' ' 22' ' ' VAL . 2.8 m -81.12 -36.88 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.969 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.667 ' HE2' HD22 ' C' ' 29' ' ' LEU . 8.6 mtmt -130.56 175.22 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.302 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.612 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 13.4 t 177.67 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 111.337 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.753 ' O ' HG23 ' B' ' 123' ' ' ILE . 0.0 OUTLIER -70.15 130.12 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.325 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.43 91.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.404 ' CZ ' ' HB ' ' B' ' 76' ' ' THR . 5.3 m-85 -91.66 143.72 26.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.151 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' B' ' 85' ' ' PHE . 35.1 m -139.32 150.01 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.072 0.463 . . . . 0.0 111.718 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' B' ' 47' ' ' ILE . 0.3 OUTLIER -90.94 -4.12 56.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.839 178.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -169.23 109.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.321 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' C' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.32 20.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.228 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.94 -24.63 59.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.275 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.547 ' O ' HG23 ' B' ' 88' ' ' VAL . 0.6 OUTLIER -78.52 -15.37 58.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.51 ' CD1' HG11 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -55.46 -23.03 23.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.267 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.99 -46.62 84.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.09 -33.23 19.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 84' ' ' ASP . 33.0 t -70.09 -49.59 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.721 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 36.4 t-20 -63.21 -35.96 82.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.04 94.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.67 -31.19 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 48.8 t80 -57.62 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 7.7 tt0 -73.41 -27.32 61.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.462 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -25.19 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.786 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -79.25 -41.09 28.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.97 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 95' ' ' PHE . 57.2 m-85 -56.36 -50.45 71.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.818 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.82 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.945 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.8 58.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.98 14.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.505 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 11.7 m-20 89.78 30.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.502 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.8 t60 -127.48 72.19 77.52 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.98 -11.02 16.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.537 2.158 . . . . 0.0 112.153 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.98 ' ND2' HD13 ' C' ' 5' ' ' ILE . 2.9 t-20 -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.03 0.443 . . . . 0.0 110.445 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.506 ' CG ' ' HA ' ' C' ' 17' ' ' PRO . 92.7 m-85 70.89 144.04 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.494 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 104' ' ' PHE . 2.0 Cg_endo -83.02 165.85 14.91 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.016 2.477 . . . . 0.0 111.917 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.835 ' HB1' ' HB2' ' C' ' 31' ' ' SER . . . -115.27 137.95 51.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.612 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -169.23 -163.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.38 107.56 16.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.571 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' CYS . . . . . 0.504 ' O ' HG13 ' B' ' 110' ' ' VAL . 5.2 m -95.21 129.11 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.845 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.533 HG12 HD23 ' C' ' 115' ' ' LEU . 7.0 m -157.71 165.59 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.409 . . . . 0.0 111.632 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 9.3 tt0 -99.57 102.86 14.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.785 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.73 162.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -79.05 -46.27 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -140.82 168.11 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' B' ' 122' ' ' GLU . 3.0 mt -144.21 161.87 42.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.549 ' O ' HG22 ' B' ' 119' ' ' VAL . 33.1 Cg_exo -59.62 135.97 67.82 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.157 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.53 18.29 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.88 17.46 8.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.549 HG22 ' O ' ' B' ' 116' ' ' PRO . 21.5 m -55.18 172.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.082 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.63 13.95 20.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.025 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.553 ' O ' HG22 ' B' ' 34' ' ' ILE . 4.6 pp -176.62 148.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.615 ' HB2' HD22 ' B' ' 115' ' ' LEU . 44.5 tt0 -150.78 137.88 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.935 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.753 HG23 ' O ' ' B' ' 76' ' ' THR . 3.4 mp -144.68 138.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 112.14 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.33 149.81 28.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.627 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.572 ' C ' HD13 ' B' ' 126' ' ' ILE . . . -131.94 126.01 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.956 0.408 . . . . 0.0 112.041 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.572 HD13 ' C ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -114.33 132.14 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.947 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.945 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -121.75 153.2 38.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.096 0.474 . . . . 0.0 111.994 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 1.04 HG21 HG21 ' C' ' 3' ' ' THR . 34.7 m -124.26 116.32 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.474 ' CD ' HD21 ' B' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 3' ' ' THR . . . . . 1.04 HG21 HG21 ' B' ' 128' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.842 0.353 . . . . 0.0 110.947 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.68 132.97 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.98 HD13 ' ND2' ' B' ' 103' ' ' ASN . 4.4 mp -55.18 152.35 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' C' ' 21' ' ' ALA . 32.5 mt -103.46 139.23 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -143.59 117.2 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.572 HG22 ' OE1' ' C' ' 20' ' ' GLN . 11.7 t -133.93 165.96 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.32 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.542 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 7.6 mmtp -121.59 -36.84 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.01 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.885 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.93 172.02 4.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.885 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 18.8 Cg_endo -59.31 -16.11 32.83 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.675 2.25 . . . . 0.0 112.899 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 77.24 151.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.977 0.418 . . . . 0.0 111.304 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.591 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -104.69 120.76 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.002 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.591 HD13 ' O ' ' C' ' 14' ' ' ALA . 22.5 mm -133.54 15.81 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.81 -146.14 4.73 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.001 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' B' ' 104' ' ' PHE . 94.1 Cg_endo -87.37 44.51 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 112.917 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.532 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -163.23 154.55 17.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.026 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' B' ' 103' ' ' ASN . 27.2 m -110.87 169.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.36 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.572 ' OE1' HG22 ' C' ' 8' ' ' THR . 56.2 mt-30 -59.02 -53.38 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' C' ' 6' ' ' ILE . . . -170.6 -177.19 2.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' B' ' 73' ' ' VAL . 9.2 m -142.24 132.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.64 ' HA ' HG23 ' C' ' 28' ' ' VAL . 20.8 t70 -103.48 104.98 15.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.549 ' CD2' HG23 ' C' ' 3' ' ' THR . 19.5 mt -80.47 -16.35 54.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.0 -104.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.27 -29.59 33.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.648 HD23 ' N ' ' C' ' 28' ' ' VAL . 5.0 tt -135.22 140.64 45.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.575 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.947 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 9.9 p -120.04 160.84 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.667 HD22 ' HE2' ' B' ' 74' ' ' LYS . 2.9 mp -145.85 127.45 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 p -106.6 136.31 46.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 31' ' ' SER . . . . . 0.835 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 1.1 t -59.62 179.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.13 95.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.25 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.821 ' HG2' HG22 ' C' ' 58' ' ' VAL . 2.0 mp0 -62.06 138.17 58.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.259 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.528 HG22 ' O ' ' C' ' 121' ' ' LEU . 0.7 OUTLIER -146.0 170.23 8.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.654 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' C' ' 34' ' ' ILE . 52.4 Cg_exo -54.36 -137.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.063 2.509 . . . . 0.0 112.29 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.427 -178.928 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.762 0.315 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.88 140.74 81.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.637 2.225 . . . . 0.0 112.358 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.45 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.083 0.468 . . . . 0.0 110.913 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 93.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.621 HD13 ' NE2' ' C' ' 50' ' ' GLN . 28.7 mm -39.01 -33.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.447 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.711 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -54.96 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.621 ' NE2' HD13 ' C' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.474 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -72.07 -44.36 63.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.36 -51.5 65.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.24 72.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.354 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.903 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.3 m -68.35 -46.4 70.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.58 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.32 -26.36 68.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -58.01 4.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 57' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.8 OUTLIER -54.9 -30.36 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.984 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.903 HG23 ' O ' ' C' ' 54' ' ' SER . 39.6 t -62.07 -34.62 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -80.86 -31.79 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -62.26 -38.52 89.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' C' ' 11' ' ' ALA . 6.0 mt -70.95 -46.31 68.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.89 -32.54 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.33 -38.39 60.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.093 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.31 65.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.139 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.1 21.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.87 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.445 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.712 HD22 ' OD2' ' C' ' 71' ' ' ASP . 14.7 mt -158.9 139.23 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.036 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.0 p -96.16 145.01 25.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -46.21 -31.81 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.598 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -59.74 -18.28 41.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.477 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.712 ' OD2' HD22 ' C' ' 67' ' ' LEU . 3.3 p-10 -88.78 -21.16 23.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 110.896 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.503 HG23 ' O ' ' C' ' 126' ' ' ILE . 64.2 mt -59.39 109.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.496 ' HB ' HG21 ' A' ' 22' ' ' VAL . 2.8 m -81.04 -36.88 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.933 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.646 ' HE2' HD22 ' A' ' 29' ' ' LEU . 8.6 mtmt -130.6 175.25 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.369 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 13.4 t 177.72 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.313 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.754 ' O ' HG23 ' C' ' 123' ' ' ILE . 0.0 OUTLIER -70.23 130.2 41.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 t -115.43 91.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' C' ' 76' ' ' THR . 5.3 m-85 -91.64 143.8 26.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.143 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' C' ' 85' ' ' PHE . 34.8 m -139.35 149.98 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 111.691 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' C' ' 47' ' ' ILE . 0.3 OUTLIER -90.99 -4.23 56.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.816 178.813 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.1 109.04 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.305 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.685 HD12 ' HB3' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -58.58 -17.19 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.0 -24.62 59.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.297 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.546 ' O ' HG23 ' C' ' 88' ' ' VAL . 0.6 OUTLIER -78.5 -15.28 58.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.827 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.513 ' CD1' HG11 ' C' ' 79' ' ' VAL . 0.3 OUTLIER -55.53 -23.04 24.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.261 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.63 84.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.01 -33.32 19.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.969 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.546 HG23 ' O ' ' C' ' 84' ' ' ASP . 32.8 t -70.06 -49.66 54.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 89' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 36.4 t-20 -63.12 -35.99 82.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.337 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.22 -42.14 94.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.973 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.68 -31.16 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.567 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.457 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 48.7 t80 -57.64 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 7.7 tt0 -73.36 -27.37 61.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -25.19 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.77 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -79.32 -41.03 28.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 95' ' ' PHE . 56.7 m-85 -56.38 -50.4 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.781 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -28.72 69.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.954 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.91 -3.78 58.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.362 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.91 14.79 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 11.7 m-20 89.79 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.822 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.499 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.8 t60 -127.55 72.17 77.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.705 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.03 -10.97 16.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.495 2.13 . . . . 0.0 112.146 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.82 ' OD1' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.998 0.428 . . . . 0.0 110.429 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.512 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 92.8 m-85 70.91 144.1 0.1 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.42 ' HB2' HG22 ' C' ' 75' ' ' THR . 2.0 Cg_endo -83.05 165.85 14.87 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.028 2.485 . . . . 0.0 111.948 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.812 ' HB1' ' HB2' ' A' ' 31' ' ' SER . . . -115.29 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.6 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -169.22 -163.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.4 p -111.36 107.48 16.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.589 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 109' ' ' CYS . . . . . 0.502 ' O ' HG13 ' C' ' 110' ' ' VAL . 5.2 m -95.21 129.18 42.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.788 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.514 HG12 HD23 ' A' ' 115' ' ' LEU . 7.1 m -157.82 165.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 9.4 tt0 -99.76 102.86 14.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.75 162.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -79.08 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.671 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -140.83 168.09 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' C' ' 122' ' ' GLU . 3.0 mt -144.21 161.82 43.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.913 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.544 ' O ' HG22 ' C' ' 119' ' ' VAL . 33.7 Cg_exo -59.52 135.99 68.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.608 2.205 . . . . 0.0 112.221 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.51 18.29 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 61.8 17.55 8.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.544 HG22 ' O ' ' C' ' 116' ' ' PRO . 21.2 m -55.18 172.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.065 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.79 14.08 19.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.988 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.534 ' O ' HD12 ' C' ' 121' ' ' LEU . 4.6 pp -176.62 148.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.489 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.619 ' HB2' HD22 ' C' ' 115' ' ' LEU . 44.4 tt0 -150.83 137.93 19.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.754 HG23 ' O ' ' C' ' 76' ' ' THR . 3.4 mp -144.74 138.35 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.11 0.481 . . . . 0.0 112.142 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.3 149.82 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.648 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.573 ' C ' HD13 ' C' ' 126' ' ' ILE . . . -131.98 126.13 33.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 112.004 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.573 HD13 ' C ' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -114.41 132.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 178.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.947 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -121.76 153.11 38.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.082 0.468 . . . . 0.0 112.029 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 3' ' ' THR . 34.6 m -124.15 116.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.47 ' CD ' HD21 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -106.27 56.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.99 0.424 . . . . 0.0 110.892 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.76 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.771 0.319 . . . . 0.0 110.86 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.83 107.65 13.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.971 HD11 HG11 ' A' ' 19' ' ' VAL . 1.7 tp -54.31 125.88 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.311 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 23' ' ' ASP . 22.4 mm -83.67 137.49 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.46 92.4 1.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -115.24 163.65 15.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.08 29.06 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -113.94 -41.78 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.807 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -72.34 178.16 1.49 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 32.3 Cg_exo -57.56 -13.83 14.98 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.808 2.339 . . . . 0.0 113.006 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 77.39 163.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 0.0 111.075 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -117.17 125.0 50.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.407 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 15' ' ' ILE . 3.3 mp -144.89 18.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.025 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.1 -137.25 3.45 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.429 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' C' ' 92' ' ' TYR . 89.8 Cg_endo -88.82 32.42 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.795 2.33 . . . . 0.0 113.23 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' C' ' 105' ' ' PRO . 0.7 OUTLIER -152.49 -178.03 6.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.392 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.971 HG11 HD11 ' A' ' 5' ' ' ILE . 10.3 m -136.68 179.79 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.689 ' NE2' ' HB3' ' A' ' 11' ' ' ALA . 15.6 mm-40 -68.86 -49.58 57.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.517 ' HB3' HG13 ' A' ' 6' ' ' ILE . . . -174.48 -177.42 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.48 HG11 ' HB ' ' C' ' 73' ' ' VAL . 4.7 m -137.88 141.58 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.714 ' HB2' HD11 ' A' ' 6' ' ' ILE . 53.5 t0 -117.97 91.01 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.59 HD11 ' CG1' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -65.95 -20.97 66.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.073 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.06 -108.85 0.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.846 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -57.85 -30.17 65.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.096 0.474 . . . . 0.0 110.229 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.411 HD23 ' C ' ' A' ' 27' ' ' LEU . 7.6 tt -124.71 124.55 42.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.736 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.072 HG23 ' HB3' ' A' ' 127' ' ' ALA . 3.4 m -105.54 171.61 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.594 HD22 ' HD2' ' C' ' 74' ' ' LYS . 1.3 mp -144.7 164.81 29.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.751 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 p -138.47 143.9 39.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.911 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.842 ' HB3' ' HB1' ' C' ' 106' ' ' ALA . 3.4 p -72.47 179.55 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.27 95.43 0.96 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.377 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.581 ' OE1' HD11 ' A' ' 61' ' ' ILE . 14.4 mm-40 -66.93 165.13 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.342 . . . . 0.0 111.015 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.645 ' HB ' HG11 ' A' ' 119' ' ' VAL . 8.6 pt -159.5 157.59 26.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.294 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 35.5 Cg_exo -58.35 -15.05 22.51 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.075 2.517 . . . . 0.0 113.024 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.606 ' CG2' HD12 ' A' ' 34' ' ' ILE . 44.0 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 0.0 111.181 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 35' ' ' PRO . 14.7 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.84 0.353 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 43' ' ' VAL . 51.8 Cg_exo -54.33 153.04 23.55 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.652 2.235 . . . . 0.0 112.414 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.74 60.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -55.02 95.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.868 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.604 HD13 ' OD2' ' A' ' 84' ' ' ASP . 8.2 tp -40.34 -32.98 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.797 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.62 -48.14 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.83 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -61.48 -48.51 80.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.827 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.636 ' HG3' HD21 ' A' ' 121' ' ' LEU . 18.8 pt20 -65.97 -33.78 76.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.481 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -71.89 -35.88 69.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.008 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.61 -45.67 78.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.681 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -39.39 85.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.656 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.809 ' O ' HG23 ' A' ' 58' ' ' VAL . 4.7 t -69.75 -32.16 70.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.656 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.632 HD13 ' CE2' ' A' ' 95' ' ' PHE . 17.3 mt -70.94 -44.97 65.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.53 -42.27 96.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.824 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -58.95 -38.16 78.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 54' ' ' SER . 12.4 t -61.56 -38.0 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.762 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -80.68 -31.02 36.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.763 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -58.72 -41.0 85.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.599 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 15.4 mt -71.54 -42.17 72.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.615 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.583 ' CD1' HD11 ' A' ' 72' ' ' ILE . 17.1 mt -68.48 -33.05 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.583 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.5 -42.82 67.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.224 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -21.36 63.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.404 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.39 -28.85 19.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.703 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.99 52.82 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.61 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 129' ' ' ARG . 6.2 mt -161.28 -172.69 3.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 0.0 110.731 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -141.75 165.09 28.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.779 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -59.69 -32.33 70.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.876 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.762 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -56.67 -26.49 56.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.473 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -82.67 -22.64 34.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.22 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.583 HD11 ' CD1' ' A' ' 62' ' ' ILE . 89.7 mt -53.59 110.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.921 0.391 . . . . 0.0 111.243 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 74' ' ' LYS . 34.4 m -78.65 -46.08 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.838 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.608 ' HD2' HD22 ' B' ' 29' ' ' LEU . 7.5 mttt -119.55 154.36 34.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.345 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.663 HG23 ' HB2' ' A' ' 105' ' ' PRO . 76.1 p -153.77 102.37 2.53 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.622 HG22 ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -69.38 124.32 23.56 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -111.07 111.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.622 ' CE1' HG22 ' A' ' 76' ' ' THR . 13.7 m-30 -109.88 133.41 53.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.995 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.686 HG11 ' HD1' ' A' ' 85' ' ' PHE . 3.1 m -130.34 150.43 34.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.1 0.476 . . . . 0.0 111.858 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.6 -1.38 58.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.889 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.31 118.95 0.31 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.477 HD23 HG21 ' A' ' 79' ' ' VAL . 51.6 mt -62.29 -14.55 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.23 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -74.14 -21.83 59.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.301 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.604 ' OD2' HD13 ' A' ' 47' ' ' ILE . 3.7 m-20 -87.0 -18.71 30.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.991 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.686 ' HD1' HG11 ' A' ' 79' ' ' VAL . 1.3 t80 -53.48 -30.98 43.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.8 -34.91 72.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.287 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.76 -42.78 13.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.324 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.1 -45.84 79.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -63.0 -38.57 91.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.081 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.21 73.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.499 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -15.08 32.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.545 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.517 ' HH ' ' HZ ' ' A' ' 96' ' ' PHE . 12.2 t80 -81.05 -38.39 27.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 111.338 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' A' ' 104' ' ' PHE . 2.4 tt0 -83.2 -27.97 29.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.516 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.83 -24.39 55.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.773 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.632 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -85.31 -37.44 19.96 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.719 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.521 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 3.9 m-85 -55.76 -55.19 35.32 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.168 0.509 . . . . 0.0 109.998 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -32.66 72.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.27 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.01 -6.72 57.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.385 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.579 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 1.5 t-20 -111.91 -4.62 14.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.494 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 15.6 m120 84.47 32.21 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.772 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.866 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 m-70 -115.81 53.16 0.93 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.605 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 58.4 Cg_endo -70.56 -22.27 28.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.539 2.159 . . . . 0.0 112.47 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.617 ' OD1' HD13 ' B' ' 5' ' ' ILE . 2.2 t-20 -50.14 -33.07 17.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.897 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.594 ' HB2' HG13 ' B' ' 19' ' ' VAL . 13.2 m-85 64.54 131.01 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.193 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.663 ' HB2' HG23 ' A' ' 75' ' ' THR . 94.2 Cg_endo -88.51 133.58 2.72 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.978 2.452 . . . . 0.0 112.615 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.964 ' HB2' HG23 ' B' ' 19' ' ' VAL . . . -97.87 129.09 44.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.058 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -162.73 -164.37 0.99 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.996 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.69 114.13 24.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.113 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.415 ' O ' HG13 ' A' ' 110' ' ' VAL . 14.6 m -92.85 138.36 31.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.219 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.771 HG12 HD23 ' B' ' 115' ' ' LEU . 23.1 m -156.73 158.38 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.986 0.422 . . . . 0.0 111.634 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.862 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 3.6 tt0 -98.99 86.29 3.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.655 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.488 HG21 HD21 ' A' ' 115' ' ' LEU . 29.0 m -57.14 156.91 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.233 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.875 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -65.74 -36.14 82.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.04 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.53 -178.25 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.735 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.783 HD23 HG12 ' C' ' 110' ' ' VAL . 27.7 mt -148.83 152.42 37.13 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.837 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.551 ' O ' HG22 ' A' ' 119' ' ' VAL . 25.9 Cg_endo -62.12 137.72 68.23 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.504 2.136 . . . . 0.0 112.162 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.409 ' HB3' HG13 ' A' ' 119' ' ' VAL . 1.1 tptt 75.17 14.1 3.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.29 13.62 8.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.188 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.645 HG11 ' HB ' ' A' ' 34' ' ' ILE . 23.0 m -58.1 156.72 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.727 0.299 . . . . 0.0 110.947 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.38 10.06 65.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.999 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.636 HD21 ' HG3' ' A' ' 50' ' ' GLN . 4.1 pp -177.26 148.26 0.59 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.085 0.469 . . . . 0.0 111.372 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.755 ' HB2' HD22 ' A' ' 115' ' ' LEU . 2.1 tt0 -126.41 150.3 48.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.087 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.679 HG21 HG21 ' A' ' 58' ' ' VAL . 29.5 mt -128.92 121.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.146 0.498 . . . . 0.0 112.277 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -130.88 144.77 51.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' A' ' 75' ' ' THR . . . -168.8 167.42 11.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 28' ' ' VAL . 1.4 mt -123.9 145.21 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.645 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 1.072 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -123.87 148.03 47.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.115 0.483 . . . . 0.0 111.868 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.752 HG21 HG21 ' B' ' 3' ' ' THR . 28.7 m -114.87 142.88 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.859 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 67' ' ' LEU . 3.2 ttm-85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.939 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.752 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.818 0.342 . . . . 0.0 110.868 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.83 107.64 13.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.963 HD11 HG11 ' B' ' 19' ' ' VAL . 1.7 tp -54.35 125.87 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.221 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' B' ' 23' ' ' ASP . 22.1 mm -83.58 137.55 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.147 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.48 92.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -115.21 163.7 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.13 29.04 3.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.448 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 0.0 OUTLIER -113.98 -41.92 3.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.872 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.705 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -71.94 178.15 1.43 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.705 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 32.3 Cg_exo -57.63 -13.8 15.14 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.787 2.325 . . . . 0.0 113.008 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 77.39 163.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.896 0.379 . . . . 0.0 111.032 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.423 ' C ' HD12 ' B' ' 15' ' ' ILE . . . -117.18 125.06 50.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.377 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.589 HG22 ' O ' ' B' ' 15' ' ' ILE . 3.3 mp -144.94 18.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.993 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.06 -137.23 3.45 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.44 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -88.81 32.4 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.844 2.363 . . . . 0.0 113.269 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -152.49 -178.09 6.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.427 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 106' ' ' ALA . 10.5 m -136.64 179.7 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.21 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.686 ' NE2' ' HB3' ' B' ' 11' ' ' ALA . 15.6 mm-40 -68.82 -49.75 55.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.944 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.509 ' HB3' HG13 ' B' ' 6' ' ' ILE . . . -174.6 -177.42 1.18 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.219 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.489 HG23 HD13 ' B' ' 29' ' ' LEU . 4.6 m -137.99 141.59 38.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.714 ' HB2' HD11 ' B' ' 6' ' ' ILE . 53.6 t0 -117.94 91.05 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.975 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.578 HD11 ' CG1' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -66.04 -20.94 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.01 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.05 -108.83 0.78 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.881 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -57.82 -30.26 65.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.048 0.452 . . . . 0.0 110.194 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.411 HD23 ' C ' ' B' ' 27' ' ' LEU . 7.6 tt -124.65 124.54 42.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.726 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.051 HG23 ' HB3' ' B' ' 127' ' ' ALA . 3.4 m -105.46 171.62 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.608 HD22 ' HD2' ' A' ' 74' ' ' LYS . 1.3 mp -144.69 164.8 29.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.7 p -138.46 143.87 39.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.818 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 3.3 p -71.93 179.67 3.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.801 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.31 95.49 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.369 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.575 ' OE1' HD11 ' B' ' 61' ' ' ILE . 14.3 mm-40 -66.95 165.09 16.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 111.004 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.608 HD12 ' CG2' ' B' ' 36' ' ' VAL . 8.7 pt -159.48 157.64 27.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.301 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' B' ' 43' ' ' VAL . 36.5 Cg_exo -58.41 -15.05 22.79 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.094 2.529 . . . . 0.0 113.045 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.608 ' CG2' HD12 ' B' ' 34' ' ' ILE . 44.1 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.397 . . . . 0.0 111.17 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' B' ' 35' ' ' PRO . 14.6 t . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.852 0.358 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' B' ' 43' ' ' VAL . 51.8 Cg_exo -54.32 153.09 23.37 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.586 2.191 . . . . 0.0 112.424 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.8 60.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.838 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.2 OUTLIER -55.04 95.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.91 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.626 HD13 ' OD2' ' B' ' 84' ' ' ASP . 8.2 tp -40.34 -32.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.86 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.57 -48.12 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -61.5 -48.55 80.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.86 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.667 ' HG3' HD21 ' B' ' 121' ' ' LEU . 18.8 pt20 -65.86 -33.9 76.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.542 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -71.75 -35.88 70.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.912 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.6 -45.71 78.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.687 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -39.32 85.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.714 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.803 ' O ' HG23 ' B' ' 58' ' ' VAL . 4.8 t -69.74 -32.23 70.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.648 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.709 HD13 ' CE2' ' B' ' 95' ' ' PHE . 17.3 mt -70.93 -44.97 65.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.59 -42.23 96.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.804 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -58.95 -38.11 78.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.854 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.803 HG23 ' O ' ' B' ' 54' ' ' SER . 12.3 t -61.6 -38.01 79.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.793 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -80.67 -30.99 36.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.799 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -58.58 -41.02 84.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.94 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.646 HG12 ' HB2' ' B' ' 11' ' ' ALA . 15.7 mt -71.51 -42.04 72.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.551 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.568 ' CD1' HD11 ' B' ' 72' ' ' ILE . 17.0 mt -68.41 -33.13 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.48 -42.76 67.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.258 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -21.36 63.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.366 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.39 -28.83 19.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.71 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.99 52.71 0.38 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.619 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' B' ' 129' ' ' ARG . 6.2 mt -161.27 -172.73 3.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.689 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 22.5 p -141.69 165.05 28.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.765 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.856 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -59.68 -32.37 70.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.856 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.743 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -56.63 -26.56 56.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.478 ' CG ' HD22 ' B' ' 67' ' ' LEU . 0.9 OUTLIER -82.42 -22.72 35.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.174 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.568 HD11 ' CD1' ' B' ' 62' ' ' ILE . 89.7 mt -53.61 110.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 111.24 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.492 HG23 ' N ' ' B' ' 74' ' ' LYS . 34.4 m -78.66 -46.11 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.89 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.591 ' HD2' HD22 ' C' ' 29' ' ' LEU . 7.5 mttt -119.56 154.4 33.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.316 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.661 HG23 ' HB2' ' B' ' 105' ' ' PRO . 75.8 p -153.78 102.32 2.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.616 HG22 ' CE1' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -69.28 124.29 23.45 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.065 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -111.04 111.84 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.616 ' CE1' HG22 ' B' ' 76' ' ' THR . 13.6 m-30 -109.85 133.36 53.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.998 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.686 HG11 ' HD1' ' B' ' 85' ' ' PHE . 3.2 m -130.33 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.14 0.495 . . . . 0.0 111.866 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.69 -1.41 58.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.849 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.27 118.91 0.31 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.488 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.474 HD23 HG21 ' B' ' 79' ' ' VAL . 52.4 mt -62.25 -14.56 39.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.263 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -74.07 -21.89 59.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.91 0.386 . . . . 0.0 110.314 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.626 ' OD2' HD13 ' B' ' 47' ' ' ILE . 3.7 m-20 -87.02 -18.71 29.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.686 ' HD1' HG11 ' B' ' 79' ' ' VAL . 1.3 t80 -53.44 -31.0 43.42 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.133 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.95 72.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.278 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.67 -42.81 13.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.338 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.44 HG22 HG13 ' B' ' 47' ' ' ILE . 26.5 t -69.08 -45.83 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.212 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -62.99 -38.51 91.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.09 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.2 73.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.503 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.94 -14.96 33.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.561 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' B' ' 96' ' ' PHE . 12.3 t80 -81.16 -38.36 27.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 111.264 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' B' ' 104' ' ' PHE . 2.4 tt0 -83.21 -27.89 29.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.545 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.87 -24.31 55.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.794 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.709 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -85.44 -37.35 19.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.672 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.521 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 3.9 m-85 -55.85 -55.18 35.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.172 0.51 . . . . 0.0 109.954 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -32.71 72.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.254 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.92 -6.82 57.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.385 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.585 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 1.5 t-20 -111.84 -4.63 14.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.499 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 15.6 m120 84.38 32.24 0.05 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.786 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.856 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.8 m-70 -115.82 53.13 0.93 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.618 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 58.5 Cg_endo -70.54 -22.33 28.65 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.565 2.177 . . . . 0.0 112.428 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.615 ' OD1' HD13 ' C' ' 5' ' ' ILE . 2.2 t-20 -50.09 -33.18 17.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.93 0.395 . . . . 0.0 110.865 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.609 ' HB2' HG13 ' C' ' 19' ' ' VAL . 13.1 m-85 64.64 130.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.2 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.661 ' HB2' HG23 ' B' ' 75' ' ' THR . 94.0 Cg_endo -88.48 133.64 2.74 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.004 2.469 . . . . 0.0 112.579 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 1.014 ' HB2' HG23 ' C' ' 19' ' ' VAL . . . -97.91 128.98 44.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.546 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -162.61 -164.33 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.958 179.325 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.73 114.13 24.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.076 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' CYS . . . . . 0.404 ' O ' HG13 ' B' ' 110' ' ' VAL . 14.5 m -92.84 138.42 31.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.21 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.789 HG12 HD23 ' C' ' 115' ' ' LEU . 23.0 m -156.74 158.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.985 0.421 . . . . 0.0 111.659 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.86 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 3.6 tt0 -99.05 86.31 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.648 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.481 HG21 HD21 ' B' ' 115' ' ' LEU . 29.3 m -57.14 156.93 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -65.74 -36.18 82.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.5 -178.22 7.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.728 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.771 HD23 HG12 ' A' ' 110' ' ' VAL . 27.7 mt -148.84 152.43 37.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.819 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.562 ' O ' HG22 ' B' ' 119' ' ' VAL . 26.1 Cg_endo -62.1 137.73 68.39 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.509 2.139 . . . . 0.0 112.18 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.403 ' HB3' HG13 ' B' ' 119' ' ' VAL . 1.1 tptt 75.13 14.12 3.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.249 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.28 13.64 8.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.142 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.589 HG11 ' HB ' ' B' ' 34' ' ' ILE . 23.0 m -58.08 156.84 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.55 9.8 64.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.019 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.667 HD21 ' HG3' ' B' ' 50' ' ' GLN . 4.1 pp -176.87 148.18 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.02 0.438 . . . . 0.0 111.39 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.754 ' HB2' HD22 ' B' ' 115' ' ' LEU . 2.1 tt0 -126.34 150.28 48.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.082 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.69 HG21 HG21 ' B' ' 58' ' ' VAL . 29.6 mt -128.96 121.34 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 112.31 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 124' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' B' ' 76' ' ' THR . 4.3 tp10 -130.77 144.82 51.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -168.8 167.48 11.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.439 HG22 ' O ' ' B' ' 28' ' ' VAL . 1.4 mt -123.89 145.2 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.661 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 1.051 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -123.86 147.94 47.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.111 0.481 . . . . 0.0 111.867 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.762 HG21 HG21 ' C' ' 3' ' ' THR . 28.9 m -114.75 142.8 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.887 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.484 ' HB2' HD11 ' B' ' 67' ' ' LEU . 3.2 ttm-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.762 HG21 HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.85 107.65 13.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.973 HD11 HG11 ' C' ' 19' ' ' VAL . 1.7 tp -54.37 125.93 10.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.237 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.701 HD11 ' HB2' ' C' ' 23' ' ' ASP . 22.2 mm -83.6 137.51 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.44 92.41 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -115.22 163.68 15.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.13 29.12 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.453 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 0.0 OUTLIER -113.96 -41.73 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.84 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.714 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -72.4 178.18 1.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.899 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.714 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 32.3 Cg_exo -57.56 -13.78 14.85 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.801 2.334 . . . . 0.0 113.003 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 77.35 163.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.114 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -117.09 125.04 50.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.469 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.592 HG22 ' O ' ' C' ' 15' ' ' ILE . 3.3 mp -144.93 18.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.007 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.09 -137.28 3.45 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.439 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 17' ' ' PRO . . . . . 0.447 ' HB2' ' CD1' ' B' ' 92' ' ' TYR . 88.0 Cg_endo -88.74 32.36 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.782 2.322 . . . . 0.0 113.254 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' B' ' 105' ' ' PRO . 0.7 OUTLIER -152.48 -178.03 6.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.868 0.366 . . . . 0.0 111.354 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 1.014 HG23 ' HB2' ' B' ' 106' ' ' ALA . 10.4 m -136.71 179.72 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.193 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.685 ' NE2' ' HB3' ' C' ' 11' ' ' ALA . 15.6 mm-40 -68.87 -49.62 56.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.969 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.521 ' HB3' HG13 ' C' ' 6' ' ' ILE . . . -174.42 -177.47 1.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.471 HG23 HD13 ' C' ' 29' ' ' LEU . 4.7 m -137.92 141.56 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.157 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.701 ' HB2' HD11 ' C' ' 6' ' ' ILE . 53.7 t0 -117.95 91.04 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.594 HD11 ' CG1' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -65.96 -21.0 66.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.06 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.1 -108.82 0.78 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.893 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -57.9 -30.2 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.015 0.436 . . . . 0.0 110.189 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.409 HD23 ' C ' ' C' ' 27' ' ' LEU . 7.6 tt -124.67 124.57 42.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.745 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 1.005 HG23 ' HB3' ' C' ' 127' ' ' ALA . 3.3 m -105.53 171.64 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.591 HD22 ' HD2' ' B' ' 74' ' ' LYS . 1.3 mp -144.72 164.79 29.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 15.3 p -138.44 143.76 39.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 31' ' ' SER . . . . . 0.825 ' HB3' ' HB1' ' B' ' 106' ' ' ALA . 3.4 p -72.18 179.54 3.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.27 95.47 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.359 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.573 ' OE1' HD11 ' C' ' 61' ' ' ILE . 14.3 mm-40 -66.96 165.19 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.635 ' HB ' HG11 ' C' ' 119' ' ' VAL . 8.7 pt -159.56 157.57 26.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.292 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.504 ' HB2' ' HA ' ' C' ' 43' ' ' VAL . 36.2 Cg_exo -58.4 -15.03 22.68 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.066 2.511 . . . . 0.0 112.997 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.607 ' CG2' HD12 ' C' ' 34' ' ' ILE . 43.9 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.39 . . . . 0.0 111.186 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.504 ' HA ' ' HB2' ' C' ' 35' ' ' PRO . 14.7 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.788 0.328 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' C' ' 43' ' ' VAL . 51.7 Cg_exo -54.39 153.12 23.62 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.608 2.206 . . . . 0.0 112.404 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.64 60.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -55.01 95.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.888 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.642 HD13 ' OD2' ' C' ' 84' ' ' ASP . 8.2 tp -40.35 -32.94 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.891 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.63 -48.17 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -61.44 -48.51 80.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.849 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.666 ' HG3' HD21 ' C' ' 121' ' ' LEU . 18.7 pt20 -65.99 -33.9 76.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -71.84 -35.93 70.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.996 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.64 -45.63 78.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.696 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -39.33 85.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.682 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.799 ' O ' HG23 ' C' ' 58' ' ' VAL . 4.8 t -69.74 -32.2 70.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.641 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.681 HD13 ' CE2' ' C' ' 95' ' ' PHE . 17.3 mt -70.99 -44.94 64.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.741 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.58 -42.26 96.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -58.94 -38.15 78.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.799 HG23 ' O ' ' C' ' 54' ' ' SER . 12.3 t -61.58 -37.97 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.774 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -80.69 -31.02 36.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.784 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -58.67 -41.07 85.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.601 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 15.7 mt -71.4 -42.17 73.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.507 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.587 ' CD1' HD11 ' C' ' 72' ' ' ILE . 16.8 mt -68.38 -33.22 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.593 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.37 -42.83 67.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.291 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.25 -21.3 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.409 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.45 -28.81 19.45 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.714 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.04 52.72 0.37 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.579 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' C' ' 129' ' ' ARG . 6.2 mt -161.26 -172.65 3.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 110.73 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -141.77 165.05 28.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.857 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -59.71 -32.29 70.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.903 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.751 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -56.72 -26.47 57.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.481 ' CG ' HD22 ' C' ' 67' ' ' LEU . 0.9 OUTLIER -82.59 -22.67 34.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.587 HD11 ' CD1' ' C' ' 62' ' ' ILE . 90.0 mt -53.62 110.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.191 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.488 HG23 ' N ' ' C' ' 74' ' ' LYS . 34.4 m -78.66 -46.05 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.9 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.594 ' HD2' HD22 ' A' ' 29' ' ' LEU . 7.5 mttt -119.61 154.38 34.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.295 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.647 HG23 ' HB2' ' C' ' 105' ' ' PRO . 76.7 p -153.75 102.33 2.53 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.614 HG22 ' CE1' ' C' ' 78' ' ' PHE . 0.2 OUTLIER -69.35 124.32 23.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 11.0 t -111.03 111.78 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.614 ' CE1' HG22 ' C' ' 76' ' ' THR . 13.6 m-30 -109.83 133.45 53.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.989 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.669 HG11 ' HD1' ' C' ' 85' ' ' PHE . 3.1 m -130.38 150.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.132 0.492 . . . . 0.0 111.831 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.64 -1.28 57.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.946 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.32 118.86 0.31 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.431 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.472 HD23 HG21 ' C' ' 79' ' ' VAL . 52.1 mt -62.17 -14.6 39.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.3 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -74.09 -21.84 59.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.868 0.366 . . . . 0.0 110.286 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.642 ' OD2' HD13 ' C' ' 47' ' ' ILE . 3.7 m-20 -87.06 -18.69 29.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.973 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.669 ' HD1' HG11 ' C' ' 79' ' ' VAL . 1.3 t80 -53.49 -30.94 43.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.141 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.95 72.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.257 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.67 -42.83 13.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.358 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.442 HG22 HG13 ' C' ' 47' ' ' ILE . 27.1 t -69.11 -45.76 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.209 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -63.05 -38.51 91.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.044 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.32 -35.3 73.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.487 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.83 -14.99 33.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.511 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.527 ' HH ' ' HZ ' ' C' ' 96' ' ' PHE . 12.3 t80 -81.14 -38.36 27.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.0 111.286 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 93' ' ' GLU . . . . . 0.45 ' HG3' ' CE1' ' C' ' 104' ' ' PHE . 2.4 tt0 -83.2 -27.94 29.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.508 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.88 -24.36 55.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.752 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.681 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -85.37 -37.36 19.97 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.713 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.527 ' HZ ' ' HH ' ' C' ' 92' ' ' TYR . 3.9 m-85 -55.83 -55.17 35.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.132 0.492 . . . . 0.0 109.984 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -32.65 72.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.214 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -6.72 56.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.424 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.576 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 1.5 t-20 -111.86 -4.65 14.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.548 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 15.5 m120 84.4 32.17 0.05 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.81 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.857 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.8 m-70 -115.79 53.18 0.93 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.587 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.403 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 58.5 Cg_endo -70.57 -22.22 28.64 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.519 2.146 . . . . 0.0 112.483 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.613 ' OD1' HD13 ' A' ' 5' ' ' ILE . 2.2 t-20 -50.18 -33.11 18.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 110.879 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.611 ' HB2' HG13 ' A' ' 19' ' ' VAL . 13.1 m-85 64.59 131.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.184 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.647 ' HB2' HG23 ' C' ' 75' ' ' THR . 94.1 Cg_endo -88.5 133.62 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.962 2.442 . . . . 0.0 112.638 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.963 ' HB2' HG23 ' A' ' 19' ' ' VAL . . . -97.94 129.01 44.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.031 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.534 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -162.61 -164.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 179.298 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.68 114.11 24.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 109' ' ' CYS . . . . . 0.416 ' O ' HG13 ' C' ' 110' ' ' VAL . 14.6 m -92.85 138.4 31.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.297 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.783 HG12 HD23 ' A' ' 115' ' ' LEU . 23.1 m -156.69 158.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.97 0.414 . . . . 0.0 111.682 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.875 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 3.6 tt0 -99.0 86.32 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.644 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.487 HG21 HD21 ' C' ' 115' ' ' LEU . 29.1 m -57.12 156.88 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.219 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.86 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -65.71 -36.21 82.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.51 -178.2 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.767 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.789 HD23 HG12 ' B' ' 110' ' ' VAL . 27.8 mt -148.85 152.42 37.07 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.825 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.55 ' O ' HG22 ' C' ' 119' ' ' VAL . 25.8 Cg_endo -62.13 137.71 68.12 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.523 2.149 . . . . 0.0 112.151 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.422 ' HB3' HG13 ' C' ' 119' ' ' VAL . 1.1 tptt 75.16 14.12 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.219 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.25 13.63 8.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.152 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.635 HG11 ' HB ' ' C' ' 34' ' ' ILE . 23.3 m -58.06 156.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.771 0.32 . . . . 0.0 110.965 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.48 10.16 64.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.044 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.666 HD21 ' HG3' ' C' ' 50' ' ' GLN . 4.1 pp -177.33 148.18 0.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.063 0.459 . . . . 0.0 111.388 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.766 ' HB2' HD22 ' C' ' 115' ' ' LEU . 2.1 tt0 -126.3 150.34 48.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.096 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.683 HG21 HG21 ' C' ' 58' ' ' VAL . 29.3 mt -128.98 121.31 54.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.502 . . . . 0.0 112.322 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 124' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' C' ' 76' ' ' THR . 4.3 tp10 -130.79 144.75 51.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' C' ' 75' ' ' THR . . . -168.75 167.5 11.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.431 HG22 ' O ' ' C' ' 28' ' ' VAL . 1.4 mt -123.96 145.27 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.624 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 1.005 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -123.89 147.95 47.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.125 0.488 . . . . 0.0 111.848 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.76 HG21 HG21 ' A' ' 3' ' ' THR . 28.8 m -114.76 142.87 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.853 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' C' ' 67' ' ' LEU . 3.2 ttm-85 -123.07 47.54 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.926 0.393 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 24' ' ' LEU . 90.1 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.961 0.41 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.537 ' O ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 60.57 -173.31 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.873 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 4' ' ' GLN . 1.1 tp 57.67 120.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.907 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.516 HG21 HG22 ' A' ' 61' ' ' ILE . 13.7 mt -148.67 134.93 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.252 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.8 138.81 48.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 0.0 111.238 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.661 HG21 ' CG1' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -139.07 148.03 42.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.838 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.01 37.16 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -137.88 -45.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.992 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.7 110.95 7.43 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.33 -14.68 45.4 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.517 2.145 . . . . 0.0 112.36 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.77 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.198 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.555 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 61.22 -165.19 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.358 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 15' ' ' ILE . 21.8 mt 77.38 17.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.252 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.02 -135.2 3.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.009 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.84 43.13 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.658 2.239 . . . . 0.0 112.568 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.555 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -177.33 -176.3 0.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.859 0.362 . . . . 0.0 110.983 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.781 HG13 ' HB2' ' C' ' 104' ' ' PHE . 16.6 m -115.26 165.25 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -56.38 -48.25 77.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 110.63 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.548 ' CB ' HG21 ' A' ' 61' ' ' ILE . . . -161.41 -175.96 5.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.523 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.476 HG11 ' O ' ' C' ' 73' ' ' VAL . 30.6 m -132.09 131.47 61.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.975 0.417 . . . . 0.0 111.42 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB2' HG12 ' A' ' 6' ' ' ILE . 61.7 t0 -105.85 86.83 2.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.056 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.613 ' HA ' HG23 ' A' ' 3' ' ' THR . 31.7 mt -60.79 -19.58 59.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.154 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.52 -108.49 0.88 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.669 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.553 ' C ' HD12 ' A' ' 27' ' ' LEU . 34.8 m-80 -57.63 -30.22 65.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.182 0.515 . . . . 0.0 109.948 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 27' ' ' LEU . 3.2 mp -124.16 136.62 54.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.506 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.977 HG23 ' HB3' ' A' ' 127' ' ' ALA . 0.7 OUTLIER -104.7 177.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.253 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.464 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -157.15 133.6 9.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.4 p -110.08 138.78 45.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 0.0 111.118 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.79 175.66 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.84 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.85 84.09 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.298 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.11 152.81 12.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 0.0 111.167 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.639 HD12 ' CG2' ' A' ' 36' ' ' VAL . 10.3 pt -132.07 142.1 43.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.023 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HG2' HG23 ' A' ' 43' ' ' VAL . 90.7 Cg_endo -79.9 53.97 4.99 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.95 2.433 . . . . 0.0 112.975 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.639 ' CG2' HD12 ' A' ' 34' ' ' ILE . 45.5 t . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.167 0.508 . . . . 0.0 110.575 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.682 HG23 ' HG3' ' A' ' 50' ' ' GLN . 7.3 p . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.45 0.167 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -50.97 139.61 41.15 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.345 2.03 . . . . 0.0 112.174 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.39 72.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.046 0.451 . . . . 0.0 111.009 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.38 91.66 1.02 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.853 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.0 mm -41.42 -35.05 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.155 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.78 -45.49 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.434 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.81 95.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.408 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.682 ' HG3' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -68.39 -32.11 71.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.189 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.56 -38.45 74.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.004 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -70.83 -48.96 51.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.51 -28.18 68.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.779 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -66.84 -45.61 77.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.795 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.25 -22.28 64.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 59' ' ' LYS . 2.7 mm-40 -72.9 -54.59 8.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.417 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 58' ' ' VAL . 29.1 p30 -55.72 -30.92 61.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.285 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 54' ' ' SER . 40.3 t -69.32 -50.36 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.929 0.395 . . . . 0.0 110.721 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 56' ' ' GLU . 2.8 ptmm? -67.39 -33.78 75.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.694 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.56 -40.92 84.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.963 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.661 ' CG1' HG21 ' A' ' 8' ' ' THR . 5.3 mt -64.99 -56.56 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.653 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.637 HD12 ' CB ' ' A' ' 127' ' ' ALA . 5.2 tt -64.43 -26.32 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.812 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.44 -41.04 33.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 110.376 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -15.49 63.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.723 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.22 -26.99 17.93 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.954 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.09 44.32 0.49 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.381 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.867 HD11 ' HB2' ' A' ' 129' ' ' ARG . 4.5 mt -157.2 139.58 14.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.878 0.371 . . . . 0.0 110.851 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 p -92.73 159.32 15.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.882 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -57.31 -34.79 69.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.692 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -49.71 -27.39 4.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.35 -28.05 47.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.081 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.483 HD12 ' HB1' ' A' ' 69' ' ' ALA . 78.8 mt -44.48 118.47 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.925 0.393 . . . . 0.0 110.984 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.696 HG11 HG13 ' A' ' 128' ' ' VAL . 10.3 m -83.62 -46.3 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.134 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.563 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 6.8 tttm -141.67 147.73 37.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.604 0.24 . . . . 0.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.761 HG21 ' OH ' ' A' ' 92' ' ' TYR . 2.3 t -141.59 117.51 10.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.396 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 108' ' ' SER . 0.2 OUTLIER -85.98 162.57 18.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.523 HG12 HG13 ' A' ' 79' ' ' VAL . 20.4 t -150.8 103.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.932 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.498 ' CD2' HG11 ' C' ' 110' ' ' VAL . 9.5 m-85 -94.06 96.24 9.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.214 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.854 HG12 HD23 ' A' ' 121' ' ' LEU . 26.9 m -97.23 148.48 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.662 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.43 ' HG3' HD12 ' A' ' 115' ' ' LEU . 7.7 mttt -79.96 -5.06 54.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.017 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.97 143.05 9.17 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.468 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 82' ' ' LEU . 8.8 mt -85.82 2.13 46.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.24 -19.98 26.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.584 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.91 -29.99 16.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.903 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.427 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 35.2 t80 -57.18 -26.31 60.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.05 -35.8 69.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.246 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.95 -33.15 18.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.25 -42.31 66.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 32.2 t30 -67.73 -39.45 84.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.59 -30.46 69.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.28 -32.55 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.761 ' OH ' HG21 ' A' ' 75' ' ' THR . 4.1 t80 -58.55 -47.71 83.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.55 -20.87 58.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.282 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 0.1 OUTLIER -77.3 -32.01 55.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.447 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -89.48 -33.34 16.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.116 0.484 . . . . 0.0 110.737 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.514 ' CG ' ' HB2' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -58.05 -53.68 55.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.893 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -32.09 70.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 95' ' ' PHE . 3.8 pt-20 -72.76 -12.61 61.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.67 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.734 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 6.4 m-80 -102.88 -13.94 16.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.103 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 58.9 m-20 97.48 41.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.986 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.882 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 2.1 m-70 -120.14 52.02 2.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.705 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 74.0 Cg_endo -74.11 -3.74 14.28 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.523 2.149 . . . . 0.0 113.077 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 6.6 t-20 -60.14 -30.75 69.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.764 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.4 m-85 65.23 113.08 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.59 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.498 ' HD3' ' CE2' ' A' ' 96' ' ' PHE . 78.2 Cg_endo -96.54 151.37 1.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.375 2.717 . . . . 0.0 112.671 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.563 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -60.01 163.36 4.79 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 137.72 10.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.176 0.513 . . . . 0.0 112.03 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.486 ' O ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -127.16 84.42 2.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.007 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 52.7 t -90.57 145.23 25.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.208 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.596 HG12 HD23 ' B' ' 115' ' ' LEU . 32.8 m -152.97 132.99 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.088 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.807 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 4.5 tt0 -67.22 82.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.876 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.745 HG21 HD21 ' A' ' 115' ' ' LEU . 12.6 m -67.03 161.71 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -79.91 -44.21 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.4 OUTLIER -148.61 164.62 33.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.817 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.745 HD21 HG21 ' A' ' 112' ' ' VAL . 4.8 mt -139.79 159.95 62.87 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.762 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 119' ' ' VAL . 75.9 Cg_exo -50.52 134.64 39.75 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.478 2.119 . . . . 0.0 112.259 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.43 14.31 9.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.41 17.89 8.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.84 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.582 HG11 ' HB ' ' A' ' 34' ' ' ILE . 16.1 m -53.83 164.77 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.167 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.596 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -87.91 -24.38 35.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.646 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.854 HD23 HG12 ' A' ' 79' ' ' VAL . 4.4 mp -153.25 147.35 25.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.163 0.506 . . . . 0.0 111.27 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.4 ' OE1' ' CD2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -132.39 138.62 47.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.779 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.8 138.02 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.384 0.611 . . . . 0.0 112.324 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.61 107.92 4.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.185 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 75' ' ' THR . . . -121.86 161.63 22.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 28' ' ' VAL . 2.3 mp -111.71 155.51 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.027 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.977 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.42 149.99 40.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.01 0.433 . . . . 0.0 111.475 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.696 HG13 HG11 ' A' ' 73' ' ' VAL . 16.0 m -113.04 179.64 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.061 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.867 ' HB2' HD11 ' A' ' 67' ' ' LEU . 20.4 ttp180 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.639 HG23 ' HA ' ' B' ' 24' ' ' LEU . 90.1 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.98 0.419 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.536 ' O ' HG22 ' B' ' 5' ' ' ILE . 0.0 OUTLIER 60.39 -173.34 0.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.88 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.536 HG22 ' O ' ' B' ' 4' ' ' GLN . 1.1 tp 57.77 120.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.921 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.498 HG21 HG22 ' B' ' 61' ' ' ILE . 13.6 mt -148.67 134.93 12.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.245 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.81 138.93 48.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 111.171 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.648 HG21 ' CG1' ' B' ' 61' ' ' ILE . 0.9 OUTLIER -139.12 148.01 42.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.778 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.09 37.17 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -137.79 -45.37 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.99 110.96 7.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.42 -14.56 44.91 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.453 2.102 . . . . 0.0 112.392 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.81 -167.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.182 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.55 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 61.26 -165.17 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.381 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.619 HG22 ' O ' ' B' ' 15' ' ' ILE . 21.6 mt 77.33 17.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.253 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.11 -135.24 3.46 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.967 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.83 43.22 1.26 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.619 2.212 . . . . 0.0 112.535 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.55 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -177.47 -176.3 0.61 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.923 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.764 HG13 ' HB2' ' A' ' 104' ' ' PHE . 16.6 m -115.25 165.27 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.443 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -56.45 -48.42 77.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.032 0.444 . . . . 0.0 110.607 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' B' ' 61' ' ' ILE . . . -161.16 -175.95 5.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.477 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.478 HG11 ' O ' ' A' ' 73' ' ' VAL . 30.5 m -132.15 131.45 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.011 0.434 . . . . 0.0 111.369 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.436 ' HB2' HG12 ' B' ' 6' ' ' ILE . 61.6 t0 -105.82 86.76 2.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.06 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.639 ' HA ' HG23 ' B' ' 3' ' ' THR . 31.4 mt -60.78 -19.54 59.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.198 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.53 -108.52 0.88 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.669 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' ASN . . . . . 0.546 ' C ' HD12 ' B' ' 27' ' ' LEU . 34.7 m-80 -57.66 -30.16 65.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.14 0.495 . . . . 0.0 109.906 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.641 ' N ' HD12 ' B' ' 27' ' ' LEU . 3.2 mp -124.21 136.68 54.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.496 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.966 HG23 ' HB3' ' B' ' 127' ' ' ALA . 0.7 OUTLIER -104.72 177.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.173 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' B' ' 21' ' ' ALA . 0.0 OUTLIER -157.22 133.63 9.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.776 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 81.7 p -110.09 139.28 45.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.884 0.373 . . . . 0.0 111.194 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.86 175.68 10.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.915 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.89 84.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.09 152.81 12.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.899 0.38 . . . . 0.0 111.198 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.645 HD12 ' CG2' ' B' ' 36' ' ' VAL . 10.3 pt -132.06 142.14 44.02 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.998 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.472 ' HG2' HG23 ' B' ' 43' ' ' VAL . 91.6 Cg_endo -79.92 53.91 4.96 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.931 2.421 . . . . 0.0 112.986 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.645 ' CG2' HD12 ' B' ' 34' ' ' ILE . 45.4 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.51 . . . . 0.0 110.586 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.666 HG23 ' HG3' ' B' ' 50' ' ' GLN . 7.4 p . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.537 0.208 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.403 ' HD2' ' HG3' ' B' ' 50' ' ' GLN . 65.6 Cg_exo -50.95 139.64 40.9 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.366 2.044 . . . . 0.0 112.144 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.46 72.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.067 0.46 . . . . 0.0 111.031 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.36 91.67 1.01 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.828 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 24.0 mm -41.44 -35.01 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.158 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.86 -45.44 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.397 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.8 95.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.432 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.666 ' HG3' HG23 ' B' ' 43' ' ' VAL . 0.0 OUTLIER -68.31 -31.68 71.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.163 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.53 -38.5 74.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.027 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -70.79 -48.91 51.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -60.58 -28.18 68.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.774 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.2 OUTLIER -66.81 -45.54 78.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.3 -22.28 64.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.401 ' HA ' ' HG2' ' B' ' 59' ' ' LYS . 2.7 mm-40 -72.88 -54.61 8.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.401 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -55.71 -30.86 61.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.38 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 54' ' ' SER . 40.4 t -69.38 -50.36 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 110.691 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.414 ' HA ' HG22 ' B' ' 62' ' ' ILE . 2.8 ptmm? -67.31 -33.8 76.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.71 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.5 -40.72 83.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.998 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.648 ' CG1' HG21 ' B' ' 8' ' ' THR . 5.3 mt -65.07 -56.53 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.667 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.652 HD12 ' CB ' ' B' ' 127' ' ' ALA . 5.2 tt -64.45 -26.26 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.44 -41.0 34.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.968 0.413 . . . . 0.0 110.423 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -15.5 63.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.74 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.17 -27.0 17.97 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.961 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.08 44.32 0.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.399 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' B' ' 129' ' ' ARG . 4.5 mt -157.23 139.6 14.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.807 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 27.2 p -92.73 159.36 15.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.879 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -57.32 -34.79 69.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.697 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -49.71 -27.23 4.53 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.999 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.65 -27.94 45.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.462 HD12 ' HB1' ' B' ' 69' ' ' ALA . 78.8 mt -44.5 118.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 120.897 0.38 . . . . 0.0 111.003 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.719 HG11 HG13 ' B' ' 128' ' ' VAL . 10.4 m -83.65 -46.24 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.13 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.58 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 6.8 tttm -141.72 147.7 37.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.645 0.26 . . . . 0.0 110.892 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.768 HG21 ' OH ' ' B' ' 92' ' ' TYR . 2.3 t -141.57 117.42 10.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.43 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.493 HG22 ' O ' ' B' ' 108' ' ' SER . 0.2 OUTLIER -85.85 162.6 18.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.332 179.366 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.521 HG12 HG13 ' B' ' 79' ' ' VAL . 20.5 t -150.82 103.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.879 0.371 . . . . 0.0 111.931 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.492 ' CD2' HG11 ' A' ' 110' ' ' VAL . 9.5 m-85 -94.03 96.28 9.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.227 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.845 HG12 HD23 ' B' ' 121' ' ' LEU . 26.9 m -97.24 148.44 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.705 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.408 ' HG3' HD12 ' B' ' 115' ' ' LEU . 7.8 mttt -80.0 -5.01 54.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.014 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.84 143.09 9.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.458 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' B' ' 82' ' ' LEU . 8.8 mt -85.85 2.09 47.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.095 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.26 -19.98 26.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.613 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.95 -29.98 16.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 35.2 t80 -57.2 -26.27 60.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.169 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.85 69.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.324 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.93 -33.18 18.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.27 -42.39 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.426 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 32.0 t30 -67.66 -39.49 84.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.65 -30.52 69.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.26 -32.49 22.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.768 ' OH ' HG21 ' B' ' 75' ' ' THR . 4.1 t80 -58.48 -47.71 83.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.56 -20.9 58.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.295 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' B' ' 98' ' ' GLU . 0.1 OUTLIER -77.3 -31.95 55.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.493 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.2 OUTLIER -89.51 -33.35 16.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.455 . . . . 0.0 110.741 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.521 ' CG ' ' HB2' ' B' ' 101' ' ' HIS . 0.1 OUTLIER -57.97 -53.7 55.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -32.04 70.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.961 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 98' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' B' ' 94' ' ' ARG . 3.8 pt-20 -72.72 -12.62 61.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 0.0 110.625 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.731 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 6.4 m-80 -102.96 -13.93 16.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.099 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 14.6 m120 97.5 41.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.964 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.879 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 2.1 m-70 -120.01 52.07 2.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.757 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 74.2 Cg_endo -74.14 -3.76 14.32 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.566 2.178 . . . . 0.0 113.087 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -60.14 -30.7 69.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.806 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.3 m-85 65.16 113.14 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.594 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.498 ' HD3' ' CE2' ' B' ' 96' ' ' PHE . 80.2 Cg_endo -96.67 151.37 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.357 2.705 . . . . 0.0 112.675 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.58 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -59.96 163.34 4.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.6 137.76 10.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.203 0.525 . . . . 0.0 112.017 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.493 ' O ' HG22 ' B' ' 76' ' ' THR . 0.1 OUTLIER -127.15 84.34 2.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.055 179.126 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 52.7 t -90.43 145.27 25.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.265 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.593 HG12 HD23 ' C' ' 115' ' ' LEU . 32.7 m -153.11 133.29 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.812 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 4.5 tt0 -67.49 82.05 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.755 HG21 HD21 ' B' ' 115' ' ' LEU . 12.6 m -67.02 161.7 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -79.93 -44.19 20.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.081 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.56 164.66 33.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.805 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.755 HD21 HG21 ' B' ' 112' ' ' VAL . 4.8 mt -139.81 159.96 62.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.783 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.564 ' O ' HG22 ' B' ' 119' ' ' VAL . 74.8 Cg_exo -50.5 134.61 39.59 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.521 2.147 . . . . 0.0 112.254 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.41 14.33 9.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.208 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.38 17.91 8.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.819 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.578 HG11 ' HB ' ' B' ' 34' ' ' ILE . 16.0 m -53.81 164.79 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.14 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 120' ' ' GLY . . . . . 0.603 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -87.89 -24.27 35.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.652 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.845 HD23 HG12 ' B' ' 79' ' ' VAL . 4.4 mp -153.45 147.41 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.111 0.482 . . . . 0.0 111.238 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.34 138.64 47.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.795 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.8 137.98 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.324 0.583 . . . . 0.0 112.348 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.59 107.91 4.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.214 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.485 ' HB2' ' CB ' ' B' ' 75' ' ' THR . . . -121.91 161.71 22.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.297 0.57 . . . . 0.0 112.507 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.437 HG23 ' O ' ' B' ' 28' ' ' VAL . 2.3 mp -111.79 155.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.977 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.966 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.34 150.06 40.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.403 . . . . 0.0 111.527 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.719 HG13 HG11 ' B' ' 73' ' ' VAL . 16.0 m -113.1 179.67 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.977 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.851 ' HB2' HD11 ' B' ' 67' ' ' LEU . 20.4 ttp180 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.948 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.644 HG23 ' HA ' ' C' ' 24' ' ' LEU . 90.1 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.934 0.397 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 4' ' ' GLN . . . . . 0.546 ' O ' HG22 ' C' ' 5' ' ' ILE . 0.0 OUTLIER 60.56 -173.35 0.12 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.824 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.546 HG22 ' O ' ' C' ' 4' ' ' GLN . 1.1 tp 57.67 120.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.916 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.518 HG21 HG22 ' C' ' 61' ' ' ILE . 13.5 mt -148.66 134.95 12.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.247 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -131.85 138.86 48.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 111.205 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.651 HG21 ' CG1' ' C' ' 61' ' ' ILE . 0.9 OUTLIER -139.12 148.01 42.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.835 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.06 37.11 1.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -137.91 -45.97 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.4 111.0 7.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.092 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.41 -14.62 45.23 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.496 2.131 . . . . 0.0 112.396 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.78 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.2 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 61.2 -165.16 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.385 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.607 HG22 ' O ' ' C' ' 15' ' ' ILE . 21.9 mt 77.33 17.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.262 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.01 -135.2 3.46 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.029 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.85 43.15 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 112.561 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.557 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -177.34 -176.29 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.986 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.806 HG13 ' HB2' ' B' ' 104' ' ' PHE . 16.5 m -115.25 165.32 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 20' ' ' GLN . . . . . 0.446 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -56.38 -47.87 78.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.099 0.476 . . . . 0.0 110.519 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.548 ' CB ' HG21 ' C' ' 61' ' ' ILE . . . -162.02 -175.78 4.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.476 HG11 ' O ' ' B' ' 73' ' ' VAL . 30.2 m -132.08 131.42 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.409 . . . . 0.0 111.351 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' C' ' 6' ' ' ILE . 61.6 t0 -105.85 86.88 2.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.093 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.644 ' HA ' HG23 ' C' ' 3' ' ' THR . 31.5 mt -60.82 -19.61 60.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.154 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.54 -108.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.693 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' ASN . . . . . 0.548 ' C ' HD12 ' C' ' 27' ' ' LEU . 34.7 m-80 -57.62 -30.21 65.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.159 0.504 . . . . 0.0 109.917 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.628 ' N ' HD12 ' C' ' 27' ' ' LEU . 3.2 mp -124.22 136.62 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.482 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 1.002 HG23 ' HB3' ' C' ' 127' ' ' ALA . 0.7 OUTLIER -104.7 177.17 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.249 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.447 ' O ' ' HB1' ' C' ' 21' ' ' ALA . 0.0 OUTLIER -157.2 133.54 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 81.3 p -109.94 138.16 46.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.83 0.348 . . . . 0.0 110.971 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 31' ' ' SER . . . . . 0.422 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 8.1 t -78.42 175.37 10.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.863 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.84 84.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.284 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.06 152.81 12.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 111.191 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.64 HD12 ' CG2' ' C' ' 36' ' ' VAL . 10.3 pt -132.05 142.17 44.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.455 ' HG2' HG23 ' C' ' 43' ' ' VAL . 91.8 Cg_endo -80.0 53.93 4.97 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.964 2.443 . . . . 0.0 112.975 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.64 ' CG2' HD12 ' C' ' 34' ' ' ILE . 45.7 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.134 0.492 . . . . 0.0 110.537 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.685 HG23 ' HG3' ' C' ' 50' ' ' GLN . 7.4 p . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.407 0.146 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.401 ' HD2' ' HG3' ' C' ' 50' ' ' GLN . 67.1 Cg_exo -50.97 139.64 41.05 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.318 2.012 . . . . 0.0 112.161 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.44 72.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.026 0.441 . . . . 0.0 111.001 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.46 91.7 1.05 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 24.1 mm -41.33 -35.13 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.192 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.79 -45.41 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.467 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.76 95.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.438 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.685 ' HG3' HG23 ' C' ' 43' ' ' VAL . 0.0 OUTLIER -68.7 -32.44 72.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.214 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.88 -38.5 73.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.116 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -70.76 -48.9 51.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.55 -28.12 68.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.799 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.597 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.2 OUTLIER -66.81 -45.6 77.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 mt -68.38 -22.2 64.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.94 -54.53 8.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.417 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' C' ' 58' ' ' VAL . 29.2 p30 -55.8 -30.9 62.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.304 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.597 HG23 ' O ' ' C' ' 54' ' ' SER . 40.3 t -69.31 -50.33 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 110.744 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' C' ' 62' ' ' ILE . 2.8 ptmm? -67.36 -33.84 76.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.753 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.52 -41.08 84.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.057 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.651 ' CG1' HG21 ' C' ' 8' ' ' THR . 5.3 mt -65.17 -56.47 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.748 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.637 HD12 ' CB ' ' C' ' 127' ' ' ALA . 5.2 tt -64.52 -26.19 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.826 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.53 -41.01 33.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.873 0.368 . . . . 0.0 110.335 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -15.48 63.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.724 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.12 -27.01 18.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.856 0.36 . . . . 0.0 111.003 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.15 44.24 0.49 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.36 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.841 HD11 ' HB2' ' C' ' 129' ' ' ARG . 4.5 mt -157.21 139.59 14.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.385 . . . . 0.0 110.828 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 27.1 p -92.75 159.38 15.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.782 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.891 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -57.34 -34.76 69.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.8 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -49.77 -27.4 4.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.909 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.07 -27.99 48.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.046 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.47 HD12 ' HB1' ' C' ' 69' ' ' ALA . 78.8 mt -44.47 118.42 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.901 0.381 . . . . 0.0 111.003 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.728 HG11 HG13 ' C' ' 128' ' ' VAL . 10.3 m -83.58 -46.26 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.196 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.571 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 6.8 tttm -141.7 147.7 37.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.626 0.25 . . . . 0.0 110.966 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.767 HG21 ' OH ' ' C' ' 92' ' ' TYR . 2.3 t -141.52 117.5 10.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.41 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.493 HG22 ' O ' ' C' ' 108' ' ' SER . 0.2 OUTLIER -85.98 162.56 18.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.309 179.413 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.51 HG12 HG13 ' C' ' 79' ' ' VAL . 20.4 t -150.81 103.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.366 . . . . 0.0 111.929 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.521 ' CD2' HG11 ' B' ' 110' ' ' VAL . 9.5 m-85 -94.04 96.32 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.187 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.831 HG12 HD23 ' C' ' 121' ' ' LEU . 27.0 m -97.27 148.46 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.652 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 80' ' ' LYS . . . . . 0.431 ' HG3' HD12 ' C' ' 115' ' ' LEU . 7.8 mttt -79.98 -5.21 55.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.027 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.87 143.06 9.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.454 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' C' ' 82' ' ' LEU . 8.8 mt -85.87 2.11 47.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.27 -19.94 26.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.571 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.93 -29.99 16.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.423 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 35.1 t80 -57.24 -26.24 60.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.129 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.84 69.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.248 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.98 -33.11 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.23 -42.35 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 89' ' ' ASN . . . . . 0.423 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 31.9 t30 -67.68 -39.52 84.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.43 -30.4 69.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.063 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.41 -32.48 22.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.767 ' OH ' HG21 ' C' ' 75' ' ' THR . 4.1 t80 -58.58 -47.71 83.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -75.57 -20.84 58.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.281 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 94' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' C' ' 98' ' ' GLU . 0.1 OUTLIER -77.39 -31.87 54.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.453 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.2 OUTLIER -89.53 -33.37 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 110.672 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.528 ' CG ' ' HB2' ' C' ' 101' ' ' HIS . 0.1 OUTLIER -57.94 -53.78 54.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.866 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -32.09 70.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.934 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 98' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' C' ' 95' ' ' PHE . 3.8 pt-20 -72.73 -12.6 61.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.652 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.745 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 6.5 m-80 -102.9 -13.97 16.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.089 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 14.6 m120 97.49 41.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.974 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.891 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 2.1 m-70 -119.95 51.99 2.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.76 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 74.0 Cg_endo -74.12 -3.77 14.33 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.549 2.166 . . . . 0.0 113.086 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 6.6 t-20 -60.16 -30.69 69.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.846 0.355 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.781 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.4 m-85 65.18 113.1 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.638 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.483 ' HD3' ' CE2' ' C' ' 96' ' ' PHE . 79.1 Cg_endo -96.61 151.3 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.388 2.725 . . . . 0.0 112.691 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.571 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -59.92 163.39 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.68 137.73 10.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.21 0.528 . . . . 0.0 112.067 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 108' ' ' SER . . . . . 0.493 ' O ' HG22 ' C' ' 76' ' ' THR . 0.1 OUTLIER -127.19 84.45 2.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.975 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 52.6 t -90.6 145.21 25.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.608 HG12 HD23 ' A' ' 115' ' ' LEU . 32.8 m -152.97 132.82 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.051 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.82 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 4.5 tt0 -67.17 82.04 0.13 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.736 HG21 HD21 ' C' ' 115' ' ' LEU . 12.5 m -67.1 161.71 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -79.93 -44.17 20.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.431 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.4 OUTLIER -148.63 164.65 33.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.736 HD21 HG21 ' C' ' 112' ' ' VAL . 4.8 mt -139.76 159.98 62.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.567 ' O ' HG22 ' C' ' 119' ' ' VAL . 75.3 Cg_exo -50.57 134.61 40.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.471 2.114 . . . . 0.0 112.283 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.44 14.37 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.174 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.35 17.97 8.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.793 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.586 HG11 ' HB ' ' C' ' 34' ' ' ILE . 16.0 m -53.84 164.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.115 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 120' ' ' GLY . . . . . 0.659 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -88.14 -24.47 34.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.592 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.831 HD23 HG12 ' C' ' 79' ' ' VAL . 4.4 mp -153.27 147.33 25.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.13 0.491 . . . . 0.0 111.338 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.39 138.62 47.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.773 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.78 138.02 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.371 0.605 . . . . 0.0 112.286 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.56 107.94 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.19 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' C' ' 75' ' ' THR . . . -121.95 161.74 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.34 0.591 . . . . 0.0 112.486 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.414 HG23 ' O ' ' C' ' 28' ' ' VAL . 2.3 mp -111.78 155.45 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.998 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 1.002 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.4 150.04 40.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.027 0.442 . . . . 0.0 111.47 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.728 HG13 HG11 ' C' ' 73' ' ' VAL . 16.0 m -113.03 179.71 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.042 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.841 ' HB2' HD11 ' C' ' 67' ' ' LEU . 20.4 ttp180 -162.23 45.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.921 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 130' ' ' LYS . . . . . 0.408 ' HE3' HD11 ' C' ' 27' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.932 HG21 HG21 ' C' ' 128' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.787 0.327 . . . . 0.0 110.883 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.59 121.0 7.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.755 HG21 HG11 ' A' ' 19' ' ' VAL . 4.7 mp -56.3 141.66 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.172 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 32.3 mt -92.58 146.42 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.271 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.28 117.32 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.699 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 t -129.29 161.58 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.031 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.68 24.85 6.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 -51.95 3.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.63 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.06 112.82 38.66 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.018 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -60.66 -16.16 41.55 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.446 2.097 . . . . 0.0 112.531 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HB1' ' OH ' ' A' ' 18' ' ' TYR . . . -56.76 -168.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.293 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 63.65 -167.48 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.341 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 15' ' ' ILE . 19.4 mm 78.26 16.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.239 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.21 -134.69 3.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.141 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HG2' ' CZ ' ' C' ' 107' ' ' ARG . 96.3 Cg_endo -85.91 23.17 0.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.657 2.238 . . . . 0.0 112.868 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.611 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -154.18 -168.73 3.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.764 0.316 . . . . 0.0 110.822 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.755 HG11 HG21 ' A' ' 5' ' ' ILE . 15.4 m -124.86 172.23 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.264 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.59 -55.09 14.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.866 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 61' ' ' ILE . . . -157.78 178.5 10.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.038 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.753 HG23 HD13 ' A' ' 29' ' ' LEU . 7.1 m -127.96 134.31 65.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.475 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.9 t70 -117.77 96.3 5.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.839 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.715 HD13 HD21 ' C' ' 27' ' ' LEU . 12.3 mt -76.35 -20.39 57.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.984 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.89 -106.02 0.73 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.825 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -59.58 -29.59 68.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 110.148 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.626 HD21 HD13 ' B' ' 24' ' ' LEU . 0.6 OUTLIER -123.15 120.12 32.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.866 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.95 HG23 ' HB3' ' A' ' 127' ' ' ALA . 5.1 m -111.13 167.51 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.992 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.753 HD13 HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.84 155.33 38.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.838 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -117.51 136.03 53.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.945 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 55.7 m -68.74 167.04 16.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.11 82.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.323 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -76.38 145.95 39.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.097 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.442 ' HB ' HG11 ' A' ' 119' ' ' VAL . 8.3 pt -128.49 160.31 63.2 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.604 ' O ' HG12 ' A' ' 36' ' ' VAL . 84.7 Cg_exo -43.3 -47.85 8.6 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.721 2.281 . . . . 0.0 111.778 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 35' ' ' PRO . 9.8 p . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.751 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.653 ' HB ' HG12 ' A' ' 119' ' ' VAL . 8.2 p . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 120.356 0.122 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 14.2 Cg_exo -69.97 143.57 50.22 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.606 2.204 . . . . 0.0 112.226 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.65 63.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.079 0.466 . . . . 0.0 110.957 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -68.3 96.05 0.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.617 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.01 -32.16 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.629 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.07 -52.45 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.592 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -63.33 -28.49 70.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.478 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HG2' ' CG ' ' A' ' 35' ' ' PRO . 0.9 OUTLIER -79.75 -28.68 40.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.458 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.49 58.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.031 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -74.42 -41.74 60.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.083 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.21 -43.81 87.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.026 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.64 ' O ' HG23 ' A' ' 58' ' ' VAL . 73.6 m -59.51 -43.62 93.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD23 HD13 ' A' ' 123' ' ' ILE . 75.4 mt -66.4 -35.41 80.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.988 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.88 -38.27 82.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.011 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.64 -36.41 84.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.746 HG21 ' CG2' ' A' ' 123' ' ' ILE . 16.0 t -69.82 -46.94 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.947 0.403 . . . . 0.0 110.943 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -72.51 -31.37 65.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.827 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.77 91.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.487 HG21 ' CB ' ' A' ' 21' ' ' ALA . 6.5 mt -65.44 -56.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 127' ' ' ALA . 4.9 tt -63.83 -26.22 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.742 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 -40.12 60.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.374 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -10.78 59.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.788 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.84 -29.62 18.48 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.875 0.369 . . . . 0.0 110.905 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.61 52.42 0.33 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.52 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.537 HD22 ' CB ' ' A' ' 71' ' ' ASP . 2.3 mt -147.88 -169.89 3.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.09 160.09 41.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.99 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.783 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -59.97 -33.56 72.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.119 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -62.82 -17.18 60.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.461 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.537 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.0 m-20 -85.28 -24.57 27.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.814 0.34 . . . . 0.0 110.829 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 47.0 mt -53.71 118.55 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.128 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.568 ' O ' HG11 ' B' ' 22' ' ' VAL . 12.4 m -89.28 -37.19 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.707 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.755 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -141.25 149.33 41.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.705 0.288 . . . . 0.0 110.774 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.689 HG23 ' HB2' ' A' ' 125' ' ' ALA . 89.3 m -144.96 110.36 5.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.95 0.405 . . . . 0.0 111.323 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.566 ' O ' HG13 ' A' ' 77' ' ' VAL . 87.8 m -95.22 157.81 15.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.246 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.665 HG12 HG12 ' A' ' 123' ' ' ILE . 3.3 m -159.1 142.46 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.084 0.468 . . . . 0.0 111.761 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' C' ' 110' ' ' VAL . 3.5 m-85 -114.0 119.09 36.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.283 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.802 HG12 HD21 ' A' ' 121' ' ' LEU . 33.2 m -107.34 152.23 9.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.114 0.483 . . . . 0.0 111.735 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.51 0.17 39.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.821 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -163.28 107.5 1.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.566 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.87 -13.89 60.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.222 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -79.66 -27.79 40.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.909 0.385 . . . . 0.0 110.493 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.32 -12.18 55.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.831 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.652 ' CD1' HG11 ' A' ' 79' ' ' VAL . 1.6 t80 -58.63 -24.52 61.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.82 -56.52 11.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.352 . . . . 0.0 111.38 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.48 -36.83 83.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 t -64.8 -42.07 93.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.16 -42.32 89.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.481 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.81 75.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.895 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 94' ' ' ARG . 20.3 mm-40 -88.69 -30.01 19.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.693 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.428 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 58.7 t80 -57.72 -49.7 75.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.014 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.44 -17.49 45.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 91' ' ' GLU . 4.6 mtp180 -75.12 -27.92 60.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.658 0.265 . . . . 0.0 111.38 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -86.19 -33.35 20.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.38 . . . . 0.0 110.525 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.471 ' CZ ' ' CD ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -56.27 -55.7 30.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.334 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.62 -28.81 70.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.889 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.47 -6.22 59.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.35 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.783 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 1.5 m120 -111.47 -5.13 14.62 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.56 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.716 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 8.7 m-80 85.42 33.31 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.803 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 20.1 t-160 -128.88 67.3 77.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.529 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 4.5 Cg_exo -75.48 -20.24 16.13 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.602 2.202 . . . . 0.0 112.525 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.704 ' CG ' HD13 ' B' ' 5' ' ' ILE . 1.4 t-20 -69.15 -36.69 77.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.063 0.459 . . . . 0.0 110.344 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' A' ' 102' ' ' PRO . 15.8 m-85 74.06 142.56 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.427 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.471 ' CD ' ' CZ ' ' A' ' 96' ' ' PHE . 73.2 Cg_endo -90.07 165.88 4.71 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.209 2.606 . . . . 0.0 111.956 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.755 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -50.1 154.11 1.24 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.424 ' HB3' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -119.02 140.98 49.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.227 0.537 . . . . 0.0 112.048 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.6 t -144.28 45.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.986 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 28.7 p -81.37 135.08 35.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.249 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' B' ' 78' ' ' PHE . 23.0 m -153.85 149.34 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.203 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.831 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -84.4 91.04 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.771 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.666 HG21 HD21 ' A' ' 115' ' ' LEU . 27.7 m -71.15 177.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.841 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -81.83 -45.95 14.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.005 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.405 ' CB ' ' HB3' ' C' ' 111' ' ' GLU . 0.1 OUTLIER -151.72 -179.72 7.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.788 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.666 HD21 HG21 ' A' ' 112' ' ' VAL . 60.0 mt -149.2 155.6 39.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.704 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.551 ' O ' HG22 ' A' ' 119' ' ' VAL . 9.2 Cg_endo -52.33 139.23 55.06 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.523 2.149 . . . . 0.0 111.977 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 7.9 mmtm 66.46 17.72 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.278 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 61.63 17.45 8.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.025 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.653 HG12 ' HB ' ' A' ' 43' ' ' VAL . 30.1 m -55.76 167.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.073 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.03 8.49 42.24 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.918 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.802 HD21 HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -172.58 154.6 3.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.086 0.469 . . . . 0.0 111.226 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.2 159.01 43.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.002 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.746 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.9 mt -144.25 145.75 21.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.38 0.609 . . . . 0.0 112.301 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.16 101.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.322 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.689 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -119.07 163.59 16.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.171 0.51 . . . . 0.0 112.194 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 72' ' ' ILE . 5.7 mt -114.43 151.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.133 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.95 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -136.06 148.39 48.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.034 0.445 . . . . 0.0 111.574 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.897 HG21 HG21 ' B' ' 3' ' ' THR . 35.0 m -115.92 151.44 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.122 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.401 ' HD2' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.819 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.897 HG21 HG21 ' A' ' 128' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.811 0.338 . . . . 0.0 110.92 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.58 120.97 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.769 HG21 HG11 ' B' ' 19' ' ' VAL . 4.7 mp -56.26 141.66 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 31.8 mt -92.61 146.33 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.318 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.2 117.41 5.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.718 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 14.3 t -129.32 161.6 29.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.036 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.69 24.85 6.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.807 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.5 -52.47 3.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.677 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.5 112.93 38.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.7 -16.16 41.84 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.436 2.09 . . . . 0.0 112.473 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.479 ' HB1' ' OH ' ' B' ' 18' ' ' TYR . . . -56.75 -168.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.252 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.617 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 63.73 -167.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.315 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.588 HG22 ' O ' ' B' ' 15' ' ' ILE . 19.4 mm 78.23 16.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.288 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.26 -134.73 3.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.163 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 107' ' ' ARG . 96.9 Cg_endo -85.84 23.18 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.685 2.256 . . . . 0.0 112.926 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.617 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -154.13 -168.71 3.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.755 0.312 . . . . 0.0 110.829 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.769 HG11 HG21 ' B' ' 5' ' ' ILE . 15.5 m -124.88 172.31 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.362 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.71 -55.16 14.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.802 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.494 ' CB ' HG21 ' B' ' 61' ' ' ILE . . . -158.13 178.44 10.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.995 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.748 HG23 HD13 ' B' ' 29' ' ' LEU . 7.2 m -127.88 134.27 65.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.463 ' HA ' HG12 ' B' ' 28' ' ' VAL . 7.8 t70 -117.67 96.23 5.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.626 HD13 HD21 ' A' ' 27' ' ' LEU . 12.4 mt -76.34 -20.42 57.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.002 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.97 -106.03 0.73 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.83 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -59.62 -29.51 68.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.038 0.447 . . . . 0.0 110.152 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.786 HD21 HD13 ' C' ' 24' ' ' LEU . 0.7 OUTLIER -123.19 120.07 32.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.872 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.998 HG23 ' HB3' ' B' ' 127' ' ' ALA . 5.1 m -111.07 167.54 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.01 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.748 HD13 HG23 ' B' ' 22' ' ' VAL . 0.0 OUTLIER -150.91 155.31 38.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -117.38 135.8 53.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 56.5 m -68.89 166.97 16.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.13 82.13 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.307 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -76.39 145.89 39.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.357 . . . . 0.0 111.15 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.436 ' HB ' HG11 ' B' ' 119' ' ' VAL . 8.2 pt -128.48 160.3 63.23 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.545 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.604 ' O ' HG12 ' B' ' 36' ' ' VAL . 84.5 Cg_exo -43.2 -47.93 8.38 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.755 2.303 . . . . 0.0 111.753 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.604 HG12 ' O ' ' B' ' 35' ' ' PRO . 9.8 p . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.717 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.684 ' HB ' HG12 ' B' ' 119' ' ' VAL . 8.2 p . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 120.368 0.128 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' B' ' 43' ' ' VAL . 14.2 Cg_exo -69.96 143.6 50.38 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.636 2.224 . . . . 0.0 112.214 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.65 63.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.995 0.426 . . . . 0.0 110.896 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.4 OUTLIER -68.22 96.05 0.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.677 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.0 -32.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.589 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.95 -52.51 15.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.64 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -63.35 -28.43 69.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.469 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.458 ' HG2' ' CG ' ' B' ' 35' ' ' PRO . 0.9 OUTLIER -79.76 -28.61 40.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.485 179.618 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.51 -35.45 58.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -74.38 -41.76 60.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.23 -43.75 87.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.615 ' O ' HG23 ' B' ' 58' ' ' VAL . 73.8 m -59.47 -43.62 93.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.034 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.503 HD23 HD13 ' B' ' 123' ' ' ILE . 75.2 mt -66.44 -35.34 80.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.89 -38.35 82.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.6 -36.35 83.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.06 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.736 HG21 ' CG2' ' B' ' 123' ' ' ILE . 16.2 t -69.85 -46.91 72.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 0.0 110.956 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' B' ' 62' ' ' ILE . 0.0 OUTLIER -72.6 -31.29 65.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.812 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.24 -40.85 91.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.932 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.494 HG21 ' CB ' ' B' ' 21' ' ' ALA . 6.4 mt -65.48 -56.86 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' B' ' 127' ' ' ALA . 5.0 tt -63.83 -26.2 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.725 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -40.07 60.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.924 0.393 . . . . 0.0 110.446 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -10.84 59.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.812 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.78 -29.72 18.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.69 52.42 0.32 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.543 HD22 ' CB ' ' B' ' 71' ' ' ASP . 2.3 mt -147.94 -169.94 3.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 110.577 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.08 160.14 40.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.982 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -59.98 -33.52 72.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -62.83 -17.17 60.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.448 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.543 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.0 m-20 -85.16 -24.64 27.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 110.805 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.69 118.53 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.095 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.621 ' O ' HG11 ' C' ' 22' ' ' VAL . 12.5 m -89.23 -37.22 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.73 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.789 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 0.0 OUTLIER -141.21 149.37 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.708 0.29 . . . . 0.0 110.78 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.685 HG23 ' HB2' ' B' ' 125' ' ' ALA . 89.2 m -144.99 110.29 5.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.568 ' O ' HG13 ' B' ' 77' ' ' VAL . 87.8 m -95.09 157.75 15.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.242 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.667 HG12 HG12 ' B' ' 123' ' ' ILE . 3.2 m -159.05 142.5 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.758 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 110' ' ' VAL . 3.5 m-85 -114.01 119.09 36.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.248 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.797 HG12 HD21 ' B' ' 121' ' ' LEU . 33.9 m -107.33 152.18 9.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.125 0.488 . . . . 0.0 111.765 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.53 -0.14 38.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.817 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.85 107.51 1.11 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.578 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.99 -13.78 60.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.215 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -79.67 -27.85 40.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 0.0 110.484 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.27 -12.17 55.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.864 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.661 ' CD1' HG11 ' B' ' 79' ' ' VAL . 1.6 t80 -58.68 -24.43 61.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.007 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.87 -56.52 11.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 111.331 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.83 83.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 34.3 t -64.83 -42.06 93.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.715 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.18 -42.2 89.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.5 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.04 -36.09 76.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.938 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' B' ' 94' ' ' ARG . 20.4 mm-40 -88.45 -29.96 19.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.724 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.419 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 58.6 t80 -57.75 -49.66 75.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.028 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.47 -17.46 45.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.504 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' B' ' 91' ' ' GLU . 4.6 mtp180 -75.09 -27.94 60.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.699 0.285 . . . . 0.0 111.414 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.9 OUTLIER -86.15 -33.48 20.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.499 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' B' ' 101' ' ' HIS . 0.9 OUTLIER -56.19 -55.76 29.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.344 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.54 -28.9 70.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.914 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -6.24 59.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.397 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.751 ' HB3' ' HB3' ' B' ' 69' ' ' ALA . 1.5 m120 -111.41 -5.15 14.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.718 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 8.6 m-80 85.44 33.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.894 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.549 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.1 t-160 -128.81 67.42 77.46 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.534 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 4.6 Cg_exo -75.48 -20.25 16.12 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.621 2.214 . . . . 0.0 112.519 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.659 ' CG ' HD13 ' C' ' 5' ' ' ILE . 1.4 t-20 -69.17 -36.68 77.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.307 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' B' ' 102' ' ' PRO . 15.8 m-85 74.07 142.52 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.453 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.462 ' CD ' ' CZ ' ' B' ' 96' ' ' PHE . 72.2 Cg_endo -90.09 165.86 4.69 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.107 2.538 . . . . 0.0 111.98 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.789 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -50.02 154.18 1.19 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.462 ' HB3' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -119.1 141.0 49.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.215 0.531 . . . . 0.0 112.068 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 30.8 t -144.26 45.83 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.954 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' B' ' 77' ' ' VAL . 28.7 p -81.44 135.02 35.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.277 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' C' ' 78' ' ' PHE . 23.4 m -153.7 149.06 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.149 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.855 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -84.49 91.04 7.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.822 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.651 HG21 HD21 ' B' ' 115' ' ' LEU . 27.6 m -71.15 177.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.206 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -81.79 -45.92 14.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.44 ' CB ' ' HB3' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -151.7 -179.53 7.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.753 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.651 HD21 HG21 ' B' ' 112' ' ' VAL . 59.5 mt -149.33 155.56 39.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.669 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.548 ' O ' HG22 ' B' ' 119' ' ' VAL . 9.3 Cg_endo -52.35 139.25 55.23 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.537 2.158 . . . . 0.0 111.987 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 8.0 mmtm 66.38 17.81 10.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.253 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 61.53 17.52 8.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.065 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.684 HG12 ' HB ' ' B' ' 43' ' ' VAL . 30.3 m -55.8 167.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.062 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.11 8.12 41.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.888 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.797 HD21 HG12 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -172.47 154.5 3.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.165 0.507 . . . . 0.0 111.296 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.12 158.95 43.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.025 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.736 ' CG2' HG21 ' B' ' 58' ' ' VAL . 28.2 mt -144.21 145.75 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.309 0.576 . . . . 0.0 112.309 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.17 101.48 1.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.344 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.685 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -119.02 163.56 16.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.198 0.523 . . . . 0.0 112.245 -178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.7 mt -114.41 151.9 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.114 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.998 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -136.06 148.32 48.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.993 0.425 . . . . 0.0 111.618 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.983 HG21 HG21 ' C' ' 3' ' ' THR . 35.0 m -115.82 151.38 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.84 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.983 HG21 HG21 ' B' ' 128' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.84 0.352 . . . . 0.0 110.891 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.56 121.02 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.728 HG21 HG11 ' C' ' 19' ' ' VAL . 4.7 mp -56.31 141.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 32.0 mt -92.61 146.37 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.234 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.24 117.37 5.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.705 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 14.3 t -129.3 161.61 29.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.037 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.72 24.89 6.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 -52.34 3.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.751 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.62 112.86 37.78 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.05 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.65 -16.13 41.34 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.436 2.09 . . . . 0.0 112.525 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.481 ' HB1' ' OH ' ' C' ' 18' ' ' TYR . . . -56.8 -168.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.249 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.627 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 63.69 -167.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.332 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.587 HG22 ' O ' ' C' ' 15' ' ' ILE . 19.4 mm 78.26 16.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.215 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.21 -134.78 3.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.14 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.8 23.16 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.609 2.206 . . . . 0.0 112.9 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.627 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -154.1 -168.61 3.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.738 0.304 . . . . 0.0 110.855 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.728 HG11 HG21 ' C' ' 5' ' ' ILE . 15.4 m -124.97 172.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.29 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -55.01 15.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.936 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -157.95 178.57 10.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.026 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.761 HG23 HD13 ' C' ' 29' ' ' LEU . 7.2 m -127.92 134.21 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.47 ' HA ' HG12 ' C' ' 28' ' ' VAL . 7.9 t70 -117.73 96.32 5.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.786 HD13 HD21 ' B' ' 27' ' ' LEU . 12.4 mt -76.37 -20.36 57.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.0 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.92 -106.03 0.73 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.839 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.62 -29.55 68.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.119 0.485 . . . . 0.0 110.186 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.715 HD21 HD13 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -123.2 120.08 32.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.875 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.982 HG23 ' HB3' ' C' ' 127' ' ' ALA . 5.2 m -111.06 167.52 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.761 HD13 HG23 ' C' ' 22' ' ' VAL . 0.0 OUTLIER -150.83 155.35 39.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.2 p -117.52 135.91 53.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.862 0.363 . . . . 0.0 110.914 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 56.3 m -68.55 166.99 15.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.818 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.03 82.14 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.341 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -76.43 145.92 38.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 111.178 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.44 ' HB ' HG11 ' C' ' 119' ' ' VAL . 8.3 pt -128.47 160.32 63.08 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.574 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.602 ' O ' HG12 ' C' ' 36' ' ' VAL . 85.6 Cg_exo -43.22 -47.92 8.43 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.73 2.286 . . . . 0.0 111.757 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.602 HG12 ' O ' ' C' ' 35' ' ' PRO . 9.8 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.769 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.659 ' HB ' HG12 ' C' ' 119' ' ' VAL . 8.2 p . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.41 0.148 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' C' ' 43' ' ' VAL . 14.2 Cg_exo -69.97 143.63 50.4 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.616 2.21 . . . . 0.0 112.235 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.62 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.044 0.45 . . . . 0.0 110.897 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.4 OUTLIER -68.29 96.06 0.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.602 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.03 -32.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.605 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.95 -52.53 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.623 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -63.36 -28.45 70.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.492 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.465 ' HG2' ' CG ' ' C' ' 35' ' ' PRO . 0.9 OUTLIER -79.69 -28.52 40.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.452 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.54 58.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -74.23 -41.87 60.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.24 -43.72 87.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.643 ' O ' HG23 ' C' ' 58' ' ' VAL . 73.7 m -59.47 -43.71 93.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.497 HD23 HD13 ' C' ' 123' ' ' ILE . 75.1 mt -66.38 -35.38 80.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.003 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.86 -38.3 82.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.014 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.63 -36.34 83.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.745 HG21 ' CG2' ' C' ' 123' ' ' ILE . 16.1 t -69.9 -46.93 72.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.923 0.392 . . . . 0.0 110.936 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' C' ' 62' ' ' ILE . 0.0 OUTLIER -72.49 -31.47 65.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.764 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.8 90.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.907 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.48 HG21 ' CB ' ' C' ' 21' ' ' ALA . 6.4 mt -65.39 -56.78 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.71 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' C' ' 127' ' ' ALA . 4.9 tt -63.89 -26.19 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.746 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -40.03 60.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.921 0.391 . . . . 0.0 110.431 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -10.75 59.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.8 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.89 -29.64 18.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.837 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.63 52.42 0.33 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.485 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.545 HD22 ' CB ' ' C' ' 71' ' ' ASP . 2.3 mt -147.91 -169.89 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 110.585 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.12 160.15 40.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.032 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -60.0 -33.5 72.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -62.92 -17.31 61.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.42 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.545 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.0 m-20 -85.18 -24.43 27.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.784 0.326 . . . . 0.0 110.786 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 47.1 mt -53.79 118.62 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.08 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.614 ' O ' HG11 ' A' ' 22' ' ' VAL . 12.5 m -89.32 -37.16 9.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.693 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.763 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 0.0 OUTLIER -141.26 149.36 41.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.782 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.699 HG23 ' HB2' ' C' ' 125' ' ' ALA . 89.5 m -145.0 110.31 5.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.92 0.391 . . . . 0.0 111.343 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.574 ' O ' HG13 ' C' ' 77' ' ' VAL . 87.8 m -95.14 157.82 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.217 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.659 HG12 HG12 ' C' ' 123' ' ' ILE . 3.3 m -159.15 142.47 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.081 0.467 . . . . 0.0 111.774 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' B' ' 110' ' ' VAL . 3.5 m-85 -114.0 119.07 35.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.283 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.772 HG12 HD21 ' C' ' 121' ' ' LEU . 33.5 m -107.31 152.23 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.102 0.477 . . . . 0.0 111.744 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.55 -0.15 38.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.806 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.85 107.45 1.11 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.572 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.89 -13.82 60.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.213 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -79.69 -27.78 40.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.482 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.29 -12.17 55.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.83 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.651 ' CD1' HG11 ' C' ' 79' ' ' VAL . 1.6 t80 -58.7 -24.45 61.43 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.996 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.86 -56.51 11.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.338 . . . . 0.0 111.353 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.82 83.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 t -64.84 -42.07 93.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.72 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.13 -42.35 89.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.483 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.97 76.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.865 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 91' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' C' ' 94' ' ' ARG . 20.4 mm-40 -88.63 -29.88 19.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.7 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.424 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 59.0 t80 -57.77 -49.68 75.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.011 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.46 -17.46 45.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.496 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 94' ' ' ARG . . . . . 0.413 ' HB2' ' HA ' ' C' ' 91' ' ' GLU . 4.6 mtp180 -75.1 -27.91 60.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.711 0.291 . . . . 0.0 111.381 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.9 OUTLIER -86.19 -33.45 20.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 110.493 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.461 ' CZ ' ' CD ' ' C' ' 105' ' ' PRO . 0.9 OUTLIER -56.2 -55.79 28.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.329 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.53 -28.91 70.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.882 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.39 -6.24 59.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.381 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.735 ' HB3' ' HB3' ' C' ' 69' ' ' ALA . 1.5 m120 -111.43 -5.14 14.64 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.588 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.716 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 8.7 m-80 85.45 33.18 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.851 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.547 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.1 t-160 -128.89 67.38 77.73 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.481 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 4.5 Cg_exo -75.42 -20.32 16.16 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.667 2.244 . . . . 0.0 112.528 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.685 ' CG ' HD13 ' A' ' 5' ' ' ILE . 1.4 t-20 -69.12 -36.77 77.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.452 . . . . 0.0 110.336 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.417 ' CB ' ' HA ' ' A' ' 18' ' ' TYR . 15.8 m-85 74.1 142.56 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.404 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.461 ' CD ' ' CZ ' ' C' ' 96' ' ' PHE . 73.5 Cg_endo -90.12 165.85 4.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.176 2.584 . . . . 0.0 111.929 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.763 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -49.99 154.03 1.22 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -119.0 140.98 49.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.275 0.559 . . . . 0.0 112.086 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 30.5 t -144.28 45.87 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.963 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 109' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' C' ' 77' ' ' VAL . 28.8 p -81.44 135.01 35.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.312 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' A' ' 78' ' ' PHE . 23.1 m -153.82 149.23 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.19 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.841 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -84.24 91.0 7.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.72 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.643 HG21 HD21 ' C' ' 115' ' ' LEU . 27.7 m -71.16 177.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.246 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -81.8 -46.0 14.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.999 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.4 ' CB ' ' HB3' ' B' ' 111' ' ' GLU . 0.1 OUTLIER -151.71 -179.79 7.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.739 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.643 HD21 HG21 ' C' ' 112' ' ' VAL . 59.7 mt -149.14 155.58 40.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.727 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.558 ' O ' HG22 ' C' ' 119' ' ' VAL . 9.2 Cg_endo -52.31 139.22 54.9 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.536 2.157 . . . . 0.0 111.992 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 8.0 mmtm 66.45 17.73 10.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.212 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 61.64 17.43 8.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.042 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.659 HG12 ' HB ' ' C' ' 43' ' ' VAL . 30.5 m -55.71 167.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -105.86 8.35 42.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.914 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.772 HD21 HG12 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -172.37 154.46 3.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.069 0.461 . . . . 0.0 111.22 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.12 159.0 43.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.027 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.745 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.8 mt -144.26 145.75 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.359 0.599 . . . . 0.0 112.334 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.17 101.49 1.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.333 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -119.04 163.57 16.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.203 0.525 . . . . 0.0 112.185 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.403 HG23 ' HG ' ' C' ' 29' ' ' LEU . 5.7 mt -114.4 151.87 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.099 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.982 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -136.03 148.39 48.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 0.0 111.629 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.932 HG21 HG21 ' A' ' 3' ' ' THR . 35.0 m -115.89 151.42 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.12 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.09 70.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.811 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.08 HG21 HG21 ' C' ' 128' ' ' VAL . 3.1 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -171.06 125.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.798 HD13 ' OD1' ' C' ' 103' ' ' ASN . 4.2 mp -56.54 141.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.585 HD12 ' HB3' ' A' ' 21' ' ' ALA . 21.9 mt -98.01 149.84 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.24 26.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.27 171.11 20.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.3 28.44 8.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.033 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.557 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 8.1 mttm -120.5 -44.96 2.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -66.55 171.48 4.23 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.868 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.889 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 29.6 Cg_endo -63.6 -12.68 32.33 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.572 2.181 . . . . 0.0 112.523 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 69.44 147.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.492 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 19' ' ' VAL . . . -126.28 120.95 31.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.838 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 15' ' ' ILE . 3.1 mp -135.23 17.1 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.073 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.92 -118.88 2.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.382 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.81 14.92 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.675 2.25 . . . . 0.0 113.316 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -147.04 -174.06 4.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.994 0.426 . . . . 0.0 111.517 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.913 HG23 ' HB2' ' C' ' 106' ' ' ALA . 18.0 m -138.61 169.34 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.798 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -49.09 79.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.602 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB3' HD12 ' A' ' 6' ' ' ILE . . . -177.02 -178.07 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.962 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 29' ' ' LEU . 15.0 m -141.48 133.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 28' ' ' VAL . 37.6 t70 -110.8 115.39 29.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.839 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.963 HD11 HD12 ' A' ' 29' ' ' LEU . 2.8 mt -90.98 -16.03 28.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -99.3 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.755 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -56.91 -29.12 62.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.183 0.516 . . . . 0.0 110.072 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -136.21 135.19 38.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.774 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.962 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 4.8 p -109.51 164.55 5.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.871 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.963 HD12 HD11 ' A' ' 24' ' ' LEU . 3.4 mt -142.6 131.28 22.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.3 p -104.71 144.9 31.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.9 ' HB3' ' HB1' ' C' ' 106' ' ' ALA . 10.2 p -82.98 178.88 7.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.4 89.73 0.82 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.195 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.803 ' HG3' HG22 ' A' ' 58' ' ' VAL . 88.3 mm-40 -56.22 144.25 30.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.969 HG23 HG23 ' A' ' 36' ' ' VAL . 9.5 tt -125.51 132.89 24.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.702 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.688 ' HB2' HG23 ' A' ' 43' ' ' VAL . 21.9 Cg_exo -65.02 65.24 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.666 2.244 . . . . 0.0 112.56 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.969 HG23 HG23 ' A' ' 34' ' ' ILE . 63.3 t . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 121.122 0.487 . . . . 0.0 110.625 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' A' ' 35' ' ' PRO . 7.2 p . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.509 0.195 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.29 138.98 23.02 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.354 2.036 . . . . 0.0 112.191 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.73 -31.08 71.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.061 0.458 . . . . 0.0 110.902 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 94.9 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.904 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 47' ' ' ILE . 21.5 mm -44.26 -31.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.878 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.78 -38.8 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.576 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.75 -54.34 36.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.47 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.38 -26.4 68.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.341 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.88 -40.77 72.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.4 -48.82 16.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.789 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.53 -46.73 88.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.745 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.855 ' O ' HG23 ' A' ' 58' ' ' VAL . 89.2 p -60.05 -37.25 79.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 92' ' ' TYR . 22.0 mt -76.54 -23.41 53.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.043 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -52.14 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.7 OUTLIER -58.08 -29.19 65.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.982 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 123' ' ' ILE . 54.4 t -65.06 -46.39 91.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.984 0.421 . . . . 0.0 110.643 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -28.96 61.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.844 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -60.84 -40.74 93.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.025 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.442 HD11 ' OE1' ' A' ' 33' ' ' GLN . 12.8 mt -73.59 -41.77 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.619 HD13 HD11 ' A' ' 72' ' ' ILE . 18.1 mt -69.48 -31.24 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.553 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.61 -37.33 59.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.034 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -22.41 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.272 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.87 -28.82 20.1 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.787 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.97 50.51 0.63 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.591 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.552 ' HB2' HG22 ' A' ' 62' ' ' ILE . 6.1 mt -146.66 -176.56 5.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.409 . . . . 0.0 110.716 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.77 163.83 31.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.778 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.459 ' O ' ' CD2' ' A' ' 101' ' ' HIS . . . -50.26 -34.57 23.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.031 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -67.49 -24.78 65.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.359 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.529 ' HB3' HD22 ' A' ' 67' ' ' LEU . 58.0 m-20 -80.46 -6.58 58.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.717 0.294 . . . . 0.0 110.959 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 62' ' ' ILE . 24.2 mt -83.81 116.1 27.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.249 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.49 HG23 ' N ' ' A' ' 74' ' ' LYS . 35.4 m -76.58 -46.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.041 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.84 ' HD3' HD12 ' A' ' 126' ' ' ILE . 11.0 mtpt -118.41 -177.6 3.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.59 0.233 . . . . 0.0 111.093 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 105' ' ' PRO . 11.1 t -179.99 101.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.895 0.378 . . . . 0.0 111.496 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.52 HG23 ' NH1' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -71.21 126.72 30.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.198 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.8 t -114.71 98.88 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -98.17 147.49 24.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.951 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -144.76 151.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.09 0.471 . . . . 0.0 111.899 -179.223 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.0 -2.6 56.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.764 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.29 110.31 0.57 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.416 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.63 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.0 mt -56.81 -18.6 13.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.322 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -75.86 -23.47 55.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.844 0.354 . . . . 0.0 110.583 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 88' ' ' VAL . 47.4 m-20 -77.97 -12.77 60.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -27.21 59.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.252 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.46 71.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.779 0.323 . . . . 0.0 111.415 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.88 -29.45 20.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.287 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 84' ' ' ASP . 26.2 t -73.84 -47.1 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -64.86 -39.32 93.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.47 -37.27 85.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -33.34 19.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.621 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.562 ' OH ' HG21 ' A' ' 75' ' ' THR . 35.3 t80 -61.16 -56.47 20.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.346 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -70.19 -15.29 62.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.333 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -40.06 66.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -84.95 -38.78 18.91 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.342 -179.26 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.493 ' CE1' ' CE1' ' A' ' 92' ' ' TYR . 11.1 m-85 -53.92 -50.63 65.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 110.32 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.94 -32.36 74.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.875 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.65 -1.9 54.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.432 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -110.4 -8.6 14.67 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.66 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.7 t-20 97.08 19.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.796 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.3 t60 -118.77 59.93 4.32 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.858 0.361 . . . . 0.0 110.927 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.403 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 43.9 Cg_endo -68.19 -17.78 45.16 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.493 2.129 . . . . 0.0 112.175 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.763 ' OD1' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -75.42 -34.2 61.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.7 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.469 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 33.2 m-85 72.26 140.19 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.103 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.688 ' HB2' HG22 ' A' ' 75' ' ' THR . 7.2 Cg_exo -71.83 166.77 28.51 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.747 2.298 . . . . 0.0 112.138 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.919 ' HB1' ' HB3' ' B' ' 31' ' ' SER . . . -107.52 131.01 54.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.726 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.582 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -167.48 -165.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.089 0.471 . . . . 0.0 111.303 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -116.24 114.93 25.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.209 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.519 ' O ' HG13 ' A' ' 110' ' ' VAL . 16.0 m -95.69 131.47 41.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.275 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.573 HG12 HD23 ' B' ' 115' ' ' LEU . 7.4 m -158.96 170.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.494 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.866 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 6.9 tt0 -110.6 95.34 5.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.804 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.3 m -60.46 157.3 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.876 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -60.89 -45.73 93.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.992 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.567 ' HB3' HD12 ' C' ' 82' ' ' LEU . 12.4 mmt180 -151.87 173.99 14.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.688 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.531 HD23 HG12 ' C' ' 110' ' ' VAL . 1.3 mt -143.66 156.26 59.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.69 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.436 ' O ' HG22 ' A' ' 119' ' ' VAL . 12.4 Cg_endo -55.93 137.75 79.91 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.489 2.126 . . . . 0.0 111.988 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.445 ' HB2' HD11 ' A' ' 34' ' ' ILE . 10.3 mttt 68.18 16.03 9.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.328 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.97 15.58 9.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.783 HG11 HG13 ' A' ' 34' ' ' ILE . 29.3 m -51.79 169.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.713 0.292 . . . . 0.0 111.075 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.532 ' O ' HD12 ' A' ' 121' ' ' LEU . . . -116.67 17.02 13.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.027 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 120' ' ' GLY . 0.2 OUTLIER -175.17 153.44 1.59 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.102 0.477 . . . . 0.0 111.397 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.5 ' HB2' HD22 ' A' ' 115' ' ' LEU . 1.1 tp10 -142.5 140.22 31.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.884 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.889 HG21 HG21 ' A' ' 58' ' ' VAL . 28.1 mm -121.79 127.01 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 112.141 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 76' ' ' THR . 1.0 OUTLIER -140.21 146.23 38.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.08 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 124' ' ' GLU . . . -170.05 174.22 5.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.267 0.555 . . . . 0.0 112.275 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.84 HD12 ' HD3' ' A' ' 74' ' ' LYS . 5.2 mt -132.28 151.28 34.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.188 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.962 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -132.48 150.78 52.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.15 0.5 . . . . 0.0 111.756 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.032 HG21 HG21 ' B' ' 3' ' ' THR . 13.0 m -110.64 116.23 51.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.874 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.546 ' HB2' HD21 ' A' ' 67' ' ' LEU . 2.1 tmt_? . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.933 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' THR . . . . . 1.032 HG21 HG21 ' A' ' 128' ' ' VAL . 3.1 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.783 0.325 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -170.98 125.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.763 HD13 ' OD1' ' A' ' 103' ' ' ASN . 4.2 mp -56.5 141.38 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' B' ' 21' ' ' ALA . 21.8 mt -97.97 149.85 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.209 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.25 26.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.3 171.14 20.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.36 28.48 8.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.99 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.549 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 8.1 mttm -120.64 -44.5 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.747 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.891 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -66.68 171.3 4.53 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.971 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.891 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 29.7 Cg_endo -63.67 -12.72 32.73 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.563 2.176 . . . . 0.0 112.488 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 69.52 147.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.474 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.61 ' HB3' ' HA ' ' B' ' 19' ' ' VAL . . . -126.32 120.94 31.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.795 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.579 HG22 ' O ' ' B' ' 15' ' ' ILE . 3.1 mp -135.21 17.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.162 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.91 -118.96 2.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.39 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -89.64 14.72 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.787 2.325 . . . . 0.0 113.306 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.99 -174.04 4.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 0.0 111.506 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' A' ' 106' ' ' ALA . 18.1 m -138.55 169.34 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.823 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -49.17 78.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 110.636 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.582 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -177.14 -177.93 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' B' ' 29' ' ' LEU . 14.9 m -141.51 133.29 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.151 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.553 ' HA ' HG23 ' B' ' 28' ' ' VAL . 37.6 t70 -110.77 115.36 29.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.928 HD11 HD12 ' B' ' 29' ' ' LEU . 2.9 mt -90.88 -16.01 28.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.231 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.65 -99.29 0.81 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.767 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -56.93 -29.05 62.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.171 0.51 . . . . 0.0 110.111 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.679 HD23 ' O ' ' B' ' 127' ' ' ALA . 0.2 OUTLIER -136.18 135.18 38.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.717 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.947 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 4.8 p -109.54 164.48 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.923 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.928 HD12 HD11 ' B' ' 24' ' ' LEU . 3.4 mt -142.49 131.32 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.888 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 41.1 p -104.71 144.85 31.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.972 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.919 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 10.3 p -83.32 179.17 7.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.013 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.43 89.75 0.82 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.199 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.823 ' HG3' HG22 ' B' ' 58' ' ' VAL . 88.3 mm-40 -56.18 144.16 30.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.936 0.398 . . . . 0.0 111.275 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.929 HG23 HG23 ' B' ' 36' ' ' VAL . 9.6 tt -125.45 132.87 24.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.703 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.676 ' HB2' HG23 ' B' ' 43' ' ' VAL . 21.9 Cg_exo -64.98 65.2 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.69 2.26 . . . . 0.0 112.59 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.929 HG23 HG23 ' B' ' 34' ' ' ILE . 63.7 t . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.12 0.486 . . . . 0.0 110.584 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.676 HG23 ' HB2' ' B' ' 35' ' ' PRO . 7.2 p . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.539 0.209 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.16 138.91 23.25 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.399 2.066 . . . . 0.0 112.283 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.68 -31.13 71.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 110.892 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.84 94.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 21.4 mm -44.27 -31.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.879 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.4 t -79.72 -38.8 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.78 -54.26 38.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.451 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.48 -26.74 68.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.344 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.68 -40.69 72.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.01 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.45 -48.71 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -59.6 -46.71 88.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.712 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.861 ' O ' HG23 ' B' ' 58' ' ' VAL . 89.9 p -60.06 -37.25 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.859 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.496 HD21 ' CD2' ' B' ' 92' ' ' TYR . 21.9 mt -76.6 -23.3 53.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -52.07 12.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.169 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.7 OUTLIER -58.01 -29.32 65.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.893 HG21 HG21 ' B' ' 123' ' ' ILE . 54.0 t -65.02 -46.39 91.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.921 0.391 . . . . 0.0 110.6 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.09 -28.94 61.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -60.86 -40.91 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.431 HD11 ' OE1' ' B' ' 33' ' ' GLN . 13.0 mt -73.21 -41.64 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.506 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.619 HD13 HD11 ' B' ' 72' ' ' ILE . 18.0 mt -69.51 -31.31 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.535 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.51 -37.39 60.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.1 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -22.38 66.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.276 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.83 -28.9 20.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.04 50.58 0.63 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.516 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.564 HD22 ' HB3' ' B' ' 71' ' ' ASP . 6.1 mt -146.73 -176.68 5.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.988 0.423 . . . . 0.0 110.672 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.68 163.92 31.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.751 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' B' ' 101' ' ' HIS . . . -50.31 -34.62 24.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.043 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.543 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -67.49 -24.86 65.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.315 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.564 ' HB3' HD22 ' B' ' 67' ' ' LEU . 57.9 m-20 -80.38 -6.6 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.929 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.619 HD11 HD13 ' B' ' 62' ' ' ILE . 24.4 mt -83.82 116.11 27.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.221 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.499 HG23 ' N ' ' B' ' 74' ' ' LYS . 35.4 m -76.52 -47.03 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.05 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.851 ' HD3' HD12 ' B' ' 126' ' ' ILE . 10.8 mtpt -118.35 -177.58 3.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.569 0.223 . . . . 0.0 111.153 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.695 HG22 ' HB2' ' B' ' 105' ' ' PRO . 11.2 t 179.98 101.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 111.539 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.525 HG23 ' NH1' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -71.18 126.76 30.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.18 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.73 98.92 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -98.21 147.36 24.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.991 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 0.9 OUTLIER -144.68 151.76 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.173 0.511 . . . . 0.0 111.927 -179.252 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.03 -2.85 56.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.732 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.13 110.37 0.59 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.402 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.641 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.0 mt -56.92 -18.59 13.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.305 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -75.76 -23.58 55.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.558 ' O ' HG23 ' B' ' 88' ' ' VAL . 47.5 m-20 -77.91 -12.78 60.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -27.18 59.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.293 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.54 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.351 . . . . 0.0 111.408 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.87 -29.38 20.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.277 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.558 HG23 ' O ' ' B' ' 84' ' ' ASP . 26.2 t -73.87 -47.09 44.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.128 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -64.9 -39.26 93.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.59 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.34 85.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.011 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.83 -33.34 19.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.646 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.534 ' OH ' HG21 ' B' ' 75' ' ' THR . 35.4 t80 -61.23 -56.39 21.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.351 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 0.2 OUTLIER -70.28 -15.21 62.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.268 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -40.04 66.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.48 ' CE2' ' CE1' ' B' ' 96' ' ' PHE . 0.0 OUTLIER -84.95 -38.81 18.86 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.378 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.498 ' CE1' ' CE1' ' B' ' 92' ' ' TYR . 11.2 m-85 -53.86 -50.68 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.042 0.449 . . . . 0.0 110.328 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.96 -32.31 73.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.877 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.63 -1.93 55.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.463 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 1.0 OUTLIER -110.39 -8.63 14.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.637 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 2.7 t-20 97.09 19.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.761 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.543 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.3 t60 -118.53 59.86 4.01 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.961 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.411 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 44.0 Cg_endo -68.18 -17.79 45.23 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.457 2.105 . . . . 0.0 112.181 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.776 ' OD1' HD13 ' C' ' 5' ' ' ILE . 0.1 OUTLIER -75.4 -34.22 61.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' B' ' 105' ' ' PRO . 33.0 m-85 72.26 140.19 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.695 ' HB2' HG22 ' B' ' 75' ' ' THR . 7.2 Cg_exo -71.87 166.74 28.61 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.724 2.283 . . . . 0.0 112.113 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.943 ' HB1' ' HB3' ' C' ' 31' ' ' SER . . . -107.45 131.02 54.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.761 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.581 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -167.51 -165.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.049 0.452 . . . . 0.0 111.33 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -116.16 114.93 25.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.224 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' CYS . . . . . 0.529 ' O ' HG13 ' B' ' 110' ' ' VAL . 16.0 m -95.69 131.52 41.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.207 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.543 HG12 HD23 ' C' ' 115' ' ' LEU . 7.2 m -158.96 170.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 111.413 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.872 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 6.9 tt0 -110.2 95.4 5.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.676 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -60.62 157.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.065 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -60.77 -45.67 93.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.041 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.63 ' HB3' HD12 ' A' ' 82' ' ' LEU . 12.4 mmt180 -151.94 173.98 14.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.733 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.573 HD23 HG12 ' A' ' 110' ' ' VAL . 1.3 mt -143.66 156.31 59.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.7 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.433 ' O ' HG22 ' B' ' 119' ' ' VAL . 12.4 Cg_endo -55.98 137.76 80.12 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.449 2.1 . . . . 0.0 112.052 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.446 ' HB2' HG13 ' B' ' 119' ' ' VAL . 10.3 mttt 68.23 15.97 9.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.356 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.99 15.62 9.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.088 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.781 HG11 HG13 ' B' ' 34' ' ' ILE . 29.2 m -51.84 169.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.057 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 120' ' ' GLY . . . . . 0.53 ' O ' HD12 ' B' ' 121' ' ' LEU . . . -116.67 16.81 13.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.016 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.53 HD12 ' O ' ' B' ' 120' ' ' GLY . 0.2 OUTLIER -175.11 153.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.109 0.481 . . . . 0.0 111.433 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.479 ' HB2' HD22 ' B' ' 115' ' ' LEU . 1.1 tp10 -142.43 140.25 31.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.903 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.893 HG21 HG21 ' B' ' 58' ' ' VAL . 28.2 mm -121.81 127.05 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.146 0.498 . . . . 0.0 112.12 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 124' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' B' ' 76' ' ' THR . 1.0 OUTLIER -140.29 146.21 38.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.051 179.146 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' B' ' 124' ' ' GLU . . . -170.01 174.24 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.286 0.565 . . . . 0.0 112.269 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.851 HD12 ' HD3' ' B' ' 74' ' ' LYS . 5.2 mt -132.35 151.2 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.172 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.947 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -132.45 150.82 52.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.053 0.454 . . . . 0.0 111.731 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.998 HG21 HG21 ' C' ' 3' ' ' THR . 13.2 m -110.67 116.21 51.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.891 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.547 ' HB2' HD21 ' B' ' 67' ' ' LEU . 2.1 tmt_? . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.975 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.998 HG21 HG21 ' B' ' 128' ' ' VAL . 3.1 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.784 0.326 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -171.06 125.28 0.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.776 HD13 ' OD1' ' B' ' 103' ' ' ASN . 4.2 mp -56.42 141.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.6 HD12 ' HB3' ' C' ' 21' ' ' ALA . 22.0 mt -98.05 149.88 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.24 26.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.28 171.15 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.34 28.42 8.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.023 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.549 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 8.0 mttm -120.65 -44.6 2.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.74 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -66.79 171.22 4.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.042 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.889 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 29.6 Cg_endo -63.61 -12.71 32.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.533 2.155 . . . . 0.0 112.506 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 69.45 147.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.488 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' C' ' 19' ' ' VAL . . . -126.35 120.99 31.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.756 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.572 HG22 ' O ' ' C' ' 15' ' ' ILE . 3.1 mp -135.24 17.14 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.11 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.95 -118.88 2.91 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.418 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.75 14.81 2.07 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.784 2.323 . . . . 0.0 113.306 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -147.07 -174.06 4.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.948 0.404 . . . . 0.0 111.495 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.89 HG23 ' HB2' ' B' ' 106' ' ' ALA . 17.8 m -138.55 169.35 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.75 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -48.89 79.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 110.592 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.6 ' HB3' HD12 ' C' ' 6' ' ' ILE . . . -177.4 -177.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.898 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' C' ' 29' ' ' LEU . 15.0 m -141.47 133.34 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.05 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.542 ' HA ' HG23 ' C' ' 28' ' ' VAL . 37.5 t70 -110.77 115.4 29.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.937 HD11 HD12 ' C' ' 29' ' ' LEU . 2.9 mt -91.01 -16.07 28.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.143 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.67 -99.27 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.762 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -56.99 -29.0 62.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.159 0.504 . . . . 0.0 110.081 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.687 HD23 ' O ' ' C' ' 127' ' ' ALA . 0.2 OUTLIER -136.17 135.22 38.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.746 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.967 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 4.8 p -109.59 164.49 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.847 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.937 HD12 HD11 ' C' ' 24' ' ' LEU . 3.4 mt -142.55 131.3 22.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.887 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 40.9 p -104.63 144.35 31.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 31' ' ' SER . . . . . 0.943 ' HB3' ' HB1' ' B' ' 106' ' ' ALA . 10.1 p -83.03 179.1 7.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.51 89.74 0.83 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.177 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.821 ' HG3' HG22 ' C' ' 58' ' ' VAL . 88.3 mm-40 -56.12 144.17 30.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.286 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.972 HG23 HG23 ' C' ' 36' ' ' VAL . 9.5 tt -125.49 132.9 24.44 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.691 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.685 ' HB2' HG23 ' C' ' 43' ' ' VAL . 21.9 Cg_exo -64.93 65.25 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.657 2.238 . . . . 0.0 112.574 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.972 HG23 HG23 ' C' ' 34' ' ' ILE . 63.5 t . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.59 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.685 HG23 ' HB2' ' C' ' 35' ' ' PRO . 7.3 p . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.504 0.192 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.24 138.92 23.09 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.407 2.072 . . . . 0.0 112.242 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.72 -31.07 71.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 94.96 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.887 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 21.5 mm -44.32 -31.0 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.933 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.79 -38.73 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.6 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.79 -54.28 37.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.478 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.52 -26.82 68.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.332 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.65 72.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.1 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.44 -48.7 16.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.763 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.62 -46.65 88.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.767 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.857 ' O ' HG23 ' C' ' 58' ' ' VAL . 90.3 p -60.04 -37.29 79.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.487 HD21 ' CD2' ' C' ' 92' ' ' TYR . 21.9 mt -76.56 -23.35 53.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.094 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.69 -52.08 12.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.203 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 57' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.6 OUTLIER -58.09 -29.2 65.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.939 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.908 HG21 HG21 ' C' ' 123' ' ' ILE . 54.3 t -65.16 -46.25 91.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.905 0.383 . . . . 0.0 110.602 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -28.87 61.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -60.87 -40.88 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.03 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.432 HD11 ' OE1' ' C' ' 33' ' ' GLN . 13.0 mt -73.13 -41.69 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.518 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.611 HD13 HD11 ' C' ' 72' ' ' ILE . 18.2 mt -69.5 -31.38 48.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.485 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.47 -37.33 60.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.106 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -22.43 66.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.276 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.88 -28.81 20.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.824 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.99 50.51 0.63 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.568 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' C' ' 71' ' ' ASP . 6.1 mt -146.67 -176.66 5.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 110.68 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.68 163.85 31.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.47 ' O ' ' CD2' ' C' ' 101' ' ' HIS . . . -50.21 -34.74 23.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.548 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -67.38 -24.72 65.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.324 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.566 ' HB3' HD22 ' C' ' 67' ' ' LEU . 57.9 m-20 -80.67 -6.52 58.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.934 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.611 HD11 HD13 ' C' ' 62' ' ' ILE . 24.7 mt -83.88 116.08 27.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.188 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.504 HG23 ' N ' ' C' ' 74' ' ' LYS . 35.4 m -76.57 -46.93 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.014 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.872 ' HD3' HD12 ' C' ' 126' ' ' ILE . 10.8 mtpt -118.4 -177.7 3.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.591 0.234 . . . . 0.0 111.158 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.683 HG22 ' HB2' ' C' ' 105' ' ' PRO . 11.1 t -179.94 101.04 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.84 0.352 . . . . 0.0 111.509 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.52 HG23 ' NH1' ' C' ' 107' ' ' ARG . 0.0 OUTLIER -71.18 126.72 30.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.233 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.67 98.89 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -98.21 147.38 24.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.957 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 0.9 OUTLIER -144.68 151.79 15.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.479 . . . . 0.0 111.959 -179.274 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.05 -2.91 56.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.727 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.09 110.28 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.327 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.0 mt -56.89 -18.57 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -75.79 -23.57 55.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.617 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.552 ' O ' HG23 ' C' ' 88' ' ' VAL . 47.7 m-20 -77.88 -12.79 60.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -27.11 60.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.27 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.59 -42.54 71.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.815 0.34 . . . . 0.0 111.381 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.84 -29.45 20.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.275 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 88' ' ' VAL . . . . . 0.552 HG23 ' O ' ' C' ' 84' ' ' ASP . 26.1 t -73.82 -47.16 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.102 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -64.82 -39.32 93.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.596 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.42 -37.28 85.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.051 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.8 -33.33 19.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.594 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.545 ' OH ' HG21 ' C' ' 75' ' ' THR . 35.5 t80 -61.23 -56.43 20.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.36 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 93' ' ' GLU . . . . . 0.426 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 0.2 OUTLIER -70.22 -15.22 62.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.302 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -40.1 66.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.483 ' CE2' ' CE1' ' C' ' 96' ' ' PHE . 0.0 OUTLIER -84.91 -38.85 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.343 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.495 ' CE1' ' CE1' ' C' ' 92' ' ' TYR . 11.2 m-85 -53.86 -50.65 65.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 110.371 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.96 -32.24 73.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.911 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -83.76 -1.81 54.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.432 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 1.0 OUTLIER -110.39 -8.69 14.66 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.667 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 2.8 t-20 97.09 19.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.795 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.548 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.3 t60 -118.57 59.88 4.07 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.859 0.362 . . . . 0.0 110.91 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CE2' ' C' ' 104' ' ' PHE . 43.4 Cg_endo -68.16 -17.85 45.35 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.486 2.124 . . . . 0.0 112.15 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.798 ' OD1' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -75.41 -34.16 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.694 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' C' ' 105' ' ' PRO . 33.2 m-85 72.24 140.14 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.08 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.683 ' HB2' HG22 ' C' ' 75' ' ' THR . 7.2 Cg_exo -71.71 166.72 28.59 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.777 2.318 . . . . 0.0 112.113 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.913 ' HB2' HG23 ' A' ' 19' ' ' VAL . . . -107.54 130.91 54.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.792 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.593 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -167.41 -165.53 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.0 111.324 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 3.1 p -116.2 114.84 24.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.256 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 109' ' ' CYS . . . . . 0.524 ' O ' HG13 ' C' ' 110' ' ' VAL . 15.8 m -95.67 131.49 41.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.265 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 115' ' ' LEU . 7.2 m -158.97 170.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.947 0.403 . . . . 0.0 111.478 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.876 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 6.9 tt0 -110.26 95.36 5.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 29.9 m -60.51 157.27 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -60.93 -45.63 93.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.011 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.641 ' HB3' HD12 ' B' ' 82' ' ' LEU . 12.3 mmt180 -151.93 173.94 14.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.727 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.543 HD23 HG12 ' B' ' 110' ' ' VAL . 1.3 mt -143.65 156.25 59.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.71 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.438 ' O ' HG22 ' C' ' 119' ' ' VAL . 12.4 Cg_endo -55.89 137.7 79.65 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.472 2.114 . . . . 0.0 112.069 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.439 ' HB2' HG13 ' C' ' 119' ' ' VAL . 10.3 mttt 68.21 16.02 9.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.392 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.89 15.69 9.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.808 HG11 HG13 ' C' ' 34' ' ' ILE . 29.3 m -51.83 169.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.736 0.303 . . . . 0.0 111.034 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 120' ' ' GLY . . . . . 0.541 ' O ' HD12 ' C' ' 121' ' ' LEU . . . -116.67 16.97 13.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.045 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.541 HD12 ' O ' ' C' ' 120' ' ' GLY . 0.2 OUTLIER -175.22 153.44 1.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.173 0.511 . . . . 0.0 111.367 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.492 ' HB2' HD22 ' C' ' 115' ' ' LEU . 1.1 tp10 -142.46 140.26 31.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.89 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.908 HG21 HG21 ' C' ' 58' ' ' VAL . 28.3 mm -121.78 127.01 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.094 0.474 . . . . 0.0 112.162 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 124' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' C' ' 76' ' ' THR . 1.0 OUTLIER -140.19 146.19 38.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.071 179.161 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' C' ' 124' ' ' GLU . . . -169.99 174.33 5.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.214 0.531 . . . . 0.0 112.332 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.872 HD12 ' HD3' ' C' ' 74' ' ' LYS . 5.2 mt -132.41 151.21 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.214 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.967 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -132.45 150.73 52.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.08 0.467 . . . . 0.0 111.739 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 1.08 HG21 HG21 ' A' ' 3' ' ' THR . 13.0 m -110.62 116.33 52.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.861 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.527 ' HB2' HD21 ' C' ' 67' ' ' LEU . 2.1 tmt_? -122.74 75.92 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.897 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.486 HG23 ' CD2' ' A' ' 24' ' ' LEU . 18.8 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.006 0.431 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HD23 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.694 HD11 ' OD1' ' C' ' 103' ' ' ASN . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.719 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 14' ' ' ALA . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.843 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' C' ' 104' ' ' PHE . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 29' ' ' LEU . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.565 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.916 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.446 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 25' ' ' GLY . 9.1 m-80 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 128' ' ' VAL . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.959 HG23 ' HB3' ' A' ' 127' ' ' ALA . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 62' ' ' ILE . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.693 ' HB ' HG11 ' A' ' 119' ' ' VAL . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 34' ' ' ILE . 32.9 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.607 0.241 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.406 ' OE1' HD13 ' A' ' 47' ' ' ILE . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.782 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 54' ' ' SER . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.719 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 30' ' ' THR . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.844 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 126' ' ' ILE . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 128' ' ' VAL . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 125' ' ' ALA . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 108' ' ' SER . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 122' ' ' GLU . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.712 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 85' ' ' PHE . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' A' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.475 ' OH ' HG21 ' A' ' 75' ' ' THR . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.743 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.844 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 m-70 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.691 ' CG ' HD11 ' B' ' 5' ' ' ILE . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.731 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 72' ' ' ILE . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 76' ' ' THR . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.596 ' HB3' HD12 ' C' ' 82' ' ' LEU . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 78' ' ' PHE . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 34' ' ' ILE . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.795 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' ' 35' ' ' PRO . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.725 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' ILE . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.959 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 73' ' ' VAL . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB3' HD21 ' A' ' 67' ' ' LEU . 14.1 ptm180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.481 HG23 ' CD2' ' B' ' 24' ' ' LEU . 19.0 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.977 0.417 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.568 ' OE1' HD23 ' B' ' 24' ' ' LEU . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.691 HD11 ' CG ' ' A' ' 103' ' ' ASN . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.722 ' HB2' ' CG1' ' B' ' 61' ' ' ILE . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.786 HD13 ' O ' ' B' ' 14' ' ' ALA . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.84 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 104' ' ' PHE . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 11' ' ' ALA . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.53 HG23 HD13 ' B' ' 29' ' ' LEU . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.562 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.515 HD13 HG12 ' B' ' 128' ' ' VAL . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' B' ' 127' ' ' ALA . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.631 HD12 ' N ' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.737 HG21 HD11 ' B' ' 62' ' ' ILE . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.484 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.716 ' HB ' HG11 ' B' ' 119' ' ' VAL . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.565 HG23 HG13 ' B' ' 34' ' ' ILE . 33.3 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.791 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.3 p . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.595 0.236 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' B' ' 47' ' ' ILE . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' B' ' 95' ' ' PHE . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' B' ' 54' ' ' SER . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.722 ' CG1' ' HB2' ' B' ' 11' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.737 HD11 HG21 ' B' ' 30' ' ' THR . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.697 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.477 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 126' ' ' ILE . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.635 HG13 HG22 ' B' ' 128' ' ' VAL . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' LYS . . . . . 0.681 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.727 HG23 ' HB2' ' B' ' 125' ' ' ALA . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 108' ' ' SER . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.702 HG13 ' O ' ' B' ' 122' ' ' GLU . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.507 HG11 ' HD1' ' B' ' 85' ' ' PHE . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.507 ' HD1' HG11 ' B' ' 79' ' ' VAL . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' B' ' 75' ' ' THR . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.742 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 101' ' ' HIS . . . . . 0.851 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.8 m-70 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.7 ' CG ' HD11 ' C' ' 5' ' ' ILE . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.72 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' B' ' 72' ' ' ILE . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.431 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.845 ' O ' HG23 ' B' ' 76' ' ' THR . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' VAL . . . . . 0.729 HG11 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.543 ' HB3' HD12 ' A' ' 82' ' ' LEU . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HB2' ' B' ' 78' ' ' PHE . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.482 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 119' ' ' VAL . . . . . 0.716 HG11 ' HB ' ' B' ' 34' ' ' ILE . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 120' ' ' GLY . . . . . 0.791 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.468 HD11 ' HG3' ' B' ' 35' ' ' PRO . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.702 ' O ' HG13 ' B' ' 77' ' ' VAL . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.56 ' CG2' HG21 ' B' ' 58' ' ' VAL . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 72' ' ' ILE . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.997 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.635 HG22 HG13 ' B' ' 73' ' ' VAL . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' B' ' 67' ' ' LEU . 14.1 ptm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.48 HG23 ' CD2' ' C' ' 24' ' ' LEU . 19.0 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 4' ' ' GLN . . . . . 0.562 ' OE1' HD23 ' C' ' 24' ' ' LEU . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 5' ' ' ILE . . . . . 0.7 HD11 ' CG ' ' B' ' 103' ' ' ASN . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 10' ' ' LYS . . . . . 0.497 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.721 ' HB2' ' CG1' ' C' ' 61' ' ' ILE . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 12' ' ' PRO . . . . . 0.67 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.779 HD13 ' O ' ' C' ' 14' ' ' ALA . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 18' ' ' TYR . . . . . 0.826 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' B' ' 104' ' ' PHE . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 22' ' ' VAL . . . . . 0.535 HG23 HD13 ' C' ' 29' ' ' LEU . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 23' ' ' ASP . . . . . 0.559 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.898 HD13 ' O ' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.482 HD13 HG12 ' C' ' 128' ' ' VAL . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.63 ' N ' HD12 ' C' ' 29' ' ' LEU . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.711 HG21 HD11 ' C' ' 62' ' ' ILE . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 34' ' ' ILE . . . . . 0.691 ' HB ' HG11 ' C' ' 119' ' ' VAL . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 36' ' ' VAL . . . . . 0.561 HG23 HG13 ' C' ' 34' ' ' ILE . 32.8 t . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 43' ' ' VAL . . . . . 0.789 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.3 p . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.582 0.229 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 46' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' C' ' 51' ' ' ALA . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 49' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.401 ' OE1' HD13 ' C' ' 47' ' ' ILE . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 54' ' ' SER . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.721 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 62' ' ' ILE . . . . . 0.711 HD11 HG21 ' C' ' 30' ' ' THR . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.694 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 71' ' ' ASP . . . . . 0.464 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 72' ' ' ILE . . . . . 0.484 HG23 ' O ' ' C' ' 126' ' ' ILE . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.636 HG13 HG22 ' C' ' 128' ' ' VAL . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 75' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' ALA . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.847 HG23 ' O ' ' C' ' 108' ' ' SER . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.714 HG13 ' O ' ' C' ' 122' ' ' GLU . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 78' ' ' PHE . . . . . 0.729 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' C' ' 85' ' ' PHE . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' C' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 92' ' ' TYR . . . . . 0.479 ' OH ' HG21 ' C' ' 75' ' ' THR . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.749 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 101' ' ' HIS . . . . . 0.851 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.8 m-70 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 103' ' ' ASN . . . . . 0.694 ' OD1' HD11 ' A' ' 5' ' ' ILE . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.704 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 105' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' C' ' 72' ' ' ILE . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 107' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 108' ' ' SER . . . . . 0.847 ' O ' HG23 ' C' ' 76' ' ' THR . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 110' ' ' VAL . . . . . 0.712 HG11 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 111' ' ' GLU . . . . . 0.731 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 113' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.581 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 115' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' C' ' 78' ' ' PHE . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 116' ' ' PRO . . . . . 0.582 ' O ' HG22 ' C' ' 119' ' ' VAL . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 117' ' ' LYS . . . . . 0.484 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' C' ' 34' ' ' ILE . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 120' ' ' GLY . . . . . 0.789 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' C' ' 35' ' ' PRO . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 77' ' ' VAL . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 123' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' HB ' ' C' ' 76' ' ' THR . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.705 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 126' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' ILE . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 127' ' ' ALA . . . . . 0.956 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 128' ' ' VAL . . . . . 0.636 HG22 HG13 ' C' ' 73' ' ' VAL . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 129' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' C' ' 67' ' ' LEU . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.869 0.366 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.23 168.49 19.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.486 HG23 ' CD2' ' A' ' 24' ' ' LEU . 18.8 m -165.16 116.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HD23 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.694 HD11 ' OD1' ' C' ' 103' ' ' ASN . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.719 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 14' ' ' ALA . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.843 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' C' ' 104' ' ' PHE . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 29' ' ' LEU . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.565 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.916 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.446 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 25' ' ' GLY . 9.1 m-80 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 128' ' ' VAL . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.959 HG23 ' HB3' ' A' ' 127' ' ' ALA . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 62' ' ' ILE . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.693 ' HB ' HG11 ' A' ' 119' ' ' VAL . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 34' ' ' ILE . 32.9 t -63.02 85.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 41' ' ' GLY . 36.7 t-20 -35.11 129.88 0.5 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.989 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.53 -10.59 29.14 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 112.178 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.5 -21.36 8.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.68 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.416 HG22 ' CG ' ' A' ' 42' ' ' GLU . 3.5 m -114.75 -25.2 8.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 63.67 56.06 21.4 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.323 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' CG ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER -164.27 -81.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.704 0.288 . . . . 0.0 111.625 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p -173.89 106.83 0.3 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.406 ' OE1' HD13 ' A' ' 47' ' ' ILE . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.782 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 54' ' ' SER . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.719 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 30' ' ' THR . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.844 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 126' ' ' ILE . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 128' ' ' VAL . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 125' ' ' ALA . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 108' ' ' SER . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 122' ' ' GLU . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.712 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 85' ' ' PHE . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' A' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.475 ' OH ' HG21 ' A' ' 75' ' ' THR . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.743 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.844 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 m-70 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.691 ' CG ' HD11 ' B' ' 5' ' ' ILE . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.731 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 72' ' ' ILE . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 76' ' ' THR . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.596 ' HB3' HD12 ' C' ' 82' ' ' LEU . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 78' ' ' PHE . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 34' ' ' ILE . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.795 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' ' 35' ' ' PRO . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.725 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' ILE . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.959 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 73' ' ' VAL . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB3' HD21 ' A' ' 67' ' ' LEU . 14.1 ptm180 -164.77 46.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.832 0.349 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.24 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.481 HG23 ' CD2' ' B' ' 24' ' ' LEU . 19.0 m -165.18 116.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.568 ' OE1' HD23 ' B' ' 24' ' ' LEU . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.691 HD11 ' CG ' ' A' ' 103' ' ' ASN . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.722 ' HB2' ' CG1' ' B' ' 61' ' ' ILE . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.786 HD13 ' O ' ' B' ' 14' ' ' ALA . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.84 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 104' ' ' PHE . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 11' ' ' ALA . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.53 HG23 HD13 ' B' ' 29' ' ' LEU . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.562 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.515 HD13 HG12 ' B' ' 128' ' ' VAL . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' B' ' 127' ' ' ALA . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.631 HD12 ' N ' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.737 HG21 HD11 ' B' ' 62' ' ' ILE . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.484 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.716 ' HB ' HG11 ' B' ' 119' ' ' VAL . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.565 HG23 HG13 ' B' ' 34' ' ' ILE . 33.3 t -63.01 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.402 ' HB3' ' HB ' ' B' ' 40' ' ' THR . 36.6 t-20 -35.14 129.93 0.51 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.935 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.58 -10.63 29.2 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.023 . . . . 0.0 112.192 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.4 -21.41 8.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.78 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' B' ' 37' ' ' ASN . 3.5 m -114.77 -25.32 8.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.456 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 63.81 56.13 20.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.401 ' CG ' HG22 ' B' ' 40' ' ' THR . 0.0 OUTLIER -164.36 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.623 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.791 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.3 p -173.94 106.72 0.3 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' B' ' 47' ' ' ILE . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' B' ' 95' ' ' PHE . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' B' ' 54' ' ' SER . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.722 ' CG1' ' HB2' ' B' ' 11' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.737 HD11 HG21 ' B' ' 30' ' ' THR . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.697 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.477 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 126' ' ' ILE . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.635 HG13 HG22 ' B' ' 128' ' ' VAL . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.681 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.727 HG23 ' HB2' ' B' ' 125' ' ' ALA . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 108' ' ' SER . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.702 HG13 ' O ' ' B' ' 122' ' ' GLU . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.507 HG11 ' HD1' ' B' ' 85' ' ' PHE . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.507 ' HD1' HG11 ' B' ' 79' ' ' VAL . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' B' ' 75' ' ' THR . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.742 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.851 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.8 m-70 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.7 ' CG ' HD11 ' C' ' 5' ' ' ILE . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.72 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' B' ' 72' ' ' ILE . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.431 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.845 ' O ' HG23 ' B' ' 76' ' ' THR . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.729 HG11 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.543 ' HB3' HD12 ' A' ' 82' ' ' LEU . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HB2' ' B' ' 78' ' ' PHE . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.482 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.716 HG11 ' HB ' ' B' ' 34' ' ' ILE . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' GLY . . . . . 0.791 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.468 HD11 ' HG3' ' B' ' 35' ' ' PRO . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.702 ' O ' HG13 ' B' ' 77' ' ' VAL . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.56 ' CG2' HG21 ' B' ' 58' ' ' VAL . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 72' ' ' ILE . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.997 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.635 HG22 HG13 ' B' ' 73' ' ' VAL . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' B' ' 67' ' ' LEU . 14.1 ptm180 -164.83 46.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.951 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.21 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.48 HG23 ' CD2' ' C' ' 24' ' ' LEU . 19.0 m -165.22 116.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.562 ' OE1' HD23 ' C' ' 24' ' ' LEU . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.7 HD11 ' CG ' ' B' ' 103' ' ' ASN . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.497 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.721 ' HB2' ' CG1' ' C' ' 61' ' ' ILE . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.67 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.779 HD13 ' O ' ' C' ' 14' ' ' ALA . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.826 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' B' ' 104' ' ' PHE . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.535 HG23 HD13 ' C' ' 29' ' ' LEU . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.559 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.898 HD13 ' O ' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.482 HD13 HG12 ' C' ' 128' ' ' VAL . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.63 ' N ' HD12 ' C' ' 29' ' ' LEU . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.711 HG21 HD11 ' C' ' 62' ' ' ILE . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.691 ' HB ' HG11 ' C' ' 119' ' ' VAL . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.561 HG23 HG13 ' C' ' 34' ' ' ILE . 32.8 t -63.06 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' C' ' 41' ' ' GLY . 36.7 t-20 -35.13 129.94 0.51 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.56 -10.6 29.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.31 2.007 . . . . 0.0 112.18 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.44 -21.43 8.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.729 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.408 HG22 ' CG ' ' C' ' 42' ' ' GLU . 3.5 m -114.8 -25.24 8.32 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 63.64 56.1 21.27 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.395 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.408 ' CG ' HG22 ' C' ' 40' ' ' THR . 0.0 OUTLIER -164.26 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.61 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.789 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.3 p -173.93 106.74 0.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.365 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' C' ' 51' ' ' ALA . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.401 ' OE1' HD13 ' C' ' 47' ' ' ILE . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 54' ' ' SER . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.721 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.711 HD11 HG21 ' C' ' 30' ' ' THR . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.694 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.464 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.484 HG23 ' O ' ' C' ' 126' ' ' ILE . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.636 HG13 HG22 ' C' ' 128' ' ' VAL . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' ALA . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.847 HG23 ' O ' ' C' ' 108' ' ' SER . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.714 HG13 ' O ' ' C' ' 122' ' ' GLU . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.729 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' C' ' 85' ' ' PHE . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' C' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.479 ' OH ' HG21 ' C' ' 75' ' ' THR . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.749 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.851 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.8 m-70 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.694 ' OD1' HD11 ' A' ' 5' ' ' ILE . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.704 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' C' ' 72' ' ' ILE . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 108' ' ' SER . . . . . 0.847 ' O ' HG23 ' C' ' 76' ' ' THR . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.712 HG11 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.731 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.581 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' C' ' 78' ' ' PHE . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.582 ' O ' HG22 ' C' ' 119' ' ' VAL . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.484 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' C' ' 34' ' ' ILE . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 120' ' ' GLY . . . . . 0.789 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' C' ' 35' ' ' PRO . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 77' ' ' VAL . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' HB ' ' C' ' 76' ' ' THR . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.705 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' ILE . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.956 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.636 HG22 HG13 ' C' ' 73' ' ' VAL . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' C' ' 67' ' ' LEU . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.827 0.346 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.8 -175.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 21.8 m 63.58 128.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.924 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.511 ' HA ' ' N ' ' A' ' 23' ' ' ASP . 12.3 pt20 43.77 -165.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.743 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.638 HD11 ' O ' ' C' ' 103' ' ' ASN . 34.3 mm 68.69 116.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.959 0.409 . . . . 0.0 111.633 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 36.3 mt -142.11 91.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.77 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -102.22 128.98 48.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.991 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 t -144.86 153.74 41.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 30.7 3.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.458 ' HG2' ' HB1' ' A' ' 60' ' ' ALA . 4.6 tptm -117.6 -36.82 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . -99.88 122.47 50.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.273 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 7.5 Cg_exo -72.93 3.07 4.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.67 2.247 . . . . 0.0 112.829 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.636 ' HB1' ' OE1' ' A' ' 33' ' ' GLN . . . -50.32 -178.17 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.998 0.428 . . . . 0.0 111.809 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.58 ' C ' HD12 ' A' ' 15' ' ' ILE . . . 64.05 118.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.048 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.9 mp -146.79 17.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.342 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.92 -148.64 4.79 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.449 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.48 ' HA ' ' CE2' ' C' ' 104' ' ' PHE . 84.8 Cg_endo -87.57 34.33 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.859 2.373 . . . . 0.0 112.957 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.456 ' CD2' ' HB2' ' C' ' 107' ' ' ARG . 9.9 p90 -130.39 164.97 23.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.776 0.322 . . . . 0.0 110.821 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.956 HG13 ' HB3' ' C' ' 104' ' ' PHE . 19.9 m -91.54 147.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.437 ' HG2' ' HB2' ' A' ' 14' ' ' ALA . 15.4 mt-30 -46.11 -48.85 17.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.44 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.627 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -157.58 -175.28 5.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.451 ' C ' HD11 ' A' ' 6' ' ' ILE . 29.1 m -136.23 129.26 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.114 0.483 . . . . 0.0 111.922 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.511 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 44.1 t0 -113.14 103.97 11.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.803 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 4' ' ' GLN . 33.6 mt -84.04 -18.69 36.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.105 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.05 -108.68 0.91 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.827 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.6 -30.19 62.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 110.065 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HG ' HG23 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -121.92 127.88 50.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.581 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.938 HG23 ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -105.75 179.4 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.243 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -159.9 146.83 16.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.0 p -121.1 142.25 50.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.8 m -79.03 165.99 22.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.26 74.4 0.28 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.987 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.636 ' OE1' ' HB1' ' A' ' 13' ' ' ALA . 17.3 mm-40 -66.46 165.21 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.031 0.444 . . . . 0.0 111.352 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.8 ' HB ' HG11 ' A' ' 119' ' ' VAL . 3.4 pt -138.99 159.07 68.44 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.243 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.531 ' O ' HG12 ' A' ' 36' ' ' VAL . 85.5 Cg_exo -42.28 -45.39 7.74 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.64 2.227 . . . . 0.0 111.932 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.84 HG22 ' HA2' ' A' ' 41' ' ' GLY . 8.5 p 44.04 25.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.565 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.409 ' H ' ' HD3' ' A' ' 44' ' ' PRO . 7.9 m120 56.12 159.92 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 0.0 111.354 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.68 -26.02 7.35 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.549 2.166 . . . . 0.0 112.031 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.91 19.68 0.26 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.341 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.92 -27.24 8.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 110.575 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.84 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . 71.41 45.11 49.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.925 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 6.4 mm-40 -146.47 -77.19 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.721 0.261 . . . . 0.0 110.789 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.731 ' HB ' HG12 ' A' ' 119' ' ' VAL . 7.1 p 172.07 128.29 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.877 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 4.9 Cg_exo -76.58 153.12 34.23 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.684 2.256 . . . . 0.0 112.091 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.1 -30.85 55.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.074 0.464 . . . . 0.0 110.741 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -68.48 94.24 0.55 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.885 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.624 HD13 ' NE2' ' A' ' 50' ' ' GLN . 28.9 mm -40.32 -33.3 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.34 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.12 -46.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.699 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' A' ' 46' ' ' ASP . . . -61.37 -36.19 79.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.706 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.66 ' HG3' HD21 ' A' ' 121' ' ' LEU . 10.4 pt20 -77.61 -28.39 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.608 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.11 -31.55 25.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.248 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -38.35 29.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.17 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.55 -31.06 66.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.871 0.367 . . . . 0.0 110.823 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.839 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -70.03 -30.85 68.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.748 HD13 ' CE2' ' A' ' 95' ' ' PHE . 57.4 mt -74.6 -33.85 62.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.38 -48.69 64.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.999 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -57.6 -48.2 80.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.092 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 54' ' ' SER . 27.2 t -59.63 -29.97 43.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 1.9 ttpp -79.15 -39.83 32.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.043 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 10' ' ' LYS . . . -62.04 -36.41 81.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.976 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 58' ' ' VAL . 8.1 mt -70.21 -51.87 35.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 127' ' ' ALA . 3.7 tt -65.26 -22.43 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.076 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -82.95 -37.74 23.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.891 0.377 . . . . 0.0 110.31 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -11.15 60.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.97 -29.93 35.22 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.925 0.393 . . . . 0.0 110.335 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.3 28.5 1.0 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.141 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -146.84 -166.97 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.329 . . . . 0.0 110.69 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.58 153.73 49.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.852 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -57.25 -38.92 74.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -51.19 -29.86 15.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.06 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.74 -22.4 58.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.627 HG23 ' O ' ' A' ' 126' ' ' ILE . 76.6 mt -47.76 114.88 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.97 0.414 . . . . 0.0 110.97 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.622 ' CG1' HG12 ' A' ' 128' ' ' VAL . 32.8 m -89.62 -31.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.702 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.771 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 78.1 tttt -134.44 163.0 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 111.055 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.739 HG23 ' HB2' ' A' ' 125' ' ' ALA . 30.4 m -158.75 139.56 12.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.303 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 108' ' ' SER . 96.7 m -123.63 147.41 47.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.176 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.9 t -149.22 109.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 111.697 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.709 ' CD2' HG11 ' C' ' 110' ' ' VAL . 8.6 m-85 -89.0 110.23 20.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.47 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.408 HG11 ' HD1' ' A' ' 85' ' ' PHE . 31.3 m -101.38 144.89 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -85.03 -1.55 56.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.221 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.2 127.22 1.46 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.512 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.15 -11.92 52.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.65 -20.82 45.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.361 . . . . 0.0 110.693 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.6 -27.25 20.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 44.3 t80 -57.68 -28.77 64.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.13 -32.28 67.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.263 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.49 -34.95 18.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.221 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.7 -39.71 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.413 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 32.8 t30 -68.89 -36.55 78.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.51 -32.39 66.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.61 -30.35 19.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.088 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.716 ' OH ' HG21 ' A' ' 75' ' ' THR . 10.0 t80 -58.43 -43.93 88.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.91 -29.36 35.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.18 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.48 75.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.036 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.748 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -89.32 -36.54 15.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.636 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.509 ' CD2' ' HB2' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -54.99 -53.59 53.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.807 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -72.82 -26.43 61.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.387 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 95' ' ' PHE . 2.4 mm-40 -76.47 -13.32 60.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.553 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 12.6 m-80 -101.4 -17.29 16.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.011 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 5.2 p-10 103.5 35.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.154 0.909 . . . . 0.0 110.396 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.852 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 2.0 m-70 -114.97 55.27 0.87 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.376 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.491 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 88.8 Cg_endo -79.12 2.74 8.04 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.661 2.241 . . . . 0.0 113.112 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.63 ' O ' HD11 ' B' ' 5' ' ' ILE . 2.2 t-20 -64.48 -30.08 71.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.765 0.317 . . . . 0.0 111.477 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.973 ' HB3' HG13 ' B' ' 19' ' ' VAL . 2.5 m-85 70.91 110.21 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.547 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 96' ' ' PHE . 66.2 Cg_endo -96.03 153.39 1.4 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.064 2.509 . . . . 0.0 112.443 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.771 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -50.27 163.09 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.236 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.441 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -134.49 143.43 47.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.147 0.499 . . . . 0.0 111.607 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 76' ' ' THR . 0.8 OUTLIER -150.73 63.81 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.305 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.09 134.69 40.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.025 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.661 HG11 ' CD2' ' B' ' 78' ' ' PHE . 26.8 m -142.22 138.49 29.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.26 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.785 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 2.9 tm-20 -68.23 83.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.686 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.21 163.91 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.233 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -74.55 -38.16 62.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.982 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.404 ' CB ' ' HB3' ' C' ' 111' ' ' GLU . 0.4 OUTLIER -161.62 -177.65 6.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.761 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.48 HD11 ' O ' ' A' ' 78' ' ' PHE . 77.8 mt -151.82 156.37 34.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.756 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.31 137.96 78.46 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.59 2.194 . . . . 0.0 112.099 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.682 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.9 OUTLIER 74.74 14.21 3.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.244 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.76 16.88 8.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.8 HG11 ' HB ' ' A' ' 34' ' ' ILE . 29.5 m -57.07 175.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.831 0.348 . . . . 0.0 111.079 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.54 12.79 15.69 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.676 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 50' ' ' GLN . 4.3 pp -176.75 148.17 0.67 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.025 0.441 . . . . 0.0 111.298 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.408 ' C ' HD13 ' A' ' 123' ' ' ILE . 1.2 tt0 -125.74 161.05 28.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.037 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' A' ' 54' ' ' SER . 0.0 OUTLIER -143.54 129.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.115 0.484 . . . . 0.0 112.012 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.09 109.51 2.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.895 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.739 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -126.73 174.61 8.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.137 0.494 . . . . 0.0 112.039 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 72' ' ' ILE . 15.3 mt -125.63 156.41 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.422 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.938 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -146.34 151.07 36.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.551 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.622 HG12 ' CG1' ' A' ' 73' ' ' VAL . 5.1 p -147.99 159.95 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.128 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.763 ' HB3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -148.44 58.86 1.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.81 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.787 0.327 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.83 -175.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.973 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' B' ' 4' ' ' GLN . 22.1 m 63.58 128.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.507 ' HA ' ' N ' ' B' ' 23' ' ' ASP . 12.3 pt20 43.82 -165.68 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.636 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.63 HD11 ' O ' ' A' ' 103' ' ' ASN . 34.2 mm 68.65 116.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.023 0.439 . . . . 0.0 111.6 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 36.4 mt -142.12 91.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.782 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -102.15 129.02 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.949 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.7 t -144.87 153.74 41.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.05 30.67 3.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.44 ' HG2' ' HB1' ' B' ' 60' ' ' ALA . 4.6 tptm -117.55 -36.78 3.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -99.9 122.3 51.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.214 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 7.4 Cg_exo -72.87 3.05 4.73 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.68 2.254 . . . . 0.0 112.84 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.664 ' HB1' ' OE1' ' B' ' 33' ' ' GLN . . . -50.24 -178.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.005 0.431 . . . . 0.0 111.796 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.593 ' C ' HD12 ' B' ' 15' ' ' ILE . . . 64.01 118.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.605 HG22 ' O ' ' B' ' 15' ' ' ILE . 2.9 mp -146.78 17.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.341 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.9 -148.71 4.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.422 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.482 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 84.1 Cg_endo -87.49 34.26 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.869 2.379 . . . . 0.0 113.005 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.444 ' CZ ' ' HA ' ' B' ' 14' ' ' ALA . 10.0 p90 -130.4 164.95 23.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 110.835 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.973 HG13 ' HB3' ' A' ' 104' ' ' PHE . 20.2 m -91.46 147.76 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.424 ' HG2' ' HB2' ' B' ' 14' ' ' ALA . 15.5 mt-30 -46.18 -48.97 17.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.414 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.655 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -157.39 -175.35 5.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.71 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.45 ' C ' HD11 ' B' ' 6' ' ' ILE . 29.2 m -136.25 129.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.09 0.471 . . . . 0.0 111.941 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.507 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 44.1 t0 -113.11 103.92 11.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.834 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.4 HD23 ' H ' ' B' ' 4' ' ' GLN . 33.2 mt -83.97 -18.71 36.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.109 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.03 -108.75 0.91 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.792 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.55 -30.21 62.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.093 0.473 . . . . 0.0 110.068 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.422 ' HG ' HG23 ' B' ' 128' ' ' VAL . 0.7 OUTLIER -121.87 127.93 51.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.603 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.909 HG23 ' HB3' ' B' ' 127' ' ' ALA . 0.3 OUTLIER -105.81 179.4 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.478 HD12 ' O ' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -159.94 146.84 16.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 35.9 p -121.11 141.98 50.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.89 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 17.6 m -78.68 165.97 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.25 74.36 0.28 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.968 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.664 ' OE1' ' HB1' ' B' ' 13' ' ' ALA . 17.2 mm-40 -66.42 165.32 14.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 111.374 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.842 ' HB ' HG11 ' B' ' 119' ' ' VAL . 3.4 pt -139.08 159.05 68.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.199 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.536 ' O ' HG12 ' B' ' 36' ' ' VAL . 85.6 Cg_exo -42.28 -45.46 7.72 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.635 2.224 . . . . 0.0 111.87 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.862 HG22 ' HA2' ' B' ' 41' ' ' GLY . 8.5 p 44.1 25.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.508 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.416 ' HA ' ' HG3' ' B' ' 44' ' ' PRO . 7.9 m120 56.05 159.97 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.954 0.407 . . . . 0.0 111.406 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.71 -26.02 7.33 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.547 2.164 . . . . 0.0 112.049 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.92 19.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.269 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 -27.33 8.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.0 110.578 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.862 ' HA2' HG22 ' B' ' 36' ' ' VAL . . . 71.55 45.1 47.9 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.932 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 6.4 mm-40 -146.43 -77.26 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.708 0.254 . . . . 0.0 110.755 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.717 ' HB ' HG12 ' B' ' 119' ' ' VAL . 7.1 p 172.15 128.32 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.854 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' B' ' 35' ' ' PRO . 5.0 Cg_exo -76.59 153.09 34.14 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.699 2.266 . . . . 0.0 112.115 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.11 -30.79 55.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.453 . . . . 0.0 110.715 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' B' ' 49' ' ' ALA . 0.4 OUTLIER -68.55 94.24 0.56 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.864 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.62 HD13 ' NE2' ' B' ' 50' ' ' GLN . 29.2 mm -40.23 -33.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.387 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.08 -46.46 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.684 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.427 ' H ' ' HB3' ' B' ' 46' ' ' ASP . . . -61.34 -36.19 79.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.742 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.669 ' HG3' HD21 ' B' ' 121' ' ' LEU . 10.4 pt20 -77.57 -28.33 51.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.575 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.19 -31.56 25.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.271 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -38.31 30.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.254 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.6 -31.08 66.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.772 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.84 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.4 OUTLIER -69.97 -30.88 68.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.801 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.792 HD13 ' CE2' ' B' ' 95' ' ' PHE . 57.3 mt -74.58 -33.88 62.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.46 -48.59 64.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.994 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -57.67 -48.16 80.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.84 HG23 ' O ' ' B' ' 54' ' ' SER . 27.1 t -59.64 -29.92 43.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.052 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 1.9 ttpp -79.26 -39.78 32.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.44 ' HB1' ' HG2' ' B' ' 10' ' ' LYS . . . -62.01 -36.47 81.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.548 HG22 HG21 ' B' ' 6' ' ' ILE . 8.2 mt -70.09 -51.89 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.998 0.428 . . . . 0.0 110.737 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' B' ' 127' ' ' ALA . 3.8 tt -65.23 -22.45 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.0 -37.73 23.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 110.3 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -11.1 60.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.737 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.93 -29.96 35.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.0 110.367 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.29 28.49 1.0 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.153 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' B' ' 129' ' ' ARG . 0.2 OUTLIER -146.83 -167.02 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.7 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.52 153.76 49.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.86 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -57.34 -38.85 74.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.652 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -51.26 -29.92 16.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.76 -22.48 58.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.96 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.629 HG23 ' O ' ' B' ' 126' ' ' ILE . 76.5 mt -47.72 114.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.893 0.377 . . . . 0.0 110.995 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.605 ' CG1' HG12 ' B' ' 128' ' ' VAL . 32.9 m -89.66 -31.57 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.66 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.751 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 78.1 tttt -134.39 163.08 30.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.017 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.73 HG23 ' HB2' ' B' ' 125' ' ' ALA . 30.4 m -158.76 139.6 12.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.297 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.626 HG23 ' O ' ' B' ' 108' ' ' SER . 96.8 m -123.68 147.41 47.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.172 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.8 t -149.22 109.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.863 0.363 . . . . 0.0 111.746 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.661 ' CD2' HG11 ' A' ' 110' ' ' VAL . 8.6 m-85 -88.97 110.22 20.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.424 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.415 HG11 ' HD1' ' B' ' 85' ' ' PHE . 31.3 m -101.37 144.86 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.447 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -85.03 -1.68 57.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.145 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.12 127.14 1.48 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.507 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' B' ' 82' ' ' LEU . 12.0 mt -66.01 -12.04 52.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.68 -20.74 45.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.789 0.328 . . . . 0.0 110.653 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.69 -27.16 20.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' B' ' 89' ' ' ASN . 44.5 t80 -57.74 -28.76 64.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.29 67.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.303 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.53 -34.96 18.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.16 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.79 -39.56 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.153 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 32.7 t30 -69.0 -36.45 77.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.47 -32.46 66.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.42 -30.43 19.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.706 ' OH ' HG21 ' B' ' 75' ' ' THR . 9.8 t80 -58.36 -43.98 88.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.94 -29.35 35.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.54 75.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.069 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.792 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.9 OUTLIER -89.2 -36.64 15.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.646 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.511 ' CD2' ' HB2' ' B' ' 101' ' ' HIS . 0.2 OUTLIER -54.88 -53.63 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.863 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -72.77 -26.49 61.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.436 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' GLU . . . . . 0.412 ' HB2' ' HA ' ' B' ' 95' ' ' PHE . 2.4 mm-40 -76.48 -13.29 60.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.568 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.567 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 12.6 m-80 -101.39 -17.35 16.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.01 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 5.3 p-10 103.6 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.148 0.905 . . . . 0.0 110.328 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.86 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 2.0 m-70 -115.06 55.25 0.89 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.387 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.487 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 89.3 Cg_endo -79.09 2.77 8.01 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.626 2.217 . . . . 0.0 113.141 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.664 ' O ' HD11 ' C' ' 5' ' ' ILE . 2.1 t-20 -64.4 -30.21 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 111.512 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.929 ' HB3' HG13 ' C' ' 19' ' ' VAL . 2.5 m-85 70.97 110.2 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.505 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' B' ' 96' ' ' PHE . 66.0 Cg_endo -95.98 153.44 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.141 2.561 . . . . 0.0 112.438 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.751 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -50.37 163.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.292 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.465 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -134.4 143.44 47.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 111.607 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.626 ' O ' HG23 ' B' ' 76' ' ' THR . 0.8 OUTLIER -150.77 63.88 0.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.283 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.05 134.74 40.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.04 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' C' ' 78' ' ' PHE . 26.9 m -142.32 139.3 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.294 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.728 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 2.8 tm-20 -68.67 84.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.78 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 m -67.4 163.95 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.133 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -74.55 -38.11 62.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.63 -177.74 6.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.484 HD11 ' O ' ' B' ' 78' ' ' PHE . 77.7 mt -151.72 156.41 34.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.772 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.37 137.92 78.59 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.577 2.185 . . . . 0.0 112.093 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.678 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.9 OUTLIER 74.8 14.2 3.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.26 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.78 16.89 8.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.069 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.842 HG11 ' HB ' ' B' ' 34' ' ' ILE . 29.6 m -57.18 175.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.83 0.347 . . . . 0.0 111.075 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.34 13.04 16.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.71 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.669 HD21 ' HG3' ' B' ' 50' ' ' GLN . 4.3 pp -176.83 148.19 0.65 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 111.275 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.79 161.0 28.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.021 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' B' ' 54' ' ' SER . 0.0 OUTLIER -143.43 129.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 112.109 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 109.48 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.888 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -126.74 174.63 8.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.134 0.493 . . . . 0.0 111.985 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.629 ' O ' HG23 ' B' ' 72' ' ' ILE . 15.2 mt -125.64 156.34 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.444 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.909 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -146.28 150.97 36.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.57 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.605 HG12 ' CG1' ' B' ' 73' ' ' VAL . 5.1 p -147.83 159.99 7.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.774 ' HB3' HD21 ' B' ' 67' ' ' LEU . 0.0 OUTLIER -148.45 58.8 1.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.881 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.75 -174.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.993 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' C' ' 4' ' ' GLN . 21.9 m 63.51 128.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.954 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.513 ' HA ' ' N ' ' C' ' 23' ' ' ASP . 12.3 pt20 43.79 -165.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.691 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.664 HD11 ' O ' ' B' ' 103' ' ' ASN . 34.4 mm 68.76 116.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.005 0.431 . . . . 0.0 111.628 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.662 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 36.6 mt -142.11 91.74 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.767 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -102.24 128.95 48.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 12.7 t -144.76 153.75 41.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.1 30.75 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.46 ' HG2' ' HB1' ' C' ' 60' ' ' ALA . 4.7 tptm -117.6 -37.08 3.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.016 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.413 ' HB2' HG13 ' C' ' 61' ' ' ILE . . . -99.59 122.48 51.29 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.186 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.84 2.94 4.82 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.731 2.288 . . . . 0.0 112.823 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.634 ' HB1' ' OE1' ' C' ' 33' ' ' GLN . . . -50.2 -178.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.966 0.412 . . . . 0.0 111.812 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.577 ' C ' HD12 ' C' ' 15' ' ' ILE . . . 63.97 118.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.096 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.598 HG22 ' O ' ' C' ' 15' ' ' ILE . 2.9 mp -146.74 17.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.364 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.9 -148.65 4.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.415 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' PRO . . . . . 0.466 ' HA ' ' CE2' ' B' ' 104' ' ' PHE . 83.3 Cg_endo -87.48 34.26 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.849 2.366 . . . . 0.0 113.037 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.465 ' CD2' ' HB2' ' B' ' 107' ' ' ARG . 9.9 p90 -130.41 164.91 23.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.775 0.322 . . . . 0.0 110.829 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.929 HG13 ' HB3' ' B' ' 104' ' ' PHE . 20.4 m -91.44 147.8 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.947 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.435 ' HG2' ' HB2' ' C' ' 14' ' ' ALA . 15.5 mt-30 -46.18 -48.73 17.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.47 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.662 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -157.43 -175.26 5.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.677 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.491 HG11 ' O ' ' B' ' 73' ' ' VAL . 29.5 m -136.27 129.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.062 0.458 . . . . 0.0 111.902 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.513 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 44.2 t0 -113.18 103.9 11.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.819 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.421 HD23 ' H ' ' C' ' 4' ' ' GLN . 33.3 mt -83.97 -18.73 36.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.108 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.05 -108.7 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.811 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.6 -30.14 62.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.146 0.498 . . . . 0.0 110.118 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.491 ' HG ' HG23 ' C' ' 128' ' ' VAL . 0.7 OUTLIER -121.91 127.9 50.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.624 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.968 HG23 ' HB3' ' C' ' 127' ' ' ALA . 0.3 OUTLIER -105.78 179.3 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.216 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.476 HD12 ' O ' ' C' ' 28' ' ' VAL . 0.1 OUTLIER -159.86 146.82 16.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.833 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.406 HG23 HD12 ' C' ' 62' ' ' ILE . 35.7 p -121.07 142.33 49.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.833 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 18.1 m -78.99 165.78 23.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.3 74.41 0.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.991 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.634 ' OE1' ' HB1' ' C' ' 13' ' ' ALA . 17.3 mm-40 -66.43 165.28 14.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.021 0.438 . . . . 0.0 111.325 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.82 ' HB ' HG11 ' C' ' 119' ' ' VAL . 3.4 pt -139.04 159.1 68.2 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.232 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.533 ' O ' HG12 ' C' ' 36' ' ' VAL . 85.3 Cg_exo -42.36 -45.41 7.89 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.623 2.216 . . . . 0.0 111.867 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.86 HG22 ' HA2' ' C' ' 41' ' ' GLY . 8.6 p 44.07 25.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.556 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.405 ' H ' ' HD3' ' C' ' 44' ' ' PRO . 7.9 m120 56.06 159.96 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 120.98 0.419 . . . . 0.0 111.359 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.59 -26.12 7.39 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.58 2.187 . . . . 0.0 112.05 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.89 19.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.286 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.99 -27.37 8.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.36 . . . . 0.0 110.563 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.86 ' HA2' HG22 ' C' ' 36' ' ' VAL . . . 71.68 45.09 46.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.953 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 6.4 mm-40 -146.48 -77.24 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.713 0.256 . . . . 0.0 110.763 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.763 ' HB ' HG12 ' C' ' 119' ' ' VAL . 7.1 p 172.17 128.33 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.914 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 43' ' ' VAL . 4.8 Cg_exo -76.68 153.14 33.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.664 2.243 . . . . 0.0 112.067 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.16 -30.76 55.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.091 0.472 . . . . 0.0 110.738 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' C' ' 49' ' ' ALA . 0.4 OUTLIER -68.54 94.31 0.56 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.888 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.623 HD13 ' NE2' ' C' ' 50' ' ' GLN . 29.2 mm -40.31 -33.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.397 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.13 -46.48 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.665 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' C' ' 46' ' ' ASP . . . -61.23 -36.28 79.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.766 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.65 ' HG3' HD21 ' C' ' 121' ' ' LEU . 10.4 pt20 -77.63 -28.11 51.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.594 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.4 -31.59 24.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.337 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -38.38 30.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.55 -31.12 66.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.807 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.822 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.4 OUTLIER -69.98 -30.87 68.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.81 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.743 HD13 ' CE2' ' C' ' 95' ' ' PHE . 57.4 mt -74.48 -33.94 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.37 -48.66 64.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.02 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -57.56 -48.24 79.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.822 HG23 ' O ' ' C' ' 54' ' ' SER . 27.2 t -59.59 -29.93 43.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.446 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 1.9 ttpp -79.21 -39.81 32.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.996 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' C' ' 10' ' ' LYS . . . -62.08 -36.23 81.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.078 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' C' ' 58' ' ' VAL . 8.1 mt -70.33 -51.9 34.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' C' ' 127' ' ' ALA . 3.8 tt -65.23 -22.42 31.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.094 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.02 -37.71 23.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.917 0.389 . . . . 0.0 110.287 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -11.08 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.713 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.99 35.06 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.964 0.412 . . . . 0.0 110.327 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.29 28.51 1.0 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.165 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.762 HD21 ' HB3' ' C' ' 129' ' ' ARG . 0.2 OUTLIER -146.88 -167.02 2.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.638 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.49 153.73 50.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.867 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -57.43 -38.71 74.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.656 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -51.16 -29.76 14.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.073 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.85 -22.56 58.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.642 HG23 ' O ' ' C' ' 126' ' ' ILE . 76.3 mt -47.66 114.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 111.013 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.628 ' CG1' HG12 ' C' ' 128' ' ' VAL . 32.8 m -89.66 -31.47 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.696 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.743 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 78.0 tttt -134.5 162.99 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.752 0.311 . . . . 0.0 111.01 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.734 HG23 ' HB2' ' C' ' 125' ' ' ALA . 30.5 m -158.75 139.58 12.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.424 . . . . 0.0 111.302 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.626 HG23 ' O ' ' C' ' 108' ' ' SER . 96.8 m -123.64 147.44 47.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.197 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.7 t -149.27 109.27 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.745 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.709 ' CD2' HG11 ' B' ' 110' ' ' VAL . 8.5 m-85 -88.95 110.19 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.476 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.409 HG11 ' HD1' ' C' ' 85' ' ' PHE . 31.6 m -101.4 144.87 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.461 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -85.02 -1.77 57.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.175 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.0 127.05 1.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.517 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 115' ' ' LEU . 12.0 mt -66.07 -11.98 52.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.63 -20.79 45.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.803 0.335 . . . . 0.0 110.673 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.63 -27.23 20.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' C' ' 89' ' ' ASN . 44.5 t80 -57.68 -28.83 64.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.102 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.29 67.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.255 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.46 -35.06 18.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.7 -39.62 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.152 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ASN . . . . . 0.413 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 32.8 t30 -68.94 -36.5 78.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.49 -32.47 66.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -30.47 19.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.022 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.692 ' OH ' HG21 ' C' ' 75' ' ' THR . 10.0 t80 -58.29 -44.01 88.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.89 -29.35 35.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.178 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.51 75.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.055 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.743 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.9 OUTLIER -89.27 -36.59 15.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 110.647 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 0.2 OUTLIER -54.95 -53.56 54.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.876 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -72.82 -26.48 61.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' GLU . . . . . 0.41 ' HB2' ' HA ' ' C' ' 95' ' ' PHE . 2.4 mm-40 -76.48 -13.24 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.608 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.566 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 12.6 m-80 -101.46 -17.29 16.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.988 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 5.2 p-10 103.49 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.138 0.899 . . . . 0.0 110.372 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.867 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 2.0 m-70 -115.04 55.35 0.89 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.352 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 88.4 Cg_endo -79.2 2.82 7.98 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.628 2.219 . . . . 0.0 113.115 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.638 ' O ' HD11 ' A' ' 5' ' ' ILE . 2.2 t-20 -64.51 -30.06 71.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 111.534 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.956 ' HB3' HG13 ' A' ' 19' ' ' VAL . 2.5 m-85 70.93 110.21 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.543 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.457 ' HG3' ' CZ ' ' C' ' 96' ' ' PHE . 65.9 Cg_endo -96.03 153.38 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.116 2.544 . . . . 0.0 112.434 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.743 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -50.31 163.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.278 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.456 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -134.44 143.45 47.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.13 0.49 . . . . 0.0 111.563 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 108' ' ' SER . . . . . 0.626 ' O ' HG23 ' C' ' 76' ' ' THR . 0.8 OUTLIER -150.76 63.82 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.332 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.05 134.76 40.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.034 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' A' ' 78' ' ' PHE . 26.8 m -142.4 139.24 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.317 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.778 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.8 tm-20 -68.7 83.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.749 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.11 164.04 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.196 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -74.65 -38.19 62.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.975 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.409 ' CB ' ' HB3' ' B' ' 111' ' ' GLU . 0.4 OUTLIER -161.59 -177.6 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.775 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.478 HD11 ' O ' ' C' ' 78' ' ' PHE . 77.3 mt -151.76 156.42 34.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.755 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.48 137.95 79.01 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.588 2.192 . . . . 0.0 112.057 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.654 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.9 OUTLIER 74.8 14.2 3.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.275 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.79 16.9 8.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.073 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.82 HG11 ' HB ' ' C' ' 34' ' ' ILE . 29.3 m -57.08 175.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.818 0.342 . . . . 0.0 111.123 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.36 13.25 16.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.766 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' C' ' 50' ' ' GLN . 4.3 pp -177.36 148.25 0.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.976 0.417 . . . . 0.0 111.249 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.403 ' C ' HD13 ' C' ' 123' ' ' ILE . 1.2 tt0 -125.69 161.02 28.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.054 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' C' ' 54' ' ' SER . 0.0 OUTLIER -143.49 129.19 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.142 0.496 . . . . 0.0 112.039 -179.454 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.04 109.52 2.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.9 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.734 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -126.8 174.63 8.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.115 0.483 . . . . 0.0 112.026 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.642 ' O ' HG23 ' C' ' 72' ' ' ILE . 15.3 mt -125.68 156.36 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.435 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.968 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -146.36 151.02 36.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 111.503 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.628 HG12 ' CG1' ' C' ' 73' ' ' VAL . 5.0 p -147.84 159.92 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.762 ' HB3' HD21 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -148.41 58.89 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.817 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.855 0.359 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -172.57 4.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.044 HG21 HG21 ' C' ' 128' ' ' VAL . 0.9 OUTLIER 61.7 113.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 132.97 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.82 HD13 ' OD1' ' C' ' 103' ' ' ASN . 4.3 mp -55.2 152.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 21' ' ' ALA . 32.7 mt -103.43 139.26 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.58 117.18 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.58 HG22 ' OE1' ' A' ' 20' ' ' GLN . 11.7 t -133.88 165.99 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.33 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.52 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 7.6 mmtp -121.62 -36.89 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.032 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.872 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.82 172.05 4.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 18.9 Cg_endo -59.39 -16.05 33.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.695 2.263 . . . . 0.0 112.85 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 77.24 151.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 111.317 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.603 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -104.67 120.71 41.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 14' ' ' ALA . 22.1 mm -133.51 15.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.072 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.85 -146.17 4.73 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.987 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' C' ' 104' ' ' PHE . 93.9 Cg_endo -87.39 44.53 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.536 2.158 . . . . 0.0 112.901 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.541 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -163.19 154.59 17.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.867 0.365 . . . . 0.0 111.033 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.465 HG13 ' O ' ' C' ' 103' ' ' ASN . 27.3 m -110.91 169.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.58 ' OE1' HG22 ' A' ' 8' ' ' THR . 56.2 mt-30 -58.96 -53.53 57.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' A' ' 6' ' ' ILE . . . -170.69 -177.09 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG21 ' HB ' ' C' ' 73' ' ' VAL . 9.3 m -142.33 132.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.166 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.645 ' HA ' HG23 ' A' ' 28' ' ' VAL . 20.8 t70 -103.47 105.01 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.567 ' CD2' HG23 ' A' ' 3' ' ' THR . 19.5 mt -80.51 -16.36 54.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.371 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.05 -104.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.28 -29.62 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.166 0.508 . . . . 0.0 110.21 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 28' ' ' VAL . 5.0 tt -135.2 140.65 45.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.95 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 9.9 p -120.04 160.88 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.123 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' HE2' ' C' ' 74' ' ' LYS . 2.9 mp -145.87 127.37 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 p -106.5 136.11 46.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.983 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.812 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 1.1 t -59.36 179.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.07 95.55 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.244 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.805 ' HG2' HG22 ' A' ' 58' ' ' VAL . 2.0 mp0 -62.07 138.14 58.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.275 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.524 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -146.04 170.18 8.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.679 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -54.26 -137.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.313 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t 74.12 73.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.411 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 41' ' ' GLY . 2.1 t-20 -34.93 115.62 0.52 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.978 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.65 -13.68 11.46 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.339 2.026 . . . . 0.0 112.144 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.81 27.87 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.086 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 42' ' ' GLU . 8.0 t -161.6 -33.37 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.908 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 96.92 66.2 0.92 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.847 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HG2' HG23 ' A' ' 40' ' ' THR . 2.7 mt-10 -82.73 -53.38 5.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.369 . . . . 0.0 111.276 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t 68.96 72.52 0.34 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.81 140.71 81.58 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.592 2.195 . . . . 0.0 112.433 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.37 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.4 93.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.791 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.616 HD13 ' NE2' ' A' ' 50' ' ' GLN . 28.9 mm -38.93 -33.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.5 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.08 -48.07 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.696 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.82 -55.04 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.616 ' NE2' HD13 ' A' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.498 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -71.93 -44.36 63.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -63.33 -51.54 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.79 -31.18 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.871 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.3 m -68.31 -46.48 70.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.29 -26.36 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.971 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -57.95 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.108 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.8 OUTLIER -54.88 -30.36 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.985 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 54' ' ' SER . 39.6 t -62.1 -34.54 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 110.517 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.99 -31.75 34.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.755 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -62.23 -38.55 89.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 11' ' ' ALA . 6.1 mt -70.93 -46.2 69.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.667 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.8 -32.62 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.28 -38.4 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.9 -24.33 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.145 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.71 -22.11 21.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.914 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.43 64.8 0.83 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' OD2' ' A' ' 71' ' ' ASP . 14.7 mt -158.9 139.2 12.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 44.0 p -96.12 145.0 25.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -46.29 -31.75 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.518 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -59.77 -18.48 43.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.715 ' OD2' HD22 ' A' ' 67' ' ' LEU . 3.2 p-10 -88.58 -21.27 24.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 126' ' ' ILE . 64.3 mt -59.35 109.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.528 ' HB ' HG21 ' B' ' 22' ' ' VAL . 2.8 m -81.11 -36.84 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.971 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HE2' HD22 ' B' ' 29' ' ' LEU . 8.6 mtmt -130.55 175.23 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.319 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.61 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 13.4 t 177.71 110.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 111.36 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.18 130.1 41.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.33 91.6 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 76' ' ' THR . 5.3 m-85 -91.7 143.77 26.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.089 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.514 HG11 ' CD1' ' A' ' 85' ' ' PHE . 35.3 m -139.31 150.0 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.023 0.44 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.57 ' HE2' HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -90.95 -4.31 56.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.796 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.04 108.99 0.46 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.687 HD12 ' HB3' ' B' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.25 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.97 -24.64 59.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 110.282 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -78.46 -15.34 58.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.832 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.514 ' CD1' HG11 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -55.52 -22.98 23.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.01 -46.63 84.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 -33.22 19.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 84' ' ' ASP . 32.6 t -70.08 -49.66 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.673 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 36.4 t-20 -63.09 -35.99 82.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.14 94.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.016 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.62 -31.1 19.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.448 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 48.7 t80 -57.67 -51.35 69.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.727 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 7.7 tt0 -73.32 -27.34 61.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -25.11 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.765 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -79.31 -41.02 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.934 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 95' ' ' PHE . 57.1 m-85 -56.45 -50.43 71.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.8 69.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.77 58.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.402 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -110.54 -6.88 14.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.7 m-20 89.68 30.9 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.8 t60 -127.57 72.17 77.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.96 -11.04 16.65 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.539 2.159 . . . . 0.0 112.153 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.844 ' OD1' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.03 42.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.447 . . . . 0.0 110.439 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CG ' ' HA ' ' B' ' 17' ' ' PRO . 92.7 m-85 70.99 144.0 0.1 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.515 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 104' ' ' PHE . 2.0 Cg_endo -82.96 165.82 15.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.057 2.504 . . . . 0.0 112.0 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' B' ' 31' ' ' SER . . . -115.28 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.779 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.61 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -169.27 -163.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.944 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.36 107.57 16.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.493 ' O ' HG13 ' A' ' 110' ' ' VAL . 5.3 m -95.25 129.16 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.798 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.519 HG12 HD23 ' B' ' 115' ' ' LEU . 7.0 m -157.79 165.71 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.949 0.405 . . . . 0.0 111.666 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 9.4 tt0 -99.75 102.87 14.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.777 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.82 162.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -79.07 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.685 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -140.81 168.08 20.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.722 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.622 HD22 ' HB2' ' A' ' 122' ' ' GLU . 3.0 mt -144.19 161.9 42.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 119' ' ' VAL . 32.7 Cg_exo -59.7 135.94 67.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.649 2.233 . . . . 0.0 112.183 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.58 18.28 7.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.87 17.47 8.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 116' ' ' PRO . 21.2 m -55.18 172.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.61 14.08 20.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.011 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 121' ' ' LEU . 4.5 pp -176.64 149.0 0.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.123 0.487 . . . . 0.0 111.508 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.622 ' HB2' HD22 ' A' ' 115' ' ' LEU . 44.5 tt0 -150.86 137.85 19.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.918 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 76' ' ' THR . 3.4 mp -144.67 138.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 112.101 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.36 149.91 28.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.569 ' C ' HD13 ' A' ' 126' ' ' ILE . . . -132.03 125.99 32.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.414 . . . . 0.0 112.027 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.569 HD13 ' C ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -114.42 132.16 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.876 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.95 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -121.74 153.14 38.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.063 0.459 . . . . 0.0 112.038 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.111 HG21 HG21 ' B' ' 3' ' ' THR . 34.6 m -124.13 116.37 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.464 ' CD ' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -106.3 57.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.971 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.849 0.357 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.6 -172.5 4.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' THR . . . . . 1.111 HG21 HG21 ' A' ' 128' ' ' VAL . 0.9 OUTLIER 61.63 113.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.72 132.95 5.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.844 HD13 ' OD1' ' A' ' 103' ' ' ASN . 4.4 mp -55.2 152.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' B' ' 21' ' ' ALA . 32.7 mt -103.43 139.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.59 117.19 9.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.575 HG23 ' H ' ' B' ' 11' ' ' ALA . 11.6 t -133.86 165.97 23.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.804 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 26.32 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.58 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 7.6 mmtt -121.6 -36.61 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -68.18 172.03 4.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 18.7 Cg_endo -59.33 -16.06 32.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.632 2.221 . . . . 0.0 112.905 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 77.23 151.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.411 . . . . 0.0 111.281 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.586 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.597 HG22 ' O ' ' B' ' 15' ' ' ILE . 22.1 mm -133.53 15.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.79 -146.1 4.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.509 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . 94.4 Cg_endo -87.38 44.49 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.637 2.224 . . . . 0.0 112.916 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -163.26 154.53 17.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.915 0.388 . . . . 0.0 110.991 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 103' ' ' ASN . 27.2 m -110.83 169.25 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.304 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.575 ' OE1' HG22 ' B' ' 8' ' ' THR . 56.3 mt-30 -59.04 -53.58 56.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -170.46 -177.16 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.528 HG21 ' HB ' ' A' ' 73' ' ' VAL . 9.2 m -142.31 132.63 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.636 ' HA ' HG23 ' B' ' 28' ' ' VAL . 20.8 t70 -103.51 104.94 15.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.554 ' CD2' HG23 ' B' ' 3' ' ' THR . 19.5 mt -80.44 -16.4 54.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -103.96 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.972 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.3 -29.56 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.082 0.468 . . . . 0.0 110.189 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.644 HD23 ' N ' ' B' ' 28' ' ' VAL . 5.0 tt -135.3 140.65 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.52 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.945 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 9.9 p -120.07 160.84 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.657 HD22 ' HE2' ' A' ' 74' ' ' LYS . 2.9 mp -145.87 127.42 15.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.68 136.36 46.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.06 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.843 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 1.1 t -59.69 179.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.01 95.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.834 ' HG2' HG22 ' B' ' 58' ' ' VAL . 2.0 mp0 -61.92 138.09 58.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.553 HG22 ' O ' ' B' ' 121' ' ' LEU . 0.7 OUTLIER -145.98 170.19 8.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.665 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 52.2 Cg_exo -54.34 -137.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.069 2.513 . . . . 0.0 112.319 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t 74.21 73.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' B' ' 41' ' ' GLY . 2.1 t-20 -34.86 115.66 0.52 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.964 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.65 -13.71 11.53 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.4 2.067 . . . . 0.0 112.11 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.54 -26.78 27.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.459 HG23 ' HG2' ' B' ' 42' ' ' GLU . 8.0 t -161.65 -33.23 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 97.1 66.02 0.92 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.791 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.459 ' HG2' HG23 ' B' ' 40' ' ' THR . 2.8 mt-10 -82.77 -53.36 5.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.371 . . . . 0.0 111.292 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t 68.91 72.59 0.34 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.83 140.7 81.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.662 2.242 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.39 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.35 93.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.618 HD13 ' NE2' ' B' ' 50' ' ' GLN . 28.9 mm -38.94 -33.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.443 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.02 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.91 -54.98 38.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.618 ' NE2' HD13 ' B' ' 47' ' ' ILE . 15.8 pt20 -61.1 -26.16 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.522 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -72.18 -44.2 63.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.901 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.33 -51.54 65.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.22 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.9 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.3 m -68.4 -46.37 70.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.32 -26.38 68.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.963 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -57.99 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.163 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.8 OUTLIER -54.86 -30.39 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.931 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.9 HG23 ' O ' ' B' ' 54' ' ' SER . 39.7 t -62.13 -34.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.95 -31.77 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -62.21 -38.49 89.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.571 HG12 ' HB2' ' B' ' 11' ' ' ALA . 6.0 mt -71.25 -46.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.83 -32.53 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.656 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.31 -38.49 60.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.34 65.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.136 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 -22.06 21.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.919 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 64.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.711 HD22 ' OD2' ' B' ' 71' ' ' ASP . 14.7 mt -158.91 139.2 12.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.022 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' B' ' 71' ' ' ASP . 43.8 p -96.1 144.99 25.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -46.26 -31.79 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.574 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -59.83 -18.27 42.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.425 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.711 ' OD2' HD22 ' B' ' 67' ' ' LEU . 3.3 p-10 -88.65 -21.23 24.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.714 0.292 . . . . 0.0 110.87 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.512 HG23 ' O ' ' B' ' 126' ' ' ILE . 64.4 mt -59.4 109.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.874 0.369 . . . . 0.0 110.839 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' C' ' 22' ' ' VAL . 2.8 m -81.12 -36.88 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.969 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.667 ' HE2' HD22 ' C' ' 29' ' ' LEU . 8.6 mtmt -130.56 175.22 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.302 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.612 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 13.4 t 177.67 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 111.337 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.753 ' O ' HG23 ' B' ' 123' ' ' ILE . 0.0 OUTLIER -70.15 130.12 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.325 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.43 91.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.404 ' CZ ' ' HB ' ' B' ' 76' ' ' THR . 5.3 m-85 -91.66 143.72 26.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.151 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' B' ' 85' ' ' PHE . 35.1 m -139.32 150.01 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.072 0.463 . . . . 0.0 111.718 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' B' ' 47' ' ' ILE . 0.3 OUTLIER -90.94 -4.12 56.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.839 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -169.23 109.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.321 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' C' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.32 20.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.228 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.94 -24.63 59.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.275 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.547 ' O ' HG23 ' B' ' 88' ' ' VAL . 0.6 OUTLIER -78.52 -15.37 58.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.51 ' CD1' HG11 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -55.46 -23.03 23.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.267 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.99 -46.62 84.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.09 -33.23 19.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 84' ' ' ASP . 33.0 t -70.09 -49.59 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.721 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 36.4 t-20 -63.21 -35.96 82.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.04 94.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.67 -31.19 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 48.8 t80 -57.62 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 7.7 tt0 -73.41 -27.32 61.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.462 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -25.19 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.786 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -79.25 -41.09 28.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.97 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 95' ' ' PHE . 57.2 m-85 -56.36 -50.45 71.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.818 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.82 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.945 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.8 58.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.98 14.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.505 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 11.7 m-20 89.78 30.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.502 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.8 t60 -127.48 72.19 77.52 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.98 -11.02 16.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.537 2.158 . . . . 0.0 112.153 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.98 ' ND2' HD13 ' C' ' 5' ' ' ILE . 2.9 t-20 -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.03 0.443 . . . . 0.0 110.445 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.506 ' CG ' ' HA ' ' C' ' 17' ' ' PRO . 92.7 m-85 70.89 144.04 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.494 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 104' ' ' PHE . 2.0 Cg_endo -83.02 165.85 14.91 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.016 2.477 . . . . 0.0 111.917 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.835 ' HB1' ' HB2' ' C' ' 31' ' ' SER . . . -115.27 137.95 51.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.612 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -169.23 -163.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.38 107.56 16.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.571 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' CYS . . . . . 0.504 ' O ' HG13 ' B' ' 110' ' ' VAL . 5.2 m -95.21 129.11 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.845 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.533 HG12 HD23 ' C' ' 115' ' ' LEU . 7.0 m -157.71 165.59 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.409 . . . . 0.0 111.632 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 9.3 tt0 -99.57 102.86 14.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.785 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.73 162.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -79.05 -46.27 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -140.82 168.11 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' B' ' 122' ' ' GLU . 3.0 mt -144.21 161.87 42.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.549 ' O ' HG22 ' B' ' 119' ' ' VAL . 33.1 Cg_exo -59.62 135.97 67.82 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.157 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.53 18.29 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.88 17.46 8.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.549 HG22 ' O ' ' B' ' 116' ' ' PRO . 21.5 m -55.18 172.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.082 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.63 13.95 20.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.025 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.553 ' O ' HG22 ' B' ' 34' ' ' ILE . 4.6 pp -176.62 148.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.615 ' HB2' HD22 ' B' ' 115' ' ' LEU . 44.5 tt0 -150.78 137.88 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.935 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.753 HG23 ' O ' ' B' ' 76' ' ' THR . 3.4 mp -144.68 138.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 112.14 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.33 149.81 28.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.627 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.572 ' C ' HD13 ' B' ' 126' ' ' ILE . . . -131.94 126.01 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.956 0.408 . . . . 0.0 112.041 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.572 HD13 ' C ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -114.33 132.14 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.947 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.945 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -121.75 153.2 38.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.096 0.474 . . . . 0.0 111.994 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 1.04 HG21 HG21 ' C' ' 3' ' ' THR . 34.7 m -124.26 116.32 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.474 ' CD ' HD21 ' B' ' 67' ' ' LEU . 0.0 OUTLIER -106.23 57.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.015 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.851 0.358 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 -172.51 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' THR . . . . . 1.04 HG21 HG21 ' B' ' 128' ' ' VAL . 0.9 OUTLIER 61.67 113.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.68 132.97 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.98 HD13 ' ND2' ' B' ' 103' ' ' ASN . 4.4 mp -55.18 152.35 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' C' ' 21' ' ' ALA . 32.5 mt -103.46 139.23 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -143.59 117.2 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.572 HG22 ' OE1' ' C' ' 20' ' ' GLN . 11.7 t -133.93 165.96 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.32 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.542 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 7.6 mmtp -121.59 -36.84 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.01 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.885 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.93 172.02 4.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.885 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 18.8 Cg_endo -59.31 -16.11 32.83 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.675 2.25 . . . . 0.0 112.899 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 77.24 151.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.977 0.418 . . . . 0.0 111.304 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.591 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -104.69 120.76 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.002 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.591 HD13 ' O ' ' C' ' 14' ' ' ALA . 22.5 mm -133.54 15.81 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.81 -146.14 4.73 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.001 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' B' ' 104' ' ' PHE . 94.1 Cg_endo -87.37 44.51 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 112.917 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.532 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -163.23 154.55 17.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.026 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' B' ' 103' ' ' ASN . 27.2 m -110.87 169.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.36 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.572 ' OE1' HG22 ' C' ' 8' ' ' THR . 56.2 mt-30 -59.02 -53.38 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' C' ' 6' ' ' ILE . . . -170.6 -177.19 2.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' B' ' 73' ' ' VAL . 9.2 m -142.24 132.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.64 ' HA ' HG23 ' C' ' 28' ' ' VAL . 20.8 t70 -103.48 104.98 15.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.549 ' CD2' HG23 ' C' ' 3' ' ' THR . 19.5 mt -80.47 -16.35 54.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.0 -104.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.27 -29.59 33.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.648 HD23 ' N ' ' C' ' 28' ' ' VAL . 5.0 tt -135.22 140.64 45.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.575 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.947 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 9.9 p -120.04 160.84 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.667 HD22 ' HE2' ' B' ' 74' ' ' LYS . 2.9 mp -145.85 127.45 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 p -106.6 136.31 46.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' SER . . . . . 0.835 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 1.1 t -59.62 179.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.13 95.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.25 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.821 ' HG2' HG22 ' C' ' 58' ' ' VAL . 2.0 mp0 -62.06 138.17 58.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.259 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.528 HG22 ' O ' ' C' ' 121' ' ' LEU . 0.7 OUTLIER -146.0 170.23 8.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.654 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' C' ' 34' ' ' ILE . 52.4 Cg_exo -54.36 -137.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.063 2.509 . . . . 0.0 112.29 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t 74.17 73.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.427 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' C' ' 41' ' ' GLY . 2.1 t-20 -34.93 115.67 0.52 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.967 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.61 -13.76 11.54 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.36 2.04 . . . . 0.0 112.088 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.56 -26.65 27.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.133 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.45 HG23 ' HG2' ' C' ' 42' ' ' GLU . 8.0 t -161.62 -33.31 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.928 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 96.98 66.09 0.92 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.79 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' C' ' 40' ' ' THR . 2.8 mt-10 -82.74 -53.36 5.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.886 0.374 . . . . 0.0 111.287 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 t 68.96 72.52 0.34 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.931 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.88 140.74 81.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.637 2.225 . . . . 0.0 112.358 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.45 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.083 0.468 . . . . 0.0 110.913 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 93.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.621 HD13 ' NE2' ' C' ' 50' ' ' GLN . 28.7 mm -39.01 -33.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.447 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.711 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -54.96 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.621 ' NE2' HD13 ' C' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.474 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -72.07 -44.36 63.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.36 -51.5 65.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.24 72.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.354 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.903 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.3 m -68.35 -46.4 70.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.58 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.32 -26.36 68.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -58.01 4.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.8 OUTLIER -54.9 -30.36 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.984 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.903 HG23 ' O ' ' C' ' 54' ' ' SER . 39.6 t -62.07 -34.62 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -80.86 -31.79 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -62.26 -38.52 89.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' C' ' 11' ' ' ALA . 6.0 mt -70.95 -46.31 68.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.89 -32.54 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.33 -38.39 60.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.093 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.31 65.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.139 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.1 21.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.87 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.445 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.712 HD22 ' OD2' ' C' ' 71' ' ' ASP . 14.7 mt -158.9 139.23 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.036 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.0 p -96.16 145.01 25.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -46.21 -31.81 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.598 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -59.74 -18.28 41.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.477 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.712 ' OD2' HD22 ' C' ' 67' ' ' LEU . 3.3 p-10 -88.78 -21.16 23.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 110.896 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.503 HG23 ' O ' ' C' ' 126' ' ' ILE . 64.2 mt -59.39 109.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.496 ' HB ' HG21 ' A' ' 22' ' ' VAL . 2.8 m -81.04 -36.88 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.933 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.646 ' HE2' HD22 ' A' ' 29' ' ' LEU . 8.6 mtmt -130.6 175.25 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.369 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 13.4 t 177.72 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.313 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.754 ' O ' HG23 ' C' ' 123' ' ' ILE . 0.0 OUTLIER -70.23 130.2 41.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 t -115.43 91.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' C' ' 76' ' ' THR . 5.3 m-85 -91.64 143.8 26.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.143 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' C' ' 85' ' ' PHE . 34.8 m -139.35 149.98 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 111.691 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' C' ' 47' ' ' ILE . 0.3 OUTLIER -90.99 -4.23 56.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.816 178.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.1 109.04 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.305 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.685 HD12 ' HB3' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -58.58 -17.19 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.0 -24.62 59.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.297 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.546 ' O ' HG23 ' C' ' 88' ' ' VAL . 0.6 OUTLIER -78.5 -15.28 58.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.827 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.513 ' CD1' HG11 ' C' ' 79' ' ' VAL . 0.3 OUTLIER -55.53 -23.04 24.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.261 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.63 84.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.01 -33.32 19.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.969 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.546 HG23 ' O ' ' C' ' 84' ' ' ASP . 32.8 t -70.06 -49.66 54.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 36.4 t-20 -63.12 -35.99 82.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.337 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.22 -42.14 94.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.973 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.68 -31.16 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.567 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.457 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 48.7 t80 -57.64 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 7.7 tt0 -73.36 -27.37 61.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -25.19 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.77 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -79.32 -41.03 28.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 95' ' ' PHE . 56.7 m-85 -56.38 -50.4 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.781 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -28.72 69.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.954 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.91 -3.78 58.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.362 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.91 14.79 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 11.7 m-20 89.79 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.822 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.499 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.8 t60 -127.55 72.17 77.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.705 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.03 -10.97 16.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.495 2.13 . . . . 0.0 112.146 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.82 ' OD1' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.998 0.428 . . . . 0.0 110.429 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.512 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 92.8 m-85 70.91 144.1 0.1 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.42 ' HB2' HG22 ' C' ' 75' ' ' THR . 2.0 Cg_endo -83.05 165.85 14.87 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.028 2.485 . . . . 0.0 111.948 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.812 ' HB1' ' HB2' ' A' ' 31' ' ' SER . . . -115.29 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.6 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -169.22 -163.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.4 p -111.36 107.48 16.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.589 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' CYS . . . . . 0.502 ' O ' HG13 ' C' ' 110' ' ' VAL . 5.2 m -95.21 129.18 42.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.788 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.514 HG12 HD23 ' A' ' 115' ' ' LEU . 7.1 m -157.82 165.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 9.4 tt0 -99.76 102.86 14.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.75 162.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -79.08 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.671 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -140.83 168.09 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' C' ' 122' ' ' GLU . 3.0 mt -144.21 161.82 43.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.913 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.544 ' O ' HG22 ' C' ' 119' ' ' VAL . 33.7 Cg_exo -59.52 135.99 68.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.608 2.205 . . . . 0.0 112.221 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.51 18.29 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 61.8 17.55 8.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.544 HG22 ' O ' ' C' ' 116' ' ' PRO . 21.2 m -55.18 172.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.065 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.79 14.08 19.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.988 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.534 ' O ' HD12 ' C' ' 121' ' ' LEU . 4.6 pp -176.62 148.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.489 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.619 ' HB2' HD22 ' C' ' 115' ' ' LEU . 44.4 tt0 -150.83 137.93 19.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.754 HG23 ' O ' ' C' ' 76' ' ' THR . 3.4 mp -144.74 138.35 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.11 0.481 . . . . 0.0 112.142 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.3 149.82 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.648 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.573 ' C ' HD13 ' C' ' 126' ' ' ILE . . . -131.98 126.13 33.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 112.004 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.573 HD13 ' C ' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -114.41 132.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 178.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.947 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -121.76 153.11 38.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.082 0.468 . . . . 0.0 112.029 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 3' ' ' THR . 34.6 m -124.15 116.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.47 ' CD ' HD21 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -106.27 56.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.99 0.424 . . . . 0.0 110.892 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.815 0.341 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.9 tpp -107.77 162.2 14.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.85 HG21 HG21 ' C' ' 128' ' ' VAL . 50.6 m 63.54 131.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -173.58 122.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.023 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.643 HD13 ' OD1' ' C' ' 103' ' ' ASN . 2.0 mp -57.27 153.16 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 23' ' ' ASP . 29.6 mt -114.16 154.75 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.421 ' N ' HG22 ' A' ' 6' ' ' ILE . 21.0 t60 -153.69 126.15 8.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.725 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -130.46 151.73 50.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.037 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -98.22 30.11 3.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.479 ' HE3' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -109.76 -39.33 5.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.745 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . -92.64 120.68 67.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.162 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 26.0 Cg_exo -62.26 -11.59 23.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.491 2.127 . . . . 0.0 112.587 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.33 -169.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 0.0 111.396 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.535 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 58.37 -164.75 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.189 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 15' ' ' ILE . 23.8 mm 80.32 16.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.107 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.69 -138.67 4.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.958 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.401 ' HB3' ' HB2' ' C' ' 93' ' ' GLU . 86.1 Cg_endo -84.03 46.13 1.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.569 2.179 . . . . 0.0 112.624 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -176.11 -169.07 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.939 0.399 . . . . 0.0 111.051 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.757 HG13 ' HB2' ' C' ' 104' ' ' PHE . 14.8 m -120.65 -179.64 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.804 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -71.16 -52.5 18.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.18 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -159.48 -178.52 7.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.795 HG11 ' O ' ' C' ' 73' ' ' VAL . 14.8 m -137.54 134.18 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.165 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.617 ' HB2' HD11 ' A' ' 6' ' ' ILE . 17.9 t0 -113.89 93.3 4.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.82 HD21 HG21 ' C' ' 73' ' ' VAL . 17.2 mt -62.6 -20.44 64.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.043 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.93 -109.57 0.81 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.922 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.31 -30.37 64.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.058 0.456 . . . . 0.0 110.19 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.49 HD21 HD22 ' B' ' 24' ' ' LEU . 0.1 OUTLIER -119.6 128.03 53.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.787 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.929 HG23 ' HB3' ' A' ' 127' ' ' ALA . 2.4 m -106.59 175.11 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.044 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.575 ' HG ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -166.84 146.11 5.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.51 HG21 HD11 ' A' ' 62' ' ' ILE . 17.5 p -109.44 147.49 32.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.044 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.527 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 16.9 t -81.86 162.33 22.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.008 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -52.73 92.96 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.621 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.632 ' HG3' HG22 ' A' ' 58' ' ' VAL . 16.4 mm-40 -65.64 151.82 45.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.842 0.353 . . . . 0.0 111.093 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.745 HG23 HG11 ' A' ' 119' ' ' VAL . 4.6 mp -126.58 134.01 25.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.65 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 61.2 Cg_endo -73.91 72.63 3.86 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.891 2.394 . . . . 0.0 112.321 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.587 HG12 ' HA2' ' A' ' 41' ' ' GLY . 38.8 t -87.35 87.92 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.787 ' HB3' HG22 ' A' ' 40' ' ' THR . 0.9 OUTLIER -33.09 126.44 0.4 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.998 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.77 -5.64 17.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.269 1.98 . . . . 0.0 112.097 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.46 -23.67 11.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.653 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.787 HG22 ' HB3' ' A' ' 37' ' ' ASN . 15.2 t -129.3 -28.98 2.28 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.762 0.315 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.587 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 77.46 52.36 5.6 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.156 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 9.6 mm-40 -147.25 -74.33 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.697 0.284 . . . . 0.0 111.245 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.693 ' HB ' HG12 ' A' ' 119' ' ' VAL . 11.2 p 172.63 115.0 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.047 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.1 140.38 60.41 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.396 2.064 . . . . 0.0 112.126 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.0 -31.44 70.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.061 0.458 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -72.86 95.87 2.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.736 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.73 -31.28 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.321 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.449 HG22 ' HB1' ' A' ' 87' ' ' ALA . 22.1 t -75.97 -51.45 20.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.385 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -62.7 -37.64 87.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.227 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -69.14 -28.07 66.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.298 179.305 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.23 -34.95 36.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.902 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -69.03 -42.28 76.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.794 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.53 82.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.799 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.3 m -71.07 -36.88 72.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -68.02 -40.45 82.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.752 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.73 -38.58 86.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.741 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.17 -43.69 97.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.978 HG21 HG21 ' A' ' 123' ' ' ILE . 24.8 t -61.15 -35.99 69.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.65 -32.76 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.698 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . . . -60.63 -39.9 89.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.81 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 58' ' ' VAL . 3.0 mt -69.23 -46.57 77.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.689 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.51 HD11 HG21 ' A' ' 30' ' ' THR . 22.1 mt -67.45 -32.67 58.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.492 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.6 -41.08 66.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.196 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -61.3 -21.95 64.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.344 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.54 -28.45 21.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.651 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.35 47.15 0.55 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.594 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 129' ' ' ARG . 5.4 mt -156.56 138.02 13.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.859 0.361 . . . . 0.0 110.95 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.6 m -93.27 159.4 15.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.798 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.864 ' HB3' ' CD2' ' A' ' 101' ' ' HIS . . . -57.32 -34.09 68.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.908 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.82 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -51.93 -28.27 15.87 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.883 0.373 . . . . 0.0 110.711 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.68 -26.69 60.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.395 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 126' ' ' ILE . 71.4 mt -47.61 118.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.763 HG21 HD21 ' B' ' 24' ' ' LEU . 26.5 m -92.14 -30.73 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.741 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 22.8 tttm -138.32 160.12 40.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.567 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.703 HG23 ' HB2' ' A' ' 125' ' ' ALA . 41.8 m -153.31 137.97 16.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.989 0.423 . . . . 0.0 111.49 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.903 HG23 ' O ' ' A' ' 108' ' ' SER . 58.5 m -126.98 140.65 52.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.043 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.651 HG13 HD13 ' A' ' 123' ' ' ILE . 21.3 t -146.26 115.61 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 111.617 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.694 ' HB2' HD21 ' A' ' 115' ' ' LEU . 9.2 m-85 -89.35 112.08 23.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.482 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.614 HG12 HD21 ' A' ' 121' ' ' LEU . 34.4 m -97.46 148.34 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.575 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 -5.62 29.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.97 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 97.4 2.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.481 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' B' ' 114' ' ' ARG . 1.9 mt -57.61 -18.11 18.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.226 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.45 -25.3 54.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.928 0.394 . . . . 0.0 110.49 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -87.13 -19.53 28.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.83 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.4 ' CD1' HG11 ' A' ' 79' ' ' VAL . 35.2 t80 -56.8 -22.48 36.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.09 -36.15 67.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 0.0 111.185 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.449 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -83.46 -44.66 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.54 -38.16 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.777 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -66.28 -41.91 89.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.81 84.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.208 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.29 -30.84 25.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.415 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 84.2 t80 -53.71 -44.36 69.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.893 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' B' ' 17' ' ' PRO . 1.5 tt0 -85.86 -21.97 27.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.284 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.13 -21.27 59.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.429 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.2 p90 -91.78 -35.04 14.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.713 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 101' ' ' HIS . 0.8 OUTLIER -56.14 -60.2 3.84 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.145 0.498 . . . . 0.0 110.093 179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -28.85 70.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.576 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -77.33 -9.97 59.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.711 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.466 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . 57.5 m-20 -113.46 -6.01 13.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.461 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.1 m120 88.04 34.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.169 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.864 ' CD2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 m-70 -116.6 53.35 1.13 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.67 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 73.6 Cg_endo -73.62 -19.26 21.66 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.739 2.293 . . . . 0.0 112.907 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.645 ' OD1' HD13 ' B' ' 5' ' ' ILE . 2.1 t-20 -46.16 -35.64 5.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.873 0.368 . . . . 0.0 111.399 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.766 ' HB2' HG13 ' B' ' 19' ' ' VAL . 13.4 m-85 68.18 106.36 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.372 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 98.6 Cg_endo -85.08 160.43 11.57 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.747 2.298 . . . . 0.0 112.319 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.741 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -54.97 154.45 5.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.575 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -113.73 150.39 33.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.0 111.315 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.903 ' O ' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -160.07 53.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.447 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.93 146.78 27.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.019 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.596 HG12 HD23 ' B' ' 115' ' ' LEU . 29.7 m -153.23 156.23 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.303 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.434 ' HA ' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -77.99 95.36 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.435 HG21 HD21 ' A' ' 115' ' ' LEU . 9.8 m -83.21 148.45 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -60.65 -46.33 90.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.996 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.449 ' HB3' HD12 ' C' ' 82' ' ' LEU . 19.5 mtt180 -155.16 171.32 20.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.728 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 122' ' ' GLU . 1.6 mt -143.31 160.14 52.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 119' ' ' VAL . 89.4 Cg_exo -46.72 136.74 16.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.443 2.095 . . . . 0.0 112.236 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.85 17.86 7.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 61.67 17.14 8.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.034 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.745 HG11 HG23 ' A' ' 34' ' ' ILE . 35.8 m -63.16 154.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.055 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.8 26.49 24.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.666 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.614 HD21 HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -178.91 158.01 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.113 0.482 . . . . 0.0 111.154 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' A' ' 115' ' ' LEU . 4.4 tt0 -152.49 148.32 27.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.179 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.978 HG21 HG21 ' A' ' 58' ' ' VAL . 23.5 mm -122.94 146.13 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 111.766 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 99.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.101 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.703 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -124.03 166.8 15.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 111.877 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 72' ' ' ILE . 9.0 mm -114.51 154.05 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.404 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.929 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -141.09 151.5 44.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.97 0.414 . . . . 0.0 111.573 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.767 HG21 HG21 ' B' ' 3' ' ' THR . 28.0 m -105.88 -179.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.942 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.771 ' HB2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -163.75 48.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.834 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 tttp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.266 -0.874 . . . . 0.0 110.878 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.843 0.354 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 6.9 tpp -107.82 162.18 14.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.767 HG21 HG21 ' A' ' 128' ' ' VAL . 51.0 m 63.56 131.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -173.52 122.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.645 HD13 ' OD1' ' A' ' 103' ' ' ASN . 2.0 mp -57.32 153.21 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' B' ' 23' ' ' ASP . 29.5 mt -114.22 154.67 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.201 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.409 ' N ' HG22 ' B' ' 6' ' ' ILE . 21.0 t60 -153.63 126.08 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.75 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -130.46 151.77 50.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.99 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -98.19 30.18 3.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.894 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -39.76 4.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.33 120.74 67.43 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.168 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.25 -11.65 23.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.48 2.12 . . . . 0.0 112.613 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.29 -169.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.011 0.434 . . . . 0.0 111.391 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.536 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 58.36 -164.75 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.266 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.617 HG22 ' O ' ' B' ' 15' ' ' ILE . 23.7 mm 80.34 16.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.126 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.74 -138.69 4.33 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.91 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 86.2 Cg_endo -84.03 46.15 1.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.583 2.189 . . . . 0.0 112.653 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.536 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -176.16 -169.15 0.3 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 111.058 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.766 HG13 ' HB2' ' A' ' 104' ' ' PHE . 14.5 m -120.55 -179.67 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.771 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -70.95 -51.33 26.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 0.0 111.038 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -161.19 -178.17 6.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.059 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.743 HG11 ' O ' ' A' ' 73' ' ' VAL . 14.9 m -137.54 134.13 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.159 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.62 ' HB2' HD11 ' B' ' 6' ' ' ILE . 17.9 t0 -113.87 93.25 4.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.763 HD21 HG21 ' A' ' 73' ' ' VAL . 17.4 mt -62.58 -20.34 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.046 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.87 -109.59 0.81 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.99 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.32 -30.38 64.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.462 . . . . 0.0 110.175 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.695 HD21 HD22 ' C' ' 24' ' ' LEU . 0.1 OUTLIER -119.62 127.98 53.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.797 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.937 HG23 ' HB3' ' B' ' 127' ' ' ALA . 2.4 m -106.53 175.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.026 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.582 ' HG ' HG23 ' B' ' 22' ' ' VAL . 0.6 OUTLIER -166.88 146.05 5.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.575 HG21 HD11 ' B' ' 62' ' ' ILE . 17.3 p -109.35 147.25 33.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.519 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 16.9 t -81.64 162.36 23.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.438 ' O ' HD12 ' B' ' 34' ' ' ILE . . . -52.68 92.87 0.01 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.614 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.651 ' HG3' HG22 ' B' ' 58' ' ' VAL . 16.3 mm-40 -65.61 151.75 45.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 111.117 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.697 HG23 HG11 ' B' ' 119' ' ' VAL . 4.6 mp -126.56 134.1 25.68 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.644 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 61.1 Cg_endo -74.0 72.73 3.89 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.88 2.387 . . . . 0.0 112.231 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.57 HG12 ' HA2' ' B' ' 41' ' ' GLY . 38.9 t -87.42 87.88 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.623 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.79 ' HB3' HG22 ' B' ' 40' ' ' THR . 0.9 OUTLIER -33.06 126.44 0.4 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.012 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.84 -5.52 17.34 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.236 1.957 . . . . 0.0 112.096 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.49 -23.73 11.72 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.653 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.79 HG22 ' HB3' ' B' ' 37' ' ' ASN . 15.2 t -129.37 -28.94 2.26 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.356 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.57 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 77.52 52.35 5.57 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.127 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 9.6 mm-40 -147.23 -74.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.683 0.278 . . . . 0.0 111.221 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.722 ' HB ' HG12 ' B' ' 119' ' ' VAL . 11.2 p 172.62 114.99 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.13 140.37 60.74 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.347 2.032 . . . . 0.0 112.158 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.96 -31.48 70.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.2 OUTLIER -72.89 95.92 2.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.743 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.71 -31.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.313 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.431 HG22 ' HB1' ' B' ' 87' ' ' ALA . 22.3 t -76.03 -51.4 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.387 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -62.7 -37.63 87.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.254 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.419 ' HG3' ' CG2' ' B' ' 43' ' ' VAL . 0.9 OUTLIER -69.14 -28.05 66.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.337 179.26 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.38 -34.97 35.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.927 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -68.99 -42.28 76.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.775 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -39.51 82.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.622 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.823 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.3 m -71.04 -36.97 72.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.717 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -67.97 -40.54 83.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.62 -38.64 87.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.758 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.09 -43.77 97.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.72 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.985 HG21 HG21 ' B' ' 123' ' ' ILE . 24.7 t -61.15 -36.05 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.792 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.48 -32.87 42.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.687 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.88 89.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' B' ' 58' ' ' VAL . 3.0 mt -69.45 -46.66 75.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.575 HD11 HG21 ' B' ' 30' ' ' THR . 22.1 mt -67.48 -32.57 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.566 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.7 -41.05 65.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.183 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -61.26 -21.98 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.358 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.55 -28.41 21.98 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.35 47.16 0.55 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.616 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.823 HD11 ' HB2' ' B' ' 129' ' ' ARG . 5.4 mt -156.54 137.98 13.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.975 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 9.4 m -93.27 159.4 15.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.819 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.85 ' HB3' ' CD2' ' B' ' 101' ' ' HIS . . . -57.29 -34.07 68.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.819 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -51.88 -28.12 15.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.975 0.417 . . . . 0.0 110.666 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.74 -26.62 60.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.416 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.558 HG23 ' O ' ' B' ' 126' ' ' ILE . 71.4 mt -47.66 118.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.026 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.78 ' O ' HG11 ' C' ' 22' ' ' VAL . 26.0 m -92.21 -30.55 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.08 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.768 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 22.8 tttm -138.43 160.02 40.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.596 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.717 HG23 ' HB2' ' B' ' 125' ' ' ALA . 42.0 m -153.27 137.97 16.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 0.0 111.461 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.924 HG23 ' O ' ' B' ' 108' ' ' SER . 58.5 m -126.98 140.65 52.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.08 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.664 HG13 HD13 ' B' ' 123' ' ' ILE . 21.3 t -146.26 115.58 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 111.551 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.659 ' HB2' HD21 ' B' ' 115' ' ' LEU . 9.1 m-85 -89.29 112.13 23.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.485 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.621 HG12 HD21 ' B' ' 121' ' ' LEU . 34.3 m -97.51 148.3 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.647 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 -5.73 29.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.95 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.67 97.43 2.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.508 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' C' ' 114' ' ' ARG . 1.9 mt -57.63 -18.13 18.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.203 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.42 -25.33 54.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -87.08 -19.51 28.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.894 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.4 ' CD1' HG11 ' B' ' 79' ' ' VAL . 35.0 t80 -56.8 -22.52 36.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.204 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.18 67.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 111.214 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.431 ' HB1' HG22 ' B' ' 48' ' ' VAL . . . -83.53 -44.65 14.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.52 -38.15 81.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.818 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.23 -41.95 89.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.834 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.99 85.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.221 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.27 -31.0 25.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.415 ' O ' ' CE2' ' B' ' 95' ' ' PHE . 84.1 t80 -53.66 -44.46 69.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' C' ' 17' ' ' PRO . 1.5 tt0 -85.8 -21.99 27.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.287 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.11 -21.27 59.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.438 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 1.2 p90 -91.83 -35.0 14.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.759 0.314 . . . . 0.0 110.695 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' B' ' 101' ' ' HIS . 0.8 OUTLIER -56.29 -60.12 3.97 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.174 0.512 . . . . 0.0 110.101 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -28.74 70.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.545 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -77.47 -9.91 59.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 110.658 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.465 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . 57.1 m-20 -113.44 -6.02 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.482 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.1 m120 88.13 34.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.189 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.85 ' CD2' ' HB3' ' B' ' 69' ' ' ALA . 1.6 m-70 -116.47 53.38 1.1 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.701 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 73.5 Cg_endo -73.78 -19.21 21.3 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.771 2.314 . . . . 0.0 112.895 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.63 ' OD1' HD13 ' C' ' 5' ' ' ILE . 2.1 t-20 -46.12 -35.64 5.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.937 0.399 . . . . 0.0 111.409 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.759 ' HB2' HG13 ' C' ' 19' ' ' VAL . 13.5 m-85 68.15 106.37 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.36 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 97.0 Cg_endo -85.08 160.38 11.57 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.711 2.274 . . . . 0.0 112.327 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.768 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -54.88 154.53 5.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.615 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.473 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -113.78 150.46 33.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.015 0.436 . . . . 0.0 111.351 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.924 ' O ' HG23 ' B' ' 76' ' ' THR . 0.4 OUTLIER -160.06 53.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.508 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.99 146.65 28.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.997 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' C' ' 78' ' ' PHE . 30.0 m -153.06 155.65 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.244 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -77.77 95.29 4.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.843 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.428 HG21 HD21 ' B' ' 115' ' ' LEU . 9.9 m -83.18 148.44 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.127 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -60.7 -46.34 90.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.477 ' HB3' HD12 ' A' ' 82' ' ' LEU . 19.4 mtt180 -155.16 171.26 20.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.719 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' B' ' 122' ' ' GLU . 1.6 mt -143.29 160.19 52.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.706 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.607 ' O ' HG22 ' B' ' 119' ' ' VAL . 89.1 Cg_exo -46.75 136.75 16.45 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.459 2.106 . . . . 0.0 112.255 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.89 17.76 7.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 61.69 17.17 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.059 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.722 HG12 ' HB ' ' B' ' 43' ' ' VAL . 35.5 m -63.2 154.66 6.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.004 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.07 26.28 25.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.708 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.621 HD21 HG12 ' B' ' 79' ' ' VAL . 0.4 OUTLIER -178.89 158.06 0.93 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.12 0.486 . . . . 0.0 111.191 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.776 ' HB2' HD22 ' B' ' 115' ' ' LEU . 4.4 tt0 -152.48 148.25 27.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.23 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.985 HG21 HG21 ' B' ' 58' ' ' VAL . 23.5 mm -122.92 146.06 28.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.065 0.46 . . . . 0.0 111.799 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.88 99.82 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.144 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.717 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -124.05 166.7 15.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.877 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.558 ' O ' HG23 ' B' ' 72' ' ' ILE . 8.9 mm -114.47 154.0 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.422 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.937 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -141.03 151.58 44.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.914 0.388 . . . . 0.0 111.557 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.814 HG21 HG21 ' C' ' 3' ' ' THR . 27.6 m -106.0 -179.42 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.894 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.823 ' HB2' HD11 ' B' ' 67' ' ' LEU . 0.0 OUTLIER -163.71 48.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.947 0.403 . . . . 0.0 110.934 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 tttp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.849 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.817 0.342 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 6.9 tpp -107.82 162.11 14.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.814 HG21 HG21 ' B' ' 128' ' ' VAL . 51.2 m 63.57 131.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -173.53 122.4 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.63 HD13 ' OD1' ' B' ' 103' ' ' ASN . 2.1 mp -57.29 153.21 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.834 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' C' ' 23' ' ' ASP . 29.0 mt -114.17 154.71 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.2 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 7' ' ' HIS . . . . . 0.408 ' N ' HG22 ' C' ' 6' ' ' ILE . 21.0 t60 -153.71 126.06 8.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.728 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -130.38 151.77 50.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.018 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -98.27 30.12 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.474 ' HE3' ' HB2' ' C' ' 60' ' ' ALA . 0.0 OUTLIER -109.84 -39.33 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.72 120.72 67.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.18 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.31 -11.58 23.23 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.486 2.124 . . . . 0.0 112.593 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.32 -169.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.0 111.415 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.528 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 58.39 -164.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.231 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.6 HG22 ' O ' ' C' ' 15' ' ' ILE . 23.8 mm 80.32 16.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.107 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.68 -138.61 4.33 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.0 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' PRO . . . . . 0.41 ' HB3' ' HB2' ' B' ' 93' ' ' GLU . 84.4 Cg_endo -84.08 46.17 1.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.621 2.214 . . . . 0.0 112.67 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.528 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -176.18 -169.12 0.3 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.92 0.391 . . . . 0.0 111.082 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.759 HG13 ' HB2' ' B' ' 104' ' ' PHE . 14.6 m -120.58 -179.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.769 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -71.21 -52.52 18.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.271 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -159.65 -178.44 7.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.78 HG11 ' O ' ' B' ' 73' ' ' VAL . 14.9 m -137.54 134.27 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.634 ' HB2' HD11 ' C' ' 6' ' ' ILE . 18.0 t0 -113.95 93.36 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.731 HD21 HG21 ' B' ' 73' ' ' VAL . 17.5 mt -62.68 -20.45 64.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.004 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.01 -109.57 0.81 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.926 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.33 -30.37 64.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.052 0.453 . . . . 0.0 110.187 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.57 HD21 HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -119.6 128.02 53.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.776 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.94 HG23 ' HB3' ' C' ' 127' ' ' ALA . 2.4 m -106.55 175.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.041 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.593 ' HG ' HG23 ' C' ' 22' ' ' VAL . 0.6 OUTLIER -166.83 146.1 5.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.807 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.491 HG21 HD11 ' C' ' 62' ' ' ILE . 17.4 p -109.61 147.62 32.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' SER . . . . . 0.529 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 16.9 t -81.76 162.24 22.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.002 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' GLY . . . . . 0.442 ' O ' HD12 ' C' ' 34' ' ' ILE . . . -52.61 92.9 0.01 OUTLIER Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.654 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.621 ' HG3' HG22 ' C' ' 58' ' ' VAL . 16.4 mm-40 -65.6 151.8 45.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 0.0 111.107 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.715 HG23 HG11 ' C' ' 119' ' ' VAL . 4.6 mp -126.57 133.98 25.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.636 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 61.2 Cg_endo -73.88 72.61 3.84 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.888 2.392 . . . . 0.0 112.292 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.585 HG12 ' HA2' ' C' ' 41' ' ' GLY . 38.7 t -87.31 87.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.68 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.786 ' HB3' HG22 ' C' ' 40' ' ' THR . 0.9 OUTLIER -33.18 126.47 0.41 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.993 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.8 -5.55 17.4 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.215 1.943 . . . . 0.0 112.11 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.5 -23.69 11.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.638 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.786 HG22 ' HB3' ' C' ' 37' ' ' ASN . 15.2 t -129.31 -28.79 2.29 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.78 0.324 . . . . 0.0 111.405 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 77.21 52.31 5.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.13 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 9.6 mm-40 -147.23 -74.38 0.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.714 0.292 . . . . 0.0 111.182 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.694 ' HB ' HG12 ' C' ' 119' ' ' VAL . 11.1 p 172.66 115.02 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.049 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.07 140.4 60.14 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.327 2.018 . . . . 0.0 112.155 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.04 -31.38 70.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.008 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -72.94 95.97 2.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.684 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.79 -31.31 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.231 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' VAL . . . . . 0.403 HG22 ' HB1' ' C' ' 87' ' ' ALA . 22.1 t -75.95 -51.47 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.383 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -62.75 -37.6 87.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.246 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.42 ' HG3' ' CG2' ' C' ' 43' ' ' VAL . 0.9 OUTLIER -69.17 -27.91 65.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.301 179.273 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.52 -34.96 35.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.951 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -69.07 -42.29 76.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -39.49 82.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.698 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.825 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.3 m -71.03 -36.98 72.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.689 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -67.96 -40.52 83.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.728 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.68 -38.66 87.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.71 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.05 -43.8 97.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.717 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 1.007 HG21 HG21 ' C' ' 123' ' ' ILE . 24.8 t -61.12 -36.08 70.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.786 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.49 -32.77 42.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.676 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.474 ' HB2' ' HE3' ' C' ' 10' ' ' LYS . . . -60.65 -40.0 90.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.799 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' C' ' 58' ' ' VAL . 3.0 mt -69.18 -46.65 77.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.655 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.491 HD11 HG21 ' C' ' 30' ' ' THR . 22.0 mt -67.43 -32.65 58.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.532 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.65 -41.03 65.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.18 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -61.3 -21.89 64.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.41 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.63 -28.41 21.89 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.623 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.32 47.14 0.55 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.613 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.812 HD11 ' HB2' ' C' ' 129' ' ' ARG . 5.4 mt -156.52 138.0 13.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.853 0.358 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 9.4 m -93.19 159.39 15.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.857 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' CD2' ' C' ' 101' ' ' HIS . . . -57.3 -34.19 68.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.815 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -51.9 -28.33 15.9 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.91 0.386 . . . . 0.0 110.712 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.55 -26.64 60.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.435 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.548 HG23 ' O ' ' C' ' 126' ' ' ILE . 71.4 mt -47.66 118.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.033 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.82 HG21 HD21 ' A' ' 24' ' ' LEU . 26.4 m -92.09 -30.7 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.093 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.742 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 22.8 tttm -138.34 160.12 40.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.576 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.69 HG23 ' HB2' ' C' ' 125' ' ' ALA . 40.6 m -153.29 137.9 16.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.043 0.449 . . . . 0.0 111.517 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.932 HG23 ' O ' ' C' ' 108' ' ' SER . 58.8 m -126.94 140.61 52.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.098 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.65 HG13 HD13 ' C' ' 123' ' ' ILE . 21.4 t -146.22 115.66 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.616 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.679 ' HB2' HD21 ' C' ' 115' ' ' LEU . 9.1 m-85 -89.33 112.07 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.494 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.586 HG12 HD21 ' C' ' 121' ' ' LEU . 34.4 m -97.44 148.37 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.115 0.483 . . . . 0.0 111.575 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 -5.59 29.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.995 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.69 97.4 2.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.53 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 114' ' ' ARG . 1.9 mt -57.64 -18.15 18.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.127 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.38 -25.33 54.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.48 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -87.12 -19.51 28.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.888 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -56.73 -22.54 36.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.06 -36.11 67.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.403 ' HB1' HG22 ' C' ' 48' ' ' VAL . . . -83.55 -44.65 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.53 -38.18 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.31 -41.89 89.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.837 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.82 84.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.201 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.41 -30.97 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.418 ' O ' ' CE2' ' C' ' 95' ' ' PHE . 84.2 t80 -53.61 -44.47 69.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 93' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 1.5 tt0 -85.82 -22.01 27.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.281 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -21.25 60.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.456 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 1.2 p90 -91.8 -35.13 14.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' C' ' 101' ' ' HIS . 0.8 OUTLIER -56.17 -60.21 3.82 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.117 0.484 . . . . 0.0 110.084 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -28.84 70.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.539 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.36 -9.96 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 0.0 110.681 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 57.2 m-20 -113.43 -6.01 13.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.491 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 11.9 m120 88.02 34.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.181 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.851 ' CD2' ' HB3' ' C' ' 69' ' ' ALA . 1.6 m-70 -116.56 53.35 1.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.664 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 73.5 Cg_endo -73.67 -19.29 21.51 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.797 2.332 . . . . 0.0 112.907 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.643 ' OD1' HD13 ' A' ' 5' ' ' ILE . 2.1 t-20 -46.18 -35.58 5.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.88 0.371 . . . . 0.0 111.388 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.757 ' HB2' HG13 ' A' ' 19' ' ' VAL . 13.5 m-85 68.12 106.39 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.36 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.431 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 96.7 Cg_endo -85.14 160.42 11.49 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.711 2.274 . . . . 0.0 112.353 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.742 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -54.9 154.46 5.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.556 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.467 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -113.75 150.46 33.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.998 0.428 . . . . 0.0 111.297 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 108' ' ' SER . . . . . 0.932 ' O ' HG23 ' C' ' 76' ' ' THR . 0.4 OUTLIER -160.1 53.96 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.425 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.92 146.75 27.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.959 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.578 HG11 ' CD2' ' A' ' 78' ' ' PHE . 30.0 m -153.11 155.34 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.288 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -77.32 95.38 4.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.721 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.427 HG21 HD21 ' C' ' 115' ' ' LEU . 10.0 m -83.2 148.45 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -60.71 -46.31 90.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.485 ' HB3' HD12 ' B' ' 82' ' ' LEU . 19.4 mtt180 -155.17 171.35 19.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.823 HD22 ' HB2' ' C' ' 122' ' ' GLU . 1.6 mt -143.36 160.17 52.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.661 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.618 ' O ' HG22 ' C' ' 119' ' ' VAL . 89.3 Cg_exo -46.76 136.73 16.52 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.496 2.131 . . . . 0.0 112.243 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.95 17.79 7.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.7 17.08 8.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.049 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.715 HG11 HG23 ' C' ' 34' ' ' ILE . 35.7 m -63.17 154.6 6.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.77 26.41 24.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.652 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.586 HD21 HG12 ' C' ' 79' ' ' VAL . 0.4 OUTLIER -178.76 157.98 0.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.08 0.467 . . . . 0.0 111.173 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.823 ' HB2' HD22 ' C' ' 115' ' ' LEU . 4.4 tt0 -152.46 148.28 27.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.226 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 1.007 HG21 HG21 ' C' ' 58' ' ' VAL . 23.2 mm -122.93 146.05 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.057 0.455 . . . . 0.0 111.81 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 99.84 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.068 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.69 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -124.08 166.86 15.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.037 0.446 . . . . 0.0 111.828 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.548 ' O ' HG23 ' C' ' 72' ' ' ILE . 8.8 mm -114.52 154.0 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.463 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.94 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -141.1 151.46 43.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.898 0.38 . . . . 0.0 111.576 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.85 HG21 HG21 ' A' ' 3' ' ' THR . 27.2 m -105.9 -179.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.884 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.812 ' HB2' HD11 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -163.71 48.1 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.884 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 tttp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.926 179.937 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.7 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.819 0.342 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -140.84 164.13 31.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.557 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER 63.81 131.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.965 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.8 136.84 3.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.637 HG23 HG21 ' A' ' 19' ' ' VAL . 4.8 mp -58.55 158.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.244 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' A' ' 21' ' ' ALA . 19.0 mt -115.13 160.58 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.043 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.475 ' N ' HG22 ' A' ' 6' ' ' ILE . 1.4 t-80 -160.73 124.48 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.997 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 61' ' ' ILE . 8.0 t -127.65 165.52 19.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.973 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.76 51.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.25 -50.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.757 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.921 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -66.41 172.34 3.25 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.03 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.921 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 32.1 Cg_endo -64.37 -11.95 30.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.586 2.19 . . . . 0.0 112.714 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 73.27 171.61 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.987 0.423 . . . . 0.0 111.352 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.768 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -166.98 122.75 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.799 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 14' ' ' ALA . 17.8 mm -141.42 17.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.377 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.58 -103.85 2.44 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.274 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.17 4.88 6.65 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.536 2.157 . . . . 0.0 112.788 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.498 ' CD1' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -160.74 177.21 10.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.673 HG13 ' HB2' ' C' ' 104' ' ' PHE . 28.4 m -132.32 166.37 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.051 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.772 ' OE1' ' HB3' ' A' ' 11' ' ' ALA . 3.9 mm-40 -52.82 -46.43 67.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . -176.21 176.79 1.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.997 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.661 HG21 ' HB ' ' C' ' 73' ' ' VAL . 3.1 m -140.19 133.89 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.458 ' CG ' HG12 ' A' ' 28' ' ' VAL . 6.9 t0 -97.26 139.69 32.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.654 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.846 HD11 HD13 ' A' ' 29' ' ' LEU . 6.6 mt -112.94 -15.86 12.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.34 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 97.01 104.45 2.23 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.294 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.2 m120 84.05 -35.72 0.06 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.783 ' HG ' HG12 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -127.2 101.5 6.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.771 179.042 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.095 HG23 ' HB3' ' A' ' 127' ' ' ALA . 3.4 m -94.89 170.34 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.377 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.909 ' HG ' HG23 ' A' ' 126' ' ' ILE . 3.6 mp -152.77 148.92 27.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.943 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 p -125.97 149.1 49.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.863 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 4.1 t -75.26 170.7 15.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.03 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.92 77.21 0.41 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.062 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -53.14 162.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.964 0.411 . . . . 0.0 111.536 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.713 HG13 HG23 ' A' ' 36' ' ' VAL . 7.5 pt -146.91 154.21 46.87 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.773 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.626 ' HG2' HG23 ' A' ' 43' ' ' VAL . 72.2 Cg_endo -77.11 48.79 2.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.925 2.416 . . . . 0.0 113.292 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.713 HG23 HG13 ' A' ' 34' ' ' ILE . 45.9 t -64.02 86.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.229 0.537 . . . . 0.0 110.473 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.672 ' HB3' HG22 ' A' ' 40' ' ' THR . 3.7 t30 -38.23 130.09 1.02 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.039 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.22 -6.98 19.22 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.228 1.952 . . . . 0.0 111.663 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.434 ' HB3' ' ND2' ' A' ' 37' ' ' ASN . . . -101.92 -28.3 12.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.552 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 42' ' ' GLU . 8.1 t -125.5 -33.63 2.77 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.967 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 85.24 62.22 1.67 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.731 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.689 ' HG3' HG23 ' A' ' 40' ' ' THR . 0.2 OUTLIER -167.25 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.694 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.626 HG23 ' HG2' ' A' ' 35' ' ' PRO . 9.9 p -170.59 125.74 0.66 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.309 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 35' ' ' PRO . 52.7 Cg_exo -54.4 141.77 71.38 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.453 2.102 . . . . 0.0 112.235 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.01 70.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 93.87 1.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.774 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' A' ' 47' ' ' ILE . 7.4 tp -42.25 -33.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.638 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.56 -46.38 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.15 -46.99 88.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.64 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.401 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 3.5 pt20 -64.89 -28.89 69.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.52 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.8 -40.87 54.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.859 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -67.81 -52.31 38.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.62 -27.97 63.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.622 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -61.86 -42.41 99.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.629 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.639 HD13 ' CE2' ' A' ' 95' ' ' PHE . 7.5 mt -74.98 -30.0 61.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 32.5 mt-10 -65.5 -36.16 83.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.086 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 54' ' ' SER . 22.4 p30 -72.43 -27.8 62.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.793 0.33 . . . . 0.0 110.598 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.864 HG21 HG21 ' A' ' 123' ' ' ILE . 35.2 t -67.63 -45.86 84.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -76.06 -28.24 57.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.18 94.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 8' ' ' THR . 16.1 mt -72.83 -40.9 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.584 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.516 ' CD1' HD11 ' A' ' 72' ' ' ILE . 18.4 mt -70.07 -33.07 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.68 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.53 -40.98 63.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.274 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -21.8 65.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.349 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.3 -28.41 17.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.734 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.24 56.65 0.26 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.606 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 129' ' ' ARG . 3.5 mt -172.77 144.17 1.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.0 p -99.43 166.06 11.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.763 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.938 ' HB3' ' CD2' ' A' ' 101' ' ' HIS . . . -62.48 -31.05 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.837 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.774 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -52.59 -26.85 14.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.911 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.463 ' CB ' HD22 ' A' ' 67' ' ' LEU . 1.2 m-20 -82.15 -24.5 35.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.898 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.566 HG21 HG22 ' A' ' 75' ' ' THR . 96.6 mt -52.9 108.31 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.922 0.392 . . . . 0.0 110.954 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.678 ' HB ' HG21 ' B' ' 22' ' ' VAL . 35.4 m -74.31 -45.29 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.816 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.599 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 5.9 mttp -125.06 163.72 21.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.626 0.25 . . . . 0.0 111.263 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.618 HG23 ' CB ' ' A' ' 105' ' ' PRO . 31.7 p -157.8 102.4 1.84 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.831 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.82 HG23 ' CD ' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -70.03 124.64 24.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.412 HG11 ' HE1' ' A' ' 85' ' ' PHE . 6.2 t -116.28 110.36 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.413 ' CE2' ' OE2' ' A' ' 124' ' ' GLU . 15.8 m-30 -107.88 119.92 40.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.973 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.602 HG12 HD21 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -114.26 152.21 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.13 0.491 . . . . 0.0 111.777 -179.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.99 1.05 57.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.846 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.3 108.56 0.28 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.546 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' B' ' 114' ' ' ARG . 3.0 mt -57.84 -17.31 15.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.274 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.23 -22.18 60.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 0.0 110.458 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 88' ' ' VAL . 75.3 m-20 -87.05 -15.49 38.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.017 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.562 ' CE2' ' ND2' ' A' ' 89' ' ' ASN . 0.2 OUTLIER -57.35 -29.67 64.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.193 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.01 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.325 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.91 -28.84 22.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.322 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 84' ' ' ASP . 21.4 t -77.76 -41.65 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.287 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.562 ' ND2' ' CE2' ' A' ' 85' ' ' PHE . 2.5 m-20 -68.17 -36.56 79.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.91 75.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.321 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.59 -32.48 18.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.052 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -61.25 -49.89 75.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.041 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.52 -21.53 57.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.468 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -27.29 50.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.554 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.639 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -85.67 -39.07 17.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 110.752 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 4.3 m-85 -55.15 -54.5 42.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.154 0.502 . . . . 0.0 110.209 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -31.93 71.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.23 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.72 -4.18 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.567 ' HB3' ' CD2' ' A' ' 101' ' ' HIS . 4.1 t-20 -112.5 -5.54 14.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.535 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 5.6 m120 86.29 30.69 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.62 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.938 ' CD2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 m-70 -117.35 54.55 1.56 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.6 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.411 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 63.4 Cg_endo -72.09 -10.05 25.4 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.704 2.269 . . . . 0.0 113.362 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.621 ' HB3' HD11 ' B' ' 5' ' ' ILE . 7.7 m-20 -56.7 -40.74 76.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.794 0.331 . . . . 0.0 110.921 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.672 ' HB2' HG13 ' B' ' 19' ' ' VAL . 26.8 m-85 72.37 90.36 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.988 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.618 ' CB ' HG23 ' A' ' 75' ' ' THR . 77.0 Cg_exo -49.27 162.06 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.557 2.172 . . . . 0.0 112.322 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.878 ' HB1' ' HB2' ' B' ' 31' ' ' SER . . . -125.4 131.18 52.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.534 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.82 ' CD ' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -163.73 -166.47 1.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.57 114.93 28.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.219 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 14.3 m -96.94 130.37 44.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.127 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.718 HG12 HD23 ' B' ' 115' ' ' LEU . 30.4 m -148.74 167.64 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.924 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.805 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 30.7 tt0 -102.28 92.34 4.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.71 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.872 HG21 HD21 ' A' ' 115' ' ' LEU . 24.5 m -62.6 157.94 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.203 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -70.32 -51.44 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.552 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.6 OUTLIER -143.17 178.45 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.718 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.872 HD21 HG21 ' A' ' 112' ' ' VAL . 73.3 mt -150.85 153.99 34.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.749 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.573 ' O ' HG22 ' A' ' 119' ' ' VAL . 36.3 Cg_endo -65.39 137.48 51.29 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.483 2.122 . . . . 0.0 112.21 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 76.66 14.84 2.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.303 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.58 14.48 9.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.095 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.638 HG11 ' HB ' ' A' ' 34' ' ' ILE . 17.3 m -58.78 160.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 111.027 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.48 21.75 21.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.782 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.602 HD21 HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -178.86 154.9 0.74 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 0.0 111.208 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HD13 ' A' ' 123' ' ' ILE . 4.3 tt0 -140.55 150.59 43.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.044 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.864 HG21 HG21 ' A' ' 58' ' ' VAL . 20.8 mm -136.8 119.67 21.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -138.4 115.87 11.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -132.11 168.67 17.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.909 HG23 ' HG ' ' A' ' 29' ' ' LEU . 4.0 mm -116.55 146.03 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.488 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 1.095 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -132.63 148.48 52.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.171 0.51 . . . . 0.0 111.944 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.783 HG12 ' HG ' ' A' ' 27' ' ' LEU . 30.8 m -132.14 162.81 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.883 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.625 ' HB3' HD21 ' A' ' 67' ' ' LEU . 9.9 ptt180 -157.03 65.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.98 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.4 pttt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.459 179.935 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 40.6 mtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.813 0.34 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -140.83 164.16 30.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.586 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER 63.8 131.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.83 136.88 3.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.026 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.638 HG23 HG21 ' B' ' 19' ' ' VAL . 4.8 mp -58.61 158.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.242 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.539 HD12 ' CB ' ' B' ' 21' ' ' ALA . 19.0 mt -115.1 160.59 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.009 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.475 ' N ' HG22 ' B' ' 6' ' ' ILE . 1.4 t-80 -160.75 124.47 3.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.464 HG22 HG12 ' B' ' 61' ' ' ILE . 8.0 t -127.69 165.57 19.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.967 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.8 51.28 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.402 ' HB3' ' CB ' ' B' ' 60' ' ' ALA . 0.7 OUTLIER -144.19 -49.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.914 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -66.79 172.41 3.41 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.073 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.914 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 32.2 Cg_endo -64.37 -11.93 30.6 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.651 2.234 . . . . 0.0 112.758 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 73.26 171.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.422 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.762 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -167.04 122.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.827 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.762 HD13 ' O ' ' B' ' 14' ' ' ALA . 17.6 mm -141.41 17.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.399 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.49 -103.89 2.45 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.308 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.11 4.83 6.69 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.567 2.178 . . . . 0.0 112.843 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.508 ' CD1' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -160.79 177.18 10.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.911 0.386 . . . . 0.0 111.291 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 104' ' ' PHE . 28.3 m -132.27 166.41 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.06 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.766 ' OE1' ' HB3' ' B' ' 11' ' ' ALA . 3.9 mm-40 -52.89 -46.44 67.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.806 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.539 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . -176.47 176.84 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.875 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.678 HG21 ' HB ' ' A' ' 73' ' ' VAL . 3.1 m -140.27 133.84 34.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.122 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.463 ' CG ' HG12 ' B' ' 28' ' ' VAL . 6.9 t0 -97.2 139.75 32.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.837 HD11 HD13 ' B' ' 29' ' ' LEU . 6.6 mt -112.98 -15.91 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.324 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 97.01 104.45 2.23 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.297 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 8.2 m120 84.07 -35.74 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.763 ' HG ' HG12 ' B' ' 128' ' ' VAL . 0.3 OUTLIER -127.19 101.52 6.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.791 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.122 HG23 ' HB3' ' B' ' 127' ' ' ALA . 3.4 m -94.91 170.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.392 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.914 ' HG ' HG23 ' B' ' 126' ' ' ILE . 3.6 mp -152.85 148.81 27.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.993 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.4 p -125.79 148.08 49.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.755 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.878 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 4.3 t -74.59 170.06 16.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.842 0.354 . . . . 0.0 110.953 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.87 77.14 0.41 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.026 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.15 162.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 111.448 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.721 ' HB ' HG11 ' B' ' 119' ' ' VAL . 7.5 pt -146.84 154.2 47.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.633 ' CG ' HG23 ' B' ' 43' ' ' VAL . 72.6 Cg_endo -77.23 48.85 2.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.903 2.402 . . . . 0.0 113.248 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.718 HG23 HG13 ' B' ' 34' ' ' ILE . 45.8 t -63.98 86.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.238 0.542 . . . . 0.0 110.545 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.666 ' HB3' HG22 ' B' ' 40' ' ' THR . 3.7 t30 -38.09 130.03 0.99 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.037 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.26 -6.95 19.15 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.171 1.914 . . . . 0.0 111.618 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.436 ' HB3' ' ND2' ' B' ' 37' ' ' ASN . . . -101.95 -28.2 12.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.545 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.709 HG23 ' HG3' ' B' ' 42' ' ' GLU . 8.0 t -125.66 -33.73 2.72 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.979 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 85.47 62.34 1.64 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.64 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.709 ' HG3' HG23 ' B' ' 40' ' ' THR . 0.2 OUTLIER -167.17 -84.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.669 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.633 HG23 ' CG ' ' B' ' 35' ' ' PRO . 9.8 p -170.53 125.78 0.67 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.308 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.8 Cg_exo -54.39 141.78 71.23 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.52 2.147 . . . . 0.0 112.21 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.77 -31.03 70.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.983 0.42 . . . . 0.0 110.941 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.13 93.77 1.86 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.817 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.4 tp -42.15 -33.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.714 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.49 HG12 ' HD2' ' B' ' 52' ' ' ARG . 22.1 t -78.59 -46.46 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.682 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.99 88.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.701 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.4 ' CB ' ' HD2' ' B' ' 44' ' ' PRO . 3.5 pt20 -65.11 -28.9 69.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.536 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.2 -41.11 42.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.319 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.49 ' HD2' HG12 ' B' ' 48' ' ' VAL . 24.3 mtp180 -67.69 -52.27 39.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.813 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.69 -27.92 63.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.575 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.6 OUTLIER -61.88 -42.44 99.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.602 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.613 HD13 ' CE2' ' B' ' 95' ' ' PHE . 7.5 mt -74.87 -30.03 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.019 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' B' ' 59' ' ' LYS . 32.5 mt-10 -65.51 -36.2 83.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.069 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' B' ' 54' ' ' SER . 22.2 p30 -72.37 -27.83 62.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.883 0.373 . . . . 0.0 110.59 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.841 HG21 HG21 ' B' ' 123' ' ' ILE . 35.1 t -67.7 -45.81 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -76.1 -28.3 57.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.991 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' B' ' 10' ' ' LYS . . . -60.64 -41.28 94.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.464 HG12 HG22 ' B' ' 8' ' ' THR . 15.9 mt -72.95 -41.05 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.565 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.493 ' CD1' HD11 ' B' ' 72' ' ' ILE . 18.3 mt -70.0 -33.14 54.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.663 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.45 -41.0 63.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.286 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.48 -21.76 65.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.392 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.36 -28.37 17.76 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.751 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.27 56.57 0.26 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.583 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.634 HD21 ' HB3' ' B' ' 129' ' ' ARG . 3.5 mt -172.8 144.12 1.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.355 . . . . 0.0 111.126 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -99.39 166.1 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.772 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.924 ' HB3' ' CD2' ' B' ' 101' ' ' HIS . . . -62.54 -31.0 71.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.788 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.769 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -52.49 -26.61 13.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.897 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.443 ' CB ' HD22 ' B' ' 67' ' ' LEU . 1.2 m-20 -82.13 -24.59 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.575 HG21 HG22 ' B' ' 75' ' ' THR . 96.7 mt -52.88 108.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.008 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.649 HG13 HG22 ' B' ' 128' ' ' VAL . 35.3 m -74.29 -45.23 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.841 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.589 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 5.9 mttp -125.05 163.77 21.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.289 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.607 HG23 ' CB ' ' B' ' 105' ' ' PRO . 31.8 p -157.83 102.5 1.84 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.787 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.829 HG23 ' CD ' ' B' ' 107' ' ' ARG . 0.1 OUTLIER -70.12 124.69 24.72 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.017 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.411 HG11 ' HE1' ' B' ' 85' ' ' PHE . 6.3 t -116.38 110.37 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.423 ' CE2' ' OE2' ' B' ' 124' ' ' GLU . 15.7 m-30 -107.85 119.96 40.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.989 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.613 HG12 HD21 ' B' ' 121' ' ' LEU . 0.7 OUTLIER -114.29 152.2 15.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.154 0.502 . . . . 0.0 111.752 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.9 0.94 57.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.849 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.26 108.55 0.28 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.507 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' C' ' 114' ' ' ARG . 3.0 mt -57.8 -17.26 14.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.302 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.23 -22.26 60.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.834 0.35 . . . . 0.0 110.397 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.413 ' O ' HG23 ' B' ' 88' ' ' VAL . 75.2 m-20 -86.98 -15.52 38.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.031 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.563 ' CE2' ' ND2' ' B' ' 89' ' ' ASN . 0.2 OUTLIER -57.28 -29.69 64.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.232 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.94 68.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.32 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.96 -28.85 22.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.301 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 84' ' ' ASP . 21.4 t -77.77 -41.57 28.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.295 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.563 ' ND2' ' CE2' ' B' ' 85' ' ' PHE . 2.5 m-20 -68.28 -36.53 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.828 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.57 -36.0 75.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.308 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.53 -32.48 18.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -61.29 -49.9 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.017 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.48 -21.6 57.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.457 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -27.27 50.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.591 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.613 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -85.68 -39.01 17.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.704 0.288 . . . . 0.0 110.765 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.52 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 4.3 m-85 -55.18 -54.5 42.54 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.136 0.493 . . . . 0.0 110.187 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -31.91 71.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.267 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.71 -4.18 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.584 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.562 ' HB3' ' CD2' ' B' ' 101' ' ' HIS . 4.1 t-20 -112.53 -5.51 14.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.547 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 5.6 m120 86.32 30.79 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.621 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.924 ' CD2' ' HB3' ' B' ' 69' ' ' ALA . 1.6 m-70 -117.35 54.56 1.56 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.679 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 63.9 Cg_endo -72.08 -10.13 25.54 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.74 2.293 . . . . 0.0 113.359 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.486 ' HB3' HD11 ' C' ' 5' ' ' ILE . 7.7 m-20 -56.6 -40.78 75.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.914 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.71 ' HB2' HG13 ' C' ' 19' ' ' VAL . 26.8 m-85 72.21 90.52 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.969 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.607 ' CB ' HG23 ' B' ' 75' ' ' THR . 78.1 Cg_exo -49.37 162.11 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.594 2.196 . . . . 0.0 112.274 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.862 ' HB1' ' HB2' ' C' ' 31' ' ' SER . . . -125.5 131.1 52.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.505 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.829 ' CD ' HG23 ' B' ' 76' ' ' THR . 0.0 OUTLIER -163.57 -166.4 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.6 114.98 28.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.176 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 14.4 m -96.9 130.38 44.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.138 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.729 HG12 HD23 ' C' ' 115' ' ' LEU . 29.8 m -148.81 167.9 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.987 0.423 . . . . 0.0 111.982 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.817 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 30.4 tt0 -102.42 92.46 4.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.708 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.871 HG21 HD21 ' B' ' 115' ' ' LEU . 24.1 m -62.76 158.05 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -70.37 -51.41 29.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.067 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.567 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -143.19 178.5 7.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.685 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.871 HD21 HG21 ' B' ' 112' ' ' VAL . 73.3 mt -150.88 153.99 34.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.769 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 36.4 Cg_endo -65.37 137.56 51.73 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.428 2.085 . . . . 0.0 112.201 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.538 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 76.6 14.84 2.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.339 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.53 14.54 9.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.085 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.721 HG11 ' HB ' ' B' ' 34' ' ' ILE . 17.1 m -58.87 160.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.762 0.315 . . . . 0.0 110.99 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.5 21.68 21.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.682 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.613 HD21 HG12 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -178.88 154.86 0.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.077 0.465 . . . . 0.0 111.204 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.704 ' O ' HD13 ' B' ' 123' ' ' ILE . 4.3 tt0 -140.61 150.57 43.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.083 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.841 HG21 HG21 ' B' ' 58' ' ' VAL . 21.0 mm -136.85 119.55 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' GLU . . . . . 0.423 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.0 OUTLIER -138.32 115.87 11.3 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -132.12 168.68 17.56 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.914 HG23 ' HG ' ' B' ' 29' ' ' LEU . 4.0 mm -116.56 146.06 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.511 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 1.122 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -132.69 148.47 52.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.163 0.506 . . . . 0.0 111.937 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.763 HG12 ' HG ' ' B' ' 27' ' ' LEU . 30.4 m -132.09 162.78 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.945 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.634 ' HB3' HD21 ' B' ' 67' ' ' LEU . 9.9 ptt180 -157.02 65.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.004 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 6.4 pttt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.424 179.897 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 40.6 mtt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.867 0.365 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -140.84 164.13 31.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.83 131.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.967 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.75 136.87 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.054 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.653 HG23 HG21 ' C' ' 19' ' ' VAL . 4.8 mp -58.54 158.24 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.181 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' C' ' 21' ' ' ALA . 18.9 mt -115.02 160.68 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.029 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' HIS . . . . . 0.482 ' N ' HG22 ' C' ' 6' ' ' ILE . 1.4 t-80 -160.76 124.45 3.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.964 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.475 HG22 HG12 ' C' ' 61' ' ' ILE . 8.0 t -127.7 165.47 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.78 51.29 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.401 ' HB3' ' CB ' ' C' ' 60' ' ' ALA . 0.7 OUTLIER -144.09 -49.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.704 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.916 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.43 172.3 3.98 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.916 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 32.1 Cg_endo -64.42 -11.95 30.84 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.598 2.199 . . . . 0.0 112.713 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 73.32 171.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.948 0.404 . . . . 0.0 111.365 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.772 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -166.98 122.82 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.798 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.772 HD13 ' O ' ' C' ' 14' ' ' ALA . 17.9 mm -141.47 17.53 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.377 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.47 -103.89 2.45 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.296 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.14 4.83 6.68 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.565 2.177 . . . . 0.0 112.805 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.512 ' CD1' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -160.72 177.18 10.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.897 0.38 . . . . 0.0 111.259 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.71 HG13 ' HB2' ' B' ' 104' ' ' PHE . 28.1 m -132.28 166.39 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.054 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.766 ' OE1' ' HB3' ' C' ' 11' ' ' ALA . 3.9 mm-40 -52.86 -46.55 67.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . -175.62 176.44 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.004 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.593 HG21 ' HB ' ' B' ' 73' ' ' VAL . 3.1 m -140.2 133.86 35.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.464 ' CG ' HG12 ' C' ' 28' ' ' VAL . 6.9 t0 -97.19 139.71 32.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.684 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.818 HD11 HD13 ' C' ' 29' ' ' LEU . 6.5 mt -112.92 -15.87 12.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.352 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 97.03 104.41 2.23 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.344 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 26' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 8.3 m120 84.1 -35.77 0.06 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.769 ' HG ' HG12 ' C' ' 128' ' ' VAL . 0.3 OUTLIER -127.16 101.63 6.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.792 178.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 1.056 HG23 ' HB3' ' C' ' 127' ' ' ALA . 3.4 m -95.0 170.4 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.315 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.903 ' HG ' HG23 ' C' ' 126' ' ' ILE . 3.6 mp -152.78 148.89 27.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.962 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.4 p -125.91 148.95 49.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' SER . . . . . 0.862 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 4.4 t -75.36 170.27 16.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.82 77.16 0.4 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.033 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -53.21 162.95 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.008 0.432 . . . . 0.0 111.412 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.724 HG13 HG23 ' C' ' 36' ' ' VAL . 7.5 pt -146.9 154.29 46.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.681 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.627 ' HG2' HG23 ' C' ' 43' ' ' VAL . 72.5 Cg_endo -77.21 48.81 2.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.911 2.407 . . . . 0.0 113.23 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.724 HG23 HG13 ' C' ' 34' ' ' ILE . 45.9 t -63.94 86.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.178 0.513 . . . . 0.0 110.469 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.664 ' HB3' HG22 ' C' ' 40' ' ' THR . 3.7 t30 -38.16 130.07 1.0 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.072 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.27 -6.94 19.14 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.186 1.924 . . . . 0.0 111.635 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.452 ' HB3' ' ND2' ' C' ' 37' ' ' ASN . . . -101.89 -28.25 12.51 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.594 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.711 HG23 ' HG3' ' C' ' 42' ' ' GLU . 8.1 t -125.62 -33.73 2.73 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.967 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 85.46 62.21 1.65 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.682 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' C' ' 40' ' ' THR . 0.2 OUTLIER -167.2 -84.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.669 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.627 HG23 ' HG2' ' C' ' 35' ' ' PRO . 10.0 p -170.57 125.77 0.66 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.335 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' C' ' 35' ' ' PRO . 52.7 Cg_exo -54.46 141.82 71.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.443 2.095 . . . . 0.0 112.224 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.0 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.059 0.457 . . . . 0.0 110.994 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -73.15 93.75 1.86 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.803 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' C' ' 47' ' ' ILE . 7.4 tp -42.11 -33.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.677 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 48' ' ' VAL . . . . . 0.427 HG12 ' HD2' ' C' ' 52' ' ' ARG . 22.0 t -78.53 -46.41 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.705 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -61.07 -46.99 88.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.688 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -65.05 -28.8 69.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.453 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.29 -40.86 50.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.051 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.427 ' HD2' HG12 ' C' ' 48' ' ' VAL . 24.2 mtp180 -67.82 -52.22 39.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.79 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -27.98 63.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.644 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.579 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.6 OUTLIER -61.82 -42.41 98.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.621 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.609 HD13 ' CE2' ' C' ' 95' ' ' PHE . 7.5 mt -74.94 -30.0 61.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.008 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' C' ' 59' ' ' LYS . 32.6 mt-10 -65.48 -36.15 83.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -72.43 -27.82 62.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.879 HG21 HG21 ' C' ' 123' ' ' ILE . 34.5 t -67.65 -45.78 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' C' ' 56' ' ' GLU . 0.0 OUTLIER -76.13 -28.34 57.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' C' ' 10' ' ' LYS . . . -60.53 -41.17 93.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.969 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.475 HG12 HG22 ' C' ' 8' ' ' THR . 15.7 mt -73.06 -41.2 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.629 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.53 ' CD1' HD11 ' C' ' 72' ' ' ILE . 18.3 mt -69.9 -33.17 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.712 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.51 -40.96 63.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.229 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -21.83 65.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.325 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.29 -28.4 17.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.3 56.65 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.545 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.622 HD21 ' HB3' ' C' ' 129' ' ' ARG . 3.5 mt -172.86 144.16 1.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.893 0.377 . . . . 0.0 111.063 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -99.41 166.08 11.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.764 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.94 ' HB3' ' CD2' ' C' ' 101' ' ' HIS . . . -62.44 -31.08 71.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.843 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.768 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -52.4 -26.62 13.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.973 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.429 ' CB ' HD22 ' C' ' 67' ' ' LEU . 1.2 m-20 -82.47 -24.51 34.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.582 HG21 HG22 ' C' ' 75' ' ' THR . 96.6 mt -52.84 108.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.989 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.661 ' HB ' HG21 ' A' ' 22' ' ' VAL . 35.4 m -74.29 -45.26 47.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.818 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.596 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 5.8 mttp -125.09 163.68 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.662 0.268 . . . . 0.0 111.248 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.621 HG23 ' CB ' ' C' ' 105' ' ' PRO . 31.8 p -157.74 102.44 1.86 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.788 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.821 HG23 ' CD ' ' C' ' 107' ' ' ARG . 0.1 OUTLIER -70.04 124.63 24.54 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.33 110.39 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.413 ' CE2' ' OE2' ' C' ' 124' ' ' GLU . 15.8 m-30 -107.86 119.97 40.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.94 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.589 HG12 HD21 ' C' ' 121' ' ' LEU . 0.8 OUTLIER -114.3 152.18 15.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.103 0.477 . . . . 0.0 111.773 -179.224 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.89 0.85 57.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.866 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.13 108.49 0.29 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.51 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.552 HD12 ' HB3' ' A' ' 114' ' ' ARG . 3.0 mt -57.76 -17.3 14.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -73.3 -22.19 60.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.384 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.418 ' O ' HG23 ' C' ' 88' ' ' VAL . 75.3 m-20 -87.01 -15.51 38.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.021 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.566 ' CE2' ' ND2' ' C' ' 89' ' ' ASN . 0.2 OUTLIER -57.33 -29.64 64.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.218 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.98 68.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.292 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.93 -28.89 22.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.273 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.418 HG23 ' O ' ' C' ' 84' ' ' ASP . 21.4 t -77.72 -41.61 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ASN . . . . . 0.566 ' ND2' ' CE2' ' C' ' 85' ' ' PHE . 2.5 m-20 -68.2 -36.6 79.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.95 75.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.274 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.51 -32.43 18.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -61.28 -49.86 75.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.084 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.5 -21.57 57.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.501 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -27.26 50.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.57 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -85.7 -39.02 17.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.703 0.287 . . . . 0.0 110.778 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.52 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 4.3 m-85 -55.12 -54.5 42.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.193 0.521 . . . . 0.0 110.231 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -31.9 71.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.264 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.73 -4.17 55.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.592 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.566 ' HB3' ' CD2' ' C' ' 101' ' ' HIS . 4.1 t-20 -112.54 -5.5 14.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.583 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 5.6 m120 86.29 30.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.631 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.94 ' CD2' ' HB3' ' C' ' 69' ' ' ALA . 1.6 m-70 -117.25 54.58 1.51 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.626 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.419 ' O ' ' CD2' ' C' ' 104' ' ' PHE . 63.4 Cg_endo -72.1 -10.04 25.37 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.744 2.296 . . . . 0.0 113.344 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.568 ' HB3' HD11 ' A' ' 5' ' ' ILE . 7.7 m-20 -56.75 -40.73 76.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.673 ' HB2' HG13 ' A' ' 19' ' ' VAL . 26.7 m-85 72.34 90.39 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.965 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.621 ' CB ' HG23 ' C' ' 75' ' ' THR . 77.2 Cg_exo -49.31 162.1 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.569 2.179 . . . . 0.0 112.303 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.863 ' HB1' ' HB2' ' A' ' 31' ' ' SER . . . -125.51 131.07 52.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.488 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.821 ' CD ' HG23 ' C' ' 76' ' ' THR . 0.0 OUTLIER -163.52 -166.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.64 114.99 28.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.195 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 14.2 m -96.9 130.33 44.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.163 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.722 HG12 HD23 ' A' ' 115' ' ' LEU . 30.2 m -148.88 168.12 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.906 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.826 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 30.6 tt0 -102.48 92.33 4.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.902 HG21 HD21 ' C' ' 115' ' ' LEU . 24.4 m -62.52 158.01 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -70.37 -51.44 29.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.485 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.6 OUTLIER -143.18 178.51 7.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.706 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.902 HD21 HG21 ' C' ' 112' ' ' VAL . 73.3 mt -150.89 153.98 33.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.786 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.562 ' O ' HG22 ' C' ' 119' ' ' VAL . 36.4 Cg_endo -65.36 137.47 51.4 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.513 2.142 . . . . 0.0 112.184 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.546 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 76.62 14.9 2.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.307 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.52 14.52 8.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.72 HG11 ' HB ' ' C' ' 34' ' ' ILE . 17.2 m -58.84 160.86 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.323 . . . . 0.0 110.969 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.45 22.05 20.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.75 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.589 HD21 HG12 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -179.19 155.05 0.7 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.122 0.487 . . . . 0.0 111.144 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.702 ' O ' HD13 ' C' ' 123' ' ' ILE . 4.2 tt0 -140.63 150.62 43.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.036 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.879 HG21 HG21 ' C' ' 58' ' ' VAL . 20.8 mm -136.88 119.55 20.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.132 0.491 . . . . 0.0 112.286 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 124' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' C' ' 78' ' ' PHE . 0.0 OUTLIER -138.33 115.89 11.31 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -132.17 168.66 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.903 HG23 ' HG ' ' C' ' 29' ' ' LEU . 4.0 mm -116.5 146.05 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.527 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 1.056 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -132.65 148.45 52.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.186 0.517 . . . . 0.0 111.895 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.769 HG12 ' HG ' ' C' ' 27' ' ' LEU . 30.5 m -132.09 162.82 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.932 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.622 ' HB3' HD21 ' C' ' 67' ' ' LEU . 9.9 ptt180 -157.05 65.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.4 pttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.449 179.924 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.767 0.318 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -177.28 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.055 HG21 HG21 ' C' ' 128' ' ' VAL . 10.4 m 63.33 141.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.849 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.89 127.17 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.604 HD13 ' CG ' ' C' ' 103' ' ' ASN . 4.6 mp -56.47 153.7 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.177 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 7' ' ' HIS . 31.9 mt -109.85 157.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.459 ' N ' HG22 ' A' ' 6' ' ' ILE . 12.0 t60 -159.46 134.84 8.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.64 HG23 ' H ' ' A' ' 11' ' ' ALA . 8.9 t -147.78 160.75 42.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.93 21.01 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.042 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.508 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 3.8 mmmt -116.59 -35.91 4.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.913 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.704 ' HB2' HG12 ' A' ' 61' ' ' ILE . . . -52.7 177.79 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.343 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.675 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 17.1 Cg_exo -67.13 -8.28 21.37 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.831 2.354 . . . . 0.0 112.705 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 76.45 147.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 110.953 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.81 121.02 39.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.199 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 15' ' ' ILE . 3.1 mp -119.36 16.52 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.971 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.8 -148.87 4.85 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.307 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.73 38.75 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.869 2.379 . . . . 0.0 113.047 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.06 164.26 28.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.884 0.374 . . . . 0.0 111.05 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.588 HG21 HG23 ' A' ' 5' ' ' ILE . 25.6 m -113.32 175.4 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.963 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.542 ' NE2' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -58.51 -48.22 81.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.936 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 61' ' ' ILE . . . -175.53 178.97 1.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.632 HG11 ' O ' ' C' ' 73' ' ' VAL . 14.3 m -134.17 132.95 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.678 ' HA ' HG23 ' A' ' 28' ' ' VAL . 9.8 t70 -111.25 118.42 35.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.742 HD22 ' CG1' ' C' ' 128' ' ' VAL . 3.7 mt -94.1 -16.96 23.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.218 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.33 -99.99 0.9 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.416 ' O ' HD22 ' A' ' 27' ' ' LEU . 4.2 m120 -59.08 -29.16 67.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.193 0.52 . . . . 0.0 109.717 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.63 ' CD2' HG12 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -129.55 139.52 51.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.547 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.92 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 4.2 p -127.92 151.34 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.009 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.921 HD12 HG23 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -134.66 135.46 42.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.743 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.3 p -108.85 136.18 48.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.066 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -63.94 143.23 58.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.827 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.55 92.17 0.01 OUTLIER Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.365 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.511 ' CG ' HG22 ' A' ' 58' ' ' VAL . 32.1 mm-40 -74.55 163.75 27.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.47 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 119' ' ' VAL . 2.1 pt -146.27 160.26 43.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.672 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.564 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 17.6 Cg_exo -66.82 54.23 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.052 2.501 . . . . 0.0 113.262 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.465 HG23 HG13 ' A' ' 34' ' ' ILE . 34.4 t -65.21 86.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.168 0.509 . . . . 0.0 110.384 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' GLY . 24.4 t-20 -36.79 133.09 0.67 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.977 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.53 -12.7 31.85 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.316 2.01 . . . . 0.0 112.109 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.9 -20.66 9.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.739 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.43 HG22 ' CG ' ' A' ' 42' ' ' GLU . 2.6 m -115.46 -23.02 9.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.848 0.356 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 58.86 56.89 22.82 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.36 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' CG ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER -162.5 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.75 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p -175.13 108.43 0.26 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.35 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.46 140.98 74.06 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.353 2.035 . . . . 0.0 112.118 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.29 -31.55 71.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.068 0.461 . . . . 0.0 110.901 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.48 91.47 0.57 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.781 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mm -41.1 -32.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.542 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.9 -42.66 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.29 -36.51 77.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.766 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.659 ' OE1' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -78.51 -20.66 50.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.605 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.94 -36.76 23.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.291 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -33.2 58.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.931 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.02 -26.68 59.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.696 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.838 ' O ' HG23 ' A' ' 58' ' ' VAL . 90.7 p -70.57 -35.35 73.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.908 HD13 ' CE2' ' A' ' 95' ' ' PHE . 8.7 mt -77.38 -33.6 55.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.074 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -51.59 69.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.977 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 54' ' ' SER . 10.3 p30 -59.45 -39.85 84.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 54' ' ' SER . 31.5 t -61.76 -35.76 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.851 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -31.53 43.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -62.62 -39.17 92.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.704 HG12 ' HB2' ' A' ' 11' ' ' ALA . 22.0 mt -69.47 -46.25 76.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.789 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mt -65.33 -31.44 53.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.765 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -41.36 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.401 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -63.2 -20.44 65.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.512 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.77 -21.51 20.66 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.064 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.03 53.19 0.8 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.383 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' A' ' 71' ' ' ASP . 11.8 mt -155.65 137.1 14.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.964 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 157.16 16.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.754 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -50.13 -36.76 31.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -58.47 -21.24 50.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.363 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.494 ' CB ' HD22 ' A' ' 67' ' ' LEU . 1.5 m-20 -77.88 -26.45 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.884 0.373 . . . . 0.0 110.588 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 35.5 mt -59.35 114.21 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.663 ' O ' HG11 ' B' ' 22' ' ' VAL . 3.4 m -84.39 -33.14 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.72 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.888 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 0.6 OUTLIER -139.86 152.68 46.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.693 0.283 . . . . 0.0 111.009 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.644 HG22 ' CB ' ' A' ' 125' ' ' ALA . 40.8 p -141.9 135.0 29.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 111.336 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 108' ' ' SER . 4.5 m -114.82 150.85 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.213 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 122' ' ' GLU . 20.3 t -148.87 112.94 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 111.613 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.431 ' HB3' HG11 ' A' ' 112' ' ' VAL . 5.5 m-85 -92.7 107.85 19.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.549 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.669 HG12 HD22 ' A' ' 121' ' ' LEU . 36.0 m -102.42 146.43 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.413 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.69 -3.07 58.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.031 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.85 125.89 2.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.25 -11.11 56.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.164 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.07 -20.52 52.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 110.632 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 88' ' ' VAL . 38.8 m-20 -95.24 7.01 47.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.291 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -84.24 -27.96 27.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.768 0.318 . . . . 0.0 111.124 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.88 77.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.176 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.7 -33.89 27.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 84' ' ' ASP . 26.7 t -77.97 -43.29 28.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.029 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -61.72 -33.07 73.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.027 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.35 -48.63 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.299 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.47 -29.85 59.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.186 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.597 ' OH ' HG21 ' A' ' 75' ' ' THR . 11.5 t80 -63.99 -37.51 87.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.148 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.47 -27.33 29.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.191 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -33.72 76.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.187 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.908 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -85.7 -34.63 21.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.553 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.524 ' CE1' ' CE1' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -57.8 -55.05 39.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.287 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -32.74 71.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.049 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -85.8 -0.86 56.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.407 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 2.6 m-20 -98.88 -18.38 17.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.189 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.603 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 20.2 m-20 104.89 25.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.11 0.881 . . . . 0.0 110.948 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.474 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.1 t-80 -123.95 66.67 40.46 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.05 -16.87 22.58 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.533 2.155 . . . . 0.0 112.393 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.578 ' CG ' HD13 ' B' ' 5' ' ' ILE . 1.8 t-20 -68.13 -35.21 77.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.793 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.569 ' O ' HG13 ' B' ' 19' ' ' VAL . 7.8 m-85 76.2 120.44 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.3 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 93.9 Cg_endo -82.41 168.87 14.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.848 2.365 . . . . 0.0 112.218 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.888 ' HB3' ' CG ' ' A' ' 74' ' ' LYS . . . -56.35 159.47 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.406 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -127.97 142.77 51.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.033 0.444 . . . . 0.0 111.528 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 76' ' ' THR . 27.9 t -150.43 66.6 0.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.453 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 11.8 m -96.75 138.76 33.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.033 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.405 HG12 HD23 ' B' ' 115' ' ' LEU . 34.6 m -145.5 139.56 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.303 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.859 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 1.0 OUTLIER -70.87 86.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.822 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.617 HG21 HD21 ' A' ' 115' ' ' LEU . 21.7 m -71.18 155.94 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.238 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.853 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -67.87 -46.82 70.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.076 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 0.0 OUTLIER -153.79 176.96 11.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.799 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.617 HD21 HG21 ' A' ' 112' ' ' VAL . 31.0 mt -147.48 155.38 45.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.814 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.542 ' O ' HG22 ' A' ' 119' ' ' VAL . 12.5 Cg_endo -55.97 136.97 77.51 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.593 2.196 . . . . 0.0 112.045 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.2 OUTLIER 74.88 13.91 3.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.244 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.98 15.95 8.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.109 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.937 HG21 HG21 ' A' ' 34' ' ' ILE . 14.1 m -55.56 146.31 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.185 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.75 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.45 -15.1 64.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.9 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.669 HD22 HG12 ' A' ' 79' ' ' VAL . 37.2 mt -151.18 147.6 27.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.085 0.469 . . . . 0.0 111.016 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.659 ' O ' HD13 ' A' ' 123' ' ' ILE . 5.3 tt0 -122.53 155.32 36.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.211 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.736 ' CG2' HG21 ' A' ' 58' ' ' VAL . 30.3 mm -130.88 133.57 62.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 0.0 111.767 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -152.42 155.88 38.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.007 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.779 ' C ' HD13 ' A' ' 126' ' ' ILE . . . -177.45 165.07 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.081 0.467 . . . . 0.0 111.833 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.921 HG23 HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -124.52 143.66 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.393 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.92 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -129.76 157.99 40.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.0 0.429 . . . . 0.0 111.775 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.012 HG21 HG21 ' B' ' 3' ' ' THR . 30.1 m -115.95 155.0 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.956 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.72 47.04 2.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.826 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.993 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.871 0.367 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -177.3 4.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.814 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' THR . . . . . 1.012 HG21 HG21 ' A' ' 128' ' ' VAL . 10.5 m 63.37 141.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.86 127.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.004 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.595 ' H ' HD12 ' B' ' 5' ' ' ILE . 4.6 mp -56.49 153.73 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.207 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.462 HG22 ' N ' ' B' ' 7' ' ' HIS . 31.7 mt -109.89 157.1 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.122 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.462 ' N ' HG22 ' B' ' 6' ' ' ILE . 11.9 t60 -159.48 134.78 8.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.642 HG23 ' H ' ' B' ' 11' ' ' ALA . 8.9 t -147.72 160.76 42.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.94 21.06 10.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.962 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.495 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 3.8 mmmt -116.68 -35.83 4.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 0.0 110.893 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.688 ' HB2' HG12 ' B' ' 61' ' ' ILE . . . -52.77 177.77 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.424 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.686 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 17.1 Cg_exo -67.05 -8.38 21.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.9 2.4 . . . . 0.0 112.689 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.51 147.76 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 111.002 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.81 120.93 39.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.206 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 15' ' ' ILE . 3.1 mp -119.27 16.6 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.984 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.81 -148.88 4.85 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.308 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.72 38.78 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.853 2.369 . . . . 0.0 113.063 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.07 164.34 28.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 111.05 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 104' ' ' PHE . 25.6 m -113.43 175.4 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.917 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.561 ' NE2' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -58.45 -48.3 81.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.981 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' B' ' 61' ' ' ILE . . . -175.62 178.98 1.49 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 73' ' ' VAL . 14.4 m -134.09 132.95 56.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.131 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.682 ' HA ' HG23 ' B' ' 28' ' ' VAL . 9.8 t70 -111.3 118.46 35.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.767 HD22 ' CG1' ' A' ' 128' ' ' VAL . 3.7 mt -94.07 -16.98 23.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.249 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.37 -100.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.468 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ASN . . . . . 0.421 ' O ' HD22 ' B' ' 27' ' ' LEU . 4.2 m120 -59.05 -29.19 67.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.719 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.625 ' CD2' HG12 ' B' ' 128' ' ' VAL . 1.0 OUTLIER -129.57 139.47 51.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.564 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.916 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 4.2 p -127.99 151.39 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.964 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.944 HD12 HG23 ' B' ' 126' ' ' ILE . 0.2 OUTLIER -134.62 135.45 42.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.76 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -108.99 136.24 48.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.028 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.15 143.35 57.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.55 92.1 0.01 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.358 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.516 ' CG ' HG22 ' B' ' 58' ' ' VAL . 32.1 mm-40 -74.53 163.76 27.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.429 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.963 HG21 HG21 ' B' ' 119' ' ' VAL . 2.2 pt -146.28 160.29 42.89 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.625 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.574 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 18.0 Cg_exo -66.96 54.35 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.058 2.505 . . . . 0.0 113.205 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.481 HG23 HG13 ' B' ' 34' ' ' ILE . 34.0 t -65.27 86.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.167 0.508 . . . . 0.0 110.361 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -36.83 133.13 0.67 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.992 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.55 -12.66 31.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.29 1.993 . . . . 0.0 112.159 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.92 -20.66 9.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.784 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.428 HG22 ' CG ' ' B' ' 42' ' ' GLU . 2.6 m -115.49 -22.96 9.03 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.779 0.323 . . . . 0.0 110.885 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.472 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 58.86 56.94 22.51 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.362 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.428 ' CG ' HG22 ' B' ' 40' ' ' THR . 0.0 OUTLIER -162.55 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.798 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.704 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.1 p -175.08 108.43 0.27 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.336 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.43 140.89 73.79 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.355 2.037 . . . . 0.0 112.183 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.18 -31.56 71.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.44 91.48 0.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.782 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mm -41.16 -32.75 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.514 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.82 -42.65 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.906 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.29 -36.55 77.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.768 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.645 ' OE1' HD12 ' B' ' 121' ' ' LEU . 0.0 OUTLIER -78.52 -20.85 49.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.614 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.8 -36.8 23.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.295 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 -33.1 58.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.01 -26.83 59.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.809 ' O ' HG23 ' B' ' 58' ' ' VAL . 90.3 p -70.53 -35.25 73.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.904 HD13 ' CE2' ' B' ' 95' ' ' PHE . 8.7 mt -77.41 -33.6 54.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -51.6 69.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' B' ' 54' ' ' SER . 10.3 p30 -59.47 -39.85 85.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.809 HG23 ' O ' ' B' ' 54' ' ' SER . 31.5 t -61.77 -35.79 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.824 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -31.53 43.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.874 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -62.62 -39.29 93.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.688 HG12 ' HB2' ' B' ' 11' ' ' ALA . 22.0 mt -69.46 -46.21 76.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.77 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.25 -31.49 54.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -41.37 60.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.327 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -63.17 -20.43 65.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.556 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.83 -21.47 20.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.049 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.02 53.16 0.81 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.363 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.498 HD22 ' CB ' ' B' ' 71' ' ' ASP . 11.8 mt -155.59 137.05 14.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.71 157.12 16.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -50.1 -36.77 30.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -58.61 -21.2 52.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.364 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.498 ' CB ' HD22 ' B' ' 67' ' ' LEU . 1.5 m-20 -77.74 -26.49 49.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 110.583 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 35.2 mt -59.39 114.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.684 ' O ' HG11 ' C' ' 22' ' ' VAL . 3.4 m -84.34 -33.13 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.745 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.883 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 0.6 OUTLIER -139.91 152.68 46.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.747 0.308 . . . . 0.0 110.953 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.648 HG22 ' CB ' ' B' ' 125' ' ' ALA . 40.7 p -141.86 135.02 29.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.997 0.427 . . . . 0.0 111.353 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.64 HG23 ' O ' ' B' ' 108' ' ' SER . 4.4 m -114.8 150.86 34.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.19 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.405 HG13 ' O ' ' B' ' 122' ' ' GLU . 20.2 t -148.83 112.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 111.637 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.448 ' HB3' HG11 ' B' ' 112' ' ' VAL . 5.6 m-85 -92.74 107.88 19.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.543 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.676 HG12 HD22 ' B' ' 121' ' ' LEU . 35.9 m -102.41 146.42 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.467 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -3.13 59.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.028 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.8 125.9 2.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.581 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.19 -11.09 56.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.202 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.06 -20.58 52.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.831 0.348 . . . . 0.0 110.615 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.7 ' O ' HG23 ' B' ' 88' ' ' VAL . 38.7 m-20 -95.25 7.0 47.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -84.25 -27.95 27.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.145 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.26 -34.92 77.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.264 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.63 -34.01 27.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 84' ' ' ASP . 26.7 t -77.95 -43.28 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.061 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -61.67 -33.19 73.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.008 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.29 -48.55 33.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.332 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.61 -29.93 59.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.615 ' HH ' HG21 ' B' ' 75' ' ' THR . 11.4 t80 -63.94 -37.63 88.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.37 -27.39 29.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.213 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -33.79 76.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.132 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.904 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.3 OUTLIER -85.7 -34.59 21.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 0.0 110.578 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.524 ' CE1' ' CE1' ' B' ' 92' ' ' TYR . 0.4 OUTLIER -57.83 -55.1 39.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.258 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -32.77 71.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.033 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -85.76 -1.0 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.381 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.547 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 2.6 m-20 -98.77 -18.42 17.99 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.192 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.594 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 20.4 m-20 104.98 25.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.117 0.885 . . . . 0.0 110.921 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.464 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.1 t-80 -124.15 66.62 42.3 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.01 -16.8 22.73 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.477 2.118 . . . . 0.0 112.393 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.647 ' CG ' HD13 ' C' ' 5' ' ' ILE . 1.7 t-20 -68.19 -35.11 77.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.851 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.564 ' O ' HG13 ' C' ' 19' ' ' VAL . 7.7 m-85 76.14 120.4 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.287 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.43 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 92.8 Cg_endo -82.36 168.9 14.5 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.798 2.332 . . . . 0.0 112.266 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.883 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -56.31 159.54 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.404 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -128.0 142.79 51.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.082 0.468 . . . . 0.0 111.535 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.64 ' O ' HG23 ' B' ' 76' ' ' THR . 27.8 t -150.46 66.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.426 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 11.8 m -96.78 138.78 33.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 34.6 m -145.44 139.32 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.388 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.866 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 1.0 OUTLIER -70.58 86.89 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.698 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.621 HG21 HD21 ' B' ' 115' ' ' LEU . 21.8 m -71.29 155.8 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.859 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -67.74 -46.89 70.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.439 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -153.79 176.92 11.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.621 HD21 HG21 ' B' ' 112' ' ' VAL . 30.5 mt -147.43 155.32 45.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.809 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.55 ' O ' HG22 ' B' ' 119' ' ' VAL . 12.4 Cg_endo -55.93 136.97 77.4 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.161 . . . . 0.0 112.099 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.428 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.2 OUTLIER 74.91 13.86 3.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.287 -179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 63.05 15.93 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.058 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.963 HG21 HG21 ' B' ' 34' ' ' ILE . 13.9 m -55.63 146.35 4.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.875 0.369 . . . . 0.0 111.177 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' GLY . . . . . 0.704 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.44 -15.19 64.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.868 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.676 HD22 HG12 ' B' ' 79' ' ' VAL . 37.1 mt -151.1 147.41 27.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.07 0.462 . . . . 0.0 111.045 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.656 ' O ' HD13 ' B' ' 123' ' ' ILE . 5.3 tt0 -122.52 155.28 36.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.246 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.72 ' CG2' HG21 ' B' ' 58' ' ' VAL . 30.3 mm -130.83 133.6 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.424 . . . . 0.0 111.76 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -152.5 155.87 38.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.93 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.778 ' C ' HD13 ' B' ' 126' ' ' ILE . . . -177.44 165.04 2.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 111.814 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.944 HG23 HD12 ' B' ' 29' ' ' LEU . 0.7 OUTLIER -124.53 143.67 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.367 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.916 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -129.74 158.0 40.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.999 0.428 . . . . 0.0 111.756 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.987 HG21 HG21 ' C' ' 3' ' ' THR . 30.3 m -115.91 155.03 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.982 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.83 47.0 2.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.854 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.959 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.798 0.332 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.46 -177.27 4.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.987 HG21 HG21 ' B' ' 128' ' ' VAL . 10.3 m 63.3 141.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.84 127.13 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.013 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.647 HD13 ' CG ' ' B' ' 103' ' ' ASN . 4.6 mp -56.48 153.7 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.46 HG22 ' N ' ' C' ' 7' ' ' HIS . 31.4 mt -109.8 157.18 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.158 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 7' ' ' HIS . . . . . 0.46 ' N ' HG22 ' C' ' 6' ' ' ILE . 11.9 t60 -159.57 134.76 8.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.644 HG23 ' H ' ' C' ' 11' ' ' ALA . 9.0 t -147.71 160.7 42.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.9 21.05 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.041 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.463 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 3.8 mmmt -116.62 -35.99 4.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.676 ' HB2' HG12 ' C' ' 61' ' ' ILE . . . -52.76 177.85 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.313 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.668 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 17.1 Cg_exo -67.09 -8.38 21.64 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.868 2.379 . . . . 0.0 112.653 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 76.56 147.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.898 0.38 . . . . 0.0 110.967 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.77 120.94 39.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.605 HG22 ' O ' ' C' ' 15' ' ' ILE . 3.1 mp -119.36 16.63 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.84 -148.84 4.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.269 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -88.72 38.76 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.827 2.351 . . . . 0.0 113.071 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.01 164.28 28.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.823 0.344 . . . . 0.0 111.055 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.593 HG21 HG23 ' C' ' 5' ' ' ILE . 25.0 m -113.36 175.41 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.907 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.547 ' NE2' ' HB3' ' C' ' 11' ' ' ALA . 0.0 OUTLIER -58.46 -48.24 81.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.947 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' C' ' 61' ' ' ILE . . . -175.67 178.98 1.47 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.932 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.684 HG11 ' O ' ' B' ' 73' ' ' VAL . 14.2 m -134.12 132.91 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.669 ' HA ' HG23 ' C' ' 28' ' ' VAL . 9.8 t70 -111.2 118.43 35.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.723 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.777 HD22 ' CG1' ' B' ' 128' ' ' VAL . 3.7 mt -94.04 -17.02 23.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.256 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.32 -100.01 0.9 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.489 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' ASN . . . . . 0.412 ' O ' HD22 ' C' ' 27' ' ' LEU . 4.2 m120 -59.04 -29.17 67.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.223 0.535 . . . . 0.0 109.755 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.656 ' CD2' HG12 ' C' ' 128' ' ' VAL . 1.0 OUTLIER -129.59 139.55 51.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.522 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.927 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 4.2 p -127.96 151.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.951 HD12 HG23 ' C' ' 126' ' ' ILE . 0.2 OUTLIER -134.61 135.5 42.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.767 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 32.9 p -108.9 136.34 48.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.103 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -64.01 143.24 58.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.77 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.5 92.12 0.01 OUTLIER Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.325 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.512 ' CG ' HG22 ' C' ' 58' ' ' VAL . 32.1 mm-40 -74.53 163.77 27.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.036 0.446 . . . . 0.0 111.432 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.954 HG21 HG21 ' C' ' 119' ' ' VAL . 2.1 pt -146.33 160.27 42.79 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.618 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.568 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 17.9 Cg_exo -66.84 54.24 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.113 2.542 . . . . 0.0 113.184 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.477 HG23 HG13 ' C' ' 34' ' ' ILE . 34.8 t -65.29 86.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 110.355 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' C' ' 41' ' ' GLY . 24.4 t-20 -36.78 133.13 0.67 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.969 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.57 -12.65 31.69 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.269 1.98 . . . . 0.0 112.165 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.92 -20.64 9.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.73 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.44 HG22 ' CG ' ' C' ' 42' ' ' GLU . 2.6 m -115.48 -23.04 9.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.854 0.359 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.472 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 58.88 56.95 22.47 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.343 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.44 ' CG ' HG22 ' C' ' 40' ' ' THR . 0.0 OUTLIER -162.45 -81.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.847 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.712 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.2 p -175.05 108.47 0.27 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.329 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' C' ' 35' ' ' PRO . 53.0 Cg_exo -54.49 140.94 74.44 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.326 2.017 . . . . 0.0 112.19 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.54 71.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.49 91.5 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.78 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 mm -41.15 -32.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.471 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.88 -42.58 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.925 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.31 -36.6 77.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.704 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.65 ' OE1' HD12 ' C' ' 121' ' ' LEU . 0.0 OUTLIER -78.51 -20.74 50.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.88 -36.69 23.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.286 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.72 -33.12 58.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.935 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -74.99 -26.82 59.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.682 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.839 ' O ' HG23 ' C' ' 58' ' ' VAL . 90.8 p -70.45 -35.38 73.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.915 HD13 ' CE2' ' C' ' 95' ' ' PHE . 8.6 mt -77.32 -33.64 55.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -51.56 69.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.993 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 57' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' C' ' 54' ' ' SER . 10.3 p30 -59.5 -39.85 85.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.929 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.839 HG23 ' O ' ' C' ' 54' ' ' SER . 31.5 t -61.77 -35.81 69.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.831 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -31.63 44.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -62.5 -39.13 92.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.676 HG12 ' HB2' ' C' ' 11' ' ' ALA . 22.0 mt -69.64 -46.28 75.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -65.34 -31.42 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -41.42 60.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.368 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -63.14 -20.46 65.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.521 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.79 -21.51 20.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.002 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.04 53.14 0.81 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.373 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.488 HD22 ' CB ' ' C' ' 71' ' ' ASP . 11.8 mt -155.63 137.09 14.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 110.978 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 157.13 16.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.738 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -50.11 -36.71 30.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -58.63 -21.24 53.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.322 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.488 ' CB ' HD22 ' C' ' 67' ' ' LEU . 1.5 m-20 -77.72 -26.49 50.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.551 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 35.3 mt -59.38 114.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.632 ' O ' HG11 ' A' ' 22' ' ' VAL . 3.5 m -84.35 -33.19 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.729 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.895 ' CG ' ' HB3' ' C' ' 106' ' ' ALA . 0.6 OUTLIER -139.87 152.66 46.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.771 0.319 . . . . 0.0 110.942 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.639 HG22 ' CB ' ' C' ' 125' ' ' ALA . 40.8 p -141.9 135.0 29.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.991 0.424 . . . . 0.0 111.381 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.651 HG23 ' O ' ' C' ' 108' ' ' SER . 4.5 m -114.83 150.78 34.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.185 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.41 HG13 ' O ' ' C' ' 122' ' ' GLU . 20.1 t -148.73 112.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 0.0 111.622 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.445 ' HB3' HG11 ' C' ' 112' ' ' VAL . 5.5 m-85 -92.68 107.83 19.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.616 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.685 HG12 HD22 ' C' ' 121' ' ' LEU . 36.0 m -102.44 146.49 10.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.391 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -2.81 58.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.058 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.15 125.94 1.96 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.624 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.28 -11.05 56.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.09 -20.53 52.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.836 0.35 . . . . 0.0 110.606 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.691 ' O ' HG23 ' C' ' 88' ' ' VAL . 38.7 m-20 -95.31 7.04 47.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.263 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -84.25 -28.0 27.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.728 0.299 . . . . 0.0 111.096 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.25 -35.0 77.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.197 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.6 -33.92 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.201 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.691 HG23 ' O ' ' C' ' 84' ' ' ASP . 26.4 t -77.89 -43.3 28.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.099 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -61.66 -33.15 73.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.011 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.37 -48.45 34.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.337 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -29.83 59.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.14 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.605 ' OH ' HG21 ' C' ' 75' ' ' THR . 11.6 t80 -63.94 -37.65 88.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.071 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.42 -27.36 29.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.167 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -33.7 76.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.151 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.915 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.3 OUTLIER -85.76 -34.59 21.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 110.544 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.522 ' CE1' ' CE1' ' C' ' 92' ' ' TYR . 0.4 OUTLIER -57.81 -55.13 38.87 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.232 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -32.77 71.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.022 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -85.71 -0.98 56.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.43 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 2.6 m-20 -98.88 -18.33 17.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.179 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 20.3 m-20 104.8 25.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.869 0.868 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.468 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.1 t-80 -124.07 66.67 41.69 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.846 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.05 -16.8 22.61 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.483 2.122 . . . . 0.0 112.476 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.604 ' CG ' HD13 ' A' ' 5' ' ' ILE . 1.7 t-20 -68.21 -35.14 77.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.852 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.56 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.8 m-85 76.18 120.49 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.264 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 94.2 Cg_endo -82.4 168.93 14.41 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.831 2.354 . . . . 0.0 112.206 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.895 ' HB3' ' CG ' ' C' ' 74' ' ' LYS . . . -56.42 159.6 3.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.393 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -128.1 142.79 51.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.083 0.468 . . . . 0.0 111.471 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' SER . . . . . 0.651 ' O ' HG23 ' C' ' 76' ' ' THR . 27.7 t -150.47 66.68 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.387 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 11.7 m -96.76 138.78 33.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.068 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.412 HG12 HD23 ' A' ' 115' ' ' LEU . 34.6 m -145.54 139.53 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.372 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.853 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -70.63 87.01 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.621 HG21 HD21 ' C' ' 115' ' ' LEU . 21.6 m -71.33 156.03 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -67.97 -46.81 70.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.993 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.75 176.92 11.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.621 HD21 HG21 ' C' ' 112' ' ' VAL . 30.5 mt -147.44 155.35 45.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.539 ' O ' HG22 ' C' ' 119' ' ' VAL . 12.3 Cg_endo -56.03 137.03 77.86 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.572 2.182 . . . . 0.0 112.058 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.2 OUTLIER 74.91 13.88 3.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 20.1 t70 63.0 15.96 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.954 HG21 HG21 ' C' ' 34' ' ' ILE . 14.1 m -55.61 146.38 4.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.856 0.36 . . . . 0.0 111.217 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 120' ' ' GLY . . . . . 0.712 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.41 -15.12 64.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.878 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.685 HD22 HG12 ' C' ' 79' ' ' VAL . 37.0 mt -150.81 147.46 27.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.0 0.429 . . . . 0.0 111.046 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.658 ' O ' HD13 ' C' ' 123' ' ' ILE . 5.3 tt0 -122.6 155.27 36.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.249 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.724 ' CG2' HG21 ' C' ' 58' ' ' VAL . 30.2 mm -130.78 133.6 63.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.004 0.43 . . . . 0.0 111.771 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -152.47 155.87 38.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.981 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.771 ' C ' HD13 ' C' ' 126' ' ' ILE . . . -177.42 165.04 2.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.834 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.951 HG23 HD12 ' C' ' 29' ' ' LEU . 0.7 OUTLIER -124.49 143.65 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.372 179.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.927 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -129.74 157.99 40.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.962 0.41 . . . . 0.0 111.787 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 1.055 HG21 HG21 ' A' ' 3' ' ' THR . 30.7 m -115.94 154.94 17.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.005 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.7 46.99 2.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.899 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.963 -179.961 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.82 0.343 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.26 42.07 15.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.838 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.13 HG21 HG21 ' C' ' 128' ' ' VAL . 5.9 m -78.24 152.97 32.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -177.96 132.51 0.15 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.008 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.576 ' HA ' HG12 ' A' ' 22' ' ' VAL . 4.3 mp -57.51 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.474 ' N ' HG22 ' A' ' 5' ' ' ILE . 32.1 mt -113.55 150.64 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.203 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -147.84 134.25 19.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.83 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.516 HG21 ' HA ' ' A' ' 61' ' ' ILE . 2.7 t -148.14 163.27 37.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.93 28.67 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -110.31 -49.88 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.776 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.717 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.85 179.3 0.62 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.981 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 31.4 Cg_exo -59.08 -15.57 28.69 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.74 2.293 . . . . 0.0 112.614 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 73.78 153.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -110.37 119.94 40.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.201 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 15' ' ' ILE . 1.9 mp -132.22 16.23 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.833 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.38 -137.96 4.61 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.417 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HB2' ' CE1' ' C' ' 92' ' ' TYR . 87.1 Cg_endo -84.33 16.61 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.755 2.303 . . . . 0.0 113.641 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.559 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 1.1 p90 -137.41 177.85 7.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.454 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 10.6 m -128.82 169.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.047 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.42 HE22 ' HB3' ' A' ' 11' ' ' ALA . 13.7 mm-40 -59.54 -55.85 29.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.006 0.431 . . . . 0.0 110.458 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.99 178.04 4.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.596 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.744 HG21 ' HB ' ' C' ' 73' ' ' VAL . 5.2 m -144.58 131.51 16.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.954 0.407 . . . . 0.0 111.164 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.512 ' HA ' HG23 ' A' ' 28' ' ' VAL . 3.6 t70 -98.98 110.55 23.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.439 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.95 HD22 HG11 ' C' ' 128' ' ' VAL . 17.2 mt -73.48 -11.52 60.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.504 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.51 -102.86 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.669 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.11 -30.05 64.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.176 0.512 . . . . 0.0 109.979 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.58 167.54 18.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.55 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.061 HG12 ' HB3' ' A' ' 127' ' ' ALA . 7.1 p -129.5 160.83 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.787 HD13 HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -136.83 122.78 20.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.28 137.71 41.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.046 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.486 ' CB ' ' HB1' ' C' ' 106' ' ' ALA . 16.8 t -71.25 172.67 8.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.32 82.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.074 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.559 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -56.38 147.51 21.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 0.0 111.385 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 5.0 pt -142.3 149.75 52.66 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.576 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 34' ' ' ILE . 1.6 Cg_endo -83.17 51.09 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.921 2.414 . . . . 0.0 112.481 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 42' ' ' GLU . 86.0 t -94.27 82.47 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.185 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.489 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 0.5 OUTLIER 157.47 -44.69 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.018 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 37' ' ' ASN . 79.9 Cg_exo -42.6 -24.39 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.285 1.99 . . . . 0.0 112.732 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.633 ' HB2' ' CA ' ' A' ' 44' ' ' PRO . . . -90.42 -30.14 17.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.047 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.514 HG22 ' C ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER 158.26 -11.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.814 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 37' ' ' ASN . . . 131.7 58.37 0.09 OUTLIER Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.088 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.767 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -178.8 -65.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.624 0.249 . . . . 0.0 111.283 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 42' ' ' GLU . 5.4 p 164.67 115.87 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.633 ' CA ' ' HB2' ' A' ' 39' ' ' ALA . 37.8 Cg_exo -59.7 147.51 91.75 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.514 2.143 . . . . 0.0 112.1 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.39 -31.0 57.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 110.943 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -67.65 95.79 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.28 -32.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.835 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 t -83.26 -43.23 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . . . -60.62 -44.11 96.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.794 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -74.27 -30.09 61.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.266 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.628 ' HB1' HG22 ' A' ' 88' ' ' VAL . . . -75.95 -33.37 59.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.369 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -30.16 29.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.12 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.21 -33.33 59.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.88 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.0 p -69.43 -35.74 76.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.573 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD22 ' HB2' ' A' ' 92' ' ' TYR . 68.5 mt -63.0 -39.71 95.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.531 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -72.22 -40.56 67.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.673 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -57.82 -41.07 81.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 54' ' ' SER . 16.4 t -60.11 -40.76 84.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.792 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.513 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -76.02 -32.41 59.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.769 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.46 86.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.516 ' HA ' HG21 ' A' ' 8' ' ' THR . 17.3 mt -68.9 -41.65 82.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.722 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.997 HD13 HD11 ' A' ' 72' ' ' ILE . 12.3 mt -69.28 -36.58 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.588 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -40.3 72.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -65.32 -19.04 65.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.539 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 6' ' ' ILE . . . -88.33 -34.17 17.73 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.73 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.48 44.84 0.3 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.812 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 129' ' ' ARG . 1.3 mt -143.0 -170.54 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.716 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.78 157.25 44.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.513 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . . . -58.12 -36.58 73.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.03 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -57.49 -26.09 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.319 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.453 ' CB ' HD22 ' A' ' 67' ' ' LEU . 9.3 m-20 -76.29 -24.48 54.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.879 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 127' ' ' ALA . 39.3 mm -54.14 118.27 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.977 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.718 ' HB ' HG21 ' B' ' 22' ' ' VAL . 5.2 m -90.85 -32.86 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.929 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.668 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 14.3 tttt -143.25 163.97 31.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.658 0.266 . . . . 0.0 111.198 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.578 HG21 ' NH2' ' A' ' 107' ' ' ARG . 3.4 t -162.15 112.52 1.56 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.376 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.414 ' HB ' ' CG ' ' A' ' 124' ' ' GLU . 27.3 m -92.87 160.17 15.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.318 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 122' ' ' GLU . 13.6 t -150.54 142.73 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.041 0.448 . . . . 0.0 111.945 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.519 ' CD2' HG11 ' C' ' 110' ' ' VAL . 3.2 m-85 -121.15 102.56 8.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.189 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.479 HG11 ' HD1' ' A' ' 85' ' ' PHE . 5.8 m -100.55 150.28 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.701 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.08 -1.86 58.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.839 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.59 124.5 1.38 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.477 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.59 HD12 ' HD3' ' B' ' 114' ' ' ARG . 9.7 mt -68.79 -10.67 58.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.196 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.97 -22.81 42.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.827 0.346 . . . . 0.0 110.574 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -88.16 -20.27 25.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.479 ' HD1' HG11 ' A' ' 79' ' ' VAL . 14.4 t80 -57.52 -22.25 43.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.358 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.49 -60.41 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.57 79.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.628 HG22 ' HB1' ' A' ' 51' ' ' ALA . 19.3 t -61.67 -37.4 77.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.915 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.589 ' HA ' ' CE2' ' A' ' 92' ' ' TYR . 36.0 t-20 -62.28 -41.94 98.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.77 -23.46 42.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.351 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.16 -42.33 19.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.77 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.601 ' HB2' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -77.34 -28.7 53.15 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.083 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.88 -33.72 39.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.966 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -72.63 -29.75 63.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.178 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -74.26 -41.65 60.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.782 0.325 . . . . 0.0 110.508 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.477 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 6.9 m-85 -52.04 -50.84 60.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.088 0.47 . . . . 0.0 110.377 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HG3' ' N ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -62.04 -28.9 69.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.135 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -90.88 2.73 55.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.42 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -119.25 -1.52 10.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 7.3 t30 85.75 28.73 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.189 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -121.52 53.63 4.02 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.617 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 45.5 Cg_endo -68.3 -20.49 42.7 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.56 2.173 . . . . 0.0 112.676 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 2.1 m-20 -60.85 -40.34 92.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.942 0.401 . . . . 0.0 110.501 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 27.6 m-85 77.36 120.98 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.833 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.547 ' HG2' HG22 ' A' ' 75' ' ' THR . 84.7 Cg_endo -83.99 162.03 13.76 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.844 2.363 . . . . 0.0 112.303 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.668 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -52.32 163.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.447 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.578 ' NH2' HG21 ' A' ' 75' ' ' THR . 13.7 ttm-85 -146.59 144.52 29.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.159 0.504 . . . . 0.0 111.876 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.14 63.31 1.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.996 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 19.8 p -79.92 134.78 36.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.278 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.61 HG12 HD23 ' B' ' 115' ' ' LEU . 33.9 m -146.25 146.62 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.193 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.6 OUTLIER -79.42 88.05 5.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 78' ' ' PHE . 5.7 m -71.75 155.4 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -71.88 -44.01 64.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.614 ' HD3' HD12 ' C' ' 82' ' ' LEU . 0.5 OUTLIER -152.1 174.71 13.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.607 HD23 HG12 ' C' ' 110' ' ' VAL . 14.0 mt -147.16 156.01 46.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.23 136.33 67.88 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.595 2.197 . . . . 0.0 112.169 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.731 ' HD2' HG21 ' A' ' 36' ' ' VAL . 3.1 ttmt 74.7 14.1 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.232 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.48 17.8 8.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 117' ' ' LYS . 23.1 m -52.1 162.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.845 0.355 . . . . 0.0 111.188 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.698 ' C ' HD13 ' A' ' 121' ' ' LEU . . . -95.42 -25.55 13.66 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.737 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.698 HD13 ' C ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -157.51 148.87 21.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.164 0.507 . . . . 0.0 111.127 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.727 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -121.43 155.98 33.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.199 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.819 HD13 ' HB2' ' A' ' 54' ' ' SER . 4.1 mp -144.06 119.99 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.071 0.462 . . . . 0.0 112.016 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.414 ' CG ' ' HB ' ' A' ' 76' ' ' THR . 0.9 OUTLIER -128.88 149.01 50.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.437 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -163.83 161.18 23.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.313 0.578 . . . . 0.0 112.455 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 28' ' ' VAL . 6.0 mt -118.0 152.44 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.058 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 1.061 ' HB3' HG12 ' A' ' 28' ' ' VAL . . . -133.3 149.9 51.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.139 0.495 . . . . 0.0 111.9 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.065 HG21 HG21 ' B' ' 3' ' ' THR . 36.0 m -122.65 139.4 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.815 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.648 ' HB2' HD21 ' A' ' 67' ' ' LEU . 32.5 ttp180 -135.47 52.3 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.976 179.937 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.3 42.01 15.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' THR . . . . . 1.065 HG21 HG21 ' A' ' 128' ' ' VAL . 5.9 m -78.21 152.97 32.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.065 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -177.95 132.5 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.084 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.582 ' HA ' HG12 ' B' ' 22' ' ' VAL . 4.3 mp -57.54 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.488 ' N ' HG22 ' B' ' 5' ' ' ILE . 32.2 mt -113.53 150.57 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.222 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -147.82 134.24 19.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.566 HG21 ' HA ' ' B' ' 61' ' ' ILE . 2.7 t -148.17 163.24 37.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.85 28.67 7.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -110.26 -49.84 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.782 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.714 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -67.98 179.29 0.63 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.714 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 31.5 Cg_exo -59.01 -15.59 28.38 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.742 2.295 . . . . 0.0 112.627 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 73.77 153.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -110.38 119.93 40.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.23 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.63 HG22 ' O ' ' B' ' 15' ' ' ILE . 1.9 mp -132.2 16.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.826 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.44 -137.96 4.6 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.429 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.428 ' HB2' ' CE1' ' A' ' 92' ' ' TYR . 88.9 Cg_endo -84.32 16.52 1.92 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.75 2.3 . . . . 0.0 113.653 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.553 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 1.1 p90 -137.37 177.84 7.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.962 0.411 . . . . 0.0 111.456 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.423 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 10.5 m -128.75 169.45 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.028 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.43 HE22 ' HB3' ' B' ' 11' ' ' ALA . 13.7 mm-40 -59.76 -55.74 30.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 110.466 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.94 178.12 4.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.594 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.718 HG21 ' HB ' ' A' ' 73' ' ' VAL . 5.2 m -144.62 131.54 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.954 0.407 . . . . 0.0 111.191 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.509 ' HA ' HG23 ' B' ' 28' ' ' VAL . 3.6 t70 -98.96 110.65 23.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.405 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.967 HD22 HG11 ' A' ' 128' ' ' VAL . 17.3 mt -73.55 -11.54 60.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.503 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.58 -102.87 0.68 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.668 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.19 -29.98 64.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.146 0.498 . . . . 0.0 109.972 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.59 167.53 18.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.523 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.071 HG12 ' HB3' ' B' ' 127' ' ' ALA . 7.1 p -129.52 160.78 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.057 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.764 HD13 HD11 ' B' ' 24' ' ' LEU . 0.1 OUTLIER -136.8 122.76 20.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.736 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.24 137.82 40.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.041 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.494 ' CB ' ' HB1' ' A' ' 106' ' ' ALA . 16.6 t -71.27 172.54 9.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.96 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.21 82.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.113 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.531 ' CB ' HG22 ' B' ' 58' ' ' VAL . 0.1 OUTLIER -56.4 147.49 21.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.022 0.439 . . . . 0.0 111.352 -179.558 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.3 149.69 52.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.552 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.415 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 1.6 Cg_endo -83.12 51.04 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.956 2.437 . . . . 0.0 112.483 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.768 HG21 ' HD2' ' B' ' 117' ' ' LYS . 86.7 t -94.26 82.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.188 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' B' ' 41' ' ' GLY . 0.5 OUTLIER 157.4 -44.68 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.965 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' B' ' 37' ' ' ASN . 81.1 Cg_exo -42.51 -24.49 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.332 2.021 . . . . 0.0 112.726 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.626 ' HB2' ' CA ' ' B' ' 44' ' ' PRO . . . -90.38 -30.18 17.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.048 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.516 HG22 ' C ' ' B' ' 39' ' ' ALA . 1.0 OUTLIER 158.28 -11.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.795 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' B' ' 37' ' ' ASN . . . 131.82 58.26 0.09 OUTLIER Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.142 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.753 ' O ' HG13 ' B' ' 36' ' ' VAL . 0.0 OUTLIER -178.76 -65.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.607 0.241 . . . . 0.0 111.307 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' B' ' 42' ' ' GLU . 5.4 p 164.64 115.88 0.02 OUTLIER Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.074 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.626 ' CA ' ' HB2' ' B' ' 39' ' ' ALA . 37.2 Cg_exo -59.76 147.61 91.53 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.458 2.105 . . . . 0.0 112.073 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.51 -30.99 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.438 . . . . 0.0 110.912 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' B' ' 49' ' ' ALA . 0.7 OUTLIER -67.6 95.73 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.862 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.22 -32.41 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.806 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -83.25 -43.22 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' B' ' 46' ' ' ASP . . . -60.61 -44.17 96.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.787 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.419 ' HG3' HD11 ' B' ' 121' ' ' LEU . 20.3 pt20 -74.13 -29.15 61.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.228 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.633 ' HB1' HG22 ' B' ' 88' ' ' VAL . . . -76.58 -33.46 58.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.429 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -30.23 29.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.123 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.11 -33.3 59.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.787 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.878 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.0 p -69.54 -35.66 75.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.565 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' B' ' 92' ' ' TYR . 68.4 mt -62.97 -39.78 95.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.504 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -72.11 -40.66 68.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.717 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.75 -41.12 81.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.878 HG23 ' O ' ' B' ' 54' ' ' SER . 16.5 t -60.09 -40.74 84.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.783 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -76.02 -32.53 59.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.747 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.33 -40.59 86.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.566 ' HA ' HG21 ' B' ' 8' ' ' THR . 17.3 mt -68.99 -41.56 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.753 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.988 HD13 HD11 ' B' ' 72' ' ' ILE . 12.3 mt -69.33 -36.58 72.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.536 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -40.21 72.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.229 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.33 -19.06 65.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.533 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.32 -34.16 17.75 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.748 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.49 44.82 0.3 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.769 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.633 HD21 ' HB2' ' B' ' 129' ' ' ARG . 1.3 mt -142.99 -170.47 3.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 110.702 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.79 157.28 44.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.515 ' HB2' ' HG3' ' B' ' 59' ' ' LYS . . . -58.19 -36.57 73.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.991 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.486 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -57.31 -25.8 59.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.294 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.472 ' CB ' HD22 ' B' ' 67' ' ' LEU . 9.4 m-20 -76.7 -24.37 53.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.924 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 1.027 HD13 ' HB2' ' B' ' 127' ' ' ALA . 39.4 mm -54.21 118.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.937 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.764 ' HB ' HG21 ' C' ' 22' ' ' VAL . 5.2 m -90.79 -32.87 5.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.958 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.701 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 14.3 tttt -143.28 163.98 31.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.695 0.283 . . . . 0.0 111.164 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.568 HG21 ' NH2' ' B' ' 107' ' ' ARG . 3.3 t -162.23 112.46 1.53 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.321 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.421 ' HB ' ' CG ' ' B' ' 124' ' ' GLU . 27.6 m -92.8 160.16 15.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.301 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.705 HG13 ' O ' ' B' ' 122' ' ' GLU . 13.6 t -150.52 142.74 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.098 0.475 . . . . 0.0 111.941 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.532 ' CD2' HG11 ' A' ' 110' ' ' VAL . 3.2 m-85 -121.11 102.58 8.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.181 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.475 HG11 ' HD1' ' B' ' 85' ' ' PHE . 5.7 m -100.58 150.33 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.069 0.461 . . . . 0.0 111.671 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.08 -2.11 58.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.846 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.16 124.33 1.48 Allowed 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.509 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.618 HD12 ' HD3' ' C' ' 114' ' ' ARG . 9.7 mt -68.86 -10.69 58.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.165 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.95 -22.76 42.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.799 0.333 . . . . 0.0 110.578 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -88.22 -20.24 25.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.475 ' HD1' HG11 ' B' ' 79' ' ' VAL . 14.3 t80 -57.53 -22.33 43.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.32 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.34 -60.46 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 0.0 111.267 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.56 79.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.633 HG22 ' HB1' ' B' ' 51' ' ' ALA . 19.1 t -61.64 -37.46 78.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.894 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.595 ' HA ' ' CE2' ' B' ' 92' ' ' TYR . 36.0 t-20 -62.25 -41.99 98.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.799 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.79 -23.5 42.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.34 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.04 -42.32 19.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.817 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.595 ' CE2' ' HA ' ' B' ' 89' ' ' ASN . 0.3 OUTLIER -77.35 -28.71 53.12 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.094 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.92 -33.66 39.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -72.62 -29.79 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.14 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -74.23 -41.69 60.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.736 0.303 . . . . 0.0 110.473 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 6.9 m-85 -52.08 -50.78 60.91 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.071 0.462 . . . . 0.0 110.372 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' B' ' 98' ' ' GLU . 0.4 OUTLIER -62.12 -28.85 69.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.116 179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 98' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 0.4 OUTLIER -90.93 2.76 55.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.433 178.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.1 OUTLIER -119.22 -1.58 10.82 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 7.3 t30 85.76 28.61 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.244 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 0.8 OUTLIER -121.36 53.65 3.87 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.593 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 45.7 Cg_endo -68.32 -20.44 42.6 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.617 2.211 . . . . 0.0 112.694 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 2.1 m-20 -60.92 -40.31 92.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 0.0 110.492 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 27.6 m-85 77.28 121.03 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.825 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.525 ' HG2' HG22 ' B' ' 75' ' ' THR . 84.2 Cg_endo -83.98 162.06 13.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.83 2.354 . . . . 0.0 112.303 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.701 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -52.46 163.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.445 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.568 ' NH2' HG21 ' B' ' 75' ' ' THR . 13.6 ttm-85 -146.57 144.58 29.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.163 0.506 . . . . 0.0 111.836 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.14 63.11 1.49 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.966 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 20.1 p -79.7 134.8 36.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.37 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.611 HG12 HD23 ' C' ' 115' ' ' LEU . 33.9 m -146.43 147.1 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.236 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.6 OUTLIER -79.92 88.07 5.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' B' ' 78' ' ' PHE . 5.7 m -71.78 155.47 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.145 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -71.91 -44.01 64.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.59 ' HD3' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -152.13 174.71 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.925 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.61 HD23 HG12 ' A' ' 110' ' ' VAL . 14.0 mt -147.15 156.04 46.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.38 136.36 67.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.608 2.205 . . . . 0.0 112.135 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.768 ' HD2' HG21 ' B' ' 36' ' ' VAL . 3.1 ttmt 74.64 14.13 3.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.293 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.52 17.76 8.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.961 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 m -52.16 162.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.216 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' GLY . . . . . 0.715 ' C ' HD13 ' B' ' 121' ' ' LEU . . . -95.24 -25.06 14.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.697 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.715 HD13 ' C ' ' B' ' 120' ' ' GLY . 0.0 OUTLIER -158.2 149.06 20.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.109 0.48 . . . . 0.0 111.099 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.705 ' O ' HG13 ' B' ' 77' ' ' VAL . 0.4 OUTLIER -121.39 156.01 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.188 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' B' ' 54' ' ' SER . 4.1 mp -144.07 119.97 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.097 0.475 . . . . 0.0 111.994 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' GLU . . . . . 0.421 ' CG ' ' HB ' ' B' ' 76' ' ' THR . 1.0 OUTLIER -128.88 148.97 50.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.434 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -163.78 161.22 23.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.297 0.57 . . . . 0.0 112.449 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.419 HG23 ' O ' ' B' ' 28' ' ' VAL . 5.9 mt -118.01 152.43 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.044 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 1.071 ' HB3' HG12 ' B' ' 28' ' ' VAL . . . -133.23 149.98 51.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.129 0.49 . . . . 0.0 111.96 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 1.044 HG21 HG21 ' C' ' 3' ' ' THR . 35.9 m -122.62 139.4 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.861 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.633 ' HB2' HD21 ' B' ' 67' ' ' LEU . 32.5 ttp180 -135.55 52.42 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 111.022 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.055 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.787 0.327 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.38 41.91 15.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.851 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 3' ' ' THR . . . . . 1.044 HG21 HG21 ' B' ' 128' ' ' VAL . 5.9 m -78.2 153.03 32.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.103 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -178.02 132.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.057 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.591 ' HA ' HG12 ' C' ' 22' ' ' VAL . 4.3 mp -57.54 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.485 ' N ' HG22 ' C' ' 5' ' ' ILE . 32.3 mt -113.49 150.54 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.243 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -147.75 134.26 19.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.588 HG21 ' HA ' ' C' ' 61' ' ' ILE . 2.7 t -148.15 163.28 37.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.94 28.63 8.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.439 ' CB ' ' HB1' ' C' ' 60' ' ' ALA . 26.6 mmtt -110.2 -49.69 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.752 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -68.1 179.27 0.65 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.984 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 31.7 Cg_exo -59.08 -15.58 28.74 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.755 2.303 . . . . 0.0 112.645 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 73.79 154.0 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.056 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -110.38 119.96 40.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.228 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.611 HG22 ' O ' ' C' ' 15' ' ' ILE . 1.9 mp -132.29 16.23 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.764 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 -137.97 4.61 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.429 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' PRO . . . . . 0.441 ' HB2' ' CE1' ' B' ' 92' ' ' TYR . 88.4 Cg_endo -84.32 16.58 1.9 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.692 2.261 . . . . 0.0 113.657 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.553 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 1.1 p90 -137.36 177.88 7.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.975 0.416 . . . . 0.0 111.435 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.418 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 10.6 m -128.78 169.41 20.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.419 HE22 ' HB3' ' C' ' 11' ' ' ALA . 13.7 mm-40 -59.63 -55.51 33.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.457 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.61 178.2 4.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.537 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.764 HG21 ' HB ' ' B' ' 73' ' ' VAL . 5.2 m -144.53 131.5 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.888 0.375 . . . . 0.0 111.179 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.492 ' HA ' HG23 ' C' ' 28' ' ' VAL . 3.6 t70 -99.0 110.63 23.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.447 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.932 HD22 HG11 ' B' ' 128' ' ' VAL . 17.2 mt -73.57 -11.48 60.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.51 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.53 -102.89 0.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.627 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.12 -30.06 64.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.173 0.511 . . . . 0.0 109.975 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.53 167.48 18.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 1.021 HG12 ' HB3' ' C' ' 127' ' ' ALA . 7.1 p -129.5 160.77 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.1 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.776 HD13 HD11 ' C' ' 24' ' ' LEU . 0.1 OUTLIER -136.74 122.79 20.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.741 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.25 137.71 41.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.958 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' SER . . . . . 0.522 ' CB ' ' HB1' ' B' ' 106' ' ' ALA . 16.6 t -71.76 172.78 9.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.034 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.33 82.74 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.11 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.573 ' CB ' HG22 ' C' ' 58' ' ' VAL . 0.0 OUTLIER -56.36 147.48 21.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.039 0.447 . . . . 0.0 111.34 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 5.0 pt -142.3 149.73 52.58 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.554 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 1.6 Cg_endo -83.2 51.08 3.5 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.938 2.425 . . . . 0.0 112.469 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.777 HG21 ' HD2' ' C' ' 117' ' ' LYS . 87.2 t -94.23 82.48 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.157 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' C' ' 41' ' ' GLY . 0.5 OUTLIER 157.43 -44.65 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.999 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' C' ' 37' ' ' ASN . 79.3 Cg_exo -42.53 -24.53 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.376 2.051 . . . . 0.0 112.714 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CA ' ' C' ' 44' ' ' PRO . . . -90.31 -30.13 17.67 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.107 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.511 HG22 ' C ' ' C' ' 39' ' ' ALA . 1.0 OUTLIER 158.26 -11.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.798 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' C' ' 37' ' ' ASN . . . 131.71 58.41 0.09 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.114 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.748 ' O ' HG13 ' C' ' 36' ' ' VAL . 0.0 OUTLIER -178.81 -65.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.58 0.229 . . . . 0.0 111.283 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' C' ' 42' ' ' GLU . 5.4 p 164.65 115.87 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.083 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.628 ' CA ' ' HB2' ' C' ' 39' ' ' ALA . 37.8 Cg_exo -59.74 147.62 91.44 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.478 2.119 . . . . 0.0 112.088 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.45 -31.03 57.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.439 . . . . 0.0 110.91 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' C' ' 49' ' ' ALA . 0.7 OUTLIER -67.64 95.69 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.873 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.27 -32.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.826 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -83.24 -43.26 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' C' ' 46' ' ' ASP . . . -60.57 -44.17 96.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.781 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -74.14 -29.65 61.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.319 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.588 ' HB1' HG22 ' C' ' 88' ' ' VAL . . . -76.18 -33.47 59.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.327 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -30.21 29.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.135 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.11 -33.32 59.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.857 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.0 p -69.45 -35.76 75.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.575 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.568 HD22 ' HB2' ' C' ' 92' ' ' TYR . 68.5 mt -62.94 -39.81 95.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.495 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -72.12 -40.65 67.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.703 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.73 -41.14 81.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.843 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.857 HG23 ' O ' ' C' ' 54' ' ' SER . 16.5 t -60.04 -40.78 84.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.529 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -76.02 -32.51 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.713 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.439 ' HB1' ' CB ' ' C' ' 10' ' ' LYS . . . -59.44 -40.57 87.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.588 ' HA ' HG21 ' C' ' 8' ' ' THR . 17.4 mt -68.67 -41.58 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.72 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 1.04 HD13 HD11 ' C' ' 72' ' ' ILE . 12.2 mt -69.27 -36.59 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.628 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -40.27 72.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.294 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.26 -19.16 65.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.526 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.428 ' HB2' HD13 ' C' ' 6' ' ' ILE . . . -88.29 -34.13 17.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.734 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.44 44.88 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.788 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' C' ' 129' ' ' ARG . 1.3 mt -143.02 -170.55 3.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.728 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.74 157.28 44.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.529 ' HB2' ' HG3' ' C' ' 59' ' ' LYS . . . -58.1 -36.56 73.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -57.51 -25.87 60.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.258 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.468 ' CB ' HD22 ' C' ' 67' ' ' LEU . 9.5 m-20 -76.35 -24.45 54.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.996 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 1.04 HD11 HD13 ' C' ' 62' ' ' ILE . 39.4 mm -54.15 118.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.744 ' HB ' HG21 ' A' ' 22' ' ' VAL . 5.1 m -90.83 -32.87 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.908 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 14.3 tttt -143.23 163.98 31.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.662 0.268 . . . . 0.0 111.188 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.576 HG21 ' NH2' ' C' ' 107' ' ' ARG . 3.4 t -162.16 112.46 1.55 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.418 ' HB ' ' CG ' ' C' ' 124' ' ' GLU . 27.3 m -92.8 160.17 15.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.305 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.723 HG13 ' O ' ' C' ' 122' ' ' GLU . 13.6 t -150.52 142.76 17.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.102 0.477 . . . . 0.0 111.918 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.557 ' CD2' HG11 ' B' ' 110' ' ' VAL . 3.2 m-85 -121.09 102.49 8.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.206 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.473 HG11 ' HD1' ' C' ' 85' ' ' PHE . 5.7 m -100.57 150.26 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.008 0.433 . . . . 0.0 111.715 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.05 -1.7 58.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.893 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.92 124.59 1.29 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.458 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.614 HD12 ' HD3' ' A' ' 114' ' ' ARG . 9.7 mt -68.76 -10.78 58.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.148 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.88 -22.83 42.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.796 0.332 . . . . 0.0 110.598 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -88.18 -20.3 25.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.473 ' HD1' HG11 ' C' ' 79' ' ' VAL . 14.3 t80 -57.54 -22.26 43.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.322 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.4 -60.47 3.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 111.28 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.69 -48.59 79.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.588 HG22 ' HB1' ' C' ' 51' ' ' ALA . 19.4 t -61.7 -37.4 77.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.944 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ASN . . . . . 0.593 ' HA ' ' CE2' ' C' ' 92' ' ' TYR . 36.0 t-20 -62.32 -41.91 98.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.774 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.76 -23.33 42.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.347 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 1.2 tp10 -82.31 -42.34 18.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.778 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.593 ' CE2' ' HA ' ' C' ' 89' ' ' ASN . 0.3 OUTLIER -77.41 -28.68 52.72 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.071 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.92 -33.78 39.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 16.5 ptp180 -72.48 -29.85 64.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.198 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.478 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -74.18 -41.71 61.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.478 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 7.0 m-85 -52.08 -50.8 60.87 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.358 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -28.88 69.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.145 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.89 2.76 55.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.437 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.1 OUTLIER -119.22 -1.63 10.81 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 7.3 t30 85.84 28.69 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.172 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.474 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 0.8 OUTLIER -121.34 53.63 3.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.627 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 45.9 Cg_endo -68.37 -20.39 42.35 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 112.675 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 2.2 m-20 -61.01 -40.17 92.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.882 0.372 . . . . 0.0 110.482 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 27.6 m-85 77.21 121.02 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.805 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.551 ' HG2' HG22 ' C' ' 75' ' ' THR . 85.0 Cg_endo -83.99 161.98 13.74 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.854 2.369 . . . . 0.0 112.288 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -52.28 163.61 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.434 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.576 ' NH2' HG21 ' C' ' 75' ' ' THR . 13.6 ttm-85 -146.62 144.5 29.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.199 0.524 . . . . 0.0 111.898 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.11 63.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.988 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 20.0 p -79.91 134.75 36.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.339 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.607 HG12 HD23 ' A' ' 115' ' ' LEU . 33.9 m -146.07 145.89 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -78.96 88.2 4.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.761 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' C' ' 78' ' ' PHE . 5.8 m -71.84 155.45 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.129 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -71.9 -44.01 64.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.618 ' HD3' HD12 ' B' ' 82' ' ' LEU . 0.5 OUTLIER -152.13 174.69 13.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.874 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.611 HD23 HG12 ' B' ' 110' ' ' VAL . 13.9 mt -147.13 155.99 46.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.942 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.21 136.38 68.22 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.621 2.214 . . . . 0.0 112.156 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.777 ' HD2' HG21 ' C' ' 36' ' ' VAL . 3.1 ttmt 74.59 14.13 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.309 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.54 17.75 8.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.41 HG13 ' HB3' ' C' ' 117' ' ' LYS . 23.2 m -52.15 162.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 120' ' ' GLY . . . . . 0.703 ' C ' HD13 ' C' ' 121' ' ' LEU . . . -95.48 -25.36 13.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.726 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.703 HD13 ' C ' ' C' ' 120' ' ' GLY . 0.0 OUTLIER -157.81 148.96 21.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.146 0.498 . . . . 0.0 111.191 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.723 ' O ' HG13 ' C' ' 77' ' ' VAL . 0.4 OUTLIER -121.42 156.03 33.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.187 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.8 HD13 ' HB2' ' C' ' 54' ' ' SER . 4.1 mp -144.05 120.05 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.062 0.458 . . . . 0.0 112.056 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 124' ' ' GLU . . . . . 0.418 ' CG ' ' HB ' ' C' ' 76' ' ' THR . 1.0 OUTLIER -128.97 148.93 50.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.429 178.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -163.8 161.2 23.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.28 0.562 . . . . 0.0 112.429 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.414 HG23 ' O ' ' C' ' 28' ' ' VAL . 5.9 mt -118.03 152.36 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.053 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 1.021 ' HB3' HG12 ' C' ' 28' ' ' VAL . . . -133.25 150.01 51.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.093 0.473 . . . . 0.0 111.946 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 1.13 HG21 HG21 ' A' ' 3' ' ' THR . 35.2 m -122.69 139.39 49.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.803 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.618 ' HB2' HD21 ' C' ' 67' ' ' LEU . 32.6 ttp180 -135.51 52.48 2.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.987 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.031 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 ttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.822 0.344 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.8 mtm -141.15 159.83 41.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.509 ' CG2' HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER 59.91 109.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.57 122.74 7.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.486 HD13 HG12 ' A' ' 22' ' ' VAL . 39.2 mm -55.67 144.39 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.543 HD12 ' CB ' ' A' ' 21' ' ' ALA . 32.8 mt -109.49 143.51 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -146.99 141.8 26.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.1 159.34 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.1 28.54 4.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.007 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -122.39 -44.16 2.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.778 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.869 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.22 171.64 4.59 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.114 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.869 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 30.4 Cg_endo -63.86 -12.68 33.0 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.538 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 69.82 147.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.009 0.433 . . . . 0.0 111.336 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.801 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -106.15 123.23 47.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.011 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.801 HD13 ' O ' ' A' ' 14' ' ' ALA . 17.6 mm -131.9 16.96 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.861 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.24 -128.05 3.19 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.385 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -90.02 24.61 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.782 2.322 . . . . 0.0 113.484 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.734 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -152.1 174.53 13.58 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.752 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG13 ' HB2' ' C' ' 104' ' ' PHE . 15.8 m -123.12 173.24 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.826 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.466 HE21 ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -59.62 -40.41 87.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.399 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . 175.62 175.22 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.803 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' C' ' 73' ' ' VAL . 1.8 m -140.22 134.87 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.35 108.86 15.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.597 HD21 HG11 ' C' ' 73' ' ' VAL . 4.1 mm? -84.18 -16.93 41.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.0 -105.75 0.86 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.993 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -53.83 -30.13 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.066 0.46 . . . . 0.0 110.298 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.9 132.8 52.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.843 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.074 HG13 ' HB3' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -131.3 151.99 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.659 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.769 HD23 HD12 ' A' ' 126' ' ' ILE . 0.5 OUTLIER -144.15 140.01 29.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.809 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.3 p -106.28 142.44 35.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.6 p -69.67 155.89 39.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.142 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.02 94.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.518 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.665 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.5 mp0 -78.23 156.22 29.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.992 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.744 ' HB ' HG11 ' A' ' 119' ' ' VAL . 7.0 pt -136.02 146.65 57.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.982 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 53.3 Cg_endo -69.36 61.56 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.863 2.375 . . . . 0.0 112.729 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.568 HG23 HG13 ' A' ' 34' ' ' ILE . 59.7 t -68.07 85.97 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.085 0.469 . . . . 0.0 110.584 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 36' ' ' VAL . 9.0 t-20 -29.46 121.22 0.29 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.242 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.58 -15.09 43.76 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.377 2.051 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.59 -15.77 10.8 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.3 -30.16 7.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.849 0.357 . . . . 0.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.49 52.66 9.83 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.413 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.484 ' O ' HG12 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -174.65 -76.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 111.208 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG21 ' H ' ' A' ' 120' ' ' GLY . 11.3 p -174.27 123.23 0.39 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.65 140.48 51.72 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.272 1.982 . . . . 0.0 112.055 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.12 -30.96 60.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.121 0.486 . . . . 0.0 111.077 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -67.02 95.68 0.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.64 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 47' ' ' ILE . 6.4 tp -45.05 -30.54 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.307 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.77 -38.68 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.485 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 46' ' ' ASP . . . -60.98 -53.94 51.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.307 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.568 ' HG3' HD21 ' A' ' 121' ' ' LEU . 17.8 pt20 -62.81 -29.43 70.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.104 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.67 ' HB1' HG13 ' A' ' 88' ' ' VAL . . . -71.18 -35.01 71.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.893 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -80.79 -41.23 23.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.808 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -40.54 96.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 58' ' ' VAL . 13.1 p -64.29 -29.92 70.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.761 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.89 HD21 ' CD2' ' A' ' 92' ' ' TYR . 8.8 mt -82.04 -18.84 41.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.807 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.49 -49.04 9.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.453 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.443 ' OD1' HG23 ' A' ' 58' ' ' VAL . 24.4 p30 -62.79 -33.18 74.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.278 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.738 HG21 ' CG2' ' A' ' 123' ' ' ILE . 92.3 t -73.16 -40.84 58.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.508 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' HA ' HD12 ' A' ' 62' ' ' ILE . 8.4 tttm -73.05 -33.38 65.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.581 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.44 91.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.76 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.2 mt -68.6 -41.78 83.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.647 HG21 HD11 ' A' ' 72' ' ' ILE . 12.8 mt -67.37 -38.83 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.696 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.8 -37.43 67.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.292 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.59 -20.2 66.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.514 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.15 19.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.985 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.15 47.89 0.79 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.429 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 129' ' ' ARG . 26.3 mt -149.05 136.09 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -87.91 163.25 16.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.161 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.716 ' HA ' HD13 ' A' ' 72' ' ' ILE . . . -54.71 -30.24 55.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.119 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.569 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -67.93 -22.16 65.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.249 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.04 -30.8 69.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 110.213 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.716 HD13 ' HA ' ' A' ' 69' ' ' ALA . 4.0 mp -67.21 108.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.623 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.636 ' HB ' HG21 ' B' ' 22' ' ' VAL . 6.6 m -78.88 -32.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.828 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.675 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 49.7 tttt -131.85 156.61 45.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.769 0.319 . . . . 0.0 110.918 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 125' ' ' ALA . 1.3 m -146.8 117.4 7.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.327 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 108' ' ' SER . 86.6 m -105.34 144.89 31.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.208 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.655 HG13 HD13 ' A' ' 123' ' ' ILE . 38.8 t -151.57 121.21 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 0.0 111.666 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.55 ' HB2' HD21 ' A' ' 115' ' ' LEU . 6.6 m-85 -95.85 118.88 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.274 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.607 HG11 ' CD1' ' A' ' 85' ' ' PHE . 13.5 m -110.54 151.98 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.187 0.518 . . . . 0.0 111.757 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -6.6 31.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.785 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.48 94.18 2.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.364 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 82' ' ' LEU . 4.8 mt -63.61 -13.93 46.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.271 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -27.94 53.12 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.84 -17.5 25.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.503 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.607 ' CD1' HG11 ' A' ' 79' ' ' VAL . 22.4 t80 -57.95 -24.53 58.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.93 -41.96 35.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.841 0.353 . . . . 0.0 111.378 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.2 -33.57 20.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.702 HG12 ' HE1' ' A' ' 92' ' ' TYR . 28.8 t -65.8 -54.52 26.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.665 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 17.1 t-20 -56.62 -43.95 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.972 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.96 70.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.786 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -34.91 77.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.89 ' CD2' HD21 ' A' ' 55' ' ' LEU . 53.3 m-85 -67.36 -45.9 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 0.0 110.156 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -25.36 66.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.335 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -77.0 -38.2 53.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.231 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -37.94 24.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.851 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 7.5 m-85 -53.36 -52.02 60.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.168 0.508 . . . . 0.0 110.225 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -30.33 70.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.318 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.66 3.22 53.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.642 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -116.34 -6.25 11.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.877 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.442 ' O ' ' CG ' ' A' ' 100' ' ' ASN . 0.2 OUTLIER 89.13 26.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.303 0.573 . . . . 0.0 110.505 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.569 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 12.9 t-160 -118.87 54.52 2.3 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.532 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.68 -18.64 32.57 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.702 2.268 . . . . 0.0 112.862 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.416 ' O ' ' CG1' ' B' ' 19' ' ' VAL . 1.9 m-20 -57.78 -39.26 77.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.85 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' B' ' 19' ' ' VAL . 8.1 m-85 81.07 123.36 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.427 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' A' ' 101' ' ' HIS . 97.1 Cg_endo -86.74 162.41 9.2 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.748 2.298 . . . . 0.0 112.707 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.675 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -56.45 140.74 44.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.533 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.443 ' HB2' ' HB3' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -102.07 138.45 39.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.032 0.444 . . . . 0.0 111.553 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.885 ' O ' HG23 ' A' ' 76' ' ' THR . 12.0 t -148.17 55.14 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.1 m -103.0 151.34 22.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.193 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.551 HG11 ' CD2' ' B' ' 78' ' ' PHE . 29.4 m -156.89 160.53 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 5.9 tt0 -86.98 94.21 9.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.87 171.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.216 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -84.41 -50.01 8.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.991 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.402 ' HB3' ' CB ' ' C' ' 111' ' ' GLU . 0.1 OUTLIER -146.13 171.36 15.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.731 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 122' ' ' GLU . 3.2 mt -143.49 160.05 52.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.575 ' O ' HG22 ' A' ' 119' ' ' VAL . 68.2 Cg_exo -50.83 135.93 42.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.506 2.137 . . . . 0.0 112.159 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.28 15.96 8.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.159 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 62.78 16.6 9.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.744 HG11 ' HB ' ' A' ' 34' ' ' ILE . 15.6 m -53.13 170.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.832 0.349 . . . . 0.0 111.147 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.543 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -101.9 -2.93 52.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.964 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.568 HD21 ' HG3' ' A' ' 50' ' ' GLN . 4.2 pp -175.92 148.49 0.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.899 0.381 . . . . 0.0 111.286 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -119.93 163.63 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.302 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.738 ' CG2' HG21 ' A' ' 58' ' ' VAL . 15.6 mm -139.75 129.93 30.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 111.862 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.86 119.04 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.082 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.529 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -133.88 161.95 33.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.03 0.443 . . . . 0.0 111.852 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.769 HD12 HD23 ' A' ' 29' ' ' LEU . 5.8 mm -111.93 150.65 14.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.474 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 1.074 ' HB3' HG13 ' A' ' 28' ' ' VAL . . . -127.43 157.86 38.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.038 0.447 . . . . 0.0 111.783 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 73' ' ' VAL . 34.6 m -130.04 116.25 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.891 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.728 ' HB2' HD21 ' A' ' 67' ' ' LEU . 75.6 ttt-85 -120.06 70.87 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.899 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ttt . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.781 0.324 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 3.8 mtm -141.14 159.91 41.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.989 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.524 ' CG2' HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER 59.85 109.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.974 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.53 122.69 7.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.515 HD13 HG12 ' B' ' 22' ' ' VAL . 39.2 mm -55.56 144.39 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.217 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.491 HD12 ' CB ' ' B' ' 21' ' ' ALA . 32.0 mt -109.44 143.41 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.156 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -146.98 141.76 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.09 159.35 43.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.16 28.48 4.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.977 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.18 -44.09 2.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.865 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -67.34 171.73 4.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.931 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.865 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 30.7 Cg_endo -63.81 -12.71 33.03 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.544 2.162 . . . . 0.0 112.612 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 69.82 147.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.378 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.792 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -106.14 123.19 47.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.792 HD13 ' O ' ' B' ' 14' ' ' ALA . 17.6 mm -131.92 17.01 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.834 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.25 -128.06 3.19 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.441 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.99 24.59 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.769 2.312 . . . . 0.0 113.494 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.725 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.7 OUTLIER -152.08 174.48 13.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.038 0.447 . . . . 0.0 111.758 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 104' ' ' PHE . 15.8 m -123.14 173.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.458 HE21 ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -59.48 -40.37 86.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.016 0.436 . . . . 0.0 110.505 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.491 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . 174.86 175.35 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.854 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.636 HG21 ' HB ' ' A' ' 73' ' ' VAL . 1.9 m -140.32 134.84 35.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.37 108.87 15.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.621 HD21 HG11 ' A' ' 73' ' ' VAL . 4.1 mm? -84.31 -16.86 41.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.01 -105.75 0.86 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -53.84 -30.16 44.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.076 0.465 . . . . 0.0 110.288 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.86 132.87 52.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.812 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.051 HG13 ' HB3' ' B' ' 127' ' ' ALA . 0.1 OUTLIER -131.37 151.97 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.66 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.782 HD23 HD12 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -144.2 139.98 29.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.812 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.3 p -106.09 141.36 37.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.425 ' HA ' ' HB1' ' A' ' 106' ' ' ALA . 79.1 p -69.3 156.1 39.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.087 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.97 94.05 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.521 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.658 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.5 mp0 -78.15 156.2 30.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 110.999 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.737 ' HB ' HG11 ' B' ' 119' ' ' VAL . 7.0 pt -136.06 146.64 57.4 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.981 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 53.5 Cg_endo -69.31 61.49 1.49 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.868 2.379 . . . . 0.0 112.733 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.591 HG23 HG13 ' B' ' 34' ' ' ILE . 60.0 t -68.07 85.97 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.105 0.478 . . . . 0.0 110.612 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' B' ' 36' ' ' VAL . 9.0 t-20 -29.46 121.2 0.29 Allowed Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.278 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.48 -15.14 43.62 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.344 2.029 . . . . 0.0 112.4 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.53 -15.87 10.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.21 -30.28 7.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.885 0.374 . . . . 0.0 110.964 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.64 52.63 9.57 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.449 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.447 ' O ' HG12 ' B' ' 119' ' ' VAL . 0.0 OUTLIER -174.62 -76.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.53 HG21 ' H ' ' B' ' 120' ' ' GLY . 11.3 p -174.29 123.22 0.39 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.08 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.61 140.46 51.85 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.294 1.996 . . . . 0.0 112.077 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.2 -30.9 60.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 111.046 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' B' ' 49' ' ' ALA . 0.2 OUTLIER -66.98 95.59 0.39 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.732 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.425 ' HA ' HD12 ' B' ' 47' ' ' ILE . 6.3 tp -45.06 -30.48 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.305 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.85 -38.68 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.452 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' B' ' 46' ' ' ASP . . . -60.88 -54.09 49.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.313 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.546 ' HG3' HD21 ' B' ' 121' ' ' LEU . 17.9 pt20 -62.66 -29.55 70.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.072 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.686 ' HB1' HG13 ' B' ' 88' ' ' VAL . . . -71.07 -34.94 71.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.802 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -80.83 -41.23 23.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.786 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -40.53 96.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.689 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.583 ' O ' HG23 ' B' ' 58' ' ' VAL . 13.0 p -64.24 -30.0 71.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.759 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.902 HD21 ' CD2' ' B' ' 92' ' ' TYR . 8.8 mt -82.05 -18.76 42.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.51 -49.1 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.409 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.432 ' OD1' HG23 ' B' ' 58' ' ' VAL . 24.8 p30 -62.66 -33.27 74.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.289 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.747 HG21 ' CG2' ' B' ' 123' ' ' ILE . 91.2 t -73.07 -40.87 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.967 0.413 . . . . 0.0 110.535 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.533 ' HA ' HD12 ' B' ' 62' ' ' ILE . 8.4 tttm -73.11 -33.31 65.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.573 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.43 91.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.71 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -68.61 -41.75 83.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.698 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.656 HG21 HD11 ' B' ' 72' ' ' ILE . 13.0 mt -67.36 -38.86 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.81 -37.45 67.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.281 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.53 -20.13 66.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.563 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.01 -25.1 18.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.971 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.14 47.87 0.8 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.733 HD21 ' HB2' ' B' ' 129' ' ' ARG . 26.4 mt -149.06 136.2 19.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.365 . . . . 0.0 110.813 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -88.05 163.27 16.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.151 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.719 ' HA ' HD13 ' B' ' 72' ' ' ILE . . . -54.73 -30.29 55.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.069 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.557 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -67.84 -22.12 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.285 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.21 -30.75 68.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 110.228 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.719 HD13 ' HA ' ' B' ' 69' ' ' ALA . 4.0 mp -67.23 108.58 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.705 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.624 HG13 HG22 ' B' ' 128' ' ' VAL . 6.5 m -78.94 -31.96 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.834 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.649 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 49.7 tttt -131.91 156.6 45.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.735 0.302 . . . . 0.0 110.96 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.541 HG23 ' HB2' ' B' ' 125' ' ' ALA . 1.3 m -146.81 117.4 7.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.309 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.873 HG23 ' O ' ' B' ' 108' ' ' SER . 86.7 m -105.38 144.88 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.235 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.63 HG13 HD13 ' B' ' 123' ' ' ILE . 38.8 t -151.5 121.22 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.946 0.403 . . . . 0.0 111.735 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.551 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.5 m-85 -95.84 118.84 33.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.25 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.614 HG11 ' CD1' ' B' ' 85' ' ' PHE . 13.5 m -110.52 152.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 0.0 111.78 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -6.58 31.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.715 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -149.66 94.25 2.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.347 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' B' ' 82' ' ' LEU . 4.7 mt -63.57 -13.97 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.31 -27.9 53.1 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.79 -17.55 25.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.519 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' B' ' 79' ' ' VAL . 22.2 t80 -57.96 -24.43 57.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.222 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.03 -41.96 36.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.799 0.333 . . . . 0.0 111.354 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.17 -33.52 20.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.696 HG12 ' HE1' ' B' ' 92' ' ' TYR . 28.4 t -65.84 -54.59 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.41 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 17.1 t-20 -56.62 -43.91 80.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.998 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.96 70.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.729 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -34.9 77.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.902 ' CD2' HD21 ' B' ' 55' ' ' LEU . 52.9 m-85 -67.38 -45.92 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.147 0.499 . . . . 0.0 110.119 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -25.41 66.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.403 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -76.96 -38.25 53.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.228 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.1 OUTLIER -82.56 -37.99 24.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.812 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' B' ' 92' ' ' TYR . 7.5 m-85 -53.32 -52.03 60.46 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.185 0.517 . . . . 0.0 110.265 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -30.27 70.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.337 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.58 3.19 53.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.6 OUTLIER -116.39 -6.17 11.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.871 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 0.2 OUTLIER 89.08 25.82 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.326 0.584 . . . . 0.0 110.495 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.557 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 12.8 t-160 -118.63 54.52 2.18 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.492 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CZ ' ' B' ' 104' ' ' PHE . 58.1 Cg_endo -70.65 -18.65 32.68 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.687 2.258 . . . . 0.0 112.862 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.42 ' O ' ' CG1' ' C' ' 19' ' ' VAL . 1.9 m-20 -57.77 -39.24 76.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.773 0.32 . . . . 0.0 110.819 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.503 ' HB2' HG13 ' C' ' 19' ' ' VAL . 8.1 m-85 81.02 123.27 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.494 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' B' ' 101' ' ' HIS . 97.1 Cg_endo -86.72 162.37 9.22 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.746 2.297 . . . . 0.0 112.648 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.649 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -56.37 140.71 44.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.553 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -102.07 138.45 39.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.08 0.467 . . . . 0.0 111.503 -179.409 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.873 ' O ' HG23 ' B' ' 76' ' ' THR . 12.0 t -148.2 55.16 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.009 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 5.1 m -102.99 151.37 22.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.187 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.533 HG11 ' CD2' ' C' ' 78' ' ' PHE . 29.5 m -156.89 160.75 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.102 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 5.8 tt0 -87.14 94.3 9.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.94 171.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.253 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -84.34 -50.14 8.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.02 171.39 14.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.742 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.819 HD22 ' HB2' ' B' ' 122' ' ' GLU . 3.2 mt -143.57 160.01 52.44 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.812 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.579 ' O ' HG22 ' B' ' 119' ' ' VAL . 68.7 Cg_exo -50.78 135.89 42.6 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.558 2.172 . . . . 0.0 112.137 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.31 15.98 8.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.064 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 62.82 16.54 9.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.021 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.737 HG11 ' HB ' ' B' ' 34' ' ' ILE . 15.6 m -53.13 170.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.832 0.349 . . . . 0.0 111.177 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' GLY . . . . . 0.53 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -101.98 -3.1 51.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.988 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' B' ' 50' ' ' GLN . 4.2 pp -175.76 148.37 0.87 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 111.255 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.819 ' HB2' HD22 ' B' ' 115' ' ' LEU . 0.0 OUTLIER -119.86 163.69 17.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.326 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.747 ' CG2' HG21 ' B' ' 58' ' ' VAL . 15.7 mm -139.77 129.89 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 111.881 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.87 118.99 5.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.074 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -133.84 161.91 33.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.979 0.419 . . . . 0.0 111.884 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.782 HD12 HD23 ' B' ' 29' ' ' LEU . 5.8 mm -111.86 150.6 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.515 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 1.051 ' HB3' HG13 ' B' ' 28' ' ' VAL . . . -127.4 157.85 38.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 111.764 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.624 HG22 HG13 ' B' ' 73' ' ' VAL . 34.1 m -130.0 116.24 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.837 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.733 ' HB2' HD21 ' B' ' 67' ' ' LEU . 75.7 ttt-85 -120.06 70.88 0.88 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.999 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.89 179.968 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 16.4 ttt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.793 0.33 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 3.8 mtm -141.17 159.8 41.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.507 ' CG2' HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER 59.91 109.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.6 122.73 7.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.5 HD13 HG12 ' C' ' 22' ' ' VAL . 39.1 mm -55.65 144.42 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.176 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.534 HD12 ' CB ' ' C' ' 21' ' ' ALA . 32.5 mt -109.52 143.46 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -146.99 141.73 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.0 159.39 43.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.15 28.5 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.33 -44.18 2.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.712 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.87 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.26 171.74 4.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.036 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.87 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 30.7 Cg_endo -63.8 -12.74 33.12 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.567 2.178 . . . . 0.0 112.615 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 69.88 147.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.322 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.803 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -106.14 123.22 47.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.053 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.803 HD13 ' O ' ' C' ' 14' ' ' ALA . 17.6 mm -131.94 17.03 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.857 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.24 -128.05 3.19 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.399 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -90.1 24.63 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.769 2.313 . . . . 0.0 113.444 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.736 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.7 OUTLIER -152.06 174.52 13.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.093 0.473 . . . . 0.0 111.727 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' B' ' 104' ' ' PHE . 15.8 m -123.12 173.28 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.802 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.469 HE21 ' HB3' ' C' ' 11' ' ' ALA . 0.0 OUTLIER -59.52 -39.94 85.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 110.374 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . 174.75 175.44 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.852 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.615 HG21 ' HB ' ' B' ' 73' ' ' VAL . 1.9 m -140.33 134.79 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.32 108.9 15.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.62 HD21 HG11 ' B' ' 73' ' ' VAL . 4.1 mm? -84.27 -16.9 41.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.96 -105.74 0.86 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.0 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -53.88 -30.13 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.082 0.468 . . . . 0.0 110.253 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.94 132.8 52.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.858 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 1.031 HG13 ' HB3' ' C' ' 127' ' ' ALA . 0.1 OUTLIER -131.29 152.06 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.656 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.799 HD23 HD12 ' C' ' 126' ' ' ILE . 0.4 OUTLIER -144.22 139.95 28.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.838 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 25.5 p -106.15 141.46 37.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.773 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 79.6 p -69.17 155.82 39.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.97 94.08 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.481 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.643 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.5 mp0 -78.17 156.07 30.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 111.02 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.756 ' HB ' HG11 ' C' ' 119' ' ' VAL . 7.0 pt -135.94 146.69 57.87 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.467 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 53.1 Cg_endo -69.37 61.51 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.821 2.347 . . . . 0.0 112.756 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.589 HG23 HG13 ' C' ' 34' ' ' ILE . 59.8 t -68.03 85.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 0.0 110.602 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' C' ' 38' ' ' PRO . 9.1 t-20 -29.48 121.22 0.29 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.201 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 37' ' ' ASN . 25.6 Cg_exo -62.53 -15.12 43.69 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.338 2.025 . . . . 0.0 112.374 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.56 -15.83 10.81 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.29 -30.13 7.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.818 0.342 . . . . 0.0 110.979 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.54 52.65 9.75 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.381 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.519 ' O ' HG12 ' C' ' 119' ' ' VAL . 0.0 OUTLIER -174.59 -76.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.784 0.326 . . . . 0.0 111.215 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.574 HG21 ' H ' ' C' ' 120' ' ' GLY . 11.3 p -174.28 123.19 0.39 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.55 140.42 52.02 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.315 2.01 . . . . 0.0 112.077 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.14 -30.98 60.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.019 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -66.95 95.6 0.38 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.698 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' C' ' 47' ' ' ILE . 6.3 tp -45.02 -30.52 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.29 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.86 -38.62 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.496 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' C' ' 46' ' ' ASP . . . -60.96 -53.93 51.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.292 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' C' ' 121' ' ' LEU . 17.9 pt20 -62.97 -29.53 70.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.052 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' C' ' 88' ' ' VAL . . . -71.34 -35.06 71.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.959 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -80.81 -41.19 23.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.754 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -40.47 96.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.662 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.597 ' O ' HG23 ' C' ' 58' ' ' VAL . 13.3 p -64.27 -30.06 71.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.906 HD21 ' CD2' ' C' ' 92' ' ' TYR . 8.8 mt -81.98 -18.81 42.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.53 -49.02 9.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.424 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' ASN . . . . . 0.434 ' OD1' HG23 ' C' ' 58' ' ' VAL . 24.4 p30 -62.75 -33.24 74.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.263 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.748 HG21 ' CG2' ' C' ' 123' ' ' ILE . 91.6 t -73.1 -40.88 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.381 . . . . 0.0 110.54 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.531 ' HA ' HD12 ' C' ' 62' ' ' ILE . 8.3 tttm -73.05 -33.28 65.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.639 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.55 92.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.775 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -68.63 -41.78 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.742 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.646 HD13 HD11 ' C' ' 72' ' ' ILE . 12.9 mt -67.41 -38.8 81.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.734 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.86 -37.39 67.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.275 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.52 -20.21 66.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.589 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.18 19.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.2 47.91 0.79 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.41 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.734 HD13 HG11 ' C' ' 28' ' ' VAL . 26.3 mt -149.08 136.15 19.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 110.846 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -88.02 163.23 16.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.157 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.734 ' HA ' HD13 ' C' ' 72' ' ' ILE . . . -54.7 -30.2 55.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.137 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.568 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -67.8 -22.14 65.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.244 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.13 -30.77 69.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.985 0.422 . . . . 0.0 110.181 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.734 HD13 ' HA ' ' C' ' 69' ' ' ALA . 4.0 mp -67.25 108.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.684 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.62 HG13 HG22 ' C' ' 128' ' ' VAL . 6.5 m -79.04 -31.92 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.826 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.68 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 49.7 tttt -131.91 156.54 45.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.946 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.537 HG23 ' HB2' ' C' ' 125' ' ' ALA . 1.3 m -146.76 117.44 7.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.306 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.885 HG23 ' O ' ' C' ' 108' ' ' SER . 86.4 m -105.35 144.95 31.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.219 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.663 HG13 HD13 ' C' ' 123' ' ' ILE . 38.8 t -151.59 121.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.391 . . . . 0.0 111.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.549 ' HB2' HD21 ' C' ' 115' ' ' LEU . 6.4 m-85 -95.74 118.81 33.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.323 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' C' ' 85' ' ' PHE . 13.4 m -110.56 151.96 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.148 0.499 . . . . 0.0 111.737 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.12 -6.74 30.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.758 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.41 94.24 2.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.342 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' C' ' 82' ' ' LEU . 4.8 mt -63.61 -14.01 47.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.247 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.34 -27.91 52.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.74 -17.57 25.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.526 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.615 ' CD1' HG11 ' C' ' 79' ' ' VAL . 22.3 t80 -58.02 -24.38 58.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.198 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.02 -41.94 36.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.841 0.353 . . . . 0.0 111.393 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.15 -33.59 20.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.766 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.698 HG12 ' HE1' ' C' ' 92' ' ' TYR . 29.4 t -65.88 -54.54 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.571 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ASN . . . . . 0.409 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 17.1 t-20 -56.58 -43.96 80.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.976 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.06 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.795 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.63 -34.89 77.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.906 ' CD2' HD21 ' C' ' 55' ' ' LEU . 53.4 m-85 -67.35 -45.92 74.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.154 0.502 . . . . 0.0 110.112 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.83 -25.45 66.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.378 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -76.98 -38.24 53.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.235 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.1 OUTLIER -82.54 -37.96 24.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.819 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' C' ' 92' ' ' TYR . 7.5 m-85 -53.35 -52.01 60.6 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.201 0.524 . . . . 0.0 110.247 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -30.3 70.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.298 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.6 3.1 53.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.666 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.6 OUTLIER -116.3 -6.23 11.81 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.889 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.435 ' O ' ' CG ' ' C' ' 100' ' ' ASN . 0.2 OUTLIER 89.16 26.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.305 0.574 . . . . 0.0 110.516 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.568 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 12.9 t-160 -118.82 54.62 2.31 Favored Pre-proline 0 CA--C 1.529 0.154 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.529 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.403 ' O ' ' CE1' ' C' ' 104' ' ' PHE . 58.4 Cg_endo -70.69 -18.69 32.47 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.726 2.284 . . . . 0.0 112.868 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.409 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 1.9 m-20 -57.77 -39.2 76.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.76 0.314 . . . . 0.0 110.849 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.502 ' HB2' HG13 ' A' ' 19' ' ' VAL . 8.1 m-85 81.05 123.26 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.463 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.426 ' HD3' ' CE1' ' C' ' 101' ' ' HIS . 98.1 Cg_endo -86.7 162.3 9.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.779 2.319 . . . . 0.0 112.713 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.68 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -56.35 140.81 44.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.565 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -102.15 138.37 39.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.057 0.456 . . . . 0.0 111.502 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 108' ' ' SER . . . . . 0.885 ' O ' HG23 ' C' ' 76' ' ' THR . 12.0 t -148.14 55.26 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.058 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -103.09 151.35 22.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.17 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.523 HG11 ' CD2' ' A' ' 78' ' ' PHE . 29.3 m -156.98 160.74 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.123 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 6.0 tt0 -87.04 94.17 9.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.8 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.88 171.19 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.237 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -84.4 -49.99 8.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.029 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.14 171.35 15.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.809 HD22 ' HB2' ' C' ' 122' ' ' GLU . 3.2 mt -143.51 160.02 52.6 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.833 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.579 ' O ' HG22 ' C' ' 119' ' ' VAL . 69.9 Cg_exo -50.92 135.9 43.63 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.477 2.118 . . . . 0.0 112.149 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.32 16.01 8.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.103 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 62.8 16.58 9.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.987 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.756 HG11 ' HB ' ' C' ' 34' ' ' ILE . 15.7 m -53.16 170.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.819 0.342 . . . . 0.0 111.163 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 120' ' ' GLY . . . . . 0.574 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -101.88 -3.23 52.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.997 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.557 HD21 ' HG3' ' C' ' 50' ' ' GLN . 4.2 pp -175.72 148.29 0.87 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.219 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.809 ' HB2' HD22 ' C' ' 115' ' ' LEU . 0.0 OUTLIER -119.87 163.65 17.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.278 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.748 ' CG2' HG21 ' C' ' 58' ' ' VAL . 15.6 mm -139.78 129.87 30.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.894 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.82 118.98 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.172 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.537 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -133.77 161.99 33.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 0.0 111.871 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.799 HD12 HD23 ' C' ' 29' ' ' LEU . 5.8 mm -111.97 150.65 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.471 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 1.031 ' HB3' HG13 ' C' ' 28' ' ' VAL . . . -127.42 157.89 38.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.043 0.449 . . . . 0.0 111.804 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.62 HG22 HG13 ' C' ' 73' ' ' VAL . 34.2 m -130.09 116.26 36.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.866 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.73 ' HB2' HD21 ' C' ' 67' ' ' LEU . 75.7 ttt-85 -120.07 70.89 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.978 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.887 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mtp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.87 0.367 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.16 175.47 6.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.524 HG21 HG21 ' C' ' 128' ' ' VAL . 11.1 m 61.32 114.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.581 ' NE2' ' HB ' ' C' ' 73' ' ' VAL . 3.0 mm100 63.2 -165.74 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.258 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.2 mp 70.25 118.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.671 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.785 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 22.3 mt -152.99 74.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.678 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -84.76 145.49 27.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 61' ' ' ILE . 1.7 t -149.83 153.46 36.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.71 35.83 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.412 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . 11.5 mmtt -121.13 -38.07 2.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.74 110.65 46.78 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.192 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.28 -16.41 46.56 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.516 2.144 . . . . 0.0 112.469 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.15 -167.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.221 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.502 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 64.87 -165.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.435 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.6 mt 79.61 17.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.119 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.91 -134.64 4.22 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.223 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.64 28.59 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.724 2.283 . . . . 0.0 113.098 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -162.3 177.28 9.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' C' ' 104' ' ' PHE . 33.6 m -106.07 162.3 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.22 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.426 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 3.6 mt-30 -55.65 -52.8 62.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.135 0.493 . . . . 0.0 110.442 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.785 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -158.44 -172.75 3.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.166 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 4' ' ' GLN . 27.6 m -145.51 130.36 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.025 0.44 . . . . 0.0 111.851 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.488 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 48.0 t0 -108.69 102.88 11.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.3 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.722 HD11 HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -66.74 -14.17 62.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 111.188 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.02 -93.08 0.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -61.26 -28.82 69.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.249 0.547 . . . . 0.0 109.593 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.97 140.49 47.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.417 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.899 HG23 ' HB3' ' A' ' 127' ' ' ALA . 2.8 m -105.05 -179.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.197 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.722 HD12 HD11 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -165.89 136.78 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -108.64 135.78 49.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.744 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.2 p -81.07 177.16 9.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.49 95.67 0.1 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.544 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.67 150.95 47.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.906 0.384 . . . . 0.0 111.053 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.748 HG23 HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -129.06 121.91 20.96 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.869 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.4 Cg_exo -67.76 58.96 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.695 2.263 . . . . 0.0 113.094 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.748 HG23 HG23 ' A' ' 34' ' ' ILE . 93.0 t -69.9 85.58 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.322 0.582 . . . . 0.0 110.639 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.904 ' HB3' HG22 ' A' ' 40' ' ' THR . 52.4 t30 -43.84 129.89 4.14 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.805 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.89 -9.64 26.1 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.988 1.792 . . . . 0.0 111.558 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.671 ' HB3' ' ND2' ' A' ' 37' ' ' ASN . . . -97.44 -32.97 11.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.625 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.904 HG22 ' HB3' ' A' ' 37' ' ' ASN . 11.6 t -117.71 -27.83 6.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.834 0.35 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 78.56 60.29 2.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.704 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.896 ' HG2' HG23 ' A' ' 40' ' ' THR . 0.3 OUTLIER 179.23 -76.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.756 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.78 ' HB ' HG12 ' A' ' 119' ' ' VAL . 11.2 p -160.96 118.44 1.44 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.234 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.56 140.96 94.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.415 2.077 . . . . 0.0 112.251 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.8 -31.1 72.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 0.0 110.929 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.54 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 1.3 m-20 -73.5 93.1 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.8 mm -42.49 -31.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.114 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.37 -42.52 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.788 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . . . -65.98 -44.72 84.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.551 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.78 67.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.449 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.28 -40.84 67.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.86 -32.59 57.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.36 -41.14 76.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.1 t -64.27 -38.91 92.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.32 -41.18 77.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.34 -44.06 92.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -60.77 -37.26 81.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.8 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.966 HG21 HG21 ' A' ' 123' ' ' ILE . 26.3 t -63.0 -45.97 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HA ' HD12 ' A' ' 62' ' ' ILE . 7.5 mttt -71.97 -32.62 67.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.782 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.412 ' HB1' ' CB ' ' A' ' 10' ' ' LYS . . . -60.44 -39.51 87.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.557 HG22 ' CG2' ' A' ' 6' ' ' ILE . 4.2 mt -70.04 -40.76 78.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.011 HD13 HD11 ' A' ' 72' ' ' ILE . 8.6 mt -70.5 -34.6 58.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.421 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -69.99 -42.61 72.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.402 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -15.73 63.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.595 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 6' ' ' ILE . . . -87.99 -33.64 18.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.942 0.401 . . . . 0.0 110.627 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.24 41.42 0.36 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.793 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.762 HD21 ' HG3' ' A' ' 129' ' ' ARG . 63.9 mt -150.25 -177.55 6.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.733 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.08 164.88 28.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.799 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -52.75 -35.02 55.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -60.86 -22.35 64.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.216 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 128' ' ' VAL . 6.9 m-20 -81.03 -18.49 46.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.767 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 62' ' ' ILE . 28.2 mm -58.44 123.61 10.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.868 HG11 HG13 ' A' ' 128' ' ' VAL . 34.8 m -92.63 -27.4 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.382 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.49 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 36.8 tttm -150.49 164.69 35.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -156.4 113.27 3.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.777 0.322 . . . . 0.0 111.526 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -100.02 152.41 20.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.303 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.422 HG13 HD13 ' A' ' 123' ' ' ILE . 21.2 t -151.74 127.36 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.821 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CE2' ' OE1' ' A' ' 124' ' ' GLU . 10.6 m-85 -105.39 115.54 30.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.328 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 85' ' ' PHE . 4.8 m -105.49 148.57 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.638 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.76 -4.52 56.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.051 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -164.59 134.23 3.8 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.549 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' B' ' 114' ' ' ARG . 1.0 OUTLIER -70.9 -8.89 56.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.274 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.35 -24.23 23.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.791 0.329 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -75.44 -22.3 57.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.084 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.576 ' CD2' HG11 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -61.68 -18.2 58.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.448 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.13 -41.12 68.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.852 0.358 . . . . 0.0 111.271 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -27.8 22.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.983 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.3 t -73.71 -47.07 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.25 -40.08 95.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.407 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.16 84.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.947 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -87.89 -28.25 21.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.554 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 95' ' ' PHE . 81.0 t80 -53.39 -44.74 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.945 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -86.9 -25.26 24.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -21.36 60.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.473 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.446 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -91.13 -33.62 15.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.863 0.363 . . . . 0.0 110.613 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.457 ' CZ ' ' CG ' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -56.45 -58.01 9.85 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.316 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -64.58 -30.74 71.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.006 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -78.16 -9.23 59.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.233 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.667 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 3.5 m120 -109.82 -5.01 15.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.393 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 21.9 m-80 84.5 38.58 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.759 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -130.69 68.86 82.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.337 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 1.4 Cg_endo -82.35 -17.46 7.67 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.971 2.447 . . . . 0.0 112.824 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 1.2 t-20 -59.27 -36.78 76.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.878 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 27.9 m-85 78.76 114.77 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.395 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' CG ' ' CZ ' ' A' ' 96' ' ' PHE . 62.3 Cg_endo -87.2 163.12 8.53 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.164 2.576 . . . . 0.0 112.147 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.46 175.6 0.23 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -173.0 163.48 4.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.331 0.586 . . . . 0.0 112.049 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.89 83.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.032 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.457 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 14.1 p -89.4 123.63 33.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.492 HG12 HD23 ' B' ' 115' ' ' LEU . 35.6 m -142.89 148.68 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.297 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.867 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.8 OUTLIER -81.69 97.34 7.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.824 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.46 160.43 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.152 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.861 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -69.61 -45.65 68.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.023 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.491 ' HB3' HD12 ' C' ' 82' ' ' LEU . 6.3 mtt-85 -156.89 176.98 12.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.824 HD22 ' HB2' ' A' ' 122' ' ' GLU . 12.8 mt -145.27 160.65 44.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.811 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.495 ' O ' HG22 ' A' ' 119' ' ' VAL . 69.2 Cg_exo -51.04 135.75 44.46 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.545 2.163 . . . . 0.0 112.218 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.607 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.1 OUTLIER 72.3 14.45 5.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.226 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.24 14.24 9.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.212 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.78 HG12 ' HB ' ' A' ' 43' ' ' VAL . 27.7 m -57.57 171.22 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.865 0.364 . . . . 0.0 111.162 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.21 21.96 16.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.474 HD21 HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -176.37 156.91 1.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.12 0.486 . . . . 0.0 111.213 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.824 ' HB2' HD22 ' A' ' 115' ' ' LEU . 6.2 tt0 -149.89 156.34 41.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.966 HG21 HG21 ' A' ' 58' ' ' VAL . 22.8 mm -133.41 136.73 54.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.153 0.502 . . . . 0.0 112.109 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 6.6 pt-20 -155.48 106.6 2.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.298 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.676 ' HB2' HG22 ' A' ' 75' ' ' THR . . . -129.05 175.28 8.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.258 0.552 . . . . 0.0 112.374 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.705 HG23 ' HG ' ' A' ' 29' ' ' LEU . 3.1 mt -125.71 157.81 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.1 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.994 ' HB2' HD13 ' A' ' 72' ' ' ILE . . . -148.8 149.11 30.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.97 0.414 . . . . 0.0 111.459 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.868 HG13 HG11 ' A' ' 73' ' ' VAL . 3.3 m -96.96 156.43 3.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.077 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.762 ' HG3' HD21 ' A' ' 67' ' ' LEU . 54.2 ttt-85 -151.43 51.58 0.83 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.887 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mtp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.885 0.374 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.14 175.4 6.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.522 HG21 HG21 ' A' ' 128' ' ' VAL . 11.1 m 61.36 114.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.555 ' NE2' ' HB ' ' A' ' 73' ' ' VAL . 2.9 mm100 63.27 -165.77 0.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.258 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.474 ' N ' HD12 ' B' ' 5' ' ' ILE . 1.2 mp 70.29 118.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.644 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.77 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 22.3 mt -153.02 74.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.648 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -84.67 145.48 27.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.507 HG21 ' HA ' ' B' ' 61' ' ' ILE . 1.7 t -149.85 153.4 36.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.65 35.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.417 ' CB ' ' HB1' ' B' ' 60' ' ' ALA . 11.5 mmtt -121.18 -38.05 2.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.73 110.71 47.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.193 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.27 -16.5 47.06 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.511 2.14 . . . . 0.0 112.447 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.08 -167.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.262 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.501 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 64.89 -165.09 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.369 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.586 HG22 ' O ' ' B' ' 15' ' ' ILE . 2.6 mt 79.65 17.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.102 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.91 -134.59 4.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.201 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -87.7 28.6 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.712 2.275 . . . . 0.0 113.089 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -162.28 177.37 9.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 111.201 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 104' ' ' PHE . 33.7 m -106.11 162.33 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.18 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.437 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 3.6 mt-30 -55.55 -52.65 63.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.221 0.534 . . . . 0.0 110.453 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.77 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -158.65 -172.72 3.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.189 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' B' ' 4' ' ' GLN . 27.7 m -145.53 130.41 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.059 0.457 . . . . 0.0 111.745 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.482 ' CG ' HG12 ' B' ' 28' ' ' VAL . 47.9 t0 -108.76 102.84 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.278 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.708 HD11 HD12 ' B' ' 29' ' ' LEU . 0.5 OUTLIER -66.74 -14.12 62.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.17 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.01 -93.05 0.59 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -61.27 -28.82 69.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 140.45 47.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.426 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.887 HG23 ' HB3' ' B' ' 127' ' ' ALA . 2.8 m -105.08 -179.25 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.183 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.708 HD12 HD11 ' B' ' 24' ' ' LEU . 0.2 OUTLIER -165.82 136.78 3.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 66.7 p -108.68 135.64 49.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 42.8 p -80.88 177.25 9.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.48 95.62 0.1 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.537 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.65 150.94 47.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.908 0.385 . . . . 0.0 111.086 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.752 HG23 HG23 ' B' ' 36' ' ' VAL . 0.6 OUTLIER -129.12 121.97 20.94 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.823 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.81 58.93 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.719 2.28 . . . . 0.0 113.037 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.752 HG23 HG23 ' B' ' 34' ' ' ILE . 93.3 t -69.88 85.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.281 0.562 . . . . 0.0 110.576 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.896 ' HB3' HG22 ' B' ' 40' ' ' THR . 52.2 t30 -43.83 129.82 4.14 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.807 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.82 -9.68 26.22 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 121.969 1.779 . . . . 0.0 111.542 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.68 ' HB3' ' ND2' ' B' ' 37' ' ' ASN . . . -97.42 -33.02 11.56 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.647 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.896 HG22 ' HB3' ' B' ' 37' ' ' ASN . 11.6 t -117.67 -27.95 6.14 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.866 0.365 . . . . 0.0 111.041 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 78.83 60.27 2.63 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.755 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.881 ' HG2' HG23 ' B' ' 40' ' ' THR . 0.2 OUTLIER 179.22 -76.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.723 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.758 ' HB ' HG12 ' B' ' 119' ' ' VAL . 11.2 p -161.01 118.49 1.44 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.173 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.68 141.07 95.37 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.364 2.043 . . . . 0.0 112.188 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.79 -31.21 72.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.554 ' HB2' ' HB3' ' B' ' 49' ' ' ALA . 1.3 m-20 -73.43 93.09 1.92 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mm -42.48 -31.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.125 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.47 -42.5 21.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.723 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' B' ' 46' ' ' ASP . . . -65.99 -44.72 84.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.565 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.71 67.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.526 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.88 67.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.82 -32.64 57.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.32 -41.17 77.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.748 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.739 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.1 t -64.23 -38.9 92.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.788 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.33 -41.2 76.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.36 -43.99 92.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -60.79 -37.29 81.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.758 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.984 HG21 HG21 ' B' ' 123' ' ' ILE . 26.5 t -63.04 -46.01 97.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' B' ' 62' ' ' ILE . 7.4 mttt -71.92 -32.64 67.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.808 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.417 ' HB1' ' CB ' ' B' ' 10' ' ' LYS . . . -60.42 -39.53 87.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.55 HG22 ' CG2' ' B' ' 6' ' ' ILE . 4.2 mt -70.18 -40.77 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.839 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.95 HD13 HD11 ' B' ' 72' ' ' ILE . 8.6 mt -70.54 -34.59 58.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.391 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -69.98 -42.68 72.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.362 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -15.82 63.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.677 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' B' ' 6' ' ' ILE . . . -87.96 -33.62 18.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.632 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.28 41.39 0.36 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.812 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.746 HD21 ' HG3' ' B' ' 129' ' ' ARG . 64.2 mt -150.32 -177.57 6.02 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.004 0.43 . . . . 0.0 110.714 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.04 164.89 28.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.8 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.635 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -52.74 -35.11 55.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.941 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -60.79 -22.24 63.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.208 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.512 ' O ' HG22 ' B' ' 128' ' ' VAL . 6.9 m-20 -81.09 -18.43 46.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.787 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 1.008 HD13 ' HB2' ' B' ' 127' ' ' ALA . 28.2 mm -58.53 123.65 10.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.857 HG11 HG13 ' B' ' 128' ' ' VAL . 34.9 m -92.69 -27.37 4.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.368 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.496 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 36.7 tttm -150.45 164.73 35.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.661 HG22 ' HB2' ' B' ' 125' ' ' ALA . 0.2 OUTLIER -156.48 113.23 3.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.727 0.299 . . . . 0.0 111.481 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -99.97 152.44 20.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.417 HG13 HD13 ' B' ' 123' ' ' ILE . 21.2 t -151.77 127.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.984 0.421 . . . . 0.0 111.801 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.403 ' CE2' ' OE1' ' B' ' 124' ' ' GLU . 10.5 m-85 -105.39 115.54 30.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.279 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.565 HG11 ' CD2' ' B' ' 85' ' ' PHE . 4.9 m -105.51 148.52 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.634 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.7 -4.63 56.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.978 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -164.65 134.18 3.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.609 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.87 -8.89 56.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.248 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.29 -24.28 23.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.804 0.335 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -75.42 -22.25 57.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.565 ' CD2' HG11 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -61.7 -18.2 58.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.406 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.21 -41.09 68.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.804 0.335 . . . . 0.0 111.27 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -27.84 22.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' B' ' 92' ' ' TYR . 27.5 t -73.67 -47.11 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.941 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.15 -40.18 95.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.426 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.97 -40.21 84.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.945 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.09 -28.18 21.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.538 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 81.3 t80 -53.4 -44.79 68.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.9 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -86.9 -25.17 24.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.052 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -21.37 60.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.455 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 1.0 OUTLIER -91.1 -33.69 15.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 110.623 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.444 ' CZ ' ' CG ' ' B' ' 105' ' ' PRO . 0.8 OUTLIER -56.39 -58.09 9.51 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.317 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -64.5 -30.72 71.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.051 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -78.17 -9.31 59.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.209 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' B' ' 69' ' ' ALA . 3.5 m120 -109.83 -4.97 15.7 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.389 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.685 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 21.9 m-80 84.53 38.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.812 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' B' ' 69' ' ' ALA . 0.8 OUTLIER -130.68 68.92 82.17 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.343 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.33 -17.48 7.69 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.006 2.471 . . . . 0.0 112.857 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 1.2 t-20 -59.25 -36.84 76.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 0.0 110.867 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.55 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 28.0 m-85 78.75 114.73 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.475 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.444 ' CG ' ' CZ ' ' B' ' 96' ' ' PHE . 62.4 Cg_endo -87.22 163.04 8.51 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.167 2.578 . . . . 0.0 112.108 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.38 175.59 0.23 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' B' ' 75' ' ' THR . 0.9 OUTLIER -173.02 163.55 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.317 0.58 . . . . 0.0 112.078 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.94 83.87 1.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.089 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' CYS . . . . . 0.442 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 14.5 p -89.38 123.68 33.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.081 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.445 HG12 HD23 ' C' ' 115' ' ' LEU . 35.6 m -143.12 149.19 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.379 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.838 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.8 OUTLIER -81.85 97.15 7.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.644 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.35 160.34 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.867 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -69.6 -45.58 68.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.026 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.514 ' HB3' HD12 ' A' ' 82' ' ' LEU . 6.3 mtt-85 -156.94 176.92 12.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' B' ' 122' ' ' GLU . 12.7 mt -145.24 160.64 45.03 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.86 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.495 ' O ' HG22 ' B' ' 119' ' ' VAL . 69.7 Cg_exo -51.07 135.76 44.68 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.511 2.141 . . . . 0.0 112.249 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.608 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.1 OUTLIER 72.23 14.51 5.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.223 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.26 14.24 9.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.145 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.758 HG12 ' HB ' ' B' ' 43' ' ' VAL . 27.7 m -57.56 171.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.879 0.371 . . . . 0.0 111.13 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.05 22.08 16.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.568 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.486 ' C ' HD13 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -176.26 156.78 1.67 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.107 0.48 . . . . 0.0 111.151 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' B' ' 115' ' ' LEU . 6.2 tt0 -149.84 156.39 41.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.104 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.984 HG21 HG21 ' B' ' 58' ' ' VAL . 22.7 mm -133.4 136.69 54.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.194 0.521 . . . . 0.0 112.091 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' GLU . . . . . 0.403 ' OE1' ' CE2' ' B' ' 78' ' ' PHE . 6.6 pt-20 -155.5 106.55 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.329 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.661 ' HB2' HG22 ' B' ' 75' ' ' THR . . . -128.99 175.31 8.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.307 0.575 . . . . 0.0 112.37 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.7 HG23 ' HG ' ' B' ' 29' ' ' LEU . 3.1 mt -125.68 157.89 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.134 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 1.008 ' HB2' HD13 ' B' ' 72' ' ' ILE . . . -148.97 149.08 30.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.0 0.429 . . . . 0.0 111.424 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.857 HG13 HG11 ' B' ' 73' ' ' VAL . 3.3 m -96.96 156.4 3.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.049 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.746 ' HG3' HD21 ' B' ' 67' ' ' LEU . 54.2 ttt-85 -151.35 51.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.86 0.362 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.16 175.48 6.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.513 HG21 HG21 ' B' ' 128' ' ' VAL . 11.1 m 61.35 114.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.578 ' NE2' ' HB ' ' B' ' 73' ' ' VAL . 3.0 mm100 63.24 -165.76 0.23 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.292 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.483 HD12 ' N ' ' C' ' 5' ' ' ILE . 1.2 mp 70.26 118.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.613 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.79 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 22.3 mt -153.05 74.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.674 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -84.67 145.56 27.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.216 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.514 HG21 ' HA ' ' C' ' 61' ' ' ILE . 1.7 t -149.91 153.38 36.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.69 35.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.422 ' CB ' ' HB1' ' C' ' 60' ' ' ALA . 11.5 mmtt -121.09 -38.06 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.87 110.79 47.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.147 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.33 -16.39 46.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.506 2.137 . . . . 0.0 112.444 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' C' ' 34' ' ' ILE . . . -57.15 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.243 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.502 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 64.78 -165.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.38 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.591 HG22 ' O ' ' C' ' 15' ' ' ILE . 2.6 mt 79.72 17.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.034 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.89 -134.6 4.22 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.3 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -87.64 28.61 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.784 2.323 . . . . 0.0 113.14 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -162.35 177.35 9.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 111.23 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.415 HG13 ' O ' ' B' ' 104' ' ' PHE . 33.7 m -106.08 162.35 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.434 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 3.6 mt-30 -55.66 -52.92 62.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.144 0.497 . . . . 0.0 110.516 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.79 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -158.14 -172.77 4.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.152 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.41 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 27.6 m -145.53 130.41 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.043 0.449 . . . . 0.0 111.855 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.481 ' CG ' HG12 ' C' ' 28' ' ' VAL . 48.2 t0 -108.75 102.88 11.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.244 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.725 HD11 HD12 ' C' ' 29' ' ' LEU . 0.5 OUTLIER -66.75 -14.14 62.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.214 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.08 -93.13 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -61.27 -28.79 69.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.232 0.539 . . . . 0.0 109.574 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 140.47 47.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.397 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.893 HG23 ' HB3' ' C' ' 127' ' ' ALA . 2.8 m -105.05 -179.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.246 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.725 HD12 HD11 ' C' ' 24' ' ' LEU . 0.2 OUTLIER -165.8 136.86 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.824 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -108.85 136.27 48.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.842 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 41.9 p -81.07 177.26 9.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.57 95.67 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.66 151.02 47.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 111.061 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.755 HG23 HG23 ' C' ' 36' ' ' VAL . 0.6 OUTLIER -129.18 121.96 20.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.85 58.9 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.715 2.277 . . . . 0.0 113.068 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.755 HG23 HG23 ' C' ' 34' ' ' ILE . 93.0 t -69.82 85.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 0.0 110.593 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.877 ' HB3' HG22 ' C' ' 40' ' ' THR . 52.5 t30 -43.87 129.89 4.17 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.816 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.86 -9.67 26.18 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 121.995 1.797 . . . . 0.0 111.569 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.672 ' HB3' ' ND2' ' C' ' 37' ' ' ASN . . . -97.46 -32.96 11.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.661 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.883 HG23 ' HG2' ' C' ' 42' ' ' GLU . 11.6 t -117.69 -27.88 6.15 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.864 0.364 . . . . 0.0 111.054 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 78.78 60.21 2.65 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.803 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.883 ' HG2' HG23 ' C' ' 40' ' ' THR . 0.3 OUTLIER 179.23 -76.76 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.875 0.337 . . . . 0.0 111.731 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.759 ' HB ' HG12 ' C' ' 119' ' ' VAL . 11.2 p -161.04 118.46 1.43 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.16 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.57 141.01 95.14 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.376 2.051 . . . . 0.0 112.23 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.83 -31.17 72.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.034 0.445 . . . . 0.0 110.91 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.544 ' HB2' ' HB3' ' C' ' 49' ' ' ALA . 1.3 m-20 -73.4 93.11 1.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.935 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mm -42.45 -31.76 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.157 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' VAL . . . . . 0.444 HG22 ' CB ' ' C' ' 87' ' ' ALA . 22.0 t -80.47 -42.43 21.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.756 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' C' ' 46' ' ' ASP . . . -66.04 -44.71 83.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.506 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -27.6 67.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.46 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.95 68.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.986 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.79 -32.63 57.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -41.12 77.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.743 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.1 t -64.23 -38.95 92.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.777 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 18.6 mt -69.33 -41.18 76.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.839 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.27 -44.09 92.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -60.8 -37.26 81.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.755 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 1.029 HG21 HG21 ' C' ' 123' ' ' ILE . 26.3 t -62.96 -46.08 97.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.556 ' HA ' HD12 ' C' ' 62' ' ' ILE . 7.4 mttt -71.92 -32.62 67.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.809 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.422 ' HB1' ' CB ' ' C' ' 10' ' ' LYS . . . -60.16 -39.58 86.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.549 HG22 ' CG2' ' C' ' 6' ' ' ILE . 4.2 mt -70.29 -40.75 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.839 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 1.036 HD13 HD11 ' C' ' 72' ' ' ILE . 8.6 mt -70.52 -34.56 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.433 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -69.98 -42.69 72.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -15.77 63.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.653 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' C' ' 6' ' ' ILE . . . -88.0 -33.69 18.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.548 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.29 41.32 0.37 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.841 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.763 HD21 ' HG3' ' C' ' 129' ' ' ARG . 64.0 mt -150.27 -177.58 6.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.936 0.398 . . . . 0.0 110.723 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.07 164.85 28.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.795 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -52.69 -35.1 54.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -60.9 -22.4 64.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.186 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.515 ' O ' HG22 ' C' ' 128' ' ' VAL . 6.9 m-20 -81.0 -18.42 46.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.788 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 1.036 HD11 HD13 ' C' ' 62' ' ' ILE . 28.2 mm -58.47 123.64 10.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.875 HG11 HG13 ' C' ' 128' ' ' VAL . 34.7 m -92.7 -27.33 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.397 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.488 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 36.7 tttm -150.47 164.76 35.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.304 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.666 HG22 ' HB2' ' C' ' 125' ' ' ALA . 0.2 OUTLIER -156.45 113.32 3.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.732 0.301 . . . . 0.0 111.479 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 94.2 m -99.97 152.44 20.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.261 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.429 HG13 HD13 ' C' ' 123' ' ' ILE . 21.2 t -151.78 127.31 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.982 0.42 . . . . 0.0 111.83 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.407 ' CE2' ' OE1' ' C' ' 124' ' ' GLU . 10.6 m-85 -105.32 115.56 30.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.3 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.569 HG11 ' CD2' ' C' ' 85' ' ' PHE . 4.8 m -105.55 148.61 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.591 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.62 -4.21 55.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.082 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -165.03 134.31 3.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.549 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 114' ' ' ARG . 1.0 OUTLIER -70.91 -8.94 56.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.236 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.22 -24.28 23.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.79 0.329 . . . . 0.0 110.888 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -75.38 -22.35 57.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.569 ' CD2' HG11 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -61.66 -18.2 58.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.416 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.18 -41.16 68.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.34 . . . . 0.0 111.229 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' C' ' 48' ' ' VAL . . . -87.5 -27.82 22.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.974 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 28.0 t -73.76 -47.03 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.18 -40.17 95.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.457 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.07 83.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.937 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.05 -28.18 21.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.571 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 81.2 t80 -53.38 -44.82 68.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.904 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.84 -25.2 24.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.076 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.34 -21.37 60.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.441 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.46 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 1.0 OUTLIER -91.14 -33.72 15.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 110.576 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.454 ' CZ ' ' CG ' ' C' ' 105' ' ' PRO . 0.7 OUTLIER -56.36 -58.07 9.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.126 0.488 . . . . 0.0 110.285 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -64.56 -30.77 71.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.994 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -78.19 -9.21 59.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.248 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.629 ' HB3' ' HB3' ' C' ' 69' ' ' ALA . 3.5 m120 -109.87 -4.98 15.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.439 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 22.1 m-80 84.48 38.55 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.77 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' C' ' 69' ' ' ALA . 0.8 OUTLIER -130.8 68.87 82.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.35 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.27 -17.51 7.75 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.974 2.449 . . . . 0.0 112.828 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 1.2 t-20 -59.28 -36.81 76.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 27.9 m-85 78.73 114.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.469 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.454 ' CG ' ' CZ ' ' C' ' 96' ' ' PHE . 62.3 Cg_endo -87.18 163.13 8.55 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.181 2.587 . . . . 0.0 112.094 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.44 175.59 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' C' ' 75' ' ' THR . 0.9 OUTLIER -173.04 163.44 4.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.263 0.554 . . . . 0.0 112.074 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.81 83.91 1.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.061 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 109' ' ' CYS . . . . . 0.464 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 13.8 p -89.42 123.65 33.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 115' ' ' LEU . 35.6 m -143.06 149.53 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.351 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.861 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -82.02 97.26 8.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.4 HG22 ' H ' ' C' ' 112' ' ' VAL . 8.1 m -78.46 160.52 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.211 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.838 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -69.65 -45.67 67.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.061 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -156.89 176.99 12.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.851 HD22 ' HB2' ' C' ' 122' ' ' GLU . 12.9 mt -145.28 160.6 45.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.497 ' O ' HG22 ' C' ' 119' ' ' VAL . 67.9 Cg_exo -50.96 135.72 43.81 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.513 2.142 . . . . 0.0 112.289 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.59 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.1 OUTLIER 72.21 14.57 5.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.238 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.2 14.2 9.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.184 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.759 HG12 ' HB ' ' C' ' 43' ' ' VAL . 27.6 m -57.5 171.18 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 111.206 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.99 22.12 16.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.538 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.494 ' C ' HD13 ' C' ' 115' ' ' LEU . 0.2 OUTLIER -176.16 156.88 1.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.098 0.475 . . . . 0.0 111.158 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.851 ' HB2' HD22 ' C' ' 115' ' ' LEU . 6.3 tt0 -149.95 156.41 41.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.054 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 1.029 HG21 HG21 ' C' ' 58' ' ' VAL . 22.8 mm -133.42 136.75 54.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.163 0.506 . . . . 0.0 112.093 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 6.6 pt-20 -155.51 106.66 2.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.346 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.666 ' HB2' HG22 ' C' ' 75' ' ' THR . . . -129.11 175.31 8.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.292 0.567 . . . . 0.0 112.368 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.693 HG23 ' HG ' ' C' ' 29' ' ' LEU . 3.1 mt -125.69 157.85 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.127 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 1.022 ' HB2' HD13 ' C' ' 72' ' ' ILE . . . -148.91 149.05 30.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.995 0.426 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.875 HG13 HG11 ' C' ' 73' ' ' VAL . 3.3 m -96.93 156.35 3.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.035 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.763 ' HG3' HD21 ' C' ' 67' ' ' LEU . 54.1 ttt-85 -151.36 51.62 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.796 0.331 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.97 144.03 54.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.791 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.688 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER 61.43 113.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.58 114.65 15.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.028 HD11 HG11 ' A' ' 19' ' ' VAL . 1.1 tp -53.34 132.64 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.312 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' A' ' 23' ' ' ASP . 12.5 mm -98.59 143.32 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -168.08 106.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.81 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.7 t -124.99 169.34 12.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.86 29.85 3.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.447 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -118.2 -40.68 2.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.682 ' HB1' ' CD ' ' A' ' 12' ' ' PRO . . . -72.38 177.37 1.82 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.173 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.682 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 22.0 Cg_exo -65.01 -10.92 27.38 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.865 2.377 . . . . 0.0 112.728 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.73 151.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.021 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.35 122.47 46.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.187 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 15' ' ' ILE . 26.4 mm -123.1 17.13 5.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.8 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.33 -132.0 3.64 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.355 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.446 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 79.9 Cg_endo -89.95 20.73 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.793 2.329 . . . . 0.0 113.355 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.576 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 1.5 p90 -140.54 178.58 7.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.951 0.405 . . . . 0.0 111.462 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.028 HG11 HD11 ' A' ' 5' ' ' ILE . 15.7 m -132.87 -179.26 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.861 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -48.9 79.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.72 -172.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.825 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.756 HG23 HD23 ' A' ' 29' ' ' LEU . 4.7 m -142.19 132.63 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.794 ' HA ' HG23 ' A' ' 28' ' ' VAL . 10.5 t0 -113.94 109.77 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.648 ' CD1' HD21 ' A' ' 29' ' ' LEU . 12.0 mt -81.05 -14.65 57.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.269 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.82 -100.09 0.71 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.53 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.727 ' C ' HD23 ' A' ' 27' ' ' LEU . 9.3 m-20 -57.62 -29.77 64.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.162 0.506 . . . . 0.0 109.775 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.917 HD22 HG12 ' A' ' 128' ' ' VAL . 1.4 mt -130.05 141.85 50.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.512 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.039 HG12 ' HB3' ' A' ' 127' ' ' ALA . 4.7 p -125.49 144.66 34.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.18 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.824 HD12 HD12 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -118.1 146.98 43.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.79 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.507 HG21 HD11 ' A' ' 62' ' ' ILE . 16.3 p -124.16 155.22 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.83 167.2 12.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.93 94.62 0.15 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.342 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.521 ' O ' HD13 ' A' ' 34' ' ' ILE . 23.2 mm-40 -58.83 150.06 24.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.363 . . . . 0.0 111.171 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 33' ' ' GLN . 22.3 mm -133.42 134.91 24.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.557 ' HD2' HG21 ' A' ' 119' ' ' VAL . 16.0 Cg_exo -68.02 56.16 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.898 2.399 . . . . 0.0 112.803 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.545 HG12 ' HA2' ' A' ' 41' ' ' GLY . 41.4 t -63.52 86.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.332 0.587 . . . . 0.0 110.654 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.79 ' HB3' HG22 ' A' ' 40' ' ' THR . 13.0 t30 -37.99 128.44 0.99 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.066 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 37' ' ' ASN . 14.0 Cg_exo -68.68 -10.61 29.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.213 1.942 . . . . 0.0 111.902 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.4 -30.33 10.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.958 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.79 HG22 ' HB3' ' A' ' 37' ' ' ASN . 11.8 t -123.3 -26.02 4.35 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.427 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.545 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 70.66 58.9 5.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.215 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.592 ' HG3' HG23 ' A' ' 40' ' ' THR . 5.8 mt-10 -154.36 -73.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.3 . . . . 0.0 111.435 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.726 HG11 ' HA ' ' A' ' 119' ' ' VAL . 7.4 p 175.44 117.66 0.12 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.94 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 35' ' ' PRO . 52.2 Cg_exo -52.04 140.27 50.12 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.315 2.01 . . . . 0.0 112.165 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.64 -30.99 69.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -75.46 94.95 3.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.799 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.725 HG13 HD11 ' A' ' 121' ' ' LEU . 2.7 tp -43.4 -31.88 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.601 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.62 -45.5 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.669 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -63.23 -48.13 79.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.569 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.727 ' OE1' HD12 ' A' ' 121' ' ' LEU . 2.7 pt20 -61.41 -29.53 69.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.392 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.75 -39.61 61.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.927 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -62.42 -48.47 79.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.06 -34.63 78.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -66.11 -31.15 71.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.726 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.768 HD13 ' CE2' ' A' ' 95' ' ' PHE . 75.6 mt -69.69 -49.84 49.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -40.83 84.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.83 -38.45 70.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 54' ' ' SER . 39.2 t -65.26 -25.86 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.716 ' HD3' ' HB2' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -83.88 -39.15 20.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.806 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -58.27 -39.68 79.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.468 HD11 ' OE1' ' A' ' 33' ' ' GLN . 50.3 mt -68.91 -53.05 28.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.917 0.389 . . . . 0.0 110.729 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 30' ' ' THR . 51.0 mt -64.66 -28.89 45.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.708 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.45 -42.54 53.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.53 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -16.07 63.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.466 ' HB2' HD12 ' A' ' 6' ' ' ILE . . . -88.45 -28.68 20.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.59 43.65 0.63 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.587 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.443 ' HB3' HG22 ' A' ' 62' ' ' ILE . 1.5 mt -149.78 -167.15 2.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.0 110.837 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.17 154.86 38.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.66 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.733 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -58.12 -36.7 73.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.943 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.1 -26.3 4.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.251 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.73 -23.63 33.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.414 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 69' ' ' ALA . 88.5 mt -44.39 120.44 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.917 0.389 . . . . 0.0 111.415 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 128' ' ' VAL . 29.3 m -90.31 -38.02 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.651 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.53 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -137.72 155.45 49.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.599 0.238 . . . . 0.0 110.974 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.803 HG21 ' OH ' ' A' ' 92' ' ' TYR . 17.3 p -143.43 152.07 41.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.027 0.441 . . . . 0.0 111.51 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 108' ' ' SER . 5.2 m -133.74 142.32 47.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.064 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -143.02 105.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 111.811 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.5 ' HB2' HD21 ' A' ' 115' ' ' LEU . 7.8 m-85 -86.98 106.28 17.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.469 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.687 HG12 ' CD2' ' A' ' 121' ' ' LEU . 18.7 m -102.71 152.59 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.549 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.13 -2.61 46.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.844 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.36 113.51 3.7 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.585 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.602 HD11 ' C ' ' B' ' 115' ' ' LEU . 6.1 mt -65.27 -13.57 58.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.056 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -81.94 -23.2 36.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.875 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.406 ' OD1' HG21 ' A' ' 47' ' ' ILE . 6.7 m-20 -80.84 -23.72 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.138 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.601 ' HD1' HG11 ' A' ' 79' ' ' VAL . 2.0 t80 -56.26 -23.88 39.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.382 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.92 74.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.199 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.44 -38.71 17.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.29 -36.06 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.6 t30 -69.31 -43.1 74.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.82 74.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.026 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.582 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -86.08 -23.26 26.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.2 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.803 ' OH ' HG21 ' A' ' 75' ' ' THR . 10.3 t80 -77.82 -27.55 50.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.565 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.1 -39.42 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -67.25 -23.13 65.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.768 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -90.85 -32.8 15.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.553 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.582 ' HA ' ' CD2' ' A' ' 101' ' ' HIS . 1.7 m-85 -60.15 -58.85 6.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.3 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -63.55 -28.17 69.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.159 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -77.79 -10.89 59.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.54 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.681 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.15 -5.92 14.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.379 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.5 OUTLIER 94.52 37.32 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.871 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.733 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 1.6 m-70 -117.9 51.98 1.33 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 65.1 Cg_endo -71.91 -21.67 24.25 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.453 2.102 . . . . 0.0 112.56 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.34 -32.98 51.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.728 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.617 ' O ' HG22 ' B' ' 19' ' ' VAL . 15.6 m-85 60.98 83.67 0.21 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.131 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 17.1 Cg_endo -58.15 159.42 18.78 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.44 2.093 . . . . 0.0 112.018 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 74' ' ' LYS . . . -50.19 169.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.783 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' B' ' 18' ' ' TYR . 2.5 ttt85 -133.4 146.42 51.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.018 0.437 . . . . 0.0 111.308 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 76' ' ' THR . 1.7 p -152.56 58.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.411 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 25.4 p -96.01 142.85 27.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.435 HG11 ' CD2' ' B' ' 78' ' ' PHE . 33.9 m -147.6 153.92 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.856 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.7 OUTLIER -80.93 83.63 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.78 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.654 ' CG2' HD11 ' A' ' 115' ' ' LEU . 9.5 m -71.99 160.82 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.111 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.852 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -67.56 -53.57 27.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.243 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.4 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 1.5 mpt_? -151.25 -178.59 6.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.964 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.654 HD11 ' CG2' ' A' ' 112' ' ' VAL . 2.1 mp -153.55 159.37 32.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.572 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.528 ' O ' HG12 ' A' ' 119' ' ' VAL . 9.6 Cg_endo -52.16 140.19 51.45 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.578 2.185 . . . . 0.0 112.21 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 66.84 14.0 9.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.559 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.71 19.23 5.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.069 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.726 ' HA ' HG11 ' A' ' 43' ' ' VAL . 3.0 p -52.33 -49.36 42.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.543 ' C ' HD13 ' A' ' 115' ' ' LEU . . . 90.31 -7.37 81.61 Favored Glycine 0 C--N 1.308 -0.978 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.293 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.727 HD12 ' OE1' ' A' ' 50' ' ' GLN . 16.7 mt -140.37 146.75 38.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.237 0.542 . . . . 0.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.424 ' HB2' ' CD2' ' A' ' 115' ' ' LEU . 26.1 tt0 -147.67 152.42 37.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.941 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.55 HD13 HD23 ' A' ' 55' ' ' LEU . 26.9 mt -138.07 127.41 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.192 0.52 . . . . 0.0 112.229 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.4 ' HG3' ' HB ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.45 132.18 18.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.391 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.685 ' CB ' HG22 ' A' ' 75' ' ' THR . . . -149.39 159.42 44.3 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.824 HD12 HD12 ' A' ' 29' ' ' LEU . 14.8 mm -105.24 153.57 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.893 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 1.039 ' HB3' HG12 ' A' ' 28' ' ' VAL . . . -137.2 152.57 50.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.013 0.435 . . . . 0.0 111.828 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.917 HG12 HD22 ' A' ' 27' ' ' LEU . 27.0 m -119.98 178.09 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.804 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -167.75 59.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.873 0.368 . . . . 0.0 111.039 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.932 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.818 0.342 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.01 144.06 54.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.796 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.717 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER 61.39 113.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.6 114.63 15.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 1.032 HD11 HG11 ' B' ' 19' ' ' VAL . 1.1 tp -53.3 132.69 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.33 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.644 HD11 ' HB2' ' B' ' 23' ' ' ASP . 12.5 mm -98.57 143.34 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -168.15 106.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 3.8 t -124.97 169.3 12.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.009 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.85 29.89 3.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.449 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 0.4 OUTLIER -118.34 -40.9 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.676 ' HB1' ' CD ' ' B' ' 12' ' ' PRO . . . -72.01 177.26 1.79 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.11 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.676 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 22.2 Cg_exo -65.01 -10.87 27.2 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.892 2.395 . . . . 0.0 112.677 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.66 151.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 111.083 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.27 122.43 46.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.202 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 15' ' ' ILE . 26.5 mm -123.08 17.13 5.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.765 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.29 -131.98 3.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.422 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.459 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 78.3 Cg_endo -89.93 20.66 1.0 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.809 2.339 . . . . 0.0 113.392 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.586 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 1.5 p90 -140.44 178.6 7.19 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.507 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.032 HG11 HD11 ' B' ' 5' ' ' ILE . 15.6 m -132.92 -179.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.867 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -48.7 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.953 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.432 ' HB2' HG21 ' B' ' 61' ' ' ILE . . . -178.07 -172.71 0.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.76 HG23 HD23 ' B' ' 29' ' ' LEU . 4.6 m -142.2 132.67 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.145 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.802 ' HA ' HG23 ' B' ' 28' ' ' VAL . 10.5 t0 -113.95 109.76 19.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.65 ' CD1' HD21 ' B' ' 29' ' ' LEU . 12.0 mt -81.07 -14.71 57.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.265 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.86 -100.05 0.7 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.548 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ASN . . . . . 0.716 ' C ' HD23 ' B' ' 27' ' ' LEU . 9.2 m-20 -57.61 -29.77 64.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.177 0.513 . . . . 0.0 109.81 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.897 HD22 HG12 ' B' ' 128' ' ' VAL . 1.4 mt -130.0 141.88 50.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.537 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.045 HG12 ' HB3' ' B' ' 127' ' ' ALA . 4.7 p -125.57 144.68 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.145 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.827 HD12 HD12 ' B' ' 126' ' ' ILE . 0.0 OUTLIER -118.06 146.94 43.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.83 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.51 HG21 HD11 ' B' ' 62' ' ' ILE . 16.1 p -124.18 155.03 39.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.832 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.99 167.11 12.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.91 94.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.329 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.528 ' O ' HD13 ' B' ' 34' ' ' ILE . 23.3 mm-40 -58.82 150.07 24.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.376 . . . . 0.0 111.153 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.528 HD13 ' O ' ' B' ' 33' ' ' GLN . 22.2 mm -133.42 134.88 24.36 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.096 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.549 ' HD2' HG21 ' B' ' 119' ' ' VAL . 16.0 Cg_exo -68.03 56.2 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.836 2.358 . . . . 0.0 112.79 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.552 HG12 ' HA2' ' B' ' 41' ' ' GLY . 41.3 t -63.52 86.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.366 0.603 . . . . 0.0 110.623 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.785 ' HB3' HG22 ' B' ' 40' ' ' THR . 13.0 t30 -38.01 128.44 0.99 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.092 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.62 -10.68 29.76 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.235 1.957 . . . . 0.0 111.921 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.37 -30.28 10.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.015 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.785 HG22 ' HB3' ' B' ' 37' ' ' ASN . 11.6 t -123.25 -26.06 4.37 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.815 0.34 . . . . 0.0 111.477 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.552 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 70.76 58.96 5.45 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.215 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.617 ' HG3' HG23 ' B' ' 40' ' ' THR . 5.8 mt-10 -154.35 -74.03 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.774 0.321 . . . . 0.0 111.398 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.717 HG11 ' HA ' ' B' ' 119' ' ' VAL . 7.4 p 175.49 117.59 0.12 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.992 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.2 Cg_exo -52.12 140.29 50.91 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.249 1.966 . . . . 0.0 112.189 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.95 69.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.032 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.435 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.1 OUTLIER -75.41 94.95 3.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.818 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.711 HG13 HD11 ' B' ' 121' ' ' LEU . 2.7 tp -43.39 -31.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.61 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.62 -45.51 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -63.27 -48.04 79.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.699 ' OE1' HD12 ' B' ' 121' ' ' LEU . 2.7 pt20 -61.56 -29.6 70.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.371 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.97 -39.6 61.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.999 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -62.37 -48.48 79.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.818 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.12 -34.58 78.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.708 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.607 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.7 OUTLIER -66.09 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.733 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.76 HD13 ' CE2' ' B' ' 95' ' ' PHE . 75.6 mt -69.75 -49.81 49.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.83 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -40.86 84.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.85 -38.48 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.64 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 54' ' ' SER . 39.0 t -65.23 -25.88 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.66 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.719 ' HD3' ' HB2' ' B' ' 69' ' ' ALA . 0.3 OUTLIER -83.86 -39.21 20.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -58.25 -39.91 80.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.456 HD11 ' OE1' ' B' ' 33' ' ' GLN . 50.6 mt -68.67 -53.01 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.733 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.51 HD11 HG21 ' B' ' 30' ' ' THR . 51.0 mt -64.7 -28.82 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.47 -42.54 52.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.546 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -16.09 63.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.643 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.511 ' HB2' HD12 ' B' ' 6' ' ' ILE . . . -88.42 -28.64 20.77 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.706 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.58 43.67 0.63 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.523 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.461 ' HB3' HG22 ' B' ' 62' ' ' ILE . 1.5 mt -149.83 -167.14 2.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 154.85 38.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.693 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.745 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -58.12 -36.66 73.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.18 -26.36 4.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.281 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -23.67 34.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.404 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.464 HG13 ' HA ' ' B' ' 69' ' ' ALA . 88.8 mt -44.44 120.36 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-O 120.923 0.392 . . . . 0.0 111.438 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.541 HG13 HG22 ' B' ' 128' ' ' VAL . 29.1 m -90.2 -38.02 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.66 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.528 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -137.79 155.47 48.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.625 0.25 . . . . 0.0 110.905 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.793 HG21 ' OH ' ' B' ' 92' ' ' TYR . 17.3 p -143.38 152.1 41.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 111.543 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.658 HG23 ' O ' ' B' ' 108' ' ' SER . 5.2 m -133.8 142.32 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.026 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.4 t -143.0 105.82 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 111.838 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.468 ' HB2' HD21 ' B' ' 115' ' ' LEU . 7.7 m-85 -86.98 106.29 17.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.687 HG12 ' CD2' ' B' ' 121' ' ' LEU . 18.7 m -102.69 152.6 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.576 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.19 -2.51 46.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.808 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.62 113.54 3.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.518 HD11 ' C ' ' C' ' 115' ' ' LEU . 6.1 mt -65.19 -13.5 58.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.96 -23.26 36.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.883 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.82 -23.67 39.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.192 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.614 ' HD1' HG11 ' B' ' 79' ' ' VAL . 2.0 t80 -56.3 -23.9 39.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.336 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.33 -36.91 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 0.0 111.209 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.48 -38.7 17.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.18 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.28 -36.07 65.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.6 t30 -69.34 -43.04 74.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.06 74.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.08 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' B' ' 94' ' ' ARG . 0.1 OUTLIER -85.95 -23.3 26.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.793 ' OH ' HG21 ' B' ' 75' ' ' THR . 10.3 t80 -77.8 -27.54 50.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.541 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.19 -39.41 12.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' B' ' 91' ' ' GLU . 0.0 OUTLIER -67.35 -23.02 65.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.76 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -90.82 -32.85 15.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.835 0.35 . . . . 0.0 110.57 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.584 ' HA ' ' CD2' ' B' ' 101' ' ' HIS . 1.6 m-85 -60.12 -58.79 7.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.309 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -63.53 -28.24 69.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.162 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -77.78 -10.85 59.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.691 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.22 -5.87 14.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.349 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 0.5 OUTLIER 94.5 37.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.873 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.745 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 1.6 m-70 -117.92 52.02 1.34 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.706 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 64.2 Cg_endo -72.05 -21.58 23.9 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.449 2.099 . . . . 0.0 112.536 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.34 -33.02 51.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.894 0.378 . . . . 0.0 110.723 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.635 ' O ' HG22 ' C' ' 19' ' ' VAL . 15.6 m-85 61.05 83.67 0.21 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.122 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 16.9 Cg_endo -58.12 159.42 18.65 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.463 2.109 . . . . 0.0 112.025 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' B' ' 74' ' ' LYS . . . -50.17 169.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.805 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.46 146.45 51.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.994 0.426 . . . . 0.0 111.286 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.658 ' O ' HG23 ' B' ' 76' ' ' THR . 1.7 p -152.61 58.43 0.81 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.42 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 25.3 p -96.04 142.78 27.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.129 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' C' ' 78' ' ' PHE . 33.9 m -147.44 153.52 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.153 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.837 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.7 OUTLIER -80.7 83.64 6.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.644 ' CG2' HD11 ' B' ' 115' ' ' LEU . 9.7 m -71.87 160.8 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.856 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -67.59 -53.54 27.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.235 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.417 ' HB3' HD12 ' A' ' 82' ' ' LEU . 1.5 mpt_? -151.28 -178.52 6.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.644 HD11 ' CG2' ' B' ' 112' ' ' VAL . 2.2 mp -153.57 159.29 32.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.577 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.525 ' O ' HG12 ' B' ' 119' ' ' VAL . 9.5 Cg_endo -52.15 140.19 51.38 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.573 2.182 . . . . 0.0 112.195 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 0.0 OUTLIER 66.86 13.97 9.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.537 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.76 19.16 5.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.078 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.717 ' HA ' HG11 ' B' ' 43' ' ' VAL . 3.1 p -52.28 -49.38 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 121.655 0.741 . . . . 0.0 111.194 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' GLY . . . . . 0.524 ' C ' HD13 ' B' ' 115' ' ' LEU . . . 90.23 -7.47 81.48 Favored Glycine 0 C--N 1.308 -1.012 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.338 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.711 HD11 HG13 ' B' ' 47' ' ' ILE . 16.7 mt -140.12 146.7 39.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.213 0.53 . . . . 0.0 111.128 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.426 ' HB2' ' CD2' ' B' ' 115' ' ' LEU . 26.1 tt0 -147.56 152.42 37.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.976 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.573 HD13 HD23 ' B' ' 55' ' ' LEU . 26.7 mt -138.1 127.39 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.258 0.552 . . . . 0.0 112.237 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.43 132.19 18.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.417 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.699 ' CB ' HG22 ' B' ' 75' ' ' THR . . . -149.43 159.4 44.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.827 HD12 HD12 ' B' ' 29' ' ' LEU . 14.8 mm -105.28 153.43 6.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.889 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 1.045 ' HB3' HG12 ' B' ' 28' ' ' VAL . . . -137.09 152.63 50.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.012 0.434 . . . . 0.0 111.845 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.897 HG12 HD22 ' B' ' 27' ' ' LEU . 27.0 m -120.06 178.05 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.834 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -167.68 59.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.887 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.85 0.357 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.11 144.12 54.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.818 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.72 HG21 HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER 61.4 113.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.57 114.64 15.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 1.026 HD11 HG11 ' C' ' 19' ' ' VAL . 1.1 tp -53.3 132.71 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.3 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' C' ' 23' ' ' ASP . 12.4 mm -98.67 143.4 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -168.16 106.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.789 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 3.7 t -124.97 169.31 12.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.8 29.87 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.454 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 0.4 OUTLIER -118.21 -40.76 2.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.677 ' HB1' ' CD ' ' C' ' 12' ' ' PRO . . . -72.21 177.24 1.84 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.213 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 22.2 Cg_exo -65.04 -10.89 27.33 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.947 2.432 . . . . 0.0 112.682 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.68 151.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.064 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.35 122.48 46.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.114 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.616 HG22 ' O ' ' C' ' 15' ' ' ILE . 26.3 mm -123.1 17.09 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.833 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.3 -131.92 3.63 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.36 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' PRO . . . . . 0.456 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 80.2 Cg_endo -90.03 20.77 0.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.759 2.306 . . . . 0.0 113.337 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.588 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 1.5 p90 -140.48 178.62 7.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.964 0.411 . . . . 0.0 111.516 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 1.026 HG11 HD11 ' C' ' 5' ' ' ILE . 15.7 m -132.92 -179.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.84 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -49.01 79.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' C' ' 61' ' ' ILE . . . -177.58 -172.78 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.825 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.789 HG23 HD23 ' C' ' 29' ' ' LEU . 4.7 m -142.24 132.64 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.161 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.788 ' HA ' HG23 ' C' ' 28' ' ' VAL . 10.5 t0 -113.97 109.83 19.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.81 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.646 ' CD1' HD21 ' C' ' 29' ' ' LEU . 12.1 mt -81.09 -14.72 57.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.231 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.88 -100.1 0.7 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.53 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' ASN . . . . . 0.722 ' C ' HD23 ' C' ' 27' ' ' LEU . 9.2 m-20 -57.6 -29.79 64.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.194 0.521 . . . . 0.0 109.839 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.93 HD22 HG12 ' C' ' 128' ' ' VAL . 1.4 mt -130.03 141.92 50.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.998 HG12 ' HB3' ' C' ' 127' ' ' ALA . 4.7 p -125.55 144.71 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.2 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.81 HD12 HD12 ' C' ' 126' ' ' ILE . 0.0 OUTLIER -118.08 147.01 43.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.51 HG21 HD11 ' C' ' 62' ' ' ILE . 16.2 p -124.15 155.18 38.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.923 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.96 167.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.958 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.89 94.6 0.14 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.314 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.521 ' O ' HD13 ' C' ' 34' ' ' ILE . 23.2 mm-40 -58.83 150.04 25.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 111.206 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.521 HD13 ' O ' ' C' ' 33' ' ' GLN . 22.4 mm -133.4 134.97 24.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.108 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.563 ' HD2' HG21 ' C' ' 119' ' ' VAL . 16.0 Cg_exo -68.09 56.2 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.874 2.383 . . . . 0.0 112.789 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.54 HG12 ' HA2' ' C' ' 41' ' ' GLY . 41.4 t -63.5 86.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.295 0.569 . . . . 0.0 110.595 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.775 ' HB3' HG22 ' C' ' 40' ' ' THR . 13.1 t30 -38.08 128.44 1.0 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.093 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' C' ' 37' ' ' ASN . 13.9 Cg_exo -68.61 -10.71 29.85 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.232 1.955 . . . . 0.0 111.91 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.29 -30.3 10.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 112.073 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.775 HG22 ' HB3' ' C' ' 37' ' ' ASN . 11.8 t -123.29 -26.0 4.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.834 0.35 . . . . 0.0 111.474 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.54 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 70.65 58.96 5.5 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.227 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.619 ' HG3' HG23 ' C' ' 40' ' ' THR . 5.9 mt-10 -154.38 -74.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.714 0.292 . . . . 0.0 111.404 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' C' ' 119' ' ' VAL . 7.4 p 175.51 117.59 0.12 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' C' ' 35' ' ' PRO . 52.1 Cg_exo -51.98 140.26 49.6 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.297 1.998 . . . . 0.0 112.204 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.67 -31.0 69.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.009 0.433 . . . . 0.0 111.065 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.1 OUTLIER -75.44 94.91 3.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.869 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.698 HG13 HD11 ' C' ' 121' ' ' LEU . 2.7 tp -43.38 -31.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.636 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 32.2 t -79.66 -45.51 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.646 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -63.22 -48.09 79.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.587 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.728 ' OE1' HD12 ' C' ' 121' ' ' LEU . 2.7 pt20 -61.53 -29.47 70.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.359 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.91 -39.61 61.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.964 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -62.38 -48.48 79.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.794 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.04 -34.62 78.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.601 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.8 OUTLIER -66.17 -31.1 71.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.762 HD13 ' CE2' ' C' ' 95' ' ' PHE . 75.5 mt -69.72 -49.89 48.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -40.82 84.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.87 -38.51 70.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.671 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.601 HG23 ' O ' ' C' ' 54' ' ' SER . 38.9 t -65.15 -25.97 38.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.678 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.711 ' HD3' ' HB2' ' C' ' 69' ' ' ALA . 0.3 OUTLIER -83.79 -39.22 20.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.755 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -58.26 -39.84 80.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.455 HD11 ' OE1' ' C' ' 33' ' ' GLN . 50.3 mt -68.69 -53.07 29.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.51 HD11 HG21 ' C' ' 30' ' ' THR . 50.9 mt -64.65 -28.87 45.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.731 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.49 -42.53 52.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.558 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -16.2 64.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.615 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.513 ' HB2' HD12 ' C' ' 6' ' ' ILE . . . -88.34 -28.74 20.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.929 0.395 . . . . 0.0 110.741 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.62 43.66 0.62 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.545 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.465 ' HB3' HG22 ' C' ' 62' ' ' ILE . 1.5 mt -149.74 -167.13 2.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.939 0.4 . . . . 0.0 110.849 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.16 154.91 38.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.71 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.741 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -58.16 -36.68 73.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.371 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.09 -26.35 4.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.285 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -23.75 34.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.381 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' C' ' 69' ' ' ALA . 88.8 mt -44.34 120.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.883 0.373 . . . . 0.0 111.416 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.565 HG13 HG22 ' C' ' 128' ' ' VAL . 29.1 m -90.17 -38.02 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.716 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.538 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -137.8 155.5 48.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.952 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.792 HG21 ' OH ' ' C' ' 92' ' ' TYR . 17.4 p -143.37 152.03 41.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.034 0.445 . . . . 0.0 111.579 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.656 HG23 ' O ' ' C' ' 108' ' ' SER . 5.3 m -133.72 142.31 47.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.007 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -143.03 105.88 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 111.787 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.488 ' HB2' HD21 ' C' ' 115' ' ' LEU . 7.7 m-85 -86.96 106.21 17.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.544 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.698 HG12 ' CD2' ' C' ' 121' ' ' LEU . 18.7 m -102.66 152.59 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.624 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.08 -2.58 46.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.802 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -154.45 113.44 3.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.635 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.56 HD11 ' C ' ' A' ' 115' ' ' LEU . 6.1 mt -65.2 -13.56 58.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.044 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.95 -23.17 36.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.443 ' OD1' HG21 ' C' ' 47' ' ' ILE . 6.6 m-20 -80.88 -23.69 38.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.156 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.615 ' HD1' HG11 ' C' ' 79' ' ' VAL . 2.0 t80 -56.25 -23.92 39.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.384 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.85 74.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.214 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.46 -38.68 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.242 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.37 -36.04 65.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.6 t30 -69.24 -43.22 74.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.12 -32.9 74.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.08 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLU . . . . . 0.588 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 0.1 OUTLIER -86.0 -23.2 26.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.156 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.792 ' OH ' HG21 ' C' ' 75' ' ' THR . 10.3 t80 -77.94 -27.5 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.538 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.1 -39.52 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' ARG . . . . . 0.588 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 0.0 OUTLIER -67.25 -23.12 65.67 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.762 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -90.88 -32.75 15.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.784 0.326 . . . . 0.0 110.529 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.588 ' HA ' ' CD2' ' C' ' 101' ' ' HIS . 1.6 m-85 -60.2 -58.81 6.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.059 0.457 . . . . 0.0 110.259 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -63.53 -28.22 69.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.141 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -77.75 -10.9 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.566 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.697 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.17 -5.85 14.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.397 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 0.5 OUTLIER 94.5 37.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.86 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.741 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 1.6 m-70 -117.93 51.99 1.34 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.723 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 64.3 Cg_endo -72.0 -21.57 24.07 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.442 2.095 . . . . 0.0 112.574 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.36 -33.01 51.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.936 0.398 . . . . 0.0 110.718 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.633 ' O ' HG22 ' A' ' 19' ' ' VAL . 15.5 m-85 60.98 83.75 0.2 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.074 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 17.1 Cg_endo -58.17 159.46 18.72 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.45 2.1 . . . . 0.0 112.005 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' C' ' 74' ' ' LYS . . . -50.26 169.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.779 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.31 146.44 51.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.0 0.429 . . . . 0.0 111.341 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' SER . . . . . 0.656 ' O ' HG23 ' C' ' 76' ' ' THR . 1.7 p -152.59 58.5 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.457 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 25.4 p -96.05 142.85 27.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.093 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.435 HG11 ' CD2' ' A' ' 78' ' ' PHE . 33.9 m -147.62 153.93 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.852 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -80.85 83.63 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.656 ' CG2' HD11 ' C' ' 115' ' ' LEU . 9.6 m -71.95 160.81 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.837 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -67.55 -53.57 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.22 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -151.25 -178.6 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.987 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.656 HD11 ' CG2' ' C' ' 112' ' ' VAL . 2.1 mp -153.56 159.39 32.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.526 ' O ' HG12 ' C' ' 119' ' ' VAL . 9.6 Cg_endo -52.18 140.17 51.75 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.598 2.199 . . . . 0.0 112.195 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 0.0 OUTLIER 66.89 13.99 9.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.515 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.72 19.21 5.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.728 ' HA ' HG11 ' C' ' 43' ' ' VAL . 3.1 p -52.34 -49.34 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.658 0.742 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 120' ' ' GLY . . . . . 0.54 ' C ' HD13 ' C' ' 115' ' ' LEU . . . 90.3 -7.49 81.41 Favored Glycine 0 C--N 1.308 -0.984 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.333 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.728 HD12 ' OE1' ' C' ' 50' ' ' GLN . 16.7 mt -140.16 146.72 39.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.246 0.546 . . . . 0.0 111.134 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.429 ' HB2' ' CD2' ' C' ' 115' ' ' LEU . 26.1 tt0 -147.67 152.39 37.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.953 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.558 HD13 HD23 ' C' ' 55' ' ' LEU . 26.7 mt -138.05 127.47 33.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.229 0.538 . . . . 0.0 112.189 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.48 132.13 18.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.431 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.699 ' CB ' HG22 ' C' ' 75' ' ' THR . . . -149.37 159.39 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.211 0.529 . . . . 0.0 112.412 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.81 HD12 HD12 ' C' ' 29' ' ' LEU . 14.7 mm -105.22 153.43 6.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.917 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.998 ' HB3' HG12 ' C' ' 28' ' ' VAL . . . -137.11 152.56 50.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.031 0.443 . . . . 0.0 111.79 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.93 HG12 HD22 ' C' ' 27' ' ' LEU . 27.0 m -119.99 178.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.842 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -167.74 59.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 111.035 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.916 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.848 0.356 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.486 ' O ' HG23 ' A' ' 3' ' ' THR . 3.6 mtt -89.47 87.97 7.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.977 HG21 HG21 ' C' ' 128' ' ' VAL . 0.0 OUTLIER -175.63 118.21 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.794 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -157.82 118.17 3.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.803 HD11 ' OD1' ' C' ' 103' ' ' ASN . 4.4 mp -58.25 138.3 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.081 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.863 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 31.9 mt -94.83 138.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.158 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -150.97 136.94 18.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.51 162.81 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.75 26.61 5.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -118.03 -40.57 2.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.64 119.65 72.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.171 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.05 -10.84 28.61 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.42 2.08 . . . . 0.0 112.596 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.45 172.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.928 0.394 . . . . 0.0 111.464 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 62.84 130.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.187 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.94 -36.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.504 0.669 . . . . 0.0 110.768 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.03 -145.11 11.19 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.368 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.69 57.97 5.78 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.731 2.287 . . . . 0.0 112.873 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.482 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -168.46 -177.3 3.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 111.08 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' C' ' 104' ' ' PHE . 27.0 m -112.8 -178.45 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.297 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.415 ' CG ' ' HB2' ' A' ' 14' ' ' ALA . 43.5 mt-30 -80.2 -50.94 9.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.982 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -156.95 179.8 8.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.268 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 m -139.57 147.3 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.082 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.908 ' HA ' HG12 ' A' ' 28' ' ' VAL . 20.3 t0 -123.23 94.32 4.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.736 HD22 HG11 ' C' ' 128' ' ' VAL . 11.0 mt -69.96 -17.37 63.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.268 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.62 -105.42 0.95 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.146 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.478 ' HB2' HD23 ' A' ' 27' ' ' LEU . 67.0 m-80 -52.6 -29.99 28.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.054 0.454 . . . . 0.0 110.525 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -137.24 134.16 35.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.773 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.01 HG23 ' HB3' ' A' ' 127' ' ' ALA . 3.0 m -113.07 172.32 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.218 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.761 HD23 HD12 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -145.67 165.71 27.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.431 HG21 HD11 ' A' ' 62' ' ' ILE . 44.3 p -130.13 135.98 48.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m -69.23 154.54 41.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.97 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 123' ' ' ILE . . . -55.26 93.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.631 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.767 ' HG2' HG22 ' A' ' 58' ' ' VAL . 1.6 mp0 -67.65 173.7 4.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.776 0.322 . . . . 0.0 111.009 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.677 ' HB ' HG11 ' A' ' 119' ' ' VAL . 7.6 pt -159.38 152.54 18.48 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.441 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.68 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 43.8 Cg_endo -68.09 74.8 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.05 2.5 . . . . 0.0 112.325 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.586 HG12 ' HA2' ' A' ' 41' ' ' GLY . 22.5 t -90.96 88.23 2.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.587 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.598 ' HB3' HG22 ' A' ' 40' ' ' THR . 0.3 OUTLIER -36.18 129.18 0.65 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.886 -179.483 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.12 -7.91 21.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.288 1.992 . . . . 0.0 112.081 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.95 -22.56 12.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.601 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 37' ' ' ASN . 4.4 t -132.69 -39.0 1.0 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.878 0.37 . . . . 0.0 110.925 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.586 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 85.79 56.92 2.25 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.305 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 12.9 mm-40 -145.12 -71.22 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 111.411 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 7.1 p 172.91 112.51 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -55.58 140.62 83.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.296 1.998 . . . . 0.0 112.144 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.06 71.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.044 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -75.75 94.93 3.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.858 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.502 HD12 ' NE2' ' A' ' 50' ' ' GLN . 6.4 tp -44.5 -31.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.427 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -38.29 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.713 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . . . -69.24 -39.97 78.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.497 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.502 ' NE2' HD12 ' A' ' 47' ' ' ILE . 6.8 pt20 -75.44 -21.88 57.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.223 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.5 -41.5 27.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.161 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.24 -34.45 63.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.76 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.15 -31.59 64.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.529 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.802 ' O ' HG23 ' A' ' 58' ' ' VAL . 68.7 p -67.31 -30.79 70.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.703 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.873 HD13 ' CE2' ' A' ' 95' ' ' PHE . 34.2 mt -79.39 -30.72 42.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.802 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.55 -55.91 20.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.985 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 9.3 p-10 -55.79 -44.99 78.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 54' ' ' SER . 45.0 t -59.25 -31.02 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -79.2 -38.42 35.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.766 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.27 81.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' A' ' 58' ' ' VAL . 6.5 mt -67.06 -51.26 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.771 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.431 HD11 HG21 ' A' ' 30' ' ' THR . 45.8 mt -63.21 -32.63 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.592 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.68 -40.71 63.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.241 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.52 -21.0 65.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.94 -25.66 20.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.812 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 47.91 0.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.482 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.808 HD22 ' OD2' ' A' ' 71' ' ' ASP . 7.2 mt -156.68 -171.62 3.74 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.724 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.6 p -142.82 -179.58 6.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.981 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.812 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -78.63 -24.89 45.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.58 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.565 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -59.81 -36.54 76.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.981 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.808 ' OD2' HD22 ' A' ' 67' ' ' LEU . 4.0 p30 -71.01 -26.51 63.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.072 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.443 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 88.3 mt -46.76 115.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.83 0.348 . . . . 0.0 110.933 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.46 HG21 HD21 ' B' ' 24' ' ' LEU . 27.3 m -91.26 -26.01 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.766 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.639 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 1.7 ttpm? -138.03 164.46 29.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.735 0.302 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 125' ' ' ALA . 91.9 m -163.63 126.58 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.045 0.45 . . . . 0.0 111.492 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 108' ' ' SER . 2.8 m -109.25 144.8 36.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.881 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.08 108.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 111.782 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.455 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.6 m-85 -91.47 107.11 18.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.278 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.757 HG12 HD22 ' A' ' 121' ' ' LEU . 30.0 m -102.21 149.95 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.201 0.524 . . . . 0.0 111.804 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.74 -6.18 49.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.818 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.44 111.99 3.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.54 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 82' ' ' LEU . 2.6 mt -61.28 -15.18 32.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -78.32 -19.45 53.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.758 0.313 . . . . 0.0 110.869 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 88' ' ' VAL . 19.2 m-20 -90.65 7.18 40.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.411 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.444 ' CD1' HG11 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -82.18 -27.46 32.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 111.172 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -36.76 76.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.123 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.38 -36.6 29.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 84' ' ' ASP . 27.9 t -75.6 -30.52 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 85' ' ' PHE . 9.9 m120 -67.19 -48.88 66.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.02 -39.18 90.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.177 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.412 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 0.6 OUTLIER -75.89 -23.94 55.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.196 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -81.73 -33.29 31.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.401 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' B' ' 17' ' ' PRO . 0.8 OUTLIER -89.65 -29.76 18.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.696 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.412 ' HG2' ' HA ' ' A' ' 91' ' ' GLU . 1.3 ppt_? -75.86 -21.59 57.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.663 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.873 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -92.01 -33.13 14.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 0.0 110.671 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.503 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 2.6 m-85 -58.98 -59.13 5.96 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.063 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -31.5 72.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.246 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.57 -11.5 60.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.419 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 4.9 m-20 -110.91 -6.53 14.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.336 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER 90.11 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.548 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.812 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 m-70 -115.21 53.41 0.81 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.025 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.1 Cg_endo -74.63 -14.51 22.07 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.51 2.14 . . . . 0.0 112.55 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.803 ' OD1' HD11 ' B' ' 5' ' ' ILE . 2.0 t30 -51.68 -33.28 33.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.093 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.751 ' CB ' HG13 ' B' ' 19' ' ' VAL . 3.6 m-85 61.47 96.46 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.031 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 59.9 Cg_endo -73.33 159.09 47.53 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.443 2.095 . . . . 0.0 112.258 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.639 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -55.71 147.69 18.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.445 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.64 142.52 45.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.005 0.431 . . . . 0.0 111.442 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.584 ' O ' HG23 ' A' ' 76' ' ' THR . 31.1 t -149.58 62.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.376 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.5 p -94.64 145.38 24.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.461 HG11 ' CD2' ' B' ' 78' ' ' PHE . 35.9 m -153.28 135.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.212 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.601 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -64.76 91.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.802 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.769 HG21 HD21 ' A' ' 115' ' ' LEU . 8.4 m -76.26 164.43 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -83.66 -44.8 14.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.411 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 0.1 OUTLIER -158.54 158.62 34.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.734 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.87 HD22 ' HB2' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -141.34 168.99 12.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.485 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 115' ' ' LEU . 74.4 Cg_exo -50.18 136.87 38.28 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.351 2.034 . . . . 0.0 112.362 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 67.13 14.31 9.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.359 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.53 20.11 5.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.021 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.677 HG11 ' HB ' ' A' ' 34' ' ' ILE . 16.0 m -53.12 149.75 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.244 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.581 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -81.52 -15.01 77.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.754 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.757 HD22 HG12 ' A' ' 79' ' ' VAL . 42.1 mt -152.3 148.65 27.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 110.848 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.87 ' HB2' HD22 ' A' ' 115' ' ' LEU . 27.2 tt0 -129.8 146.71 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.21 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.401 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 29.0 mm -120.1 150.27 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.035 0.445 . . . . 0.0 111.763 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.22 147.45 6.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.694 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -173.83 164.34 4.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.098 0.475 . . . . 0.0 112.129 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.761 HD12 HD23 ' A' ' 29' ' ' LEU . 5.6 mm -117.59 151.83 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.362 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 1.01 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -131.49 147.53 52.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.976 0.417 . . . . 0.0 111.739 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.969 HG21 HG21 ' B' ' 3' ' ' THR . 27.1 m -109.6 152.01 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.055 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.786 ' HB2' HD11 ' A' ' 67' ' ' LEU . 11.7 ttp180 -173.18 73.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.78 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.86 0.362 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' MET . . . . . 0.491 ' O ' HG23 ' B' ' 3' ' ' THR . 3.6 mtt -89.48 87.99 7.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.969 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -175.58 118.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -157.81 118.18 3.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.009 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.803 HD11 ' OD1' ' A' ' 103' ' ' ASN . 4.4 mp -58.22 138.26 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.084 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.865 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 31.8 mt -94.83 138.11 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -150.94 136.92 18.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.52 162.77 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.72 26.67 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -118.11 -40.86 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -85.24 119.68 72.61 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 17.8 Cg_exo -66.03 -10.88 28.71 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.424 2.083 . . . . 0.0 112.572 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.43 172.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.525 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.487 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 62.86 130.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.207 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.95 -36.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.509 0.671 . . . . 0.0 110.773 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.04 -145.18 11.29 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.313 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 94.3 Cg_endo -83.64 58.01 5.82 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.715 2.276 . . . . 0.0 112.896 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -168.54 -177.29 3.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 111.067 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.751 HG13 ' CB ' ' A' ' 104' ' ' PHE . 27.0 m -112.77 -178.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.418 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 43.5 mt-30 -80.3 -51.05 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.044 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.865 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -156.59 179.75 8.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.272 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.56 147.32 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.076 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.916 ' HA ' HG12 ' B' ' 28' ' ' VAL . 20.4 t0 -123.24 94.39 4.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.786 HD22 HG11 ' A' ' 128' ' ' VAL . 11.0 mt -70.02 -17.42 63.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.61 -105.32 0.95 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.12 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ASN . . . . . 0.483 ' HB2' HD23 ' B' ' 27' ' ' LEU . 67.3 m-80 -52.66 -29.97 29.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.472 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' B' ' 26' ' ' ASN . 0.2 OUTLIER -137.29 134.17 35.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.776 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.017 HG23 ' HB3' ' B' ' 127' ' ' ALA . 3.0 m -113.03 172.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.737 HD23 HD12 ' B' ' 126' ' ' ILE . 1.0 OUTLIER -145.7 165.69 28.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.672 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.418 HG21 HD11 ' B' ' 62' ' ' ILE . 44.2 p -130.13 136.0 48.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 48.6 m -69.34 154.41 42.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' B' ' 123' ' ' ILE . . . -55.21 93.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.608 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.755 ' HG2' HG22 ' B' ' 58' ' ' VAL . 1.6 mp0 -67.66 173.66 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.734 0.302 . . . . 0.0 111.004 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.68 ' HB ' HG11 ' B' ' 119' ' ' VAL . 7.7 pt -159.37 152.59 18.55 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.004 0.43 . . . . 0.0 111.467 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.667 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 44.0 Cg_endo -68.14 74.81 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.108 2.538 . . . . 0.0 112.338 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.583 HG12 ' HA2' ' B' ' 41' ' ' GLY . 22.6 t -91.01 88.15 2.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.55 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.604 ' HB3' HG22 ' B' ' 40' ' ' THR . 0.3 OUTLIER -36.1 129.16 0.64 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.922 -179.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.12 -7.85 21.77 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.261 1.974 . . . . 0.0 112.108 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.99 -22.53 12.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.577 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.604 HG22 ' HB3' ' B' ' 37' ' ' ASN . 4.5 t -132.76 -38.94 0.99 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.909 0.385 . . . . 0.0 111.002 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.583 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 85.77 56.86 2.27 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.32 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.439 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 12.9 mm-40 -145.08 -71.13 0.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.682 0.277 . . . . 0.0 111.441 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 7.1 p 172.89 112.54 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -55.63 140.64 84.07 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.331 2.021 . . . . 0.0 112.153 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.1 71.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' B' ' 49' ' ' ALA . 1.0 OUTLIER -75.74 94.91 3.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.863 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.497 HD12 ' NE2' ' B' ' 50' ' ' GLN . 6.3 tp -44.43 -31.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.408 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.19 -38.27 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.733 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' B' ' 46' ' ' ASP . . . -69.28 -39.99 78.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.463 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.497 ' NE2' HD12 ' B' ' 47' ' ' ILE . 6.8 pt20 -75.52 -21.83 57.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.239 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.6 -41.49 26.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.213 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.26 -34.47 63.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.15 -31.51 64.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.57 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.795 ' O ' HG23 ' B' ' 58' ' ' VAL . 68.9 p -67.31 -30.82 70.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.84 HD13 ' CE2' ' B' ' 95' ' ' PHE . 34.4 mt -79.38 -30.7 42.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.6 -55.9 20.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 9.3 p-10 -55.76 -45.03 78.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.795 HG23 ' O ' ' B' ' 54' ' ' SER . 44.9 t -59.27 -30.94 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.768 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -79.22 -38.47 35.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.16 81.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' B' ' 58' ' ' VAL . 6.5 mt -67.02 -51.41 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.792 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.418 HD11 HG21 ' B' ' 30' ' ' THR . 45.8 mt -63.19 -32.64 57.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.598 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.64 -40.69 63.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.266 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.56 -21.0 65.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.485 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.89 -25.68 20.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.1 47.96 0.54 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.461 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.809 HD22 ' OD2' ' B' ' 71' ' ' ASP . 7.2 mt -156.75 -171.65 3.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.764 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 76.8 p -142.82 -179.65 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.809 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -78.59 -24.93 45.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.577 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.579 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -59.79 -36.47 76.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.029 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.809 ' OD2' HD22 ' B' ' 67' ' ' LEU . 4.0 p30 -71.06 -26.51 63.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.055 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 105' ' ' PRO . 88.3 mt -46.8 115.63 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.445 HG21 HD21 ' C' ' 24' ' ' LEU . 27.3 m -91.21 -25.95 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.762 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.636 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 1.7 ttpm? -138.11 164.42 29.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.0 110.936 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 125' ' ' ALA . 91.7 m -163.58 126.63 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.048 0.451 . . . . 0.0 111.484 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.587 HG23 ' O ' ' B' ' 108' ' ' SER . 2.8 m -109.28 144.78 36.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.03 108.4 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.914 0.388 . . . . 0.0 111.828 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.461 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.6 m-85 -91.46 107.16 19.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.24 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.753 HG12 HD22 ' B' ' 121' ' ' LEU . 30.2 m -102.22 149.97 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.158 0.504 . . . . 0.0 111.838 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.89 -6.14 49.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.747 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.45 111.96 3.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.516 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' B' ' 82' ' ' LEU . 2.6 mt -61.15 -15.24 31.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.242 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -78.31 -19.52 53.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.603 ' O ' HG23 ' B' ' 88' ' ' VAL . 19.2 m-20 -90.62 7.26 40.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.448 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.448 ' CD1' HG11 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -82.25 -27.48 32.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.749 0.309 . . . . 0.0 111.114 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.19 -36.8 75.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.157 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.36 -36.63 29.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.603 HG23 ' O ' ' B' ' 84' ' ' ASP . 28.8 t -75.63 -30.48 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' B' ' 85' ' ' PHE . 9.9 m120 -67.21 -48.93 66.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.94 -39.32 90.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.78 -23.98 55.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -81.78 -33.29 30.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.399 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.71 -29.68 18.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.657 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -75.88 -21.57 57.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.668 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.84 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -92.04 -33.13 14.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 110.671 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.495 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 2.6 m-85 -58.95 -59.11 5.99 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.09 0.472 . . . . 0.0 110.138 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -31.46 72.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.297 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.49 -11.6 60.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.436 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.49 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 4.9 m-20 -110.88 -6.44 14.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.336 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 0.9 OUTLIER 90.11 35.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.619 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.809 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.6 m-70 -115.3 53.43 0.83 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.959 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 71.8 Cg_endo -74.56 -14.61 22.21 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.541 2.161 . . . . 0.0 112.577 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.789 ' OD1' HD11 ' C' ' 5' ' ' ILE . 2.0 t30 -51.59 -33.33 32.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.135 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.727 ' CB ' HG13 ' C' ' 19' ' ' VAL . 3.6 m-85 61.49 96.48 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 59.9 Cg_endo -73.34 159.05 47.56 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.404 2.069 . . . . 0.0 112.255 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.636 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -55.59 147.72 17.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.458 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.76 142.49 45.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.032 0.444 . . . . 0.0 111.471 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.587 ' O ' HG23 ' B' ' 76' ' ' THR . 31.2 t -149.52 62.87 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.352 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 18.8 p -94.62 145.41 24.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.233 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.464 HG11 ' CD2' ' C' ' 78' ' ' PHE . 35.9 m -153.33 135.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.244 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -64.78 91.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.77 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.739 HG21 HD21 ' B' ' 115' ' ' LEU . 8.2 m -76.35 164.45 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.236 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -83.6 -44.88 14.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.106 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.425 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -158.51 158.68 34.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.706 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.863 HD22 ' HB2' ' B' ' 122' ' ' GLU . 0.9 OUTLIER -141.4 168.95 12.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.495 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' B' ' 115' ' ' LEU . 74.5 Cg_exo -50.16 136.89 38.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.352 2.035 . . . . 0.0 112.325 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.11 14.28 9.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.398 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.56 20.07 5.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.041 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.68 HG11 ' HB ' ' B' ' 34' ' ' ILE . 16.0 m -53.1 149.77 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.198 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 120' ' ' GLY . . . . . 0.581 ' O ' HD23 ' B' ' 121' ' ' LEU . . . -81.56 -15.15 76.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.769 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.753 HD22 HG12 ' B' ' 79' ' ' VAL . 42.5 mt -152.21 148.63 27.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.959 0.409 . . . . 0.0 110.848 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.863 ' HB2' HD22 ' B' ' 115' ' ' LEU . 27.0 tt0 -129.68 146.63 51.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.284 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.415 ' O ' ' HA2' ' B' ' 32' ' ' GLY . 29.3 mm -120.11 150.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 111.748 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.16 147.48 6.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.69 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.517 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -173.87 164.4 4.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 112.133 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.737 HD12 HD23 ' B' ' 29' ' ' LEU . 5.6 mm -117.74 151.85 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.334 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 1.017 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -131.45 147.54 52.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 111.781 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.945 HG21 HG21 ' C' ' 3' ' ' THR . 27.1 m -109.62 151.93 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.086 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.786 ' HB2' HD11 ' B' ' 67' ' ' LEU . 11.7 ttp180 -173.09 73.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.79 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.94 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.844 0.354 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' MET . . . . . 0.477 ' O ' HG23 ' C' ' 3' ' ' THR . 3.6 mtt -89.51 87.93 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.945 HG21 HG21 ' B' ' 128' ' ' VAL . 0.0 OUTLIER -175.57 118.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.742 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -157.87 118.22 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.789 HD11 ' OD1' ' B' ' 103' ' ' ASN . 4.4 mp -58.19 138.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.092 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.83 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 31.6 mt -94.73 138.08 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.169 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -151.0 136.91 18.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.49 162.77 34.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.71 26.65 5.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -118.06 -40.69 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.791 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' C' ' 12' ' ' PRO . . . -85.5 119.67 72.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.124 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' C' ' 11' ' ' ALA . 17.8 Cg_exo -66.03 -10.88 28.73 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.496 2.131 . . . . 0.0 112.601 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.5 172.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.472 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 62.94 130.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.16 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.91 -36.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.495 0.664 . . . . 0.0 110.741 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.06 -145.12 11.23 Favored Glycine 0 C--N 1.315 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.364 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.68 57.95 5.78 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.702 2.268 . . . . 0.0 112.901 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -168.45 -177.37 3.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.086 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.727 HG13 ' CB ' ' B' ' 104' ' ' PHE . 27.0 m -112.73 -178.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.328 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 43.4 mt-30 -80.31 -51.2 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.05 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.83 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -156.41 179.68 9.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.282 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.5 147.37 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.921 ' HA ' HG12 ' C' ' 28' ' ' VAL . 20.4 t0 -123.25 94.36 4.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.773 HD22 HG11 ' B' ' 128' ' ' VAL . 11.0 mt -69.99 -17.4 63.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.232 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.62 -105.37 0.95 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.178 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' ASN . . . . . 0.499 ' HB2' HD23 ' C' ' 27' ' ' LEU . 67.0 m-80 -52.53 -30.07 28.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.038 0.447 . . . . 0.0 110.517 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' C' ' 26' ' ' ASN . 0.2 OUTLIER -137.21 134.14 35.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.824 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.998 HG23 ' HB3' ' C' ' 127' ' ' ALA . 3.0 m -113.0 172.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.256 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.753 HD23 HD12 ' C' ' 126' ' ' ILE . 1.0 OUTLIER -145.68 165.65 28.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.69 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 44.1 p -130.14 135.96 48.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -69.43 154.44 42.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.032 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' C' ' 123' ' ' ILE . . . -55.26 93.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.647 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.746 ' HG2' HG22 ' C' ' 58' ' ' VAL . 1.6 mp0 -67.58 173.7 4.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.742 0.306 . . . . 0.0 110.991 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.671 ' HB ' HG11 ' C' ' 119' ' ' VAL . 7.7 pt -159.37 152.52 18.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.484 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.672 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 43.7 Cg_endo -68.14 74.84 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.112 2.541 . . . . 0.0 112.304 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.604 HG12 ' HA2' ' C' ' 41' ' ' GLY . 22.5 t -90.99 88.14 2.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.589 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.586 ' HB3' HG22 ' C' ' 40' ' ' THR . 0.3 OUTLIER -36.13 129.16 0.64 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.939 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.1 -7.84 21.75 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.339 2.026 . . . . 0.0 112.084 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.02 -22.54 12.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.582 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.586 HG22 ' HB3' ' C' ' 37' ' ' ASN . 4.5 t -132.73 -39.0 0.99 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.869 0.366 . . . . 0.0 110.988 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 85.77 56.92 2.26 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.275 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.446 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 13.0 mm-40 -145.09 -71.19 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.389 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 7.2 p 172.92 112.56 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.67 140.65 84.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.304 2.002 . . . . 0.0 112.151 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.13 71.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.979 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' C' ' 49' ' ' ALA . 1.0 OUTLIER -75.76 94.9 3.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.822 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 tp -44.43 -31.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.39 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.25 -38.21 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.723 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' C' ' 46' ' ' ASP . . . -69.25 -40.05 78.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.46 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -75.5 -21.95 57.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.241 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.69 -41.59 26.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.181 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.28 -34.36 63.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.786 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.16 -31.56 64.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.556 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.815 ' O ' HG23 ' C' ' 58' ' ' VAL . 69.0 p -67.28 -30.87 70.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.696 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.795 HD13 ' CE2' ' C' ' 95' ' ' PHE . 34.4 mt -79.34 -30.71 42.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.851 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.53 -55.89 20.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.031 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 9.3 p-10 -55.77 -45.06 78.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.815 HG23 ' O ' ' C' ' 54' ' ' SER . 45.1 t -59.19 -31.03 45.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -79.24 -38.5 35.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.701 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.9 80.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' C' ' 58' ' ' VAL . 6.5 mt -67.32 -51.52 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.826 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 mt -63.18 -32.69 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.6 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.66 -40.66 63.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.28 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.58 -20.96 65.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.485 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.9 -25.67 20.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.858 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.11 47.91 0.54 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.453 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.822 HD22 ' OD2' ' C' ' 71' ' ' ASP . 7.2 mt -156.71 -171.64 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.712 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 77.7 p -142.77 -179.6 6.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.804 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -78.64 -24.95 44.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.52 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.575 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -59.82 -36.54 77.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.822 ' OD2' HD22 ' C' ' 67' ' ' LEU . 4.0 p30 -71.11 -26.34 62.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.062 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' C' ' 105' ' ' PRO . 88.4 mt -46.81 115.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.87 0.367 . . . . 0.0 110.953 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.44 HG21 HD21 ' A' ' 24' ' ' LEU . 27.3 m -91.2 -26.0 5.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.78 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 1.7 ttpm? -138.08 164.45 29.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.704 0.288 . . . . 0.0 110.913 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.486 HG23 ' HB2' ' C' ' 125' ' ' ALA . 91.0 m -163.54 126.62 2.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.994 0.426 . . . . 0.0 111.502 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.6 HG23 ' O ' ' C' ' 108' ' ' SER . 2.8 m -109.34 144.79 37.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.845 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.01 108.39 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 111.844 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.464 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.6 m-85 -91.44 107.11 18.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.332 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.73 HG12 HD22 ' C' ' 121' ' ' LEU . 29.9 m -102.14 149.94 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.137 0.494 . . . . 0.0 111.837 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.81 -6.36 49.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.858 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.13 111.91 3.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.488 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.22 -15.21 32.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.282 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -78.33 -19.51 53.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.767 0.318 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.608 ' O ' HG23 ' C' ' 88' ' ' VAL . 19.2 m-20 -90.64 7.26 40.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.372 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.447 ' CD1' HG11 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -82.32 -27.41 32.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 111.117 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.31 -36.67 76.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.162 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.41 -36.66 29.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.608 HG23 ' O ' ' C' ' 84' ' ' ASP . 28.3 t -75.63 -30.47 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 89' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' C' ' 85' ' ' PHE . 9.9 m120 -67.16 -48.95 66.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.1 90.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 91' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 0.6 OUTLIER -75.91 -23.91 55.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.248 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -81.71 -33.32 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.378 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 93' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' C' ' 104' ' ' PHE . 0.8 OUTLIER -89.69 -29.72 18.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.651 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 94' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 1.3 ppt_? -75.88 -21.54 57.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.686 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.795 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -92.02 -33.18 14.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.795 0.331 . . . . 0.0 110.669 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 2.6 m-85 -59.03 -59.05 6.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.032 0.444 . . . . 0.0 110.124 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -31.5 72.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.279 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.53 -11.5 60.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.436 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 4.9 m-20 -110.93 -6.49 14.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.302 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 0.9 OUTLIER 90.21 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.539 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.804 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.6 m-70 -115.37 53.38 0.84 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.0 Cg_endo -74.57 -14.61 22.2 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.514 2.143 . . . . 0.0 112.563 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.803 ' OD1' HD11 ' A' ' 5' ' ' ILE . 2.0 t30 -51.61 -33.27 32.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.125 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.74 ' CB ' HG13 ' A' ' 19' ' ' VAL . 3.7 m-85 61.5 96.45 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.016 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 60.2 Cg_endo -73.26 159.17 47.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.389 2.059 . . . . 0.0 112.293 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.648 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -55.77 147.64 18.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.65 142.47 45.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.034 0.445 . . . . 0.0 111.476 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 108' ' ' SER . . . . . 0.6 ' O ' HG23 ' C' ' 76' ' ' THR . 31.0 t -149.49 62.84 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.346 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 18.5 p -94.59 145.36 24.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.221 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.455 HG11 ' CD2' ' A' ' 78' ' ' PHE . 35.8 m -153.24 134.88 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.195 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.636 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.51 91.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.761 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.753 HG21 HD21 ' C' ' 115' ' ' LEU . 8.4 m -76.28 164.41 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.286 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -83.68 -44.81 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.432 ' HB2' ' HB3' ' B' ' 111' ' ' GLU . 0.1 OUTLIER -158.56 158.61 34.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.746 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.86 HD22 ' HB2' ' C' ' 122' ' ' GLU . 0.9 OUTLIER -141.37 168.98 12.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.501 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' C' ' 115' ' ' LEU . 74.1 Cg_exo -50.19 136.88 38.37 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.37 2.047 . . . . 0.0 112.275 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.11 14.35 9.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.366 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.54 20.14 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.009 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.671 HG11 ' HB ' ' C' ' 34' ' ' ILE . 16.0 m -53.21 149.81 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 120' ' ' GLY . . . . . 0.595 ' O ' HD23 ' C' ' 121' ' ' LEU . . . -81.72 -15.13 76.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.794 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.73 HD22 HG12 ' C' ' 79' ' ' VAL . 41.9 mt -152.16 148.53 27.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.89 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.86 ' HB2' HD22 ' C' ' 115' ' ' LEU . 27.1 tt0 -129.68 146.68 51.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.26 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' C' ' 32' ' ' GLY . 29.3 mm -120.18 150.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.064 0.459 . . . . 0.0 111.742 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.09 147.46 6.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.65 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -173.83 164.38 4.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.111 0.482 . . . . 0.0 112.119 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.753 HD12 HD23 ' C' ' 29' ' ' LEU . 5.6 mm -117.67 151.85 19.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.303 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.998 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -131.46 147.58 52.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 111.771 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.977 HG21 HG21 ' A' ' 3' ' ' THR . 27.1 m -109.66 151.97 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.062 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.797 ' HB2' HD11 ' C' ' 67' ' ' LEU . 11.7 ttp180 -173.09 73.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.759 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.76 0.314 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.4 tpp -137.2 166.65 23.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.821 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER 60.1 101.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.12 110.6 17.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.859 HD11 HG21 ' A' ' 19' ' ' VAL . 2.3 tp -54.99 129.66 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.192 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.634 HD12 ' CB ' ' A' ' 21' ' ' ALA . 32.1 mt -90.53 151.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.412 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.78 108.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.818 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.09 170.28 10.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.69 22.27 10.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.926 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.5 -37.96 6.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.638 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -100.46 127.87 31.73 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.058 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 7.8 Cg_exo -72.1 -1.67 10.41 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.668 2.246 . . . . 0.0 112.701 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' HE21 ' A' ' 20' ' ' GLN . . . -46.92 170.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.862 0.363 . . . . 0.0 111.586 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.27 119.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.115 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 15' ' ' ILE . 13.5 mt -154.79 15.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.858 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.36 -114.64 0.5 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.974 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HB2' ' CD1' ' C' ' 92' ' ' TYR . 92.8 Cg_endo -81.01 50.98 3.76 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.664 2.242 . . . . 0.0 112.981 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.484 ' CG ' ' HB2' ' C' ' 107' ' ' ARG . 1.7 p90 -178.7 156.84 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.0 111.002 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.859 HG21 HD11 ' A' ' 5' ' ' ILE . 31.2 m -106.69 -174.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.174 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.699 HE21 ' HB3' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -73.68 -43.8 58.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.634 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . -176.93 177.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.742 HG12 HD12 ' A' ' 5' ' ' ILE . 18.6 m -138.38 133.75 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.809 ' HA ' HG23 ' A' ' 28' ' ' VAL . 37.5 t70 -103.86 102.8 12.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.657 HD22 HG11 ' C' ' 128' ' ' VAL . 11.8 mt -81.07 -17.88 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.16 -103.57 0.9 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.954 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.35 -29.11 63.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.086 0.47 . . . . 0.0 110.286 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -132.18 122.98 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.923 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.029 HG12 ' HB3' ' A' ' 127' ' ' ALA . 4.2 p -109.28 145.75 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.98 139.53 53.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.9 p -112.93 161.84 16.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.771 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.6 p -95.65 165.55 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.099 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.53 94.34 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.342 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.19 146.14 54.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.248 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.784 ' HB ' HG11 ' A' ' 119' ' ' VAL . 9.5 pt -134.46 142.08 41.44 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.794 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 7.8 Cg_exo -72.56 55.16 2.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.961 2.441 . . . . 0.0 113.138 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.579 HG22 HD12 ' A' ' 34' ' ' ILE . 20.5 t -62.05 85.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.241 0.544 . . . . 0.0 110.554 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 41' ' ' GLY . 12.6 t-20 -35.52 125.58 0.61 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.098 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.78 -7.75 21.73 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.108 1.872 . . . . 0.0 111.672 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.84 -28.09 13.3 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.653 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.485 HG23 ' CG ' ' A' ' 42' ' ' GLU . 4.7 t -128.84 -30.57 2.25 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.398 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.526 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 83.08 62.13 1.85 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.536 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' CG ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER -161.4 -81.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.674 0.273 . . . . 0.0 111.418 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.617 HG21 ' H ' ' A' ' 120' ' ' GLY . 11.4 p -177.15 110.31 0.23 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.379 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 35' ' ' PRO . 52.5 Cg_exo -52.53 140.44 54.62 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.477 2.118 . . . . 0.0 112.422 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.64 -32.05 70.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 92.69 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.615 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 47' ' ' ILE . 22.5 mm -40.12 -32.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.373 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.87 -56.46 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . . . -63.08 -28.74 70.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.772 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -80.59 -28.83 37.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.675 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' CB ' HG22 ' A' ' 88' ' ' VAL . . . -79.28 -34.8 42.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.538 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.52 -28.79 52.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.179 -179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.25 -48.17 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 110.838 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -59.65 -35.74 75.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.759 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.636 HD13 ' CE2' ' A' ' 95' ' ' PHE . 9.8 mt -64.3 -54.76 28.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.15 -31.44 68.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -67.96 -33.84 75.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.791 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 54' ' ' SER . 39.3 t -69.95 -49.44 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -29.67 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.988 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.42 95.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.61 HG22 HG21 ' A' ' 6' ' ' ILE . 5.3 mt -72.39 -42.57 64.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.536 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.981 HD13 HD11 ' A' ' 72' ' ' ILE . 21.1 mt -69.15 -30.85 47.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.822 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.11 -40.79 59.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.328 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.73 -19.49 65.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.602 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.54 -26.81 19.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.47 41.59 0.67 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.529 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.569 HD22 ' OD2' ' A' ' 71' ' ' ASP . 18.4 mt -155.28 147.11 23.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 110.669 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -101.49 -179.65 4.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.747 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.0 ' HB3' ' CD2' ' A' ' 101' ' ' HIS . . . -78.8 -23.07 45.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.773 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -62.98 -33.52 75.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.569 ' OD2' HD22 ' A' ' 67' ' ' LEU . 10.7 p30 -75.47 -21.76 57.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.71 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.063 HD13 ' HB2' ' A' ' 127' ' ' ALA . 26.4 mm -52.44 121.02 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.86 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' B' ' 22' ' ' VAL . 7.3 m -89.55 -32.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.013 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.825 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -130.11 165.67 21.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.571 0.224 . . . . 0.0 110.937 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 74' ' ' LYS . 6.1 p -162.47 105.91 1.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.831 0.348 . . . . 0.0 111.544 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 108' ' ' SER . 4.6 m -91.92 155.34 18.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.158 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.605 HG22 HG22 ' A' ' 123' ' ' ILE . 21.2 t -150.93 103.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.911 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.537 ' CD2' HG11 ' C' ' 110' ' ' VAL . 10.8 m-85 -89.7 99.73 12.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.358 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.863 HG12 HD23 ' A' ' 121' ' ' LEU . 19.1 m -98.41 147.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.588 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.21 -3.71 50.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.231 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -160.98 142.24 11.78 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.627 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.502 HD12 ' HB3' ' B' ' 114' ' ' ARG . 6.6 mt -82.91 1.55 38.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.26 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -98.67 -24.3 15.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.824 0.345 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.81 -27.01 60.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.01 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.546 ' HD2' HG11 ' A' ' 79' ' ' VAL . 1.8 t80 -59.31 -18.65 39.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.58 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.28 -57.78 10.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 111.382 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.93 71.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG22 ' CB ' ' A' ' 51' ' ' ALA . 26.7 t -70.73 -41.27 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.981 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.11 -47.36 80.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.726 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.49 75.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -92.31 -15.95 26.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.685 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.464 ' OH ' HG21 ' A' ' 75' ' ' THR . 12.4 t80 -81.66 -38.33 26.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.729 0.299 . . . . 0.0 111.281 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.0 -28.71 22.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.346 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.21 -21.81 59.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.649 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.636 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -92.07 -34.39 14.4 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.983 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.505 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 3.1 m-85 -57.3 -57.79 11.1 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.091 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.28 -29.81 70.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.097 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.92 -10.17 59.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.49 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.567 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 1.7 t-20 -108.57 -8.83 15.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.311 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 4.3 t30 88.96 33.24 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.445 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 1.0 ' CD2' ' HB3' ' A' ' 69' ' ' ALA . 2.0 m-70 -116.83 54.35 1.31 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.842 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 80.2 Cg_endo -75.22 -11.59 21.08 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.618 2.212 . . . . 0.0 112.823 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.612 ' OD1' HD13 ' B' ' 5' ' ' ILE . 2.2 t-20 -47.96 -37.55 14.78 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.763 ' O ' HG13 ' B' ' 19' ' ' VAL . 11.6 m-85 63.96 83.89 0.19 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.387 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.76 156.16 63.23 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.611 2.207 . . . . 0.0 112.018 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.825 ' HB3' ' CG ' ' A' ' 74' ' ' LYS . . . -53.38 162.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.572 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.484 ' HB2' ' CG ' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -133.01 143.74 49.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.22 0.534 . . . . 0.0 111.734 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 76' ' ' THR . 5.7 t -143.64 65.23 1.32 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.802 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.91 140.26 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.275 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' B' ' 78' ' ' PHE . 35.7 m -149.94 132.48 6.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.018 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.843 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 2.4 tt0 -63.73 86.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 78' ' ' PHE . 6.7 m -72.57 161.22 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.115 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -77.17 -45.81 25.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.501 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -153.57 168.08 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.637 HD22 ' CB ' ' A' ' 122' ' ' GLU . 1.3 mp -142.7 160.62 52.95 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.708 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' O ' HG22 ' A' ' 119' ' ' VAL . 71.5 Cg_exo -48.75 136.03 27.89 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.486 2.124 . . . . 0.0 112.228 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.475 ' HB2' HG13 ' A' ' 119' ' ' VAL . 6.0 mmtm 64.39 16.73 10.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.319 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.72 17.76 9.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.913 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.784 HG11 ' HB ' ' A' ' 34' ' ' ILE . 30.2 m -53.31 122.52 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.302 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -55.32 -21.45 26.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.909 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.863 HD23 HG12 ' A' ' 79' ' ' VAL . 1.6 mp -152.77 147.67 26.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.278 0.561 . . . . 0.0 111.53 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.637 ' CB ' HD22 ' A' ' 115' ' ' LEU . 11.8 tt0 -139.21 151.48 46.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.407 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 77' ' ' VAL . 5.8 pt -150.29 139.28 15.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.4 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 1.1 pm0 -138.74 142.94 38.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.053 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -149.62 172.6 14.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.496 ' O ' HG23 ' A' ' 72' ' ' ILE . 9.4 mt -125.68 153.96 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.064 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' A' ' 72' ' ' ILE . . . -135.4 152.96 51.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.035 0.445 . . . . 0.0 111.797 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.795 HG21 HG21 ' B' ' 3' ' ' THR . 30.0 m -115.98 164.15 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.999 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB2' HD21 ' A' ' 67' ' ' LEU . 28.2 ttt85 -164.06 64.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.815 0.34 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 1.4 tpp -137.17 166.64 23.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.795 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER 60.1 101.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.13 110.63 17.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.946 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.876 HD11 HG21 ' B' ' 19' ' ' VAL . 2.3 tp -55.02 129.66 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.22 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.639 HD12 ' CB ' ' B' ' 21' ' ' ALA . 31.4 mt -90.43 151.53 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.413 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.81 108.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.06 170.32 10.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.981 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.73 22.24 10.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.55 -38.05 6.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.645 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -100.32 127.88 31.91 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.05 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 7.7 Cg_exo -72.11 -1.67 10.42 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.618 2.212 . . . . 0.0 112.751 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.693 ' HB3' HE21 ' B' ' 20' ' ' GLN . . . -46.88 170.17 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.867 0.365 . . . . 0.0 111.544 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.18 119.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.053 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.607 HG22 ' O ' ' B' ' 15' ' ' ILE . 13.3 mt -154.73 15.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.908 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.33 -114.66 0.5 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.977 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.462 ' HB2' ' CD1' ' A' ' 92' ' ' TYR . 92.5 Cg_endo -80.95 50.93 3.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.7 2.267 . . . . 0.0 112.992 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.484 ' CG ' ' HB2' ' A' ' 107' ' ' ARG . 1.7 p90 -178.69 156.81 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.9 0.381 . . . . 0.0 110.996 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.876 HG21 HD11 ' B' ' 5' ' ' ILE . 30.8 m -106.69 -174.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.17 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.693 HE21 ' HB3' ' B' ' 13' ' ' ALA . 1.0 OUTLIER -73.53 -43.54 59.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.639 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . -177.06 177.46 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.719 HG12 HD12 ' B' ' 5' ' ' ILE . 18.6 m -138.37 133.78 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.146 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.829 ' HA ' HG23 ' B' ' 28' ' ' VAL . 37.5 t70 -103.93 102.84 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.684 HD22 HG11 ' A' ' 128' ' ' VAL . 11.9 mt -81.08 -17.93 48.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.2 -103.6 0.9 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.895 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.32 -29.1 63.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.088 0.471 . . . . 0.0 110.287 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.424 ' HG ' HG12 ' B' ' 128' ' ' VAL . 0.2 OUTLIER -132.21 122.96 26.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.884 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.053 HG12 ' HB3' ' B' ' 127' ' ' ALA . 4.2 p -109.29 145.8 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.844 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.403 HD23 ' HD2' ' A' ' 74' ' ' LYS . 5.2 mp -124.95 139.52 53.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.993 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 77.3 p -112.97 161.89 16.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.745 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 27.6 p -95.6 165.59 12.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.51 94.27 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.335 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.21 146.18 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.753 ' HB ' HG11 ' B' ' 119' ' ' VAL . 9.4 pt -134.5 142.06 41.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.815 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 7.9 Cg_exo -72.58 55.18 2.58 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.964 2.443 . . . . 0.0 113.146 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.574 HG22 HD12 ' B' ' 34' ' ' ILE . 20.5 t -61.99 85.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.585 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' B' ' 41' ' ' GLY . 12.6 t-20 -35.44 125.62 0.6 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.052 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.78 -7.8 21.84 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.148 1.898 . . . . 0.0 111.703 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.84 -28.04 13.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.703 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.489 HG23 ' CG ' ' B' ' 42' ' ' GLU . 4.7 t -128.86 -30.42 2.25 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.306 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.525 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 82.78 62.25 1.87 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.509 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.489 ' CG ' HG23 ' B' ' 40' ' ' THR . 0.4 OUTLIER -161.46 -81.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 0.0 111.435 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.616 HG13 ' O ' ' B' ' 43' ' ' VAL . 11.5 p -177.15 110.36 0.23 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.341 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.8 Cg_exo -52.65 140.45 55.82 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.46 2.107 . . . . 0.0 112.407 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.0 70.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.2 92.7 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.613 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' B' ' 47' ' ' ILE . 22.4 mm -40.16 -32.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.35 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.87 -56.43 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.749 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.43 ' HA ' ' HG2' ' B' ' 52' ' ' ARG . . . -63.05 -28.79 70.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.752 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -80.4 -28.3 37.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.634 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.492 ' CB ' HG22 ' B' ' 88' ' ' VAL . . . -79.43 -34.86 41.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.535 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' B' ' 49' ' ' ALA . 0.0 OUTLIER -77.48 -28.84 52.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.169 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.24 -48.11 65.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.82 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.765 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.5 OUTLIER -59.61 -35.79 75.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.66 HD13 ' CE2' ' B' ' 95' ' ' PHE . 9.8 mt -64.24 -54.8 27.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.24 -31.31 68.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.404 ' ND2' ' HD3' ' B' ' 12' ' ' PRO . 26.0 m120 -68.04 -33.71 75.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.765 HG23 ' O ' ' B' ' 54' ' ' SER . 39.2 t -70.0 -49.39 56.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -29.7 65.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.937 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.49 95.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.822 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.588 HG22 HG21 ' B' ' 6' ' ' ILE . 5.3 mt -72.29 -42.51 65.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.532 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 1.006 HD13 HD11 ' B' ' 72' ' ' ILE . 21.1 mt -69.1 -30.92 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.815 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -75.16 -40.7 59.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.337 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.78 -19.51 65.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.56 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.49 -26.85 19.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.47 41.69 0.67 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.469 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.568 HD22 ' OD2' ' B' ' 71' ' ' ASP . 18.4 mt -155.28 147.16 23.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 110.695 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -101.58 -179.73 4.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.719 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 1.01 ' HB3' ' CD2' ' B' ' 101' ' ' HIS . . . -78.75 -23.1 45.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 110.465 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.753 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -62.86 -33.55 75.52 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.568 ' OD2' HD22 ' B' ' 67' ' ' LEU . 10.6 p30 -75.35 -21.81 58.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.702 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 1.126 HD13 ' HB2' ' B' ' 127' ' ' ALA . 26.6 mm -52.54 121.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.79 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.639 ' HB ' HG21 ' C' ' 22' ' ' VAL . 7.2 m -89.61 -32.72 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.019 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.852 ' HG2' ' HB3' ' B' ' 106' ' ' ALA . 0.8 OUTLIER -130.19 165.65 21.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.567 0.222 . . . . 0.0 110.916 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.612 HG23 ' O ' ' B' ' 74' ' ' LYS . 6.1 p -162.43 105.9 1.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 111.523 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.536 HG23 ' O ' ' B' ' 108' ' ' SER . 4.6 m -91.89 155.4 18.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.219 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.602 HG22 HG22 ' B' ' 123' ' ' ILE . 21.2 t -150.97 103.15 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.834 0.349 . . . . 0.0 111.908 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.603 ' CD2' HG11 ' A' ' 110' ' ' VAL . 10.9 m-85 -89.84 99.86 12.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.247 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.857 HG12 HD23 ' B' ' 121' ' ' LEU . 19.0 m -98.52 147.71 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.58 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.27 -3.7 50.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.222 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -161.03 142.26 11.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.646 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.497 HD12 ' HB3' ' C' ' 114' ' ' ARG . 6.6 mt -82.97 1.58 39.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.256 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -98.68 -24.21 15.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.85 -26.96 60.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.549 ' HD2' HG11 ' B' ' 79' ' ' VAL . 1.8 t80 -59.3 -18.73 40.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.586 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.23 -57.82 10.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.36 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.96 71.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.158 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.492 HG22 ' CB ' ' B' ' 51' ' ' ALA . 26.3 t -70.72 -41.29 77.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.99 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.16 -47.32 80.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.733 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.52 75.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -92.2 -15.98 26.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.667 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' C' ' 17' ' ' PRO . 12.5 t80 -81.65 -38.29 26.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.771 0.32 . . . . 0.0 111.314 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.02 -28.78 22.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.329 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.15 -21.81 59.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.695 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.66 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -92.07 -34.47 14.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.941 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.489 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 3.1 m-85 -57.31 -57.76 11.22 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.07 0.462 . . . . 0.0 110.092 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.29 -29.78 70.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.121 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.96 -10.16 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.476 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.575 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 1.7 t-20 -108.58 -8.79 15.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.34 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 4.3 t30 88.97 33.13 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.457 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 1.01 ' CD2' ' HB3' ' B' ' 69' ' ' ALA . 2.0 m-70 -116.73 54.45 1.29 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.859 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 79.1 Cg_endo -75.3 -11.62 20.95 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.68 2.253 . . . . 0.0 112.777 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.594 ' OD1' HD13 ' C' ' 5' ' ' ILE . 2.2 t-20 -47.91 -37.59 14.56 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.941 0.4 . . . . 0.0 111.035 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.772 ' O ' HG13 ' C' ' 19' ' ' VAL . 11.6 m-85 64.01 83.84 0.19 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.396 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.75 156.17 63.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.604 2.203 . . . . 0.0 112.022 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.852 ' HB3' ' HG2' ' B' ' 74' ' ' LYS . . . -53.36 162.55 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.519 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.479 ' HB2' ' CG ' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -133.07 143.71 49.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.178 0.513 . . . . 0.0 111.689 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.536 ' O ' HG23 ' B' ' 76' ' ' THR . 5.6 t -143.66 65.29 1.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.759 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.99 140.25 30.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.245 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' C' ' 78' ' ' PHE . 35.8 m -150.01 132.54 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.984 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 2.4 tt0 -63.71 86.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.84 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' B' ' 78' ' ' PHE . 6.8 m -72.43 161.2 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -77.18 -45.85 25.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.502 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -153.58 168.03 27.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.623 HD22 ' CB ' ' B' ' 122' ' ' GLU . 1.3 mp -142.64 160.63 53.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.711 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.493 ' O ' HG22 ' B' ' 119' ' ' VAL . 71.6 Cg_exo -48.74 136.02 27.85 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.443 2.096 . . . . 0.0 112.259 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.476 ' HB2' HG13 ' B' ' 119' ' ' VAL . 6.0 mmtm 64.45 16.66 10.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.331 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.81 17.76 9.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.875 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.753 HG11 ' HB ' ' B' ' 34' ' ' ILE . 30.6 m -53.4 122.63 3.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.265 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 120' ' ' GLY . . . . . 0.584 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -55.28 -21.71 27.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.894 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.857 HD23 HG12 ' B' ' 79' ' ' VAL . 1.6 mp -152.6 147.58 26.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.268 0.556 . . . . 0.0 111.496 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.623 ' CB ' HD22 ' B' ' 115' ' ' LEU . 11.8 tt0 -139.18 151.52 46.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.407 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.602 HG22 HG22 ' B' ' 77' ' ' VAL . 5.8 pt -150.29 139.23 15.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -138.73 142.98 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.041 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -149.61 172.62 14.74 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.49 ' O ' HG23 ' B' ' 72' ' ' ILE . 9.5 mt -125.69 154.04 34.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.008 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 1.126 ' HB2' HD13 ' B' ' 72' ' ' ILE . . . -135.39 153.03 51.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.016 0.436 . . . . 0.0 111.849 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.834 HG21 HG21 ' C' ' 3' ' ' THR . 30.1 m -116.02 164.09 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.95 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.502 ' HB2' HD21 ' B' ' 67' ' ' LEU . 28.2 ttt85 -164.03 64.98 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.908 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.869 0.366 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 1.4 tpp -137.13 166.7 23.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.834 HG21 HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER 60.07 101.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.1 110.64 17.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.89 HD11 HG21 ' C' ' 19' ' ' VAL . 2.3 tp -55.01 129.66 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.678 HD12 ' CB ' ' C' ' 21' ' ' ALA . 31.2 mt -90.51 151.59 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.4 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.81 108.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.801 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.11 170.27 10.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.69 22.32 10.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.83 -38.3 6.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' C' ' 12' ' ' PRO . . . -99.92 127.96 32.25 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.115 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' C' ' 11' ' ' ALA . 7.8 Cg_exo -72.11 -1.75 10.53 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.653 2.235 . . . . 0.0 112.731 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.689 ' HB3' HE21 ' C' ' 20' ' ' GLN . . . -46.83 170.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.864 0.364 . . . . 0.0 111.592 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.18 119.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.088 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.604 HG22 ' O ' ' C' ' 15' ' ' ILE . 13.5 mt -154.73 15.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.881 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.42 -114.73 0.51 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.929 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' PRO . . . . . 0.465 ' HB2' ' CD1' ' B' ' 92' ' ' TYR . 93.3 Cg_endo -80.97 51.0 3.76 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.647 2.231 . . . . 0.0 113.018 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' B' ' 107' ' ' ARG . 1.7 p90 -178.65 156.84 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.952 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.89 HG21 HD11 ' C' ' 5' ' ' ILE . 30.9 m -106.72 -174.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.15 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.689 HE21 ' HB3' ' C' ' 13' ' ' ALA . 1.0 OUTLIER -73.6 -43.49 59.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.956 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.678 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . -176.95 177.6 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.088 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.751 HG12 HD12 ' C' ' 5' ' ' ILE . 18.6 m -138.42 133.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.839 ' HA ' HG23 ' C' ' 28' ' ' VAL . 37.5 t70 -103.97 102.68 12.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.715 HD23 HG23 ' C' ' 3' ' ' THR . 11.8 mt -80.91 -17.94 48.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.109 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.22 -103.57 0.9 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.915 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.38 -29.04 63.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.084 0.468 . . . . 0.0 110.279 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.463 ' HG ' HG12 ' C' ' 128' ' ' VAL . 0.2 OUTLIER -132.23 122.87 25.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.905 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 1.0 HG12 ' HB3' ' C' ' 127' ' ' ALA . 4.2 p -109.22 145.77 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.893 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.89 139.63 53.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 0.0 110.979 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 76.2 p -113.17 162.2 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.747 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 27.5 p -95.94 165.57 12.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.111 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.55 94.3 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.325 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.19 146.16 54.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.767 ' HB ' HG11 ' C' ' 119' ' ' VAL . 9.5 pt -134.47 142.06 41.37 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.847 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.523 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 7.9 Cg_exo -72.54 55.2 2.56 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.939 2.426 . . . . 0.0 113.138 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.567 HG22 HD12 ' C' ' 34' ' ' ILE . 20.6 t -62.03 85.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.194 0.521 . . . . 0.0 110.513 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' C' ' 41' ' ' GLY . 12.6 t-20 -35.47 125.53 0.61 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.1 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.74 -7.83 21.91 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.141 1.894 . . . . 0.0 111.626 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.82 -28.07 13.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.678 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.491 HG23 ' CG ' ' C' ' 42' ' ' GLU . 4.7 t -128.95 -30.69 2.21 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.342 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.519 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 83.25 62.19 1.83 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.569 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.491 ' CG ' HG23 ' C' ' 40' ' ' THR . 0.4 OUTLIER -161.47 -81.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.685 0.278 . . . . 0.0 111.4 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.61 ' O ' HG13 ' C' ' 43' ' ' VAL . 11.4 p -177.12 110.37 0.23 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.324 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' C' ' 35' ' ' PRO . 52.6 Cg_exo -52.59 140.45 55.26 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.488 2.125 . . . . 0.0 112.443 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.74 -32.01 70.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 92.77 0.12 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.635 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mm -40.23 -32.4 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.351 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.86 -56.45 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.71 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.422 ' HA ' ' HG2' ' C' ' 52' ' ' ARG . . . -63.1 -28.71 70.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.773 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -80.54 -28.77 37.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.626 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.411 ' CB ' HG22 ' C' ' 88' ' ' VAL . . . -79.19 -34.82 42.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.581 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' C' ' 49' ' ' ALA . 0.0 OUTLIER -77.51 -28.86 52.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.181 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.24 -48.11 65.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.836 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.775 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.5 OUTLIER -59.68 -35.72 75.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.611 HD13 ' CE2' ' C' ' 95' ' ' PHE . 9.7 mt -64.28 -54.79 27.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.925 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.19 -31.4 68.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -67.97 -33.8 75.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.828 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.775 HG23 ' O ' ' C' ' 54' ' ' SER . 39.1 t -69.91 -49.47 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -29.8 65.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.67 -41.25 94.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.616 HG22 HG21 ' C' ' 6' ' ' ILE . 5.3 mt -72.51 -42.58 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.574 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 1.003 HD13 HD11 ' C' ' 72' ' ' ILE . 21.0 mt -69.13 -30.85 47.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.852 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.19 -40.67 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.923 0.392 . . . . 0.0 110.335 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -19.44 65.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.531 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.52 -26.86 19.54 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.907 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.49 41.64 0.67 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.512 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.57 HD22 ' OD2' ' C' ' 71' ' ' ASP . 18.5 mt -155.29 147.1 23.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.661 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -101.47 -179.74 4.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.99 ' HB3' ' CD2' ' C' ' 101' ' ' HIS . . . -78.72 -23.06 45.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.789 0.328 . . . . 0.0 110.49 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.766 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -62.98 -33.37 75.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.57 ' OD2' HD22 ' C' ' 67' ' ' LEU . 10.7 p30 -75.81 -21.64 57.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 1.039 HD13 ' HB2' ' C' ' 127' ' ' ALA . 26.4 mm -52.53 121.12 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.848 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.619 ' HB ' HG21 ' A' ' 22' ' ' VAL . 7.1 m -89.68 -32.7 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.013 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.846 ' HG2' ' HB3' ' C' ' 106' ' ' ALA . 0.8 OUTLIER -130.25 165.62 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.576 0.227 . . . . 0.0 110.888 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.618 HG23 ' O ' ' C' ' 74' ' ' LYS . 6.1 p -162.44 105.84 1.13 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.811 0.338 . . . . 0.0 111.559 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.554 HG23 ' O ' ' C' ' 108' ' ' SER . 4.6 m -91.87 155.39 18.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.177 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.611 HG22 HG22 ' C' ' 123' ' ' ILE . 21.1 t -151.02 103.12 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.909 0.385 . . . . 0.0 111.935 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.586 ' CD2' HG11 ' B' ' 110' ' ' VAL . 10.9 m-85 -89.78 99.82 12.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.301 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.865 HG12 HD23 ' C' ' 121' ' ' LEU . 19.0 m -98.49 147.72 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.527 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.21 -3.43 49.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.176 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -161.27 142.17 11.29 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.639 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 114' ' ' ARG . 6.6 mt -82.92 1.61 38.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.233 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -98.66 -24.21 15.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.768 0.318 . . . . 0.0 110.9 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.86 -27.01 60.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.034 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.543 ' HD2' HG11 ' C' ' 79' ' ' VAL . 1.8 t80 -59.35 -18.6 39.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.619 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.35 -57.81 10.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 111.338 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.0 71.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.411 HG22 ' CB ' ' C' ' 51' ' ' ALA . 27.2 t -70.77 -41.19 77.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.17 -47.36 80.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.704 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.42 75.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.298 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -92.28 -15.88 26.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.721 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 12.5 t80 -81.71 -38.33 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.307 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.05 -28.68 22.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.333 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.15 -21.89 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.69 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.611 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -91.98 -34.49 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.972 -179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.497 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 3.1 m-85 -57.23 -57.79 11.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 110.13 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.25 -29.83 70.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.128 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.98 -10.09 59.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.489 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.559 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 1.7 t-20 -108.67 -8.8 15.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.29 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 4.3 t30 89.0 33.3 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.454 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.99 ' CD2' ' HB3' ' C' ' 69' ' ' ALA . 2.0 m-70 -116.97 54.48 1.37 Allowed Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.84 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 77.0 Cg_endo -75.32 -11.62 20.91 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.646 2.23 . . . . 0.0 112.761 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.615 ' OD1' HD13 ' A' ' 5' ' ' ILE . 2.2 t-20 -47.91 -37.52 14.44 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.876 0.37 . . . . 0.0 111.089 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.753 ' O ' HG13 ' A' ' 19' ' ' VAL . 11.5 m-85 63.93 83.84 0.19 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.41 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 33.8 Cg_endo -64.64 156.15 62.82 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.618 2.212 . . . . 0.0 112.076 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.846 ' HB3' ' HG2' ' C' ' 74' ' ' LYS . . . -53.44 162.6 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.567 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.484 ' HB2' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -133.14 143.74 49.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.185 0.516 . . . . 0.0 111.681 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 108' ' ' SER . . . . . 0.554 ' O ' HG23 ' C' ' 76' ' ' THR . 5.6 t -143.63 65.23 1.32 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.787 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.88 140.29 29.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.306 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.537 HG11 ' CD2' ' A' ' 78' ' ' PHE . 35.7 m -150.11 132.55 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.044 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.839 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.5 tt0 -63.59 86.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' C' ' 78' ' ' PHE . 6.7 m -72.48 161.21 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.188 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -77.2 -45.79 25.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.114 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.497 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -153.61 168.12 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.645 HD22 ' CB ' ' C' ' 122' ' ' GLU . 1.3 mp -142.73 160.62 52.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.693 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.485 ' O ' HG22 ' C' ' 119' ' ' VAL . 71.2 Cg_exo -48.76 136.06 27.92 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.41 2.073 . . . . 0.0 112.273 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.463 ' HB2' HG13 ' C' ' 119' ' ' VAL . 6.0 mmtm 64.46 16.65 10.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.286 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.74 17.85 9.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.879 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.767 HG11 ' HB ' ' C' ' 34' ' ' ILE . 30.5 m -53.41 122.54 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 120' ' ' GLY . . . . . 0.603 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -55.14 -21.53 25.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.905 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.865 HD23 HG12 ' C' ' 79' ' ' VAL . 1.6 mp -152.56 147.58 26.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.321 0.582 . . . . 0.0 111.489 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.645 ' CB ' HD22 ' C' ' 115' ' ' LEU . 11.8 tt0 -139.23 151.5 46.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.394 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.611 HG22 HG22 ' C' ' 77' ' ' VAL . 5.8 pt -150.28 139.22 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 1.1 pm0 -138.72 142.98 38.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.06 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -149.6 172.62 14.74 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' C' ' 72' ' ' ILE . 9.4 mt -125.69 154.05 34.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.046 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 1.039 ' HB2' HD13 ' C' ' 72' ' ' ILE . . . -135.46 153.16 51.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.001 0.429 . . . . 0.0 111.834 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.821 HG21 HG21 ' A' ' 3' ' ' THR . 30.2 m -116.12 164.16 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.0 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.537 ' HB2' HD21 ' C' ' 67' ' ' LEU . 28.2 ttt85 -164.07 64.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.785 0.326 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.859 ' O ' HD13 ' A' ' 24' ' ' LEU . 3.2 mtm -123.02 55.15 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.737 HG21 HG21 ' C' ' 128' ' ' VAL . 0.0 OUTLIER -178.34 135.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.41 131.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.712 HD12 HG11 ' A' ' 19' ' ' VAL . 39.0 mm -59.0 155.13 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' A' ' 21' ' ' ALA . 31.3 mt -121.13 133.61 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.33 149.19 28.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.686 HG22 ' OE1' ' A' ' 20' ' ' GLN . 11.3 t -150.84 165.59 33.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.946 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.89 25.56 5.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 5.5 mmtp -110.06 -50.97 2.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.655 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.13 114.03 50.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.58 -12.53 36.19 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.358 2.038 . . . . 0.0 112.621 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 15' ' ' ILE . . . -64.83 -169.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 62.18 -169.42 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.25 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.3 mt 77.17 17.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.228 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.11 -127.96 2.92 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.245 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -87.44 33.91 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.759 2.306 . . . . 0.0 112.861 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -175.87 156.8 1.85 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.025 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.712 HG11 HD12 ' A' ' 5' ' ' ILE . 35.0 m -92.26 152.6 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.06 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.686 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER -56.93 -36.51 70.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.409 . . . . 0.0 110.451 179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . -176.31 163.13 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.941 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -128.15 136.88 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.878 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.873 ' HA ' HG12 ' A' ' 28' ' ' VAL . 1.6 p30 -110.25 120.43 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.231 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.01 HD21 HG11 ' C' ' 128' ' ' VAL . 0.8 OUTLIER -90.53 -20.68 22.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.916 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.12 -108.66 0.77 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.672 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -60.38 -29.2 68.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.126 0.489 . . . . 0.0 110.067 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.724 ' HG ' HG12 ' A' ' 128' ' ' VAL . 7.4 mp -126.44 115.2 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.811 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.873 HG12 ' HA ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -105.37 176.24 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.197 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 28' ' ' VAL . 4.7 mp -150.53 161.66 42.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.408 HG21 HD11 ' A' ' 62' ' ' ILE . 23.4 p -126.16 159.21 33.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.074 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -95.06 168.07 10.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.196 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.09 94.74 0.1 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.263 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.451 ' CD ' HD11 ' A' ' 61' ' ' ILE . 47.0 mm-40 -73.6 165.73 24.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.909 0.385 . . . . 0.0 111.19 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.522 HG13 HG23 ' A' ' 36' ' ' VAL . 10.3 pt -149.93 143.05 16.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.015 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 43' ' ' VAL . 73.7 Cg_endo -75.05 59.38 5.21 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.794 2.33 . . . . 0.0 112.875 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.522 HG23 HG13 ' A' ' 34' ' ' ILE . 46.3 t -65.04 84.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.263 0.554 . . . . 0.0 110.643 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.455 ' HB3' ' OG1' ' A' ' 40' ' ' THR . 28.3 t30 -41.01 135.53 1.67 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.994 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.04 -5.91 16.81 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.222 1.948 . . . . 0.0 111.822 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.12 -28.45 9.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.349 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 37' ' ' ASN . 65.6 p -115.81 -29.26 6.45 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.865 0.364 . . . . 0.0 110.829 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 75.76 55.77 4.81 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.543 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.28 -79.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.639 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.6 HG21 ' H ' ' A' ' 120' ' ' GLY . 11.2 p -159.16 123.32 2.12 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.412 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 31.8 Cg_exo -58.26 150.18 68.27 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.388 2.059 . . . . 0.0 112.035 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.47 -30.79 68.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.978 0.418 . . . . 0.0 110.893 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -71.51 97.45 1.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.829 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.439 HD12 ' NE2' ' A' ' 50' ' ' GLN . 9.2 tp -42.14 -32.22 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.767 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -48.62 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -60.58 -41.04 93.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.752 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' NE2' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -70.01 -30.85 68.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.583 179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.34 -37.49 71.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.196 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -78.95 -35.62 42.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.92 -36.08 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.854 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -74.81 -31.67 61.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.752 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.6 mt -72.74 -36.28 67.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.8 -44.31 73.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -58.68 -46.57 86.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.948 HG21 ' CG2' ' A' ' 123' ' ' ILE . 21.4 t -60.72 -31.85 50.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.96 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.592 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 3.3 tttt -80.61 -32.51 36.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -67.14 -35.98 80.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 58' ' ' VAL . 5.8 mt -69.7 -45.24 78.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.76 HG22 ' HB3' ' A' ' 67' ' ' LEU . 11.0 mt -65.75 -35.28 74.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.458 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.94 75.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.327 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -21.42 63.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.422 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.45 -28.31 20.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.71 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.92 54.44 0.35 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.615 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.76 ' HB3' HG22 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 158.01 23.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.878 0.37 . . . . 0.0 110.671 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.429 ' O ' HD23 ' A' ' 67' ' ' LEU . 2.1 p -115.33 156.85 24.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.161 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.798 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -57.97 -35.91 71.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.057 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -50.64 -26.74 5.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.455 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.561 ' CB ' HD21 ' A' ' 67' ' ' LEU . 4.7 m-20 -85.5 -18.67 32.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.297 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.495 HD12 ' CB ' ' A' ' 127' ' ' ALA . 0.5 OUTLIER -54.5 117.89 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.506 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.665 HG11 HD21 ' B' ' 24' ' ' LEU . 29.0 m -88.13 -33.73 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.92 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.698 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 4.2 tttm -128.32 169.77 13.84 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.454 HG22 ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -169.93 112.97 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.875 0.369 . . . . 0.0 111.409 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.7 m -99.96 151.77 20.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.173 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 109' ' ' CYS . 5.0 m -146.48 128.85 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 111.929 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.535 ' HB2' HD21 ' A' ' 115' ' ' LEU . 4.1 m-85 -107.6 129.68 54.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.144 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.8 149.5 27.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.463 . . . . 0.0 111.721 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 115' ' ' LEU . 12.3 mttt -88.41 -4.2 58.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.781 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -160.57 115.55 2.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.384 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' B' ' 114' ' ' ARG . 3.1 mt -66.38 -11.23 50.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.088 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -80.83 -19.06 45.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.779 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -87.02 -19.53 28.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.07 -20.93 43.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.31 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.73 -39.2 65.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 111.283 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.54 -29.25 21.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.0 t -72.39 -44.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.31 -42.36 93.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.615 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.4 73.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -27.52 19.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.515 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.43 ' O ' ' CD2' ' A' ' 96' ' ' PHE . 68.6 t80 -54.08 -49.03 69.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.891 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.6 -27.44 25.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.54 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.23 -20.24 60.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.619 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.3 OUTLIER -90.14 -38.84 13.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.933 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 101' ' ' HIS . 14.6 m-85 -55.61 -58.81 6.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.604 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -64.74 -28.15 69.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.704 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -72.88 -13.58 61.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.317 . . . . 0.0 110.883 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 58.7 m-80 -111.18 -10.75 14.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.472 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 2.4 p-10 99.56 33.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.907 0.754 . . . . 0.0 111.004 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.798 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.2 m-70 -115.11 56.43 0.98 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.552 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 54.4 Cg_endo -68.64 -15.14 40.84 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.659 2.239 . . . . 0.0 113.363 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.548 ' HB3' HD11 ' B' ' 5' ' ' ILE . 3.1 m-20 -53.86 -43.19 69.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.913 0.387 . . . . 0.0 110.606 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.684 ' O ' HG13 ' B' ' 19' ' ' VAL . 30.4 m-85 71.85 84.13 0.13 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.959 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 19.1 Cg_endo -59.25 155.67 39.14 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.772 2.314 . . . . 0.0 112.327 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.698 ' HB3' ' CG ' ' A' ' 74' ' ' LYS . . . -51.39 158.16 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.234 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.9 ttp-105 -134.66 141.38 46.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.131 0.491 . . . . 0.0 111.854 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.42 66.12 1.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.064 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.4 ' HA ' HG23 ' A' ' 77' ' ' VAL . 28.0 p -79.49 130.88 35.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.188 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.5 m -148.82 144.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.981 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.842 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 2.3 tt0 -86.68 94.6 9.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.817 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' A' ' 115' ' ' LEU . 36.0 m -73.49 159.9 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -70.94 -37.13 72.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.434 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -160.84 166.96 27.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.976 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.543 ' C ' HD11 ' C' ' 82' ' ' LEU . 1.4 mt -143.39 155.71 60.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.673 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.34 135.85 70.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.563 2.175 . . . . 0.0 112.018 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.681 ' HB3' HG13 ' A' ' 119' ' ' VAL . 1.4 tppt? 69.62 20.36 7.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.18 26.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.118 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 117' ' ' LYS . 22.1 m -55.66 174.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.206 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.6 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -96.04 -15.13 43.14 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.569 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.623 HD22 ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -172.49 148.88 2.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.046 0.45 . . . . 0.0 111.168 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.716 ' O ' HD13 ' A' ' 123' ' ' ILE . 4.6 mt-10 -116.4 167.25 11.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.322 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.948 ' CG2' HG21 ' A' ' 58' ' ' VAL . 22.9 mm -141.88 131.87 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.206 0.527 . . . . 0.0 112.196 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.53 117.75 4.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.204 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -140.3 176.03 9.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.467 HG23 ' HG ' ' A' ' 29' ' ' LEU . 6.7 mt -119.88 154.69 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.038 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.859 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -139.37 150.75 45.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.908 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.948 HG11 HD21 ' B' ' 24' ' ' LEU . 33.0 m -125.1 126.67 71.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.665 ' HG3' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -94.93 43.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.042 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.928 179.876 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.815 0.34 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' MET . . . . . 0.86 ' O ' HD13 ' B' ' 24' ' ' LEU . 3.2 mtm -122.98 55.25 1.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.809 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.766 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -178.4 135.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.49 131.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.67 HD12 HG11 ' B' ' 19' ' ' VAL . 39.0 mm -58.96 155.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.542 HD12 ' CB ' ' B' ' 21' ' ' ALA . 31.6 mt -121.23 133.67 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.34 149.19 28.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.789 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.665 HG22 ' OE1' ' B' ' 20' ' ' GLN . 11.3 t -150.85 165.56 33.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.92 25.62 5.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.014 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.44 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 5.5 mmtp -110.13 -50.88 2.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.677 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.16 114.04 50.14 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.966 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.66 -12.5 36.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.35 2.034 . . . . 0.0 112.595 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.74 -169.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.548 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 62.18 -169.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.196 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.583 HG22 ' O ' ' B' ' 15' ' ' ILE . 2.3 mt 77.19 17.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.22 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.06 -127.91 2.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.225 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.51 33.94 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 112.892 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -175.85 156.78 1.85 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.85 0.357 . . . . 0.0 110.999 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 104' ' ' PHE . 35.1 m -92.27 152.59 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.064 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.665 ' OE1' HG22 ' B' ' 8' ' ' THR . 0.8 OUTLIER -56.88 -36.52 70.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 110.492 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.542 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . -176.58 163.15 2.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.037 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.494 HG13 HG21 ' B' ' 19' ' ' VAL . 0.2 OUTLIER -128.13 136.95 58.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.835 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.867 ' HA ' HG12 ' B' ' 28' ' ' VAL . 1.6 p30 -110.3 120.48 42.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.219 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.948 HD21 HG11 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -90.5 -20.77 22.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.18 -108.79 0.78 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.64 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -60.26 -29.32 68.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.04 0.448 . . . . 0.0 109.998 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.718 ' HG ' HG12 ' B' ' 128' ' ' VAL . 7.3 mp -126.37 115.15 19.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.795 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.894 HG23 ' HB3' ' B' ' 127' ' ' ALA . 0.9 OUTLIER -105.28 176.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.198 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.581 HD12 ' C ' ' B' ' 28' ' ' VAL . 4.7 mp -150.48 161.68 42.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.933 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.41 HG21 HD11 ' B' ' 62' ' ' ILE . 23.8 p -126.1 158.89 34.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.033 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.6 m -94.6 168.14 11.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.037 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.13 94.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.293 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.468 ' CG ' HG22 ' B' ' 58' ' ' VAL . 47.2 mm-40 -73.59 165.81 24.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 111.16 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.513 HG13 HG23 ' B' ' 36' ' ' VAL . 10.2 pt -150.03 143.03 16.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.992 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.52 ' HG2' HG23 ' B' ' 43' ' ' VAL . 73.7 Cg_endo -75.03 59.38 5.19 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.755 2.304 . . . . 0.0 112.898 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.513 HG23 HG13 ' B' ' 34' ' ' ILE . 46.3 t -65.03 84.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.297 0.57 . . . . 0.0 110.627 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.465 ' HB3' ' OG1' ' B' ' 40' ' ' THR . 28.3 t30 -40.99 135.54 1.66 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.997 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.04 -5.96 16.85 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.244 1.963 . . . . 0.0 111.823 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.1 -28.35 9.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.36 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' B' ' 37' ' ' ASN . 66.5 p -115.96 -29.41 6.35 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.827 0.346 . . . . 0.0 110.788 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 75.88 55.79 4.75 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.61 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.21 -79.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.687 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.568 HG21 ' H ' ' B' ' 120' ' ' GLY . 11.1 p -159.1 123.36 2.14 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.388 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' B' ' 35' ' ' PRO . 31.3 Cg_exo -58.34 150.18 68.94 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.373 2.049 . . . . 0.0 112.036 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.5 -30.69 68.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.026 0.441 . . . . 0.0 110.921 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.1 OUTLIER -71.55 97.43 1.68 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.829 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.442 HD12 ' NE2' ' B' ' 50' ' ' GLN . 9.1 tp -42.02 -32.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.756 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.22 -48.67 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.827 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -60.47 -41.11 93.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.768 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.443 ' NE2' HD12 ' B' ' 121' ' ' LEU . 0.9 OUTLIER -69.97 -30.91 68.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.562 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.41 -37.57 71.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.257 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -79.01 -35.7 42.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -36.16 73.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.854 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.1 OUTLIER -74.78 -31.78 61.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 34.9 mt -72.69 -36.24 67.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.86 -44.25 73.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -58.71 -46.56 87.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.949 HG21 ' CG2' ' B' ' 123' ' ' ILE . 21.5 t -60.73 -31.87 50.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.949 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.588 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 3.3 tttt -80.66 -32.48 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -66.95 -35.95 81.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' B' ' 58' ' ' VAL . 5.8 mt -69.77 -45.21 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.838 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.77 HG22 ' HB3' ' B' ' 67' ' ' LEU . 11.0 mt -65.75 -35.34 74.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.47 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 -42.94 76.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.303 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -21.47 63.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.403 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.51 -28.2 20.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.698 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.85 54.42 0.36 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.649 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.77 ' HB3' HG22 ' B' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 157.96 23.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.84 0.353 . . . . 0.0 110.672 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.428 ' O ' HD23 ' B' ' 67' ' ' LEU . 2.1 p -115.29 156.92 24.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.222 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.827 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -58.06 -35.86 71.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.051 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.581 ' HB2' ' OD1' ' B' ' 100' ' ' ASN . . . -50.67 -26.75 5.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.413 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.557 ' CB ' HD21 ' B' ' 67' ' ' LEU . 4.7 m-20 -85.49 -18.68 32.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.361 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' B' ' 69' ' ' ALA . 0.5 OUTLIER -54.51 117.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 110.556 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.648 HG11 HD21 ' C' ' 24' ' ' LEU . 28.7 m -88.17 -33.7 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.876 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.701 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 4.2 tttm -128.32 169.83 13.78 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.79 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.442 HG22 ' HB2' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -170.02 112.86 0.47 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.86 0.362 . . . . 0.0 111.378 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' B' ' 124' ' ' GLU . 24.6 m -99.9 151.84 20.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.147 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.404 HG23 ' HA ' ' B' ' 109' ' ' CYS . 4.9 m -146.57 128.85 7.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.017 0.437 . . . . 0.0 111.901 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.529 ' HB2' HD21 ' B' ' 115' ' ' LEU . 4.0 m-85 -107.58 129.68 54.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.125 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.8 149.49 27.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.065 0.46 . . . . 0.0 111.774 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' B' ' 115' ' ' LEU . 12.3 mttt -88.45 -4.4 58.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.735 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.48 115.51 2.24 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.387 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.476 HD11 ' C ' ' C' ' 115' ' ' LEU . 3.2 mt -66.33 -11.28 50.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -80.8 -19.08 45.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -86.98 -19.57 28.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.172 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.08 -20.9 43.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.339 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.27 65.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.817 0.341 . . . . 0.0 111.289 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.51 -29.19 21.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' B' ' 92' ' ' TYR . 28.5 t -72.37 -44.94 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.36 -42.35 92.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.559 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.41 73.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -27.52 18.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.517 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.433 ' O ' ' CD2' ' B' ' 96' ' ' PHE . 68.6 t80 -54.06 -49.13 69.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.885 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.54 -27.45 25.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.54 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.16 -20.26 60.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.648 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.3 OUTLIER -90.13 -38.86 13.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.0 110.932 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' B' ' 101' ' ' HIS . 14.8 m-85 -55.55 -58.88 5.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.584 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -64.75 -28.11 69.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.743 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -72.87 -13.59 61.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 110.919 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.525 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 58.8 m-80 -111.13 -10.83 14.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.482 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.581 ' OD1' ' HB2' ' B' ' 70' ' ' ALA . 2.3 p-10 99.57 33.26 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.832 0.707 . . . . 0.0 110.99 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.827 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.2 m-70 -115.01 56.36 0.94 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.553 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.401 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 53.8 Cg_endo -68.65 -15.17 40.85 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 113.335 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.543 ' HB3' HD11 ' C' ' 5' ' ' ILE . 3.1 m-20 -53.91 -43.08 69.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.62 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.693 ' O ' HG13 ' C' ' 19' ' ' VAL . 30.3 m-85 71.77 84.15 0.13 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.966 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 19.1 Cg_endo -59.22 155.67 39.0 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.749 2.299 . . . . 0.0 112.358 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.701 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.32 158.34 0.84 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.291 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.432 ' HB3' ' CD2' ' C' ' 18' ' ' TYR . 2.9 ttp-105 -134.84 141.31 46.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.13 0.491 . . . . 0.0 111.838 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.39 66.03 1.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.11 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' CYS . . . . . 0.404 ' HA ' HG23 ' B' ' 77' ' ' VAL . 28.0 p -79.42 130.89 35.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.18 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 20.9 m -148.79 143.91 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.982 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.839 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 2.3 tt0 -86.45 94.33 9.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' B' ' 115' ' ' LEU . 35.8 m -73.29 159.87 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.842 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -70.93 -37.12 72.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.57 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -160.87 166.91 27.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.004 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.545 ' C ' HD11 ' A' ' 82' ' ' LEU . 1.4 mt -143.33 155.73 61.08 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.41 135.83 70.94 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.578 2.186 . . . . 0.0 112.031 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.674 ' HB3' HG13 ' B' ' 119' ' ' VAL . 1.4 tppt? 69.69 20.31 6.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.975 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.19 26.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' B' ' 117' ' ' LYS . 21.6 m -55.78 174.49 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' GLY . . . . . 0.568 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -96.08 -15.58 41.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.554 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.61 ' C ' HD22 ' B' ' 121' ' ' LEU . 0.0 OUTLIER -172.09 148.74 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 111.184 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.715 ' O ' HD13 ' B' ' 123' ' ' ILE . 4.5 mt-10 -116.4 167.23 11.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.264 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.949 ' CG2' HG21 ' B' ' 58' ' ' VAL . 22.6 mm -141.91 131.85 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.188 0.518 . . . . 0.0 112.219 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' GLU . . . . . 0.401 ' HG3' ' HB ' ' B' ' 76' ' ' THR . 0.0 OUTLIER -153.57 117.69 4.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.166 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -140.22 176.05 9.08 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.469 HG23 ' HG ' ' B' ' 29' ' ' LEU . 6.7 mt -119.86 154.68 22.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.072 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.894 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -139.36 150.82 45.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.833 0.349 . . . . 0.0 111.902 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 1.027 HG11 HD21 ' C' ' 24' ' ' LEU . 33.0 m -125.22 126.66 71.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.678 ' HG3' HD12 ' B' ' 67' ' ' LEU . 0.4 OUTLIER -94.85 43.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.07 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.922 179.867 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 2' ' ' MET . . . . . 0.847 ' O ' HD13 ' C' ' 24' ' ' LEU . 3.2 mtm -122.99 55.13 1.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.794 HG21 HG21 ' B' ' 128' ' ' VAL . 0.0 OUTLIER -178.37 135.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.42 131.19 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.672 HD12 HG11 ' C' ' 19' ' ' VAL . 38.9 mm -58.94 155.15 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.536 HD12 ' CB ' ' C' ' 21' ' ' ALA . 31.3 mt -121.25 133.55 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.25 149.17 28.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.84 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.689 HG22 ' OE1' ' C' ' 20' ' ' GLN . 11.3 t -150.83 165.6 33.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.93 25.62 5.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.028 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.448 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 5.5 mmtp -110.11 -51.18 2.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.662 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.84 114.15 50.27 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.902 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.53 -12.57 36.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.369 2.046 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.406 ' O ' HD12 ' C' ' 15' ' ' ILE . . . -64.82 -169.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.14 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.547 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 62.24 -169.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.186 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.577 HG22 ' O ' ' C' ' 15' ' ' ILE . 2.3 mt 77.2 17.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.191 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.09 -128.0 2.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.23 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.4 33.88 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.728 2.285 . . . . 0.0 112.918 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.547 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -175.82 156.83 1.87 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.91 0.386 . . . . 0.0 110.987 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.693 HG13 ' O ' ' B' ' 104' ' ' PHE . 35.1 m -92.29 152.59 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.048 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.689 ' OE1' HG22 ' C' ' 8' ' ' THR . 0.8 OUTLIER -56.87 -36.54 70.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.439 . . . . 0.0 110.573 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.536 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . -176.26 163.09 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.934 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.478 HG13 HG21 ' C' ' 19' ' ' VAL . 0.2 OUTLIER -128.07 136.92 58.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.866 ' HA ' HG12 ' C' ' 28' ' ' VAL . 1.6 p30 -110.31 120.49 42.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.201 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 1.027 HD21 HG11 ' B' ' 128' ' ' VAL . 0.8 OUTLIER -90.57 -20.66 22.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.1 -108.67 0.77 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.664 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -60.42 -29.22 68.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.147 0.498 . . . . 0.0 110.072 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.709 ' HG ' HG12 ' C' ' 128' ' ' VAL . 7.3 mp -126.42 115.15 19.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.795 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.889 HG23 ' HB3' ' C' ' 127' ' ' ALA . 0.9 OUTLIER -105.31 176.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.203 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.581 HD12 ' C ' ' C' ' 28' ' ' VAL . 4.7 mp -150.56 161.64 42.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.3 p -126.22 158.99 34.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.006 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -94.64 167.99 11.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.1 94.8 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.251 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.453 ' CG ' HG22 ' C' ' 58' ' ' VAL . 47.2 mm-40 -73.59 165.78 24.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.204 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.541 ' HB ' HG11 ' C' ' 119' ' ' VAL . 10.3 pt -149.98 143.06 16.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.993 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.493 ' HG2' HG23 ' C' ' 43' ' ' VAL . 73.6 Cg_endo -75.01 59.31 5.16 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.782 2.321 . . . . 0.0 112.941 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.509 HG23 HG13 ' C' ' 34' ' ' ILE . 46.4 t -64.98 84.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.222 0.534 . . . . 0.0 110.612 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' C' ' 40' ' ' THR . 28.2 t30 -40.99 135.5 1.66 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.989 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.99 -5.95 16.88 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.255 1.97 . . . . 0.0 111.816 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.17 -28.29 9.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.347 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' C' ' 37' ' ' ASN . 65.7 p -115.94 -29.37 6.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.87 0.367 . . . . 0.0 110.85 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 75.88 55.78 4.75 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.599 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.29 -79.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.644 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.585 HG21 ' H ' ' C' ' 120' ' ' GLY . 11.3 p -159.12 123.38 2.14 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.464 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' C' ' 35' ' ' PRO . 31.2 Cg_exo -58.42 150.21 69.42 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.355 2.037 . . . . 0.0 112.016 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.5 -30.7 68.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.034 0.445 . . . . 0.0 110.9 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.1 OUTLIER -71.51 97.41 1.66 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.807 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.45 HD12 ' NE2' ' C' ' 50' ' ' GLN . 9.2 tp -42.17 -32.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.754 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -48.68 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.791 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -60.47 -41.09 93.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.789 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.45 ' NE2' HD12 ' C' ' 47' ' ' ILE . 0.9 OUTLIER -69.96 -30.88 68.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.627 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.54 -37.63 71.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.192 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' C' ' 49' ' ' ALA . 3.5 ptm180 -79.0 -35.6 42.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -36.13 73.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.846 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.1 OUTLIER -74.89 -31.68 61.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.694 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 34.8 mt -72.74 -36.3 67.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.789 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.75 -44.27 74.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.951 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -58.71 -46.56 87.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.951 HG21 ' CG2' ' C' ' 123' ' ' ILE . 21.4 t -60.72 -31.93 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.607 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 3.3 tttt -80.61 -32.44 36.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -67.02 -35.94 81.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.023 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' C' ' 58' ' ' VAL . 5.9 mt -69.7 -45.32 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.762 HG22 ' HB3' ' C' ' 67' ' ' LEU . 10.9 mt -65.66 -35.32 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.9 75.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -21.54 63.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.409 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.43 -28.26 21.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.692 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.9 54.43 0.35 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.578 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.762 ' HB3' HG22 ' C' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 157.96 23.84 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.632 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 68' ' ' THR . . . . . 0.426 ' O ' HD23 ' C' ' 67' ' ' LEU . 2.1 p -115.37 156.88 24.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.188 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.816 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -58.05 -35.84 71.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.065 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.579 ' HB2' ' OD1' ' C' ' 100' ' ' ASN . . . -50.67 -26.62 5.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.548 ' CB ' HD21 ' C' ' 67' ' ' LEU . 4.7 m-20 -85.64 -18.69 32.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.323 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' C' ' 69' ' ' ALA . 0.5 OUTLIER -54.49 117.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.521 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.702 HG11 HD21 ' A' ' 24' ' ' LEU . 28.4 m -88.16 -33.73 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.874 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.692 ' CG ' ' HB3' ' C' ' 106' ' ' ALA . 4.2 tttm -128.27 169.75 13.84 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.811 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.442 HG22 ' HB2' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -169.95 112.94 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.852 0.358 . . . . 0.0 111.442 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -99.96 151.83 20.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.159 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.409 HG23 ' HA ' ' C' ' 109' ' ' CYS . 5.0 m -146.49 128.86 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.935 0.398 . . . . 0.0 112.004 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.504 ' HB2' HD21 ' C' ' 115' ' ' LEU . 4.1 m-85 -107.65 129.64 54.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.143 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.83 149.5 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.026 0.441 . . . . 0.0 111.772 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 80' ' ' LYS . . . . . 0.43 ' HG3' HD12 ' C' ' 115' ' ' LEU . 12.3 mttt -88.46 -4.53 58.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.773 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.21 115.44 2.31 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.384 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.543 HD11 ' C ' ' A' ' 115' ' ' LEU . 3.1 mt -66.35 -11.25 50.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.126 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -80.79 -19.1 45.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.817 0.342 . . . . 0.0 110.83 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -86.98 -19.55 28.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.223 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.07 -20.91 43.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.342 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.72 -39.2 65.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.837 0.351 . . . . 0.0 111.315 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -29.2 21.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.962 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' C' ' 92' ' ' TYR . 29.3 t -72.39 -45.01 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.32 -42.37 93.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.561 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.52 73.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.974 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -27.49 19.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.494 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.427 ' O ' ' CD2' ' C' ' 96' ' ' PHE . 68.8 t80 -54.08 -49.04 69.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.892 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.6 -27.47 25.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.542 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.16 -20.29 60.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.604 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.501 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 0.3 OUTLIER -90.19 -38.77 13.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.826 0.346 . . . . 0.0 110.954 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' C' ' 101' ' ' HIS . 14.7 m-85 -55.58 -58.85 6.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -64.7 -28.22 69.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.684 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -72.86 -13.54 61.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.783 0.325 . . . . 0.0 110.94 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.524 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 58.9 m-80 -111.11 -10.93 14.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.476 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.579 ' OD1' ' HB2' ' C' ' 70' ' ' ALA . 2.4 p-10 99.66 33.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.524 0.73 . . . . 0.0 110.95 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.816 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.2 m-70 -115.13 56.3 0.98 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.581 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.404 ' O ' ' CD2' ' C' ' 104' ' ' PHE . 53.9 Cg_endo -68.6 -15.21 41.06 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.659 2.239 . . . . 0.0 113.35 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.525 ' HB3' HD11 ' A' ' 5' ' ' ILE . 3.1 m-20 -53.81 -43.14 69.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 110.601 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.691 ' O ' HG13 ' A' ' 19' ' ' VAL . 30.4 m-85 71.8 84.12 0.13 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.988 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 19.0 Cg_endo -59.23 155.72 38.78 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.768 2.312 . . . . 0.0 112.298 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.692 ' HB3' ' CG ' ' C' ' 74' ' ' LYS . . . -51.4 158.1 0.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.253 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' A' ' 18' ' ' TYR . 2.9 ttp-105 -134.65 141.37 46.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.107 0.479 . . . . 0.0 111.827 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.42 66.11 1.47 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.063 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 109' ' ' CYS . . . . . 0.409 ' HA ' HG23 ' C' ' 77' ' ' VAL . 28.0 p -79.45 130.87 35.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.18 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 20.6 m -148.9 144.74 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.053 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.804 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.3 tt0 -87.02 94.51 9.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.76 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.42 HG21 ' HG ' ' C' ' 115' ' ' LEU . 36.0 m -73.43 159.89 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -70.97 -37.08 72.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.069 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.446 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -160.88 166.9 27.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.036 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' C' ' 78' ' ' PHE . 1.4 mt -143.35 155.72 61.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.743 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.39 135.91 71.26 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.577 2.184 . . . . 0.0 111.979 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.696 ' HB3' HG13 ' C' ' 119' ' ' VAL . 1.4 tppt? 69.6 20.38 7.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.938 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.16 26.31 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.095 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.696 HG13 ' HB3' ' C' ' 117' ' ' LYS . 21.9 m -55.67 174.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.246 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 120' ' ' GLY . . . . . 0.585 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -96.12 -15.22 42.55 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.537 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.624 ' C ' HD22 ' C' ' 121' ' ' LEU . 0.0 OUTLIER -172.18 148.74 2.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.993 0.425 . . . . 0.0 111.204 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.719 ' O ' HD13 ' C' ' 123' ' ' ILE . 4.6 mt-10 -116.33 167.31 11.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.289 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.951 ' CG2' HG21 ' C' ' 58' ' ' VAL . 22.8 mm -141.99 131.8 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.208 0.527 . . . . 0.0 112.177 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.52 117.75 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.166 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -140.28 176.03 9.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.459 HG23 ' HG ' ' C' ' 29' ' ' LEU . 6.7 mt -119.85 154.67 22.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.038 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.889 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -139.4 150.79 45.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.839 0.352 . . . . 0.0 111.884 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 1.01 HG11 HD21 ' A' ' 24' ' ' LEU . 33.0 m -125.14 126.69 71.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.092 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.671 ' HG3' HD12 ' C' ' 67' ' ' LEU . 0.4 OUTLIER -94.89 43.5 1.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.095 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.935 179.867 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.869 0.366 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.23 168.49 19.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.486 HG23 ' CD2' ' A' ' 24' ' ' LEU . 18.8 m -165.16 116.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HD23 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.694 HD11 ' OD1' ' C' ' 103' ' ' ASN . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.719 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 14' ' ' ALA . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.843 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' C' ' 104' ' ' PHE . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 29' ' ' LEU . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.565 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.916 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.446 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 25' ' ' GLY . 9.1 m-80 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 128' ' ' VAL . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.959 HG23 ' HB3' ' A' ' 127' ' ' ALA . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 62' ' ' ILE . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.693 ' HB ' HG11 ' A' ' 119' ' ' VAL . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 34' ' ' ILE . 32.9 t -63.02 85.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 41' ' ' GLY . 36.7 t-20 -35.11 129.88 0.5 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.989 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.53 -10.59 29.14 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 112.178 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.5 -21.36 8.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.68 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.416 HG22 ' CG ' ' A' ' 42' ' ' GLU . 3.5 m -114.75 -25.2 8.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 63.67 56.06 21.4 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.323 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' CG ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER -164.27 -81.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.704 0.288 . . . . 0.0 111.625 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p -173.89 106.83 0.3 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.406 ' OE1' HD13 ' A' ' 47' ' ' ILE . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.782 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 54' ' ' SER . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.719 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 30' ' ' THR . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.844 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 126' ' ' ILE . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 128' ' ' VAL . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 125' ' ' ALA . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 108' ' ' SER . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 122' ' ' GLU . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.712 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 85' ' ' PHE . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' A' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.475 ' OH ' HG21 ' A' ' 75' ' ' THR . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.743 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.844 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 m-70 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.691 ' CG ' HD11 ' B' ' 5' ' ' ILE . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.731 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 72' ' ' ILE . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 76' ' ' THR . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.596 ' HB3' HD12 ' C' ' 82' ' ' LEU . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 78' ' ' PHE . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 34' ' ' ILE . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.795 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' ' 35' ' ' PRO . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.725 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' ILE . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.959 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 73' ' ' VAL . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB3' HD21 ' A' ' 67' ' ' LEU . 14.1 ptm180 -164.77 46.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.832 0.349 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.24 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.481 HG23 ' CD2' ' B' ' 24' ' ' LEU . 19.0 m -165.18 116.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.568 ' OE1' HD23 ' B' ' 24' ' ' LEU . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.691 HD11 ' CG ' ' A' ' 103' ' ' ASN . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.722 ' HB2' ' CG1' ' B' ' 61' ' ' ILE . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.786 HD13 ' O ' ' B' ' 14' ' ' ALA . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.84 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 104' ' ' PHE . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 11' ' ' ALA . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.53 HG23 HD13 ' B' ' 29' ' ' LEU . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.562 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.515 HD13 HG12 ' B' ' 128' ' ' VAL . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' B' ' 127' ' ' ALA . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.631 HD12 ' N ' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.737 HG21 HD11 ' B' ' 62' ' ' ILE . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.484 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.716 ' HB ' HG11 ' B' ' 119' ' ' VAL . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.565 HG23 HG13 ' B' ' 34' ' ' ILE . 33.3 t -63.01 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.402 ' HB3' ' HB ' ' B' ' 40' ' ' THR . 36.6 t-20 -35.14 129.93 0.51 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.935 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.58 -10.63 29.2 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.023 . . . . 0.0 112.192 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.4 -21.41 8.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.78 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' B' ' 37' ' ' ASN . 3.5 m -114.77 -25.32 8.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.456 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 63.81 56.13 20.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.357 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.401 ' CG ' HG22 ' B' ' 40' ' ' THR . 0.0 OUTLIER -164.36 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.623 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.791 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.3 p -173.94 106.72 0.3 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' B' ' 47' ' ' ILE . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' B' ' 95' ' ' PHE . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' B' ' 54' ' ' SER . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.722 ' CG1' ' HB2' ' B' ' 11' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.737 HD11 HG21 ' B' ' 30' ' ' THR . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.697 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.477 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 126' ' ' ILE . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.635 HG13 HG22 ' B' ' 128' ' ' VAL . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.681 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.727 HG23 ' HB2' ' B' ' 125' ' ' ALA . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 108' ' ' SER . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.702 HG13 ' O ' ' B' ' 122' ' ' GLU . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.507 HG11 ' HD1' ' B' ' 85' ' ' PHE . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.507 ' HD1' HG11 ' B' ' 79' ' ' VAL . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' B' ' 75' ' ' THR . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.742 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.851 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.8 m-70 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.7 ' CG ' HD11 ' C' ' 5' ' ' ILE . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.72 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' B' ' 72' ' ' ILE . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.431 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.845 ' O ' HG23 ' B' ' 76' ' ' THR . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.729 HG11 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.543 ' HB3' HD12 ' A' ' 82' ' ' LEU . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HB2' ' B' ' 78' ' ' PHE . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.482 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.716 HG11 ' HB ' ' B' ' 34' ' ' ILE . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' GLY . . . . . 0.791 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.468 HD11 ' HG3' ' B' ' 35' ' ' PRO . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.702 ' O ' HG13 ' B' ' 77' ' ' VAL . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.56 ' CG2' HG21 ' B' ' 58' ' ' VAL . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 72' ' ' ILE . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.997 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.635 HG22 HG13 ' B' ' 73' ' ' VAL . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' B' ' 67' ' ' LEU . 14.1 ptm180 -164.83 46.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.951 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.21 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.48 HG23 ' CD2' ' C' ' 24' ' ' LEU . 19.0 m -165.22 116.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.562 ' OE1' HD23 ' C' ' 24' ' ' LEU . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.7 HD11 ' CG ' ' B' ' 103' ' ' ASN . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.497 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.721 ' HB2' ' CG1' ' C' ' 61' ' ' ILE . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.67 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.779 HD13 ' O ' ' C' ' 14' ' ' ALA . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.826 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' B' ' 104' ' ' PHE . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.535 HG23 HD13 ' C' ' 29' ' ' LEU . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.559 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.898 HD13 ' O ' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.482 HD13 HG12 ' C' ' 128' ' ' VAL . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.63 ' N ' HD12 ' C' ' 29' ' ' LEU . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.711 HG21 HD11 ' C' ' 62' ' ' ILE . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.691 ' HB ' HG11 ' C' ' 119' ' ' VAL . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.561 HG23 HG13 ' C' ' 34' ' ' ILE . 32.8 t -63.06 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' C' ' 41' ' ' GLY . 36.7 t-20 -35.13 129.94 0.51 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.56 -10.6 29.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.31 2.007 . . . . 0.0 112.18 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.44 -21.43 8.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.729 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.408 HG22 ' CG ' ' C' ' 42' ' ' GLU . 3.5 m -114.8 -25.24 8.32 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 63.64 56.1 21.27 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.395 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.408 ' CG ' HG22 ' C' ' 40' ' ' THR . 0.0 OUTLIER -164.26 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.61 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.789 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.3 p -173.93 106.74 0.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.365 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' C' ' 51' ' ' ALA . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.401 ' OE1' HD13 ' C' ' 47' ' ' ILE . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 54' ' ' SER . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.721 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.711 HD11 HG21 ' C' ' 30' ' ' THR . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.694 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.464 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.484 HG23 ' O ' ' C' ' 126' ' ' ILE . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.636 HG13 HG22 ' C' ' 128' ' ' VAL . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' ALA . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.847 HG23 ' O ' ' C' ' 108' ' ' SER . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.714 HG13 ' O ' ' C' ' 122' ' ' GLU . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.729 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' C' ' 85' ' ' PHE . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' C' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.479 ' OH ' HG21 ' C' ' 75' ' ' THR . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.749 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.851 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.8 m-70 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.694 ' OD1' HD11 ' A' ' 5' ' ' ILE . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.704 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' C' ' 72' ' ' ILE . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 108' ' ' SER . . . . . 0.847 ' O ' HG23 ' C' ' 76' ' ' THR . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.712 HG11 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.731 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.581 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' C' ' 78' ' ' PHE . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.582 ' O ' HG22 ' C' ' 119' ' ' VAL . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.484 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' C' ' 34' ' ' ILE . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 120' ' ' GLY . . . . . 0.789 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' C' ' 35' ' ' PRO . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 77' ' ' VAL . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' HB ' ' C' ' 76' ' ' THR . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.705 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' ILE . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.956 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.636 HG22 HG13 ' C' ' 73' ' ' VAL . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' C' ' 67' ' ' LEU . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.855 0.359 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -172.57 4.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.044 HG21 HG21 ' C' ' 128' ' ' VAL . 0.9 OUTLIER 61.7 113.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 132.97 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.82 HD13 ' OD1' ' C' ' 103' ' ' ASN . 4.3 mp -55.2 152.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 21' ' ' ALA . 32.7 mt -103.43 139.26 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.58 117.18 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.58 HG22 ' OE1' ' A' ' 20' ' ' GLN . 11.7 t -133.88 165.99 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.33 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.52 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 7.6 mmtp -121.62 -36.89 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.032 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.872 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.82 172.05 4.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 18.9 Cg_endo -59.39 -16.05 33.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.695 2.263 . . . . 0.0 112.85 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 77.24 151.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 111.317 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.603 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -104.67 120.71 41.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 14' ' ' ALA . 22.1 mm -133.51 15.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.072 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.85 -146.17 4.73 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.987 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' C' ' 104' ' ' PHE . 93.9 Cg_endo -87.39 44.53 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.536 2.158 . . . . 0.0 112.901 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.541 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -163.19 154.59 17.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.867 0.365 . . . . 0.0 111.033 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.465 HG13 ' O ' ' C' ' 103' ' ' ASN . 27.3 m -110.91 169.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.58 ' OE1' HG22 ' A' ' 8' ' ' THR . 56.2 mt-30 -58.96 -53.53 57.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' A' ' 6' ' ' ILE . . . -170.69 -177.09 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG21 ' HB ' ' C' ' 73' ' ' VAL . 9.3 m -142.33 132.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.166 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.645 ' HA ' HG23 ' A' ' 28' ' ' VAL . 20.8 t70 -103.47 105.01 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.567 ' CD2' HG23 ' A' ' 3' ' ' THR . 19.5 mt -80.51 -16.36 54.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.371 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.05 -104.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.28 -29.62 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.166 0.508 . . . . 0.0 110.21 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 28' ' ' VAL . 5.0 tt -135.2 140.65 45.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.95 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 9.9 p -120.04 160.88 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.123 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' HE2' ' C' ' 74' ' ' LYS . 2.9 mp -145.87 127.37 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 p -106.5 136.11 46.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.983 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.812 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 1.1 t -59.36 179.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.07 95.55 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.244 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.805 ' HG2' HG22 ' A' ' 58' ' ' VAL . 2.0 mp0 -62.07 138.14 58.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.275 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.524 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -146.04 170.18 8.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.679 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -54.26 -137.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.313 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t 74.12 73.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.411 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 41' ' ' GLY . 2.1 t-20 -34.93 115.62 0.52 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.978 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.65 -13.68 11.46 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.339 2.026 . . . . 0.0 112.144 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.81 27.87 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.086 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 42' ' ' GLU . 8.0 t -161.6 -33.37 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.908 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 96.92 66.2 0.92 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.847 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HG2' HG23 ' A' ' 40' ' ' THR . 2.7 mt-10 -82.73 -53.38 5.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.369 . . . . 0.0 111.276 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t 68.96 72.52 0.34 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.81 140.71 81.58 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.592 2.195 . . . . 0.0 112.433 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.37 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.4 93.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.791 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.616 HD13 ' NE2' ' A' ' 50' ' ' GLN . 28.9 mm -38.93 -33.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.5 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.08 -48.07 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.696 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.82 -55.04 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.616 ' NE2' HD13 ' A' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.498 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -71.93 -44.36 63.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -63.33 -51.54 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.79 -31.18 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.871 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.3 m -68.31 -46.48 70.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.29 -26.36 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.971 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -57.95 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.108 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.8 OUTLIER -54.88 -30.36 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.985 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 54' ' ' SER . 39.6 t -62.1 -34.54 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 110.517 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.99 -31.75 34.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.755 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -62.23 -38.55 89.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 11' ' ' ALA . 6.1 mt -70.93 -46.2 69.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.667 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.8 -32.62 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.28 -38.4 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.9 -24.33 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.145 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.71 -22.11 21.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.914 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.43 64.8 0.83 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' OD2' ' A' ' 71' ' ' ASP . 14.7 mt -158.9 139.2 12.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 44.0 p -96.12 145.0 25.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -46.29 -31.75 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.518 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -59.77 -18.48 43.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.715 ' OD2' HD22 ' A' ' 67' ' ' LEU . 3.2 p-10 -88.58 -21.27 24.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 126' ' ' ILE . 64.3 mt -59.35 109.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.528 ' HB ' HG21 ' B' ' 22' ' ' VAL . 2.8 m -81.11 -36.84 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.971 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HE2' HD22 ' B' ' 29' ' ' LEU . 8.6 mtmt -130.55 175.23 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.319 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.61 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 13.4 t 177.71 110.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 111.36 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.18 130.1 41.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.33 91.6 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 76' ' ' THR . 5.3 m-85 -91.7 143.77 26.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.089 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.514 HG11 ' CD1' ' A' ' 85' ' ' PHE . 35.3 m -139.31 150.0 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.023 0.44 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.57 ' HE2' HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -90.95 -4.31 56.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.796 178.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.04 108.99 0.46 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.687 HD12 ' HB3' ' B' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.25 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.97 -24.64 59.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 110.282 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -78.46 -15.34 58.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.832 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.514 ' CD1' HG11 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -55.52 -22.98 23.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.01 -46.63 84.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 -33.22 19.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 84' ' ' ASP . 32.6 t -70.08 -49.66 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.673 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 36.4 t-20 -63.09 -35.99 82.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.14 94.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.016 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.62 -31.1 19.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.448 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 48.7 t80 -57.67 -51.35 69.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.727 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 7.7 tt0 -73.32 -27.34 61.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -25.11 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.765 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -79.31 -41.02 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.934 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 95' ' ' PHE . 57.1 m-85 -56.45 -50.43 71.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.8 69.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.77 58.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.402 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -110.54 -6.88 14.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.7 m-20 89.68 30.9 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.8 t60 -127.57 72.17 77.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.96 -11.04 16.65 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.539 2.159 . . . . 0.0 112.153 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.844 ' OD1' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.03 42.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.447 . . . . 0.0 110.439 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CG ' ' HA ' ' B' ' 17' ' ' PRO . 92.7 m-85 70.99 144.0 0.1 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.515 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 104' ' ' PHE . 2.0 Cg_endo -82.96 165.82 15.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.057 2.504 . . . . 0.0 112.0 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' B' ' 31' ' ' SER . . . -115.28 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.779 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.61 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -169.27 -163.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.944 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.36 107.57 16.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.493 ' O ' HG13 ' A' ' 110' ' ' VAL . 5.3 m -95.25 129.16 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.798 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.519 HG12 HD23 ' B' ' 115' ' ' LEU . 7.0 m -157.79 165.71 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.949 0.405 . . . . 0.0 111.666 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 9.4 tt0 -99.75 102.87 14.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.777 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.82 162.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -79.07 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.685 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -140.81 168.08 20.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.722 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.622 HD22 ' HB2' ' A' ' 122' ' ' GLU . 3.0 mt -144.19 161.9 42.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 119' ' ' VAL . 32.7 Cg_exo -59.7 135.94 67.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.649 2.233 . . . . 0.0 112.183 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.58 18.28 7.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.87 17.47 8.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 116' ' ' PRO . 21.2 m -55.18 172.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.61 14.08 20.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.011 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 121' ' ' LEU . 4.5 pp -176.64 149.0 0.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.123 0.487 . . . . 0.0 111.508 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.622 ' HB2' HD22 ' A' ' 115' ' ' LEU . 44.5 tt0 -150.86 137.85 19.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.918 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 76' ' ' THR . 3.4 mp -144.67 138.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 112.101 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.36 149.91 28.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.569 ' C ' HD13 ' A' ' 126' ' ' ILE . . . -132.03 125.99 32.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.414 . . . . 0.0 112.027 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.569 HD13 ' C ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -114.42 132.16 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.876 178.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.95 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -121.74 153.14 38.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.063 0.459 . . . . 0.0 112.038 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.111 HG21 HG21 ' B' ' 3' ' ' THR . 34.6 m -124.13 116.37 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.464 ' CD ' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -106.3 57.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.971 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.849 0.357 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.6 -172.5 4.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' THR . . . . . 1.111 HG21 HG21 ' A' ' 128' ' ' VAL . 0.9 OUTLIER 61.63 113.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.72 132.95 5.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.844 HD13 ' OD1' ' A' ' 103' ' ' ASN . 4.4 mp -55.2 152.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' B' ' 21' ' ' ALA . 32.7 mt -103.43 139.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.59 117.19 9.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.575 HG23 ' H ' ' B' ' 11' ' ' ALA . 11.6 t -133.86 165.97 23.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.804 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 26.32 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.58 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 7.6 mmtt -121.6 -36.61 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -68.18 172.03 4.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 18.7 Cg_endo -59.33 -16.06 32.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.632 2.221 . . . . 0.0 112.905 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 77.23 151.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.411 . . . . 0.0 111.281 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.586 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.597 HG22 ' O ' ' B' ' 15' ' ' ILE . 22.1 mm -133.53 15.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.79 -146.1 4.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.509 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . 94.4 Cg_endo -87.38 44.49 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.637 2.224 . . . . 0.0 112.916 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -163.26 154.53 17.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.915 0.388 . . . . 0.0 110.991 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 103' ' ' ASN . 27.2 m -110.83 169.25 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.304 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.575 ' OE1' HG22 ' B' ' 8' ' ' THR . 56.3 mt-30 -59.04 -53.58 56.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -170.46 -177.16 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.528 HG21 ' HB ' ' A' ' 73' ' ' VAL . 9.2 m -142.31 132.63 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.636 ' HA ' HG23 ' B' ' 28' ' ' VAL . 20.8 t70 -103.51 104.94 15.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.554 ' CD2' HG23 ' B' ' 3' ' ' THR . 19.5 mt -80.44 -16.4 54.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -103.96 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.972 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.3 -29.56 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.082 0.468 . . . . 0.0 110.189 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.644 HD23 ' N ' ' B' ' 28' ' ' VAL . 5.0 tt -135.3 140.65 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.52 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.945 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 9.9 p -120.07 160.84 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.657 HD22 ' HE2' ' A' ' 74' ' ' LYS . 2.9 mp -145.87 127.42 15.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.68 136.36 46.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.06 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.843 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 1.1 t -59.69 179.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.01 95.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.834 ' HG2' HG22 ' B' ' 58' ' ' VAL . 2.0 mp0 -61.92 138.09 58.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.553 HG22 ' O ' ' B' ' 121' ' ' LEU . 0.7 OUTLIER -145.98 170.19 8.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.665 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 52.2 Cg_exo -54.34 -137.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.069 2.513 . . . . 0.0 112.319 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t 74.21 73.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' B' ' 41' ' ' GLY . 2.1 t-20 -34.86 115.66 0.52 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.964 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.65 -13.71 11.53 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.4 2.067 . . . . 0.0 112.11 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.54 -26.78 27.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.459 HG23 ' HG2' ' B' ' 42' ' ' GLU . 8.0 t -161.65 -33.23 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 97.1 66.02 0.92 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.791 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.459 ' HG2' HG23 ' B' ' 40' ' ' THR . 2.8 mt-10 -82.77 -53.36 5.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.371 . . . . 0.0 111.292 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t 68.91 72.59 0.34 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.83 140.7 81.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.662 2.242 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.39 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.35 93.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.618 HD13 ' NE2' ' B' ' 50' ' ' GLN . 28.9 mm -38.94 -33.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.443 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.02 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.91 -54.98 38.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.618 ' NE2' HD13 ' B' ' 47' ' ' ILE . 15.8 pt20 -61.1 -26.16 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.522 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -72.18 -44.2 63.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.901 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.33 -51.54 65.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.22 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.9 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.3 m -68.4 -46.37 70.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.32 -26.38 68.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.963 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -57.99 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.163 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.8 OUTLIER -54.86 -30.39 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.931 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.9 HG23 ' O ' ' B' ' 54' ' ' SER . 39.7 t -62.13 -34.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.95 -31.77 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -62.21 -38.49 89.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.571 HG12 ' HB2' ' B' ' 11' ' ' ALA . 6.0 mt -71.25 -46.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.83 -32.53 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.656 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.31 -38.49 60.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.34 65.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.136 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 -22.06 21.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.919 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 64.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.711 HD22 ' OD2' ' B' ' 71' ' ' ASP . 14.7 mt -158.91 139.2 12.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.022 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' B' ' 71' ' ' ASP . 43.8 p -96.1 144.99 25.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -46.26 -31.79 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.574 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -59.83 -18.27 42.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.425 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.711 ' OD2' HD22 ' B' ' 67' ' ' LEU . 3.3 p-10 -88.65 -21.23 24.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.714 0.292 . . . . 0.0 110.87 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.512 HG23 ' O ' ' B' ' 126' ' ' ILE . 64.4 mt -59.4 109.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.874 0.369 . . . . 0.0 110.839 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' C' ' 22' ' ' VAL . 2.8 m -81.12 -36.88 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.969 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.667 ' HE2' HD22 ' C' ' 29' ' ' LEU . 8.6 mtmt -130.56 175.22 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.302 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.612 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 13.4 t 177.67 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 111.337 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.753 ' O ' HG23 ' B' ' 123' ' ' ILE . 0.0 OUTLIER -70.15 130.12 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.325 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.43 91.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.404 ' CZ ' ' HB ' ' B' ' 76' ' ' THR . 5.3 m-85 -91.66 143.72 26.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.151 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' B' ' 85' ' ' PHE . 35.1 m -139.32 150.01 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.072 0.463 . . . . 0.0 111.718 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' B' ' 47' ' ' ILE . 0.3 OUTLIER -90.94 -4.12 56.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.839 178.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -169.23 109.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.321 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' C' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.32 20.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.228 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.94 -24.63 59.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.275 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.547 ' O ' HG23 ' B' ' 88' ' ' VAL . 0.6 OUTLIER -78.52 -15.37 58.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.51 ' CD1' HG11 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -55.46 -23.03 23.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.267 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.99 -46.62 84.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.09 -33.23 19.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 84' ' ' ASP . 33.0 t -70.09 -49.59 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.721 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 36.4 t-20 -63.21 -35.96 82.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.04 94.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.67 -31.19 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 48.8 t80 -57.62 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 7.7 tt0 -73.41 -27.32 61.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.462 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -25.19 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.786 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -79.25 -41.09 28.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.97 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 95' ' ' PHE . 57.2 m-85 -56.36 -50.45 71.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.818 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.82 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.945 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.8 58.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.98 14.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.505 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 11.7 m-20 89.78 30.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.502 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.8 t60 -127.48 72.19 77.52 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.98 -11.02 16.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.537 2.158 . . . . 0.0 112.153 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.98 ' ND2' HD13 ' C' ' 5' ' ' ILE . 2.9 t-20 -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.03 0.443 . . . . 0.0 110.445 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.506 ' CG ' ' HA ' ' C' ' 17' ' ' PRO . 92.7 m-85 70.89 144.04 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.494 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 104' ' ' PHE . 2.0 Cg_endo -83.02 165.85 14.91 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.016 2.477 . . . . 0.0 111.917 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.835 ' HB1' ' HB2' ' C' ' 31' ' ' SER . . . -115.27 137.95 51.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.612 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -169.23 -163.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.38 107.56 16.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.571 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' CYS . . . . . 0.504 ' O ' HG13 ' B' ' 110' ' ' VAL . 5.2 m -95.21 129.11 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.845 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.533 HG12 HD23 ' C' ' 115' ' ' LEU . 7.0 m -157.71 165.59 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.409 . . . . 0.0 111.632 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 9.3 tt0 -99.57 102.86 14.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.785 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.73 162.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -79.05 -46.27 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -140.82 168.11 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' B' ' 122' ' ' GLU . 3.0 mt -144.21 161.87 42.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.549 ' O ' HG22 ' B' ' 119' ' ' VAL . 33.1 Cg_exo -59.62 135.97 67.82 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.157 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.53 18.29 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.88 17.46 8.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.549 HG22 ' O ' ' B' ' 116' ' ' PRO . 21.5 m -55.18 172.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.082 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.63 13.95 20.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.025 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.553 ' O ' HG22 ' B' ' 34' ' ' ILE . 4.6 pp -176.62 148.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.615 ' HB2' HD22 ' B' ' 115' ' ' LEU . 44.5 tt0 -150.78 137.88 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.935 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.753 HG23 ' O ' ' B' ' 76' ' ' THR . 3.4 mp -144.68 138.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 112.14 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.33 149.81 28.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.627 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.572 ' C ' HD13 ' B' ' 126' ' ' ILE . . . -131.94 126.01 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.956 0.408 . . . . 0.0 112.041 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.572 HD13 ' C ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -114.33 132.14 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.947 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.945 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -121.75 153.2 38.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.096 0.474 . . . . 0.0 111.994 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 1.04 HG21 HG21 ' C' ' 3' ' ' THR . 34.7 m -124.26 116.32 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.474 ' CD ' HD21 ' B' ' 67' ' ' LEU . 0.0 OUTLIER -106.23 57.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.015 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.851 0.358 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 -172.51 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 3' ' ' THR . . . . . 1.04 HG21 HG21 ' B' ' 128' ' ' VAL . 0.9 OUTLIER 61.67 113.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.68 132.97 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.98 HD13 ' ND2' ' B' ' 103' ' ' ASN . 4.4 mp -55.18 152.35 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' C' ' 21' ' ' ALA . 32.5 mt -103.46 139.23 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -143.59 117.2 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.572 HG22 ' OE1' ' C' ' 20' ' ' GLN . 11.7 t -133.93 165.96 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.32 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.542 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 7.6 mmtp -121.59 -36.84 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.01 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.885 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.93 172.02 4.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.885 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 18.8 Cg_endo -59.31 -16.11 32.83 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.675 2.25 . . . . 0.0 112.899 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 77.24 151.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.977 0.418 . . . . 0.0 111.304 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.591 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -104.69 120.76 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.002 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.591 HD13 ' O ' ' C' ' 14' ' ' ALA . 22.5 mm -133.54 15.81 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.81 -146.14 4.73 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.001 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' B' ' 104' ' ' PHE . 94.1 Cg_endo -87.37 44.51 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 112.917 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.532 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -163.23 154.55 17.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.026 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' B' ' 103' ' ' ASN . 27.2 m -110.87 169.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.36 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.572 ' OE1' HG22 ' C' ' 8' ' ' THR . 56.2 mt-30 -59.02 -53.38 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' C' ' 6' ' ' ILE . . . -170.6 -177.19 2.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' B' ' 73' ' ' VAL . 9.2 m -142.24 132.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.64 ' HA ' HG23 ' C' ' 28' ' ' VAL . 20.8 t70 -103.48 104.98 15.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.549 ' CD2' HG23 ' C' ' 3' ' ' THR . 19.5 mt -80.47 -16.35 54.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.0 -104.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.27 -29.59 33.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.648 HD23 ' N ' ' C' ' 28' ' ' VAL . 5.0 tt -135.22 140.64 45.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.575 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.947 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 9.9 p -120.04 160.84 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.667 HD22 ' HE2' ' B' ' 74' ' ' LYS . 2.9 mp -145.85 127.45 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 p -106.6 136.31 46.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 31' ' ' SER . . . . . 0.835 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 1.1 t -59.62 179.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.13 95.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.25 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.821 ' HG2' HG22 ' C' ' 58' ' ' VAL . 2.0 mp0 -62.06 138.17 58.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.259 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.528 HG22 ' O ' ' C' ' 121' ' ' LEU . 0.7 OUTLIER -146.0 170.23 8.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.654 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' C' ' 34' ' ' ILE . 52.4 Cg_exo -54.36 -137.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.063 2.509 . . . . 0.0 112.29 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t 74.17 73.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.427 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' C' ' 41' ' ' GLY . 2.1 t-20 -34.93 115.67 0.52 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.967 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.61 -13.76 11.54 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.36 2.04 . . . . 0.0 112.088 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.56 -26.65 27.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.133 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.45 HG23 ' HG2' ' C' ' 42' ' ' GLU . 8.0 t -161.62 -33.31 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.928 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 96.98 66.09 0.92 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.79 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' C' ' 40' ' ' THR . 2.8 mt-10 -82.74 -53.36 5.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.886 0.374 . . . . 0.0 111.287 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 t 68.96 72.52 0.34 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.931 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.88 140.74 81.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.637 2.225 . . . . 0.0 112.358 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.45 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.083 0.468 . . . . 0.0 110.913 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 93.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.621 HD13 ' NE2' ' C' ' 50' ' ' GLN . 28.7 mm -39.01 -33.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.447 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.711 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -54.96 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.621 ' NE2' HD13 ' C' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.474 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -72.07 -44.36 63.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.36 -51.5 65.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.24 72.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.354 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.903 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.3 m -68.35 -46.4 70.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.58 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.32 -26.36 68.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -58.01 4.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 57' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.8 OUTLIER -54.9 -30.36 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.984 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.903 HG23 ' O ' ' C' ' 54' ' ' SER . 39.6 t -62.07 -34.62 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -80.86 -31.79 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -62.26 -38.52 89.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' C' ' 11' ' ' ALA . 6.0 mt -70.95 -46.31 68.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.89 -32.54 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.33 -38.39 60.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.093 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.31 65.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.139 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.1 21.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.87 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.445 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.712 HD22 ' OD2' ' C' ' 71' ' ' ASP . 14.7 mt -158.9 139.23 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.036 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.0 p -96.16 145.01 25.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -46.21 -31.81 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.598 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -59.74 -18.28 41.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.477 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.712 ' OD2' HD22 ' C' ' 67' ' ' LEU . 3.3 p-10 -88.78 -21.16 23.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 110.896 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.503 HG23 ' O ' ' C' ' 126' ' ' ILE . 64.2 mt -59.39 109.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.496 ' HB ' HG21 ' A' ' 22' ' ' VAL . 2.8 m -81.04 -36.88 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.933 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.646 ' HE2' HD22 ' A' ' 29' ' ' LEU . 8.6 mtmt -130.6 175.25 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.369 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 13.4 t 177.72 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.313 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.754 ' O ' HG23 ' C' ' 123' ' ' ILE . 0.0 OUTLIER -70.23 130.2 41.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 t -115.43 91.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' C' ' 76' ' ' THR . 5.3 m-85 -91.64 143.8 26.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.143 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' C' ' 85' ' ' PHE . 34.8 m -139.35 149.98 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 111.691 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' C' ' 47' ' ' ILE . 0.3 OUTLIER -90.99 -4.23 56.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.816 178.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.1 109.04 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.305 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.685 HD12 ' HB3' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -58.58 -17.19 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.0 -24.62 59.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.297 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.546 ' O ' HG23 ' C' ' 88' ' ' VAL . 0.6 OUTLIER -78.5 -15.28 58.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.827 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.513 ' CD1' HG11 ' C' ' 79' ' ' VAL . 0.3 OUTLIER -55.53 -23.04 24.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.261 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.63 84.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.01 -33.32 19.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.969 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.546 HG23 ' O ' ' C' ' 84' ' ' ASP . 32.8 t -70.06 -49.66 54.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 89' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 36.4 t-20 -63.12 -35.99 82.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.337 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.22 -42.14 94.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.973 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.68 -31.16 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.567 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.457 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 48.7 t80 -57.64 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 7.7 tt0 -73.36 -27.37 61.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -25.19 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.77 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -79.32 -41.03 28.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 95' ' ' PHE . 56.7 m-85 -56.38 -50.4 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.781 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -28.72 69.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.954 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.91 -3.78 58.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.362 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.91 14.79 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 11.7 m-20 89.79 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.822 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.499 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.8 t60 -127.55 72.17 77.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.705 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.03 -10.97 16.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.495 2.13 . . . . 0.0 112.146 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.82 ' OD1' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.998 0.428 . . . . 0.0 110.429 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.512 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 92.8 m-85 70.91 144.1 0.1 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.42 ' HB2' HG22 ' C' ' 75' ' ' THR . 2.0 Cg_endo -83.05 165.85 14.87 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.028 2.485 . . . . 0.0 111.948 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.812 ' HB1' ' HB2' ' A' ' 31' ' ' SER . . . -115.29 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.6 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -169.22 -163.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.4 p -111.36 107.48 16.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.589 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 109' ' ' CYS . . . . . 0.502 ' O ' HG13 ' C' ' 110' ' ' VAL . 5.2 m -95.21 129.18 42.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.788 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.514 HG12 HD23 ' A' ' 115' ' ' LEU . 7.1 m -157.82 165.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 9.4 tt0 -99.76 102.86 14.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.75 162.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -79.08 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.671 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -140.83 168.09 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' C' ' 122' ' ' GLU . 3.0 mt -144.21 161.82 43.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.913 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.544 ' O ' HG22 ' C' ' 119' ' ' VAL . 33.7 Cg_exo -59.52 135.99 68.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.608 2.205 . . . . 0.0 112.221 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.51 18.29 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 61.8 17.55 8.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.544 HG22 ' O ' ' C' ' 116' ' ' PRO . 21.2 m -55.18 172.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.065 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.79 14.08 19.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.988 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.534 ' O ' HD12 ' C' ' 121' ' ' LEU . 4.6 pp -176.62 148.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.489 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.619 ' HB2' HD22 ' C' ' 115' ' ' LEU . 44.4 tt0 -150.83 137.93 19.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.754 HG23 ' O ' ' C' ' 76' ' ' THR . 3.4 mp -144.74 138.35 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.11 0.481 . . . . 0.0 112.142 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.3 149.82 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.648 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.573 ' C ' HD13 ' C' ' 126' ' ' ILE . . . -131.98 126.13 33.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 112.004 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.573 HD13 ' C ' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -114.41 132.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 178.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.947 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -121.76 153.11 38.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.082 0.468 . . . . 0.0 112.029 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 3' ' ' THR . 34.6 m -124.15 116.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.47 ' CD ' HD21 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -106.27 56.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.99 0.424 . . . . 0.0 110.892 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.894 0.378 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mtt -95.93 -170.65 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.76 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER 62.99 106.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.83 107.65 13.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.971 HD11 HG11 ' A' ' 19' ' ' VAL . 1.7 tp -54.31 125.88 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.311 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 23' ' ' ASP . 22.4 mm -83.67 137.49 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.46 92.4 1.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -115.24 163.65 15.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.08 29.06 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -113.94 -41.78 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.807 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -72.34 178.16 1.49 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 32.3 Cg_exo -57.56 -13.83 14.98 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.808 2.339 . . . . 0.0 113.006 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 77.39 163.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 0.0 111.075 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -117.17 125.0 50.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.407 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 15' ' ' ILE . 3.3 mp -144.89 18.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.025 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.1 -137.25 3.45 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.429 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' C' ' 92' ' ' TYR . 89.8 Cg_endo -88.82 32.42 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.795 2.33 . . . . 0.0 113.23 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' C' ' 105' ' ' PRO . 0.7 OUTLIER -152.49 -178.03 6.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.392 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.971 HG11 HD11 ' A' ' 5' ' ' ILE . 10.3 m -136.68 179.79 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.689 ' NE2' ' HB3' ' A' ' 11' ' ' ALA . 15.6 mm-40 -68.86 -49.58 57.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.517 ' HB3' HG13 ' A' ' 6' ' ' ILE . . . -174.48 -177.42 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.48 HG11 ' HB ' ' C' ' 73' ' ' VAL . 4.7 m -137.88 141.58 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.714 ' HB2' HD11 ' A' ' 6' ' ' ILE . 53.5 t0 -117.97 91.01 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.59 HD11 ' CG1' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -65.95 -20.97 66.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.073 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.06 -108.85 0.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.846 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -57.85 -30.17 65.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.096 0.474 . . . . 0.0 110.229 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.411 HD23 ' C ' ' A' ' 27' ' ' LEU . 7.6 tt -124.71 124.55 42.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.736 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.072 HG23 ' HB3' ' A' ' 127' ' ' ALA . 3.4 m -105.54 171.61 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.594 HD22 ' HD2' ' C' ' 74' ' ' LYS . 1.3 mp -144.7 164.81 29.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.751 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 p -138.47 143.9 39.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.911 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.842 ' HB3' ' HB1' ' C' ' 106' ' ' ALA . 3.4 p -72.47 179.55 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.27 95.43 0.96 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.377 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.581 ' OE1' HD11 ' A' ' 61' ' ' ILE . 14.4 mm-40 -66.93 165.13 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.342 . . . . 0.0 111.015 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.645 ' HB ' HG11 ' A' ' 119' ' ' VAL . 8.6 pt -159.5 157.59 26.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.294 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 35.5 Cg_exo -58.35 -15.05 22.51 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.075 2.517 . . . . 0.0 113.024 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.606 ' CG2' HD12 ' A' ' 34' ' ' ILE . 44.0 t -50.03 89.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -43.86 117.35 2.62 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.576 -179.763 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 31.3 Cg_exo -58.28 -14.19 19.03 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.292 1.994 . . . . 0.0 112.249 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.78 -26.92 25.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.305 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.2 t -158.77 -32.82 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.991 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 92.68 66.73 1.1 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.408 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -77.55 -65.17 1.0 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.962 0.411 . . . . 0.0 111.104 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 35' ' ' PRO . 14.7 t 69.52 62.44 0.55 Allowed Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.966 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 43' ' ' VAL . 51.8 Cg_exo -54.33 153.04 23.55 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.652 2.235 . . . . 0.0 112.414 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.74 60.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -55.02 95.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.868 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.604 HD13 ' OD2' ' A' ' 84' ' ' ASP . 8.2 tp -40.34 -32.98 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.797 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.62 -48.14 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.83 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -61.48 -48.51 80.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.827 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.636 ' HG3' HD21 ' A' ' 121' ' ' LEU . 18.8 pt20 -65.97 -33.78 76.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.481 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -71.89 -35.88 69.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.008 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.61 -45.67 78.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.681 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -39.39 85.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.656 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.809 ' O ' HG23 ' A' ' 58' ' ' VAL . 4.7 t -69.75 -32.16 70.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.656 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.632 HD13 ' CE2' ' A' ' 95' ' ' PHE . 17.3 mt -70.94 -44.97 65.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.53 -42.27 96.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.824 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -58.95 -38.16 78.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 54' ' ' SER . 12.4 t -61.56 -38.0 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.762 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -80.68 -31.02 36.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.763 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -58.72 -41.0 85.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.599 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 15.4 mt -71.54 -42.17 72.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.615 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.583 ' CD1' HD11 ' A' ' 72' ' ' ILE . 17.1 mt -68.48 -33.05 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.583 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.5 -42.82 67.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.224 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -21.36 63.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.404 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.39 -28.85 19.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.703 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.99 52.82 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.61 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 129' ' ' ARG . 6.2 mt -161.28 -172.69 3.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 0.0 110.731 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -141.75 165.09 28.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.779 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -59.69 -32.33 70.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.876 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.762 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -56.67 -26.49 56.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.473 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -82.67 -22.64 34.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.22 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.583 HD11 ' CD1' ' A' ' 62' ' ' ILE . 89.7 mt -53.59 110.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.921 0.391 . . . . 0.0 111.243 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 74' ' ' LYS . 34.4 m -78.65 -46.08 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.838 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.608 ' HD2' HD22 ' B' ' 29' ' ' LEU . 7.5 mttt -119.55 154.36 34.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.345 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.663 HG23 ' HB2' ' A' ' 105' ' ' PRO . 76.1 p -153.77 102.37 2.53 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.622 HG22 ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -69.38 124.32 23.56 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -111.07 111.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.622 ' CE1' HG22 ' A' ' 76' ' ' THR . 13.7 m-30 -109.88 133.41 53.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.995 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.686 HG11 ' HD1' ' A' ' 85' ' ' PHE . 3.1 m -130.34 150.43 34.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.1 0.476 . . . . 0.0 111.858 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.6 -1.38 58.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.889 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.31 118.95 0.31 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.477 HD23 HG21 ' A' ' 79' ' ' VAL . 51.6 mt -62.29 -14.55 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.23 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -74.14 -21.83 59.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.301 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.604 ' OD2' HD13 ' A' ' 47' ' ' ILE . 3.7 m-20 -87.0 -18.71 30.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.991 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.686 ' HD1' HG11 ' A' ' 79' ' ' VAL . 1.3 t80 -53.48 -30.98 43.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.8 -34.91 72.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.287 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.76 -42.78 13.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.324 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.1 -45.84 79.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -63.0 -38.57 91.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.081 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.21 73.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.499 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -15.08 32.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.545 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.517 ' HH ' ' HZ ' ' A' ' 96' ' ' PHE . 12.2 t80 -81.05 -38.39 27.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 111.338 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' A' ' 104' ' ' PHE . 2.4 tt0 -83.2 -27.97 29.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.516 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.83 -24.39 55.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.773 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.632 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -85.31 -37.44 19.96 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.719 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.521 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 3.9 m-85 -55.76 -55.19 35.32 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.168 0.509 . . . . 0.0 109.998 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -32.66 72.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.27 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.01 -6.72 57.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.385 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.579 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 1.5 t-20 -111.91 -4.62 14.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.494 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 15.6 m120 84.47 32.21 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.772 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.866 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 m-70 -115.81 53.16 0.93 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.605 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 58.4 Cg_endo -70.56 -22.27 28.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.539 2.159 . . . . 0.0 112.47 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.617 ' OD1' HD13 ' B' ' 5' ' ' ILE . 2.2 t-20 -50.14 -33.07 17.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.897 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.594 ' HB2' HG13 ' B' ' 19' ' ' VAL . 13.2 m-85 64.54 131.01 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.193 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.663 ' HB2' HG23 ' A' ' 75' ' ' THR . 94.2 Cg_endo -88.51 133.58 2.72 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.978 2.452 . . . . 0.0 112.615 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.964 ' HB2' HG23 ' B' ' 19' ' ' VAL . . . -97.87 129.09 44.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.058 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -162.73 -164.37 0.99 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.996 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.69 114.13 24.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.113 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.415 ' O ' HG13 ' A' ' 110' ' ' VAL . 14.6 m -92.85 138.36 31.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.219 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.771 HG12 HD23 ' B' ' 115' ' ' LEU . 23.1 m -156.73 158.38 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.986 0.422 . . . . 0.0 111.634 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.862 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 3.6 tt0 -98.99 86.29 3.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.655 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.488 HG21 HD21 ' A' ' 115' ' ' LEU . 29.0 m -57.14 156.91 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.233 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.875 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -65.74 -36.14 82.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.04 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.53 -178.25 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.735 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.783 HD23 HG12 ' C' ' 110' ' ' VAL . 27.7 mt -148.83 152.42 37.13 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.837 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.551 ' O ' HG22 ' A' ' 119' ' ' VAL . 25.9 Cg_endo -62.12 137.72 68.23 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.504 2.136 . . . . 0.0 112.162 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.409 ' HB3' HG13 ' A' ' 119' ' ' VAL . 1.1 tptt 75.17 14.1 3.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.29 13.62 8.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.188 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.645 HG11 ' HB ' ' A' ' 34' ' ' ILE . 23.0 m -58.1 156.72 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.727 0.299 . . . . 0.0 110.947 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.38 10.06 65.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.999 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.636 HD21 ' HG3' ' A' ' 50' ' ' GLN . 4.1 pp -177.26 148.26 0.59 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.085 0.469 . . . . 0.0 111.372 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.755 ' HB2' HD22 ' A' ' 115' ' ' LEU . 2.1 tt0 -126.41 150.3 48.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.087 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.679 HG21 HG21 ' A' ' 58' ' ' VAL . 29.5 mt -128.92 121.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.146 0.498 . . . . 0.0 112.277 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -130.88 144.77 51.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' A' ' 75' ' ' THR . . . -168.8 167.42 11.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 28' ' ' VAL . 1.4 mt -123.9 145.21 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.645 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 1.072 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -123.87 148.03 47.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.115 0.483 . . . . 0.0 111.868 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.752 HG21 HG21 ' B' ' 3' ' ' THR . 28.7 m -114.87 142.88 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.859 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 67' ' ' LEU . 3.2 ttm-85 -123.09 47.55 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.939 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.918 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.802 0.334 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mtt -95.89 -170.7 2.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.752 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER 63.04 106.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.83 107.64 13.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.963 HD11 HG11 ' B' ' 19' ' ' VAL . 1.7 tp -54.35 125.87 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.221 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' B' ' 23' ' ' ASP . 22.1 mm -83.58 137.55 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.147 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.48 92.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -115.21 163.7 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.13 29.04 3.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.448 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 0.0 OUTLIER -113.98 -41.92 3.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.872 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.705 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -71.94 178.15 1.43 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.705 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 32.3 Cg_exo -57.63 -13.8 15.14 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.787 2.325 . . . . 0.0 113.008 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 77.39 163.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.896 0.379 . . . . 0.0 111.032 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.423 ' C ' HD12 ' B' ' 15' ' ' ILE . . . -117.18 125.06 50.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.377 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.589 HG22 ' O ' ' B' ' 15' ' ' ILE . 3.3 mp -144.94 18.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.993 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.06 -137.23 3.45 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.44 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -88.81 32.4 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.844 2.363 . . . . 0.0 113.269 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -152.49 -178.09 6.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.427 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 106' ' ' ALA . 10.5 m -136.64 179.7 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.21 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.686 ' NE2' ' HB3' ' B' ' 11' ' ' ALA . 15.6 mm-40 -68.82 -49.75 55.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.944 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.509 ' HB3' HG13 ' B' ' 6' ' ' ILE . . . -174.6 -177.42 1.18 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.219 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.489 HG23 HD13 ' B' ' 29' ' ' LEU . 4.6 m -137.99 141.59 38.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.714 ' HB2' HD11 ' B' ' 6' ' ' ILE . 53.6 t0 -117.94 91.05 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.975 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.578 HD11 ' CG1' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -66.04 -20.94 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.01 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.05 -108.83 0.78 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.881 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -57.82 -30.26 65.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.048 0.452 . . . . 0.0 110.194 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.411 HD23 ' C ' ' B' ' 27' ' ' LEU . 7.6 tt -124.65 124.54 42.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.726 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.051 HG23 ' HB3' ' B' ' 127' ' ' ALA . 3.4 m -105.46 171.62 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.608 HD22 ' HD2' ' A' ' 74' ' ' LYS . 1.3 mp -144.69 164.8 29.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.7 p -138.46 143.87 39.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.818 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 3.3 p -71.93 179.67 3.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.801 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.31 95.49 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.369 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.575 ' OE1' HD11 ' B' ' 61' ' ' ILE . 14.3 mm-40 -66.95 165.09 16.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 111.004 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.608 HD12 ' CG2' ' B' ' 36' ' ' VAL . 8.7 pt -159.48 157.64 27.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.301 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' B' ' 43' ' ' VAL . 36.5 Cg_exo -58.41 -15.05 22.79 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.094 2.529 . . . . 0.0 113.045 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.608 ' CG2' HD12 ' B' ' 34' ' ' ILE . 44.1 t -50.01 89.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.397 . . . . 0.0 111.17 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' B' ' 41' ' ' GLY . 0.8 OUTLIER -43.89 117.39 2.64 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.558 -179.733 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.409 ' HB3' ' O ' ' B' ' 11' ' ' ALA . 31.4 Cg_exo -58.35 -14.16 19.21 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.272 1.981 . . . . 0.0 112.191 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.75 -26.96 25.54 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.311 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 12.2 t -158.71 -33.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.972 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 92.7 66.86 1.1 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.418 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -77.56 -65.18 0.99 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.978 0.418 . . . . 0.0 111.116 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' B' ' 35' ' ' PRO . 14.6 t 69.58 62.34 0.55 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.982 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' B' ' 43' ' ' VAL . 51.8 Cg_exo -54.32 153.09 23.37 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.586 2.191 . . . . 0.0 112.424 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.8 60.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.838 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.2 OUTLIER -55.04 95.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.91 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.626 HD13 ' OD2' ' B' ' 84' ' ' ASP . 8.2 tp -40.34 -32.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.86 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.57 -48.12 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -61.5 -48.55 80.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.86 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.667 ' HG3' HD21 ' B' ' 121' ' ' LEU . 18.8 pt20 -65.86 -33.9 76.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.542 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -71.75 -35.88 70.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.912 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.6 -45.71 78.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.687 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -39.32 85.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.714 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.803 ' O ' HG23 ' B' ' 58' ' ' VAL . 4.8 t -69.74 -32.23 70.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.648 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.709 HD13 ' CE2' ' B' ' 95' ' ' PHE . 17.3 mt -70.93 -44.97 65.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.59 -42.23 96.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.804 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -58.95 -38.11 78.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.854 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.803 HG23 ' O ' ' B' ' 54' ' ' SER . 12.3 t -61.6 -38.01 79.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.793 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -80.67 -30.99 36.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.799 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -58.58 -41.02 84.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.94 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.646 HG12 ' HB2' ' B' ' 11' ' ' ALA . 15.7 mt -71.51 -42.04 72.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.551 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.568 ' CD1' HD11 ' B' ' 72' ' ' ILE . 17.0 mt -68.41 -33.13 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.48 -42.76 67.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.258 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -21.36 63.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.366 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.39 -28.83 19.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.71 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.99 52.71 0.38 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.619 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' B' ' 129' ' ' ARG . 6.2 mt -161.27 -172.73 3.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.689 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 22.5 p -141.69 165.05 28.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.765 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.856 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -59.68 -32.37 70.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.856 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.743 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -56.63 -26.56 56.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.478 ' CG ' HD22 ' B' ' 67' ' ' LEU . 0.9 OUTLIER -82.42 -22.72 35.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.174 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.568 HD11 ' CD1' ' B' ' 62' ' ' ILE . 89.7 mt -53.61 110.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 111.24 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.492 HG23 ' N ' ' B' ' 74' ' ' LYS . 34.4 m -78.66 -46.11 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.89 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.591 ' HD2' HD22 ' C' ' 29' ' ' LEU . 7.5 mttt -119.56 154.4 33.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.316 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.661 HG23 ' HB2' ' B' ' 105' ' ' PRO . 75.8 p -153.78 102.32 2.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.616 HG22 ' CE1' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -69.28 124.29 23.45 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.065 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -111.04 111.84 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.616 ' CE1' HG22 ' B' ' 76' ' ' THR . 13.6 m-30 -109.85 133.36 53.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.998 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.686 HG11 ' HD1' ' B' ' 85' ' ' PHE . 3.2 m -130.33 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.14 0.495 . . . . 0.0 111.866 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.69 -1.41 58.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.849 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.27 118.91 0.31 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.488 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.474 HD23 HG21 ' B' ' 79' ' ' VAL . 52.4 mt -62.25 -14.56 39.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.263 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -74.07 -21.89 59.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.91 0.386 . . . . 0.0 110.314 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.626 ' OD2' HD13 ' B' ' 47' ' ' ILE . 3.7 m-20 -87.02 -18.71 29.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.686 ' HD1' HG11 ' B' ' 79' ' ' VAL . 1.3 t80 -53.44 -31.0 43.42 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.133 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.95 72.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.278 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.67 -42.81 13.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.338 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.44 HG22 HG13 ' B' ' 47' ' ' ILE . 26.5 t -69.08 -45.83 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.212 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -62.99 -38.51 91.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.09 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.2 73.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.503 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.94 -14.96 33.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.561 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' B' ' 96' ' ' PHE . 12.3 t80 -81.16 -38.36 27.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 111.264 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' B' ' 104' ' ' PHE . 2.4 tt0 -83.21 -27.89 29.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.545 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.87 -24.31 55.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.794 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.709 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -85.44 -37.35 19.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.672 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.521 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 3.9 m-85 -55.85 -55.18 35.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.172 0.51 . . . . 0.0 109.954 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -32.71 72.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.254 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.92 -6.82 57.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.385 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.585 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 1.5 t-20 -111.84 -4.63 14.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.499 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 15.6 m120 84.38 32.24 0.05 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.786 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.856 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.8 m-70 -115.82 53.13 0.93 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.618 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 58.5 Cg_endo -70.54 -22.33 28.65 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.565 2.177 . . . . 0.0 112.428 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.615 ' OD1' HD13 ' C' ' 5' ' ' ILE . 2.2 t-20 -50.09 -33.18 17.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.93 0.395 . . . . 0.0 110.865 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.609 ' HB2' HG13 ' C' ' 19' ' ' VAL . 13.1 m-85 64.64 130.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.2 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.661 ' HB2' HG23 ' B' ' 75' ' ' THR . 94.0 Cg_endo -88.48 133.64 2.74 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.004 2.469 . . . . 0.0 112.579 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 1.014 ' HB2' HG23 ' C' ' 19' ' ' VAL . . . -97.91 128.98 44.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.546 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -162.61 -164.33 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.958 179.325 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.73 114.13 24.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.076 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' CYS . . . . . 0.404 ' O ' HG13 ' B' ' 110' ' ' VAL . 14.5 m -92.84 138.42 31.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.21 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.789 HG12 HD23 ' C' ' 115' ' ' LEU . 23.0 m -156.74 158.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.985 0.421 . . . . 0.0 111.659 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.86 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 3.6 tt0 -99.05 86.31 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.648 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.481 HG21 HD21 ' B' ' 115' ' ' LEU . 29.3 m -57.14 156.93 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -65.74 -36.18 82.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.5 -178.22 7.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.728 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.771 HD23 HG12 ' A' ' 110' ' ' VAL . 27.7 mt -148.84 152.43 37.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.819 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.562 ' O ' HG22 ' B' ' 119' ' ' VAL . 26.1 Cg_endo -62.1 137.73 68.39 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.509 2.139 . . . . 0.0 112.18 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.403 ' HB3' HG13 ' B' ' 119' ' ' VAL . 1.1 tptt 75.13 14.12 3.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.249 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.28 13.64 8.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.142 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.589 HG11 ' HB ' ' B' ' 34' ' ' ILE . 23.0 m -58.08 156.84 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.55 9.8 64.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.019 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.667 HD21 ' HG3' ' B' ' 50' ' ' GLN . 4.1 pp -176.87 148.18 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.02 0.438 . . . . 0.0 111.39 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.754 ' HB2' HD22 ' B' ' 115' ' ' LEU . 2.1 tt0 -126.34 150.28 48.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.082 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.69 HG21 HG21 ' B' ' 58' ' ' VAL . 29.6 mt -128.96 121.34 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 112.31 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 124' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' B' ' 76' ' ' THR . 4.3 tp10 -130.77 144.82 51.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -168.8 167.48 11.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.439 HG22 ' O ' ' B' ' 28' ' ' VAL . 1.4 mt -123.89 145.2 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.661 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 1.051 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -123.86 147.94 47.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.111 0.481 . . . . 0.0 111.867 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.762 HG21 HG21 ' C' ' 3' ' ' THR . 28.9 m -114.75 142.8 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.887 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.484 ' HB2' HD11 ' B' ' 67' ' ' LEU . 3.2 ttm-85 -122.98 47.49 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.951 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.861 0.363 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mtt -95.92 -170.69 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.762 HG21 HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER 62.98 106.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.901 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.85 107.65 13.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.973 HD11 HG11 ' C' ' 19' ' ' VAL . 1.7 tp -54.37 125.93 10.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.237 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.701 HD11 ' HB2' ' C' ' 23' ' ' ASP . 22.2 mm -83.6 137.51 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.44 92.41 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -115.22 163.68 15.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.13 29.12 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.453 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 0.0 OUTLIER -113.96 -41.73 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.84 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.714 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -72.4 178.18 1.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.899 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.714 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 32.3 Cg_exo -57.56 -13.78 14.85 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.801 2.334 . . . . 0.0 113.003 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 77.35 163.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.114 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -117.09 125.04 50.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.469 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.592 HG22 ' O ' ' C' ' 15' ' ' ILE . 3.3 mp -144.93 18.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.007 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.09 -137.28 3.45 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.439 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 17' ' ' PRO . . . . . 0.447 ' HB2' ' CD1' ' B' ' 92' ' ' TYR . 88.0 Cg_endo -88.74 32.36 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.782 2.322 . . . . 0.0 113.254 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' B' ' 105' ' ' PRO . 0.7 OUTLIER -152.48 -178.03 6.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.868 0.366 . . . . 0.0 111.354 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 1.014 HG23 ' HB2' ' B' ' 106' ' ' ALA . 10.4 m -136.71 179.72 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.193 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.685 ' NE2' ' HB3' ' C' ' 11' ' ' ALA . 15.6 mm-40 -68.87 -49.62 56.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.969 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.521 ' HB3' HG13 ' C' ' 6' ' ' ILE . . . -174.42 -177.47 1.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.471 HG23 HD13 ' C' ' 29' ' ' LEU . 4.7 m -137.92 141.56 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.157 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.701 ' HB2' HD11 ' C' ' 6' ' ' ILE . 53.7 t0 -117.95 91.04 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.594 HD11 ' CG1' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -65.96 -21.0 66.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.06 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.1 -108.82 0.78 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.893 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -57.9 -30.2 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.015 0.436 . . . . 0.0 110.189 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.409 HD23 ' C ' ' C' ' 27' ' ' LEU . 7.6 tt -124.67 124.57 42.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.745 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 1.005 HG23 ' HB3' ' C' ' 127' ' ' ALA . 3.3 m -105.53 171.64 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.591 HD22 ' HD2' ' B' ' 74' ' ' LYS . 1.3 mp -144.72 164.79 29.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 15.3 p -138.44 143.76 39.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 31' ' ' SER . . . . . 0.825 ' HB3' ' HB1' ' B' ' 106' ' ' ALA . 3.4 p -72.18 179.54 3.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.27 95.47 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.359 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.573 ' OE1' HD11 ' C' ' 61' ' ' ILE . 14.3 mm-40 -66.96 165.19 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.635 ' HB ' HG11 ' C' ' 119' ' ' VAL . 8.7 pt -159.56 157.57 26.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.292 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.504 ' HB2' ' HA ' ' C' ' 43' ' ' VAL . 36.2 Cg_exo -58.4 -15.03 22.68 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.066 2.511 . . . . 0.0 112.997 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.607 ' CG2' HD12 ' C' ' 34' ' ' ILE . 43.9 t -49.97 89.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.39 . . . . 0.0 111.186 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' C' ' 41' ' ' GLY . 0.8 OUTLIER -43.92 117.41 2.66 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.579 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' C' ' 11' ' ' ALA . 31.3 Cg_exo -58.32 -14.14 19.04 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.297 1.998 . . . . 0.0 112.239 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.79 -26.94 25.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.288 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 12.2 t -158.75 -32.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.02 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 92.79 66.72 1.09 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.397 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -77.58 -65.15 1.0 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.992 0.425 . . . . 0.0 111.107 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.504 ' HA ' ' HB2' ' C' ' 35' ' ' PRO . 14.7 t 69.55 62.4 0.55 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.964 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' C' ' 43' ' ' VAL . 51.7 Cg_exo -54.39 153.12 23.62 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.608 2.206 . . . . 0.0 112.404 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.64 60.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -55.01 95.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.888 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.642 HD13 ' OD2' ' C' ' 84' ' ' ASP . 8.2 tp -40.35 -32.94 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.891 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.63 -48.17 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -61.44 -48.51 80.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.849 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.666 ' HG3' HD21 ' C' ' 121' ' ' LEU . 18.7 pt20 -65.99 -33.9 76.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -71.84 -35.93 70.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.996 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.64 -45.63 78.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.696 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -39.33 85.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.682 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.799 ' O ' HG23 ' C' ' 58' ' ' VAL . 4.8 t -69.74 -32.2 70.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.641 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.681 HD13 ' CE2' ' C' ' 95' ' ' PHE . 17.3 mt -70.99 -44.94 64.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.741 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.58 -42.26 96.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -58.94 -38.15 78.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.799 HG23 ' O ' ' C' ' 54' ' ' SER . 12.3 t -61.58 -37.97 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.774 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -80.69 -31.02 36.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.784 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -58.67 -41.07 85.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.601 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 15.7 mt -71.4 -42.17 73.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.507 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.587 ' CD1' HD11 ' C' ' 72' ' ' ILE . 16.8 mt -68.38 -33.22 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.593 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.37 -42.83 67.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.291 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.25 -21.3 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.409 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.45 -28.81 19.45 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.714 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.04 52.72 0.37 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.579 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' C' ' 129' ' ' ARG . 6.2 mt -161.26 -172.65 3.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 110.73 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -141.77 165.05 28.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.857 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -59.71 -32.29 70.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.903 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.751 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -56.72 -26.47 57.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.481 ' CG ' HD22 ' C' ' 67' ' ' LEU . 0.9 OUTLIER -82.59 -22.67 34.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.587 HD11 ' CD1' ' C' ' 62' ' ' ILE . 90.0 mt -53.62 110.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.191 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.488 HG23 ' N ' ' C' ' 74' ' ' LYS . 34.4 m -78.66 -46.05 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.9 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.594 ' HD2' HD22 ' A' ' 29' ' ' LEU . 7.5 mttt -119.61 154.38 34.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.295 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.647 HG23 ' HB2' ' C' ' 105' ' ' PRO . 76.7 p -153.75 102.33 2.53 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.614 HG22 ' CE1' ' C' ' 78' ' ' PHE . 0.2 OUTLIER -69.35 124.32 23.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 11.0 t -111.03 111.78 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.614 ' CE1' HG22 ' C' ' 76' ' ' THR . 13.6 m-30 -109.83 133.45 53.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.989 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.669 HG11 ' HD1' ' C' ' 85' ' ' PHE . 3.1 m -130.38 150.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.132 0.492 . . . . 0.0 111.831 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.64 -1.28 57.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.946 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.32 118.86 0.31 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.431 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.472 HD23 HG21 ' C' ' 79' ' ' VAL . 52.1 mt -62.17 -14.6 39.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.3 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -74.09 -21.84 59.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.868 0.366 . . . . 0.0 110.286 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.642 ' OD2' HD13 ' C' ' 47' ' ' ILE . 3.7 m-20 -87.06 -18.69 29.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.973 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.669 ' HD1' HG11 ' C' ' 79' ' ' VAL . 1.3 t80 -53.49 -30.94 43.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.141 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.95 72.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.257 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.67 -42.83 13.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.358 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.442 HG22 HG13 ' C' ' 47' ' ' ILE . 27.1 t -69.11 -45.76 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.209 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -63.05 -38.51 91.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.044 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.32 -35.3 73.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.487 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.83 -14.99 33.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.511 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.527 ' HH ' ' HZ ' ' C' ' 96' ' ' PHE . 12.3 t80 -81.14 -38.36 27.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.0 111.286 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 93' ' ' GLU . . . . . 0.45 ' HG3' ' CE1' ' C' ' 104' ' ' PHE . 2.4 tt0 -83.2 -27.94 29.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.508 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.88 -24.36 55.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.752 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.681 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -85.37 -37.36 19.97 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.713 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.527 ' HZ ' ' HH ' ' C' ' 92' ' ' TYR . 3.9 m-85 -55.83 -55.17 35.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.132 0.492 . . . . 0.0 109.984 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -32.65 72.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.214 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -6.72 56.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.424 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.576 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 1.5 t-20 -111.86 -4.65 14.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.548 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 15.5 m120 84.4 32.17 0.05 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.81 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.857 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.8 m-70 -115.79 53.18 0.93 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.587 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.403 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 58.5 Cg_endo -70.57 -22.22 28.64 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.519 2.146 . . . . 0.0 112.483 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.613 ' OD1' HD13 ' A' ' 5' ' ' ILE . 2.2 t-20 -50.18 -33.11 18.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 110.879 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.611 ' HB2' HG13 ' A' ' 19' ' ' VAL . 13.1 m-85 64.59 131.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.184 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.647 ' HB2' HG23 ' C' ' 75' ' ' THR . 94.1 Cg_endo -88.5 133.62 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.962 2.442 . . . . 0.0 112.638 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.963 ' HB2' HG23 ' A' ' 19' ' ' VAL . . . -97.94 129.01 44.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.031 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.534 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -162.61 -164.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 179.298 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.68 114.11 24.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 109' ' ' CYS . . . . . 0.416 ' O ' HG13 ' C' ' 110' ' ' VAL . 14.6 m -92.85 138.4 31.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.297 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.783 HG12 HD23 ' A' ' 115' ' ' LEU . 23.1 m -156.69 158.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.97 0.414 . . . . 0.0 111.682 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.875 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 3.6 tt0 -99.0 86.32 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.644 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.487 HG21 HD21 ' C' ' 115' ' ' LEU . 29.1 m -57.12 156.88 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.219 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.86 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -65.71 -36.21 82.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.51 -178.2 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.767 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.789 HD23 HG12 ' B' ' 110' ' ' VAL . 27.8 mt -148.85 152.42 37.07 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.825 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.55 ' O ' HG22 ' C' ' 119' ' ' VAL . 25.8 Cg_endo -62.13 137.71 68.12 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.523 2.149 . . . . 0.0 112.151 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.422 ' HB3' HG13 ' C' ' 119' ' ' VAL . 1.1 tptt 75.16 14.12 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.219 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.25 13.63 8.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.152 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.635 HG11 ' HB ' ' C' ' 34' ' ' ILE . 23.3 m -58.06 156.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.771 0.32 . . . . 0.0 110.965 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.48 10.16 64.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.044 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.666 HD21 ' HG3' ' C' ' 50' ' ' GLN . 4.1 pp -177.33 148.18 0.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.063 0.459 . . . . 0.0 111.388 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.766 ' HB2' HD22 ' C' ' 115' ' ' LEU . 2.1 tt0 -126.3 150.34 48.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.096 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.683 HG21 HG21 ' C' ' 58' ' ' VAL . 29.3 mt -128.98 121.31 54.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.502 . . . . 0.0 112.322 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 124' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' C' ' 76' ' ' THR . 4.3 tp10 -130.79 144.75 51.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' C' ' 75' ' ' THR . . . -168.75 167.5 11.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.431 HG22 ' O ' ' C' ' 28' ' ' VAL . 1.4 mt -123.96 145.27 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.624 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 1.005 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -123.89 147.95 47.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.125 0.488 . . . . 0.0 111.848 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.76 HG21 HG21 ' A' ' 3' ' ' THR . 28.8 m -114.76 142.87 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.853 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' C' ' 67' ' ' LEU . 3.2 ttm-85 -123.07 47.54 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.926 0.393 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.814 0.34 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.3 ttt 59.5 -172.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.806 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 24' ' ' LEU . 90.1 m 62.39 149.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.977 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.537 ' O ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 60.57 -173.31 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.873 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 4' ' ' GLN . 1.1 tp 57.67 120.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.907 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.516 HG21 HG22 ' A' ' 61' ' ' ILE . 13.7 mt -148.67 134.93 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.252 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.8 138.81 48.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 0.0 111.238 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.661 HG21 ' CG1' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -139.07 148.03 42.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.838 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.01 37.16 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -137.88 -45.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.992 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.7 110.95 7.43 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.33 -14.68 45.4 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.517 2.145 . . . . 0.0 112.36 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.77 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.198 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.555 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 61.22 -165.19 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.358 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 15' ' ' ILE . 21.8 mt 77.38 17.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.252 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.02 -135.2 3.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.009 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.84 43.13 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.658 2.239 . . . . 0.0 112.568 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.555 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -177.33 -176.3 0.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.859 0.362 . . . . 0.0 110.983 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.781 HG13 ' HB2' ' C' ' 104' ' ' PHE . 16.6 m -115.26 165.25 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -56.38 -48.25 77.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 110.63 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.548 ' CB ' HG21 ' A' ' 61' ' ' ILE . . . -161.41 -175.96 5.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.523 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.476 HG11 ' O ' ' C' ' 73' ' ' VAL . 30.6 m -132.09 131.47 61.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.975 0.417 . . . . 0.0 111.42 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB2' HG12 ' A' ' 6' ' ' ILE . 61.7 t0 -105.85 86.83 2.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.056 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.613 ' HA ' HG23 ' A' ' 3' ' ' THR . 31.7 mt -60.79 -19.58 59.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.154 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.52 -108.49 0.88 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.669 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.553 ' C ' HD12 ' A' ' 27' ' ' LEU . 34.8 m-80 -57.63 -30.22 65.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.182 0.515 . . . . 0.0 109.948 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 27' ' ' LEU . 3.2 mp -124.16 136.62 54.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.506 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.977 HG23 ' HB3' ' A' ' 127' ' ' ALA . 0.7 OUTLIER -104.7 177.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.253 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.464 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -157.15 133.6 9.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.4 p -110.08 138.78 45.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 0.0 111.118 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.79 175.66 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.84 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.85 84.09 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.298 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.11 152.81 12.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 0.0 111.167 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.639 HD12 ' CG2' ' A' ' 36' ' ' VAL . 10.3 pt -132.07 142.1 43.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.023 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HG2' HG23 ' A' ' 43' ' ' VAL . 90.7 Cg_endo -79.9 53.97 4.99 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.95 2.433 . . . . 0.0 112.975 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.639 ' CG2' HD12 ' A' ' 34' ' ' ILE . 45.5 t -63.01 85.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.167 0.508 . . . . 0.0 110.575 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -35.76 131.72 0.56 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.953 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.62 -13.46 32.53 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.256 1.97 . . . . 0.0 112.077 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.64 -19.96 10.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.576 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.96 -29.99 7.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.924 0.392 . . . . 0.0 110.664 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.72 51.83 23.18 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.518 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -171.06 -80.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.772 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.682 HG23 ' HG3' ' A' ' 50' ' ' GLN . 7.3 p -166.04 112.72 0.75 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.173 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -50.97 139.61 41.15 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.345 2.03 . . . . 0.0 112.174 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.39 72.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.046 0.451 . . . . 0.0 111.009 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.38 91.66 1.02 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.853 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.0 mm -41.42 -35.05 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.155 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.78 -45.49 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.434 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.81 95.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.408 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.682 ' HG3' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -68.39 -32.11 71.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.189 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.56 -38.45 74.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.004 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -70.83 -48.96 51.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.51 -28.18 68.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.779 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -66.84 -45.61 77.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.795 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.25 -22.28 64.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 59' ' ' LYS . 2.7 mm-40 -72.9 -54.59 8.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.417 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 58' ' ' VAL . 29.1 p30 -55.72 -30.92 61.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.285 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 54' ' ' SER . 40.3 t -69.32 -50.36 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.929 0.395 . . . . 0.0 110.721 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 56' ' ' GLU . 2.8 ptmm? -67.39 -33.78 75.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.694 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.56 -40.92 84.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.963 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.661 ' CG1' HG21 ' A' ' 8' ' ' THR . 5.3 mt -64.99 -56.56 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.653 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.637 HD12 ' CB ' ' A' ' 127' ' ' ALA . 5.2 tt -64.43 -26.32 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.812 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.44 -41.04 33.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 110.376 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -15.49 63.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.723 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.22 -26.99 17.93 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.954 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.09 44.32 0.49 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.381 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.867 HD11 ' HB2' ' A' ' 129' ' ' ARG . 4.5 mt -157.2 139.58 14.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.878 0.371 . . . . 0.0 110.851 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 p -92.73 159.32 15.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.882 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -57.31 -34.79 69.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.692 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -49.71 -27.39 4.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.35 -28.05 47.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.081 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.483 HD12 ' HB1' ' A' ' 69' ' ' ALA . 78.8 mt -44.48 118.47 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.925 0.393 . . . . 0.0 110.984 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.696 HG11 HG13 ' A' ' 128' ' ' VAL . 10.3 m -83.62 -46.3 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.134 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.563 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 6.8 tttm -141.67 147.73 37.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.604 0.24 . . . . 0.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.761 HG21 ' OH ' ' A' ' 92' ' ' TYR . 2.3 t -141.59 117.51 10.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.396 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 108' ' ' SER . 0.2 OUTLIER -85.98 162.57 18.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.523 HG12 HG13 ' A' ' 79' ' ' VAL . 20.4 t -150.8 103.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.932 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.498 ' CD2' HG11 ' C' ' 110' ' ' VAL . 9.5 m-85 -94.06 96.24 9.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.214 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.854 HG12 HD23 ' A' ' 121' ' ' LEU . 26.9 m -97.23 148.48 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.662 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.43 ' HG3' HD12 ' A' ' 115' ' ' LEU . 7.7 mttt -79.96 -5.06 54.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.017 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.97 143.05 9.17 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.468 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 82' ' ' LEU . 8.8 mt -85.82 2.13 46.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.24 -19.98 26.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.584 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.91 -29.99 16.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.903 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.427 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 35.2 t80 -57.18 -26.31 60.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.05 -35.8 69.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.246 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.95 -33.15 18.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.25 -42.31 66.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 32.2 t30 -67.73 -39.45 84.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.59 -30.46 69.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.28 -32.55 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.761 ' OH ' HG21 ' A' ' 75' ' ' THR . 4.1 t80 -58.55 -47.71 83.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.55 -20.87 58.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.282 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 0.1 OUTLIER -77.3 -32.01 55.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.447 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -89.48 -33.34 16.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.116 0.484 . . . . 0.0 110.737 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.514 ' CG ' ' HB2' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -58.05 -53.68 55.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.893 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -32.09 70.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 95' ' ' PHE . 3.8 pt-20 -72.76 -12.61 61.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.67 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.734 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 6.4 m-80 -102.88 -13.94 16.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.103 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 58.9 m-20 97.48 41.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.986 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.882 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 2.1 m-70 -120.14 52.02 2.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.705 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 74.0 Cg_endo -74.11 -3.74 14.28 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.523 2.149 . . . . 0.0 113.077 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 6.6 t-20 -60.14 -30.75 69.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.764 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.4 m-85 65.23 113.08 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.59 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.498 ' HD3' ' CE2' ' A' ' 96' ' ' PHE . 78.2 Cg_endo -96.54 151.37 1.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.375 2.717 . . . . 0.0 112.671 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.563 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -60.01 163.36 4.79 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 137.72 10.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.176 0.513 . . . . 0.0 112.03 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.486 ' O ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -127.16 84.42 2.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.007 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 52.7 t -90.57 145.23 25.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.208 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.596 HG12 HD23 ' B' ' 115' ' ' LEU . 32.8 m -152.97 132.99 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.088 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.807 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 4.5 tt0 -67.22 82.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.876 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.745 HG21 HD21 ' A' ' 115' ' ' LEU . 12.6 m -67.03 161.71 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -79.91 -44.21 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.4 OUTLIER -148.61 164.62 33.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.817 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.745 HD21 HG21 ' A' ' 112' ' ' VAL . 4.8 mt -139.79 159.95 62.87 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.762 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 119' ' ' VAL . 75.9 Cg_exo -50.52 134.64 39.75 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.478 2.119 . . . . 0.0 112.259 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.43 14.31 9.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.41 17.89 8.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.84 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.582 HG11 ' HB ' ' A' ' 34' ' ' ILE . 16.1 m -53.83 164.77 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.167 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.596 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -87.91 -24.38 35.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.646 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.854 HD23 HG12 ' A' ' 79' ' ' VAL . 4.4 mp -153.25 147.35 25.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.163 0.506 . . . . 0.0 111.27 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.4 ' OE1' ' CD2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -132.39 138.62 47.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.779 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.8 138.02 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.384 0.611 . . . . 0.0 112.324 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.61 107.92 4.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.185 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 75' ' ' THR . . . -121.86 161.63 22.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 28' ' ' VAL . 2.3 mp -111.71 155.51 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.027 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.977 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.42 149.99 40.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.01 0.433 . . . . 0.0 111.475 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.696 HG13 HG11 ' A' ' 73' ' ' VAL . 16.0 m -113.04 179.64 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.061 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.867 ' HB2' HD11 ' A' ' 67' ' ' LEU . 20.4 ttp180 -162.2 45.59 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.925 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.819 0.342 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 1.3 ttt 59.46 -172.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.639 HG23 ' HA ' ' B' ' 24' ' ' LEU . 90.1 m 62.43 149.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.03 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.536 ' O ' HG22 ' B' ' 5' ' ' ILE . 0.0 OUTLIER 60.39 -173.34 0.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.88 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.536 HG22 ' O ' ' B' ' 4' ' ' GLN . 1.1 tp 57.77 120.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.921 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.498 HG21 HG22 ' B' ' 61' ' ' ILE . 13.6 mt -148.67 134.93 12.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.245 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.81 138.93 48.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 111.171 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.648 HG21 ' CG1' ' B' ' 61' ' ' ILE . 0.9 OUTLIER -139.12 148.01 42.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.778 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.09 37.17 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -137.79 -45.37 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.99 110.96 7.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.42 -14.56 44.91 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.453 2.102 . . . . 0.0 112.392 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.81 -167.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.182 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.55 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 61.26 -165.17 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.381 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.619 HG22 ' O ' ' B' ' 15' ' ' ILE . 21.6 mt 77.33 17.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.253 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.11 -135.24 3.46 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.967 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.83 43.22 1.26 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.619 2.212 . . . . 0.0 112.535 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.55 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -177.47 -176.3 0.61 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.923 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.764 HG13 ' HB2' ' A' ' 104' ' ' PHE . 16.6 m -115.25 165.27 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.443 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -56.45 -48.42 77.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.032 0.444 . . . . 0.0 110.607 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' B' ' 61' ' ' ILE . . . -161.16 -175.95 5.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.477 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.478 HG11 ' O ' ' A' ' 73' ' ' VAL . 30.5 m -132.15 131.45 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.011 0.434 . . . . 0.0 111.369 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.436 ' HB2' HG12 ' B' ' 6' ' ' ILE . 61.6 t0 -105.82 86.76 2.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.06 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.639 ' HA ' HG23 ' B' ' 3' ' ' THR . 31.4 mt -60.78 -19.54 59.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.198 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.53 -108.52 0.88 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.669 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' ASN . . . . . 0.546 ' C ' HD12 ' B' ' 27' ' ' LEU . 34.7 m-80 -57.66 -30.16 65.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.14 0.495 . . . . 0.0 109.906 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.641 ' N ' HD12 ' B' ' 27' ' ' LEU . 3.2 mp -124.21 136.68 54.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.496 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.966 HG23 ' HB3' ' B' ' 127' ' ' ALA . 0.7 OUTLIER -104.72 177.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.173 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' B' ' 21' ' ' ALA . 0.0 OUTLIER -157.22 133.63 9.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.776 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 81.7 p -110.09 139.28 45.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.884 0.373 . . . . 0.0 111.194 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.86 175.68 10.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.915 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.89 84.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.09 152.81 12.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.899 0.38 . . . . 0.0 111.198 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.645 HD12 ' CG2' ' B' ' 36' ' ' VAL . 10.3 pt -132.06 142.14 44.02 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.998 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.472 ' HG2' HG23 ' B' ' 43' ' ' VAL . 91.6 Cg_endo -79.92 53.91 4.96 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.931 2.421 . . . . 0.0 112.986 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.645 ' CG2' HD12 ' B' ' 34' ' ' ILE . 45.4 t -62.93 85.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.51 . . . . 0.0 110.586 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 41' ' ' GLY . 28.0 t-20 -35.75 131.69 0.56 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.011 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.66 -13.41 32.38 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.259 1.972 . . . . 0.0 112.031 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.6 -20.02 10.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.562 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.89 -30.01 7.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.045 0.45 . . . . 0.0 110.654 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 69.65 51.82 23.6 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.56 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -171.09 -80.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.796 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.666 HG23 ' HG3' ' B' ' 50' ' ' GLN . 7.4 p -166.06 112.75 0.75 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.127 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.403 ' HD2' ' HG3' ' B' ' 50' ' ' GLN . 65.6 Cg_exo -50.95 139.64 40.9 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.366 2.044 . . . . 0.0 112.144 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.46 72.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.067 0.46 . . . . 0.0 111.031 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.36 91.67 1.01 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.828 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 24.0 mm -41.44 -35.01 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.158 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.86 -45.44 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.397 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.8 95.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.432 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.666 ' HG3' HG23 ' B' ' 43' ' ' VAL . 0.0 OUTLIER -68.31 -31.68 71.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.163 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.53 -38.5 74.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.027 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -70.79 -48.91 51.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -60.58 -28.18 68.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.774 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.2 OUTLIER -66.81 -45.54 78.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.3 -22.28 64.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.401 ' HA ' ' HG2' ' B' ' 59' ' ' LYS . 2.7 mm-40 -72.88 -54.61 8.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.401 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -55.71 -30.86 61.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.38 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 54' ' ' SER . 40.4 t -69.38 -50.36 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 110.691 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.414 ' HA ' HG22 ' B' ' 62' ' ' ILE . 2.8 ptmm? -67.31 -33.8 76.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.71 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.5 -40.72 83.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.998 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.648 ' CG1' HG21 ' B' ' 8' ' ' THR . 5.3 mt -65.07 -56.53 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.667 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.652 HD12 ' CB ' ' B' ' 127' ' ' ALA . 5.2 tt -64.45 -26.26 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.44 -41.0 34.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.968 0.413 . . . . 0.0 110.423 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -15.5 63.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.74 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.17 -27.0 17.97 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.961 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.08 44.32 0.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.399 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' B' ' 129' ' ' ARG . 4.5 mt -157.23 139.6 14.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.807 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 27.2 p -92.73 159.36 15.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.879 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -57.32 -34.79 69.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.697 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -49.71 -27.23 4.53 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.999 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.65 -27.94 45.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.462 HD12 ' HB1' ' B' ' 69' ' ' ALA . 78.8 mt -44.5 118.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 120.897 0.38 . . . . 0.0 111.003 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.719 HG11 HG13 ' B' ' 128' ' ' VAL . 10.4 m -83.65 -46.24 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.13 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.58 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 6.8 tttm -141.72 147.7 37.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.645 0.26 . . . . 0.0 110.892 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.768 HG21 ' OH ' ' B' ' 92' ' ' TYR . 2.3 t -141.57 117.42 10.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.43 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.493 HG22 ' O ' ' B' ' 108' ' ' SER . 0.2 OUTLIER -85.85 162.6 18.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.332 179.366 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.521 HG12 HG13 ' B' ' 79' ' ' VAL . 20.5 t -150.82 103.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.879 0.371 . . . . 0.0 111.931 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.492 ' CD2' HG11 ' A' ' 110' ' ' VAL . 9.5 m-85 -94.03 96.28 9.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.227 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.845 HG12 HD23 ' B' ' 121' ' ' LEU . 26.9 m -97.24 148.44 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.705 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.408 ' HG3' HD12 ' B' ' 115' ' ' LEU . 7.8 mttt -80.0 -5.01 54.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.014 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.84 143.09 9.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.458 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' B' ' 82' ' ' LEU . 8.8 mt -85.85 2.09 47.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.095 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.26 -19.98 26.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.613 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.95 -29.98 16.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 35.2 t80 -57.2 -26.27 60.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.169 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.85 69.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.324 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.93 -33.18 18.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.27 -42.39 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.426 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 32.0 t30 -67.66 -39.49 84.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.65 -30.52 69.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.26 -32.49 22.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.768 ' OH ' HG21 ' B' ' 75' ' ' THR . 4.1 t80 -58.48 -47.71 83.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.56 -20.9 58.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.295 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' B' ' 98' ' ' GLU . 0.1 OUTLIER -77.3 -31.95 55.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.493 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.2 OUTLIER -89.51 -33.35 16.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.455 . . . . 0.0 110.741 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.521 ' CG ' ' HB2' ' B' ' 101' ' ' HIS . 0.1 OUTLIER -57.97 -53.7 55.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -32.04 70.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.961 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' B' ' 94' ' ' ARG . 3.8 pt-20 -72.72 -12.62 61.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 0.0 110.625 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.731 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 6.4 m-80 -102.96 -13.93 16.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.099 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 14.6 m120 97.5 41.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.964 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.879 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 2.1 m-70 -120.01 52.07 2.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.757 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 74.2 Cg_endo -74.14 -3.76 14.32 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.566 2.178 . . . . 0.0 113.087 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -60.14 -30.7 69.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.806 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.3 m-85 65.16 113.14 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.594 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.498 ' HD3' ' CE2' ' B' ' 96' ' ' PHE . 80.2 Cg_endo -96.67 151.37 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.357 2.705 . . . . 0.0 112.675 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.58 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -59.96 163.34 4.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.6 137.76 10.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.203 0.525 . . . . 0.0 112.017 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.493 ' O ' HG22 ' B' ' 76' ' ' THR . 0.1 OUTLIER -127.15 84.34 2.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.055 179.126 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 52.7 t -90.43 145.27 25.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.265 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.593 HG12 HD23 ' C' ' 115' ' ' LEU . 32.7 m -153.11 133.29 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.812 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 4.5 tt0 -67.49 82.05 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.755 HG21 HD21 ' B' ' 115' ' ' LEU . 12.6 m -67.02 161.7 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -79.93 -44.19 20.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.081 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.56 164.66 33.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.805 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.755 HD21 HG21 ' B' ' 112' ' ' VAL . 4.8 mt -139.81 159.96 62.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.783 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.564 ' O ' HG22 ' B' ' 119' ' ' VAL . 74.8 Cg_exo -50.5 134.61 39.59 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.521 2.147 . . . . 0.0 112.254 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.41 14.33 9.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.208 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.38 17.91 8.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.819 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.578 HG11 ' HB ' ' B' ' 34' ' ' ILE . 16.0 m -53.81 164.79 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.14 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 120' ' ' GLY . . . . . 0.603 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -87.89 -24.27 35.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.652 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.845 HD23 HG12 ' B' ' 79' ' ' VAL . 4.4 mp -153.45 147.41 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.111 0.482 . . . . 0.0 111.238 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.34 138.64 47.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.795 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.8 137.98 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.324 0.583 . . . . 0.0 112.348 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.59 107.91 4.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.214 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.485 ' HB2' ' CB ' ' B' ' 75' ' ' THR . . . -121.91 161.71 22.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.297 0.57 . . . . 0.0 112.507 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.437 HG23 ' O ' ' B' ' 28' ' ' VAL . 2.3 mp -111.79 155.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.977 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.966 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.34 150.06 40.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.403 . . . . 0.0 111.527 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.719 HG13 HG11 ' B' ' 73' ' ' VAL . 16.0 m -113.1 179.67 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.977 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.851 ' HB2' HD11 ' B' ' 67' ' ' LEU . 20.4 ttp180 -162.21 45.62 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.948 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.838 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.78 0.324 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 1.3 ttt 59.52 -172.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.644 HG23 ' HA ' ' C' ' 24' ' ' LEU . 90.1 m 62.42 149.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.546 ' O ' HG22 ' C' ' 5' ' ' ILE . 0.0 OUTLIER 60.56 -173.35 0.12 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.824 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.546 HG22 ' O ' ' C' ' 4' ' ' GLN . 1.1 tp 57.67 120.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.916 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.518 HG21 HG22 ' C' ' 61' ' ' ILE . 13.5 mt -148.66 134.95 12.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.247 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -131.85 138.86 48.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 111.205 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.651 HG21 ' CG1' ' C' ' 61' ' ' ILE . 0.9 OUTLIER -139.12 148.01 42.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.835 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.06 37.11 1.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -137.91 -45.97 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.4 111.0 7.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.092 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.41 -14.62 45.23 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.496 2.131 . . . . 0.0 112.396 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.78 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.2 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 61.2 -165.16 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.385 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.607 HG22 ' O ' ' C' ' 15' ' ' ILE . 21.9 mt 77.33 17.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.262 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.01 -135.2 3.46 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.029 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.85 43.15 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 112.561 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.557 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -177.34 -176.29 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.986 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.806 HG13 ' HB2' ' B' ' 104' ' ' PHE . 16.5 m -115.25 165.32 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 20' ' ' GLN . . . . . 0.446 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -56.38 -47.87 78.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.099 0.476 . . . . 0.0 110.519 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.548 ' CB ' HG21 ' C' ' 61' ' ' ILE . . . -162.02 -175.78 4.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.476 HG11 ' O ' ' B' ' 73' ' ' VAL . 30.2 m -132.08 131.42 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.409 . . . . 0.0 111.351 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' C' ' 6' ' ' ILE . 61.6 t0 -105.85 86.88 2.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.093 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.644 ' HA ' HG23 ' C' ' 3' ' ' THR . 31.5 mt -60.82 -19.61 60.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.154 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.54 -108.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.693 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' ASN . . . . . 0.548 ' C ' HD12 ' C' ' 27' ' ' LEU . 34.7 m-80 -57.62 -30.21 65.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.159 0.504 . . . . 0.0 109.917 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.628 ' N ' HD12 ' C' ' 27' ' ' LEU . 3.2 mp -124.22 136.62 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.482 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 1.002 HG23 ' HB3' ' C' ' 127' ' ' ALA . 0.7 OUTLIER -104.7 177.17 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.249 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.447 ' O ' ' HB1' ' C' ' 21' ' ' ALA . 0.0 OUTLIER -157.2 133.54 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 81.3 p -109.94 138.16 46.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.83 0.348 . . . . 0.0 110.971 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 31' ' ' SER . . . . . 0.422 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 8.1 t -78.42 175.37 10.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.863 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.84 84.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.284 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.06 152.81 12.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 111.191 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.64 HD12 ' CG2' ' C' ' 36' ' ' VAL . 10.3 pt -132.05 142.17 44.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.455 ' HG2' HG23 ' C' ' 43' ' ' VAL . 91.8 Cg_endo -80.0 53.93 4.97 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.964 2.443 . . . . 0.0 112.975 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.64 ' CG2' HD12 ' C' ' 34' ' ' ILE . 45.7 t -63.0 85.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.134 0.492 . . . . 0.0 110.537 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' C' ' 41' ' ' GLY . 27.9 t-20 -35.74 131.67 0.56 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.015 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.64 -13.42 32.44 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.318 2.012 . . . . 0.0 112.008 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.66 -20.0 10.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.548 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.02 -30.16 7.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.988 0.423 . . . . 0.0 110.634 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 69.77 51.98 22.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.484 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -170.98 -80.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.724 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.685 HG23 ' HG3' ' C' ' 50' ' ' GLN . 7.4 p -165.99 112.71 0.76 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.169 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.401 ' HD2' ' HG3' ' C' ' 50' ' ' GLN . 67.1 Cg_exo -50.97 139.64 41.05 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.318 2.012 . . . . 0.0 112.161 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.44 72.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.026 0.441 . . . . 0.0 111.001 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.46 91.7 1.05 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 24.1 mm -41.33 -35.13 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.192 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.79 -45.41 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.467 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.76 95.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.438 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.685 ' HG3' HG23 ' C' ' 43' ' ' VAL . 0.0 OUTLIER -68.7 -32.44 72.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.214 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.88 -38.5 73.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.116 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -70.76 -48.9 51.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.55 -28.12 68.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.799 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.597 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.2 OUTLIER -66.81 -45.6 77.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 mt -68.38 -22.2 64.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.94 -54.53 8.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.417 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' C' ' 58' ' ' VAL . 29.2 p30 -55.8 -30.9 62.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.304 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.597 HG23 ' O ' ' C' ' 54' ' ' SER . 40.3 t -69.31 -50.33 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 110.744 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' C' ' 62' ' ' ILE . 2.8 ptmm? -67.36 -33.84 76.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.753 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.52 -41.08 84.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.057 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.651 ' CG1' HG21 ' C' ' 8' ' ' THR . 5.3 mt -65.17 -56.47 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.748 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.637 HD12 ' CB ' ' C' ' 127' ' ' ALA . 5.2 tt -64.52 -26.19 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.826 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.53 -41.01 33.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.873 0.368 . . . . 0.0 110.335 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -15.48 63.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.724 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.12 -27.01 18.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.856 0.36 . . . . 0.0 111.003 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.15 44.24 0.49 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.36 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.841 HD11 ' HB2' ' C' ' 129' ' ' ARG . 4.5 mt -157.21 139.59 14.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.385 . . . . 0.0 110.828 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 27.1 p -92.75 159.38 15.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.782 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.891 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -57.34 -34.76 69.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.8 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -49.77 -27.4 4.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.909 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.07 -27.99 48.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.046 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.47 HD12 ' HB1' ' C' ' 69' ' ' ALA . 78.8 mt -44.47 118.42 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.901 0.381 . . . . 0.0 111.003 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.728 HG11 HG13 ' C' ' 128' ' ' VAL . 10.3 m -83.58 -46.26 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.196 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.571 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 6.8 tttm -141.7 147.7 37.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.626 0.25 . . . . 0.0 110.966 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.767 HG21 ' OH ' ' C' ' 92' ' ' TYR . 2.3 t -141.52 117.5 10.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.41 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.493 HG22 ' O ' ' C' ' 108' ' ' SER . 0.2 OUTLIER -85.98 162.56 18.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.309 179.413 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.51 HG12 HG13 ' C' ' 79' ' ' VAL . 20.4 t -150.81 103.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.366 . . . . 0.0 111.929 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.521 ' CD2' HG11 ' B' ' 110' ' ' VAL . 9.5 m-85 -94.04 96.32 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.187 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.831 HG12 HD23 ' C' ' 121' ' ' LEU . 27.0 m -97.27 148.46 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.652 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 80' ' ' LYS . . . . . 0.431 ' HG3' HD12 ' C' ' 115' ' ' LEU . 7.8 mttt -79.98 -5.21 55.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.027 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.87 143.06 9.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.454 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' C' ' 82' ' ' LEU . 8.8 mt -85.87 2.11 47.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.27 -19.94 26.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.571 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.93 -29.99 16.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.423 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 35.1 t80 -57.24 -26.24 60.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.129 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.84 69.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.248 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.98 -33.11 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.23 -42.35 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 89' ' ' ASN . . . . . 0.423 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 31.9 t30 -67.68 -39.52 84.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.43 -30.4 69.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.063 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.41 -32.48 22.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.767 ' OH ' HG21 ' C' ' 75' ' ' THR . 4.1 t80 -58.58 -47.71 83.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -75.57 -20.84 58.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.281 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 94' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' C' ' 98' ' ' GLU . 0.1 OUTLIER -77.39 -31.87 54.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.453 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.2 OUTLIER -89.53 -33.37 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 110.672 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.528 ' CG ' ' HB2' ' C' ' 101' ' ' HIS . 0.1 OUTLIER -57.94 -53.78 54.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.866 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -32.09 70.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.934 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 98' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' C' ' 95' ' ' PHE . 3.8 pt-20 -72.73 -12.6 61.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.652 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.745 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 6.5 m-80 -102.9 -13.97 16.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.089 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 14.6 m120 97.49 41.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.974 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.891 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 2.1 m-70 -119.95 51.99 2.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.76 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 74.0 Cg_endo -74.12 -3.77 14.33 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.549 2.166 . . . . 0.0 113.086 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 6.6 t-20 -60.16 -30.69 69.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.846 0.355 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.781 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.4 m-85 65.18 113.1 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.638 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.483 ' HD3' ' CE2' ' C' ' 96' ' ' PHE . 79.1 Cg_endo -96.61 151.3 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.388 2.725 . . . . 0.0 112.691 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.571 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -59.92 163.39 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.68 137.73 10.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.21 0.528 . . . . 0.0 112.067 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 108' ' ' SER . . . . . 0.493 ' O ' HG22 ' C' ' 76' ' ' THR . 0.1 OUTLIER -127.19 84.45 2.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.975 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 52.6 t -90.6 145.21 25.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.608 HG12 HD23 ' A' ' 115' ' ' LEU . 32.8 m -152.97 132.82 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.051 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.82 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 4.5 tt0 -67.17 82.04 0.13 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.736 HG21 HD21 ' C' ' 115' ' ' LEU . 12.5 m -67.1 161.71 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -79.93 -44.17 20.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.431 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.4 OUTLIER -148.63 164.65 33.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.736 HD21 HG21 ' C' ' 112' ' ' VAL . 4.8 mt -139.76 159.98 62.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.567 ' O ' HG22 ' C' ' 119' ' ' VAL . 75.3 Cg_exo -50.57 134.61 40.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.471 2.114 . . . . 0.0 112.283 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.44 14.37 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.174 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.35 17.97 8.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.793 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.586 HG11 ' HB ' ' C' ' 34' ' ' ILE . 16.0 m -53.84 164.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.115 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 120' ' ' GLY . . . . . 0.659 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -88.14 -24.47 34.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.592 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.831 HD23 HG12 ' C' ' 79' ' ' VAL . 4.4 mp -153.27 147.33 25.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.13 0.491 . . . . 0.0 111.338 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.39 138.62 47.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.773 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.78 138.02 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.371 0.605 . . . . 0.0 112.286 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.56 107.94 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.19 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' C' ' 75' ' ' THR . . . -121.95 161.74 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.34 0.591 . . . . 0.0 112.486 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.414 HG23 ' O ' ' C' ' 28' ' ' VAL . 2.3 mp -111.78 155.45 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.998 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 1.002 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.4 150.04 40.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.027 0.442 . . . . 0.0 111.47 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.728 HG13 HG11 ' C' ' 73' ' ' VAL . 16.0 m -113.03 179.71 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.042 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.841 ' HB2' HD11 ' C' ' 67' ' ' LEU . 20.4 ttp180 -162.23 45.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.921 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 130' ' ' LYS . . . . . 0.408 ' HE3' HD11 ' C' ' 27' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mmm . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.807 0.337 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.81 175.19 10.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.932 HG21 HG21 ' C' ' 128' ' ' VAL . 0.6 OUTLIER 62.15 117.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.59 121.0 7.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.755 HG21 HG11 ' A' ' 19' ' ' VAL . 4.7 mp -56.3 141.66 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.172 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 32.3 mt -92.58 146.42 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.271 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.28 117.32 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.699 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 t -129.29 161.58 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.031 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.68 24.85 6.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 -51.95 3.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.63 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.06 112.82 38.66 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.018 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -60.66 -16.16 41.55 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.446 2.097 . . . . 0.0 112.531 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HB1' ' OH ' ' A' ' 18' ' ' TYR . . . -56.76 -168.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.293 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 63.65 -167.48 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.341 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 15' ' ' ILE . 19.4 mm 78.26 16.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.239 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.21 -134.69 3.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.141 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HG2' ' CZ ' ' C' ' 107' ' ' ARG . 96.3 Cg_endo -85.91 23.17 0.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.657 2.238 . . . . 0.0 112.868 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.611 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -154.18 -168.73 3.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.764 0.316 . . . . 0.0 110.822 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.755 HG11 HG21 ' A' ' 5' ' ' ILE . 15.4 m -124.86 172.23 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.264 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.59 -55.09 14.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.866 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 61' ' ' ILE . . . -157.78 178.5 10.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.038 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.753 HG23 HD13 ' A' ' 29' ' ' LEU . 7.1 m -127.96 134.31 65.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.9 t70 -117.77 96.3 5.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.839 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.715 HD13 HD21 ' C' ' 27' ' ' LEU . 12.3 mt -76.35 -20.39 57.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.984 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.89 -106.02 0.73 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.825 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -59.58 -29.59 68.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 110.148 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.626 HD21 HD13 ' B' ' 24' ' ' LEU . 0.6 OUTLIER -123.15 120.12 32.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.866 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.95 HG23 ' HB3' ' A' ' 127' ' ' ALA . 5.1 m -111.13 167.51 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.992 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.753 HD13 HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.84 155.33 38.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.838 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -117.51 136.03 53.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.945 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 55.7 m -68.74 167.04 16.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.11 82.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.323 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -76.38 145.95 39.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.097 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.442 ' HB ' HG11 ' A' ' 119' ' ' VAL . 8.3 pt -128.49 160.31 63.2 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.604 ' O ' HG12 ' A' ' 36' ' ' VAL . 84.7 Cg_exo -43.3 -47.85 8.6 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.721 2.281 . . . . 0.0 111.778 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.847 HG22 ' HA2' ' A' ' 41' ' ' GLY . 9.8 p 46.91 21.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.751 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 36' ' ' VAL . 7.2 t-20 58.7 138.7 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.881 0.372 . . . . 0.0 111.45 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HG3' ' A' ' 44' ' ' PRO . 5.4 Cg_endo -47.71 -34.02 20.11 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.009 2.473 . . . . 0.0 113.258 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.63 17.75 0.13 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.4 HG21 ' OE2' ' A' ' 42' ' ' GLU . 2.3 m -107.22 -17.69 14.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.366 . . . . 0.0 110.428 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.847 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . 70.09 43.18 65.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.887 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -143.34 -83.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.567 0.222 . . . . 0.0 110.791 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.653 ' HB ' HG12 ' A' ' 119' ' ' VAL . 8.2 p 174.11 128.06 0.11 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.943 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 14.2 Cg_exo -69.97 143.57 50.22 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.606 2.204 . . . . 0.0 112.226 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.65 63.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.079 0.466 . . . . 0.0 110.957 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -68.3 96.05 0.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.617 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.01 -32.16 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.629 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.07 -52.45 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.592 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -63.33 -28.49 70.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.478 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HG2' ' CG ' ' A' ' 35' ' ' PRO . 0.9 OUTLIER -79.75 -28.68 40.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.458 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.49 58.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.031 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -74.42 -41.74 60.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.083 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.21 -43.81 87.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.026 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.64 ' O ' HG23 ' A' ' 58' ' ' VAL . 73.6 m -59.51 -43.62 93.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD23 HD13 ' A' ' 123' ' ' ILE . 75.4 mt -66.4 -35.41 80.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.988 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.88 -38.27 82.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.011 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.64 -36.41 84.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.746 HG21 ' CG2' ' A' ' 123' ' ' ILE . 16.0 t -69.82 -46.94 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.947 0.403 . . . . 0.0 110.943 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -72.51 -31.37 65.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.827 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.77 91.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.487 HG21 ' CB ' ' A' ' 21' ' ' ALA . 6.5 mt -65.44 -56.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 127' ' ' ALA . 4.9 tt -63.83 -26.22 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.742 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 -40.12 60.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.374 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -10.78 59.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.788 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.84 -29.62 18.48 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.875 0.369 . . . . 0.0 110.905 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.61 52.42 0.33 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.52 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.537 HD22 ' CB ' ' A' ' 71' ' ' ASP . 2.3 mt -147.88 -169.89 3.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.09 160.09 41.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.99 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.783 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -59.97 -33.56 72.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.119 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -62.82 -17.18 60.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.461 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.0 m-20 -85.28 -24.57 27.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.814 0.34 . . . . 0.0 110.829 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 47.0 mt -53.71 118.55 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.128 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.568 ' O ' HG11 ' B' ' 22' ' ' VAL . 12.4 m -89.28 -37.19 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.707 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.755 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -141.25 149.33 41.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.705 0.288 . . . . 0.0 110.774 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.689 HG23 ' HB2' ' A' ' 125' ' ' ALA . 89.3 m -144.96 110.36 5.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.95 0.405 . . . . 0.0 111.323 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.566 ' O ' HG13 ' A' ' 77' ' ' VAL . 87.8 m -95.22 157.81 15.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.246 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.665 HG12 HG12 ' A' ' 123' ' ' ILE . 3.3 m -159.1 142.46 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.084 0.468 . . . . 0.0 111.761 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' C' ' 110' ' ' VAL . 3.5 m-85 -114.0 119.09 36.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.283 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.802 HG12 HD21 ' A' ' 121' ' ' LEU . 33.2 m -107.34 152.23 9.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.114 0.483 . . . . 0.0 111.735 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.51 0.17 39.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.821 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -163.28 107.5 1.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.566 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.87 -13.89 60.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.222 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -79.66 -27.79 40.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.909 0.385 . . . . 0.0 110.493 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.32 -12.18 55.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.831 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.652 ' CD1' HG11 ' A' ' 79' ' ' VAL . 1.6 t80 -58.63 -24.52 61.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.82 -56.52 11.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.352 . . . . 0.0 111.38 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.48 -36.83 83.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 t -64.8 -42.07 93.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.16 -42.32 89.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.481 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.81 75.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.895 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 94' ' ' ARG . 20.3 mm-40 -88.69 -30.01 19.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.693 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.428 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 58.7 t80 -57.72 -49.7 75.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.014 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.44 -17.49 45.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 91' ' ' GLU . 4.6 mtp180 -75.12 -27.92 60.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.658 0.265 . . . . 0.0 111.38 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -86.19 -33.35 20.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.38 . . . . 0.0 110.525 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.471 ' CZ ' ' CD ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -56.27 -55.7 30.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.334 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.62 -28.81 70.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.889 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.47 -6.22 59.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.35 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.783 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 1.5 m120 -111.47 -5.13 14.62 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.56 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.716 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 8.7 m-80 85.42 33.31 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.803 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 20.1 t-160 -128.88 67.3 77.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.529 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 4.5 Cg_exo -75.48 -20.24 16.13 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.602 2.202 . . . . 0.0 112.525 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.704 ' CG ' HD13 ' B' ' 5' ' ' ILE . 1.4 t-20 -69.15 -36.69 77.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.063 0.459 . . . . 0.0 110.344 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' A' ' 102' ' ' PRO . 15.8 m-85 74.06 142.56 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.427 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.471 ' CD ' ' CZ ' ' A' ' 96' ' ' PHE . 73.2 Cg_endo -90.07 165.88 4.71 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.209 2.606 . . . . 0.0 111.956 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.755 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -50.1 154.11 1.24 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.424 ' HB3' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -119.02 140.98 49.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.227 0.537 . . . . 0.0 112.048 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.6 t -144.28 45.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.986 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 28.7 p -81.37 135.08 35.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.249 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' B' ' 78' ' ' PHE . 23.0 m -153.85 149.34 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.203 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.831 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -84.4 91.04 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.771 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.666 HG21 HD21 ' A' ' 115' ' ' LEU . 27.7 m -71.15 177.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.841 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -81.83 -45.95 14.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.005 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.405 ' CB ' ' HB3' ' C' ' 111' ' ' GLU . 0.1 OUTLIER -151.72 -179.72 7.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.788 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.666 HD21 HG21 ' A' ' 112' ' ' VAL . 60.0 mt -149.2 155.6 39.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.704 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.551 ' O ' HG22 ' A' ' 119' ' ' VAL . 9.2 Cg_endo -52.33 139.23 55.06 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.523 2.149 . . . . 0.0 111.977 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 7.9 mmtm 66.46 17.72 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.278 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 61.63 17.45 8.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.025 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.653 HG12 ' HB ' ' A' ' 43' ' ' VAL . 30.1 m -55.76 167.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.073 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.03 8.49 42.24 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.918 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.802 HD21 HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -172.58 154.6 3.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.086 0.469 . . . . 0.0 111.226 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.2 159.01 43.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.002 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.746 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.9 mt -144.25 145.75 21.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.38 0.609 . . . . 0.0 112.301 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.16 101.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.322 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.689 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -119.07 163.59 16.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.171 0.51 . . . . 0.0 112.194 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 72' ' ' ILE . 5.7 mt -114.43 151.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.133 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.95 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -136.06 148.39 48.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.034 0.445 . . . . 0.0 111.574 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.897 HG21 HG21 ' B' ' 3' ' ' THR . 35.0 m -115.92 151.44 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.122 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.401 ' HD2' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.08 70.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.819 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.884 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 71.2 mmm . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.821 0.343 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.87 175.14 10.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.897 HG21 HG21 ' A' ' 128' ' ' VAL . 0.6 OUTLIER 62.16 117.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.58 120.97 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.769 HG21 HG11 ' B' ' 19' ' ' VAL . 4.7 mp -56.26 141.66 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 31.8 mt -92.61 146.33 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.318 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.2 117.41 5.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.718 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 14.3 t -129.32 161.6 29.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.036 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.69 24.85 6.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.807 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.5 -52.47 3.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.677 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.5 112.93 38.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.7 -16.16 41.84 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.436 2.09 . . . . 0.0 112.473 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.479 ' HB1' ' OH ' ' B' ' 18' ' ' TYR . . . -56.75 -168.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.252 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.617 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 63.73 -167.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.315 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.588 HG22 ' O ' ' B' ' 15' ' ' ILE . 19.4 mm 78.23 16.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.288 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.26 -134.73 3.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.163 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 107' ' ' ARG . 96.9 Cg_endo -85.84 23.18 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.685 2.256 . . . . 0.0 112.926 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.617 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -154.13 -168.71 3.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.755 0.312 . . . . 0.0 110.829 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.769 HG11 HG21 ' B' ' 5' ' ' ILE . 15.5 m -124.88 172.31 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.362 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.71 -55.16 14.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.802 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.494 ' CB ' HG21 ' B' ' 61' ' ' ILE . . . -158.13 178.44 10.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.995 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.748 HG23 HD13 ' B' ' 29' ' ' LEU . 7.2 m -127.88 134.27 65.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.463 ' HA ' HG12 ' B' ' 28' ' ' VAL . 7.8 t70 -117.67 96.23 5.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.626 HD13 HD21 ' A' ' 27' ' ' LEU . 12.4 mt -76.34 -20.42 57.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.002 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.97 -106.03 0.73 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.83 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -59.62 -29.51 68.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.038 0.447 . . . . 0.0 110.152 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.786 HD21 HD13 ' C' ' 24' ' ' LEU . 0.7 OUTLIER -123.19 120.07 32.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.872 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.998 HG23 ' HB3' ' B' ' 127' ' ' ALA . 5.1 m -111.07 167.54 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.01 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.748 HD13 HG23 ' B' ' 22' ' ' VAL . 0.0 OUTLIER -150.91 155.31 38.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -117.38 135.8 53.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 56.5 m -68.89 166.97 16.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.13 82.13 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.307 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -76.39 145.89 39.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.357 . . . . 0.0 111.15 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.436 ' HB ' HG11 ' B' ' 119' ' ' VAL . 8.2 pt -128.48 160.3 63.23 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.545 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.604 ' O ' HG12 ' B' ' 36' ' ' VAL . 84.5 Cg_exo -43.2 -47.93 8.38 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.755 2.303 . . . . 0.0 111.753 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.872 HG22 ' HA2' ' B' ' 41' ' ' GLY . 9.8 p 46.91 21.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.717 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.412 ' O ' ' O ' ' B' ' 36' ' ' VAL . 7.2 t-20 58.72 138.69 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.895 0.378 . . . . 0.0 111.455 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' HG3' ' B' ' 44' ' ' PRO . 5.4 Cg_endo -47.75 -34.01 20.38 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.042 2.495 . . . . 0.0 113.207 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.63 17.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -107.35 -17.79 14.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 110.445 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.872 ' HA2' HG22 ' B' ' 36' ' ' VAL . . . 70.14 43.36 64.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.89 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.442 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 0.0 OUTLIER -143.37 -83.31 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.602 0.239 . . . . 0.0 110.833 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.684 ' HB ' HG12 ' B' ' 119' ' ' VAL . 8.2 p 174.08 128.05 0.11 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.927 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' B' ' 43' ' ' VAL . 14.2 Cg_exo -69.96 143.6 50.38 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.636 2.224 . . . . 0.0 112.214 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.65 63.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.995 0.426 . . . . 0.0 110.896 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.4 OUTLIER -68.22 96.05 0.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.677 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.0 -32.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.589 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.95 -52.51 15.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.64 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -63.35 -28.43 69.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.469 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.458 ' HG2' ' CG ' ' B' ' 35' ' ' PRO . 0.9 OUTLIER -79.76 -28.61 40.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.485 179.618 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.51 -35.45 58.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -74.38 -41.76 60.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.23 -43.75 87.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.615 ' O ' HG23 ' B' ' 58' ' ' VAL . 73.8 m -59.47 -43.62 93.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.034 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.503 HD23 HD13 ' B' ' 123' ' ' ILE . 75.2 mt -66.44 -35.34 80.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.89 -38.35 82.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.6 -36.35 83.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.06 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.736 HG21 ' CG2' ' B' ' 123' ' ' ILE . 16.2 t -69.85 -46.91 72.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 0.0 110.956 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' B' ' 62' ' ' ILE . 0.0 OUTLIER -72.6 -31.29 65.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.812 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.24 -40.85 91.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.932 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.494 HG21 ' CB ' ' B' ' 21' ' ' ALA . 6.4 mt -65.48 -56.86 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' B' ' 127' ' ' ALA . 5.0 tt -63.83 -26.2 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.725 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -40.07 60.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.924 0.393 . . . . 0.0 110.446 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -10.84 59.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.812 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.78 -29.72 18.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.69 52.42 0.32 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.543 HD22 ' CB ' ' B' ' 71' ' ' ASP . 2.3 mt -147.94 -169.94 3.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 110.577 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.08 160.14 40.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.982 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -59.98 -33.52 72.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -62.83 -17.17 60.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.448 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.543 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.0 m-20 -85.16 -24.64 27.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 110.805 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.69 118.53 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.095 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.621 ' O ' HG11 ' C' ' 22' ' ' VAL . 12.5 m -89.23 -37.22 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.73 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.789 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 0.0 OUTLIER -141.21 149.37 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.708 0.29 . . . . 0.0 110.78 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.685 HG23 ' HB2' ' B' ' 125' ' ' ALA . 89.2 m -144.99 110.29 5.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.568 ' O ' HG13 ' B' ' 77' ' ' VAL . 87.8 m -95.09 157.75 15.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.242 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.667 HG12 HG12 ' B' ' 123' ' ' ILE . 3.2 m -159.05 142.5 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.758 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 110' ' ' VAL . 3.5 m-85 -114.01 119.09 36.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.248 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.797 HG12 HD21 ' B' ' 121' ' ' LEU . 33.9 m -107.33 152.18 9.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.125 0.488 . . . . 0.0 111.765 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.53 -0.14 38.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.817 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.85 107.51 1.11 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.578 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.99 -13.78 60.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.215 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -79.67 -27.85 40.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 0.0 110.484 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.27 -12.17 55.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.864 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.661 ' CD1' HG11 ' B' ' 79' ' ' VAL . 1.6 t80 -58.68 -24.43 61.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.007 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.87 -56.52 11.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 111.331 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.83 83.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 34.3 t -64.83 -42.06 93.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.715 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.18 -42.2 89.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.5 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.04 -36.09 76.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.938 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' B' ' 94' ' ' ARG . 20.4 mm-40 -88.45 -29.96 19.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.724 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.419 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 58.6 t80 -57.75 -49.66 75.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.028 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.47 -17.46 45.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.504 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' B' ' 91' ' ' GLU . 4.6 mtp180 -75.09 -27.94 60.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.699 0.285 . . . . 0.0 111.414 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.9 OUTLIER -86.15 -33.48 20.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.499 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' B' ' 101' ' ' HIS . 0.9 OUTLIER -56.19 -55.76 29.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.344 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.54 -28.9 70.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.914 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -6.24 59.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.397 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.751 ' HB3' ' HB3' ' B' ' 69' ' ' ALA . 1.5 m120 -111.41 -5.15 14.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.718 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 8.6 m-80 85.44 33.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.894 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.549 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.1 t-160 -128.81 67.42 77.46 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.534 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 4.6 Cg_exo -75.48 -20.25 16.12 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.621 2.214 . . . . 0.0 112.519 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.659 ' CG ' HD13 ' C' ' 5' ' ' ILE . 1.4 t-20 -69.17 -36.68 77.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.307 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' B' ' 102' ' ' PRO . 15.8 m-85 74.07 142.52 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.453 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.462 ' CD ' ' CZ ' ' B' ' 96' ' ' PHE . 72.2 Cg_endo -90.09 165.86 4.69 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.107 2.538 . . . . 0.0 111.98 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.789 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -50.02 154.18 1.19 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.462 ' HB3' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -119.1 141.0 49.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.215 0.531 . . . . 0.0 112.068 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 30.8 t -144.26 45.83 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.954 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' B' ' 77' ' ' VAL . 28.7 p -81.44 135.02 35.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.277 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' C' ' 78' ' ' PHE . 23.4 m -153.7 149.06 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.149 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.855 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -84.49 91.04 7.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.822 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.651 HG21 HD21 ' B' ' 115' ' ' LEU . 27.6 m -71.15 177.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.206 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -81.79 -45.92 14.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.44 ' CB ' ' HB3' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -151.7 -179.53 7.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.753 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.651 HD21 HG21 ' B' ' 112' ' ' VAL . 59.5 mt -149.33 155.56 39.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.669 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.548 ' O ' HG22 ' B' ' 119' ' ' VAL . 9.3 Cg_endo -52.35 139.25 55.23 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.537 2.158 . . . . 0.0 111.987 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 8.0 mmtm 66.38 17.81 10.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.253 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 61.53 17.52 8.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.065 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.684 HG12 ' HB ' ' B' ' 43' ' ' VAL . 30.3 m -55.8 167.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.062 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.11 8.12 41.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.888 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.797 HD21 HG12 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -172.47 154.5 3.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.165 0.507 . . . . 0.0 111.296 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.12 158.95 43.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.025 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.736 ' CG2' HG21 ' B' ' 58' ' ' VAL . 28.2 mt -144.21 145.75 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.309 0.576 . . . . 0.0 112.309 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.17 101.48 1.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.344 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.685 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -119.02 163.56 16.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.198 0.523 . . . . 0.0 112.245 -178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.7 mt -114.41 151.9 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.114 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.998 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -136.06 148.32 48.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.993 0.425 . . . . 0.0 111.618 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.983 HG21 HG21 ' C' ' 3' ' ' THR . 35.0 m -115.82 151.38 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.06 70.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.84 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mmm . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.792 0.33 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.83 175.15 10.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.983 HG21 HG21 ' B' ' 128' ' ' VAL . 0.6 OUTLIER 62.15 117.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.56 121.02 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.728 HG21 HG11 ' C' ' 19' ' ' VAL . 4.7 mp -56.31 141.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 32.0 mt -92.61 146.37 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.234 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.24 117.37 5.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.705 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 14.3 t -129.3 161.61 29.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.037 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.72 24.89 6.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 -52.34 3.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.751 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.62 112.86 37.78 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.05 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.65 -16.13 41.34 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.436 2.09 . . . . 0.0 112.525 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.481 ' HB1' ' OH ' ' C' ' 18' ' ' TYR . . . -56.8 -168.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.249 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.627 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 63.69 -167.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.332 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.587 HG22 ' O ' ' C' ' 15' ' ' ILE . 19.4 mm 78.26 16.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.215 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.21 -134.78 3.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.14 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.8 23.16 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.609 2.206 . . . . 0.0 112.9 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.627 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -154.1 -168.61 3.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.738 0.304 . . . . 0.0 110.855 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.728 HG11 HG21 ' C' ' 5' ' ' ILE . 15.4 m -124.97 172.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.29 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -55.01 15.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.936 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -157.95 178.57 10.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.026 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.761 HG23 HD13 ' C' ' 29' ' ' LEU . 7.2 m -127.92 134.21 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.47 ' HA ' HG12 ' C' ' 28' ' ' VAL . 7.9 t70 -117.73 96.32 5.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.786 HD13 HD21 ' B' ' 27' ' ' LEU . 12.4 mt -76.37 -20.36 57.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.0 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.92 -106.03 0.73 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.839 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.62 -29.55 68.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.119 0.485 . . . . 0.0 110.186 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.715 HD21 HD13 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -123.2 120.08 32.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.875 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.982 HG23 ' HB3' ' C' ' 127' ' ' ALA . 5.2 m -111.06 167.52 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.761 HD13 HG23 ' C' ' 22' ' ' VAL . 0.0 OUTLIER -150.83 155.35 39.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.2 p -117.52 135.91 53.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.862 0.363 . . . . 0.0 110.914 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 56.3 m -68.55 166.99 15.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.818 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.03 82.14 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.341 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -76.43 145.92 38.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 111.178 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.44 ' HB ' HG11 ' C' ' 119' ' ' VAL . 8.3 pt -128.47 160.32 63.08 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.574 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.602 ' O ' HG12 ' C' ' 36' ' ' VAL . 85.6 Cg_exo -43.22 -47.92 8.43 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.73 2.286 . . . . 0.0 111.757 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.899 HG22 ' HA2' ' C' ' 41' ' ' GLY . 9.8 p 46.94 21.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.769 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' C' ' 36' ' ' VAL . 7.1 t-20 58.73 138.71 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.902 0.382 . . . . 0.0 111.496 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HG3' ' C' ' 44' ' ' PRO . 5.4 Cg_endo -47.78 -33.99 20.53 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.058 2.505 . . . . 0.0 113.215 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.64 17.71 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -107.16 -17.59 14.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 110.46 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.899 ' HA2' HG22 ' C' ' 36' ' ' VAL . . . 69.95 43.19 66.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.894 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.444 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 0.0 OUTLIER -143.32 -83.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.61 0.243 . . . . 0.0 110.842 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.659 ' HB ' HG12 ' C' ' 119' ' ' VAL . 8.2 p 174.06 128.05 0.11 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.936 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.427 ' HG3' ' HD3' ' C' ' 38' ' ' PRO . 14.2 Cg_exo -69.97 143.63 50.4 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.616 2.21 . . . . 0.0 112.235 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.62 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.044 0.45 . . . . 0.0 110.897 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.4 OUTLIER -68.29 96.06 0.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.602 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.03 -32.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.605 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.95 -52.53 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.623 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -63.36 -28.45 70.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.492 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.465 ' HG2' ' CG ' ' C' ' 35' ' ' PRO . 0.9 OUTLIER -79.69 -28.52 40.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.452 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.54 58.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -74.23 -41.87 60.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.24 -43.72 87.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.643 ' O ' HG23 ' C' ' 58' ' ' VAL . 73.7 m -59.47 -43.71 93.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.497 HD23 HD13 ' C' ' 123' ' ' ILE . 75.1 mt -66.38 -35.38 80.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.003 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.86 -38.3 82.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.014 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.63 -36.34 83.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.745 HG21 ' CG2' ' C' ' 123' ' ' ILE . 16.1 t -69.9 -46.93 72.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.923 0.392 . . . . 0.0 110.936 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' C' ' 62' ' ' ILE . 0.0 OUTLIER -72.49 -31.47 65.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.764 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.8 90.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.907 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.48 HG21 ' CB ' ' C' ' 21' ' ' ALA . 6.4 mt -65.39 -56.78 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.71 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' C' ' 127' ' ' ALA . 4.9 tt -63.89 -26.19 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.746 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -40.03 60.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.921 0.391 . . . . 0.0 110.431 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -10.75 59.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.8 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.89 -29.64 18.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.837 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.63 52.42 0.33 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.485 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.545 HD22 ' CB ' ' C' ' 71' ' ' ASP . 2.3 mt -147.91 -169.89 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 110.585 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.12 160.15 40.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.032 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -60.0 -33.5 72.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -62.92 -17.31 61.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.42 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.545 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.0 m-20 -85.18 -24.43 27.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.784 0.326 . . . . 0.0 110.786 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 47.1 mt -53.79 118.62 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.08 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.614 ' O ' HG11 ' A' ' 22' ' ' VAL . 12.5 m -89.32 -37.16 9.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.693 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.763 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 0.0 OUTLIER -141.26 149.36 41.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.782 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.699 HG23 ' HB2' ' C' ' 125' ' ' ALA . 89.5 m -145.0 110.31 5.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.92 0.391 . . . . 0.0 111.343 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.574 ' O ' HG13 ' C' ' 77' ' ' VAL . 87.8 m -95.14 157.82 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.217 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.659 HG12 HG12 ' C' ' 123' ' ' ILE . 3.3 m -159.15 142.47 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.081 0.467 . . . . 0.0 111.774 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' B' ' 110' ' ' VAL . 3.5 m-85 -114.0 119.07 35.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.283 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.772 HG12 HD21 ' C' ' 121' ' ' LEU . 33.5 m -107.31 152.23 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.102 0.477 . . . . 0.0 111.744 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.55 -0.15 38.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.806 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.85 107.45 1.11 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.572 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.89 -13.82 60.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.213 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -79.69 -27.78 40.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.482 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.29 -12.17 55.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.83 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.651 ' CD1' HG11 ' C' ' 79' ' ' VAL . 1.6 t80 -58.7 -24.45 61.43 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.996 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.86 -56.51 11.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.338 . . . . 0.0 111.353 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.82 83.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 t -64.84 -42.07 93.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.72 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.13 -42.35 89.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.483 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.97 76.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.865 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 91' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' C' ' 94' ' ' ARG . 20.4 mm-40 -88.63 -29.88 19.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.7 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.424 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 59.0 t80 -57.77 -49.68 75.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.011 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.46 -17.46 45.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.496 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 94' ' ' ARG . . . . . 0.413 ' HB2' ' HA ' ' C' ' 91' ' ' GLU . 4.6 mtp180 -75.1 -27.91 60.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.711 0.291 . . . . 0.0 111.381 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.9 OUTLIER -86.19 -33.45 20.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 110.493 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.461 ' CZ ' ' CD ' ' C' ' 105' ' ' PRO . 0.9 OUTLIER -56.2 -55.79 28.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.329 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.53 -28.91 70.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.882 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.39 -6.24 59.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.381 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.735 ' HB3' ' HB3' ' C' ' 69' ' ' ALA . 1.5 m120 -111.43 -5.14 14.64 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.588 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.716 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 8.7 m-80 85.45 33.18 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.851 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.547 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.1 t-160 -128.89 67.38 77.73 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.481 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 4.5 Cg_exo -75.42 -20.32 16.16 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.667 2.244 . . . . 0.0 112.528 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.685 ' CG ' HD13 ' A' ' 5' ' ' ILE . 1.4 t-20 -69.12 -36.77 77.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.452 . . . . 0.0 110.336 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.417 ' CB ' ' HA ' ' A' ' 18' ' ' TYR . 15.8 m-85 74.1 142.56 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.404 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.461 ' CD ' ' CZ ' ' C' ' 96' ' ' PHE . 73.5 Cg_endo -90.12 165.85 4.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.176 2.584 . . . . 0.0 111.929 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.763 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -49.99 154.03 1.22 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -119.0 140.98 49.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.275 0.559 . . . . 0.0 112.086 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 30.5 t -144.28 45.87 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.963 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 109' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' C' ' 77' ' ' VAL . 28.8 p -81.44 135.01 35.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.312 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' A' ' 78' ' ' PHE . 23.1 m -153.82 149.23 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.19 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.841 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -84.24 91.0 7.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.72 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.643 HG21 HD21 ' C' ' 115' ' ' LEU . 27.7 m -71.16 177.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.246 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -81.8 -46.0 14.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.999 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.4 ' CB ' ' HB3' ' B' ' 111' ' ' GLU . 0.1 OUTLIER -151.71 -179.79 7.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.739 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.643 HD21 HG21 ' C' ' 112' ' ' VAL . 59.7 mt -149.14 155.58 40.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.727 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.558 ' O ' HG22 ' C' ' 119' ' ' VAL . 9.2 Cg_endo -52.31 139.22 54.9 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.536 2.157 . . . . 0.0 111.992 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 8.0 mmtm 66.45 17.73 10.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.212 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 61.64 17.43 8.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.042 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.659 HG12 ' HB ' ' C' ' 43' ' ' VAL . 30.5 m -55.71 167.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -105.86 8.35 42.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.914 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.772 HD21 HG12 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -172.37 154.46 3.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.069 0.461 . . . . 0.0 111.22 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.12 159.0 43.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.027 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.745 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.8 mt -144.26 145.75 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.359 0.599 . . . . 0.0 112.334 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.17 101.49 1.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.333 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -119.04 163.57 16.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.203 0.525 . . . . 0.0 112.185 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.403 HG23 ' HG ' ' C' ' 29' ' ' LEU . 5.7 mt -114.4 151.87 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.099 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.982 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -136.03 148.39 48.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 0.0 111.629 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.932 HG21 HG21 ' A' ' 3' ' ' THR . 35.0 m -115.89 151.42 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.12 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.09 70.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.811 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.774 0.321 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.03 111.98 23.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.08 HG21 HG21 ' C' ' 128' ' ' VAL . 3.1 m 61.68 114.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -171.06 125.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.798 HD13 ' OD1' ' C' ' 103' ' ' ASN . 4.2 mp -56.54 141.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.585 HD12 ' HB3' ' A' ' 21' ' ' ALA . 21.9 mt -98.01 149.84 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.24 26.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.27 171.11 20.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.3 28.44 8.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.033 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.557 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 8.1 mttm -120.5 -44.96 2.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -66.55 171.48 4.23 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.868 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.889 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 29.6 Cg_endo -63.6 -12.68 32.33 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.572 2.181 . . . . 0.0 112.523 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 69.44 147.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.492 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 19' ' ' VAL . . . -126.28 120.95 31.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.838 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 15' ' ' ILE . 3.1 mp -135.23 17.1 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.073 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.92 -118.88 2.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.382 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.81 14.92 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.675 2.25 . . . . 0.0 113.316 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -147.04 -174.06 4.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.994 0.426 . . . . 0.0 111.517 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.913 HG23 ' HB2' ' C' ' 106' ' ' ALA . 18.0 m -138.61 169.34 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.798 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -49.09 79.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.602 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB3' HD12 ' A' ' 6' ' ' ILE . . . -177.02 -178.07 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.962 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 29' ' ' LEU . 15.0 m -141.48 133.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 28' ' ' VAL . 37.6 t70 -110.8 115.39 29.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.839 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.963 HD11 HD12 ' A' ' 29' ' ' LEU . 2.8 mt -90.98 -16.03 28.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -99.3 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.755 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -56.91 -29.12 62.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.183 0.516 . . . . 0.0 110.072 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -136.21 135.19 38.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.774 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.962 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 4.8 p -109.51 164.55 5.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.871 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.963 HD12 HD11 ' A' ' 24' ' ' LEU . 3.4 mt -142.6 131.28 22.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.3 p -104.71 144.9 31.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.9 ' HB3' ' HB1' ' C' ' 106' ' ' ALA . 10.2 p -82.98 178.88 7.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.4 89.73 0.82 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.195 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.803 ' HG3' HG22 ' A' ' 58' ' ' VAL . 88.3 mm-40 -56.22 144.25 30.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.969 HG23 HG23 ' A' ' 36' ' ' VAL . 9.5 tt -125.51 132.89 24.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.702 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.688 ' HB2' HG23 ' A' ' 43' ' ' VAL . 21.9 Cg_exo -65.02 65.24 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.666 2.244 . . . . 0.0 112.56 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.969 HG23 HG23 ' A' ' 34' ' ' ILE . 63.3 t -84.8 88.21 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.122 0.487 . . . . 0.0 110.625 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -33.86 134.48 0.35 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.893 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.27 -20.79 20.84 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.489 2.126 . . . . 0.0 112.277 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.35 -3.59 14.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.601 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.543 HG22 ' CG ' ' A' ' 42' ' ' GLU . 3.7 m -126.22 -30.26 2.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.829 0.347 . . . . 0.0 110.83 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.99 53.44 30.27 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.325 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.543 ' CG ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER -165.59 -82.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.507 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' A' ' 35' ' ' PRO . 7.2 p 175.55 125.17 0.14 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.074 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.402 ' HG3' ' NE2' ' A' ' 53' ' ' GLN . 64.5 Cg_endo -75.29 138.98 23.02 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.354 2.036 . . . . 0.0 112.191 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.73 -31.08 71.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.061 0.458 . . . . 0.0 110.902 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 94.9 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.904 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 47' ' ' ILE . 21.5 mm -44.26 -31.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.878 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.78 -38.8 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.576 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.75 -54.34 36.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.47 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.38 -26.4 68.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.341 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.88 -40.77 72.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.4 -48.82 16.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.789 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.402 ' NE2' ' HG3' ' A' ' 44' ' ' PRO . 17.7 mt-30 -59.53 -46.73 88.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.745 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.855 ' O ' HG23 ' A' ' 58' ' ' VAL . 89.2 p -60.05 -37.25 79.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 92' ' ' TYR . 22.0 mt -76.54 -23.41 53.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.043 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -52.14 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.7 OUTLIER -58.08 -29.19 65.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.982 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 123' ' ' ILE . 54.4 t -65.06 -46.39 91.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.984 0.421 . . . . 0.0 110.643 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -28.96 61.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.844 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -60.84 -40.74 93.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.025 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.442 HD11 ' OE1' ' A' ' 33' ' ' GLN . 12.8 mt -73.59 -41.77 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.619 HD13 HD11 ' A' ' 72' ' ' ILE . 18.1 mt -69.48 -31.24 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.553 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.61 -37.33 59.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.034 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -22.41 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.272 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.87 -28.82 20.1 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.787 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.97 50.51 0.63 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.591 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.552 ' HB2' HG22 ' A' ' 62' ' ' ILE . 6.1 mt -146.66 -176.56 5.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.409 . . . . 0.0 110.716 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.77 163.83 31.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.778 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.459 ' O ' ' CD2' ' A' ' 101' ' ' HIS . . . -50.26 -34.57 23.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.031 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -67.49 -24.78 65.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.359 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.529 ' HB3' HD22 ' A' ' 67' ' ' LEU . 58.0 m-20 -80.46 -6.58 58.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.717 0.294 . . . . 0.0 110.959 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 62' ' ' ILE . 24.2 mt -83.81 116.1 27.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.249 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.49 HG23 ' N ' ' A' ' 74' ' ' LYS . 35.4 m -76.58 -46.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.041 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.84 ' HD3' HD12 ' A' ' 126' ' ' ILE . 11.0 mtpt -118.41 -177.6 3.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.59 0.233 . . . . 0.0 111.093 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 105' ' ' PRO . 11.1 t -179.99 101.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.895 0.378 . . . . 0.0 111.496 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.52 HG23 ' NH1' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -71.21 126.72 30.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.198 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.8 t -114.71 98.88 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -98.17 147.49 24.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.951 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -144.76 151.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.09 0.471 . . . . 0.0 111.899 -179.223 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.0 -2.6 56.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.764 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.29 110.31 0.57 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.416 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.63 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.0 mt -56.81 -18.6 13.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.322 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -75.86 -23.47 55.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.844 0.354 . . . . 0.0 110.583 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 88' ' ' VAL . 47.4 m-20 -77.97 -12.77 60.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -27.21 59.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.252 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.46 71.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.779 0.323 . . . . 0.0 111.415 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.88 -29.45 20.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.287 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 84' ' ' ASP . 26.2 t -73.84 -47.1 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -64.86 -39.32 93.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.47 -37.27 85.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -33.34 19.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.621 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.562 ' OH ' HG21 ' A' ' 75' ' ' THR . 35.3 t80 -61.16 -56.47 20.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.346 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -70.19 -15.29 62.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.333 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -40.06 66.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -84.95 -38.78 18.91 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.342 -179.26 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.493 ' CE1' ' CE1' ' A' ' 92' ' ' TYR . 11.1 m-85 -53.92 -50.63 65.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 110.32 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.94 -32.36 74.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.875 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.65 -1.9 54.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.432 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -110.4 -8.6 14.67 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.66 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.7 t-20 97.08 19.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.796 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.3 t60 -118.77 59.93 4.32 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.858 0.361 . . . . 0.0 110.927 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.403 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 43.9 Cg_endo -68.19 -17.78 45.16 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.493 2.129 . . . . 0.0 112.175 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.763 ' OD1' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -75.42 -34.2 61.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.7 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.469 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 33.2 m-85 72.26 140.19 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.103 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.688 ' HB2' HG22 ' A' ' 75' ' ' THR . 7.2 Cg_exo -71.83 166.77 28.51 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.747 2.298 . . . . 0.0 112.138 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.919 ' HB1' ' HB3' ' B' ' 31' ' ' SER . . . -107.52 131.01 54.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.726 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.582 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -167.48 -165.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.089 0.471 . . . . 0.0 111.303 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -116.24 114.93 25.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.209 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.519 ' O ' HG13 ' A' ' 110' ' ' VAL . 16.0 m -95.69 131.47 41.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.275 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.573 HG12 HD23 ' B' ' 115' ' ' LEU . 7.4 m -158.96 170.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.494 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.866 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 6.9 tt0 -110.6 95.34 5.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.804 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.3 m -60.46 157.3 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.876 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -60.89 -45.73 93.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.992 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.567 ' HB3' HD12 ' C' ' 82' ' ' LEU . 12.4 mmt180 -151.87 173.99 14.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.688 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.531 HD23 HG12 ' C' ' 110' ' ' VAL . 1.3 mt -143.66 156.26 59.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.69 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.436 ' O ' HG22 ' A' ' 119' ' ' VAL . 12.4 Cg_endo -55.93 137.75 79.91 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.489 2.126 . . . . 0.0 111.988 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.445 ' HB2' HD11 ' A' ' 34' ' ' ILE . 10.3 mttt 68.18 16.03 9.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.328 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.97 15.58 9.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.783 HG11 HG13 ' A' ' 34' ' ' ILE . 29.3 m -51.79 169.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.713 0.292 . . . . 0.0 111.075 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.532 ' O ' HD12 ' A' ' 121' ' ' LEU . . . -116.67 17.02 13.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.027 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 120' ' ' GLY . 0.2 OUTLIER -175.17 153.44 1.59 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.102 0.477 . . . . 0.0 111.397 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.5 ' HB2' HD22 ' A' ' 115' ' ' LEU . 1.1 tp10 -142.5 140.22 31.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.884 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.889 HG21 HG21 ' A' ' 58' ' ' VAL . 28.1 mm -121.79 127.01 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 112.141 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 76' ' ' THR . 1.0 OUTLIER -140.21 146.23 38.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.08 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 124' ' ' GLU . . . -170.05 174.22 5.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.267 0.555 . . . . 0.0 112.275 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.84 HD12 ' HD3' ' A' ' 74' ' ' LYS . 5.2 mt -132.28 151.28 34.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.188 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.962 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -132.48 150.78 52.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.15 0.5 . . . . 0.0 111.756 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.032 HG21 HG21 ' B' ' 3' ' ' THR . 13.0 m -110.64 116.23 51.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.874 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.546 ' HB2' HD21 ' A' ' 67' ' ' LEU . 2.1 tmt_? -122.67 75.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.933 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.866 179.928 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.841 0.353 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.01 112.04 23.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' THR . . . . . 1.032 HG21 HG21 ' A' ' 128' ' ' VAL . 3.1 m 61.6 114.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -170.98 125.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.763 HD13 ' OD1' ' A' ' 103' ' ' ASN . 4.2 mp -56.5 141.38 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' B' ' 21' ' ' ALA . 21.8 mt -97.97 149.85 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.209 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.25 26.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.3 171.14 20.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.36 28.48 8.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.99 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.549 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 8.1 mttm -120.64 -44.5 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.747 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.891 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -66.68 171.3 4.53 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.971 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.891 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 29.7 Cg_endo -63.67 -12.72 32.73 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.563 2.176 . . . . 0.0 112.488 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 69.52 147.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.474 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.61 ' HB3' ' HA ' ' B' ' 19' ' ' VAL . . . -126.32 120.94 31.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.795 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.579 HG22 ' O ' ' B' ' 15' ' ' ILE . 3.1 mp -135.21 17.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.162 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.91 -118.96 2.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.39 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -89.64 14.72 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.787 2.325 . . . . 0.0 113.306 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.99 -174.04 4.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 0.0 111.506 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' A' ' 106' ' ' ALA . 18.1 m -138.55 169.34 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.823 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -49.17 78.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 110.636 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.582 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -177.14 -177.93 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' B' ' 29' ' ' LEU . 14.9 m -141.51 133.29 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.151 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.553 ' HA ' HG23 ' B' ' 28' ' ' VAL . 37.6 t70 -110.77 115.36 29.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.928 HD11 HD12 ' B' ' 29' ' ' LEU . 2.9 mt -90.88 -16.01 28.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.231 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.65 -99.29 0.81 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.767 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -56.93 -29.05 62.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.171 0.51 . . . . 0.0 110.111 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.679 HD23 ' O ' ' B' ' 127' ' ' ALA . 0.2 OUTLIER -136.18 135.18 38.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.717 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.947 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 4.8 p -109.54 164.48 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.923 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.928 HD12 HD11 ' B' ' 24' ' ' LEU . 3.4 mt -142.49 131.32 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.888 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 41.1 p -104.71 144.85 31.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.972 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.919 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 10.3 p -83.32 179.17 7.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.013 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.43 89.75 0.82 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.199 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.823 ' HG3' HG22 ' B' ' 58' ' ' VAL . 88.3 mm-40 -56.18 144.16 30.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.936 0.398 . . . . 0.0 111.275 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.929 HG23 HG23 ' B' ' 36' ' ' VAL . 9.6 tt -125.45 132.87 24.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.703 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.676 ' HB2' HG23 ' B' ' 43' ' ' VAL . 21.9 Cg_exo -64.98 65.2 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.69 2.26 . . . . 0.0 112.59 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.929 HG23 HG23 ' B' ' 34' ' ' ILE . 63.7 t -84.85 88.25 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.12 0.486 . . . . 0.0 110.584 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -33.82 134.48 0.35 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.849 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.28 -20.82 20.78 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.443 2.095 . . . . 0.0 112.232 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.25 -3.76 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.61 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.535 HG22 ' CG ' ' B' ' 42' ' ' GLU . 3.7 m -126.16 -30.17 2.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.851 0.358 . . . . 0.0 110.793 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.85 53.44 30.8 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.232 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.535 ' CG ' HG22 ' B' ' 40' ' ' THR . 0.0 OUTLIER -165.55 -82.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.49 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.676 HG23 ' HB2' ' B' ' 35' ' ' PRO . 7.2 p 175.6 125.17 0.14 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.053 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.442 ' HG3' ' NE2' ' B' ' 53' ' ' GLN . 66.3 Cg_endo -75.16 138.91 23.25 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.399 2.066 . . . . 0.0 112.283 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.68 -31.13 71.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 110.892 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.84 94.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 21.4 mm -44.27 -31.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.879 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.4 t -79.72 -38.8 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.78 -54.26 38.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.451 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.48 -26.74 68.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.344 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.68 -40.69 72.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.01 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.45 -48.71 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.442 ' NE2' ' HG3' ' B' ' 44' ' ' PRO . 17.6 mt-30 -59.6 -46.71 88.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.712 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.861 ' O ' HG23 ' B' ' 58' ' ' VAL . 89.9 p -60.06 -37.25 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.859 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.496 HD21 ' CD2' ' B' ' 92' ' ' TYR . 21.9 mt -76.6 -23.3 53.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -52.07 12.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.169 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.7 OUTLIER -58.01 -29.32 65.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.893 HG21 HG21 ' B' ' 123' ' ' ILE . 54.0 t -65.02 -46.39 91.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.921 0.391 . . . . 0.0 110.6 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.09 -28.94 61.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -60.86 -40.91 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.431 HD11 ' OE1' ' B' ' 33' ' ' GLN . 13.0 mt -73.21 -41.64 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.506 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.619 HD13 HD11 ' B' ' 72' ' ' ILE . 18.0 mt -69.51 -31.31 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.535 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.51 -37.39 60.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.1 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -22.38 66.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.276 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.83 -28.9 20.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.04 50.58 0.63 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.516 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.564 HD22 ' HB3' ' B' ' 71' ' ' ASP . 6.1 mt -146.73 -176.68 5.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.988 0.423 . . . . 0.0 110.672 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.68 163.92 31.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.751 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' B' ' 101' ' ' HIS . . . -50.31 -34.62 24.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.043 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.543 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -67.49 -24.86 65.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.315 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.564 ' HB3' HD22 ' B' ' 67' ' ' LEU . 57.9 m-20 -80.38 -6.6 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.929 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.619 HD11 HD13 ' B' ' 62' ' ' ILE . 24.4 mt -83.82 116.11 27.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.221 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.499 HG23 ' N ' ' B' ' 74' ' ' LYS . 35.4 m -76.52 -47.03 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.05 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.851 ' HD3' HD12 ' B' ' 126' ' ' ILE . 10.8 mtpt -118.35 -177.58 3.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.569 0.223 . . . . 0.0 111.153 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.695 HG22 ' HB2' ' B' ' 105' ' ' PRO . 11.2 t 179.98 101.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 111.539 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.525 HG23 ' NH1' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -71.18 126.76 30.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.18 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.73 98.92 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -98.21 147.36 24.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.991 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 0.9 OUTLIER -144.68 151.76 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.173 0.511 . . . . 0.0 111.927 -179.252 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.03 -2.85 56.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.732 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.13 110.37 0.59 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.402 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.641 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.0 mt -56.92 -18.59 13.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.305 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -75.76 -23.58 55.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.558 ' O ' HG23 ' B' ' 88' ' ' VAL . 47.5 m-20 -77.91 -12.78 60.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -27.18 59.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.293 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.54 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.351 . . . . 0.0 111.408 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.87 -29.38 20.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.277 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.558 HG23 ' O ' ' B' ' 84' ' ' ASP . 26.2 t -73.87 -47.09 44.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.128 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -64.9 -39.26 93.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.59 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.34 85.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.011 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.83 -33.34 19.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.646 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.534 ' OH ' HG21 ' B' ' 75' ' ' THR . 35.4 t80 -61.23 -56.39 21.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.351 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 0.2 OUTLIER -70.28 -15.21 62.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.268 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -40.04 66.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.48 ' CE2' ' CE1' ' B' ' 96' ' ' PHE . 0.0 OUTLIER -84.95 -38.81 18.86 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.378 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.498 ' CE1' ' CE1' ' B' ' 92' ' ' TYR . 11.2 m-85 -53.86 -50.68 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.042 0.449 . . . . 0.0 110.328 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.96 -32.31 73.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.877 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.63 -1.93 55.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.463 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 1.0 OUTLIER -110.39 -8.63 14.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.637 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 2.7 t-20 97.09 19.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.761 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.543 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.3 t60 -118.53 59.86 4.01 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.961 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.411 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 44.0 Cg_endo -68.18 -17.79 45.23 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.457 2.105 . . . . 0.0 112.181 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.776 ' OD1' HD13 ' C' ' 5' ' ' ILE . 0.1 OUTLIER -75.4 -34.22 61.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' B' ' 105' ' ' PRO . 33.0 m-85 72.26 140.19 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.695 ' HB2' HG22 ' B' ' 75' ' ' THR . 7.2 Cg_exo -71.87 166.74 28.61 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.724 2.283 . . . . 0.0 112.113 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.943 ' HB1' ' HB3' ' C' ' 31' ' ' SER . . . -107.45 131.02 54.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.761 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.581 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -167.51 -165.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.049 0.452 . . . . 0.0 111.33 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -116.16 114.93 25.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.224 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' CYS . . . . . 0.529 ' O ' HG13 ' B' ' 110' ' ' VAL . 16.0 m -95.69 131.52 41.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.207 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.543 HG12 HD23 ' C' ' 115' ' ' LEU . 7.2 m -158.96 170.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 111.413 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.872 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 6.9 tt0 -110.2 95.4 5.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.676 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -60.62 157.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.065 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -60.77 -45.67 93.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.041 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.63 ' HB3' HD12 ' A' ' 82' ' ' LEU . 12.4 mmt180 -151.94 173.98 14.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.733 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.573 HD23 HG12 ' A' ' 110' ' ' VAL . 1.3 mt -143.66 156.31 59.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.7 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.433 ' O ' HG22 ' B' ' 119' ' ' VAL . 12.4 Cg_endo -55.98 137.76 80.12 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.449 2.1 . . . . 0.0 112.052 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.446 ' HB2' HG13 ' B' ' 119' ' ' VAL . 10.3 mttt 68.23 15.97 9.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.356 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.99 15.62 9.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.088 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.781 HG11 HG13 ' B' ' 34' ' ' ILE . 29.2 m -51.84 169.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.057 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 120' ' ' GLY . . . . . 0.53 ' O ' HD12 ' B' ' 121' ' ' LEU . . . -116.67 16.81 13.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.016 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.53 HD12 ' O ' ' B' ' 120' ' ' GLY . 0.2 OUTLIER -175.11 153.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.109 0.481 . . . . 0.0 111.433 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.479 ' HB2' HD22 ' B' ' 115' ' ' LEU . 1.1 tp10 -142.43 140.25 31.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.903 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.893 HG21 HG21 ' B' ' 58' ' ' VAL . 28.2 mm -121.81 127.05 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.146 0.498 . . . . 0.0 112.12 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 124' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' B' ' 76' ' ' THR . 1.0 OUTLIER -140.29 146.21 38.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.051 179.146 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' B' ' 124' ' ' GLU . . . -170.01 174.24 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.286 0.565 . . . . 0.0 112.269 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.851 HD12 ' HD3' ' B' ' 74' ' ' LYS . 5.2 mt -132.35 151.2 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.172 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.947 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -132.45 150.82 52.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.053 0.454 . . . . 0.0 111.731 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.998 HG21 HG21 ' C' ' 3' ' ' THR . 13.2 m -110.67 116.21 51.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.891 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.547 ' HB2' HD21 ' B' ' 67' ' ' LEU . 2.1 tmt_? -122.66 75.88 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.975 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.915 179.931 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.812 0.339 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.0 112.0 23.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.998 HG21 HG21 ' B' ' 128' ' ' VAL . 3.1 m 61.6 114.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -171.06 125.28 0.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.776 HD13 ' OD1' ' B' ' 103' ' ' ASN . 4.2 mp -56.42 141.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.6 HD12 ' HB3' ' C' ' 21' ' ' ALA . 22.0 mt -98.05 149.88 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.24 26.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.28 171.15 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.34 28.42 8.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.023 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.549 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 8.0 mttm -120.65 -44.6 2.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.74 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -66.79 171.22 4.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.042 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.889 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 29.6 Cg_endo -63.61 -12.71 32.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.533 2.155 . . . . 0.0 112.506 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 69.45 147.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.488 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' C' ' 19' ' ' VAL . . . -126.35 120.99 31.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.756 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.572 HG22 ' O ' ' C' ' 15' ' ' ILE . 3.1 mp -135.24 17.14 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.11 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.95 -118.88 2.91 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.418 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.75 14.81 2.07 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.784 2.323 . . . . 0.0 113.306 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -147.07 -174.06 4.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.948 0.404 . . . . 0.0 111.495 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.89 HG23 ' HB2' ' B' ' 106' ' ' ALA . 17.8 m -138.55 169.35 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.75 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -48.89 79.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 110.592 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.6 ' HB3' HD12 ' C' ' 6' ' ' ILE . . . -177.4 -177.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.898 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' C' ' 29' ' ' LEU . 15.0 m -141.47 133.34 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.05 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.542 ' HA ' HG23 ' C' ' 28' ' ' VAL . 37.5 t70 -110.77 115.4 29.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.937 HD11 HD12 ' C' ' 29' ' ' LEU . 2.9 mt -91.01 -16.07 28.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.143 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.67 -99.27 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.762 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -56.99 -29.0 62.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.159 0.504 . . . . 0.0 110.081 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.687 HD23 ' O ' ' C' ' 127' ' ' ALA . 0.2 OUTLIER -136.17 135.22 38.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.746 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.967 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 4.8 p -109.59 164.49 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.847 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.937 HD12 HD11 ' C' ' 24' ' ' LEU . 3.4 mt -142.55 131.3 22.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.887 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 40.9 p -104.63 144.35 31.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 31' ' ' SER . . . . . 0.943 ' HB3' ' HB1' ' B' ' 106' ' ' ALA . 10.1 p -83.03 179.1 7.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.51 89.74 0.83 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.177 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.821 ' HG3' HG22 ' C' ' 58' ' ' VAL . 88.3 mm-40 -56.12 144.17 30.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.286 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.972 HG23 HG23 ' C' ' 36' ' ' VAL . 9.5 tt -125.49 132.9 24.44 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.691 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.685 ' HB2' HG23 ' C' ' 43' ' ' VAL . 21.9 Cg_exo -64.93 65.25 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.657 2.238 . . . . 0.0 112.574 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.972 HG23 HG23 ' C' ' 34' ' ' ILE . 63.5 t -84.9 88.24 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.59 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -33.83 134.47 0.35 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.867 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.25 -20.84 20.83 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.445 2.097 . . . . 0.0 112.249 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.27 -3.64 14.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.619 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.535 HG22 ' CG ' ' C' ' 42' ' ' GLU . 3.7 m -126.25 -30.21 2.93 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.9 53.49 30.32 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.306 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.535 ' CG ' HG22 ' C' ' 40' ' ' THR . 0.0 OUTLIER -165.52 -82.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.486 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.685 HG23 ' HB2' ' C' ' 35' ' ' PRO . 7.3 p 175.62 125.14 0.14 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.102 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.41 ' HG3' ' NE2' ' C' ' 53' ' ' GLN . 65.5 Cg_endo -75.24 138.92 23.09 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.407 2.072 . . . . 0.0 112.242 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.72 -31.07 71.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 94.96 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.887 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 21.5 mm -44.32 -31.0 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.933 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.79 -38.73 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.6 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.79 -54.28 37.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.478 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.52 -26.82 68.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.332 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.65 72.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.1 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.44 -48.7 16.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.763 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 53' ' ' GLN . . . . . 0.41 ' NE2' ' HG3' ' C' ' 44' ' ' PRO . 17.7 mt-30 -59.62 -46.65 88.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.767 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.857 ' O ' HG23 ' C' ' 58' ' ' VAL . 90.3 p -60.04 -37.29 79.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.487 HD21 ' CD2' ' C' ' 92' ' ' TYR . 21.9 mt -76.56 -23.35 53.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.094 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.69 -52.08 12.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.203 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 57' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.6 OUTLIER -58.09 -29.2 65.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.939 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.908 HG21 HG21 ' C' ' 123' ' ' ILE . 54.3 t -65.16 -46.25 91.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.905 0.383 . . . . 0.0 110.602 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -28.87 61.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -60.87 -40.88 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.03 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.432 HD11 ' OE1' ' C' ' 33' ' ' GLN . 13.0 mt -73.13 -41.69 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.518 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.611 HD13 HD11 ' C' ' 72' ' ' ILE . 18.2 mt -69.5 -31.38 48.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.485 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.47 -37.33 60.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.106 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -22.43 66.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.276 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.88 -28.81 20.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.824 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.99 50.51 0.63 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.568 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' C' ' 71' ' ' ASP . 6.1 mt -146.67 -176.66 5.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 110.68 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.68 163.85 31.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.47 ' O ' ' CD2' ' C' ' 101' ' ' HIS . . . -50.21 -34.74 23.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.548 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -67.38 -24.72 65.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.324 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.566 ' HB3' HD22 ' C' ' 67' ' ' LEU . 57.9 m-20 -80.67 -6.52 58.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.934 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.611 HD11 HD13 ' C' ' 62' ' ' ILE . 24.7 mt -83.88 116.08 27.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.188 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.504 HG23 ' N ' ' C' ' 74' ' ' LYS . 35.4 m -76.57 -46.93 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.014 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.872 ' HD3' HD12 ' C' ' 126' ' ' ILE . 10.8 mtpt -118.4 -177.7 3.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.591 0.234 . . . . 0.0 111.158 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.683 HG22 ' HB2' ' C' ' 105' ' ' PRO . 11.1 t -179.94 101.04 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.84 0.352 . . . . 0.0 111.509 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.52 HG23 ' NH1' ' C' ' 107' ' ' ARG . 0.0 OUTLIER -71.18 126.72 30.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.233 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.67 98.89 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -98.21 147.38 24.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.957 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 0.9 OUTLIER -144.68 151.79 15.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.479 . . . . 0.0 111.959 -179.274 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.05 -2.91 56.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.727 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.09 110.28 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.327 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.0 mt -56.89 -18.57 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -75.79 -23.57 55.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.617 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.552 ' O ' HG23 ' C' ' 88' ' ' VAL . 47.7 m-20 -77.88 -12.79 60.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -27.11 60.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.27 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.59 -42.54 71.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.815 0.34 . . . . 0.0 111.381 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.84 -29.45 20.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.275 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 88' ' ' VAL . . . . . 0.552 HG23 ' O ' ' C' ' 84' ' ' ASP . 26.1 t -73.82 -47.16 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.102 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -64.82 -39.32 93.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.596 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.42 -37.28 85.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.051 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.8 -33.33 19.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.594 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.545 ' OH ' HG21 ' C' ' 75' ' ' THR . 35.5 t80 -61.23 -56.43 20.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.36 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 93' ' ' GLU . . . . . 0.426 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 0.2 OUTLIER -70.22 -15.22 62.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.302 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -40.1 66.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.483 ' CE2' ' CE1' ' C' ' 96' ' ' PHE . 0.0 OUTLIER -84.91 -38.85 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.343 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.495 ' CE1' ' CE1' ' C' ' 92' ' ' TYR . 11.2 m-85 -53.86 -50.65 65.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 110.371 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.96 -32.24 73.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.911 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -83.76 -1.81 54.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.432 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 1.0 OUTLIER -110.39 -8.69 14.66 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.667 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 2.8 t-20 97.09 19.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.795 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.548 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.3 t60 -118.57 59.88 4.07 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.859 0.362 . . . . 0.0 110.91 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CE2' ' C' ' 104' ' ' PHE . 43.4 Cg_endo -68.16 -17.85 45.35 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.486 2.124 . . . . 0.0 112.15 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.798 ' OD1' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -75.41 -34.16 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.694 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' C' ' 105' ' ' PRO . 33.2 m-85 72.24 140.14 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.08 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.683 ' HB2' HG22 ' C' ' 75' ' ' THR . 7.2 Cg_exo -71.71 166.72 28.59 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.777 2.318 . . . . 0.0 112.113 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.913 ' HB2' HG23 ' A' ' 19' ' ' VAL . . . -107.54 130.91 54.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.792 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.593 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -167.41 -165.53 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.0 111.324 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 3.1 p -116.2 114.84 24.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.256 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 109' ' ' CYS . . . . . 0.524 ' O ' HG13 ' C' ' 110' ' ' VAL . 15.8 m -95.67 131.49 41.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.265 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 115' ' ' LEU . 7.2 m -158.97 170.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.947 0.403 . . . . 0.0 111.478 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.876 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 6.9 tt0 -110.26 95.36 5.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 29.9 m -60.51 157.27 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -60.93 -45.63 93.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.011 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.641 ' HB3' HD12 ' B' ' 82' ' ' LEU . 12.3 mmt180 -151.93 173.94 14.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.727 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.543 HD23 HG12 ' B' ' 110' ' ' VAL . 1.3 mt -143.65 156.25 59.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.71 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.438 ' O ' HG22 ' C' ' 119' ' ' VAL . 12.4 Cg_endo -55.89 137.7 79.65 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.472 2.114 . . . . 0.0 112.069 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.439 ' HB2' HG13 ' C' ' 119' ' ' VAL . 10.3 mttt 68.21 16.02 9.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.392 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.89 15.69 9.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.808 HG11 HG13 ' C' ' 34' ' ' ILE . 29.3 m -51.83 169.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.736 0.303 . . . . 0.0 111.034 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 120' ' ' GLY . . . . . 0.541 ' O ' HD12 ' C' ' 121' ' ' LEU . . . -116.67 16.97 13.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.045 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.541 HD12 ' O ' ' C' ' 120' ' ' GLY . 0.2 OUTLIER -175.22 153.44 1.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.173 0.511 . . . . 0.0 111.367 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.492 ' HB2' HD22 ' C' ' 115' ' ' LEU . 1.1 tp10 -142.46 140.26 31.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.89 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.908 HG21 HG21 ' C' ' 58' ' ' VAL . 28.3 mm -121.78 127.01 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.094 0.474 . . . . 0.0 112.162 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 124' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' C' ' 76' ' ' THR . 1.0 OUTLIER -140.19 146.19 38.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.071 179.161 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' C' ' 124' ' ' GLU . . . -169.99 174.33 5.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.214 0.531 . . . . 0.0 112.332 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.872 HD12 ' HD3' ' C' ' 74' ' ' LYS . 5.2 mt -132.41 151.21 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.214 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.967 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -132.45 150.73 52.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.08 0.467 . . . . 0.0 111.739 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 1.08 HG21 HG21 ' A' ' 3' ' ' THR . 13.0 m -110.62 116.33 52.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.861 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.527 ' HB2' HD21 ' C' ' 67' ' ' LEU . 2.1 tmt_? -122.74 75.92 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.897 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.869 0.366 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.23 168.49 19.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.486 HG23 ' CD2' ' A' ' 24' ' ' LEU . 18.8 m -165.16 116.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HD23 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.694 HD11 ' OD1' ' C' ' 103' ' ' ASN . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.719 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 14' ' ' ALA . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.843 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' C' ' 104' ' ' PHE . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 29' ' ' LEU . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.565 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.916 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.446 ' O ' ' ND2' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 25' ' ' GLY . 9.1 m-80 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 128' ' ' VAL . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.959 HG23 ' HB3' ' A' ' 127' ' ' ALA . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 62' ' ' ILE . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.693 ' HB ' HG11 ' A' ' 119' ' ' VAL . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 34' ' ' ILE . 32.9 t -63.02 85.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 41' ' ' GLY . 36.7 t-20 -35.11 129.88 0.5 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.989 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.53 -10.59 29.14 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 112.178 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.5 -21.36 8.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.68 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.416 HG22 ' CG ' ' A' ' 42' ' ' GLU . 3.5 m -114.75 -25.2 8.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 63.67 56.06 21.4 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.323 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' CG ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER -164.27 -81.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.704 0.288 . . . . 0.0 111.625 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p -173.89 106.83 0.3 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.406 ' OE1' HD13 ' A' ' 47' ' ' ILE . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.782 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 54' ' ' SER . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.719 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 30' ' ' THR . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.844 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 126' ' ' ILE . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 128' ' ' VAL . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 125' ' ' ALA . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 108' ' ' SER . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 122' ' ' GLU . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.712 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 85' ' ' PHE . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' A' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.475 ' OH ' HG21 ' A' ' 75' ' ' THR . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.743 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.844 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 m-70 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.691 ' CG ' HD11 ' B' ' 5' ' ' ILE . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.731 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 72' ' ' ILE . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 76' ' ' THR . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.596 ' HB3' HD12 ' C' ' 82' ' ' LEU . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 78' ' ' PHE . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 34' ' ' ILE . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.795 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' ' 35' ' ' PRO . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.725 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' ILE . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.959 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 73' ' ' VAL . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB3' HD21 ' A' ' 67' ' ' LEU . 14.1 ptm180 -164.77 46.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.832 0.349 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.24 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.481 HG23 ' CD2' ' B' ' 24' ' ' LEU . 19.0 m -165.18 116.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.568 ' OE1' HD23 ' B' ' 24' ' ' LEU . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.691 HD11 ' CG ' ' A' ' 103' ' ' ASN . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.722 ' HB2' ' CG1' ' B' ' 61' ' ' ILE . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.786 HD13 ' O ' ' B' ' 14' ' ' ALA . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.84 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 104' ' ' PHE . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 11' ' ' ALA . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.53 HG23 HD13 ' B' ' 29' ' ' LEU . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.562 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.515 HD13 HG12 ' B' ' 128' ' ' VAL . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' B' ' 127' ' ' ALA . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.631 HD12 ' N ' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.737 HG21 HD11 ' B' ' 62' ' ' ILE . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.484 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.716 ' HB ' HG11 ' B' ' 119' ' ' VAL . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.565 HG23 HG13 ' B' ' 34' ' ' ILE . 33.3 t -63.01 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.402 ' HB3' ' HB ' ' B' ' 40' ' ' THR . 36.6 t-20 -35.14 129.93 0.51 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.935 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.58 -10.63 29.2 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.023 . . . . 0.0 112.192 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.4 -21.41 8.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.78 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' B' ' 37' ' ' ASN . 3.5 m -114.77 -25.32 8.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.456 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 63.81 56.13 20.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.357 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.401 ' CG ' HG22 ' B' ' 40' ' ' THR . 0.0 OUTLIER -164.36 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.623 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.791 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.3 p -173.94 106.72 0.3 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' B' ' 47' ' ' ILE . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' B' ' 95' ' ' PHE . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' B' ' 54' ' ' SER . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.722 ' CG1' ' HB2' ' B' ' 11' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.737 HD11 HG21 ' B' ' 30' ' ' THR . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.697 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.477 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 126' ' ' ILE . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.635 HG13 HG22 ' B' ' 128' ' ' VAL . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' LYS . . . . . 0.681 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.727 HG23 ' HB2' ' B' ' 125' ' ' ALA . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 108' ' ' SER . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.702 HG13 ' O ' ' B' ' 122' ' ' GLU . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.507 HG11 ' HD1' ' B' ' 85' ' ' PHE . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.507 ' HD1' HG11 ' B' ' 79' ' ' VAL . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' B' ' 75' ' ' THR . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.742 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 101' ' ' HIS . . . . . 0.851 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.8 m-70 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.7 ' CG ' HD11 ' C' ' 5' ' ' ILE . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.72 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' B' ' 72' ' ' ILE . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.431 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.845 ' O ' HG23 ' B' ' 76' ' ' THR . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.729 HG11 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.543 ' HB3' HD12 ' A' ' 82' ' ' LEU . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HB2' ' B' ' 78' ' ' PHE . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.482 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 119' ' ' VAL . . . . . 0.716 HG11 ' HB ' ' B' ' 34' ' ' ILE . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 120' ' ' GLY . . . . . 0.791 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.468 HD11 ' HG3' ' B' ' 35' ' ' PRO . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.702 ' O ' HG13 ' B' ' 77' ' ' VAL . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.56 ' CG2' HG21 ' B' ' 58' ' ' VAL . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 72' ' ' ILE . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.997 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.635 HG22 HG13 ' B' ' 73' ' ' VAL . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' B' ' 67' ' ' LEU . 14.1 ptm180 -164.83 46.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.951 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.21 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.48 HG23 ' CD2' ' C' ' 24' ' ' LEU . 19.0 m -165.22 116.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.562 ' OE1' HD23 ' C' ' 24' ' ' LEU . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 5' ' ' ILE . . . . . 0.7 HD11 ' CG ' ' B' ' 103' ' ' ASN . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 10' ' ' LYS . . . . . 0.497 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.721 ' HB2' ' CG1' ' C' ' 61' ' ' ILE . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 12' ' ' PRO . . . . . 0.67 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.779 HD13 ' O ' ' C' ' 14' ' ' ALA . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 18' ' ' TYR . . . . . 0.826 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' B' ' 104' ' ' PHE . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 22' ' ' VAL . . . . . 0.535 HG23 HD13 ' C' ' 29' ' ' LEU . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.559 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.898 HD13 ' O ' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.482 HD13 HG12 ' C' ' 128' ' ' VAL . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.63 ' N ' HD12 ' C' ' 29' ' ' LEU . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.711 HG21 HD11 ' C' ' 62' ' ' ILE . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.691 ' HB ' HG11 ' C' ' 119' ' ' VAL . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 36' ' ' VAL . . . . . 0.561 HG23 HG13 ' C' ' 34' ' ' ILE . 32.8 t -63.06 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' C' ' 41' ' ' GLY . 36.7 t-20 -35.13 129.94 0.51 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.56 -10.6 29.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.31 2.007 . . . . 0.0 112.18 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.44 -21.43 8.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.729 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 40' ' ' THR . . . . . 0.408 HG22 ' CG ' ' C' ' 42' ' ' GLU . 3.5 m -114.8 -25.24 8.32 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 41' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 63.64 56.1 21.27 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.395 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.408 ' CG ' HG22 ' C' ' 40' ' ' THR . 0.0 OUTLIER -164.26 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.61 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 43' ' ' VAL . . . . . 0.789 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.3 p -173.93 106.74 0.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.365 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 46' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' C' ' 51' ' ' ALA . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 49' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.401 ' OE1' HD13 ' C' ' 47' ' ' ILE . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 54' ' ' SER . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.721 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 62' ' ' ILE . . . . . 0.711 HD11 HG21 ' C' ' 30' ' ' THR . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.694 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 71' ' ' ASP . . . . . 0.464 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 72' ' ' ILE . . . . . 0.484 HG23 ' O ' ' C' ' 126' ' ' ILE . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.636 HG13 HG22 ' C' ' 128' ' ' VAL . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 75' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' ALA . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.847 HG23 ' O ' ' C' ' 108' ' ' SER . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.714 HG13 ' O ' ' C' ' 122' ' ' GLU . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.729 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' C' ' 85' ' ' PHE . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' C' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 92' ' ' TYR . . . . . 0.479 ' OH ' HG21 ' C' ' 75' ' ' THR . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.749 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 101' ' ' HIS . . . . . 0.851 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.8 m-70 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 103' ' ' ASN . . . . . 0.694 ' OD1' HD11 ' A' ' 5' ' ' ILE . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.704 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 105' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' C' ' 72' ' ' ILE . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 107' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 108' ' ' SER . . . . . 0.847 ' O ' HG23 ' C' ' 76' ' ' THR . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.712 HG11 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 111' ' ' GLU . . . . . 0.731 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.581 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 115' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' C' ' 78' ' ' PHE . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 116' ' ' PRO . . . . . 0.582 ' O ' HG22 ' C' ' 119' ' ' VAL . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 117' ' ' LYS . . . . . 0.484 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' C' ' 34' ' ' ILE . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 120' ' ' GLY . . . . . 0.789 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' C' ' 35' ' ' PRO . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 77' ' ' VAL . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 123' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' HB ' ' C' ' 76' ' ' THR . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.705 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 126' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' ILE . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 127' ' ' ALA . . . . . 0.956 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 128' ' ' VAL . . . . . 0.636 HG22 HG13 ' C' ' 73' ' ' VAL . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 129' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' C' ' 67' ' ' LEU . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.486 HG23 ' CD2' ' A' ' 24' ' ' LEU . 18.8 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.006 0.431 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HD23 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.694 HD11 ' OD1' ' C' ' 103' ' ' ASN . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.719 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 14' ' ' ALA . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.843 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' C' ' 104' ' ' PHE . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 29' ' ' LEU . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.565 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.916 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.0 m120 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 128' ' ' VAL . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.959 HG23 ' HB3' ' A' ' 127' ' ' ALA . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 62' ' ' ILE . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.693 ' HB ' HG11 ' A' ' 119' ' ' VAL . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 34' ' ' ILE . 32.9 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.607 0.241 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.406 ' OE1' HD13 ' A' ' 47' ' ' ILE . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.782 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 54' ' ' SER . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.719 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 30' ' ' THR . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.044 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.895 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 126' ' ' ILE . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 128' ' ' VAL . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 125' ' ' ALA . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 108' ' ' SER . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 122' ' ' GLU . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.712 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 85' ' ' PHE . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' A' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.475 ' OH ' HG21 ' A' ' 75' ' ' THR . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.539 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 1.044 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.3 m170 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.691 ' CG ' HD11 ' B' ' 5' ' ' ILE . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.731 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 72' ' ' ILE . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 76' ' ' THR . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.596 ' HB3' HD12 ' C' ' 82' ' ' LEU . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 78' ' ' PHE . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 34' ' ' ILE . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.795 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' ' 35' ' ' PRO . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.725 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' ILE . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.959 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 73' ' ' VAL . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB3' HD21 ' A' ' 67' ' ' LEU . 14.1 ptm180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.481 HG23 ' CD2' ' B' ' 24' ' ' LEU . 19.0 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.977 0.417 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.568 ' OE1' HD23 ' B' ' 24' ' ' LEU . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.691 HD11 ' CG ' ' A' ' 103' ' ' ASN . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.722 ' HB2' ' CG1' ' B' ' 61' ' ' ILE . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.786 HD13 ' O ' ' B' ' 14' ' ' ALA . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.84 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 104' ' ' PHE . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 11' ' ' ALA . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.53 HG23 HD13 ' B' ' 29' ' ' LEU . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.562 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.515 HD13 HG12 ' B' ' 128' ' ' VAL . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' B' ' 127' ' ' ALA . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.631 HD12 ' N ' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.737 HG21 HD11 ' B' ' 62' ' ' ILE . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.484 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.716 ' HB ' HG11 ' B' ' 119' ' ' VAL . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.565 HG23 HG13 ' B' ' 34' ' ' ILE . 33.3 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.791 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.3 p . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.595 0.236 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' B' ' 47' ' ' ILE . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' B' ' 95' ' ' PHE . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' B' ' 54' ' ' SER . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.722 ' CG1' ' HB2' ' B' ' 11' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.737 HD11 HG21 ' B' ' 30' ' ' THR . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 1.051 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.897 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.477 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 126' ' ' ILE . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.635 HG13 HG22 ' B' ' 128' ' ' VAL . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.681 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.727 HG23 ' HB2' ' B' ' 125' ' ' ALA . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 108' ' ' SER . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.702 HG13 ' O ' ' B' ' 122' ' ' GLU . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.507 HG11 ' HD1' ' B' ' 85' ' ' PHE . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.507 ' HD1' HG11 ' B' ' 79' ' ' VAL . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' B' ' 75' ' ' THR . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.542 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 1.051 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 3.4 m170 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.7 ' CG ' HD11 ' C' ' 5' ' ' ILE . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.72 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' B' ' 72' ' ' ILE . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.431 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.845 ' O ' HG23 ' B' ' 76' ' ' THR . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.729 HG11 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.543 ' HB3' HD12 ' A' ' 82' ' ' LEU . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HB2' ' B' ' 78' ' ' PHE . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.482 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.716 HG11 ' HB ' ' B' ' 34' ' ' ILE . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . 0.791 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.468 HD11 ' HG3' ' B' ' 35' ' ' PRO . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.702 ' O ' HG13 ' B' ' 77' ' ' VAL . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.56 ' CG2' HG21 ' B' ' 58' ' ' VAL . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 72' ' ' ILE . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.997 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.635 HG22 HG13 ' B' ' 73' ' ' VAL . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' B' ' 67' ' ' LEU . 14.1 ptm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.48 HG23 ' CD2' ' C' ' 24' ' ' LEU . 19.0 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . 0.562 ' OE1' HD23 ' C' ' 24' ' ' LEU . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.7 HD11 ' CG ' ' B' ' 103' ' ' ASN . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.497 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.721 ' HB2' ' CG1' ' C' ' 61' ' ' ILE . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.67 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.779 HD13 ' O ' ' C' ' 14' ' ' ALA . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.826 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' B' ' 104' ' ' PHE . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.535 HG23 HD13 ' C' ' 29' ' ' LEU . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.559 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.898 HD13 ' O ' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.482 HD13 HG12 ' C' ' 128' ' ' VAL . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.63 ' N ' HD12 ' C' ' 29' ' ' LEU . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.711 HG21 HD11 ' C' ' 62' ' ' ILE . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.691 ' HB ' HG11 ' C' ' 119' ' ' VAL . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.561 HG23 HG13 ' C' ' 34' ' ' ILE . 32.8 t . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.789 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.3 p . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.582 0.229 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' C' ' 51' ' ' ALA . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.401 ' OE1' HD13 ' C' ' 47' ' ' ILE . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 54' ' ' SER . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.721 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.711 HD11 HG21 ' C' ' 30' ' ' THR . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 1.059 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.886 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.464 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.484 HG23 ' O ' ' C' ' 126' ' ' ILE . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.636 HG13 HG22 ' C' ' 128' ' ' VAL . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' ALA . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.847 HG23 ' O ' ' C' ' 108' ' ' SER . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.714 HG13 ' O ' ' C' ' 122' ' ' GLU . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.729 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' C' ' 85' ' ' PHE . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' C' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.479 ' OH ' HG21 ' C' ' 75' ' ' THR . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.549 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 1.059 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 3.3 m170 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.694 ' OD1' HD11 ' A' ' 5' ' ' ILE . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.704 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' C' ' 72' ' ' ILE . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . 0.847 ' O ' HG23 ' C' ' 76' ' ' THR . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.712 HG11 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.731 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.581 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' C' ' 78' ' ' PHE . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.582 ' O ' HG22 ' C' ' 119' ' ' VAL . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.484 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' C' ' 34' ' ' ILE . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . 0.789 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' C' ' 35' ' ' PRO . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 77' ' ' VAL . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' HB ' ' C' ' 76' ' ' THR . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.705 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' ILE . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.956 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.636 HG22 HG13 ' C' ' 73' ' ' VAL . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' C' ' 67' ' ' LEU . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 21.8 m . . . . . 0 N--CA 1.46 0.051 0 CA-C-O 120.813 0.34 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.511 ' HA ' ' N ' ' A' ' 23' ' ' ASP . 12.3 pt20 43.77 -165.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.743 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.638 HD11 ' O ' ' C' ' 103' ' ' ASN . 34.3 mm 68.69 116.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.959 0.409 . . . . 0.0 111.633 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 36.3 mt -142.11 91.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.77 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -102.22 128.98 48.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.991 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 t -144.86 153.74 41.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 30.7 3.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.458 ' HG2' ' HB1' ' A' ' 60' ' ' ALA . 4.6 tptm -117.6 -36.82 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . -99.88 122.47 50.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.273 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 7.5 Cg_exo -72.93 3.07 4.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.67 2.247 . . . . 0.0 112.829 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.636 ' HB1' ' OE1' ' A' ' 33' ' ' GLN . . . -50.32 -178.17 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.998 0.428 . . . . 0.0 111.809 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.58 ' C ' HD12 ' A' ' 15' ' ' ILE . . . 64.05 118.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.048 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.9 mp -146.79 17.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.342 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.92 -148.64 4.79 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.449 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.48 ' HA ' ' CE2' ' C' ' 104' ' ' PHE . 84.8 Cg_endo -87.57 34.33 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.859 2.373 . . . . 0.0 112.957 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.456 ' CD2' ' HB2' ' C' ' 107' ' ' ARG . 9.9 p90 -130.39 164.97 23.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.776 0.322 . . . . 0.0 110.821 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.956 HG13 ' HB3' ' C' ' 104' ' ' PHE . 19.9 m -91.54 147.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.437 ' HG2' ' HB2' ' A' ' 14' ' ' ALA . 15.4 mt-30 -46.11 -48.85 17.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.44 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.627 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -157.58 -175.28 5.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.451 ' C ' HD11 ' A' ' 6' ' ' ILE . 29.1 m -136.23 129.26 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.114 0.483 . . . . 0.0 111.922 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.511 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 44.1 t0 -113.14 103.97 11.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.803 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 4' ' ' GLN . 33.6 mt -84.04 -18.69 36.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.105 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.05 -108.68 0.91 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.827 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.6 -30.19 62.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 110.065 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HG ' HG23 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -121.92 127.88 50.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.581 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.938 HG23 ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -105.75 179.4 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.243 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -159.9 146.83 16.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.0 p -121.1 142.25 50.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.8 m -79.03 165.99 22.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.26 74.4 0.28 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.987 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.636 ' OE1' ' HB1' ' A' ' 13' ' ' ALA . 17.3 mm-40 -66.46 165.21 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.031 0.444 . . . . 0.0 111.352 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.8 ' HB ' HG11 ' A' ' 119' ' ' VAL . 3.4 pt -138.99 159.07 68.44 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.243 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.531 ' O ' HG12 ' A' ' 36' ' ' VAL . 85.5 Cg_exo -42.28 -45.39 7.74 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.64 2.227 . . . . 0.0 111.932 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 35' ' ' PRO . 8.5 p . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.565 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.731 ' HB ' HG12 ' A' ' 119' ' ' VAL . 7.1 p . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 120.347 0.118 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 4.9 Cg_exo -76.58 153.12 34.23 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.684 2.256 . . . . 0.0 112.091 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.1 -30.85 55.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.074 0.464 . . . . 0.0 110.741 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -68.48 94.24 0.55 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.885 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.624 HD13 ' NE2' ' A' ' 50' ' ' GLN . 28.9 mm -40.32 -33.3 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.34 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.12 -46.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.699 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' A' ' 46' ' ' ASP . . . -61.37 -36.19 79.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.706 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.66 ' HG3' HD21 ' A' ' 121' ' ' LEU . 10.4 pt20 -77.61 -28.39 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.608 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.11 -31.55 25.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.248 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -38.35 29.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.17 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.55 -31.06 66.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.871 0.367 . . . . 0.0 110.823 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.839 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -70.03 -30.85 68.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.748 HD13 ' CE2' ' A' ' 95' ' ' PHE . 57.4 mt -74.6 -33.85 62.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.38 -48.69 64.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.999 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -57.6 -48.2 80.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.092 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 54' ' ' SER . 27.2 t -59.63 -29.97 43.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 1.9 ttpp -79.15 -39.83 32.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.043 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 10' ' ' LYS . . . -62.04 -36.41 81.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.976 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 58' ' ' VAL . 8.1 mt -70.21 -51.87 35.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 127' ' ' ALA . 3.7 tt -65.26 -22.43 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.076 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -82.95 -37.74 23.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.891 0.377 . . . . 0.0 110.31 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -11.15 60.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.97 -29.93 35.22 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.925 0.393 . . . . 0.0 110.335 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.3 28.5 1.0 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.141 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -146.84 -166.97 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.329 . . . . 0.0 110.69 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.58 153.73 49.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.852 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -57.25 -38.92 74.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -51.19 -29.86 15.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.06 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.74 -22.4 58.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.627 HG23 ' O ' ' A' ' 126' ' ' ILE . 76.6 mt -47.76 114.88 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.97 0.414 . . . . 0.0 110.97 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.622 ' CG1' HG12 ' A' ' 128' ' ' VAL . 32.8 m -89.62 -31.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.702 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.771 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 78.1 tttt -134.44 163.0 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 111.055 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.739 HG23 ' HB2' ' A' ' 125' ' ' ALA . 30.4 m -158.75 139.56 12.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.303 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 108' ' ' SER . 96.7 m -123.63 147.41 47.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.176 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.9 t -149.22 109.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 111.697 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.709 ' CD2' HG11 ' C' ' 110' ' ' VAL . 8.6 m-85 -89.0 110.23 20.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.47 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.408 HG11 ' HD1' ' A' ' 85' ' ' PHE . 31.3 m -101.38 144.89 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -85.03 -1.55 56.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.221 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.2 127.22 1.46 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.512 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.15 -11.92 52.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.65 -20.82 45.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.361 . . . . 0.0 110.693 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.6 -27.25 20.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 44.3 t80 -57.68 -28.77 64.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.13 -32.28 67.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.263 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.49 -34.95 18.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.221 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.7 -39.71 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.413 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 32.8 t30 -68.89 -36.55 78.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.51 -32.39 66.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.61 -30.35 19.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.088 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.716 ' OH ' HG21 ' A' ' 75' ' ' THR . 10.0 t80 -58.43 -43.93 88.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.91 -29.36 35.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.18 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.48 75.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.036 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.748 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -89.32 -36.54 15.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.636 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.509 ' CD2' ' HB2' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -54.99 -53.59 53.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.807 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -72.82 -26.43 61.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.387 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 95' ' ' PHE . 2.4 mm-40 -76.47 -13.32 60.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.553 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 12.6 m-80 -101.4 -17.29 16.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.011 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 5.2 p-10 103.5 35.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.154 0.909 . . . . 0.0 110.396 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.852 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 2.0 m-70 -114.97 55.27 0.87 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.376 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.491 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 88.8 Cg_endo -79.12 2.74 8.04 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.661 2.241 . . . . 0.0 113.112 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.63 ' O ' HD11 ' B' ' 5' ' ' ILE . 2.0 t30 -64.48 -30.08 71.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.765 0.317 . . . . 0.0 111.477 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.973 ' HB3' HG13 ' B' ' 19' ' ' VAL . 2.5 m-85 70.91 110.21 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.547 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 96' ' ' PHE . 66.2 Cg_endo -96.03 153.39 1.4 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.064 2.509 . . . . 0.0 112.443 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.771 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -50.27 163.09 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.236 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.441 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -134.49 143.43 47.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.147 0.499 . . . . 0.0 111.607 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 76' ' ' THR . 0.8 OUTLIER -150.73 63.81 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.305 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.09 134.69 40.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.025 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.661 HG11 ' CD2' ' B' ' 78' ' ' PHE . 26.8 m -142.22 138.49 29.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.26 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.785 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 2.9 tm-20 -68.23 83.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.686 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.21 163.91 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.233 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -74.55 -38.16 62.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.982 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.404 ' CB ' ' HB3' ' C' ' 111' ' ' GLU . 0.4 OUTLIER -161.62 -177.65 6.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.761 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.48 HD11 ' O ' ' A' ' 78' ' ' PHE . 77.8 mt -151.82 156.37 34.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.756 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.31 137.96 78.46 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.59 2.194 . . . . 0.0 112.099 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.682 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.9 OUTLIER 74.74 14.21 3.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.244 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.76 16.88 8.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.8 HG11 ' HB ' ' A' ' 34' ' ' ILE . 29.5 m -57.07 175.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.831 0.348 . . . . 0.0 111.079 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.54 12.79 15.69 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.676 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 50' ' ' GLN . 4.3 pp -176.75 148.17 0.67 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.025 0.441 . . . . 0.0 111.298 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.408 ' C ' HD13 ' A' ' 123' ' ' ILE . 1.2 tt0 -125.74 161.05 28.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.037 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' A' ' 54' ' ' SER . 0.0 OUTLIER -143.54 129.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.115 0.484 . . . . 0.0 112.012 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.09 109.51 2.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.895 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.739 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -126.73 174.61 8.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.137 0.494 . . . . 0.0 112.039 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 72' ' ' ILE . 15.3 mt -125.63 156.41 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.422 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.938 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -146.34 151.07 36.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.551 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.622 HG12 ' CG1' ' A' ' 73' ' ' VAL . 5.1 p -147.99 159.95 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.128 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.763 ' HB3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.81 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' B' ' 4' ' ' GLN . 22.1 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.794 0.33 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.507 ' HA ' ' N ' ' B' ' 23' ' ' ASP . 12.3 pt20 43.82 -165.68 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.636 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.63 HD11 ' O ' ' A' ' 103' ' ' ASN . 34.2 mm 68.65 116.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.023 0.439 . . . . 0.0 111.6 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 36.4 mt -142.12 91.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.782 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -102.15 129.02 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.949 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.7 t -144.87 153.74 41.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.05 30.67 3.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.44 ' HG2' ' HB1' ' B' ' 60' ' ' ALA . 4.6 tptm -117.55 -36.78 3.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -99.9 122.3 51.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.214 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 7.4 Cg_exo -72.87 3.05 4.73 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.68 2.254 . . . . 0.0 112.84 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.664 ' HB1' ' OE1' ' B' ' 33' ' ' GLN . . . -50.24 -178.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.005 0.431 . . . . 0.0 111.796 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.593 ' C ' HD12 ' B' ' 15' ' ' ILE . . . 64.01 118.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.605 HG22 ' O ' ' B' ' 15' ' ' ILE . 2.9 mp -146.78 17.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.341 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.9 -148.71 4.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.422 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.482 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 84.1 Cg_endo -87.49 34.26 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.869 2.379 . . . . 0.0 113.005 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.444 ' CZ ' ' HA ' ' B' ' 14' ' ' ALA . 10.0 p90 -130.4 164.95 23.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 110.835 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.973 HG13 ' HB3' ' A' ' 104' ' ' PHE . 20.2 m -91.46 147.76 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.424 ' HG2' ' HB2' ' B' ' 14' ' ' ALA . 15.5 mt-30 -46.18 -48.97 17.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.414 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.655 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -157.39 -175.35 5.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.71 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.45 ' C ' HD11 ' B' ' 6' ' ' ILE . 29.2 m -136.25 129.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.09 0.471 . . . . 0.0 111.941 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.507 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 44.1 t0 -113.11 103.92 11.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.834 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.4 HD23 ' H ' ' B' ' 4' ' ' GLN . 33.2 mt -83.97 -18.71 36.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.109 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.03 -108.75 0.91 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.792 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.55 -30.21 62.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.093 0.473 . . . . 0.0 110.068 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.422 ' HG ' HG23 ' B' ' 128' ' ' VAL . 0.7 OUTLIER -121.87 127.93 51.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.603 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.909 HG23 ' HB3' ' B' ' 127' ' ' ALA . 0.3 OUTLIER -105.81 179.4 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.478 HD12 ' O ' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -159.94 146.84 16.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 35.9 p -121.11 141.98 50.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.89 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 17.6 m -78.68 165.97 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.25 74.36 0.28 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.968 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.664 ' OE1' ' HB1' ' B' ' 13' ' ' ALA . 17.2 mm-40 -66.42 165.32 14.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 111.374 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.842 ' HB ' HG11 ' B' ' 119' ' ' VAL . 3.4 pt -139.08 159.05 68.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.199 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.536 ' O ' HG12 ' B' ' 36' ' ' VAL . 85.6 Cg_exo -42.28 -45.46 7.72 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.635 2.224 . . . . 0.0 111.87 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.536 HG12 ' O ' ' B' ' 35' ' ' PRO . 8.5 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.508 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.717 ' HB ' HG12 ' B' ' 119' ' ' VAL . 7.1 p . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.365 0.126 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' B' ' 35' ' ' PRO . 5.0 Cg_exo -76.59 153.09 34.14 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.699 2.266 . . . . 0.0 112.115 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.11 -30.79 55.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.453 . . . . 0.0 110.715 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' B' ' 49' ' ' ALA . 0.4 OUTLIER -68.55 94.24 0.56 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.864 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.62 HD13 ' NE2' ' B' ' 50' ' ' GLN . 29.2 mm -40.23 -33.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.387 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.08 -46.46 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.684 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.427 ' H ' ' HB3' ' B' ' 46' ' ' ASP . . . -61.34 -36.19 79.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.742 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.669 ' HG3' HD21 ' B' ' 121' ' ' LEU . 10.4 pt20 -77.57 -28.33 51.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.575 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.19 -31.56 25.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.271 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -38.31 30.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.254 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.6 -31.08 66.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.772 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.84 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.4 OUTLIER -69.97 -30.88 68.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.801 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.792 HD13 ' CE2' ' B' ' 95' ' ' PHE . 57.3 mt -74.58 -33.88 62.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.46 -48.59 64.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.994 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -57.67 -48.16 80.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.84 HG23 ' O ' ' B' ' 54' ' ' SER . 27.1 t -59.64 -29.92 43.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.052 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 1.9 ttpp -79.26 -39.78 32.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.44 ' HB1' ' HG2' ' B' ' 10' ' ' LYS . . . -62.01 -36.47 81.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.548 HG22 HG21 ' B' ' 6' ' ' ILE . 8.2 mt -70.09 -51.89 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.998 0.428 . . . . 0.0 110.737 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' B' ' 127' ' ' ALA . 3.8 tt -65.23 -22.45 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.0 -37.73 23.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 110.3 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -11.1 60.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.737 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.93 -29.96 35.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.0 110.367 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.29 28.49 1.0 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.153 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' B' ' 129' ' ' ARG . 0.2 OUTLIER -146.83 -167.02 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.7 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.52 153.76 49.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.86 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -57.34 -38.85 74.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.652 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -51.26 -29.92 16.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.76 -22.48 58.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.96 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.629 HG23 ' O ' ' B' ' 126' ' ' ILE . 76.5 mt -47.72 114.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.893 0.377 . . . . 0.0 110.995 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.605 ' CG1' HG12 ' B' ' 128' ' ' VAL . 32.9 m -89.66 -31.57 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.66 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.751 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 78.1 tttt -134.39 163.08 30.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.017 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.73 HG23 ' HB2' ' B' ' 125' ' ' ALA . 30.4 m -158.76 139.6 12.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.297 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.626 HG23 ' O ' ' B' ' 108' ' ' SER . 96.8 m -123.68 147.41 47.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.172 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.8 t -149.22 109.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.863 0.363 . . . . 0.0 111.746 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.661 ' CD2' HG11 ' A' ' 110' ' ' VAL . 8.6 m-85 -88.97 110.22 20.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.424 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.415 HG11 ' HD1' ' B' ' 85' ' ' PHE . 31.3 m -101.37 144.86 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.447 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -85.03 -1.68 57.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.145 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.12 127.14 1.48 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.507 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' B' ' 82' ' ' LEU . 12.0 mt -66.01 -12.04 52.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.68 -20.74 45.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.789 0.328 . . . . 0.0 110.653 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.69 -27.16 20.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' B' ' 89' ' ' ASN . 44.5 t80 -57.74 -28.76 64.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.29 67.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.303 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.53 -34.96 18.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.16 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.79 -39.56 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.153 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 32.7 t30 -69.0 -36.45 77.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.47 -32.46 66.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.42 -30.43 19.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.706 ' OH ' HG21 ' B' ' 75' ' ' THR . 9.8 t80 -58.36 -43.98 88.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.94 -29.35 35.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.54 75.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.069 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.792 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.9 OUTLIER -89.2 -36.64 15.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.646 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.511 ' CD2' ' HB2' ' B' ' 101' ' ' HIS . 0.2 OUTLIER -54.88 -53.63 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.863 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -72.77 -26.49 61.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.436 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . 0.412 ' HB2' ' HA ' ' B' ' 95' ' ' PHE . 2.4 mm-40 -76.48 -13.29 60.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.568 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.567 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 12.6 m-80 -101.39 -17.35 16.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.01 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 5.3 p-10 103.6 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.148 0.905 . . . . 0.0 110.328 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.86 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 2.0 m-70 -115.06 55.25 0.89 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.387 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.487 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 89.3 Cg_endo -79.09 2.77 8.01 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.626 2.217 . . . . 0.0 113.141 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.664 ' O ' HD11 ' C' ' 5' ' ' ILE . 2.0 t30 -64.4 -30.21 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 111.512 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.929 ' HB3' HG13 ' C' ' 19' ' ' VAL . 2.5 m-85 70.97 110.2 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.505 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' B' ' 96' ' ' PHE . 66.0 Cg_endo -95.98 153.44 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.141 2.561 . . . . 0.0 112.438 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.751 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -50.37 163.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.292 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.465 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -134.4 143.44 47.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 111.607 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.626 ' O ' HG23 ' B' ' 76' ' ' THR . 0.8 OUTLIER -150.77 63.88 0.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.283 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.05 134.74 40.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.04 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' C' ' 78' ' ' PHE . 26.9 m -142.32 139.3 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.294 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.728 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 2.8 tm-20 -68.67 84.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.78 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 m -67.4 163.95 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.133 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -74.55 -38.11 62.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.63 -177.74 6.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.484 HD11 ' O ' ' B' ' 78' ' ' PHE . 77.7 mt -151.72 156.41 34.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.772 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.37 137.92 78.59 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.577 2.185 . . . . 0.0 112.093 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.678 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.9 OUTLIER 74.8 14.2 3.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.26 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.78 16.89 8.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.069 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.842 HG11 ' HB ' ' B' ' 34' ' ' ILE . 29.6 m -57.18 175.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.83 0.347 . . . . 0.0 111.075 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.34 13.04 16.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.71 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.669 HD21 ' HG3' ' B' ' 50' ' ' GLN . 4.3 pp -176.83 148.19 0.65 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 111.275 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.79 161.0 28.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.021 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' B' ' 54' ' ' SER . 0.0 OUTLIER -143.43 129.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 112.109 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 109.48 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.888 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -126.74 174.63 8.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.134 0.493 . . . . 0.0 111.985 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.629 ' O ' HG23 ' B' ' 72' ' ' ILE . 15.2 mt -125.64 156.34 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.444 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.909 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -146.28 150.97 36.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.57 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.605 HG12 ' CG1' ' B' ' 73' ' ' VAL . 5.1 p -147.83 159.99 7.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.774 ' HB3' HD21 ' B' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.881 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' C' ' 4' ' ' GLN . 21.9 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.808 0.337 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . 0.513 ' HA ' ' N ' ' C' ' 23' ' ' ASP . 12.3 pt20 43.79 -165.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.691 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.664 HD11 ' O ' ' B' ' 103' ' ' ASN . 34.4 mm 68.76 116.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.005 0.431 . . . . 0.0 111.628 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.662 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 36.6 mt -142.11 91.74 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.767 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -102.24 128.95 48.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 12.7 t -144.76 153.75 41.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.1 30.75 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.46 ' HG2' ' HB1' ' C' ' 60' ' ' ALA . 4.7 tptm -117.6 -37.08 3.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.016 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.413 ' HB2' HG13 ' C' ' 61' ' ' ILE . . . -99.59 122.48 51.29 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.186 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.84 2.94 4.82 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.731 2.288 . . . . 0.0 112.823 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.634 ' HB1' ' OE1' ' C' ' 33' ' ' GLN . . . -50.2 -178.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.966 0.412 . . . . 0.0 111.812 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.577 ' C ' HD12 ' C' ' 15' ' ' ILE . . . 63.97 118.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.096 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.598 HG22 ' O ' ' C' ' 15' ' ' ILE . 2.9 mp -146.74 17.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.364 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.9 -148.65 4.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.415 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . 0.466 ' HA ' ' CE2' ' B' ' 104' ' ' PHE . 83.3 Cg_endo -87.48 34.26 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.849 2.366 . . . . 0.0 113.037 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.465 ' CD2' ' HB2' ' B' ' 107' ' ' ARG . 9.9 p90 -130.41 164.91 23.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.775 0.322 . . . . 0.0 110.829 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.929 HG13 ' HB3' ' B' ' 104' ' ' PHE . 20.4 m -91.44 147.8 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.947 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.435 ' HG2' ' HB2' ' C' ' 14' ' ' ALA . 15.5 mt-30 -46.18 -48.73 17.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.47 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.662 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -157.43 -175.26 5.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.677 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.491 HG11 ' O ' ' B' ' 73' ' ' VAL . 29.5 m -136.27 129.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.062 0.458 . . . . 0.0 111.902 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.513 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 44.2 t0 -113.18 103.9 11.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.819 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.421 HD23 ' H ' ' C' ' 4' ' ' GLN . 33.3 mt -83.97 -18.73 36.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.108 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.05 -108.7 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.811 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.6 -30.14 62.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.146 0.498 . . . . 0.0 110.118 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.491 ' HG ' HG23 ' C' ' 128' ' ' VAL . 0.7 OUTLIER -121.91 127.9 50.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.624 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.968 HG23 ' HB3' ' C' ' 127' ' ' ALA . 0.3 OUTLIER -105.78 179.3 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.216 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.476 HD12 ' O ' ' C' ' 28' ' ' VAL . 0.1 OUTLIER -159.86 146.82 16.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.833 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.406 HG23 HD12 ' C' ' 62' ' ' ILE . 35.7 p -121.07 142.33 49.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.833 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 18.1 m -78.99 165.78 23.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.3 74.41 0.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.991 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.634 ' OE1' ' HB1' ' C' ' 13' ' ' ALA . 17.3 mm-40 -66.43 165.28 14.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.021 0.438 . . . . 0.0 111.325 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.82 ' HB ' HG11 ' C' ' 119' ' ' VAL . 3.4 pt -139.04 159.1 68.2 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.232 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.533 ' O ' HG12 ' C' ' 36' ' ' VAL . 85.3 Cg_exo -42.36 -45.41 7.89 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.623 2.216 . . . . 0.0 111.867 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.533 HG12 ' O ' ' C' ' 35' ' ' PRO . 8.6 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.556 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.763 ' HB ' HG12 ' C' ' 119' ' ' VAL . 7.1 p . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 120.351 0.119 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 43' ' ' VAL . 4.8 Cg_exo -76.68 153.14 33.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.664 2.243 . . . . 0.0 112.067 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.16 -30.76 55.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.091 0.472 . . . . 0.0 110.738 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' C' ' 49' ' ' ALA . 0.4 OUTLIER -68.54 94.31 0.56 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.888 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.623 HD13 ' NE2' ' C' ' 50' ' ' GLN . 29.2 mm -40.31 -33.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.397 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.13 -46.48 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.665 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' C' ' 46' ' ' ASP . . . -61.23 -36.28 79.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.766 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.65 ' HG3' HD21 ' C' ' 121' ' ' LEU . 10.4 pt20 -77.63 -28.11 51.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.594 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.4 -31.59 24.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.337 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -38.38 30.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.55 -31.12 66.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.807 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.822 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.4 OUTLIER -69.98 -30.87 68.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.81 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.743 HD13 ' CE2' ' C' ' 95' ' ' PHE . 57.4 mt -74.48 -33.94 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.37 -48.66 64.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.02 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -57.56 -48.24 79.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.822 HG23 ' O ' ' C' ' 54' ' ' SER . 27.2 t -59.59 -29.93 43.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.446 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 1.9 ttpp -79.21 -39.81 32.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.996 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' C' ' 10' ' ' LYS . . . -62.08 -36.23 81.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.078 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' C' ' 58' ' ' VAL . 8.1 mt -70.33 -51.9 34.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' C' ' 127' ' ' ALA . 3.8 tt -65.23 -22.42 31.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.094 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.02 -37.71 23.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.917 0.389 . . . . 0.0 110.287 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -11.08 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.713 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.99 35.06 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.964 0.412 . . . . 0.0 110.327 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.29 28.51 1.0 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.165 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.762 HD21 ' HB3' ' C' ' 129' ' ' ARG . 0.2 OUTLIER -146.88 -167.02 2.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.638 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.49 153.73 50.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.867 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -57.43 -38.71 74.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.656 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -51.16 -29.76 14.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.073 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.85 -22.56 58.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.642 HG23 ' O ' ' C' ' 126' ' ' ILE . 76.3 mt -47.66 114.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 111.013 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.628 ' CG1' HG12 ' C' ' 128' ' ' VAL . 32.8 m -89.66 -31.47 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.696 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.743 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 78.0 tttt -134.5 162.99 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.752 0.311 . . . . 0.0 111.01 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.734 HG23 ' HB2' ' C' ' 125' ' ' ALA . 30.5 m -158.75 139.58 12.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.424 . . . . 0.0 111.302 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.626 HG23 ' O ' ' C' ' 108' ' ' SER . 96.8 m -123.64 147.44 47.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.197 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.7 t -149.27 109.27 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.745 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.709 ' CD2' HG11 ' B' ' 110' ' ' VAL . 8.5 m-85 -88.95 110.19 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.476 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.409 HG11 ' HD1' ' C' ' 85' ' ' PHE . 31.6 m -101.4 144.87 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.461 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -85.02 -1.77 57.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.175 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.0 127.05 1.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.517 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 115' ' ' LEU . 12.0 mt -66.07 -11.98 52.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.63 -20.79 45.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.803 0.335 . . . . 0.0 110.673 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.63 -27.23 20.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' C' ' 89' ' ' ASN . 44.5 t80 -57.68 -28.83 64.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.102 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.29 67.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.255 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.46 -35.06 18.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.7 -39.62 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.152 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . 0.413 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 32.8 t30 -68.94 -36.5 78.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.49 -32.47 66.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -30.47 19.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.022 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.692 ' OH ' HG21 ' C' ' 75' ' ' THR . 10.0 t80 -58.29 -44.01 88.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.89 -29.35 35.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.178 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.51 75.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.055 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.743 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.9 OUTLIER -89.27 -36.59 15.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 110.647 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 0.2 OUTLIER -54.95 -53.56 54.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.876 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -72.82 -26.48 61.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . 0.41 ' HB2' ' HA ' ' C' ' 95' ' ' PHE . 2.4 mm-40 -76.48 -13.24 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.608 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.566 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 12.6 m-80 -101.46 -17.29 16.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.988 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 5.2 p-10 103.49 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.138 0.899 . . . . 0.0 110.372 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.867 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 2.0 m-70 -115.04 55.35 0.89 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.352 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 88.4 Cg_endo -79.2 2.82 7.98 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.628 2.219 . . . . 0.0 113.115 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.638 ' O ' HD11 ' A' ' 5' ' ' ILE . 2.0 t30 -64.51 -30.06 71.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 111.534 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.956 ' HB3' HG13 ' A' ' 19' ' ' VAL . 2.5 m-85 70.93 110.21 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.543 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.457 ' HG3' ' CZ ' ' C' ' 96' ' ' PHE . 65.9 Cg_endo -96.03 153.38 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.116 2.544 . . . . 0.0 112.434 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.743 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -50.31 163.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.278 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.456 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -134.44 143.45 47.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.13 0.49 . . . . 0.0 111.563 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . 0.626 ' O ' HG23 ' C' ' 76' ' ' THR . 0.8 OUTLIER -150.76 63.82 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.332 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.05 134.76 40.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.034 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' A' ' 78' ' ' PHE . 26.8 m -142.4 139.24 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.317 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.778 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.8 tm-20 -68.7 83.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.749 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.11 164.04 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.196 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -74.65 -38.19 62.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.975 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.409 ' CB ' ' HB3' ' B' ' 111' ' ' GLU . 0.4 OUTLIER -161.59 -177.6 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.775 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.478 HD11 ' O ' ' C' ' 78' ' ' PHE . 77.3 mt -151.76 156.42 34.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.755 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.48 137.95 79.01 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.588 2.192 . . . . 0.0 112.057 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.654 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.9 OUTLIER 74.8 14.2 3.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.275 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.79 16.9 8.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.073 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.82 HG11 ' HB ' ' C' ' 34' ' ' ILE . 29.3 m -57.08 175.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.818 0.342 . . . . 0.0 111.123 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.36 13.25 16.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.766 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' C' ' 50' ' ' GLN . 4.3 pp -177.36 148.25 0.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.976 0.417 . . . . 0.0 111.249 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.403 ' C ' HD13 ' C' ' 123' ' ' ILE . 1.2 tt0 -125.69 161.02 28.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.054 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' C' ' 54' ' ' SER . 0.0 OUTLIER -143.49 129.19 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.142 0.496 . . . . 0.0 112.039 -179.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.04 109.52 2.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.9 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.734 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -126.8 174.63 8.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.115 0.483 . . . . 0.0 112.026 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.642 ' O ' HG23 ' C' ' 72' ' ' ILE . 15.3 mt -125.68 156.36 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.435 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.968 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -146.36 151.02 36.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 111.503 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.628 HG12 ' CG1' ' C' ' 73' ' ' VAL . 5.0 p -147.84 159.92 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.762 ' HB3' HD21 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -148.41 58.89 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.817 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.044 HG21 HG21 ' C' ' 128' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.817 0.341 . . . . 0.0 110.954 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 132.97 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.82 HD13 ' OD1' ' C' ' 103' ' ' ASN . 4.3 mp -55.2 152.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 21' ' ' ALA . 32.7 mt -103.43 139.26 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.58 117.18 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.58 HG22 ' OE1' ' A' ' 20' ' ' GLN . 11.7 t -133.88 165.99 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.33 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.52 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 7.6 mmtp -121.62 -36.89 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.032 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.872 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.82 172.05 4.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 18.9 Cg_endo -59.39 -16.05 33.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.695 2.263 . . . . 0.0 112.85 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 77.24 151.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 111.317 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.603 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -104.67 120.71 41.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 14' ' ' ALA . 22.1 mm -133.51 15.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.072 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.85 -146.17 4.73 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.987 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' C' ' 104' ' ' PHE . 93.9 Cg_endo -87.39 44.53 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.536 2.158 . . . . 0.0 112.901 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.541 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -163.19 154.59 17.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.867 0.365 . . . . 0.0 111.033 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.465 HG13 ' O ' ' C' ' 103' ' ' ASN . 27.3 m -110.91 169.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.58 ' OE1' HG22 ' A' ' 8' ' ' THR . 56.2 mt-30 -58.96 -53.53 57.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' A' ' 6' ' ' ILE . . . -170.69 -177.09 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG21 ' HB ' ' C' ' 73' ' ' VAL . 9.3 m -142.33 132.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.166 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.645 ' HA ' HG23 ' A' ' 28' ' ' VAL . 20.8 t70 -103.47 105.01 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.567 ' CD2' HG23 ' A' ' 3' ' ' THR . 19.5 mt -80.51 -16.36 54.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.371 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.05 -104.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.28 -29.62 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.166 0.508 . . . . 0.0 110.21 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 28' ' ' VAL . 5.0 tt -135.2 140.65 45.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.95 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 9.9 p -120.04 160.88 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.123 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' HE2' ' C' ' 74' ' ' LYS . 2.9 mp -145.87 127.37 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 p -106.5 136.11 46.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.983 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.812 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 1.1 t -59.36 179.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.07 95.55 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.244 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.805 ' HG2' HG22 ' A' ' 58' ' ' VAL . 2.9 mp0 -62.07 138.14 58.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.275 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.524 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -146.04 170.18 8.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.679 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -54.26 -137.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.313 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.411 -178.926 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.81 140.71 81.58 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.592 2.195 . . . . 0.0 112.433 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.37 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.4 93.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.791 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.616 HD13 ' NE2' ' A' ' 50' ' ' GLN . 28.9 mm -38.93 -33.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.5 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.08 -48.07 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.696 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.82 -55.04 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.616 ' NE2' HD13 ' A' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.498 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -71.93 -44.36 63.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -63.33 -51.54 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.79 -31.18 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.871 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.3 m -68.31 -46.48 70.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.29 -26.36 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.971 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -57.95 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.108 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.8 OUTLIER -54.88 -30.36 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.985 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 54' ' ' SER . 39.6 t -62.1 -34.54 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 110.517 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.99 -31.75 34.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.755 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -62.23 -38.55 89.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 11' ' ' ALA . 6.1 mt -70.93 -46.2 69.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.667 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.8 -32.62 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.28 -38.4 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.9 -24.33 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.145 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.71 -22.11 21.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.914 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.43 64.8 0.83 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' OD2' ' A' ' 71' ' ' ASP . 14.7 mt -158.9 139.2 12.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 44.0 p -96.12 145.0 25.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -46.29 -31.75 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.518 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -59.77 -18.48 43.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.715 ' OD2' HD22 ' A' ' 67' ' ' LEU . 3.2 p-10 -88.58 -21.27 24.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 126' ' ' ILE . 64.3 mt -59.35 109.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.528 ' HB ' HG21 ' B' ' 22' ' ' VAL . 2.8 m -81.11 -36.84 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.971 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HE2' HD22 ' B' ' 29' ' ' LEU . 8.6 mtmt -130.55 175.23 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.319 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.61 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 13.4 t 177.71 110.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 111.36 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.18 130.1 41.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.33 91.6 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 76' ' ' THR . 5.3 m-85 -91.7 143.77 26.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.089 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.514 HG11 ' CD1' ' A' ' 85' ' ' PHE . 35.3 m -139.31 150.0 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.023 0.44 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.57 ' HE2' HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -90.95 -4.31 56.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.796 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.04 108.99 0.46 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.687 HD12 ' HB3' ' B' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.25 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.97 -24.64 59.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 110.282 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -78.46 -15.34 58.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.832 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.514 ' CD1' HG11 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -55.52 -22.98 23.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.01 -46.63 84.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 -33.22 19.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 84' ' ' ASP . 32.6 t -70.08 -49.66 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.673 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 36.4 t-20 -63.09 -35.99 82.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.14 94.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.016 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.62 -31.1 19.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.448 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 48.7 t80 -57.67 -51.35 69.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.727 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 7.7 tt0 -73.32 -27.34 61.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -25.11 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.765 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -79.31 -41.02 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.934 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 95' ' ' PHE . 57.1 m-85 -56.45 -50.43 71.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.8 69.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.77 58.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.402 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -110.54 -6.88 14.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.7 m-20 89.68 30.9 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 19.9 t-160 -127.57 72.17 77.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.96 -11.04 16.65 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.539 2.159 . . . . 0.0 112.153 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.844 ' OD1' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.03 42.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.447 . . . . 0.0 110.439 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CG ' ' HA ' ' B' ' 17' ' ' PRO . 92.7 m-85 70.99 144.0 0.1 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.515 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 104' ' ' PHE . 2.0 Cg_endo -82.96 165.82 15.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.057 2.504 . . . . 0.0 112.0 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' B' ' 31' ' ' SER . . . -115.28 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.779 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.61 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -169.27 -163.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.944 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.36 107.57 16.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.493 ' O ' HG13 ' A' ' 110' ' ' VAL . 5.3 m -95.25 129.16 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.798 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.519 HG12 HD23 ' B' ' 115' ' ' LEU . 7.0 m -157.79 165.71 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.949 0.405 . . . . 0.0 111.666 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 9.4 tt0 -99.75 102.87 14.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.777 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.82 162.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -79.07 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.685 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -140.81 168.08 20.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.722 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.622 HD22 ' HB2' ' A' ' 122' ' ' GLU . 3.0 mt -144.19 161.9 42.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 119' ' ' VAL . 32.7 Cg_exo -59.7 135.94 67.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.649 2.233 . . . . 0.0 112.183 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.58 18.28 7.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.87 17.47 8.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 116' ' ' PRO . 21.2 m -55.18 172.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.61 14.08 20.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.011 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 121' ' ' LEU . 4.5 pp -176.64 149.0 0.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.123 0.487 . . . . 0.0 111.508 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.622 ' HB2' HD22 ' A' ' 115' ' ' LEU . 44.5 tt0 -150.86 137.85 19.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.918 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 76' ' ' THR . 3.4 mp -144.67 138.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 112.101 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.36 149.91 28.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.569 ' C ' HD13 ' A' ' 126' ' ' ILE . . . -132.03 125.99 32.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.414 . . . . 0.0 112.027 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.569 HD13 ' C ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -114.42 132.16 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.876 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.95 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -121.74 153.14 38.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.063 0.459 . . . . 0.0 112.038 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.111 HG21 HG21 ' B' ' 3' ' ' THR . 34.6 m -124.13 116.37 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.464 ' CD ' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 1.111 HG21 HG21 ' A' ' 128' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.72 132.95 5.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.844 HD13 ' OD1' ' A' ' 103' ' ' ASN . 4.4 mp -55.2 152.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' B' ' 21' ' ' ALA . 32.7 mt -103.43 139.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.59 117.19 9.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.575 HG23 ' H ' ' B' ' 11' ' ' ALA . 11.6 t -133.86 165.97 23.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.804 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 26.32 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.58 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 7.6 mmtt -121.6 -36.61 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -68.18 172.03 4.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 18.7 Cg_endo -59.33 -16.06 32.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.632 2.221 . . . . 0.0 112.905 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 77.23 151.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.411 . . . . 0.0 111.281 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.586 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.597 HG22 ' O ' ' B' ' 15' ' ' ILE . 22.1 mm -133.53 15.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.79 -146.1 4.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.509 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . 94.4 Cg_endo -87.38 44.49 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.637 2.224 . . . . 0.0 112.916 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -163.26 154.53 17.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.915 0.388 . . . . 0.0 110.991 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 103' ' ' ASN . 27.2 m -110.83 169.25 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.304 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.575 ' OE1' HG22 ' B' ' 8' ' ' THR . 56.3 mt-30 -59.04 -53.58 56.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -170.46 -177.16 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.528 HG21 ' HB ' ' A' ' 73' ' ' VAL . 9.2 m -142.31 132.63 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.636 ' HA ' HG23 ' B' ' 28' ' ' VAL . 20.8 t70 -103.51 104.94 15.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.554 ' CD2' HG23 ' B' ' 3' ' ' THR . 19.5 mt -80.44 -16.4 54.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -103.96 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.972 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.3 -29.56 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.082 0.468 . . . . 0.0 110.189 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.644 HD23 ' N ' ' B' ' 28' ' ' VAL . 5.0 tt -135.3 140.65 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.52 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.945 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 9.9 p -120.07 160.84 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.657 HD22 ' HE2' ' A' ' 74' ' ' LYS . 2.9 mp -145.87 127.42 15.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.68 136.36 46.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.06 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.843 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 1.1 t -59.69 179.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.01 95.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.834 ' HG2' HG22 ' B' ' 58' ' ' VAL . 2.9 mp0 -61.92 138.09 58.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.553 HG22 ' O ' ' B' ' 121' ' ' LEU . 0.7 OUTLIER -145.98 170.19 8.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.665 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 52.2 Cg_exo -54.34 -137.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.069 2.513 . . . . 0.0 112.319 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -178.922 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.83 140.7 81.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.662 2.242 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.39 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.35 93.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.618 HD13 ' NE2' ' B' ' 50' ' ' GLN . 28.9 mm -38.94 -33.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.443 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.02 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.91 -54.98 38.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.618 ' NE2' HD13 ' B' ' 47' ' ' ILE . 15.8 pt20 -61.1 -26.16 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.522 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -72.18 -44.2 63.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.901 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.33 -51.54 65.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.22 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.9 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.3 m -68.4 -46.37 70.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.32 -26.38 68.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.963 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -57.99 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.163 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.8 OUTLIER -54.86 -30.39 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.931 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.9 HG23 ' O ' ' B' ' 54' ' ' SER . 39.7 t -62.13 -34.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.95 -31.77 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -62.21 -38.49 89.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.571 HG12 ' HB2' ' B' ' 11' ' ' ALA . 6.0 mt -71.25 -46.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.83 -32.53 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.656 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.31 -38.49 60.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.34 65.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.136 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 -22.06 21.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.919 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 64.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.711 HD22 ' OD2' ' B' ' 71' ' ' ASP . 14.7 mt -158.91 139.2 12.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.022 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' B' ' 71' ' ' ASP . 43.8 p -96.1 144.99 25.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -46.26 -31.79 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.574 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -59.83 -18.27 42.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.425 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.711 ' OD2' HD22 ' B' ' 67' ' ' LEU . 3.3 p-10 -88.65 -21.23 24.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.714 0.292 . . . . 0.0 110.87 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.512 HG23 ' O ' ' B' ' 126' ' ' ILE . 64.4 mt -59.4 109.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.874 0.369 . . . . 0.0 110.839 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' C' ' 22' ' ' VAL . 2.8 m -81.12 -36.88 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.969 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.667 ' HE2' HD22 ' C' ' 29' ' ' LEU . 8.6 mtmt -130.56 175.22 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.302 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.612 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 13.4 t 177.67 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 111.337 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.753 ' O ' HG23 ' B' ' 123' ' ' ILE . 0.0 OUTLIER -70.15 130.12 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.325 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.43 91.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.404 ' CZ ' ' HB ' ' B' ' 76' ' ' THR . 5.3 m-85 -91.66 143.72 26.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.151 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' B' ' 85' ' ' PHE . 35.1 m -139.32 150.01 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.072 0.463 . . . . 0.0 111.718 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' B' ' 47' ' ' ILE . 0.3 OUTLIER -90.94 -4.12 56.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.839 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -169.23 109.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.321 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' C' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.32 20.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.228 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.94 -24.63 59.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.275 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.547 ' O ' HG23 ' B' ' 88' ' ' VAL . 0.6 OUTLIER -78.52 -15.37 58.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.51 ' CD1' HG11 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -55.46 -23.03 23.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.267 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.99 -46.62 84.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.09 -33.23 19.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 84' ' ' ASP . 33.0 t -70.09 -49.59 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.721 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 36.4 t-20 -63.21 -35.96 82.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.04 94.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.67 -31.19 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 48.8 t80 -57.62 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 7.7 tt0 -73.41 -27.32 61.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.462 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -25.19 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.786 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -79.25 -41.09 28.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.97 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 95' ' ' PHE . 57.2 m-85 -56.36 -50.45 71.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.818 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.82 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.945 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.8 58.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.98 14.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.505 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 11.7 m-20 89.78 30.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.502 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.0 t-160 -127.48 72.19 77.52 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.98 -11.02 16.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.537 2.158 . . . . 0.0 112.153 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.83 ' OD1' HD13 ' C' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.03 0.443 . . . . 0.0 110.445 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.506 ' CG ' ' HA ' ' C' ' 17' ' ' PRO . 92.7 m-85 70.89 144.04 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.494 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 104' ' ' PHE . 2.0 Cg_endo -83.02 165.85 14.91 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.016 2.477 . . . . 0.0 111.917 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.835 ' HB1' ' HB2' ' C' ' 31' ' ' SER . . . -115.27 137.95 51.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.612 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -169.23 -163.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.38 107.56 16.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.571 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . 0.504 ' O ' HG13 ' B' ' 110' ' ' VAL . 5.2 m -95.21 129.11 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.845 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.533 HG12 HD23 ' C' ' 115' ' ' LEU . 7.0 m -157.71 165.59 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.409 . . . . 0.0 111.632 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 9.3 tt0 -99.57 102.86 14.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.785 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.73 162.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -79.05 -46.27 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -140.82 168.11 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' B' ' 122' ' ' GLU . 3.0 mt -144.21 161.87 42.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.549 ' O ' HG22 ' B' ' 119' ' ' VAL . 33.1 Cg_exo -59.62 135.97 67.82 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.157 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.53 18.29 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.88 17.46 8.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.549 HG22 ' O ' ' B' ' 116' ' ' PRO . 21.5 m -55.18 172.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.082 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.63 13.95 20.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.025 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.553 ' O ' HG22 ' B' ' 34' ' ' ILE . 4.6 pp -176.62 148.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.615 ' HB2' HD22 ' B' ' 115' ' ' LEU . 44.5 tt0 -150.78 137.88 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.935 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.753 HG23 ' O ' ' B' ' 76' ' ' THR . 3.4 mp -144.68 138.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 112.14 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.33 149.81 28.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.627 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.572 ' C ' HD13 ' B' ' 126' ' ' ILE . . . -131.94 126.01 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.956 0.408 . . . . 0.0 112.041 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.572 HD13 ' C ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -114.33 132.14 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.947 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.945 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -121.75 153.2 38.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.096 0.474 . . . . 0.0 111.994 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 1.04 HG21 HG21 ' C' ' 3' ' ' THR . 34.7 m -124.26 116.32 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.474 ' CD ' HD21 ' B' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 1.04 HG21 HG21 ' B' ' 128' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.842 0.353 . . . . 0.0 110.947 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.68 132.97 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.83 HD13 ' OD1' ' B' ' 103' ' ' ASN . 4.4 mp -55.18 152.35 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' C' ' 21' ' ' ALA . 32.5 mt -103.46 139.23 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -143.59 117.2 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.572 HG22 ' OE1' ' C' ' 20' ' ' GLN . 11.7 t -133.93 165.96 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.32 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.542 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 7.6 mmtp -121.59 -36.84 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.01 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.885 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.93 172.02 4.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.885 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 18.8 Cg_endo -59.31 -16.11 32.83 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.675 2.25 . . . . 0.0 112.899 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 77.24 151.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.977 0.418 . . . . 0.0 111.304 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.591 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -104.69 120.76 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.002 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.591 HD13 ' O ' ' C' ' 14' ' ' ALA . 22.5 mm -133.54 15.81 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.81 -146.14 4.73 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.001 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' B' ' 104' ' ' PHE . 94.1 Cg_endo -87.37 44.51 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 112.917 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.532 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -163.23 154.55 17.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.026 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' B' ' 103' ' ' ASN . 27.2 m -110.87 169.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.36 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.572 ' OE1' HG22 ' C' ' 8' ' ' THR . 56.2 mt-30 -59.02 -53.38 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' C' ' 6' ' ' ILE . . . -170.6 -177.19 2.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' B' ' 73' ' ' VAL . 9.2 m -142.24 132.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.64 ' HA ' HG23 ' C' ' 28' ' ' VAL . 20.8 t70 -103.48 104.98 15.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.549 ' CD2' HG23 ' C' ' 3' ' ' THR . 19.5 mt -80.47 -16.35 54.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.0 -104.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.27 -29.59 33.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.648 HD23 ' N ' ' C' ' 28' ' ' VAL . 5.0 tt -135.22 140.64 45.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.575 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.947 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 9.9 p -120.04 160.84 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.667 HD22 ' HE2' ' B' ' 74' ' ' LYS . 2.9 mp -145.85 127.45 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 p -106.6 136.31 46.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . 0.835 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 1.1 t -59.62 179.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.13 95.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.25 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.821 ' HG2' HG22 ' C' ' 58' ' ' VAL . 2.9 mp0 -62.06 138.17 58.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.259 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.528 HG22 ' O ' ' C' ' 121' ' ' LEU . 0.7 OUTLIER -146.0 170.23 8.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.654 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' C' ' 34' ' ' ILE . 52.4 Cg_exo -54.36 -137.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.063 2.509 . . . . 0.0 112.29 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.427 -178.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.762 0.315 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.88 140.74 81.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.637 2.225 . . . . 0.0 112.358 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.45 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.083 0.468 . . . . 0.0 110.913 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 93.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.621 HD13 ' NE2' ' C' ' 50' ' ' GLN . 28.7 mm -39.01 -33.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.447 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.711 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -54.96 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.621 ' NE2' HD13 ' C' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.474 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -72.07 -44.36 63.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.36 -51.5 65.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.24 72.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.354 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.903 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.3 m -68.35 -46.4 70.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.58 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.32 -26.36 68.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -58.01 4.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.8 OUTLIER -54.9 -30.36 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.984 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.903 HG23 ' O ' ' C' ' 54' ' ' SER . 39.6 t -62.07 -34.62 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -80.86 -31.79 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -62.26 -38.52 89.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' C' ' 11' ' ' ALA . 6.0 mt -70.95 -46.31 68.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.89 -32.54 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.33 -38.39 60.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.093 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.31 65.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.139 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.1 21.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.87 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.445 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.712 HD22 ' OD2' ' C' ' 71' ' ' ASP . 14.7 mt -158.9 139.23 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.036 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.0 p -96.16 145.01 25.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -46.21 -31.81 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.598 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -59.74 -18.28 41.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.477 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.712 ' OD2' HD22 ' C' ' 67' ' ' LEU . 3.3 p-10 -88.78 -21.16 23.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 110.896 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.503 HG23 ' O ' ' C' ' 126' ' ' ILE . 64.2 mt -59.39 109.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.496 ' HB ' HG21 ' A' ' 22' ' ' VAL . 2.8 m -81.04 -36.88 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.933 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.646 ' HE2' HD22 ' A' ' 29' ' ' LEU . 8.6 mtmt -130.6 175.25 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.369 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 13.4 t 177.72 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.313 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.754 ' O ' HG23 ' C' ' 123' ' ' ILE . 0.0 OUTLIER -70.23 130.2 41.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 t -115.43 91.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' C' ' 76' ' ' THR . 5.3 m-85 -91.64 143.8 26.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.143 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' C' ' 85' ' ' PHE . 34.8 m -139.35 149.98 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 111.691 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' C' ' 47' ' ' ILE . 0.3 OUTLIER -90.99 -4.23 56.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.816 178.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.1 109.04 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.305 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.685 HD12 ' HB3' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -58.58 -17.19 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.0 -24.62 59.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.297 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.546 ' O ' HG23 ' C' ' 88' ' ' VAL . 0.6 OUTLIER -78.5 -15.28 58.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.827 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.513 ' CD1' HG11 ' C' ' 79' ' ' VAL . 0.3 OUTLIER -55.53 -23.04 24.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.261 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.63 84.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.01 -33.32 19.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.969 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.546 HG23 ' O ' ' C' ' 84' ' ' ASP . 32.8 t -70.06 -49.66 54.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 36.4 t-20 -63.12 -35.99 82.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.337 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.22 -42.14 94.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.973 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.68 -31.16 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.567 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.457 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 48.7 t80 -57.64 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 7.7 tt0 -73.36 -27.37 61.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -25.19 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.77 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -79.32 -41.03 28.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 95' ' ' PHE . 56.7 m-85 -56.38 -50.4 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.781 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -28.72 69.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.954 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.91 -3.78 58.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.362 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.91 14.79 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 11.7 m-20 89.79 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.822 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.499 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.0 t-160 -127.55 72.17 77.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.705 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.03 -10.97 16.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.495 2.13 . . . . 0.0 112.146 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.82 ' OD1' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.998 0.428 . . . . 0.0 110.429 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.512 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 92.8 m-85 70.91 144.1 0.1 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.42 ' HB2' HG22 ' C' ' 75' ' ' THR . 2.0 Cg_endo -83.05 165.85 14.87 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.028 2.485 . . . . 0.0 111.948 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.812 ' HB1' ' HB2' ' A' ' 31' ' ' SER . . . -115.29 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.6 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -169.22 -163.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.4 p -111.36 107.48 16.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.589 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . 0.502 ' O ' HG13 ' C' ' 110' ' ' VAL . 5.2 m -95.21 129.18 42.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.788 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.514 HG12 HD23 ' A' ' 115' ' ' LEU . 7.1 m -157.82 165.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 9.4 tt0 -99.76 102.86 14.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.75 162.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -79.08 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.671 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -140.83 168.09 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' C' ' 122' ' ' GLU . 3.0 mt -144.21 161.82 43.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.913 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.544 ' O ' HG22 ' C' ' 119' ' ' VAL . 33.7 Cg_exo -59.52 135.99 68.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.608 2.205 . . . . 0.0 112.221 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.51 18.29 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 61.8 17.55 8.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.544 HG22 ' O ' ' C' ' 116' ' ' PRO . 21.2 m -55.18 172.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.065 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.79 14.08 19.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.988 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.534 ' O ' HD12 ' C' ' 121' ' ' LEU . 4.6 pp -176.62 148.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.489 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.619 ' HB2' HD22 ' C' ' 115' ' ' LEU . 44.4 tt0 -150.83 137.93 19.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.754 HG23 ' O ' ' C' ' 76' ' ' THR . 3.4 mp -144.74 138.35 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.11 0.481 . . . . 0.0 112.142 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.3 149.82 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.648 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.573 ' C ' HD13 ' C' ' 126' ' ' ILE . . . -131.98 126.13 33.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 112.004 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.573 HD13 ' C ' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -114.41 132.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 178.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.947 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -121.76 153.11 38.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.082 0.468 . . . . 0.0 112.029 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 3' ' ' THR . 34.6 m -124.15 116.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.47 ' CD ' HD21 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -106.27 56.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.99 0.424 . . . . 0.0 110.892 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.85 HG21 HG21 ' C' ' 128' ' ' VAL . 50.6 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.797 0.332 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -173.58 122.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.023 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.793 HD13 ' ND2' ' C' ' 103' ' ' ASN . 2.0 mp -57.27 153.16 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 23' ' ' ASP . 29.6 mt -114.16 154.75 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.421 ' N ' HG22 ' A' ' 6' ' ' ILE . 21.0 t60 -153.69 126.15 8.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.725 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -130.46 151.73 50.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.037 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -98.22 30.11 3.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.479 ' HE3' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -109.76 -39.33 5.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.745 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . -92.64 120.68 67.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.162 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 26.0 Cg_exo -62.26 -11.59 23.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.491 2.127 . . . . 0.0 112.587 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.33 -169.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 0.0 111.396 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.535 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 58.37 -164.75 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.189 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 15' ' ' ILE . 23.8 mm 80.32 16.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.107 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.69 -138.67 4.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.958 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.401 ' HB3' ' HB2' ' C' ' 93' ' ' GLU . 86.1 Cg_endo -84.03 46.13 1.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.569 2.179 . . . . 0.0 112.624 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -176.11 -169.07 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.939 0.399 . . . . 0.0 111.051 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.757 HG13 ' HB2' ' C' ' 104' ' ' PHE . 14.8 m -120.65 -179.64 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.804 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -71.16 -52.5 18.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.18 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -159.48 -178.52 7.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.795 HG11 ' O ' ' C' ' 73' ' ' VAL . 14.8 m -137.54 134.18 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.165 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.617 ' HB2' HD11 ' A' ' 6' ' ' ILE . 17.9 t0 -113.89 93.3 4.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.82 HD21 HG21 ' C' ' 73' ' ' VAL . 17.2 mt -62.6 -20.44 64.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.043 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.93 -109.57 0.81 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.922 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.31 -30.37 64.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.058 0.456 . . . . 0.0 110.19 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.49 HD21 HD22 ' B' ' 24' ' ' LEU . 0.1 OUTLIER -119.6 128.03 53.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.787 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.929 HG23 ' HB3' ' A' ' 127' ' ' ALA . 2.4 m -106.59 175.11 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.044 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.575 ' HG ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -166.84 146.11 5.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.51 HG21 HD11 ' A' ' 62' ' ' ILE . 17.5 p -109.44 147.49 32.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.044 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.527 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 16.9 t -81.86 162.33 22.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.008 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -52.73 92.96 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.621 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.632 ' HG3' HG22 ' A' ' 58' ' ' VAL . 16.4 mm-40 -65.64 151.82 45.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.842 0.353 . . . . 0.0 111.093 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.745 HG23 HG11 ' A' ' 119' ' ' VAL . 4.6 mp -126.58 134.01 25.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.65 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 61.2 Cg_endo -73.91 72.63 3.86 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.891 2.394 . . . . 0.0 112.321 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 179.57 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.693 ' HB ' HG12 ' A' ' 119' ' ' VAL . 11.2 p . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.509 0.195 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.1 140.38 60.41 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.396 2.064 . . . . 0.0 112.126 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.0 -31.44 70.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.061 0.458 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -72.86 95.87 2.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.736 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.73 -31.28 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.321 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.449 HG22 ' HB1' ' A' ' 87' ' ' ALA . 22.1 t -75.97 -51.45 20.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.385 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -62.7 -37.64 87.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.227 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -69.14 -28.07 66.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.298 179.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.23 -34.95 36.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.902 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -69.03 -42.28 76.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.794 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.53 82.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.799 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.3 m -71.07 -36.88 72.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -68.02 -40.45 82.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.752 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.73 -38.58 86.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.741 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.17 -43.69 97.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.978 HG21 HG21 ' A' ' 123' ' ' ILE . 24.8 t -61.15 -35.99 69.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.65 -32.76 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.698 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . . . -60.63 -39.9 89.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.81 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 58' ' ' VAL . 3.0 mt -69.23 -46.57 77.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.689 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.51 HD11 HG21 ' A' ' 30' ' ' THR . 22.1 mt -67.45 -32.67 58.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.492 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.6 -41.08 66.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.196 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -61.3 -21.95 64.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.344 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.54 -28.45 21.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.651 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.35 47.15 0.55 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.594 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 129' ' ' ARG . 5.4 mt -156.56 138.02 13.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.859 0.361 . . . . 0.0 110.95 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.6 m -93.27 159.4 15.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.798 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.864 ' HB3' ' CD2' ' A' ' 101' ' ' HIS . . . -57.32 -34.09 68.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.908 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.82 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -51.93 -28.27 15.87 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.883 0.373 . . . . 0.0 110.711 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.68 -26.69 60.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.395 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 126' ' ' ILE . 71.4 mt -47.61 118.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.763 HG21 HD21 ' B' ' 24' ' ' LEU . 26.5 m -92.14 -30.73 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.741 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 22.8 tttm -138.32 160.12 40.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.567 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.703 HG23 ' HB2' ' A' ' 125' ' ' ALA . 41.8 m -153.31 137.97 16.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.989 0.423 . . . . 0.0 111.49 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.903 HG23 ' O ' ' A' ' 108' ' ' SER . 58.5 m -126.98 140.65 52.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.043 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.651 HG13 HD13 ' A' ' 123' ' ' ILE . 21.3 t -146.26 115.61 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 111.617 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.694 ' HB2' HD21 ' A' ' 115' ' ' LEU . 9.2 m-85 -89.35 112.08 23.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.482 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.614 HG12 HD21 ' A' ' 121' ' ' LEU . 34.4 m -97.46 148.34 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.575 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 -5.62 29.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.97 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 97.4 2.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.481 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' B' ' 114' ' ' ARG . 1.9 mt -57.61 -18.11 18.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.226 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.45 -25.3 54.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.928 0.394 . . . . 0.0 110.49 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -87.13 -19.53 28.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.83 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.4 ' CD1' HG11 ' A' ' 79' ' ' VAL . 35.2 t80 -56.8 -22.48 36.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.09 -36.15 67.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 0.0 111.185 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.449 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -83.46 -44.66 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.54 -38.16 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.777 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -66.28 -41.91 89.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.81 84.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.208 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.29 -30.84 25.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.415 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 84.2 t80 -53.71 -44.36 69.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.893 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' B' ' 17' ' ' PRO . 1.5 tt0 -85.86 -21.97 27.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.284 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.13 -21.27 59.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.429 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.2 p90 -91.78 -35.04 14.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.713 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 101' ' ' HIS . 0.8 OUTLIER -56.14 -60.2 3.84 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.145 0.498 . . . . 0.0 110.093 179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -28.85 70.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.576 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -77.33 -9.97 59.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.711 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.466 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . 57.5 m-20 -113.46 -6.01 13.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.461 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.1 m120 88.04 34.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.169 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.864 ' CD2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 m-70 -116.6 53.35 1.13 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.67 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 73.6 Cg_endo -73.62 -19.26 21.66 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.739 2.293 . . . . 0.0 112.907 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.789 ' ND2' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -46.16 -35.64 5.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.873 0.368 . . . . 0.0 111.399 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.766 ' HB2' HG13 ' B' ' 19' ' ' VAL . 13.4 m-85 68.18 106.36 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.372 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 98.6 Cg_endo -85.08 160.43 11.57 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.747 2.298 . . . . 0.0 112.319 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.741 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -54.97 154.45 5.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.575 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -113.73 150.39 33.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.0 111.315 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.903 ' O ' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -160.07 53.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.447 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.93 146.78 27.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.019 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.596 HG12 HD23 ' B' ' 115' ' ' LEU . 29.7 m -153.23 156.23 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.303 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.434 ' HA ' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -77.99 95.36 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.435 HG21 HD21 ' A' ' 115' ' ' LEU . 9.8 m -83.21 148.45 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -60.65 -46.33 90.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.996 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.449 ' HB3' HD12 ' C' ' 82' ' ' LEU . 19.5 mtt180 -155.16 171.32 20.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.728 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 122' ' ' GLU . 1.6 mt -143.31 160.14 52.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 119' ' ' VAL . 89.4 Cg_exo -46.72 136.74 16.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.443 2.095 . . . . 0.0 112.236 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.85 17.86 7.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 61.67 17.14 8.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.034 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.745 HG11 HG23 ' A' ' 34' ' ' ILE . 35.8 m -63.16 154.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.055 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.8 26.49 24.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.666 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.614 HD21 HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -178.91 158.01 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.113 0.482 . . . . 0.0 111.154 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' A' ' 115' ' ' LEU . 4.4 tt0 -152.49 148.32 27.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.179 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.978 HG21 HG21 ' A' ' 58' ' ' VAL . 23.5 mm -122.94 146.13 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 111.766 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 99.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.101 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.703 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -124.03 166.8 15.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 111.877 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 72' ' ' ILE . 9.0 mm -114.51 154.05 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.404 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.929 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -141.09 151.5 44.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.97 0.414 . . . . 0.0 111.573 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.767 HG21 HG21 ' B' ' 3' ' ' THR . 28.0 m -105.88 -179.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.942 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.771 ' HB2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.834 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.767 HG21 HG21 ' A' ' 128' ' ' VAL . 51.0 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -173.52 122.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.789 HD13 ' ND2' ' A' ' 103' ' ' ASN . 2.0 mp -57.32 153.21 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' B' ' 23' ' ' ASP . 29.5 mt -114.22 154.67 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.201 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.409 ' N ' HG22 ' B' ' 6' ' ' ILE . 21.0 t60 -153.63 126.08 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.75 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -130.46 151.77 50.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.99 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -98.19 30.18 3.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.894 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -39.76 4.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.33 120.74 67.43 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.168 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.25 -11.65 23.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.48 2.12 . . . . 0.0 112.613 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.29 -169.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.011 0.434 . . . . 0.0 111.391 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.536 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 58.36 -164.75 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.266 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.617 HG22 ' O ' ' B' ' 15' ' ' ILE . 23.7 mm 80.34 16.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.126 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.74 -138.69 4.33 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.91 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 86.2 Cg_endo -84.03 46.15 1.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.583 2.189 . . . . 0.0 112.653 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.536 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -176.16 -169.15 0.3 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 111.058 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.766 HG13 ' HB2' ' A' ' 104' ' ' PHE . 14.5 m -120.55 -179.67 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.771 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -70.95 -51.33 26.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 0.0 111.038 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -161.19 -178.17 6.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.059 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.743 HG11 ' O ' ' A' ' 73' ' ' VAL . 14.9 m -137.54 134.13 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.159 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.62 ' HB2' HD11 ' B' ' 6' ' ' ILE . 17.9 t0 -113.87 93.25 4.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.763 HD21 HG21 ' A' ' 73' ' ' VAL . 17.4 mt -62.58 -20.34 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.046 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.87 -109.59 0.81 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.99 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.32 -30.38 64.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.462 . . . . 0.0 110.175 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.695 HD21 HD22 ' C' ' 24' ' ' LEU . 0.1 OUTLIER -119.62 127.98 53.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.797 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.937 HG23 ' HB3' ' B' ' 127' ' ' ALA . 2.4 m -106.53 175.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.026 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.582 ' HG ' HG23 ' B' ' 22' ' ' VAL . 0.6 OUTLIER -166.88 146.05 5.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.575 HG21 HD11 ' B' ' 62' ' ' ILE . 17.3 p -109.35 147.25 33.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.519 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 16.9 t -81.64 162.36 23.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.438 ' O ' HD12 ' B' ' 34' ' ' ILE . . . -52.68 92.87 0.01 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.614 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.651 ' HG3' HG22 ' B' ' 58' ' ' VAL . 16.3 mm-40 -65.61 151.75 45.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 111.117 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.697 HG23 HG11 ' B' ' 119' ' ' VAL . 4.6 mp -126.56 134.1 25.68 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.644 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 61.1 Cg_endo -74.0 72.73 3.89 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.88 2.387 . . . . 0.0 112.231 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.623 179.563 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.722 ' HB ' HG12 ' B' ' 119' ' ' VAL . 11.2 p . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.521 0.2 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.13 140.37 60.74 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.347 2.032 . . . . 0.0 112.158 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.96 -31.48 70.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.2 OUTLIER -72.89 95.92 2.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.743 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.71 -31.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.313 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.431 HG22 ' HB1' ' B' ' 87' ' ' ALA . 22.3 t -76.03 -51.4 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.387 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -62.7 -37.63 87.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.254 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.419 ' HG3' ' CG2' ' B' ' 43' ' ' VAL . 0.9 OUTLIER -69.14 -28.05 66.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.337 179.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.38 -34.97 35.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.927 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -68.99 -42.28 76.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.775 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -39.51 82.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.622 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.823 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.3 m -71.04 -36.97 72.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.717 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -67.97 -40.54 83.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.62 -38.64 87.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.758 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.09 -43.77 97.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.72 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.985 HG21 HG21 ' B' ' 123' ' ' ILE . 24.7 t -61.15 -36.05 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.792 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.48 -32.87 42.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.687 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.88 89.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' B' ' 58' ' ' VAL . 3.0 mt -69.45 -46.66 75.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.575 HD11 HG21 ' B' ' 30' ' ' THR . 22.1 mt -67.48 -32.57 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.566 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.7 -41.05 65.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.183 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -61.26 -21.98 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.358 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.55 -28.41 21.98 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.35 47.16 0.55 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.616 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.823 HD11 ' HB2' ' B' ' 129' ' ' ARG . 5.4 mt -156.54 137.98 13.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.975 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 9.4 m -93.27 159.4 15.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.819 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.85 ' HB3' ' CD2' ' B' ' 101' ' ' HIS . . . -57.29 -34.07 68.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.819 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -51.88 -28.12 15.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.975 0.417 . . . . 0.0 110.666 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.74 -26.62 60.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.416 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.558 HG23 ' O ' ' B' ' 126' ' ' ILE . 71.4 mt -47.66 118.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.026 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.78 ' O ' HG11 ' C' ' 22' ' ' VAL . 26.0 m -92.21 -30.55 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.08 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.768 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 22.8 tttm -138.43 160.02 40.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.596 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.717 HG23 ' HB2' ' B' ' 125' ' ' ALA . 42.0 m -153.27 137.97 16.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 0.0 111.461 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.924 HG23 ' O ' ' B' ' 108' ' ' SER . 58.5 m -126.98 140.65 52.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.08 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.664 HG13 HD13 ' B' ' 123' ' ' ILE . 21.3 t -146.26 115.58 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 111.551 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.659 ' HB2' HD21 ' B' ' 115' ' ' LEU . 9.1 m-85 -89.29 112.13 23.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.485 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.621 HG12 HD21 ' B' ' 121' ' ' LEU . 34.3 m -97.51 148.3 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.647 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 -5.73 29.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.95 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.67 97.43 2.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.508 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' C' ' 114' ' ' ARG . 1.9 mt -57.63 -18.13 18.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.203 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.42 -25.33 54.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -87.08 -19.51 28.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.894 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.4 ' CD1' HG11 ' B' ' 79' ' ' VAL . 35.0 t80 -56.8 -22.52 36.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.204 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.18 67.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 111.214 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.431 ' HB1' HG22 ' B' ' 48' ' ' VAL . . . -83.53 -44.65 14.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.52 -38.15 81.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.818 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.23 -41.95 89.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.834 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.99 85.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.221 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.27 -31.0 25.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.415 ' O ' ' CE2' ' B' ' 95' ' ' PHE . 84.1 t80 -53.66 -44.46 69.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' C' ' 17' ' ' PRO . 1.5 tt0 -85.8 -21.99 27.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.287 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.11 -21.27 59.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.438 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 1.2 p90 -91.83 -35.0 14.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.759 0.314 . . . . 0.0 110.695 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' B' ' 101' ' ' HIS . 0.8 OUTLIER -56.29 -60.12 3.97 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.174 0.512 . . . . 0.0 110.101 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -28.74 70.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.545 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -77.47 -9.91 59.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 110.658 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.465 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . 57.1 m-20 -113.44 -6.02 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.482 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.1 m120 88.13 34.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.189 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.85 ' CD2' ' HB3' ' B' ' 69' ' ' ALA . 1.6 m-70 -116.47 53.38 1.1 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.701 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 73.5 Cg_endo -73.78 -19.21 21.3 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.771 2.314 . . . . 0.0 112.895 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.78 ' ND2' HD13 ' C' ' 5' ' ' ILE . 0.1 OUTLIER -46.12 -35.64 5.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.937 0.399 . . . . 0.0 111.409 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.759 ' HB2' HG13 ' C' ' 19' ' ' VAL . 13.5 m-85 68.15 106.37 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.36 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 97.0 Cg_endo -85.08 160.38 11.57 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.711 2.274 . . . . 0.0 112.327 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.768 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -54.88 154.53 5.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.615 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.473 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -113.78 150.46 33.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.015 0.436 . . . . 0.0 111.351 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.924 ' O ' HG23 ' B' ' 76' ' ' THR . 0.4 OUTLIER -160.06 53.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.508 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.99 146.65 28.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.997 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' C' ' 78' ' ' PHE . 30.0 m -153.06 155.65 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.244 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -77.77 95.29 4.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.843 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.428 HG21 HD21 ' B' ' 115' ' ' LEU . 9.9 m -83.18 148.44 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.127 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -60.7 -46.34 90.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.477 ' HB3' HD12 ' A' ' 82' ' ' LEU . 19.4 mtt180 -155.16 171.26 20.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.719 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' B' ' 122' ' ' GLU . 1.6 mt -143.29 160.19 52.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.706 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.607 ' O ' HG22 ' B' ' 119' ' ' VAL . 89.1 Cg_exo -46.75 136.75 16.45 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.459 2.106 . . . . 0.0 112.255 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.89 17.76 7.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 61.69 17.17 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.059 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.722 HG12 ' HB ' ' B' ' 43' ' ' VAL . 35.5 m -63.2 154.66 6.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.004 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.07 26.28 25.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.708 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.621 HD21 HG12 ' B' ' 79' ' ' VAL . 0.4 OUTLIER -178.89 158.06 0.93 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.12 0.486 . . . . 0.0 111.191 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.776 ' HB2' HD22 ' B' ' 115' ' ' LEU . 4.4 tt0 -152.48 148.25 27.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.23 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.985 HG21 HG21 ' B' ' 58' ' ' VAL . 23.5 mm -122.92 146.06 28.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.065 0.46 . . . . 0.0 111.799 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.88 99.82 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.144 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.717 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -124.05 166.7 15.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.877 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.558 ' O ' HG23 ' B' ' 72' ' ' ILE . 8.9 mm -114.47 154.0 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.422 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.937 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -141.03 151.58 44.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.914 0.388 . . . . 0.0 111.557 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.814 HG21 HG21 ' C' ' 3' ' ' THR . 27.6 m -106.0 -179.42 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.894 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.823 ' HB2' HD11 ' B' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.947 0.403 . . . . 0.0 110.934 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.814 HG21 HG21 ' B' ' 128' ' ' VAL . 51.2 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.844 0.354 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -173.53 122.4 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.78 HD13 ' ND2' ' B' ' 103' ' ' ASN . 2.1 mp -57.29 153.21 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.834 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' C' ' 23' ' ' ASP . 29.0 mt -114.17 154.71 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.2 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . 0.408 ' N ' HG22 ' C' ' 6' ' ' ILE . 21.0 t60 -153.71 126.06 8.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.728 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -130.38 151.77 50.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.018 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -98.27 30.12 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.474 ' HE3' ' HB2' ' C' ' 60' ' ' ALA . 0.0 OUTLIER -109.84 -39.33 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.72 120.72 67.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.18 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.31 -11.58 23.23 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.486 2.124 . . . . 0.0 112.593 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.32 -169.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.0 111.415 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.528 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 58.39 -164.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.231 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.6 HG22 ' O ' ' C' ' 15' ' ' ILE . 23.8 mm 80.32 16.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.107 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.68 -138.61 4.33 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.0 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . 0.41 ' HB3' ' HB2' ' B' ' 93' ' ' GLU . 84.4 Cg_endo -84.08 46.17 1.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.621 2.214 . . . . 0.0 112.67 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.528 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -176.18 -169.12 0.3 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.92 0.391 . . . . 0.0 111.082 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.759 HG13 ' HB2' ' B' ' 104' ' ' PHE . 14.6 m -120.58 -179.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.769 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -71.21 -52.52 18.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.271 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -159.65 -178.44 7.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.78 HG11 ' O ' ' B' ' 73' ' ' VAL . 14.9 m -137.54 134.27 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.634 ' HB2' HD11 ' C' ' 6' ' ' ILE . 18.0 t0 -113.95 93.36 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.731 HD21 HG21 ' B' ' 73' ' ' VAL . 17.5 mt -62.68 -20.45 64.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.004 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.01 -109.57 0.81 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.926 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.33 -30.37 64.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.052 0.453 . . . . 0.0 110.187 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.57 HD21 HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -119.6 128.02 53.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.776 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.94 HG23 ' HB3' ' C' ' 127' ' ' ALA . 2.4 m -106.55 175.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.041 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.593 ' HG ' HG23 ' C' ' 22' ' ' VAL . 0.6 OUTLIER -166.83 146.1 5.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.807 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.491 HG21 HD11 ' C' ' 62' ' ' ILE . 17.4 p -109.61 147.62 32.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . 0.529 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 16.9 t -81.76 162.24 22.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.002 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . 0.442 ' O ' HD12 ' C' ' 34' ' ' ILE . . . -52.61 92.9 0.01 OUTLIER Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.654 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.621 ' HG3' HG22 ' C' ' 58' ' ' VAL . 16.4 mm-40 -65.6 151.8 45.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 0.0 111.107 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.715 HG23 HG11 ' C' ' 119' ' ' VAL . 4.6 mp -126.57 133.98 25.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.636 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 61.2 Cg_endo -73.88 72.61 3.84 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.888 2.392 . . . . 0.0 112.292 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.68 179.543 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.694 ' HB ' HG12 ' C' ' 119' ' ' VAL . 11.1 p . . . . . 0 CA--C 1.53 0.183 0 CA-C-O 120.499 0.19 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.07 140.4 60.14 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.327 2.018 . . . . 0.0 112.155 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.04 -31.38 70.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.008 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -72.94 95.97 2.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.684 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.79 -31.31 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.231 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . 0.403 HG22 ' HB1' ' C' ' 87' ' ' ALA . 22.1 t -75.95 -51.47 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.383 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -62.75 -37.6 87.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.246 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.42 ' HG3' ' CG2' ' C' ' 43' ' ' VAL . 0.9 OUTLIER -69.17 -27.91 65.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.301 179.273 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.52 -34.96 35.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.951 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -69.07 -42.29 76.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -39.49 82.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.698 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.825 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.3 m -71.03 -36.98 72.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.689 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -67.96 -40.52 83.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.728 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.68 -38.66 87.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.71 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.05 -43.8 97.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.717 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 1.007 HG21 HG21 ' C' ' 123' ' ' ILE . 24.8 t -61.12 -36.08 70.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.786 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.49 -32.77 42.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.676 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.474 ' HB2' ' HE3' ' C' ' 10' ' ' LYS . . . -60.65 -40.0 90.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.799 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' C' ' 58' ' ' VAL . 3.0 mt -69.18 -46.65 77.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.655 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.491 HD11 HG21 ' C' ' 30' ' ' THR . 22.0 mt -67.43 -32.65 58.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.532 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.65 -41.03 65.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.18 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -61.3 -21.89 64.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.41 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.63 -28.41 21.89 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.623 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.32 47.14 0.55 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.613 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.812 HD11 ' HB2' ' C' ' 129' ' ' ARG . 5.4 mt -156.52 138.0 13.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.853 0.358 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 9.4 m -93.19 159.39 15.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.857 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' CD2' ' C' ' 101' ' ' HIS . . . -57.3 -34.19 68.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.815 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -51.9 -28.33 15.9 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.91 0.386 . . . . 0.0 110.712 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.55 -26.64 60.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.435 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.548 HG23 ' O ' ' C' ' 126' ' ' ILE . 71.4 mt -47.66 118.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.033 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.82 HG21 HD21 ' A' ' 24' ' ' LEU . 26.4 m -92.09 -30.7 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.093 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.742 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 22.8 tttm -138.34 160.12 40.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.576 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.69 HG23 ' HB2' ' C' ' 125' ' ' ALA . 40.6 m -153.29 137.9 16.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.043 0.449 . . . . 0.0 111.517 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.932 HG23 ' O ' ' C' ' 108' ' ' SER . 58.8 m -126.94 140.61 52.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.098 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.65 HG13 HD13 ' C' ' 123' ' ' ILE . 21.4 t -146.22 115.66 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.616 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.679 ' HB2' HD21 ' C' ' 115' ' ' LEU . 9.1 m-85 -89.33 112.07 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.494 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.586 HG12 HD21 ' C' ' 121' ' ' LEU . 34.4 m -97.44 148.37 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.115 0.483 . . . . 0.0 111.575 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 -5.59 29.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.995 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.69 97.4 2.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.53 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 114' ' ' ARG . 1.9 mt -57.64 -18.15 18.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.127 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.38 -25.33 54.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.48 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -87.12 -19.51 28.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.888 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -56.73 -22.54 36.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.06 -36.11 67.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.403 ' HB1' HG22 ' C' ' 48' ' ' VAL . . . -83.55 -44.65 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.53 -38.18 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.31 -41.89 89.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.837 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.82 84.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.201 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.41 -30.97 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.418 ' O ' ' CE2' ' C' ' 95' ' ' PHE . 84.2 t80 -53.61 -44.47 69.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 1.5 tt0 -85.82 -22.01 27.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.281 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -21.25 60.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.456 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 1.2 p90 -91.8 -35.13 14.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' C' ' 101' ' ' HIS . 0.8 OUTLIER -56.17 -60.21 3.82 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.117 0.484 . . . . 0.0 110.084 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -28.84 70.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.539 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.36 -9.96 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 0.0 110.681 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 57.2 m-20 -113.43 -6.01 13.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.491 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 11.9 m120 88.02 34.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.181 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.851 ' CD2' ' HB3' ' C' ' 69' ' ' ALA . 1.6 m-70 -116.56 53.35 1.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.664 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 73.5 Cg_endo -73.67 -19.29 21.51 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.797 2.332 . . . . 0.0 112.907 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.793 ' ND2' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -46.18 -35.58 5.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.88 0.371 . . . . 0.0 111.388 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.757 ' HB2' HG13 ' A' ' 19' ' ' VAL . 13.5 m-85 68.12 106.39 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.36 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.431 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 96.7 Cg_endo -85.14 160.42 11.49 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.711 2.274 . . . . 0.0 112.353 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.742 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -54.9 154.46 5.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.556 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.467 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -113.75 150.46 33.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.998 0.428 . . . . 0.0 111.297 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . 0.932 ' O ' HG23 ' C' ' 76' ' ' THR . 0.4 OUTLIER -160.1 53.96 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.425 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.92 146.75 27.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.959 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.578 HG11 ' CD2' ' A' ' 78' ' ' PHE . 30.0 m -153.11 155.34 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.288 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -77.32 95.38 4.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.721 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.427 HG21 HD21 ' C' ' 115' ' ' LEU . 10.0 m -83.2 148.45 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -60.71 -46.31 90.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.485 ' HB3' HD12 ' B' ' 82' ' ' LEU . 19.4 mtt180 -155.17 171.35 19.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.823 HD22 ' HB2' ' C' ' 122' ' ' GLU . 1.6 mt -143.36 160.17 52.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.661 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.618 ' O ' HG22 ' C' ' 119' ' ' VAL . 89.3 Cg_exo -46.76 136.73 16.52 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.496 2.131 . . . . 0.0 112.243 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.95 17.79 7.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.7 17.08 8.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.049 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.715 HG11 HG23 ' C' ' 34' ' ' ILE . 35.7 m -63.17 154.6 6.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.77 26.41 24.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.652 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.586 HD21 HG12 ' C' ' 79' ' ' VAL . 0.4 OUTLIER -178.76 157.98 0.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.08 0.467 . . . . 0.0 111.173 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.823 ' HB2' HD22 ' C' ' 115' ' ' LEU . 4.4 tt0 -152.46 148.28 27.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.226 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 1.007 HG21 HG21 ' C' ' 58' ' ' VAL . 23.2 mm -122.93 146.05 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.057 0.455 . . . . 0.0 111.81 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 99.84 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.068 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.69 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -124.08 166.86 15.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.037 0.446 . . . . 0.0 111.828 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.548 ' O ' HG23 ' C' ' 72' ' ' ILE . 8.8 mm -114.52 154.0 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.463 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.94 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -141.1 151.46 43.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.898 0.38 . . . . 0.0 111.576 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.85 HG21 HG21 ' A' ' 3' ' ' THR . 27.2 m -105.9 -179.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.884 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.812 ' HB2' HD11 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -163.71 48.1 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.884 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 tttp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.926 179.937 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.557 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.8 136.84 3.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.637 HG23 HG21 ' A' ' 19' ' ' VAL . 4.8 mp -58.55 158.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.244 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' A' ' 21' ' ' ALA . 19.0 mt -115.13 160.58 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.043 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.475 ' N ' HG22 ' A' ' 6' ' ' ILE . 4.7 t-160 -160.73 124.48 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.997 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 61' ' ' ILE . 8.0 t -127.65 165.52 19.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.973 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.76 51.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.25 -50.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.757 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.921 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -66.41 172.34 3.25 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.03 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.921 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 32.1 Cg_endo -64.37 -11.95 30.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.586 2.19 . . . . 0.0 112.714 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 73.27 171.61 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.987 0.423 . . . . 0.0 111.352 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.768 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -166.98 122.75 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.799 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 14' ' ' ALA . 17.8 mm -141.42 17.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.377 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.58 -103.85 2.44 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.274 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.17 4.88 6.65 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.536 2.157 . . . . 0.0 112.788 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.498 ' CD1' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -160.74 177.21 10.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.673 HG13 ' HB2' ' C' ' 104' ' ' PHE . 28.4 m -132.32 166.37 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.051 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.772 ' OE1' ' HB3' ' A' ' 11' ' ' ALA . 3.9 mm-40 -52.82 -46.43 67.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . -176.21 176.79 1.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.997 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.661 HG21 ' HB ' ' C' ' 73' ' ' VAL . 3.1 m -140.19 133.89 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.458 ' CG ' HG12 ' A' ' 28' ' ' VAL . 6.9 t0 -97.26 139.69 32.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.654 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.846 HD11 HD13 ' A' ' 29' ' ' LEU . 6.6 mt -112.94 -15.86 12.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.34 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 97.01 104.45 2.23 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.294 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 15.6 m-80 84.05 -35.72 0.06 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.783 ' HG ' HG12 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -127.2 101.5 6.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.771 179.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.095 HG23 ' HB3' ' A' ' 127' ' ' ALA . 3.4 m -94.89 170.34 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.377 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.909 ' HG ' HG23 ' A' ' 126' ' ' ILE . 3.6 mp -152.77 148.92 27.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.943 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 p -125.97 149.1 49.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.863 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 4.1 t -75.26 170.7 15.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.03 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.92 77.21 0.41 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.062 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.14 162.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.964 0.411 . . . . 0.0 111.536 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.713 HG13 HG23 ' A' ' 36' ' ' VAL . 7.5 pt -146.91 154.21 46.87 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.773 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.626 ' HG2' HG23 ' A' ' 43' ' ' VAL . 72.2 Cg_endo -77.11 48.79 2.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.925 2.416 . . . . 0.0 113.292 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.713 HG23 HG13 ' A' ' 34' ' ' ILE . 45.9 t . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 121.229 0.537 . . . . 0.0 110.473 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.626 HG23 ' HG2' ' A' ' 35' ' ' PRO . 9.9 p . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.551 0.215 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 35' ' ' PRO . 52.7 Cg_exo -54.4 141.77 71.38 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.453 2.102 . . . . 0.0 112.235 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.01 70.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 93.87 1.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.774 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' A' ' 47' ' ' ILE . 7.4 tp -42.25 -33.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.638 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.56 -46.38 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.15 -46.99 88.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.64 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.401 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 3.5 pt20 -64.89 -28.89 69.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.52 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.8 -40.87 54.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.859 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -67.81 -52.31 38.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.62 -27.97 63.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.622 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -61.86 -42.41 99.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.629 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.639 HD13 ' CE2' ' A' ' 95' ' ' PHE . 7.5 mt -74.98 -30.0 61.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 32.5 mt-10 -65.5 -36.16 83.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.086 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 54' ' ' SER . 22.4 p30 -72.43 -27.8 62.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.793 0.33 . . . . 0.0 110.598 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.864 HG21 HG21 ' A' ' 123' ' ' ILE . 35.2 t -67.63 -45.86 84.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -76.06 -28.24 57.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.18 94.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 8' ' ' THR . 16.1 mt -72.83 -40.9 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.584 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.516 ' CD1' HD11 ' A' ' 72' ' ' ILE . 18.4 mt -70.07 -33.07 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.68 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.53 -40.98 63.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.274 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -21.8 65.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.349 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.3 -28.41 17.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.734 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.24 56.65 0.26 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.606 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 129' ' ' ARG . 3.5 mt -172.77 144.17 1.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.0 p -99.43 166.06 11.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.763 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.022 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -62.48 -31.05 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.837 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.974 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -52.59 -26.85 14.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.911 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.463 ' CB ' HD22 ' A' ' 67' ' ' LEU . 1.2 m-20 -82.15 -24.5 35.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.898 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.566 HG21 HG22 ' A' ' 75' ' ' THR . 96.6 mt -52.9 108.31 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.922 0.392 . . . . 0.0 110.954 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.678 ' HB ' HG21 ' B' ' 22' ' ' VAL . 35.4 m -74.31 -45.29 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.816 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.599 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 5.9 mttp -125.06 163.72 21.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.626 0.25 . . . . 0.0 111.263 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.618 HG23 ' CB ' ' A' ' 105' ' ' PRO . 31.7 p -157.8 102.4 1.84 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.831 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.82 HG23 ' CD ' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -70.03 124.64 24.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.412 HG11 ' HE1' ' A' ' 85' ' ' PHE . 6.2 t -116.28 110.36 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.413 ' CE2' ' OE2' ' A' ' 124' ' ' GLU . 15.8 m-30 -107.88 119.92 40.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.973 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.602 HG12 HD21 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -114.26 152.21 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.13 0.491 . . . . 0.0 111.777 -179.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.99 1.05 57.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.846 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.3 108.56 0.28 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.546 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' B' ' 114' ' ' ARG . 3.0 mt -57.84 -17.31 15.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.274 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.23 -22.18 60.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 0.0 110.458 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 88' ' ' VAL . 75.3 m-20 -87.05 -15.49 38.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.017 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.412 ' HE1' HG11 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -57.35 -29.67 64.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.193 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.01 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.325 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.91 -28.84 22.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.322 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 84' ' ' ASP . 21.4 t -77.76 -41.65 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.287 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.408 ' OD1' ' CE2' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -68.17 -36.56 79.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.91 75.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.321 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.59 -32.48 18.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.052 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -61.25 -49.89 75.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.041 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.52 -21.53 57.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.468 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -27.29 50.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.554 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.639 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -85.67 -39.07 17.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 110.752 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 4.3 m-85 -55.15 -54.5 42.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.154 0.502 . . . . 0.0 110.209 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -31.93 71.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.23 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.72 -4.18 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.711 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 4.1 t-20 -112.5 -5.54 14.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.535 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 5.6 m120 86.29 30.69 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.62 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 1.022 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 2.9 m170 -117.35 54.55 1.56 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.6 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.411 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 63.4 Cg_endo -72.09 -10.05 25.4 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.704 2.269 . . . . 0.0 113.362 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.621 ' HB3' HD11 ' B' ' 5' ' ' ILE . 7.7 m-20 -56.7 -40.74 76.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.794 0.331 . . . . 0.0 110.921 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.672 ' HB2' HG13 ' B' ' 19' ' ' VAL . 26.8 m-85 72.37 90.36 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.988 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.618 ' CB ' HG23 ' A' ' 75' ' ' THR . 77.0 Cg_exo -49.27 162.06 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.557 2.172 . . . . 0.0 112.322 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.878 ' HB1' ' HB2' ' B' ' 31' ' ' SER . . . -125.4 131.18 52.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.534 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.82 ' CD ' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -163.73 -166.47 1.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.57 114.93 28.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.219 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 14.3 m -96.94 130.37 44.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.127 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.718 HG12 HD23 ' B' ' 115' ' ' LEU . 30.4 m -148.74 167.64 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.924 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.805 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 30.7 tt0 -102.28 92.34 4.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.71 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.872 HG21 HD21 ' A' ' 115' ' ' LEU . 24.5 m -62.6 157.94 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.203 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -70.32 -51.44 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.552 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.6 OUTLIER -143.17 178.45 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.718 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.872 HD21 HG21 ' A' ' 112' ' ' VAL . 73.3 mt -150.85 153.99 34.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.749 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.573 ' O ' HG22 ' A' ' 119' ' ' VAL . 36.3 Cg_endo -65.39 137.48 51.29 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.483 2.122 . . . . 0.0 112.21 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 76.66 14.84 2.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.303 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.58 14.48 9.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.095 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.638 HG11 ' HB ' ' A' ' 34' ' ' ILE . 17.3 m -58.78 160.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 111.027 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.48 21.75 21.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.782 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.602 HD21 HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -178.86 154.9 0.74 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 0.0 111.208 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HD13 ' A' ' 123' ' ' ILE . 4.3 tt0 -140.55 150.59 43.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.044 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.864 HG21 HG21 ' A' ' 58' ' ' VAL . 20.8 mm -136.8 119.67 21.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -138.4 115.87 11.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -132.11 168.67 17.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.909 HG23 ' HG ' ' A' ' 29' ' ' LEU . 4.0 mm -116.55 146.03 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.488 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 1.095 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -132.63 148.48 52.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.171 0.51 . . . . 0.0 111.944 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.783 HG12 ' HG ' ' A' ' 27' ' ' LEU . 30.8 m -132.14 162.81 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.883 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.625 ' HB3' HD21 ' A' ' 67' ' ' LEU . 9.9 ptt180 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.98 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.586 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.776 0.322 . . . . 0.0 110.953 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.83 136.88 3.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.026 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.638 HG23 HG21 ' B' ' 19' ' ' VAL . 4.8 mp -58.61 158.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.242 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.539 HD12 ' CB ' ' B' ' 21' ' ' ALA . 19.0 mt -115.1 160.59 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.009 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.475 ' N ' HG22 ' B' ' 6' ' ' ILE . 4.7 t-160 -160.75 124.47 3.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.464 HG22 HG12 ' B' ' 61' ' ' ILE . 8.0 t -127.69 165.57 19.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.967 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.8 51.28 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.402 ' HB3' ' CB ' ' B' ' 60' ' ' ALA . 0.7 OUTLIER -144.19 -49.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.914 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -66.79 172.41 3.41 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.073 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.914 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 32.2 Cg_endo -64.37 -11.93 30.6 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.651 2.234 . . . . 0.0 112.758 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 73.26 171.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.422 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.762 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -167.04 122.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.827 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.762 HD13 ' O ' ' B' ' 14' ' ' ALA . 17.6 mm -141.41 17.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.399 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.49 -103.89 2.45 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.308 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.11 4.83 6.69 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.567 2.178 . . . . 0.0 112.843 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.508 ' CD1' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -160.79 177.18 10.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.911 0.386 . . . . 0.0 111.291 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 104' ' ' PHE . 28.3 m -132.27 166.41 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.06 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.766 ' OE1' ' HB3' ' B' ' 11' ' ' ALA . 3.9 mm-40 -52.89 -46.44 67.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.806 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.539 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . -176.47 176.84 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.875 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.678 HG21 ' HB ' ' A' ' 73' ' ' VAL . 3.1 m -140.27 133.84 34.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.122 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.463 ' CG ' HG12 ' B' ' 28' ' ' VAL . 6.9 t0 -97.2 139.75 32.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.837 HD11 HD13 ' B' ' 29' ' ' LEU . 6.6 mt -112.98 -15.91 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.324 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 97.01 104.45 2.23 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.297 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 15.7 m-80 84.07 -35.74 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.763 ' HG ' HG12 ' B' ' 128' ' ' VAL . 0.3 OUTLIER -127.19 101.52 6.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.791 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.122 HG23 ' HB3' ' B' ' 127' ' ' ALA . 3.4 m -94.91 170.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.392 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.914 ' HG ' HG23 ' B' ' 126' ' ' ILE . 3.6 mp -152.85 148.81 27.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.993 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.4 p -125.79 148.08 49.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.755 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.878 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 4.3 t -74.59 170.06 16.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.842 0.354 . . . . 0.0 110.953 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.87 77.14 0.41 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.026 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.15 162.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 111.448 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.721 ' HB ' HG11 ' B' ' 119' ' ' VAL . 7.5 pt -146.84 154.2 47.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.633 ' CG ' HG23 ' B' ' 43' ' ' VAL . 72.6 Cg_endo -77.23 48.85 2.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.903 2.402 . . . . 0.0 113.248 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.718 HG23 HG13 ' B' ' 34' ' ' ILE . 45.8 t . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.238 0.542 . . . . 0.0 110.545 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.633 HG23 ' CG ' ' B' ' 35' ' ' PRO . 9.8 p . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.566 0.222 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.8 Cg_exo -54.39 141.78 71.23 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.52 2.147 . . . . 0.0 112.21 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.77 -31.03 70.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.983 0.42 . . . . 0.0 110.941 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.13 93.77 1.86 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.817 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.4 tp -42.15 -33.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.714 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.49 HG12 ' HD2' ' B' ' 52' ' ' ARG . 22.1 t -78.59 -46.46 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.682 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.99 88.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.701 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.4 ' CB ' ' HD2' ' B' ' 44' ' ' PRO . 3.5 pt20 -65.11 -28.9 69.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.536 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.2 -41.11 42.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.319 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.49 ' HD2' HG12 ' B' ' 48' ' ' VAL . 24.3 mtp180 -67.69 -52.27 39.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.813 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.69 -27.92 63.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.575 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.6 OUTLIER -61.88 -42.44 99.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.602 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.613 HD13 ' CE2' ' B' ' 95' ' ' PHE . 7.5 mt -74.87 -30.03 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.019 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' B' ' 59' ' ' LYS . 32.5 mt-10 -65.51 -36.2 83.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.069 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' B' ' 54' ' ' SER . 22.2 p30 -72.37 -27.83 62.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.883 0.373 . . . . 0.0 110.59 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.841 HG21 HG21 ' B' ' 123' ' ' ILE . 35.1 t -67.7 -45.81 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -76.1 -28.3 57.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.991 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' B' ' 10' ' ' LYS . . . -60.64 -41.28 94.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.464 HG12 HG22 ' B' ' 8' ' ' THR . 15.9 mt -72.95 -41.05 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.565 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.493 ' CD1' HD11 ' B' ' 72' ' ' ILE . 18.3 mt -70.0 -33.14 54.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.663 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.45 -41.0 63.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.286 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.48 -21.76 65.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.392 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.36 -28.37 17.76 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.751 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.27 56.57 0.26 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.583 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.634 HD21 ' HB3' ' B' ' 129' ' ' ARG . 3.5 mt -172.8 144.12 1.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.355 . . . . 0.0 111.126 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -99.39 166.1 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.772 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 1.032 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -62.54 -31.0 71.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.788 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.961 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -52.49 -26.61 13.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.897 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.443 ' CB ' HD22 ' B' ' 67' ' ' LEU . 1.2 m-20 -82.13 -24.59 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.575 HG21 HG22 ' B' ' 75' ' ' THR . 96.7 mt -52.88 108.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.008 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.649 HG13 HG22 ' B' ' 128' ' ' VAL . 35.3 m -74.29 -45.23 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.841 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.589 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 5.9 mttp -125.05 163.77 21.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.289 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.607 HG23 ' CB ' ' B' ' 105' ' ' PRO . 31.8 p -157.83 102.5 1.84 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.787 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.829 HG23 ' CD ' ' B' ' 107' ' ' ARG . 0.1 OUTLIER -70.12 124.69 24.72 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.411 HG11 ' HE1' ' B' ' 85' ' ' PHE . 6.3 t -116.38 110.37 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.423 ' CE2' ' OE2' ' B' ' 124' ' ' GLU . 15.7 m-30 -107.85 119.96 40.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.989 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.613 HG12 HD21 ' B' ' 121' ' ' LEU . 0.7 OUTLIER -114.29 152.2 15.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.154 0.502 . . . . 0.0 111.752 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.9 0.94 57.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.849 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.26 108.55 0.28 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.507 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' C' ' 114' ' ' ARG . 3.0 mt -57.8 -17.26 14.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.302 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.23 -22.26 60.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.834 0.35 . . . . 0.0 110.397 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.413 ' O ' HG23 ' B' ' 88' ' ' VAL . 75.2 m-20 -86.98 -15.52 38.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.031 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.413 ' CE2' ' OD1' ' B' ' 89' ' ' ASN . 0.2 OUTLIER -57.28 -29.69 64.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.232 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.94 68.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.32 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.96 -28.85 22.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.301 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 84' ' ' ASP . 21.4 t -77.77 -41.57 28.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.295 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.413 ' OD1' ' CE2' ' B' ' 85' ' ' PHE . 0.3 OUTLIER -68.28 -36.53 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.828 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.57 -36.0 75.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.308 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.53 -32.48 18.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -61.29 -49.9 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.017 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.48 -21.6 57.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.457 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -27.27 50.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.591 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.613 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -85.68 -39.01 17.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.704 0.288 . . . . 0.0 110.765 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.52 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 4.3 m-85 -55.18 -54.5 42.54 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.136 0.493 . . . . 0.0 110.187 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -31.91 71.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.267 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.71 -4.18 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.584 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.708 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 4.1 t-20 -112.53 -5.51 14.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.547 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 5.6 m120 86.32 30.79 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.621 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 1.032 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 2.9 m170 -117.35 54.56 1.56 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.679 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 63.9 Cg_endo -72.08 -10.13 25.54 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.74 2.293 . . . . 0.0 113.359 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.486 ' HB3' HD11 ' C' ' 5' ' ' ILE . 7.7 m-20 -56.6 -40.78 75.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.914 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.71 ' HB2' HG13 ' C' ' 19' ' ' VAL . 26.8 m-85 72.21 90.52 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.969 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.607 ' CB ' HG23 ' B' ' 75' ' ' THR . 78.1 Cg_exo -49.37 162.11 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.594 2.196 . . . . 0.0 112.274 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.862 ' HB1' ' HB2' ' C' ' 31' ' ' SER . . . -125.5 131.1 52.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.505 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.829 ' CD ' HG23 ' B' ' 76' ' ' THR . 0.0 OUTLIER -163.57 -166.4 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.6 114.98 28.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.176 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 14.4 m -96.9 130.38 44.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.138 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.729 HG12 HD23 ' C' ' 115' ' ' LEU . 29.8 m -148.81 167.9 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.987 0.423 . . . . 0.0 111.982 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.817 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 30.4 tt0 -102.42 92.46 4.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.708 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.871 HG21 HD21 ' B' ' 115' ' ' LEU . 24.1 m -62.76 158.05 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -70.37 -51.41 29.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.067 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.567 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -143.19 178.5 7.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.685 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.871 HD21 HG21 ' B' ' 112' ' ' VAL . 73.3 mt -150.88 153.99 34.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.769 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 36.4 Cg_endo -65.37 137.56 51.73 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.428 2.085 . . . . 0.0 112.201 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.538 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 76.6 14.84 2.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.339 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.53 14.54 9.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.085 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.721 HG11 ' HB ' ' B' ' 34' ' ' ILE . 17.1 m -58.87 160.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.762 0.315 . . . . 0.0 110.99 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.5 21.68 21.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.682 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.613 HD21 HG12 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -178.88 154.86 0.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.077 0.465 . . . . 0.0 111.204 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.704 ' O ' HD13 ' B' ' 123' ' ' ILE . 4.3 tt0 -140.61 150.57 43.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.083 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.841 HG21 HG21 ' B' ' 58' ' ' VAL . 21.0 mm -136.85 119.55 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . 0.423 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.0 OUTLIER -138.32 115.87 11.3 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -132.12 168.68 17.56 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.914 HG23 ' HG ' ' B' ' 29' ' ' LEU . 4.0 mm -116.56 146.06 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.511 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 1.122 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -132.69 148.47 52.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.163 0.506 . . . . 0.0 111.937 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.763 HG12 ' HG ' ' B' ' 27' ' ' LEU . 30.4 m -132.09 162.78 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.945 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.634 ' HB3' HD21 ' B' ' 67' ' ' LEU . 9.9 ptt180 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.004 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.815 0.34 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.75 136.87 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.054 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.653 HG23 HG21 ' C' ' 19' ' ' VAL . 4.8 mp -58.54 158.24 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.181 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' C' ' 21' ' ' ALA . 18.9 mt -115.02 160.68 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.029 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . 0.482 ' N ' HG22 ' C' ' 6' ' ' ILE . 4.7 t-160 -160.76 124.45 3.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.964 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.475 HG22 HG12 ' C' ' 61' ' ' ILE . 8.0 t -127.7 165.47 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.78 51.29 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.401 ' HB3' ' CB ' ' C' ' 60' ' ' ALA . 0.7 OUTLIER -144.09 -49.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.704 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.916 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.43 172.3 3.98 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.916 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 32.1 Cg_endo -64.42 -11.95 30.84 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.598 2.199 . . . . 0.0 112.713 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 73.32 171.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.948 0.404 . . . . 0.0 111.365 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.772 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -166.98 122.82 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.798 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.772 HD13 ' O ' ' C' ' 14' ' ' ALA . 17.9 mm -141.47 17.53 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.377 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.47 -103.89 2.45 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.296 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.14 4.83 6.68 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.565 2.177 . . . . 0.0 112.805 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.512 ' CD1' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -160.72 177.18 10.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.897 0.38 . . . . 0.0 111.259 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.71 HG13 ' HB2' ' B' ' 104' ' ' PHE . 28.1 m -132.28 166.39 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.054 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.766 ' OE1' ' HB3' ' C' ' 11' ' ' ALA . 3.9 mm-40 -52.86 -46.55 67.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . -175.62 176.44 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.004 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.593 HG21 ' HB ' ' B' ' 73' ' ' VAL . 3.1 m -140.2 133.86 35.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.464 ' CG ' HG12 ' C' ' 28' ' ' VAL . 6.9 t0 -97.19 139.71 32.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.684 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.818 HD11 HD13 ' C' ' 29' ' ' LEU . 6.5 mt -112.92 -15.87 12.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.352 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 97.03 104.41 2.23 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.344 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 16.0 m-80 84.1 -35.77 0.06 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.769 ' HG ' HG12 ' C' ' 128' ' ' VAL . 0.3 OUTLIER -127.16 101.63 6.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.792 178.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 1.056 HG23 ' HB3' ' C' ' 127' ' ' ALA . 3.4 m -95.0 170.4 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.315 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.903 ' HG ' HG23 ' C' ' 126' ' ' ILE . 3.6 mp -152.78 148.89 27.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.962 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.4 p -125.91 148.95 49.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . 0.862 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 4.4 t -75.36 170.27 16.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.82 77.16 0.4 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.033 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.21 162.95 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.008 0.432 . . . . 0.0 111.412 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.724 HG13 HG23 ' C' ' 36' ' ' VAL . 7.5 pt -146.9 154.29 46.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.681 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.627 ' HG2' HG23 ' C' ' 43' ' ' VAL . 72.5 Cg_endo -77.21 48.81 2.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.911 2.407 . . . . 0.0 113.23 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.724 HG23 HG13 ' C' ' 34' ' ' ILE . 45.9 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 121.178 0.513 . . . . 0.0 110.469 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.627 HG23 ' HG2' ' C' ' 35' ' ' PRO . 10.0 p . . . . . 0 CA--C 1.53 0.2 0 CA-C-O 120.496 0.189 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' C' ' 35' ' ' PRO . 52.7 Cg_exo -54.46 141.82 71.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.443 2.095 . . . . 0.0 112.224 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.0 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.059 0.457 . . . . 0.0 110.994 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -73.15 93.75 1.86 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.803 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' C' ' 47' ' ' ILE . 7.4 tp -42.11 -33.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.677 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . 0.427 HG12 ' HD2' ' C' ' 52' ' ' ARG . 22.0 t -78.53 -46.41 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.705 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -61.07 -46.99 88.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.688 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -65.05 -28.8 69.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.453 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.29 -40.86 50.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.051 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.427 ' HD2' HG12 ' C' ' 48' ' ' VAL . 24.2 mtp180 -67.82 -52.22 39.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.79 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -27.98 63.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.644 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.579 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.6 OUTLIER -61.82 -42.41 98.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.621 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.609 HD13 ' CE2' ' C' ' 95' ' ' PHE . 7.5 mt -74.94 -30.0 61.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.008 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' C' ' 59' ' ' LYS . 32.6 mt-10 -65.48 -36.15 83.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -72.43 -27.82 62.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.879 HG21 HG21 ' C' ' 123' ' ' ILE . 34.5 t -67.65 -45.78 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' C' ' 56' ' ' GLU . 0.0 OUTLIER -76.13 -28.34 57.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' C' ' 10' ' ' LYS . . . -60.53 -41.17 93.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.969 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.475 HG12 HG22 ' C' ' 8' ' ' THR . 15.7 mt -73.06 -41.2 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.629 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.53 ' CD1' HD11 ' C' ' 72' ' ' ILE . 18.3 mt -69.9 -33.17 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.712 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.51 -40.96 63.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.229 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -21.83 65.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.325 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.29 -28.4 17.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.3 56.65 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.545 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.622 HD21 ' HB3' ' C' ' 129' ' ' ARG . 3.5 mt -172.86 144.16 1.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.893 0.377 . . . . 0.0 111.063 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -99.41 166.08 11.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.764 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 1.015 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -62.44 -31.08 71.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.843 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.976 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -52.4 -26.62 13.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.973 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.429 ' CB ' HD22 ' C' ' 67' ' ' LEU . 1.2 m-20 -82.47 -24.51 34.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.582 HG21 HG22 ' C' ' 75' ' ' THR . 96.6 mt -52.84 108.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.989 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.661 ' HB ' HG21 ' A' ' 22' ' ' VAL . 35.4 m -74.29 -45.26 47.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.818 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.596 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 5.8 mttp -125.09 163.68 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.662 0.268 . . . . 0.0 111.248 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.621 HG23 ' CB ' ' C' ' 105' ' ' PRO . 31.8 p -157.74 102.44 1.86 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.788 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.821 HG23 ' CD ' ' C' ' 107' ' ' ARG . 0.1 OUTLIER -70.04 124.63 24.54 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.33 110.39 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.413 ' CE2' ' OE2' ' C' ' 124' ' ' GLU . 15.8 m-30 -107.86 119.97 40.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.94 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.589 HG12 HD21 ' C' ' 121' ' ' LEU . 0.8 OUTLIER -114.3 152.18 15.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.103 0.477 . . . . 0.0 111.773 -179.224 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.89 0.85 57.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.866 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.13 108.49 0.29 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.51 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.552 HD12 ' HB3' ' A' ' 114' ' ' ARG . 3.0 mt -57.76 -17.3 14.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -73.3 -22.19 60.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.384 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.418 ' O ' HG23 ' C' ' 88' ' ' VAL . 75.3 m-20 -87.01 -15.51 38.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.021 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.415 ' CE2' ' OD1' ' C' ' 89' ' ' ASN . 0.2 OUTLIER -57.33 -29.64 64.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.218 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.98 68.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.292 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.93 -28.89 22.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.273 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.418 HG23 ' O ' ' C' ' 84' ' ' ASP . 21.4 t -77.72 -41.61 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . 0.415 ' OD1' ' CE2' ' C' ' 85' ' ' PHE . 0.3 OUTLIER -68.2 -36.6 79.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.881 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.95 75.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.274 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.51 -32.43 18.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -61.28 -49.86 75.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.084 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.5 -21.57 57.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.501 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -27.26 50.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.57 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -85.7 -39.02 17.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.703 0.287 . . . . 0.0 110.778 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.52 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 4.3 m-85 -55.12 -54.5 42.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.193 0.521 . . . . 0.0 110.231 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -31.9 71.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.264 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.73 -4.17 55.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.592 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.709 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 4.1 t-20 -112.54 -5.5 14.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.583 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 5.6 m120 86.29 30.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.631 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 1.015 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 2.9 m170 -117.25 54.58 1.51 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.626 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.419 ' O ' ' CD2' ' C' ' 104' ' ' PHE . 63.4 Cg_endo -72.1 -10.04 25.37 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.744 2.296 . . . . 0.0 113.344 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.568 ' HB3' HD11 ' A' ' 5' ' ' ILE . 7.7 m-20 -56.75 -40.73 76.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.673 ' HB2' HG13 ' A' ' 19' ' ' VAL . 26.7 m-85 72.34 90.39 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.965 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.621 ' CB ' HG23 ' C' ' 75' ' ' THR . 77.2 Cg_exo -49.31 162.1 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.569 2.179 . . . . 0.0 112.303 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.863 ' HB1' ' HB2' ' A' ' 31' ' ' SER . . . -125.51 131.07 52.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.488 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.821 ' CD ' HG23 ' C' ' 76' ' ' THR . 0.0 OUTLIER -163.52 -166.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.64 114.99 28.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.195 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 14.2 m -96.9 130.33 44.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.163 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.722 HG12 HD23 ' A' ' 115' ' ' LEU . 30.2 m -148.88 168.12 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.906 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.826 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 30.6 tt0 -102.48 92.33 4.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.902 HG21 HD21 ' C' ' 115' ' ' LEU . 24.4 m -62.52 158.01 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -70.37 -51.44 29.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.485 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.6 OUTLIER -143.18 178.51 7.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.706 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.902 HD21 HG21 ' C' ' 112' ' ' VAL . 73.3 mt -150.89 153.98 33.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.786 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.562 ' O ' HG22 ' C' ' 119' ' ' VAL . 36.4 Cg_endo -65.36 137.47 51.4 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.513 2.142 . . . . 0.0 112.184 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.546 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 76.62 14.9 2.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.307 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.52 14.52 8.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.72 HG11 ' HB ' ' C' ' 34' ' ' ILE . 17.2 m -58.84 160.86 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.323 . . . . 0.0 110.969 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.45 22.05 20.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.75 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.589 HD21 HG12 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -179.19 155.05 0.7 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.122 0.487 . . . . 0.0 111.144 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.702 ' O ' HD13 ' C' ' 123' ' ' ILE . 4.2 tt0 -140.63 150.62 43.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.036 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.879 HG21 HG21 ' C' ' 58' ' ' VAL . 20.8 mm -136.88 119.55 20.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.132 0.491 . . . . 0.0 112.286 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' C' ' 78' ' ' PHE . 0.0 OUTLIER -138.33 115.89 11.31 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -132.17 168.66 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.903 HG23 ' HG ' ' C' ' 29' ' ' LEU . 4.0 mm -116.5 146.05 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.527 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 1.056 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -132.65 148.45 52.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.186 0.517 . . . . 0.0 111.895 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.769 HG12 ' HG ' ' C' ' 27' ' ' LEU . 30.5 m -132.09 162.82 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.932 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.622 ' HB3' HD21 ' C' ' 67' ' ' LEU . 9.9 ptt180 -157.05 65.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.4 pttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.449 179.924 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.055 HG21 HG21 ' C' ' 128' ' ' VAL . 10.4 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.827 0.346 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.89 127.17 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.604 HD13 ' CG ' ' C' ' 103' ' ' ASN . 4.6 mp -56.47 153.7 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.177 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 7' ' ' HIS . 31.9 mt -109.85 157.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.459 ' N ' HG22 ' A' ' 6' ' ' ILE . 12.0 t60 -159.46 134.84 8.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.64 HG23 ' H ' ' A' ' 11' ' ' ALA . 8.9 t -147.78 160.75 42.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.93 21.01 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.042 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.508 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 3.8 mmmt -116.59 -35.91 4.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.913 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.704 ' HB2' HG12 ' A' ' 61' ' ' ILE . . . -52.7 177.79 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.343 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.675 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 17.1 Cg_exo -67.13 -8.28 21.37 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.831 2.354 . . . . 0.0 112.705 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 76.45 147.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 110.953 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.81 121.02 39.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.199 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 15' ' ' ILE . 3.1 mp -119.36 16.52 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.971 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.8 -148.87 4.85 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.307 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.73 38.75 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.869 2.379 . . . . 0.0 113.047 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.06 164.26 28.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.884 0.374 . . . . 0.0 111.05 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.588 HG21 HG23 ' A' ' 5' ' ' ILE . 25.6 m -113.32 175.4 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.963 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.542 ' NE2' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -58.51 -48.22 81.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.936 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 61' ' ' ILE . . . -175.53 178.97 1.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.632 HG11 ' O ' ' C' ' 73' ' ' VAL . 14.3 m -134.17 132.95 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.678 ' HA ' HG23 ' A' ' 28' ' ' VAL . 9.8 t70 -111.25 118.42 35.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.742 HD22 ' CG1' ' C' ' 128' ' ' VAL . 3.7 mt -94.1 -16.96 23.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.218 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.33 -99.99 0.9 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.416 ' O ' HD22 ' A' ' 27' ' ' LEU . 4.2 m120 -59.08 -29.16 67.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.193 0.52 . . . . 0.0 109.717 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.63 ' CD2' HG12 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -129.55 139.52 51.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.547 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.92 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 4.2 p -127.92 151.34 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.009 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.921 HD12 HG23 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -134.66 135.46 42.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.743 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.3 p -108.85 136.18 48.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.066 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -63.94 143.23 58.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.827 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.55 92.17 0.01 OUTLIER Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.365 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.511 ' CG ' HG22 ' A' ' 58' ' ' VAL . 32.1 mm-40 -74.55 163.75 27.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.47 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 119' ' ' VAL . 2.1 pt -146.27 160.26 43.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.672 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.564 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 17.6 Cg_exo -66.82 54.23 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.052 2.501 . . . . 0.0 113.262 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.465 HG23 HG13 ' A' ' 34' ' ' ILE . 34.4 t . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.168 0.509 . . . . 0.0 110.384 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.75 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.591 0.234 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.46 140.98 74.06 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.353 2.035 . . . . 0.0 112.118 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.29 -31.55 71.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.068 0.461 . . . . 0.0 110.901 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.48 91.47 0.57 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.781 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mm -41.1 -32.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.542 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.9 -42.66 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.29 -36.51 77.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.766 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.659 ' OE1' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -78.51 -20.66 50.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.605 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.94 -36.76 23.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.291 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -33.2 58.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.931 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.02 -26.68 59.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.696 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.838 ' O ' HG23 ' A' ' 58' ' ' VAL . 90.7 p -70.57 -35.35 73.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.908 HD13 ' CE2' ' A' ' 95' ' ' PHE . 8.7 mt -77.38 -33.6 55.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.074 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -51.59 69.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.977 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 54' ' ' SER . 10.3 p30 -59.45 -39.85 84.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 54' ' ' SER . 31.5 t -61.76 -35.76 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.851 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -31.53 43.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -62.62 -39.17 92.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.704 HG12 ' HB2' ' A' ' 11' ' ' ALA . 22.0 mt -69.47 -46.25 76.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.789 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mt -65.33 -31.44 53.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.765 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -41.36 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.401 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -63.2 -20.44 65.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.512 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.77 -21.51 20.66 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.064 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.03 53.19 0.8 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.383 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' A' ' 71' ' ' ASP . 11.8 mt -155.65 137.1 14.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.964 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 157.16 16.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.754 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -50.13 -36.76 31.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -58.47 -21.24 50.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.363 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.494 ' CB ' HD22 ' A' ' 67' ' ' LEU . 1.5 m-20 -77.88 -26.45 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.884 0.373 . . . . 0.0 110.588 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 35.5 mt -59.35 114.21 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.663 ' O ' HG11 ' B' ' 22' ' ' VAL . 3.4 m -84.39 -33.14 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.72 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.888 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 0.6 OUTLIER -139.86 152.68 46.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.693 0.283 . . . . 0.0 111.009 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.644 HG22 ' CB ' ' A' ' 125' ' ' ALA . 40.8 p -141.9 135.0 29.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 111.336 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 108' ' ' SER . 4.5 m -114.82 150.85 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.213 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 122' ' ' GLU . 20.3 t -148.87 112.94 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 111.613 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.431 ' HB3' HG11 ' A' ' 112' ' ' VAL . 5.5 m-85 -92.7 107.85 19.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.549 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.669 HG12 HD22 ' A' ' 121' ' ' LEU . 36.0 m -102.42 146.43 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.413 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.69 -3.07 58.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.031 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.85 125.89 2.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.25 -11.11 56.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.164 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.07 -20.52 52.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 110.632 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 88' ' ' VAL . 38.8 m-20 -95.24 7.01 47.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.291 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -84.24 -27.96 27.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.768 0.318 . . . . 0.0 111.124 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.88 77.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.176 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.7 -33.89 27.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 84' ' ' ASP . 26.7 t -77.97 -43.29 28.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.029 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -61.72 -33.07 73.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.027 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.35 -48.63 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.299 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.47 -29.85 59.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.186 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.597 ' OH ' HG21 ' A' ' 75' ' ' THR . 11.5 t80 -63.99 -37.51 87.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.148 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.47 -27.33 29.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.191 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -33.72 76.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.187 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.908 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -85.7 -34.63 21.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.553 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.524 ' CE1' ' CE1' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -57.8 -55.05 39.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.287 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -32.74 71.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.049 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -85.8 -0.86 56.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.407 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 2.6 m-20 -98.88 -18.38 17.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.189 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.603 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 20.2 m-20 104.89 25.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.11 0.881 . . . . 0.0 110.948 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.474 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.1 t-80 -123.95 66.67 40.46 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.05 -16.87 22.58 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.533 2.155 . . . . 0.0 112.393 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.578 ' CG ' HD13 ' B' ' 5' ' ' ILE . 0.4 OUTLIER -68.13 -35.21 77.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.793 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.569 ' O ' HG13 ' B' ' 19' ' ' VAL . 7.8 m-85 76.2 120.44 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.3 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 93.9 Cg_endo -82.41 168.87 14.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.848 2.365 . . . . 0.0 112.218 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.888 ' HB3' ' CG ' ' A' ' 74' ' ' LYS . . . -56.35 159.47 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.406 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -127.97 142.77 51.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.033 0.444 . . . . 0.0 111.528 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 76' ' ' THR . 27.9 t -150.43 66.6 0.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.453 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 11.8 m -96.75 138.76 33.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.033 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.405 HG12 HD23 ' B' ' 115' ' ' LEU . 34.6 m -145.5 139.56 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.303 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.859 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 1.0 OUTLIER -70.87 86.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.822 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.617 HG21 HD21 ' A' ' 115' ' ' LEU . 21.7 m -71.18 155.94 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.238 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.853 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -67.87 -46.82 70.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.076 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 0.0 OUTLIER -153.79 176.96 11.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.799 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.617 HD21 HG21 ' A' ' 112' ' ' VAL . 31.0 mt -147.48 155.38 45.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.814 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.542 ' O ' HG22 ' A' ' 119' ' ' VAL . 12.5 Cg_endo -55.97 136.97 77.51 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.593 2.196 . . . . 0.0 112.045 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.2 OUTLIER 74.88 13.91 3.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.244 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.98 15.95 8.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.109 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.937 HG21 HG21 ' A' ' 34' ' ' ILE . 14.1 m -55.56 146.31 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.185 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.75 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.45 -15.1 64.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.9 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.669 HD22 HG12 ' A' ' 79' ' ' VAL . 37.2 mt -151.18 147.6 27.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.085 0.469 . . . . 0.0 111.016 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.659 ' O ' HD13 ' A' ' 123' ' ' ILE . 5.3 tt0 -122.53 155.32 36.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.211 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.736 ' CG2' HG21 ' A' ' 58' ' ' VAL . 30.3 mm -130.88 133.57 62.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 0.0 111.767 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -152.42 155.88 38.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.007 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.779 ' C ' HD13 ' A' ' 126' ' ' ILE . . . -177.45 165.07 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.081 0.467 . . . . 0.0 111.833 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.921 HG23 HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -124.52 143.66 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.393 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.92 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -129.76 157.99 40.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.0 0.429 . . . . 0.0 111.775 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.012 HG21 HG21 ' B' ' 3' ' ' THR . 30.1 m -115.95 155.0 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.956 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.826 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 1.012 HG21 HG21 ' A' ' 128' ' ' VAL . 10.5 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.78 0.324 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.86 127.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.004 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.595 ' H ' HD12 ' B' ' 5' ' ' ILE . 4.6 mp -56.49 153.73 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.207 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.462 HG22 ' N ' ' B' ' 7' ' ' HIS . 31.7 mt -109.89 157.1 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.122 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.462 ' N ' HG22 ' B' ' 6' ' ' ILE . 11.9 t60 -159.48 134.78 8.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.642 HG23 ' H ' ' B' ' 11' ' ' ALA . 8.9 t -147.72 160.76 42.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.94 21.06 10.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.962 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.495 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 3.8 mmmt -116.68 -35.83 4.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 0.0 110.893 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.688 ' HB2' HG12 ' B' ' 61' ' ' ILE . . . -52.77 177.77 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.424 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.686 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 17.1 Cg_exo -67.05 -8.38 21.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.9 2.4 . . . . 0.0 112.689 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.51 147.76 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 111.002 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.81 120.93 39.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.206 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 15' ' ' ILE . 3.1 mp -119.27 16.6 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.984 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.81 -148.88 4.85 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.308 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.72 38.78 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.853 2.369 . . . . 0.0 113.063 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.07 164.34 28.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 111.05 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 104' ' ' PHE . 25.6 m -113.43 175.4 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.917 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.561 ' NE2' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -58.45 -48.3 81.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.981 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' B' ' 61' ' ' ILE . . . -175.62 178.98 1.49 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 73' ' ' VAL . 14.4 m -134.09 132.95 56.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.131 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.682 ' HA ' HG23 ' B' ' 28' ' ' VAL . 9.8 t70 -111.3 118.46 35.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.767 HD22 ' CG1' ' A' ' 128' ' ' VAL . 3.7 mt -94.07 -16.98 23.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.249 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.37 -100.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.468 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . 0.421 ' O ' HD22 ' B' ' 27' ' ' LEU . 4.2 m120 -59.05 -29.19 67.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.719 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.625 ' CD2' HG12 ' B' ' 128' ' ' VAL . 1.0 OUTLIER -129.57 139.47 51.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.564 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.916 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 4.2 p -127.99 151.39 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.964 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.944 HD12 HG23 ' B' ' 126' ' ' ILE . 0.2 OUTLIER -134.62 135.45 42.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.76 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -108.99 136.24 48.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.028 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.15 143.35 57.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.55 92.1 0.01 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.358 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.516 ' CG ' HG22 ' B' ' 58' ' ' VAL . 32.1 mm-40 -74.53 163.76 27.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.429 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.963 HG21 HG21 ' B' ' 119' ' ' VAL . 2.2 pt -146.28 160.29 42.89 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.625 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.574 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 18.0 Cg_exo -66.96 54.35 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.058 2.505 . . . . 0.0 113.205 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.481 HG23 HG13 ' B' ' 34' ' ' ILE . 34.0 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 121.167 0.508 . . . . 0.0 110.361 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.704 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.1 p . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.589 0.233 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.43 140.89 73.79 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.355 2.037 . . . . 0.0 112.183 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.18 -31.56 71.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.44 91.48 0.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.782 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mm -41.16 -32.75 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.514 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.82 -42.65 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.906 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.29 -36.55 77.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.768 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.645 ' OE1' HD12 ' B' ' 121' ' ' LEU . 0.0 OUTLIER -78.52 -20.85 49.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.614 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.8 -36.8 23.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.295 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 -33.1 58.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.01 -26.83 59.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.809 ' O ' HG23 ' B' ' 58' ' ' VAL . 90.3 p -70.53 -35.25 73.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.904 HD13 ' CE2' ' B' ' 95' ' ' PHE . 8.7 mt -77.41 -33.6 54.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -51.6 69.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' B' ' 54' ' ' SER . 10.3 p30 -59.47 -39.85 85.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.809 HG23 ' O ' ' B' ' 54' ' ' SER . 31.5 t -61.77 -35.79 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.824 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -31.53 43.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.874 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -62.62 -39.29 93.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.688 HG12 ' HB2' ' B' ' 11' ' ' ALA . 22.0 mt -69.46 -46.21 76.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.77 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.25 -31.49 54.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -41.37 60.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.327 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -63.17 -20.43 65.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.556 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.83 -21.47 20.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.049 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.02 53.16 0.81 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.363 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.498 HD22 ' CB ' ' B' ' 71' ' ' ASP . 11.8 mt -155.59 137.05 14.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.71 157.12 16.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -50.1 -36.77 30.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -58.61 -21.2 52.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.364 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.498 ' CB ' HD22 ' B' ' 67' ' ' LEU . 1.5 m-20 -77.74 -26.49 49.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 110.583 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 35.2 mt -59.39 114.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.684 ' O ' HG11 ' C' ' 22' ' ' VAL . 3.4 m -84.34 -33.13 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.745 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.883 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 0.6 OUTLIER -139.91 152.68 46.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.747 0.308 . . . . 0.0 110.953 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.648 HG22 ' CB ' ' B' ' 125' ' ' ALA . 40.7 p -141.86 135.02 29.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.997 0.427 . . . . 0.0 111.353 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.64 HG23 ' O ' ' B' ' 108' ' ' SER . 4.4 m -114.8 150.86 34.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.19 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.405 HG13 ' O ' ' B' ' 122' ' ' GLU . 20.2 t -148.83 112.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 111.637 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.448 ' HB3' HG11 ' B' ' 112' ' ' VAL . 5.6 m-85 -92.74 107.88 19.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.543 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.676 HG12 HD22 ' B' ' 121' ' ' LEU . 35.9 m -102.41 146.42 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.467 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -3.13 59.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.028 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.8 125.9 2.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.581 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.19 -11.09 56.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.202 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.06 -20.58 52.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.831 0.348 . . . . 0.0 110.615 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.7 ' O ' HG23 ' B' ' 88' ' ' VAL . 38.7 m-20 -95.25 7.0 47.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -84.25 -27.95 27.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.145 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.26 -34.92 77.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.264 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.63 -34.01 27.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 84' ' ' ASP . 26.7 t -77.95 -43.28 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.061 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -61.67 -33.19 73.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.008 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.29 -48.55 33.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.332 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.61 -29.93 59.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.615 ' HH ' HG21 ' B' ' 75' ' ' THR . 11.4 t80 -63.94 -37.63 88.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.37 -27.39 29.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.213 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -33.79 76.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.132 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.904 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.3 OUTLIER -85.7 -34.59 21.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 0.0 110.578 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.524 ' CE1' ' CE1' ' B' ' 92' ' ' TYR . 0.4 OUTLIER -57.83 -55.1 39.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.258 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -32.77 71.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.033 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -85.76 -1.0 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.381 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.547 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 2.6 m-20 -98.77 -18.42 17.99 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.192 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.594 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 20.4 m-20 104.98 25.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.117 0.885 . . . . 0.0 110.921 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.464 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.1 t-80 -124.15 66.62 42.3 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.01 -16.8 22.73 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.477 2.118 . . . . 0.0 112.393 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.647 ' CG ' HD13 ' C' ' 5' ' ' ILE . 0.4 OUTLIER -68.19 -35.11 77.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.851 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.564 ' O ' HG13 ' C' ' 19' ' ' VAL . 7.7 m-85 76.14 120.4 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.287 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.43 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 92.8 Cg_endo -82.36 168.9 14.5 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.798 2.332 . . . . 0.0 112.266 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.883 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -56.31 159.54 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.404 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -128.0 142.79 51.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.082 0.468 . . . . 0.0 111.535 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.64 ' O ' HG23 ' B' ' 76' ' ' THR . 27.8 t -150.46 66.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.426 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 11.8 m -96.78 138.78 33.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 34.6 m -145.44 139.32 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.388 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.866 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 1.0 OUTLIER -70.58 86.89 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.698 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.621 HG21 HD21 ' B' ' 115' ' ' LEU . 21.8 m -71.29 155.8 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.859 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -67.74 -46.89 70.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.439 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -153.79 176.92 11.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.621 HD21 HG21 ' B' ' 112' ' ' VAL . 30.5 mt -147.43 155.32 45.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.809 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.55 ' O ' HG22 ' B' ' 119' ' ' VAL . 12.4 Cg_endo -55.93 136.97 77.4 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.161 . . . . 0.0 112.099 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.428 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.2 OUTLIER 74.91 13.86 3.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.287 -179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 63.05 15.93 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.058 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.963 HG21 HG21 ' B' ' 34' ' ' ILE . 13.9 m -55.63 146.35 4.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.875 0.369 . . . . 0.0 111.177 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . 0.704 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.44 -15.19 64.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.868 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.676 HD22 HG12 ' B' ' 79' ' ' VAL . 37.1 mt -151.1 147.41 27.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.07 0.462 . . . . 0.0 111.045 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.656 ' O ' HD13 ' B' ' 123' ' ' ILE . 5.3 tt0 -122.52 155.28 36.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.246 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.72 ' CG2' HG21 ' B' ' 58' ' ' VAL . 30.3 mm -130.83 133.6 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.424 . . . . 0.0 111.76 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -152.5 155.87 38.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.93 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.778 ' C ' HD13 ' B' ' 126' ' ' ILE . . . -177.44 165.04 2.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 111.814 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.944 HG23 HD12 ' B' ' 29' ' ' LEU . 0.7 OUTLIER -124.53 143.67 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.367 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.916 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -129.74 158.0 40.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.999 0.428 . . . . 0.0 111.756 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.987 HG21 HG21 ' C' ' 3' ' ' THR . 30.3 m -115.91 155.03 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.982 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.854 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.987 HG21 HG21 ' B' ' 128' ' ' VAL . 10.3 m . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.794 0.33 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.84 127.13 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.013 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.647 HD13 ' CG ' ' B' ' 103' ' ' ASN . 4.6 mp -56.48 153.7 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.46 HG22 ' N ' ' C' ' 7' ' ' HIS . 31.4 mt -109.8 157.18 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.158 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . 0.46 ' N ' HG22 ' C' ' 6' ' ' ILE . 11.9 t60 -159.57 134.76 8.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.644 HG23 ' H ' ' C' ' 11' ' ' ALA . 9.0 t -147.71 160.7 42.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.9 21.05 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.041 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.463 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 3.8 mmmt -116.62 -35.99 4.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.676 ' HB2' HG12 ' C' ' 61' ' ' ILE . . . -52.76 177.85 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.313 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.668 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 17.1 Cg_exo -67.09 -8.38 21.64 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.868 2.379 . . . . 0.0 112.653 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 76.56 147.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.898 0.38 . . . . 0.0 110.967 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.77 120.94 39.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.605 HG22 ' O ' ' C' ' 15' ' ' ILE . 3.1 mp -119.36 16.63 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.84 -148.84 4.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.269 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -88.72 38.76 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.827 2.351 . . . . 0.0 113.071 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.01 164.28 28.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.823 0.344 . . . . 0.0 111.055 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.593 HG21 HG23 ' C' ' 5' ' ' ILE . 25.0 m -113.36 175.41 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.907 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.547 ' NE2' ' HB3' ' C' ' 11' ' ' ALA . 0.0 OUTLIER -58.46 -48.24 81.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.947 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' C' ' 61' ' ' ILE . . . -175.67 178.98 1.47 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.932 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.684 HG11 ' O ' ' B' ' 73' ' ' VAL . 14.2 m -134.12 132.91 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.669 ' HA ' HG23 ' C' ' 28' ' ' VAL . 9.8 t70 -111.2 118.43 35.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.723 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.777 HD22 ' CG1' ' B' ' 128' ' ' VAL . 3.7 mt -94.04 -17.02 23.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.256 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.32 -100.01 0.9 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.489 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . 0.412 ' O ' HD22 ' C' ' 27' ' ' LEU . 4.2 m120 -59.04 -29.17 67.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.223 0.535 . . . . 0.0 109.755 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.656 ' CD2' HG12 ' C' ' 128' ' ' VAL . 1.0 OUTLIER -129.59 139.55 51.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.522 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.927 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 4.2 p -127.96 151.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.951 HD12 HG23 ' C' ' 126' ' ' ILE . 0.2 OUTLIER -134.61 135.5 42.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.767 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 32.9 p -108.9 136.34 48.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.103 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -64.01 143.24 58.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.77 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.5 92.12 0.01 OUTLIER Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.325 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.512 ' CG ' HG22 ' C' ' 58' ' ' VAL . 32.1 mm-40 -74.53 163.77 27.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.036 0.446 . . . . 0.0 111.432 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.954 HG21 HG21 ' C' ' 119' ' ' VAL . 2.1 pt -146.33 160.27 42.79 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.618 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.568 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 17.9 Cg_exo -66.84 54.24 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.113 2.542 . . . . 0.0 113.184 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.477 HG23 HG13 ' C' ' 34' ' ' ILE . 34.8 t . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 110.355 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.712 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.2 p . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.572 0.225 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' C' ' 35' ' ' PRO . 53.0 Cg_exo -54.49 140.94 74.44 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.326 2.017 . . . . 0.0 112.19 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.54 71.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.49 91.5 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.78 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 mm -41.15 -32.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.471 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.88 -42.58 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.925 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.31 -36.6 77.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.704 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.65 ' OE1' HD12 ' C' ' 121' ' ' LEU . 0.0 OUTLIER -78.51 -20.74 50.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.88 -36.69 23.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.286 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.72 -33.12 58.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.935 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -74.99 -26.82 59.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.682 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.839 ' O ' HG23 ' C' ' 58' ' ' VAL . 90.8 p -70.45 -35.38 73.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.915 HD13 ' CE2' ' C' ' 95' ' ' PHE . 8.6 mt -77.32 -33.64 55.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -51.56 69.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.993 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' C' ' 54' ' ' SER . 10.3 p30 -59.5 -39.85 85.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.929 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.839 HG23 ' O ' ' C' ' 54' ' ' SER . 31.5 t -61.77 -35.81 69.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.831 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -31.63 44.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -62.5 -39.13 92.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.676 HG12 ' HB2' ' C' ' 11' ' ' ALA . 22.0 mt -69.64 -46.28 75.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -65.34 -31.42 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -41.42 60.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.368 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -63.14 -20.46 65.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.521 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.79 -21.51 20.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.002 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.04 53.14 0.81 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.373 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.488 HD22 ' CB ' ' C' ' 71' ' ' ASP . 11.8 mt -155.63 137.09 14.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 110.978 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 157.13 16.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.738 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -50.11 -36.71 30.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -58.63 -21.24 53.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.322 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.488 ' CB ' HD22 ' C' ' 67' ' ' LEU . 1.5 m-20 -77.72 -26.49 50.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.551 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 35.3 mt -59.38 114.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.632 ' O ' HG11 ' A' ' 22' ' ' VAL . 3.5 m -84.35 -33.19 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.729 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.895 ' CG ' ' HB3' ' C' ' 106' ' ' ALA . 0.6 OUTLIER -139.87 152.66 46.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.771 0.319 . . . . 0.0 110.942 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.639 HG22 ' CB ' ' C' ' 125' ' ' ALA . 40.8 p -141.9 135.0 29.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.991 0.424 . . . . 0.0 111.381 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.651 HG23 ' O ' ' C' ' 108' ' ' SER . 4.5 m -114.83 150.78 34.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.185 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.41 HG13 ' O ' ' C' ' 122' ' ' GLU . 20.1 t -148.73 112.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 0.0 111.622 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.445 ' HB3' HG11 ' C' ' 112' ' ' VAL . 5.5 m-85 -92.68 107.83 19.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.616 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.685 HG12 HD22 ' C' ' 121' ' ' LEU . 36.0 m -102.44 146.49 10.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.391 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -2.81 58.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.058 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.15 125.94 1.96 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.624 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.28 -11.05 56.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.09 -20.53 52.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.836 0.35 . . . . 0.0 110.606 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.691 ' O ' HG23 ' C' ' 88' ' ' VAL . 38.7 m-20 -95.31 7.04 47.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.263 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -84.25 -28.0 27.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.728 0.299 . . . . 0.0 111.096 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.25 -35.0 77.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.197 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.6 -33.92 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.201 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.691 HG23 ' O ' ' C' ' 84' ' ' ASP . 26.4 t -77.89 -43.3 28.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.099 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -61.66 -33.15 73.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.011 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.37 -48.45 34.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.337 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -29.83 59.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.14 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.605 ' OH ' HG21 ' C' ' 75' ' ' THR . 11.6 t80 -63.94 -37.65 88.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.071 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.42 -27.36 29.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.167 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -33.7 76.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.151 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.915 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.3 OUTLIER -85.76 -34.59 21.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 110.544 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.522 ' CE1' ' CE1' ' C' ' 92' ' ' TYR . 0.4 OUTLIER -57.81 -55.13 38.87 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.232 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -32.77 71.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.022 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -85.71 -0.98 56.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.43 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 2.6 m-20 -98.88 -18.33 17.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.179 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 20.3 m-20 104.8 25.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.869 0.868 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.468 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.1 t-80 -124.07 66.67 41.69 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.846 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.05 -16.8 22.61 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.483 2.122 . . . . 0.0 112.476 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.604 ' CG ' HD13 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -68.21 -35.14 77.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.852 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.56 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.8 m-85 76.18 120.49 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.264 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 94.2 Cg_endo -82.4 168.93 14.41 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.831 2.354 . . . . 0.0 112.206 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.895 ' HB3' ' CG ' ' C' ' 74' ' ' LYS . . . -56.42 159.6 3.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.393 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -128.1 142.79 51.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.083 0.468 . . . . 0.0 111.471 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . 0.651 ' O ' HG23 ' C' ' 76' ' ' THR . 27.7 t -150.47 66.68 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.387 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 11.7 m -96.76 138.78 33.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.068 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.412 HG12 HD23 ' A' ' 115' ' ' LEU . 34.6 m -145.54 139.53 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.372 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.853 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -70.63 87.01 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.621 HG21 HD21 ' C' ' 115' ' ' LEU . 21.6 m -71.33 156.03 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -67.97 -46.81 70.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.993 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.75 176.92 11.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.621 HD21 HG21 ' C' ' 112' ' ' VAL . 30.5 mt -147.44 155.35 45.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.539 ' O ' HG22 ' C' ' 119' ' ' VAL . 12.3 Cg_endo -56.03 137.03 77.86 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.572 2.182 . . . . 0.0 112.058 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.2 OUTLIER 74.91 13.88 3.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 20.1 t70 63.0 15.96 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.954 HG21 HG21 ' C' ' 34' ' ' ILE . 14.1 m -55.61 146.38 4.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.856 0.36 . . . . 0.0 111.217 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . 0.712 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.41 -15.12 64.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.878 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.685 HD22 HG12 ' C' ' 79' ' ' VAL . 37.0 mt -150.81 147.46 27.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.0 0.429 . . . . 0.0 111.046 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.658 ' O ' HD13 ' C' ' 123' ' ' ILE . 5.3 tt0 -122.6 155.27 36.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.249 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.724 ' CG2' HG21 ' C' ' 58' ' ' VAL . 30.2 mm -130.78 133.6 63.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.004 0.43 . . . . 0.0 111.771 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -152.47 155.87 38.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.981 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.771 ' C ' HD13 ' C' ' 126' ' ' ILE . . . -177.42 165.04 2.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.834 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.951 HG23 HD12 ' C' ' 29' ' ' LEU . 0.7 OUTLIER -124.49 143.65 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.372 179.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.927 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -129.74 157.99 40.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.962 0.41 . . . . 0.0 111.787 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 1.055 HG21 HG21 ' A' ' 3' ' ' THR . 30.7 m -115.94 154.94 17.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.005 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.7 46.99 2.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.899 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.963 -179.961 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.13 HG21 HG21 ' C' ' 128' ' ' VAL . 5.9 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.762 0.315 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -177.96 132.51 0.15 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.008 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.576 ' HA ' HG12 ' A' ' 22' ' ' VAL . 4.3 mp -57.51 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.474 ' N ' HG22 ' A' ' 5' ' ' ILE . 32.1 mt -113.55 150.64 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.203 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -147.84 134.25 19.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.83 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.516 HG21 ' HA ' ' A' ' 61' ' ' ILE . 2.7 t -148.14 163.27 37.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.93 28.67 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -110.31 -49.88 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.776 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.717 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.85 179.3 0.62 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.981 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 31.4 Cg_exo -59.08 -15.57 28.69 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.74 2.293 . . . . 0.0 112.614 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 73.78 153.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -110.37 119.94 40.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.201 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 15' ' ' ILE . 1.9 mp -132.22 16.23 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.833 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.38 -137.96 4.61 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.417 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HB2' ' CE1' ' C' ' 92' ' ' TYR . 87.1 Cg_endo -84.33 16.61 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.755 2.303 . . . . 0.0 113.641 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.559 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 1.1 p90 -137.41 177.85 7.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.454 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 10.6 m -128.82 169.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.047 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.42 HE22 ' HB3' ' A' ' 11' ' ' ALA . 13.7 mm-40 -59.54 -55.85 29.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.006 0.431 . . . . 0.0 110.458 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.99 178.04 4.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.596 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.744 HG21 ' HB ' ' C' ' 73' ' ' VAL . 5.2 m -144.58 131.51 16.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.954 0.407 . . . . 0.0 111.164 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.512 ' HA ' HG23 ' A' ' 28' ' ' VAL . 3.6 t70 -98.98 110.55 23.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.439 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.95 HD22 HG11 ' C' ' 128' ' ' VAL . 17.2 mt -73.48 -11.52 60.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.504 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.51 -102.86 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.669 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.11 -30.05 64.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.176 0.512 . . . . 0.0 109.979 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.58 167.54 18.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.55 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.061 HG12 ' HB3' ' A' ' 127' ' ' ALA . 7.1 p -129.5 160.83 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.787 HD13 HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -136.83 122.78 20.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.28 137.71 41.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.046 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.486 ' CB ' ' HB1' ' C' ' 106' ' ' ALA . 16.8 t -71.25 172.67 8.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.32 82.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.074 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.559 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -56.38 147.51 21.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 0.0 111.385 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 5.0 pt -142.3 149.75 52.66 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.576 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 34' ' ' ILE . 1.6 Cg_endo -83.17 51.09 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.921 2.414 . . . . 0.0 112.481 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.731 HG21 ' HD2' ' A' ' 117' ' ' LYS . 86.0 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.185 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 43' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.556 0.217 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 37.8 Cg_exo -59.7 147.51 91.75 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.514 2.143 . . . . 0.0 112.1 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.39 -31.0 57.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 110.943 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -67.65 95.79 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.28 -32.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.835 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 t -83.26 -43.23 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . . . -60.62 -44.11 96.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.794 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -74.27 -30.09 61.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.266 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.628 ' HB1' HG22 ' A' ' 88' ' ' VAL . . . -75.95 -33.37 59.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.369 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -30.16 29.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.12 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.21 -33.33 59.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.88 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.0 p -69.43 -35.74 76.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.573 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD22 ' HB2' ' A' ' 92' ' ' TYR . 68.5 mt -63.0 -39.71 95.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.531 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -72.22 -40.56 67.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.673 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -57.82 -41.07 81.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 54' ' ' SER . 16.4 t -60.11 -40.76 84.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.792 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.513 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -76.02 -32.41 59.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.769 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.46 86.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.516 ' HA ' HG21 ' A' ' 8' ' ' THR . 17.3 mt -68.9 -41.65 82.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.722 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.997 HD13 HD11 ' A' ' 72' ' ' ILE . 12.3 mt -69.28 -36.58 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.588 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -40.3 72.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -65.32 -19.04 65.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.539 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 6' ' ' ILE . . . -88.33 -34.17 17.73 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.73 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.48 44.84 0.3 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.812 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 129' ' ' ARG . 1.3 mt -143.0 -170.54 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.716 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.78 157.25 44.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.513 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . . . -58.12 -36.58 73.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.03 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -57.49 -26.09 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.319 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.453 ' CB ' HD22 ' A' ' 67' ' ' LEU . 9.3 m-20 -76.29 -24.48 54.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.879 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 127' ' ' ALA . 39.3 mm -54.14 118.27 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.977 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.718 ' HB ' HG21 ' B' ' 22' ' ' VAL . 5.2 m -90.85 -32.86 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.929 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.668 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 14.3 tttt -143.25 163.97 31.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.658 0.266 . . . . 0.0 111.198 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.578 HG21 ' NH2' ' A' ' 107' ' ' ARG . 3.4 t -162.15 112.52 1.56 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.376 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.414 ' HB ' ' CG ' ' A' ' 124' ' ' GLU . 27.3 m -92.87 160.17 15.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.318 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 122' ' ' GLU . 13.6 t -150.54 142.73 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.041 0.448 . . . . 0.0 111.945 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.519 ' CD2' HG11 ' C' ' 110' ' ' VAL . 3.2 m-85 -121.15 102.56 8.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.189 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.479 HG11 ' HD1' ' A' ' 85' ' ' PHE . 5.8 m -100.55 150.28 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.701 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.08 -1.86 58.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.839 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.59 124.5 1.38 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.477 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.59 HD12 ' HD3' ' B' ' 114' ' ' ARG . 9.7 mt -68.79 -10.67 58.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.196 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.97 -22.81 42.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.827 0.346 . . . . 0.0 110.574 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -88.16 -20.27 25.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.479 ' HD1' HG11 ' A' ' 79' ' ' VAL . 14.4 t80 -57.52 -22.25 43.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.358 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.49 -60.41 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.57 79.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.628 HG22 ' HB1' ' A' ' 51' ' ' ALA . 19.3 t -61.67 -37.4 77.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.915 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.589 ' HA ' ' CE2' ' A' ' 92' ' ' TYR . 36.0 t-20 -62.28 -41.94 98.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.77 -23.46 42.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.351 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.16 -42.33 19.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.77 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.601 ' HB2' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -77.34 -28.7 53.15 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.083 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.88 -33.72 39.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.966 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -72.63 -29.75 63.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.178 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -74.26 -41.65 60.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.782 0.325 . . . . 0.0 110.508 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.477 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 6.9 m-85 -52.04 -50.84 60.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.088 0.47 . . . . 0.0 110.377 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HG3' ' N ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -62.04 -28.9 69.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.135 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -90.88 2.73 55.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.42 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -119.25 -1.52 10.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 7.3 t30 85.75 28.73 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.189 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -121.52 53.63 4.02 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.617 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 45.5 Cg_endo -68.3 -20.49 42.7 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.56 2.173 . . . . 0.0 112.676 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 2.1 m-20 -60.85 -40.34 92.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.942 0.401 . . . . 0.0 110.501 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 27.6 m-85 77.36 120.98 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.833 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.547 ' HG2' HG22 ' A' ' 75' ' ' THR . 84.7 Cg_endo -83.99 162.03 13.76 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.844 2.363 . . . . 0.0 112.303 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.668 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -52.32 163.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.447 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.578 ' NH2' HG21 ' A' ' 75' ' ' THR . 13.7 ttm-85 -146.59 144.52 29.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.159 0.504 . . . . 0.0 111.876 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.14 63.31 1.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.996 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 19.8 p -79.92 134.78 36.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.278 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.61 HG12 HD23 ' B' ' 115' ' ' LEU . 33.9 m -146.25 146.62 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.193 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.6 OUTLIER -79.42 88.05 5.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 78' ' ' PHE . 5.7 m -71.75 155.4 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -71.88 -44.01 64.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.614 ' HD3' HD12 ' C' ' 82' ' ' LEU . 0.5 OUTLIER -152.1 174.71 13.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.607 HD23 HG12 ' C' ' 110' ' ' VAL . 14.0 mt -147.16 156.01 46.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.23 136.33 67.88 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.595 2.197 . . . . 0.0 112.169 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.731 ' HD2' HG21 ' A' ' 36' ' ' VAL . 3.1 ttmt 74.7 14.1 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.232 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.48 17.8 8.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 117' ' ' LYS . 23.1 m -52.1 162.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.845 0.355 . . . . 0.0 111.188 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.698 ' C ' HD13 ' A' ' 121' ' ' LEU . . . -95.42 -25.55 13.66 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.737 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.698 HD13 ' C ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -157.51 148.87 21.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.164 0.507 . . . . 0.0 111.127 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.727 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -121.43 155.98 33.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.199 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.819 HD13 ' HB2' ' A' ' 54' ' ' SER . 4.1 mp -144.06 119.99 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.071 0.462 . . . . 0.0 112.016 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.414 ' CG ' ' HB ' ' A' ' 76' ' ' THR . 0.9 OUTLIER -128.88 149.01 50.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.437 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -163.83 161.18 23.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.313 0.578 . . . . 0.0 112.455 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 28' ' ' VAL . 6.0 mt -118.0 152.44 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.058 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 1.061 ' HB3' HG12 ' A' ' 28' ' ' VAL . . . -133.3 149.9 51.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.139 0.495 . . . . 0.0 111.9 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.065 HG21 HG21 ' B' ' 3' ' ' THR . 36.0 m -122.65 139.4 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.815 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.648 ' HB2' HD21 ' A' ' 67' ' ' LEU . 32.5 ttp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 1.065 HG21 HG21 ' A' ' 128' ' ' VAL . 5.9 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.829 0.347 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -177.95 132.5 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.084 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.582 ' HA ' HG12 ' B' ' 22' ' ' VAL . 4.3 mp -57.54 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.488 ' N ' HG22 ' B' ' 5' ' ' ILE . 32.2 mt -113.53 150.57 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.222 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -147.82 134.24 19.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.566 HG21 ' HA ' ' B' ' 61' ' ' ILE . 2.7 t -148.17 163.24 37.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.85 28.67 7.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -110.26 -49.84 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.782 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.714 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -67.98 179.29 0.63 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.714 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 31.5 Cg_exo -59.01 -15.59 28.38 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.742 2.295 . . . . 0.0 112.627 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 73.77 153.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -110.38 119.93 40.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.23 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.63 HG22 ' O ' ' B' ' 15' ' ' ILE . 1.9 mp -132.2 16.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.826 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.44 -137.96 4.6 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.429 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.428 ' HB2' ' CE1' ' A' ' 92' ' ' TYR . 88.9 Cg_endo -84.32 16.52 1.92 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.75 2.3 . . . . 0.0 113.653 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.553 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 1.1 p90 -137.37 177.84 7.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.962 0.411 . . . . 0.0 111.456 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.423 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 10.5 m -128.75 169.45 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.028 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.43 HE22 ' HB3' ' B' ' 11' ' ' ALA . 13.7 mm-40 -59.76 -55.74 30.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 110.466 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.94 178.12 4.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.594 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.718 HG21 ' HB ' ' A' ' 73' ' ' VAL . 5.2 m -144.62 131.54 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.954 0.407 . . . . 0.0 111.191 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.509 ' HA ' HG23 ' B' ' 28' ' ' VAL . 3.6 t70 -98.96 110.65 23.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.405 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.967 HD22 HG11 ' A' ' 128' ' ' VAL . 17.3 mt -73.55 -11.54 60.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.503 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.58 -102.87 0.68 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.668 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.19 -29.98 64.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.146 0.498 . . . . 0.0 109.972 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.59 167.53 18.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.523 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.071 HG12 ' HB3' ' B' ' 127' ' ' ALA . 7.1 p -129.52 160.78 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.057 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.764 HD13 HD11 ' B' ' 24' ' ' LEU . 0.1 OUTLIER -136.8 122.76 20.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.736 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.24 137.82 40.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.041 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.494 ' CB ' ' HB1' ' A' ' 106' ' ' ALA . 16.6 t -71.27 172.54 9.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.96 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.21 82.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.113 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.531 ' CB ' HG22 ' B' ' 58' ' ' VAL . 0.1 OUTLIER -56.4 147.49 21.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.022 0.439 . . . . 0.0 111.352 -179.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.3 149.69 52.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.552 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.415 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 1.6 Cg_endo -83.12 51.04 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.956 2.437 . . . . 0.0 112.483 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.768 HG21 ' HD2' ' B' ' 117' ' ' LYS . 86.7 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.188 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.458 HG13 ' O ' ' B' ' 43' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.465 0.304 0 CA-C-O 120.495 0.188 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.76 147.61 91.53 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.458 2.105 . . . . 0.0 112.073 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.51 -30.99 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.438 . . . . 0.0 110.912 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' B' ' 49' ' ' ALA . 0.7 OUTLIER -67.6 95.73 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.862 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.22 -32.41 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.806 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -83.25 -43.22 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' B' ' 46' ' ' ASP . . . -60.61 -44.17 96.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.787 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.419 ' HG3' HD11 ' B' ' 121' ' ' LEU . 20.3 pt20 -74.13 -29.15 61.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.228 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.633 ' HB1' HG22 ' B' ' 88' ' ' VAL . . . -76.58 -33.46 58.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.429 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -30.23 29.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.123 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.11 -33.3 59.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.787 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.878 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.0 p -69.54 -35.66 75.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.565 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' B' ' 92' ' ' TYR . 68.4 mt -62.97 -39.78 95.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.504 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -72.11 -40.66 68.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.717 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.75 -41.12 81.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.878 HG23 ' O ' ' B' ' 54' ' ' SER . 16.5 t -60.09 -40.74 84.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.783 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -76.02 -32.53 59.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.747 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.33 -40.59 86.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.566 ' HA ' HG21 ' B' ' 8' ' ' THR . 17.3 mt -68.99 -41.56 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.753 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.988 HD13 HD11 ' B' ' 72' ' ' ILE . 12.3 mt -69.33 -36.58 72.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.536 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -40.21 72.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.229 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.33 -19.06 65.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.533 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.32 -34.16 17.75 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.748 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.49 44.82 0.3 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.769 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.633 HD21 ' HB2' ' B' ' 129' ' ' ARG . 1.3 mt -142.99 -170.47 3.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 110.702 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.79 157.28 44.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.515 ' HB2' ' HG3' ' B' ' 59' ' ' LYS . . . -58.19 -36.57 73.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.991 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.486 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -57.31 -25.8 59.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.294 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.472 ' CB ' HD22 ' B' ' 67' ' ' LEU . 9.4 m-20 -76.7 -24.37 53.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.924 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 1.027 HD13 ' HB2' ' B' ' 127' ' ' ALA . 39.4 mm -54.21 118.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.937 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.764 ' HB ' HG21 ' C' ' 22' ' ' VAL . 5.2 m -90.79 -32.87 5.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.958 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.701 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 14.3 tttt -143.28 163.98 31.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.695 0.283 . . . . 0.0 111.164 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.568 HG21 ' NH2' ' B' ' 107' ' ' ARG . 3.3 t -162.23 112.46 1.53 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.321 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.421 ' HB ' ' CG ' ' B' ' 124' ' ' GLU . 27.6 m -92.8 160.16 15.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.301 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.705 HG13 ' O ' ' B' ' 122' ' ' GLU . 13.6 t -150.52 142.74 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.098 0.475 . . . . 0.0 111.941 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.532 ' CD2' HG11 ' A' ' 110' ' ' VAL . 3.2 m-85 -121.11 102.58 8.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.181 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.475 HG11 ' HD1' ' B' ' 85' ' ' PHE . 5.7 m -100.58 150.33 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.069 0.461 . . . . 0.0 111.671 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.08 -2.11 58.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.846 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.16 124.33 1.48 Allowed 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.509 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.618 HD12 ' HD3' ' C' ' 114' ' ' ARG . 9.7 mt -68.86 -10.69 58.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.165 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.95 -22.76 42.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.799 0.333 . . . . 0.0 110.578 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -88.22 -20.24 25.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.475 ' HD1' HG11 ' B' ' 79' ' ' VAL . 14.3 t80 -57.53 -22.33 43.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.32 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.34 -60.46 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 0.0 111.267 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.56 79.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.633 HG22 ' HB1' ' B' ' 51' ' ' ALA . 19.1 t -61.64 -37.46 78.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.894 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.595 ' HA ' ' CE2' ' B' ' 92' ' ' TYR . 36.0 t-20 -62.25 -41.99 98.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.799 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.79 -23.5 42.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.34 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.04 -42.32 19.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.817 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.595 ' CE2' ' HA ' ' B' ' 89' ' ' ASN . 0.3 OUTLIER -77.35 -28.71 53.12 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.094 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.92 -33.66 39.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -72.62 -29.79 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.14 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -74.23 -41.69 60.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.736 0.303 . . . . 0.0 110.473 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 6.9 m-85 -52.08 -50.78 60.91 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.071 0.462 . . . . 0.0 110.372 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' B' ' 98' ' ' GLU . 0.4 OUTLIER -62.12 -28.85 69.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.116 179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 0.4 OUTLIER -90.93 2.76 55.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.433 178.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.1 OUTLIER -119.22 -1.58 10.82 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 7.3 t30 85.76 28.61 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.244 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 0.8 OUTLIER -121.36 53.65 3.87 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.593 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 45.7 Cg_endo -68.32 -20.44 42.6 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.617 2.211 . . . . 0.0 112.694 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 2.1 m-20 -60.92 -40.31 92.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 0.0 110.492 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 27.6 m-85 77.28 121.03 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.825 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.525 ' HG2' HG22 ' B' ' 75' ' ' THR . 84.2 Cg_endo -83.98 162.06 13.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.83 2.354 . . . . 0.0 112.303 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.701 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -52.46 163.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.445 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.568 ' NH2' HG21 ' B' ' 75' ' ' THR . 13.6 ttm-85 -146.57 144.58 29.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.163 0.506 . . . . 0.0 111.836 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.14 63.11 1.49 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.966 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 20.1 p -79.7 134.8 36.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.37 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.611 HG12 HD23 ' C' ' 115' ' ' LEU . 33.9 m -146.43 147.1 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.236 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.6 OUTLIER -79.92 88.07 5.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' B' ' 78' ' ' PHE . 5.7 m -71.78 155.47 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.145 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -71.91 -44.01 64.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.59 ' HD3' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -152.13 174.71 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.925 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.61 HD23 HG12 ' A' ' 110' ' ' VAL . 14.0 mt -147.15 156.04 46.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.38 136.36 67.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.608 2.205 . . . . 0.0 112.135 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.768 ' HD2' HG21 ' B' ' 36' ' ' VAL . 3.1 ttmt 74.64 14.13 3.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.293 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.52 17.76 8.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.961 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 m -52.16 162.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.216 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . 0.715 ' C ' HD13 ' B' ' 121' ' ' LEU . . . -95.24 -25.06 14.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.697 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.715 HD13 ' C ' ' B' ' 120' ' ' GLY . 0.0 OUTLIER -158.2 149.06 20.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.109 0.48 . . . . 0.0 111.099 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.705 ' O ' HG13 ' B' ' 77' ' ' VAL . 0.4 OUTLIER -121.39 156.01 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.188 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' B' ' 54' ' ' SER . 4.1 mp -144.07 119.97 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.097 0.475 . . . . 0.0 111.994 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . 0.421 ' CG ' ' HB ' ' B' ' 76' ' ' THR . 1.0 OUTLIER -128.88 148.97 50.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.434 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -163.78 161.22 23.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.297 0.57 . . . . 0.0 112.449 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.419 HG23 ' O ' ' B' ' 28' ' ' VAL . 5.9 mt -118.01 152.43 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.044 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 1.071 ' HB3' HG12 ' B' ' 28' ' ' VAL . . . -133.23 149.98 51.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.129 0.49 . . . . 0.0 111.96 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 1.044 HG21 HG21 ' C' ' 3' ' ' THR . 35.9 m -122.62 139.4 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.861 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.633 ' HB2' HD21 ' B' ' 67' ' ' LEU . 32.5 ttp180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 111.022 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 1.044 HG21 HG21 ' B' ' 128' ' ' VAL . 5.9 m . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.826 0.346 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -178.02 132.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.057 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.591 ' HA ' HG12 ' C' ' 22' ' ' VAL . 4.3 mp -57.54 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.485 ' N ' HG22 ' C' ' 5' ' ' ILE . 32.3 mt -113.49 150.54 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.243 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -147.75 134.26 19.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.588 HG21 ' HA ' ' C' ' 61' ' ' ILE . 2.7 t -148.15 163.28 37.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.94 28.63 8.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.439 ' CB ' ' HB1' ' C' ' 60' ' ' ALA . 26.6 mmtt -110.2 -49.69 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.752 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -68.1 179.27 0.65 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.984 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 31.7 Cg_exo -59.08 -15.58 28.74 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.755 2.303 . . . . 0.0 112.645 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 73.79 154.0 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.056 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -110.38 119.96 40.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.228 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.611 HG22 ' O ' ' C' ' 15' ' ' ILE . 1.9 mp -132.29 16.23 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.764 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 -137.97 4.61 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.429 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . 0.441 ' HB2' ' CE1' ' B' ' 92' ' ' TYR . 88.4 Cg_endo -84.32 16.58 1.9 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.692 2.261 . . . . 0.0 113.657 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.553 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 1.1 p90 -137.36 177.88 7.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.975 0.416 . . . . 0.0 111.435 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.418 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 10.6 m -128.78 169.41 20.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.419 HE22 ' HB3' ' C' ' 11' ' ' ALA . 13.7 mm-40 -59.63 -55.51 33.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.457 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.61 178.2 4.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.537 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.764 HG21 ' HB ' ' B' ' 73' ' ' VAL . 5.2 m -144.53 131.5 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.888 0.375 . . . . 0.0 111.179 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.492 ' HA ' HG23 ' C' ' 28' ' ' VAL . 3.6 t70 -99.0 110.63 23.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.447 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.932 HD22 HG11 ' B' ' 128' ' ' VAL . 17.2 mt -73.57 -11.48 60.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.51 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.53 -102.89 0.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.627 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.12 -30.06 64.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.173 0.511 . . . . 0.0 109.975 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.53 167.48 18.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 1.021 HG12 ' HB3' ' C' ' 127' ' ' ALA . 7.1 p -129.5 160.77 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.1 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.776 HD13 HD11 ' C' ' 24' ' ' LEU . 0.1 OUTLIER -136.74 122.79 20.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.741 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.25 137.71 41.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.958 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . 0.522 ' CB ' ' HB1' ' B' ' 106' ' ' ALA . 16.6 t -71.76 172.78 9.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.034 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.33 82.74 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.11 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.573 ' CB ' HG22 ' C' ' 58' ' ' VAL . 0.0 OUTLIER -56.36 147.48 21.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.039 0.447 . . . . 0.0 111.34 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 5.0 pt -142.3 149.73 52.58 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.554 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 1.6 Cg_endo -83.2 51.08 3.5 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.938 2.425 . . . . 0.0 112.469 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.777 HG21 ' HD2' ' C' ' 117' ' ' LYS . 87.2 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.157 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.462 ' O ' HG13 ' C' ' 43' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 120.539 0.209 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' C' ' 35' ' ' PRO . 37.8 Cg_exo -59.74 147.62 91.44 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.478 2.119 . . . . 0.0 112.088 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.45 -31.03 57.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.439 . . . . 0.0 110.91 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' C' ' 49' ' ' ALA . 0.7 OUTLIER -67.64 95.69 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.873 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.27 -32.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.826 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -83.24 -43.26 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' C' ' 46' ' ' ASP . . . -60.57 -44.17 96.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.781 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -74.14 -29.65 61.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.319 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.588 ' HB1' HG22 ' C' ' 88' ' ' VAL . . . -76.18 -33.47 59.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.327 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -30.21 29.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.135 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.11 -33.32 59.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.857 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.0 p -69.45 -35.76 75.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.575 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.568 HD22 ' HB2' ' C' ' 92' ' ' TYR . 68.5 mt -62.94 -39.81 95.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.495 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -72.12 -40.65 67.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.703 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.73 -41.14 81.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.843 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.857 HG23 ' O ' ' C' ' 54' ' ' SER . 16.5 t -60.04 -40.78 84.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.529 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -76.02 -32.51 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.713 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.439 ' HB1' ' CB ' ' C' ' 10' ' ' LYS . . . -59.44 -40.57 87.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.588 ' HA ' HG21 ' C' ' 8' ' ' THR . 17.4 mt -68.67 -41.58 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.72 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 1.04 HD13 HD11 ' C' ' 72' ' ' ILE . 12.2 mt -69.27 -36.59 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.628 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -40.27 72.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.294 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.26 -19.16 65.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.526 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . 0.428 ' HB2' HD13 ' C' ' 6' ' ' ILE . . . -88.29 -34.13 17.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.734 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.44 44.88 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.788 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' C' ' 129' ' ' ARG . 1.3 mt -143.02 -170.55 3.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.728 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.74 157.28 44.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.529 ' HB2' ' HG3' ' C' ' 59' ' ' LYS . . . -58.1 -36.56 73.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -57.51 -25.87 60.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.258 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.468 ' CB ' HD22 ' C' ' 67' ' ' LEU . 9.5 m-20 -76.35 -24.45 54.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.996 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 1.04 HD11 HD13 ' C' ' 62' ' ' ILE . 39.4 mm -54.15 118.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.744 ' HB ' HG21 ' A' ' 22' ' ' VAL . 5.1 m -90.83 -32.87 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.908 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 14.3 tttt -143.23 163.98 31.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.662 0.268 . . . . 0.0 111.188 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.576 HG21 ' NH2' ' C' ' 107' ' ' ARG . 3.4 t -162.16 112.46 1.55 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.418 ' HB ' ' CG ' ' C' ' 124' ' ' GLU . 27.3 m -92.8 160.17 15.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.305 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.723 HG13 ' O ' ' C' ' 122' ' ' GLU . 13.6 t -150.52 142.76 17.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.102 0.477 . . . . 0.0 111.918 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.557 ' CD2' HG11 ' B' ' 110' ' ' VAL . 3.2 m-85 -121.09 102.49 8.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.206 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.473 HG11 ' HD1' ' C' ' 85' ' ' PHE . 5.7 m -100.57 150.26 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.008 0.433 . . . . 0.0 111.715 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.05 -1.7 58.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.893 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.92 124.59 1.29 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.458 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.614 HD12 ' HD3' ' A' ' 114' ' ' ARG . 9.7 mt -68.76 -10.78 58.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.148 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.88 -22.83 42.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.796 0.332 . . . . 0.0 110.598 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -88.18 -20.3 25.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.473 ' HD1' HG11 ' C' ' 79' ' ' VAL . 14.3 t80 -57.54 -22.26 43.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.322 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.4 -60.47 3.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 111.28 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.69 -48.59 79.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.588 HG22 ' HB1' ' C' ' 51' ' ' ALA . 19.4 t -61.7 -37.4 77.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.944 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . 0.593 ' HA ' ' CE2' ' C' ' 92' ' ' TYR . 36.0 t-20 -62.32 -41.91 98.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.774 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.76 -23.33 42.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.347 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 1.2 tp10 -82.31 -42.34 18.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.778 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.593 ' CE2' ' HA ' ' C' ' 89' ' ' ASN . 0.3 OUTLIER -77.41 -28.68 52.72 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.071 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.92 -33.78 39.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 16.5 ptp180 -72.48 -29.85 64.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.198 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.478 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -74.18 -41.71 61.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.478 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 7.0 m-85 -52.08 -50.8 60.87 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.358 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -28.88 69.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.145 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.89 2.76 55.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.437 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.1 OUTLIER -119.22 -1.63 10.81 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 7.3 t30 85.84 28.69 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.172 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.474 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 0.8 OUTLIER -121.34 53.63 3.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.627 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 45.9 Cg_endo -68.37 -20.39 42.35 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 112.675 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 2.2 m-20 -61.01 -40.17 92.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.882 0.372 . . . . 0.0 110.482 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 27.6 m-85 77.21 121.02 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.805 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.551 ' HG2' HG22 ' C' ' 75' ' ' THR . 85.0 Cg_endo -83.99 161.98 13.74 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.854 2.369 . . . . 0.0 112.288 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -52.28 163.61 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.434 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.576 ' NH2' HG21 ' C' ' 75' ' ' THR . 13.6 ttm-85 -146.62 144.5 29.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.199 0.524 . . . . 0.0 111.898 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.11 63.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.988 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 20.0 p -79.91 134.75 36.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.339 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.607 HG12 HD23 ' A' ' 115' ' ' LEU . 33.9 m -146.07 145.89 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -78.96 88.2 4.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.761 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' C' ' 78' ' ' PHE . 5.8 m -71.84 155.45 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.129 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -71.9 -44.01 64.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.618 ' HD3' HD12 ' B' ' 82' ' ' LEU . 0.5 OUTLIER -152.13 174.69 13.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.874 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.611 HD23 HG12 ' B' ' 110' ' ' VAL . 13.9 mt -147.13 155.99 46.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.942 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.21 136.38 68.22 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.621 2.214 . . . . 0.0 112.156 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.777 ' HD2' HG21 ' C' ' 36' ' ' VAL . 3.1 ttmt 74.59 14.13 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.309 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.54 17.75 8.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.41 HG13 ' HB3' ' C' ' 117' ' ' LYS . 23.2 m -52.15 162.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . 0.703 ' C ' HD13 ' C' ' 121' ' ' LEU . . . -95.48 -25.36 13.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.726 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.703 HD13 ' C ' ' C' ' 120' ' ' GLY . 0.0 OUTLIER -157.81 148.96 21.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.146 0.498 . . . . 0.0 111.191 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.723 ' O ' HG13 ' C' ' 77' ' ' VAL . 0.4 OUTLIER -121.42 156.03 33.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.187 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.8 HD13 ' HB2' ' C' ' 54' ' ' SER . 4.1 mp -144.05 120.05 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.062 0.458 . . . . 0.0 112.056 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . 0.418 ' CG ' ' HB ' ' C' ' 76' ' ' THR . 1.0 OUTLIER -128.97 148.93 50.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.429 178.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -163.8 161.2 23.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.28 0.562 . . . . 0.0 112.429 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.414 HG23 ' O ' ' C' ' 28' ' ' VAL . 5.9 mt -118.03 152.36 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.053 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 1.021 ' HB3' HG12 ' C' ' 28' ' ' VAL . . . -133.25 150.01 51.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.093 0.473 . . . . 0.0 111.946 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 1.13 HG21 HG21 ' A' ' 3' ' ' THR . 35.2 m -122.69 139.39 49.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.803 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.618 ' HB2' HD21 ' C' ' 67' ' ' LEU . 32.6 ttp180 -135.51 52.48 2.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.987 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.031 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.509 ' CG2' HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.827 0.346 . . . . 0.0 110.924 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.57 122.74 7.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.486 HD13 HG12 ' A' ' 22' ' ' VAL . 39.2 mm -55.67 144.39 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.543 HD12 ' CB ' ' A' ' 21' ' ' ALA . 32.8 mt -109.49 143.51 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -146.99 141.8 26.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.1 159.34 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.1 28.54 4.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.007 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -122.39 -44.16 2.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.778 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.869 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.22 171.64 4.59 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.114 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.869 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 30.4 Cg_endo -63.86 -12.68 33.0 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.538 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 69.82 147.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.009 0.433 . . . . 0.0 111.336 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.801 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -106.15 123.23 47.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.011 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.801 HD13 ' O ' ' A' ' 14' ' ' ALA . 17.6 mm -131.9 16.96 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.861 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.24 -128.05 3.19 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.385 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -90.02 24.61 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.782 2.322 . . . . 0.0 113.484 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.734 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -152.1 174.53 13.58 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.752 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG13 ' HB2' ' C' ' 104' ' ' PHE . 15.8 m -123.12 173.24 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.826 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.466 HE21 ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -59.62 -40.41 87.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.399 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . 175.62 175.22 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.803 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' C' ' 73' ' ' VAL . 1.8 m -140.22 134.87 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.35 108.86 15.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.597 HD21 HG11 ' C' ' 73' ' ' VAL . 4.1 mm? -84.18 -16.93 41.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.0 -105.75 0.86 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.993 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -53.83 -30.13 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.066 0.46 . . . . 0.0 110.298 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.9 132.8 52.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.843 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.074 HG13 ' HB3' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -131.3 151.99 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.659 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.769 HD23 HD12 ' A' ' 126' ' ' ILE . 0.5 OUTLIER -144.15 140.01 29.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.809 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.3 p -106.28 142.44 35.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.6 p -69.67 155.89 39.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.142 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.02 94.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.518 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.665 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.5 mp0 -78.23 156.22 29.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.992 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.744 ' HB ' HG11 ' A' ' 119' ' ' VAL . 7.0 pt -136.02 146.65 57.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.982 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 53.3 Cg_endo -69.36 61.56 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.863 2.375 . . . . 0.0 112.729 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.568 HG23 HG13 ' A' ' 34' ' ' ILE . 59.7 t . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.085 0.469 . . . . 0.0 110.584 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG21 ' H ' ' A' ' 120' ' ' GLY . 11.3 p . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.52 0.2 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.65 140.48 51.72 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.272 1.982 . . . . 0.0 112.055 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.12 -30.96 60.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.121 0.486 . . . . 0.0 111.077 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -67.02 95.68 0.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.64 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 47' ' ' ILE . 6.4 tp -45.05 -30.54 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.307 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.77 -38.68 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.485 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 46' ' ' ASP . . . -60.98 -53.94 51.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.307 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.568 ' HG3' HD21 ' A' ' 121' ' ' LEU . 17.8 pt20 -62.81 -29.43 70.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.104 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.67 ' HB1' HG13 ' A' ' 88' ' ' VAL . . . -71.18 -35.01 71.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.893 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -80.79 -41.23 23.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.808 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -40.54 96.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 58' ' ' VAL . 13.1 p -64.29 -29.92 70.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.761 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.89 HD21 ' CD2' ' A' ' 92' ' ' TYR . 8.8 mt -82.04 -18.84 41.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.807 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.49 -49.04 9.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.453 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.443 ' OD1' HG23 ' A' ' 58' ' ' VAL . 24.4 p30 -62.79 -33.18 74.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.278 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.738 HG21 ' CG2' ' A' ' 123' ' ' ILE . 92.3 t -73.16 -40.84 58.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.508 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.535 ' HA ' HD12 ' A' ' 62' ' ' ILE . 8.4 tttm -73.05 -33.38 65.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.581 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.44 91.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.76 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.2 mt -68.6 -41.78 83.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.647 HG21 HD11 ' A' ' 72' ' ' ILE . 12.8 mt -67.37 -38.83 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.696 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.8 -37.43 67.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.292 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.59 -20.2 66.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.514 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.15 19.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.985 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.15 47.89 0.79 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.429 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 129' ' ' ARG . 26.3 mt -149.05 136.09 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -87.91 163.25 16.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.161 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.716 ' HA ' HD13 ' A' ' 72' ' ' ILE . . . -54.71 -30.24 55.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.119 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.569 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -67.93 -22.16 65.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.249 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.04 -30.8 69.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 110.213 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.716 HD13 ' HA ' ' A' ' 69' ' ' ALA . 4.0 mp -67.21 108.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.623 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.636 ' HB ' HG21 ' B' ' 22' ' ' VAL . 6.6 m -78.88 -32.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.828 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.675 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 49.7 tttt -131.85 156.61 45.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.769 0.319 . . . . 0.0 110.918 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 125' ' ' ALA . 1.3 m -146.8 117.4 7.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.327 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 108' ' ' SER . 86.6 m -105.34 144.89 31.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.208 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.655 HG13 HD13 ' A' ' 123' ' ' ILE . 38.8 t -151.57 121.21 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 0.0 111.666 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.55 ' HB2' HD21 ' A' ' 115' ' ' LEU . 6.6 m-85 -95.85 118.88 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.274 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.607 HG11 ' CD1' ' A' ' 85' ' ' PHE . 13.5 m -110.54 151.98 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.187 0.518 . . . . 0.0 111.757 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -6.6 31.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.785 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.48 94.18 2.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.364 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 82' ' ' LEU . 4.8 mt -63.61 -13.93 46.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.271 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.3 -27.94 53.12 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.84 -17.5 25.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.503 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.607 ' CD1' HG11 ' A' ' 79' ' ' VAL . 22.4 t80 -57.95 -24.53 58.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.93 -41.96 35.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.841 0.353 . . . . 0.0 111.378 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.2 -33.57 20.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.702 HG12 ' HE1' ' A' ' 92' ' ' TYR . 28.8 t -65.8 -54.52 26.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.665 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 17.1 t-20 -56.62 -43.95 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.972 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.96 70.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.786 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -34.91 77.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.89 ' CD2' HD21 ' A' ' 55' ' ' LEU . 53.3 m-85 -67.36 -45.9 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 0.0 110.156 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -25.36 66.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.335 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -77.0 -38.2 53.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.231 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -37.94 24.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.851 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 7.5 m-85 -53.36 -52.02 60.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.168 0.508 . . . . 0.0 110.225 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -30.33 70.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.318 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.66 3.22 53.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.642 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.504 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -116.34 -6.25 11.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.877 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER 89.13 26.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.303 0.573 . . . . 0.0 110.505 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.569 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 12.9 t-160 -118.87 54.52 2.3 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.532 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.68 -18.64 32.57 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.702 2.268 . . . . 0.0 112.862 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.416 ' O ' ' CG1' ' B' ' 19' ' ' VAL . 1.9 m-20 -57.78 -39.26 77.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.85 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' B' ' 19' ' ' VAL . 8.1 m-85 81.07 123.36 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.427 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' A' ' 101' ' ' HIS . 97.1 Cg_endo -86.74 162.41 9.2 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.748 2.298 . . . . 0.0 112.707 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.675 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -56.45 140.74 44.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.533 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.443 ' HB2' ' HB3' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -102.07 138.45 39.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.032 0.444 . . . . 0.0 111.553 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.885 ' O ' HG23 ' A' ' 76' ' ' THR . 12.0 t -148.17 55.14 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.1 m -103.0 151.34 22.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.193 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.551 HG11 ' CD2' ' B' ' 78' ' ' PHE . 29.4 m -156.89 160.53 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 5.9 tt0 -86.98 94.21 9.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.87 171.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.216 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -84.41 -50.01 8.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.991 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.402 ' HB3' ' CB ' ' C' ' 111' ' ' GLU . 0.1 OUTLIER -146.13 171.36 15.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.731 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 122' ' ' GLU . 3.2 mt -143.49 160.05 52.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.575 ' O ' HG22 ' A' ' 119' ' ' VAL . 68.2 Cg_exo -50.83 135.93 42.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.506 2.137 . . . . 0.0 112.159 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.28 15.96 8.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.159 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 62.78 16.6 9.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.744 HG11 ' HB ' ' A' ' 34' ' ' ILE . 15.6 m -53.13 170.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.832 0.349 . . . . 0.0 111.147 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.543 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -101.9 -2.93 52.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.964 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.568 HD21 ' HG3' ' A' ' 50' ' ' GLN . 4.2 pp -175.92 148.49 0.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.899 0.381 . . . . 0.0 111.286 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -119.93 163.63 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.302 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.738 ' CG2' HG21 ' A' ' 58' ' ' VAL . 15.6 mm -139.75 129.93 30.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 111.862 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.86 119.04 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.082 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.529 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -133.88 161.95 33.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.03 0.443 . . . . 0.0 111.852 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.769 HD12 HD23 ' A' ' 29' ' ' LEU . 5.8 mm -111.93 150.65 14.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.474 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 1.074 ' HB3' HG13 ' A' ' 28' ' ' VAL . . . -127.43 157.86 38.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.038 0.447 . . . . 0.0 111.783 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 73' ' ' VAL . 34.6 m -130.04 116.25 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.891 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.728 ' HB2' HD21 ' A' ' 67' ' ' LEU . 75.6 ttt-85 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.524 ' CG2' HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.821 0.343 . . . . 0.0 110.974 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.53 122.69 7.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.515 HD13 HG12 ' B' ' 22' ' ' VAL . 39.2 mm -55.56 144.39 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.217 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.491 HD12 ' CB ' ' B' ' 21' ' ' ALA . 32.0 mt -109.44 143.41 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.156 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -146.98 141.76 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.09 159.35 43.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.16 28.48 4.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.977 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.18 -44.09 2.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.865 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -67.34 171.73 4.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.931 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.865 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 30.7 Cg_endo -63.81 -12.71 33.03 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.544 2.162 . . . . 0.0 112.612 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 69.82 147.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.378 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.792 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -106.14 123.19 47.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.792 HD13 ' O ' ' B' ' 14' ' ' ALA . 17.6 mm -131.92 17.01 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.834 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.25 -128.06 3.19 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.441 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.99 24.59 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.769 2.312 . . . . 0.0 113.494 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.725 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.7 OUTLIER -152.08 174.48 13.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.038 0.447 . . . . 0.0 111.758 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 104' ' ' PHE . 15.8 m -123.14 173.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.458 HE21 ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -59.48 -40.37 86.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.016 0.436 . . . . 0.0 110.505 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.491 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . 174.86 175.35 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.854 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.636 HG21 ' HB ' ' A' ' 73' ' ' VAL . 1.9 m -140.32 134.84 35.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.37 108.87 15.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.621 HD21 HG11 ' A' ' 73' ' ' VAL . 4.1 mm? -84.31 -16.86 41.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.01 -105.75 0.86 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -53.84 -30.16 44.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.076 0.465 . . . . 0.0 110.288 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.86 132.87 52.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.812 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.051 HG13 ' HB3' ' B' ' 127' ' ' ALA . 0.1 OUTLIER -131.37 151.97 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.66 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.782 HD23 HD12 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -144.2 139.98 29.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.812 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.3 p -106.09 141.36 37.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.425 ' HA ' ' HB1' ' A' ' 106' ' ' ALA . 79.1 p -69.3 156.1 39.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.087 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.97 94.05 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.521 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.658 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.5 mp0 -78.15 156.2 30.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 110.999 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.737 ' HB ' HG11 ' B' ' 119' ' ' VAL . 7.0 pt -136.06 146.64 57.4 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.981 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 53.5 Cg_endo -69.31 61.49 1.49 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.868 2.379 . . . . 0.0 112.733 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.591 HG23 HG13 ' B' ' 34' ' ' ILE . 60.0 t . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.105 0.478 . . . . 0.0 110.612 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.53 HG21 ' H ' ' B' ' 120' ' ' GLY . 11.3 p . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.507 0.194 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.61 140.46 51.85 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.294 1.996 . . . . 0.0 112.077 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.2 -30.9 60.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 111.046 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' B' ' 49' ' ' ALA . 0.2 OUTLIER -66.98 95.59 0.39 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.732 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.425 ' HA ' HD12 ' B' ' 47' ' ' ILE . 6.3 tp -45.06 -30.48 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.305 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.85 -38.68 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.452 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' B' ' 46' ' ' ASP . . . -60.88 -54.09 49.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.313 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.546 ' HG3' HD21 ' B' ' 121' ' ' LEU . 17.9 pt20 -62.66 -29.55 70.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.072 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.686 ' HB1' HG13 ' B' ' 88' ' ' VAL . . . -71.07 -34.94 71.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.802 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -80.83 -41.23 23.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.786 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -40.53 96.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.689 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.583 ' O ' HG23 ' B' ' 58' ' ' VAL . 13.0 p -64.24 -30.0 71.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.759 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.902 HD21 ' CD2' ' B' ' 92' ' ' TYR . 8.8 mt -82.05 -18.76 42.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.51 -49.1 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.409 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.432 ' OD1' HG23 ' B' ' 58' ' ' VAL . 24.8 p30 -62.66 -33.27 74.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.289 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.747 HG21 ' CG2' ' B' ' 123' ' ' ILE . 91.2 t -73.07 -40.87 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.967 0.413 . . . . 0.0 110.535 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.533 ' HA ' HD12 ' B' ' 62' ' ' ILE . 8.4 tttm -73.11 -33.31 65.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.573 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.43 91.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.71 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -68.61 -41.75 83.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.698 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.656 HG21 HD11 ' B' ' 72' ' ' ILE . 13.0 mt -67.36 -38.86 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.81 -37.45 67.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.281 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.53 -20.13 66.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.563 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.01 -25.1 18.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.971 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.14 47.87 0.8 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.733 HD21 ' HB2' ' B' ' 129' ' ' ARG . 26.4 mt -149.06 136.2 19.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.365 . . . . 0.0 110.813 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -88.05 163.27 16.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.151 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.719 ' HA ' HD13 ' B' ' 72' ' ' ILE . . . -54.73 -30.29 55.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.069 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.557 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -67.84 -22.12 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.285 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.21 -30.75 68.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 110.228 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.719 HD13 ' HA ' ' B' ' 69' ' ' ALA . 4.0 mp -67.23 108.58 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.705 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.624 HG13 HG22 ' B' ' 128' ' ' VAL . 6.5 m -78.94 -31.96 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.834 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.649 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 49.7 tttt -131.91 156.6 45.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.735 0.302 . . . . 0.0 110.96 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.541 HG23 ' HB2' ' B' ' 125' ' ' ALA . 1.3 m -146.81 117.4 7.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.309 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.873 HG23 ' O ' ' B' ' 108' ' ' SER . 86.7 m -105.38 144.88 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.235 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.63 HG13 HD13 ' B' ' 123' ' ' ILE . 38.8 t -151.5 121.22 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.946 0.403 . . . . 0.0 111.735 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.551 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.5 m-85 -95.84 118.84 33.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.25 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.614 HG11 ' CD1' ' B' ' 85' ' ' PHE . 13.5 m -110.52 152.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 0.0 111.78 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -6.58 31.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.715 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -149.66 94.25 2.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.347 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' B' ' 82' ' ' LEU . 4.7 mt -63.57 -13.97 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.31 -27.9 53.1 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.79 -17.55 25.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.519 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' B' ' 79' ' ' VAL . 22.2 t80 -57.96 -24.43 57.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.222 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.03 -41.96 36.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.799 0.333 . . . . 0.0 111.354 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.17 -33.52 20.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.696 HG12 ' HE1' ' B' ' 92' ' ' TYR . 28.4 t -65.84 -54.59 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.41 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 17.1 t-20 -56.62 -43.91 80.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.998 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.96 70.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.729 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -34.9 77.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.902 ' CD2' HD21 ' B' ' 55' ' ' LEU . 52.9 m-85 -67.38 -45.92 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.147 0.499 . . . . 0.0 110.119 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -25.41 66.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.403 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -76.96 -38.25 53.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.228 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.1 OUTLIER -82.56 -37.99 24.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.812 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' B' ' 92' ' ' TYR . 7.5 m-85 -53.32 -52.03 60.46 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.185 0.517 . . . . 0.0 110.265 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -30.27 70.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.337 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.58 3.19 53.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.488 ' O ' ' ND2' ' B' ' 100' ' ' ASN . 0.6 OUTLIER -116.39 -6.17 11.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.871 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 99' ' ' ASN . 0.0 OUTLIER 89.08 25.82 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.326 0.584 . . . . 0.0 110.495 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.557 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 12.8 t-160 -118.63 54.52 2.18 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.492 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CZ ' ' B' ' 104' ' ' PHE . 58.1 Cg_endo -70.65 -18.65 32.68 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.687 2.258 . . . . 0.0 112.862 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.42 ' O ' ' CG1' ' C' ' 19' ' ' VAL . 1.9 m-20 -57.77 -39.24 76.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.773 0.32 . . . . 0.0 110.819 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.503 ' HB2' HG13 ' C' ' 19' ' ' VAL . 8.1 m-85 81.02 123.27 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.494 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' B' ' 101' ' ' HIS . 97.1 Cg_endo -86.72 162.37 9.22 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.746 2.297 . . . . 0.0 112.648 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.649 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -56.37 140.71 44.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.553 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -102.07 138.45 39.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.08 0.467 . . . . 0.0 111.503 -179.409 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.873 ' O ' HG23 ' B' ' 76' ' ' THR . 12.0 t -148.2 55.16 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.009 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 5.1 m -102.99 151.37 22.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.187 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.533 HG11 ' CD2' ' C' ' 78' ' ' PHE . 29.5 m -156.89 160.75 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.102 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 5.8 tt0 -87.14 94.3 9.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.94 171.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.253 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -84.34 -50.14 8.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.02 171.39 14.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.742 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.819 HD22 ' HB2' ' B' ' 122' ' ' GLU . 3.2 mt -143.57 160.01 52.44 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.812 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.579 ' O ' HG22 ' B' ' 119' ' ' VAL . 68.7 Cg_exo -50.78 135.89 42.6 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.558 2.172 . . . . 0.0 112.137 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.31 15.98 8.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.064 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 62.82 16.54 9.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.021 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.737 HG11 ' HB ' ' B' ' 34' ' ' ILE . 15.6 m -53.13 170.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.832 0.349 . . . . 0.0 111.177 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . 0.53 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -101.98 -3.1 51.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.988 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' B' ' 50' ' ' GLN . 4.2 pp -175.76 148.37 0.87 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 111.255 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.819 ' HB2' HD22 ' B' ' 115' ' ' LEU . 0.0 OUTLIER -119.86 163.69 17.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.326 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.747 ' CG2' HG21 ' B' ' 58' ' ' VAL . 15.7 mm -139.77 129.89 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 111.881 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.87 118.99 5.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.074 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -133.84 161.91 33.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.979 0.419 . . . . 0.0 111.884 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.782 HD12 HD23 ' B' ' 29' ' ' LEU . 5.8 mm -111.86 150.6 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.515 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 1.051 ' HB3' HG13 ' B' ' 28' ' ' VAL . . . -127.4 157.85 38.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 111.764 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.624 HG22 HG13 ' B' ' 73' ' ' VAL . 34.1 m -130.0 116.24 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.837 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.733 ' HB2' HD21 ' B' ' 67' ' ' LEU . 75.7 ttt-85 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.999 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.507 ' CG2' HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.79 0.329 . . . . 0.0 110.903 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.6 122.73 7.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.5 HD13 HG12 ' C' ' 22' ' ' VAL . 39.1 mm -55.65 144.42 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.176 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.534 HD12 ' CB ' ' C' ' 21' ' ' ALA . 32.5 mt -109.52 143.46 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -146.99 141.73 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.0 159.39 43.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.15 28.5 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.33 -44.18 2.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.712 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.87 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.26 171.74 4.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.036 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.87 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 30.7 Cg_endo -63.8 -12.74 33.12 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.567 2.178 . . . . 0.0 112.615 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 69.88 147.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.322 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.803 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -106.14 123.22 47.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.053 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.803 HD13 ' O ' ' C' ' 14' ' ' ALA . 17.6 mm -131.94 17.03 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.857 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.24 -128.05 3.19 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.399 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -90.1 24.63 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.769 2.313 . . . . 0.0 113.444 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.736 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.7 OUTLIER -152.06 174.52 13.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.093 0.473 . . . . 0.0 111.727 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' B' ' 104' ' ' PHE . 15.8 m -123.12 173.28 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.802 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.469 HE21 ' HB3' ' C' ' 11' ' ' ALA . 0.0 OUTLIER -59.52 -39.94 85.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 110.374 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . 174.75 175.44 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.852 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.615 HG21 ' HB ' ' B' ' 73' ' ' VAL . 1.9 m -140.33 134.79 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.32 108.9 15.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.62 HD21 HG11 ' B' ' 73' ' ' VAL . 4.1 mm? -84.27 -16.9 41.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.96 -105.74 0.86 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.0 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -53.88 -30.13 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.082 0.468 . . . . 0.0 110.253 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.94 132.8 52.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.858 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 1.031 HG13 ' HB3' ' C' ' 127' ' ' ALA . 0.1 OUTLIER -131.29 152.06 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.656 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.799 HD23 HD12 ' C' ' 126' ' ' ILE . 0.4 OUTLIER -144.22 139.95 28.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.838 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 25.5 p -106.15 141.46 37.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.773 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 79.6 p -69.17 155.82 39.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.97 94.08 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.481 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.643 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.5 mp0 -78.17 156.07 30.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 111.02 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.756 ' HB ' HG11 ' C' ' 119' ' ' VAL . 7.0 pt -135.94 146.69 57.87 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.467 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 53.1 Cg_endo -69.37 61.51 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.821 2.347 . . . . 0.0 112.756 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.589 HG23 HG13 ' C' ' 34' ' ' ILE . 59.8 t . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 0.0 110.602 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.574 HG21 ' H ' ' C' ' 120' ' ' GLY . 11.3 p . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.504 0.193 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.55 140.42 52.02 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.315 2.01 . . . . 0.0 112.077 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.14 -30.98 60.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.019 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -66.95 95.6 0.38 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.698 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' C' ' 47' ' ' ILE . 6.3 tp -45.02 -30.52 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.29 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.86 -38.62 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.496 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' C' ' 46' ' ' ASP . . . -60.96 -53.93 51.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.292 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' C' ' 121' ' ' LEU . 17.9 pt20 -62.97 -29.53 70.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.052 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' C' ' 88' ' ' VAL . . . -71.34 -35.06 71.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.959 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -80.81 -41.19 23.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.754 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -40.47 96.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.662 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.597 ' O ' HG23 ' C' ' 58' ' ' VAL . 13.3 p -64.27 -30.06 71.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.906 HD21 ' CD2' ' C' ' 92' ' ' TYR . 8.8 mt -81.98 -18.81 42.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.53 -49.02 9.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.424 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . 0.434 ' OD1' HG23 ' C' ' 58' ' ' VAL . 24.4 p30 -62.75 -33.24 74.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.263 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.748 HG21 ' CG2' ' C' ' 123' ' ' ILE . 91.6 t -73.1 -40.88 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.381 . . . . 0.0 110.54 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.531 ' HA ' HD12 ' C' ' 62' ' ' ILE . 8.3 tttm -73.05 -33.28 65.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.639 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.55 92.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.775 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -68.63 -41.78 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.742 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.646 HD13 HD11 ' C' ' 72' ' ' ILE . 12.9 mt -67.41 -38.8 81.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.734 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.86 -37.39 67.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.275 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.52 -20.21 66.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.589 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.18 19.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.2 47.91 0.79 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.41 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.734 HD13 HG11 ' C' ' 28' ' ' VAL . 26.3 mt -149.08 136.15 19.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 110.846 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -88.02 163.23 16.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.157 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.734 ' HA ' HD13 ' C' ' 72' ' ' ILE . . . -54.7 -30.2 55.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.137 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.568 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -67.8 -22.14 65.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.244 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.13 -30.77 69.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.985 0.422 . . . . 0.0 110.181 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.734 HD13 ' HA ' ' C' ' 69' ' ' ALA . 4.0 mp -67.25 108.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.684 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.62 HG13 HG22 ' C' ' 128' ' ' VAL . 6.5 m -79.04 -31.92 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.826 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.68 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 49.7 tttt -131.91 156.54 45.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.946 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.537 HG23 ' HB2' ' C' ' 125' ' ' ALA . 1.3 m -146.76 117.44 7.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.306 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.885 HG23 ' O ' ' C' ' 108' ' ' SER . 86.4 m -105.35 144.95 31.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.219 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.663 HG13 HD13 ' C' ' 123' ' ' ILE . 38.8 t -151.59 121.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.391 . . . . 0.0 111.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.549 ' HB2' HD21 ' C' ' 115' ' ' LEU . 6.4 m-85 -95.74 118.81 33.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.323 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' C' ' 85' ' ' PHE . 13.4 m -110.56 151.96 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.148 0.499 . . . . 0.0 111.737 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.12 -6.74 30.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.758 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.41 94.24 2.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.342 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' C' ' 82' ' ' LEU . 4.8 mt -63.61 -14.01 47.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.247 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.34 -27.91 52.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.74 -17.57 25.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.526 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.615 ' CD1' HG11 ' C' ' 79' ' ' VAL . 22.3 t80 -58.02 -24.38 58.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.198 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.02 -41.94 36.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.841 0.353 . . . . 0.0 111.393 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.15 -33.59 20.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.766 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.698 HG12 ' HE1' ' C' ' 92' ' ' TYR . 29.4 t -65.88 -54.54 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.571 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . 0.409 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 17.1 t-20 -56.58 -43.96 80.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.976 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.06 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.795 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.63 -34.89 77.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.906 ' CD2' HD21 ' C' ' 55' ' ' LEU . 53.4 m-85 -67.35 -45.92 74.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.154 0.502 . . . . 0.0 110.112 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.83 -25.45 66.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.378 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -76.98 -38.24 53.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.235 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.1 OUTLIER -82.54 -37.96 24.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.819 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' C' ' 92' ' ' TYR . 7.5 m-85 -53.35 -52.01 60.6 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.201 0.524 . . . . 0.0 110.247 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -30.3 70.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.298 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.6 3.1 53.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.666 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' C' ' 100' ' ' ASN . 0.6 OUTLIER -116.3 -6.23 11.81 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.889 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' C' ' 99' ' ' ASN . 0.0 OUTLIER 89.16 26.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.305 0.574 . . . . 0.0 110.516 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.568 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 12.9 t-160 -118.82 54.62 2.31 Favored Pre-proline 0 CA--C 1.529 0.154 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.529 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.403 ' O ' ' CE1' ' C' ' 104' ' ' PHE . 58.4 Cg_endo -70.69 -18.69 32.47 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.726 2.284 . . . . 0.0 112.868 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.409 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 1.9 m-20 -57.77 -39.2 76.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.76 0.314 . . . . 0.0 110.849 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.502 ' HB2' HG13 ' A' ' 19' ' ' VAL . 8.1 m-85 81.05 123.26 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.463 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.426 ' HD3' ' CE1' ' C' ' 101' ' ' HIS . 98.1 Cg_endo -86.7 162.3 9.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.779 2.319 . . . . 0.0 112.713 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.68 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -56.35 140.81 44.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.565 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -102.15 138.37 39.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.057 0.456 . . . . 0.0 111.502 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . 0.885 ' O ' HG23 ' C' ' 76' ' ' THR . 12.0 t -148.14 55.26 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.058 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -103.09 151.35 22.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.17 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.523 HG11 ' CD2' ' A' ' 78' ' ' PHE . 29.3 m -156.98 160.74 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.123 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 6.0 tt0 -87.04 94.17 9.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.8 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.88 171.19 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.237 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -84.4 -49.99 8.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.029 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.14 171.35 15.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.809 HD22 ' HB2' ' C' ' 122' ' ' GLU . 3.2 mt -143.51 160.02 52.6 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.833 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.579 ' O ' HG22 ' C' ' 119' ' ' VAL . 69.9 Cg_exo -50.92 135.9 43.63 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.477 2.118 . . . . 0.0 112.149 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.32 16.01 8.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.103 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 62.8 16.58 9.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.987 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.756 HG11 ' HB ' ' C' ' 34' ' ' ILE . 15.7 m -53.16 170.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.819 0.342 . . . . 0.0 111.163 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . 0.574 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -101.88 -3.23 52.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.997 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.557 HD21 ' HG3' ' C' ' 50' ' ' GLN . 4.2 pp -175.72 148.29 0.87 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.219 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.809 ' HB2' HD22 ' C' ' 115' ' ' LEU . 0.0 OUTLIER -119.87 163.65 17.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.278 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.748 ' CG2' HG21 ' C' ' 58' ' ' VAL . 15.6 mm -139.78 129.87 30.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.894 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.82 118.98 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.172 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.537 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -133.77 161.99 33.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 0.0 111.871 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.799 HD12 HD23 ' C' ' 29' ' ' LEU . 5.8 mm -111.97 150.65 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.471 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 1.031 ' HB3' HG13 ' C' ' 28' ' ' VAL . . . -127.42 157.89 38.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.043 0.449 . . . . 0.0 111.804 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.62 HG22 HG13 ' C' ' 73' ' ' VAL . 34.2 m -130.09 116.26 36.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.866 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.73 ' HB2' HD21 ' C' ' 67' ' ' LEU . 75.7 ttt-85 -120.07 70.89 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.978 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.887 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.524 HG21 HG21 ' C' ' 128' ' ' VAL . 11.1 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.934 0.397 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.581 ' NE2' ' HB ' ' C' ' 73' ' ' VAL . 3.0 mm100 63.2 -165.74 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.258 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.2 mp 70.25 118.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.671 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.785 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 22.3 mt -152.99 74.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.678 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -84.76 145.49 27.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 61' ' ' ILE . 1.7 t -149.83 153.46 36.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.71 35.83 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.412 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . 11.5 mmtt -121.13 -38.07 2.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.74 110.65 46.78 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.192 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.28 -16.41 46.56 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.516 2.144 . . . . 0.0 112.469 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.15 -167.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.221 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.502 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 64.87 -165.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.435 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.6 mt 79.61 17.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.119 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.91 -134.64 4.22 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.223 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.64 28.59 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.724 2.283 . . . . 0.0 113.098 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -162.3 177.28 9.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' C' ' 104' ' ' PHE . 33.6 m -106.07 162.3 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.22 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.426 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 3.6 mt-30 -55.65 -52.8 62.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.135 0.493 . . . . 0.0 110.442 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.785 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -158.44 -172.75 3.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.166 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 4' ' ' GLN . 27.6 m -145.51 130.36 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.025 0.44 . . . . 0.0 111.851 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.488 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 48.0 t0 -108.69 102.88 11.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.3 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.722 HD11 HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -66.74 -14.17 62.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 111.188 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.02 -93.08 0.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -61.26 -28.82 69.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.249 0.547 . . . . 0.0 109.593 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.97 140.49 47.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.417 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.899 HG23 ' HB3' ' A' ' 127' ' ' ALA . 2.8 m -105.05 -179.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.197 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.722 HD12 HD11 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -165.89 136.78 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -108.64 135.78 49.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.744 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.2 p -81.07 177.16 9.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.49 95.67 0.1 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.544 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.67 150.95 47.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.906 0.384 . . . . 0.0 111.053 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.748 HG23 HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -129.06 121.91 20.96 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.869 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.4 Cg_exo -67.76 58.96 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.695 2.263 . . . . 0.0 113.094 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.748 HG23 HG23 ' A' ' 34' ' ' ILE . 93.0 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 121.322 0.582 . . . . 0.0 110.639 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.78 ' HB ' HG12 ' A' ' 119' ' ' VAL . 11.2 p . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.522 0.201 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.56 140.96 94.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.415 2.077 . . . . 0.0 112.251 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.8 -31.1 72.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 0.0 110.929 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.54 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 1.3 m-20 -73.5 93.1 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.8 mm -42.49 -31.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.114 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.37 -42.52 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.788 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . . . -65.98 -44.72 84.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.551 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.78 67.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.449 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.28 -40.84 67.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.86 -32.59 57.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.36 -41.14 76.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.1 t -64.27 -38.91 92.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.32 -41.18 77.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.34 -44.06 92.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -60.77 -37.26 81.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.8 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.966 HG21 HG21 ' A' ' 123' ' ' ILE . 26.3 t -63.0 -45.97 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HA ' HD12 ' A' ' 62' ' ' ILE . 7.5 mttt -71.97 -32.62 67.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.782 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.412 ' HB1' ' CB ' ' A' ' 10' ' ' LYS . . . -60.44 -39.51 87.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.557 HG22 ' CG2' ' A' ' 6' ' ' ILE . 4.2 mt -70.04 -40.76 78.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.011 HD13 HD11 ' A' ' 72' ' ' ILE . 8.6 mt -70.5 -34.6 58.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.421 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -69.99 -42.61 72.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.402 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -15.73 63.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.595 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 6' ' ' ILE . . . -87.99 -33.64 18.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.942 0.401 . . . . 0.0 110.627 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.24 41.42 0.36 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.793 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.762 HD21 ' HG3' ' A' ' 129' ' ' ARG . 63.9 mt -150.25 -177.55 6.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.733 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.08 164.88 28.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.799 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -52.75 -35.02 55.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -60.86 -22.35 64.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.216 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 128' ' ' VAL . 6.9 m-20 -81.03 -18.49 46.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.767 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 62' ' ' ILE . 28.2 mm -58.44 123.61 10.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.868 HG11 HG13 ' A' ' 128' ' ' VAL . 34.8 m -92.63 -27.4 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.382 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.49 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 36.8 tttm -150.49 164.69 35.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -156.4 113.27 3.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.777 0.322 . . . . 0.0 111.526 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -100.02 152.41 20.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.303 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.422 HG13 HD13 ' A' ' 123' ' ' ILE . 21.2 t -151.74 127.36 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.821 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CE2' ' OE1' ' A' ' 124' ' ' GLU . 10.6 m-85 -105.39 115.54 30.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.328 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 85' ' ' PHE . 4.8 m -105.49 148.57 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.638 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.76 -4.52 56.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.051 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -164.59 134.23 3.8 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.549 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' B' ' 114' ' ' ARG . 1.0 OUTLIER -70.9 -8.89 56.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.274 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.35 -24.23 23.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.791 0.329 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -75.44 -22.3 57.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.084 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.576 ' CD2' HG11 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -61.68 -18.2 58.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.448 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.13 -41.12 68.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.852 0.358 . . . . 0.0 111.271 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -27.8 22.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.983 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.3 t -73.71 -47.07 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.25 -40.08 95.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.407 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.16 84.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.947 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -87.89 -28.25 21.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.554 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 95' ' ' PHE . 81.0 t80 -53.39 -44.74 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.945 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -86.9 -25.26 24.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -21.36 60.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.473 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.446 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -91.13 -33.62 15.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.863 0.363 . . . . 0.0 110.613 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.457 ' CZ ' ' CG ' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -56.45 -58.01 9.85 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.316 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -64.58 -30.74 71.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.006 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -78.16 -9.23 59.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.233 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.667 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 3.5 m120 -109.82 -5.01 15.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.393 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 21.9 m-80 84.5 38.58 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.759 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.506 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 17.2 t-160 -130.69 68.86 82.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.337 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 1.4 Cg_endo -82.35 -17.46 7.67 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.971 2.447 . . . . 0.0 112.824 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -59.27 -36.78 76.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.878 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 27.9 m-85 78.76 114.77 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.395 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' CG ' ' CZ ' ' A' ' 96' ' ' PHE . 62.3 Cg_endo -87.2 163.12 8.53 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.164 2.576 . . . . 0.0 112.147 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.46 175.6 0.23 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -173.0 163.48 4.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.331 0.586 . . . . 0.0 112.049 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.89 83.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.032 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.457 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 14.1 p -89.4 123.63 33.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.492 HG12 HD23 ' B' ' 115' ' ' LEU . 35.6 m -142.89 148.68 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.297 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.867 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.8 OUTLIER -81.69 97.34 7.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.824 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.46 160.43 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.152 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.861 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -69.61 -45.65 68.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.023 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.491 ' HB3' HD12 ' C' ' 82' ' ' LEU . 6.3 mtt-85 -156.89 176.98 12.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.824 HD22 ' HB2' ' A' ' 122' ' ' GLU . 12.8 mt -145.27 160.65 44.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.811 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.495 ' O ' HG22 ' A' ' 119' ' ' VAL . 69.2 Cg_exo -51.04 135.75 44.46 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.545 2.163 . . . . 0.0 112.218 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.607 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.1 OUTLIER 72.3 14.45 5.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.226 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.24 14.24 9.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.212 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.78 HG12 ' HB ' ' A' ' 43' ' ' VAL . 27.7 m -57.57 171.22 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.865 0.364 . . . . 0.0 111.162 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.21 21.96 16.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.474 HD21 HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -176.37 156.91 1.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.12 0.486 . . . . 0.0 111.213 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.824 ' HB2' HD22 ' A' ' 115' ' ' LEU . 6.2 tt0 -149.89 156.34 41.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.966 HG21 HG21 ' A' ' 58' ' ' VAL . 22.8 mm -133.41 136.73 54.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.153 0.502 . . . . 0.0 112.109 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 6.6 pt-20 -155.48 106.6 2.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.298 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.676 ' HB2' HG22 ' A' ' 75' ' ' THR . . . -129.05 175.28 8.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.258 0.552 . . . . 0.0 112.374 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.705 HG23 ' HG ' ' A' ' 29' ' ' LEU . 3.1 mt -125.71 157.81 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.1 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.994 ' HB2' HD13 ' A' ' 72' ' ' ILE . . . -148.8 149.11 30.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.97 0.414 . . . . 0.0 111.459 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.868 HG13 HG11 ' A' ' 73' ' ' VAL . 3.3 m -96.96 156.43 3.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.077 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.762 ' HG3' HD21 ' A' ' 67' ' ' LEU . 54.2 ttt-85 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.522 HG21 HG21 ' A' ' 128' ' ' VAL . 11.1 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.917 0.389 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.555 ' NE2' ' HB ' ' A' ' 73' ' ' VAL . 2.9 mm100 63.27 -165.77 0.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.258 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.474 ' N ' HD12 ' B' ' 5' ' ' ILE . 1.2 mp 70.29 118.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.644 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.77 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 22.3 mt -153.02 74.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.648 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -84.67 145.48 27.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.507 HG21 ' HA ' ' B' ' 61' ' ' ILE . 1.7 t -149.85 153.4 36.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.65 35.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.417 ' CB ' ' HB1' ' B' ' 60' ' ' ALA . 11.5 mmtt -121.18 -38.05 2.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.73 110.71 47.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.193 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.27 -16.5 47.06 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.511 2.14 . . . . 0.0 112.447 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.08 -167.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.262 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.501 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 64.89 -165.09 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.369 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.586 HG22 ' O ' ' B' ' 15' ' ' ILE . 2.6 mt 79.65 17.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.102 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.91 -134.59 4.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.201 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -87.7 28.6 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.712 2.275 . . . . 0.0 113.089 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -162.28 177.37 9.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 111.201 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 104' ' ' PHE . 33.7 m -106.11 162.33 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.18 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.437 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 3.6 mt-30 -55.55 -52.65 63.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.221 0.534 . . . . 0.0 110.453 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.77 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -158.65 -172.72 3.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.189 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' B' ' 4' ' ' GLN . 27.7 m -145.53 130.41 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.059 0.457 . . . . 0.0 111.745 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.482 ' CG ' HG12 ' B' ' 28' ' ' VAL . 47.9 t0 -108.76 102.84 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.278 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.708 HD11 HD12 ' B' ' 29' ' ' LEU . 0.5 OUTLIER -66.74 -14.12 62.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.17 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.01 -93.05 0.59 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -61.27 -28.82 69.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 140.45 47.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.426 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.887 HG23 ' HB3' ' B' ' 127' ' ' ALA . 2.8 m -105.08 -179.25 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.183 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.708 HD12 HD11 ' B' ' 24' ' ' LEU . 0.2 OUTLIER -165.82 136.78 3.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 66.7 p -108.68 135.64 49.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 42.8 p -80.88 177.25 9.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.48 95.62 0.1 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.537 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.65 150.94 47.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.908 0.385 . . . . 0.0 111.086 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.752 HG23 HG23 ' B' ' 36' ' ' VAL . 0.6 OUTLIER -129.12 121.97 20.94 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.823 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.81 58.93 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.719 2.28 . . . . 0.0 113.037 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.752 HG23 HG23 ' B' ' 34' ' ' ILE . 93.3 t . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 121.281 0.562 . . . . 0.0 110.576 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.758 ' HB ' HG12 ' B' ' 119' ' ' VAL . 11.2 p . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.525 0.202 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.68 141.07 95.37 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.364 2.043 . . . . 0.0 112.188 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.79 -31.21 72.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.554 ' HB2' ' HB3' ' B' ' 49' ' ' ALA . 1.3 m-20 -73.43 93.09 1.92 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mm -42.48 -31.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.125 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.47 -42.5 21.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.723 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' B' ' 46' ' ' ASP . . . -65.99 -44.72 84.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.565 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.71 67.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.526 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.88 67.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.82 -32.64 57.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.32 -41.17 77.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.748 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.739 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.1 t -64.23 -38.9 92.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.788 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.33 -41.2 76.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.36 -43.99 92.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -60.79 -37.29 81.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.758 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.984 HG21 HG21 ' B' ' 123' ' ' ILE . 26.5 t -63.04 -46.01 97.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' B' ' 62' ' ' ILE . 7.4 mttt -71.92 -32.64 67.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.808 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.417 ' HB1' ' CB ' ' B' ' 10' ' ' LYS . . . -60.42 -39.53 87.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.55 HG22 ' CG2' ' B' ' 6' ' ' ILE . 4.2 mt -70.18 -40.77 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.839 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.95 HD13 HD11 ' B' ' 72' ' ' ILE . 8.6 mt -70.54 -34.59 58.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.391 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -69.98 -42.68 72.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.362 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -15.82 63.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.677 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' B' ' 6' ' ' ILE . . . -87.96 -33.62 18.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.632 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.28 41.39 0.36 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.812 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.746 HD21 ' HG3' ' B' ' 129' ' ' ARG . 64.2 mt -150.32 -177.57 6.02 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.004 0.43 . . . . 0.0 110.714 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.04 164.89 28.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.8 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.635 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -52.74 -35.11 55.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.941 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -60.79 -22.24 63.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.208 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.512 ' O ' HG22 ' B' ' 128' ' ' VAL . 6.9 m-20 -81.09 -18.43 46.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.787 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 1.008 HD13 ' HB2' ' B' ' 127' ' ' ALA . 28.2 mm -58.53 123.65 10.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.857 HG11 HG13 ' B' ' 128' ' ' VAL . 34.9 m -92.69 -27.37 4.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.368 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.496 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 36.7 tttm -150.45 164.73 35.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.661 HG22 ' HB2' ' B' ' 125' ' ' ALA . 0.2 OUTLIER -156.48 113.23 3.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.727 0.299 . . . . 0.0 111.481 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -99.97 152.44 20.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.417 HG13 HD13 ' B' ' 123' ' ' ILE . 21.2 t -151.77 127.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.984 0.421 . . . . 0.0 111.801 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.403 ' CE2' ' OE1' ' B' ' 124' ' ' GLU . 10.5 m-85 -105.39 115.54 30.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.279 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.565 HG11 ' CD2' ' B' ' 85' ' ' PHE . 4.9 m -105.51 148.52 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.634 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.7 -4.63 56.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.978 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -164.65 134.18 3.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.609 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.87 -8.89 56.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.248 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.29 -24.28 23.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.804 0.335 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -75.42 -22.25 57.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.565 ' CD2' HG11 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -61.7 -18.2 58.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.406 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.21 -41.09 68.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.804 0.335 . . . . 0.0 111.27 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -27.84 22.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' B' ' 92' ' ' TYR . 27.5 t -73.67 -47.11 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.941 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.15 -40.18 95.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.426 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.97 -40.21 84.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.945 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.09 -28.18 21.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.538 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 81.3 t80 -53.4 -44.79 68.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.9 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -86.9 -25.17 24.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.052 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -21.37 60.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.455 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 1.0 OUTLIER -91.1 -33.69 15.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 110.623 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.444 ' CZ ' ' CG ' ' B' ' 105' ' ' PRO . 0.8 OUTLIER -56.39 -58.09 9.51 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.317 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -64.5 -30.72 71.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.051 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -78.17 -9.31 59.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.209 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' B' ' 69' ' ' ALA . 3.5 m120 -109.83 -4.97 15.7 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.389 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.685 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 21.9 m-80 84.53 38.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.812 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.507 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 17.2 t-160 -130.68 68.92 82.17 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.343 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.33 -17.48 7.69 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.006 2.471 . . . . 0.0 112.857 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 0.1 OUTLIER -59.25 -36.84 76.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 0.0 110.867 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.55 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 28.0 m-85 78.75 114.73 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.475 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.444 ' CG ' ' CZ ' ' B' ' 96' ' ' PHE . 62.4 Cg_endo -87.22 163.04 8.51 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.167 2.578 . . . . 0.0 112.108 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.38 175.59 0.23 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' B' ' 75' ' ' THR . 0.9 OUTLIER -173.02 163.55 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.317 0.58 . . . . 0.0 112.078 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.94 83.87 1.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.089 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . 0.442 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 14.5 p -89.38 123.68 33.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.081 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.445 HG12 HD23 ' C' ' 115' ' ' LEU . 35.6 m -143.12 149.19 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.379 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.838 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.8 OUTLIER -81.85 97.15 7.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.644 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.35 160.34 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.867 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -69.6 -45.58 68.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.026 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.514 ' HB3' HD12 ' A' ' 82' ' ' LEU . 6.3 mtt-85 -156.94 176.92 12.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' B' ' 122' ' ' GLU . 12.7 mt -145.24 160.64 45.03 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.86 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.495 ' O ' HG22 ' B' ' 119' ' ' VAL . 69.7 Cg_exo -51.07 135.76 44.68 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.511 2.141 . . . . 0.0 112.249 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.608 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.1 OUTLIER 72.23 14.51 5.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.223 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.26 14.24 9.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.145 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.758 HG12 ' HB ' ' B' ' 43' ' ' VAL . 27.7 m -57.56 171.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.879 0.371 . . . . 0.0 111.13 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.05 22.08 16.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.568 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.486 ' C ' HD13 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -176.26 156.78 1.67 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.107 0.48 . . . . 0.0 111.151 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' B' ' 115' ' ' LEU . 6.2 tt0 -149.84 156.39 41.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.104 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.984 HG21 HG21 ' B' ' 58' ' ' VAL . 22.7 mm -133.4 136.69 54.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.194 0.521 . . . . 0.0 112.091 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . 0.403 ' OE1' ' CE2' ' B' ' 78' ' ' PHE . 6.6 pt-20 -155.5 106.55 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.329 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.661 ' HB2' HG22 ' B' ' 75' ' ' THR . . . -128.99 175.31 8.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.307 0.575 . . . . 0.0 112.37 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.7 HG23 ' HG ' ' B' ' 29' ' ' LEU . 3.1 mt -125.68 157.89 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.134 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 1.008 ' HB2' HD13 ' B' ' 72' ' ' ILE . . . -148.97 149.08 30.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.0 0.429 . . . . 0.0 111.424 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.857 HG13 HG11 ' B' ' 73' ' ' VAL . 3.3 m -96.96 156.4 3.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.049 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.746 ' HG3' HD21 ' B' ' 67' ' ' LEU . 54.2 ttt-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.513 HG21 HG21 ' B' ' 128' ' ' VAL . 11.1 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.9 0.381 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . 0.578 ' NE2' ' HB ' ' B' ' 73' ' ' VAL . 3.0 mm100 63.24 -165.76 0.23 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.292 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.483 HD12 ' N ' ' C' ' 5' ' ' ILE . 1.2 mp 70.26 118.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.613 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.79 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 22.3 mt -153.05 74.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.674 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -84.67 145.56 27.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.216 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.514 HG21 ' HA ' ' C' ' 61' ' ' ILE . 1.7 t -149.91 153.38 36.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.69 35.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.422 ' CB ' ' HB1' ' C' ' 60' ' ' ALA . 11.5 mmtt -121.09 -38.06 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.87 110.79 47.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.147 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.33 -16.39 46.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.506 2.137 . . . . 0.0 112.444 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' C' ' 34' ' ' ILE . . . -57.15 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.243 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.502 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 64.78 -165.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.38 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.591 HG22 ' O ' ' C' ' 15' ' ' ILE . 2.6 mt 79.72 17.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.034 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.89 -134.6 4.22 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.3 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -87.64 28.61 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.784 2.323 . . . . 0.0 113.14 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -162.35 177.35 9.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 111.23 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.415 HG13 ' O ' ' B' ' 104' ' ' PHE . 33.7 m -106.08 162.35 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.434 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 3.6 mt-30 -55.66 -52.92 62.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.144 0.497 . . . . 0.0 110.516 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.79 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -158.14 -172.77 4.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.152 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.41 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 27.6 m -145.53 130.41 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.043 0.449 . . . . 0.0 111.855 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.481 ' CG ' HG12 ' C' ' 28' ' ' VAL . 48.2 t0 -108.75 102.88 11.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.244 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.725 HD11 HD12 ' C' ' 29' ' ' LEU . 0.5 OUTLIER -66.75 -14.14 62.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.214 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.08 -93.13 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -61.27 -28.79 69.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.232 0.539 . . . . 0.0 109.574 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 140.47 47.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.397 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.893 HG23 ' HB3' ' C' ' 127' ' ' ALA . 2.8 m -105.05 -179.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.246 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.725 HD12 HD11 ' C' ' 24' ' ' LEU . 0.2 OUTLIER -165.8 136.86 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.824 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -108.85 136.27 48.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.842 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 41.9 p -81.07 177.26 9.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.57 95.67 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.66 151.02 47.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 111.061 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.755 HG23 HG23 ' C' ' 36' ' ' VAL . 0.6 OUTLIER -129.18 121.96 20.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.85 58.9 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.715 2.277 . . . . 0.0 113.068 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.755 HG23 HG23 ' C' ' 34' ' ' ILE . 93.0 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 0.0 110.593 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.759 ' HB ' HG12 ' C' ' 119' ' ' VAL . 11.2 p . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.531 0.205 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.57 141.01 95.14 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.376 2.051 . . . . 0.0 112.23 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.83 -31.17 72.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.034 0.445 . . . . 0.0 110.91 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.544 ' HB2' ' HB3' ' C' ' 49' ' ' ALA . 1.3 m-20 -73.4 93.11 1.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.935 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mm -42.45 -31.76 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.157 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . 0.444 HG22 ' CB ' ' C' ' 87' ' ' ALA . 22.0 t -80.47 -42.43 21.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.756 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' C' ' 46' ' ' ASP . . . -66.04 -44.71 83.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.506 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -27.6 67.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.46 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.95 68.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.986 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.79 -32.63 57.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -41.12 77.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.743 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.1 t -64.23 -38.95 92.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.777 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 18.6 mt -69.33 -41.18 76.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.839 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.27 -44.09 92.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -60.8 -37.26 81.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.755 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 1.029 HG21 HG21 ' C' ' 123' ' ' ILE . 26.3 t -62.96 -46.08 97.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.556 ' HA ' HD12 ' C' ' 62' ' ' ILE . 7.4 mttt -71.92 -32.62 67.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.809 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.422 ' HB1' ' CB ' ' C' ' 10' ' ' LYS . . . -60.16 -39.58 86.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.549 HG22 ' CG2' ' C' ' 6' ' ' ILE . 4.2 mt -70.29 -40.75 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.839 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 1.036 HD13 HD11 ' C' ' 72' ' ' ILE . 8.6 mt -70.52 -34.56 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.433 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -69.98 -42.69 72.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -15.77 63.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.653 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' C' ' 6' ' ' ILE . . . -88.0 -33.69 18.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.548 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.29 41.32 0.37 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.841 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.763 HD21 ' HG3' ' C' ' 129' ' ' ARG . 64.0 mt -150.27 -177.58 6.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.936 0.398 . . . . 0.0 110.723 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.07 164.85 28.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.795 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -52.69 -35.1 54.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -60.9 -22.4 64.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.186 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.515 ' O ' HG22 ' C' ' 128' ' ' VAL . 6.9 m-20 -81.0 -18.42 46.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.788 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 1.036 HD11 HD13 ' C' ' 62' ' ' ILE . 28.2 mm -58.47 123.64 10.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.875 HG11 HG13 ' C' ' 128' ' ' VAL . 34.7 m -92.7 -27.33 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.397 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.488 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 36.7 tttm -150.47 164.76 35.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.304 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.666 HG22 ' HB2' ' C' ' 125' ' ' ALA . 0.2 OUTLIER -156.45 113.32 3.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.732 0.301 . . . . 0.0 111.479 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 94.2 m -99.97 152.44 20.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.261 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.429 HG13 HD13 ' C' ' 123' ' ' ILE . 21.2 t -151.78 127.31 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.982 0.42 . . . . 0.0 111.83 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.407 ' CE2' ' OE1' ' C' ' 124' ' ' GLU . 10.6 m-85 -105.32 115.56 30.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.3 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.569 HG11 ' CD2' ' C' ' 85' ' ' PHE . 4.8 m -105.55 148.61 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.591 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.62 -4.21 55.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.082 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -165.03 134.31 3.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.549 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 114' ' ' ARG . 1.0 OUTLIER -70.91 -8.94 56.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.236 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.22 -24.28 23.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.79 0.329 . . . . 0.0 110.888 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -75.38 -22.35 57.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.569 ' CD2' HG11 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -61.66 -18.2 58.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.416 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.18 -41.16 68.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.34 . . . . 0.0 111.229 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' C' ' 48' ' ' VAL . . . -87.5 -27.82 22.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.974 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 28.0 t -73.76 -47.03 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.18 -40.17 95.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.457 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.07 83.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.937 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.05 -28.18 21.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.571 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 81.2 t80 -53.38 -44.82 68.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.904 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.84 -25.2 24.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.076 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.34 -21.37 60.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.441 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.46 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 1.0 OUTLIER -91.14 -33.72 15.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 110.576 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.454 ' CZ ' ' CG ' ' C' ' 105' ' ' PRO . 0.7 OUTLIER -56.36 -58.07 9.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.126 0.488 . . . . 0.0 110.285 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -64.56 -30.77 71.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.994 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -78.19 -9.21 59.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.248 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.629 ' HB3' ' HB3' ' C' ' 69' ' ' ALA . 3.5 m120 -109.87 -4.98 15.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.439 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 22.1 m-80 84.48 38.55 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.77 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.504 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 17.2 t-160 -130.8 68.87 82.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.35 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.27 -17.51 7.75 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.974 2.449 . . . . 0.0 112.828 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 0.1 OUTLIER -59.28 -36.81 76.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 110.828 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 27.9 m-85 78.73 114.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.469 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.454 ' CG ' ' CZ ' ' C' ' 96' ' ' PHE . 62.3 Cg_endo -87.18 163.13 8.55 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.181 2.587 . . . . 0.0 112.094 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.44 175.59 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' C' ' 75' ' ' THR . 0.9 OUTLIER -173.04 163.44 4.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.263 0.554 . . . . 0.0 112.074 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.81 83.91 1.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.061 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . 0.464 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 13.8 p -89.42 123.65 33.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 115' ' ' LEU . 35.6 m -143.06 149.53 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.351 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.861 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -82.02 97.26 8.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.4 HG22 ' H ' ' C' ' 112' ' ' VAL . 8.1 m -78.46 160.52 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.211 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.838 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -69.65 -45.67 67.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.061 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -156.89 176.99 12.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.851 HD22 ' HB2' ' C' ' 122' ' ' GLU . 12.9 mt -145.28 160.6 45.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.497 ' O ' HG22 ' C' ' 119' ' ' VAL . 67.9 Cg_exo -50.96 135.72 43.81 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.513 2.142 . . . . 0.0 112.289 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.59 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.1 OUTLIER 72.21 14.57 5.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.238 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.2 14.2 9.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.184 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.759 HG12 ' HB ' ' C' ' 43' ' ' VAL . 27.6 m -57.5 171.18 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 111.206 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.99 22.12 16.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.538 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.494 ' C ' HD13 ' C' ' 115' ' ' LEU . 0.2 OUTLIER -176.16 156.88 1.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.098 0.475 . . . . 0.0 111.158 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.851 ' HB2' HD22 ' C' ' 115' ' ' LEU . 6.3 tt0 -149.95 156.41 41.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.054 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 1.029 HG21 HG21 ' C' ' 58' ' ' VAL . 22.8 mm -133.42 136.75 54.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.163 0.506 . . . . 0.0 112.093 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 6.6 pt-20 -155.51 106.66 2.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.346 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.666 ' HB2' HG22 ' C' ' 75' ' ' THR . . . -129.11 175.31 8.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.292 0.567 . . . . 0.0 112.368 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.693 HG23 ' HG ' ' C' ' 29' ' ' LEU . 3.1 mt -125.69 157.85 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.127 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 1.022 ' HB2' HD13 ' C' ' 72' ' ' ILE . . . -148.91 149.05 30.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.995 0.426 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.875 HG13 HG11 ' C' ' 73' ' ' VAL . 3.3 m -96.93 156.35 3.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.035 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.763 ' HG3' HD21 ' C' ' 67' ' ' LEU . 54.1 ttt-85 -151.36 51.62 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.688 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.82 0.343 . . . . 0.0 110.887 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.58 114.65 15.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.028 HD11 HG11 ' A' ' 19' ' ' VAL . 1.1 tp -53.34 132.64 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.312 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' A' ' 23' ' ' ASP . 12.5 mm -98.59 143.32 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -168.08 106.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.81 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.7 t -124.99 169.34 12.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.86 29.85 3.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.447 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -118.2 -40.68 2.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.682 ' HB1' ' CD ' ' A' ' 12' ' ' PRO . . . -72.38 177.37 1.82 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.173 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.682 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 22.0 Cg_exo -65.01 -10.92 27.38 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.865 2.377 . . . . 0.0 112.728 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.73 151.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.021 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.35 122.47 46.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.187 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 15' ' ' ILE . 26.4 mm -123.1 17.13 5.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.8 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.33 -132.0 3.64 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.355 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.446 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 79.9 Cg_endo -89.95 20.73 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.793 2.329 . . . . 0.0 113.355 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.576 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 1.5 p90 -140.54 178.58 7.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.951 0.405 . . . . 0.0 111.462 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.028 HG11 HD11 ' A' ' 5' ' ' ILE . 15.7 m -132.87 -179.26 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.861 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -48.9 79.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.72 -172.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.825 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.756 HG23 HD23 ' A' ' 29' ' ' LEU . 4.7 m -142.19 132.63 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.794 ' HA ' HG23 ' A' ' 28' ' ' VAL . 10.5 t0 -113.94 109.77 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.648 ' CD1' HD21 ' A' ' 29' ' ' LEU . 12.0 mt -81.05 -14.65 57.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.269 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.82 -100.09 0.71 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.53 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.727 ' C ' HD23 ' A' ' 27' ' ' LEU . 9.3 m-20 -57.62 -29.77 64.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.162 0.506 . . . . 0.0 109.775 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.917 HD22 HG12 ' A' ' 128' ' ' VAL . 1.4 mt -130.05 141.85 50.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.512 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.039 HG12 ' HB3' ' A' ' 127' ' ' ALA . 4.7 p -125.49 144.66 34.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.18 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.824 HD12 HD12 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -118.1 146.98 43.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.79 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.507 HG21 HD11 ' A' ' 62' ' ' ILE . 16.3 p -124.16 155.22 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.83 167.2 12.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.93 94.62 0.15 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.342 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.521 ' O ' HD13 ' A' ' 34' ' ' ILE . 23.2 mm-40 -58.83 150.06 24.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.363 . . . . 0.0 111.171 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 33' ' ' GLN . 22.3 mm -133.42 134.91 24.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.557 ' HD2' HG21 ' A' ' 119' ' ' VAL . 16.0 Cg_exo -68.02 56.16 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.898 2.399 . . . . 0.0 112.803 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 121.332 0.587 . . . . 0.0 110.654 179.45 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.726 HG11 ' HA ' ' A' ' 119' ' ' VAL . 7.4 p . . . . . 0 CA--C 1.53 0.183 0 CA-C-O 120.512 0.196 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 35' ' ' PRO . 52.2 Cg_exo -52.04 140.27 50.12 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.315 2.01 . . . . 0.0 112.165 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.64 -30.99 69.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -75.46 94.95 3.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.799 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.725 HG13 HD11 ' A' ' 121' ' ' LEU . 2.7 tp -43.4 -31.88 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.601 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.62 -45.5 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.669 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -63.23 -48.13 79.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.569 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.727 ' OE1' HD12 ' A' ' 121' ' ' LEU . 2.7 pt20 -61.41 -29.53 69.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.392 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.75 -39.61 61.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.927 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -62.42 -48.47 79.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.06 -34.63 78.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -66.11 -31.15 71.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.726 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.768 HD13 ' CE2' ' A' ' 95' ' ' PHE . 75.6 mt -69.69 -49.84 49.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -40.83 84.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.83 -38.45 70.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 54' ' ' SER . 39.2 t -65.26 -25.86 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.716 ' HD3' ' HB2' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -83.88 -39.15 20.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.806 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -58.27 -39.68 79.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.468 HD11 ' OE1' ' A' ' 33' ' ' GLN . 50.3 mt -68.91 -53.05 28.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.917 0.389 . . . . 0.0 110.729 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 30' ' ' THR . 51.0 mt -64.66 -28.89 45.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.708 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.45 -42.54 53.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.53 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -16.07 63.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.466 ' HB2' HD12 ' A' ' 6' ' ' ILE . . . -88.45 -28.68 20.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.59 43.65 0.63 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.587 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.443 ' HB3' HG22 ' A' ' 62' ' ' ILE . 1.5 mt -149.78 -167.15 2.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.0 110.837 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.17 154.86 38.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.66 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.872 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -58.12 -36.7 73.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.943 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.458 ' HB2' ' HD2' ' A' ' 101' ' ' HIS . . . -50.1 -26.3 4.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.251 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.73 -23.63 33.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.414 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 69' ' ' ALA . 88.5 mt -44.39 120.44 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.917 0.389 . . . . 0.0 111.415 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 128' ' ' VAL . 29.3 m -90.31 -38.02 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.651 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.53 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -137.72 155.45 49.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.599 0.238 . . . . 0.0 110.974 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.803 HG21 ' OH ' ' A' ' 92' ' ' TYR . 17.3 p -143.43 152.07 41.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.027 0.441 . . . . 0.0 111.51 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 108' ' ' SER . 5.2 m -133.74 142.32 47.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.064 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -143.02 105.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 111.811 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.5 ' HB2' HD21 ' A' ' 115' ' ' LEU . 7.8 m-85 -86.98 106.28 17.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.469 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.687 HG12 ' CD2' ' A' ' 121' ' ' LEU . 18.7 m -102.71 152.59 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.549 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.13 -2.61 46.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.844 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.36 113.51 3.7 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.585 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.602 HD11 ' C ' ' B' ' 115' ' ' LEU . 6.1 mt -65.27 -13.57 58.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.056 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -81.94 -23.2 36.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.875 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.406 ' OD1' HG21 ' A' ' 47' ' ' ILE . 6.7 m-20 -80.84 -23.72 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.138 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.601 ' HD1' HG11 ' A' ' 79' ' ' VAL . 2.0 t80 -56.26 -23.88 39.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.382 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.92 74.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.199 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.44 -38.71 17.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.29 -36.06 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.6 t30 -69.31 -43.1 74.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.82 74.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.026 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.582 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -86.08 -23.26 26.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.2 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.803 ' OH ' HG21 ' A' ' 75' ' ' THR . 10.3 t80 -77.82 -27.55 50.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.565 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.1 -39.42 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -67.25 -23.13 65.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.768 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -90.85 -32.8 15.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.553 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.519 ' CD2' ' HB2' ' A' ' 101' ' ' HIS . 1.7 m-85 -60.15 -58.85 6.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.3 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -63.55 -28.17 69.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.159 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -77.79 -10.89 59.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.54 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 2.2 m-80 -111.15 -5.92 14.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.379 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.5 OUTLIER 94.52 37.32 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.871 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.872 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 1.8 m170 -117.9 51.98 1.33 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 65.1 Cg_endo -71.91 -21.67 24.25 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.453 2.102 . . . . 0.0 112.56 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.34 -32.98 51.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.728 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.617 ' O ' HG22 ' B' ' 19' ' ' VAL . 15.6 m-85 60.98 83.67 0.21 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.131 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 17.1 Cg_endo -58.15 159.42 18.78 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.44 2.093 . . . . 0.0 112.018 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 74' ' ' LYS . . . -50.19 169.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.783 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' B' ' 18' ' ' TYR . 2.5 ttt85 -133.4 146.42 51.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.018 0.437 . . . . 0.0 111.308 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 76' ' ' THR . 1.7 p -152.56 58.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.411 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 25.4 p -96.01 142.85 27.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.435 HG11 ' CD2' ' B' ' 78' ' ' PHE . 33.9 m -147.6 153.92 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.856 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.7 OUTLIER -80.93 83.63 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.78 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.654 ' CG2' HD11 ' A' ' 115' ' ' LEU . 9.5 m -71.99 160.82 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.111 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.852 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -67.56 -53.57 27.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.243 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.4 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 1.5 mpt_? -151.25 -178.59 6.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.964 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.654 HD11 ' CG2' ' A' ' 112' ' ' VAL . 2.1 mp -153.55 159.37 32.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.572 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.528 ' O ' HG12 ' A' ' 119' ' ' VAL . 9.6 Cg_endo -52.16 140.19 51.45 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.578 2.185 . . . . 0.0 112.21 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 66.84 14.0 9.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.559 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.71 19.23 5.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.069 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.726 ' HA ' HG11 ' A' ' 43' ' ' VAL . 3.0 p -52.33 -49.36 42.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.543 ' C ' HD13 ' A' ' 115' ' ' LEU . . . 90.31 -7.37 81.61 Favored Glycine 0 C--N 1.308 -0.978 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.293 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.727 HD12 ' OE1' ' A' ' 50' ' ' GLN . 16.7 mt -140.37 146.75 38.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.237 0.542 . . . . 0.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.424 ' HB2' ' CD2' ' A' ' 115' ' ' LEU . 26.1 tt0 -147.67 152.42 37.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.941 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.55 HD13 HD23 ' A' ' 55' ' ' LEU . 26.9 mt -138.07 127.41 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.192 0.52 . . . . 0.0 112.229 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.4 ' HG3' ' HB ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.45 132.18 18.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.391 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.685 ' CB ' HG22 ' A' ' 75' ' ' THR . . . -149.39 159.42 44.3 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.824 HD12 HD12 ' A' ' 29' ' ' LEU . 14.8 mm -105.24 153.57 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.893 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 1.039 ' HB3' HG12 ' A' ' 28' ' ' VAL . . . -137.2 152.57 50.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.013 0.435 . . . . 0.0 111.828 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.917 HG12 HD22 ' A' ' 27' ' ' LEU . 27.0 m -119.98 178.09 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.804 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.873 0.368 . . . . 0.0 111.039 -179.885 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.717 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.828 0.347 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.6 114.63 15.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 1.032 HD11 HG11 ' B' ' 19' ' ' VAL . 1.1 tp -53.3 132.69 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.33 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.644 HD11 ' HB2' ' B' ' 23' ' ' ASP . 12.5 mm -98.57 143.34 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.402 ' CD2' ' OE1' ' B' ' 20' ' ' GLN . 1.1 m80 -168.15 106.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 3.8 t -124.97 169.3 12.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.009 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.85 29.89 3.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.449 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 0.4 OUTLIER -118.34 -40.9 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.676 ' HB1' ' CD ' ' B' ' 12' ' ' PRO . . . -72.01 177.26 1.79 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.11 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.676 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 22.2 Cg_exo -65.01 -10.87 27.2 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.892 2.395 . . . . 0.0 112.677 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.66 151.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 111.083 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.27 122.43 46.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.202 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 15' ' ' ILE . 26.5 mm -123.08 17.13 5.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.765 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.29 -131.98 3.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.422 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.459 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 78.3 Cg_endo -89.93 20.66 1.0 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.809 2.339 . . . . 0.0 113.392 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.586 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 1.5 p90 -140.44 178.6 7.19 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.507 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.032 HG11 HD11 ' B' ' 5' ' ' ILE . 15.6 m -132.92 -179.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.867 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.402 ' OE1' ' CD2' ' B' ' 7' ' ' HIS . 0.1 OUTLIER -58.92 -48.7 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.953 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.432 ' HB2' HG21 ' B' ' 61' ' ' ILE . . . -178.07 -172.71 0.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.76 HG23 HD23 ' B' ' 29' ' ' LEU . 4.6 m -142.2 132.67 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.145 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.802 ' HA ' HG23 ' B' ' 28' ' ' VAL . 10.5 t0 -113.95 109.76 19.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.65 ' CD1' HD21 ' B' ' 29' ' ' LEU . 12.0 mt -81.07 -14.71 57.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.265 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.86 -100.05 0.7 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.548 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . 0.716 ' C ' HD23 ' B' ' 27' ' ' LEU . 9.2 m-20 -57.61 -29.77 64.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.177 0.513 . . . . 0.0 109.81 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.897 HD22 HG12 ' B' ' 128' ' ' VAL . 1.4 mt -130.0 141.88 50.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.537 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.045 HG12 ' HB3' ' B' ' 127' ' ' ALA . 4.7 p -125.57 144.68 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.145 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.827 HD12 HD12 ' B' ' 126' ' ' ILE . 0.0 OUTLIER -118.06 146.94 43.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.83 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.51 HG21 HD11 ' B' ' 62' ' ' ILE . 16.1 p -124.18 155.03 39.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.832 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.99 167.11 12.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.91 94.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.329 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.528 ' O ' HD13 ' B' ' 34' ' ' ILE . 23.3 mm-40 -58.82 150.07 24.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.376 . . . . 0.0 111.153 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.528 HD13 ' O ' ' B' ' 33' ' ' GLN . 22.2 mm -133.42 134.88 24.36 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.096 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.549 ' HD2' HG21 ' B' ' 119' ' ' VAL . 16.0 Cg_exo -68.03 56.2 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.836 2.358 . . . . 0.0 112.79 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 121.366 0.603 . . . . 0.0 110.623 179.442 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.717 HG11 ' HA ' ' B' ' 119' ' ' VAL . 7.4 p . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.391 0.139 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.2 Cg_exo -52.12 140.29 50.91 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.249 1.966 . . . . 0.0 112.189 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.95 69.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.032 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.435 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.1 OUTLIER -75.41 94.95 3.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.818 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.711 HG13 HD11 ' B' ' 121' ' ' LEU . 2.7 tp -43.39 -31.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.61 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.62 -45.51 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -63.27 -48.04 79.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.699 ' OE1' HD12 ' B' ' 121' ' ' LEU . 2.7 pt20 -61.56 -29.6 70.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.371 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.97 -39.6 61.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.999 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -62.37 -48.48 79.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.818 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.12 -34.58 78.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.708 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.607 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.7 OUTLIER -66.09 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.733 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.76 HD13 ' CE2' ' B' ' 95' ' ' PHE . 75.6 mt -69.75 -49.81 49.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.83 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -40.86 84.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.85 -38.48 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.64 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 54' ' ' SER . 39.0 t -65.23 -25.88 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.66 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.719 ' HD3' ' HB2' ' B' ' 69' ' ' ALA . 0.3 OUTLIER -83.86 -39.21 20.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -58.25 -39.91 80.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.456 HD11 ' OE1' ' B' ' 33' ' ' GLN . 50.6 mt -68.67 -53.01 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.733 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.51 HD11 HG21 ' B' ' 30' ' ' THR . 51.0 mt -64.7 -28.82 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.47 -42.54 52.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.546 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -16.09 63.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.643 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . 0.511 ' HB2' HD12 ' B' ' 6' ' ' ILE . . . -88.42 -28.64 20.77 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.706 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.58 43.67 0.63 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.523 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.461 ' HB3' HG22 ' B' ' 62' ' ' ILE . 1.5 mt -149.83 -167.14 2.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 154.85 38.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.693 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.873 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -58.12 -36.66 73.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.46 ' HB2' ' HD2' ' B' ' 101' ' ' HIS . . . -50.18 -26.36 4.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.281 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -23.67 34.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.404 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.464 HG13 ' HA ' ' B' ' 69' ' ' ALA . 88.8 mt -44.44 120.36 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-O 120.923 0.392 . . . . 0.0 111.438 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.541 HG13 HG22 ' B' ' 128' ' ' VAL . 29.1 m -90.2 -38.02 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.66 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.528 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -137.79 155.47 48.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.625 0.25 . . . . 0.0 110.905 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.793 HG21 ' OH ' ' B' ' 92' ' ' TYR . 17.3 p -143.38 152.1 41.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 111.543 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.658 HG23 ' O ' ' B' ' 108' ' ' SER . 5.2 m -133.8 142.32 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.026 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.4 t -143.0 105.82 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 111.838 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.468 ' HB2' HD21 ' B' ' 115' ' ' LEU . 7.7 m-85 -86.98 106.29 17.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.687 HG12 ' CD2' ' B' ' 121' ' ' LEU . 18.7 m -102.69 152.6 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.576 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.19 -2.51 46.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.808 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.62 113.54 3.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.518 HD11 ' C ' ' C' ' 115' ' ' LEU . 6.1 mt -65.19 -13.5 58.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.96 -23.26 36.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.883 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.82 -23.67 39.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.192 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.614 ' HD1' HG11 ' B' ' 79' ' ' VAL . 2.0 t80 -56.3 -23.9 39.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.336 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.33 -36.91 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 0.0 111.209 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.48 -38.7 17.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.18 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.28 -36.07 65.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.6 t30 -69.34 -43.04 74.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.06 74.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.08 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' B' ' 94' ' ' ARG . 0.1 OUTLIER -85.95 -23.3 26.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.793 ' OH ' HG21 ' B' ' 75' ' ' THR . 10.3 t80 -77.8 -27.54 50.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.541 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.19 -39.41 12.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' B' ' 91' ' ' GLU . 0.0 OUTLIER -67.35 -23.02 65.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.76 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -90.82 -32.85 15.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.835 0.35 . . . . 0.0 110.57 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' B' ' 101' ' ' HIS . 1.6 m-85 -60.12 -58.79 7.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.309 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -63.53 -28.24 69.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.162 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -77.78 -10.85 59.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 2.2 m-80 -111.22 -5.87 14.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.349 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 0.5 OUTLIER 94.5 37.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.873 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.873 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 1.8 m170 -117.92 52.02 1.34 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.706 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 64.2 Cg_endo -72.05 -21.58 23.9 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.449 2.099 . . . . 0.0 112.536 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.34 -33.02 51.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.894 0.378 . . . . 0.0 110.723 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.635 ' O ' HG22 ' C' ' 19' ' ' VAL . 15.6 m-85 61.05 83.67 0.21 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.122 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 16.9 Cg_endo -58.12 159.42 18.65 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.463 2.109 . . . . 0.0 112.025 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' B' ' 74' ' ' LYS . . . -50.17 169.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.805 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.46 146.45 51.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.994 0.426 . . . . 0.0 111.286 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.658 ' O ' HG23 ' B' ' 76' ' ' THR . 1.7 p -152.61 58.43 0.81 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.42 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 25.3 p -96.04 142.78 27.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.129 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' C' ' 78' ' ' PHE . 33.9 m -147.44 153.52 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.153 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.837 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.7 OUTLIER -80.7 83.64 6.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.644 ' CG2' HD11 ' B' ' 115' ' ' LEU . 9.7 m -71.87 160.8 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.856 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -67.59 -53.54 27.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.235 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.417 ' HB3' HD12 ' A' ' 82' ' ' LEU . 1.5 mpt_? -151.28 -178.52 6.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.644 HD11 ' CG2' ' B' ' 112' ' ' VAL . 2.2 mp -153.57 159.29 32.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.577 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.525 ' O ' HG12 ' B' ' 119' ' ' VAL . 9.5 Cg_endo -52.15 140.19 51.38 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.573 2.182 . . . . 0.0 112.195 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 0.0 OUTLIER 66.86 13.97 9.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.537 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.76 19.16 5.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.078 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.717 ' HA ' HG11 ' B' ' 43' ' ' VAL . 3.1 p -52.28 -49.38 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 121.655 0.741 . . . . 0.0 111.194 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . 0.524 ' C ' HD13 ' B' ' 115' ' ' LEU . . . 90.23 -7.47 81.48 Favored Glycine 0 C--N 1.308 -1.012 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.338 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.711 HD11 HG13 ' B' ' 47' ' ' ILE . 16.7 mt -140.12 146.7 39.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.213 0.53 . . . . 0.0 111.128 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.426 ' HB2' ' CD2' ' B' ' 115' ' ' LEU . 26.1 tt0 -147.56 152.42 37.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.976 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.573 HD13 HD23 ' B' ' 55' ' ' LEU . 26.7 mt -138.1 127.39 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.258 0.552 . . . . 0.0 112.237 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.43 132.19 18.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.417 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.699 ' CB ' HG22 ' B' ' 75' ' ' THR . . . -149.43 159.4 44.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.827 HD12 HD12 ' B' ' 29' ' ' LEU . 14.8 mm -105.28 153.43 6.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.889 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 1.045 ' HB3' HG12 ' B' ' 28' ' ' VAL . . . -137.09 152.63 50.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.012 0.434 . . . . 0.0 111.845 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.897 HG12 HD22 ' B' ' 27' ' ' LEU . 27.0 m -120.06 178.05 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.834 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 -179.838 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.72 HG21 HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.819 0.342 . . . . 0.0 110.942 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.57 114.64 15.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 1.026 HD11 HG11 ' C' ' 19' ' ' VAL . 1.1 tp -53.3 132.71 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.3 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' C' ' 23' ' ' ASP . 12.4 mm -98.67 143.4 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -168.16 106.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.789 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 3.7 t -124.97 169.31 12.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.8 29.87 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.454 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 0.4 OUTLIER -118.21 -40.76 2.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.677 ' HB1' ' CD ' ' C' ' 12' ' ' PRO . . . -72.21 177.24 1.84 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.213 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 22.2 Cg_exo -65.04 -10.89 27.33 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.947 2.432 . . . . 0.0 112.682 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.68 151.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.064 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.35 122.48 46.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.114 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.616 HG22 ' O ' ' C' ' 15' ' ' ILE . 26.3 mm -123.1 17.09 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.833 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.3 -131.92 3.63 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.36 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . 0.456 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 80.2 Cg_endo -90.03 20.77 0.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.759 2.306 . . . . 0.0 113.337 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.588 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 1.5 p90 -140.48 178.62 7.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.964 0.411 . . . . 0.0 111.516 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 1.026 HG11 HD11 ' C' ' 5' ' ' ILE . 15.7 m -132.92 -179.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.84 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -49.01 79.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' C' ' 61' ' ' ILE . . . -177.58 -172.78 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.825 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.789 HG23 HD23 ' C' ' 29' ' ' LEU . 4.7 m -142.24 132.64 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.161 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.788 ' HA ' HG23 ' C' ' 28' ' ' VAL . 10.5 t0 -113.97 109.83 19.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.81 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.646 ' CD1' HD21 ' C' ' 29' ' ' LEU . 12.1 mt -81.09 -14.72 57.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.231 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.88 -100.1 0.7 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.53 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . 0.722 ' C ' HD23 ' C' ' 27' ' ' LEU . 9.2 m-20 -57.6 -29.79 64.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.194 0.521 . . . . 0.0 109.839 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.93 HD22 HG12 ' C' ' 128' ' ' VAL . 1.4 mt -130.03 141.92 50.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.998 HG12 ' HB3' ' C' ' 127' ' ' ALA . 4.7 p -125.55 144.71 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.2 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.81 HD12 HD12 ' C' ' 126' ' ' ILE . 0.0 OUTLIER -118.08 147.01 43.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.51 HG21 HD11 ' C' ' 62' ' ' ILE . 16.2 p -124.15 155.18 38.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.923 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.96 167.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.958 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.89 94.6 0.14 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.314 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.521 ' O ' HD13 ' C' ' 34' ' ' ILE . 23.2 mm-40 -58.83 150.04 25.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 111.206 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.521 HD13 ' O ' ' C' ' 33' ' ' GLN . 22.4 mm -133.4 134.97 24.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.108 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.563 ' HD2' HG21 ' C' ' 119' ' ' VAL . 16.0 Cg_exo -68.09 56.2 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.874 2.383 . . . . 0.0 112.789 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.411 HG21 ' HB3' ' C' ' 12' ' ' PRO . 41.4 t . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 121.295 0.569 . . . . 0.0 110.595 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' C' ' 119' ' ' VAL . 7.4 p . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.478 0.18 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' C' ' 35' ' ' PRO . 52.1 Cg_exo -51.98 140.26 49.6 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.297 1.998 . . . . 0.0 112.204 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.67 -31.0 69.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.009 0.433 . . . . 0.0 111.065 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.1 OUTLIER -75.44 94.91 3.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.869 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.698 HG13 HD11 ' C' ' 121' ' ' LEU . 2.7 tp -43.38 -31.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.636 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 32.2 t -79.66 -45.51 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.646 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -63.22 -48.09 79.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.587 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.728 ' OE1' HD12 ' C' ' 121' ' ' LEU . 2.7 pt20 -61.53 -29.47 70.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.359 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.91 -39.61 61.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.964 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -62.38 -48.48 79.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.794 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.04 -34.62 78.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.601 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.8 OUTLIER -66.17 -31.1 71.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.762 HD13 ' CE2' ' C' ' 95' ' ' PHE . 75.5 mt -69.72 -49.89 48.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -40.82 84.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.87 -38.51 70.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.671 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.601 HG23 ' O ' ' C' ' 54' ' ' SER . 38.9 t -65.15 -25.97 38.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.678 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.711 ' HD3' ' HB2' ' C' ' 69' ' ' ALA . 0.3 OUTLIER -83.79 -39.22 20.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.755 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -58.26 -39.84 80.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.455 HD11 ' OE1' ' C' ' 33' ' ' GLN . 50.3 mt -68.69 -53.07 29.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.51 HD11 HG21 ' C' ' 30' ' ' THR . 50.9 mt -64.65 -28.87 45.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.731 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.49 -42.53 52.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.558 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -16.2 64.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.615 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . 0.513 ' HB2' HD12 ' C' ' 6' ' ' ILE . . . -88.34 -28.74 20.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.929 0.395 . . . . 0.0 110.741 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.62 43.66 0.62 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.545 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.465 ' HB3' HG22 ' C' ' 62' ' ' ILE . 1.5 mt -149.74 -167.13 2.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.939 0.4 . . . . 0.0 110.849 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.16 154.91 38.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.71 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.861 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -58.16 -36.68 73.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.371 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.449 ' HB2' ' HD2' ' C' ' 101' ' ' HIS . . . -50.09 -26.35 4.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.285 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -23.75 34.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.381 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' C' ' 69' ' ' ALA . 88.8 mt -44.34 120.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.883 0.373 . . . . 0.0 111.416 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.565 HG13 HG22 ' C' ' 128' ' ' VAL . 29.1 m -90.17 -38.02 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.716 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.538 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -137.8 155.5 48.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.952 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.792 HG21 ' OH ' ' C' ' 92' ' ' TYR . 17.4 p -143.37 152.03 41.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.034 0.445 . . . . 0.0 111.579 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.656 HG23 ' O ' ' C' ' 108' ' ' SER . 5.3 m -133.72 142.31 47.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.007 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -143.03 105.88 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 111.787 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.488 ' HB2' HD21 ' C' ' 115' ' ' LEU . 7.7 m-85 -86.96 106.21 17.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.544 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.698 HG12 ' CD2' ' C' ' 121' ' ' LEU . 18.7 m -102.66 152.59 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.624 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.08 -2.58 46.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.802 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -154.45 113.44 3.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.635 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.56 HD11 ' C ' ' A' ' 115' ' ' LEU . 6.1 mt -65.2 -13.56 58.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.044 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.95 -23.17 36.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.443 ' OD1' HG21 ' C' ' 47' ' ' ILE . 6.6 m-20 -80.88 -23.69 38.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.156 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.615 ' HD1' HG11 ' C' ' 79' ' ' VAL . 2.0 t80 -56.25 -23.92 39.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.384 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.85 74.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.214 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.46 -38.68 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.242 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.37 -36.04 65.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.6 t30 -69.24 -43.22 74.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.12 -32.9 74.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.08 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . 0.588 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 0.1 OUTLIER -86.0 -23.2 26.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.156 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.792 ' OH ' HG21 ' C' ' 75' ' ' THR . 10.3 t80 -77.94 -27.5 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.538 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.1 -39.52 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . 0.588 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 0.0 OUTLIER -67.25 -23.12 65.67 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.762 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -90.88 -32.75 15.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.784 0.326 . . . . 0.0 110.529 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.523 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 1.6 m-85 -60.2 -58.81 6.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.059 0.457 . . . . 0.0 110.259 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -63.53 -28.22 69.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.141 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -77.75 -10.9 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.566 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 2.2 m-80 -111.17 -5.85 14.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.397 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 0.5 OUTLIER 94.5 37.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.86 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.861 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 1.8 m170 -117.93 51.99 1.34 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.723 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 64.3 Cg_endo -72.0 -21.57 24.07 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.442 2.095 . . . . 0.0 112.574 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.36 -33.01 51.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.936 0.398 . . . . 0.0 110.718 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.633 ' O ' HG22 ' A' ' 19' ' ' VAL . 15.5 m-85 60.98 83.75 0.2 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.074 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 17.1 Cg_endo -58.17 159.46 18.72 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.45 2.1 . . . . 0.0 112.005 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' C' ' 74' ' ' LYS . . . -50.26 169.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.779 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.31 146.44 51.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.0 0.429 . . . . 0.0 111.341 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . 0.656 ' O ' HG23 ' C' ' 76' ' ' THR . 1.7 p -152.59 58.5 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.457 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 25.4 p -96.05 142.85 27.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.093 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.435 HG11 ' CD2' ' A' ' 78' ' ' PHE . 33.9 m -147.62 153.93 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.852 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -80.85 83.63 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.656 ' CG2' HD11 ' C' ' 115' ' ' LEU . 9.6 m -71.95 160.81 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.837 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -67.55 -53.57 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.22 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -151.25 -178.6 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.987 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.656 HD11 ' CG2' ' C' ' 112' ' ' VAL . 2.1 mp -153.56 159.39 32.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.526 ' O ' HG12 ' C' ' 119' ' ' VAL . 9.6 Cg_endo -52.18 140.17 51.75 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.598 2.199 . . . . 0.0 112.195 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 0.0 OUTLIER 66.89 13.99 9.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.515 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.72 19.21 5.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.728 ' HA ' HG11 ' C' ' 43' ' ' VAL . 3.1 p -52.34 -49.34 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.658 0.742 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . 0.54 ' C ' HD13 ' C' ' 115' ' ' LEU . . . 90.3 -7.49 81.41 Favored Glycine 0 C--N 1.308 -0.984 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.333 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.728 HD12 ' OE1' ' C' ' 50' ' ' GLN . 16.7 mt -140.16 146.72 39.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.246 0.546 . . . . 0.0 111.134 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.429 ' HB2' ' CD2' ' C' ' 115' ' ' LEU . 26.1 tt0 -147.67 152.39 37.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.953 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.558 HD13 HD23 ' C' ' 55' ' ' LEU . 26.7 mt -138.05 127.47 33.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.229 0.538 . . . . 0.0 112.189 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.48 132.13 18.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.431 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.699 ' CB ' HG22 ' C' ' 75' ' ' THR . . . -149.37 159.39 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.211 0.529 . . . . 0.0 112.412 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.81 HD12 HD12 ' C' ' 29' ' ' LEU . 14.7 mm -105.22 153.43 6.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.917 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.998 ' HB3' HG12 ' C' ' 28' ' ' VAL . . . -137.11 152.56 50.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.031 0.443 . . . . 0.0 111.79 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.93 HG12 HD22 ' C' ' 27' ' ' LEU . 27.0 m -119.99 178.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.842 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -167.74 59.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 111.035 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.916 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.977 HG21 HG21 ' C' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.798 0.332 . . . . 0.0 110.794 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -157.82 118.17 3.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.803 HD11 ' OD1' ' C' ' 103' ' ' ASN . 4.4 mp -58.25 138.3 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.081 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.863 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 31.9 mt -94.83 138.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.158 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -150.97 136.94 18.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.51 162.81 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.75 26.61 5.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -118.03 -40.57 2.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.64 119.65 72.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.171 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.05 -10.84 28.61 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.42 2.08 . . . . 0.0 112.596 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.45 172.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.928 0.394 . . . . 0.0 111.464 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 62.84 130.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.187 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.94 -36.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.504 0.669 . . . . 0.0 110.768 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.03 -145.11 11.19 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.368 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.69 57.97 5.78 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.731 2.287 . . . . 0.0 112.873 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.482 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -168.46 -177.3 3.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 111.08 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' C' ' 104' ' ' PHE . 27.0 m -112.8 -178.45 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.297 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.415 ' CG ' ' HB2' ' A' ' 14' ' ' ALA . 43.5 mt-30 -80.2 -50.94 9.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.982 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -156.95 179.8 8.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.268 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 m -139.57 147.3 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.082 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.908 ' HA ' HG12 ' A' ' 28' ' ' VAL . 20.3 t0 -123.23 94.32 4.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.736 HD22 HG11 ' C' ' 128' ' ' VAL . 11.0 mt -69.96 -17.37 63.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.268 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.62 -105.42 0.95 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.146 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.478 ' HB2' HD23 ' A' ' 27' ' ' LEU . 67.0 m-80 -52.6 -29.99 28.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.054 0.454 . . . . 0.0 110.525 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -137.24 134.16 35.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.773 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.01 HG23 ' HB3' ' A' ' 127' ' ' ALA . 3.0 m -113.07 172.32 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.218 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.761 HD23 HD12 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -145.67 165.71 27.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.431 HG21 HD11 ' A' ' 62' ' ' ILE . 44.3 p -130.13 135.98 48.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m -69.23 154.54 41.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.97 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 123' ' ' ILE . . . -55.26 93.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.631 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.767 ' HG2' HG22 ' A' ' 58' ' ' VAL . 1.6 mp0 -67.65 173.7 4.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.776 0.322 . . . . 0.0 111.009 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.677 ' HB ' HG11 ' A' ' 119' ' ' VAL . 7.6 pt -159.38 152.54 18.48 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.441 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.68 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 43.8 Cg_endo -68.09 74.8 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.05 2.5 . . . . 0.0 112.325 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.508 HG23 HG13 ' A' ' 34' ' ' ILE . 22.5 t . . . . . 0 C--N 1.32 -0.698 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.587 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 7.1 p . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.507 0.194 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -55.58 140.62 83.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.296 1.998 . . . . 0.0 112.144 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.06 71.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.044 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -75.75 94.93 3.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.858 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.502 HD12 ' NE2' ' A' ' 50' ' ' GLN . 6.4 tp -44.5 -31.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.427 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -38.29 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.713 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . . . -69.24 -39.97 78.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.497 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.502 ' NE2' HD12 ' A' ' 47' ' ' ILE . 6.8 pt20 -75.44 -21.88 57.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.223 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.5 -41.5 27.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.161 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.24 -34.45 63.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.76 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.15 -31.59 64.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.529 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.802 ' O ' HG23 ' A' ' 58' ' ' VAL . 68.7 p -67.31 -30.79 70.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.703 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.873 HD13 ' CE2' ' A' ' 95' ' ' PHE . 34.2 mt -79.39 -30.72 42.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.802 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.55 -55.91 20.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.985 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 9.3 p-10 -55.79 -44.99 78.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 54' ' ' SER . 45.0 t -59.25 -31.02 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -79.2 -38.42 35.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.766 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.27 81.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' A' ' 58' ' ' VAL . 6.5 mt -67.06 -51.26 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.771 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.431 HD11 HG21 ' A' ' 30' ' ' THR . 45.8 mt -63.21 -32.63 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.592 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.68 -40.71 63.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.241 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.52 -21.0 65.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.94 -25.66 20.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.812 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 47.91 0.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.482 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.808 HD22 ' OD2' ' A' ' 71' ' ' ASP . 7.2 mt -156.68 -171.62 3.74 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.724 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.6 p -142.82 -179.58 6.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.981 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.812 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -78.63 -24.89 45.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.58 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.565 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -59.81 -36.54 76.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.981 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.808 ' OD2' HD22 ' A' ' 67' ' ' LEU . 4.0 p30 -71.01 -26.51 63.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.072 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.443 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 88.3 mt -46.76 115.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.83 0.348 . . . . 0.0 110.933 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.46 HG21 HD21 ' B' ' 24' ' ' LEU . 27.3 m -91.26 -26.01 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.766 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.639 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 1.7 ttpm? -138.03 164.46 29.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.735 0.302 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 125' ' ' ALA . 91.9 m -163.63 126.58 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.045 0.45 . . . . 0.0 111.492 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 108' ' ' SER . 2.8 m -109.25 144.8 36.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.881 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.08 108.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 111.782 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.455 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.6 m-85 -91.47 107.11 18.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.278 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.757 HG12 HD22 ' A' ' 121' ' ' LEU . 30.0 m -102.21 149.95 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.201 0.524 . . . . 0.0 111.804 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.74 -6.18 49.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.818 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.44 111.99 3.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.54 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 82' ' ' LEU . 2.6 mt -61.28 -15.18 32.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -78.32 -19.45 53.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.758 0.313 . . . . 0.0 110.869 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 88' ' ' VAL . 19.2 m-20 -90.65 7.18 40.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.411 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.444 ' CD1' HG11 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -82.18 -27.46 32.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 111.172 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -36.76 76.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.123 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.38 -36.6 29.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 84' ' ' ASP . 27.9 t -75.6 -30.52 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 85' ' ' PHE . 9.9 m120 -67.19 -48.88 66.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.02 -39.18 90.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.177 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.412 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 0.6 OUTLIER -75.89 -23.94 55.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.196 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -81.73 -33.29 31.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.401 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' B' ' 17' ' ' PRO . 0.8 OUTLIER -89.65 -29.76 18.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.696 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.412 ' HG2' ' HA ' ' A' ' 91' ' ' GLU . 1.3 ppt_? -75.86 -21.59 57.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.663 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.873 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -92.01 -33.13 14.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 0.0 110.671 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.503 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 2.6 m-85 -58.98 -59.13 5.96 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.063 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -31.5 72.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.246 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.57 -11.5 60.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.419 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 4.9 m-20 -110.91 -6.53 14.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.336 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 8.1 t-20 90.11 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.548 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.812 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 m-70 -115.21 53.41 0.81 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.025 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.1 Cg_endo -74.63 -14.51 22.07 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.51 2.14 . . . . 0.0 112.55 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.803 ' OD1' HD11 ' B' ' 5' ' ' ILE . 2.0 t30 -51.68 -33.28 33.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.093 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.751 ' CB ' HG13 ' B' ' 19' ' ' VAL . 3.6 m-85 61.47 96.46 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.031 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 59.9 Cg_endo -73.33 159.09 47.53 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.443 2.095 . . . . 0.0 112.258 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.639 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -55.71 147.69 18.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.445 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.64 142.52 45.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.005 0.431 . . . . 0.0 111.442 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.584 ' O ' HG23 ' A' ' 76' ' ' THR . 31.1 t -149.58 62.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.376 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.5 p -94.64 145.38 24.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.461 HG11 ' CD2' ' B' ' 78' ' ' PHE . 35.9 m -153.28 135.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.212 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.601 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -64.76 91.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.802 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.769 HG21 HD21 ' A' ' 115' ' ' LEU . 8.4 m -76.26 164.43 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -83.66 -44.8 14.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.411 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 0.1 OUTLIER -158.54 158.62 34.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.734 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.87 HD22 ' HB2' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -141.34 168.99 12.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.485 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 115' ' ' LEU . 74.4 Cg_exo -50.18 136.87 38.28 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.351 2.034 . . . . 0.0 112.362 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 67.13 14.31 9.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.359 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.53 20.11 5.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.021 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.677 HG11 ' HB ' ' A' ' 34' ' ' ILE . 16.0 m -53.12 149.75 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.244 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.581 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -81.52 -15.01 77.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.754 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.757 HD22 HG12 ' A' ' 79' ' ' VAL . 42.1 mt -152.3 148.65 27.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 110.848 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.87 ' HB2' HD22 ' A' ' 115' ' ' LEU . 27.2 tt0 -129.8 146.71 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.21 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.401 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 29.0 mm -120.1 150.27 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.035 0.445 . . . . 0.0 111.763 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.22 147.45 6.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.694 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -173.83 164.34 4.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.098 0.475 . . . . 0.0 112.129 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.761 HD12 HD23 ' A' ' 29' ' ' LEU . 5.6 mm -117.59 151.83 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.362 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 1.01 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -131.49 147.53 52.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.976 0.417 . . . . 0.0 111.739 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.969 HG21 HG21 ' B' ' 3' ' ' THR . 27.1 m -109.6 152.01 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.055 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.786 ' HB2' HD11 ' A' ' 67' ' ' LEU . 11.7 ttp180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.78 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.969 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.778 0.323 . . . . 0.0 110.809 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -157.81 118.18 3.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.009 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.803 HD11 ' OD1' ' A' ' 103' ' ' ASN . 4.4 mp -58.22 138.26 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.084 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.865 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 31.8 mt -94.83 138.11 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -150.94 136.92 18.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.52 162.77 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.72 26.67 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -118.11 -40.86 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -85.24 119.68 72.61 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 17.8 Cg_exo -66.03 -10.88 28.71 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.424 2.083 . . . . 0.0 112.572 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.43 172.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.525 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.487 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 62.86 130.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.207 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.95 -36.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.509 0.671 . . . . 0.0 110.773 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.04 -145.18 11.29 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.313 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 94.3 Cg_endo -83.64 58.01 5.82 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.715 2.276 . . . . 0.0 112.896 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -168.54 -177.29 3.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 111.067 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.751 HG13 ' CB ' ' A' ' 104' ' ' PHE . 27.0 m -112.77 -178.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.418 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 43.5 mt-30 -80.3 -51.05 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.044 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.865 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -156.59 179.75 8.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.272 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.56 147.32 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.076 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.916 ' HA ' HG12 ' B' ' 28' ' ' VAL . 20.4 t0 -123.24 94.39 4.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.786 HD22 HG11 ' A' ' 128' ' ' VAL . 11.0 mt -70.02 -17.42 63.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.61 -105.32 0.95 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.12 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . 0.483 ' HB2' HD23 ' B' ' 27' ' ' LEU . 67.3 m-80 -52.66 -29.97 29.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.472 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' B' ' 26' ' ' ASN . 0.2 OUTLIER -137.29 134.17 35.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.776 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.017 HG23 ' HB3' ' B' ' 127' ' ' ALA . 3.0 m -113.03 172.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.737 HD23 HD12 ' B' ' 126' ' ' ILE . 1.0 OUTLIER -145.7 165.69 28.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.672 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.418 HG21 HD11 ' B' ' 62' ' ' ILE . 44.2 p -130.13 136.0 48.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 48.6 m -69.34 154.41 42.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' B' ' 123' ' ' ILE . . . -55.21 93.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.608 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.755 ' HG2' HG22 ' B' ' 58' ' ' VAL . 1.6 mp0 -67.66 173.66 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.734 0.302 . . . . 0.0 111.004 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.68 ' HB ' HG11 ' B' ' 119' ' ' VAL . 7.7 pt -159.37 152.59 18.55 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.004 0.43 . . . . 0.0 111.467 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.667 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 44.0 Cg_endo -68.14 74.81 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.108 2.538 . . . . 0.0 112.338 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.509 HG23 HG13 ' B' ' 34' ' ' ILE . 22.6 t . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.55 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 7.1 p . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.496 0.189 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -55.63 140.64 84.07 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.331 2.021 . . . . 0.0 112.153 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.1 71.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' B' ' 49' ' ' ALA . 1.0 OUTLIER -75.74 94.91 3.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.863 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.497 HD12 ' NE2' ' B' ' 50' ' ' GLN . 6.3 tp -44.43 -31.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.408 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.19 -38.27 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.733 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' B' ' 46' ' ' ASP . . . -69.28 -39.99 78.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.463 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.497 ' NE2' HD12 ' B' ' 47' ' ' ILE . 6.8 pt20 -75.52 -21.83 57.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.239 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.6 -41.49 26.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.213 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.26 -34.47 63.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.15 -31.51 64.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.57 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.795 ' O ' HG23 ' B' ' 58' ' ' VAL . 68.9 p -67.31 -30.82 70.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.84 HD13 ' CE2' ' B' ' 95' ' ' PHE . 34.4 mt -79.38 -30.7 42.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.6 -55.9 20.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 9.3 p-10 -55.76 -45.03 78.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.795 HG23 ' O ' ' B' ' 54' ' ' SER . 44.9 t -59.27 -30.94 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.768 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -79.22 -38.47 35.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.16 81.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' B' ' 58' ' ' VAL . 6.5 mt -67.02 -51.41 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.792 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.418 HD11 HG21 ' B' ' 30' ' ' THR . 45.8 mt -63.19 -32.64 57.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.598 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.64 -40.69 63.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.266 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.56 -21.0 65.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.485 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.89 -25.68 20.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.1 47.96 0.54 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.461 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.809 HD22 ' OD2' ' B' ' 71' ' ' ASP . 7.2 mt -156.75 -171.65 3.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.764 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 76.8 p -142.82 -179.65 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.809 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -78.59 -24.93 45.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.577 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.579 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -59.79 -36.47 76.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.029 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.809 ' OD2' HD22 ' B' ' 67' ' ' LEU . 4.0 p30 -71.06 -26.51 63.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.055 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 105' ' ' PRO . 88.3 mt -46.8 115.63 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.445 HG21 HD21 ' C' ' 24' ' ' LEU . 27.3 m -91.21 -25.95 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.762 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.636 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 1.7 ttpm? -138.11 164.42 29.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.0 110.936 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 125' ' ' ALA . 91.7 m -163.58 126.63 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.048 0.451 . . . . 0.0 111.484 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.587 HG23 ' O ' ' B' ' 108' ' ' SER . 2.8 m -109.28 144.78 36.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.03 108.4 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.914 0.388 . . . . 0.0 111.828 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.461 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.6 m-85 -91.46 107.16 19.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.24 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.753 HG12 HD22 ' B' ' 121' ' ' LEU . 30.2 m -102.22 149.97 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.158 0.504 . . . . 0.0 111.838 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.89 -6.14 49.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.747 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.45 111.96 3.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.516 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' B' ' 82' ' ' LEU . 2.6 mt -61.15 -15.24 31.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.242 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -78.31 -19.52 53.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.603 ' O ' HG23 ' B' ' 88' ' ' VAL . 19.2 m-20 -90.62 7.26 40.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.448 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.448 ' CD1' HG11 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -82.25 -27.48 32.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.749 0.309 . . . . 0.0 111.114 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.19 -36.8 75.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.157 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.36 -36.63 29.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.603 HG23 ' O ' ' B' ' 84' ' ' ASP . 28.8 t -75.63 -30.48 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' B' ' 85' ' ' PHE . 9.9 m120 -67.21 -48.93 66.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.94 -39.32 90.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.78 -23.98 55.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -81.78 -33.29 30.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.399 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.71 -29.68 18.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.657 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -75.88 -21.57 57.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.668 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.84 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -92.04 -33.13 14.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 110.671 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.495 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 2.6 m-85 -58.95 -59.11 5.99 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.09 0.472 . . . . 0.0 110.138 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -31.46 72.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.297 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.49 -11.6 60.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.436 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.49 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 4.9 m-20 -110.88 -6.44 14.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.336 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 8.1 t-20 90.11 35.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.619 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.809 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.6 m-70 -115.3 53.43 0.83 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.959 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 71.8 Cg_endo -74.56 -14.61 22.21 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.541 2.161 . . . . 0.0 112.577 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.789 ' OD1' HD11 ' C' ' 5' ' ' ILE . 2.0 t30 -51.59 -33.33 32.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.135 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.727 ' CB ' HG13 ' C' ' 19' ' ' VAL . 3.6 m-85 61.49 96.48 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 59.9 Cg_endo -73.34 159.05 47.56 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.404 2.069 . . . . 0.0 112.255 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.636 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -55.59 147.72 17.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.458 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.76 142.49 45.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.032 0.444 . . . . 0.0 111.471 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.587 ' O ' HG23 ' B' ' 76' ' ' THR . 31.2 t -149.52 62.87 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.352 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 18.8 p -94.62 145.41 24.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.233 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.464 HG11 ' CD2' ' C' ' 78' ' ' PHE . 35.9 m -153.33 135.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.244 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -64.78 91.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.77 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.739 HG21 HD21 ' B' ' 115' ' ' LEU . 8.2 m -76.35 164.45 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.236 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -83.6 -44.88 14.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.106 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.425 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -158.51 158.68 34.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.706 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.863 HD22 ' HB2' ' B' ' 122' ' ' GLU . 0.9 OUTLIER -141.4 168.95 12.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.495 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' B' ' 115' ' ' LEU . 74.5 Cg_exo -50.16 136.89 38.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.352 2.035 . . . . 0.0 112.325 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.11 14.28 9.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.398 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.56 20.07 5.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.041 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.68 HG11 ' HB ' ' B' ' 34' ' ' ILE . 16.0 m -53.1 149.77 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.198 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . 0.581 ' O ' HD23 ' B' ' 121' ' ' LEU . . . -81.56 -15.15 76.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.769 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.753 HD22 HG12 ' B' ' 79' ' ' VAL . 42.5 mt -152.21 148.63 27.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.959 0.409 . . . . 0.0 110.848 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.863 ' HB2' HD22 ' B' ' 115' ' ' LEU . 27.0 tt0 -129.68 146.63 51.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.284 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.415 ' O ' ' HA2' ' B' ' 32' ' ' GLY . 29.3 mm -120.11 150.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 111.748 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.16 147.48 6.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.69 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.517 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -173.87 164.4 4.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 112.133 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.737 HD12 HD23 ' B' ' 29' ' ' LEU . 5.6 mm -117.74 151.85 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.334 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 1.017 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -131.45 147.54 52.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 111.781 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.945 HG21 HG21 ' C' ' 3' ' ' THR . 27.1 m -109.62 151.93 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.086 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.786 ' HB2' HD11 ' B' ' 67' ' ' LEU . 11.7 ttp180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.79 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.945 HG21 HG21 ' B' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.793 0.33 . . . . 0.0 110.742 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -157.87 118.22 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.789 HD11 ' OD1' ' B' ' 103' ' ' ASN . 4.4 mp -58.19 138.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.092 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.83 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 31.6 mt -94.73 138.08 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.169 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -151.0 136.91 18.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.49 162.77 34.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.71 26.65 5.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -118.06 -40.69 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.791 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' C' ' 12' ' ' PRO . . . -85.5 119.67 72.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.124 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' C' ' 11' ' ' ALA . 17.8 Cg_exo -66.03 -10.88 28.73 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.496 2.131 . . . . 0.0 112.601 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.5 172.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.472 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 62.94 130.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.16 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.91 -36.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.495 0.664 . . . . 0.0 110.741 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.06 -145.12 11.23 Favored Glycine 0 C--N 1.315 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.364 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.68 57.95 5.78 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.702 2.268 . . . . 0.0 112.901 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -168.45 -177.37 3.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.086 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.727 HG13 ' CB ' ' B' ' 104' ' ' PHE . 27.0 m -112.73 -178.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.328 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 43.4 mt-30 -80.31 -51.2 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.05 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.83 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -156.41 179.68 9.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.282 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.5 147.37 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.921 ' HA ' HG12 ' C' ' 28' ' ' VAL . 20.4 t0 -123.25 94.36 4.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.773 HD22 HG11 ' B' ' 128' ' ' VAL . 11.0 mt -69.99 -17.4 63.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.232 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.62 -105.37 0.95 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.178 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . 0.499 ' HB2' HD23 ' C' ' 27' ' ' LEU . 67.0 m-80 -52.53 -30.07 28.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.038 0.447 . . . . 0.0 110.517 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' C' ' 26' ' ' ASN . 0.2 OUTLIER -137.21 134.14 35.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.824 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.998 HG23 ' HB3' ' C' ' 127' ' ' ALA . 3.0 m -113.0 172.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.256 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.753 HD23 HD12 ' C' ' 126' ' ' ILE . 1.0 OUTLIER -145.68 165.65 28.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.69 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 44.1 p -130.14 135.96 48.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -69.43 154.44 42.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.032 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' C' ' 123' ' ' ILE . . . -55.26 93.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.647 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.746 ' HG2' HG22 ' C' ' 58' ' ' VAL . 1.6 mp0 -67.58 173.7 4.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.742 0.306 . . . . 0.0 110.991 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.671 ' HB ' HG11 ' C' ' 119' ' ' VAL . 7.7 pt -159.37 152.52 18.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.484 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.672 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 43.7 Cg_endo -68.14 74.84 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.112 2.541 . . . . 0.0 112.304 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.5 HG23 HG13 ' C' ' 34' ' ' ILE . 22.5 t . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.589 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 7.2 p . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.487 0.184 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.67 140.65 84.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.304 2.002 . . . . 0.0 112.151 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.13 71.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.979 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' C' ' 49' ' ' ALA . 1.0 OUTLIER -75.76 94.9 3.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.822 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.493 HD12 ' NE2' ' C' ' 50' ' ' GLN . 6.3 tp -44.43 -31.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.39 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.25 -38.21 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.723 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' C' ' 46' ' ' ASP . . . -69.25 -40.05 78.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.46 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.493 ' NE2' HD12 ' C' ' 47' ' ' ILE . 6.8 pt20 -75.5 -21.95 57.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.241 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.69 -41.59 26.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.181 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.28 -34.36 63.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.786 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.16 -31.56 64.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.556 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.815 ' O ' HG23 ' C' ' 58' ' ' VAL . 69.0 p -67.28 -30.87 70.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.696 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.795 HD13 ' CE2' ' C' ' 95' ' ' PHE . 34.4 mt -79.34 -30.71 42.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.851 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.53 -55.89 20.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.031 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 9.3 p-10 -55.77 -45.06 78.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.815 HG23 ' O ' ' C' ' 54' ' ' SER . 45.1 t -59.19 -31.03 45.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -79.24 -38.5 35.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.701 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.9 80.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' C' ' 58' ' ' VAL . 6.5 mt -67.32 -51.52 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.826 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 mt -63.18 -32.69 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.6 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.66 -40.66 63.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.28 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.58 -20.96 65.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.485 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.9 -25.67 20.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.858 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.11 47.91 0.54 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.453 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.822 HD22 ' OD2' ' C' ' 71' ' ' ASP . 7.2 mt -156.71 -171.64 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.712 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 77.7 p -142.77 -179.6 6.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.804 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -78.64 -24.95 44.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.52 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.575 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -59.82 -36.54 77.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.822 ' OD2' HD22 ' C' ' 67' ' ' LEU . 4.0 p30 -71.11 -26.34 62.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.062 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' C' ' 105' ' ' PRO . 88.4 mt -46.81 115.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.87 0.367 . . . . 0.0 110.953 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.44 HG21 HD21 ' A' ' 24' ' ' LEU . 27.3 m -91.2 -26.0 5.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.78 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 1.7 ttpm? -138.08 164.45 29.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.704 0.288 . . . . 0.0 110.913 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.486 HG23 ' HB2' ' C' ' 125' ' ' ALA . 91.0 m -163.54 126.62 2.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.994 0.426 . . . . 0.0 111.502 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.6 HG23 ' O ' ' C' ' 108' ' ' SER . 2.8 m -109.34 144.79 37.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.845 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.01 108.39 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 111.844 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.464 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.6 m-85 -91.44 107.11 18.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.332 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.73 HG12 HD22 ' C' ' 121' ' ' LEU . 29.9 m -102.14 149.94 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.137 0.494 . . . . 0.0 111.837 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.81 -6.36 49.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.858 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.13 111.91 3.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.488 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.22 -15.21 32.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.282 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -78.33 -19.51 53.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.767 0.318 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.608 ' O ' HG23 ' C' ' 88' ' ' VAL . 19.2 m-20 -90.64 7.26 40.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.372 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.447 ' CD1' HG11 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -82.32 -27.41 32.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 111.117 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.31 -36.67 76.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.162 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.41 -36.66 29.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.608 HG23 ' O ' ' C' ' 84' ' ' ASP . 28.3 t -75.63 -30.47 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' C' ' 85' ' ' PHE . 9.9 m120 -67.16 -48.95 66.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.1 90.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 0.6 OUTLIER -75.91 -23.91 55.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.248 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -81.71 -33.32 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.378 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' C' ' 104' ' ' PHE . 0.8 OUTLIER -89.69 -29.72 18.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.651 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 1.3 ppt_? -75.88 -21.54 57.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.686 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.795 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -92.02 -33.18 14.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.795 0.331 . . . . 0.0 110.669 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 2.6 m-85 -59.03 -59.05 6.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.032 0.444 . . . . 0.0 110.124 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -31.5 72.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.279 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.53 -11.5 60.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.436 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 4.9 m-20 -110.93 -6.49 14.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.302 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 8.1 t-20 90.21 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.539 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.804 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.6 m-70 -115.37 53.38 0.84 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.0 Cg_endo -74.57 -14.61 22.2 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.514 2.143 . . . . 0.0 112.563 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.803 ' OD1' HD11 ' A' ' 5' ' ' ILE . 2.0 t30 -51.61 -33.27 32.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.125 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.74 ' CB ' HG13 ' A' ' 19' ' ' VAL . 3.7 m-85 61.5 96.45 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.016 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 60.2 Cg_endo -73.26 159.17 47.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.389 2.059 . . . . 0.0 112.293 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.648 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -55.77 147.64 18.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.65 142.47 45.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.034 0.445 . . . . 0.0 111.476 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . 0.6 ' O ' HG23 ' C' ' 76' ' ' THR . 31.0 t -149.49 62.84 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.346 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 18.5 p -94.59 145.36 24.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.221 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.455 HG11 ' CD2' ' A' ' 78' ' ' PHE . 35.8 m -153.24 134.88 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.195 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.636 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.51 91.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.761 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.753 HG21 HD21 ' C' ' 115' ' ' LEU . 8.4 m -76.28 164.41 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.286 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -83.68 -44.81 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.432 ' HB2' ' HB3' ' B' ' 111' ' ' GLU . 0.1 OUTLIER -158.56 158.61 34.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.746 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.86 HD22 ' HB2' ' C' ' 122' ' ' GLU . 0.9 OUTLIER -141.37 168.98 12.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.501 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' C' ' 115' ' ' LEU . 74.1 Cg_exo -50.19 136.88 38.37 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.37 2.047 . . . . 0.0 112.275 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.11 14.35 9.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.366 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.54 20.14 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.009 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.671 HG11 ' HB ' ' C' ' 34' ' ' ILE . 16.0 m -53.21 149.81 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . 0.595 ' O ' HD23 ' C' ' 121' ' ' LEU . . . -81.72 -15.13 76.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.794 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.73 HD22 HG12 ' C' ' 79' ' ' VAL . 41.9 mt -152.16 148.53 27.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.89 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.86 ' HB2' HD22 ' C' ' 115' ' ' LEU . 27.1 tt0 -129.68 146.68 51.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.26 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' C' ' 32' ' ' GLY . 29.3 mm -120.18 150.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.064 0.459 . . . . 0.0 111.742 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.09 147.46 6.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.65 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -173.83 164.38 4.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.111 0.482 . . . . 0.0 112.119 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.753 HD12 HD23 ' C' ' 29' ' ' LEU . 5.6 mm -117.67 151.85 19.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.303 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.998 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -131.46 147.58 52.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 111.771 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.977 HG21 HG21 ' A' ' 3' ' ' THR . 27.1 m -109.66 151.97 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.062 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.797 ' HB2' HD11 ' C' ' 67' ' ' LEU . 11.7 ttp180 -173.09 73.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.759 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.821 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.12 110.6 17.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.859 HD11 HG21 ' A' ' 19' ' ' VAL . 2.3 tp -54.99 129.66 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.192 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.634 HD12 ' CB ' ' A' ' 21' ' ' ALA . 32.1 mt -90.53 151.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.412 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.78 108.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.818 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.09 170.28 10.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.69 22.27 10.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.926 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.5 -37.96 6.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.638 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -100.46 127.87 31.73 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.058 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 7.8 Cg_exo -72.1 -1.67 10.41 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.668 2.246 . . . . 0.0 112.701 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' HE21 ' A' ' 20' ' ' GLN . . . -46.92 170.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.862 0.363 . . . . 0.0 111.586 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.27 119.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.115 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 15' ' ' ILE . 13.5 mt -154.79 15.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.858 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.36 -114.64 0.5 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.974 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HB2' ' CD1' ' C' ' 92' ' ' TYR . 92.8 Cg_endo -81.01 50.98 3.76 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.664 2.242 . . . . 0.0 112.981 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.484 ' CG ' ' HB2' ' C' ' 107' ' ' ARG . 1.7 p90 -178.7 156.84 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.0 111.002 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.859 HG21 HD11 ' A' ' 5' ' ' ILE . 31.2 m -106.69 -174.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.174 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.699 HE21 ' HB3' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -73.68 -43.8 58.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.634 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . -176.93 177.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.742 HG12 HD12 ' A' ' 5' ' ' ILE . 18.6 m -138.38 133.75 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.809 ' HA ' HG23 ' A' ' 28' ' ' VAL . 37.5 t70 -103.86 102.8 12.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.657 HD22 HG11 ' C' ' 128' ' ' VAL . 11.8 mt -81.07 -17.88 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.16 -103.57 0.9 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.954 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.35 -29.11 63.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.086 0.47 . . . . 0.0 110.286 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -132.18 122.98 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.923 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.029 HG12 ' HB3' ' A' ' 127' ' ' ALA . 4.2 p -109.28 145.75 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.98 139.53 53.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.9 p -112.93 161.84 16.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.771 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.6 p -95.65 165.55 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.099 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.53 94.34 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.342 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.19 146.14 54.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.248 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.784 ' HB ' HG11 ' A' ' 119' ' ' VAL . 9.5 pt -134.46 142.08 41.44 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.794 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 7.8 Cg_exo -72.56 55.16 2.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.961 2.441 . . . . 0.0 113.138 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.579 HG22 HD12 ' A' ' 34' ' ' ILE . 20.5 t . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.241 0.544 . . . . 0.0 110.554 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.617 HG21 ' H ' ' A' ' 120' ' ' GLY . 11.4 p . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 120.665 0.269 . . . . 0.0 111.379 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 35' ' ' PRO . 52.5 Cg_exo -52.53 140.44 54.62 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.477 2.118 . . . . 0.0 112.422 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.64 -32.05 70.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 92.69 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.615 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 47' ' ' ILE . 22.5 mm -40.12 -32.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.373 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.87 -56.46 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . . . -63.08 -28.74 70.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.772 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.486 HE22 HD12 ' A' ' 121' ' ' LEU . 3.0 tt0 -80.59 -28.83 37.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.675 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' CB ' HG22 ' A' ' 88' ' ' VAL . . . -79.28 -34.8 42.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.538 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.52 -28.79 52.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.179 -179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.25 -48.17 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 110.838 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -59.65 -35.74 75.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.759 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.636 HD13 ' CE2' ' A' ' 95' ' ' PHE . 9.8 mt -64.3 -54.76 28.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.15 -31.44 68.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -67.96 -33.84 75.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.791 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 54' ' ' SER . 39.3 t -69.95 -49.44 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -29.67 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.988 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.42 95.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.61 HG22 HG21 ' A' ' 6' ' ' ILE . 5.3 mt -72.39 -42.57 64.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.536 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.981 HD13 HD11 ' A' ' 72' ' ' ILE . 21.1 mt -69.15 -30.85 47.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.822 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.11 -40.79 59.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.328 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.73 -19.49 65.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.602 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.54 -26.81 19.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.47 41.59 0.67 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.529 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.569 HD22 ' OD2' ' A' ' 71' ' ' ASP . 18.4 mt -155.28 147.11 23.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 110.669 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -101.49 -179.65 4.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.747 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.985 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -78.8 -23.07 45.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.973 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -62.98 -33.52 75.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.569 ' OD2' HD22 ' A' ' 67' ' ' LEU . 10.7 p30 -75.47 -21.76 57.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.71 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.063 HD13 ' HB2' ' A' ' 127' ' ' ALA . 26.4 mm -52.44 121.02 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.86 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' B' ' 22' ' ' VAL . 7.3 m -89.55 -32.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.013 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.825 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -130.11 165.67 21.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.571 0.224 . . . . 0.0 110.937 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 74' ' ' LYS . 6.1 p -162.47 105.91 1.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.831 0.348 . . . . 0.0 111.544 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 108' ' ' SER . 4.6 m -91.92 155.34 18.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.158 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.605 HG22 HG22 ' A' ' 123' ' ' ILE . 21.2 t -150.93 103.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.911 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.537 ' CD2' HG11 ' C' ' 110' ' ' VAL . 10.8 m-85 -89.7 99.73 12.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.358 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.863 HG12 HD23 ' A' ' 121' ' ' LEU . 19.1 m -98.41 147.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.588 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.21 -3.71 50.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.231 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -160.98 142.24 11.78 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.627 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.502 HD12 ' HB3' ' B' ' 114' ' ' ARG . 6.6 mt -82.91 1.55 38.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.26 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -98.67 -24.3 15.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.824 0.345 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.81 -27.01 60.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.01 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.546 ' HD2' HG11 ' A' ' 79' ' ' VAL . 1.8 t80 -59.31 -18.65 39.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.58 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.28 -57.78 10.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 111.382 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.93 71.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG22 ' CB ' ' A' ' 51' ' ' ALA . 26.7 t -70.73 -41.27 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.981 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.11 -47.36 80.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.726 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.49 75.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -92.31 -15.95 26.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.685 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.464 ' OH ' HG21 ' A' ' 75' ' ' THR . 12.4 t80 -81.66 -38.33 26.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.729 0.299 . . . . 0.0 111.281 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.0 -28.71 22.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.346 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.21 -21.81 59.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.649 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.636 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -92.07 -34.39 14.4 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.983 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.505 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 3.1 m-85 -57.3 -57.79 11.1 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.091 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.28 -29.81 70.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.097 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.92 -10.17 59.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.49 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.705 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 1.7 t-20 -108.57 -8.83 15.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.311 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 4.3 t30 88.96 33.24 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.445 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.985 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 4.2 m170 -116.83 54.35 1.31 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.842 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 80.2 Cg_endo -75.22 -11.59 21.08 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.618 2.212 . . . . 0.0 112.823 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.762 ' ND2' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -47.96 -37.55 14.78 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.763 ' O ' HG13 ' B' ' 19' ' ' VAL . 11.6 m-85 63.96 83.89 0.19 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.387 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.76 156.16 63.23 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.611 2.207 . . . . 0.0 112.018 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.825 ' HB3' ' CG ' ' A' ' 74' ' ' LYS . . . -53.38 162.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.572 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.484 ' HB2' ' CG ' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -133.01 143.74 49.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.22 0.534 . . . . 0.0 111.734 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 76' ' ' THR . 5.7 t -143.64 65.23 1.32 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.802 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.91 140.26 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.275 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' B' ' 78' ' ' PHE . 35.7 m -149.94 132.48 6.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.018 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.843 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 2.4 tt0 -63.73 86.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 78' ' ' PHE . 6.7 m -72.57 161.22 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.115 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -77.17 -45.81 25.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.501 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -153.57 168.08 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.637 HD22 ' CB ' ' A' ' 122' ' ' GLU . 1.3 mp -142.7 160.62 52.95 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.708 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' O ' HG22 ' A' ' 119' ' ' VAL . 71.5 Cg_exo -48.75 136.03 27.89 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.486 2.124 . . . . 0.0 112.228 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.475 ' HB2' HG13 ' A' ' 119' ' ' VAL . 6.0 mmtm 64.39 16.73 10.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.319 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.72 17.76 9.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.913 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.784 HG11 ' HB ' ' A' ' 34' ' ' ILE . 30.2 m -53.31 122.52 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.302 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -55.32 -21.45 26.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.909 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.863 HD23 HG12 ' A' ' 79' ' ' VAL . 1.6 mp -152.77 147.67 26.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.278 0.561 . . . . 0.0 111.53 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.637 ' CB ' HD22 ' A' ' 115' ' ' LEU . 11.8 tt0 -139.21 151.48 46.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.407 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 77' ' ' VAL . 5.8 pt -150.29 139.28 15.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.4 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 1.1 pm0 -138.74 142.94 38.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.053 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -149.62 172.6 14.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.496 ' O ' HG23 ' A' ' 72' ' ' ILE . 9.4 mt -125.68 153.96 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.064 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' A' ' 72' ' ' ILE . . . -135.4 152.96 51.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.035 0.445 . . . . 0.0 111.797 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.795 HG21 HG21 ' B' ' 3' ' ' THR . 30.0 m -115.98 164.15 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.999 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB2' HD21 ' A' ' 67' ' ' LEU . 28.2 ttt85 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.795 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.13 110.63 17.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.946 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.876 HD11 HG21 ' B' ' 19' ' ' VAL . 2.3 tp -55.02 129.66 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.22 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.639 HD12 ' CB ' ' B' ' 21' ' ' ALA . 31.4 mt -90.43 151.53 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.413 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.81 108.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.06 170.32 10.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.981 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.73 22.24 10.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.55 -38.05 6.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.645 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -100.32 127.88 31.91 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.05 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 7.7 Cg_exo -72.11 -1.67 10.42 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.618 2.212 . . . . 0.0 112.751 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.693 ' HB3' HE21 ' B' ' 20' ' ' GLN . . . -46.88 170.17 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.867 0.365 . . . . 0.0 111.544 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.18 119.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.053 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.607 HG22 ' O ' ' B' ' 15' ' ' ILE . 13.3 mt -154.73 15.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.908 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.33 -114.66 0.5 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.977 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.462 ' HB2' ' CD1' ' A' ' 92' ' ' TYR . 92.5 Cg_endo -80.95 50.93 3.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.7 2.267 . . . . 0.0 112.992 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.484 ' CG ' ' HB2' ' A' ' 107' ' ' ARG . 1.7 p90 -178.69 156.81 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.9 0.381 . . . . 0.0 110.996 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.876 HG21 HD11 ' B' ' 5' ' ' ILE . 30.8 m -106.69 -174.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.17 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.693 HE21 ' HB3' ' B' ' 13' ' ' ALA . 1.0 OUTLIER -73.53 -43.54 59.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.639 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . -177.06 177.46 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.719 HG12 HD12 ' B' ' 5' ' ' ILE . 18.6 m -138.37 133.78 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.146 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.829 ' HA ' HG23 ' B' ' 28' ' ' VAL . 37.5 t70 -103.93 102.84 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.684 HD22 HG11 ' A' ' 128' ' ' VAL . 11.9 mt -81.08 -17.93 48.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.2 -103.6 0.9 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.895 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.32 -29.1 63.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.088 0.471 . . . . 0.0 110.287 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.424 ' HG ' HG12 ' B' ' 128' ' ' VAL . 0.2 OUTLIER -132.21 122.96 26.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.884 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.053 HG12 ' HB3' ' B' ' 127' ' ' ALA . 4.2 p -109.29 145.8 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.844 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.403 HD23 ' HD2' ' A' ' 74' ' ' LYS . 5.2 mp -124.95 139.52 53.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.993 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 77.3 p -112.97 161.89 16.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.745 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 27.6 p -95.6 165.59 12.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.51 94.27 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.335 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.21 146.18 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.753 ' HB ' HG11 ' B' ' 119' ' ' VAL . 9.4 pt -134.5 142.06 41.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.815 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 7.9 Cg_exo -72.58 55.18 2.58 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.964 2.443 . . . . 0.0 113.146 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.574 HG22 HD12 ' B' ' 34' ' ' ILE . 20.5 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.585 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.616 HG13 ' O ' ' B' ' 43' ' ' VAL . 11.5 p . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 120.649 0.261 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.8 Cg_exo -52.65 140.45 55.82 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.46 2.107 . . . . 0.0 112.407 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.0 70.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.2 92.7 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.613 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' B' ' 47' ' ' ILE . 22.4 mm -40.16 -32.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.35 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.87 -56.43 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.749 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.43 ' HA ' ' HG2' ' B' ' 52' ' ' ARG . . . -63.05 -28.79 70.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.752 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.492 HE22 HD12 ' B' ' 121' ' ' LEU . 3.0 tt0 -80.4 -28.3 37.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.634 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.492 ' CB ' HG22 ' B' ' 88' ' ' VAL . . . -79.43 -34.86 41.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.535 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' B' ' 49' ' ' ALA . 0.0 OUTLIER -77.48 -28.84 52.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.169 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.24 -48.11 65.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.82 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.765 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.5 OUTLIER -59.61 -35.79 75.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.66 HD13 ' CE2' ' B' ' 95' ' ' PHE . 9.8 mt -64.24 -54.8 27.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.24 -31.31 68.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.404 ' ND2' ' HD3' ' B' ' 12' ' ' PRO . 26.0 m120 -68.04 -33.71 75.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.765 HG23 ' O ' ' B' ' 54' ' ' SER . 39.2 t -70.0 -49.39 56.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -29.7 65.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.937 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.49 95.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.822 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.588 HG22 HG21 ' B' ' 6' ' ' ILE . 5.3 mt -72.29 -42.51 65.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.532 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 1.006 HD13 HD11 ' B' ' 72' ' ' ILE . 21.1 mt -69.1 -30.92 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.815 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -75.16 -40.7 59.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.337 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.78 -19.51 65.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.56 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.49 -26.85 19.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.47 41.69 0.67 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.469 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.568 HD22 ' OD2' ' B' ' 71' ' ' ASP . 18.4 mt -155.28 147.16 23.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 110.695 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -101.58 -179.73 4.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.719 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.999 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -78.75 -23.1 45.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 110.465 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.953 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -62.86 -33.55 75.52 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.568 ' OD2' HD22 ' B' ' 67' ' ' LEU . 10.6 p30 -75.35 -21.81 58.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.702 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 1.126 HD13 ' HB2' ' B' ' 127' ' ' ALA . 26.6 mm -52.54 121.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.79 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.639 ' HB ' HG21 ' C' ' 22' ' ' VAL . 7.2 m -89.61 -32.72 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.019 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.852 ' HG2' ' HB3' ' B' ' 106' ' ' ALA . 0.8 OUTLIER -130.19 165.65 21.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.567 0.222 . . . . 0.0 110.916 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.612 HG23 ' O ' ' B' ' 74' ' ' LYS . 6.1 p -162.43 105.9 1.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 111.523 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.536 HG23 ' O ' ' B' ' 108' ' ' SER . 4.6 m -91.89 155.4 18.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.219 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.602 HG22 HG22 ' B' ' 123' ' ' ILE . 21.2 t -150.97 103.15 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.834 0.349 . . . . 0.0 111.908 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.603 ' CD2' HG11 ' A' ' 110' ' ' VAL . 10.9 m-85 -89.84 99.86 12.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.247 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.857 HG12 HD23 ' B' ' 121' ' ' LEU . 19.0 m -98.52 147.71 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.58 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.27 -3.7 50.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.222 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -161.03 142.26 11.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.646 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.497 HD12 ' HB3' ' C' ' 114' ' ' ARG . 6.6 mt -82.97 1.58 39.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.256 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -98.68 -24.21 15.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.85 -26.96 60.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.549 ' HD2' HG11 ' B' ' 79' ' ' VAL . 1.8 t80 -59.3 -18.73 40.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.586 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.23 -57.82 10.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.36 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.96 71.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.158 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.492 HG22 ' CB ' ' B' ' 51' ' ' ALA . 26.3 t -70.72 -41.29 77.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.99 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.16 -47.32 80.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.733 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.52 75.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -92.2 -15.98 26.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.667 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' C' ' 17' ' ' PRO . 12.5 t80 -81.65 -38.29 26.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.771 0.32 . . . . 0.0 111.314 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.02 -28.78 22.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.329 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.15 -21.81 59.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.695 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.66 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -92.07 -34.47 14.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.941 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.489 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 3.1 m-85 -57.31 -57.76 11.22 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.07 0.462 . . . . 0.0 110.092 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.29 -29.78 70.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.121 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.96 -10.16 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.476 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.711 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 1.7 t-20 -108.58 -8.79 15.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.34 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 4.3 t30 88.97 33.13 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.457 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.999 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 4.2 m170 -116.73 54.45 1.29 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.859 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 79.1 Cg_endo -75.3 -11.62 20.95 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.68 2.253 . . . . 0.0 112.777 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.753 ' ND2' HD13 ' C' ' 5' ' ' ILE . 0.1 OUTLIER -47.91 -37.59 14.56 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.941 0.4 . . . . 0.0 111.035 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.772 ' O ' HG13 ' C' ' 19' ' ' VAL . 11.6 m-85 64.01 83.84 0.19 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.396 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.75 156.17 63.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.604 2.203 . . . . 0.0 112.022 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.852 ' HB3' ' HG2' ' B' ' 74' ' ' LYS . . . -53.36 162.55 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.519 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.479 ' HB2' ' CG ' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -133.07 143.71 49.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.178 0.513 . . . . 0.0 111.689 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.536 ' O ' HG23 ' B' ' 76' ' ' THR . 5.6 t -143.66 65.29 1.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.759 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.99 140.25 30.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.245 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' C' ' 78' ' ' PHE . 35.8 m -150.01 132.54 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.984 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 2.4 tt0 -63.71 86.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.84 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' B' ' 78' ' ' PHE . 6.8 m -72.43 161.2 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -77.18 -45.85 25.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.502 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -153.58 168.03 27.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.623 HD22 ' CB ' ' B' ' 122' ' ' GLU . 1.3 mp -142.64 160.63 53.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.711 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.493 ' O ' HG22 ' B' ' 119' ' ' VAL . 71.6 Cg_exo -48.74 136.02 27.85 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.443 2.096 . . . . 0.0 112.259 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.476 ' HB2' HG13 ' B' ' 119' ' ' VAL . 6.0 mmtm 64.45 16.66 10.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.331 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.81 17.76 9.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.875 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.753 HG11 ' HB ' ' B' ' 34' ' ' ILE . 30.6 m -53.4 122.63 3.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.265 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . 0.584 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -55.28 -21.71 27.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.894 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.857 HD23 HG12 ' B' ' 79' ' ' VAL . 1.6 mp -152.6 147.58 26.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.268 0.556 . . . . 0.0 111.496 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.623 ' CB ' HD22 ' B' ' 115' ' ' LEU . 11.8 tt0 -139.18 151.52 46.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.407 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.602 HG22 HG22 ' B' ' 77' ' ' VAL . 5.8 pt -150.29 139.23 15.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -138.73 142.98 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.041 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -149.61 172.62 14.74 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.49 ' O ' HG23 ' B' ' 72' ' ' ILE . 9.5 mt -125.69 154.04 34.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.008 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 1.126 ' HB2' HD13 ' B' ' 72' ' ' ILE . . . -135.39 153.03 51.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.016 0.436 . . . . 0.0 111.849 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.834 HG21 HG21 ' C' ' 3' ' ' THR . 30.1 m -116.02 164.09 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.95 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.502 ' HB2' HD21 ' B' ' 67' ' ' LEU . 28.2 ttt85 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.908 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.834 HG21 HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.828 0.347 . . . . 0.0 110.88 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.1 110.64 17.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.89 HD11 HG21 ' C' ' 19' ' ' VAL . 2.3 tp -55.01 129.66 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.678 HD12 ' CB ' ' C' ' 21' ' ' ALA . 31.2 mt -90.51 151.59 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.4 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.81 108.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.801 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.11 170.27 10.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.69 22.32 10.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.83 -38.3 6.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' C' ' 12' ' ' PRO . . . -99.92 127.96 32.25 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.115 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' C' ' 11' ' ' ALA . 7.8 Cg_exo -72.11 -1.75 10.53 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.653 2.235 . . . . 0.0 112.731 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.689 ' HB3' HE21 ' C' ' 20' ' ' GLN . . . -46.83 170.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.864 0.364 . . . . 0.0 111.592 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.18 119.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.088 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.604 HG22 ' O ' ' C' ' 15' ' ' ILE . 13.5 mt -154.73 15.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.881 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.42 -114.73 0.51 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.929 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . 0.465 ' HB2' ' CD1' ' B' ' 92' ' ' TYR . 93.3 Cg_endo -80.97 51.0 3.76 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.647 2.231 . . . . 0.0 113.018 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' B' ' 107' ' ' ARG . 1.7 p90 -178.65 156.84 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.952 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.89 HG21 HD11 ' C' ' 5' ' ' ILE . 30.9 m -106.72 -174.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.15 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.689 HE21 ' HB3' ' C' ' 13' ' ' ALA . 1.0 OUTLIER -73.6 -43.49 59.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.956 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.678 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . -176.95 177.6 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.088 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.751 HG12 HD12 ' C' ' 5' ' ' ILE . 18.6 m -138.42 133.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.839 ' HA ' HG23 ' C' ' 28' ' ' VAL . 37.5 t70 -103.97 102.68 12.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.715 HD23 HG23 ' C' ' 3' ' ' THR . 11.8 mt -80.91 -17.94 48.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.109 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.22 -103.57 0.9 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.915 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.38 -29.04 63.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.084 0.468 . . . . 0.0 110.279 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.463 ' HG ' HG12 ' C' ' 128' ' ' VAL . 0.2 OUTLIER -132.23 122.87 25.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.905 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 1.0 HG12 ' HB3' ' C' ' 127' ' ' ALA . 4.2 p -109.22 145.77 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.893 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.89 139.63 53.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 0.0 110.979 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 76.2 p -113.17 162.2 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.747 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 27.5 p -95.94 165.57 12.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.111 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.55 94.3 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.325 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.19 146.16 54.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.767 ' HB ' HG11 ' C' ' 119' ' ' VAL . 9.5 pt -134.47 142.06 41.37 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.847 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.523 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 7.9 Cg_exo -72.54 55.2 2.56 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.939 2.426 . . . . 0.0 113.138 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.567 HG22 HD12 ' C' ' 34' ' ' ILE . 20.6 t . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.194 0.521 . . . . 0.0 110.513 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.61 ' O ' HG13 ' C' ' 43' ' ' VAL . 11.4 p . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 120.64 0.257 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' C' ' 35' ' ' PRO . 52.6 Cg_exo -52.59 140.45 55.26 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.488 2.125 . . . . 0.0 112.443 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.74 -32.01 70.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 92.77 0.12 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.635 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mm -40.23 -32.4 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.351 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.86 -56.45 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.71 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.422 ' HA ' ' HG2' ' C' ' 52' ' ' ARG . . . -63.1 -28.71 70.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.773 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.476 HE22 HD12 ' C' ' 121' ' ' LEU . 3.0 tt0 -80.54 -28.77 37.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.626 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.411 ' CB ' HG22 ' C' ' 88' ' ' VAL . . . -79.19 -34.82 42.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.581 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' C' ' 49' ' ' ALA . 0.0 OUTLIER -77.51 -28.86 52.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.181 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.24 -48.11 65.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.836 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.775 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.5 OUTLIER -59.68 -35.72 75.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.611 HD13 ' CE2' ' C' ' 95' ' ' PHE . 9.7 mt -64.28 -54.79 27.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.925 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.19 -31.4 68.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -67.97 -33.8 75.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.828 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.775 HG23 ' O ' ' C' ' 54' ' ' SER . 39.1 t -69.91 -49.47 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -29.8 65.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.67 -41.25 94.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.616 HG22 HG21 ' C' ' 6' ' ' ILE . 5.3 mt -72.51 -42.58 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.574 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 1.003 HD13 HD11 ' C' ' 72' ' ' ILE . 21.0 mt -69.13 -30.85 47.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.852 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.19 -40.67 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.923 0.392 . . . . 0.0 110.335 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -19.44 65.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.531 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.52 -26.86 19.54 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.907 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.49 41.64 0.67 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.512 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.57 HD22 ' OD2' ' C' ' 71' ' ' ASP . 18.5 mt -155.29 147.1 23.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.661 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -101.47 -179.74 4.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.99 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -78.72 -23.06 45.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.789 0.328 . . . . 0.0 110.49 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.949 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -62.98 -33.37 75.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.57 ' OD2' HD22 ' C' ' 67' ' ' LEU . 10.7 p30 -75.81 -21.64 57.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 1.039 HD13 ' HB2' ' C' ' 127' ' ' ALA . 26.4 mm -52.53 121.12 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.848 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.619 ' HB ' HG21 ' A' ' 22' ' ' VAL . 7.1 m -89.68 -32.7 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.013 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.846 ' HG2' ' HB3' ' C' ' 106' ' ' ALA . 0.8 OUTLIER -130.25 165.62 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.576 0.227 . . . . 0.0 110.888 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.618 HG23 ' O ' ' C' ' 74' ' ' LYS . 6.1 p -162.44 105.84 1.13 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.811 0.338 . . . . 0.0 111.559 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.554 HG23 ' O ' ' C' ' 108' ' ' SER . 4.6 m -91.87 155.39 18.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.177 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.611 HG22 HG22 ' C' ' 123' ' ' ILE . 21.1 t -151.02 103.12 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.909 0.385 . . . . 0.0 111.935 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.586 ' CD2' HG11 ' B' ' 110' ' ' VAL . 10.9 m-85 -89.78 99.82 12.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.301 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.865 HG12 HD23 ' C' ' 121' ' ' LEU . 19.0 m -98.49 147.72 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.527 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.21 -3.43 49.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.176 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -161.27 142.17 11.29 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.639 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 114' ' ' ARG . 6.6 mt -82.92 1.61 38.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.233 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -98.66 -24.21 15.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.768 0.318 . . . . 0.0 110.9 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.86 -27.01 60.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.034 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.543 ' HD2' HG11 ' C' ' 79' ' ' VAL . 1.8 t80 -59.35 -18.6 39.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.619 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.35 -57.81 10.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 111.338 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.0 71.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.411 HG22 ' CB ' ' C' ' 51' ' ' ALA . 27.2 t -70.77 -41.19 77.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.17 -47.36 80.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.704 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.42 75.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.298 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -92.28 -15.88 26.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.721 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 12.5 t80 -81.71 -38.33 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.307 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.05 -28.68 22.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.333 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.15 -21.89 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.69 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.611 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -91.98 -34.49 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.972 -179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.497 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 3.1 m-85 -57.23 -57.79 11.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 110.13 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.25 -29.83 70.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.128 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.98 -10.09 59.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.489 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.714 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 1.7 t-20 -108.67 -8.8 15.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.29 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 4.3 t30 89.0 33.3 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.454 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.99 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 4.2 m170 -116.97 54.48 1.37 Allowed Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.84 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 77.0 Cg_endo -75.32 -11.62 20.91 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.646 2.23 . . . . 0.0 112.761 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.753 ' ND2' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -47.91 -37.52 14.44 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.876 0.37 . . . . 0.0 111.089 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.753 ' O ' HG13 ' A' ' 19' ' ' VAL . 11.5 m-85 63.93 83.84 0.19 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.41 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 33.8 Cg_endo -64.64 156.15 62.82 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.618 2.212 . . . . 0.0 112.076 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.846 ' HB3' ' HG2' ' C' ' 74' ' ' LYS . . . -53.44 162.6 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.567 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.484 ' HB2' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -133.14 143.74 49.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.185 0.516 . . . . 0.0 111.681 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . 0.554 ' O ' HG23 ' C' ' 76' ' ' THR . 5.6 t -143.63 65.23 1.32 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.787 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.88 140.29 29.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.306 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.537 HG11 ' CD2' ' A' ' 78' ' ' PHE . 35.7 m -150.11 132.55 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.044 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.839 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.5 tt0 -63.59 86.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' C' ' 78' ' ' PHE . 6.7 m -72.48 161.21 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.188 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -77.2 -45.79 25.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.114 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.497 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -153.61 168.12 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.645 HD22 ' CB ' ' C' ' 122' ' ' GLU . 1.3 mp -142.73 160.62 52.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.693 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.485 ' O ' HG22 ' C' ' 119' ' ' VAL . 71.2 Cg_exo -48.76 136.06 27.92 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.41 2.073 . . . . 0.0 112.273 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.463 ' HB2' HG13 ' C' ' 119' ' ' VAL . 6.0 mmtm 64.46 16.65 10.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.286 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.74 17.85 9.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.879 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.767 HG11 ' HB ' ' C' ' 34' ' ' ILE . 30.5 m -53.41 122.54 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . 0.603 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -55.14 -21.53 25.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.905 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.865 HD23 HG12 ' C' ' 79' ' ' VAL . 1.6 mp -152.56 147.58 26.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.321 0.582 . . . . 0.0 111.489 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.645 ' CB ' HD22 ' C' ' 115' ' ' LEU . 11.8 tt0 -139.23 151.5 46.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.394 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.611 HG22 HG22 ' C' ' 77' ' ' VAL . 5.8 pt -150.28 139.22 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 1.1 pm0 -138.72 142.98 38.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.06 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -149.6 172.62 14.74 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' C' ' 72' ' ' ILE . 9.4 mt -125.69 154.05 34.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.046 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 1.039 ' HB2' HD13 ' C' ' 72' ' ' ILE . . . -135.46 153.16 51.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.001 0.429 . . . . 0.0 111.834 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.821 HG21 HG21 ' A' ' 3' ' ' THR . 30.2 m -116.12 164.16 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.0 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.537 ' HB2' HD21 ' C' ' 67' ' ' LEU . 28.2 ttt85 -164.07 64.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.737 HG21 HG21 ' C' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.779 0.323 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.41 131.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.712 HD12 HG11 ' A' ' 19' ' ' VAL . 39.0 mm -59.0 155.13 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' A' ' 21' ' ' ALA . 31.3 mt -121.13 133.61 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.33 149.19 28.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.686 HG22 ' OE1' ' A' ' 20' ' ' GLN . 11.3 t -150.84 165.59 33.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.946 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.89 25.56 5.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 5.5 mmtp -110.06 -50.97 2.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.655 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.13 114.03 50.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.58 -12.53 36.19 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.358 2.038 . . . . 0.0 112.621 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 15' ' ' ILE . . . -64.83 -169.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 62.18 -169.42 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.25 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.3 mt 77.17 17.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.228 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.11 -127.96 2.92 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.245 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -87.44 33.91 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.759 2.306 . . . . 0.0 112.861 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -175.87 156.8 1.85 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.025 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.712 HG11 HD12 ' A' ' 5' ' ' ILE . 35.0 m -92.26 152.6 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.06 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.686 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER -56.93 -36.51 70.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.409 . . . . 0.0 110.451 179.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . -176.31 163.13 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.941 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -128.15 136.88 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.878 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.873 ' HA ' HG12 ' A' ' 28' ' ' VAL . 1.6 p30 -110.25 120.43 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.231 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.01 HD21 HG11 ' C' ' 128' ' ' VAL . 0.8 OUTLIER -90.53 -20.68 22.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.916 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.12 -108.66 0.77 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.672 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -60.38 -29.2 68.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.126 0.489 . . . . 0.0 110.067 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.724 ' HG ' HG12 ' A' ' 128' ' ' VAL . 7.4 mp -126.44 115.2 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.811 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.873 HG12 ' HA ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -105.37 176.24 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.197 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 28' ' ' VAL . 4.7 mp -150.53 161.66 42.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.408 HG21 HD11 ' A' ' 62' ' ' ILE . 23.4 p -126.16 159.21 33.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.074 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -95.06 168.07 10.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.196 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.09 94.74 0.1 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.263 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.451 ' CD ' HD11 ' A' ' 61' ' ' ILE . 47.0 mm-40 -73.6 165.73 24.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.909 0.385 . . . . 0.0 111.19 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.522 HG13 HG23 ' A' ' 36' ' ' VAL . 10.3 pt -149.93 143.05 16.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.015 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 43' ' ' VAL . 73.7 Cg_endo -75.05 59.38 5.21 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.794 2.33 . . . . 0.0 112.875 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.522 HG23 HG13 ' A' ' 34' ' ' ILE . 46.3 t . . . . . 0 C--N 1.326 -0.453 0 CA-C-O 121.263 0.554 . . . . 0.0 110.643 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.6 HG21 ' H ' ' A' ' 120' ' ' GLY . 11.2 p . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.543 0.211 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 31.8 Cg_exo -58.26 150.18 68.27 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.388 2.059 . . . . 0.0 112.035 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.47 -30.79 68.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.978 0.418 . . . . 0.0 110.893 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -71.51 97.45 1.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.829 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.439 HD12 ' NE2' ' A' ' 50' ' ' GLN . 9.2 tp -42.14 -32.22 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.767 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -48.62 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -60.58 -41.04 93.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.752 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' NE2' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -70.01 -30.85 68.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.583 179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.34 -37.49 71.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.196 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -78.95 -35.62 42.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.92 -36.08 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.854 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -74.81 -31.67 61.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.752 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.6 mt -72.74 -36.28 67.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.8 -44.31 73.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -58.68 -46.57 86.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.948 HG21 ' CG2' ' A' ' 123' ' ' ILE . 21.4 t -60.72 -31.85 50.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.96 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.592 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 3.3 tttt -80.61 -32.51 36.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -67.14 -35.98 80.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 58' ' ' VAL . 5.8 mt -69.7 -45.24 78.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.76 HG22 ' HB3' ' A' ' 67' ' ' LEU . 11.0 mt -65.75 -35.28 74.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.458 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.94 75.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.327 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -21.42 63.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.422 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.45 -28.31 20.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.71 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.92 54.44 0.35 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.615 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.76 ' HB3' HG22 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 158.01 23.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.878 0.37 . . . . 0.0 110.671 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.429 ' O ' HD23 ' A' ' 67' ' ' LEU . 2.1 p -115.33 156.85 24.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.161 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.798 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -57.97 -35.91 71.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.057 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -50.64 -26.74 5.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.455 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.561 ' CB ' HD21 ' A' ' 67' ' ' LEU . 4.7 m-20 -85.5 -18.67 32.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.297 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.495 HD12 ' CB ' ' A' ' 127' ' ' ALA . 0.5 OUTLIER -54.5 117.89 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.506 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.665 HG11 HD21 ' B' ' 24' ' ' LEU . 29.0 m -88.13 -33.73 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.92 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.698 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 4.2 tttm -128.32 169.77 13.84 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.454 HG22 ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -169.93 112.97 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.875 0.369 . . . . 0.0 111.409 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.7 m -99.96 151.77 20.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.173 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 109' ' ' CYS . 5.0 m -146.48 128.85 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 111.929 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.535 ' HB2' HD21 ' A' ' 115' ' ' LEU . 4.1 m-85 -107.6 129.68 54.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.144 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.8 149.5 27.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.463 . . . . 0.0 111.721 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 115' ' ' LEU . 12.3 mttt -88.41 -4.2 58.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.781 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -160.57 115.55 2.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.384 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' B' ' 114' ' ' ARG . 3.1 mt -66.38 -11.23 50.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.088 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -80.83 -19.06 45.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.779 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -87.02 -19.53 28.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.07 -20.93 43.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.31 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.73 -39.2 65.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 111.283 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.54 -29.25 21.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.0 t -72.39 -44.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.31 -42.36 93.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.615 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.4 73.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -27.52 19.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.515 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.43 ' O ' ' CD2' ' A' ' 96' ' ' PHE . 68.6 t80 -54.08 -49.03 69.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.891 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.6 -27.44 25.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.54 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.23 -20.24 60.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.619 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.3 OUTLIER -90.14 -38.84 13.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.933 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 101' ' ' HIS . 14.6 m-85 -55.61 -58.81 6.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.604 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -64.74 -28.15 69.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.704 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -72.88 -13.58 61.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.317 . . . . 0.0 110.883 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 58.7 m-80 -111.18 -10.75 14.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.472 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 2.4 p-10 99.56 33.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.907 0.754 . . . . 0.0 111.004 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.798 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.2 m-70 -115.11 56.43 0.98 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.552 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 54.4 Cg_endo -68.64 -15.14 40.84 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.659 2.239 . . . . 0.0 113.363 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.548 ' HB3' HD11 ' B' ' 5' ' ' ILE . 3.1 m-20 -53.86 -43.19 69.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.913 0.387 . . . . 0.0 110.606 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.684 ' O ' HG13 ' B' ' 19' ' ' VAL . 30.4 m-85 71.85 84.13 0.13 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.959 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 19.1 Cg_endo -59.25 155.67 39.14 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.772 2.314 . . . . 0.0 112.327 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.698 ' HB3' ' CG ' ' A' ' 74' ' ' LYS . . . -51.39 158.16 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.234 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.9 ttp-105 -134.66 141.38 46.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.131 0.491 . . . . 0.0 111.854 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.42 66.12 1.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.064 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.4 ' HA ' HG23 ' A' ' 77' ' ' VAL . 28.0 p -79.49 130.88 35.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.188 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.5 m -148.82 144.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.981 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.842 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 2.3 tt0 -86.68 94.6 9.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.817 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' A' ' 115' ' ' LEU . 36.0 m -73.49 159.9 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -70.94 -37.13 72.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.434 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -160.84 166.96 27.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.976 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.543 ' C ' HD11 ' C' ' 82' ' ' LEU . 1.4 mt -143.39 155.71 60.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.673 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.34 135.85 70.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.563 2.175 . . . . 0.0 112.018 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.681 ' HB3' HG13 ' A' ' 119' ' ' VAL . 1.4 tppt? 69.62 20.36 7.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.18 26.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.118 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 117' ' ' LYS . 22.1 m -55.66 174.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.206 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.6 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -96.04 -15.13 43.14 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.569 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.623 HD22 ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -172.49 148.88 2.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.046 0.45 . . . . 0.0 111.168 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.716 ' O ' HD13 ' A' ' 123' ' ' ILE . 4.6 mt-10 -116.4 167.25 11.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.322 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.948 ' CG2' HG21 ' A' ' 58' ' ' VAL . 22.9 mm -141.88 131.87 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.206 0.527 . . . . 0.0 112.196 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.53 117.75 4.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.204 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -140.3 176.03 9.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.467 HG23 ' HG ' ' A' ' 29' ' ' LEU . 6.7 mt -119.88 154.69 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.038 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.859 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -139.37 150.75 45.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.908 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.948 HG11 HD21 ' B' ' 24' ' ' LEU . 33.0 m -125.1 126.67 71.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.665 ' HG3' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.042 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.766 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.819 0.342 . . . . 0.0 110.87 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.49 131.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.67 HD12 HG11 ' B' ' 19' ' ' VAL . 39.0 mm -58.96 155.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.542 HD12 ' CB ' ' B' ' 21' ' ' ALA . 31.6 mt -121.23 133.67 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.34 149.19 28.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.789 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.665 HG22 ' OE1' ' B' ' 20' ' ' GLN . 11.3 t -150.85 165.56 33.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.92 25.62 5.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.014 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.44 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 5.5 mmtp -110.13 -50.88 2.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.677 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.16 114.04 50.14 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.966 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.66 -12.5 36.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.35 2.034 . . . . 0.0 112.595 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.74 -169.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.548 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 62.18 -169.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.196 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.583 HG22 ' O ' ' B' ' 15' ' ' ILE . 2.3 mt 77.19 17.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.22 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.06 -127.91 2.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.225 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.51 33.94 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 112.892 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -175.85 156.78 1.85 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.85 0.357 . . . . 0.0 110.999 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 104' ' ' PHE . 35.1 m -92.27 152.59 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.064 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.665 ' OE1' HG22 ' B' ' 8' ' ' THR . 0.8 OUTLIER -56.88 -36.52 70.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 110.492 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.542 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . -176.58 163.15 2.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.037 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.494 HG13 HG21 ' B' ' 19' ' ' VAL . 0.2 OUTLIER -128.13 136.95 58.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.835 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.867 ' HA ' HG12 ' B' ' 28' ' ' VAL . 1.6 p30 -110.3 120.48 42.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.219 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.948 HD21 HG11 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -90.5 -20.77 22.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.18 -108.79 0.78 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.64 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -60.26 -29.32 68.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.04 0.448 . . . . 0.0 109.998 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.718 ' HG ' HG12 ' B' ' 128' ' ' VAL . 7.3 mp -126.37 115.15 19.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.795 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.894 HG23 ' HB3' ' B' ' 127' ' ' ALA . 0.9 OUTLIER -105.28 176.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.198 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.581 HD12 ' C ' ' B' ' 28' ' ' VAL . 4.7 mp -150.48 161.68 42.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.933 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.41 HG21 HD11 ' B' ' 62' ' ' ILE . 23.8 p -126.1 158.89 34.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.033 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.6 m -94.6 168.14 11.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.037 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.13 94.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.293 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.468 ' CG ' HG22 ' B' ' 58' ' ' VAL . 47.2 mm-40 -73.59 165.81 24.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 111.16 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.513 HG13 HG23 ' B' ' 36' ' ' VAL . 10.2 pt -150.03 143.03 16.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.992 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.52 ' HG2' HG23 ' B' ' 43' ' ' VAL . 73.7 Cg_endo -75.03 59.38 5.19 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.755 2.304 . . . . 0.0 112.898 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.513 HG23 HG13 ' B' ' 34' ' ' ILE . 46.3 t . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 121.297 0.57 . . . . 0.0 110.627 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.568 HG21 ' H ' ' B' ' 120' ' ' GLY . 11.1 p . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.475 0.179 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' B' ' 35' ' ' PRO . 31.3 Cg_exo -58.34 150.18 68.94 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.373 2.049 . . . . 0.0 112.036 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.5 -30.69 68.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.026 0.441 . . . . 0.0 110.921 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.1 OUTLIER -71.55 97.43 1.68 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.829 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.442 HD12 ' NE2' ' B' ' 50' ' ' GLN . 9.1 tp -42.02 -32.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.756 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.22 -48.67 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.827 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -60.47 -41.11 93.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.768 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.443 ' NE2' HD12 ' B' ' 121' ' ' LEU . 0.9 OUTLIER -69.97 -30.91 68.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.562 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.41 -37.57 71.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.257 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -79.01 -35.7 42.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -36.16 73.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.854 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.1 OUTLIER -74.78 -31.78 61.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 34.9 mt -72.69 -36.24 67.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.86 -44.25 73.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -58.71 -46.56 87.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.949 HG21 ' CG2' ' B' ' 123' ' ' ILE . 21.5 t -60.73 -31.87 50.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.949 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.588 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 3.3 tttt -80.66 -32.48 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -66.95 -35.95 81.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' B' ' 58' ' ' VAL . 5.8 mt -69.77 -45.21 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.838 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.77 HG22 ' HB3' ' B' ' 67' ' ' LEU . 11.0 mt -65.75 -35.34 74.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.47 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 -42.94 76.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.303 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -21.47 63.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.403 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.51 -28.2 20.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.698 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.85 54.42 0.36 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.649 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.77 ' HB3' HG22 ' B' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 157.96 23.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.84 0.353 . . . . 0.0 110.672 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.428 ' O ' HD23 ' B' ' 67' ' ' LEU . 2.1 p -115.29 156.92 24.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.222 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.827 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -58.06 -35.86 71.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.051 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.581 ' HB2' ' OD1' ' B' ' 100' ' ' ASN . . . -50.67 -26.75 5.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.413 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.557 ' CB ' HD21 ' B' ' 67' ' ' LEU . 4.7 m-20 -85.49 -18.68 32.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.361 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' B' ' 69' ' ' ALA . 0.5 OUTLIER -54.51 117.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 110.556 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.648 HG11 HD21 ' C' ' 24' ' ' LEU . 28.7 m -88.17 -33.7 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.876 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.701 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 4.2 tttm -128.32 169.83 13.78 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.79 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.442 HG22 ' HB2' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -170.02 112.86 0.47 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.86 0.362 . . . . 0.0 111.378 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' B' ' 124' ' ' GLU . 24.6 m -99.9 151.84 20.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.147 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.404 HG23 ' HA ' ' B' ' 109' ' ' CYS . 4.9 m -146.57 128.85 7.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.017 0.437 . . . . 0.0 111.901 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.529 ' HB2' HD21 ' B' ' 115' ' ' LEU . 4.0 m-85 -107.58 129.68 54.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.125 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.8 149.49 27.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.065 0.46 . . . . 0.0 111.774 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' B' ' 115' ' ' LEU . 12.3 mttt -88.45 -4.4 58.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.735 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.48 115.51 2.24 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.387 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.476 HD11 ' C ' ' C' ' 115' ' ' LEU . 3.2 mt -66.33 -11.28 50.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -80.8 -19.08 45.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -86.98 -19.57 28.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.172 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.08 -20.9 43.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.339 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.27 65.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.817 0.341 . . . . 0.0 111.289 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.51 -29.19 21.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' B' ' 92' ' ' TYR . 28.5 t -72.37 -44.94 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.36 -42.35 92.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.559 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.41 73.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -27.52 18.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.517 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.433 ' O ' ' CD2' ' B' ' 96' ' ' PHE . 68.6 t80 -54.06 -49.13 69.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.885 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.54 -27.45 25.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.54 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.16 -20.26 60.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.648 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.3 OUTLIER -90.13 -38.86 13.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.0 110.932 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' B' ' 101' ' ' HIS . 14.8 m-85 -55.55 -58.88 5.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.584 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -64.75 -28.11 69.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.743 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -72.87 -13.59 61.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 110.919 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.525 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 58.8 m-80 -111.13 -10.83 14.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.482 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.581 ' OD1' ' HB2' ' B' ' 70' ' ' ALA . 2.3 p-10 99.57 33.26 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.832 0.707 . . . . 0.0 110.99 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.827 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.2 m-70 -115.01 56.36 0.94 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.553 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.401 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 53.8 Cg_endo -68.65 -15.17 40.85 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 113.335 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.543 ' HB3' HD11 ' C' ' 5' ' ' ILE . 3.1 m-20 -53.91 -43.08 69.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.62 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.693 ' O ' HG13 ' C' ' 19' ' ' VAL . 30.3 m-85 71.77 84.15 0.13 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.966 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 19.1 Cg_endo -59.22 155.67 39.0 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.749 2.299 . . . . 0.0 112.358 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.701 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.32 158.34 0.84 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.291 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.432 ' HB3' ' CD2' ' C' ' 18' ' ' TYR . 2.9 ttp-105 -134.84 141.31 46.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.13 0.491 . . . . 0.0 111.838 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.39 66.03 1.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.11 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . 0.404 ' HA ' HG23 ' B' ' 77' ' ' VAL . 28.0 p -79.42 130.89 35.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.18 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 20.9 m -148.79 143.91 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.982 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.839 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 2.3 tt0 -86.45 94.33 9.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' B' ' 115' ' ' LEU . 35.8 m -73.29 159.87 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.842 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -70.93 -37.12 72.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.57 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -160.87 166.91 27.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.004 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.545 ' C ' HD11 ' A' ' 82' ' ' LEU . 1.4 mt -143.33 155.73 61.08 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.41 135.83 70.94 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.578 2.186 . . . . 0.0 112.031 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.674 ' HB3' HG13 ' B' ' 119' ' ' VAL . 1.4 tppt? 69.69 20.31 6.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.975 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.19 26.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' B' ' 117' ' ' LYS . 21.6 m -55.78 174.49 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . 0.568 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -96.08 -15.58 41.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.554 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.61 ' C ' HD22 ' B' ' 121' ' ' LEU . 0.0 OUTLIER -172.09 148.74 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 111.184 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.715 ' O ' HD13 ' B' ' 123' ' ' ILE . 4.5 mt-10 -116.4 167.23 11.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.264 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.949 ' CG2' HG21 ' B' ' 58' ' ' VAL . 22.6 mm -141.91 131.85 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.188 0.518 . . . . 0.0 112.219 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . 0.401 ' HG3' ' HB ' ' B' ' 76' ' ' THR . 0.0 OUTLIER -153.57 117.69 4.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.166 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -140.22 176.05 9.08 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.469 HG23 ' HG ' ' B' ' 29' ' ' LEU . 6.7 mt -119.86 154.68 22.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.072 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.894 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -139.36 150.82 45.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.833 0.349 . . . . 0.0 111.902 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 1.027 HG11 HD21 ' C' ' 24' ' ' LEU . 33.0 m -125.22 126.66 71.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.678 ' HG3' HD12 ' B' ' 67' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.07 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.794 HG21 HG21 ' B' ' 128' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.845 0.355 . . . . 0.0 110.9 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.42 131.19 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.672 HD12 HG11 ' C' ' 19' ' ' VAL . 38.9 mm -58.94 155.15 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.536 HD12 ' CB ' ' C' ' 21' ' ' ALA . 31.3 mt -121.25 133.55 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.25 149.17 28.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.84 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.689 HG22 ' OE1' ' C' ' 20' ' ' GLN . 11.3 t -150.83 165.6 33.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.93 25.62 5.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.028 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.448 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 5.5 mmtp -110.11 -51.18 2.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.662 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.84 114.15 50.27 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.902 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.53 -12.57 36.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.369 2.046 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.406 ' O ' HD12 ' C' ' 15' ' ' ILE . . . -64.82 -169.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.14 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.547 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 62.24 -169.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.186 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.577 HG22 ' O ' ' C' ' 15' ' ' ILE . 2.3 mt 77.2 17.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.191 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.09 -128.0 2.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.23 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.4 33.88 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.728 2.285 . . . . 0.0 112.918 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.547 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -175.82 156.83 1.87 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.91 0.386 . . . . 0.0 110.987 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.693 HG13 ' O ' ' B' ' 104' ' ' PHE . 35.1 m -92.29 152.59 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.048 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.689 ' OE1' HG22 ' C' ' 8' ' ' THR . 0.8 OUTLIER -56.87 -36.54 70.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.439 . . . . 0.0 110.573 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.536 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . -176.26 163.09 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.934 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.478 HG13 HG21 ' C' ' 19' ' ' VAL . 0.2 OUTLIER -128.07 136.92 58.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.866 ' HA ' HG12 ' C' ' 28' ' ' VAL . 1.6 p30 -110.31 120.49 42.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.201 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 1.027 HD21 HG11 ' B' ' 128' ' ' VAL . 0.8 OUTLIER -90.57 -20.66 22.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.1 -108.67 0.77 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.664 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -60.42 -29.22 68.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.147 0.498 . . . . 0.0 110.072 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.709 ' HG ' HG12 ' C' ' 128' ' ' VAL . 7.3 mp -126.42 115.15 19.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.795 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.889 HG23 ' HB3' ' C' ' 127' ' ' ALA . 0.9 OUTLIER -105.31 176.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.203 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.581 HD12 ' C ' ' C' ' 28' ' ' VAL . 4.7 mp -150.56 161.64 42.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.3 p -126.22 158.99 34.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.006 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -94.64 167.99 11.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.1 94.8 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.251 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.453 ' CG ' HG22 ' C' ' 58' ' ' VAL . 47.2 mm-40 -73.59 165.78 24.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.204 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.541 ' HB ' HG11 ' C' ' 119' ' ' VAL . 10.3 pt -149.98 143.06 16.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.993 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.493 ' HG2' HG23 ' C' ' 43' ' ' VAL . 73.6 Cg_endo -75.01 59.31 5.16 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.782 2.321 . . . . 0.0 112.941 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.509 HG23 HG13 ' C' ' 34' ' ' ILE . 46.4 t . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 121.222 0.534 . . . . 0.0 110.612 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.585 HG21 ' H ' ' C' ' 120' ' ' GLY . 11.3 p . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.528 0.204 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' C' ' 35' ' ' PRO . 31.2 Cg_exo -58.42 150.21 69.42 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.355 2.037 . . . . 0.0 112.016 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.5 -30.7 68.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.034 0.445 . . . . 0.0 110.9 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.1 OUTLIER -71.51 97.41 1.66 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.807 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.45 HD12 ' NE2' ' C' ' 50' ' ' GLN . 9.2 tp -42.17 -32.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.754 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -48.68 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.791 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -60.47 -41.09 93.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.789 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.45 ' NE2' HD12 ' C' ' 47' ' ' ILE . 0.9 OUTLIER -69.96 -30.88 68.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.627 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.54 -37.63 71.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.192 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' C' ' 49' ' ' ALA . 3.5 ptm180 -79.0 -35.6 42.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -36.13 73.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.846 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.1 OUTLIER -74.89 -31.68 61.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.694 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 34.8 mt -72.74 -36.3 67.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.789 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.75 -44.27 74.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.951 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -58.71 -46.56 87.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.951 HG21 ' CG2' ' C' ' 123' ' ' ILE . 21.4 t -60.72 -31.93 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.607 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 3.3 tttt -80.61 -32.44 36.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -67.02 -35.94 81.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.023 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' C' ' 58' ' ' VAL . 5.9 mt -69.7 -45.32 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.762 HG22 ' HB3' ' C' ' 67' ' ' LEU . 10.9 mt -65.66 -35.32 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.9 75.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -21.54 63.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.409 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.43 -28.26 21.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.692 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.9 54.43 0.35 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.578 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.762 ' HB3' HG22 ' C' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 157.96 23.84 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.632 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . 0.426 ' O ' HD23 ' C' ' 67' ' ' LEU . 2.1 p -115.37 156.88 24.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.188 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.816 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -58.05 -35.84 71.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.065 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.579 ' HB2' ' OD1' ' C' ' 100' ' ' ASN . . . -50.67 -26.62 5.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.548 ' CB ' HD21 ' C' ' 67' ' ' LEU . 4.7 m-20 -85.64 -18.69 32.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.323 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' C' ' 69' ' ' ALA . 0.5 OUTLIER -54.49 117.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.521 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.702 HG11 HD21 ' A' ' 24' ' ' LEU . 28.4 m -88.16 -33.73 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.874 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.692 ' CG ' ' HB3' ' C' ' 106' ' ' ALA . 4.2 tttm -128.27 169.75 13.84 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.811 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.442 HG22 ' HB2' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -169.95 112.94 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.852 0.358 . . . . 0.0 111.442 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -99.96 151.83 20.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.159 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.409 HG23 ' HA ' ' C' ' 109' ' ' CYS . 5.0 m -146.49 128.86 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.935 0.398 . . . . 0.0 112.004 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.504 ' HB2' HD21 ' C' ' 115' ' ' LEU . 4.1 m-85 -107.65 129.64 54.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.143 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.83 149.5 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.026 0.441 . . . . 0.0 111.772 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . 0.43 ' HG3' HD12 ' C' ' 115' ' ' LEU . 12.3 mttt -88.46 -4.53 58.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.773 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.21 115.44 2.31 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.384 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.543 HD11 ' C ' ' A' ' 115' ' ' LEU . 3.1 mt -66.35 -11.25 50.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.126 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -80.79 -19.1 45.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.817 0.342 . . . . 0.0 110.83 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -86.98 -19.55 28.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.223 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.07 -20.91 43.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.342 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.72 -39.2 65.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.837 0.351 . . . . 0.0 111.315 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -29.2 21.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.962 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' C' ' 92' ' ' TYR . 29.3 t -72.39 -45.01 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.32 -42.37 93.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.561 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.52 73.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.974 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -27.49 19.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.494 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.427 ' O ' ' CD2' ' C' ' 96' ' ' PHE . 68.8 t80 -54.08 -49.04 69.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.892 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.6 -27.47 25.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.542 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.16 -20.29 60.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.604 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.501 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 0.3 OUTLIER -90.19 -38.77 13.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.826 0.346 . . . . 0.0 110.954 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' C' ' 101' ' ' HIS . 14.7 m-85 -55.58 -58.85 6.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -64.7 -28.22 69.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.684 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -72.86 -13.54 61.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.783 0.325 . . . . 0.0 110.94 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.524 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 58.9 m-80 -111.11 -10.93 14.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.476 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.579 ' OD1' ' HB2' ' C' ' 70' ' ' ALA . 2.4 p-10 99.66 33.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.524 0.73 . . . . 0.0 110.95 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.816 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.2 m-70 -115.13 56.3 0.98 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.581 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.404 ' O ' ' CD2' ' C' ' 104' ' ' PHE . 53.9 Cg_endo -68.6 -15.21 41.06 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.659 2.239 . . . . 0.0 113.35 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.525 ' HB3' HD11 ' A' ' 5' ' ' ILE . 3.1 m-20 -53.81 -43.14 69.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 110.601 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.691 ' O ' HG13 ' A' ' 19' ' ' VAL . 30.4 m-85 71.8 84.12 0.13 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.988 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 19.0 Cg_endo -59.23 155.72 38.78 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.768 2.312 . . . . 0.0 112.298 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.692 ' HB3' ' CG ' ' C' ' 74' ' ' LYS . . . -51.4 158.1 0.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.253 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' A' ' 18' ' ' TYR . 2.9 ttp-105 -134.65 141.37 46.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.107 0.479 . . . . 0.0 111.827 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.42 66.11 1.47 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.063 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . 0.409 ' HA ' HG23 ' C' ' 77' ' ' VAL . 28.0 p -79.45 130.87 35.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.18 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 20.6 m -148.9 144.74 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.053 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.804 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.3 tt0 -87.02 94.51 9.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.76 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.42 HG21 ' HG ' ' C' ' 115' ' ' LEU . 36.0 m -73.43 159.89 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -70.97 -37.08 72.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.069 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.446 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -160.88 166.9 27.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.036 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' C' ' 78' ' ' PHE . 1.4 mt -143.35 155.72 61.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.743 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.39 135.91 71.26 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.577 2.184 . . . . 0.0 111.979 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.696 ' HB3' HG13 ' C' ' 119' ' ' VAL . 1.4 tppt? 69.6 20.38 7.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.938 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.16 26.31 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.095 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.696 HG13 ' HB3' ' C' ' 117' ' ' LYS . 21.9 m -55.67 174.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.246 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . 0.585 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -96.12 -15.22 42.55 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.537 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.624 ' C ' HD22 ' C' ' 121' ' ' LEU . 0.0 OUTLIER -172.18 148.74 2.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.993 0.425 . . . . 0.0 111.204 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.719 ' O ' HD13 ' C' ' 123' ' ' ILE . 4.6 mt-10 -116.33 167.31 11.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.289 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.951 ' CG2' HG21 ' C' ' 58' ' ' VAL . 22.8 mm -141.99 131.8 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.208 0.527 . . . . 0.0 112.177 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.52 117.75 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.166 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -140.28 176.03 9.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.459 HG23 ' HG ' ' C' ' 29' ' ' LEU . 6.7 mt -119.85 154.67 22.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.038 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.889 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -139.4 150.79 45.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.839 0.352 . . . . 0.0 111.884 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 1.01 HG11 HD21 ' A' ' 24' ' ' LEU . 33.0 m -125.14 126.69 71.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.092 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.671 ' HG3' HD12 ' C' ' 67' ' ' LEU . 0.4 OUTLIER -94.89 43.5 1.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.095 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.935 179.867 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.486 HG23 ' CD2' ' A' ' 24' ' ' LEU . 18.8 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.006 0.431 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HD23 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.694 HD11 ' OD1' ' C' ' 103' ' ' ASN . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.719 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 14' ' ' ALA . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.843 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' C' ' 104' ' ' PHE . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 29' ' ' LEU . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.565 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.916 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.0 m120 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 128' ' ' VAL . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.959 HG23 ' HB3' ' A' ' 127' ' ' ALA . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 62' ' ' ILE . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.693 ' HB ' HG11 ' A' ' 119' ' ' VAL . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 34' ' ' ILE . 32.9 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.607 0.241 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.406 ' OE1' HD13 ' A' ' 47' ' ' ILE . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.782 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 54' ' ' SER . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.719 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 30' ' ' THR . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.044 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.895 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 126' ' ' ILE . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 128' ' ' VAL . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 125' ' ' ALA . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 108' ' ' SER . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 122' ' ' GLU . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.712 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 85' ' ' PHE . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' A' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.475 ' OH ' HG21 ' A' ' 75' ' ' THR . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.539 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 1.044 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.3 m170 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.691 ' CG ' HD11 ' B' ' 5' ' ' ILE . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.731 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 72' ' ' ILE . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 76' ' ' THR . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.596 ' HB3' HD12 ' C' ' 82' ' ' LEU . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 78' ' ' PHE . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 34' ' ' ILE . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.795 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' ' 35' ' ' PRO . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.725 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' ILE . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.959 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 73' ' ' VAL . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB3' HD21 ' A' ' 67' ' ' LEU . 14.1 ptm180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.481 HG23 ' CD2' ' B' ' 24' ' ' LEU . 19.0 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.977 0.417 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.568 ' OE1' HD23 ' B' ' 24' ' ' LEU . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.691 HD11 ' CG ' ' A' ' 103' ' ' ASN . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.722 ' HB2' ' CG1' ' B' ' 61' ' ' ILE . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.786 HD13 ' O ' ' B' ' 14' ' ' ALA . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.84 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 104' ' ' PHE . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 11' ' ' ALA . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.53 HG23 HD13 ' B' ' 29' ' ' LEU . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.562 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.515 HD13 HG12 ' B' ' 128' ' ' VAL . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' B' ' 127' ' ' ALA . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.631 HD12 ' N ' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.737 HG21 HD11 ' B' ' 62' ' ' ILE . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.484 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.716 ' HB ' HG11 ' B' ' 119' ' ' VAL . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.565 HG23 HG13 ' B' ' 34' ' ' ILE . 33.3 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.791 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.3 p . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.595 0.236 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' B' ' 47' ' ' ILE . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' B' ' 95' ' ' PHE . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' B' ' 54' ' ' SER . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.722 ' CG1' ' HB2' ' B' ' 11' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.737 HD11 HG21 ' B' ' 30' ' ' THR . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 1.051 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.897 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.477 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 126' ' ' ILE . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.635 HG13 HG22 ' B' ' 128' ' ' VAL . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.681 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.727 HG23 ' HB2' ' B' ' 125' ' ' ALA . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 108' ' ' SER . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.702 HG13 ' O ' ' B' ' 122' ' ' GLU . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.507 HG11 ' HD1' ' B' ' 85' ' ' PHE . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.507 ' HD1' HG11 ' B' ' 79' ' ' VAL . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' B' ' 75' ' ' THR . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.542 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 1.051 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 3.4 m170 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.7 ' CG ' HD11 ' C' ' 5' ' ' ILE . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.72 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' B' ' 72' ' ' ILE . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.431 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.845 ' O ' HG23 ' B' ' 76' ' ' THR . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.729 HG11 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.543 ' HB3' HD12 ' A' ' 82' ' ' LEU . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HB2' ' B' ' 78' ' ' PHE . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.482 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.716 HG11 ' HB ' ' B' ' 34' ' ' ILE . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . 0.791 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.468 HD11 ' HG3' ' B' ' 35' ' ' PRO . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.702 ' O ' HG13 ' B' ' 77' ' ' VAL . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.56 ' CG2' HG21 ' B' ' 58' ' ' VAL . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 72' ' ' ILE . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.997 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.635 HG22 HG13 ' B' ' 73' ' ' VAL . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' B' ' 67' ' ' LEU . 14.1 ptm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.48 HG23 ' CD2' ' C' ' 24' ' ' LEU . 19.0 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . 0.562 ' OE1' HD23 ' C' ' 24' ' ' LEU . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.7 HD11 ' CG ' ' B' ' 103' ' ' ASN . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.497 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.721 ' HB2' ' CG1' ' C' ' 61' ' ' ILE . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.67 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.779 HD13 ' O ' ' C' ' 14' ' ' ALA . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.826 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' B' ' 104' ' ' PHE . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.535 HG23 HD13 ' C' ' 29' ' ' LEU . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.559 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.898 HD13 ' O ' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.482 HD13 HG12 ' C' ' 128' ' ' VAL . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.63 ' N ' HD12 ' C' ' 29' ' ' LEU . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.711 HG21 HD11 ' C' ' 62' ' ' ILE . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.691 ' HB ' HG11 ' C' ' 119' ' ' VAL . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.561 HG23 HG13 ' C' ' 34' ' ' ILE . 32.8 t . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.789 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.3 p . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.582 0.229 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' C' ' 51' ' ' ALA . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.401 ' OE1' HD13 ' C' ' 47' ' ' ILE . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 54' ' ' SER . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.721 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.711 HD11 HG21 ' C' ' 30' ' ' THR . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 1.059 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.886 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.464 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.484 HG23 ' O ' ' C' ' 126' ' ' ILE . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.636 HG13 HG22 ' C' ' 128' ' ' VAL . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' ALA . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.847 HG23 ' O ' ' C' ' 108' ' ' SER . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.714 HG13 ' O ' ' C' ' 122' ' ' GLU . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.729 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' C' ' 85' ' ' PHE . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' C' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.479 ' OH ' HG21 ' C' ' 75' ' ' THR . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.549 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 1.059 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 3.3 m170 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.694 ' OD1' HD11 ' A' ' 5' ' ' ILE . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.704 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' C' ' 72' ' ' ILE . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . 0.847 ' O ' HG23 ' C' ' 76' ' ' THR . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.712 HG11 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.731 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.581 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' C' ' 78' ' ' PHE . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.582 ' O ' HG22 ' C' ' 119' ' ' VAL . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.484 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' C' ' 34' ' ' ILE . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . 0.789 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' C' ' 35' ' ' PRO . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 77' ' ' VAL . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' HB ' ' C' ' 76' ' ' THR . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.705 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' ILE . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.956 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.636 HG22 HG13 ' C' ' 73' ' ' VAL . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' C' ' 67' ' ' LEU . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.044 HG21 HG21 ' C' ' 128' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.817 0.341 . . . . 0.0 110.954 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 132.97 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.82 HD13 ' OD1' ' C' ' 103' ' ' ASN . 4.3 mp -55.2 152.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 21' ' ' ALA . 32.7 mt -103.43 139.26 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.58 117.18 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.58 HG22 ' OE1' ' A' ' 20' ' ' GLN . 11.7 t -133.88 165.99 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.33 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.52 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 7.6 mmtp -121.62 -36.89 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.032 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.872 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.82 172.05 4.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 18.9 Cg_endo -59.39 -16.05 33.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.695 2.263 . . . . 0.0 112.85 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 77.24 151.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 111.317 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.603 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -104.67 120.71 41.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 14' ' ' ALA . 22.1 mm -133.51 15.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.072 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.85 -146.17 4.73 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.987 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' C' ' 104' ' ' PHE . 93.9 Cg_endo -87.39 44.53 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.536 2.158 . . . . 0.0 112.901 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.541 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -163.19 154.59 17.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.867 0.365 . . . . 0.0 111.033 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.465 HG13 ' O ' ' C' ' 103' ' ' ASN . 27.3 m -110.91 169.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.58 ' OE1' HG22 ' A' ' 8' ' ' THR . 56.2 mt-30 -58.96 -53.53 57.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' A' ' 6' ' ' ILE . . . -170.69 -177.09 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG21 ' HB ' ' C' ' 73' ' ' VAL . 9.3 m -142.33 132.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.166 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.645 ' HA ' HG23 ' A' ' 28' ' ' VAL . 20.8 t70 -103.47 105.01 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.567 ' CD2' HG23 ' A' ' 3' ' ' THR . 19.5 mt -80.51 -16.36 54.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.371 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.05 -104.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.28 -29.62 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.166 0.508 . . . . 0.0 110.21 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 28' ' ' VAL . 5.0 tt -135.2 140.65 45.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.95 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 9.9 p -120.04 160.88 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.123 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' HE2' ' C' ' 74' ' ' LYS . 2.9 mp -145.87 127.37 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 p -106.5 136.11 46.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.983 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.812 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 1.1 t -59.36 179.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.07 95.55 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.244 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.805 ' HG2' HG22 ' A' ' 58' ' ' VAL . 2.9 mp0 -62.07 138.14 58.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.275 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.524 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -146.04 170.18 8.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.679 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -54.26 -137.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.313 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.411 -178.926 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.81 140.71 81.58 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.592 2.195 . . . . 0.0 112.433 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.37 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.4 93.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.791 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.616 HD13 ' NE2' ' A' ' 50' ' ' GLN . 28.9 mm -38.93 -33.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.5 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.08 -48.07 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.696 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.82 -55.04 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.616 ' NE2' HD13 ' A' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.498 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -71.93 -44.36 63.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -63.33 -51.54 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.79 -31.18 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.871 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.3 m -68.31 -46.48 70.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.29 -26.36 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.971 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -57.95 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.108 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.8 OUTLIER -54.88 -30.36 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.985 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 54' ' ' SER . 39.6 t -62.1 -34.54 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 110.517 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.99 -31.75 34.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.755 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -62.23 -38.55 89.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 11' ' ' ALA . 6.1 mt -70.93 -46.2 69.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.667 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.8 -32.62 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.28 -38.4 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.9 -24.33 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.145 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.71 -22.11 21.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.914 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.43 64.8 0.83 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' OD2' ' A' ' 71' ' ' ASP . 14.7 mt -158.9 139.2 12.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 44.0 p -96.12 145.0 25.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -46.29 -31.75 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.518 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -59.77 -18.48 43.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.715 ' OD2' HD22 ' A' ' 67' ' ' LEU . 3.2 p-10 -88.58 -21.27 24.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 126' ' ' ILE . 64.3 mt -59.35 109.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.528 ' HB ' HG21 ' B' ' 22' ' ' VAL . 2.8 m -81.11 -36.84 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.971 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HE2' HD22 ' B' ' 29' ' ' LEU . 8.6 mtmt -130.55 175.23 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.319 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.61 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 13.4 t 177.71 110.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 111.36 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.18 130.1 41.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.33 91.6 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 76' ' ' THR . 5.3 m-85 -91.7 143.77 26.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.089 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.514 HG11 ' CD1' ' A' ' 85' ' ' PHE . 35.3 m -139.31 150.0 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.023 0.44 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.57 ' HE2' HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -90.95 -4.31 56.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.796 178.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.04 108.99 0.46 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.687 HD12 ' HB3' ' B' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.25 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.97 -24.64 59.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 110.282 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -78.46 -15.34 58.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.832 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.514 ' CD1' HG11 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -55.52 -22.98 23.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.01 -46.63 84.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 -33.22 19.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 84' ' ' ASP . 32.6 t -70.08 -49.66 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.673 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 36.4 t-20 -63.09 -35.99 82.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.14 94.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.016 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.62 -31.1 19.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.448 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 48.7 t80 -57.67 -51.35 69.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.727 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 7.7 tt0 -73.32 -27.34 61.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -25.11 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.765 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -79.31 -41.02 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.934 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 95' ' ' PHE . 57.1 m-85 -56.45 -50.43 71.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.8 69.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.77 58.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.402 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -110.54 -6.88 14.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.7 m-20 89.68 30.9 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 19.9 t-160 -127.57 72.17 77.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.96 -11.04 16.65 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.539 2.159 . . . . 0.0 112.153 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.844 ' OD1' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.03 42.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.447 . . . . 0.0 110.439 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CG ' ' HA ' ' B' ' 17' ' ' PRO . 92.7 m-85 70.99 144.0 0.1 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.515 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 104' ' ' PHE . 2.0 Cg_endo -82.96 165.82 15.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.057 2.504 . . . . 0.0 112.0 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' B' ' 31' ' ' SER . . . -115.28 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.779 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.61 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -169.27 -163.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.944 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.36 107.57 16.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.493 ' O ' HG13 ' A' ' 110' ' ' VAL . 5.3 m -95.25 129.16 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.798 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.519 HG12 HD23 ' B' ' 115' ' ' LEU . 7.0 m -157.79 165.71 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.949 0.405 . . . . 0.0 111.666 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 9.4 tt0 -99.75 102.87 14.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.777 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.82 162.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -79.07 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.685 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -140.81 168.08 20.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.722 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.622 HD22 ' HB2' ' A' ' 122' ' ' GLU . 3.0 mt -144.19 161.9 42.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 119' ' ' VAL . 32.7 Cg_exo -59.7 135.94 67.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.649 2.233 . . . . 0.0 112.183 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.58 18.28 7.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.87 17.47 8.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 116' ' ' PRO . 21.2 m -55.18 172.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.61 14.08 20.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.011 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 121' ' ' LEU . 4.5 pp -176.64 149.0 0.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.123 0.487 . . . . 0.0 111.508 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.622 ' HB2' HD22 ' A' ' 115' ' ' LEU . 44.5 tt0 -150.86 137.85 19.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.918 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 76' ' ' THR . 3.4 mp -144.67 138.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 112.101 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.36 149.91 28.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.569 ' C ' HD13 ' A' ' 126' ' ' ILE . . . -132.03 125.99 32.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.414 . . . . 0.0 112.027 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.569 HD13 ' C ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -114.42 132.16 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.876 178.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.95 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -121.74 153.14 38.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.063 0.459 . . . . 0.0 112.038 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.111 HG21 HG21 ' B' ' 3' ' ' THR . 34.6 m -124.13 116.37 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.464 ' CD ' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 1.111 HG21 HG21 ' A' ' 128' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.72 132.95 5.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.844 HD13 ' OD1' ' A' ' 103' ' ' ASN . 4.4 mp -55.2 152.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' B' ' 21' ' ' ALA . 32.7 mt -103.43 139.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.59 117.19 9.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.575 HG23 ' H ' ' B' ' 11' ' ' ALA . 11.6 t -133.86 165.97 23.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.804 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 26.32 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.58 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 7.6 mmtt -121.6 -36.61 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -68.18 172.03 4.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 18.7 Cg_endo -59.33 -16.06 32.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.632 2.221 . . . . 0.0 112.905 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 77.23 151.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.411 . . . . 0.0 111.281 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.586 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.597 HG22 ' O ' ' B' ' 15' ' ' ILE . 22.1 mm -133.53 15.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.79 -146.1 4.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.509 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . 94.4 Cg_endo -87.38 44.49 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.637 2.224 . . . . 0.0 112.916 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -163.26 154.53 17.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.915 0.388 . . . . 0.0 110.991 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 103' ' ' ASN . 27.2 m -110.83 169.25 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.304 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.575 ' OE1' HG22 ' B' ' 8' ' ' THR . 56.3 mt-30 -59.04 -53.58 56.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -170.46 -177.16 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.528 HG21 ' HB ' ' A' ' 73' ' ' VAL . 9.2 m -142.31 132.63 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.636 ' HA ' HG23 ' B' ' 28' ' ' VAL . 20.8 t70 -103.51 104.94 15.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.554 ' CD2' HG23 ' B' ' 3' ' ' THR . 19.5 mt -80.44 -16.4 54.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -103.96 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.972 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.3 -29.56 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.082 0.468 . . . . 0.0 110.189 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.644 HD23 ' N ' ' B' ' 28' ' ' VAL . 5.0 tt -135.3 140.65 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.52 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.945 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 9.9 p -120.07 160.84 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.657 HD22 ' HE2' ' A' ' 74' ' ' LYS . 2.9 mp -145.87 127.42 15.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.68 136.36 46.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.06 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.843 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 1.1 t -59.69 179.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.01 95.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.834 ' HG2' HG22 ' B' ' 58' ' ' VAL . 2.9 mp0 -61.92 138.09 58.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.553 HG22 ' O ' ' B' ' 121' ' ' LEU . 0.7 OUTLIER -145.98 170.19 8.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.665 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 52.2 Cg_exo -54.34 -137.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.069 2.513 . . . . 0.0 112.319 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -178.922 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.83 140.7 81.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.662 2.242 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.39 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.35 93.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.618 HD13 ' NE2' ' B' ' 50' ' ' GLN . 28.9 mm -38.94 -33.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.443 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.02 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.91 -54.98 38.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.618 ' NE2' HD13 ' B' ' 47' ' ' ILE . 15.8 pt20 -61.1 -26.16 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.522 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -72.18 -44.2 63.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.901 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.33 -51.54 65.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.22 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.9 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.3 m -68.4 -46.37 70.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.32 -26.38 68.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.963 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -57.99 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.163 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.8 OUTLIER -54.86 -30.39 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.931 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.9 HG23 ' O ' ' B' ' 54' ' ' SER . 39.7 t -62.13 -34.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.95 -31.77 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -62.21 -38.49 89.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.571 HG12 ' HB2' ' B' ' 11' ' ' ALA . 6.0 mt -71.25 -46.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.83 -32.53 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.656 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.31 -38.49 60.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.34 65.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.136 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 -22.06 21.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.919 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 64.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.711 HD22 ' OD2' ' B' ' 71' ' ' ASP . 14.7 mt -158.91 139.2 12.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.022 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' B' ' 71' ' ' ASP . 43.8 p -96.1 144.99 25.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -46.26 -31.79 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.574 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -59.83 -18.27 42.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.425 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.711 ' OD2' HD22 ' B' ' 67' ' ' LEU . 3.3 p-10 -88.65 -21.23 24.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.714 0.292 . . . . 0.0 110.87 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.512 HG23 ' O ' ' B' ' 126' ' ' ILE . 64.4 mt -59.4 109.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.874 0.369 . . . . 0.0 110.839 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' C' ' 22' ' ' VAL . 2.8 m -81.12 -36.88 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.969 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.667 ' HE2' HD22 ' C' ' 29' ' ' LEU . 8.6 mtmt -130.56 175.22 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.302 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.612 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 13.4 t 177.67 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 111.337 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.753 ' O ' HG23 ' B' ' 123' ' ' ILE . 0.0 OUTLIER -70.15 130.12 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.325 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.43 91.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.404 ' CZ ' ' HB ' ' B' ' 76' ' ' THR . 5.3 m-85 -91.66 143.72 26.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.151 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' B' ' 85' ' ' PHE . 35.1 m -139.32 150.01 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.072 0.463 . . . . 0.0 111.718 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' B' ' 47' ' ' ILE . 0.3 OUTLIER -90.94 -4.12 56.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.839 178.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -169.23 109.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.321 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' C' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.32 20.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.228 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.94 -24.63 59.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.275 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.547 ' O ' HG23 ' B' ' 88' ' ' VAL . 0.6 OUTLIER -78.52 -15.37 58.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.51 ' CD1' HG11 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -55.46 -23.03 23.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.267 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.99 -46.62 84.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.09 -33.23 19.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 84' ' ' ASP . 33.0 t -70.09 -49.59 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.721 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 36.4 t-20 -63.21 -35.96 82.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.04 94.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.67 -31.19 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 48.8 t80 -57.62 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 7.7 tt0 -73.41 -27.32 61.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.462 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -25.19 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.786 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -79.25 -41.09 28.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.97 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 95' ' ' PHE . 57.2 m-85 -56.36 -50.45 71.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.818 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.82 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.945 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.8 58.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.98 14.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.505 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 11.7 m-20 89.78 30.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.502 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.0 t-160 -127.48 72.19 77.52 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.98 -11.02 16.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.537 2.158 . . . . 0.0 112.153 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.83 ' OD1' HD13 ' C' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.03 0.443 . . . . 0.0 110.445 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.506 ' CG ' ' HA ' ' C' ' 17' ' ' PRO . 92.7 m-85 70.89 144.04 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.494 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 104' ' ' PHE . 2.0 Cg_endo -83.02 165.85 14.91 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.016 2.477 . . . . 0.0 111.917 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.835 ' HB1' ' HB2' ' C' ' 31' ' ' SER . . . -115.27 137.95 51.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.612 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -169.23 -163.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.38 107.56 16.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.571 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . 0.504 ' O ' HG13 ' B' ' 110' ' ' VAL . 5.2 m -95.21 129.11 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.845 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.533 HG12 HD23 ' C' ' 115' ' ' LEU . 7.0 m -157.71 165.59 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.409 . . . . 0.0 111.632 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 9.3 tt0 -99.57 102.86 14.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.785 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.73 162.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -79.05 -46.27 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -140.82 168.11 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' B' ' 122' ' ' GLU . 3.0 mt -144.21 161.87 42.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.549 ' O ' HG22 ' B' ' 119' ' ' VAL . 33.1 Cg_exo -59.62 135.97 67.82 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.157 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.53 18.29 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.88 17.46 8.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.549 HG22 ' O ' ' B' ' 116' ' ' PRO . 21.5 m -55.18 172.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.082 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.63 13.95 20.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.025 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.553 ' O ' HG22 ' B' ' 34' ' ' ILE . 4.6 pp -176.62 148.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.615 ' HB2' HD22 ' B' ' 115' ' ' LEU . 44.5 tt0 -150.78 137.88 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.935 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.753 HG23 ' O ' ' B' ' 76' ' ' THR . 3.4 mp -144.68 138.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 112.14 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.33 149.81 28.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.627 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.572 ' C ' HD13 ' B' ' 126' ' ' ILE . . . -131.94 126.01 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.956 0.408 . . . . 0.0 112.041 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.572 HD13 ' C ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -114.33 132.14 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.947 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.945 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -121.75 153.2 38.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.096 0.474 . . . . 0.0 111.994 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 1.04 HG21 HG21 ' C' ' 3' ' ' THR . 34.7 m -124.26 116.32 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.474 ' CD ' HD21 ' B' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 1.04 HG21 HG21 ' B' ' 128' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.842 0.353 . . . . 0.0 110.947 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.68 132.97 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.83 HD13 ' OD1' ' B' ' 103' ' ' ASN . 4.4 mp -55.18 152.35 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' C' ' 21' ' ' ALA . 32.5 mt -103.46 139.23 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -143.59 117.2 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.572 HG22 ' OE1' ' C' ' 20' ' ' GLN . 11.7 t -133.93 165.96 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.32 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.542 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 7.6 mmtp -121.59 -36.84 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.01 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.885 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.93 172.02 4.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.885 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 18.8 Cg_endo -59.31 -16.11 32.83 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.675 2.25 . . . . 0.0 112.899 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 77.24 151.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.977 0.418 . . . . 0.0 111.304 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.591 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -104.69 120.76 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.002 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.591 HD13 ' O ' ' C' ' 14' ' ' ALA . 22.5 mm -133.54 15.81 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.81 -146.14 4.73 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.001 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' B' ' 104' ' ' PHE . 94.1 Cg_endo -87.37 44.51 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 112.917 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.532 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -163.23 154.55 17.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.026 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' B' ' 103' ' ' ASN . 27.2 m -110.87 169.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.36 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.572 ' OE1' HG22 ' C' ' 8' ' ' THR . 56.2 mt-30 -59.02 -53.38 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' C' ' 6' ' ' ILE . . . -170.6 -177.19 2.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' B' ' 73' ' ' VAL . 9.2 m -142.24 132.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.64 ' HA ' HG23 ' C' ' 28' ' ' VAL . 20.8 t70 -103.48 104.98 15.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.549 ' CD2' HG23 ' C' ' 3' ' ' THR . 19.5 mt -80.47 -16.35 54.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.0 -104.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.27 -29.59 33.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.648 HD23 ' N ' ' C' ' 28' ' ' VAL . 5.0 tt -135.22 140.64 45.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.575 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.947 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 9.9 p -120.04 160.84 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.667 HD22 ' HE2' ' B' ' 74' ' ' LYS . 2.9 mp -145.85 127.45 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 p -106.6 136.31 46.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . 0.835 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 1.1 t -59.62 179.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.13 95.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.25 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.821 ' HG2' HG22 ' C' ' 58' ' ' VAL . 2.9 mp0 -62.06 138.17 58.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.259 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.528 HG22 ' O ' ' C' ' 121' ' ' LEU . 0.7 OUTLIER -146.0 170.23 8.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.654 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' C' ' 34' ' ' ILE . 52.4 Cg_exo -54.36 -137.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.063 2.509 . . . . 0.0 112.29 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.427 -178.928 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.762 0.315 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.88 140.74 81.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.637 2.225 . . . . 0.0 112.358 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.45 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.083 0.468 . . . . 0.0 110.913 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 93.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.621 HD13 ' NE2' ' C' ' 50' ' ' GLN . 28.7 mm -39.01 -33.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.447 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.711 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -54.96 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.621 ' NE2' HD13 ' C' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.474 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -72.07 -44.36 63.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.36 -51.5 65.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.24 72.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.354 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.903 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.3 m -68.35 -46.4 70.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.58 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.32 -26.36 68.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -58.01 4.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.8 OUTLIER -54.9 -30.36 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.984 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.903 HG23 ' O ' ' C' ' 54' ' ' SER . 39.6 t -62.07 -34.62 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -80.86 -31.79 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -62.26 -38.52 89.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' C' ' 11' ' ' ALA . 6.0 mt -70.95 -46.31 68.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.89 -32.54 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.33 -38.39 60.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.093 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.31 65.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.139 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.1 21.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.87 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.445 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.712 HD22 ' OD2' ' C' ' 71' ' ' ASP . 14.7 mt -158.9 139.23 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.036 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.0 p -96.16 145.01 25.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -46.21 -31.81 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.598 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -59.74 -18.28 41.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.477 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.712 ' OD2' HD22 ' C' ' 67' ' ' LEU . 3.3 p-10 -88.78 -21.16 23.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 110.896 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.503 HG23 ' O ' ' C' ' 126' ' ' ILE . 64.2 mt -59.39 109.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.496 ' HB ' HG21 ' A' ' 22' ' ' VAL . 2.8 m -81.04 -36.88 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.933 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.646 ' HE2' HD22 ' A' ' 29' ' ' LEU . 8.6 mtmt -130.6 175.25 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.369 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 13.4 t 177.72 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.313 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.754 ' O ' HG23 ' C' ' 123' ' ' ILE . 0.0 OUTLIER -70.23 130.2 41.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 t -115.43 91.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' C' ' 76' ' ' THR . 5.3 m-85 -91.64 143.8 26.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.143 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' C' ' 85' ' ' PHE . 34.8 m -139.35 149.98 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 111.691 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' C' ' 47' ' ' ILE . 0.3 OUTLIER -90.99 -4.23 56.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.816 178.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.1 109.04 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.305 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.685 HD12 ' HB3' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -58.58 -17.19 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.0 -24.62 59.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.297 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.546 ' O ' HG23 ' C' ' 88' ' ' VAL . 0.6 OUTLIER -78.5 -15.28 58.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.827 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.513 ' CD1' HG11 ' C' ' 79' ' ' VAL . 0.3 OUTLIER -55.53 -23.04 24.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.261 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.63 84.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.01 -33.32 19.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.969 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.546 HG23 ' O ' ' C' ' 84' ' ' ASP . 32.8 t -70.06 -49.66 54.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 36.4 t-20 -63.12 -35.99 82.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.337 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.22 -42.14 94.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.973 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.68 -31.16 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.567 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.457 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 48.7 t80 -57.64 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 7.7 tt0 -73.36 -27.37 61.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -25.19 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.77 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -79.32 -41.03 28.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 95' ' ' PHE . 56.7 m-85 -56.38 -50.4 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.781 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -28.72 69.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.954 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.91 -3.78 58.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.362 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.91 14.79 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 11.7 m-20 89.79 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.822 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.499 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.0 t-160 -127.55 72.17 77.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.705 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.03 -10.97 16.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.495 2.13 . . . . 0.0 112.146 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.82 ' OD1' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.998 0.428 . . . . 0.0 110.429 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.512 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 92.8 m-85 70.91 144.1 0.1 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.42 ' HB2' HG22 ' C' ' 75' ' ' THR . 2.0 Cg_endo -83.05 165.85 14.87 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.028 2.485 . . . . 0.0 111.948 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.812 ' HB1' ' HB2' ' A' ' 31' ' ' SER . . . -115.29 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.6 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -169.22 -163.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.4 p -111.36 107.48 16.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.589 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . 0.502 ' O ' HG13 ' C' ' 110' ' ' VAL . 5.2 m -95.21 129.18 42.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.788 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.514 HG12 HD23 ' A' ' 115' ' ' LEU . 7.1 m -157.82 165.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 9.4 tt0 -99.76 102.86 14.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.75 162.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -79.08 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.671 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -140.83 168.09 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' C' ' 122' ' ' GLU . 3.0 mt -144.21 161.82 43.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.913 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.544 ' O ' HG22 ' C' ' 119' ' ' VAL . 33.7 Cg_exo -59.52 135.99 68.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.608 2.205 . . . . 0.0 112.221 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.51 18.29 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 61.8 17.55 8.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.544 HG22 ' O ' ' C' ' 116' ' ' PRO . 21.2 m -55.18 172.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.065 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.79 14.08 19.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.988 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.534 ' O ' HD12 ' C' ' 121' ' ' LEU . 4.6 pp -176.62 148.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.489 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.619 ' HB2' HD22 ' C' ' 115' ' ' LEU . 44.4 tt0 -150.83 137.93 19.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.754 HG23 ' O ' ' C' ' 76' ' ' THR . 3.4 mp -144.74 138.35 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.11 0.481 . . . . 0.0 112.142 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.3 149.82 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.648 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.573 ' C ' HD13 ' C' ' 126' ' ' ILE . . . -131.98 126.13 33.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 112.004 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.573 HD13 ' C ' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -114.41 132.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 178.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.947 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -121.76 153.11 38.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.082 0.468 . . . . 0.0 112.029 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 3' ' ' THR . 34.6 m -124.15 116.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.47 ' CD ' HD21 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -106.27 56.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.99 0.424 . . . . 0.0 110.892 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.76 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.771 0.319 . . . . 0.0 110.86 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.83 107.65 13.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.971 HD11 HG11 ' A' ' 19' ' ' VAL . 1.7 tp -54.31 125.88 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.311 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 23' ' ' ASP . 22.4 mm -83.67 137.49 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.46 92.4 1.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -115.24 163.65 15.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.08 29.06 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -113.94 -41.78 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.807 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -72.34 178.16 1.49 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 32.3 Cg_exo -57.56 -13.83 14.98 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.808 2.339 . . . . 0.0 113.006 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 77.39 163.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 0.0 111.075 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -117.17 125.0 50.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.407 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 15' ' ' ILE . 3.3 mp -144.89 18.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.025 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.1 -137.25 3.45 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.429 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' C' ' 92' ' ' TYR . 89.8 Cg_endo -88.82 32.42 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.795 2.33 . . . . 0.0 113.23 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' C' ' 105' ' ' PRO . 0.7 OUTLIER -152.49 -178.03 6.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.392 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.971 HG11 HD11 ' A' ' 5' ' ' ILE . 10.3 m -136.68 179.79 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.689 ' NE2' ' HB3' ' A' ' 11' ' ' ALA . 15.6 mm-40 -68.86 -49.58 57.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.517 ' HB3' HG13 ' A' ' 6' ' ' ILE . . . -174.48 -177.42 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.48 HG11 ' HB ' ' C' ' 73' ' ' VAL . 4.7 m -137.88 141.58 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.714 ' HB2' HD11 ' A' ' 6' ' ' ILE . 53.5 t0 -117.97 91.01 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.59 HD11 ' CG1' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -65.95 -20.97 66.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.073 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.06 -108.85 0.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.846 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -57.85 -30.17 65.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.096 0.474 . . . . 0.0 110.229 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.411 HD23 ' C ' ' A' ' 27' ' ' LEU . 7.6 tt -124.71 124.55 42.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.736 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.072 HG23 ' HB3' ' A' ' 127' ' ' ALA . 3.4 m -105.54 171.61 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.594 HD22 ' HD2' ' C' ' 74' ' ' LYS . 1.3 mp -144.7 164.81 29.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.751 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 p -138.47 143.9 39.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.911 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.842 ' HB3' ' HB1' ' C' ' 106' ' ' ALA . 3.4 p -72.47 179.55 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.27 95.43 0.96 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.377 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.581 ' OE1' HD11 ' A' ' 61' ' ' ILE . 14.4 mm-40 -66.93 165.13 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.342 . . . . 0.0 111.015 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.645 ' HB ' HG11 ' A' ' 119' ' ' VAL . 8.6 pt -159.5 157.59 26.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.294 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 35.5 Cg_exo -58.35 -15.05 22.51 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.075 2.517 . . . . 0.0 113.024 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.606 ' CG2' HD12 ' A' ' 34' ' ' ILE . 44.0 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 0.0 111.181 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 35' ' ' PRO . 14.7 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.84 0.353 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 43' ' ' VAL . 51.8 Cg_exo -54.33 153.04 23.55 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.652 2.235 . . . . 0.0 112.414 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.74 60.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -55.02 95.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.868 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.604 HD13 ' OD2' ' A' ' 84' ' ' ASP . 8.2 tp -40.34 -32.98 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.797 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.62 -48.14 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.83 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -61.48 -48.51 80.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.827 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.636 ' HG3' HD21 ' A' ' 121' ' ' LEU . 18.8 pt20 -65.97 -33.78 76.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.481 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -71.89 -35.88 69.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.008 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.61 -45.67 78.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.681 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -39.39 85.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.656 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.809 ' O ' HG23 ' A' ' 58' ' ' VAL . 4.7 t -69.75 -32.16 70.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.656 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.632 HD13 ' CE2' ' A' ' 95' ' ' PHE . 17.3 mt -70.94 -44.97 65.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.53 -42.27 96.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.824 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -58.95 -38.16 78.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 54' ' ' SER . 12.4 t -61.56 -38.0 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.762 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -80.68 -31.02 36.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.763 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -58.72 -41.0 85.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.599 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 15.4 mt -71.54 -42.17 72.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.615 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.583 ' CD1' HD11 ' A' ' 72' ' ' ILE . 17.1 mt -68.48 -33.05 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.583 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.5 -42.82 67.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.224 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -21.36 63.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.404 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.39 -28.85 19.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.703 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.99 52.82 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.61 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 129' ' ' ARG . 6.2 mt -161.28 -172.69 3.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 0.0 110.731 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -141.75 165.09 28.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.779 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.066 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -59.69 -32.33 70.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.876 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.962 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -56.67 -26.49 56.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.473 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -82.67 -22.64 34.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.22 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.583 HD11 ' CD1' ' A' ' 62' ' ' ILE . 89.7 mt -53.59 110.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.921 0.391 . . . . 0.0 111.243 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 74' ' ' LYS . 34.4 m -78.65 -46.08 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.838 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.608 ' HD2' HD22 ' B' ' 29' ' ' LEU . 7.5 mttt -119.55 154.36 34.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.345 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.663 HG23 ' HB2' ' A' ' 105' ' ' PRO . 76.1 p -153.77 102.37 2.53 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.622 HG22 ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -69.38 124.32 23.56 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -111.07 111.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.622 ' CE1' HG22 ' A' ' 76' ' ' THR . 13.7 m-30 -109.88 133.41 53.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.995 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.686 HG11 ' HD1' ' A' ' 85' ' ' PHE . 3.1 m -130.34 150.43 34.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.1 0.476 . . . . 0.0 111.858 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.6 -1.38 58.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.889 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.31 118.95 0.31 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.477 HD23 HG21 ' A' ' 79' ' ' VAL . 51.6 mt -62.29 -14.55 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.23 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -74.14 -21.83 59.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.301 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.604 ' OD2' HD13 ' A' ' 47' ' ' ILE . 3.7 m-20 -87.0 -18.71 30.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.991 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.686 ' HD1' HG11 ' A' ' 79' ' ' VAL . 1.3 t80 -53.48 -30.98 43.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.8 -34.91 72.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.287 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.76 -42.78 13.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.324 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.1 -45.84 79.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -63.0 -38.57 91.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.081 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.21 73.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.499 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -15.08 32.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.545 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.517 ' HH ' ' HZ ' ' A' ' 96' ' ' PHE . 12.2 t80 -81.05 -38.39 27.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 111.338 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' A' ' 104' ' ' PHE . 2.4 tt0 -83.2 -27.97 29.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.516 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.83 -24.39 55.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.773 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.632 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -85.31 -37.44 19.96 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.719 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.521 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 3.9 m-85 -55.76 -55.19 35.32 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.168 0.509 . . . . 0.0 109.998 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -32.66 72.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.27 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.01 -6.72 57.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.385 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.709 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 1.5 t-20 -111.91 -4.62 14.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.494 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 15.6 m120 84.47 32.21 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.772 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 1.066 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.4 m170 -115.81 53.16 0.93 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.605 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 58.4 Cg_endo -70.56 -22.27 28.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.539 2.159 . . . . 0.0 112.47 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.767 ' ND2' HD13 ' B' ' 5' ' ' ILE . 2.8 t30 -50.14 -33.07 17.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.897 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.594 ' HB2' HG13 ' B' ' 19' ' ' VAL . 13.2 m-85 64.54 131.01 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.193 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.663 ' HB2' HG23 ' A' ' 75' ' ' THR . 94.2 Cg_endo -88.51 133.58 2.72 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.978 2.452 . . . . 0.0 112.615 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.964 ' HB2' HG23 ' B' ' 19' ' ' VAL . . . -97.87 129.09 44.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.058 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -162.73 -164.37 0.99 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.996 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.69 114.13 24.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.113 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.415 ' O ' HG13 ' A' ' 110' ' ' VAL . 14.6 m -92.85 138.36 31.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.219 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.771 HG12 HD23 ' B' ' 115' ' ' LEU . 23.1 m -156.73 158.38 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.986 0.422 . . . . 0.0 111.634 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.862 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 3.6 tt0 -98.99 86.29 3.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.655 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.488 HG21 HD21 ' A' ' 115' ' ' LEU . 29.0 m -57.14 156.91 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.233 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.875 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -65.74 -36.14 82.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.04 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.53 -178.25 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.735 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.783 HD23 HG12 ' C' ' 110' ' ' VAL . 27.7 mt -148.83 152.42 37.13 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.837 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.551 ' O ' HG22 ' A' ' 119' ' ' VAL . 25.9 Cg_endo -62.12 137.72 68.23 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.504 2.136 . . . . 0.0 112.162 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.409 ' HB3' HG13 ' A' ' 119' ' ' VAL . 1.1 tptt 75.17 14.1 3.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.29 13.62 8.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.188 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.645 HG11 ' HB ' ' A' ' 34' ' ' ILE . 23.0 m -58.1 156.72 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.727 0.299 . . . . 0.0 110.947 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.38 10.06 65.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.999 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.636 HD21 ' HG3' ' A' ' 50' ' ' GLN . 4.1 pp -177.26 148.26 0.59 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.085 0.469 . . . . 0.0 111.372 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.755 ' HB2' HD22 ' A' ' 115' ' ' LEU . 2.1 tt0 -126.41 150.3 48.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.087 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.679 HG21 HG21 ' A' ' 58' ' ' VAL . 29.5 mt -128.92 121.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.146 0.498 . . . . 0.0 112.277 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -130.88 144.77 51.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' A' ' 75' ' ' THR . . . -168.8 167.42 11.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 28' ' ' VAL . 1.4 mt -123.9 145.21 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.645 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 1.072 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -123.87 148.03 47.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.115 0.483 . . . . 0.0 111.868 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.752 HG21 HG21 ' B' ' 3' ' ' THR . 28.7 m -114.87 142.88 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.859 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 67' ' ' LEU . 3.2 ttm-85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.939 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.752 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.818 0.342 . . . . 0.0 110.868 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.83 107.64 13.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.963 HD11 HG11 ' B' ' 19' ' ' VAL . 1.7 tp -54.35 125.87 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.221 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' B' ' 23' ' ' ASP . 22.1 mm -83.58 137.55 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.147 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.48 92.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -115.21 163.7 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.13 29.04 3.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.448 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 0.0 OUTLIER -113.98 -41.92 3.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.872 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.705 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -71.94 178.15 1.43 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.705 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 32.3 Cg_exo -57.63 -13.8 15.14 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.787 2.325 . . . . 0.0 113.008 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 77.39 163.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.896 0.379 . . . . 0.0 111.032 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.423 ' C ' HD12 ' B' ' 15' ' ' ILE . . . -117.18 125.06 50.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.377 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.589 HG22 ' O ' ' B' ' 15' ' ' ILE . 3.3 mp -144.94 18.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.993 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.06 -137.23 3.45 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.44 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -88.81 32.4 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.844 2.363 . . . . 0.0 113.269 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -152.49 -178.09 6.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.427 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 106' ' ' ALA . 10.5 m -136.64 179.7 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.21 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.686 ' NE2' ' HB3' ' B' ' 11' ' ' ALA . 15.6 mm-40 -68.82 -49.75 55.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.944 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.509 ' HB3' HG13 ' B' ' 6' ' ' ILE . . . -174.6 -177.42 1.18 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.219 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.489 HG23 HD13 ' B' ' 29' ' ' LEU . 4.6 m -137.99 141.59 38.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.714 ' HB2' HD11 ' B' ' 6' ' ' ILE . 53.6 t0 -117.94 91.05 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.975 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.578 HD11 ' CG1' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -66.04 -20.94 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.01 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.05 -108.83 0.78 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.881 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -57.82 -30.26 65.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.048 0.452 . . . . 0.0 110.194 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.411 HD23 ' C ' ' B' ' 27' ' ' LEU . 7.6 tt -124.65 124.54 42.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.726 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.051 HG23 ' HB3' ' B' ' 127' ' ' ALA . 3.4 m -105.46 171.62 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.608 HD22 ' HD2' ' A' ' 74' ' ' LYS . 1.3 mp -144.69 164.8 29.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.7 p -138.46 143.87 39.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.818 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 3.3 p -71.93 179.67 3.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.801 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.31 95.49 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.369 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.575 ' OE1' HD11 ' B' ' 61' ' ' ILE . 14.3 mm-40 -66.95 165.09 16.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 111.004 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.608 HD12 ' CG2' ' B' ' 36' ' ' VAL . 8.7 pt -159.48 157.64 27.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.301 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' B' ' 43' ' ' VAL . 36.5 Cg_exo -58.41 -15.05 22.79 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.094 2.529 . . . . 0.0 113.045 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.608 ' CG2' HD12 ' B' ' 34' ' ' ILE . 44.1 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.397 . . . . 0.0 111.17 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' B' ' 35' ' ' PRO . 14.6 t . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.852 0.358 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' B' ' 43' ' ' VAL . 51.8 Cg_exo -54.32 153.09 23.37 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.586 2.191 . . . . 0.0 112.424 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.8 60.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.838 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.2 OUTLIER -55.04 95.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.91 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.626 HD13 ' OD2' ' B' ' 84' ' ' ASP . 8.2 tp -40.34 -32.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.86 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.57 -48.12 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -61.5 -48.55 80.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.86 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.667 ' HG3' HD21 ' B' ' 121' ' ' LEU . 18.8 pt20 -65.86 -33.9 76.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.542 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -71.75 -35.88 70.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.912 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.6 -45.71 78.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.687 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -39.32 85.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.714 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.803 ' O ' HG23 ' B' ' 58' ' ' VAL . 4.8 t -69.74 -32.23 70.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.648 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.709 HD13 ' CE2' ' B' ' 95' ' ' PHE . 17.3 mt -70.93 -44.97 65.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.59 -42.23 96.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.804 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -58.95 -38.11 78.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.854 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.803 HG23 ' O ' ' B' ' 54' ' ' SER . 12.3 t -61.6 -38.01 79.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.793 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -80.67 -30.99 36.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.799 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -58.58 -41.02 84.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.94 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.646 HG12 ' HB2' ' B' ' 11' ' ' ALA . 15.7 mt -71.51 -42.04 72.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.551 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.568 ' CD1' HD11 ' B' ' 72' ' ' ILE . 17.0 mt -68.41 -33.13 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.48 -42.76 67.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.258 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -21.36 63.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.366 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.39 -28.83 19.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.71 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.99 52.71 0.38 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.619 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' B' ' 129' ' ' ARG . 6.2 mt -161.27 -172.73 3.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.689 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 22.5 p -141.69 165.05 28.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.765 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 1.056 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -59.68 -32.37 70.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.856 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.96 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -56.63 -26.56 56.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.478 ' CG ' HD22 ' B' ' 67' ' ' LEU . 0.9 OUTLIER -82.42 -22.72 35.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.174 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.568 HD11 ' CD1' ' B' ' 62' ' ' ILE . 89.7 mt -53.61 110.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 111.24 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.492 HG23 ' N ' ' B' ' 74' ' ' LYS . 34.4 m -78.66 -46.11 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.89 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.591 ' HD2' HD22 ' C' ' 29' ' ' LEU . 7.5 mttt -119.56 154.4 33.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.316 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.661 HG23 ' HB2' ' B' ' 105' ' ' PRO . 75.8 p -153.78 102.32 2.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.616 HG22 ' CE1' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -69.28 124.29 23.45 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -111.04 111.84 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.616 ' CE1' HG22 ' B' ' 76' ' ' THR . 13.6 m-30 -109.85 133.36 53.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.998 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.686 HG11 ' HD1' ' B' ' 85' ' ' PHE . 3.2 m -130.33 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.14 0.495 . . . . 0.0 111.866 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.69 -1.41 58.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.849 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.27 118.91 0.31 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.488 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.474 HD23 HG21 ' B' ' 79' ' ' VAL . 52.4 mt -62.25 -14.56 39.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.263 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -74.07 -21.89 59.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.91 0.386 . . . . 0.0 110.314 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.626 ' OD2' HD13 ' B' ' 47' ' ' ILE . 3.7 m-20 -87.02 -18.71 29.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.686 ' HD1' HG11 ' B' ' 79' ' ' VAL . 1.3 t80 -53.44 -31.0 43.42 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.133 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.95 72.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.278 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.67 -42.81 13.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.338 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.44 HG22 HG13 ' B' ' 47' ' ' ILE . 26.5 t -69.08 -45.83 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.212 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -62.99 -38.51 91.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.09 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.2 73.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.503 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.94 -14.96 33.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.561 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' B' ' 96' ' ' PHE . 12.3 t80 -81.16 -38.36 27.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 111.264 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' B' ' 104' ' ' PHE . 2.4 tt0 -83.21 -27.89 29.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.545 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.87 -24.31 55.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.794 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.709 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -85.44 -37.35 19.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.672 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.521 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 3.9 m-85 -55.85 -55.18 35.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.172 0.51 . . . . 0.0 109.954 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -32.71 72.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.254 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.92 -6.82 57.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.385 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.714 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 1.5 t-20 -111.84 -4.63 14.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.499 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 15.6 m120 84.38 32.24 0.05 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.786 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 1.056 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 3.5 m170 -115.82 53.13 0.93 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.618 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 58.5 Cg_endo -70.54 -22.33 28.65 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.565 2.177 . . . . 0.0 112.428 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.765 ' ND2' HD13 ' C' ' 5' ' ' ILE . 2.8 t30 -50.09 -33.18 17.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.93 0.395 . . . . 0.0 110.865 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.609 ' HB2' HG13 ' C' ' 19' ' ' VAL . 13.1 m-85 64.64 130.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.2 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.661 ' HB2' HG23 ' B' ' 75' ' ' THR . 94.0 Cg_endo -88.48 133.64 2.74 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.004 2.469 . . . . 0.0 112.579 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 1.014 ' HB2' HG23 ' C' ' 19' ' ' VAL . . . -97.91 128.98 44.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.546 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -162.61 -164.33 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.958 179.325 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.73 114.13 24.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.076 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . 0.404 ' O ' HG13 ' B' ' 110' ' ' VAL . 14.5 m -92.84 138.42 31.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.21 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.789 HG12 HD23 ' C' ' 115' ' ' LEU . 23.0 m -156.74 158.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.985 0.421 . . . . 0.0 111.659 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.86 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 3.6 tt0 -99.05 86.31 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.648 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.481 HG21 HD21 ' B' ' 115' ' ' LEU . 29.3 m -57.14 156.93 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -65.74 -36.18 82.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.5 -178.22 7.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.728 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.771 HD23 HG12 ' A' ' 110' ' ' VAL . 27.7 mt -148.84 152.43 37.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.819 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.562 ' O ' HG22 ' B' ' 119' ' ' VAL . 26.1 Cg_endo -62.1 137.73 68.39 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.509 2.139 . . . . 0.0 112.18 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.403 ' HB3' HG13 ' B' ' 119' ' ' VAL . 1.1 tptt 75.13 14.12 3.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.249 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.28 13.64 8.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.142 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.589 HG11 ' HB ' ' B' ' 34' ' ' ILE . 23.0 m -58.08 156.84 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.55 9.8 64.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.019 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.667 HD21 ' HG3' ' B' ' 50' ' ' GLN . 4.1 pp -176.87 148.18 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.02 0.438 . . . . 0.0 111.39 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.754 ' HB2' HD22 ' B' ' 115' ' ' LEU . 2.1 tt0 -126.34 150.28 48.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.082 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.69 HG21 HG21 ' B' ' 58' ' ' VAL . 29.6 mt -128.96 121.34 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 112.31 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' B' ' 76' ' ' THR . 4.3 tp10 -130.77 144.82 51.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -168.8 167.48 11.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.439 HG22 ' O ' ' B' ' 28' ' ' VAL . 1.4 mt -123.89 145.2 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.661 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 1.051 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -123.86 147.94 47.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.111 0.481 . . . . 0.0 111.867 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.762 HG21 HG21 ' C' ' 3' ' ' THR . 28.9 m -114.75 142.8 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.887 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.484 ' HB2' HD11 ' B' ' 67' ' ' LEU . 3.2 ttm-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.762 HG21 HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.85 107.65 13.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.973 HD11 HG11 ' C' ' 19' ' ' VAL . 1.7 tp -54.37 125.93 10.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.237 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.701 HD11 ' HB2' ' C' ' 23' ' ' ASP . 22.2 mm -83.6 137.51 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.44 92.41 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -115.22 163.68 15.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.13 29.12 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.453 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 0.0 OUTLIER -113.96 -41.73 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.84 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.714 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -72.4 178.18 1.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.899 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.714 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 32.3 Cg_exo -57.56 -13.78 14.85 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.801 2.334 . . . . 0.0 113.003 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 77.35 163.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.114 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -117.09 125.04 50.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.469 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.592 HG22 ' O ' ' C' ' 15' ' ' ILE . 3.3 mp -144.93 18.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.007 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.09 -137.28 3.45 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.439 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . 0.447 ' HB2' ' CD1' ' B' ' 92' ' ' TYR . 88.0 Cg_endo -88.74 32.36 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.782 2.322 . . . . 0.0 113.254 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' B' ' 105' ' ' PRO . 0.7 OUTLIER -152.48 -178.03 6.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.868 0.366 . . . . 0.0 111.354 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 1.014 HG23 ' HB2' ' B' ' 106' ' ' ALA . 10.4 m -136.71 179.72 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.193 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.685 ' NE2' ' HB3' ' C' ' 11' ' ' ALA . 15.6 mm-40 -68.87 -49.62 56.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.969 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.521 ' HB3' HG13 ' C' ' 6' ' ' ILE . . . -174.42 -177.47 1.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.471 HG23 HD13 ' C' ' 29' ' ' LEU . 4.7 m -137.92 141.56 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.157 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.701 ' HB2' HD11 ' C' ' 6' ' ' ILE . 53.7 t0 -117.95 91.04 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.594 HD11 ' CG1' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -65.96 -21.0 66.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.06 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.1 -108.82 0.78 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.893 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -57.9 -30.2 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.015 0.436 . . . . 0.0 110.189 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.409 HD23 ' C ' ' C' ' 27' ' ' LEU . 7.6 tt -124.67 124.57 42.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.745 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 1.005 HG23 ' HB3' ' C' ' 127' ' ' ALA . 3.3 m -105.53 171.64 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.591 HD22 ' HD2' ' B' ' 74' ' ' LYS . 1.3 mp -144.72 164.79 29.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 15.3 p -138.44 143.76 39.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . 0.825 ' HB3' ' HB1' ' B' ' 106' ' ' ALA . 3.4 p -72.18 179.54 3.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.27 95.47 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.359 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.573 ' OE1' HD11 ' C' ' 61' ' ' ILE . 14.3 mm-40 -66.96 165.19 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.635 ' HB ' HG11 ' C' ' 119' ' ' VAL . 8.7 pt -159.56 157.57 26.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.292 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.504 ' HB2' ' HA ' ' C' ' 43' ' ' VAL . 36.2 Cg_exo -58.4 -15.03 22.68 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.066 2.511 . . . . 0.0 112.997 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.607 ' CG2' HD12 ' C' ' 34' ' ' ILE . 43.9 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.39 . . . . 0.0 111.186 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.504 ' HA ' ' HB2' ' C' ' 35' ' ' PRO . 14.7 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.788 0.328 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' C' ' 43' ' ' VAL . 51.7 Cg_exo -54.39 153.12 23.62 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.608 2.206 . . . . 0.0 112.404 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.64 60.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -55.01 95.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.888 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.642 HD13 ' OD2' ' C' ' 84' ' ' ASP . 8.2 tp -40.35 -32.94 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.891 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.63 -48.17 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -61.44 -48.51 80.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.849 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.666 ' HG3' HD21 ' C' ' 121' ' ' LEU . 18.7 pt20 -65.99 -33.9 76.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -71.84 -35.93 70.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.996 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.64 -45.63 78.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.696 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -39.33 85.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.682 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.799 ' O ' HG23 ' C' ' 58' ' ' VAL . 4.8 t -69.74 -32.2 70.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.641 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.681 HD13 ' CE2' ' C' ' 95' ' ' PHE . 17.3 mt -70.99 -44.94 64.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.741 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.58 -42.26 96.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -58.94 -38.15 78.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.799 HG23 ' O ' ' C' ' 54' ' ' SER . 12.3 t -61.58 -37.97 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.774 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -80.69 -31.02 36.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.784 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -58.67 -41.07 85.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.601 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 15.7 mt -71.4 -42.17 73.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.507 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.587 ' CD1' HD11 ' C' ' 72' ' ' ILE . 16.8 mt -68.38 -33.22 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.593 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.37 -42.83 67.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.291 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.25 -21.3 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.409 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.45 -28.81 19.45 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.714 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.04 52.72 0.37 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.579 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' C' ' 129' ' ' ARG . 6.2 mt -161.26 -172.65 3.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 110.73 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -141.77 165.05 28.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 1.057 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -59.71 -32.29 70.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.903 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.951 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -56.72 -26.47 57.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.481 ' CG ' HD22 ' C' ' 67' ' ' LEU . 0.9 OUTLIER -82.59 -22.67 34.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.587 HD11 ' CD1' ' C' ' 62' ' ' ILE . 90.0 mt -53.62 110.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.191 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.488 HG23 ' N ' ' C' ' 74' ' ' LYS . 34.4 m -78.66 -46.05 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.9 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.594 ' HD2' HD22 ' A' ' 29' ' ' LEU . 7.5 mttt -119.61 154.38 34.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.295 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.647 HG23 ' HB2' ' C' ' 105' ' ' PRO . 76.7 p -153.75 102.33 2.53 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.614 HG22 ' CE1' ' C' ' 78' ' ' PHE . 0.2 OUTLIER -69.35 124.32 23.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 11.0 t -111.03 111.78 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.614 ' CE1' HG22 ' C' ' 76' ' ' THR . 13.6 m-30 -109.83 133.45 53.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.989 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.669 HG11 ' HD1' ' C' ' 85' ' ' PHE . 3.1 m -130.38 150.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.132 0.492 . . . . 0.0 111.831 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.64 -1.28 57.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.946 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.32 118.86 0.31 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.431 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.472 HD23 HG21 ' C' ' 79' ' ' VAL . 52.1 mt -62.17 -14.6 39.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.3 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -74.09 -21.84 59.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.868 0.366 . . . . 0.0 110.286 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.642 ' OD2' HD13 ' C' ' 47' ' ' ILE . 3.7 m-20 -87.06 -18.69 29.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.973 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.669 ' HD1' HG11 ' C' ' 79' ' ' VAL . 1.3 t80 -53.49 -30.94 43.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.141 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.95 72.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.257 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.67 -42.83 13.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.358 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.442 HG22 HG13 ' C' ' 47' ' ' ILE . 27.1 t -69.11 -45.76 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.209 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -63.05 -38.51 91.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.044 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.32 -35.3 73.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.487 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.83 -14.99 33.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.511 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.527 ' HH ' ' HZ ' ' C' ' 96' ' ' PHE . 12.3 t80 -81.14 -38.36 27.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.0 111.286 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . 0.45 ' HG3' ' CE1' ' C' ' 104' ' ' PHE . 2.4 tt0 -83.2 -27.94 29.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.508 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.88 -24.36 55.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.752 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.681 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -85.37 -37.36 19.97 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.713 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.527 ' HZ ' ' HH ' ' C' ' 92' ' ' TYR . 3.9 m-85 -55.83 -55.17 35.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.132 0.492 . . . . 0.0 109.984 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -32.65 72.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.214 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -6.72 56.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.424 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.717 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 1.5 t-20 -111.86 -4.65 14.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.548 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 15.5 m120 84.4 32.17 0.05 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.81 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 1.057 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 3.5 m170 -115.79 53.18 0.93 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.587 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.403 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 58.5 Cg_endo -70.57 -22.22 28.64 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.519 2.146 . . . . 0.0 112.483 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.763 ' ND2' HD13 ' A' ' 5' ' ' ILE . 2.8 t30 -50.18 -33.11 18.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 110.879 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.611 ' HB2' HG13 ' A' ' 19' ' ' VAL . 13.1 m-85 64.59 131.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.184 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.647 ' HB2' HG23 ' C' ' 75' ' ' THR . 94.1 Cg_endo -88.5 133.62 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.962 2.442 . . . . 0.0 112.638 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.963 ' HB2' HG23 ' A' ' 19' ' ' VAL . . . -97.94 129.01 44.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.031 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.534 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -162.61 -164.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 179.298 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.68 114.11 24.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . 0.416 ' O ' HG13 ' C' ' 110' ' ' VAL . 14.6 m -92.85 138.4 31.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.297 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.783 HG12 HD23 ' A' ' 115' ' ' LEU . 23.1 m -156.69 158.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.97 0.414 . . . . 0.0 111.682 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.875 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 3.6 tt0 -99.0 86.32 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.644 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.487 HG21 HD21 ' C' ' 115' ' ' LEU . 29.1 m -57.12 156.88 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.219 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.86 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -65.71 -36.21 82.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.51 -178.2 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.767 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.789 HD23 HG12 ' B' ' 110' ' ' VAL . 27.8 mt -148.85 152.42 37.07 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.825 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.55 ' O ' HG22 ' C' ' 119' ' ' VAL . 25.8 Cg_endo -62.13 137.71 68.12 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.523 2.149 . . . . 0.0 112.151 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.422 ' HB3' HG13 ' C' ' 119' ' ' VAL . 1.1 tptt 75.16 14.12 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.219 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.25 13.63 8.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.152 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.635 HG11 ' HB ' ' C' ' 34' ' ' ILE . 23.3 m -58.06 156.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.771 0.32 . . . . 0.0 110.965 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.48 10.16 64.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.044 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.666 HD21 ' HG3' ' C' ' 50' ' ' GLN . 4.1 pp -177.33 148.18 0.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.063 0.459 . . . . 0.0 111.388 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.766 ' HB2' HD22 ' C' ' 115' ' ' LEU . 2.1 tt0 -126.3 150.34 48.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.096 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.683 HG21 HG21 ' C' ' 58' ' ' VAL . 29.3 mt -128.98 121.31 54.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.502 . . . . 0.0 112.322 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' C' ' 76' ' ' THR . 4.3 tp10 -130.79 144.75 51.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' C' ' 75' ' ' THR . . . -168.75 167.5 11.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.431 HG22 ' O ' ' C' ' 28' ' ' VAL . 1.4 mt -123.96 145.27 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.624 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 1.005 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -123.89 147.95 47.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.125 0.488 . . . . 0.0 111.848 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.76 HG21 HG21 ' A' ' 3' ' ' THR . 28.8 m -114.76 142.87 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.853 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' C' ' 67' ' ' LEU . 3.2 ttm-85 -123.07 47.54 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.926 0.393 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 24' ' ' LEU . 90.1 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.961 0.41 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.537 ' O ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 60.57 -173.31 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.873 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 4' ' ' GLN . 1.1 tp 57.67 120.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.907 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.516 HG21 HG22 ' A' ' 61' ' ' ILE . 13.7 mt -148.67 134.93 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.252 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.8 138.81 48.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 0.0 111.238 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.661 HG21 ' CG1' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -139.07 148.03 42.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.838 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.01 37.16 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -137.88 -45.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.992 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.7 110.95 7.43 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.33 -14.68 45.4 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.517 2.145 . . . . 0.0 112.36 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.77 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.198 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.555 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 61.22 -165.19 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.358 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 15' ' ' ILE . 21.8 mt 77.38 17.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.252 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.02 -135.2 3.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.009 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.84 43.13 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.658 2.239 . . . . 0.0 112.568 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.555 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -177.33 -176.3 0.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.859 0.362 . . . . 0.0 110.983 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.781 HG13 ' HB2' ' C' ' 104' ' ' PHE . 16.6 m -115.26 165.25 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -56.38 -48.25 77.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 110.63 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.548 ' CB ' HG21 ' A' ' 61' ' ' ILE . . . -161.41 -175.96 5.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.523 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.476 HG11 ' O ' ' C' ' 73' ' ' VAL . 30.6 m -132.09 131.47 61.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.975 0.417 . . . . 0.0 111.42 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB2' HG12 ' A' ' 6' ' ' ILE . 61.7 t0 -105.85 86.83 2.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.056 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.613 ' HA ' HG23 ' A' ' 3' ' ' THR . 31.7 mt -60.79 -19.58 59.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.154 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.52 -108.49 0.88 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.669 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.553 ' C ' HD12 ' A' ' 27' ' ' LEU . 34.8 m-80 -57.63 -30.22 65.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.182 0.515 . . . . 0.0 109.948 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 27' ' ' LEU . 3.2 mp -124.16 136.62 54.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.506 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.977 HG23 ' HB3' ' A' ' 127' ' ' ALA . 0.7 OUTLIER -104.7 177.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.253 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.464 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -157.15 133.6 9.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.4 p -110.08 138.78 45.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 0.0 111.118 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.79 175.66 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.84 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.85 84.09 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.298 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.11 152.81 12.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 0.0 111.167 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.639 HD12 ' CG2' ' A' ' 36' ' ' VAL . 10.3 pt -132.07 142.1 43.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.023 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HG2' HG23 ' A' ' 43' ' ' VAL . 90.7 Cg_endo -79.9 53.97 4.99 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.95 2.433 . . . . 0.0 112.975 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.639 ' CG2' HD12 ' A' ' 34' ' ' ILE . 45.5 t . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.167 0.508 . . . . 0.0 110.575 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.682 HG23 ' HG3' ' A' ' 50' ' ' GLN . 7.3 p . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.45 0.167 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -50.97 139.61 41.15 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.345 2.03 . . . . 0.0 112.174 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.39 72.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.046 0.451 . . . . 0.0 111.009 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.38 91.66 1.02 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.853 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.0 mm -41.42 -35.05 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.155 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.78 -45.49 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.434 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.81 95.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.408 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.682 ' HG3' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -68.39 -32.11 71.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.189 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.56 -38.45 74.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.004 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -70.83 -48.96 51.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.51 -28.18 68.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.779 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -66.84 -45.61 77.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.795 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.25 -22.28 64.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 59' ' ' LYS . 2.7 mm-40 -72.9 -54.59 8.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.417 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 58' ' ' VAL . 29.1 p30 -55.72 -30.92 61.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.285 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 54' ' ' SER . 40.3 t -69.32 -50.36 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.929 0.395 . . . . 0.0 110.721 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 56' ' ' GLU . 2.8 ptmm? -67.39 -33.78 75.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.694 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.56 -40.92 84.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.963 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.661 ' CG1' HG21 ' A' ' 8' ' ' THR . 5.3 mt -64.99 -56.56 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.653 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.637 HD12 ' CB ' ' A' ' 127' ' ' ALA . 5.2 tt -64.43 -26.32 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.812 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.44 -41.04 33.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 110.376 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -15.49 63.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.723 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.22 -26.99 17.93 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.954 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.09 44.32 0.49 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.381 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.867 HD11 ' HB2' ' A' ' 129' ' ' ARG . 4.5 mt -157.2 139.58 14.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.878 0.371 . . . . 0.0 110.851 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 p -92.73 159.32 15.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.082 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -57.31 -34.79 69.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.892 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -49.71 -27.39 4.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.35 -28.05 47.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.081 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.483 HD12 ' HB1' ' A' ' 69' ' ' ALA . 78.8 mt -44.48 118.47 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.925 0.393 . . . . 0.0 110.984 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.696 HG11 HG13 ' A' ' 128' ' ' VAL . 10.3 m -83.62 -46.3 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.134 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.563 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 6.8 tttm -141.67 147.73 37.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.604 0.24 . . . . 0.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.761 HG21 ' OH ' ' A' ' 92' ' ' TYR . 2.3 t -141.59 117.51 10.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.396 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 108' ' ' SER . 0.2 OUTLIER -85.98 162.57 18.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.523 HG12 HG13 ' A' ' 79' ' ' VAL . 20.4 t -150.8 103.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.932 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.498 ' CD2' HG11 ' C' ' 110' ' ' VAL . 9.5 m-85 -94.06 96.24 9.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.214 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.854 HG12 HD23 ' A' ' 121' ' ' LEU . 26.9 m -97.23 148.48 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.662 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.43 ' HG3' HD12 ' A' ' 115' ' ' LEU . 7.7 mttt -79.96 -5.06 54.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.017 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.97 143.05 9.17 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.468 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 82' ' ' LEU . 8.8 mt -85.82 2.13 46.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.24 -19.98 26.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.584 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.91 -29.99 16.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.903 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.427 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 35.2 t80 -57.18 -26.31 60.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.05 -35.8 69.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.246 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.95 -33.15 18.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.25 -42.31 66.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 32.2 t30 -67.73 -39.45 84.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.59 -30.46 69.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.28 -32.55 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.761 ' OH ' HG21 ' A' ' 75' ' ' THR . 4.1 t80 -58.55 -47.71 83.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.55 -20.87 58.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.282 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 0.1 OUTLIER -77.3 -32.01 55.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.447 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -89.48 -33.34 16.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.116 0.484 . . . . 0.0 110.737 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.514 ' CG ' ' HB2' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -58.05 -53.68 55.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.893 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -32.09 70.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 95' ' ' PHE . 3.8 pt-20 -72.76 -12.61 61.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.67 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.561 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 6.4 m-80 -102.88 -13.94 16.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.103 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 58.9 m-20 97.48 41.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.986 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 1.082 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.9 m170 -120.14 52.02 2.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.705 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 74.0 Cg_endo -74.11 -3.74 14.28 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.523 2.149 . . . . 0.0 113.077 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 0.6 OUTLIER -60.14 -30.75 69.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.764 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.4 m-85 65.23 113.08 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.59 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.498 ' HD3' ' CE2' ' A' ' 96' ' ' PHE . 78.2 Cg_endo -96.54 151.37 1.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.375 2.717 . . . . 0.0 112.671 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.563 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -60.01 163.36 4.79 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 137.72 10.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.176 0.513 . . . . 0.0 112.03 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.486 ' O ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -127.16 84.42 2.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.007 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 52.7 t -90.57 145.23 25.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.208 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.596 HG12 HD23 ' B' ' 115' ' ' LEU . 32.8 m -152.97 132.99 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.088 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.807 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 4.5 tt0 -67.22 82.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.876 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.745 HG21 HD21 ' A' ' 115' ' ' LEU . 12.6 m -67.03 161.71 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -79.91 -44.21 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.4 OUTLIER -148.61 164.62 33.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.817 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.745 HD21 HG21 ' A' ' 112' ' ' VAL . 4.8 mt -139.79 159.95 62.87 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.762 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 119' ' ' VAL . 75.9 Cg_exo -50.52 134.64 39.75 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.478 2.119 . . . . 0.0 112.259 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.43 14.31 9.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.41 17.89 8.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.84 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.582 HG11 ' HB ' ' A' ' 34' ' ' ILE . 16.1 m -53.83 164.77 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.167 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.596 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -87.91 -24.38 35.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.646 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.854 HD23 HG12 ' A' ' 79' ' ' VAL . 4.4 mp -153.25 147.35 25.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.163 0.506 . . . . 0.0 111.27 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.4 ' OE1' ' CD2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -132.39 138.62 47.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.779 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.8 138.02 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.384 0.611 . . . . 0.0 112.324 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.61 107.92 4.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.185 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 75' ' ' THR . . . -121.86 161.63 22.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 28' ' ' VAL . 2.3 mp -111.71 155.51 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.027 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.977 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.42 149.99 40.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.01 0.433 . . . . 0.0 111.475 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.696 HG13 HG11 ' A' ' 73' ' ' VAL . 16.0 m -113.04 179.64 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.061 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.867 ' HB2' HD11 ' A' ' 67' ' ' LEU . 20.4 ttp180 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.639 HG23 ' HA ' ' B' ' 24' ' ' LEU . 90.1 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.98 0.419 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.536 ' O ' HG22 ' B' ' 5' ' ' ILE . 0.0 OUTLIER 60.39 -173.34 0.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.88 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.536 HG22 ' O ' ' B' ' 4' ' ' GLN . 1.1 tp 57.77 120.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.921 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.498 HG21 HG22 ' B' ' 61' ' ' ILE . 13.6 mt -148.67 134.93 12.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.245 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.81 138.93 48.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 111.171 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.648 HG21 ' CG1' ' B' ' 61' ' ' ILE . 0.9 OUTLIER -139.12 148.01 42.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.778 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.09 37.17 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -137.79 -45.37 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.99 110.96 7.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.42 -14.56 44.91 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.453 2.102 . . . . 0.0 112.392 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.81 -167.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.182 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.55 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 61.26 -165.17 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.381 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.619 HG22 ' O ' ' B' ' 15' ' ' ILE . 21.6 mt 77.33 17.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.253 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.11 -135.24 3.46 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.967 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.83 43.22 1.26 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.619 2.212 . . . . 0.0 112.535 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.55 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -177.47 -176.3 0.61 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.923 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.764 HG13 ' HB2' ' A' ' 104' ' ' PHE . 16.6 m -115.25 165.27 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.443 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -56.45 -48.42 77.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.032 0.444 . . . . 0.0 110.607 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' B' ' 61' ' ' ILE . . . -161.16 -175.95 5.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.477 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.478 HG11 ' O ' ' A' ' 73' ' ' VAL . 30.5 m -132.15 131.45 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.011 0.434 . . . . 0.0 111.369 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.436 ' HB2' HG12 ' B' ' 6' ' ' ILE . 61.6 t0 -105.82 86.76 2.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.06 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.639 ' HA ' HG23 ' B' ' 3' ' ' THR . 31.4 mt -60.78 -19.54 59.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.198 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.53 -108.52 0.88 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.669 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . 0.546 ' C ' HD12 ' B' ' 27' ' ' LEU . 34.7 m-80 -57.66 -30.16 65.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.14 0.495 . . . . 0.0 109.906 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.641 ' N ' HD12 ' B' ' 27' ' ' LEU . 3.2 mp -124.21 136.68 54.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.496 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.966 HG23 ' HB3' ' B' ' 127' ' ' ALA . 0.7 OUTLIER -104.72 177.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.173 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' B' ' 21' ' ' ALA . 0.0 OUTLIER -157.22 133.63 9.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.776 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 81.7 p -110.09 139.28 45.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.884 0.373 . . . . 0.0 111.194 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.86 175.68 10.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.915 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.89 84.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.09 152.81 12.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.899 0.38 . . . . 0.0 111.198 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.645 HD12 ' CG2' ' B' ' 36' ' ' VAL . 10.3 pt -132.06 142.14 44.02 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.998 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.472 ' HG2' HG23 ' B' ' 43' ' ' VAL . 91.6 Cg_endo -79.92 53.91 4.96 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.931 2.421 . . . . 0.0 112.986 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.645 ' CG2' HD12 ' B' ' 34' ' ' ILE . 45.4 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.51 . . . . 0.0 110.586 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.666 HG23 ' HG3' ' B' ' 50' ' ' GLN . 7.4 p . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.537 0.208 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.403 ' HD2' ' HG3' ' B' ' 50' ' ' GLN . 65.6 Cg_exo -50.95 139.64 40.9 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.366 2.044 . . . . 0.0 112.144 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.46 72.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.067 0.46 . . . . 0.0 111.031 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.36 91.67 1.01 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.828 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 24.0 mm -41.44 -35.01 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.158 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.86 -45.44 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.397 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.8 95.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.432 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.666 ' HG3' HG23 ' B' ' 43' ' ' VAL . 0.0 OUTLIER -68.31 -31.68 71.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.163 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.53 -38.5 74.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.027 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -70.79 -48.91 51.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -60.58 -28.18 68.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.774 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.2 OUTLIER -66.81 -45.54 78.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.3 -22.28 64.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.401 ' HA ' ' HG2' ' B' ' 59' ' ' LYS . 2.7 mm-40 -72.88 -54.61 8.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.401 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -55.71 -30.86 61.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.38 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 54' ' ' SER . 40.4 t -69.38 -50.36 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 110.691 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.414 ' HA ' HG22 ' B' ' 62' ' ' ILE . 2.8 ptmm? -67.31 -33.8 76.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.71 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.5 -40.72 83.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.998 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.648 ' CG1' HG21 ' B' ' 8' ' ' THR . 5.3 mt -65.07 -56.53 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.667 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.652 HD12 ' CB ' ' B' ' 127' ' ' ALA . 5.2 tt -64.45 -26.26 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.44 -41.0 34.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.968 0.413 . . . . 0.0 110.423 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -15.5 63.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.74 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.17 -27.0 17.97 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.961 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.08 44.32 0.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.399 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' B' ' 129' ' ' ARG . 4.5 mt -157.23 139.6 14.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.807 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 27.2 p -92.73 159.36 15.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 1.066 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -57.32 -34.79 69.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.897 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -49.71 -27.23 4.53 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.999 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.65 -27.94 45.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.462 HD12 ' HB1' ' B' ' 69' ' ' ALA . 78.8 mt -44.5 118.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 120.897 0.38 . . . . 0.0 111.003 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.719 HG11 HG13 ' B' ' 128' ' ' VAL . 10.4 m -83.65 -46.24 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.13 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.58 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 6.8 tttm -141.72 147.7 37.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.645 0.26 . . . . 0.0 110.892 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.768 HG21 ' OH ' ' B' ' 92' ' ' TYR . 2.3 t -141.57 117.42 10.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.43 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.493 HG22 ' O ' ' B' ' 108' ' ' SER . 0.2 OUTLIER -85.85 162.6 18.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.332 179.366 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.521 HG12 HG13 ' B' ' 79' ' ' VAL . 20.5 t -150.82 103.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.879 0.371 . . . . 0.0 111.931 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.492 ' CD2' HG11 ' A' ' 110' ' ' VAL . 9.5 m-85 -94.03 96.28 9.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.227 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.845 HG12 HD23 ' B' ' 121' ' ' LEU . 26.9 m -97.24 148.44 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.705 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.408 ' HG3' HD12 ' B' ' 115' ' ' LEU . 7.8 mttt -80.0 -5.01 54.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.014 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.84 143.09 9.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.458 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' B' ' 82' ' ' LEU . 8.8 mt -85.85 2.09 47.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.095 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.26 -19.98 26.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.613 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.95 -29.98 16.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 35.2 t80 -57.2 -26.27 60.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.169 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.85 69.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.324 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.93 -33.18 18.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.27 -42.39 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.426 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 32.0 t30 -67.66 -39.49 84.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.65 -30.52 69.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.26 -32.49 22.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.768 ' OH ' HG21 ' B' ' 75' ' ' THR . 4.1 t80 -58.48 -47.71 83.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.56 -20.9 58.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.295 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' B' ' 98' ' ' GLU . 0.1 OUTLIER -77.3 -31.95 55.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.493 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.2 OUTLIER -89.51 -33.35 16.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.455 . . . . 0.0 110.741 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.521 ' CG ' ' HB2' ' B' ' 101' ' ' HIS . 0.1 OUTLIER -57.97 -53.7 55.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -32.04 70.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.961 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' B' ' 94' ' ' ARG . 3.8 pt-20 -72.72 -12.62 61.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 0.0 110.625 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.564 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 6.4 m-80 -102.96 -13.93 16.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.099 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 59.2 m-20 97.5 41.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.964 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 1.066 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 4.0 m170 -120.01 52.07 2.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.757 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 74.2 Cg_endo -74.14 -3.76 14.32 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.566 2.178 . . . . 0.0 113.087 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -30.7 69.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.806 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.3 m-85 65.16 113.14 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.594 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.498 ' HD3' ' CE2' ' B' ' 96' ' ' PHE . 80.2 Cg_endo -96.67 151.37 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.357 2.705 . . . . 0.0 112.675 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.58 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -59.96 163.34 4.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.6 137.76 10.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.203 0.525 . . . . 0.0 112.017 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.493 ' O ' HG22 ' B' ' 76' ' ' THR . 0.1 OUTLIER -127.15 84.34 2.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.055 179.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 52.7 t -90.43 145.27 25.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.265 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.593 HG12 HD23 ' C' ' 115' ' ' LEU . 32.7 m -153.11 133.29 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.812 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 4.5 tt0 -67.49 82.05 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.755 HG21 HD21 ' B' ' 115' ' ' LEU . 12.6 m -67.02 161.7 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -79.93 -44.19 20.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.081 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.56 164.66 33.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.805 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.755 HD21 HG21 ' B' ' 112' ' ' VAL . 4.8 mt -139.81 159.96 62.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.783 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.564 ' O ' HG22 ' B' ' 119' ' ' VAL . 74.8 Cg_exo -50.5 134.61 39.59 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.521 2.147 . . . . 0.0 112.254 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.41 14.33 9.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.208 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.38 17.91 8.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.819 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.578 HG11 ' HB ' ' B' ' 34' ' ' ILE . 16.0 m -53.81 164.79 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.14 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . 0.603 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -87.89 -24.27 35.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.652 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.845 HD23 HG12 ' B' ' 79' ' ' VAL . 4.4 mp -153.45 147.41 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.111 0.482 . . . . 0.0 111.238 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.34 138.64 47.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.795 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.8 137.98 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.324 0.583 . . . . 0.0 112.348 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.59 107.91 4.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.214 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.485 ' HB2' ' CB ' ' B' ' 75' ' ' THR . . . -121.91 161.71 22.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.297 0.57 . . . . 0.0 112.507 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.437 HG23 ' O ' ' B' ' 28' ' ' VAL . 2.3 mp -111.79 155.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.977 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.966 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.34 150.06 40.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.403 . . . . 0.0 111.527 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.719 HG13 HG11 ' B' ' 73' ' ' VAL . 16.0 m -113.1 179.67 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.977 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.851 ' HB2' HD11 ' B' ' 67' ' ' LEU . 20.4 ttp180 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.948 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.644 HG23 ' HA ' ' C' ' 24' ' ' LEU . 90.1 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.934 0.397 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . 0.546 ' O ' HG22 ' C' ' 5' ' ' ILE . 0.0 OUTLIER 60.56 -173.35 0.12 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.824 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.546 HG22 ' O ' ' C' ' 4' ' ' GLN . 1.1 tp 57.67 120.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.916 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.518 HG21 HG22 ' C' ' 61' ' ' ILE . 13.5 mt -148.66 134.95 12.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.247 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -131.85 138.86 48.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 111.205 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.651 HG21 ' CG1' ' C' ' 61' ' ' ILE . 0.9 OUTLIER -139.12 148.01 42.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.835 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.06 37.11 1.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -137.91 -45.97 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.4 111.0 7.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.092 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.41 -14.62 45.23 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.496 2.131 . . . . 0.0 112.396 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.78 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.2 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 61.2 -165.16 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.385 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.607 HG22 ' O ' ' C' ' 15' ' ' ILE . 21.9 mt 77.33 17.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.262 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.01 -135.2 3.46 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.029 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.85 43.15 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 112.561 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.557 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -177.34 -176.29 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.986 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.806 HG13 ' HB2' ' B' ' 104' ' ' PHE . 16.5 m -115.25 165.32 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.446 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -56.38 -47.87 78.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.099 0.476 . . . . 0.0 110.519 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.548 ' CB ' HG21 ' C' ' 61' ' ' ILE . . . -162.02 -175.78 4.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.476 HG11 ' O ' ' B' ' 73' ' ' VAL . 30.2 m -132.08 131.42 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.409 . . . . 0.0 111.351 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' C' ' 6' ' ' ILE . 61.6 t0 -105.85 86.88 2.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.093 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.644 ' HA ' HG23 ' C' ' 3' ' ' THR . 31.5 mt -60.82 -19.61 60.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.154 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.54 -108.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.693 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . 0.548 ' C ' HD12 ' C' ' 27' ' ' LEU . 34.7 m-80 -57.62 -30.21 65.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.159 0.504 . . . . 0.0 109.917 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.628 ' N ' HD12 ' C' ' 27' ' ' LEU . 3.2 mp -124.22 136.62 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.482 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 1.002 HG23 ' HB3' ' C' ' 127' ' ' ALA . 0.7 OUTLIER -104.7 177.17 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.249 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.447 ' O ' ' HB1' ' C' ' 21' ' ' ALA . 0.0 OUTLIER -157.2 133.54 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 81.3 p -109.94 138.16 46.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.83 0.348 . . . . 0.0 110.971 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . 0.422 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 8.1 t -78.42 175.37 10.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.863 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.84 84.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.284 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.06 152.81 12.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 111.191 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.64 HD12 ' CG2' ' C' ' 36' ' ' VAL . 10.3 pt -132.05 142.17 44.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.455 ' HG2' HG23 ' C' ' 43' ' ' VAL . 91.8 Cg_endo -80.0 53.93 4.97 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.964 2.443 . . . . 0.0 112.975 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.64 ' CG2' HD12 ' C' ' 34' ' ' ILE . 45.7 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.134 0.492 . . . . 0.0 110.537 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.685 HG23 ' HG3' ' C' ' 50' ' ' GLN . 7.4 p . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.407 0.146 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.401 ' HD2' ' HG3' ' C' ' 50' ' ' GLN . 67.1 Cg_exo -50.97 139.64 41.05 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.318 2.012 . . . . 0.0 112.161 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.44 72.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.026 0.441 . . . . 0.0 111.001 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.46 91.7 1.05 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 24.1 mm -41.33 -35.13 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.192 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.79 -45.41 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.467 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.76 95.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.438 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.685 ' HG3' HG23 ' C' ' 43' ' ' VAL . 0.0 OUTLIER -68.7 -32.44 72.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.214 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.88 -38.5 73.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.116 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -70.76 -48.9 51.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.55 -28.12 68.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.799 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.597 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.2 OUTLIER -66.81 -45.6 77.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 mt -68.38 -22.2 64.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.94 -54.53 8.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.417 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' C' ' 58' ' ' VAL . 29.2 p30 -55.8 -30.9 62.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.304 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.597 HG23 ' O ' ' C' ' 54' ' ' SER . 40.3 t -69.31 -50.33 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 110.744 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' C' ' 62' ' ' ILE . 2.8 ptmm? -67.36 -33.84 76.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.753 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.52 -41.08 84.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.057 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.651 ' CG1' HG21 ' C' ' 8' ' ' THR . 5.3 mt -65.17 -56.47 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.748 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.637 HD12 ' CB ' ' C' ' 127' ' ' ALA . 5.2 tt -64.52 -26.19 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.826 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.53 -41.01 33.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.873 0.368 . . . . 0.0 110.335 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -15.48 63.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.724 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.12 -27.01 18.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.856 0.36 . . . . 0.0 111.003 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.15 44.24 0.49 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.36 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.841 HD11 ' HB2' ' C' ' 129' ' ' ARG . 4.5 mt -157.21 139.59 14.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.385 . . . . 0.0 110.828 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 27.1 p -92.75 159.38 15.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.782 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 1.088 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -57.34 -34.76 69.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.8 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -49.77 -27.4 4.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.909 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.07 -27.99 48.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.046 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.47 HD12 ' HB1' ' C' ' 69' ' ' ALA . 78.8 mt -44.47 118.42 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.901 0.381 . . . . 0.0 111.003 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.728 HG11 HG13 ' C' ' 128' ' ' VAL . 10.3 m -83.58 -46.26 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.196 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.571 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 6.8 tttm -141.7 147.7 37.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.626 0.25 . . . . 0.0 110.966 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.767 HG21 ' OH ' ' C' ' 92' ' ' TYR . 2.3 t -141.52 117.5 10.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.41 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.493 HG22 ' O ' ' C' ' 108' ' ' SER . 0.2 OUTLIER -85.98 162.56 18.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.309 179.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.51 HG12 HG13 ' C' ' 79' ' ' VAL . 20.4 t -150.81 103.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.366 . . . . 0.0 111.929 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.521 ' CD2' HG11 ' B' ' 110' ' ' VAL . 9.5 m-85 -94.04 96.32 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.187 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.831 HG12 HD23 ' C' ' 121' ' ' LEU . 27.0 m -97.27 148.46 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.652 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . 0.431 ' HG3' HD12 ' C' ' 115' ' ' LEU . 7.8 mttt -79.98 -5.21 55.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.027 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.87 143.06 9.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.454 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' C' ' 82' ' ' LEU . 8.8 mt -85.87 2.11 47.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.27 -19.94 26.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.571 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.93 -29.99 16.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.423 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 35.1 t80 -57.24 -26.24 60.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.129 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.84 69.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.248 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.98 -33.11 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.23 -42.35 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . 0.423 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 31.9 t30 -67.68 -39.52 84.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.43 -30.4 69.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.063 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.41 -32.48 22.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.767 ' OH ' HG21 ' C' ' 75' ' ' THR . 4.1 t80 -58.58 -47.71 83.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -75.57 -20.84 58.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.281 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' C' ' 98' ' ' GLU . 0.1 OUTLIER -77.39 -31.87 54.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.453 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.2 OUTLIER -89.53 -33.37 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 110.672 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.528 ' CG ' ' HB2' ' C' ' 101' ' ' HIS . 0.1 OUTLIER -57.94 -53.78 54.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.866 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -32.09 70.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.934 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' C' ' 95' ' ' PHE . 3.8 pt-20 -72.73 -12.6 61.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.652 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.563 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 6.5 m-80 -102.9 -13.97 16.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.089 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 59.1 m-20 97.49 41.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.974 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 1.088 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 3.9 m170 -119.95 51.99 2.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.76 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 74.0 Cg_endo -74.12 -3.77 14.33 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.549 2.166 . . . . 0.0 113.086 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 0.6 OUTLIER -60.16 -30.69 69.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.846 0.355 . . . . 0.0 111.144 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.781 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.4 m-85 65.18 113.1 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.638 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.483 ' HD3' ' CE2' ' C' ' 96' ' ' PHE . 79.1 Cg_endo -96.61 151.3 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.388 2.725 . . . . 0.0 112.691 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.571 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -59.92 163.39 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.68 137.73 10.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.21 0.528 . . . . 0.0 112.067 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . 0.493 ' O ' HG22 ' C' ' 76' ' ' THR . 0.1 OUTLIER -127.19 84.45 2.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.975 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 52.6 t -90.6 145.21 25.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.608 HG12 HD23 ' A' ' 115' ' ' LEU . 32.8 m -152.97 132.82 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.051 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.82 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 4.5 tt0 -67.17 82.04 0.13 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.736 HG21 HD21 ' C' ' 115' ' ' LEU . 12.5 m -67.1 161.71 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -79.93 -44.17 20.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.431 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.4 OUTLIER -148.63 164.65 33.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.736 HD21 HG21 ' C' ' 112' ' ' VAL . 4.8 mt -139.76 159.98 62.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.567 ' O ' HG22 ' C' ' 119' ' ' VAL . 75.3 Cg_exo -50.57 134.61 40.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.471 2.114 . . . . 0.0 112.283 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.44 14.37 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.174 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.35 17.97 8.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.793 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.586 HG11 ' HB ' ' C' ' 34' ' ' ILE . 16.0 m -53.84 164.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.115 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . 0.659 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -88.14 -24.47 34.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.592 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.831 HD23 HG12 ' C' ' 79' ' ' VAL . 4.4 mp -153.27 147.33 25.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.13 0.491 . . . . 0.0 111.338 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.39 138.62 47.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.773 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.78 138.02 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.371 0.605 . . . . 0.0 112.286 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.56 107.94 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.19 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' C' ' 75' ' ' THR . . . -121.95 161.74 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.34 0.591 . . . . 0.0 112.486 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.414 HG23 ' O ' ' C' ' 28' ' ' VAL . 2.3 mp -111.78 155.45 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.998 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 1.002 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.4 150.04 40.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.027 0.442 . . . . 0.0 111.47 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.728 HG13 HG11 ' C' ' 73' ' ' VAL . 16.0 m -113.03 179.71 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.042 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.841 ' HB2' HD11 ' C' ' 67' ' ' LEU . 20.4 ttp180 -162.23 45.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.921 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . 0.408 ' HE3' HD11 ' C' ' 27' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.932 HG21 HG21 ' C' ' 128' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.787 0.327 . . . . 0.0 110.883 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.59 121.0 7.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.755 HG21 HG11 ' A' ' 19' ' ' VAL . 4.7 mp -56.3 141.66 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.172 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 32.3 mt -92.58 146.42 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.271 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.431 ' CD2' ' HG3' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -151.28 117.32 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.699 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 t -129.29 161.58 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.031 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.68 24.85 6.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 -51.95 3.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.63 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.06 112.82 38.66 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.018 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -60.66 -16.16 41.55 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.446 2.097 . . . . 0.0 112.531 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HB1' ' OH ' ' A' ' 18' ' ' TYR . . . -56.76 -168.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.293 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 63.65 -167.48 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.341 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 15' ' ' ILE . 19.4 mm 78.26 16.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.239 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.21 -134.69 3.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.141 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HG2' ' CZ ' ' C' ' 107' ' ' ARG . 96.3 Cg_endo -85.91 23.17 0.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.657 2.238 . . . . 0.0 112.868 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.611 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -154.18 -168.73 3.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.764 0.316 . . . . 0.0 110.822 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.755 HG11 HG21 ' A' ' 5' ' ' ILE . 15.4 m -124.86 172.23 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.264 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.431 ' HG3' ' CD2' ' A' ' 7' ' ' HIS . 0.3 OUTLIER -67.59 -55.09 14.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.866 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 61' ' ' ILE . . . -157.78 178.5 10.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.038 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.753 HG23 HD13 ' A' ' 29' ' ' LEU . 7.1 m -127.96 134.31 65.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.475 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.9 t70 -117.77 96.3 5.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.839 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.715 HD13 HD21 ' C' ' 27' ' ' LEU . 12.3 mt -76.35 -20.39 57.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.984 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.89 -106.02 0.73 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.825 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -59.58 -29.59 68.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 110.148 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.626 HD21 HD13 ' B' ' 24' ' ' LEU . 0.6 OUTLIER -123.15 120.12 32.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.866 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.95 HG23 ' HB3' ' A' ' 127' ' ' ALA . 5.1 m -111.13 167.51 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.992 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.753 HD13 HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.84 155.33 38.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.838 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -117.51 136.03 53.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.945 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 55.7 m -68.74 167.04 16.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.11 82.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.323 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -76.38 145.95 39.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.097 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.442 ' HB ' HG11 ' A' ' 119' ' ' VAL . 8.3 pt -128.49 160.31 63.2 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.604 ' O ' HG12 ' A' ' 36' ' ' VAL . 84.7 Cg_exo -43.3 -47.85 8.6 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.721 2.281 . . . . 0.0 111.778 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 35' ' ' PRO . 9.8 p . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.751 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.653 ' HB ' HG12 ' A' ' 119' ' ' VAL . 8.2 p . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 120.356 0.122 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 14.2 Cg_exo -69.97 143.57 50.22 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.606 2.204 . . . . 0.0 112.226 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.65 63.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.079 0.466 . . . . 0.0 110.957 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -68.3 96.05 0.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.617 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.01 -32.16 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.629 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.07 -52.45 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.592 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -63.33 -28.49 70.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.478 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HG2' ' CG ' ' A' ' 35' ' ' PRO . 0.9 OUTLIER -79.75 -28.68 40.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.458 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.49 58.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.031 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -74.42 -41.74 60.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.083 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.21 -43.81 87.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.026 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.64 ' O ' HG23 ' A' ' 58' ' ' VAL . 73.6 m -59.51 -43.62 93.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD23 HD13 ' A' ' 123' ' ' ILE . 75.4 mt -66.4 -35.41 80.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.988 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.88 -38.27 82.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.011 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.64 -36.41 84.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.746 HG21 ' CG2' ' A' ' 123' ' ' ILE . 16.0 t -69.82 -46.94 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.947 0.403 . . . . 0.0 110.943 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -72.51 -31.37 65.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.827 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.77 91.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.487 HG21 ' CB ' ' A' ' 21' ' ' ALA . 6.5 mt -65.44 -56.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 127' ' ' ALA . 4.9 tt -63.83 -26.22 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.742 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 -40.12 60.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.374 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -10.78 59.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.788 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.84 -29.62 18.48 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.875 0.369 . . . . 0.0 110.905 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.61 52.42 0.33 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.52 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.537 HD22 ' CB ' ' A' ' 71' ' ' ASP . 2.3 mt -147.88 -169.89 3.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.09 160.09 41.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.99 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.783 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -59.97 -33.56 72.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.119 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -62.82 -17.18 60.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.461 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.537 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.0 m-20 -85.28 -24.57 27.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.814 0.34 . . . . 0.0 110.829 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 47.0 mt -53.71 118.55 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.128 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.568 ' O ' HG11 ' B' ' 22' ' ' VAL . 12.4 m -89.28 -37.19 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.707 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.755 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -141.25 149.33 41.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.705 0.288 . . . . 0.0 110.774 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.689 HG23 ' HB2' ' A' ' 125' ' ' ALA . 89.3 m -144.96 110.36 5.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.95 0.405 . . . . 0.0 111.323 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.566 ' O ' HG13 ' A' ' 77' ' ' VAL . 87.8 m -95.22 157.81 15.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.246 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.665 HG12 HG12 ' A' ' 123' ' ' ILE . 3.3 m -159.1 142.46 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.084 0.468 . . . . 0.0 111.761 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' C' ' 110' ' ' VAL . 3.5 m-85 -114.0 119.09 36.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.283 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.802 HG12 HD21 ' A' ' 121' ' ' LEU . 33.2 m -107.34 152.23 9.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.114 0.483 . . . . 0.0 111.735 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.51 0.17 39.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.821 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -163.28 107.5 1.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.566 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.87 -13.89 60.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.222 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -79.66 -27.79 40.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.909 0.385 . . . . 0.0 110.493 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.32 -12.18 55.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.831 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.652 ' CD1' HG11 ' A' ' 79' ' ' VAL . 1.6 t80 -58.63 -24.52 61.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.82 -56.52 11.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.352 . . . . 0.0 111.38 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.48 -36.83 83.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 t -64.8 -42.07 93.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.16 -42.32 89.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.481 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.81 75.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.895 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 94' ' ' ARG . 20.3 mm-40 -88.69 -30.01 19.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.693 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.428 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 58.7 t80 -57.72 -49.7 75.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.014 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.44 -17.49 45.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 91' ' ' GLU . 4.6 mtp180 -75.12 -27.92 60.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.658 0.265 . . . . 0.0 111.38 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -86.19 -33.35 20.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.38 . . . . 0.0 110.525 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.471 ' CZ ' ' CD ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -56.27 -55.7 30.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.334 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.62 -28.81 70.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.889 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.47 -6.22 59.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.35 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.783 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 1.5 m120 -111.47 -5.13 14.62 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.56 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.716 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 7.0 m120 85.42 33.31 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.803 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 20.1 t-160 -128.88 67.3 77.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.529 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 4.5 Cg_exo -75.48 -20.24 16.13 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.602 2.202 . . . . 0.0 112.525 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.704 ' CG ' HD13 ' B' ' 5' ' ' ILE . 0.3 OUTLIER -69.15 -36.69 77.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.063 0.459 . . . . 0.0 110.344 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' A' ' 102' ' ' PRO . 15.8 m-85 74.06 142.56 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.427 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.471 ' CD ' ' CZ ' ' A' ' 96' ' ' PHE . 73.2 Cg_endo -90.07 165.88 4.71 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.209 2.606 . . . . 0.0 111.956 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.755 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -50.1 154.11 1.24 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.424 ' HB3' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -119.02 140.98 49.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.227 0.537 . . . . 0.0 112.048 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.6 t -144.28 45.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.986 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 28.7 p -81.37 135.08 35.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.249 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' B' ' 78' ' ' PHE . 23.0 m -153.85 149.34 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.203 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.831 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -84.4 91.04 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.771 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.666 HG21 HD21 ' A' ' 115' ' ' LEU . 27.7 m -71.15 177.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.841 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -81.83 -45.95 14.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.005 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.405 ' CB ' ' HB3' ' C' ' 111' ' ' GLU . 0.1 OUTLIER -151.72 -179.72 7.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.788 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.666 HD21 HG21 ' A' ' 112' ' ' VAL . 60.0 mt -149.2 155.6 39.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.704 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.551 ' O ' HG22 ' A' ' 119' ' ' VAL . 9.2 Cg_endo -52.33 139.23 55.06 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.523 2.149 . . . . 0.0 111.977 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 7.9 mmtm 66.46 17.72 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.278 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 61.63 17.45 8.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.025 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.653 HG12 ' HB ' ' A' ' 43' ' ' VAL . 30.1 m -55.76 167.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.073 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.03 8.49 42.24 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.918 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.802 HD21 HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -172.58 154.6 3.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.086 0.469 . . . . 0.0 111.226 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.2 159.01 43.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.002 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.746 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.9 mt -144.25 145.75 21.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.38 0.609 . . . . 0.0 112.301 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.16 101.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.322 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.689 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -119.07 163.59 16.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.171 0.51 . . . . 0.0 112.194 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 72' ' ' ILE . 5.7 mt -114.43 151.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.133 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.95 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -136.06 148.39 48.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.034 0.445 . . . . 0.0 111.574 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.897 HG21 HG21 ' B' ' 3' ' ' THR . 35.0 m -115.92 151.44 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.122 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.401 ' HD2' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.819 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.897 HG21 HG21 ' A' ' 128' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.811 0.338 . . . . 0.0 110.92 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.58 120.97 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.769 HG21 HG11 ' B' ' 19' ' ' VAL . 4.7 mp -56.26 141.66 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 31.8 mt -92.61 146.33 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.318 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.406 ' CD2' ' HG3' ' B' ' 20' ' ' GLN . 0.1 OUTLIER -151.2 117.41 5.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.718 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 14.3 t -129.32 161.6 29.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.036 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.69 24.85 6.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.807 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.5 -52.47 3.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.677 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.5 112.93 38.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.7 -16.16 41.84 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.436 2.09 . . . . 0.0 112.473 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.479 ' HB1' ' OH ' ' B' ' 18' ' ' TYR . . . -56.75 -168.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.252 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.617 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 63.73 -167.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.315 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.588 HG22 ' O ' ' B' ' 15' ' ' ILE . 19.4 mm 78.23 16.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.288 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.26 -134.73 3.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.163 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 107' ' ' ARG . 96.9 Cg_endo -85.84 23.18 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.685 2.256 . . . . 0.0 112.926 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.617 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -154.13 -168.71 3.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.755 0.312 . . . . 0.0 110.829 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.769 HG11 HG21 ' B' ' 5' ' ' ILE . 15.5 m -124.88 172.31 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.362 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.406 ' HG3' ' CD2' ' B' ' 7' ' ' HIS . 0.3 OUTLIER -67.71 -55.16 14.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.802 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.494 ' CB ' HG21 ' B' ' 61' ' ' ILE . . . -158.13 178.44 10.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.995 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.748 HG23 HD13 ' B' ' 29' ' ' LEU . 7.2 m -127.88 134.27 65.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.463 ' HA ' HG12 ' B' ' 28' ' ' VAL . 7.8 t70 -117.67 96.23 5.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.626 HD13 HD21 ' A' ' 27' ' ' LEU . 12.4 mt -76.34 -20.42 57.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.002 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.97 -106.03 0.73 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.83 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -59.62 -29.51 68.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.038 0.447 . . . . 0.0 110.152 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.786 HD21 HD13 ' C' ' 24' ' ' LEU . 0.7 OUTLIER -123.19 120.07 32.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.872 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.998 HG23 ' HB3' ' B' ' 127' ' ' ALA . 5.1 m -111.07 167.54 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.01 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.748 HD13 HG23 ' B' ' 22' ' ' VAL . 0.0 OUTLIER -150.91 155.31 38.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -117.38 135.8 53.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 56.5 m -68.89 166.97 16.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.13 82.13 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.307 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -76.39 145.89 39.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.357 . . . . 0.0 111.15 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.436 ' HB ' HG11 ' B' ' 119' ' ' VAL . 8.2 pt -128.48 160.3 63.23 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.545 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.604 ' O ' HG12 ' B' ' 36' ' ' VAL . 84.5 Cg_exo -43.2 -47.93 8.38 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.755 2.303 . . . . 0.0 111.753 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.604 HG12 ' O ' ' B' ' 35' ' ' PRO . 9.8 p . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.717 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.684 ' HB ' HG12 ' B' ' 119' ' ' VAL . 8.2 p . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 120.368 0.128 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' B' ' 43' ' ' VAL . 14.2 Cg_exo -69.96 143.6 50.38 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.636 2.224 . . . . 0.0 112.214 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.65 63.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.995 0.426 . . . . 0.0 110.896 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.4 OUTLIER -68.22 96.05 0.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.677 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.0 -32.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.589 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.95 -52.51 15.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.64 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -63.35 -28.43 69.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.469 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.458 ' HG2' ' CG ' ' B' ' 35' ' ' PRO . 0.9 OUTLIER -79.76 -28.61 40.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.485 179.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.51 -35.45 58.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -74.38 -41.76 60.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.23 -43.75 87.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.615 ' O ' HG23 ' B' ' 58' ' ' VAL . 73.8 m -59.47 -43.62 93.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.034 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.503 HD23 HD13 ' B' ' 123' ' ' ILE . 75.2 mt -66.44 -35.34 80.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.89 -38.35 82.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.6 -36.35 83.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.06 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.736 HG21 ' CG2' ' B' ' 123' ' ' ILE . 16.2 t -69.85 -46.91 72.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 0.0 110.956 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' B' ' 62' ' ' ILE . 0.0 OUTLIER -72.6 -31.29 65.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.812 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.24 -40.85 91.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.932 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.494 HG21 ' CB ' ' B' ' 21' ' ' ALA . 6.4 mt -65.48 -56.86 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' B' ' 127' ' ' ALA . 5.0 tt -63.83 -26.2 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.725 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -40.07 60.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.924 0.393 . . . . 0.0 110.446 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -10.84 59.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.812 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.78 -29.72 18.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.69 52.42 0.32 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.543 HD22 ' CB ' ' B' ' 71' ' ' ASP . 2.3 mt -147.94 -169.94 3.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 110.577 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.08 160.14 40.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.982 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -59.98 -33.52 72.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -62.83 -17.17 60.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.448 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.543 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.0 m-20 -85.16 -24.64 27.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 110.805 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.69 118.53 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.095 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.621 ' O ' HG11 ' C' ' 22' ' ' VAL . 12.5 m -89.23 -37.22 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.73 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.789 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 0.0 OUTLIER -141.21 149.37 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.708 0.29 . . . . 0.0 110.78 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.685 HG23 ' HB2' ' B' ' 125' ' ' ALA . 89.2 m -144.99 110.29 5.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.568 ' O ' HG13 ' B' ' 77' ' ' VAL . 87.8 m -95.09 157.75 15.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.242 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.667 HG12 HG12 ' B' ' 123' ' ' ILE . 3.2 m -159.05 142.5 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.758 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 110' ' ' VAL . 3.5 m-85 -114.01 119.09 36.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.248 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.797 HG12 HD21 ' B' ' 121' ' ' LEU . 33.9 m -107.33 152.18 9.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.125 0.488 . . . . 0.0 111.765 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.53 -0.14 38.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.817 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.85 107.51 1.11 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.578 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.99 -13.78 60.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.215 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -79.67 -27.85 40.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 0.0 110.484 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.27 -12.17 55.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.864 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.661 ' CD1' HG11 ' B' ' 79' ' ' VAL . 1.6 t80 -58.68 -24.43 61.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.007 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.87 -56.52 11.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 111.331 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.83 83.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 34.3 t -64.83 -42.06 93.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.715 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.18 -42.2 89.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.5 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.04 -36.09 76.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.938 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' B' ' 94' ' ' ARG . 20.4 mm-40 -88.45 -29.96 19.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.724 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.419 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 58.6 t80 -57.75 -49.66 75.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.028 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.47 -17.46 45.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.504 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' B' ' 91' ' ' GLU . 4.6 mtp180 -75.09 -27.94 60.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.699 0.285 . . . . 0.0 111.414 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.9 OUTLIER -86.15 -33.48 20.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.499 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' B' ' 101' ' ' HIS . 0.9 OUTLIER -56.19 -55.76 29.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.344 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.54 -28.9 70.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.914 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -6.24 59.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.397 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.751 ' HB3' ' HB3' ' B' ' 69' ' ' ALA . 1.5 m120 -111.41 -5.15 14.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.718 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 6.9 m120 85.44 33.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.894 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.549 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.1 t-160 -128.81 67.42 77.46 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.534 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 4.6 Cg_exo -75.48 -20.25 16.12 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.621 2.214 . . . . 0.0 112.519 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.659 ' CG ' HD13 ' C' ' 5' ' ' ILE . 0.3 OUTLIER -69.17 -36.68 77.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.307 179.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' B' ' 102' ' ' PRO . 15.8 m-85 74.07 142.52 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.453 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.462 ' CD ' ' CZ ' ' B' ' 96' ' ' PHE . 72.2 Cg_endo -90.09 165.86 4.69 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.107 2.538 . . . . 0.0 111.98 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.789 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -50.02 154.18 1.19 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.462 ' HB3' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -119.1 141.0 49.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.215 0.531 . . . . 0.0 112.068 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 30.8 t -144.26 45.83 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.954 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' B' ' 77' ' ' VAL . 28.7 p -81.44 135.02 35.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.277 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' C' ' 78' ' ' PHE . 23.4 m -153.7 149.06 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.149 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.855 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -84.49 91.04 7.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.822 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.651 HG21 HD21 ' B' ' 115' ' ' LEU . 27.6 m -71.15 177.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.206 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -81.79 -45.92 14.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.44 ' CB ' ' HB3' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -151.7 -179.53 7.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.753 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.651 HD21 HG21 ' B' ' 112' ' ' VAL . 59.5 mt -149.33 155.56 39.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.669 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.548 ' O ' HG22 ' B' ' 119' ' ' VAL . 9.3 Cg_endo -52.35 139.25 55.23 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.537 2.158 . . . . 0.0 111.987 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 8.0 mmtm 66.38 17.81 10.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.253 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 61.53 17.52 8.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.065 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.684 HG12 ' HB ' ' B' ' 43' ' ' VAL . 30.3 m -55.8 167.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.062 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.11 8.12 41.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.888 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.797 HD21 HG12 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -172.47 154.5 3.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.165 0.507 . . . . 0.0 111.296 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.12 158.95 43.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.025 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.736 ' CG2' HG21 ' B' ' 58' ' ' VAL . 28.2 mt -144.21 145.75 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.309 0.576 . . . . 0.0 112.309 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.17 101.48 1.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.344 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.685 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -119.02 163.56 16.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.198 0.523 . . . . 0.0 112.245 -178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.7 mt -114.41 151.9 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.114 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.998 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -136.06 148.32 48.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.993 0.425 . . . . 0.0 111.618 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.983 HG21 HG21 ' C' ' 3' ' ' THR . 35.0 m -115.82 151.38 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.84 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.983 HG21 HG21 ' B' ' 128' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.84 0.352 . . . . 0.0 110.891 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.56 121.02 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.728 HG21 HG11 ' C' ' 19' ' ' VAL . 4.7 mp -56.31 141.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 32.0 mt -92.61 146.37 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.234 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . 0.423 ' CD2' ' HG3' ' C' ' 20' ' ' GLN . 0.1 OUTLIER -151.24 117.37 5.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.705 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 14.3 t -129.3 161.61 29.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.037 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.72 24.89 6.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 -52.34 3.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.751 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.62 112.86 37.78 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.05 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.65 -16.13 41.34 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.436 2.09 . . . . 0.0 112.525 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.481 ' HB1' ' OH ' ' C' ' 18' ' ' TYR . . . -56.8 -168.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.249 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.627 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 63.69 -167.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.332 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.587 HG22 ' O ' ' C' ' 15' ' ' ILE . 19.4 mm 78.26 16.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.215 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.21 -134.78 3.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.14 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.8 23.16 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.609 2.206 . . . . 0.0 112.9 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.627 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -154.1 -168.61 3.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.738 0.304 . . . . 0.0 110.855 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.728 HG11 HG21 ' C' ' 5' ' ' ILE . 15.4 m -124.97 172.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.29 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . 0.423 ' HG3' ' CD2' ' C' ' 7' ' ' HIS . 0.3 OUTLIER -67.61 -55.01 15.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.936 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -157.95 178.57 10.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.026 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.761 HG23 HD13 ' C' ' 29' ' ' LEU . 7.2 m -127.92 134.21 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.47 ' HA ' HG12 ' C' ' 28' ' ' VAL . 7.9 t70 -117.73 96.32 5.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.786 HD13 HD21 ' B' ' 27' ' ' LEU . 12.4 mt -76.37 -20.36 57.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.0 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.92 -106.03 0.73 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.839 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.62 -29.55 68.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.119 0.485 . . . . 0.0 110.186 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.715 HD21 HD13 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -123.2 120.08 32.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.875 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.982 HG23 ' HB3' ' C' ' 127' ' ' ALA . 5.2 m -111.06 167.52 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.761 HD13 HG23 ' C' ' 22' ' ' VAL . 0.0 OUTLIER -150.83 155.35 39.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.2 p -117.52 135.91 53.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.862 0.363 . . . . 0.0 110.914 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 56.3 m -68.55 166.99 15.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.818 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.03 82.14 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.341 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -76.43 145.92 38.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 111.178 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.44 ' HB ' HG11 ' C' ' 119' ' ' VAL . 8.3 pt -128.47 160.32 63.08 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.574 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.602 ' O ' HG12 ' C' ' 36' ' ' VAL . 85.6 Cg_exo -43.22 -47.92 8.43 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.73 2.286 . . . . 0.0 111.757 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.602 HG12 ' O ' ' C' ' 35' ' ' PRO . 9.8 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.769 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.659 ' HB ' HG12 ' C' ' 119' ' ' VAL . 8.2 p . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.41 0.148 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' C' ' 43' ' ' VAL . 14.2 Cg_exo -69.97 143.63 50.4 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.616 2.21 . . . . 0.0 112.235 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.62 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.044 0.45 . . . . 0.0 110.897 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.4 OUTLIER -68.29 96.06 0.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.602 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.03 -32.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.605 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.95 -52.53 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.623 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -63.36 -28.45 70.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.492 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.465 ' HG2' ' CG ' ' C' ' 35' ' ' PRO . 0.9 OUTLIER -79.69 -28.52 40.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.452 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.54 58.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -74.23 -41.87 60.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.24 -43.72 87.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.643 ' O ' HG23 ' C' ' 58' ' ' VAL . 73.7 m -59.47 -43.71 93.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.497 HD23 HD13 ' C' ' 123' ' ' ILE . 75.1 mt -66.38 -35.38 80.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.003 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.86 -38.3 82.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.014 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.63 -36.34 83.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.745 HG21 ' CG2' ' C' ' 123' ' ' ILE . 16.1 t -69.9 -46.93 72.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.923 0.392 . . . . 0.0 110.936 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' C' ' 62' ' ' ILE . 0.0 OUTLIER -72.49 -31.47 65.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.764 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.8 90.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.907 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.48 HG21 ' CB ' ' C' ' 21' ' ' ALA . 6.4 mt -65.39 -56.78 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.71 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' C' ' 127' ' ' ALA . 4.9 tt -63.89 -26.19 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.746 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -40.03 60.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.921 0.391 . . . . 0.0 110.431 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -10.75 59.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.8 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.89 -29.64 18.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.837 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.63 52.42 0.33 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.485 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.545 HD22 ' CB ' ' C' ' 71' ' ' ASP . 2.3 mt -147.91 -169.89 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 110.585 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.12 160.15 40.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.032 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -60.0 -33.5 72.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -62.92 -17.31 61.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.42 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.545 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.0 m-20 -85.18 -24.43 27.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.784 0.326 . . . . 0.0 110.786 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 47.1 mt -53.79 118.62 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.08 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.614 ' O ' HG11 ' A' ' 22' ' ' VAL . 12.5 m -89.32 -37.16 9.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.693 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.763 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 0.0 OUTLIER -141.26 149.36 41.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.782 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.699 HG23 ' HB2' ' C' ' 125' ' ' ALA . 89.5 m -145.0 110.31 5.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.92 0.391 . . . . 0.0 111.343 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.574 ' O ' HG13 ' C' ' 77' ' ' VAL . 87.8 m -95.14 157.82 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.217 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.659 HG12 HG12 ' C' ' 123' ' ' ILE . 3.3 m -159.15 142.47 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.081 0.467 . . . . 0.0 111.774 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' B' ' 110' ' ' VAL . 3.5 m-85 -114.0 119.07 35.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.283 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.772 HG12 HD21 ' C' ' 121' ' ' LEU . 33.5 m -107.31 152.23 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.102 0.477 . . . . 0.0 111.744 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.55 -0.15 38.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.806 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.85 107.45 1.11 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.572 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.89 -13.82 60.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.213 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -79.69 -27.78 40.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.482 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.29 -12.17 55.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.83 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.651 ' CD1' HG11 ' C' ' 79' ' ' VAL . 1.6 t80 -58.7 -24.45 61.43 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.996 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.86 -56.51 11.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.338 . . . . 0.0 111.353 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.82 83.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 t -64.84 -42.07 93.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.72 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.13 -42.35 89.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.483 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.97 76.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.865 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' C' ' 94' ' ' ARG . 20.4 mm-40 -88.63 -29.88 19.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.7 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.424 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 59.0 t80 -57.77 -49.68 75.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.011 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.46 -17.46 45.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.496 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . 0.413 ' HB2' ' HA ' ' C' ' 91' ' ' GLU . 4.6 mtp180 -75.1 -27.91 60.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.711 0.291 . . . . 0.0 111.381 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.9 OUTLIER -86.19 -33.45 20.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 110.493 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.461 ' CZ ' ' CD ' ' C' ' 105' ' ' PRO . 0.9 OUTLIER -56.2 -55.79 28.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.329 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.53 -28.91 70.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.882 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.39 -6.24 59.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.381 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.735 ' HB3' ' HB3' ' C' ' 69' ' ' ALA . 1.5 m120 -111.43 -5.14 14.64 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.588 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.716 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 6.9 m120 85.45 33.18 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.851 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.547 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.1 t-160 -128.89 67.38 77.73 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.481 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 4.5 Cg_exo -75.42 -20.32 16.16 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.667 2.244 . . . . 0.0 112.528 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.685 ' CG ' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -69.12 -36.77 77.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.452 . . . . 0.0 110.336 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.417 ' CB ' ' HA ' ' A' ' 18' ' ' TYR . 15.8 m-85 74.1 142.56 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.404 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.461 ' CD ' ' CZ ' ' C' ' 96' ' ' PHE . 73.5 Cg_endo -90.12 165.85 4.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.176 2.584 . . . . 0.0 111.929 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.763 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -49.99 154.03 1.22 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -119.0 140.98 49.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.275 0.559 . . . . 0.0 112.086 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 30.5 t -144.28 45.87 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.963 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' C' ' 77' ' ' VAL . 28.8 p -81.44 135.01 35.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.312 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' A' ' 78' ' ' PHE . 23.1 m -153.82 149.23 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.19 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.841 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -84.24 91.0 7.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.72 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.643 HG21 HD21 ' C' ' 115' ' ' LEU . 27.7 m -71.16 177.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.246 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -81.8 -46.0 14.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.999 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.4 ' CB ' ' HB3' ' B' ' 111' ' ' GLU . 0.1 OUTLIER -151.71 -179.79 7.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.739 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.643 HD21 HG21 ' C' ' 112' ' ' VAL . 59.7 mt -149.14 155.58 40.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.727 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.558 ' O ' HG22 ' C' ' 119' ' ' VAL . 9.2 Cg_endo -52.31 139.22 54.9 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.536 2.157 . . . . 0.0 111.992 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 8.0 mmtm 66.45 17.73 10.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.212 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 61.64 17.43 8.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.042 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.659 HG12 ' HB ' ' C' ' 43' ' ' VAL . 30.5 m -55.71 167.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -105.86 8.35 42.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.914 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.772 HD21 HG12 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -172.37 154.46 3.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.069 0.461 . . . . 0.0 111.22 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.12 159.0 43.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.027 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.745 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.8 mt -144.26 145.75 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.359 0.599 . . . . 0.0 112.334 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.17 101.49 1.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.333 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -119.04 163.57 16.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.203 0.525 . . . . 0.0 112.185 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.403 HG23 ' HG ' ' C' ' 29' ' ' LEU . 5.7 mt -114.4 151.87 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.099 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.982 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -136.03 148.39 48.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 0.0 111.629 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.932 HG21 HG21 ' A' ' 3' ' ' THR . 35.0 m -115.89 151.42 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.12 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.09 70.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.811 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.08 HG21 HG21 ' C' ' 128' ' ' VAL . 3.1 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -171.06 125.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.798 HD13 ' OD1' ' C' ' 103' ' ' ASN . 4.2 mp -56.54 141.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.585 HD12 ' HB3' ' A' ' 21' ' ' ALA . 21.9 mt -98.01 149.84 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.24 26.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.27 171.11 20.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.3 28.44 8.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.033 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.557 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 8.1 mttm -120.5 -44.96 2.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -66.55 171.48 4.23 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.868 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.889 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 29.6 Cg_endo -63.6 -12.68 32.33 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.572 2.181 . . . . 0.0 112.523 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 69.44 147.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.492 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 19' ' ' VAL . . . -126.28 120.95 31.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.838 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 15' ' ' ILE . 3.1 mp -135.23 17.1 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.073 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.92 -118.88 2.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.382 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.81 14.92 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.675 2.25 . . . . 0.0 113.316 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -147.04 -174.06 4.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.994 0.426 . . . . 0.0 111.517 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.913 HG23 ' HB2' ' C' ' 106' ' ' ALA . 18.0 m -138.61 169.34 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.798 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -49.09 79.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.602 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB3' HD12 ' A' ' 6' ' ' ILE . . . -177.02 -178.07 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.962 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 29' ' ' LEU . 15.0 m -141.48 133.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 28' ' ' VAL . 37.6 t70 -110.8 115.39 29.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.839 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.963 HD11 HD12 ' A' ' 29' ' ' LEU . 2.8 mt -90.98 -16.03 28.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -99.3 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.755 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -56.91 -29.12 62.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.183 0.516 . . . . 0.0 110.072 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -136.21 135.19 38.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.774 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.962 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 4.8 p -109.51 164.55 5.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.871 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.963 HD12 HD11 ' A' ' 24' ' ' LEU . 3.4 mt -142.6 131.28 22.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.3 p -104.71 144.9 31.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.9 ' HB3' ' HB1' ' C' ' 106' ' ' ALA . 10.2 p -82.98 178.88 7.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.4 89.73 0.82 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.195 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.803 ' HG3' HG22 ' A' ' 58' ' ' VAL . 88.3 mm-40 -56.22 144.25 30.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.969 HG23 HG23 ' A' ' 36' ' ' VAL . 9.5 tt -125.51 132.89 24.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.702 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.688 ' HB2' HG23 ' A' ' 43' ' ' VAL . 21.9 Cg_exo -65.02 65.24 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.666 2.244 . . . . 0.0 112.56 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.969 HG23 HG23 ' A' ' 34' ' ' ILE . 63.3 t . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 121.122 0.487 . . . . 0.0 110.625 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' A' ' 35' ' ' PRO . 7.2 p . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.509 0.195 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.29 138.98 23.02 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.354 2.036 . . . . 0.0 112.191 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.73 -31.08 71.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.061 0.458 . . . . 0.0 110.902 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 94.9 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.904 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 47' ' ' ILE . 21.5 mm -44.26 -31.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.878 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.78 -38.8 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.576 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.75 -54.34 36.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.47 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.38 -26.4 68.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.341 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.88 -40.77 72.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.4 -48.82 16.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.789 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.53 -46.73 88.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.745 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.855 ' O ' HG23 ' A' ' 58' ' ' VAL . 89.2 p -60.05 -37.25 79.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 92' ' ' TYR . 22.0 mt -76.54 -23.41 53.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.043 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -52.14 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.7 OUTLIER -58.08 -29.19 65.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.982 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 123' ' ' ILE . 54.4 t -65.06 -46.39 91.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.984 0.421 . . . . 0.0 110.643 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -28.96 61.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.844 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -60.84 -40.74 93.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.025 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.442 HD11 ' OE1' ' A' ' 33' ' ' GLN . 12.8 mt -73.59 -41.77 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.619 HD13 HD11 ' A' ' 72' ' ' ILE . 18.1 mt -69.48 -31.24 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.553 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.61 -37.33 59.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.034 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -22.41 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.272 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.87 -28.82 20.1 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.787 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.97 50.51 0.63 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.591 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.552 ' HB2' HG22 ' A' ' 62' ' ' ILE . 6.1 mt -146.66 -176.56 5.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.409 . . . . 0.0 110.716 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.77 163.83 31.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.778 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.459 ' O ' ' CD2' ' A' ' 101' ' ' HIS . . . -50.26 -34.57 23.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.031 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -67.49 -24.78 65.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.359 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.529 ' HB3' HD22 ' A' ' 67' ' ' LEU . 58.0 m-20 -80.46 -6.58 58.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.717 0.294 . . . . 0.0 110.959 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 62' ' ' ILE . 24.2 mt -83.81 116.1 27.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.249 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.49 HG23 ' N ' ' A' ' 74' ' ' LYS . 35.4 m -76.58 -46.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.041 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.84 ' HD3' HD12 ' A' ' 126' ' ' ILE . 11.0 mtpt -118.41 -177.6 3.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.59 0.233 . . . . 0.0 111.093 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 105' ' ' PRO . 11.1 t -179.99 101.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.895 0.378 . . . . 0.0 111.496 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.52 HG23 ' NH1' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -71.21 126.72 30.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.198 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.8 t -114.71 98.88 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -98.17 147.49 24.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.951 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -144.76 151.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.09 0.471 . . . . 0.0 111.899 -179.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.0 -2.6 56.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.764 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.29 110.31 0.57 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.416 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.63 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.0 mt -56.81 -18.6 13.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.322 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -75.86 -23.47 55.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.844 0.354 . . . . 0.0 110.583 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 88' ' ' VAL . 47.4 m-20 -77.97 -12.77 60.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -27.21 59.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.252 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.46 71.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.779 0.323 . . . . 0.0 111.415 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.88 -29.45 20.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.287 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 84' ' ' ASP . 26.2 t -73.84 -47.1 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -64.86 -39.32 93.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.47 -37.27 85.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -33.34 19.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.621 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.562 ' OH ' HG21 ' A' ' 75' ' ' THR . 35.3 t80 -61.16 -56.47 20.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.346 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -70.19 -15.29 62.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.333 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -40.06 66.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -84.95 -38.78 18.91 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.342 -179.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.493 ' CE1' ' CE1' ' A' ' 92' ' ' TYR . 11.1 m-85 -53.92 -50.63 65.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 110.32 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.94 -32.36 74.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.875 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.65 -1.9 54.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.432 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -110.4 -8.6 14.67 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.66 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.7 t-20 97.08 19.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.796 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.3 t60 -118.77 59.93 4.32 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.858 0.361 . . . . 0.0 110.927 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.403 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 43.9 Cg_endo -68.19 -17.78 45.16 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.493 2.129 . . . . 0.0 112.175 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.763 ' OD1' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -75.42 -34.2 61.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.7 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.469 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 33.2 m-85 72.26 140.19 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.103 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.688 ' HB2' HG22 ' A' ' 75' ' ' THR . 7.2 Cg_exo -71.83 166.77 28.51 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.747 2.298 . . . . 0.0 112.138 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.919 ' HB1' ' HB3' ' B' ' 31' ' ' SER . . . -107.52 131.01 54.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.726 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.582 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -167.48 -165.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.089 0.471 . . . . 0.0 111.303 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -116.24 114.93 25.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.209 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.519 ' O ' HG13 ' A' ' 110' ' ' VAL . 16.0 m -95.69 131.47 41.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.275 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.573 HG12 HD23 ' B' ' 115' ' ' LEU . 7.4 m -158.96 170.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.494 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.866 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 6.9 tt0 -110.6 95.34 5.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.804 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.3 m -60.46 157.3 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.876 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -60.89 -45.73 93.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.992 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.567 ' HB3' HD12 ' C' ' 82' ' ' LEU . 12.4 mmt180 -151.87 173.99 14.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.688 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.531 HD23 HG12 ' C' ' 110' ' ' VAL . 1.3 mt -143.66 156.26 59.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.69 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.436 ' O ' HG22 ' A' ' 119' ' ' VAL . 12.4 Cg_endo -55.93 137.75 79.91 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.489 2.126 . . . . 0.0 111.988 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.445 ' HB2' HD11 ' A' ' 34' ' ' ILE . 10.3 mttt 68.18 16.03 9.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.328 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.97 15.58 9.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.783 HG11 HG13 ' A' ' 34' ' ' ILE . 29.3 m -51.79 169.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.713 0.292 . . . . 0.0 111.075 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.532 ' O ' HD12 ' A' ' 121' ' ' LEU . . . -116.67 17.02 13.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.027 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 120' ' ' GLY . 0.2 OUTLIER -175.17 153.44 1.59 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.102 0.477 . . . . 0.0 111.397 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.5 ' HB2' HD22 ' A' ' 115' ' ' LEU . 1.1 tp10 -142.5 140.22 31.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.884 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.889 HG21 HG21 ' A' ' 58' ' ' VAL . 28.1 mm -121.79 127.01 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 112.141 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 76' ' ' THR . 1.0 OUTLIER -140.21 146.23 38.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.08 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 124' ' ' GLU . . . -170.05 174.22 5.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.267 0.555 . . . . 0.0 112.275 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.84 HD12 ' HD3' ' A' ' 74' ' ' LYS . 5.2 mt -132.28 151.28 34.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.188 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.962 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -132.48 150.78 52.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.15 0.5 . . . . 0.0 111.756 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.032 HG21 HG21 ' B' ' 3' ' ' THR . 13.0 m -110.64 116.23 51.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.874 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.546 ' HB2' HD21 ' A' ' 67' ' ' LEU . 2.1 tmt_? . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.933 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 1.032 HG21 HG21 ' A' ' 128' ' ' VAL . 3.1 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.783 0.325 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -170.98 125.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.763 HD13 ' OD1' ' A' ' 103' ' ' ASN . 4.2 mp -56.5 141.38 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' B' ' 21' ' ' ALA . 21.8 mt -97.97 149.85 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.209 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.25 26.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.3 171.14 20.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.36 28.48 8.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.99 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.549 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 8.1 mttm -120.64 -44.5 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.747 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.891 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -66.68 171.3 4.53 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.971 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.891 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 29.7 Cg_endo -63.67 -12.72 32.73 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.563 2.176 . . . . 0.0 112.488 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 69.52 147.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.474 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.61 ' HB3' ' HA ' ' B' ' 19' ' ' VAL . . . -126.32 120.94 31.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.795 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.579 HG22 ' O ' ' B' ' 15' ' ' ILE . 3.1 mp -135.21 17.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.162 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.91 -118.96 2.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.39 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -89.64 14.72 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.787 2.325 . . . . 0.0 113.306 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.99 -174.04 4.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 0.0 111.506 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' A' ' 106' ' ' ALA . 18.1 m -138.55 169.34 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.823 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -49.17 78.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 110.636 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.582 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -177.14 -177.93 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' B' ' 29' ' ' LEU . 14.9 m -141.51 133.29 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.151 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.553 ' HA ' HG23 ' B' ' 28' ' ' VAL . 37.6 t70 -110.77 115.36 29.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.928 HD11 HD12 ' B' ' 29' ' ' LEU . 2.9 mt -90.88 -16.01 28.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.231 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.65 -99.29 0.81 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.767 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -56.93 -29.05 62.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.171 0.51 . . . . 0.0 110.111 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.679 HD23 ' O ' ' B' ' 127' ' ' ALA . 0.2 OUTLIER -136.18 135.18 38.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.717 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.947 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 4.8 p -109.54 164.48 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.923 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.928 HD12 HD11 ' B' ' 24' ' ' LEU . 3.4 mt -142.49 131.32 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.888 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 41.1 p -104.71 144.85 31.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.972 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.919 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 10.3 p -83.32 179.17 7.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.013 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.43 89.75 0.82 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.199 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.823 ' HG3' HG22 ' B' ' 58' ' ' VAL . 88.3 mm-40 -56.18 144.16 30.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.936 0.398 . . . . 0.0 111.275 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.929 HG23 HG23 ' B' ' 36' ' ' VAL . 9.6 tt -125.45 132.87 24.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.703 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.676 ' HB2' HG23 ' B' ' 43' ' ' VAL . 21.9 Cg_exo -64.98 65.2 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.69 2.26 . . . . 0.0 112.59 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.929 HG23 HG23 ' B' ' 34' ' ' ILE . 63.7 t . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.12 0.486 . . . . 0.0 110.584 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.676 HG23 ' HB2' ' B' ' 35' ' ' PRO . 7.2 p . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.539 0.209 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.16 138.91 23.25 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.399 2.066 . . . . 0.0 112.283 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.68 -31.13 71.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 110.892 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.84 94.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 21.4 mm -44.27 -31.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.879 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.4 t -79.72 -38.8 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.78 -54.26 38.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.451 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.48 -26.74 68.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.344 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.68 -40.69 72.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.01 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.45 -48.71 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -59.6 -46.71 88.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.712 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.861 ' O ' HG23 ' B' ' 58' ' ' VAL . 89.9 p -60.06 -37.25 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.859 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.496 HD21 ' CD2' ' B' ' 92' ' ' TYR . 21.9 mt -76.6 -23.3 53.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -52.07 12.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.169 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.7 OUTLIER -58.01 -29.32 65.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.893 HG21 HG21 ' B' ' 123' ' ' ILE . 54.0 t -65.02 -46.39 91.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.921 0.391 . . . . 0.0 110.6 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.09 -28.94 61.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -60.86 -40.91 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.431 HD11 ' OE1' ' B' ' 33' ' ' GLN . 13.0 mt -73.21 -41.64 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.506 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.619 HD13 HD11 ' B' ' 72' ' ' ILE . 18.0 mt -69.51 -31.31 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.535 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.51 -37.39 60.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.1 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -22.38 66.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.276 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.83 -28.9 20.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.04 50.58 0.63 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.516 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.564 HD22 ' HB3' ' B' ' 71' ' ' ASP . 6.1 mt -146.73 -176.68 5.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.988 0.423 . . . . 0.0 110.672 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.68 163.92 31.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.751 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' B' ' 101' ' ' HIS . . . -50.31 -34.62 24.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.043 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.543 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -67.49 -24.86 65.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.315 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.564 ' HB3' HD22 ' B' ' 67' ' ' LEU . 57.9 m-20 -80.38 -6.6 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.929 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.619 HD11 HD13 ' B' ' 62' ' ' ILE . 24.4 mt -83.82 116.11 27.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.221 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.499 HG23 ' N ' ' B' ' 74' ' ' LYS . 35.4 m -76.52 -47.03 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.05 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.851 ' HD3' HD12 ' B' ' 126' ' ' ILE . 10.8 mtpt -118.35 -177.58 3.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.569 0.223 . . . . 0.0 111.153 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.695 HG22 ' HB2' ' B' ' 105' ' ' PRO . 11.2 t 179.98 101.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 111.539 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.525 HG23 ' NH1' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -71.18 126.76 30.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.18 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.73 98.92 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -98.21 147.36 24.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.991 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 0.9 OUTLIER -144.68 151.76 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.173 0.511 . . . . 0.0 111.927 -179.252 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.03 -2.85 56.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.732 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.13 110.37 0.59 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.402 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.641 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.0 mt -56.92 -18.59 13.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.305 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -75.76 -23.58 55.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.558 ' O ' HG23 ' B' ' 88' ' ' VAL . 47.5 m-20 -77.91 -12.78 60.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -27.18 59.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.293 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.54 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.351 . . . . 0.0 111.408 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.87 -29.38 20.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.277 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.558 HG23 ' O ' ' B' ' 84' ' ' ASP . 26.2 t -73.87 -47.09 44.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.128 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -64.9 -39.26 93.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.59 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.34 85.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.011 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.83 -33.34 19.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.646 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.534 ' OH ' HG21 ' B' ' 75' ' ' THR . 35.4 t80 -61.23 -56.39 21.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.351 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 0.2 OUTLIER -70.28 -15.21 62.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.268 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -40.04 66.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.48 ' CE2' ' CE1' ' B' ' 96' ' ' PHE . 0.0 OUTLIER -84.95 -38.81 18.86 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.378 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.498 ' CE1' ' CE1' ' B' ' 92' ' ' TYR . 11.2 m-85 -53.86 -50.68 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.042 0.449 . . . . 0.0 110.328 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.96 -32.31 73.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.877 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.63 -1.93 55.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.463 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 1.0 OUTLIER -110.39 -8.63 14.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.637 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 2.7 t-20 97.09 19.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.761 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 0.543 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.3 t60 -118.53 59.86 4.01 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.961 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.411 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 44.0 Cg_endo -68.18 -17.79 45.23 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.457 2.105 . . . . 0.0 112.181 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.776 ' OD1' HD13 ' C' ' 5' ' ' ILE . 0.1 OUTLIER -75.4 -34.22 61.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' B' ' 105' ' ' PRO . 33.0 m-85 72.26 140.19 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.695 ' HB2' HG22 ' B' ' 75' ' ' THR . 7.2 Cg_exo -71.87 166.74 28.61 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.724 2.283 . . . . 0.0 112.113 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.943 ' HB1' ' HB3' ' C' ' 31' ' ' SER . . . -107.45 131.02 54.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.761 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.581 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -167.51 -165.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.049 0.452 . . . . 0.0 111.33 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -116.16 114.93 25.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.224 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . 0.529 ' O ' HG13 ' B' ' 110' ' ' VAL . 16.0 m -95.69 131.52 41.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.207 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.543 HG12 HD23 ' C' ' 115' ' ' LEU . 7.2 m -158.96 170.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 111.413 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.872 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 6.9 tt0 -110.2 95.4 5.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.676 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -60.62 157.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.065 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -60.77 -45.67 93.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.041 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.63 ' HB3' HD12 ' A' ' 82' ' ' LEU . 12.4 mmt180 -151.94 173.98 14.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.733 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.573 HD23 HG12 ' A' ' 110' ' ' VAL . 1.3 mt -143.66 156.31 59.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.7 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.433 ' O ' HG22 ' B' ' 119' ' ' VAL . 12.4 Cg_endo -55.98 137.76 80.12 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.449 2.1 . . . . 0.0 112.052 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.446 ' HB2' HG13 ' B' ' 119' ' ' VAL . 10.3 mttt 68.23 15.97 9.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.356 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.99 15.62 9.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.088 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.781 HG11 HG13 ' B' ' 34' ' ' ILE . 29.2 m -51.84 169.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.057 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . 0.53 ' O ' HD12 ' B' ' 121' ' ' LEU . . . -116.67 16.81 13.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.016 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.53 HD12 ' O ' ' B' ' 120' ' ' GLY . 0.2 OUTLIER -175.11 153.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.109 0.481 . . . . 0.0 111.433 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.479 ' HB2' HD22 ' B' ' 115' ' ' LEU . 1.1 tp10 -142.43 140.25 31.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.903 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.893 HG21 HG21 ' B' ' 58' ' ' VAL . 28.2 mm -121.81 127.05 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.146 0.498 . . . . 0.0 112.12 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' B' ' 76' ' ' THR . 1.0 OUTLIER -140.29 146.21 38.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.051 179.146 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' B' ' 124' ' ' GLU . . . -170.01 174.24 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.286 0.565 . . . . 0.0 112.269 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.851 HD12 ' HD3' ' B' ' 74' ' ' LYS . 5.2 mt -132.35 151.2 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.172 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.947 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -132.45 150.82 52.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.053 0.454 . . . . 0.0 111.731 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.998 HG21 HG21 ' C' ' 3' ' ' THR . 13.2 m -110.67 116.21 51.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.891 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.547 ' HB2' HD21 ' B' ' 67' ' ' LEU . 2.1 tmt_? . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.975 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.998 HG21 HG21 ' B' ' 128' ' ' VAL . 3.1 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.784 0.326 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -171.06 125.28 0.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.776 HD13 ' OD1' ' B' ' 103' ' ' ASN . 4.2 mp -56.42 141.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.6 HD12 ' HB3' ' C' ' 21' ' ' ALA . 22.0 mt -98.05 149.88 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.24 26.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.28 171.15 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.34 28.42 8.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.023 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.549 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 8.0 mttm -120.65 -44.6 2.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.74 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -66.79 171.22 4.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.042 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.889 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 29.6 Cg_endo -63.61 -12.71 32.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.533 2.155 . . . . 0.0 112.506 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 69.45 147.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.488 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' C' ' 19' ' ' VAL . . . -126.35 120.99 31.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.756 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.572 HG22 ' O ' ' C' ' 15' ' ' ILE . 3.1 mp -135.24 17.14 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.11 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.95 -118.88 2.91 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.418 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.75 14.81 2.07 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.784 2.323 . . . . 0.0 113.306 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -147.07 -174.06 4.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.948 0.404 . . . . 0.0 111.495 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.89 HG23 ' HB2' ' B' ' 106' ' ' ALA . 17.8 m -138.55 169.35 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.75 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -48.89 79.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 110.592 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.6 ' HB3' HD12 ' C' ' 6' ' ' ILE . . . -177.4 -177.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.898 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' C' ' 29' ' ' LEU . 15.0 m -141.47 133.34 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.05 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.542 ' HA ' HG23 ' C' ' 28' ' ' VAL . 37.5 t70 -110.77 115.4 29.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.937 HD11 HD12 ' C' ' 29' ' ' LEU . 2.9 mt -91.01 -16.07 28.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.143 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.67 -99.27 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.762 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -56.99 -29.0 62.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.159 0.504 . . . . 0.0 110.081 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.687 HD23 ' O ' ' C' ' 127' ' ' ALA . 0.2 OUTLIER -136.17 135.22 38.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.746 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.967 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 4.8 p -109.59 164.49 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.847 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.937 HD12 HD11 ' C' ' 24' ' ' LEU . 3.4 mt -142.55 131.3 22.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.887 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 40.9 p -104.63 144.35 31.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . 0.943 ' HB3' ' HB1' ' B' ' 106' ' ' ALA . 10.1 p -83.03 179.1 7.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.51 89.74 0.83 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.177 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.821 ' HG3' HG22 ' C' ' 58' ' ' VAL . 88.3 mm-40 -56.12 144.17 30.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.286 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.972 HG23 HG23 ' C' ' 36' ' ' VAL . 9.5 tt -125.49 132.9 24.44 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.691 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.685 ' HB2' HG23 ' C' ' 43' ' ' VAL . 21.9 Cg_exo -64.93 65.25 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.657 2.238 . . . . 0.0 112.574 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.972 HG23 HG23 ' C' ' 34' ' ' ILE . 63.5 t . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.59 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.685 HG23 ' HB2' ' C' ' 35' ' ' PRO . 7.3 p . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.504 0.192 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.24 138.92 23.09 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.407 2.072 . . . . 0.0 112.242 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.72 -31.07 71.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 94.96 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.887 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 21.5 mm -44.32 -31.0 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.933 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.79 -38.73 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.6 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.79 -54.28 37.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.478 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.52 -26.82 68.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.332 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.65 72.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.1 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.44 -48.7 16.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.763 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.62 -46.65 88.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.767 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.857 ' O ' HG23 ' C' ' 58' ' ' VAL . 90.3 p -60.04 -37.29 79.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.487 HD21 ' CD2' ' C' ' 92' ' ' TYR . 21.9 mt -76.56 -23.35 53.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.094 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.69 -52.08 12.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.203 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.6 OUTLIER -58.09 -29.2 65.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.939 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.908 HG21 HG21 ' C' ' 123' ' ' ILE . 54.3 t -65.16 -46.25 91.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.905 0.383 . . . . 0.0 110.602 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -28.87 61.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -60.87 -40.88 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.03 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.432 HD11 ' OE1' ' C' ' 33' ' ' GLN . 13.0 mt -73.13 -41.69 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.518 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.611 HD13 HD11 ' C' ' 72' ' ' ILE . 18.2 mt -69.5 -31.38 48.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.485 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.47 -37.33 60.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.106 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -22.43 66.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.276 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.88 -28.81 20.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.824 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.99 50.51 0.63 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.568 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' C' ' 71' ' ' ASP . 6.1 mt -146.67 -176.66 5.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 110.68 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.68 163.85 31.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.47 ' O ' ' CD2' ' C' ' 101' ' ' HIS . . . -50.21 -34.74 23.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.548 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -67.38 -24.72 65.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.324 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.566 ' HB3' HD22 ' C' ' 67' ' ' LEU . 57.9 m-20 -80.67 -6.52 58.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.934 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.611 HD11 HD13 ' C' ' 62' ' ' ILE . 24.7 mt -83.88 116.08 27.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.188 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.504 HG23 ' N ' ' C' ' 74' ' ' LYS . 35.4 m -76.57 -46.93 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.014 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.872 ' HD3' HD12 ' C' ' 126' ' ' ILE . 10.8 mtpt -118.4 -177.7 3.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.591 0.234 . . . . 0.0 111.158 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.683 HG22 ' HB2' ' C' ' 105' ' ' PRO . 11.1 t -179.94 101.04 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.84 0.352 . . . . 0.0 111.509 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.52 HG23 ' NH1' ' C' ' 107' ' ' ARG . 0.0 OUTLIER -71.18 126.72 30.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.233 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.67 98.89 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -98.21 147.38 24.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.957 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 0.9 OUTLIER -144.68 151.79 15.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.479 . . . . 0.0 111.959 -179.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.05 -2.91 56.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.727 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.09 110.28 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.327 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.0 mt -56.89 -18.57 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -75.79 -23.57 55.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.617 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.552 ' O ' HG23 ' C' ' 88' ' ' VAL . 47.7 m-20 -77.88 -12.79 60.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -27.11 60.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.27 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.59 -42.54 71.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.815 0.34 . . . . 0.0 111.381 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.84 -29.45 20.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.275 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . 0.552 HG23 ' O ' ' C' ' 84' ' ' ASP . 26.1 t -73.82 -47.16 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.102 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -64.82 -39.32 93.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.596 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.42 -37.28 85.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.051 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.8 -33.33 19.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.594 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.545 ' OH ' HG21 ' C' ' 75' ' ' THR . 35.5 t80 -61.23 -56.43 20.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.36 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . 0.426 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 0.2 OUTLIER -70.22 -15.22 62.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.302 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -40.1 66.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.483 ' CE2' ' CE1' ' C' ' 96' ' ' PHE . 0.0 OUTLIER -84.91 -38.85 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.343 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.495 ' CE1' ' CE1' ' C' ' 92' ' ' TYR . 11.2 m-85 -53.86 -50.65 65.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 110.371 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.96 -32.24 73.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.911 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -83.76 -1.81 54.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.432 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 1.0 OUTLIER -110.39 -8.69 14.66 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.667 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 2.8 t-20 97.09 19.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.795 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 0.548 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.3 t60 -118.57 59.88 4.07 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.859 0.362 . . . . 0.0 110.91 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CE2' ' C' ' 104' ' ' PHE . 43.4 Cg_endo -68.16 -17.85 45.35 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.486 2.124 . . . . 0.0 112.15 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.798 ' OD1' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -75.41 -34.16 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.694 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' C' ' 105' ' ' PRO . 33.2 m-85 72.24 140.14 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.08 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.683 ' HB2' HG22 ' C' ' 75' ' ' THR . 7.2 Cg_exo -71.71 166.72 28.59 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.777 2.318 . . . . 0.0 112.113 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.913 ' HB2' HG23 ' A' ' 19' ' ' VAL . . . -107.54 130.91 54.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.792 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.593 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -167.41 -165.53 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.0 111.324 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 3.1 p -116.2 114.84 24.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.256 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . 0.524 ' O ' HG13 ' C' ' 110' ' ' VAL . 15.8 m -95.67 131.49 41.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.265 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 115' ' ' LEU . 7.2 m -158.97 170.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.947 0.403 . . . . 0.0 111.478 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.876 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 6.9 tt0 -110.26 95.36 5.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 29.9 m -60.51 157.27 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -60.93 -45.63 93.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.011 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.641 ' HB3' HD12 ' B' ' 82' ' ' LEU . 12.3 mmt180 -151.93 173.94 14.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.727 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.543 HD23 HG12 ' B' ' 110' ' ' VAL . 1.3 mt -143.65 156.25 59.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.71 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.438 ' O ' HG22 ' C' ' 119' ' ' VAL . 12.4 Cg_endo -55.89 137.7 79.65 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.472 2.114 . . . . 0.0 112.069 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.439 ' HB2' HG13 ' C' ' 119' ' ' VAL . 10.3 mttt 68.21 16.02 9.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.392 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.89 15.69 9.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.808 HG11 HG13 ' C' ' 34' ' ' ILE . 29.3 m -51.83 169.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.736 0.303 . . . . 0.0 111.034 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . 0.541 ' O ' HD12 ' C' ' 121' ' ' LEU . . . -116.67 16.97 13.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.045 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.541 HD12 ' O ' ' C' ' 120' ' ' GLY . 0.2 OUTLIER -175.22 153.44 1.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.173 0.511 . . . . 0.0 111.367 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.492 ' HB2' HD22 ' C' ' 115' ' ' LEU . 1.1 tp10 -142.46 140.26 31.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.89 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.908 HG21 HG21 ' C' ' 58' ' ' VAL . 28.3 mm -121.78 127.01 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.094 0.474 . . . . 0.0 112.162 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' C' ' 76' ' ' THR . 1.0 OUTLIER -140.19 146.19 38.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.071 179.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' C' ' 124' ' ' GLU . . . -169.99 174.33 5.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.214 0.531 . . . . 0.0 112.332 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.872 HD12 ' HD3' ' C' ' 74' ' ' LYS . 5.2 mt -132.41 151.21 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.214 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.967 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -132.45 150.73 52.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.08 0.467 . . . . 0.0 111.739 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 1.08 HG21 HG21 ' A' ' 3' ' ' THR . 13.0 m -110.62 116.33 52.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.861 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.527 ' HB2' HD21 ' C' ' 67' ' ' LEU . 2.1 tmt_? -122.74 75.92 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.897 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.486 HG23 ' CD2' ' A' ' 24' ' ' LEU . 18.8 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.006 0.431 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HD23 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.694 HD11 ' OD1' ' C' ' 103' ' ' ASN . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.719 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 14' ' ' ALA . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.843 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' C' ' 104' ' ' PHE . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 29' ' ' LEU . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.565 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.916 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.0 m120 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 128' ' ' VAL . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.959 HG23 ' HB3' ' A' ' 127' ' ' ALA . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 62' ' ' ILE . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.693 ' HB ' HG11 ' A' ' 119' ' ' VAL . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 34' ' ' ILE . 32.9 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.607 0.241 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.406 ' OE1' HD13 ' A' ' 47' ' ' ILE . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.782 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 54' ' ' SER . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.719 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 30' ' ' THR . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.044 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.895 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 126' ' ' ILE . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 128' ' ' VAL . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 125' ' ' ALA . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 108' ' ' SER . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 122' ' ' GLU . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.712 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 85' ' ' PHE . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' A' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.475 ' OH ' HG21 ' A' ' 75' ' ' THR . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.539 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 1.044 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.3 m170 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.691 ' CG ' HD11 ' B' ' 5' ' ' ILE . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.731 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 72' ' ' ILE . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 76' ' ' THR . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.596 ' HB3' HD12 ' C' ' 82' ' ' LEU . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 78' ' ' PHE . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 34' ' ' ILE . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.795 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' ' 35' ' ' PRO . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.725 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' ILE . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.959 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 73' ' ' VAL . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB3' HD21 ' A' ' 67' ' ' LEU . 14.1 ptm180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.481 HG23 ' CD2' ' B' ' 24' ' ' LEU . 19.0 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.977 0.417 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.568 ' OE1' HD23 ' B' ' 24' ' ' LEU . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.691 HD11 ' CG ' ' A' ' 103' ' ' ASN . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.722 ' HB2' ' CG1' ' B' ' 61' ' ' ILE . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.786 HD13 ' O ' ' B' ' 14' ' ' ALA . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.84 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 104' ' ' PHE . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 11' ' ' ALA . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.53 HG23 HD13 ' B' ' 29' ' ' LEU . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.562 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.515 HD13 HG12 ' B' ' 128' ' ' VAL . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' B' ' 127' ' ' ALA . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.631 HD12 ' N ' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.737 HG21 HD11 ' B' ' 62' ' ' ILE . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.484 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.716 ' HB ' HG11 ' B' ' 119' ' ' VAL . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.565 HG23 HG13 ' B' ' 34' ' ' ILE . 33.3 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.791 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.3 p . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.595 0.236 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' B' ' 47' ' ' ILE . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' B' ' 95' ' ' PHE . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' B' ' 54' ' ' SER . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.722 ' CG1' ' HB2' ' B' ' 11' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.737 HD11 HG21 ' B' ' 30' ' ' THR . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 1.051 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.897 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.477 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 126' ' ' ILE . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.635 HG13 HG22 ' B' ' 128' ' ' VAL . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' LYS . . . . . 0.681 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.727 HG23 ' HB2' ' B' ' 125' ' ' ALA . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 108' ' ' SER . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.702 HG13 ' O ' ' B' ' 122' ' ' GLU . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.507 HG11 ' HD1' ' B' ' 85' ' ' PHE . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.507 ' HD1' HG11 ' B' ' 79' ' ' VAL . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' B' ' 75' ' ' THR . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.542 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . 1.051 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 3.4 m170 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.7 ' CG ' HD11 ' C' ' 5' ' ' ILE . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.72 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' B' ' 72' ' ' ILE . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.431 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.845 ' O ' HG23 ' B' ' 76' ' ' THR . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' VAL . . . . . 0.729 HG11 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.543 ' HB3' HD12 ' A' ' 82' ' ' LEU . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HB2' ' B' ' 78' ' ' PHE . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.482 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' VAL . . . . . 0.716 HG11 ' HB ' ' B' ' 34' ' ' ILE . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' GLY . . . . . 0.791 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.468 HD11 ' HG3' ' B' ' 35' ' ' PRO . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.702 ' O ' HG13 ' B' ' 77' ' ' VAL . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.56 ' CG2' HG21 ' B' ' 58' ' ' VAL . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 72' ' ' ILE . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.997 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.635 HG22 HG13 ' B' ' 73' ' ' VAL . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' B' ' 67' ' ' LEU . 14.1 ptm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.48 HG23 ' CD2' ' C' ' 24' ' ' LEU . 19.0 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 4' ' ' GLN . . . . . 0.562 ' OE1' HD23 ' C' ' 24' ' ' LEU . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 5' ' ' ILE . . . . . 0.7 HD11 ' CG ' ' B' ' 103' ' ' ASN . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . 0.497 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.721 ' HB2' ' CG1' ' C' ' 61' ' ' ILE . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' PRO . . . . . 0.67 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.779 HD13 ' O ' ' C' ' 14' ' ' ALA . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' TYR . . . . . 0.826 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' B' ' 104' ' ' PHE . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' VAL . . . . . 0.535 HG23 HD13 ' C' ' 29' ' ' LEU . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . 0.559 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.898 HD13 ' O ' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.482 HD13 HG12 ' C' ' 128' ' ' VAL . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.63 ' N ' HD12 ' C' ' 29' ' ' LEU . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.711 HG21 HD11 ' C' ' 62' ' ' ILE . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' ILE . . . . . 0.691 ' HB ' HG11 ' C' ' 119' ' ' VAL . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . 0.561 HG23 HG13 ' C' ' 34' ' ' ILE . 32.8 t . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . 0.789 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.3 p . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.582 0.229 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' C' ' 51' ' ' ALA . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.401 ' OE1' HD13 ' C' ' 47' ' ' ILE . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 54' ' ' SER . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.721 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . 0.711 HD11 HG21 ' C' ' 30' ' ' THR . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 1.059 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.886 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' ASP . . . . . 0.464 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' ILE . . . . . 0.484 HG23 ' O ' ' C' ' 126' ' ' ILE . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.636 HG13 HG22 ' C' ' 128' ' ' VAL . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' ALA . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.847 HG23 ' O ' ' C' ' 108' ' ' SER . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.714 HG13 ' O ' ' C' ' 122' ' ' GLU . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' PHE . . . . . 0.729 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' C' ' 85' ' ' PHE . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' C' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' TYR . . . . . 0.479 ' OH ' HG21 ' C' ' 75' ' ' THR . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.549 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 101' ' ' HIS . . . . . 1.059 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 3.3 m170 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 103' ' ' ASN . . . . . 0.694 ' OD1' HD11 ' A' ' 5' ' ' ILE . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.704 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 105' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' C' ' 72' ' ' ILE . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 107' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 108' ' ' SER . . . . . 0.847 ' O ' HG23 ' C' ' 76' ' ' THR . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 110' ' ' VAL . . . . . 0.712 HG11 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . 0.731 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 113' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.581 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' C' ' 78' ' ' PHE . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 116' ' ' PRO . . . . . 0.582 ' O ' HG22 ' C' ' 119' ' ' VAL . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 117' ' ' LYS . . . . . 0.484 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' C' ' 34' ' ' ILE . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 120' ' ' GLY . . . . . 0.789 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' C' ' 35' ' ' PRO . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 77' ' ' VAL . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 123' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' HB ' ' C' ' 76' ' ' THR . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.705 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 126' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' ILE . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 127' ' ' ALA . . . . . 0.956 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 128' ' ' VAL . . . . . 0.636 HG22 HG13 ' C' ' 73' ' ' VAL . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 129' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' C' ' 67' ' ' LEU . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.869 0.366 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.23 168.49 19.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.486 HG23 ' CD2' ' A' ' 24' ' ' LEU . 18.8 m -165.16 116.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HD23 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.694 HD11 ' OD1' ' C' ' 103' ' ' ASN . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.719 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 14' ' ' ALA . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.843 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' C' ' 104' ' ' PHE . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 29' ' ' LEU . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.565 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.916 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.0 m120 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 128' ' ' VAL . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.959 HG23 ' HB3' ' A' ' 127' ' ' ALA . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 62' ' ' ILE . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.693 ' HB ' HG11 ' A' ' 119' ' ' VAL . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 34' ' ' ILE . 32.9 t -63.02 85.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 41' ' ' GLY . 36.7 t-20 -35.11 129.88 0.5 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.989 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.53 -10.59 29.14 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 112.178 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.5 -21.36 8.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.68 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.416 HG22 ' CG ' ' A' ' 42' ' ' GLU . 3.5 m -114.75 -25.2 8.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 63.67 56.06 21.4 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.323 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' CG ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER -164.27 -81.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.704 0.288 . . . . 0.0 111.625 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p -173.89 106.83 0.3 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.406 ' OE1' HD13 ' A' ' 47' ' ' ILE . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.782 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 54' ' ' SER . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.719 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 30' ' ' THR . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.044 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.895 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 126' ' ' ILE . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 128' ' ' VAL . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 125' ' ' ALA . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 108' ' ' SER . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 122' ' ' GLU . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.712 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 85' ' ' PHE . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' A' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.475 ' OH ' HG21 ' A' ' 75' ' ' THR . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.539 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 1.044 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.3 m170 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.691 ' CG ' HD11 ' B' ' 5' ' ' ILE . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.731 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 72' ' ' ILE . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 76' ' ' THR . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.596 ' HB3' HD12 ' C' ' 82' ' ' LEU . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 78' ' ' PHE . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 34' ' ' ILE . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.795 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' ' 35' ' ' PRO . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.725 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' ILE . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.959 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 73' ' ' VAL . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB3' HD21 ' A' ' 67' ' ' LEU . 14.1 ptm180 -164.77 46.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.832 0.349 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.24 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.481 HG23 ' CD2' ' B' ' 24' ' ' LEU . 19.0 m -165.18 116.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.568 ' OE1' HD23 ' B' ' 24' ' ' LEU . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.691 HD11 ' CG ' ' A' ' 103' ' ' ASN . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.722 ' HB2' ' CG1' ' B' ' 61' ' ' ILE . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.786 HD13 ' O ' ' B' ' 14' ' ' ALA . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.84 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 104' ' ' PHE . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 11' ' ' ALA . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.53 HG23 HD13 ' B' ' 29' ' ' LEU . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.562 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.515 HD13 HG12 ' B' ' 128' ' ' VAL . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' B' ' 127' ' ' ALA . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.631 HD12 ' N ' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.737 HG21 HD11 ' B' ' 62' ' ' ILE . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.484 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.716 ' HB ' HG11 ' B' ' 119' ' ' VAL . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.565 HG23 HG13 ' B' ' 34' ' ' ILE . 33.3 t -63.01 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.402 ' HB3' ' HB ' ' B' ' 40' ' ' THR . 36.6 t-20 -35.14 129.93 0.51 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.935 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.58 -10.63 29.2 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.023 . . . . 0.0 112.192 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.4 -21.41 8.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.78 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' B' ' 37' ' ' ASN . 3.5 m -114.77 -25.32 8.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.456 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 63.81 56.13 20.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.401 ' CG ' HG22 ' B' ' 40' ' ' THR . 0.0 OUTLIER -164.36 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.623 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.791 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.3 p -173.94 106.72 0.3 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' B' ' 47' ' ' ILE . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' B' ' 95' ' ' PHE . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' B' ' 54' ' ' SER . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.722 ' CG1' ' HB2' ' B' ' 11' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.737 HD11 HG21 ' B' ' 30' ' ' THR . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 1.051 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.897 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.477 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 126' ' ' ILE . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.635 HG13 HG22 ' B' ' 128' ' ' VAL . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.681 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.727 HG23 ' HB2' ' B' ' 125' ' ' ALA . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 108' ' ' SER . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.702 HG13 ' O ' ' B' ' 122' ' ' GLU . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.507 HG11 ' HD1' ' B' ' 85' ' ' PHE . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.507 ' HD1' HG11 ' B' ' 79' ' ' VAL . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' B' ' 75' ' ' THR . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.542 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 1.051 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 3.4 m170 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.7 ' CG ' HD11 ' C' ' 5' ' ' ILE . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.72 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' B' ' 72' ' ' ILE . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.431 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.845 ' O ' HG23 ' B' ' 76' ' ' THR . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.729 HG11 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.543 ' HB3' HD12 ' A' ' 82' ' ' LEU . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HB2' ' B' ' 78' ' ' PHE . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.482 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.716 HG11 ' HB ' ' B' ' 34' ' ' ILE . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . 0.791 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.468 HD11 ' HG3' ' B' ' 35' ' ' PRO . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.702 ' O ' HG13 ' B' ' 77' ' ' VAL . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.56 ' CG2' HG21 ' B' ' 58' ' ' VAL . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 72' ' ' ILE . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.997 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.635 HG22 HG13 ' B' ' 73' ' ' VAL . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' B' ' 67' ' ' LEU . 14.1 ptm180 -164.83 46.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.951 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.21 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.48 HG23 ' CD2' ' C' ' 24' ' ' LEU . 19.0 m -165.22 116.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.562 ' OE1' HD23 ' C' ' 24' ' ' LEU . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.7 HD11 ' CG ' ' B' ' 103' ' ' ASN . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.497 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.721 ' HB2' ' CG1' ' C' ' 61' ' ' ILE . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.67 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.779 HD13 ' O ' ' C' ' 14' ' ' ALA . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.826 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' B' ' 104' ' ' PHE . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.535 HG23 HD13 ' C' ' 29' ' ' LEU . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.559 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.898 HD13 ' O ' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.482 HD13 HG12 ' C' ' 128' ' ' VAL . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.63 ' N ' HD12 ' C' ' 29' ' ' LEU . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.711 HG21 HD11 ' C' ' 62' ' ' ILE . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.691 ' HB ' HG11 ' C' ' 119' ' ' VAL . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.561 HG23 HG13 ' C' ' 34' ' ' ILE . 32.8 t -63.06 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' C' ' 41' ' ' GLY . 36.7 t-20 -35.13 129.94 0.51 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.56 -10.6 29.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.31 2.007 . . . . 0.0 112.18 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.44 -21.43 8.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.729 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.408 HG22 ' CG ' ' C' ' 42' ' ' GLU . 3.5 m -114.8 -25.24 8.32 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 63.64 56.1 21.27 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.395 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.408 ' CG ' HG22 ' C' ' 40' ' ' THR . 0.0 OUTLIER -164.26 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.61 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.789 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.3 p -173.93 106.74 0.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.365 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' C' ' 51' ' ' ALA . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.401 ' OE1' HD13 ' C' ' 47' ' ' ILE . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 54' ' ' SER . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.721 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.711 HD11 HG21 ' C' ' 30' ' ' THR . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 1.059 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.886 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.464 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.484 HG23 ' O ' ' C' ' 126' ' ' ILE . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.636 HG13 HG22 ' C' ' 128' ' ' VAL . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' ALA . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.847 HG23 ' O ' ' C' ' 108' ' ' SER . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.714 HG13 ' O ' ' C' ' 122' ' ' GLU . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.729 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' C' ' 85' ' ' PHE . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' C' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.479 ' OH ' HG21 ' C' ' 75' ' ' THR . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.549 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 1.059 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 3.3 m170 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.694 ' OD1' HD11 ' A' ' 5' ' ' ILE . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.704 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' C' ' 72' ' ' ILE . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . 0.847 ' O ' HG23 ' C' ' 76' ' ' THR . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.712 HG11 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.731 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.581 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' C' ' 78' ' ' PHE . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.582 ' O ' HG22 ' C' ' 119' ' ' VAL . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.484 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' C' ' 34' ' ' ILE . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . 0.789 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' C' ' 35' ' ' PRO . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 77' ' ' VAL . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' HB ' ' C' ' 76' ' ' THR . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.705 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' ILE . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.956 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.636 HG22 HG13 ' C' ' 73' ' ' VAL . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' C' ' 67' ' ' LEU . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.827 0.346 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.8 -175.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 21.8 m 63.58 128.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.924 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.511 ' HA ' ' N ' ' A' ' 23' ' ' ASP . 12.3 pt20 43.77 -165.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.743 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.638 HD11 ' O ' ' C' ' 103' ' ' ASN . 34.3 mm 68.69 116.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.959 0.409 . . . . 0.0 111.633 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 36.3 mt -142.11 91.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.77 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -102.22 128.98 48.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.991 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 t -144.86 153.74 41.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 30.7 3.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.458 ' HG2' ' HB1' ' A' ' 60' ' ' ALA . 4.6 tptm -117.6 -36.82 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . -99.88 122.47 50.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.273 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 7.5 Cg_exo -72.93 3.07 4.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.67 2.247 . . . . 0.0 112.829 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.636 ' HB1' ' OE1' ' A' ' 33' ' ' GLN . . . -50.32 -178.17 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.998 0.428 . . . . 0.0 111.809 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.58 ' C ' HD12 ' A' ' 15' ' ' ILE . . . 64.05 118.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.048 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.9 mp -146.79 17.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.342 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.92 -148.64 4.79 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.449 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.48 ' HA ' ' CE2' ' C' ' 104' ' ' PHE . 84.8 Cg_endo -87.57 34.33 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.859 2.373 . . . . 0.0 112.957 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.456 ' CD2' ' HB2' ' C' ' 107' ' ' ARG . 9.9 p90 -130.39 164.97 23.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.776 0.322 . . . . 0.0 110.821 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.956 HG13 ' HB3' ' C' ' 104' ' ' PHE . 19.9 m -91.54 147.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.437 ' HG2' ' HB2' ' A' ' 14' ' ' ALA . 15.4 mt-30 -46.11 -48.85 17.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.44 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.627 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -157.58 -175.28 5.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.451 ' C ' HD11 ' A' ' 6' ' ' ILE . 29.1 m -136.23 129.26 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.114 0.483 . . . . 0.0 111.922 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.511 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 44.1 t0 -113.14 103.97 11.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.803 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 4' ' ' GLN . 33.6 mt -84.04 -18.69 36.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.105 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.05 -108.68 0.91 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.827 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.6 -30.19 62.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 110.065 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HG ' HG23 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -121.92 127.88 50.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.581 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.938 HG23 ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -105.75 179.4 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.243 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -159.9 146.83 16.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.0 p -121.1 142.25 50.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.8 m -79.03 165.99 22.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.26 74.4 0.28 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.987 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.636 ' OE1' ' HB1' ' A' ' 13' ' ' ALA . 17.3 mm-40 -66.46 165.21 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.031 0.444 . . . . 0.0 111.352 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.8 ' HB ' HG11 ' A' ' 119' ' ' VAL . 3.4 pt -138.99 159.07 68.44 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.243 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.531 ' O ' HG12 ' A' ' 36' ' ' VAL . 85.5 Cg_exo -42.28 -45.39 7.74 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.64 2.227 . . . . 0.0 111.932 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.84 HG22 ' HA2' ' A' ' 41' ' ' GLY . 8.5 p 44.04 25.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.565 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.409 ' H ' ' HD3' ' A' ' 44' ' ' PRO . 7.9 m120 56.12 159.92 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 0.0 111.354 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.68 -26.02 7.35 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.549 2.166 . . . . 0.0 112.031 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.91 19.68 0.26 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.341 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.92 -27.24 8.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 110.575 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.84 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . 71.41 45.11 49.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.925 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 6.4 mm-40 -146.47 -77.19 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.721 0.261 . . . . 0.0 110.789 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.731 ' HB ' HG12 ' A' ' 119' ' ' VAL . 7.1 p 172.07 128.29 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.877 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 4.9 Cg_exo -76.58 153.12 34.23 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.684 2.256 . . . . 0.0 112.091 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.1 -30.85 55.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.074 0.464 . . . . 0.0 110.741 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -68.48 94.24 0.55 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.885 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.624 HD13 ' NE2' ' A' ' 50' ' ' GLN . 28.9 mm -40.32 -33.3 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.34 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.12 -46.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.699 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' A' ' 46' ' ' ASP . . . -61.37 -36.19 79.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.706 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.66 ' HG3' HD21 ' A' ' 121' ' ' LEU . 10.4 pt20 -77.61 -28.39 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.608 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.11 -31.55 25.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.248 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -38.35 29.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.17 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.55 -31.06 66.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.871 0.367 . . . . 0.0 110.823 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.839 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -70.03 -30.85 68.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.748 HD13 ' CE2' ' A' ' 95' ' ' PHE . 57.4 mt -74.6 -33.85 62.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.38 -48.69 64.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.999 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -57.6 -48.2 80.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.092 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 54' ' ' SER . 27.2 t -59.63 -29.97 43.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 1.9 ttpp -79.15 -39.83 32.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.043 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 10' ' ' LYS . . . -62.04 -36.41 81.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.976 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 58' ' ' VAL . 8.1 mt -70.21 -51.87 35.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 127' ' ' ALA . 3.7 tt -65.26 -22.43 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.076 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -82.95 -37.74 23.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.891 0.377 . . . . 0.0 110.31 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -11.15 60.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.97 -29.93 35.22 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.925 0.393 . . . . 0.0 110.335 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.3 28.5 1.0 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.141 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -146.84 -166.97 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.329 . . . . 0.0 110.69 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.58 153.73 49.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.852 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -57.25 -38.92 74.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -51.19 -29.86 15.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.06 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.74 -22.4 58.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.627 HG23 ' O ' ' A' ' 126' ' ' ILE . 76.6 mt -47.76 114.88 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.97 0.414 . . . . 0.0 110.97 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.622 ' CG1' HG12 ' A' ' 128' ' ' VAL . 32.8 m -89.62 -31.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.702 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.771 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 78.1 tttt -134.44 163.0 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 111.055 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.739 HG23 ' HB2' ' A' ' 125' ' ' ALA . 30.4 m -158.75 139.56 12.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.303 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 108' ' ' SER . 96.7 m -123.63 147.41 47.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.176 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.9 t -149.22 109.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 111.697 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.709 ' CD2' HG11 ' C' ' 110' ' ' VAL . 8.6 m-85 -89.0 110.23 20.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.47 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.408 HG11 ' HD1' ' A' ' 85' ' ' PHE . 31.3 m -101.38 144.89 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -85.03 -1.55 56.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.221 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.2 127.22 1.46 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.512 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.15 -11.92 52.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.65 -20.82 45.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.361 . . . . 0.0 110.693 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.6 -27.25 20.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 44.3 t80 -57.68 -28.77 64.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.13 -32.28 67.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.263 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.49 -34.95 18.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.221 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.7 -39.71 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.413 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 32.8 t30 -68.89 -36.55 78.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.51 -32.39 66.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.61 -30.35 19.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.088 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.716 ' OH ' HG21 ' A' ' 75' ' ' THR . 10.0 t80 -58.43 -43.93 88.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.91 -29.36 35.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.18 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.48 75.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.036 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.748 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -89.32 -36.54 15.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.636 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.509 ' CD2' ' HB2' ' A' ' 101' ' ' HIS . 0.2 OUTLIER -54.99 -53.59 53.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.807 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -72.82 -26.43 61.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.387 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 95' ' ' PHE . 2.4 mm-40 -76.47 -13.32 60.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.553 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 12.6 m-80 -101.4 -17.29 16.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.011 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 5.2 p-10 103.5 35.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.154 0.909 . . . . 0.0 110.396 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.852 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 2.0 m-70 -114.97 55.27 0.87 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.376 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.491 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 88.8 Cg_endo -79.12 2.74 8.04 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.661 2.241 . . . . 0.0 113.112 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.63 ' O ' HD11 ' B' ' 5' ' ' ILE . 2.0 t30 -64.48 -30.08 71.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.765 0.317 . . . . 0.0 111.477 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.973 ' HB3' HG13 ' B' ' 19' ' ' VAL . 2.5 m-85 70.91 110.21 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.547 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 96' ' ' PHE . 66.2 Cg_endo -96.03 153.39 1.4 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.064 2.509 . . . . 0.0 112.443 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.771 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -50.27 163.09 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.236 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.441 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -134.49 143.43 47.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.147 0.499 . . . . 0.0 111.607 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 76' ' ' THR . 0.8 OUTLIER -150.73 63.81 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.305 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.09 134.69 40.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.025 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.661 HG11 ' CD2' ' B' ' 78' ' ' PHE . 26.8 m -142.22 138.49 29.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.26 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.785 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 2.9 tm-20 -68.23 83.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.686 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.21 163.91 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.233 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -74.55 -38.16 62.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.982 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.404 ' CB ' ' HB3' ' C' ' 111' ' ' GLU . 0.4 OUTLIER -161.62 -177.65 6.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.761 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.48 HD11 ' O ' ' A' ' 78' ' ' PHE . 77.8 mt -151.82 156.37 34.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.756 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.31 137.96 78.46 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.59 2.194 . . . . 0.0 112.099 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.682 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.9 OUTLIER 74.74 14.21 3.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.244 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.76 16.88 8.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.8 HG11 ' HB ' ' A' ' 34' ' ' ILE . 29.5 m -57.07 175.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.831 0.348 . . . . 0.0 111.079 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.54 12.79 15.69 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.676 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 50' ' ' GLN . 4.3 pp -176.75 148.17 0.67 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.025 0.441 . . . . 0.0 111.298 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.408 ' C ' HD13 ' A' ' 123' ' ' ILE . 1.2 tt0 -125.74 161.05 28.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.037 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' A' ' 54' ' ' SER . 0.0 OUTLIER -143.54 129.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.115 0.484 . . . . 0.0 112.012 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.09 109.51 2.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.895 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.739 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -126.73 174.61 8.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.137 0.494 . . . . 0.0 112.039 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 72' ' ' ILE . 15.3 mt -125.63 156.41 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.422 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.938 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -146.34 151.07 36.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.551 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.622 HG12 ' CG1' ' A' ' 73' ' ' VAL . 5.1 p -147.99 159.95 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.128 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.763 ' HB3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -148.44 58.86 1.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.81 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.787 0.327 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.83 -175.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.973 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' B' ' 4' ' ' GLN . 22.1 m 63.58 128.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.507 ' HA ' ' N ' ' B' ' 23' ' ' ASP . 12.3 pt20 43.82 -165.68 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.636 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.63 HD11 ' O ' ' A' ' 103' ' ' ASN . 34.2 mm 68.65 116.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.023 0.439 . . . . 0.0 111.6 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 36.4 mt -142.12 91.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.782 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -102.15 129.02 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.949 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.7 t -144.87 153.74 41.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.05 30.67 3.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.44 ' HG2' ' HB1' ' B' ' 60' ' ' ALA . 4.6 tptm -117.55 -36.78 3.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -99.9 122.3 51.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.214 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 7.4 Cg_exo -72.87 3.05 4.73 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.68 2.254 . . . . 0.0 112.84 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.664 ' HB1' ' OE1' ' B' ' 33' ' ' GLN . . . -50.24 -178.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.005 0.431 . . . . 0.0 111.796 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.593 ' C ' HD12 ' B' ' 15' ' ' ILE . . . 64.01 118.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.605 HG22 ' O ' ' B' ' 15' ' ' ILE . 2.9 mp -146.78 17.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.341 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.9 -148.71 4.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.422 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.482 ' HA ' ' CE2' ' A' ' 104' ' ' PHE . 84.1 Cg_endo -87.49 34.26 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.869 2.379 . . . . 0.0 113.005 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.444 ' CZ ' ' HA ' ' B' ' 14' ' ' ALA . 10.0 p90 -130.4 164.95 23.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 110.835 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.973 HG13 ' HB3' ' A' ' 104' ' ' PHE . 20.2 m -91.46 147.76 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.424 ' HG2' ' HB2' ' B' ' 14' ' ' ALA . 15.5 mt-30 -46.18 -48.97 17.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.414 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.655 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -157.39 -175.35 5.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.71 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.45 ' C ' HD11 ' B' ' 6' ' ' ILE . 29.2 m -136.25 129.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.09 0.471 . . . . 0.0 111.941 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.507 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 44.1 t0 -113.11 103.92 11.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.834 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.4 HD23 ' H ' ' B' ' 4' ' ' GLN . 33.2 mt -83.97 -18.71 36.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.109 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.03 -108.75 0.91 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.792 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.55 -30.21 62.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.093 0.473 . . . . 0.0 110.068 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.422 ' HG ' HG23 ' B' ' 128' ' ' VAL . 0.7 OUTLIER -121.87 127.93 51.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.603 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.909 HG23 ' HB3' ' B' ' 127' ' ' ALA . 0.3 OUTLIER -105.81 179.4 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.478 HD12 ' O ' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -159.94 146.84 16.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 35.9 p -121.11 141.98 50.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.89 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 17.6 m -78.68 165.97 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.25 74.36 0.28 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.968 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.664 ' OE1' ' HB1' ' B' ' 13' ' ' ALA . 17.2 mm-40 -66.42 165.32 14.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 111.374 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.842 ' HB ' HG11 ' B' ' 119' ' ' VAL . 3.4 pt -139.08 159.05 68.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.199 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.536 ' O ' HG12 ' B' ' 36' ' ' VAL . 85.6 Cg_exo -42.28 -45.46 7.72 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.635 2.224 . . . . 0.0 111.87 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.862 HG22 ' HA2' ' B' ' 41' ' ' GLY . 8.5 p 44.1 25.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.508 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.416 ' HA ' ' HG3' ' B' ' 44' ' ' PRO . 7.9 m120 56.05 159.97 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.954 0.407 . . . . 0.0 111.406 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.71 -26.02 7.33 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.547 2.164 . . . . 0.0 112.049 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.92 19.74 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.269 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 -27.33 8.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.0 110.578 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.862 ' HA2' HG22 ' B' ' 36' ' ' VAL . . . 71.55 45.1 47.9 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.932 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 6.4 mm-40 -146.43 -77.26 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.708 0.254 . . . . 0.0 110.755 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.717 ' HB ' HG12 ' B' ' 119' ' ' VAL . 7.1 p 172.15 128.32 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.854 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' B' ' 35' ' ' PRO . 5.0 Cg_exo -76.59 153.09 34.14 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.699 2.266 . . . . 0.0 112.115 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.11 -30.79 55.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.453 . . . . 0.0 110.715 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' B' ' 49' ' ' ALA . 0.4 OUTLIER -68.55 94.24 0.56 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.864 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.62 HD13 ' NE2' ' B' ' 50' ' ' GLN . 29.2 mm -40.23 -33.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.387 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.08 -46.46 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.684 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.427 ' H ' ' HB3' ' B' ' 46' ' ' ASP . . . -61.34 -36.19 79.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.742 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.669 ' HG3' HD21 ' B' ' 121' ' ' LEU . 10.4 pt20 -77.57 -28.33 51.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.575 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.19 -31.56 25.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.271 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -38.31 30.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.254 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.6 -31.08 66.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.772 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.84 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.4 OUTLIER -69.97 -30.88 68.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.801 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.792 HD13 ' CE2' ' B' ' 95' ' ' PHE . 57.3 mt -74.58 -33.88 62.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.46 -48.59 64.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.994 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -57.67 -48.16 80.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.84 HG23 ' O ' ' B' ' 54' ' ' SER . 27.1 t -59.64 -29.92 43.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.052 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 1.9 ttpp -79.26 -39.78 32.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.44 ' HB1' ' HG2' ' B' ' 10' ' ' LYS . . . -62.01 -36.47 81.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.548 HG22 HG21 ' B' ' 6' ' ' ILE . 8.2 mt -70.09 -51.89 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.998 0.428 . . . . 0.0 110.737 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' B' ' 127' ' ' ALA . 3.8 tt -65.23 -22.45 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.0 -37.73 23.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 110.3 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -11.1 60.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.737 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.93 -29.96 35.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.0 110.367 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.29 28.49 1.0 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.153 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' B' ' 129' ' ' ARG . 0.2 OUTLIER -146.83 -167.02 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.7 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.52 153.76 49.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.86 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -57.34 -38.85 74.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.652 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -51.26 -29.92 16.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.76 -22.48 58.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.96 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.629 HG23 ' O ' ' B' ' 126' ' ' ILE . 76.5 mt -47.72 114.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.893 0.377 . . . . 0.0 110.995 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.605 ' CG1' HG12 ' B' ' 128' ' ' VAL . 32.9 m -89.66 -31.57 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.66 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.751 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 78.1 tttt -134.39 163.08 30.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.017 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.73 HG23 ' HB2' ' B' ' 125' ' ' ALA . 30.4 m -158.76 139.6 12.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.297 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.626 HG23 ' O ' ' B' ' 108' ' ' SER . 96.8 m -123.68 147.41 47.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.172 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.8 t -149.22 109.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.863 0.363 . . . . 0.0 111.746 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.661 ' CD2' HG11 ' A' ' 110' ' ' VAL . 8.6 m-85 -88.97 110.22 20.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.424 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.415 HG11 ' HD1' ' B' ' 85' ' ' PHE . 31.3 m -101.37 144.86 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.447 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -85.03 -1.68 57.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.145 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.12 127.14 1.48 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.507 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' B' ' 82' ' ' LEU . 12.0 mt -66.01 -12.04 52.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.68 -20.74 45.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.789 0.328 . . . . 0.0 110.653 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.69 -27.16 20.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' B' ' 89' ' ' ASN . 44.5 t80 -57.74 -28.76 64.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.29 67.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.303 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.53 -34.96 18.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.16 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.79 -39.56 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.153 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 32.7 t30 -69.0 -36.45 77.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.47 -32.46 66.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.42 -30.43 19.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.706 ' OH ' HG21 ' B' ' 75' ' ' THR . 9.8 t80 -58.36 -43.98 88.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.94 -29.35 35.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.54 75.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.069 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.792 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.9 OUTLIER -89.2 -36.64 15.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.646 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.511 ' CD2' ' HB2' ' B' ' 101' ' ' HIS . 0.2 OUTLIER -54.88 -53.63 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.863 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -72.77 -26.49 61.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.436 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . 0.412 ' HB2' ' HA ' ' B' ' 95' ' ' PHE . 2.4 mm-40 -76.48 -13.29 60.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.568 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.567 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 12.6 m-80 -101.39 -17.35 16.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.01 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 5.3 p-10 103.6 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.148 0.905 . . . . 0.0 110.328 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.86 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 2.0 m-70 -115.06 55.25 0.89 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.387 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.487 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 89.3 Cg_endo -79.09 2.77 8.01 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.626 2.217 . . . . 0.0 113.141 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.664 ' O ' HD11 ' C' ' 5' ' ' ILE . 2.0 t30 -64.4 -30.21 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 111.512 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.929 ' HB3' HG13 ' C' ' 19' ' ' VAL . 2.5 m-85 70.97 110.2 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.505 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' B' ' 96' ' ' PHE . 66.0 Cg_endo -95.98 153.44 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.141 2.561 . . . . 0.0 112.438 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.751 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -50.37 163.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.292 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.465 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -134.4 143.44 47.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 111.607 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.626 ' O ' HG23 ' B' ' 76' ' ' THR . 0.8 OUTLIER -150.77 63.88 0.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.283 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.05 134.74 40.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.04 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' C' ' 78' ' ' PHE . 26.9 m -142.32 139.3 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.294 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.728 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 2.8 tm-20 -68.67 84.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.78 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 m -67.4 163.95 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.133 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -74.55 -38.11 62.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.63 -177.74 6.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.484 HD11 ' O ' ' B' ' 78' ' ' PHE . 77.7 mt -151.72 156.41 34.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.772 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.37 137.92 78.59 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.577 2.185 . . . . 0.0 112.093 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.678 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.9 OUTLIER 74.8 14.2 3.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.26 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.78 16.89 8.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.069 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.842 HG11 ' HB ' ' B' ' 34' ' ' ILE . 29.6 m -57.18 175.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.83 0.347 . . . . 0.0 111.075 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.34 13.04 16.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.71 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.669 HD21 ' HG3' ' B' ' 50' ' ' GLN . 4.3 pp -176.83 148.19 0.65 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 111.275 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.79 161.0 28.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.021 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' B' ' 54' ' ' SER . 0.0 OUTLIER -143.43 129.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 112.109 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 109.48 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.888 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -126.74 174.63 8.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.134 0.493 . . . . 0.0 111.985 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.629 ' O ' HG23 ' B' ' 72' ' ' ILE . 15.2 mt -125.64 156.34 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.444 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.909 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -146.28 150.97 36.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.57 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.605 HG12 ' CG1' ' B' ' 73' ' ' VAL . 5.1 p -147.83 159.99 7.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.774 ' HB3' HD21 ' B' ' 67' ' ' LEU . 0.0 OUTLIER -148.45 58.8 1.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.881 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.75 -174.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.993 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' C' ' 4' ' ' GLN . 21.9 m 63.51 128.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.954 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.513 ' HA ' ' N ' ' C' ' 23' ' ' ASP . 12.3 pt20 43.79 -165.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.691 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.664 HD11 ' O ' ' B' ' 103' ' ' ASN . 34.4 mm 68.76 116.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.005 0.431 . . . . 0.0 111.628 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.662 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 36.6 mt -142.11 91.74 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.767 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -102.24 128.95 48.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 12.7 t -144.76 153.75 41.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.1 30.75 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.46 ' HG2' ' HB1' ' C' ' 60' ' ' ALA . 4.7 tptm -117.6 -37.08 3.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.016 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.413 ' HB2' HG13 ' C' ' 61' ' ' ILE . . . -99.59 122.48 51.29 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.186 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.84 2.94 4.82 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.731 2.288 . . . . 0.0 112.823 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.634 ' HB1' ' OE1' ' C' ' 33' ' ' GLN . . . -50.2 -178.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.966 0.412 . . . . 0.0 111.812 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.577 ' C ' HD12 ' C' ' 15' ' ' ILE . . . 63.97 118.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.096 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.598 HG22 ' O ' ' C' ' 15' ' ' ILE . 2.9 mp -146.74 17.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.364 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.9 -148.65 4.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.415 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . 0.466 ' HA ' ' CE2' ' B' ' 104' ' ' PHE . 83.3 Cg_endo -87.48 34.26 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.849 2.366 . . . . 0.0 113.037 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.465 ' CD2' ' HB2' ' B' ' 107' ' ' ARG . 9.9 p90 -130.41 164.91 23.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.775 0.322 . . . . 0.0 110.829 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.929 HG13 ' HB3' ' B' ' 104' ' ' PHE . 20.4 m -91.44 147.8 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.947 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.435 ' HG2' ' HB2' ' C' ' 14' ' ' ALA . 15.5 mt-30 -46.18 -48.73 17.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.47 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.662 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -157.43 -175.26 5.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.677 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.491 HG11 ' O ' ' B' ' 73' ' ' VAL . 29.5 m -136.27 129.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.062 0.458 . . . . 0.0 111.902 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.513 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 44.2 t0 -113.18 103.9 11.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.819 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.421 HD23 ' H ' ' C' ' 4' ' ' GLN . 33.3 mt -83.97 -18.73 36.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.108 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.05 -108.7 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.811 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -56.6 -30.14 62.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.146 0.498 . . . . 0.0 110.118 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.491 ' HG ' HG23 ' C' ' 128' ' ' VAL . 0.7 OUTLIER -121.91 127.9 50.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.624 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.968 HG23 ' HB3' ' C' ' 127' ' ' ALA . 0.3 OUTLIER -105.78 179.3 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.216 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.476 HD12 ' O ' ' C' ' 28' ' ' VAL . 0.1 OUTLIER -159.86 146.82 16.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.833 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.406 HG23 HD12 ' C' ' 62' ' ' ILE . 35.7 p -121.07 142.33 49.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.833 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 18.1 m -78.99 165.78 23.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.3 74.41 0.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.991 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.634 ' OE1' ' HB1' ' C' ' 13' ' ' ALA . 17.3 mm-40 -66.43 165.28 14.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.021 0.438 . . . . 0.0 111.325 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.82 ' HB ' HG11 ' C' ' 119' ' ' VAL . 3.4 pt -139.04 159.1 68.2 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.232 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.533 ' O ' HG12 ' C' ' 36' ' ' VAL . 85.3 Cg_exo -42.36 -45.41 7.89 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.623 2.216 . . . . 0.0 111.867 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.86 HG22 ' HA2' ' C' ' 41' ' ' GLY . 8.6 p 44.07 25.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.556 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.405 ' H ' ' HD3' ' C' ' 44' ' ' PRO . 7.9 m120 56.06 159.96 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 120.98 0.419 . . . . 0.0 111.359 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.59 -26.12 7.39 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.58 2.187 . . . . 0.0 112.05 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.89 19.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.286 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.99 -27.37 8.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.36 . . . . 0.0 110.563 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.86 ' HA2' HG22 ' C' ' 36' ' ' VAL . . . 71.68 45.09 46.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.953 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 6.4 mm-40 -146.48 -77.24 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.713 0.256 . . . . 0.0 110.763 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.763 ' HB ' HG12 ' C' ' 119' ' ' VAL . 7.1 p 172.17 128.33 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.914 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 43' ' ' VAL . 4.8 Cg_exo -76.68 153.14 33.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.664 2.243 . . . . 0.0 112.067 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.16 -30.76 55.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.091 0.472 . . . . 0.0 110.738 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' C' ' 49' ' ' ALA . 0.4 OUTLIER -68.54 94.31 0.56 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.888 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.623 HD13 ' NE2' ' C' ' 50' ' ' GLN . 29.2 mm -40.31 -33.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.397 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.13 -46.48 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.665 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' C' ' 46' ' ' ASP . . . -61.23 -36.28 79.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.766 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.65 ' HG3' HD21 ' C' ' 121' ' ' LEU . 10.4 pt20 -77.63 -28.11 51.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.594 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.4 -31.59 24.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.337 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -38.38 30.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -71.55 -31.12 66.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.807 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.822 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.4 OUTLIER -69.98 -30.87 68.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.81 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.743 HD13 ' CE2' ' C' ' 95' ' ' PHE . 57.4 mt -74.48 -33.94 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.37 -48.66 64.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.02 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -57.56 -48.24 79.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.822 HG23 ' O ' ' C' ' 54' ' ' SER . 27.2 t -59.59 -29.93 43.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.072 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.446 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 1.9 ttpp -79.21 -39.81 32.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.996 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' C' ' 10' ' ' LYS . . . -62.08 -36.23 81.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.078 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' C' ' 58' ' ' VAL . 8.1 mt -70.33 -51.9 34.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' C' ' 127' ' ' ALA . 3.8 tt -65.23 -22.42 31.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.094 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.02 -37.71 23.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.917 0.389 . . . . 0.0 110.287 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -11.08 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.713 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.99 35.06 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.964 0.412 . . . . 0.0 110.327 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.29 28.51 1.0 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.165 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.762 HD21 ' HB3' ' C' ' 129' ' ' ARG . 0.2 OUTLIER -146.88 -167.02 2.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.638 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.5 m -137.49 153.73 50.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.867 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -57.43 -38.71 74.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.656 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -51.16 -29.76 14.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.073 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.85 -22.56 58.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.642 HG23 ' O ' ' C' ' 126' ' ' ILE . 76.3 mt -47.66 114.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 111.013 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.628 ' CG1' HG12 ' C' ' 128' ' ' VAL . 32.8 m -89.66 -31.47 5.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.696 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.743 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 78.0 tttt -134.5 162.99 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.752 0.311 . . . . 0.0 111.01 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.734 HG23 ' HB2' ' C' ' 125' ' ' ALA . 30.5 m -158.75 139.58 12.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.424 . . . . 0.0 111.302 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.626 HG23 ' O ' ' C' ' 108' ' ' SER . 96.8 m -123.64 147.44 47.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.197 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.7 t -149.27 109.27 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.745 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.709 ' CD2' HG11 ' B' ' 110' ' ' VAL . 8.5 m-85 -88.95 110.19 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.476 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.409 HG11 ' HD1' ' C' ' 85' ' ' PHE . 31.6 m -101.4 144.87 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.461 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -85.02 -1.77 57.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.175 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -167.0 127.05 1.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.517 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 115' ' ' LEU . 12.0 mt -66.07 -11.98 52.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.63 -20.79 45.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.803 0.335 . . . . 0.0 110.673 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.63 -27.23 20.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' C' ' 89' ' ' ASN . 44.5 t80 -57.68 -28.83 64.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.102 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.29 67.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.255 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.46 -35.06 18.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.7 -39.62 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.152 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . 0.413 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 32.8 t30 -68.94 -36.5 78.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.49 -32.47 66.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -30.47 19.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.022 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.692 ' OH ' HG21 ' C' ' 75' ' ' THR . 10.0 t80 -58.29 -44.01 88.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.89 -29.35 35.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.178 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -33.51 75.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.055 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.743 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.9 OUTLIER -89.27 -36.59 15.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 110.647 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 0.2 OUTLIER -54.95 -53.56 54.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.876 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -72.82 -26.48 61.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . 0.41 ' HB2' ' HA ' ' C' ' 95' ' ' PHE . 2.4 mm-40 -76.48 -13.24 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.608 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.566 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 12.6 m-80 -101.46 -17.29 16.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.988 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 5.2 p-10 103.49 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.138 0.899 . . . . 0.0 110.372 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.867 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 2.0 m-70 -115.04 55.35 0.89 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.352 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 88.4 Cg_endo -79.2 2.82 7.98 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.628 2.219 . . . . 0.0 113.115 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.638 ' O ' HD11 ' A' ' 5' ' ' ILE . 2.0 t30 -64.51 -30.06 71.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 111.534 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.956 ' HB3' HG13 ' A' ' 19' ' ' VAL . 2.5 m-85 70.93 110.21 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.543 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.457 ' HG3' ' CZ ' ' C' ' 96' ' ' PHE . 65.9 Cg_endo -96.03 153.38 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.116 2.544 . . . . 0.0 112.434 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.743 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -50.31 163.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.278 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.456 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -134.44 143.45 47.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.13 0.49 . . . . 0.0 111.563 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . 0.626 ' O ' HG23 ' C' ' 76' ' ' THR . 0.8 OUTLIER -150.76 63.82 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.332 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 26.7 p -98.05 134.76 40.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.034 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' A' ' 78' ' ' PHE . 26.8 m -142.4 139.24 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.317 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.778 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.8 tm-20 -68.7 83.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.749 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.11 164.04 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.196 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -74.65 -38.19 62.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.975 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.409 ' CB ' ' HB3' ' B' ' 111' ' ' GLU . 0.4 OUTLIER -161.59 -177.6 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.775 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.478 HD11 ' O ' ' C' ' 78' ' ' PHE . 77.3 mt -151.76 156.42 34.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.755 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.48 137.95 79.01 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.588 2.192 . . . . 0.0 112.057 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.654 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.9 OUTLIER 74.8 14.2 3.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.275 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.79 16.9 8.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.073 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.82 HG11 ' HB ' ' C' ' 34' ' ' ILE . 29.3 m -57.08 175.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.818 0.342 . . . . 0.0 111.123 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.36 13.25 16.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.766 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' C' ' 50' ' ' GLN . 4.3 pp -177.36 148.25 0.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.976 0.417 . . . . 0.0 111.249 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.403 ' C ' HD13 ' C' ' 123' ' ' ILE . 1.2 tt0 -125.69 161.02 28.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.054 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' C' ' 54' ' ' SER . 0.0 OUTLIER -143.49 129.19 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.142 0.496 . . . . 0.0 112.039 -179.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.04 109.52 2.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.9 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.734 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -126.8 174.63 8.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.115 0.483 . . . . 0.0 112.026 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.642 ' O ' HG23 ' C' ' 72' ' ' ILE . 15.3 mt -125.68 156.36 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.435 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.968 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -146.36 151.02 36.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 111.503 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.628 HG12 ' CG1' ' C' ' 73' ' ' VAL . 5.0 p -147.84 159.92 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.762 ' HB3' HD21 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -148.41 58.89 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.817 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.855 0.359 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -172.57 4.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.044 HG21 HG21 ' C' ' 128' ' ' VAL . 0.9 OUTLIER 61.7 113.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 132.97 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.82 HD13 ' OD1' ' C' ' 103' ' ' ASN . 4.3 mp -55.2 152.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 21' ' ' ALA . 32.7 mt -103.43 139.26 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.58 117.18 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.58 HG22 ' OE1' ' A' ' 20' ' ' GLN . 11.7 t -133.88 165.99 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.33 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.52 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 7.6 mmtp -121.62 -36.89 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.032 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.872 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.82 172.05 4.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 18.9 Cg_endo -59.39 -16.05 33.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.695 2.263 . . . . 0.0 112.85 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 77.24 151.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 111.317 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.603 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -104.67 120.71 41.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 14' ' ' ALA . 22.1 mm -133.51 15.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.072 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.85 -146.17 4.73 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.987 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' C' ' 104' ' ' PHE . 93.9 Cg_endo -87.39 44.53 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.536 2.158 . . . . 0.0 112.901 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.541 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -163.19 154.59 17.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.867 0.365 . . . . 0.0 111.033 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.465 HG13 ' O ' ' C' ' 103' ' ' ASN . 27.3 m -110.91 169.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.58 ' OE1' HG22 ' A' ' 8' ' ' THR . 56.2 mt-30 -58.96 -53.53 57.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' A' ' 6' ' ' ILE . . . -170.69 -177.09 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG21 ' HB ' ' C' ' 73' ' ' VAL . 9.3 m -142.33 132.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.166 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.645 ' HA ' HG23 ' A' ' 28' ' ' VAL . 20.8 t70 -103.47 105.01 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.567 ' CD2' HG23 ' A' ' 3' ' ' THR . 19.5 mt -80.51 -16.36 54.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.371 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.05 -104.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.28 -29.62 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.166 0.508 . . . . 0.0 110.21 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 28' ' ' VAL . 5.0 tt -135.2 140.65 45.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.95 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 9.9 p -120.04 160.88 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.123 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' HE2' ' C' ' 74' ' ' LYS . 2.9 mp -145.87 127.37 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 p -106.5 136.11 46.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.983 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.812 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 1.1 t -59.36 179.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.07 95.55 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.244 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.805 ' HG2' HG22 ' A' ' 58' ' ' VAL . 2.9 mp0 -62.07 138.14 58.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.275 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.524 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -146.04 170.18 8.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.679 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -54.26 -137.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.313 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t 74.12 73.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.411 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 41' ' ' GLY . 2.1 t-20 -34.93 115.62 0.52 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.978 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.65 -13.68 11.46 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.339 2.026 . . . . 0.0 112.144 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.81 27.87 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.086 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 42' ' ' GLU . 8.0 t -161.6 -33.37 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.908 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 96.92 66.2 0.92 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.847 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HG2' HG23 ' A' ' 40' ' ' THR . 2.7 mt-10 -82.73 -53.38 5.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.369 . . . . 0.0 111.276 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t 68.96 72.52 0.34 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.81 140.71 81.58 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.592 2.195 . . . . 0.0 112.433 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.37 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.4 93.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.791 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.616 HD13 ' NE2' ' A' ' 50' ' ' GLN . 28.9 mm -38.93 -33.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.5 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.08 -48.07 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.696 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.82 -55.04 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.616 ' NE2' HD13 ' A' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.498 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -71.93 -44.36 63.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -63.33 -51.54 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.79 -31.18 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.871 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.3 m -68.31 -46.48 70.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.29 -26.36 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.971 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -57.95 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.108 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.8 OUTLIER -54.88 -30.36 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.985 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 54' ' ' SER . 39.6 t -62.1 -34.54 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 110.517 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.99 -31.75 34.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.755 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -62.23 -38.55 89.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 11' ' ' ALA . 6.1 mt -70.93 -46.2 69.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.667 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.8 -32.62 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.28 -38.4 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.9 -24.33 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.145 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.71 -22.11 21.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.914 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.43 64.8 0.83 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' OD2' ' A' ' 71' ' ' ASP . 14.7 mt -158.9 139.2 12.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 44.0 p -96.12 145.0 25.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -46.29 -31.75 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.518 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -59.77 -18.48 43.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.715 ' OD2' HD22 ' A' ' 67' ' ' LEU . 3.2 p-10 -88.58 -21.27 24.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 126' ' ' ILE . 64.3 mt -59.35 109.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.528 ' HB ' HG21 ' B' ' 22' ' ' VAL . 2.8 m -81.11 -36.84 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.971 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HE2' HD22 ' B' ' 29' ' ' LEU . 8.6 mtmt -130.55 175.23 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.319 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.61 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 13.4 t 177.71 110.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 111.36 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.18 130.1 41.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.33 91.6 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 76' ' ' THR . 5.3 m-85 -91.7 143.77 26.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.089 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.514 HG11 ' CD1' ' A' ' 85' ' ' PHE . 35.3 m -139.31 150.0 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.023 0.44 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.57 ' HE2' HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -90.95 -4.31 56.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.796 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.04 108.99 0.46 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.687 HD12 ' HB3' ' B' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.25 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.97 -24.64 59.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 110.282 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -78.46 -15.34 58.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.832 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.514 ' CD1' HG11 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -55.52 -22.98 23.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.01 -46.63 84.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 -33.22 19.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 84' ' ' ASP . 32.6 t -70.08 -49.66 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.673 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 36.4 t-20 -63.09 -35.99 82.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.14 94.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.016 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.62 -31.1 19.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.448 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 48.7 t80 -57.67 -51.35 69.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.727 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 7.7 tt0 -73.32 -27.34 61.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -25.11 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.765 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -79.31 -41.02 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.934 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 95' ' ' PHE . 57.1 m-85 -56.45 -50.43 71.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.8 69.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.77 58.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.402 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -110.54 -6.88 14.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.7 m-20 89.68 30.9 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 19.9 t-160 -127.57 72.17 77.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.96 -11.04 16.65 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.539 2.159 . . . . 0.0 112.153 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.844 ' OD1' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.03 42.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.447 . . . . 0.0 110.439 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CG ' ' HA ' ' B' ' 17' ' ' PRO . 92.7 m-85 70.99 144.0 0.1 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.515 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 104' ' ' PHE . 2.0 Cg_endo -82.96 165.82 15.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.057 2.504 . . . . 0.0 112.0 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' B' ' 31' ' ' SER . . . -115.28 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.779 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.61 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -169.27 -163.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.944 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.36 107.57 16.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.493 ' O ' HG13 ' A' ' 110' ' ' VAL . 5.3 m -95.25 129.16 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.798 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.519 HG12 HD23 ' B' ' 115' ' ' LEU . 7.0 m -157.79 165.71 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.949 0.405 . . . . 0.0 111.666 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 9.4 tt0 -99.75 102.87 14.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.777 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.82 162.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -79.07 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.685 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -140.81 168.08 20.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.722 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.622 HD22 ' HB2' ' A' ' 122' ' ' GLU . 3.0 mt -144.19 161.9 42.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 119' ' ' VAL . 32.7 Cg_exo -59.7 135.94 67.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.649 2.233 . . . . 0.0 112.183 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.58 18.28 7.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.87 17.47 8.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 116' ' ' PRO . 21.2 m -55.18 172.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.61 14.08 20.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.011 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 121' ' ' LEU . 4.5 pp -176.64 149.0 0.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.123 0.487 . . . . 0.0 111.508 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.622 ' HB2' HD22 ' A' ' 115' ' ' LEU . 44.5 tt0 -150.86 137.85 19.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.918 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 76' ' ' THR . 3.4 mp -144.67 138.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 112.101 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.36 149.91 28.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.569 ' C ' HD13 ' A' ' 126' ' ' ILE . . . -132.03 125.99 32.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.414 . . . . 0.0 112.027 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.569 HD13 ' C ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -114.42 132.16 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.876 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.95 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -121.74 153.14 38.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.063 0.459 . . . . 0.0 112.038 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.111 HG21 HG21 ' B' ' 3' ' ' THR . 34.6 m -124.13 116.37 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.464 ' CD ' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -106.3 57.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.971 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.849 0.357 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.6 -172.5 4.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 1.111 HG21 HG21 ' A' ' 128' ' ' VAL . 0.9 OUTLIER 61.63 113.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.72 132.95 5.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.844 HD13 ' OD1' ' A' ' 103' ' ' ASN . 4.4 mp -55.2 152.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' B' ' 21' ' ' ALA . 32.7 mt -103.43 139.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.59 117.19 9.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.575 HG23 ' H ' ' B' ' 11' ' ' ALA . 11.6 t -133.86 165.97 23.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.804 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 26.32 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.58 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 7.6 mmtt -121.6 -36.61 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -68.18 172.03 4.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 18.7 Cg_endo -59.33 -16.06 32.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.632 2.221 . . . . 0.0 112.905 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 77.23 151.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.411 . . . . 0.0 111.281 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.586 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.597 HG22 ' O ' ' B' ' 15' ' ' ILE . 22.1 mm -133.53 15.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.79 -146.1 4.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.509 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . 94.4 Cg_endo -87.38 44.49 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.637 2.224 . . . . 0.0 112.916 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -163.26 154.53 17.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.915 0.388 . . . . 0.0 110.991 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 103' ' ' ASN . 27.2 m -110.83 169.25 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.304 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.575 ' OE1' HG22 ' B' ' 8' ' ' THR . 56.3 mt-30 -59.04 -53.58 56.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -170.46 -177.16 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.528 HG21 ' HB ' ' A' ' 73' ' ' VAL . 9.2 m -142.31 132.63 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.636 ' HA ' HG23 ' B' ' 28' ' ' VAL . 20.8 t70 -103.51 104.94 15.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.554 ' CD2' HG23 ' B' ' 3' ' ' THR . 19.5 mt -80.44 -16.4 54.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -103.96 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.972 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.3 -29.56 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.082 0.468 . . . . 0.0 110.189 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.644 HD23 ' N ' ' B' ' 28' ' ' VAL . 5.0 tt -135.3 140.65 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.52 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.945 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 9.9 p -120.07 160.84 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.657 HD22 ' HE2' ' A' ' 74' ' ' LYS . 2.9 mp -145.87 127.42 15.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.68 136.36 46.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.06 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.843 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 1.1 t -59.69 179.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.01 95.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.834 ' HG2' HG22 ' B' ' 58' ' ' VAL . 2.9 mp0 -61.92 138.09 58.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.553 HG22 ' O ' ' B' ' 121' ' ' LEU . 0.7 OUTLIER -145.98 170.19 8.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.665 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 52.2 Cg_exo -54.34 -137.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.069 2.513 . . . . 0.0 112.319 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t 74.21 73.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' B' ' 41' ' ' GLY . 2.1 t-20 -34.86 115.66 0.52 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.964 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.65 -13.71 11.53 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.4 2.067 . . . . 0.0 112.11 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.54 -26.78 27.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.459 HG23 ' HG2' ' B' ' 42' ' ' GLU . 8.0 t -161.65 -33.23 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 97.1 66.02 0.92 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.791 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.459 ' HG2' HG23 ' B' ' 40' ' ' THR . 2.8 mt-10 -82.77 -53.36 5.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.371 . . . . 0.0 111.292 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t 68.91 72.59 0.34 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.83 140.7 81.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.662 2.242 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.39 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.35 93.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.618 HD13 ' NE2' ' B' ' 50' ' ' GLN . 28.9 mm -38.94 -33.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.443 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.02 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.91 -54.98 38.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.618 ' NE2' HD13 ' B' ' 47' ' ' ILE . 15.8 pt20 -61.1 -26.16 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.522 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -72.18 -44.2 63.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.901 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.33 -51.54 65.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.22 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.9 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.3 m -68.4 -46.37 70.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.32 -26.38 68.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.963 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -57.99 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.163 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.8 OUTLIER -54.86 -30.39 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.931 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.9 HG23 ' O ' ' B' ' 54' ' ' SER . 39.7 t -62.13 -34.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.95 -31.77 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -62.21 -38.49 89.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.571 HG12 ' HB2' ' B' ' 11' ' ' ALA . 6.0 mt -71.25 -46.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.83 -32.53 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.656 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.31 -38.49 60.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.34 65.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.136 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 -22.06 21.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.919 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 64.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.711 HD22 ' OD2' ' B' ' 71' ' ' ASP . 14.7 mt -158.91 139.2 12.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.022 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' B' ' 71' ' ' ASP . 43.8 p -96.1 144.99 25.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -46.26 -31.79 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.574 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -59.83 -18.27 42.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.425 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.711 ' OD2' HD22 ' B' ' 67' ' ' LEU . 3.3 p-10 -88.65 -21.23 24.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.714 0.292 . . . . 0.0 110.87 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.512 HG23 ' O ' ' B' ' 126' ' ' ILE . 64.4 mt -59.4 109.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.874 0.369 . . . . 0.0 110.839 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' C' ' 22' ' ' VAL . 2.8 m -81.12 -36.88 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.969 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.667 ' HE2' HD22 ' C' ' 29' ' ' LEU . 8.6 mtmt -130.56 175.22 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.302 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.612 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 13.4 t 177.67 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 111.337 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.753 ' O ' HG23 ' B' ' 123' ' ' ILE . 0.0 OUTLIER -70.15 130.12 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.325 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.43 91.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.404 ' CZ ' ' HB ' ' B' ' 76' ' ' THR . 5.3 m-85 -91.66 143.72 26.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.151 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' B' ' 85' ' ' PHE . 35.1 m -139.32 150.01 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.072 0.463 . . . . 0.0 111.718 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' B' ' 47' ' ' ILE . 0.3 OUTLIER -90.94 -4.12 56.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.839 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -169.23 109.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.321 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' C' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.32 20.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.228 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.94 -24.63 59.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.275 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.547 ' O ' HG23 ' B' ' 88' ' ' VAL . 0.6 OUTLIER -78.52 -15.37 58.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.51 ' CD1' HG11 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -55.46 -23.03 23.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.267 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.99 -46.62 84.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.09 -33.23 19.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 84' ' ' ASP . 33.0 t -70.09 -49.59 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.721 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 36.4 t-20 -63.21 -35.96 82.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.04 94.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.67 -31.19 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 48.8 t80 -57.62 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 7.7 tt0 -73.41 -27.32 61.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.462 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -25.19 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.786 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -79.25 -41.09 28.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.97 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 95' ' ' PHE . 57.2 m-85 -56.36 -50.45 71.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.818 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.82 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.945 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.8 58.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.98 14.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.505 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 11.7 m-20 89.78 30.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.502 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.0 t-160 -127.48 72.19 77.52 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.98 -11.02 16.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.537 2.158 . . . . 0.0 112.153 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.83 ' OD1' HD13 ' C' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.03 0.443 . . . . 0.0 110.445 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.506 ' CG ' ' HA ' ' C' ' 17' ' ' PRO . 92.7 m-85 70.89 144.04 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.494 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 104' ' ' PHE . 2.0 Cg_endo -83.02 165.85 14.91 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.016 2.477 . . . . 0.0 111.917 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.835 ' HB1' ' HB2' ' C' ' 31' ' ' SER . . . -115.27 137.95 51.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.612 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -169.23 -163.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.38 107.56 16.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.571 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . 0.504 ' O ' HG13 ' B' ' 110' ' ' VAL . 5.2 m -95.21 129.11 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.845 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.533 HG12 HD23 ' C' ' 115' ' ' LEU . 7.0 m -157.71 165.59 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.409 . . . . 0.0 111.632 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 9.3 tt0 -99.57 102.86 14.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.785 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.73 162.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -79.05 -46.27 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -140.82 168.11 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' B' ' 122' ' ' GLU . 3.0 mt -144.21 161.87 42.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.549 ' O ' HG22 ' B' ' 119' ' ' VAL . 33.1 Cg_exo -59.62 135.97 67.82 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.157 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.53 18.29 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.88 17.46 8.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.549 HG22 ' O ' ' B' ' 116' ' ' PRO . 21.5 m -55.18 172.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.082 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.63 13.95 20.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.025 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.553 ' O ' HG22 ' B' ' 34' ' ' ILE . 4.6 pp -176.62 148.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.615 ' HB2' HD22 ' B' ' 115' ' ' LEU . 44.5 tt0 -150.78 137.88 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.935 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.753 HG23 ' O ' ' B' ' 76' ' ' THR . 3.4 mp -144.68 138.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 112.14 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.33 149.81 28.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.627 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.572 ' C ' HD13 ' B' ' 126' ' ' ILE . . . -131.94 126.01 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.956 0.408 . . . . 0.0 112.041 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.572 HD13 ' C ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -114.33 132.14 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.947 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.945 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -121.75 153.2 38.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.096 0.474 . . . . 0.0 111.994 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 1.04 HG21 HG21 ' C' ' 3' ' ' THR . 34.7 m -124.26 116.32 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.474 ' CD ' HD21 ' B' ' 67' ' ' LEU . 0.0 OUTLIER -106.23 57.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.015 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.851 0.358 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 -172.51 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 1.04 HG21 HG21 ' B' ' 128' ' ' VAL . 0.9 OUTLIER 61.67 113.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.68 132.97 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.83 HD13 ' OD1' ' B' ' 103' ' ' ASN . 4.4 mp -55.18 152.35 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' C' ' 21' ' ' ALA . 32.5 mt -103.46 139.23 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -143.59 117.2 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.572 HG22 ' OE1' ' C' ' 20' ' ' GLN . 11.7 t -133.93 165.96 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.32 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.542 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 7.6 mmtp -121.59 -36.84 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.01 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.885 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.93 172.02 4.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.885 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 18.8 Cg_endo -59.31 -16.11 32.83 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.675 2.25 . . . . 0.0 112.899 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 77.24 151.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.977 0.418 . . . . 0.0 111.304 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.591 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -104.69 120.76 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.002 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.591 HD13 ' O ' ' C' ' 14' ' ' ALA . 22.5 mm -133.54 15.81 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.81 -146.14 4.73 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.001 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' B' ' 104' ' ' PHE . 94.1 Cg_endo -87.37 44.51 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 112.917 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.532 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -163.23 154.55 17.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.026 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' B' ' 103' ' ' ASN . 27.2 m -110.87 169.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.36 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.572 ' OE1' HG22 ' C' ' 8' ' ' THR . 56.2 mt-30 -59.02 -53.38 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' C' ' 6' ' ' ILE . . . -170.6 -177.19 2.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' B' ' 73' ' ' VAL . 9.2 m -142.24 132.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.64 ' HA ' HG23 ' C' ' 28' ' ' VAL . 20.8 t70 -103.48 104.98 15.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.549 ' CD2' HG23 ' C' ' 3' ' ' THR . 19.5 mt -80.47 -16.35 54.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.0 -104.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.27 -29.59 33.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.648 HD23 ' N ' ' C' ' 28' ' ' VAL . 5.0 tt -135.22 140.64 45.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.575 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.947 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 9.9 p -120.04 160.84 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.667 HD22 ' HE2' ' B' ' 74' ' ' LYS . 2.9 mp -145.85 127.45 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 p -106.6 136.31 46.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . 0.835 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 1.1 t -59.62 179.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.13 95.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.25 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.821 ' HG2' HG22 ' C' ' 58' ' ' VAL . 2.9 mp0 -62.06 138.17 58.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.259 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.528 HG22 ' O ' ' C' ' 121' ' ' LEU . 0.7 OUTLIER -146.0 170.23 8.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.654 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' C' ' 34' ' ' ILE . 52.4 Cg_exo -54.36 -137.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.063 2.509 . . . . 0.0 112.29 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t 74.17 73.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.427 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' C' ' 41' ' ' GLY . 2.1 t-20 -34.93 115.67 0.52 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.967 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.61 -13.76 11.54 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.36 2.04 . . . . 0.0 112.088 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.56 -26.65 27.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.133 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.45 HG23 ' HG2' ' C' ' 42' ' ' GLU . 8.0 t -161.62 -33.31 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.928 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 96.98 66.09 0.92 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.79 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' C' ' 40' ' ' THR . 2.8 mt-10 -82.74 -53.36 5.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.886 0.374 . . . . 0.0 111.287 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 t 68.96 72.52 0.34 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.931 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.88 140.74 81.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.637 2.225 . . . . 0.0 112.358 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.45 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.083 0.468 . . . . 0.0 110.913 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 93.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.621 HD13 ' NE2' ' C' ' 50' ' ' GLN . 28.7 mm -39.01 -33.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.447 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.711 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -54.96 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.621 ' NE2' HD13 ' C' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.474 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -72.07 -44.36 63.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.36 -51.5 65.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.24 72.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.354 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.903 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.3 m -68.35 -46.4 70.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.58 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.32 -26.36 68.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -58.01 4.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.8 OUTLIER -54.9 -30.36 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.984 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.903 HG23 ' O ' ' C' ' 54' ' ' SER . 39.6 t -62.07 -34.62 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -80.86 -31.79 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -62.26 -38.52 89.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' C' ' 11' ' ' ALA . 6.0 mt -70.95 -46.31 68.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.89 -32.54 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.33 -38.39 60.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.093 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.31 65.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.139 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.1 21.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.87 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.445 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.712 HD22 ' OD2' ' C' ' 71' ' ' ASP . 14.7 mt -158.9 139.23 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.036 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.0 p -96.16 145.01 25.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -46.21 -31.81 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.598 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -59.74 -18.28 41.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.477 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.712 ' OD2' HD22 ' C' ' 67' ' ' LEU . 3.3 p-10 -88.78 -21.16 23.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 110.896 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.503 HG23 ' O ' ' C' ' 126' ' ' ILE . 64.2 mt -59.39 109.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.496 ' HB ' HG21 ' A' ' 22' ' ' VAL . 2.8 m -81.04 -36.88 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.933 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.646 ' HE2' HD22 ' A' ' 29' ' ' LEU . 8.6 mtmt -130.6 175.25 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.369 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 13.4 t 177.72 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.313 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.754 ' O ' HG23 ' C' ' 123' ' ' ILE . 0.0 OUTLIER -70.23 130.2 41.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 t -115.43 91.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' C' ' 76' ' ' THR . 5.3 m-85 -91.64 143.8 26.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.143 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' C' ' 85' ' ' PHE . 34.8 m -139.35 149.98 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 111.691 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' C' ' 47' ' ' ILE . 0.3 OUTLIER -90.99 -4.23 56.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.816 178.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.1 109.04 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.305 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.685 HD12 ' HB3' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -58.58 -17.19 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.0 -24.62 59.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.297 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.546 ' O ' HG23 ' C' ' 88' ' ' VAL . 0.6 OUTLIER -78.5 -15.28 58.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.827 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.513 ' CD1' HG11 ' C' ' 79' ' ' VAL . 0.3 OUTLIER -55.53 -23.04 24.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.261 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.63 84.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.01 -33.32 19.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.969 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.546 HG23 ' O ' ' C' ' 84' ' ' ASP . 32.8 t -70.06 -49.66 54.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 36.4 t-20 -63.12 -35.99 82.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.337 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.22 -42.14 94.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.973 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.68 -31.16 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.567 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.457 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 48.7 t80 -57.64 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 7.7 tt0 -73.36 -27.37 61.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -25.19 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.77 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -79.32 -41.03 28.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 95' ' ' PHE . 56.7 m-85 -56.38 -50.4 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.781 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -28.72 69.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.954 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.91 -3.78 58.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.362 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.91 14.79 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 11.7 m-20 89.79 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.822 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.499 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.0 t-160 -127.55 72.17 77.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.705 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.03 -10.97 16.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.495 2.13 . . . . 0.0 112.146 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.82 ' OD1' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.998 0.428 . . . . 0.0 110.429 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.512 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 92.8 m-85 70.91 144.1 0.1 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.42 ' HB2' HG22 ' C' ' 75' ' ' THR . 2.0 Cg_endo -83.05 165.85 14.87 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.028 2.485 . . . . 0.0 111.948 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.812 ' HB1' ' HB2' ' A' ' 31' ' ' SER . . . -115.29 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.6 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -169.22 -163.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.4 p -111.36 107.48 16.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.589 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . 0.502 ' O ' HG13 ' C' ' 110' ' ' VAL . 5.2 m -95.21 129.18 42.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.788 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.514 HG12 HD23 ' A' ' 115' ' ' LEU . 7.1 m -157.82 165.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 9.4 tt0 -99.76 102.86 14.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.75 162.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -79.08 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.671 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -140.83 168.09 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' C' ' 122' ' ' GLU . 3.0 mt -144.21 161.82 43.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.913 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.544 ' O ' HG22 ' C' ' 119' ' ' VAL . 33.7 Cg_exo -59.52 135.99 68.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.608 2.205 . . . . 0.0 112.221 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.51 18.29 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 61.8 17.55 8.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.544 HG22 ' O ' ' C' ' 116' ' ' PRO . 21.2 m -55.18 172.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.065 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.79 14.08 19.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.988 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.534 ' O ' HD12 ' C' ' 121' ' ' LEU . 4.6 pp -176.62 148.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.489 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.619 ' HB2' HD22 ' C' ' 115' ' ' LEU . 44.4 tt0 -150.83 137.93 19.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.754 HG23 ' O ' ' C' ' 76' ' ' THR . 3.4 mp -144.74 138.35 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.11 0.481 . . . . 0.0 112.142 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.3 149.82 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.648 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.573 ' C ' HD13 ' C' ' 126' ' ' ILE . . . -131.98 126.13 33.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 112.004 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.573 HD13 ' C ' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -114.41 132.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 178.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.947 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -121.76 153.11 38.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.082 0.468 . . . . 0.0 112.029 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 3' ' ' THR . 34.6 m -124.15 116.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.47 ' CD ' HD21 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -106.27 56.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.99 0.424 . . . . 0.0 110.892 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.815 0.341 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.9 tpp -107.77 162.2 14.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.85 HG21 HG21 ' C' ' 128' ' ' VAL . 50.6 m 63.54 131.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -173.58 122.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.023 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.793 HD13 ' ND2' ' C' ' 103' ' ' ASN . 2.0 mp -57.27 153.16 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 23' ' ' ASP . 29.6 mt -114.16 154.75 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.421 ' N ' HG22 ' A' ' 6' ' ' ILE . 21.0 t60 -153.69 126.15 8.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.725 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -130.46 151.73 50.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.037 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -98.22 30.11 3.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.479 ' HE3' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -109.76 -39.33 5.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.745 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . . . -92.64 120.68 67.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.162 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 26.0 Cg_exo -62.26 -11.59 23.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.491 2.127 . . . . 0.0 112.587 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.33 -169.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.951 0.405 . . . . 0.0 111.396 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.535 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 58.37 -164.75 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.189 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 15' ' ' ILE . 23.8 mm 80.32 16.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.107 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.69 -138.67 4.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.958 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.401 ' HB3' ' HB2' ' C' ' 93' ' ' GLU . 86.1 Cg_endo -84.03 46.13 1.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.569 2.179 . . . . 0.0 112.624 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -176.11 -169.07 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.939 0.399 . . . . 0.0 111.051 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.757 HG13 ' HB2' ' C' ' 104' ' ' PHE . 14.8 m -120.65 -179.64 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.804 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -71.16 -52.5 18.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.18 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -159.48 -178.52 7.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.795 HG11 ' O ' ' C' ' 73' ' ' VAL . 14.8 m -137.54 134.18 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.165 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.617 ' HB2' HD11 ' A' ' 6' ' ' ILE . 17.9 t0 -113.89 93.3 4.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.82 HD21 HG21 ' C' ' 73' ' ' VAL . 17.2 mt -62.6 -20.44 64.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.043 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.93 -109.57 0.81 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.922 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.31 -30.37 64.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.058 0.456 . . . . 0.0 110.19 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.49 HD21 HD22 ' B' ' 24' ' ' LEU . 0.1 OUTLIER -119.6 128.03 53.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.787 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.929 HG23 ' HB3' ' A' ' 127' ' ' ALA . 2.4 m -106.59 175.11 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.044 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.575 ' HG ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -166.84 146.11 5.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.51 HG21 HD11 ' A' ' 62' ' ' ILE . 17.5 p -109.44 147.49 32.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.044 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.527 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 16.9 t -81.86 162.33 22.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.008 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 34' ' ' ILE . . . -52.73 92.96 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.621 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.632 ' HG3' HG22 ' A' ' 58' ' ' VAL . 16.4 mm-40 -65.64 151.82 45.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.842 0.353 . . . . 0.0 111.093 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.745 HG23 HG11 ' A' ' 119' ' ' VAL . 4.6 mp -126.58 134.01 25.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.65 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 61.2 Cg_endo -73.91 72.63 3.86 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.891 2.394 . . . . 0.0 112.321 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.587 HG12 ' HA2' ' A' ' 41' ' ' GLY . 38.8 t -87.35 87.92 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.787 ' HB3' HG22 ' A' ' 40' ' ' THR . 0.9 OUTLIER -33.09 126.44 0.4 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.998 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.77 -5.64 17.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.269 1.98 . . . . 0.0 112.097 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.46 -23.67 11.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.653 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.787 HG22 ' HB3' ' A' ' 37' ' ' ASN . 15.2 t -129.3 -28.98 2.28 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.762 0.315 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.587 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 77.46 52.36 5.6 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.156 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 9.6 mm-40 -147.25 -74.33 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.697 0.284 . . . . 0.0 111.245 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.693 ' HB ' HG12 ' A' ' 119' ' ' VAL . 11.2 p 172.63 115.0 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.047 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.1 140.38 60.41 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.396 2.064 . . . . 0.0 112.126 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.0 -31.44 70.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.061 0.458 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -72.86 95.87 2.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.736 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.73 -31.28 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.321 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.449 HG22 ' HB1' ' A' ' 87' ' ' ALA . 22.1 t -75.97 -51.45 20.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.385 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -62.7 -37.64 87.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.227 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -69.14 -28.07 66.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.298 179.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.23 -34.95 36.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.902 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -69.03 -42.28 76.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.794 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.53 82.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.799 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.3 m -71.07 -36.88 72.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -68.02 -40.45 82.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.752 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.73 -38.58 86.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.741 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.17 -43.69 97.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.978 HG21 HG21 ' A' ' 123' ' ' ILE . 24.8 t -61.15 -35.99 69.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.65 -32.76 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.698 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . . . -60.63 -39.9 89.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.81 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 58' ' ' VAL . 3.0 mt -69.23 -46.57 77.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.689 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.51 HD11 HG21 ' A' ' 30' ' ' THR . 22.1 mt -67.45 -32.67 58.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.492 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.6 -41.08 66.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.196 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -61.3 -21.95 64.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.344 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.54 -28.45 21.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.651 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.35 47.15 0.55 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.594 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 129' ' ' ARG . 5.4 mt -156.56 138.02 13.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.859 0.361 . . . . 0.0 110.95 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.6 m -93.27 159.4 15.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.798 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.864 ' HB3' ' CD2' ' A' ' 101' ' ' HIS . . . -57.32 -34.09 68.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.908 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.82 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -51.93 -28.27 15.87 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.883 0.373 . . . . 0.0 110.711 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.68 -26.69 60.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.395 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 126' ' ' ILE . 71.4 mt -47.61 118.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.763 HG21 HD21 ' B' ' 24' ' ' LEU . 26.5 m -92.14 -30.73 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.741 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 22.8 tttm -138.32 160.12 40.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.567 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.703 HG23 ' HB2' ' A' ' 125' ' ' ALA . 41.8 m -153.31 137.97 16.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.989 0.423 . . . . 0.0 111.49 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.903 HG23 ' O ' ' A' ' 108' ' ' SER . 58.5 m -126.98 140.65 52.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.043 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.651 HG13 HD13 ' A' ' 123' ' ' ILE . 21.3 t -146.26 115.61 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 111.617 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.694 ' HB2' HD21 ' A' ' 115' ' ' LEU . 9.2 m-85 -89.35 112.08 23.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.482 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.614 HG12 HD21 ' A' ' 121' ' ' LEU . 34.4 m -97.46 148.34 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.575 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 -5.62 29.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.97 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 97.4 2.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.481 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' B' ' 114' ' ' ARG . 1.9 mt -57.61 -18.11 18.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.226 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.45 -25.3 54.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.928 0.394 . . . . 0.0 110.49 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -87.13 -19.53 28.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.83 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.4 ' CD1' HG11 ' A' ' 79' ' ' VAL . 35.2 t80 -56.8 -22.48 36.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.09 -36.15 67.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 0.0 111.185 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.449 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -83.46 -44.66 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.54 -38.16 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.777 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -66.28 -41.91 89.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.81 84.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.208 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.29 -30.84 25.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.415 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 84.2 t80 -53.71 -44.36 69.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.893 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' B' ' 17' ' ' PRO . 1.5 tt0 -85.86 -21.97 27.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.284 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.13 -21.27 59.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.429 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.2 p90 -91.78 -35.04 14.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.713 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 101' ' ' HIS . 0.8 OUTLIER -56.14 -60.2 3.84 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.145 0.498 . . . . 0.0 110.093 179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -28.85 70.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.576 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -77.33 -9.97 59.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.711 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.466 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . 57.5 m-20 -113.46 -6.01 13.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.461 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.1 m120 88.04 34.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.169 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.864 ' CD2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 m-70 -116.6 53.35 1.13 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.67 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 73.6 Cg_endo -73.62 -19.26 21.66 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.739 2.293 . . . . 0.0 112.907 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.789 ' ND2' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -46.16 -35.64 5.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.873 0.368 . . . . 0.0 111.399 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.766 ' HB2' HG13 ' B' ' 19' ' ' VAL . 13.4 m-85 68.18 106.36 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.372 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 98.6 Cg_endo -85.08 160.43 11.57 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.747 2.298 . . . . 0.0 112.319 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.741 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -54.97 154.45 5.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.575 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -113.73 150.39 33.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.0 111.315 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.903 ' O ' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -160.07 53.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.447 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.93 146.78 27.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.019 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.596 HG12 HD23 ' B' ' 115' ' ' LEU . 29.7 m -153.23 156.23 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.303 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.434 ' HA ' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -77.99 95.36 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.435 HG21 HD21 ' A' ' 115' ' ' LEU . 9.8 m -83.21 148.45 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -60.65 -46.33 90.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.996 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.449 ' HB3' HD12 ' C' ' 82' ' ' LEU . 19.5 mtt180 -155.16 171.32 20.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.728 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 122' ' ' GLU . 1.6 mt -143.31 160.14 52.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 119' ' ' VAL . 89.4 Cg_exo -46.72 136.74 16.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.443 2.095 . . . . 0.0 112.236 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.85 17.86 7.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 61.67 17.14 8.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.034 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.745 HG11 HG23 ' A' ' 34' ' ' ILE . 35.8 m -63.16 154.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.055 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.8 26.49 24.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.666 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.614 HD21 HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -178.91 158.01 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.113 0.482 . . . . 0.0 111.154 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' A' ' 115' ' ' LEU . 4.4 tt0 -152.49 148.32 27.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.179 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.978 HG21 HG21 ' A' ' 58' ' ' VAL . 23.5 mm -122.94 146.13 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 111.766 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 99.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.101 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.703 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -124.03 166.8 15.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 111.877 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 72' ' ' ILE . 9.0 mm -114.51 154.05 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.404 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.929 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -141.09 151.5 44.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.97 0.414 . . . . 0.0 111.573 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.767 HG21 HG21 ' B' ' 3' ' ' THR . 28.0 m -105.88 -179.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.942 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.771 ' HB2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -163.75 48.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.834 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 tttp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.266 -0.874 . . . . 0.0 110.878 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.843 0.354 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 6.9 tpp -107.82 162.18 14.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.767 HG21 HG21 ' A' ' 128' ' ' VAL . 51.0 m 63.56 131.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -173.52 122.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.789 HD13 ' ND2' ' A' ' 103' ' ' ASN . 2.0 mp -57.32 153.21 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' B' ' 23' ' ' ASP . 29.5 mt -114.22 154.67 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.201 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.409 ' N ' HG22 ' B' ' 6' ' ' ILE . 21.0 t60 -153.63 126.08 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.75 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -130.46 151.77 50.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.99 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -98.19 30.18 3.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.894 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -39.76 4.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.33 120.74 67.43 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.168 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.25 -11.65 23.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.48 2.12 . . . . 0.0 112.613 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.29 -169.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.011 0.434 . . . . 0.0 111.391 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.536 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 58.36 -164.75 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.266 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.617 HG22 ' O ' ' B' ' 15' ' ' ILE . 23.7 mm 80.34 16.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.126 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.74 -138.69 4.33 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.91 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 86.2 Cg_endo -84.03 46.15 1.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.583 2.189 . . . . 0.0 112.653 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.536 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -176.16 -169.15 0.3 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 111.058 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.766 HG13 ' HB2' ' A' ' 104' ' ' PHE . 14.5 m -120.55 -179.67 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.771 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -70.95 -51.33 26.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 0.0 111.038 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -161.19 -178.17 6.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.059 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.743 HG11 ' O ' ' A' ' 73' ' ' VAL . 14.9 m -137.54 134.13 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.159 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.62 ' HB2' HD11 ' B' ' 6' ' ' ILE . 17.9 t0 -113.87 93.25 4.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.763 HD21 HG21 ' A' ' 73' ' ' VAL . 17.4 mt -62.58 -20.34 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.046 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.87 -109.59 0.81 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.99 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.32 -30.38 64.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.462 . . . . 0.0 110.175 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.695 HD21 HD22 ' C' ' 24' ' ' LEU . 0.1 OUTLIER -119.62 127.98 53.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.797 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.937 HG23 ' HB3' ' B' ' 127' ' ' ALA . 2.4 m -106.53 175.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.026 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.582 ' HG ' HG23 ' B' ' 22' ' ' VAL . 0.6 OUTLIER -166.88 146.05 5.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.575 HG21 HD11 ' B' ' 62' ' ' ILE . 17.3 p -109.35 147.25 33.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.519 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 16.9 t -81.64 162.36 23.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.438 ' O ' HD12 ' B' ' 34' ' ' ILE . . . -52.68 92.87 0.01 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.614 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.651 ' HG3' HG22 ' B' ' 58' ' ' VAL . 16.3 mm-40 -65.61 151.75 45.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 111.117 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.697 HG23 HG11 ' B' ' 119' ' ' VAL . 4.6 mp -126.56 134.1 25.68 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.644 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 61.1 Cg_endo -74.0 72.73 3.89 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.88 2.387 . . . . 0.0 112.231 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.57 HG12 ' HA2' ' B' ' 41' ' ' GLY . 38.9 t -87.42 87.88 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.623 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.79 ' HB3' HG22 ' B' ' 40' ' ' THR . 0.9 OUTLIER -33.06 126.44 0.4 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.012 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.84 -5.52 17.34 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.236 1.957 . . . . 0.0 112.096 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.49 -23.73 11.72 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.653 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.79 HG22 ' HB3' ' B' ' 37' ' ' ASN . 15.2 t -129.37 -28.94 2.26 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.356 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.57 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 77.52 52.35 5.57 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.127 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 9.6 mm-40 -147.23 -74.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.683 0.278 . . . . 0.0 111.221 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.722 ' HB ' HG12 ' B' ' 119' ' ' VAL . 11.2 p 172.62 114.99 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.13 140.37 60.74 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.347 2.032 . . . . 0.0 112.158 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.96 -31.48 70.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.2 OUTLIER -72.89 95.92 2.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.743 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.71 -31.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.313 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.431 HG22 ' HB1' ' B' ' 87' ' ' ALA . 22.3 t -76.03 -51.4 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.387 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -62.7 -37.63 87.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.254 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.419 ' HG3' ' CG2' ' B' ' 43' ' ' VAL . 0.9 OUTLIER -69.14 -28.05 66.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.337 179.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.38 -34.97 35.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.927 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -68.99 -42.28 76.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.775 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -39.51 82.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.622 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.823 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.3 m -71.04 -36.97 72.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.717 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -67.97 -40.54 83.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.62 -38.64 87.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.758 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.09 -43.77 97.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.72 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.985 HG21 HG21 ' B' ' 123' ' ' ILE . 24.7 t -61.15 -36.05 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.792 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.48 -32.87 42.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.687 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.88 89.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' B' ' 58' ' ' VAL . 3.0 mt -69.45 -46.66 75.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.575 HD11 HG21 ' B' ' 30' ' ' THR . 22.1 mt -67.48 -32.57 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.566 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.7 -41.05 65.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.183 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -61.26 -21.98 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.358 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.55 -28.41 21.98 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.35 47.16 0.55 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.616 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.823 HD11 ' HB2' ' B' ' 129' ' ' ARG . 5.4 mt -156.54 137.98 13.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 110.975 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 9.4 m -93.27 159.4 15.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.819 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.85 ' HB3' ' CD2' ' B' ' 101' ' ' HIS . . . -57.29 -34.07 68.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.819 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -51.88 -28.12 15.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.975 0.417 . . . . 0.0 110.666 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.74 -26.62 60.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.416 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.558 HG23 ' O ' ' B' ' 126' ' ' ILE . 71.4 mt -47.66 118.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.026 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.78 ' O ' HG11 ' C' ' 22' ' ' VAL . 26.0 m -92.21 -30.55 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.08 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.768 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 22.8 tttm -138.43 160.02 40.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.596 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.717 HG23 ' HB2' ' B' ' 125' ' ' ALA . 42.0 m -153.27 137.97 16.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 0.0 111.461 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.924 HG23 ' O ' ' B' ' 108' ' ' SER . 58.5 m -126.98 140.65 52.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.08 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.664 HG13 HD13 ' B' ' 123' ' ' ILE . 21.3 t -146.26 115.58 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 111.551 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.659 ' HB2' HD21 ' B' ' 115' ' ' LEU . 9.1 m-85 -89.29 112.13 23.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.485 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.621 HG12 HD21 ' B' ' 121' ' ' LEU . 34.3 m -97.51 148.3 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.647 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 -5.73 29.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.95 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.67 97.43 2.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.508 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' C' ' 114' ' ' ARG . 1.9 mt -57.63 -18.13 18.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.203 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.42 -25.33 54.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -87.08 -19.51 28.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.894 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.4 ' CD1' HG11 ' B' ' 79' ' ' VAL . 35.0 t80 -56.8 -22.52 36.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.204 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.18 67.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 111.214 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.431 ' HB1' HG22 ' B' ' 48' ' ' VAL . . . -83.53 -44.65 14.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.52 -38.15 81.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.818 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.23 -41.95 89.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.834 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.99 85.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.221 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.27 -31.0 25.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.415 ' O ' ' CE2' ' B' ' 95' ' ' PHE . 84.1 t80 -53.66 -44.46 69.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' C' ' 17' ' ' PRO . 1.5 tt0 -85.8 -21.99 27.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.287 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.11 -21.27 59.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.438 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 1.2 p90 -91.83 -35.0 14.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.759 0.314 . . . . 0.0 110.695 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' B' ' 101' ' ' HIS . 0.8 OUTLIER -56.29 -60.12 3.97 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.174 0.512 . . . . 0.0 110.101 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -28.74 70.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.545 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -77.47 -9.91 59.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 110.658 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.465 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . 57.1 m-20 -113.44 -6.02 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.482 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.1 m120 88.13 34.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.189 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.85 ' CD2' ' HB3' ' B' ' 69' ' ' ALA . 1.6 m-70 -116.47 53.38 1.1 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.701 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 73.5 Cg_endo -73.78 -19.21 21.3 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.771 2.314 . . . . 0.0 112.895 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.78 ' ND2' HD13 ' C' ' 5' ' ' ILE . 0.1 OUTLIER -46.12 -35.64 5.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.937 0.399 . . . . 0.0 111.409 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.759 ' HB2' HG13 ' C' ' 19' ' ' VAL . 13.5 m-85 68.15 106.37 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.36 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 97.0 Cg_endo -85.08 160.38 11.57 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.711 2.274 . . . . 0.0 112.327 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.768 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -54.88 154.53 5.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.615 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.473 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -113.78 150.46 33.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.015 0.436 . . . . 0.0 111.351 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.924 ' O ' HG23 ' B' ' 76' ' ' THR . 0.4 OUTLIER -160.06 53.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.508 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.99 146.65 28.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.997 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' C' ' 78' ' ' PHE . 30.0 m -153.06 155.65 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.244 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -77.77 95.29 4.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.843 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.428 HG21 HD21 ' B' ' 115' ' ' LEU . 9.9 m -83.18 148.44 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.127 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -60.7 -46.34 90.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.477 ' HB3' HD12 ' A' ' 82' ' ' LEU . 19.4 mtt180 -155.16 171.26 20.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.719 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' B' ' 122' ' ' GLU . 1.6 mt -143.29 160.19 52.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.706 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.607 ' O ' HG22 ' B' ' 119' ' ' VAL . 89.1 Cg_exo -46.75 136.75 16.45 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.459 2.106 . . . . 0.0 112.255 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.89 17.76 7.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 61.69 17.17 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.059 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.722 HG12 ' HB ' ' B' ' 43' ' ' VAL . 35.5 m -63.2 154.66 6.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.004 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.07 26.28 25.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.708 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.621 HD21 HG12 ' B' ' 79' ' ' VAL . 0.4 OUTLIER -178.89 158.06 0.93 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.12 0.486 . . . . 0.0 111.191 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.776 ' HB2' HD22 ' B' ' 115' ' ' LEU . 4.4 tt0 -152.48 148.25 27.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.23 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.985 HG21 HG21 ' B' ' 58' ' ' VAL . 23.5 mm -122.92 146.06 28.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.065 0.46 . . . . 0.0 111.799 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.88 99.82 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.144 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.717 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -124.05 166.7 15.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.877 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.558 ' O ' HG23 ' B' ' 72' ' ' ILE . 8.9 mm -114.47 154.0 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.422 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.937 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -141.03 151.58 44.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.914 0.388 . . . . 0.0 111.557 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.814 HG21 HG21 ' C' ' 3' ' ' THR . 27.6 m -106.0 -179.42 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.894 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.823 ' HB2' HD11 ' B' ' 67' ' ' LEU . 0.0 OUTLIER -163.71 48.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.947 0.403 . . . . 0.0 110.934 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 tttp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.849 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.817 0.342 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 6.9 tpp -107.82 162.11 14.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.814 HG21 HG21 ' B' ' 128' ' ' VAL . 51.2 m 63.57 131.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -173.53 122.4 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.78 HD13 ' ND2' ' B' ' 103' ' ' ASN . 2.1 mp -57.29 153.21 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.834 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' C' ' 23' ' ' ASP . 29.0 mt -114.17 154.71 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.2 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . 0.408 ' N ' HG22 ' C' ' 6' ' ' ILE . 21.0 t60 -153.71 126.06 8.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.728 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -130.38 151.77 50.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.018 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -98.27 30.12 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.474 ' HE3' ' HB2' ' C' ' 60' ' ' ALA . 0.0 OUTLIER -109.84 -39.33 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.72 120.72 67.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.18 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.31 -11.58 23.23 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.486 2.124 . . . . 0.0 112.593 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.32 -169.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.0 111.415 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.528 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 58.39 -164.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.231 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.6 HG22 ' O ' ' C' ' 15' ' ' ILE . 23.8 mm 80.32 16.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.107 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.68 -138.61 4.33 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.0 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . 0.41 ' HB3' ' HB2' ' B' ' 93' ' ' GLU . 84.4 Cg_endo -84.08 46.17 1.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.621 2.214 . . . . 0.0 112.67 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.528 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -176.18 -169.12 0.3 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.92 0.391 . . . . 0.0 111.082 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.759 HG13 ' HB2' ' B' ' 104' ' ' PHE . 14.6 m -120.58 -179.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.769 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -71.21 -52.52 18.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.271 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -159.65 -178.44 7.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.78 HG11 ' O ' ' B' ' 73' ' ' VAL . 14.9 m -137.54 134.27 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.634 ' HB2' HD11 ' C' ' 6' ' ' ILE . 18.0 t0 -113.95 93.36 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.731 HD21 HG21 ' B' ' 73' ' ' VAL . 17.5 mt -62.68 -20.45 64.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.004 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.01 -109.57 0.81 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.926 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -57.33 -30.37 64.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.052 0.453 . . . . 0.0 110.187 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.57 HD21 HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -119.6 128.02 53.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.776 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.94 HG23 ' HB3' ' C' ' 127' ' ' ALA . 2.4 m -106.55 175.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.041 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.593 ' HG ' HG23 ' C' ' 22' ' ' VAL . 0.6 OUTLIER -166.83 146.1 5.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.807 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.491 HG21 HD11 ' C' ' 62' ' ' ILE . 17.4 p -109.61 147.62 32.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . 0.529 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 16.9 t -81.76 162.24 22.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.002 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . 0.442 ' O ' HD12 ' C' ' 34' ' ' ILE . . . -52.61 92.9 0.01 OUTLIER Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.654 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.621 ' HG3' HG22 ' C' ' 58' ' ' VAL . 16.4 mm-40 -65.6 151.8 45.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 0.0 111.107 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.715 HG23 HG11 ' C' ' 119' ' ' VAL . 4.6 mp -126.57 133.98 25.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.636 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 61.2 Cg_endo -73.88 72.61 3.84 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.888 2.392 . . . . 0.0 112.292 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.585 HG12 ' HA2' ' C' ' 41' ' ' GLY . 38.7 t -87.31 87.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.68 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.786 ' HB3' HG22 ' C' ' 40' ' ' THR . 0.9 OUTLIER -33.18 126.47 0.41 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.993 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.8 -5.55 17.4 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.215 1.943 . . . . 0.0 112.11 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.5 -23.69 11.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.638 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.786 HG22 ' HB3' ' C' ' 37' ' ' ASN . 15.2 t -129.31 -28.79 2.29 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.78 0.324 . . . . 0.0 111.405 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 77.21 52.31 5.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.13 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 9.6 mm-40 -147.23 -74.38 0.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.714 0.292 . . . . 0.0 111.182 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.694 ' HB ' HG12 ' C' ' 119' ' ' VAL . 11.1 p 172.66 115.02 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.049 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.07 140.4 60.14 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.327 2.018 . . . . 0.0 112.155 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.04 -31.38 70.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.008 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -72.94 95.97 2.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.684 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -43.79 -31.31 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.231 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . 0.403 HG22 ' HB1' ' C' ' 87' ' ' ALA . 22.1 t -75.95 -51.47 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.383 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -62.75 -37.6 87.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.246 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.42 ' HG3' ' CG2' ' C' ' 43' ' ' VAL . 0.9 OUTLIER -69.17 -27.91 65.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.301 179.273 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.52 -34.96 35.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.951 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -69.07 -42.29 76.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -39.49 82.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.698 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.825 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.3 m -71.03 -36.98 72.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.689 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -67.96 -40.52 83.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.728 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.68 -38.66 87.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.71 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.05 -43.8 97.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.717 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 1.007 HG21 HG21 ' C' ' 123' ' ' ILE . 24.8 t -61.12 -36.08 70.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.786 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -79.49 -32.77 42.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.676 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.474 ' HB2' ' HE3' ' C' ' 10' ' ' LYS . . . -60.65 -40.0 90.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.799 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' C' ' 58' ' ' VAL . 3.0 mt -69.18 -46.65 77.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.655 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.491 HD11 HG21 ' C' ' 30' ' ' THR . 22.0 mt -67.43 -32.65 58.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.532 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.65 -41.03 65.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.18 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -61.3 -21.89 64.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.41 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.63 -28.41 21.89 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.623 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.32 47.14 0.55 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.613 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.812 HD11 ' HB2' ' C' ' 129' ' ' ARG . 5.4 mt -156.52 138.0 13.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.853 0.358 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 9.4 m -93.19 159.39 15.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.857 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.851 ' HB3' ' CD2' ' C' ' 101' ' ' HIS . . . -57.3 -34.19 68.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.815 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -51.9 -28.33 15.9 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.91 0.386 . . . . 0.0 110.712 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.55 -26.64 60.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.435 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.548 HG23 ' O ' ' C' ' 126' ' ' ILE . 71.4 mt -47.66 118.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.033 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.82 HG21 HD21 ' A' ' 24' ' ' LEU . 26.4 m -92.09 -30.7 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.093 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.742 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 22.8 tttm -138.34 160.12 40.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.576 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.69 HG23 ' HB2' ' C' ' 125' ' ' ALA . 40.6 m -153.29 137.9 16.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.043 0.449 . . . . 0.0 111.517 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.932 HG23 ' O ' ' C' ' 108' ' ' SER . 58.8 m -126.94 140.61 52.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.098 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.65 HG13 HD13 ' C' ' 123' ' ' ILE . 21.4 t -146.22 115.66 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.616 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.679 ' HB2' HD21 ' C' ' 115' ' ' LEU . 9.1 m-85 -89.33 112.07 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.494 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.586 HG12 HD21 ' C' ' 121' ' ' LEU . 34.4 m -97.44 148.37 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.115 0.483 . . . . 0.0 111.575 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 -5.59 29.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.995 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.69 97.4 2.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.53 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 114' ' ' ARG . 1.9 mt -57.64 -18.15 18.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.127 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -76.38 -25.33 54.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.48 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -87.12 -19.51 28.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.888 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -56.73 -22.54 36.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.06 -36.11 67.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.403 ' HB1' HG22 ' C' ' 48' ' ' VAL . . . -83.55 -44.65 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.53 -38.18 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.31 -41.89 89.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.837 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.82 84.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.201 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.41 -30.97 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.418 ' O ' ' CE2' ' C' ' 95' ' ' PHE . 84.2 t80 -53.61 -44.47 69.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 1.5 tt0 -85.82 -22.01 27.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.281 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -21.25 60.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.456 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 1.2 p90 -91.8 -35.13 14.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' C' ' 101' ' ' HIS . 0.8 OUTLIER -56.17 -60.21 3.82 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.117 0.484 . . . . 0.0 110.084 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -28.84 70.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.539 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.36 -9.96 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 0.0 110.681 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 57.2 m-20 -113.43 -6.01 13.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.491 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 11.9 m120 88.02 34.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.181 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.851 ' CD2' ' HB3' ' C' ' 69' ' ' ALA . 1.6 m-70 -116.56 53.35 1.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.664 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 73.5 Cg_endo -73.67 -19.29 21.51 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.797 2.332 . . . . 0.0 112.907 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.793 ' ND2' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -46.18 -35.58 5.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.88 0.371 . . . . 0.0 111.388 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.757 ' HB2' HG13 ' A' ' 19' ' ' VAL . 13.5 m-85 68.12 106.39 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.36 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.431 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 96.7 Cg_endo -85.14 160.42 11.49 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.711 2.274 . . . . 0.0 112.353 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.742 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -54.9 154.46 5.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.556 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.467 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -113.75 150.46 33.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.998 0.428 . . . . 0.0 111.297 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . 0.932 ' O ' HG23 ' C' ' 76' ' ' THR . 0.4 OUTLIER -160.1 53.96 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.425 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 24.5 p -102.92 146.75 27.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.959 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.578 HG11 ' CD2' ' A' ' 78' ' ' PHE . 30.0 m -153.11 155.34 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.288 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -77.32 95.38 4.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.721 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.427 HG21 HD21 ' C' ' 115' ' ' LEU . 10.0 m -83.2 148.45 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -60.71 -46.31 90.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.485 ' HB3' HD12 ' B' ' 82' ' ' LEU . 19.4 mtt180 -155.17 171.35 19.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.823 HD22 ' HB2' ' C' ' 122' ' ' GLU . 1.6 mt -143.36 160.17 52.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.661 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.618 ' O ' HG22 ' C' ' 119' ' ' VAL . 89.3 Cg_exo -46.76 136.73 16.52 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.496 2.131 . . . . 0.0 112.243 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 69.95 17.79 7.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.7 17.08 8.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.049 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.715 HG11 HG23 ' C' ' 34' ' ' ILE . 35.7 m -63.17 154.6 6.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -99.77 26.41 24.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.652 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.586 HD21 HG12 ' C' ' 79' ' ' VAL . 0.4 OUTLIER -178.76 157.98 0.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.08 0.467 . . . . 0.0 111.173 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.823 ' HB2' HD22 ' C' ' 115' ' ' LEU . 4.4 tt0 -152.46 148.28 27.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.226 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 1.007 HG21 HG21 ' C' ' 58' ' ' VAL . 23.2 mm -122.93 146.05 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.057 0.455 . . . . 0.0 111.81 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 99.84 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.068 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.69 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -124.08 166.86 15.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.037 0.446 . . . . 0.0 111.828 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.548 ' O ' HG23 ' C' ' 72' ' ' ILE . 8.8 mm -114.52 154.0 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.463 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.94 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -141.1 151.46 43.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.898 0.38 . . . . 0.0 111.576 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.85 HG21 HG21 ' A' ' 3' ' ' THR . 27.2 m -105.9 -179.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.884 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.812 ' HB2' HD11 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -163.71 48.1 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.884 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 tttp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.926 179.937 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.7 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.819 0.342 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -140.84 164.13 31.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.557 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER 63.81 131.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.965 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.8 136.84 3.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.637 HG23 HG21 ' A' ' 19' ' ' VAL . 4.8 mp -58.55 158.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.244 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' A' ' 21' ' ' ALA . 19.0 mt -115.13 160.58 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.043 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.475 ' N ' HG22 ' A' ' 6' ' ' ILE . 4.7 t-160 -160.73 124.48 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.997 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 61' ' ' ILE . 8.0 t -127.65 165.52 19.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.973 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.76 51.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.25 -50.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.757 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.921 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -66.41 172.34 3.25 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.03 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.921 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 32.1 Cg_endo -64.37 -11.95 30.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.586 2.19 . . . . 0.0 112.714 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 73.27 171.61 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.987 0.423 . . . . 0.0 111.352 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.768 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -166.98 122.75 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.799 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 14' ' ' ALA . 17.8 mm -141.42 17.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.377 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.58 -103.85 2.44 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.274 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.17 4.88 6.65 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.536 2.157 . . . . 0.0 112.788 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.498 ' CD1' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -160.74 177.21 10.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 111.299 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.673 HG13 ' HB2' ' C' ' 104' ' ' PHE . 28.4 m -132.32 166.37 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.051 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.772 ' OE1' ' HB3' ' A' ' 11' ' ' ALA . 3.9 mm-40 -52.82 -46.43 67.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . -176.21 176.79 1.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.997 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.661 HG21 ' HB ' ' C' ' 73' ' ' VAL . 3.1 m -140.19 133.89 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.458 ' CG ' HG12 ' A' ' 28' ' ' VAL . 6.9 t0 -97.26 139.69 32.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.654 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.846 HD11 HD13 ' A' ' 29' ' ' LEU . 6.6 mt -112.94 -15.86 12.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.34 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 97.01 104.45 2.23 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.294 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 15.6 m-80 84.05 -35.72 0.06 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.783 ' HG ' HG12 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -127.2 101.5 6.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.771 179.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.095 HG23 ' HB3' ' A' ' 127' ' ' ALA . 3.4 m -94.89 170.34 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.377 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.909 ' HG ' HG23 ' A' ' 126' ' ' ILE . 3.6 mp -152.77 148.92 27.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.943 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 p -125.97 149.1 49.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.863 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 4.1 t -75.26 170.7 15.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.03 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.92 77.21 0.41 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.062 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.14 162.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.964 0.411 . . . . 0.0 111.536 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.713 HG13 HG23 ' A' ' 36' ' ' VAL . 7.5 pt -146.91 154.21 46.87 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.773 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.626 ' HG2' HG23 ' A' ' 43' ' ' VAL . 72.2 Cg_endo -77.11 48.79 2.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.925 2.416 . . . . 0.0 113.292 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.713 HG23 HG13 ' A' ' 34' ' ' ILE . 45.9 t -64.02 86.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.229 0.537 . . . . 0.0 110.473 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.672 ' HB3' HG22 ' A' ' 40' ' ' THR . 3.7 t30 -38.23 130.09 1.02 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.039 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.22 -6.98 19.22 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.228 1.952 . . . . 0.0 111.663 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.434 ' HB3' ' ND2' ' A' ' 37' ' ' ASN . . . -101.92 -28.3 12.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.552 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 42' ' ' GLU . 8.1 t -125.5 -33.63 2.77 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.967 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 85.24 62.22 1.67 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.731 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.689 ' HG3' HG23 ' A' ' 40' ' ' THR . 0.2 OUTLIER -167.25 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.694 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.626 HG23 ' HG2' ' A' ' 35' ' ' PRO . 9.9 p -170.59 125.74 0.66 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.309 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 35' ' ' PRO . 52.7 Cg_exo -54.4 141.77 71.38 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.453 2.102 . . . . 0.0 112.235 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.01 70.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 93.87 1.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.774 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' A' ' 47' ' ' ILE . 7.4 tp -42.25 -33.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.638 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.56 -46.38 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.15 -46.99 88.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.64 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.401 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 3.5 pt20 -64.89 -28.89 69.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.52 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.8 -40.87 54.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.859 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -67.81 -52.31 38.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.62 -27.97 63.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.622 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -61.86 -42.41 99.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.629 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.639 HD13 ' CE2' ' A' ' 95' ' ' PHE . 7.5 mt -74.98 -30.0 61.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 32.5 mt-10 -65.5 -36.16 83.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.086 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 54' ' ' SER . 22.4 p30 -72.43 -27.8 62.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.793 0.33 . . . . 0.0 110.598 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.864 HG21 HG21 ' A' ' 123' ' ' ILE . 35.2 t -67.63 -45.86 84.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -76.06 -28.24 57.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.18 94.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 8' ' ' THR . 16.1 mt -72.83 -40.9 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.584 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.516 ' CD1' HD11 ' A' ' 72' ' ' ILE . 18.4 mt -70.07 -33.07 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.68 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.53 -40.98 63.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.274 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -21.8 65.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.349 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.3 -28.41 17.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.734 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.24 56.65 0.26 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.606 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 129' ' ' ARG . 3.5 mt -172.77 144.17 1.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.0 p -99.43 166.06 11.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.763 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.022 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -62.48 -31.05 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.837 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.974 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -52.59 -26.85 14.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.911 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.463 ' CB ' HD22 ' A' ' 67' ' ' LEU . 1.2 m-20 -82.15 -24.5 35.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.898 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.566 HG21 HG22 ' A' ' 75' ' ' THR . 96.6 mt -52.9 108.31 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.922 0.392 . . . . 0.0 110.954 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.678 ' HB ' HG21 ' B' ' 22' ' ' VAL . 35.4 m -74.31 -45.29 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.816 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.599 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 5.9 mttp -125.06 163.72 21.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.626 0.25 . . . . 0.0 111.263 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.618 HG23 ' CB ' ' A' ' 105' ' ' PRO . 31.7 p -157.8 102.4 1.84 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.831 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.82 HG23 ' CD ' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -70.03 124.64 24.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.412 HG11 ' HE1' ' A' ' 85' ' ' PHE . 6.2 t -116.28 110.36 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.413 ' CE2' ' OE2' ' A' ' 124' ' ' GLU . 15.8 m-30 -107.88 119.92 40.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.973 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.602 HG12 HD21 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -114.26 152.21 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.13 0.491 . . . . 0.0 111.777 -179.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.99 1.05 57.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.846 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.3 108.56 0.28 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.546 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' B' ' 114' ' ' ARG . 3.0 mt -57.84 -17.31 15.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.274 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.23 -22.18 60.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 0.0 110.458 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 88' ' ' VAL . 75.3 m-20 -87.05 -15.49 38.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.017 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.412 ' HE1' HG11 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -57.35 -29.67 64.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.193 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.01 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.325 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.91 -28.84 22.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.322 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 84' ' ' ASP . 21.4 t -77.76 -41.65 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.287 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.408 ' OD1' ' CE2' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -68.17 -36.56 79.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.91 75.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.321 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.59 -32.48 18.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.052 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -61.25 -49.89 75.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.041 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.52 -21.53 57.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.468 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -27.29 50.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.554 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.639 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -85.67 -39.07 17.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 110.752 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 4.3 m-85 -55.15 -54.5 42.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.154 0.502 . . . . 0.0 110.209 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -31.93 71.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.23 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.72 -4.18 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.711 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 4.1 t-20 -112.5 -5.54 14.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.535 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 5.6 m120 86.29 30.69 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.62 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 1.022 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 2.9 m170 -117.35 54.55 1.56 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.6 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.411 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 63.4 Cg_endo -72.09 -10.05 25.4 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.704 2.269 . . . . 0.0 113.362 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.621 ' HB3' HD11 ' B' ' 5' ' ' ILE . 7.7 m-20 -56.7 -40.74 76.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.794 0.331 . . . . 0.0 110.921 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.672 ' HB2' HG13 ' B' ' 19' ' ' VAL . 26.8 m-85 72.37 90.36 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.988 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.618 ' CB ' HG23 ' A' ' 75' ' ' THR . 77.0 Cg_exo -49.27 162.06 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.557 2.172 . . . . 0.0 112.322 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.878 ' HB1' ' HB2' ' B' ' 31' ' ' SER . . . -125.4 131.18 52.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.534 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.82 ' CD ' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -163.73 -166.47 1.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.57 114.93 28.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.219 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 14.3 m -96.94 130.37 44.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.127 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.718 HG12 HD23 ' B' ' 115' ' ' LEU . 30.4 m -148.74 167.64 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.924 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.805 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 30.7 tt0 -102.28 92.34 4.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.71 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.872 HG21 HD21 ' A' ' 115' ' ' LEU . 24.5 m -62.6 157.94 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.203 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -70.32 -51.44 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.552 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.6 OUTLIER -143.17 178.45 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.718 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.872 HD21 HG21 ' A' ' 112' ' ' VAL . 73.3 mt -150.85 153.99 34.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.749 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.573 ' O ' HG22 ' A' ' 119' ' ' VAL . 36.3 Cg_endo -65.39 137.48 51.29 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.483 2.122 . . . . 0.0 112.21 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 76.66 14.84 2.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.303 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.58 14.48 9.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.095 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.638 HG11 ' HB ' ' A' ' 34' ' ' ILE . 17.3 m -58.78 160.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 111.027 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.48 21.75 21.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.782 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.602 HD21 HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -178.86 154.9 0.74 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 0.0 111.208 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HD13 ' A' ' 123' ' ' ILE . 4.3 tt0 -140.55 150.59 43.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.044 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.864 HG21 HG21 ' A' ' 58' ' ' VAL . 20.8 mm -136.8 119.67 21.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -138.4 115.87 11.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -132.11 168.67 17.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.909 HG23 ' HG ' ' A' ' 29' ' ' LEU . 4.0 mm -116.55 146.03 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.488 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 1.095 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -132.63 148.48 52.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.171 0.51 . . . . 0.0 111.944 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.783 HG12 ' HG ' ' A' ' 27' ' ' LEU . 30.8 m -132.14 162.81 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.883 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.625 ' HB3' HD21 ' A' ' 67' ' ' LEU . 9.9 ptt180 -157.03 65.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.98 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.4 pttt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.459 179.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 40.6 mtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.813 0.34 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -140.83 164.16 30.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.586 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER 63.8 131.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.83 136.88 3.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.026 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.638 HG23 HG21 ' B' ' 19' ' ' VAL . 4.8 mp -58.61 158.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.242 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.539 HD12 ' CB ' ' B' ' 21' ' ' ALA . 19.0 mt -115.1 160.59 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.009 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.475 ' N ' HG22 ' B' ' 6' ' ' ILE . 4.7 t-160 -160.75 124.47 3.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.464 HG22 HG12 ' B' ' 61' ' ' ILE . 8.0 t -127.69 165.57 19.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.967 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.8 51.28 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.402 ' HB3' ' CB ' ' B' ' 60' ' ' ALA . 0.7 OUTLIER -144.19 -49.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.914 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -66.79 172.41 3.41 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.073 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.914 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 32.2 Cg_endo -64.37 -11.93 30.6 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.651 2.234 . . . . 0.0 112.758 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 73.26 171.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.422 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.762 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -167.04 122.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.827 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.762 HD13 ' O ' ' B' ' 14' ' ' ALA . 17.6 mm -141.41 17.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.399 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.49 -103.89 2.45 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.308 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.11 4.83 6.69 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.567 2.178 . . . . 0.0 112.843 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.508 ' CD1' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -160.79 177.18 10.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.911 0.386 . . . . 0.0 111.291 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 104' ' ' PHE . 28.3 m -132.27 166.41 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.06 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.766 ' OE1' ' HB3' ' B' ' 11' ' ' ALA . 3.9 mm-40 -52.89 -46.44 67.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.806 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.539 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . -176.47 176.84 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.875 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.678 HG21 ' HB ' ' A' ' 73' ' ' VAL . 3.1 m -140.27 133.84 34.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.122 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.463 ' CG ' HG12 ' B' ' 28' ' ' VAL . 6.9 t0 -97.2 139.75 32.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.837 HD11 HD13 ' B' ' 29' ' ' LEU . 6.6 mt -112.98 -15.91 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.324 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 97.01 104.45 2.23 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.297 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 15.7 m-80 84.07 -35.74 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.763 ' HG ' HG12 ' B' ' 128' ' ' VAL . 0.3 OUTLIER -127.19 101.52 6.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.791 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.122 HG23 ' HB3' ' B' ' 127' ' ' ALA . 3.4 m -94.91 170.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.392 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.914 ' HG ' HG23 ' B' ' 126' ' ' ILE . 3.6 mp -152.85 148.81 27.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.993 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.4 p -125.79 148.08 49.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.755 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.878 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 4.3 t -74.59 170.06 16.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.842 0.354 . . . . 0.0 110.953 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.87 77.14 0.41 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.026 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.15 162.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 111.448 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.721 ' HB ' HG11 ' B' ' 119' ' ' VAL . 7.5 pt -146.84 154.2 47.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.633 ' CG ' HG23 ' B' ' 43' ' ' VAL . 72.6 Cg_endo -77.23 48.85 2.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.903 2.402 . . . . 0.0 113.248 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.718 HG23 HG13 ' B' ' 34' ' ' ILE . 45.8 t -63.98 86.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.238 0.542 . . . . 0.0 110.545 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.666 ' HB3' HG22 ' B' ' 40' ' ' THR . 3.7 t30 -38.09 130.03 0.99 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.037 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.26 -6.95 19.15 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.171 1.914 . . . . 0.0 111.618 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.436 ' HB3' ' ND2' ' B' ' 37' ' ' ASN . . . -101.95 -28.2 12.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.545 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.709 HG23 ' HG3' ' B' ' 42' ' ' GLU . 8.0 t -125.66 -33.73 2.72 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.979 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 85.47 62.34 1.64 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.64 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.709 ' HG3' HG23 ' B' ' 40' ' ' THR . 0.2 OUTLIER -167.17 -84.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.669 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.633 HG23 ' CG ' ' B' ' 35' ' ' PRO . 9.8 p -170.53 125.78 0.67 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.308 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.8 Cg_exo -54.39 141.78 71.23 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.52 2.147 . . . . 0.0 112.21 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.77 -31.03 70.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.983 0.42 . . . . 0.0 110.941 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.13 93.77 1.86 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.817 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.4 tp -42.15 -33.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.714 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.49 HG12 ' HD2' ' B' ' 52' ' ' ARG . 22.1 t -78.59 -46.46 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.682 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.99 88.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.701 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.4 ' CB ' ' HD2' ' B' ' 44' ' ' PRO . 3.5 pt20 -65.11 -28.9 69.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.536 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.2 -41.11 42.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.319 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.49 ' HD2' HG12 ' B' ' 48' ' ' VAL . 24.3 mtp180 -67.69 -52.27 39.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.813 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.69 -27.92 63.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.575 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.6 OUTLIER -61.88 -42.44 99.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.602 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.613 HD13 ' CE2' ' B' ' 95' ' ' PHE . 7.5 mt -74.87 -30.03 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.019 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' B' ' 59' ' ' LYS . 32.5 mt-10 -65.51 -36.2 83.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.069 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' B' ' 54' ' ' SER . 22.2 p30 -72.37 -27.83 62.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.883 0.373 . . . . 0.0 110.59 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.841 HG21 HG21 ' B' ' 123' ' ' ILE . 35.1 t -67.7 -45.81 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -76.1 -28.3 57.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.991 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' B' ' 10' ' ' LYS . . . -60.64 -41.28 94.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.464 HG12 HG22 ' B' ' 8' ' ' THR . 15.9 mt -72.95 -41.05 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.565 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.493 ' CD1' HD11 ' B' ' 72' ' ' ILE . 18.3 mt -70.0 -33.14 54.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.663 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.45 -41.0 63.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.286 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.48 -21.76 65.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.392 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.36 -28.37 17.76 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.751 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.27 56.57 0.26 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.583 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.634 HD21 ' HB3' ' B' ' 129' ' ' ARG . 3.5 mt -172.8 144.12 1.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.355 . . . . 0.0 111.126 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -99.39 166.1 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.772 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 1.032 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -62.54 -31.0 71.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.788 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.961 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -52.49 -26.61 13.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.897 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.443 ' CB ' HD22 ' B' ' 67' ' ' LEU . 1.2 m-20 -82.13 -24.59 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.575 HG21 HG22 ' B' ' 75' ' ' THR . 96.7 mt -52.88 108.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.008 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.649 HG13 HG22 ' B' ' 128' ' ' VAL . 35.3 m -74.29 -45.23 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.841 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.589 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 5.9 mttp -125.05 163.77 21.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.289 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.607 HG23 ' CB ' ' B' ' 105' ' ' PRO . 31.8 p -157.83 102.5 1.84 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.787 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.829 HG23 ' CD ' ' B' ' 107' ' ' ARG . 0.1 OUTLIER -70.12 124.69 24.72 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.411 HG11 ' HE1' ' B' ' 85' ' ' PHE . 6.3 t -116.38 110.37 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.423 ' CE2' ' OE2' ' B' ' 124' ' ' GLU . 15.7 m-30 -107.85 119.96 40.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.989 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.613 HG12 HD21 ' B' ' 121' ' ' LEU . 0.7 OUTLIER -114.29 152.2 15.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.154 0.502 . . . . 0.0 111.752 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.9 0.94 57.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.849 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.26 108.55 0.28 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.507 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' C' ' 114' ' ' ARG . 3.0 mt -57.8 -17.26 14.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.302 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.23 -22.26 60.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.834 0.35 . . . . 0.0 110.397 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.413 ' O ' HG23 ' B' ' 88' ' ' VAL . 75.2 m-20 -86.98 -15.52 38.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.031 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.413 ' CE2' ' OD1' ' B' ' 89' ' ' ASN . 0.2 OUTLIER -57.28 -29.69 64.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.232 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.94 68.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.32 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.96 -28.85 22.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.301 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 84' ' ' ASP . 21.4 t -77.77 -41.57 28.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.295 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.413 ' OD1' ' CE2' ' B' ' 85' ' ' PHE . 0.3 OUTLIER -68.28 -36.53 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.828 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.57 -36.0 75.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.308 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.53 -32.48 18.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -61.29 -49.9 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.017 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.48 -21.6 57.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.457 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -27.27 50.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.591 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.613 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -85.68 -39.01 17.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.704 0.288 . . . . 0.0 110.765 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.52 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 4.3 m-85 -55.18 -54.5 42.54 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.136 0.493 . . . . 0.0 110.187 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -31.91 71.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.267 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.71 -4.18 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.584 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.708 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 4.1 t-20 -112.53 -5.51 14.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.547 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 5.6 m120 86.32 30.79 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.621 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 1.032 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 2.9 m170 -117.35 54.56 1.56 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.679 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 63.9 Cg_endo -72.08 -10.13 25.54 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.74 2.293 . . . . 0.0 113.359 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.486 ' HB3' HD11 ' C' ' 5' ' ' ILE . 7.7 m-20 -56.6 -40.78 75.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.914 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.71 ' HB2' HG13 ' C' ' 19' ' ' VAL . 26.8 m-85 72.21 90.52 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.969 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.607 ' CB ' HG23 ' B' ' 75' ' ' THR . 78.1 Cg_exo -49.37 162.11 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.594 2.196 . . . . 0.0 112.274 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.862 ' HB1' ' HB2' ' C' ' 31' ' ' SER . . . -125.5 131.1 52.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.505 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.829 ' CD ' HG23 ' B' ' 76' ' ' THR . 0.0 OUTLIER -163.57 -166.4 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.6 114.98 28.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.176 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 14.4 m -96.9 130.38 44.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.138 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.729 HG12 HD23 ' C' ' 115' ' ' LEU . 29.8 m -148.81 167.9 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.987 0.423 . . . . 0.0 111.982 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.817 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 30.4 tt0 -102.42 92.46 4.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.708 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.871 HG21 HD21 ' B' ' 115' ' ' LEU . 24.1 m -62.76 158.05 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -70.37 -51.41 29.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.067 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.567 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -143.19 178.5 7.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.685 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.871 HD21 HG21 ' B' ' 112' ' ' VAL . 73.3 mt -150.88 153.99 34.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.769 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 36.4 Cg_endo -65.37 137.56 51.73 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.428 2.085 . . . . 0.0 112.201 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.538 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 76.6 14.84 2.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.339 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.53 14.54 9.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.085 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.721 HG11 ' HB ' ' B' ' 34' ' ' ILE . 17.1 m -58.87 160.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.762 0.315 . . . . 0.0 110.99 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.5 21.68 21.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.682 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.613 HD21 HG12 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -178.88 154.86 0.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.077 0.465 . . . . 0.0 111.204 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.704 ' O ' HD13 ' B' ' 123' ' ' ILE . 4.3 tt0 -140.61 150.57 43.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.083 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.841 HG21 HG21 ' B' ' 58' ' ' VAL . 21.0 mm -136.85 119.55 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . 0.423 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.0 OUTLIER -138.32 115.87 11.3 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -132.12 168.68 17.56 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.914 HG23 ' HG ' ' B' ' 29' ' ' LEU . 4.0 mm -116.56 146.06 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.511 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 1.122 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -132.69 148.47 52.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.163 0.506 . . . . 0.0 111.937 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.763 HG12 ' HG ' ' B' ' 27' ' ' LEU . 30.4 m -132.09 162.78 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.945 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.634 ' HB3' HD21 ' B' ' 67' ' ' LEU . 9.9 ptt180 -157.02 65.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.004 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 6.4 pttt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.424 179.897 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 40.6 mtt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.867 0.365 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -140.84 164.13 31.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.83 131.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.967 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.75 136.87 3.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.054 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.653 HG23 HG21 ' C' ' 19' ' ' VAL . 4.8 mp -58.54 158.24 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.181 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' C' ' 21' ' ' ALA . 18.9 mt -115.02 160.68 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.029 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . 0.482 ' N ' HG22 ' C' ' 6' ' ' ILE . 4.7 t-160 -160.76 124.45 3.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.964 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.475 HG22 HG12 ' C' ' 61' ' ' ILE . 8.0 t -127.7 165.47 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -102.78 51.29 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.401 ' HB3' ' CB ' ' C' ' 60' ' ' ALA . 0.7 OUTLIER -144.09 -49.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.704 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.916 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.43 172.3 3.98 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.916 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 32.1 Cg_endo -64.42 -11.95 30.84 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.598 2.199 . . . . 0.0 112.713 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 73.32 171.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.948 0.404 . . . . 0.0 111.365 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.772 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -166.98 122.82 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.798 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.772 HD13 ' O ' ' C' ' 14' ' ' ALA . 17.9 mm -141.47 17.53 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.377 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.47 -103.89 2.45 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.296 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.14 4.83 6.68 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.565 2.177 . . . . 0.0 112.805 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.512 ' CD1' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -160.72 177.18 10.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.897 0.38 . . . . 0.0 111.259 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.71 HG13 ' HB2' ' B' ' 104' ' ' PHE . 28.1 m -132.28 166.39 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.054 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.766 ' OE1' ' HB3' ' C' ' 11' ' ' ALA . 3.9 mm-40 -52.86 -46.55 67.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . -175.62 176.44 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.004 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.593 HG21 ' HB ' ' B' ' 73' ' ' VAL . 3.1 m -140.2 133.86 35.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.464 ' CG ' HG12 ' C' ' 28' ' ' VAL . 6.9 t0 -97.19 139.71 32.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.684 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.818 HD11 HD13 ' C' ' 29' ' ' LEU . 6.5 mt -112.92 -15.87 12.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.352 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 97.03 104.41 2.23 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.344 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 16.0 m-80 84.1 -35.77 0.06 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.769 ' HG ' HG12 ' C' ' 128' ' ' VAL . 0.3 OUTLIER -127.16 101.63 6.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.792 178.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 1.056 HG23 ' HB3' ' C' ' 127' ' ' ALA . 3.4 m -95.0 170.4 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.315 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.903 ' HG ' HG23 ' C' ' 126' ' ' ILE . 3.6 mp -152.78 148.89 27.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.962 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 4.4 p -125.91 148.95 49.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . 0.862 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 4.4 t -75.36 170.27 16.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.82 77.16 0.4 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.033 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -53.21 162.95 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.008 0.432 . . . . 0.0 111.412 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.724 HG13 HG23 ' C' ' 36' ' ' VAL . 7.5 pt -146.9 154.29 46.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.681 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.627 ' HG2' HG23 ' C' ' 43' ' ' VAL . 72.5 Cg_endo -77.21 48.81 2.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.911 2.407 . . . . 0.0 113.23 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.724 HG23 HG13 ' C' ' 34' ' ' ILE . 45.9 t -63.94 86.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.178 0.513 . . . . 0.0 110.469 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.664 ' HB3' HG22 ' C' ' 40' ' ' THR . 3.7 t30 -38.16 130.07 1.0 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.072 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.27 -6.94 19.14 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.186 1.924 . . . . 0.0 111.635 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.452 ' HB3' ' ND2' ' C' ' 37' ' ' ASN . . . -101.89 -28.25 12.51 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.594 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.711 HG23 ' HG3' ' C' ' 42' ' ' GLU . 8.1 t -125.62 -33.73 2.73 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.967 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 85.46 62.21 1.65 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.682 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' C' ' 40' ' ' THR . 0.2 OUTLIER -167.2 -84.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.669 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.627 HG23 ' HG2' ' C' ' 35' ' ' PRO . 10.0 p -170.57 125.77 0.66 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.335 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' C' ' 35' ' ' PRO . 52.7 Cg_exo -54.46 141.82 71.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.443 2.095 . . . . 0.0 112.224 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.0 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.059 0.457 . . . . 0.0 110.994 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -73.15 93.75 1.86 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.803 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' C' ' 47' ' ' ILE . 7.4 tp -42.11 -33.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.677 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . 0.427 HG12 ' HD2' ' C' ' 52' ' ' ARG . 22.0 t -78.53 -46.41 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.705 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -61.07 -46.99 88.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.688 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -65.05 -28.8 69.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.453 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.29 -40.86 50.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.051 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.427 ' HD2' HG12 ' C' ' 48' ' ' VAL . 24.2 mtp180 -67.82 -52.22 39.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.79 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -27.98 63.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.644 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.579 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.6 OUTLIER -61.82 -42.41 98.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.621 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.609 HD13 ' CE2' ' C' ' 95' ' ' PHE . 7.5 mt -74.94 -30.0 61.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.008 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' C' ' 59' ' ' LYS . 32.6 mt-10 -65.48 -36.15 83.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -72.43 -27.82 62.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.879 HG21 HG21 ' C' ' 123' ' ' ILE . 34.5 t -67.65 -45.78 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' C' ' 56' ' ' GLU . 0.0 OUTLIER -76.13 -28.34 57.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' C' ' 10' ' ' LYS . . . -60.53 -41.17 93.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.969 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.475 HG12 HG22 ' C' ' 8' ' ' THR . 15.7 mt -73.06 -41.2 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.629 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.53 ' CD1' HD11 ' C' ' 72' ' ' ILE . 18.3 mt -69.9 -33.17 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.712 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -73.51 -40.96 63.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.229 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -21.83 65.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.325 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.29 -28.4 17.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.3 56.65 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.545 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.622 HD21 ' HB3' ' C' ' 129' ' ' ARG . 3.5 mt -172.86 144.16 1.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.893 0.377 . . . . 0.0 111.063 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -99.41 166.08 11.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.764 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 1.015 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -62.44 -31.08 71.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.843 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.976 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -52.4 -26.62 13.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.973 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.429 ' CB ' HD22 ' C' ' 67' ' ' LEU . 1.2 m-20 -82.47 -24.51 34.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.582 HG21 HG22 ' C' ' 75' ' ' THR . 96.6 mt -52.84 108.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.989 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.661 ' HB ' HG21 ' A' ' 22' ' ' VAL . 35.4 m -74.29 -45.26 47.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.818 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.596 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 5.8 mttp -125.09 163.68 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.662 0.268 . . . . 0.0 111.248 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.621 HG23 ' CB ' ' C' ' 105' ' ' PRO . 31.8 p -157.74 102.44 1.86 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.788 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.821 HG23 ' CD ' ' C' ' 107' ' ' ARG . 0.1 OUTLIER -70.04 124.63 24.54 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.33 110.39 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.413 ' CE2' ' OE2' ' C' ' 124' ' ' GLU . 15.8 m-30 -107.86 119.97 40.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.94 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.589 HG12 HD21 ' C' ' 121' ' ' LEU . 0.8 OUTLIER -114.3 152.18 15.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.103 0.477 . . . . 0.0 111.773 -179.224 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -92.89 0.85 57.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.866 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -171.13 108.49 0.29 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.51 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.552 HD12 ' HB3' ' A' ' 114' ' ' ARG . 3.0 mt -57.76 -17.3 14.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -73.3 -22.19 60.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.384 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.418 ' O ' HG23 ' C' ' 88' ' ' VAL . 75.3 m-20 -87.01 -15.51 38.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.021 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.415 ' CE2' ' OD1' ' C' ' 89' ' ' ASN . 0.2 OUTLIER -57.33 -29.64 64.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.218 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.98 68.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.292 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.93 -28.89 22.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.273 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.418 HG23 ' O ' ' C' ' 84' ' ' ASP . 21.4 t -77.72 -41.61 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . 0.415 ' OD1' ' CE2' ' C' ' 85' ' ' PHE . 0.3 OUTLIER -68.2 -36.6 79.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.881 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.95 75.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.274 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.51 -32.43 18.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -61.28 -49.86 75.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.084 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -75.5 -21.57 57.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.501 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -27.26 50.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.57 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -85.7 -39.02 17.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.703 0.287 . . . . 0.0 110.778 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.52 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 4.3 m-85 -55.12 -54.5 42.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.193 0.521 . . . . 0.0 110.231 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -31.9 71.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.264 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.73 -4.17 55.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.592 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.709 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 4.1 t-20 -112.54 -5.5 14.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.583 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 5.6 m120 86.29 30.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.631 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 1.015 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 2.9 m170 -117.25 54.58 1.51 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.626 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.419 ' O ' ' CD2' ' C' ' 104' ' ' PHE . 63.4 Cg_endo -72.1 -10.04 25.37 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.744 2.296 . . . . 0.0 113.344 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.568 ' HB3' HD11 ' A' ' 5' ' ' ILE . 7.7 m-20 -56.75 -40.73 76.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.673 ' HB2' HG13 ' A' ' 19' ' ' VAL . 26.7 m-85 72.34 90.39 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.965 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.621 ' CB ' HG23 ' C' ' 75' ' ' THR . 77.2 Cg_exo -49.31 162.1 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.569 2.179 . . . . 0.0 112.303 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.863 ' HB1' ' HB2' ' A' ' 31' ' ' SER . . . -125.51 131.07 52.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.488 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.821 ' CD ' HG23 ' C' ' 76' ' ' THR . 0.0 OUTLIER -163.52 -166.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -111.64 114.99 28.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.195 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 14.2 m -96.9 130.33 44.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.163 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.722 HG12 HD23 ' A' ' 115' ' ' LEU . 30.2 m -148.88 168.12 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.906 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.826 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 30.6 tt0 -102.48 92.33 4.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.902 HG21 HD21 ' C' ' 115' ' ' LEU . 24.4 m -62.52 158.01 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -70.37 -51.44 29.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.485 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.6 OUTLIER -143.18 178.51 7.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.706 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.902 HD21 HG21 ' C' ' 112' ' ' VAL . 73.3 mt -150.89 153.98 33.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.786 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.562 ' O ' HG22 ' C' ' 119' ' ' VAL . 36.4 Cg_endo -65.36 137.47 51.4 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.513 2.142 . . . . 0.0 112.184 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.546 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 76.62 14.9 2.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.307 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.1 t0 64.52 14.52 8.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.72 HG11 ' HB ' ' C' ' 34' ' ' ILE . 17.2 m -58.84 160.86 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.323 . . . . 0.0 110.969 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.45 22.05 20.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.75 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.589 HD21 HG12 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -179.19 155.05 0.7 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.122 0.487 . . . . 0.0 111.144 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.702 ' O ' HD13 ' C' ' 123' ' ' ILE . 4.2 tt0 -140.63 150.62 43.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.036 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.879 HG21 HG21 ' C' ' 58' ' ' VAL . 20.8 mm -136.88 119.55 20.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.132 0.491 . . . . 0.0 112.286 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' C' ' 78' ' ' PHE . 0.0 OUTLIER -138.33 115.89 11.31 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -132.17 168.66 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.903 HG23 ' HG ' ' C' ' 29' ' ' LEU . 4.0 mm -116.5 146.05 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.527 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 1.056 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -132.65 148.45 52.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.186 0.517 . . . . 0.0 111.895 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.769 HG12 ' HG ' ' C' ' 27' ' ' LEU . 30.5 m -132.09 162.82 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.932 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.622 ' HB3' HD21 ' C' ' 67' ' ' LEU . 9.9 ptt180 -157.05 65.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.4 pttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.449 179.924 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.767 0.318 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -177.28 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.055 HG21 HG21 ' C' ' 128' ' ' VAL . 10.4 m 63.33 141.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.849 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.89 127.17 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.604 HD13 ' CG ' ' C' ' 103' ' ' ASN . 4.6 mp -56.47 153.7 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.177 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 7' ' ' HIS . 31.9 mt -109.85 157.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.459 ' N ' HG22 ' A' ' 6' ' ' ILE . 12.0 t60 -159.46 134.84 8.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.64 HG23 ' H ' ' A' ' 11' ' ' ALA . 8.9 t -147.78 160.75 42.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.93 21.01 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.042 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.508 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 3.8 mmmt -116.59 -35.91 4.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.913 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.704 ' HB2' HG12 ' A' ' 61' ' ' ILE . . . -52.7 177.79 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.343 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.675 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 17.1 Cg_exo -67.13 -8.28 21.37 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.831 2.354 . . . . 0.0 112.705 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 76.45 147.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 110.953 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.81 121.02 39.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.199 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 15' ' ' ILE . 3.1 mp -119.36 16.52 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.971 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.8 -148.87 4.85 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.307 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.73 38.75 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.869 2.379 . . . . 0.0 113.047 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.06 164.26 28.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.884 0.374 . . . . 0.0 111.05 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.588 HG21 HG23 ' A' ' 5' ' ' ILE . 25.6 m -113.32 175.4 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.963 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.542 ' NE2' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -58.51 -48.22 81.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.936 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 61' ' ' ILE . . . -175.53 178.97 1.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.632 HG11 ' O ' ' C' ' 73' ' ' VAL . 14.3 m -134.17 132.95 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.678 ' HA ' HG23 ' A' ' 28' ' ' VAL . 9.8 t70 -111.25 118.42 35.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.742 HD22 ' CG1' ' C' ' 128' ' ' VAL . 3.7 mt -94.1 -16.96 23.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.218 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.33 -99.99 0.9 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.416 ' O ' HD22 ' A' ' 27' ' ' LEU . 4.2 m120 -59.08 -29.16 67.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.193 0.52 . . . . 0.0 109.717 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.63 ' CD2' HG12 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -129.55 139.52 51.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.547 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.92 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 4.2 p -127.92 151.34 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.009 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.921 HD12 HG23 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -134.66 135.46 42.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.743 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.3 p -108.85 136.18 48.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.066 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -63.94 143.23 58.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.827 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.55 92.17 0.01 OUTLIER Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.365 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.511 ' CG ' HG22 ' A' ' 58' ' ' VAL . 32.1 mm-40 -74.55 163.75 27.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.47 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 119' ' ' VAL . 2.1 pt -146.27 160.26 43.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.672 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.564 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 17.6 Cg_exo -66.82 54.23 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.052 2.501 . . . . 0.0 113.262 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.465 HG23 HG13 ' A' ' 34' ' ' ILE . 34.4 t -65.21 86.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.168 0.509 . . . . 0.0 110.384 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' GLY . 24.4 t-20 -36.79 133.09 0.67 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.977 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.53 -12.7 31.85 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.316 2.01 . . . . 0.0 112.109 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.9 -20.66 9.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.739 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.43 HG22 ' CG ' ' A' ' 42' ' ' GLU . 2.6 m -115.46 -23.02 9.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.848 0.356 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 58.86 56.89 22.82 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.36 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' CG ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER -162.5 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.75 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p -175.13 108.43 0.26 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.35 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.46 140.98 74.06 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.353 2.035 . . . . 0.0 112.118 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.29 -31.55 71.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.068 0.461 . . . . 0.0 110.901 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.48 91.47 0.57 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.781 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mm -41.1 -32.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.542 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.9 -42.66 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.29 -36.51 77.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.766 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.659 ' OE1' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -78.51 -20.66 50.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.605 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.94 -36.76 23.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.291 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -33.2 58.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.931 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.02 -26.68 59.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.696 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.838 ' O ' HG23 ' A' ' 58' ' ' VAL . 90.7 p -70.57 -35.35 73.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.908 HD13 ' CE2' ' A' ' 95' ' ' PHE . 8.7 mt -77.38 -33.6 55.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.074 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -51.59 69.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.977 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 54' ' ' SER . 10.3 p30 -59.45 -39.85 84.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 54' ' ' SER . 31.5 t -61.76 -35.76 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.851 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -31.53 43.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -62.62 -39.17 92.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.704 HG12 ' HB2' ' A' ' 11' ' ' ALA . 22.0 mt -69.47 -46.25 76.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.789 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mt -65.33 -31.44 53.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.765 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -41.36 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.401 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -63.2 -20.44 65.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.512 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.77 -21.51 20.66 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.064 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.03 53.19 0.8 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.383 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' A' ' 71' ' ' ASP . 11.8 mt -155.65 137.1 14.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.964 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 157.16 16.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.754 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -50.13 -36.76 31.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -58.47 -21.24 50.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.363 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.494 ' CB ' HD22 ' A' ' 67' ' ' LEU . 1.5 m-20 -77.88 -26.45 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.884 0.373 . . . . 0.0 110.588 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 35.5 mt -59.35 114.21 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.663 ' O ' HG11 ' B' ' 22' ' ' VAL . 3.4 m -84.39 -33.14 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.72 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.888 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 0.6 OUTLIER -139.86 152.68 46.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.693 0.283 . . . . 0.0 111.009 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.644 HG22 ' CB ' ' A' ' 125' ' ' ALA . 40.8 p -141.9 135.0 29.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 111.336 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 108' ' ' SER . 4.5 m -114.82 150.85 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.213 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 122' ' ' GLU . 20.3 t -148.87 112.94 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 111.613 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.431 ' HB3' HG11 ' A' ' 112' ' ' VAL . 5.5 m-85 -92.7 107.85 19.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.549 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.669 HG12 HD22 ' A' ' 121' ' ' LEU . 36.0 m -102.42 146.43 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.413 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.69 -3.07 58.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.031 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.85 125.89 2.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.25 -11.11 56.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.164 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.07 -20.52 52.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 110.632 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 88' ' ' VAL . 38.8 m-20 -95.24 7.01 47.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.291 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -84.24 -27.96 27.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.768 0.318 . . . . 0.0 111.124 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.88 77.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.176 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.7 -33.89 27.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 84' ' ' ASP . 26.7 t -77.97 -43.29 28.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.029 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -61.72 -33.07 73.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.027 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.35 -48.63 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.299 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.47 -29.85 59.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.186 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.597 ' OH ' HG21 ' A' ' 75' ' ' THR . 11.5 t80 -63.99 -37.51 87.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.148 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.47 -27.33 29.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.191 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -33.72 76.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.187 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.908 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -85.7 -34.63 21.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.553 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.524 ' CE1' ' CE1' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -57.8 -55.05 39.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.287 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -32.74 71.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.049 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -85.8 -0.86 56.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.407 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 2.6 m-20 -98.88 -18.38 17.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.189 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.603 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 20.2 m-20 104.89 25.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.11 0.881 . . . . 0.0 110.948 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.474 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.1 t-80 -123.95 66.67 40.46 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.05 -16.87 22.58 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.533 2.155 . . . . 0.0 112.393 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.578 ' CG ' HD13 ' B' ' 5' ' ' ILE . 0.4 OUTLIER -68.13 -35.21 77.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.793 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.569 ' O ' HG13 ' B' ' 19' ' ' VAL . 7.8 m-85 76.2 120.44 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.3 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 93.9 Cg_endo -82.41 168.87 14.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.848 2.365 . . . . 0.0 112.218 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.888 ' HB3' ' CG ' ' A' ' 74' ' ' LYS . . . -56.35 159.47 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.406 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -127.97 142.77 51.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.033 0.444 . . . . 0.0 111.528 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 76' ' ' THR . 27.9 t -150.43 66.6 0.95 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.453 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 11.8 m -96.75 138.76 33.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.033 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.405 HG12 HD23 ' B' ' 115' ' ' LEU . 34.6 m -145.5 139.56 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.303 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.859 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 1.0 OUTLIER -70.87 86.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.822 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.617 HG21 HD21 ' A' ' 115' ' ' LEU . 21.7 m -71.18 155.94 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.238 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.853 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -67.87 -46.82 70.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.076 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 0.0 OUTLIER -153.79 176.96 11.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.799 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.617 HD21 HG21 ' A' ' 112' ' ' VAL . 31.0 mt -147.48 155.38 45.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.814 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.542 ' O ' HG22 ' A' ' 119' ' ' VAL . 12.5 Cg_endo -55.97 136.97 77.51 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.593 2.196 . . . . 0.0 112.045 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.2 OUTLIER 74.88 13.91 3.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.244 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.98 15.95 8.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.109 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.937 HG21 HG21 ' A' ' 34' ' ' ILE . 14.1 m -55.56 146.31 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.185 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.75 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.45 -15.1 64.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.9 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.669 HD22 HG12 ' A' ' 79' ' ' VAL . 37.2 mt -151.18 147.6 27.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.085 0.469 . . . . 0.0 111.016 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.659 ' O ' HD13 ' A' ' 123' ' ' ILE . 5.3 tt0 -122.53 155.32 36.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.211 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.736 ' CG2' HG21 ' A' ' 58' ' ' VAL . 30.3 mm -130.88 133.57 62.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 0.0 111.767 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -152.42 155.88 38.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.007 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.779 ' C ' HD13 ' A' ' 126' ' ' ILE . . . -177.45 165.07 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.081 0.467 . . . . 0.0 111.833 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.921 HG23 HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -124.52 143.66 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.393 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.92 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -129.76 157.99 40.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.0 0.429 . . . . 0.0 111.775 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.012 HG21 HG21 ' B' ' 3' ' ' THR . 30.1 m -115.95 155.0 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.956 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.72 47.04 2.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.826 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.993 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.871 0.367 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -177.3 4.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.814 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 1.012 HG21 HG21 ' A' ' 128' ' ' VAL . 10.5 m 63.37 141.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.86 127.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.004 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.595 ' H ' HD12 ' B' ' 5' ' ' ILE . 4.6 mp -56.49 153.73 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.207 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.462 HG22 ' N ' ' B' ' 7' ' ' HIS . 31.7 mt -109.89 157.1 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.122 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.462 ' N ' HG22 ' B' ' 6' ' ' ILE . 11.9 t60 -159.48 134.78 8.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.642 HG23 ' H ' ' B' ' 11' ' ' ALA . 8.9 t -147.72 160.76 42.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.94 21.06 10.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.962 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.495 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 3.8 mmmt -116.68 -35.83 4.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 0.0 110.893 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.688 ' HB2' HG12 ' B' ' 61' ' ' ILE . . . -52.77 177.77 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.424 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.686 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 17.1 Cg_exo -67.05 -8.38 21.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.9 2.4 . . . . 0.0 112.689 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.51 147.76 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 111.002 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.81 120.93 39.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.206 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 15' ' ' ILE . 3.1 mp -119.27 16.6 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.984 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.81 -148.88 4.85 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.308 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -88.72 38.78 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.853 2.369 . . . . 0.0 113.063 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.07 164.34 28.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 111.05 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 104' ' ' PHE . 25.6 m -113.43 175.4 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.917 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.561 ' NE2' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -58.45 -48.3 81.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.981 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' B' ' 61' ' ' ILE . . . -175.62 178.98 1.49 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 73' ' ' VAL . 14.4 m -134.09 132.95 56.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.131 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.682 ' HA ' HG23 ' B' ' 28' ' ' VAL . 9.8 t70 -111.3 118.46 35.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.767 HD22 ' CG1' ' A' ' 128' ' ' VAL . 3.7 mt -94.07 -16.98 23.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.249 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.37 -100.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.468 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . 0.421 ' O ' HD22 ' B' ' 27' ' ' LEU . 4.2 m120 -59.05 -29.19 67.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.719 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.625 ' CD2' HG12 ' B' ' 128' ' ' VAL . 1.0 OUTLIER -129.57 139.47 51.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.564 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.916 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 4.2 p -127.99 151.39 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.964 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.944 HD12 HG23 ' B' ' 126' ' ' ILE . 0.2 OUTLIER -134.62 135.45 42.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.76 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -108.99 136.24 48.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.028 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.15 143.35 57.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.55 92.1 0.01 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.358 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.516 ' CG ' HG22 ' B' ' 58' ' ' VAL . 32.1 mm-40 -74.53 163.76 27.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.429 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.963 HG21 HG21 ' B' ' 119' ' ' VAL . 2.2 pt -146.28 160.29 42.89 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.625 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.574 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 18.0 Cg_exo -66.96 54.35 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.058 2.505 . . . . 0.0 113.205 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.481 HG23 HG13 ' B' ' 34' ' ' ILE . 34.0 t -65.27 86.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.167 0.508 . . . . 0.0 110.361 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -36.83 133.13 0.67 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.992 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.55 -12.66 31.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.29 1.993 . . . . 0.0 112.159 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.92 -20.66 9.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.784 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.428 HG22 ' CG ' ' B' ' 42' ' ' GLU . 2.6 m -115.49 -22.96 9.03 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.779 0.323 . . . . 0.0 110.885 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.472 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 58.86 56.94 22.51 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.362 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.428 ' CG ' HG22 ' B' ' 40' ' ' THR . 0.0 OUTLIER -162.55 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.798 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.704 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.1 p -175.08 108.43 0.27 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.336 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.43 140.89 73.79 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.355 2.037 . . . . 0.0 112.183 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.18 -31.56 71.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.44 91.48 0.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.782 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mm -41.16 -32.75 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.514 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.82 -42.65 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.906 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.29 -36.55 77.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.768 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.645 ' OE1' HD12 ' B' ' 121' ' ' LEU . 0.0 OUTLIER -78.52 -20.85 49.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.614 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.8 -36.8 23.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.295 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 -33.1 58.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.01 -26.83 59.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.809 ' O ' HG23 ' B' ' 58' ' ' VAL . 90.3 p -70.53 -35.25 73.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.904 HD13 ' CE2' ' B' ' 95' ' ' PHE . 8.7 mt -77.41 -33.6 54.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -51.6 69.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' B' ' 54' ' ' SER . 10.3 p30 -59.47 -39.85 85.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.809 HG23 ' O ' ' B' ' 54' ' ' SER . 31.5 t -61.77 -35.79 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.824 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -31.53 43.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.874 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -62.62 -39.29 93.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.688 HG12 ' HB2' ' B' ' 11' ' ' ALA . 22.0 mt -69.46 -46.21 76.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.77 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.25 -31.49 54.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -41.37 60.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.327 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -63.17 -20.43 65.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.556 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.83 -21.47 20.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.049 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.02 53.16 0.81 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.363 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.498 HD22 ' CB ' ' B' ' 71' ' ' ASP . 11.8 mt -155.59 137.05 14.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.71 157.12 16.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -50.1 -36.77 30.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -58.61 -21.2 52.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.364 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.498 ' CB ' HD22 ' B' ' 67' ' ' LEU . 1.5 m-20 -77.74 -26.49 49.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 110.583 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' B' ' 127' ' ' ALA . 35.2 mt -59.39 114.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.684 ' O ' HG11 ' C' ' 22' ' ' VAL . 3.4 m -84.34 -33.13 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.745 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.883 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 0.6 OUTLIER -139.91 152.68 46.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.747 0.308 . . . . 0.0 110.953 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.648 HG22 ' CB ' ' B' ' 125' ' ' ALA . 40.7 p -141.86 135.02 29.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.997 0.427 . . . . 0.0 111.353 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.64 HG23 ' O ' ' B' ' 108' ' ' SER . 4.4 m -114.8 150.86 34.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.19 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.405 HG13 ' O ' ' B' ' 122' ' ' GLU . 20.2 t -148.83 112.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 111.637 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.448 ' HB3' HG11 ' B' ' 112' ' ' VAL . 5.6 m-85 -92.74 107.88 19.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.543 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.676 HG12 HD22 ' B' ' 121' ' ' LEU . 35.9 m -102.41 146.42 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.467 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -3.13 59.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.028 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.8 125.9 2.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.581 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.19 -11.09 56.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.202 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.06 -20.58 52.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.831 0.348 . . . . 0.0 110.615 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.7 ' O ' HG23 ' B' ' 88' ' ' VAL . 38.7 m-20 -95.25 7.0 47.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -84.25 -27.95 27.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.145 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.26 -34.92 77.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.264 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.63 -34.01 27.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 84' ' ' ASP . 26.7 t -77.95 -43.28 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.061 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -61.67 -33.19 73.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.008 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.29 -48.55 33.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.332 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.61 -29.93 59.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.615 ' HH ' HG21 ' B' ' 75' ' ' THR . 11.4 t80 -63.94 -37.63 88.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.37 -27.39 29.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.213 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -33.79 76.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.132 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.904 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.3 OUTLIER -85.7 -34.59 21.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 0.0 110.578 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.524 ' CE1' ' CE1' ' B' ' 92' ' ' TYR . 0.4 OUTLIER -57.83 -55.1 39.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.258 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -32.77 71.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.033 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -85.76 -1.0 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.381 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.547 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 2.6 m-20 -98.77 -18.42 17.99 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.192 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.594 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 20.4 m-20 104.98 25.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.117 0.885 . . . . 0.0 110.921 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.464 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.1 t-80 -124.15 66.62 42.3 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.01 -16.8 22.73 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.477 2.118 . . . . 0.0 112.393 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.647 ' CG ' HD13 ' C' ' 5' ' ' ILE . 0.4 OUTLIER -68.19 -35.11 77.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.851 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.564 ' O ' HG13 ' C' ' 19' ' ' VAL . 7.7 m-85 76.14 120.4 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.287 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.43 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 92.8 Cg_endo -82.36 168.9 14.5 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.798 2.332 . . . . 0.0 112.266 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.883 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -56.31 159.54 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.404 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -128.0 142.79 51.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.082 0.468 . . . . 0.0 111.535 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.64 ' O ' HG23 ' B' ' 76' ' ' THR . 27.8 t -150.46 66.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.426 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 11.8 m -96.78 138.78 33.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 34.6 m -145.44 139.32 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.388 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.866 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 1.0 OUTLIER -70.58 86.89 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.698 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.621 HG21 HD21 ' B' ' 115' ' ' LEU . 21.8 m -71.29 155.8 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.859 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -67.74 -46.89 70.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.439 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -153.79 176.92 11.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.621 HD21 HG21 ' B' ' 112' ' ' VAL . 30.5 mt -147.43 155.32 45.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.809 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.55 ' O ' HG22 ' B' ' 119' ' ' VAL . 12.4 Cg_endo -55.93 136.97 77.4 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.161 . . . . 0.0 112.099 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.428 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.2 OUTLIER 74.91 13.86 3.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.287 -179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 63.05 15.93 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.058 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.963 HG21 HG21 ' B' ' 34' ' ' ILE . 13.9 m -55.63 146.35 4.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.875 0.369 . . . . 0.0 111.177 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . 0.704 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.44 -15.19 64.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.868 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.676 HD22 HG12 ' B' ' 79' ' ' VAL . 37.1 mt -151.1 147.41 27.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.07 0.462 . . . . 0.0 111.045 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.656 ' O ' HD13 ' B' ' 123' ' ' ILE . 5.3 tt0 -122.52 155.28 36.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.246 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.72 ' CG2' HG21 ' B' ' 58' ' ' VAL . 30.3 mm -130.83 133.6 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.424 . . . . 0.0 111.76 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -152.5 155.87 38.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.93 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.778 ' C ' HD13 ' B' ' 126' ' ' ILE . . . -177.44 165.04 2.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 111.814 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.944 HG23 HD12 ' B' ' 29' ' ' LEU . 0.7 OUTLIER -124.53 143.67 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.367 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.916 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -129.74 158.0 40.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.999 0.428 . . . . 0.0 111.756 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.987 HG21 HG21 ' C' ' 3' ' ' THR . 30.3 m -115.91 155.03 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.982 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.83 47.0 2.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.854 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.959 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.798 0.332 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.46 -177.27 4.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.987 HG21 HG21 ' B' ' 128' ' ' VAL . 10.3 m 63.3 141.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -172.84 127.13 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.013 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.647 HD13 ' CG ' ' B' ' 103' ' ' ASN . 4.6 mp -56.48 153.7 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.46 HG22 ' N ' ' C' ' 7' ' ' HIS . 31.4 mt -109.8 157.18 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.158 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . 0.46 ' N ' HG22 ' C' ' 6' ' ' ILE . 11.9 t60 -159.57 134.76 8.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.644 HG23 ' H ' ' C' ' 11' ' ' ALA . 9.0 t -147.71 160.7 42.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -96.9 21.05 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.041 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.463 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 3.8 mmmt -116.62 -35.99 4.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.676 ' HB2' HG12 ' C' ' 61' ' ' ILE . . . -52.76 177.85 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.313 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.668 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 17.1 Cg_exo -67.09 -8.38 21.64 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.868 2.379 . . . . 0.0 112.653 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 76.56 147.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.898 0.38 . . . . 0.0 110.967 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.77 120.94 39.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.605 HG22 ' O ' ' C' ' 15' ' ' ILE . 3.1 mp -119.36 16.63 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.84 -148.84 4.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.269 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -88.72 38.76 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.827 2.351 . . . . 0.0 113.071 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -137.01 164.28 28.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.823 0.344 . . . . 0.0 111.055 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.593 HG21 HG23 ' C' ' 5' ' ' ILE . 25.0 m -113.36 175.41 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.907 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.547 ' NE2' ' HB3' ' C' ' 11' ' ' ALA . 0.0 OUTLIER -58.46 -48.24 81.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.947 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' C' ' 61' ' ' ILE . . . -175.67 178.98 1.47 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.932 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.684 HG11 ' O ' ' B' ' 73' ' ' VAL . 14.2 m -134.12 132.91 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.669 ' HA ' HG23 ' C' ' 28' ' ' VAL . 9.8 t70 -111.2 118.43 35.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.723 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.777 HD22 ' CG1' ' B' ' 128' ' ' VAL . 3.7 mt -94.04 -17.02 23.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.256 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.32 -100.01 0.9 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.489 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . 0.412 ' O ' HD22 ' C' ' 27' ' ' LEU . 4.2 m120 -59.04 -29.17 67.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.223 0.535 . . . . 0.0 109.755 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.656 ' CD2' HG12 ' C' ' 128' ' ' VAL . 1.0 OUTLIER -129.59 139.55 51.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.522 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.927 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 4.2 p -127.96 151.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.951 HD12 HG23 ' C' ' 126' ' ' ILE . 0.2 OUTLIER -134.61 135.5 42.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.767 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 32.9 p -108.9 136.34 48.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.103 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -64.01 143.24 58.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.77 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.5 92.12 0.01 OUTLIER Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.325 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.512 ' CG ' HG22 ' C' ' 58' ' ' VAL . 32.1 mm-40 -74.53 163.77 27.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.036 0.446 . . . . 0.0 111.432 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.954 HG21 HG21 ' C' ' 119' ' ' VAL . 2.1 pt -146.33 160.27 42.79 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.618 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.568 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 17.9 Cg_exo -66.84 54.24 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.113 2.542 . . . . 0.0 113.184 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.477 HG23 HG13 ' C' ' 34' ' ' ILE . 34.8 t -65.29 86.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 110.355 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' C' ' 41' ' ' GLY . 24.4 t-20 -36.78 133.13 0.67 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.969 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.57 -12.65 31.69 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.269 1.98 . . . . 0.0 112.165 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.92 -20.64 9.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.73 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.44 HG22 ' CG ' ' C' ' 42' ' ' GLU . 2.6 m -115.48 -23.04 9.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.854 0.359 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.472 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 58.88 56.95 22.47 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.343 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.44 ' CG ' HG22 ' C' ' 40' ' ' THR . 0.0 OUTLIER -162.45 -81.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.847 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.712 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.2 p -175.05 108.47 0.27 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.329 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' C' ' 35' ' ' PRO . 53.0 Cg_exo -54.49 140.94 74.44 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.326 2.017 . . . . 0.0 112.19 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.54 71.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.49 91.5 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.78 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 mm -41.15 -32.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.471 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.88 -42.58 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.925 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.31 -36.6 77.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.704 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.65 ' OE1' HD12 ' C' ' 121' ' ' LEU . 0.0 OUTLIER -78.51 -20.74 50.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.88 -36.69 23.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.286 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.72 -33.12 58.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.935 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -74.99 -26.82 59.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.682 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.839 ' O ' HG23 ' C' ' 58' ' ' VAL . 90.8 p -70.45 -35.38 73.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.915 HD13 ' CE2' ' C' ' 95' ' ' PHE . 8.6 mt -77.32 -33.64 55.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -51.56 69.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.993 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' C' ' 54' ' ' SER . 10.3 p30 -59.5 -39.85 85.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.929 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.839 HG23 ' O ' ' C' ' 54' ' ' SER . 31.5 t -61.77 -35.81 69.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.831 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -31.63 44.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -62.5 -39.13 92.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.676 HG12 ' HB2' ' C' ' 11' ' ' ALA . 22.0 mt -69.64 -46.28 75.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -65.34 -31.42 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -41.42 60.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.368 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -63.14 -20.46 65.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.521 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.79 -21.51 20.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.002 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.04 53.14 0.81 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.373 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.488 HD22 ' CB ' ' C' ' 71' ' ' ASP . 11.8 mt -155.63 137.09 14.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 110.978 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 157.13 16.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.738 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -50.11 -36.71 30.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -58.63 -21.24 53.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.322 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.488 ' CB ' HD22 ' C' ' 67' ' ' LEU . 1.5 m-20 -77.72 -26.49 50.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.551 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' C' ' 127' ' ' ALA . 35.3 mt -59.38 114.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.632 ' O ' HG11 ' A' ' 22' ' ' VAL . 3.5 m -84.35 -33.19 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.729 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.895 ' CG ' ' HB3' ' C' ' 106' ' ' ALA . 0.6 OUTLIER -139.87 152.66 46.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.771 0.319 . . . . 0.0 110.942 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.639 HG22 ' CB ' ' C' ' 125' ' ' ALA . 40.8 p -141.9 135.0 29.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.991 0.424 . . . . 0.0 111.381 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.651 HG23 ' O ' ' C' ' 108' ' ' SER . 4.5 m -114.83 150.78 34.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.185 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.41 HG13 ' O ' ' C' ' 122' ' ' GLU . 20.1 t -148.73 112.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 0.0 111.622 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.445 ' HB3' HG11 ' C' ' 112' ' ' VAL . 5.5 m-85 -92.68 107.83 19.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.616 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.685 HG12 HD22 ' C' ' 121' ' ' LEU . 36.0 m -102.44 146.49 10.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.391 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -2.81 58.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.058 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.15 125.94 1.96 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.624 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.28 -11.05 56.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -78.09 -20.53 52.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.836 0.35 . . . . 0.0 110.606 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.691 ' O ' HG23 ' C' ' 88' ' ' VAL . 38.7 m-20 -95.31 7.04 47.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.263 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -84.25 -28.0 27.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.728 0.299 . . . . 0.0 111.096 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.25 -35.0 77.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.197 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.6 -33.92 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.201 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.691 HG23 ' O ' ' C' ' 84' ' ' ASP . 26.4 t -77.89 -43.3 28.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.099 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -61.66 -33.15 73.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.011 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.37 -48.45 34.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.337 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -29.83 59.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.14 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.605 ' OH ' HG21 ' C' ' 75' ' ' THR . 11.6 t80 -63.94 -37.65 88.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.071 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.42 -27.36 29.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.167 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -33.7 76.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.151 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.915 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.3 OUTLIER -85.76 -34.59 21.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 110.544 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.522 ' CE1' ' CE1' ' C' ' 92' ' ' TYR . 0.4 OUTLIER -57.81 -55.13 38.87 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.232 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -32.77 71.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.022 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -85.71 -0.98 56.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.43 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 2.6 m-20 -98.88 -18.33 17.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.179 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 20.3 m-20 104.8 25.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.869 0.868 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.468 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.1 t-80 -124.07 66.67 41.69 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.846 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.05 -16.8 22.61 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.483 2.122 . . . . 0.0 112.476 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.604 ' CG ' HD13 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -68.21 -35.14 77.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.852 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.56 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.8 m-85 76.18 120.49 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.264 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 94.2 Cg_endo -82.4 168.93 14.41 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.831 2.354 . . . . 0.0 112.206 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.895 ' HB3' ' CG ' ' C' ' 74' ' ' LYS . . . -56.42 159.6 3.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.393 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -128.1 142.79 51.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.083 0.468 . . . . 0.0 111.471 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . 0.651 ' O ' HG23 ' C' ' 76' ' ' THR . 27.7 t -150.47 66.68 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.387 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 11.7 m -96.76 138.78 33.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.068 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.412 HG12 HD23 ' A' ' 115' ' ' LEU . 34.6 m -145.54 139.53 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.372 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.853 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -70.63 87.01 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.621 HG21 HD21 ' C' ' 115' ' ' LEU . 21.6 m -71.33 156.03 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -67.97 -46.81 70.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.993 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.75 176.92 11.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.621 HD21 HG21 ' C' ' 112' ' ' VAL . 30.5 mt -147.44 155.35 45.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.539 ' O ' HG22 ' C' ' 119' ' ' VAL . 12.3 Cg_endo -56.03 137.03 77.86 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.572 2.182 . . . . 0.0 112.058 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.2 OUTLIER 74.91 13.88 3.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 20.1 t70 63.0 15.96 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.954 HG21 HG21 ' C' ' 34' ' ' ILE . 14.1 m -55.61 146.38 4.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.856 0.36 . . . . 0.0 111.217 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . 0.712 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.41 -15.12 64.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.878 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.685 HD22 HG12 ' C' ' 79' ' ' VAL . 37.0 mt -150.81 147.46 27.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.0 0.429 . . . . 0.0 111.046 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.658 ' O ' HD13 ' C' ' 123' ' ' ILE . 5.3 tt0 -122.6 155.27 36.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.249 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.724 ' CG2' HG21 ' C' ' 58' ' ' VAL . 30.2 mm -130.78 133.6 63.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.004 0.43 . . . . 0.0 111.771 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -152.47 155.87 38.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.981 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.771 ' C ' HD13 ' C' ' 126' ' ' ILE . . . -177.42 165.04 2.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.834 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.951 HG23 HD12 ' C' ' 29' ' ' LEU . 0.7 OUTLIER -124.49 143.65 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.372 179.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.927 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -129.74 157.99 40.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.962 0.41 . . . . 0.0 111.787 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 1.055 HG21 HG21 ' A' ' 3' ' ' THR . 30.7 m -115.94 154.94 17.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.005 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.7 46.99 2.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.899 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.963 -179.961 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.82 0.343 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.26 42.07 15.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.838 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.13 HG21 HG21 ' C' ' 128' ' ' VAL . 5.9 m -78.24 152.97 32.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -177.96 132.51 0.15 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.008 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.576 ' HA ' HG12 ' A' ' 22' ' ' VAL . 4.3 mp -57.51 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.474 ' N ' HG22 ' A' ' 5' ' ' ILE . 32.1 mt -113.55 150.64 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.203 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -147.84 134.25 19.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.83 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.516 HG21 ' HA ' ' A' ' 61' ' ' ILE . 2.7 t -148.14 163.27 37.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.93 28.67 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -110.31 -49.88 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.776 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.717 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.85 179.3 0.62 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.981 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 31.4 Cg_exo -59.08 -15.57 28.69 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.74 2.293 . . . . 0.0 112.614 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 73.78 153.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -110.37 119.94 40.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.201 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 15' ' ' ILE . 1.9 mp -132.22 16.23 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.833 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.38 -137.96 4.61 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.417 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HB2' ' CE1' ' C' ' 92' ' ' TYR . 87.1 Cg_endo -84.33 16.61 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.755 2.303 . . . . 0.0 113.641 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.559 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 1.1 p90 -137.41 177.85 7.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.454 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 10.6 m -128.82 169.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.047 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.42 HE22 ' HB3' ' A' ' 11' ' ' ALA . 13.7 mm-40 -59.54 -55.85 29.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.006 0.431 . . . . 0.0 110.458 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.99 178.04 4.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.596 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.744 HG21 ' HB ' ' C' ' 73' ' ' VAL . 5.2 m -144.58 131.51 16.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.954 0.407 . . . . 0.0 111.164 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.512 ' HA ' HG23 ' A' ' 28' ' ' VAL . 3.6 t70 -98.98 110.55 23.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.439 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.95 HD22 HG11 ' C' ' 128' ' ' VAL . 17.2 mt -73.48 -11.52 60.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.504 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.51 -102.86 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.669 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.11 -30.05 64.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.176 0.512 . . . . 0.0 109.979 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.58 167.54 18.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.55 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.061 HG12 ' HB3' ' A' ' 127' ' ' ALA . 7.1 p -129.5 160.83 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.787 HD13 HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -136.83 122.78 20.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.28 137.71 41.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.046 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.486 ' CB ' ' HB1' ' C' ' 106' ' ' ALA . 16.8 t -71.25 172.67 8.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.32 82.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.074 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.559 ' CB ' HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -56.38 147.51 21.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 0.0 111.385 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 5.0 pt -142.3 149.75 52.66 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.576 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 34' ' ' ILE . 1.6 Cg_endo -83.17 51.09 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.921 2.414 . . . . 0.0 112.481 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 42' ' ' GLU . 86.0 t -94.27 82.47 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.185 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.489 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 0.5 OUTLIER 157.47 -44.69 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.018 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 37' ' ' ASN . 79.9 Cg_exo -42.6 -24.39 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.285 1.99 . . . . 0.0 112.732 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.633 ' HB2' ' CA ' ' A' ' 44' ' ' PRO . . . -90.42 -30.14 17.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.047 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.514 HG22 ' C ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER 158.26 -11.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.814 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 37' ' ' ASN . . . 131.7 58.37 0.09 OUTLIER Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.088 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.767 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -178.8 -65.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.624 0.249 . . . . 0.0 111.283 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 42' ' ' GLU . 5.4 p 164.67 115.87 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.633 ' CA ' ' HB2' ' A' ' 39' ' ' ALA . 37.8 Cg_exo -59.7 147.51 91.75 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.514 2.143 . . . . 0.0 112.1 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.39 -31.0 57.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 110.943 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -67.65 95.79 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.28 -32.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.835 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 t -83.26 -43.23 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . . . -60.62 -44.11 96.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.794 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -74.27 -30.09 61.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.266 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.628 ' HB1' HG22 ' A' ' 88' ' ' VAL . . . -75.95 -33.37 59.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.369 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -30.16 29.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.12 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.21 -33.33 59.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.88 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.0 p -69.43 -35.74 76.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.573 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD22 ' HB2' ' A' ' 92' ' ' TYR . 68.5 mt -63.0 -39.71 95.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.531 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -72.22 -40.56 67.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.673 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -57.82 -41.07 81.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 54' ' ' SER . 16.4 t -60.11 -40.76 84.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.792 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.513 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -76.02 -32.41 59.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.769 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.46 86.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.516 ' HA ' HG21 ' A' ' 8' ' ' THR . 17.3 mt -68.9 -41.65 82.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.722 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.997 HD13 HD11 ' A' ' 72' ' ' ILE . 12.3 mt -69.28 -36.58 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.588 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -40.3 72.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -65.32 -19.04 65.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.539 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 6' ' ' ILE . . . -88.33 -34.17 17.73 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.73 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.48 44.84 0.3 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.812 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 129' ' ' ARG . 1.3 mt -143.0 -170.54 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.716 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.78 157.25 44.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.513 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . . . -58.12 -36.58 73.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.03 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -57.49 -26.09 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.319 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.453 ' CB ' HD22 ' A' ' 67' ' ' LEU . 9.3 m-20 -76.29 -24.48 54.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.879 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 127' ' ' ALA . 39.3 mm -54.14 118.27 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.977 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.718 ' HB ' HG21 ' B' ' 22' ' ' VAL . 5.2 m -90.85 -32.86 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.929 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.668 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 14.3 tttt -143.25 163.97 31.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.658 0.266 . . . . 0.0 111.198 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.578 HG21 ' NH2' ' A' ' 107' ' ' ARG . 3.4 t -162.15 112.52 1.56 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.376 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.414 ' HB ' ' CG ' ' A' ' 124' ' ' GLU . 27.3 m -92.87 160.17 15.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.318 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 122' ' ' GLU . 13.6 t -150.54 142.73 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.041 0.448 . . . . 0.0 111.945 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.519 ' CD2' HG11 ' C' ' 110' ' ' VAL . 3.2 m-85 -121.15 102.56 8.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.189 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.479 HG11 ' HD1' ' A' ' 85' ' ' PHE . 5.8 m -100.55 150.28 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.701 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.08 -1.86 58.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.839 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.59 124.5 1.38 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.477 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.59 HD12 ' HD3' ' B' ' 114' ' ' ARG . 9.7 mt -68.79 -10.67 58.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.196 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.97 -22.81 42.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.827 0.346 . . . . 0.0 110.574 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -88.16 -20.27 25.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.479 ' HD1' HG11 ' A' ' 79' ' ' VAL . 14.4 t80 -57.52 -22.25 43.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.358 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.49 -60.41 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.57 79.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.628 HG22 ' HB1' ' A' ' 51' ' ' ALA . 19.3 t -61.67 -37.4 77.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.915 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.589 ' HA ' ' CE2' ' A' ' 92' ' ' TYR . 36.0 t-20 -62.28 -41.94 98.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.77 -23.46 42.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.351 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.16 -42.33 19.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.77 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.601 ' HB2' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -77.34 -28.7 53.15 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.083 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.88 -33.72 39.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.966 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -72.63 -29.75 63.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.178 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -74.26 -41.65 60.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.782 0.325 . . . . 0.0 110.508 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.477 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 6.9 m-85 -52.04 -50.84 60.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.088 0.47 . . . . 0.0 110.377 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HG3' ' N ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -62.04 -28.9 69.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.135 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -90.88 2.73 55.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.42 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -119.25 -1.52 10.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 7.3 t30 85.75 28.73 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.189 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -121.52 53.63 4.02 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.617 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 45.5 Cg_endo -68.3 -20.49 42.7 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.56 2.173 . . . . 0.0 112.676 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 2.1 m-20 -60.85 -40.34 92.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.942 0.401 . . . . 0.0 110.501 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 27.6 m-85 77.36 120.98 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.833 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.547 ' HG2' HG22 ' A' ' 75' ' ' THR . 84.7 Cg_endo -83.99 162.03 13.76 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.844 2.363 . . . . 0.0 112.303 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.668 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -52.32 163.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.447 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.578 ' NH2' HG21 ' A' ' 75' ' ' THR . 13.7 ttm-85 -146.59 144.52 29.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.159 0.504 . . . . 0.0 111.876 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.14 63.31 1.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.996 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 19.8 p -79.92 134.78 36.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.278 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.61 HG12 HD23 ' B' ' 115' ' ' LEU . 33.9 m -146.25 146.62 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.193 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.6 OUTLIER -79.42 88.05 5.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 78' ' ' PHE . 5.7 m -71.75 155.4 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -71.88 -44.01 64.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.614 ' HD3' HD12 ' C' ' 82' ' ' LEU . 0.5 OUTLIER -152.1 174.71 13.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.607 HD23 HG12 ' C' ' 110' ' ' VAL . 14.0 mt -147.16 156.01 46.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.23 136.33 67.88 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.595 2.197 . . . . 0.0 112.169 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.731 ' HD2' HG21 ' A' ' 36' ' ' VAL . 3.1 ttmt 74.7 14.1 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.232 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.48 17.8 8.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 117' ' ' LYS . 23.1 m -52.1 162.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.845 0.355 . . . . 0.0 111.188 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.698 ' C ' HD13 ' A' ' 121' ' ' LEU . . . -95.42 -25.55 13.66 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.737 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.698 HD13 ' C ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -157.51 148.87 21.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.164 0.507 . . . . 0.0 111.127 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.727 ' O ' HG13 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -121.43 155.98 33.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.199 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.819 HD13 ' HB2' ' A' ' 54' ' ' SER . 4.1 mp -144.06 119.99 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.071 0.462 . . . . 0.0 112.016 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.414 ' CG ' ' HB ' ' A' ' 76' ' ' THR . 0.9 OUTLIER -128.88 149.01 50.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.437 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -163.83 161.18 23.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.313 0.578 . . . . 0.0 112.455 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 28' ' ' VAL . 6.0 mt -118.0 152.44 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.058 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 1.061 ' HB3' HG12 ' A' ' 28' ' ' VAL . . . -133.3 149.9 51.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.139 0.495 . . . . 0.0 111.9 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.065 HG21 HG21 ' B' ' 3' ' ' THR . 36.0 m -122.65 139.4 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.815 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.648 ' HB2' HD21 ' A' ' 67' ' ' LEU . 32.5 ttp180 -135.47 52.3 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.034 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.976 179.937 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.3 42.01 15.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 1.065 HG21 HG21 ' A' ' 128' ' ' VAL . 5.9 m -78.21 152.97 32.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.065 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -177.95 132.5 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.084 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.582 ' HA ' HG12 ' B' ' 22' ' ' VAL . 4.3 mp -57.54 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.488 ' N ' HG22 ' B' ' 5' ' ' ILE . 32.2 mt -113.53 150.57 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.222 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -147.82 134.24 19.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.566 HG21 ' HA ' ' B' ' 61' ' ' ILE . 2.7 t -148.17 163.24 37.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.85 28.67 7.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -110.26 -49.84 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.782 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.714 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -67.98 179.29 0.63 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.714 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 31.5 Cg_exo -59.01 -15.59 28.38 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.742 2.295 . . . . 0.0 112.627 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 73.77 153.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -110.38 119.93 40.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.23 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.63 HG22 ' O ' ' B' ' 15' ' ' ILE . 1.9 mp -132.2 16.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.826 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.44 -137.96 4.6 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.429 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.428 ' HB2' ' CE1' ' A' ' 92' ' ' TYR . 88.9 Cg_endo -84.32 16.52 1.92 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.75 2.3 . . . . 0.0 113.653 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.553 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 1.1 p90 -137.37 177.84 7.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.962 0.411 . . . . 0.0 111.456 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.423 ' HA ' ' CB ' ' B' ' 14' ' ' ALA . 10.5 m -128.75 169.45 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.028 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.43 HE22 ' HB3' ' B' ' 11' ' ' ALA . 13.7 mm-40 -59.76 -55.74 30.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 110.466 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.94 178.12 4.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.594 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.718 HG21 ' HB ' ' A' ' 73' ' ' VAL . 5.2 m -144.62 131.54 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.954 0.407 . . . . 0.0 111.191 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.509 ' HA ' HG23 ' B' ' 28' ' ' VAL . 3.6 t70 -98.96 110.65 23.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.405 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.967 HD22 HG11 ' A' ' 128' ' ' VAL . 17.3 mt -73.55 -11.54 60.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.503 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.58 -102.87 0.68 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.668 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.19 -29.98 64.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.146 0.498 . . . . 0.0 109.972 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.59 167.53 18.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.523 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.071 HG12 ' HB3' ' B' ' 127' ' ' ALA . 7.1 p -129.52 160.78 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.057 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.764 HD13 HD11 ' B' ' 24' ' ' LEU . 0.1 OUTLIER -136.8 122.76 20.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.736 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.24 137.82 40.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.041 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.494 ' CB ' ' HB1' ' A' ' 106' ' ' ALA . 16.6 t -71.27 172.54 9.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.96 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.21 82.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.113 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.531 ' CB ' HG22 ' B' ' 58' ' ' VAL . 0.1 OUTLIER -56.4 147.49 21.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.022 0.439 . . . . 0.0 111.352 -179.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.3 149.69 52.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.552 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.415 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 1.6 Cg_endo -83.12 51.04 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.956 2.437 . . . . 0.0 112.483 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.768 HG21 ' HD2' ' B' ' 117' ' ' LYS . 86.7 t -94.26 82.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.188 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' B' ' 41' ' ' GLY . 0.5 OUTLIER 157.4 -44.68 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.965 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' B' ' 37' ' ' ASN . 81.1 Cg_exo -42.51 -24.49 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.332 2.021 . . . . 0.0 112.726 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.626 ' HB2' ' CA ' ' B' ' 44' ' ' PRO . . . -90.38 -30.18 17.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.048 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.516 HG22 ' C ' ' B' ' 39' ' ' ALA . 1.0 OUTLIER 158.28 -11.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.795 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' B' ' 37' ' ' ASN . . . 131.82 58.26 0.09 OUTLIER Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.142 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.753 ' O ' HG13 ' B' ' 36' ' ' VAL . 0.0 OUTLIER -178.76 -65.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.607 0.241 . . . . 0.0 111.307 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' B' ' 42' ' ' GLU . 5.4 p 164.64 115.88 0.02 OUTLIER Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.074 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.626 ' CA ' ' HB2' ' B' ' 39' ' ' ALA . 37.2 Cg_exo -59.76 147.61 91.53 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.458 2.105 . . . . 0.0 112.073 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.51 -30.99 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.021 0.438 . . . . 0.0 110.912 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' B' ' 49' ' ' ALA . 0.7 OUTLIER -67.6 95.73 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.862 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.22 -32.41 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.806 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -83.25 -43.22 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' B' ' 46' ' ' ASP . . . -60.61 -44.17 96.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.787 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.419 ' HG3' HD11 ' B' ' 121' ' ' LEU . 20.3 pt20 -74.13 -29.15 61.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.228 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.633 ' HB1' HG22 ' B' ' 88' ' ' VAL . . . -76.58 -33.46 58.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.429 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -30.23 29.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.123 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.11 -33.3 59.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.787 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.878 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.0 p -69.54 -35.66 75.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.565 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' B' ' 92' ' ' TYR . 68.4 mt -62.97 -39.78 95.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.504 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -72.11 -40.66 68.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.717 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.75 -41.12 81.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.878 HG23 ' O ' ' B' ' 54' ' ' SER . 16.5 t -60.09 -40.74 84.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.783 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -76.02 -32.53 59.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.747 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.33 -40.59 86.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.566 ' HA ' HG21 ' B' ' 8' ' ' THR . 17.3 mt -68.99 -41.56 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.753 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.988 HD13 HD11 ' B' ' 72' ' ' ILE . 12.3 mt -69.33 -36.58 72.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.536 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -40.21 72.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.229 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.33 -19.06 65.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.533 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.32 -34.16 17.75 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.748 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.49 44.82 0.3 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.769 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.633 HD21 ' HB2' ' B' ' 129' ' ' ARG . 1.3 mt -142.99 -170.47 3.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 110.702 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.79 157.28 44.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.515 ' HB2' ' HG3' ' B' ' 59' ' ' LYS . . . -58.19 -36.57 73.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.991 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.486 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -57.31 -25.8 59.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.294 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.472 ' CB ' HD22 ' B' ' 67' ' ' LEU . 9.4 m-20 -76.7 -24.37 53.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.924 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 1.027 HD13 ' HB2' ' B' ' 127' ' ' ALA . 39.4 mm -54.21 118.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.937 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.764 ' HB ' HG21 ' C' ' 22' ' ' VAL . 5.2 m -90.79 -32.87 5.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.958 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.701 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 14.3 tttt -143.28 163.98 31.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.695 0.283 . . . . 0.0 111.164 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.568 HG21 ' NH2' ' B' ' 107' ' ' ARG . 3.3 t -162.23 112.46 1.53 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.321 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.421 ' HB ' ' CG ' ' B' ' 124' ' ' GLU . 27.6 m -92.8 160.16 15.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.301 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.705 HG13 ' O ' ' B' ' 122' ' ' GLU . 13.6 t -150.52 142.74 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.098 0.475 . . . . 0.0 111.941 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.532 ' CD2' HG11 ' A' ' 110' ' ' VAL . 3.2 m-85 -121.11 102.58 8.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.181 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.475 HG11 ' HD1' ' B' ' 85' ' ' PHE . 5.7 m -100.58 150.33 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.069 0.461 . . . . 0.0 111.671 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.08 -2.11 58.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.846 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.16 124.33 1.48 Allowed 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.509 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.618 HD12 ' HD3' ' C' ' 114' ' ' ARG . 9.7 mt -68.86 -10.69 58.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.165 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.95 -22.76 42.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.799 0.333 . . . . 0.0 110.578 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -88.22 -20.24 25.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.475 ' HD1' HG11 ' B' ' 79' ' ' VAL . 14.3 t80 -57.53 -22.33 43.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.32 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.34 -60.46 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 0.0 111.267 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.56 79.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.633 HG22 ' HB1' ' B' ' 51' ' ' ALA . 19.1 t -61.64 -37.46 78.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.894 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.595 ' HA ' ' CE2' ' B' ' 92' ' ' TYR . 36.0 t-20 -62.25 -41.99 98.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.799 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.79 -23.5 42.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.34 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.04 -42.32 19.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.817 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.595 ' CE2' ' HA ' ' B' ' 89' ' ' ASN . 0.3 OUTLIER -77.35 -28.71 53.12 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.094 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.92 -33.66 39.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -72.62 -29.79 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.14 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CZ ' ' CE1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -74.23 -41.69 60.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.736 0.303 . . . . 0.0 110.473 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 6.9 m-85 -52.08 -50.78 60.91 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.071 0.462 . . . . 0.0 110.372 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' B' ' 98' ' ' GLU . 0.4 OUTLIER -62.12 -28.85 69.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.116 179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 0.4 OUTLIER -90.93 2.76 55.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.433 178.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.1 OUTLIER -119.22 -1.58 10.82 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 7.3 t30 85.76 28.61 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.244 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 0.8 OUTLIER -121.36 53.65 3.87 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.593 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 45.7 Cg_endo -68.32 -20.44 42.6 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.617 2.211 . . . . 0.0 112.694 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 2.1 m-20 -60.92 -40.31 92.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 0.0 110.492 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 27.6 m-85 77.28 121.03 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.825 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.525 ' HG2' HG22 ' B' ' 75' ' ' THR . 84.2 Cg_endo -83.98 162.06 13.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.83 2.354 . . . . 0.0 112.303 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.701 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -52.46 163.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.445 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.568 ' NH2' HG21 ' B' ' 75' ' ' THR . 13.6 ttm-85 -146.57 144.58 29.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.163 0.506 . . . . 0.0 111.836 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.14 63.11 1.49 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.966 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 20.1 p -79.7 134.8 36.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.37 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.611 HG12 HD23 ' C' ' 115' ' ' LEU . 33.9 m -146.43 147.1 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.236 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.6 OUTLIER -79.92 88.07 5.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' B' ' 78' ' ' PHE . 5.7 m -71.78 155.47 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.145 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -71.91 -44.01 64.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.59 ' HD3' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -152.13 174.71 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.925 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.61 HD23 HG12 ' A' ' 110' ' ' VAL . 14.0 mt -147.15 156.04 46.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.38 136.36 67.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.608 2.205 . . . . 0.0 112.135 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.768 ' HD2' HG21 ' B' ' 36' ' ' VAL . 3.1 ttmt 74.64 14.13 3.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.293 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.52 17.76 8.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.961 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 m -52.16 162.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.216 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . 0.715 ' C ' HD13 ' B' ' 121' ' ' LEU . . . -95.24 -25.06 14.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.697 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.715 HD13 ' C ' ' B' ' 120' ' ' GLY . 0.0 OUTLIER -158.2 149.06 20.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.109 0.48 . . . . 0.0 111.099 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.705 ' O ' HG13 ' B' ' 77' ' ' VAL . 0.4 OUTLIER -121.39 156.01 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.188 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' B' ' 54' ' ' SER . 4.1 mp -144.07 119.97 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.097 0.475 . . . . 0.0 111.994 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . 0.421 ' CG ' ' HB ' ' B' ' 76' ' ' THR . 1.0 OUTLIER -128.88 148.97 50.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.434 178.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -163.78 161.22 23.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.297 0.57 . . . . 0.0 112.449 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.419 HG23 ' O ' ' B' ' 28' ' ' VAL . 5.9 mt -118.01 152.43 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.044 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 1.071 ' HB3' HG12 ' B' ' 28' ' ' VAL . . . -133.23 149.98 51.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.129 0.49 . . . . 0.0 111.96 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 1.044 HG21 HG21 ' C' ' 3' ' ' THR . 35.9 m -122.62 139.4 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.861 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.633 ' HB2' HD21 ' B' ' 67' ' ' LEU . 32.5 ttp180 -135.55 52.42 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 111.022 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.055 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.787 0.327 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.38 41.91 15.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.851 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 1.044 HG21 HG21 ' B' ' 128' ' ' VAL . 5.9 m -78.2 153.03 32.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.103 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -178.02 132.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.057 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.591 ' HA ' HG12 ' C' ' 22' ' ' VAL . 4.3 mp -57.54 158.18 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.485 ' N ' HG22 ' C' ' 5' ' ' ILE . 32.3 mt -113.49 150.54 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.243 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -147.75 134.26 19.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.588 HG21 ' HA ' ' C' ' 61' ' ' ILE . 2.7 t -148.15 163.28 37.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.94 28.63 8.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.439 ' CB ' ' HB1' ' C' ' 60' ' ' ALA . 26.6 mmtt -110.2 -49.69 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.752 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -68.1 179.27 0.65 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.984 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 31.7 Cg_exo -59.08 -15.58 28.74 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.755 2.303 . . . . 0.0 112.645 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 73.79 154.0 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.056 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -110.38 119.96 40.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.228 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.611 HG22 ' O ' ' C' ' 15' ' ' ILE . 1.9 mp -132.29 16.23 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.764 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 -137.97 4.61 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.429 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . 0.441 ' HB2' ' CE1' ' B' ' 92' ' ' TYR . 88.4 Cg_endo -84.32 16.58 1.9 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.692 2.261 . . . . 0.0 113.657 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.553 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 1.1 p90 -137.36 177.88 7.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.975 0.416 . . . . 0.0 111.435 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.418 ' HA ' ' CB ' ' C' ' 14' ' ' ALA . 10.6 m -128.78 169.41 20.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.419 HE22 ' HB3' ' C' ' 11' ' ' ALA . 13.7 mm-40 -59.63 -55.51 33.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.457 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.61 178.2 4.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.537 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.764 HG21 ' HB ' ' B' ' 73' ' ' VAL . 5.2 m -144.53 131.5 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.888 0.375 . . . . 0.0 111.179 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.492 ' HA ' HG23 ' C' ' 28' ' ' VAL . 3.6 t70 -99.0 110.63 23.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.447 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.932 HD22 HG11 ' B' ' 128' ' ' VAL . 17.2 mt -73.57 -11.48 60.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.51 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.53 -102.89 0.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.627 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -57.12 -30.06 64.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.173 0.511 . . . . 0.0 109.975 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.53 167.48 18.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 1.021 HG12 ' HB3' ' C' ' 127' ' ' ALA . 7.1 p -129.5 160.77 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.1 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.776 HD13 HD11 ' C' ' 24' ' ' LEU . 0.1 OUTLIER -136.74 122.79 20.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.741 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 29.8 p -103.25 137.71 41.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.958 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . 0.522 ' CB ' ' HB1' ' B' ' 106' ' ' ALA . 16.6 t -71.76 172.78 9.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.034 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.33 82.74 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.11 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.573 ' CB ' HG22 ' C' ' 58' ' ' VAL . 0.0 OUTLIER -56.36 147.48 21.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.039 0.447 . . . . 0.0 111.34 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' C' ' 35' ' ' PRO . 5.0 pt -142.3 149.73 52.58 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.554 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 1.6 Cg_endo -83.2 51.08 3.5 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.938 2.425 . . . . 0.0 112.469 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.777 HG21 ' HD2' ' C' ' 117' ' ' LYS . 87.2 t -94.23 82.48 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.157 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' C' ' 41' ' ' GLY . 0.5 OUTLIER 157.43 -44.65 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.999 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' C' ' 37' ' ' ASN . 79.3 Cg_exo -42.53 -24.53 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.376 2.051 . . . . 0.0 112.714 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CA ' ' C' ' 44' ' ' PRO . . . -90.31 -30.13 17.67 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.107 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.511 HG22 ' C ' ' C' ' 39' ' ' ALA . 1.0 OUTLIER 158.26 -11.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.798 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' C' ' 37' ' ' ASN . . . 131.71 58.41 0.09 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.114 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.748 ' O ' HG13 ' C' ' 36' ' ' VAL . 0.0 OUTLIER -178.81 -65.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.58 0.229 . . . . 0.0 111.283 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' C' ' 42' ' ' GLU . 5.4 p 164.65 115.87 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.083 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.628 ' CA ' ' HB2' ' C' ' 39' ' ' ALA . 37.8 Cg_exo -59.74 147.62 91.44 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.478 2.119 . . . . 0.0 112.088 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.45 -31.03 57.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.439 . . . . 0.0 110.91 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' C' ' 49' ' ' ALA . 0.7 OUTLIER -67.64 95.69 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.873 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tp -41.27 -32.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.826 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -83.24 -43.26 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' C' ' 46' ' ' ASP . . . -60.57 -44.17 96.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.781 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -74.14 -29.65 61.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.319 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.588 ' HB1' HG22 ' C' ' 88' ' ' VAL . . . -76.18 -33.47 59.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.327 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -30.21 29.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.135 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -76.11 -33.32 59.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.857 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.0 p -69.45 -35.76 75.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.575 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.568 HD22 ' HB2' ' C' ' 92' ' ' TYR . 68.5 mt -62.94 -39.81 95.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.495 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -72.12 -40.65 67.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.703 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.73 -41.14 81.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.843 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.857 HG23 ' O ' ' C' ' 54' ' ' SER . 16.5 t -60.04 -40.78 84.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.529 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -76.02 -32.51 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.713 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.439 ' HB1' ' CB ' ' C' ' 10' ' ' LYS . . . -59.44 -40.57 87.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.588 ' HA ' HG21 ' C' ' 8' ' ' THR . 17.4 mt -68.67 -41.58 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.72 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 1.04 HD13 HD11 ' C' ' 72' ' ' ILE . 12.2 mt -69.27 -36.59 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.628 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -40.27 72.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.294 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -65.26 -19.16 65.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.526 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.428 ' HB2' HD13 ' C' ' 6' ' ' ILE . . . -88.29 -34.13 17.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.734 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.44 44.88 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.788 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' C' ' 129' ' ' ARG . 1.3 mt -143.02 -170.55 3.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.728 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.74 157.28 44.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.529 ' HB2' ' HG3' ' C' ' 59' ' ' LYS . . . -58.1 -36.56 73.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -57.51 -25.87 60.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.258 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.468 ' CB ' HD22 ' C' ' 67' ' ' LEU . 9.5 m-20 -76.35 -24.45 54.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.996 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 1.04 HD11 HD13 ' C' ' 62' ' ' ILE . 39.4 mm -54.15 118.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.744 ' HB ' HG21 ' A' ' 22' ' ' VAL . 5.1 m -90.83 -32.87 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.908 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 14.3 tttt -143.23 163.98 31.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.662 0.268 . . . . 0.0 111.188 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.576 HG21 ' NH2' ' C' ' 107' ' ' ARG . 3.4 t -162.16 112.46 1.55 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.418 ' HB ' ' CG ' ' C' ' 124' ' ' GLU . 27.3 m -92.8 160.17 15.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.305 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.723 HG13 ' O ' ' C' ' 122' ' ' GLU . 13.6 t -150.52 142.76 17.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.102 0.477 . . . . 0.0 111.918 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.557 ' CD2' HG11 ' B' ' 110' ' ' VAL . 3.2 m-85 -121.09 102.49 8.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.206 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.473 HG11 ' HD1' ' C' ' 85' ' ' PHE . 5.7 m -100.57 150.26 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.008 0.433 . . . . 0.0 111.715 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.05 -1.7 58.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.893 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -166.92 124.59 1.29 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.458 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.614 HD12 ' HD3' ' A' ' 114' ' ' ARG . 9.7 mt -68.76 -10.78 58.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.148 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -79.88 -22.83 42.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.796 0.332 . . . . 0.0 110.598 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -88.18 -20.3 25.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.473 ' HD1' HG11 ' C' ' 79' ' ' VAL . 14.3 t80 -57.54 -22.26 43.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.322 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.4 -60.47 3.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 111.28 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.69 -48.59 79.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.588 HG22 ' HB1' ' C' ' 51' ' ' ALA . 19.4 t -61.7 -37.4 77.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.944 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . 0.593 ' HA ' ' CE2' ' C' ' 92' ' ' TYR . 36.0 t-20 -62.32 -41.91 98.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.774 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.76 -23.33 42.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.347 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 1.2 tp10 -82.31 -42.34 18.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.778 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.593 ' CE2' ' HA ' ' C' ' 89' ' ' ASN . 0.3 OUTLIER -77.41 -28.68 52.72 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.071 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -79.92 -33.78 39.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 16.5 ptp180 -72.48 -29.85 64.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.198 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.478 ' CZ ' ' CE1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -74.18 -41.71 61.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.478 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 7.0 m-85 -52.08 -50.8 60.87 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.358 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -28.88 69.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.145 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.89 2.76 55.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.437 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.1 OUTLIER -119.22 -1.63 10.81 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 7.3 t30 85.84 28.69 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.172 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.474 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 0.8 OUTLIER -121.34 53.63 3.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.627 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 45.9 Cg_endo -68.37 -20.39 42.35 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 112.675 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 2.2 m-20 -61.01 -40.17 92.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.882 0.372 . . . . 0.0 110.482 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 27.6 m-85 77.21 121.02 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.805 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.551 ' HG2' HG22 ' C' ' 75' ' ' THR . 85.0 Cg_endo -83.99 161.98 13.74 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.854 2.369 . . . . 0.0 112.288 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -52.28 163.61 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.434 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.576 ' NH2' HG21 ' C' ' 75' ' ' THR . 13.6 ttm-85 -146.62 144.5 29.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.199 0.524 . . . . 0.0 111.898 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -140.11 63.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.988 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 20.0 p -79.91 134.75 36.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.339 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.607 HG12 HD23 ' A' ' 115' ' ' LEU . 33.9 m -146.07 145.89 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -78.96 88.2 4.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.761 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' C' ' 78' ' ' PHE . 5.8 m -71.84 155.45 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.129 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -71.9 -44.01 64.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.618 ' HD3' HD12 ' B' ' 82' ' ' LEU . 0.5 OUTLIER -152.13 174.69 13.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.874 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.611 HD23 HG12 ' B' ' 110' ' ' VAL . 13.9 mt -147.13 155.99 46.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.942 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.21 136.38 68.22 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.621 2.214 . . . . 0.0 112.156 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.777 ' HD2' HG21 ' C' ' 36' ' ' VAL . 3.1 ttmt 74.59 14.13 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.309 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.54 17.75 8.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.41 HG13 ' HB3' ' C' ' 117' ' ' LYS . 23.2 m -52.15 162.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . 0.703 ' C ' HD13 ' C' ' 121' ' ' LEU . . . -95.48 -25.36 13.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.726 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.703 HD13 ' C ' ' C' ' 120' ' ' GLY . 0.0 OUTLIER -157.81 148.96 21.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.146 0.498 . . . . 0.0 111.191 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.723 ' O ' HG13 ' C' ' 77' ' ' VAL . 0.4 OUTLIER -121.42 156.03 33.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.187 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.8 HD13 ' HB2' ' C' ' 54' ' ' SER . 4.1 mp -144.05 120.05 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.062 0.458 . . . . 0.0 112.056 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . 0.418 ' CG ' ' HB ' ' C' ' 76' ' ' THR . 1.0 OUTLIER -128.97 148.93 50.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.429 178.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -163.8 161.2 23.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.28 0.562 . . . . 0.0 112.429 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.414 HG23 ' O ' ' C' ' 28' ' ' VAL . 5.9 mt -118.03 152.36 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.053 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 1.021 ' HB3' HG12 ' C' ' 28' ' ' VAL . . . -133.25 150.01 51.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.093 0.473 . . . . 0.0 111.946 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 1.13 HG21 HG21 ' A' ' 3' ' ' THR . 35.2 m -122.69 139.39 49.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.803 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.618 ' HB2' HD21 ' C' ' 67' ' ' LEU . 32.6 ttp180 -135.51 52.48 2.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.987 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.031 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 ttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.822 0.344 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.8 mtm -141.15 159.83 41.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.509 ' CG2' HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER 59.91 109.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.57 122.74 7.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.486 HD13 HG12 ' A' ' 22' ' ' VAL . 39.2 mm -55.67 144.39 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.543 HD12 ' CB ' ' A' ' 21' ' ' ALA . 32.8 mt -109.49 143.51 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -146.99 141.8 26.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.1 159.34 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.1 28.54 4.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.007 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -122.39 -44.16 2.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.778 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.869 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.22 171.64 4.59 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.114 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.869 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 30.4 Cg_endo -63.86 -12.68 33.0 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.538 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 69.82 147.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.009 0.433 . . . . 0.0 111.336 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.801 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -106.15 123.23 47.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.011 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.801 HD13 ' O ' ' A' ' 14' ' ' ALA . 17.6 mm -131.9 16.96 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.861 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.24 -128.05 3.19 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.385 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -90.02 24.61 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.782 2.322 . . . . 0.0 113.484 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.734 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -152.1 174.53 13.58 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.752 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG13 ' HB2' ' C' ' 104' ' ' PHE . 15.8 m -123.12 173.24 9.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.826 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.466 HE21 ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -59.62 -40.41 87.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 110.399 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . 175.62 175.22 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.803 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' C' ' 73' ' ' VAL . 1.8 m -140.22 134.87 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.35 108.86 15.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.597 HD21 HG11 ' C' ' 73' ' ' VAL . 4.1 mm? -84.18 -16.93 41.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.0 -105.75 0.86 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.993 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -53.83 -30.13 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.066 0.46 . . . . 0.0 110.298 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.9 132.8 52.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.843 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.074 HG13 ' HB3' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -131.3 151.99 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.659 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.769 HD23 HD12 ' A' ' 126' ' ' ILE . 0.5 OUTLIER -144.15 140.01 29.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.809 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.3 p -106.28 142.44 35.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.6 p -69.67 155.89 39.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.142 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.02 94.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.518 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.665 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.5 mp0 -78.23 156.22 29.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.992 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.744 ' HB ' HG11 ' A' ' 119' ' ' VAL . 7.0 pt -136.02 146.65 57.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.982 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 53.3 Cg_endo -69.36 61.56 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.863 2.375 . . . . 0.0 112.729 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.568 HG23 HG13 ' A' ' 34' ' ' ILE . 59.7 t -68.07 85.97 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.085 0.469 . . . . 0.0 110.584 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 36' ' ' VAL . 9.0 t-20 -29.46 121.22 0.29 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.242 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.58 -15.09 43.76 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.377 2.051 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.59 -15.77 10.8 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.3 -30.16 7.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.849 0.357 . . . . 0.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.49 52.66 9.83 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.413 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.484 ' O ' HG12 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -174.65 -76.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 111.208 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG21 ' H ' ' A' ' 120' ' ' GLY . 11.3 p -174.27 123.23 0.39 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.65 140.48 51.72 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.272 1.982 . . . . 0.0 112.055 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.12 -30.96 60.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.121 0.486 . . . . 0.0 111.077 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -67.02 95.68 0.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.64 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 47' ' ' ILE . 6.4 tp -45.05 -30.54 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.307 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.77 -38.68 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.485 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 46' ' ' ASP . . . -60.98 -53.94 51.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.307 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.568 ' HG3' HD21 ' A' ' 121' ' ' LEU . 17.8 pt20 -62.81 -29.43 70.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.104 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.67 ' HB1' HG13 ' A' ' 88' ' ' VAL . . . -71.18 -35.01 71.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.893 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -80.79 -41.23 23.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.808 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -40.54 96.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 58' ' ' VAL . 13.1 p -64.29 -29.92 70.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.761 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.89 HD21 ' CD2' ' A' ' 92' ' ' TYR . 8.8 mt -82.04 -18.84 41.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.807 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.49 -49.04 9.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.453 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.443 ' OD1' HG23 ' A' ' 58' ' ' VAL . 24.4 p30 -62.79 -33.18 74.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.278 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.738 HG21 ' CG2' ' A' ' 123' ' ' ILE . 92.3 t -73.16 -40.84 58.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.508 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' HA ' HD12 ' A' ' 62' ' ' ILE . 8.4 tttm -73.05 -33.38 65.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.581 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.44 91.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.76 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.2 mt -68.6 -41.78 83.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.647 HG21 HD11 ' A' ' 72' ' ' ILE . 12.8 mt -67.37 -38.83 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.696 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.8 -37.43 67.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.292 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.59 -20.2 66.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.514 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.15 19.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.985 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.15 47.89 0.79 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.429 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 129' ' ' ARG . 26.3 mt -149.05 136.09 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -87.91 163.25 16.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.161 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.716 ' HA ' HD13 ' A' ' 72' ' ' ILE . . . -54.71 -30.24 55.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.119 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.569 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -67.93 -22.16 65.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.249 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.04 -30.8 69.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 110.213 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.716 HD13 ' HA ' ' A' ' 69' ' ' ALA . 4.0 mp -67.21 108.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.623 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.636 ' HB ' HG21 ' B' ' 22' ' ' VAL . 6.6 m -78.88 -32.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.828 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.675 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 49.7 tttt -131.85 156.61 45.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.769 0.319 . . . . 0.0 110.918 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 125' ' ' ALA . 1.3 m -146.8 117.4 7.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.327 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 108' ' ' SER . 86.6 m -105.34 144.89 31.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.208 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.655 HG13 HD13 ' A' ' 123' ' ' ILE . 38.8 t -151.57 121.21 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 0.0 111.666 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.55 ' HB2' HD21 ' A' ' 115' ' ' LEU . 6.6 m-85 -95.85 118.88 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.274 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.607 HG11 ' CD1' ' A' ' 85' ' ' PHE . 13.5 m -110.54 151.98 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.187 0.518 . . . . 0.0 111.757 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -6.6 31.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.785 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.48 94.18 2.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.364 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 82' ' ' LEU . 4.8 mt -63.61 -13.93 46.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.271 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.3 -27.94 53.12 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.84 -17.5 25.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.503 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.607 ' CD1' HG11 ' A' ' 79' ' ' VAL . 22.4 t80 -57.95 -24.53 58.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.93 -41.96 35.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.841 0.353 . . . . 0.0 111.378 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.2 -33.57 20.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.702 HG12 ' HE1' ' A' ' 92' ' ' TYR . 28.8 t -65.8 -54.52 26.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.665 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 17.1 t-20 -56.62 -43.95 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.972 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.96 70.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.786 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -34.91 77.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.89 ' CD2' HD21 ' A' ' 55' ' ' LEU . 53.3 m-85 -67.36 -45.9 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 0.0 110.156 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -25.36 66.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.335 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -77.0 -38.2 53.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.231 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -37.94 24.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.851 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 7.5 m-85 -53.36 -52.02 60.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.168 0.508 . . . . 0.0 110.225 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -30.33 70.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.318 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.66 3.22 53.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.642 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.504 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -116.34 -6.25 11.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.877 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER 89.13 26.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.303 0.573 . . . . 0.0 110.505 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.569 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 12.9 t-160 -118.87 54.52 2.3 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.532 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.68 -18.64 32.57 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.702 2.268 . . . . 0.0 112.862 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.416 ' O ' ' CG1' ' B' ' 19' ' ' VAL . 1.9 m-20 -57.78 -39.26 77.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.85 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' B' ' 19' ' ' VAL . 8.1 m-85 81.07 123.36 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.427 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' A' ' 101' ' ' HIS . 97.1 Cg_endo -86.74 162.41 9.2 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.748 2.298 . . . . 0.0 112.707 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.675 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -56.45 140.74 44.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.533 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.443 ' HB2' ' HB3' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -102.07 138.45 39.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.032 0.444 . . . . 0.0 111.553 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.885 ' O ' HG23 ' A' ' 76' ' ' THR . 12.0 t -148.17 55.14 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 5.1 m -103.0 151.34 22.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.193 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.551 HG11 ' CD2' ' B' ' 78' ' ' PHE . 29.4 m -156.89 160.53 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 5.9 tt0 -86.98 94.21 9.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.87 171.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.216 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -84.41 -50.01 8.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.991 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.402 ' HB3' ' CB ' ' C' ' 111' ' ' GLU . 0.1 OUTLIER -146.13 171.36 15.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.731 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 122' ' ' GLU . 3.2 mt -143.49 160.05 52.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.575 ' O ' HG22 ' A' ' 119' ' ' VAL . 68.2 Cg_exo -50.83 135.93 42.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.506 2.137 . . . . 0.0 112.159 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.28 15.96 8.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.159 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 62.78 16.6 9.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.744 HG11 ' HB ' ' A' ' 34' ' ' ILE . 15.6 m -53.13 170.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.832 0.349 . . . . 0.0 111.147 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.543 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -101.9 -2.93 52.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.964 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.568 HD21 ' HG3' ' A' ' 50' ' ' GLN . 4.2 pp -175.92 148.49 0.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.899 0.381 . . . . 0.0 111.286 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -119.93 163.63 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.302 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.738 ' CG2' HG21 ' A' ' 58' ' ' VAL . 15.6 mm -139.75 129.93 30.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 111.862 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.86 119.04 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.082 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.529 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -133.88 161.95 33.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.03 0.443 . . . . 0.0 111.852 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.769 HD12 HD23 ' A' ' 29' ' ' LEU . 5.8 mm -111.93 150.65 14.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.474 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 1.074 ' HB3' HG13 ' A' ' 28' ' ' VAL . . . -127.43 157.86 38.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.038 0.447 . . . . 0.0 111.783 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 73' ' ' VAL . 34.6 m -130.04 116.25 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.891 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.728 ' HB2' HD21 ' A' ' 67' ' ' LEU . 75.6 ttt-85 -120.06 70.87 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.899 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ttt . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.781 0.324 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 3.8 mtm -141.14 159.91 41.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.989 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.524 ' CG2' HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER 59.85 109.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.974 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.53 122.69 7.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.836 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.515 HD13 HG12 ' B' ' 22' ' ' VAL . 39.2 mm -55.56 144.39 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.217 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.491 HD12 ' CB ' ' B' ' 21' ' ' ALA . 32.0 mt -109.44 143.41 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.156 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -146.98 141.76 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.09 159.35 43.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.16 28.48 4.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.977 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.18 -44.09 2.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.865 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -67.34 171.73 4.6 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.931 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.865 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 30.7 Cg_endo -63.81 -12.71 33.03 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.544 2.162 . . . . 0.0 112.612 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 69.82 147.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.378 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.792 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -106.14 123.19 47.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.792 HD13 ' O ' ' B' ' 14' ' ' ALA . 17.6 mm -131.92 17.01 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.834 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.25 -128.06 3.19 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.441 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.99 24.59 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.769 2.312 . . . . 0.0 113.494 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.725 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.7 OUTLIER -152.08 174.48 13.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.038 0.447 . . . . 0.0 111.758 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 104' ' ' PHE . 15.8 m -123.14 173.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.458 HE21 ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -59.48 -40.37 86.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.016 0.436 . . . . 0.0 110.505 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.491 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . 174.86 175.35 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.854 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.636 HG21 ' HB ' ' A' ' 73' ' ' VAL . 1.9 m -140.32 134.84 35.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.37 108.87 15.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.621 HD21 HG11 ' A' ' 73' ' ' VAL . 4.1 mm? -84.31 -16.86 41.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.01 -105.75 0.86 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -53.84 -30.16 44.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.076 0.465 . . . . 0.0 110.288 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.86 132.87 52.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.812 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.051 HG13 ' HB3' ' B' ' 127' ' ' ALA . 0.1 OUTLIER -131.37 151.97 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.66 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.782 HD23 HD12 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -144.2 139.98 29.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.812 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.3 p -106.09 141.36 37.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.425 ' HA ' ' HB1' ' A' ' 106' ' ' ALA . 79.1 p -69.3 156.1 39.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.087 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.97 94.05 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.521 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.658 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.5 mp0 -78.15 156.2 30.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 110.999 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.737 ' HB ' HG11 ' B' ' 119' ' ' VAL . 7.0 pt -136.06 146.64 57.4 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.981 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 53.5 Cg_endo -69.31 61.49 1.49 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.868 2.379 . . . . 0.0 112.733 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.591 HG23 HG13 ' B' ' 34' ' ' ILE . 60.0 t -68.07 85.97 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.105 0.478 . . . . 0.0 110.612 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' B' ' 36' ' ' VAL . 9.0 t-20 -29.46 121.2 0.29 Allowed Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.278 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.48 -15.14 43.62 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.344 2.029 . . . . 0.0 112.4 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.53 -15.87 10.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.21 -30.28 7.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.885 0.374 . . . . 0.0 110.964 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.64 52.63 9.57 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.449 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.447 ' O ' HG12 ' B' ' 119' ' ' VAL . 0.0 OUTLIER -174.62 -76.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.53 HG21 ' H ' ' B' ' 120' ' ' GLY . 11.3 p -174.29 123.22 0.39 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.08 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.61 140.46 51.85 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.294 1.996 . . . . 0.0 112.077 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.2 -30.9 60.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 111.046 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' B' ' 49' ' ' ALA . 0.2 OUTLIER -66.98 95.59 0.39 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.732 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.425 ' HA ' HD12 ' B' ' 47' ' ' ILE . 6.3 tp -45.06 -30.48 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.305 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.85 -38.68 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.452 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' B' ' 46' ' ' ASP . . . -60.88 -54.09 49.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.313 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.546 ' HG3' HD21 ' B' ' 121' ' ' LEU . 17.9 pt20 -62.66 -29.55 70.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.072 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.686 ' HB1' HG13 ' B' ' 88' ' ' VAL . . . -71.07 -34.94 71.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.802 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -80.83 -41.23 23.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.786 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -40.53 96.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.689 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.583 ' O ' HG23 ' B' ' 58' ' ' VAL . 13.0 p -64.24 -30.0 71.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.759 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.902 HD21 ' CD2' ' B' ' 92' ' ' TYR . 8.8 mt -82.05 -18.76 42.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.51 -49.1 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.409 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.432 ' OD1' HG23 ' B' ' 58' ' ' VAL . 24.8 p30 -62.66 -33.27 74.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.289 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.747 HG21 ' CG2' ' B' ' 123' ' ' ILE . 91.2 t -73.07 -40.87 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.967 0.413 . . . . 0.0 110.535 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.533 ' HA ' HD12 ' B' ' 62' ' ' ILE . 8.4 tttm -73.11 -33.31 65.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.573 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.43 91.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.71 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -68.61 -41.75 83.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.698 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.656 HG21 HD11 ' B' ' 72' ' ' ILE . 13.0 mt -67.36 -38.86 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.81 -37.45 67.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.281 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.53 -20.13 66.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.563 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.01 -25.1 18.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.971 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.14 47.87 0.8 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.733 HD21 ' HB2' ' B' ' 129' ' ' ARG . 26.4 mt -149.06 136.2 19.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.365 . . . . 0.0 110.813 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -88.05 163.27 16.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.151 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.719 ' HA ' HD13 ' B' ' 72' ' ' ILE . . . -54.73 -30.29 55.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.069 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.557 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -67.84 -22.12 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.285 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.21 -30.75 68.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 110.228 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.719 HD13 ' HA ' ' B' ' 69' ' ' ALA . 4.0 mp -67.23 108.58 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.705 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.624 HG13 HG22 ' B' ' 128' ' ' VAL . 6.5 m -78.94 -31.96 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.834 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.649 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 49.7 tttt -131.91 156.6 45.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.735 0.302 . . . . 0.0 110.96 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.541 HG23 ' HB2' ' B' ' 125' ' ' ALA . 1.3 m -146.81 117.4 7.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.309 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.873 HG23 ' O ' ' B' ' 108' ' ' SER . 86.7 m -105.38 144.88 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.235 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.63 HG13 HD13 ' B' ' 123' ' ' ILE . 38.8 t -151.5 121.22 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.946 0.403 . . . . 0.0 111.735 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.551 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.5 m-85 -95.84 118.84 33.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.25 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.614 HG11 ' CD1' ' B' ' 85' ' ' PHE . 13.5 m -110.52 152.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 0.0 111.78 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -6.58 31.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.715 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -149.66 94.25 2.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.347 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' B' ' 82' ' ' LEU . 4.7 mt -63.57 -13.97 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.31 -27.9 53.1 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.79 -17.55 25.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.519 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' B' ' 79' ' ' VAL . 22.2 t80 -57.96 -24.43 57.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.222 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.03 -41.96 36.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.799 0.333 . . . . 0.0 111.354 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.17 -33.52 20.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.696 HG12 ' HE1' ' B' ' 92' ' ' TYR . 28.4 t -65.84 -54.59 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.41 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 17.1 t-20 -56.62 -43.91 80.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.998 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.96 70.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.729 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -34.9 77.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.902 ' CD2' HD21 ' B' ' 55' ' ' LEU . 52.9 m-85 -67.38 -45.92 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.147 0.499 . . . . 0.0 110.119 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -25.41 66.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.403 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -76.96 -38.25 53.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.228 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.1 OUTLIER -82.56 -37.99 24.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.812 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' B' ' 92' ' ' TYR . 7.5 m-85 -53.32 -52.03 60.46 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.185 0.517 . . . . 0.0 110.265 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -30.27 70.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.337 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.58 3.19 53.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.488 ' O ' ' ND2' ' B' ' 100' ' ' ASN . 0.6 OUTLIER -116.39 -6.17 11.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.871 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 99' ' ' ASN . 0.0 OUTLIER 89.08 25.82 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.326 0.584 . . . . 0.0 110.495 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.557 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 12.8 t-160 -118.63 54.52 2.18 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.492 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CZ ' ' B' ' 104' ' ' PHE . 58.1 Cg_endo -70.65 -18.65 32.68 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.687 2.258 . . . . 0.0 112.862 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.42 ' O ' ' CG1' ' C' ' 19' ' ' VAL . 1.9 m-20 -57.77 -39.24 76.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.773 0.32 . . . . 0.0 110.819 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.503 ' HB2' HG13 ' C' ' 19' ' ' VAL . 8.1 m-85 81.02 123.27 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.494 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' B' ' 101' ' ' HIS . 97.1 Cg_endo -86.72 162.37 9.22 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.746 2.297 . . . . 0.0 112.648 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.649 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -56.37 140.71 44.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.553 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -102.07 138.45 39.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.08 0.467 . . . . 0.0 111.503 -179.409 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.873 ' O ' HG23 ' B' ' 76' ' ' THR . 12.0 t -148.2 55.16 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.009 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 5.1 m -102.99 151.37 22.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.187 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.533 HG11 ' CD2' ' C' ' 78' ' ' PHE . 29.5 m -156.89 160.75 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.102 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 5.8 tt0 -87.14 94.3 9.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.94 171.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.253 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -84.34 -50.14 8.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.02 171.39 14.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.742 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.819 HD22 ' HB2' ' B' ' 122' ' ' GLU . 3.2 mt -143.57 160.01 52.44 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.812 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.579 ' O ' HG22 ' B' ' 119' ' ' VAL . 68.7 Cg_exo -50.78 135.89 42.6 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.558 2.172 . . . . 0.0 112.137 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.31 15.98 8.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.064 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 62.82 16.54 9.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.021 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.737 HG11 ' HB ' ' B' ' 34' ' ' ILE . 15.6 m -53.13 170.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.832 0.349 . . . . 0.0 111.177 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . 0.53 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -101.98 -3.1 51.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.988 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' B' ' 50' ' ' GLN . 4.2 pp -175.76 148.37 0.87 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 111.255 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.819 ' HB2' HD22 ' B' ' 115' ' ' LEU . 0.0 OUTLIER -119.86 163.69 17.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.326 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.747 ' CG2' HG21 ' B' ' 58' ' ' VAL . 15.7 mm -139.77 129.89 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 111.881 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.87 118.99 5.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.074 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -133.84 161.91 33.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.979 0.419 . . . . 0.0 111.884 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.782 HD12 HD23 ' B' ' 29' ' ' LEU . 5.8 mm -111.86 150.6 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.515 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 1.051 ' HB3' HG13 ' B' ' 28' ' ' VAL . . . -127.4 157.85 38.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 111.764 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.624 HG22 HG13 ' B' ' 73' ' ' VAL . 34.1 m -130.0 116.24 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.837 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.733 ' HB2' HD21 ' B' ' 67' ' ' LEU . 75.7 ttt-85 -120.06 70.88 0.88 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.999 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.89 179.968 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 16.4 ttt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.793 0.33 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 3.8 mtm -141.17 159.8 41.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.507 ' CG2' HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER 59.91 109.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.6 122.73 7.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.5 HD13 HG12 ' C' ' 22' ' ' VAL . 39.1 mm -55.65 144.42 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.176 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.534 HD12 ' CB ' ' C' ' 21' ' ' ALA . 32.5 mt -109.52 143.46 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -146.99 141.73 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -146.0 159.39 43.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.15 28.5 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.33 -44.18 2.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.712 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.87 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.26 171.74 4.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.036 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.87 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 30.7 Cg_endo -63.8 -12.74 33.12 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.567 2.178 . . . . 0.0 112.615 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 69.88 147.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.322 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.803 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -106.14 123.22 47.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.053 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.803 HD13 ' O ' ' C' ' 14' ' ' ALA . 17.6 mm -131.94 17.03 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.857 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.24 -128.05 3.19 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.399 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -90.1 24.63 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.769 2.313 . . . . 0.0 113.444 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.736 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.7 OUTLIER -152.06 174.52 13.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.093 0.473 . . . . 0.0 111.727 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' B' ' 104' ' ' PHE . 15.8 m -123.12 173.28 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.802 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.469 HE21 ' HB3' ' C' ' 11' ' ' ALA . 0.0 OUTLIER -59.52 -39.94 85.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 110.374 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . 174.75 175.44 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.852 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.615 HG21 ' HB ' ' B' ' 73' ' ' VAL . 1.9 m -140.33 134.79 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.32 108.9 15.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.62 HD21 HG11 ' B' ' 73' ' ' VAL . 4.1 mm? -84.27 -16.9 41.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.96 -105.74 0.86 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.0 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -53.88 -30.13 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.082 0.468 . . . . 0.0 110.253 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.94 132.8 52.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.858 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 1.031 HG13 ' HB3' ' C' ' 127' ' ' ALA . 0.1 OUTLIER -131.29 152.06 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.656 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.799 HD23 HD12 ' C' ' 126' ' ' ILE . 0.4 OUTLIER -144.22 139.95 28.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.838 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 25.5 p -106.15 141.46 37.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.773 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 79.6 p -69.17 155.82 39.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.97 94.08 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.481 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.643 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.5 mp0 -78.17 156.07 30.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 111.02 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.756 ' HB ' HG11 ' C' ' 119' ' ' VAL . 7.0 pt -135.94 146.69 57.87 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.467 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 53.1 Cg_endo -69.37 61.51 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.821 2.347 . . . . 0.0 112.756 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.589 HG23 HG13 ' C' ' 34' ' ' ILE . 59.8 t -68.03 85.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 0.0 110.602 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' C' ' 38' ' ' PRO . 9.1 t-20 -29.48 121.22 0.29 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.201 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 37' ' ' ASN . 25.6 Cg_exo -62.53 -15.12 43.69 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.338 2.025 . . . . 0.0 112.374 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.56 -15.83 10.81 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.29 -30.13 7.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.818 0.342 . . . . 0.0 110.979 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.54 52.65 9.75 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.381 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.519 ' O ' HG12 ' C' ' 119' ' ' VAL . 0.0 OUTLIER -174.59 -76.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.784 0.326 . . . . 0.0 111.215 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.574 HG21 ' H ' ' C' ' 120' ' ' GLY . 11.3 p -174.28 123.19 0.39 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.55 140.42 52.02 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.315 2.01 . . . . 0.0 112.077 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.14 -30.98 60.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.019 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -66.95 95.6 0.38 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.698 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' C' ' 47' ' ' ILE . 6.3 tp -45.02 -30.52 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.29 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.86 -38.62 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.496 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' C' ' 46' ' ' ASP . . . -60.96 -53.93 51.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.292 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' C' ' 121' ' ' LEU . 17.9 pt20 -62.97 -29.53 70.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.052 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.635 ' HB1' HG13 ' C' ' 88' ' ' VAL . . . -71.34 -35.06 71.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.959 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -80.81 -41.19 23.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.754 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -40.47 96.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.662 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.597 ' O ' HG23 ' C' ' 58' ' ' VAL . 13.3 p -64.27 -30.06 71.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.906 HD21 ' CD2' ' C' ' 92' ' ' TYR . 8.8 mt -81.98 -18.81 42.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.53 -49.02 9.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.424 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . 0.434 ' OD1' HG23 ' C' ' 58' ' ' VAL . 24.4 p30 -62.75 -33.24 74.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.263 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.748 HG21 ' CG2' ' C' ' 123' ' ' ILE . 91.6 t -73.1 -40.88 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.381 . . . . 0.0 110.54 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.531 ' HA ' HD12 ' C' ' 62' ' ' ILE . 8.3 tttm -73.05 -33.28 65.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.639 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.55 92.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.775 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -68.63 -41.78 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.742 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.646 HD13 HD11 ' C' ' 72' ' ' ILE . 12.9 mt -67.41 -38.8 81.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.734 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.86 -37.39 67.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.275 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -65.52 -20.21 66.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.589 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.18 19.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.2 47.91 0.79 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.41 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.734 HD13 HG11 ' C' ' 28' ' ' VAL . 26.3 mt -149.08 136.15 19.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 110.846 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 2.8 m -88.02 163.23 16.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.157 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.734 ' HA ' HD13 ' C' ' 72' ' ' ILE . . . -54.7 -30.2 55.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.137 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.568 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -67.8 -22.14 65.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.244 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.13 -30.77 69.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.985 0.422 . . . . 0.0 110.181 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.734 HD13 ' HA ' ' C' ' 69' ' ' ALA . 4.0 mp -67.25 108.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.684 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.62 HG13 HG22 ' C' ' 128' ' ' VAL . 6.5 m -79.04 -31.92 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.826 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.68 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 49.7 tttt -131.91 156.54 45.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.946 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.537 HG23 ' HB2' ' C' ' 125' ' ' ALA . 1.3 m -146.76 117.44 7.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.306 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.885 HG23 ' O ' ' C' ' 108' ' ' SER . 86.4 m -105.35 144.95 31.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.219 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.663 HG13 HD13 ' C' ' 123' ' ' ILE . 38.8 t -151.59 121.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.391 . . . . 0.0 111.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.549 ' HB2' HD21 ' C' ' 115' ' ' LEU . 6.4 m-85 -95.74 118.81 33.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.323 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' C' ' 85' ' ' PHE . 13.4 m -110.56 151.96 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.148 0.499 . . . . 0.0 111.737 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.12 -6.74 30.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.758 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.41 94.24 2.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.342 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' C' ' 82' ' ' LEU . 4.8 mt -63.61 -14.01 47.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.247 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.34 -27.91 52.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -91.74 -17.57 25.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.526 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.615 ' CD1' HG11 ' C' ' 79' ' ' VAL . 22.3 t80 -58.02 -24.38 58.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.198 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.02 -41.94 36.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.841 0.353 . . . . 0.0 111.393 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.15 -33.59 20.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.766 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.698 HG12 ' HE1' ' C' ' 92' ' ' TYR . 29.4 t -65.88 -54.54 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.571 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . 0.409 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 17.1 t-20 -56.58 -43.96 80.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.976 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.06 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.795 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.63 -34.89 77.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.906 ' CD2' HD21 ' C' ' 55' ' ' LEU . 53.4 m-85 -67.35 -45.92 74.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.154 0.502 . . . . 0.0 110.112 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.83 -25.45 66.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.378 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -76.98 -38.24 53.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.235 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.1 OUTLIER -82.54 -37.96 24.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.819 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' C' ' 92' ' ' TYR . 7.5 m-85 -53.35 -52.01 60.6 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.201 0.524 . . . . 0.0 110.247 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -30.3 70.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.298 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.6 3.1 53.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.666 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' C' ' 100' ' ' ASN . 0.6 OUTLIER -116.3 -6.23 11.81 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.889 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' C' ' 99' ' ' ASN . 0.0 OUTLIER 89.16 26.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.305 0.574 . . . . 0.0 110.516 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.568 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 12.9 t-160 -118.82 54.62 2.31 Favored Pre-proline 0 CA--C 1.529 0.154 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.529 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.403 ' O ' ' CE1' ' C' ' 104' ' ' PHE . 58.4 Cg_endo -70.69 -18.69 32.47 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.726 2.284 . . . . 0.0 112.868 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.409 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 1.9 m-20 -57.77 -39.2 76.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.76 0.314 . . . . 0.0 110.849 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.502 ' HB2' HG13 ' A' ' 19' ' ' VAL . 8.1 m-85 81.05 123.26 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.463 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.426 ' HD3' ' CE1' ' C' ' 101' ' ' HIS . 98.1 Cg_endo -86.7 162.3 9.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.779 2.319 . . . . 0.0 112.713 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.68 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -56.35 140.81 44.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.565 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -102.15 138.37 39.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.057 0.456 . . . . 0.0 111.502 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . 0.885 ' O ' HG23 ' C' ' 76' ' ' THR . 12.0 t -148.14 55.26 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.058 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 5.2 m -103.09 151.35 22.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.17 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.523 HG11 ' CD2' ' A' ' 78' ' ' PHE . 29.3 m -156.98 160.74 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.123 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 6.0 tt0 -87.04 94.17 9.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.8 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.88 171.19 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.237 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -84.4 -49.99 8.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.029 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.14 171.35 15.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.809 HD22 ' HB2' ' C' ' 122' ' ' GLU . 3.2 mt -143.51 160.02 52.6 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.833 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.579 ' O ' HG22 ' C' ' 119' ' ' VAL . 69.9 Cg_exo -50.92 135.9 43.63 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.477 2.118 . . . . 0.0 112.149 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.32 16.01 8.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.103 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 62.8 16.58 9.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.987 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.756 HG11 ' HB ' ' C' ' 34' ' ' ILE . 15.7 m -53.16 170.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.819 0.342 . . . . 0.0 111.163 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . 0.574 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -101.88 -3.23 52.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.997 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.557 HD21 ' HG3' ' C' ' 50' ' ' GLN . 4.2 pp -175.72 148.29 0.87 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.219 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.809 ' HB2' HD22 ' C' ' 115' ' ' LEU . 0.0 OUTLIER -119.87 163.65 17.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.278 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.748 ' CG2' HG21 ' C' ' 58' ' ' VAL . 15.6 mm -139.78 129.87 30.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.894 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.82 118.98 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.172 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.537 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -133.77 161.99 33.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 0.0 111.871 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.799 HD12 HD23 ' C' ' 29' ' ' LEU . 5.8 mm -111.97 150.65 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.471 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 1.031 ' HB3' HG13 ' C' ' 28' ' ' VAL . . . -127.42 157.89 38.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.043 0.449 . . . . 0.0 111.804 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.62 HG22 HG13 ' C' ' 73' ' ' VAL . 34.2 m -130.09 116.26 36.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.866 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.73 ' HB2' HD21 ' C' ' 67' ' ' LEU . 75.7 ttt-85 -120.07 70.89 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.978 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.887 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mtp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.87 0.367 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.16 175.47 6.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.524 HG21 HG21 ' C' ' 128' ' ' VAL . 11.1 m 61.32 114.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.581 ' NE2' ' HB ' ' C' ' 73' ' ' VAL . 3.0 mm100 63.2 -165.74 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.258 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.2 mp 70.25 118.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.671 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.785 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 22.3 mt -152.99 74.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.678 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -84.76 145.49 27.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 61' ' ' ILE . 1.7 t -149.83 153.46 36.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.71 35.83 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.412 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . 11.5 mmtt -121.13 -38.07 2.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.74 110.65 46.78 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.192 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.28 -16.41 46.56 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.516 2.144 . . . . 0.0 112.469 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.15 -167.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.221 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.502 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 64.87 -165.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.435 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.6 mt 79.61 17.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.119 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.91 -134.64 4.22 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.223 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.64 28.59 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.724 2.283 . . . . 0.0 113.098 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -162.3 177.28 9.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' C' ' 104' ' ' PHE . 33.6 m -106.07 162.3 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.22 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.426 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 3.6 mt-30 -55.65 -52.8 62.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.135 0.493 . . . . 0.0 110.442 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.785 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -158.44 -172.75 3.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.166 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 4' ' ' GLN . 27.6 m -145.51 130.36 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.025 0.44 . . . . 0.0 111.851 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.488 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 48.0 t0 -108.69 102.88 11.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.3 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.722 HD11 HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -66.74 -14.17 62.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 0.0 111.188 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.02 -93.08 0.59 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -61.26 -28.82 69.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.249 0.547 . . . . 0.0 109.593 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.97 140.49 47.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.417 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.899 HG23 ' HB3' ' A' ' 127' ' ' ALA . 2.8 m -105.05 -179.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.197 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.722 HD12 HD11 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -165.89 136.78 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -108.64 135.78 49.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.744 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.2 p -81.07 177.16 9.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.49 95.67 0.1 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.544 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.67 150.95 47.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.906 0.384 . . . . 0.0 111.053 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.748 HG23 HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -129.06 121.91 20.96 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.869 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.4 Cg_exo -67.76 58.96 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.695 2.263 . . . . 0.0 113.094 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.748 HG23 HG23 ' A' ' 34' ' ' ILE . 93.0 t -69.9 85.58 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.322 0.582 . . . . 0.0 110.639 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.904 ' HB3' HG22 ' A' ' 40' ' ' THR . 52.4 t30 -43.84 129.89 4.14 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.805 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.89 -9.64 26.1 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.988 1.792 . . . . 0.0 111.558 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.671 ' HB3' ' ND2' ' A' ' 37' ' ' ASN . . . -97.44 -32.97 11.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.625 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.904 HG22 ' HB3' ' A' ' 37' ' ' ASN . 11.6 t -117.71 -27.83 6.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.834 0.35 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 78.56 60.29 2.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.704 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.896 ' HG2' HG23 ' A' ' 40' ' ' THR . 0.3 OUTLIER 179.23 -76.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.756 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.78 ' HB ' HG12 ' A' ' 119' ' ' VAL . 11.2 p -160.96 118.44 1.44 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.234 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.56 140.96 94.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.415 2.077 . . . . 0.0 112.251 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.8 -31.1 72.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 0.0 110.929 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.54 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 1.3 m-20 -73.5 93.1 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.8 mm -42.49 -31.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.114 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.37 -42.52 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.788 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . . . -65.98 -44.72 84.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.551 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.78 67.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.449 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.28 -40.84 67.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.86 -32.59 57.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.36 -41.14 76.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.1 t -64.27 -38.91 92.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.32 -41.18 77.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.34 -44.06 92.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -60.77 -37.26 81.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.8 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.966 HG21 HG21 ' A' ' 123' ' ' ILE . 26.3 t -63.0 -45.97 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HA ' HD12 ' A' ' 62' ' ' ILE . 7.5 mttt -71.97 -32.62 67.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.782 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.412 ' HB1' ' CB ' ' A' ' 10' ' ' LYS . . . -60.44 -39.51 87.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.557 HG22 ' CG2' ' A' ' 6' ' ' ILE . 4.2 mt -70.04 -40.76 78.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.011 HD13 HD11 ' A' ' 72' ' ' ILE . 8.6 mt -70.5 -34.6 58.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.421 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -69.99 -42.61 72.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.402 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -15.73 63.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.595 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 6' ' ' ILE . . . -87.99 -33.64 18.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.942 0.401 . . . . 0.0 110.627 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.24 41.42 0.36 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.793 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.762 HD21 ' HG3' ' A' ' 129' ' ' ARG . 63.9 mt -150.25 -177.55 6.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.733 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.08 164.88 28.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.799 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -52.75 -35.02 55.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -60.86 -22.35 64.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.216 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 128' ' ' VAL . 6.9 m-20 -81.03 -18.49 46.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.767 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 62' ' ' ILE . 28.2 mm -58.44 123.61 10.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.868 HG11 HG13 ' A' ' 128' ' ' VAL . 34.8 m -92.63 -27.4 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.382 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.49 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 36.8 tttm -150.49 164.69 35.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -156.4 113.27 3.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.777 0.322 . . . . 0.0 111.526 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -100.02 152.41 20.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.303 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.422 HG13 HD13 ' A' ' 123' ' ' ILE . 21.2 t -151.74 127.36 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.821 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CE2' ' OE1' ' A' ' 124' ' ' GLU . 10.6 m-85 -105.39 115.54 30.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.328 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 85' ' ' PHE . 4.8 m -105.49 148.57 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.638 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.76 -4.52 56.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.051 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -164.59 134.23 3.8 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.549 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' B' ' 114' ' ' ARG . 1.0 OUTLIER -70.9 -8.89 56.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.274 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.35 -24.23 23.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.791 0.329 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -75.44 -22.3 57.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.084 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.576 ' CD2' HG11 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -61.68 -18.2 58.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.448 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.13 -41.12 68.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.852 0.358 . . . . 0.0 111.271 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -27.8 22.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.983 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.3 t -73.71 -47.07 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.25 -40.08 95.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.407 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.16 84.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.947 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -87.89 -28.25 21.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.554 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 95' ' ' PHE . 81.0 t80 -53.39 -44.74 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.945 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -86.9 -25.26 24.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -21.36 60.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.473 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.446 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -91.13 -33.62 15.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.863 0.363 . . . . 0.0 110.613 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.457 ' CZ ' ' CG ' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -56.45 -58.01 9.85 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.316 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -64.58 -30.74 71.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.006 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -78.16 -9.23 59.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.233 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.667 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 3.5 m120 -109.82 -5.01 15.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.393 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 21.9 m-80 84.5 38.58 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.759 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.506 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 17.2 t-160 -130.69 68.86 82.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.337 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 1.4 Cg_endo -82.35 -17.46 7.67 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.971 2.447 . . . . 0.0 112.824 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -59.27 -36.78 76.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.878 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 27.9 m-85 78.76 114.77 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.395 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' CG ' ' CZ ' ' A' ' 96' ' ' PHE . 62.3 Cg_endo -87.2 163.12 8.53 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.164 2.576 . . . . 0.0 112.147 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.46 175.6 0.23 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -173.0 163.48 4.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.331 0.586 . . . . 0.0 112.049 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.89 83.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.032 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.457 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 14.1 p -89.4 123.63 33.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.492 HG12 HD23 ' B' ' 115' ' ' LEU . 35.6 m -142.89 148.68 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.297 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.867 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.8 OUTLIER -81.69 97.34 7.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.824 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.46 160.43 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.152 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.861 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -69.61 -45.65 68.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.023 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.491 ' HB3' HD12 ' C' ' 82' ' ' LEU . 6.3 mtt-85 -156.89 176.98 12.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.824 HD22 ' HB2' ' A' ' 122' ' ' GLU . 12.8 mt -145.27 160.65 44.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.811 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.495 ' O ' HG22 ' A' ' 119' ' ' VAL . 69.2 Cg_exo -51.04 135.75 44.46 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.545 2.163 . . . . 0.0 112.218 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.607 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.1 OUTLIER 72.3 14.45 5.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.226 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.24 14.24 9.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.212 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.78 HG12 ' HB ' ' A' ' 43' ' ' VAL . 27.7 m -57.57 171.22 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.865 0.364 . . . . 0.0 111.162 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.21 21.96 16.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.474 HD21 HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -176.37 156.91 1.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.12 0.486 . . . . 0.0 111.213 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.824 ' HB2' HD22 ' A' ' 115' ' ' LEU . 6.2 tt0 -149.89 156.34 41.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.966 HG21 HG21 ' A' ' 58' ' ' VAL . 22.8 mm -133.41 136.73 54.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.153 0.502 . . . . 0.0 112.109 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 6.6 pt-20 -155.48 106.6 2.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.298 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.676 ' HB2' HG22 ' A' ' 75' ' ' THR . . . -129.05 175.28 8.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.258 0.552 . . . . 0.0 112.374 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.705 HG23 ' HG ' ' A' ' 29' ' ' LEU . 3.1 mt -125.71 157.81 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.1 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.994 ' HB2' HD13 ' A' ' 72' ' ' ILE . . . -148.8 149.11 30.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.97 0.414 . . . . 0.0 111.459 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.868 HG13 HG11 ' A' ' 73' ' ' VAL . 3.3 m -96.96 156.43 3.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.077 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.762 ' HG3' HD21 ' A' ' 67' ' ' LEU . 54.2 ttt-85 -151.43 51.58 0.83 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.887 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mtp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.885 0.374 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.14 175.4 6.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.522 HG21 HG21 ' A' ' 128' ' ' VAL . 11.1 m 61.36 114.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.555 ' NE2' ' HB ' ' A' ' 73' ' ' VAL . 2.9 mm100 63.27 -165.77 0.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.258 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.474 ' N ' HD12 ' B' ' 5' ' ' ILE . 1.2 mp 70.29 118.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.644 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.77 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 22.3 mt -153.02 74.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.648 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -84.67 145.48 27.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.507 HG21 ' HA ' ' B' ' 61' ' ' ILE . 1.7 t -149.85 153.4 36.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.65 35.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.417 ' CB ' ' HB1' ' B' ' 60' ' ' ALA . 11.5 mmtt -121.18 -38.05 2.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.73 110.71 47.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.193 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.27 -16.5 47.06 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.511 2.14 . . . . 0.0 112.447 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.08 -167.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.262 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.501 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 64.89 -165.09 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.369 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.586 HG22 ' O ' ' B' ' 15' ' ' ILE . 2.6 mt 79.65 17.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.102 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.91 -134.59 4.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.201 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -87.7 28.6 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.712 2.275 . . . . 0.0 113.089 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -162.28 177.37 9.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 111.201 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 104' ' ' PHE . 33.7 m -106.11 162.33 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.18 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.437 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 3.6 mt-30 -55.55 -52.65 63.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.221 0.534 . . . . 0.0 110.453 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.77 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -158.65 -172.72 3.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.189 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' B' ' 4' ' ' GLN . 27.7 m -145.53 130.41 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.059 0.457 . . . . 0.0 111.745 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.482 ' CG ' HG12 ' B' ' 28' ' ' VAL . 47.9 t0 -108.76 102.84 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.278 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.708 HD11 HD12 ' B' ' 29' ' ' LEU . 0.5 OUTLIER -66.74 -14.12 62.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.17 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.01 -93.05 0.59 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -61.27 -28.82 69.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 140.45 47.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.426 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.887 HG23 ' HB3' ' B' ' 127' ' ' ALA . 2.8 m -105.08 -179.25 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.183 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.708 HD12 HD11 ' B' ' 24' ' ' LEU . 0.2 OUTLIER -165.82 136.78 3.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 66.7 p -108.68 135.64 49.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 42.8 p -80.88 177.25 9.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.48 95.62 0.1 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.537 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.65 150.94 47.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.908 0.385 . . . . 0.0 111.086 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.752 HG23 HG23 ' B' ' 36' ' ' VAL . 0.6 OUTLIER -129.12 121.97 20.94 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.823 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.81 58.93 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.719 2.28 . . . . 0.0 113.037 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.752 HG23 HG23 ' B' ' 34' ' ' ILE . 93.3 t -69.88 85.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.281 0.562 . . . . 0.0 110.576 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.896 ' HB3' HG22 ' B' ' 40' ' ' THR . 52.2 t30 -43.83 129.82 4.14 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.807 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.82 -9.68 26.22 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 121.969 1.779 . . . . 0.0 111.542 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.68 ' HB3' ' ND2' ' B' ' 37' ' ' ASN . . . -97.42 -33.02 11.56 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.647 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.896 HG22 ' HB3' ' B' ' 37' ' ' ASN . 11.6 t -117.67 -27.95 6.14 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.866 0.365 . . . . 0.0 111.041 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 78.83 60.27 2.63 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.755 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.881 ' HG2' HG23 ' B' ' 40' ' ' THR . 0.2 OUTLIER 179.22 -76.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.723 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.758 ' HB ' HG12 ' B' ' 119' ' ' VAL . 11.2 p -161.01 118.49 1.44 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.173 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.68 141.07 95.37 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.364 2.043 . . . . 0.0 112.188 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.79 -31.21 72.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.554 ' HB2' ' HB3' ' B' ' 49' ' ' ALA . 1.3 m-20 -73.43 93.09 1.92 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mm -42.48 -31.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.125 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.47 -42.5 21.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.723 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' B' ' 46' ' ' ASP . . . -65.99 -44.72 84.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.565 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -27.71 67.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.526 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.88 67.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.82 -32.64 57.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.32 -41.17 77.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.748 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.739 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.1 t -64.23 -38.9 92.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.788 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.33 -41.2 76.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.36 -43.99 92.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -60.79 -37.29 81.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.758 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.984 HG21 HG21 ' B' ' 123' ' ' ILE . 26.5 t -63.04 -46.01 97.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' B' ' 62' ' ' ILE . 7.4 mttt -71.92 -32.64 67.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.808 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.417 ' HB1' ' CB ' ' B' ' 10' ' ' LYS . . . -60.42 -39.53 87.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.55 HG22 ' CG2' ' B' ' 6' ' ' ILE . 4.2 mt -70.18 -40.77 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.839 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.95 HD13 HD11 ' B' ' 72' ' ' ILE . 8.6 mt -70.54 -34.59 58.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.391 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -69.98 -42.68 72.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.362 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -15.82 63.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.677 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' B' ' 6' ' ' ILE . . . -87.96 -33.62 18.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.632 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.28 41.39 0.36 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.812 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.746 HD21 ' HG3' ' B' ' 129' ' ' ARG . 64.2 mt -150.32 -177.57 6.02 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.004 0.43 . . . . 0.0 110.714 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.04 164.89 28.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.8 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.635 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -52.74 -35.11 55.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.941 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -60.79 -22.24 63.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.208 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.512 ' O ' HG22 ' B' ' 128' ' ' VAL . 6.9 m-20 -81.09 -18.43 46.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.787 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 1.008 HD13 ' HB2' ' B' ' 127' ' ' ALA . 28.2 mm -58.53 123.65 10.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.857 HG11 HG13 ' B' ' 128' ' ' VAL . 34.9 m -92.69 -27.37 4.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.368 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.496 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 36.7 tttm -150.45 164.73 35.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.661 HG22 ' HB2' ' B' ' 125' ' ' ALA . 0.2 OUTLIER -156.48 113.23 3.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.727 0.299 . . . . 0.0 111.481 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 94.3 m -99.97 152.44 20.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.417 HG13 HD13 ' B' ' 123' ' ' ILE . 21.2 t -151.77 127.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.984 0.421 . . . . 0.0 111.801 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.403 ' CE2' ' OE1' ' B' ' 124' ' ' GLU . 10.5 m-85 -105.39 115.54 30.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.279 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.565 HG11 ' CD2' ' B' ' 85' ' ' PHE . 4.9 m -105.51 148.52 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.634 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.7 -4.63 56.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.978 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -164.65 134.18 3.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.609 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.87 -8.89 56.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.248 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.29 -24.28 23.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.804 0.335 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -75.42 -22.25 57.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.565 ' CD2' HG11 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -61.7 -18.2 58.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.406 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.21 -41.09 68.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.804 0.335 . . . . 0.0 111.27 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -27.84 22.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' B' ' 92' ' ' TYR . 27.5 t -73.67 -47.11 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.941 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.15 -40.18 95.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.426 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.97 -40.21 84.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.945 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.09 -28.18 21.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.538 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 81.3 t80 -53.4 -44.79 68.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.9 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -86.9 -25.17 24.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.052 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -21.37 60.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.455 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 1.0 OUTLIER -91.1 -33.69 15.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 110.623 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.444 ' CZ ' ' CG ' ' B' ' 105' ' ' PRO . 0.8 OUTLIER -56.39 -58.09 9.51 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.317 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -64.5 -30.72 71.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.051 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -78.17 -9.31 59.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.209 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' B' ' 69' ' ' ALA . 3.5 m120 -109.83 -4.97 15.7 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.389 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.685 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 21.9 m-80 84.53 38.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.812 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.507 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 17.2 t-160 -130.68 68.92 82.17 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.343 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.33 -17.48 7.69 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.006 2.471 . . . . 0.0 112.857 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' B' ' 104' ' ' PHE . 0.1 OUTLIER -59.25 -36.84 76.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 0.0 110.867 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.55 ' HB2' ' O ' ' B' ' 103' ' ' ASN . 28.0 m-85 78.75 114.73 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.475 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.444 ' CG ' ' CZ ' ' B' ' 96' ' ' PHE . 62.4 Cg_endo -87.22 163.04 8.51 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.167 2.578 . . . . 0.0 112.108 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.38 175.59 0.23 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' B' ' 75' ' ' THR . 0.9 OUTLIER -173.02 163.55 4.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.317 0.58 . . . . 0.0 112.078 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.94 83.87 1.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.089 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . 0.442 ' HB2' ' CE2' ' B' ' 85' ' ' PHE . 14.5 p -89.38 123.68 33.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.081 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.445 HG12 HD23 ' C' ' 115' ' ' LEU . 35.6 m -143.12 149.19 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.379 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.838 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.8 OUTLIER -81.85 97.15 7.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.644 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 8.1 m -78.35 160.34 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.867 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -69.6 -45.58 68.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.026 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.514 ' HB3' HD12 ' A' ' 82' ' ' LEU . 6.3 mtt-85 -156.94 176.92 12.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' B' ' 122' ' ' GLU . 12.7 mt -145.24 160.64 45.03 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.86 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.495 ' O ' HG22 ' B' ' 119' ' ' VAL . 69.7 Cg_exo -51.07 135.76 44.68 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.511 2.141 . . . . 0.0 112.249 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.608 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.1 OUTLIER 72.23 14.51 5.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.223 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.26 14.24 9.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.145 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.758 HG12 ' HB ' ' B' ' 43' ' ' VAL . 27.7 m -57.56 171.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.879 0.371 . . . . 0.0 111.13 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.05 22.08 16.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.568 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.486 ' C ' HD13 ' B' ' 115' ' ' LEU . 0.2 OUTLIER -176.26 156.78 1.67 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.107 0.48 . . . . 0.0 111.151 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' B' ' 115' ' ' LEU . 6.2 tt0 -149.84 156.39 41.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.104 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.984 HG21 HG21 ' B' ' 58' ' ' VAL . 22.7 mm -133.4 136.69 54.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.194 0.521 . . . . 0.0 112.091 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . 0.403 ' OE1' ' CE2' ' B' ' 78' ' ' PHE . 6.6 pt-20 -155.5 106.55 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.329 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.661 ' HB2' HG22 ' B' ' 75' ' ' THR . . . -128.99 175.31 8.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.307 0.575 . . . . 0.0 112.37 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.7 HG23 ' HG ' ' B' ' 29' ' ' LEU . 3.1 mt -125.68 157.89 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.134 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 1.008 ' HB2' HD13 ' B' ' 72' ' ' ILE . . . -148.97 149.08 30.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.0 0.429 . . . . 0.0 111.424 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.857 HG13 HG11 ' B' ' 73' ' ' VAL . 3.3 m -96.96 156.4 3.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.049 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.746 ' HG3' HD21 ' B' ' 67' ' ' LEU . 54.2 ttt-85 -151.35 51.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.86 0.362 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.16 175.48 6.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.513 HG21 HG21 ' B' ' 128' ' ' VAL . 11.1 m 61.35 114.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.578 ' NE2' ' HB ' ' B' ' 73' ' ' VAL . 3.0 mm100 63.24 -165.76 0.23 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.292 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.483 HD12 ' N ' ' C' ' 5' ' ' ILE . 1.2 mp 70.26 118.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.613 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.79 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 22.3 mt -153.05 74.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.674 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -84.67 145.56 27.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.216 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.514 HG21 ' HA ' ' C' ' 61' ' ' ILE . 1.7 t -149.91 153.38 36.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -97.69 35.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.422 ' CB ' ' HB1' ' C' ' 60' ' ' ALA . 11.5 mmtt -121.09 -38.06 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.87 110.79 47.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.147 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.33 -16.39 46.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.506 2.137 . . . . 0.0 112.444 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' C' ' 34' ' ' ILE . . . -57.15 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.243 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.502 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 64.78 -165.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.38 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.591 HG22 ' O ' ' C' ' 15' ' ' ILE . 2.6 mt 79.72 17.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.034 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.89 -134.6 4.22 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.3 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -87.64 28.61 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.784 2.323 . . . . 0.0 113.14 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -162.35 177.35 9.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 111.23 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.415 HG13 ' O ' ' B' ' 104' ' ' PHE . 33.7 m -106.08 162.35 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.434 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 3.6 mt-30 -55.66 -52.92 62.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.144 0.497 . . . . 0.0 110.516 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.79 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -158.14 -172.77 4.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.152 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.41 ' HB ' ' NE2' ' C' ' 4' ' ' GLN . 27.6 m -145.53 130.41 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.043 0.449 . . . . 0.0 111.855 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.481 ' CG ' HG12 ' C' ' 28' ' ' VAL . 48.2 t0 -108.75 102.88 11.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.244 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.725 HD11 HD12 ' C' ' 29' ' ' LEU . 0.5 OUTLIER -66.75 -14.14 62.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.214 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.08 -93.13 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -61.27 -28.79 69.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.232 0.539 . . . . 0.0 109.574 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 140.47 47.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.397 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.893 HG23 ' HB3' ' C' ' 127' ' ' ALA . 2.8 m -105.05 -179.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.246 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.725 HD12 HD11 ' C' ' 24' ' ' LEU . 0.2 OUTLIER -165.8 136.86 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.824 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -108.85 136.27 48.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.842 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 41.9 p -81.07 177.26 9.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.57 95.67 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.66 151.02 47.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 111.061 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.755 HG23 HG23 ' C' ' 36' ' ' VAL . 0.6 OUTLIER -129.18 121.96 20.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.85 58.9 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.715 2.277 . . . . 0.0 113.068 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.755 HG23 HG23 ' C' ' 34' ' ' ILE . 93.0 t -69.82 85.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 0.0 110.593 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.877 ' HB3' HG22 ' C' ' 40' ' ' THR . 52.5 t30 -43.87 129.89 4.17 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.816 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.86 -9.67 26.18 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 121.995 1.797 . . . . 0.0 111.569 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.672 ' HB3' ' ND2' ' C' ' 37' ' ' ASN . . . -97.46 -32.96 11.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.661 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.883 HG23 ' HG2' ' C' ' 42' ' ' GLU . 11.6 t -117.69 -27.88 6.15 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.864 0.364 . . . . 0.0 111.054 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 78.78 60.21 2.65 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.803 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.883 ' HG2' HG23 ' C' ' 40' ' ' THR . 0.3 OUTLIER 179.23 -76.76 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.875 0.337 . . . . 0.0 111.731 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.759 ' HB ' HG12 ' C' ' 119' ' ' VAL . 11.2 p -161.04 118.46 1.43 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.16 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.57 141.01 95.14 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.376 2.051 . . . . 0.0 112.23 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.83 -31.17 72.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.034 0.445 . . . . 0.0 110.91 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.544 ' HB2' ' HB3' ' C' ' 49' ' ' ALA . 1.3 m-20 -73.4 93.11 1.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.935 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mm -42.45 -31.76 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.157 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . 0.444 HG22 ' CB ' ' C' ' 87' ' ' ALA . 22.0 t -80.47 -42.43 21.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.756 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' C' ' 46' ' ' ASP . . . -66.04 -44.71 83.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.506 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -27.6 67.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.46 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.95 68.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.986 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -76.79 -32.63 57.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -41.12 77.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.743 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.1 t -64.23 -38.95 92.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.777 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 18.6 mt -69.33 -41.18 76.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.839 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.27 -44.09 92.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -60.8 -37.26 81.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.755 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 1.029 HG21 HG21 ' C' ' 123' ' ' ILE . 26.3 t -62.96 -46.08 97.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.556 ' HA ' HD12 ' C' ' 62' ' ' ILE . 7.4 mttt -71.92 -32.62 67.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.809 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.422 ' HB1' ' CB ' ' C' ' 10' ' ' LYS . . . -60.16 -39.58 86.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.549 HG22 ' CG2' ' C' ' 6' ' ' ILE . 4.2 mt -70.29 -40.75 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.839 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 1.036 HD13 HD11 ' C' ' 72' ' ' ILE . 8.6 mt -70.52 -34.56 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.433 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -69.98 -42.69 72.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -15.77 63.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.653 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' C' ' 6' ' ' ILE . . . -88.0 -33.69 18.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.548 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.29 41.32 0.37 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.841 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.763 HD21 ' HG3' ' C' ' 129' ' ' ARG . 64.0 mt -150.27 -177.58 6.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.936 0.398 . . . . 0.0 110.723 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.07 164.85 28.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.795 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -52.69 -35.1 54.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -60.9 -22.4 64.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.186 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.515 ' O ' HG22 ' C' ' 128' ' ' VAL . 6.9 m-20 -81.0 -18.42 46.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.788 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 1.036 HD11 HD13 ' C' ' 62' ' ' ILE . 28.2 mm -58.47 123.64 10.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.875 HG11 HG13 ' C' ' 128' ' ' VAL . 34.7 m -92.7 -27.33 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.397 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.488 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 36.7 tttm -150.47 164.76 35.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.304 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.666 HG22 ' HB2' ' C' ' 125' ' ' ALA . 0.2 OUTLIER -156.45 113.32 3.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.732 0.301 . . . . 0.0 111.479 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 94.2 m -99.97 152.44 20.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.261 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.429 HG13 HD13 ' C' ' 123' ' ' ILE . 21.2 t -151.78 127.31 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.982 0.42 . . . . 0.0 111.83 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.407 ' CE2' ' OE1' ' C' ' 124' ' ' GLU . 10.6 m-85 -105.32 115.56 30.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.3 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.569 HG11 ' CD2' ' C' ' 85' ' ' PHE . 4.8 m -105.55 148.61 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.591 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.62 -4.21 55.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.082 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -165.03 134.31 3.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.549 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 114' ' ' ARG . 1.0 OUTLIER -70.91 -8.94 56.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.236 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -88.22 -24.28 23.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.79 0.329 . . . . 0.0 110.888 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -75.38 -22.35 57.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.569 ' CD2' HG11 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -61.66 -18.2 58.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.416 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.18 -41.16 68.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.34 . . . . 0.0 111.229 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' C' ' 48' ' ' VAL . . . -87.5 -27.82 22.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.974 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 28.0 t -73.76 -47.03 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.18 -40.17 95.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.457 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.07 83.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.937 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.05 -28.18 21.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.571 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 81.2 t80 -53.38 -44.82 68.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.904 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.84 -25.2 24.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.076 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.34 -21.37 60.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.441 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.46 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 1.0 OUTLIER -91.14 -33.72 15.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 110.576 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.454 ' CZ ' ' CG ' ' C' ' 105' ' ' PRO . 0.7 OUTLIER -56.36 -58.07 9.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.126 0.488 . . . . 0.0 110.285 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -64.56 -30.77 71.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.994 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -78.19 -9.21 59.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.248 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.629 ' HB3' ' HB3' ' C' ' 69' ' ' ALA . 3.5 m120 -109.87 -4.98 15.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.439 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 22.1 m-80 84.48 38.55 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.77 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.504 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 17.2 t-160 -130.8 68.87 82.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.35 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.27 -17.51 7.75 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.974 2.449 . . . . 0.0 112.828 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 0.1 OUTLIER -59.28 -36.81 76.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 110.828 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' C' ' 103' ' ' ASN . 27.9 m-85 78.73 114.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.469 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.454 ' CG ' ' CZ ' ' C' ' 96' ' ' PHE . 62.3 Cg_endo -87.18 163.13 8.55 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.181 2.587 . . . . 0.0 112.094 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.44 175.59 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' C' ' 75' ' ' THR . 0.9 OUTLIER -173.04 163.44 4.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.263 0.554 . . . . 0.0 112.074 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.81 83.91 1.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.061 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . 0.464 ' HB2' ' CE2' ' C' ' 85' ' ' PHE . 13.8 p -89.42 123.65 33.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 115' ' ' LEU . 35.6 m -143.06 149.53 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.351 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.861 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -82.02 97.26 8.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.4 HG22 ' H ' ' C' ' 112' ' ' VAL . 8.1 m -78.46 160.52 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.211 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.838 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -69.65 -45.67 67.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.061 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -156.89 176.99 12.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.851 HD22 ' HB2' ' C' ' 122' ' ' GLU . 12.9 mt -145.28 160.6 45.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.497 ' O ' HG22 ' C' ' 119' ' ' VAL . 67.9 Cg_exo -50.96 135.72 43.81 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.513 2.142 . . . . 0.0 112.289 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.59 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.1 OUTLIER 72.21 14.57 5.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.238 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.2 14.2 9.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.184 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.759 HG12 ' HB ' ' C' ' 43' ' ' VAL . 27.6 m -57.5 171.18 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 111.206 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.99 22.12 16.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.538 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.494 ' C ' HD13 ' C' ' 115' ' ' LEU . 0.2 OUTLIER -176.16 156.88 1.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.098 0.475 . . . . 0.0 111.158 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.851 ' HB2' HD22 ' C' ' 115' ' ' LEU . 6.3 tt0 -149.95 156.41 41.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.054 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 1.029 HG21 HG21 ' C' ' 58' ' ' VAL . 22.8 mm -133.42 136.75 54.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.163 0.506 . . . . 0.0 112.093 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 6.6 pt-20 -155.51 106.66 2.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.346 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.666 ' HB2' HG22 ' C' ' 75' ' ' THR . . . -129.11 175.31 8.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.292 0.567 . . . . 0.0 112.368 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.693 HG23 ' HG ' ' C' ' 29' ' ' LEU . 3.1 mt -125.69 157.85 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.127 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 1.022 ' HB2' HD13 ' C' ' 72' ' ' ILE . . . -148.91 149.05 30.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.995 0.426 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.875 HG13 HG11 ' C' ' 73' ' ' VAL . 3.3 m -96.93 156.35 3.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.035 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.763 ' HG3' HD21 ' C' ' 67' ' ' LEU . 54.1 ttt-85 -151.36 51.62 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.796 0.331 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.97 144.03 54.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.791 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.688 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER 61.43 113.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.58 114.65 15.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.028 HD11 HG11 ' A' ' 19' ' ' VAL . 1.1 tp -53.34 132.64 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.312 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' A' ' 23' ' ' ASP . 12.5 mm -98.59 143.32 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -168.08 106.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.81 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.7 t -124.99 169.34 12.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.86 29.85 3.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.447 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -118.2 -40.68 2.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.682 ' HB1' ' CD ' ' A' ' 12' ' ' PRO . . . -72.38 177.37 1.82 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.173 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.682 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 22.0 Cg_exo -65.01 -10.92 27.38 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.865 2.377 . . . . 0.0 112.728 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.73 151.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.021 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.35 122.47 46.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.187 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 15' ' ' ILE . 26.4 mm -123.1 17.13 5.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.8 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.33 -132.0 3.64 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.355 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.446 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 79.9 Cg_endo -89.95 20.73 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.793 2.329 . . . . 0.0 113.355 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.576 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 1.5 p90 -140.54 178.58 7.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.951 0.405 . . . . 0.0 111.462 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.028 HG11 HD11 ' A' ' 5' ' ' ILE . 15.7 m -132.87 -179.26 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.861 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -48.9 79.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -177.72 -172.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.825 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.756 HG23 HD23 ' A' ' 29' ' ' LEU . 4.7 m -142.19 132.63 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.794 ' HA ' HG23 ' A' ' 28' ' ' VAL . 10.5 t0 -113.94 109.77 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.648 ' CD1' HD21 ' A' ' 29' ' ' LEU . 12.0 mt -81.05 -14.65 57.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.269 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.82 -100.09 0.71 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.53 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.727 ' C ' HD23 ' A' ' 27' ' ' LEU . 9.3 m-20 -57.62 -29.77 64.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.162 0.506 . . . . 0.0 109.775 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.917 HD22 HG12 ' A' ' 128' ' ' VAL . 1.4 mt -130.05 141.85 50.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.512 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.039 HG12 ' HB3' ' A' ' 127' ' ' ALA . 4.7 p -125.49 144.66 34.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.18 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.824 HD12 HD12 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -118.1 146.98 43.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.79 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.507 HG21 HD11 ' A' ' 62' ' ' ILE . 16.3 p -124.16 155.22 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.83 167.2 12.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.93 94.62 0.15 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.342 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.521 ' O ' HD13 ' A' ' 34' ' ' ILE . 23.2 mm-40 -58.83 150.06 24.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.363 . . . . 0.0 111.171 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 33' ' ' GLN . 22.3 mm -133.42 134.91 24.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.557 ' HD2' HG21 ' A' ' 119' ' ' VAL . 16.0 Cg_exo -68.02 56.16 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.898 2.399 . . . . 0.0 112.803 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.545 HG12 ' HA2' ' A' ' 41' ' ' GLY . 41.4 t -63.52 86.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.332 0.587 . . . . 0.0 110.654 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.79 ' HB3' HG22 ' A' ' 40' ' ' THR . 13.0 t30 -37.99 128.44 0.99 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.066 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 37' ' ' ASN . 14.0 Cg_exo -68.68 -10.61 29.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.213 1.942 . . . . 0.0 111.902 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.4 -30.33 10.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.958 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.79 HG22 ' HB3' ' A' ' 37' ' ' ASN . 11.8 t -123.3 -26.02 4.35 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.427 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.545 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 70.66 58.9 5.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.215 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.592 ' HG3' HG23 ' A' ' 40' ' ' THR . 5.8 mt-10 -154.36 -73.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.3 . . . . 0.0 111.435 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.726 HG11 ' HA ' ' A' ' 119' ' ' VAL . 7.4 p 175.44 117.66 0.12 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.94 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 35' ' ' PRO . 52.2 Cg_exo -52.04 140.27 50.12 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.315 2.01 . . . . 0.0 112.165 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.64 -30.99 69.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -75.46 94.95 3.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.799 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.725 HG13 HD11 ' A' ' 121' ' ' LEU . 2.7 tp -43.4 -31.88 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.601 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.62 -45.5 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.669 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -63.23 -48.13 79.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.569 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.727 ' OE1' HD12 ' A' ' 121' ' ' LEU . 2.7 pt20 -61.41 -29.53 69.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.392 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.75 -39.61 61.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.927 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -62.42 -48.47 79.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.06 -34.63 78.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -66.11 -31.15 71.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.726 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.768 HD13 ' CE2' ' A' ' 95' ' ' PHE . 75.6 mt -69.69 -49.84 49.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -40.83 84.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.83 -38.45 70.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 54' ' ' SER . 39.2 t -65.26 -25.86 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.716 ' HD3' ' HB2' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -83.88 -39.15 20.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.806 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -58.27 -39.68 79.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.468 HD11 ' OE1' ' A' ' 33' ' ' GLN . 50.3 mt -68.91 -53.05 28.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.917 0.389 . . . . 0.0 110.729 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 30' ' ' THR . 51.0 mt -64.66 -28.89 45.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.708 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.45 -42.54 53.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.53 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -16.07 63.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.466 ' HB2' HD12 ' A' ' 6' ' ' ILE . . . -88.45 -28.68 20.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.59 43.65 0.63 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.587 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.443 ' HB3' HG22 ' A' ' 62' ' ' ILE . 1.5 mt -149.78 -167.15 2.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.0 110.837 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.17 154.86 38.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.66 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.872 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -58.12 -36.7 73.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.943 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.458 ' HB2' ' HD2' ' A' ' 101' ' ' HIS . . . -50.1 -26.3 4.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.251 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.73 -23.63 33.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.414 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 69' ' ' ALA . 88.5 mt -44.39 120.44 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.917 0.389 . . . . 0.0 111.415 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 128' ' ' VAL . 29.3 m -90.31 -38.02 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.651 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.53 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -137.72 155.45 49.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.599 0.238 . . . . 0.0 110.974 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.803 HG21 ' OH ' ' A' ' 92' ' ' TYR . 17.3 p -143.43 152.07 41.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.027 0.441 . . . . 0.0 111.51 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 108' ' ' SER . 5.2 m -133.74 142.32 47.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.064 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -143.02 105.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 111.811 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.5 ' HB2' HD21 ' A' ' 115' ' ' LEU . 7.8 m-85 -86.98 106.28 17.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.469 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.687 HG12 ' CD2' ' A' ' 121' ' ' LEU . 18.7 m -102.71 152.59 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.549 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.13 -2.61 46.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.844 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.36 113.51 3.7 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.585 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.602 HD11 ' C ' ' B' ' 115' ' ' LEU . 6.1 mt -65.27 -13.57 58.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.056 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -81.94 -23.2 36.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.875 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.406 ' OD1' HG21 ' A' ' 47' ' ' ILE . 6.7 m-20 -80.84 -23.72 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.138 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.601 ' HD1' HG11 ' A' ' 79' ' ' VAL . 2.0 t80 -56.26 -23.88 39.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.382 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.92 74.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.199 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.44 -38.71 17.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.29 -36.06 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.6 t30 -69.31 -43.1 74.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.82 74.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.026 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.582 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -86.08 -23.26 26.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.2 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.803 ' OH ' HG21 ' A' ' 75' ' ' THR . 10.3 t80 -77.82 -27.55 50.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.565 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.1 -39.42 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -67.25 -23.13 65.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.768 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -90.85 -32.8 15.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.553 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.519 ' CD2' ' HB2' ' A' ' 101' ' ' HIS . 1.7 m-85 -60.15 -58.85 6.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.3 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -63.55 -28.17 69.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.159 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -77.79 -10.89 59.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.54 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 2.2 m-80 -111.15 -5.92 14.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.379 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.5 OUTLIER 94.52 37.32 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.871 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.872 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 1.8 m170 -117.9 51.98 1.33 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 65.1 Cg_endo -71.91 -21.67 24.25 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.453 2.102 . . . . 0.0 112.56 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.34 -32.98 51.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.728 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.617 ' O ' HG22 ' B' ' 19' ' ' VAL . 15.6 m-85 60.98 83.67 0.21 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.131 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 17.1 Cg_endo -58.15 159.42 18.78 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.44 2.093 . . . . 0.0 112.018 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 74' ' ' LYS . . . -50.19 169.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.783 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' B' ' 18' ' ' TYR . 2.5 ttt85 -133.4 146.42 51.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.018 0.437 . . . . 0.0 111.308 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 76' ' ' THR . 1.7 p -152.56 58.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.411 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 25.4 p -96.01 142.85 27.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.435 HG11 ' CD2' ' B' ' 78' ' ' PHE . 33.9 m -147.6 153.92 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.856 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.7 OUTLIER -80.93 83.63 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.78 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.654 ' CG2' HD11 ' A' ' 115' ' ' LEU . 9.5 m -71.99 160.82 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.111 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.852 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -67.56 -53.57 27.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.243 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.4 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 1.5 mpt_? -151.25 -178.59 6.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.964 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.654 HD11 ' CG2' ' A' ' 112' ' ' VAL . 2.1 mp -153.55 159.37 32.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.572 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.528 ' O ' HG12 ' A' ' 119' ' ' VAL . 9.6 Cg_endo -52.16 140.19 51.45 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.578 2.185 . . . . 0.0 112.21 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 66.84 14.0 9.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.559 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.71 19.23 5.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.069 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.726 ' HA ' HG11 ' A' ' 43' ' ' VAL . 3.0 p -52.33 -49.36 42.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.543 ' C ' HD13 ' A' ' 115' ' ' LEU . . . 90.31 -7.37 81.61 Favored Glycine 0 C--N 1.308 -0.978 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.293 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.727 HD12 ' OE1' ' A' ' 50' ' ' GLN . 16.7 mt -140.37 146.75 38.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.237 0.542 . . . . 0.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.424 ' HB2' ' CD2' ' A' ' 115' ' ' LEU . 26.1 tt0 -147.67 152.42 37.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.941 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.55 HD13 HD23 ' A' ' 55' ' ' LEU . 26.9 mt -138.07 127.41 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.192 0.52 . . . . 0.0 112.229 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.4 ' HG3' ' HB ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.45 132.18 18.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.391 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.685 ' CB ' HG22 ' A' ' 75' ' ' THR . . . -149.39 159.42 44.3 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.824 HD12 HD12 ' A' ' 29' ' ' LEU . 14.8 mm -105.24 153.57 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.893 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 1.039 ' HB3' HG12 ' A' ' 28' ' ' VAL . . . -137.2 152.57 50.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.013 0.435 . . . . 0.0 111.828 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.917 HG12 HD22 ' A' ' 27' ' ' LEU . 27.0 m -119.98 178.09 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.804 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -167.75 59.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.873 0.368 . . . . 0.0 111.039 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.932 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.818 0.342 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.01 144.06 54.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.796 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.717 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER 61.39 113.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.6 114.63 15.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 1.032 HD11 HG11 ' B' ' 19' ' ' VAL . 1.1 tp -53.3 132.69 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.33 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.644 HD11 ' HB2' ' B' ' 23' ' ' ASP . 12.5 mm -98.57 143.34 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.402 ' CD2' ' OE1' ' B' ' 20' ' ' GLN . 1.1 m80 -168.15 106.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 3.8 t -124.97 169.3 12.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.009 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.85 29.89 3.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.449 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 0.4 OUTLIER -118.34 -40.9 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.676 ' HB1' ' CD ' ' B' ' 12' ' ' PRO . . . -72.01 177.26 1.79 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.11 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.676 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 22.2 Cg_exo -65.01 -10.87 27.2 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.892 2.395 . . . . 0.0 112.677 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.66 151.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 111.083 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.27 122.43 46.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.202 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 15' ' ' ILE . 26.5 mm -123.08 17.13 5.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.765 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.29 -131.98 3.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.422 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.459 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 78.3 Cg_endo -89.93 20.66 1.0 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.809 2.339 . . . . 0.0 113.392 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.586 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 1.5 p90 -140.44 178.6 7.19 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.507 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.032 HG11 HD11 ' B' ' 5' ' ' ILE . 15.6 m -132.92 -179.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.867 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.402 ' OE1' ' CD2' ' B' ' 7' ' ' HIS . 0.1 OUTLIER -58.92 -48.7 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.953 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.432 ' HB2' HG21 ' B' ' 61' ' ' ILE . . . -178.07 -172.71 0.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.76 HG23 HD23 ' B' ' 29' ' ' LEU . 4.6 m -142.2 132.67 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.145 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.802 ' HA ' HG23 ' B' ' 28' ' ' VAL . 10.5 t0 -113.95 109.76 19.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.65 ' CD1' HD21 ' B' ' 29' ' ' LEU . 12.0 mt -81.07 -14.71 57.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.265 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.86 -100.05 0.7 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.548 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . 0.716 ' C ' HD23 ' B' ' 27' ' ' LEU . 9.2 m-20 -57.61 -29.77 64.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.177 0.513 . . . . 0.0 109.81 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.897 HD22 HG12 ' B' ' 128' ' ' VAL . 1.4 mt -130.0 141.88 50.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.537 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.045 HG12 ' HB3' ' B' ' 127' ' ' ALA . 4.7 p -125.57 144.68 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.145 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.827 HD12 HD12 ' B' ' 126' ' ' ILE . 0.0 OUTLIER -118.06 146.94 43.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.83 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.51 HG21 HD11 ' B' ' 62' ' ' ILE . 16.1 p -124.18 155.03 39.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.832 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.99 167.11 12.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.91 94.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.329 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.528 ' O ' HD13 ' B' ' 34' ' ' ILE . 23.3 mm-40 -58.82 150.07 24.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.376 . . . . 0.0 111.153 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.528 HD13 ' O ' ' B' ' 33' ' ' GLN . 22.2 mm -133.42 134.88 24.36 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.096 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.549 ' HD2' HG21 ' B' ' 119' ' ' VAL . 16.0 Cg_exo -68.03 56.2 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.836 2.358 . . . . 0.0 112.79 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.552 HG12 ' HA2' ' B' ' 41' ' ' GLY . 41.3 t -63.52 86.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.366 0.603 . . . . 0.0 110.623 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.785 ' HB3' HG22 ' B' ' 40' ' ' THR . 13.0 t30 -38.01 128.44 0.99 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.092 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.62 -10.68 29.76 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.235 1.957 . . . . 0.0 111.921 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.37 -30.28 10.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.015 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.785 HG22 ' HB3' ' B' ' 37' ' ' ASN . 11.6 t -123.25 -26.06 4.37 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.815 0.34 . . . . 0.0 111.477 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.552 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 70.76 58.96 5.45 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.215 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.617 ' HG3' HG23 ' B' ' 40' ' ' THR . 5.8 mt-10 -154.35 -74.03 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.774 0.321 . . . . 0.0 111.398 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.717 HG11 ' HA ' ' B' ' 119' ' ' VAL . 7.4 p 175.49 117.59 0.12 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.992 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.2 Cg_exo -52.12 140.29 50.91 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.249 1.966 . . . . 0.0 112.189 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.95 69.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.032 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.435 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.1 OUTLIER -75.41 94.95 3.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.818 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.711 HG13 HD11 ' B' ' 121' ' ' LEU . 2.7 tp -43.39 -31.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.61 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.62 -45.51 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -63.27 -48.04 79.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.699 ' OE1' HD12 ' B' ' 121' ' ' LEU . 2.7 pt20 -61.56 -29.6 70.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.371 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.97 -39.6 61.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.999 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -62.37 -48.48 79.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.818 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.12 -34.58 78.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.708 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.607 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.7 OUTLIER -66.09 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.733 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.76 HD13 ' CE2' ' B' ' 95' ' ' PHE . 75.6 mt -69.75 -49.81 49.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.83 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -40.86 84.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.85 -38.48 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.64 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 54' ' ' SER . 39.0 t -65.23 -25.88 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.66 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.719 ' HD3' ' HB2' ' B' ' 69' ' ' ALA . 0.3 OUTLIER -83.86 -39.21 20.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -58.25 -39.91 80.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.456 HD11 ' OE1' ' B' ' 33' ' ' GLN . 50.6 mt -68.67 -53.01 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.733 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.51 HD11 HG21 ' B' ' 30' ' ' THR . 51.0 mt -64.7 -28.82 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.47 -42.54 52.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.546 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -16.09 63.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.643 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.511 ' HB2' HD12 ' B' ' 6' ' ' ILE . . . -88.42 -28.64 20.77 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.706 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.58 43.67 0.63 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.523 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.461 ' HB3' HG22 ' B' ' 62' ' ' ILE . 1.5 mt -149.83 -167.14 2.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 154.85 38.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.693 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.873 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -58.12 -36.66 73.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.46 ' HB2' ' HD2' ' B' ' 101' ' ' HIS . . . -50.18 -26.36 4.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.281 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -23.67 34.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.404 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.464 HG13 ' HA ' ' B' ' 69' ' ' ALA . 88.8 mt -44.44 120.36 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-O 120.923 0.392 . . . . 0.0 111.438 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.541 HG13 HG22 ' B' ' 128' ' ' VAL . 29.1 m -90.2 -38.02 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.66 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.528 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -137.79 155.47 48.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.625 0.25 . . . . 0.0 110.905 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.793 HG21 ' OH ' ' B' ' 92' ' ' TYR . 17.3 p -143.38 152.1 41.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 111.543 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.658 HG23 ' O ' ' B' ' 108' ' ' SER . 5.2 m -133.8 142.32 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.026 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 20.4 t -143.0 105.82 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 111.838 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.468 ' HB2' HD21 ' B' ' 115' ' ' LEU . 7.7 m-85 -86.98 106.29 17.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.687 HG12 ' CD2' ' B' ' 121' ' ' LEU . 18.7 m -102.69 152.6 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.576 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.19 -2.51 46.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.808 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.62 113.54 3.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.518 HD11 ' C ' ' C' ' 115' ' ' LEU . 6.1 mt -65.19 -13.5 58.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.96 -23.26 36.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.883 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.82 -23.67 39.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.192 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.614 ' HD1' HG11 ' B' ' 79' ' ' VAL . 2.0 t80 -56.3 -23.9 39.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.336 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.33 -36.91 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 0.0 111.209 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.48 -38.7 17.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.18 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.28 -36.07 65.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.6 t30 -69.34 -43.04 74.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.06 74.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.08 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' B' ' 94' ' ' ARG . 0.1 OUTLIER -85.95 -23.3 26.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.793 ' OH ' HG21 ' B' ' 75' ' ' THR . 10.3 t80 -77.8 -27.54 50.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.541 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.19 -39.41 12.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' B' ' 91' ' ' GLU . 0.0 OUTLIER -67.35 -23.02 65.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.76 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -90.82 -32.85 15.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.835 0.35 . . . . 0.0 110.57 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' B' ' 101' ' ' HIS . 1.6 m-85 -60.12 -58.79 7.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.309 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -63.53 -28.24 69.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.162 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -77.78 -10.85 59.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 2.2 m-80 -111.22 -5.87 14.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.349 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 0.5 OUTLIER 94.5 37.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.873 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.873 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 1.8 m170 -117.92 52.02 1.34 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.706 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 64.2 Cg_endo -72.05 -21.58 23.9 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.449 2.099 . . . . 0.0 112.536 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.34 -33.02 51.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.894 0.378 . . . . 0.0 110.723 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.635 ' O ' HG22 ' C' ' 19' ' ' VAL . 15.6 m-85 61.05 83.67 0.21 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.122 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 16.9 Cg_endo -58.12 159.42 18.65 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.463 2.109 . . . . 0.0 112.025 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' B' ' 74' ' ' LYS . . . -50.17 169.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.805 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.46 146.45 51.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.994 0.426 . . . . 0.0 111.286 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.658 ' O ' HG23 ' B' ' 76' ' ' THR . 1.7 p -152.61 58.43 0.81 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.42 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 25.3 p -96.04 142.78 27.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.129 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' C' ' 78' ' ' PHE . 33.9 m -147.44 153.52 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.153 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.837 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.7 OUTLIER -80.7 83.64 6.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.644 ' CG2' HD11 ' B' ' 115' ' ' LEU . 9.7 m -71.87 160.8 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.856 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -67.59 -53.54 27.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.235 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.417 ' HB3' HD12 ' A' ' 82' ' ' LEU . 1.5 mpt_? -151.28 -178.52 6.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.644 HD11 ' CG2' ' B' ' 112' ' ' VAL . 2.2 mp -153.57 159.29 32.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.577 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.525 ' O ' HG12 ' B' ' 119' ' ' VAL . 9.5 Cg_endo -52.15 140.19 51.38 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.573 2.182 . . . . 0.0 112.195 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 0.0 OUTLIER 66.86 13.97 9.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.537 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.76 19.16 5.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.078 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.717 ' HA ' HG11 ' B' ' 43' ' ' VAL . 3.1 p -52.28 -49.38 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 121.655 0.741 . . . . 0.0 111.194 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . 0.524 ' C ' HD13 ' B' ' 115' ' ' LEU . . . 90.23 -7.47 81.48 Favored Glycine 0 C--N 1.308 -1.012 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.338 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.711 HD11 HG13 ' B' ' 47' ' ' ILE . 16.7 mt -140.12 146.7 39.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.213 0.53 . . . . 0.0 111.128 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.426 ' HB2' ' CD2' ' B' ' 115' ' ' LEU . 26.1 tt0 -147.56 152.42 37.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.976 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.573 HD13 HD23 ' B' ' 55' ' ' LEU . 26.7 mt -138.1 127.39 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.258 0.552 . . . . 0.0 112.237 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.43 132.19 18.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.417 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.699 ' CB ' HG22 ' B' ' 75' ' ' THR . . . -149.43 159.4 44.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.827 HD12 HD12 ' B' ' 29' ' ' LEU . 14.8 mm -105.28 153.43 6.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.889 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 1.045 ' HB3' HG12 ' B' ' 28' ' ' VAL . . . -137.09 152.63 50.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.012 0.434 . . . . 0.0 111.845 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.897 HG12 HD22 ' B' ' 27' ' ' LEU . 27.0 m -120.06 178.05 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.834 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -167.68 59.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.887 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.85 0.357 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.11 144.12 54.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.818 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.72 HG21 HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER 61.4 113.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.57 114.64 15.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 1.026 HD11 HG11 ' C' ' 19' ' ' VAL . 1.1 tp -53.3 132.71 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.3 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' C' ' 23' ' ' ASP . 12.4 mm -98.67 143.4 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -168.16 106.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.789 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 3.7 t -124.97 169.31 12.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.8 29.87 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.454 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 0.4 OUTLIER -118.21 -40.76 2.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.677 ' HB1' ' CD ' ' C' ' 12' ' ' PRO . . . -72.21 177.24 1.84 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.213 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 22.2 Cg_exo -65.04 -10.89 27.33 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.947 2.432 . . . . 0.0 112.682 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.68 151.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.064 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.35 122.48 46.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.114 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.616 HG22 ' O ' ' C' ' 15' ' ' ILE . 26.3 mm -123.1 17.09 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.833 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.3 -131.92 3.63 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.36 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . 0.456 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 80.2 Cg_endo -90.03 20.77 0.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.759 2.306 . . . . 0.0 113.337 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.588 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 1.5 p90 -140.48 178.62 7.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.964 0.411 . . . . 0.0 111.516 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 1.026 HG11 HD11 ' C' ' 5' ' ' ILE . 15.7 m -132.92 -179.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.84 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -49.01 79.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' C' ' 61' ' ' ILE . . . -177.58 -172.78 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.825 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.789 HG23 HD23 ' C' ' 29' ' ' LEU . 4.7 m -142.24 132.64 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.161 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.788 ' HA ' HG23 ' C' ' 28' ' ' VAL . 10.5 t0 -113.97 109.83 19.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.81 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.646 ' CD1' HD21 ' C' ' 29' ' ' LEU . 12.1 mt -81.09 -14.72 57.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.231 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.88 -100.1 0.7 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.53 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . 0.722 ' C ' HD23 ' C' ' 27' ' ' LEU . 9.2 m-20 -57.6 -29.79 64.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.194 0.521 . . . . 0.0 109.839 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.93 HD22 HG12 ' C' ' 128' ' ' VAL . 1.4 mt -130.03 141.92 50.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.998 HG12 ' HB3' ' C' ' 127' ' ' ALA . 4.7 p -125.55 144.71 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.2 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.81 HD12 HD12 ' C' ' 126' ' ' ILE . 0.0 OUTLIER -118.08 147.01 43.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.51 HG21 HD11 ' C' ' 62' ' ' ILE . 16.2 p -124.15 155.18 38.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.923 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.96 167.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.958 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.89 94.6 0.14 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.314 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.521 ' O ' HD13 ' C' ' 34' ' ' ILE . 23.2 mm-40 -58.83 150.04 25.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 111.206 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.521 HD13 ' O ' ' C' ' 33' ' ' GLN . 22.4 mm -133.4 134.97 24.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.108 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.563 ' HD2' HG21 ' C' ' 119' ' ' VAL . 16.0 Cg_exo -68.09 56.2 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.874 2.383 . . . . 0.0 112.789 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.54 HG12 ' HA2' ' C' ' 41' ' ' GLY . 41.4 t -63.5 86.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.295 0.569 . . . . 0.0 110.595 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.775 ' HB3' HG22 ' C' ' 40' ' ' THR . 13.1 t30 -38.08 128.44 1.0 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.093 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' C' ' 37' ' ' ASN . 13.9 Cg_exo -68.61 -10.71 29.85 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.232 1.955 . . . . 0.0 111.91 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.29 -30.3 10.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 112.073 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.775 HG22 ' HB3' ' C' ' 37' ' ' ASN . 11.8 t -123.29 -26.0 4.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.834 0.35 . . . . 0.0 111.474 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.54 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 70.65 58.96 5.5 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.227 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.619 ' HG3' HG23 ' C' ' 40' ' ' THR . 5.9 mt-10 -154.38 -74.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.714 0.292 . . . . 0.0 111.404 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' C' ' 119' ' ' VAL . 7.4 p 175.51 117.59 0.12 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' C' ' 35' ' ' PRO . 52.1 Cg_exo -51.98 140.26 49.6 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.297 1.998 . . . . 0.0 112.204 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.67 -31.0 69.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.009 0.433 . . . . 0.0 111.065 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.1 OUTLIER -75.44 94.91 3.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.869 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.698 HG13 HD11 ' C' ' 121' ' ' LEU . 2.7 tp -43.38 -31.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.636 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 32.2 t -79.66 -45.51 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.646 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -63.22 -48.09 79.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.587 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.728 ' OE1' HD12 ' C' ' 121' ' ' LEU . 2.7 pt20 -61.53 -29.47 70.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.359 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.91 -39.61 61.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.964 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -62.38 -48.48 79.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.794 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -64.04 -34.62 78.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.601 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.8 OUTLIER -66.17 -31.1 71.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.762 HD13 ' CE2' ' C' ' 95' ' ' PHE . 75.5 mt -69.72 -49.89 48.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -40.82 84.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.87 -38.51 70.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.671 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.601 HG23 ' O ' ' C' ' 54' ' ' SER . 38.9 t -65.15 -25.97 38.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.678 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.711 ' HD3' ' HB2' ' C' ' 69' ' ' ALA . 0.3 OUTLIER -83.79 -39.22 20.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.755 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -58.26 -39.84 80.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.455 HD11 ' OE1' ' C' ' 33' ' ' GLN . 50.3 mt -68.69 -53.07 29.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.51 HD11 HG21 ' C' ' 30' ' ' THR . 50.9 mt -64.65 -28.87 45.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.731 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.49 -42.53 52.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.558 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -16.2 64.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.615 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.513 ' HB2' HD12 ' C' ' 6' ' ' ILE . . . -88.34 -28.74 20.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.929 0.395 . . . . 0.0 110.741 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.62 43.66 0.62 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.545 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.465 ' HB3' HG22 ' C' ' 62' ' ' ILE . 1.5 mt -149.74 -167.13 2.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.939 0.4 . . . . 0.0 110.849 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.16 154.91 38.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.71 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.861 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -58.16 -36.68 73.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.371 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.449 ' HB2' ' HD2' ' C' ' 101' ' ' HIS . . . -50.09 -26.35 4.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.285 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -23.75 34.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.381 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' C' ' 69' ' ' ALA . 88.8 mt -44.34 120.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.883 0.373 . . . . 0.0 111.416 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.565 HG13 HG22 ' C' ' 128' ' ' VAL . 29.1 m -90.17 -38.02 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.716 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.538 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -137.8 155.5 48.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.952 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.792 HG21 ' OH ' ' C' ' 92' ' ' TYR . 17.4 p -143.37 152.03 41.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.034 0.445 . . . . 0.0 111.579 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.656 HG23 ' O ' ' C' ' 108' ' ' SER . 5.3 m -133.72 142.31 47.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.007 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 20.5 t -143.03 105.88 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 111.787 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.488 ' HB2' HD21 ' C' ' 115' ' ' LEU . 7.7 m-85 -86.96 106.21 17.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.544 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.698 HG12 ' CD2' ' C' ' 121' ' ' LEU . 18.7 m -102.66 152.59 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.624 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.08 -2.58 46.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.802 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -154.45 113.44 3.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.635 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.56 HD11 ' C ' ' A' ' 115' ' ' LEU . 6.1 mt -65.2 -13.56 58.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.044 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -81.95 -23.17 36.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.443 ' OD1' HG21 ' C' ' 47' ' ' ILE . 6.6 m-20 -80.88 -23.69 38.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.156 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.615 ' HD1' HG11 ' C' ' 79' ' ' VAL . 2.0 t80 -56.25 -23.92 39.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.384 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.85 74.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.214 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.46 -38.68 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.242 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.37 -36.04 65.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.6 t30 -69.24 -43.22 74.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.12 -32.9 74.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.08 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . 0.588 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 0.1 OUTLIER -86.0 -23.2 26.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.156 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.792 ' OH ' HG21 ' C' ' 75' ' ' THR . 10.3 t80 -77.94 -27.5 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.538 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -90.1 -39.52 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . 0.588 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 0.0 OUTLIER -67.25 -23.12 65.67 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.762 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -90.88 -32.75 15.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.784 0.326 . . . . 0.0 110.529 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.523 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 1.6 m-85 -60.2 -58.81 6.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.059 0.457 . . . . 0.0 110.259 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -63.53 -28.22 69.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.141 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -77.75 -10.9 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.566 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 2.2 m-80 -111.17 -5.85 14.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.397 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 0.5 OUTLIER 94.5 37.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.86 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.861 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 1.8 m170 -117.93 51.99 1.34 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.723 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 64.3 Cg_endo -72.0 -21.57 24.07 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.442 2.095 . . . . 0.0 112.574 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -53.36 -33.01 51.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.936 0.398 . . . . 0.0 110.718 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.633 ' O ' HG22 ' A' ' 19' ' ' VAL . 15.5 m-85 60.98 83.75 0.2 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.074 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 17.1 Cg_endo -58.17 159.46 18.72 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.45 2.1 . . . . 0.0 112.005 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' C' ' 74' ' ' LYS . . . -50.26 169.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.779 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -133.31 146.44 51.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.0 0.429 . . . . 0.0 111.341 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . 0.656 ' O ' HG23 ' C' ' 76' ' ' THR . 1.7 p -152.59 58.5 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.457 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 25.4 p -96.05 142.85 27.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.093 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.435 HG11 ' CD2' ' A' ' 78' ' ' PHE . 33.9 m -147.62 153.93 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.852 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -80.85 83.63 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.656 ' CG2' HD11 ' C' ' 115' ' ' LEU . 9.6 m -71.95 160.81 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.837 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -67.55 -53.57 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.22 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -151.25 -178.6 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.987 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.656 HD11 ' CG2' ' C' ' 112' ' ' VAL . 2.1 mp -153.56 159.39 32.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.526 ' O ' HG12 ' C' ' 119' ' ' VAL . 9.6 Cg_endo -52.18 140.17 51.75 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.598 2.199 . . . . 0.0 112.195 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 0.0 OUTLIER 66.89 13.99 9.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.515 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.72 19.21 5.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.728 ' HA ' HG11 ' C' ' 43' ' ' VAL . 3.1 p -52.34 -49.34 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.658 0.742 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . 0.54 ' C ' HD13 ' C' ' 115' ' ' LEU . . . 90.3 -7.49 81.41 Favored Glycine 0 C--N 1.308 -0.984 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.333 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.728 HD12 ' OE1' ' C' ' 50' ' ' GLN . 16.7 mt -140.16 146.72 39.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.246 0.546 . . . . 0.0 111.134 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.429 ' HB2' ' CD2' ' C' ' 115' ' ' LEU . 26.1 tt0 -147.67 152.39 37.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.953 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.558 HD13 HD23 ' C' ' 55' ' ' LEU . 26.7 mt -138.05 127.47 33.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.229 0.538 . . . . 0.0 112.189 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.48 132.13 18.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.431 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.699 ' CB ' HG22 ' C' ' 75' ' ' THR . . . -149.37 159.39 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.211 0.529 . . . . 0.0 112.412 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.81 HD12 HD12 ' C' ' 29' ' ' LEU . 14.7 mm -105.22 153.43 6.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.917 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.998 ' HB3' HG12 ' C' ' 28' ' ' VAL . . . -137.11 152.56 50.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.031 0.443 . . . . 0.0 111.79 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.93 HG12 HD22 ' C' ' 27' ' ' LEU . 27.0 m -119.99 178.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.842 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -167.74 59.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 111.035 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.916 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.848 0.356 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.486 ' O ' HG23 ' A' ' 3' ' ' THR . 3.6 mtt -89.47 87.97 7.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.977 HG21 HG21 ' C' ' 128' ' ' VAL . 0.0 OUTLIER -175.63 118.21 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.794 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -157.82 118.17 3.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.803 HD11 ' OD1' ' C' ' 103' ' ' ASN . 4.4 mp -58.25 138.3 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.081 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.863 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 31.9 mt -94.83 138.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.158 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -150.97 136.94 18.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.51 162.81 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.75 26.61 5.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -118.03 -40.57 2.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.64 119.65 72.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.171 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.05 -10.84 28.61 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.42 2.08 . . . . 0.0 112.596 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.45 172.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.928 0.394 . . . . 0.0 111.464 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 62.84 130.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.187 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.94 -36.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.504 0.669 . . . . 0.0 110.768 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.03 -145.11 11.19 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.368 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.69 57.97 5.78 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.731 2.287 . . . . 0.0 112.873 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.482 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -168.46 -177.3 3.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 111.08 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' C' ' 104' ' ' PHE . 27.0 m -112.8 -178.45 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.297 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.415 ' CG ' ' HB2' ' A' ' 14' ' ' ALA . 43.5 mt-30 -80.2 -50.94 9.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.982 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -156.95 179.8 8.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.268 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 m -139.57 147.3 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.082 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.908 ' HA ' HG12 ' A' ' 28' ' ' VAL . 20.3 t0 -123.23 94.32 4.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.736 HD22 HG11 ' C' ' 128' ' ' VAL . 11.0 mt -69.96 -17.37 63.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.268 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.62 -105.42 0.95 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.146 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.478 ' HB2' HD23 ' A' ' 27' ' ' LEU . 67.0 m-80 -52.6 -29.99 28.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.054 0.454 . . . . 0.0 110.525 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -137.24 134.16 35.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.773 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.01 HG23 ' HB3' ' A' ' 127' ' ' ALA . 3.0 m -113.07 172.32 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.218 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.761 HD23 HD12 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -145.67 165.71 27.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.431 HG21 HD11 ' A' ' 62' ' ' ILE . 44.3 p -130.13 135.98 48.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m -69.23 154.54 41.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.97 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 123' ' ' ILE . . . -55.26 93.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.631 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.767 ' HG2' HG22 ' A' ' 58' ' ' VAL . 1.6 mp0 -67.65 173.7 4.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.776 0.322 . . . . 0.0 111.009 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.677 ' HB ' HG11 ' A' ' 119' ' ' VAL . 7.6 pt -159.38 152.54 18.48 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.441 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.68 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 43.8 Cg_endo -68.09 74.8 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.05 2.5 . . . . 0.0 112.325 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.586 HG12 ' HA2' ' A' ' 41' ' ' GLY . 22.5 t -90.96 88.23 2.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.587 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.598 ' HB3' HG22 ' A' ' 40' ' ' THR . 0.3 OUTLIER -36.18 129.18 0.65 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.886 -179.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.12 -7.91 21.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.288 1.992 . . . . 0.0 112.081 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.95 -22.56 12.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.601 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 37' ' ' ASN . 4.4 t -132.69 -39.0 1.0 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.878 0.37 . . . . 0.0 110.925 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.586 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 85.79 56.92 2.25 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.305 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 12.9 mm-40 -145.12 -71.22 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 111.411 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 35' ' ' PRO . 7.1 p 172.91 112.51 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -55.58 140.62 83.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.296 1.998 . . . . 0.0 112.144 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.06 71.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.044 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -75.75 94.93 3.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.858 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.502 HD12 ' NE2' ' A' ' 50' ' ' GLN . 6.4 tp -44.5 -31.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.427 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -38.29 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.713 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . . . -69.24 -39.97 78.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.497 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.502 ' NE2' HD12 ' A' ' 47' ' ' ILE . 6.8 pt20 -75.44 -21.88 57.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.223 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.5 -41.5 27.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.161 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.24 -34.45 63.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.76 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.15 -31.59 64.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.529 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.802 ' O ' HG23 ' A' ' 58' ' ' VAL . 68.7 p -67.31 -30.79 70.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.703 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.873 HD13 ' CE2' ' A' ' 95' ' ' PHE . 34.2 mt -79.39 -30.72 42.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.802 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.55 -55.91 20.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.985 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 9.3 p-10 -55.79 -44.99 78.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 54' ' ' SER . 45.0 t -59.25 -31.02 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -79.2 -38.42 35.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.766 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.27 81.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' A' ' 58' ' ' VAL . 6.5 mt -67.06 -51.26 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.771 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.431 HD11 HG21 ' A' ' 30' ' ' THR . 45.8 mt -63.21 -32.63 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.592 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.68 -40.71 63.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.241 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.52 -21.0 65.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.94 -25.66 20.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.812 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 47.91 0.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.482 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.808 HD22 ' OD2' ' A' ' 71' ' ' ASP . 7.2 mt -156.68 -171.62 3.74 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.724 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.6 p -142.82 -179.58 6.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.981 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.812 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -78.63 -24.89 45.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.58 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.565 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -59.81 -36.54 76.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.981 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.808 ' OD2' HD22 ' A' ' 67' ' ' LEU . 4.0 p30 -71.01 -26.51 63.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.072 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.443 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 88.3 mt -46.76 115.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.83 0.348 . . . . 0.0 110.933 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.46 HG21 HD21 ' B' ' 24' ' ' LEU . 27.3 m -91.26 -26.01 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.766 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.639 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 1.7 ttpm? -138.03 164.46 29.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.735 0.302 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 125' ' ' ALA . 91.9 m -163.63 126.58 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.045 0.45 . . . . 0.0 111.492 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 108' ' ' SER . 2.8 m -109.25 144.8 36.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.881 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.08 108.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 111.782 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.455 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.6 m-85 -91.47 107.11 18.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.278 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.757 HG12 HD22 ' A' ' 121' ' ' LEU . 30.0 m -102.21 149.95 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.201 0.524 . . . . 0.0 111.804 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.74 -6.18 49.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.818 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.44 111.99 3.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.54 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 82' ' ' LEU . 2.6 mt -61.28 -15.18 32.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -78.32 -19.45 53.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.758 0.313 . . . . 0.0 110.869 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 88' ' ' VAL . 19.2 m-20 -90.65 7.18 40.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.411 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.444 ' CD1' HG11 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -82.18 -27.46 32.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 111.172 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -36.76 76.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.123 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.38 -36.6 29.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 84' ' ' ASP . 27.9 t -75.6 -30.52 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 85' ' ' PHE . 9.9 m120 -67.19 -48.88 66.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.02 -39.18 90.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.177 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.412 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 0.6 OUTLIER -75.89 -23.94 55.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.196 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -81.73 -33.29 31.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.401 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' B' ' 17' ' ' PRO . 0.8 OUTLIER -89.65 -29.76 18.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.696 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.412 ' HG2' ' HA ' ' A' ' 91' ' ' GLU . 1.3 ppt_? -75.86 -21.59 57.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.663 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.873 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -92.01 -33.13 14.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 0.0 110.671 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.503 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 2.6 m-85 -58.98 -59.13 5.96 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.063 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -31.5 72.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.246 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.57 -11.5 60.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.419 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 4.9 m-20 -110.91 -6.53 14.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.336 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 8.1 t-20 90.11 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.548 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.812 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 m-70 -115.21 53.41 0.81 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.025 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.1 Cg_endo -74.63 -14.51 22.07 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.51 2.14 . . . . 0.0 112.55 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.803 ' OD1' HD11 ' B' ' 5' ' ' ILE . 2.0 t30 -51.68 -33.28 33.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.093 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.751 ' CB ' HG13 ' B' ' 19' ' ' VAL . 3.6 m-85 61.47 96.46 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.031 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 59.9 Cg_endo -73.33 159.09 47.53 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.443 2.095 . . . . 0.0 112.258 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.639 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -55.71 147.69 18.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.445 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.64 142.52 45.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.005 0.431 . . . . 0.0 111.442 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.584 ' O ' HG23 ' A' ' 76' ' ' THR . 31.1 t -149.58 62.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.376 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.5 p -94.64 145.38 24.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.461 HG11 ' CD2' ' B' ' 78' ' ' PHE . 35.9 m -153.28 135.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.212 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.601 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -64.76 91.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.802 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.769 HG21 HD21 ' A' ' 115' ' ' LEU . 8.4 m -76.26 164.43 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -83.66 -44.8 14.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.411 ' HB2' ' HB3' ' C' ' 111' ' ' GLU . 0.1 OUTLIER -158.54 158.62 34.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.734 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.87 HD22 ' HB2' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -141.34 168.99 12.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.485 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 115' ' ' LEU . 74.4 Cg_exo -50.18 136.87 38.28 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.351 2.034 . . . . 0.0 112.362 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 67.13 14.31 9.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.359 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.53 20.11 5.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.021 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.677 HG11 ' HB ' ' A' ' 34' ' ' ILE . 16.0 m -53.12 149.75 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.244 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.581 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -81.52 -15.01 77.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.754 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.757 HD22 HG12 ' A' ' 79' ' ' VAL . 42.1 mt -152.3 148.65 27.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 110.848 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.87 ' HB2' HD22 ' A' ' 115' ' ' LEU . 27.2 tt0 -129.8 146.71 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.21 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.401 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 29.0 mm -120.1 150.27 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.035 0.445 . . . . 0.0 111.763 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.22 147.45 6.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.694 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -173.83 164.34 4.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.098 0.475 . . . . 0.0 112.129 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.761 HD12 HD23 ' A' ' 29' ' ' LEU . 5.6 mm -117.59 151.83 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.362 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 1.01 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -131.49 147.53 52.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.976 0.417 . . . . 0.0 111.739 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.969 HG21 HG21 ' B' ' 3' ' ' THR . 27.1 m -109.6 152.01 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.055 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.786 ' HB2' HD11 ' A' ' 67' ' ' LEU . 11.7 ttp180 -173.18 73.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.78 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.86 0.362 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . 0.491 ' O ' HG23 ' B' ' 3' ' ' THR . 3.6 mtt -89.48 87.99 7.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.969 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -175.58 118.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -157.81 118.18 3.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.009 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.803 HD11 ' OD1' ' A' ' 103' ' ' ASN . 4.4 mp -58.22 138.26 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.084 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.865 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 31.8 mt -94.83 138.11 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -150.94 136.92 18.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.52 162.77 34.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.72 26.67 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -118.11 -40.86 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -85.24 119.68 72.61 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 17.8 Cg_exo -66.03 -10.88 28.71 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.424 2.083 . . . . 0.0 112.572 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.43 172.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.525 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.487 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 62.86 130.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.207 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.95 -36.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.509 0.671 . . . . 0.0 110.773 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.04 -145.18 11.29 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.313 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 94.3 Cg_endo -83.64 58.01 5.82 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.715 2.276 . . . . 0.0 112.896 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -168.54 -177.29 3.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 111.067 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.751 HG13 ' CB ' ' A' ' 104' ' ' PHE . 27.0 m -112.77 -178.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.418 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 43.5 mt-30 -80.3 -51.05 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.044 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.865 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -156.59 179.75 8.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.272 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.56 147.32 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.076 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.916 ' HA ' HG12 ' B' ' 28' ' ' VAL . 20.4 t0 -123.24 94.39 4.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.786 HD22 HG11 ' A' ' 128' ' ' VAL . 11.0 mt -70.02 -17.42 63.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.61 -105.32 0.95 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.12 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . 0.483 ' HB2' HD23 ' B' ' 27' ' ' LEU . 67.3 m-80 -52.66 -29.97 29.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.472 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' B' ' 26' ' ' ASN . 0.2 OUTLIER -137.29 134.17 35.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.776 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.017 HG23 ' HB3' ' B' ' 127' ' ' ALA . 3.0 m -113.03 172.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.737 HD23 HD12 ' B' ' 126' ' ' ILE . 1.0 OUTLIER -145.7 165.69 28.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.672 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.418 HG21 HD11 ' B' ' 62' ' ' ILE . 44.2 p -130.13 136.0 48.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 48.6 m -69.34 154.41 42.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' B' ' 123' ' ' ILE . . . -55.21 93.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.608 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.755 ' HG2' HG22 ' B' ' 58' ' ' VAL . 1.6 mp0 -67.66 173.66 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.734 0.302 . . . . 0.0 111.004 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.68 ' HB ' HG11 ' B' ' 119' ' ' VAL . 7.7 pt -159.37 152.59 18.55 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.004 0.43 . . . . 0.0 111.467 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.667 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 44.0 Cg_endo -68.14 74.81 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.108 2.538 . . . . 0.0 112.338 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.583 HG12 ' HA2' ' B' ' 41' ' ' GLY . 22.6 t -91.01 88.15 2.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.55 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.604 ' HB3' HG22 ' B' ' 40' ' ' THR . 0.3 OUTLIER -36.1 129.16 0.64 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.922 -179.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.12 -7.85 21.77 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.261 1.974 . . . . 0.0 112.108 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.99 -22.53 12.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.577 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.604 HG22 ' HB3' ' B' ' 37' ' ' ASN . 4.5 t -132.76 -38.94 0.99 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.909 0.385 . . . . 0.0 111.002 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.583 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 85.77 56.86 2.27 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.32 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.439 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 12.9 mm-40 -145.08 -71.13 0.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.682 0.277 . . . . 0.0 111.441 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' B' ' 35' ' ' PRO . 7.1 p 172.89 112.54 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -55.63 140.64 84.07 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.331 2.021 . . . . 0.0 112.153 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.1 71.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' B' ' 49' ' ' ALA . 1.0 OUTLIER -75.74 94.91 3.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.863 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.497 HD12 ' NE2' ' B' ' 50' ' ' GLN . 6.3 tp -44.43 -31.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.408 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.19 -38.27 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.733 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' B' ' 46' ' ' ASP . . . -69.28 -39.99 78.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.463 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.497 ' NE2' HD12 ' B' ' 47' ' ' ILE . 6.8 pt20 -75.52 -21.83 57.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.239 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.6 -41.49 26.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.213 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.26 -34.47 63.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.15 -31.51 64.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.57 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.795 ' O ' HG23 ' B' ' 58' ' ' VAL . 68.9 p -67.31 -30.82 70.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.84 HD13 ' CE2' ' B' ' 95' ' ' PHE . 34.4 mt -79.38 -30.7 42.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.6 -55.9 20.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 9.3 p-10 -55.76 -45.03 78.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.795 HG23 ' O ' ' B' ' 54' ' ' SER . 44.9 t -59.27 -30.94 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.768 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -79.22 -38.47 35.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.16 81.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' B' ' 58' ' ' VAL . 6.5 mt -67.02 -51.41 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.792 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.418 HD11 HG21 ' B' ' 30' ' ' THR . 45.8 mt -63.19 -32.64 57.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.598 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.64 -40.69 63.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.266 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.56 -21.0 65.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.485 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.89 -25.68 20.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.1 47.96 0.54 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.461 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.809 HD22 ' OD2' ' B' ' 71' ' ' ASP . 7.2 mt -156.75 -171.65 3.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.764 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 76.8 p -142.82 -179.65 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.809 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -78.59 -24.93 45.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.577 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.579 ' HB2' ' ND1' ' B' ' 101' ' ' HIS . . . -59.79 -36.47 76.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.029 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.809 ' OD2' HD22 ' B' ' 67' ' ' LEU . 4.0 p30 -71.06 -26.51 63.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.055 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 105' ' ' PRO . 88.3 mt -46.8 115.63 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.445 HG21 HD21 ' C' ' 24' ' ' LEU . 27.3 m -91.21 -25.95 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.762 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.636 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 1.7 ttpm? -138.11 164.42 29.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.0 110.936 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 125' ' ' ALA . 91.7 m -163.58 126.63 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.048 0.451 . . . . 0.0 111.484 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.587 HG23 ' O ' ' B' ' 108' ' ' SER . 2.8 m -109.28 144.78 36.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.03 108.4 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.914 0.388 . . . . 0.0 111.828 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.461 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.6 m-85 -91.46 107.16 19.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.24 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.753 HG12 HD22 ' B' ' 121' ' ' LEU . 30.2 m -102.22 149.97 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.158 0.504 . . . . 0.0 111.838 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.89 -6.14 49.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.747 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.45 111.96 3.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.516 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' B' ' 82' ' ' LEU . 2.6 mt -61.15 -15.24 31.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.242 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -78.31 -19.52 53.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.603 ' O ' HG23 ' B' ' 88' ' ' VAL . 19.2 m-20 -90.62 7.26 40.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.448 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.448 ' CD1' HG11 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -82.25 -27.48 32.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.749 0.309 . . . . 0.0 111.114 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.19 -36.8 75.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.157 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.36 -36.63 29.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.603 HG23 ' O ' ' B' ' 84' ' ' ASP . 28.8 t -75.63 -30.48 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' B' ' 85' ' ' PHE . 9.9 m120 -67.21 -48.93 66.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.94 -39.32 90.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.78 -23.98 55.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -81.78 -33.29 30.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.399 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.71 -29.68 18.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.657 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -75.88 -21.57 57.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.668 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.84 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -92.04 -33.13 14.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 110.671 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.495 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 2.6 m-85 -58.95 -59.11 5.99 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.09 0.472 . . . . 0.0 110.138 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -31.46 72.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.297 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.49 -11.6 60.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.436 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.49 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 4.9 m-20 -110.88 -6.44 14.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.336 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 8.1 t-20 90.11 35.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.619 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.809 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.6 m-70 -115.3 53.43 0.83 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.959 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 71.8 Cg_endo -74.56 -14.61 22.21 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.541 2.161 . . . . 0.0 112.577 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.789 ' OD1' HD11 ' C' ' 5' ' ' ILE . 2.0 t30 -51.59 -33.33 32.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.135 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.727 ' CB ' HG13 ' C' ' 19' ' ' VAL . 3.6 m-85 61.49 96.48 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 59.9 Cg_endo -73.34 159.05 47.56 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.404 2.069 . . . . 0.0 112.255 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.636 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -55.59 147.72 17.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.458 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.76 142.49 45.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.032 0.444 . . . . 0.0 111.471 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.587 ' O ' HG23 ' B' ' 76' ' ' THR . 31.2 t -149.52 62.87 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.352 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 18.8 p -94.62 145.41 24.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.233 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.464 HG11 ' CD2' ' C' ' 78' ' ' PHE . 35.9 m -153.33 135.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.244 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -64.78 91.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.77 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.739 HG21 HD21 ' B' ' 115' ' ' LEU . 8.2 m -76.35 164.45 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.236 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -83.6 -44.88 14.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.106 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.425 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -158.51 158.68 34.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.706 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.863 HD22 ' HB2' ' B' ' 122' ' ' GLU . 0.9 OUTLIER -141.4 168.95 12.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.495 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' B' ' 115' ' ' LEU . 74.5 Cg_exo -50.16 136.89 38.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.352 2.035 . . . . 0.0 112.325 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.11 14.28 9.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.398 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.56 20.07 5.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.041 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.68 HG11 ' HB ' ' B' ' 34' ' ' ILE . 16.0 m -53.1 149.77 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.198 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . 0.581 ' O ' HD23 ' B' ' 121' ' ' LEU . . . -81.56 -15.15 76.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.769 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.753 HD22 HG12 ' B' ' 79' ' ' VAL . 42.5 mt -152.21 148.63 27.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.959 0.409 . . . . 0.0 110.848 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.863 ' HB2' HD22 ' B' ' 115' ' ' LEU . 27.0 tt0 -129.68 146.63 51.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.284 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.415 ' O ' ' HA2' ' B' ' 32' ' ' GLY . 29.3 mm -120.11 150.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 111.748 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.16 147.48 6.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.69 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.517 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -173.87 164.4 4.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 112.133 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.737 HD12 HD23 ' B' ' 29' ' ' LEU . 5.6 mm -117.74 151.85 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.334 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 1.017 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -131.45 147.54 52.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 111.781 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.945 HG21 HG21 ' C' ' 3' ' ' THR . 27.1 m -109.62 151.93 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.086 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.786 ' HB2' HD11 ' B' ' 67' ' ' LEU . 11.7 ttp180 -173.09 73.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.79 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.94 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.844 0.354 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . 0.477 ' O ' HG23 ' C' ' 3' ' ' THR . 3.6 mtt -89.51 87.93 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.945 HG21 HG21 ' B' ' 128' ' ' VAL . 0.0 OUTLIER -175.57 118.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.742 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -157.87 118.22 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.789 HD11 ' OD1' ' B' ' 103' ' ' ASN . 4.4 mp -58.19 138.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.092 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.83 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 31.6 mt -94.73 138.08 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.169 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -151.0 136.91 18.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -143.49 162.77 34.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.71 26.65 5.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -118.06 -40.69 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.791 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' C' ' 12' ' ' PRO . . . -85.5 119.67 72.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.124 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' C' ' 11' ' ' ALA . 17.8 Cg_exo -66.03 -10.88 28.73 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.496 2.131 . . . . 0.0 112.601 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.5 172.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.472 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 62.94 130.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.16 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -179.91 -36.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.495 0.664 . . . . 0.0 110.741 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.06 -145.12 11.23 Favored Glycine 0 C--N 1.315 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.364 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.68 57.95 5.78 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.702 2.268 . . . . 0.0 112.901 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -168.45 -177.37 3.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.086 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.727 HG13 ' CB ' ' B' ' 104' ' ' PHE . 27.0 m -112.73 -178.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.328 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 43.4 mt-30 -80.31 -51.2 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.05 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.83 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -156.41 179.68 9.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.282 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.5 147.37 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.921 ' HA ' HG12 ' C' ' 28' ' ' VAL . 20.4 t0 -123.25 94.36 4.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.773 HD22 HG11 ' B' ' 128' ' ' VAL . 11.0 mt -69.99 -17.4 63.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.232 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.62 -105.37 0.95 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.178 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . 0.499 ' HB2' HD23 ' C' ' 27' ' ' LEU . 67.0 m-80 -52.53 -30.07 28.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.038 0.447 . . . . 0.0 110.517 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' C' ' 26' ' ' ASN . 0.2 OUTLIER -137.21 134.14 35.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.824 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.998 HG23 ' HB3' ' C' ' 127' ' ' ALA . 3.0 m -113.0 172.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.256 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.753 HD23 HD12 ' C' ' 126' ' ' ILE . 1.0 OUTLIER -145.68 165.65 28.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.69 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 44.1 p -130.14 135.96 48.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -69.43 154.44 42.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.032 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' C' ' 123' ' ' ILE . . . -55.26 93.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.647 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.746 ' HG2' HG22 ' C' ' 58' ' ' VAL . 1.6 mp0 -67.58 173.7 4.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.742 0.306 . . . . 0.0 110.991 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.671 ' HB ' HG11 ' C' ' 119' ' ' VAL . 7.7 pt -159.37 152.52 18.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.484 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.672 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 43.7 Cg_endo -68.14 74.84 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.112 2.541 . . . . 0.0 112.304 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.604 HG12 ' HA2' ' C' ' 41' ' ' GLY . 22.5 t -90.99 88.14 2.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.589 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.586 ' HB3' HG22 ' C' ' 40' ' ' THR . 0.3 OUTLIER -36.13 129.16 0.64 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.939 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.1 -7.84 21.75 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.339 2.026 . . . . 0.0 112.084 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.02 -22.54 12.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.582 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.586 HG22 ' HB3' ' C' ' 37' ' ' ASN . 4.5 t -132.73 -39.0 0.99 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.869 0.366 . . . . 0.0 110.988 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 85.77 56.92 2.26 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.275 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.446 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 13.0 mm-40 -145.09 -71.19 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.389 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' C' ' 35' ' ' PRO . 7.2 p 172.92 112.56 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.67 140.65 84.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.304 2.002 . . . . 0.0 112.151 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.13 71.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.979 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' C' ' 49' ' ' ALA . 1.0 OUTLIER -75.76 94.9 3.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.822 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.493 HD12 ' NE2' ' C' ' 50' ' ' GLN . 6.3 tp -44.43 -31.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.39 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.25 -38.21 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.723 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' C' ' 46' ' ' ASP . . . -69.25 -40.05 78.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.46 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.493 ' NE2' HD12 ' C' ' 47' ' ' ILE . 6.8 pt20 -75.5 -21.95 57.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.241 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.69 -41.59 26.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.181 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -74.28 -34.36 63.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.786 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.16 -31.56 64.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.556 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.815 ' O ' HG23 ' C' ' 58' ' ' VAL . 69.0 p -67.28 -30.87 70.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.696 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.795 HD13 ' CE2' ' C' ' 95' ' ' PHE . 34.4 mt -79.34 -30.71 42.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.851 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.53 -55.89 20.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.031 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 9.3 p-10 -55.77 -45.06 78.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.815 HG23 ' O ' ' C' ' 54' ' ' SER . 45.1 t -59.19 -31.03 45.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -79.24 -38.5 35.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.701 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.9 80.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' C' ' 58' ' ' VAL . 6.5 mt -67.32 -51.52 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.826 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 mt -63.18 -32.69 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.6 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -73.66 -40.66 63.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.28 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -62.58 -20.96 65.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.485 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.9 -25.67 20.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.858 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.11 47.91 0.54 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.453 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.822 HD22 ' OD2' ' C' ' 71' ' ' ASP . 7.2 mt -156.71 -171.64 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.712 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 77.7 p -142.77 -179.6 6.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.804 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -78.64 -24.95 44.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.52 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.575 ' HB2' ' ND1' ' C' ' 101' ' ' HIS . . . -59.82 -36.54 77.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.822 ' OD2' HD22 ' C' ' 67' ' ' LEU . 4.0 p30 -71.11 -26.34 62.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.062 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' C' ' 105' ' ' PRO . 88.4 mt -46.81 115.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.87 0.367 . . . . 0.0 110.953 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.44 HG21 HD21 ' A' ' 24' ' ' LEU . 27.3 m -91.2 -26.0 5.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.78 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 1.7 ttpm? -138.08 164.45 29.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.704 0.288 . . . . 0.0 110.913 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.486 HG23 ' HB2' ' C' ' 125' ' ' ALA . 91.0 m -163.54 126.62 2.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.994 0.426 . . . . 0.0 111.502 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.6 HG23 ' O ' ' C' ' 108' ' ' SER . 2.8 m -109.34 144.79 37.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.845 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 t -142.01 108.39 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 111.844 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.464 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.6 m-85 -91.44 107.11 18.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.332 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.73 HG12 HD22 ' C' ' 121' ' ' LEU . 29.9 m -102.14 149.94 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.137 0.494 . . . . 0.0 111.837 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.81 -6.36 49.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.858 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.13 111.91 3.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.488 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.22 -15.21 32.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.282 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -78.33 -19.51 53.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.767 0.318 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.608 ' O ' HG23 ' C' ' 88' ' ' VAL . 19.2 m-20 -90.64 7.26 40.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.372 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.447 ' CD1' HG11 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -82.32 -27.41 32.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 111.117 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.31 -36.67 76.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.162 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.41 -36.66 29.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.608 HG23 ' O ' ' C' ' 84' ' ' ASP . 28.3 t -75.63 -30.47 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' C' ' 85' ' ' PHE . 9.9 m120 -67.16 -48.95 66.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.1 90.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' C' ' 94' ' ' ARG . 0.6 OUTLIER -75.91 -23.91 55.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.248 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -81.71 -33.32 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.378 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' C' ' 104' ' ' PHE . 0.8 OUTLIER -89.69 -29.72 18.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.651 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' C' ' 91' ' ' GLU . 1.3 ppt_? -75.88 -21.54 57.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.686 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.795 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -92.02 -33.18 14.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.795 0.331 . . . . 0.0 110.669 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 2.6 m-85 -59.03 -59.05 6.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.032 0.444 . . . . 0.0 110.124 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -31.5 72.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.279 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.53 -11.5 60.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.436 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 4.9 m-20 -110.93 -6.49 14.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.302 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 8.1 t-20 90.21 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.539 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.804 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.6 m-70 -115.37 53.38 0.84 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.0 Cg_endo -74.57 -14.61 22.2 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.514 2.143 . . . . 0.0 112.563 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.803 ' OD1' HD11 ' A' ' 5' ' ' ILE . 2.0 t30 -51.61 -33.27 32.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.125 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.74 ' CB ' HG13 ' A' ' 19' ' ' VAL . 3.7 m-85 61.5 96.45 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.016 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 60.2 Cg_endo -73.26 159.17 47.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.389 2.059 . . . . 0.0 112.293 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.648 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -55.77 147.64 18.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.65 142.47 45.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.034 0.445 . . . . 0.0 111.476 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . 0.6 ' O ' HG23 ' C' ' 76' ' ' THR . 31.0 t -149.49 62.84 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.346 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 18.5 p -94.59 145.36 24.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.221 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.455 HG11 ' CD2' ' A' ' 78' ' ' PHE . 35.8 m -153.24 134.88 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.195 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.636 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.51 91.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.761 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.753 HG21 HD21 ' C' ' 115' ' ' LEU . 8.4 m -76.28 164.41 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.286 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -83.68 -44.81 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.041 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.432 ' HB2' ' HB3' ' B' ' 111' ' ' GLU . 0.1 OUTLIER -158.56 158.61 34.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.746 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.86 HD22 ' HB2' ' C' ' 122' ' ' GLU . 0.9 OUTLIER -141.37 168.98 12.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.501 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' C' ' 115' ' ' LEU . 74.1 Cg_exo -50.19 136.88 38.37 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.37 2.047 . . . . 0.0 112.275 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.11 14.35 9.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.366 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 57.54 20.14 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.009 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.671 HG11 ' HB ' ' C' ' 34' ' ' ILE . 16.0 m -53.21 149.81 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . 0.595 ' O ' HD23 ' C' ' 121' ' ' LEU . . . -81.72 -15.13 76.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.794 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.73 HD22 HG12 ' C' ' 79' ' ' VAL . 41.9 mt -152.16 148.53 27.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.89 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.86 ' HB2' HD22 ' C' ' 115' ' ' LEU . 27.1 tt0 -129.68 146.68 51.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.26 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' C' ' 32' ' ' GLY . 29.3 mm -120.18 150.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.064 0.459 . . . . 0.0 111.742 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -166.09 147.46 6.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.65 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -173.83 164.38 4.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.111 0.482 . . . . 0.0 112.119 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.753 HD12 HD23 ' C' ' 29' ' ' LEU . 5.6 mm -117.67 151.85 19.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.303 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.998 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -131.46 147.58 52.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 111.771 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.977 HG21 HG21 ' A' ' 3' ' ' THR . 27.1 m -109.66 151.97 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.062 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.797 ' HB2' HD11 ' C' ' 67' ' ' LEU . 11.7 ttp180 -173.09 73.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.759 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.76 0.314 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.4 tpp -137.2 166.65 23.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.821 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER 60.1 101.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.12 110.6 17.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.859 HD11 HG21 ' A' ' 19' ' ' VAL . 2.3 tp -54.99 129.66 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.192 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.634 HD12 ' CB ' ' A' ' 21' ' ' ALA . 32.1 mt -90.53 151.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.412 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.78 108.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.818 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.09 170.28 10.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.69 22.27 10.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.926 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.5 -37.96 6.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.638 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -100.46 127.87 31.73 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.058 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 7.8 Cg_exo -72.1 -1.67 10.41 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.668 2.246 . . . . 0.0 112.701 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' HE21 ' A' ' 20' ' ' GLN . . . -46.92 170.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.862 0.363 . . . . 0.0 111.586 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.27 119.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.115 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 15' ' ' ILE . 13.5 mt -154.79 15.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.858 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.36 -114.64 0.5 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.974 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HB2' ' CD1' ' C' ' 92' ' ' TYR . 92.8 Cg_endo -81.01 50.98 3.76 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.664 2.242 . . . . 0.0 112.981 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.484 ' CG ' ' HB2' ' C' ' 107' ' ' ARG . 1.7 p90 -178.7 156.84 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.0 111.002 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.859 HG21 HD11 ' A' ' 5' ' ' ILE . 31.2 m -106.69 -174.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.174 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.699 HE21 ' HB3' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -73.68 -43.8 58.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.634 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . -176.93 177.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.742 HG12 HD12 ' A' ' 5' ' ' ILE . 18.6 m -138.38 133.75 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.809 ' HA ' HG23 ' A' ' 28' ' ' VAL . 37.5 t70 -103.86 102.8 12.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.657 HD22 HG11 ' C' ' 128' ' ' VAL . 11.8 mt -81.07 -17.88 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.16 -103.57 0.9 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.954 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.35 -29.11 63.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.086 0.47 . . . . 0.0 110.286 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -132.18 122.98 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.923 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.029 HG12 ' HB3' ' A' ' 127' ' ' ALA . 4.2 p -109.28 145.75 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.98 139.53 53.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.9 p -112.93 161.84 16.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.771 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.6 p -95.65 165.55 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.099 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.53 94.34 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.342 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.19 146.14 54.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.248 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.784 ' HB ' HG11 ' A' ' 119' ' ' VAL . 9.5 pt -134.46 142.08 41.44 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.794 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 7.8 Cg_exo -72.56 55.16 2.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.961 2.441 . . . . 0.0 113.138 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.579 HG22 HD12 ' A' ' 34' ' ' ILE . 20.5 t -62.05 85.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.241 0.544 . . . . 0.0 110.554 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 41' ' ' GLY . 12.6 t-20 -35.52 125.58 0.61 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.098 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.78 -7.75 21.73 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.108 1.872 . . . . 0.0 111.672 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.84 -28.09 13.3 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.653 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.485 HG23 ' CG ' ' A' ' 42' ' ' GLU . 4.7 t -128.84 -30.57 2.25 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.398 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.526 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 83.08 62.13 1.85 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.536 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' CG ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER -161.4 -81.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.674 0.273 . . . . 0.0 111.418 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.617 HG21 ' H ' ' A' ' 120' ' ' GLY . 11.4 p -177.15 110.31 0.23 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.379 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 35' ' ' PRO . 52.5 Cg_exo -52.53 140.44 54.62 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.477 2.118 . . . . 0.0 112.422 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.64 -32.05 70.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 92.69 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.615 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 47' ' ' ILE . 22.5 mm -40.12 -32.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.373 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.87 -56.46 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . . . -63.08 -28.74 70.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.772 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.486 HE22 HD12 ' A' ' 121' ' ' LEU . 3.0 tt0 -80.59 -28.83 37.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.675 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' CB ' HG22 ' A' ' 88' ' ' VAL . . . -79.28 -34.8 42.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.538 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.52 -28.79 52.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.179 -179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.25 -48.17 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 110.838 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -59.65 -35.74 75.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.759 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.636 HD13 ' CE2' ' A' ' 95' ' ' PHE . 9.8 mt -64.3 -54.76 28.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.15 -31.44 68.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -67.96 -33.84 75.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.791 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 54' ' ' SER . 39.3 t -69.95 -49.44 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -29.67 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.988 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.42 95.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.61 HG22 HG21 ' A' ' 6' ' ' ILE . 5.3 mt -72.39 -42.57 64.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.536 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.981 HD13 HD11 ' A' ' 72' ' ' ILE . 21.1 mt -69.15 -30.85 47.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.822 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.11 -40.79 59.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.328 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.73 -19.49 65.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.602 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.54 -26.81 19.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.47 41.59 0.67 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.529 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.569 HD22 ' OD2' ' A' ' 71' ' ' ASP . 18.4 mt -155.28 147.11 23.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 110.669 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -101.49 -179.65 4.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.747 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.985 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -78.8 -23.07 45.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.973 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -62.98 -33.52 75.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.569 ' OD2' HD22 ' A' ' 67' ' ' LEU . 10.7 p30 -75.47 -21.76 57.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.71 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.063 HD13 ' HB2' ' A' ' 127' ' ' ALA . 26.4 mm -52.44 121.02 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.86 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' B' ' 22' ' ' VAL . 7.3 m -89.55 -32.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.013 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.825 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -130.11 165.67 21.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.571 0.224 . . . . 0.0 110.937 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 74' ' ' LYS . 6.1 p -162.47 105.91 1.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.831 0.348 . . . . 0.0 111.544 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 108' ' ' SER . 4.6 m -91.92 155.34 18.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.158 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.605 HG22 HG22 ' A' ' 123' ' ' ILE . 21.2 t -150.93 103.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.911 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.537 ' CD2' HG11 ' C' ' 110' ' ' VAL . 10.8 m-85 -89.7 99.73 12.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.358 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.863 HG12 HD23 ' A' ' 121' ' ' LEU . 19.1 m -98.41 147.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.588 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.21 -3.71 50.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.231 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -160.98 142.24 11.78 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.627 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.502 HD12 ' HB3' ' B' ' 114' ' ' ARG . 6.6 mt -82.91 1.55 38.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.26 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -98.67 -24.3 15.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.824 0.345 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.81 -27.01 60.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.01 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.546 ' HD2' HG11 ' A' ' 79' ' ' VAL . 1.8 t80 -59.31 -18.65 39.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.58 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.28 -57.78 10.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 111.382 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.93 71.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG22 ' CB ' ' A' ' 51' ' ' ALA . 26.7 t -70.73 -41.27 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.981 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.11 -47.36 80.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.726 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.49 75.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -92.31 -15.95 26.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.685 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.464 ' OH ' HG21 ' A' ' 75' ' ' THR . 12.4 t80 -81.66 -38.33 26.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.729 0.299 . . . . 0.0 111.281 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.0 -28.71 22.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.346 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.21 -21.81 59.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.649 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.636 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -92.07 -34.39 14.4 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.983 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.505 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 3.1 m-85 -57.3 -57.79 11.1 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.091 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.28 -29.81 70.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.097 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.92 -10.17 59.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.49 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.705 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 1.7 t-20 -108.57 -8.83 15.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.311 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 4.3 t30 88.96 33.24 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.445 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.985 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 4.2 m170 -116.83 54.35 1.31 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.842 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 80.2 Cg_endo -75.22 -11.59 21.08 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.618 2.212 . . . . 0.0 112.823 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.762 ' ND2' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -47.96 -37.55 14.78 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.763 ' O ' HG13 ' B' ' 19' ' ' VAL . 11.6 m-85 63.96 83.89 0.19 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.387 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.76 156.16 63.23 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.611 2.207 . . . . 0.0 112.018 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.825 ' HB3' ' CG ' ' A' ' 74' ' ' LYS . . . -53.38 162.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.572 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.484 ' HB2' ' CG ' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -133.01 143.74 49.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.22 0.534 . . . . 0.0 111.734 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 76' ' ' THR . 5.7 t -143.64 65.23 1.32 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.802 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.91 140.26 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.275 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' B' ' 78' ' ' PHE . 35.7 m -149.94 132.48 6.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.018 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.843 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 2.4 tt0 -63.73 86.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 78' ' ' PHE . 6.7 m -72.57 161.22 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.115 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -77.17 -45.81 25.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.501 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -153.57 168.08 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.637 HD22 ' CB ' ' A' ' 122' ' ' GLU . 1.3 mp -142.7 160.62 52.95 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.708 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' O ' HG22 ' A' ' 119' ' ' VAL . 71.5 Cg_exo -48.75 136.03 27.89 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.486 2.124 . . . . 0.0 112.228 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.475 ' HB2' HG13 ' A' ' 119' ' ' VAL . 6.0 mmtm 64.39 16.73 10.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.319 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.72 17.76 9.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.913 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.784 HG11 ' HB ' ' A' ' 34' ' ' ILE . 30.2 m -53.31 122.52 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.302 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -55.32 -21.45 26.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.909 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.863 HD23 HG12 ' A' ' 79' ' ' VAL . 1.6 mp -152.77 147.67 26.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.278 0.561 . . . . 0.0 111.53 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.637 ' CB ' HD22 ' A' ' 115' ' ' LEU . 11.8 tt0 -139.21 151.48 46.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.407 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 77' ' ' VAL . 5.8 pt -150.29 139.28 15.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.4 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 1.1 pm0 -138.74 142.94 38.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.053 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -149.62 172.6 14.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.496 ' O ' HG23 ' A' ' 72' ' ' ILE . 9.4 mt -125.68 153.96 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.064 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' A' ' 72' ' ' ILE . . . -135.4 152.96 51.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.035 0.445 . . . . 0.0 111.797 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.795 HG21 HG21 ' B' ' 3' ' ' THR . 30.0 m -115.98 164.15 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.999 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB2' HD21 ' A' ' 67' ' ' LEU . 28.2 ttt85 -164.06 64.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.815 0.34 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 1.4 tpp -137.17 166.64 23.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.795 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER 60.1 101.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.13 110.63 17.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.946 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.876 HD11 HG21 ' B' ' 19' ' ' VAL . 2.3 tp -55.02 129.66 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.22 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.639 HD12 ' CB ' ' B' ' 21' ' ' ALA . 31.4 mt -90.43 151.53 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.413 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.81 108.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.06 170.32 10.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.981 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.73 22.24 10.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.55 -38.05 6.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.645 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' B' ' 12' ' ' PRO . . . -100.32 127.88 31.91 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.05 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 11' ' ' ALA . 7.7 Cg_exo -72.11 -1.67 10.42 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.618 2.212 . . . . 0.0 112.751 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.693 ' HB3' HE21 ' B' ' 20' ' ' GLN . . . -46.88 170.17 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.867 0.365 . . . . 0.0 111.544 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.18 119.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.053 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.607 HG22 ' O ' ' B' ' 15' ' ' ILE . 13.3 mt -154.73 15.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.908 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.33 -114.66 0.5 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.977 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.462 ' HB2' ' CD1' ' A' ' 92' ' ' TYR . 92.5 Cg_endo -80.95 50.93 3.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.7 2.267 . . . . 0.0 112.992 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.484 ' CG ' ' HB2' ' A' ' 107' ' ' ARG . 1.7 p90 -178.69 156.81 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.9 0.381 . . . . 0.0 110.996 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.876 HG21 HD11 ' B' ' 5' ' ' ILE . 30.8 m -106.69 -174.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.17 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.693 HE21 ' HB3' ' B' ' 13' ' ' ALA . 1.0 OUTLIER -73.53 -43.54 59.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.639 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . -177.06 177.46 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.719 HG12 HD12 ' B' ' 5' ' ' ILE . 18.6 m -138.37 133.78 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.146 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.829 ' HA ' HG23 ' B' ' 28' ' ' VAL . 37.5 t70 -103.93 102.84 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.684 HD22 HG11 ' A' ' 128' ' ' VAL . 11.9 mt -81.08 -17.93 48.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.2 -103.6 0.9 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.895 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.32 -29.1 63.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.088 0.471 . . . . 0.0 110.287 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.424 ' HG ' HG12 ' B' ' 128' ' ' VAL . 0.2 OUTLIER -132.21 122.96 26.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.884 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.053 HG12 ' HB3' ' B' ' 127' ' ' ALA . 4.2 p -109.29 145.8 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.844 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.403 HD23 ' HD2' ' A' ' 74' ' ' LYS . 5.2 mp -124.95 139.52 53.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.993 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 77.3 p -112.97 161.89 16.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.745 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 27.6 p -95.6 165.59 12.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.51 94.27 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.335 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.21 146.18 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.753 ' HB ' HG11 ' B' ' 119' ' ' VAL . 9.4 pt -134.5 142.06 41.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.815 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 7.9 Cg_exo -72.58 55.18 2.58 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.964 2.443 . . . . 0.0 113.146 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.574 HG22 HD12 ' B' ' 34' ' ' ILE . 20.5 t -61.99 85.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.585 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' B' ' 41' ' ' GLY . 12.6 t-20 -35.44 125.62 0.6 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.052 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.78 -7.8 21.84 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.148 1.898 . . . . 0.0 111.703 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.84 -28.04 13.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.703 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.489 HG23 ' CG ' ' B' ' 42' ' ' GLU . 4.7 t -128.86 -30.42 2.25 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.306 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.525 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 82.78 62.25 1.87 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.509 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.489 ' CG ' HG23 ' B' ' 40' ' ' THR . 0.4 OUTLIER -161.46 -81.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 0.0 111.435 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.616 HG13 ' O ' ' B' ' 43' ' ' VAL . 11.5 p -177.15 110.36 0.23 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.341 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' B' ' 35' ' ' PRO . 52.8 Cg_exo -52.65 140.45 55.82 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.46 2.107 . . . . 0.0 112.407 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.0 70.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.2 92.7 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.613 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' B' ' 47' ' ' ILE . 22.4 mm -40.16 -32.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.35 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.87 -56.43 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.749 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.43 ' HA ' ' HG2' ' B' ' 52' ' ' ARG . . . -63.05 -28.79 70.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.752 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.492 HE22 HD12 ' B' ' 121' ' ' LEU . 3.0 tt0 -80.4 -28.3 37.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.634 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.492 ' CB ' HG22 ' B' ' 88' ' ' VAL . . . -79.43 -34.86 41.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.535 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' B' ' 49' ' ' ALA . 0.0 OUTLIER -77.48 -28.84 52.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.169 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.24 -48.11 65.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.82 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.765 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.5 OUTLIER -59.61 -35.79 75.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.66 HD13 ' CE2' ' B' ' 95' ' ' PHE . 9.8 mt -64.24 -54.8 27.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.24 -31.31 68.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.404 ' ND2' ' HD3' ' B' ' 12' ' ' PRO . 26.0 m120 -68.04 -33.71 75.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.765 HG23 ' O ' ' B' ' 54' ' ' SER . 39.2 t -70.0 -49.39 56.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -29.7 65.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.937 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.49 95.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.822 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.588 HG22 HG21 ' B' ' 6' ' ' ILE . 5.3 mt -72.29 -42.51 65.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.532 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 1.006 HD13 HD11 ' B' ' 72' ' ' ILE . 21.1 mt -69.1 -30.92 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.815 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -75.16 -40.7 59.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.337 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.78 -19.51 65.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.56 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.49 -26.85 19.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.47 41.69 0.67 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.469 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.568 HD22 ' OD2' ' B' ' 71' ' ' ASP . 18.4 mt -155.28 147.16 23.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.824 0.345 . . . . 0.0 110.695 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -101.58 -179.73 4.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.719 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.999 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -78.75 -23.1 45.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 110.465 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.953 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -62.86 -33.55 75.52 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.568 ' OD2' HD22 ' B' ' 67' ' ' LEU . 10.6 p30 -75.35 -21.81 58.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.702 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 1.126 HD13 ' HB2' ' B' ' 127' ' ' ALA . 26.6 mm -52.54 121.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.79 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.639 ' HB ' HG21 ' C' ' 22' ' ' VAL . 7.2 m -89.61 -32.72 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.019 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.852 ' HG2' ' HB3' ' B' ' 106' ' ' ALA . 0.8 OUTLIER -130.19 165.65 21.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.567 0.222 . . . . 0.0 110.916 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.612 HG23 ' O ' ' B' ' 74' ' ' LYS . 6.1 p -162.43 105.9 1.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 111.523 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.536 HG23 ' O ' ' B' ' 108' ' ' SER . 4.6 m -91.89 155.4 18.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.219 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.602 HG22 HG22 ' B' ' 123' ' ' ILE . 21.2 t -150.97 103.15 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.834 0.349 . . . . 0.0 111.908 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.603 ' CD2' HG11 ' A' ' 110' ' ' VAL . 10.9 m-85 -89.84 99.86 12.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.247 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.857 HG12 HD23 ' B' ' 121' ' ' LEU . 19.0 m -98.52 147.71 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.58 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.27 -3.7 50.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.222 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -161.03 142.26 11.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.646 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.497 HD12 ' HB3' ' C' ' 114' ' ' ARG . 6.6 mt -82.97 1.58 39.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.256 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -98.68 -24.21 15.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.85 -26.96 60.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.549 ' HD2' HG11 ' B' ' 79' ' ' VAL . 1.8 t80 -59.3 -18.73 40.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.586 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.23 -57.82 10.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.36 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.96 71.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.158 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.492 HG22 ' CB ' ' B' ' 51' ' ' ALA . 26.3 t -70.72 -41.29 77.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.99 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.16 -47.32 80.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.733 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.52 75.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -92.2 -15.98 26.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.667 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' C' ' 17' ' ' PRO . 12.5 t80 -81.65 -38.29 26.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.771 0.32 . . . . 0.0 111.314 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.02 -28.78 22.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.329 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.15 -21.81 59.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.695 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.66 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -92.07 -34.47 14.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.941 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.489 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 3.1 m-85 -57.31 -57.76 11.22 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.07 0.462 . . . . 0.0 110.092 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.29 -29.78 70.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.121 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.96 -10.16 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.476 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.711 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 1.7 t-20 -108.58 -8.79 15.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.34 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 4.3 t30 88.97 33.13 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.457 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.999 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 4.2 m170 -116.73 54.45 1.29 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.859 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 79.1 Cg_endo -75.3 -11.62 20.95 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.68 2.253 . . . . 0.0 112.777 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.753 ' ND2' HD13 ' C' ' 5' ' ' ILE . 0.1 OUTLIER -47.91 -37.59 14.56 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.941 0.4 . . . . 0.0 111.035 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.772 ' O ' HG13 ' C' ' 19' ' ' VAL . 11.6 m-85 64.01 83.84 0.19 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.396 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.75 156.17 63.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.604 2.203 . . . . 0.0 112.022 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.852 ' HB3' ' HG2' ' B' ' 74' ' ' LYS . . . -53.36 162.55 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.519 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.479 ' HB2' ' CG ' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -133.07 143.71 49.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.178 0.513 . . . . 0.0 111.689 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.536 ' O ' HG23 ' B' ' 76' ' ' THR . 5.6 t -143.66 65.29 1.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.759 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.99 140.25 30.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.245 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' C' ' 78' ' ' PHE . 35.8 m -150.01 132.54 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.984 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 2.4 tt0 -63.71 86.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.84 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' B' ' 78' ' ' PHE . 6.8 m -72.43 161.2 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -77.18 -45.85 25.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.502 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -153.58 168.03 27.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.623 HD22 ' CB ' ' B' ' 122' ' ' GLU . 1.3 mp -142.64 160.63 53.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.711 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.493 ' O ' HG22 ' B' ' 119' ' ' VAL . 71.6 Cg_exo -48.74 136.02 27.85 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.443 2.096 . . . . 0.0 112.259 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.476 ' HB2' HG13 ' B' ' 119' ' ' VAL . 6.0 mmtm 64.45 16.66 10.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.331 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.81 17.76 9.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.875 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.753 HG11 ' HB ' ' B' ' 34' ' ' ILE . 30.6 m -53.4 122.63 3.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.265 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . 0.584 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -55.28 -21.71 27.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.894 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.857 HD23 HG12 ' B' ' 79' ' ' VAL . 1.6 mp -152.6 147.58 26.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.268 0.556 . . . . 0.0 111.496 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.623 ' CB ' HD22 ' B' ' 115' ' ' LEU . 11.8 tt0 -139.18 151.52 46.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.407 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.602 HG22 HG22 ' B' ' 77' ' ' VAL . 5.8 pt -150.29 139.23 15.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -138.73 142.98 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.041 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -149.61 172.62 14.74 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.49 ' O ' HG23 ' B' ' 72' ' ' ILE . 9.5 mt -125.69 154.04 34.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.008 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 1.126 ' HB2' HD13 ' B' ' 72' ' ' ILE . . . -135.39 153.03 51.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.016 0.436 . . . . 0.0 111.849 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.834 HG21 HG21 ' C' ' 3' ' ' THR . 30.1 m -116.02 164.09 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.95 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.502 ' HB2' HD21 ' B' ' 67' ' ' LEU . 28.2 ttt85 -164.03 64.98 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.908 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.869 0.366 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 1.4 tpp -137.13 166.7 23.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.834 HG21 HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER 60.07 101.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.1 110.64 17.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.89 HD11 HG21 ' C' ' 19' ' ' VAL . 2.3 tp -55.01 129.66 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.678 HD12 ' CB ' ' C' ' 21' ' ' ALA . 31.2 mt -90.51 151.59 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.4 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -176.81 108.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.801 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -124.11 170.27 10.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.69 22.32 10.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -106.83 -38.3 6.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' C' ' 12' ' ' PRO . . . -99.92 127.96 32.25 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.115 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' C' ' 11' ' ' ALA . 7.8 Cg_exo -72.11 -1.75 10.53 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.653 2.235 . . . . 0.0 112.731 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.689 ' HB3' HE21 ' C' ' 20' ' ' GLN . . . -46.83 170.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.864 0.364 . . . . 0.0 111.592 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.18 119.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.088 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.604 HG22 ' O ' ' C' ' 15' ' ' ILE . 13.5 mt -154.73 15.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.881 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.42 -114.73 0.51 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.929 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . 0.465 ' HB2' ' CD1' ' B' ' 92' ' ' TYR . 93.3 Cg_endo -80.97 51.0 3.76 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.647 2.231 . . . . 0.0 113.018 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' B' ' 107' ' ' ARG . 1.7 p90 -178.65 156.84 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.952 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.89 HG21 HD11 ' C' ' 5' ' ' ILE . 30.9 m -106.72 -174.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.15 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.689 HE21 ' HB3' ' C' ' 13' ' ' ALA . 1.0 OUTLIER -73.6 -43.49 59.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.956 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.678 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . -176.95 177.6 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.088 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.751 HG12 HD12 ' C' ' 5' ' ' ILE . 18.6 m -138.42 133.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.839 ' HA ' HG23 ' C' ' 28' ' ' VAL . 37.5 t70 -103.97 102.68 12.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.715 HD23 HG23 ' C' ' 3' ' ' THR . 11.8 mt -80.91 -17.94 48.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.109 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.22 -103.57 0.9 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.915 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.38 -29.04 63.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.084 0.468 . . . . 0.0 110.279 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.463 ' HG ' HG12 ' C' ' 128' ' ' VAL . 0.2 OUTLIER -132.23 122.87 25.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.905 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 1.0 HG12 ' HB3' ' C' ' 127' ' ' ALA . 4.2 p -109.22 145.77 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.893 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.89 139.63 53.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 0.0 110.979 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 76.2 p -113.17 162.2 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.747 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 27.5 p -95.94 165.57 12.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.111 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.55 94.3 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.325 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.19 146.16 54.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.767 ' HB ' HG11 ' C' ' 119' ' ' VAL . 9.5 pt -134.47 142.06 41.37 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.847 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.523 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 7.9 Cg_exo -72.54 55.2 2.56 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.939 2.426 . . . . 0.0 113.138 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.567 HG22 HD12 ' C' ' 34' ' ' ILE . 20.6 t -62.03 85.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.194 0.521 . . . . 0.0 110.513 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' C' ' 41' ' ' GLY . 12.6 t-20 -35.47 125.53 0.61 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.1 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.74 -7.83 21.91 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.141 1.894 . . . . 0.0 111.626 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.82 -28.07 13.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.678 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.491 HG23 ' CG ' ' C' ' 42' ' ' GLU . 4.7 t -128.95 -30.69 2.21 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.342 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.519 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 83.25 62.19 1.83 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.569 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.491 ' CG ' HG23 ' C' ' 40' ' ' THR . 0.4 OUTLIER -161.47 -81.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.685 0.278 . . . . 0.0 111.4 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.61 ' O ' HG13 ' C' ' 43' ' ' VAL . 11.4 p -177.12 110.37 0.23 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.324 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' C' ' 35' ' ' PRO . 52.6 Cg_exo -52.59 140.45 55.26 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.488 2.125 . . . . 0.0 112.443 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.74 -32.01 70.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 92.77 0.12 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.635 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mm -40.23 -32.4 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.351 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.86 -56.45 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.71 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.422 ' HA ' ' HG2' ' C' ' 52' ' ' ARG . . . -63.1 -28.71 70.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.773 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.476 HE22 HD12 ' C' ' 121' ' ' LEU . 3.0 tt0 -80.54 -28.77 37.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.626 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.411 ' CB ' HG22 ' C' ' 88' ' ' VAL . . . -79.19 -34.82 42.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.581 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' C' ' 49' ' ' ALA . 0.0 OUTLIER -77.51 -28.86 52.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.181 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -68.24 -48.11 65.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.836 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.775 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.5 OUTLIER -59.68 -35.72 75.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.773 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.611 HD13 ' CE2' ' C' ' 95' ' ' PHE . 9.7 mt -64.28 -54.79 27.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.925 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -59.19 -31.4 68.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -67.97 -33.8 75.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.828 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.775 HG23 ' O ' ' C' ' 54' ' ' SER . 39.1 t -69.91 -49.47 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -29.8 65.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.67 -41.25 94.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.616 HG22 HG21 ' C' ' 6' ' ' ILE . 5.3 mt -72.51 -42.58 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.574 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 1.003 HD13 HD11 ' C' ' 72' ' ' ILE . 21.0 mt -69.13 -30.85 47.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.852 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.19 -40.67 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.923 0.392 . . . . 0.0 110.335 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -19.44 65.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.531 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.52 -26.86 19.54 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.907 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.49 41.64 0.67 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.512 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.57 HD22 ' OD2' ' C' ' 71' ' ' ASP . 18.5 mt -155.29 147.1 23.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.661 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -101.47 -179.74 4.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.99 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -78.72 -23.06 45.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.789 0.328 . . . . 0.0 110.49 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.949 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -62.98 -33.37 75.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.57 ' OD2' HD22 ' C' ' 67' ' ' LEU . 10.7 p30 -75.81 -21.64 57.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 1.039 HD13 ' HB2' ' C' ' 127' ' ' ALA . 26.4 mm -52.53 121.12 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.848 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.619 ' HB ' HG21 ' A' ' 22' ' ' VAL . 7.1 m -89.68 -32.7 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.013 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.846 ' HG2' ' HB3' ' C' ' 106' ' ' ALA . 0.8 OUTLIER -130.25 165.62 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.576 0.227 . . . . 0.0 110.888 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.618 HG23 ' O ' ' C' ' 74' ' ' LYS . 6.1 p -162.44 105.84 1.13 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.811 0.338 . . . . 0.0 111.559 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.554 HG23 ' O ' ' C' ' 108' ' ' SER . 4.6 m -91.87 155.39 18.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.177 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.611 HG22 HG22 ' C' ' 123' ' ' ILE . 21.1 t -151.02 103.12 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.909 0.385 . . . . 0.0 111.935 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.586 ' CD2' HG11 ' B' ' 110' ' ' VAL . 10.9 m-85 -89.78 99.82 12.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.301 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.865 HG12 HD23 ' C' ' 121' ' ' LEU . 19.0 m -98.49 147.72 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.527 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -80.21 -3.43 49.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.176 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -161.27 142.17 11.29 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.639 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 114' ' ' ARG . 6.6 mt -82.92 1.61 38.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.233 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -98.66 -24.21 15.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.768 0.318 . . . . 0.0 110.9 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.86 -27.01 60.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.034 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.543 ' HD2' HG11 ' C' ' 79' ' ' VAL . 1.8 t80 -59.35 -18.6 39.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.619 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.35 -57.81 10.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 111.338 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.0 71.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.411 HG22 ' CB ' ' C' ' 51' ' ' ALA . 27.2 t -70.77 -41.19 77.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.17 -47.36 80.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.704 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.42 75.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.298 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -92.28 -15.88 26.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.721 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 12.5 t80 -81.71 -38.33 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.307 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.05 -28.68 22.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.333 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -74.15 -21.89 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.69 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.611 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -91.98 -34.49 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.972 -179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.497 ' CE1' ' CZ ' ' C' ' 95' ' ' PHE . 3.1 m-85 -57.23 -57.79 11.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 110.13 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -64.25 -29.83 70.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.128 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.98 -10.09 59.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.489 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.714 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 1.7 t-20 -108.67 -8.8 15.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.29 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 4.3 t30 89.0 33.3 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.454 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.99 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 4.2 m170 -116.97 54.48 1.37 Allowed Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.84 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 77.0 Cg_endo -75.32 -11.62 20.91 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.646 2.23 . . . . 0.0 112.761 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.753 ' ND2' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -47.91 -37.52 14.44 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.876 0.37 . . . . 0.0 111.089 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.753 ' O ' HG13 ' A' ' 19' ' ' VAL . 11.5 m-85 63.93 83.84 0.19 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.41 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 33.8 Cg_endo -64.64 156.15 62.82 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.618 2.212 . . . . 0.0 112.076 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.846 ' HB3' ' HG2' ' C' ' 74' ' ' LYS . . . -53.44 162.6 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.567 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.484 ' HB2' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -133.14 143.74 49.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.185 0.516 . . . . 0.0 111.681 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . 0.554 ' O ' HG23 ' C' ' 76' ' ' THR . 5.6 t -143.63 65.23 1.32 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.787 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.88 140.29 29.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.306 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.537 HG11 ' CD2' ' A' ' 78' ' ' PHE . 35.7 m -150.11 132.55 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.044 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.839 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.5 tt0 -63.59 86.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' C' ' 78' ' ' PHE . 6.7 m -72.48 161.21 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.188 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -77.2 -45.79 25.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.114 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.497 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -153.61 168.12 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.645 HD22 ' CB ' ' C' ' 122' ' ' GLU . 1.3 mp -142.73 160.62 52.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.693 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.485 ' O ' HG22 ' C' ' 119' ' ' VAL . 71.2 Cg_exo -48.76 136.06 27.92 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.41 2.073 . . . . 0.0 112.273 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.463 ' HB2' HG13 ' C' ' 119' ' ' VAL . 6.0 mmtm 64.46 16.65 10.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.286 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.74 17.85 9.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.879 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.767 HG11 ' HB ' ' C' ' 34' ' ' ILE . 30.5 m -53.41 122.54 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . 0.603 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -55.14 -21.53 25.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.905 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.865 HD23 HG12 ' C' ' 79' ' ' VAL . 1.6 mp -152.56 147.58 26.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.321 0.582 . . . . 0.0 111.489 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.645 ' CB ' HD22 ' C' ' 115' ' ' LEU . 11.8 tt0 -139.23 151.5 46.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.394 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.611 HG22 HG22 ' C' ' 77' ' ' VAL . 5.8 pt -150.28 139.22 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . 0.407 ' OE1' ' CE2' ' C' ' 78' ' ' PHE . 1.1 pm0 -138.72 142.98 38.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.06 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -149.6 172.62 14.74 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' C' ' 72' ' ' ILE . 9.4 mt -125.69 154.05 34.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.046 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 1.039 ' HB2' HD13 ' C' ' 72' ' ' ILE . . . -135.46 153.16 51.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.001 0.429 . . . . 0.0 111.834 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.821 HG21 HG21 ' A' ' 3' ' ' THR . 30.2 m -116.12 164.16 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.0 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.537 ' HB2' HD21 ' C' ' 67' ' ' LEU . 28.2 ttt85 -164.07 64.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.785 0.326 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.859 ' O ' HD13 ' A' ' 24' ' ' LEU . 3.2 mtm -123.02 55.15 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.737 HG21 HG21 ' C' ' 128' ' ' VAL . 0.0 OUTLIER -178.34 135.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.41 131.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.712 HD12 HG11 ' A' ' 19' ' ' VAL . 39.0 mm -59.0 155.13 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' A' ' 21' ' ' ALA . 31.3 mt -121.13 133.61 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.33 149.19 28.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.686 HG22 ' OE1' ' A' ' 20' ' ' GLN . 11.3 t -150.84 165.59 33.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.946 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.89 25.56 5.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.032 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 5.5 mmtp -110.06 -50.97 2.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.655 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.13 114.03 50.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.58 -12.53 36.19 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.358 2.038 . . . . 0.0 112.621 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 15' ' ' ILE . . . -64.83 -169.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 62.18 -169.42 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.25 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 15' ' ' ILE . 2.3 mt 77.17 17.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.228 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.11 -127.96 2.92 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.245 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -87.44 33.91 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.759 2.306 . . . . 0.0 112.861 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -175.87 156.8 1.85 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.025 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.712 HG11 HD12 ' A' ' 5' ' ' ILE . 35.0 m -92.26 152.6 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.06 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.686 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER -56.93 -36.51 70.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.409 . . . . 0.0 110.451 179.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.547 ' CB ' HD12 ' A' ' 6' ' ' ILE . . . -176.31 163.13 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.941 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -128.15 136.88 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.878 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.873 ' HA ' HG12 ' A' ' 28' ' ' VAL . 1.6 p30 -110.25 120.43 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.231 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.01 HD21 HG11 ' C' ' 128' ' ' VAL . 0.8 OUTLIER -90.53 -20.68 22.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.916 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.12 -108.66 0.77 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.672 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -60.38 -29.2 68.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.126 0.489 . . . . 0.0 110.067 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.724 ' HG ' HG12 ' A' ' 128' ' ' VAL . 7.4 mp -126.44 115.2 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.811 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.873 HG12 ' HA ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -105.37 176.24 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.197 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 28' ' ' VAL . 4.7 mp -150.53 161.66 42.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.408 HG21 HD11 ' A' ' 62' ' ' ILE . 23.4 p -126.16 159.21 33.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.074 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -95.06 168.07 10.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.196 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.09 94.74 0.1 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.263 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.451 ' CD ' HD11 ' A' ' 61' ' ' ILE . 47.0 mm-40 -73.6 165.73 24.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.909 0.385 . . . . 0.0 111.19 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.522 HG13 HG23 ' A' ' 36' ' ' VAL . 10.3 pt -149.93 143.05 16.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.015 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 43' ' ' VAL . 73.7 Cg_endo -75.05 59.38 5.21 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.794 2.33 . . . . 0.0 112.875 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.522 HG23 HG13 ' A' ' 34' ' ' ILE . 46.3 t -65.04 84.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.263 0.554 . . . . 0.0 110.643 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.455 ' HB3' ' OG1' ' A' ' 40' ' ' THR . 28.3 t30 -41.01 135.53 1.67 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.994 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.04 -5.91 16.81 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.222 1.948 . . . . 0.0 111.822 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.12 -28.45 9.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.349 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 37' ' ' ASN . 65.6 p -115.81 -29.26 6.45 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.865 0.364 . . . . 0.0 110.829 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 75.76 55.77 4.81 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.543 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.28 -79.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.639 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.6 HG21 ' H ' ' A' ' 120' ' ' GLY . 11.2 p -159.16 123.32 2.12 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.412 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 35' ' ' PRO . 31.8 Cg_exo -58.26 150.18 68.27 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.388 2.059 . . . . 0.0 112.035 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.47 -30.79 68.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.978 0.418 . . . . 0.0 110.893 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -71.51 97.45 1.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.829 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.439 HD12 ' NE2' ' A' ' 50' ' ' GLN . 9.2 tp -42.14 -32.22 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.767 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -48.62 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -60.58 -41.04 93.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.752 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' NE2' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -70.01 -30.85 68.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.583 179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.34 -37.49 71.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.196 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -78.95 -35.62 42.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.92 -36.08 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.854 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -74.81 -31.67 61.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.752 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.6 mt -72.74 -36.28 67.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.8 -44.31 73.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -58.68 -46.57 86.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.948 HG21 ' CG2' ' A' ' 123' ' ' ILE . 21.4 t -60.72 -31.85 50.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.96 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.592 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 3.3 tttt -80.61 -32.51 36.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -67.14 -35.98 80.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 58' ' ' VAL . 5.8 mt -69.7 -45.24 78.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.76 HG22 ' HB3' ' A' ' 67' ' ' LEU . 11.0 mt -65.75 -35.28 74.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.458 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.94 75.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.327 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -21.42 63.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.422 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.45 -28.31 20.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.71 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.92 54.44 0.35 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.615 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.76 ' HB3' HG22 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 158.01 23.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.878 0.37 . . . . 0.0 110.671 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.429 ' O ' HD23 ' A' ' 67' ' ' LEU . 2.1 p -115.33 156.85 24.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.161 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.798 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . . . -57.97 -35.91 71.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.057 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB2' ' ND1' ' A' ' 101' ' ' HIS . . . -50.64 -26.74 5.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.455 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.561 ' CB ' HD21 ' A' ' 67' ' ' LEU . 4.7 m-20 -85.5 -18.67 32.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.297 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.495 HD12 ' CB ' ' A' ' 127' ' ' ALA . 0.5 OUTLIER -54.5 117.89 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.506 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.665 HG11 HD21 ' B' ' 24' ' ' LEU . 29.0 m -88.13 -33.73 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.92 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.698 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 4.2 tttm -128.32 169.77 13.84 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.454 HG22 ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -169.93 112.97 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.875 0.369 . . . . 0.0 111.409 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.7 m -99.96 151.77 20.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.173 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 109' ' ' CYS . 5.0 m -146.48 128.85 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 111.929 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.535 ' HB2' HD21 ' A' ' 115' ' ' LEU . 4.1 m-85 -107.6 129.68 54.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.144 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.8 149.5 27.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.463 . . . . 0.0 111.721 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 115' ' ' LEU . 12.3 mttt -88.41 -4.2 58.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.781 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -160.57 115.55 2.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.384 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' B' ' 114' ' ' ARG . 3.1 mt -66.38 -11.23 50.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.088 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -80.83 -19.06 45.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.779 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -87.02 -19.53 28.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.07 -20.93 43.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.31 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.73 -39.2 65.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 111.283 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.54 -29.25 21.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.0 t -72.39 -44.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.31 -42.36 93.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.615 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.4 73.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -27.52 19.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.515 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.43 ' O ' ' CD2' ' A' ' 96' ' ' PHE . 68.6 t80 -54.08 -49.03 69.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.891 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.6 -27.44 25.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.54 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.23 -20.24 60.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.619 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.3 OUTLIER -90.14 -38.84 13.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.933 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 101' ' ' HIS . 14.6 m-85 -55.61 -58.81 6.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.604 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -64.74 -28.15 69.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.704 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -72.88 -13.58 61.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.317 . . . . 0.0 110.883 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 58.7 m-80 -111.18 -10.75 14.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.472 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 2.4 p-10 99.56 33.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.907 0.754 . . . . 0.0 111.004 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.798 ' NE2' ' HB3' ' A' ' 69' ' ' ALA . 1.2 m-70 -115.11 56.43 0.98 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.552 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 54.4 Cg_endo -68.64 -15.14 40.84 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.659 2.239 . . . . 0.0 113.363 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.548 ' HB3' HD11 ' B' ' 5' ' ' ILE . 3.1 m-20 -53.86 -43.19 69.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.913 0.387 . . . . 0.0 110.606 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.684 ' O ' HG13 ' B' ' 19' ' ' VAL . 30.4 m-85 71.85 84.13 0.13 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.959 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 19.1 Cg_endo -59.25 155.67 39.14 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.772 2.314 . . . . 0.0 112.327 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.698 ' HB3' ' CG ' ' A' ' 74' ' ' LYS . . . -51.39 158.16 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.234 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.9 ttp-105 -134.66 141.38 46.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.131 0.491 . . . . 0.0 111.854 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.42 66.12 1.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.064 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.4 ' HA ' HG23 ' A' ' 77' ' ' VAL . 28.0 p -79.49 130.88 35.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.188 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.5 m -148.82 144.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.981 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.842 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 2.3 tt0 -86.68 94.6 9.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.817 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' A' ' 115' ' ' LEU . 36.0 m -73.49 159.9 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -70.94 -37.13 72.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.434 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -160.84 166.96 27.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.976 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.543 ' C ' HD11 ' C' ' 82' ' ' LEU . 1.4 mt -143.39 155.71 60.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.673 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.34 135.85 70.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.563 2.175 . . . . 0.0 112.018 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.681 ' HB3' HG13 ' A' ' 119' ' ' VAL . 1.4 tppt? 69.62 20.36 7.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.18 26.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.118 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 117' ' ' LYS . 22.1 m -55.66 174.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.206 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.6 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -96.04 -15.13 43.14 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.569 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.623 HD22 ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -172.49 148.88 2.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.046 0.45 . . . . 0.0 111.168 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.716 ' O ' HD13 ' A' ' 123' ' ' ILE . 4.6 mt-10 -116.4 167.25 11.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.322 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.948 ' CG2' HG21 ' A' ' 58' ' ' VAL . 22.9 mm -141.88 131.87 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.206 0.527 . . . . 0.0 112.196 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.53 117.75 4.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.204 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 74' ' ' LYS . . . -140.3 176.03 9.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.467 HG23 ' HG ' ' A' ' 29' ' ' LEU . 6.7 mt -119.88 154.69 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.038 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.859 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -139.37 150.75 45.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.908 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.948 HG11 HD21 ' B' ' 24' ' ' LEU . 33.0 m -125.1 126.67 71.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.665 ' HG3' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -94.93 43.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.042 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.928 179.876 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.815 0.34 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . 0.86 ' O ' HD13 ' B' ' 24' ' ' LEU . 3.2 mtm -122.98 55.25 1.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.809 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.766 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -178.4 135.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.49 131.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.67 HD12 HG11 ' B' ' 19' ' ' VAL . 39.0 mm -58.96 155.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.542 HD12 ' CB ' ' B' ' 21' ' ' ALA . 31.6 mt -121.23 133.67 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.34 149.19 28.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.789 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.665 HG22 ' OE1' ' B' ' 20' ' ' GLN . 11.3 t -150.85 165.56 33.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.92 25.62 5.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.014 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.44 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 5.5 mmtp -110.13 -50.88 2.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.677 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.16 114.04 50.14 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.966 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.66 -12.5 36.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.35 2.034 . . . . 0.0 112.595 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.74 -169.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.548 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 62.18 -169.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.196 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.583 HG22 ' O ' ' B' ' 15' ' ' ILE . 2.3 mt 77.19 17.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.22 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.06 -127.91 2.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.225 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.51 33.94 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 112.892 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -175.85 156.78 1.85 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.85 0.357 . . . . 0.0 110.999 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 104' ' ' PHE . 35.1 m -92.27 152.59 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.064 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.665 ' OE1' HG22 ' B' ' 8' ' ' THR . 0.8 OUTLIER -56.88 -36.52 70.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 110.492 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.542 ' CB ' HD12 ' B' ' 6' ' ' ILE . . . -176.58 163.15 2.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.037 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.494 HG13 HG21 ' B' ' 19' ' ' VAL . 0.2 OUTLIER -128.13 136.95 58.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.835 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.867 ' HA ' HG12 ' B' ' 28' ' ' VAL . 1.6 p30 -110.3 120.48 42.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.219 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.948 HD21 HG11 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -90.5 -20.77 22.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.18 -108.79 0.78 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.64 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -60.26 -29.32 68.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.04 0.448 . . . . 0.0 109.998 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.718 ' HG ' HG12 ' B' ' 128' ' ' VAL . 7.3 mp -126.37 115.15 19.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.795 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.894 HG23 ' HB3' ' B' ' 127' ' ' ALA . 0.9 OUTLIER -105.28 176.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.198 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.581 HD12 ' C ' ' B' ' 28' ' ' VAL . 4.7 mp -150.48 161.68 42.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.933 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.41 HG21 HD11 ' B' ' 62' ' ' ILE . 23.8 p -126.1 158.89 34.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.033 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.6 m -94.6 168.14 11.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.037 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.13 94.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.293 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.468 ' CG ' HG22 ' B' ' 58' ' ' VAL . 47.2 mm-40 -73.59 165.81 24.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 111.16 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.513 HG13 HG23 ' B' ' 36' ' ' VAL . 10.2 pt -150.03 143.03 16.23 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.992 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.52 ' HG2' HG23 ' B' ' 43' ' ' VAL . 73.7 Cg_endo -75.03 59.38 5.19 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.755 2.304 . . . . 0.0 112.898 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.513 HG23 HG13 ' B' ' 34' ' ' ILE . 46.3 t -65.03 84.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.297 0.57 . . . . 0.0 110.627 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.465 ' HB3' ' OG1' ' B' ' 40' ' ' THR . 28.3 t30 -40.99 135.54 1.66 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.997 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.04 -5.96 16.85 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.244 1.963 . . . . 0.0 111.823 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.1 -28.35 9.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.36 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' B' ' 37' ' ' ASN . 66.5 p -115.96 -29.41 6.35 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.827 0.346 . . . . 0.0 110.788 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 75.88 55.79 4.75 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.61 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.21 -79.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.687 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.568 HG21 ' H ' ' B' ' 120' ' ' GLY . 11.1 p -159.1 123.36 2.14 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.388 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' B' ' 35' ' ' PRO . 31.3 Cg_exo -58.34 150.18 68.94 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.373 2.049 . . . . 0.0 112.036 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.5 -30.69 68.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.026 0.441 . . . . 0.0 110.921 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.1 OUTLIER -71.55 97.43 1.68 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.829 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.442 HD12 ' NE2' ' B' ' 50' ' ' GLN . 9.1 tp -42.02 -32.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.756 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.22 -48.67 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.827 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -60.47 -41.11 93.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.768 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.443 ' NE2' HD12 ' B' ' 121' ' ' LEU . 0.9 OUTLIER -69.97 -30.91 68.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.562 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.41 -37.57 71.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.257 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -79.01 -35.7 42.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -36.16 73.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.854 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.1 OUTLIER -74.78 -31.78 61.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 34.9 mt -72.69 -36.24 67.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.86 -44.25 73.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -58.71 -46.56 87.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.949 HG21 ' CG2' ' B' ' 123' ' ' ILE . 21.5 t -60.73 -31.87 50.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.949 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.588 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 3.3 tttt -80.66 -32.48 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -66.95 -35.95 81.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' B' ' 58' ' ' VAL . 5.8 mt -69.77 -45.21 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.838 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.77 HG22 ' HB3' ' B' ' 67' ' ' LEU . 11.0 mt -65.75 -35.34 74.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.47 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 -42.94 76.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.303 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -21.47 63.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.403 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.51 -28.2 20.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.698 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.85 54.42 0.36 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.649 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.77 ' HB3' HG22 ' B' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 157.96 23.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.84 0.353 . . . . 0.0 110.672 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.428 ' O ' HD23 ' B' ' 67' ' ' LEU . 2.1 p -115.29 156.92 24.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.222 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.827 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . . . -58.06 -35.86 71.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.051 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.581 ' HB2' ' OD1' ' B' ' 100' ' ' ASN . . . -50.67 -26.75 5.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.413 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.557 ' CB ' HD21 ' B' ' 67' ' ' LEU . 4.7 m-20 -85.49 -18.68 32.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.361 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' B' ' 69' ' ' ALA . 0.5 OUTLIER -54.51 117.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 110.556 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.648 HG11 HD21 ' C' ' 24' ' ' LEU . 28.7 m -88.17 -33.7 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.876 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.701 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 4.2 tttm -128.32 169.83 13.78 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.79 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.442 HG22 ' HB2' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -170.02 112.86 0.47 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.86 0.362 . . . . 0.0 111.378 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' B' ' 124' ' ' GLU . 24.6 m -99.9 151.84 20.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.147 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.404 HG23 ' HA ' ' B' ' 109' ' ' CYS . 4.9 m -146.57 128.85 7.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.017 0.437 . . . . 0.0 111.901 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.529 ' HB2' HD21 ' B' ' 115' ' ' LEU . 4.0 m-85 -107.58 129.68 54.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.125 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.8 149.49 27.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.065 0.46 . . . . 0.0 111.774 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' B' ' 115' ' ' LEU . 12.3 mttt -88.45 -4.4 58.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.735 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.48 115.51 2.24 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.387 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.476 HD11 ' C ' ' C' ' 115' ' ' LEU . 3.2 mt -66.33 -11.28 50.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -80.8 -19.08 45.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -86.98 -19.57 28.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.172 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.08 -20.9 43.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.339 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.27 65.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.817 0.341 . . . . 0.0 111.289 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.51 -29.19 21.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' B' ' 92' ' ' TYR . 28.5 t -72.37 -44.94 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.36 -42.35 92.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.559 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.41 73.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -27.52 18.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.517 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.433 ' O ' ' CD2' ' B' ' 96' ' ' PHE . 68.6 t80 -54.06 -49.13 69.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.885 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.54 -27.45 25.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.54 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.16 -20.26 60.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.648 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.3 OUTLIER -90.13 -38.86 13.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.0 110.932 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' B' ' 101' ' ' HIS . 14.8 m-85 -55.55 -58.88 5.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.584 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -64.75 -28.11 69.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.743 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -72.87 -13.59 61.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 110.919 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.525 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 58.8 m-80 -111.13 -10.83 14.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.482 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.581 ' OD1' ' HB2' ' B' ' 70' ' ' ALA . 2.3 p-10 99.57 33.26 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.832 0.707 . . . . 0.0 110.99 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.827 ' NE2' ' HB3' ' B' ' 69' ' ' ALA . 1.2 m-70 -115.01 56.36 0.94 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.553 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.401 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 53.8 Cg_endo -68.65 -15.17 40.85 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 113.335 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.543 ' HB3' HD11 ' C' ' 5' ' ' ILE . 3.1 m-20 -53.91 -43.08 69.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.62 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.693 ' O ' HG13 ' C' ' 19' ' ' VAL . 30.3 m-85 71.77 84.15 0.13 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.966 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' B' ' 72' ' ' ILE . 19.1 Cg_endo -59.22 155.67 39.0 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.749 2.299 . . . . 0.0 112.358 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.701 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.32 158.34 0.84 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.291 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.432 ' HB3' ' CD2' ' C' ' 18' ' ' TYR . 2.9 ttp-105 -134.84 141.31 46.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.13 0.491 . . . . 0.0 111.838 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.39 66.03 1.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.11 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . 0.404 ' HA ' HG23 ' B' ' 77' ' ' VAL . 28.0 p -79.42 130.89 35.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.18 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 20.9 m -148.79 143.91 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.982 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.839 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 2.3 tt0 -86.45 94.33 9.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' B' ' 115' ' ' LEU . 35.8 m -73.29 159.87 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.842 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -70.93 -37.12 72.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.57 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -160.87 166.91 27.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.004 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.545 ' C ' HD11 ' A' ' 82' ' ' LEU . 1.4 mt -143.33 155.73 61.08 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.41 135.83 70.94 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.578 2.186 . . . . 0.0 112.031 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.674 ' HB3' HG13 ' B' ' 119' ' ' VAL . 1.4 tppt? 69.69 20.31 6.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.975 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.19 26.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' B' ' 117' ' ' LYS . 21.6 m -55.78 174.49 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . 0.568 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -96.08 -15.58 41.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.554 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.61 ' C ' HD22 ' B' ' 121' ' ' LEU . 0.0 OUTLIER -172.09 148.74 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 111.184 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.715 ' O ' HD13 ' B' ' 123' ' ' ILE . 4.5 mt-10 -116.4 167.23 11.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.264 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.949 ' CG2' HG21 ' B' ' 58' ' ' VAL . 22.6 mm -141.91 131.85 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.188 0.518 . . . . 0.0 112.219 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . 0.401 ' HG3' ' HB ' ' B' ' 76' ' ' THR . 0.0 OUTLIER -153.57 117.69 4.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.166 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -140.22 176.05 9.08 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.469 HG23 ' HG ' ' B' ' 29' ' ' LEU . 6.7 mt -119.86 154.68 22.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.072 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.894 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -139.36 150.82 45.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.833 0.349 . . . . 0.0 111.902 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 1.027 HG11 HD21 ' C' ' 24' ' ' LEU . 33.0 m -125.22 126.66 71.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.678 ' HG3' HD12 ' B' ' 67' ' ' LEU . 0.4 OUTLIER -94.85 43.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.07 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.922 179.867 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . 0.847 ' O ' HD13 ' C' ' 24' ' ' LEU . 3.2 mtm -122.99 55.13 1.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.794 HG21 HG21 ' B' ' 128' ' ' VAL . 0.0 OUTLIER -178.37 135.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.42 131.19 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.672 HD12 HG11 ' C' ' 19' ' ' VAL . 38.9 mm -58.94 155.15 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.536 HD12 ' CB ' ' C' ' 21' ' ' ALA . 31.3 mt -121.25 133.55 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -152.25 149.17 28.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.84 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.689 HG22 ' OE1' ' C' ' 20' ' ' GLN . 11.3 t -150.83 165.6 33.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -97.93 25.62 5.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.028 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.448 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 5.5 mmtp -110.11 -51.18 2.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.662 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.84 114.15 50.27 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.902 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.53 -12.57 36.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.369 2.046 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.406 ' O ' HD12 ' C' ' 15' ' ' ILE . . . -64.82 -169.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.14 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.547 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 62.24 -169.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.186 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.577 HG22 ' O ' ' C' ' 15' ' ' ILE . 2.3 mt 77.2 17.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.191 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.09 -128.0 2.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.23 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.4 33.88 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.728 2.285 . . . . 0.0 112.918 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.547 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -175.82 156.83 1.87 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.91 0.386 . . . . 0.0 110.987 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.693 HG13 ' O ' ' B' ' 104' ' ' PHE . 35.1 m -92.29 152.59 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.048 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.689 ' OE1' HG22 ' C' ' 8' ' ' THR . 0.8 OUTLIER -56.87 -36.54 70.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.439 . . . . 0.0 110.573 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.536 ' CB ' HD12 ' C' ' 6' ' ' ILE . . . -176.26 163.09 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.934 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.478 HG13 HG21 ' C' ' 19' ' ' VAL . 0.2 OUTLIER -128.07 136.92 58.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.866 ' HA ' HG12 ' C' ' 28' ' ' VAL . 1.6 p30 -110.31 120.49 42.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.201 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 1.027 HD21 HG11 ' B' ' 128' ' ' VAL . 0.8 OUTLIER -90.57 -20.66 22.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.1 -108.67 0.77 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.664 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -60.42 -29.22 68.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.147 0.498 . . . . 0.0 110.072 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.709 ' HG ' HG12 ' C' ' 128' ' ' VAL . 7.3 mp -126.42 115.15 19.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.795 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.889 HG23 ' HB3' ' C' ' 127' ' ' ALA . 0.9 OUTLIER -105.31 176.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.203 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.581 HD12 ' C ' ' C' ' 28' ' ' VAL . 4.7 mp -150.56 161.64 42.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.3 p -126.22 158.99 34.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.006 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -94.64 167.99 11.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.1 94.8 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.251 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.453 ' CG ' HG22 ' C' ' 58' ' ' VAL . 47.2 mm-40 -73.59 165.78 24.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.204 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.541 ' HB ' HG11 ' C' ' 119' ' ' VAL . 10.3 pt -149.98 143.06 16.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.993 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.493 ' HG2' HG23 ' C' ' 43' ' ' VAL . 73.6 Cg_endo -75.01 59.31 5.16 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.782 2.321 . . . . 0.0 112.941 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.509 HG23 HG13 ' C' ' 34' ' ' ILE . 46.4 t -64.98 84.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.222 0.534 . . . . 0.0 110.612 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' C' ' 40' ' ' THR . 28.2 t30 -40.99 135.5 1.66 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.989 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.99 -5.95 16.88 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.255 1.97 . . . . 0.0 111.816 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.17 -28.29 9.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.347 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' C' ' 37' ' ' ASN . 65.7 p -115.94 -29.37 6.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.87 0.367 . . . . 0.0 110.85 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 75.88 55.78 4.75 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.599 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.29 -79.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.644 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.585 HG21 ' H ' ' C' ' 120' ' ' GLY . 11.3 p -159.12 123.38 2.14 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.464 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' C' ' 35' ' ' PRO . 31.2 Cg_exo -58.42 150.21 69.42 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.355 2.037 . . . . 0.0 112.016 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.5 -30.7 68.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.034 0.445 . . . . 0.0 110.9 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.1 OUTLIER -71.51 97.41 1.66 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.807 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.45 HD12 ' NE2' ' C' ' 50' ' ' GLN . 9.2 tp -42.17 -32.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.754 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.24 -48.68 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.791 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -60.47 -41.09 93.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.789 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.45 ' NE2' HD12 ' C' ' 47' ' ' ILE . 0.9 OUTLIER -69.96 -30.88 68.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.627 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.54 -37.63 71.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.192 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' C' ' 49' ' ' ALA . 3.5 ptm180 -79.0 -35.6 42.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -36.13 73.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.846 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.1 OUTLIER -74.89 -31.68 61.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.694 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 34.8 mt -72.74 -36.3 67.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.789 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.75 -44.27 74.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.951 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -58.71 -46.56 87.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.951 HG21 ' CG2' ' C' ' 123' ' ' ILE . 21.4 t -60.72 -31.93 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.607 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 3.3 tttt -80.61 -32.44 36.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -67.02 -35.94 81.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.023 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' C' ' 58' ' ' VAL . 5.9 mt -69.7 -45.32 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.762 HG22 ' HB3' ' C' ' 67' ' ' LEU . 10.9 mt -65.66 -35.32 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.9 75.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -21.54 63.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.409 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.43 -28.26 21.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.692 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.9 54.43 0.35 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.578 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.762 ' HB3' HG22 ' C' ' 62' ' ' ILE . 0.3 OUTLIER -162.19 157.96 23.84 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.632 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . 0.426 ' O ' HD23 ' C' ' 67' ' ' LEU . 2.1 p -115.37 156.88 24.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.188 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.816 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . . . -58.05 -35.84 71.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.065 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.579 ' HB2' ' OD1' ' C' ' 100' ' ' ASN . . . -50.67 -26.62 5.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.548 ' CB ' HD21 ' C' ' 67' ' ' LEU . 4.7 m-20 -85.64 -18.69 32.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.323 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' C' ' 69' ' ' ALA . 0.5 OUTLIER -54.49 117.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.521 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.702 HG11 HD21 ' A' ' 24' ' ' LEU . 28.4 m -88.16 -33.73 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.874 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.692 ' CG ' ' HB3' ' C' ' 106' ' ' ALA . 4.2 tttm -128.27 169.75 13.84 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.811 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.442 HG22 ' HB2' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -169.95 112.94 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.852 0.358 . . . . 0.0 111.442 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -99.96 151.83 20.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.159 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.409 HG23 ' HA ' ' C' ' 109' ' ' CYS . 5.0 m -146.49 128.86 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.935 0.398 . . . . 0.0 112.004 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.504 ' HB2' HD21 ' C' ' 115' ' ' LEU . 4.1 m-85 -107.65 129.64 54.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.143 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.83 149.5 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.026 0.441 . . . . 0.0 111.772 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . 0.43 ' HG3' HD12 ' C' ' 115' ' ' LEU . 12.3 mttt -88.46 -4.53 58.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.773 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.21 115.44 2.31 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.384 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.543 HD11 ' C ' ' A' ' 115' ' ' LEU . 3.1 mt -66.35 -11.25 50.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.126 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -80.79 -19.1 45.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.817 0.342 . . . . 0.0 110.83 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -86.98 -19.55 28.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.223 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.07 -20.91 43.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.342 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.72 -39.2 65.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.837 0.351 . . . . 0.0 111.315 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.55 -29.2 21.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.962 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' C' ' 92' ' ' TYR . 29.3 t -72.39 -45.01 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.32 -42.37 93.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.561 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.52 73.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.974 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -27.49 19.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.494 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.427 ' O ' ' CD2' ' C' ' 96' ' ' PHE . 68.8 t80 -54.08 -49.04 69.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.892 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.6 -27.47 25.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.542 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -73.16 -20.29 60.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.604 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.501 ' C ' ' CD1' ' C' ' 95' ' ' PHE . 0.3 OUTLIER -90.19 -38.77 13.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.826 0.346 . . . . 0.0 110.954 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' C' ' 101' ' ' HIS . 14.7 m-85 -55.58 -58.85 6.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -64.7 -28.22 69.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.684 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -72.86 -13.54 61.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.783 0.325 . . . . 0.0 110.94 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.524 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 58.9 m-80 -111.11 -10.93 14.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.476 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.579 ' OD1' ' HB2' ' C' ' 70' ' ' ALA . 2.4 p-10 99.66 33.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.524 0.73 . . . . 0.0 110.95 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.816 ' NE2' ' HB3' ' C' ' 69' ' ' ALA . 1.2 m-70 -115.13 56.3 0.98 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.581 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.404 ' O ' ' CD2' ' C' ' 104' ' ' PHE . 53.9 Cg_endo -68.6 -15.21 41.06 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.659 2.239 . . . . 0.0 113.35 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.525 ' HB3' HD11 ' A' ' 5' ' ' ILE . 3.1 m-20 -53.81 -43.14 69.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 110.601 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.691 ' O ' HG13 ' A' ' 19' ' ' VAL . 30.4 m-85 71.8 84.12 0.13 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.988 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' C' ' 72' ' ' ILE . 19.0 Cg_endo -59.23 155.72 38.78 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.768 2.312 . . . . 0.0 112.298 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.692 ' HB3' ' CG ' ' C' ' 74' ' ' LYS . . . -51.4 158.1 0.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.253 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' A' ' 18' ' ' TYR . 2.9 ttp-105 -134.65 141.37 46.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.107 0.479 . . . . 0.0 111.827 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 11.2 t -137.42 66.11 1.47 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.063 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . 0.409 ' HA ' HG23 ' C' ' 77' ' ' VAL . 28.0 p -79.45 130.87 35.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.18 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . . . . . . . . . 20.6 m -148.9 144.74 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.053 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.804 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.3 tt0 -87.02 94.51 9.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.76 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.42 HG21 ' HG ' ' C' ' 115' ' ' LEU . 36.0 m -73.43 159.89 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -70.97 -37.08 72.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.069 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.446 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -160.88 166.9 27.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.036 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' C' ' 78' ' ' PHE . 1.4 mt -143.35 155.72 61.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.743 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.39 135.91 71.26 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.577 2.184 . . . . 0.0 111.979 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.696 ' HB3' HG13 ' C' ' 119' ' ' VAL . 1.4 tppt? 69.6 20.38 7.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.938 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.16 26.31 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.095 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.696 HG13 ' HB3' ' C' ' 117' ' ' LYS . 21.9 m -55.67 174.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.246 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . 0.585 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -96.12 -15.22 42.55 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.537 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.624 ' C ' HD22 ' C' ' 121' ' ' LEU . 0.0 OUTLIER -172.18 148.74 2.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.993 0.425 . . . . 0.0 111.204 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.719 ' O ' HD13 ' C' ' 123' ' ' ILE . 4.6 mt-10 -116.33 167.31 11.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.289 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.951 ' CG2' HG21 ' C' ' 58' ' ' VAL . 22.8 mm -141.99 131.8 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.208 0.527 . . . . 0.0 112.177 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.52 117.75 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.166 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' C' ' 74' ' ' LYS . . . -140.28 176.03 9.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.459 HG23 ' HG ' ' C' ' 29' ' ' LEU . 6.7 mt -119.85 154.67 22.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.038 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.889 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -139.4 150.79 45.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.839 0.352 . . . . 0.0 111.884 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 1.01 HG11 HD21 ' A' ' 24' ' ' LEU . 33.0 m -125.14 126.69 71.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.092 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.671 ' HG3' HD12 ' C' ' 67' ' ' LEU . 0.4 OUTLIER -94.89 43.5 1.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.095 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.935 179.867 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.869 0.366 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.23 168.49 19.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.486 HG23 ' CD2' ' A' ' 24' ' ' LEU . 18.8 m -165.16 116.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HD23 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.694 HD11 ' OD1' ' C' ' 103' ' ' ASN . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.719 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 14' ' ' ALA . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.843 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' C' ' 104' ' ' PHE . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 29' ' ' LEU . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.565 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.916 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.0 m120 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 128' ' ' VAL . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.959 HG23 ' HB3' ' A' ' 127' ' ' ALA . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 62' ' ' ILE . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.693 ' HB ' HG11 ' A' ' 119' ' ' VAL . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 34' ' ' ILE . 32.9 t -63.02 85.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 41' ' ' GLY . 36.7 t-20 -35.11 129.88 0.5 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.989 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.53 -10.59 29.14 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 112.178 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.5 -21.36 8.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.68 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.416 HG22 ' CG ' ' A' ' 42' ' ' GLU . 3.5 m -114.75 -25.2 8.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 63.67 56.06 21.4 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.323 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' CG ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER -164.27 -81.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.704 0.288 . . . . 0.0 111.625 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p -173.89 106.83 0.3 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.406 ' OE1' HD13 ' A' ' 47' ' ' ILE . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.782 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 54' ' ' SER . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.719 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 30' ' ' THR . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.044 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.895 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 126' ' ' ILE . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 128' ' ' VAL . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 125' ' ' ALA . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 108' ' ' SER . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 122' ' ' GLU . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.712 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 85' ' ' PHE . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' A' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.475 ' OH ' HG21 ' A' ' 75' ' ' THR . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.539 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 1.044 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.3 m170 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.691 ' CG ' HD11 ' B' ' 5' ' ' ILE . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.731 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 72' ' ' ILE . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 76' ' ' THR . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.596 ' HB3' HD12 ' C' ' 82' ' ' LEU . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 78' ' ' PHE . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 34' ' ' ILE . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.795 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' ' 35' ' ' PRO . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.725 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' ILE . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.959 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 73' ' ' VAL . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB3' HD21 ' A' ' 67' ' ' LEU . 14.1 ptm180 -164.77 46.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.832 0.349 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.24 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.481 HG23 ' CD2' ' B' ' 24' ' ' LEU . 19.0 m -165.18 116.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.568 ' OE1' HD23 ' B' ' 24' ' ' LEU . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.691 HD11 ' CG ' ' A' ' 103' ' ' ASN . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.722 ' HB2' ' CG1' ' B' ' 61' ' ' ILE . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.786 HD13 ' O ' ' B' ' 14' ' ' ALA . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.84 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 104' ' ' PHE . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 11' ' ' ALA . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.53 HG23 HD13 ' B' ' 29' ' ' LEU . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.562 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.515 HD13 HG12 ' B' ' 128' ' ' VAL . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' B' ' 127' ' ' ALA . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.631 HD12 ' N ' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.737 HG21 HD11 ' B' ' 62' ' ' ILE . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.484 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.716 ' HB ' HG11 ' B' ' 119' ' ' VAL . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.565 HG23 HG13 ' B' ' 34' ' ' ILE . 33.3 t -63.01 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.402 ' HB3' ' HB ' ' B' ' 40' ' ' THR . 36.6 t-20 -35.14 129.93 0.51 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.935 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.58 -10.63 29.2 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.023 . . . . 0.0 112.192 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.4 -21.41 8.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.78 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' B' ' 37' ' ' ASN . 3.5 m -114.77 -25.32 8.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.456 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 63.81 56.13 20.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.357 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.401 ' CG ' HG22 ' B' ' 40' ' ' THR . 0.0 OUTLIER -164.36 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.623 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.791 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.3 p -173.94 106.72 0.3 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' B' ' 47' ' ' ILE . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' B' ' 95' ' ' PHE . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' B' ' 54' ' ' SER . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.722 ' CG1' ' HB2' ' B' ' 11' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.737 HD11 HG21 ' B' ' 30' ' ' THR . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 1.051 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.897 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.477 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 126' ' ' ILE . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.635 HG13 HG22 ' B' ' 128' ' ' VAL . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.681 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.727 HG23 ' HB2' ' B' ' 125' ' ' ALA . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 108' ' ' SER . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.702 HG13 ' O ' ' B' ' 122' ' ' GLU . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.507 HG11 ' HD1' ' B' ' 85' ' ' PHE . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.507 ' HD1' HG11 ' B' ' 79' ' ' VAL . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' B' ' 75' ' ' THR . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.542 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 1.051 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 3.4 m170 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.7 ' CG ' HD11 ' C' ' 5' ' ' ILE . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.72 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' B' ' 72' ' ' ILE . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.431 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.845 ' O ' HG23 ' B' ' 76' ' ' THR . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.729 HG11 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.543 ' HB3' HD12 ' A' ' 82' ' ' LEU . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HB2' ' B' ' 78' ' ' PHE . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.482 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.716 HG11 ' HB ' ' B' ' 34' ' ' ILE . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . 0.791 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.468 HD11 ' HG3' ' B' ' 35' ' ' PRO . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.702 ' O ' HG13 ' B' ' 77' ' ' VAL . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.56 ' CG2' HG21 ' B' ' 58' ' ' VAL . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 72' ' ' ILE . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.997 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.635 HG22 HG13 ' B' ' 73' ' ' VAL . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' B' ' 67' ' ' LEU . 14.1 ptm180 -164.83 46.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.951 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.21 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.48 HG23 ' CD2' ' C' ' 24' ' ' LEU . 19.0 m -165.22 116.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.562 ' OE1' HD23 ' C' ' 24' ' ' LEU . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.7 HD11 ' CG ' ' B' ' 103' ' ' ASN . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.497 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.721 ' HB2' ' CG1' ' C' ' 61' ' ' ILE . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.67 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.779 HD13 ' O ' ' C' ' 14' ' ' ALA . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.826 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' B' ' 104' ' ' PHE . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.535 HG23 HD13 ' C' ' 29' ' ' LEU . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.559 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.898 HD13 ' O ' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.482 HD13 HG12 ' C' ' 128' ' ' VAL . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.63 ' N ' HD12 ' C' ' 29' ' ' LEU . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.711 HG21 HD11 ' C' ' 62' ' ' ILE . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.691 ' HB ' HG11 ' C' ' 119' ' ' VAL . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.561 HG23 HG13 ' C' ' 34' ' ' ILE . 32.8 t -63.06 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' C' ' 41' ' ' GLY . 36.7 t-20 -35.13 129.94 0.51 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.56 -10.6 29.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.31 2.007 . . . . 0.0 112.18 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.44 -21.43 8.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.729 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.408 HG22 ' CG ' ' C' ' 42' ' ' GLU . 3.5 m -114.8 -25.24 8.32 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 63.64 56.1 21.27 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.395 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.408 ' CG ' HG22 ' C' ' 40' ' ' THR . 0.0 OUTLIER -164.26 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.61 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.789 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.3 p -173.93 106.74 0.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.365 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' C' ' 51' ' ' ALA . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.401 ' OE1' HD13 ' C' ' 47' ' ' ILE . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 54' ' ' SER . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.721 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.711 HD11 HG21 ' C' ' 30' ' ' THR . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 1.059 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.886 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.464 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.484 HG23 ' O ' ' C' ' 126' ' ' ILE . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.636 HG13 HG22 ' C' ' 128' ' ' VAL . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' ALA . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.847 HG23 ' O ' ' C' ' 108' ' ' SER . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.714 HG13 ' O ' ' C' ' 122' ' ' GLU . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.729 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' C' ' 85' ' ' PHE . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' C' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.479 ' OH ' HG21 ' C' ' 75' ' ' THR . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.549 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 1.059 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 3.3 m170 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.694 ' OD1' HD11 ' A' ' 5' ' ' ILE . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.704 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' C' ' 72' ' ' ILE . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . 0.847 ' O ' HG23 ' C' ' 76' ' ' THR . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.712 HG11 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.731 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.581 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' C' ' 78' ' ' PHE . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.582 ' O ' HG22 ' C' ' 119' ' ' VAL . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.484 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' C' ' 34' ' ' ILE . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . 0.789 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' C' ' 35' ' ' PRO . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 77' ' ' VAL . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' HB ' ' C' ' 76' ' ' THR . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.705 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' ILE . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.956 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.636 HG22 HG13 ' C' ' 73' ' ' VAL . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' C' ' 67' ' ' LEU . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.855 0.359 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -172.57 4.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.044 HG21 HG21 ' C' ' 128' ' ' VAL . 0.9 OUTLIER 61.7 113.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.76 132.97 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.82 HD13 ' OD1' ' C' ' 103' ' ' ASN . 4.3 mp -55.2 152.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 21' ' ' ALA . 32.7 mt -103.43 139.26 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.58 117.18 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.58 HG22 ' OE1' ' A' ' 20' ' ' GLN . 11.7 t -133.88 165.99 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.33 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.52 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 7.6 mmtp -121.62 -36.89 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.032 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.872 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -67.82 172.05 4.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 18.9 Cg_endo -59.39 -16.05 33.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.695 2.263 . . . . 0.0 112.85 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 77.24 151.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 111.317 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.603 ' O ' HD13 ' A' ' 15' ' ' ILE . . . -104.67 120.71 41.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 14' ' ' ALA . 22.1 mm -133.51 15.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.072 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.85 -146.17 4.73 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.987 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' C' ' 104' ' ' PHE . 93.9 Cg_endo -87.39 44.53 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.536 2.158 . . . . 0.0 112.901 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.541 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -163.19 154.59 17.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.867 0.365 . . . . 0.0 111.033 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.465 HG13 ' O ' ' C' ' 103' ' ' ASN . 27.3 m -110.91 169.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.58 ' OE1' HG22 ' A' ' 8' ' ' THR . 56.2 mt-30 -58.96 -53.53 57.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' A' ' 6' ' ' ILE . . . -170.69 -177.09 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG21 ' HB ' ' C' ' 73' ' ' VAL . 9.3 m -142.33 132.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.166 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.645 ' HA ' HG23 ' A' ' 28' ' ' VAL . 20.8 t70 -103.47 105.01 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.567 ' CD2' HG23 ' A' ' 3' ' ' THR . 19.5 mt -80.51 -16.36 54.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.371 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.05 -104.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.28 -29.62 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.166 0.508 . . . . 0.0 110.21 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 28' ' ' VAL . 5.0 tt -135.2 140.65 45.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.95 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 9.9 p -120.04 160.88 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.123 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' HE2' ' C' ' 74' ' ' LYS . 2.9 mp -145.87 127.37 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 p -106.5 136.11 46.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.983 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.812 ' HB2' ' HB1' ' C' ' 106' ' ' ALA . 1.1 t -59.36 179.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.07 95.55 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.244 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.805 ' HG2' HG22 ' A' ' 58' ' ' VAL . 2.9 mp0 -62.07 138.14 58.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.275 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.524 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -146.04 170.18 8.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.679 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -54.26 -137.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.313 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t 74.12 73.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.411 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 41' ' ' GLY . 2.1 t-20 -34.93 115.62 0.52 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.978 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.65 -13.68 11.46 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.339 2.026 . . . . 0.0 112.144 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.81 27.87 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.086 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 42' ' ' GLU . 8.0 t -161.6 -33.37 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.908 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 96.92 66.2 0.92 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.847 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HG2' HG23 ' A' ' 40' ' ' THR . 2.7 mt-10 -82.73 -53.38 5.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.369 . . . . 0.0 111.276 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t 68.96 72.52 0.34 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.81 140.71 81.58 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.592 2.195 . . . . 0.0 112.433 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.37 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.4 93.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.791 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.616 HD13 ' NE2' ' A' ' 50' ' ' GLN . 28.9 mm -38.93 -33.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.5 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.08 -48.07 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.696 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.82 -55.04 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.616 ' NE2' HD13 ' A' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.498 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -71.93 -44.36 63.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -63.33 -51.54 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.79 -31.18 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.871 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.3 m -68.31 -46.48 70.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.29 -26.36 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.971 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -57.95 4.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.108 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.8 OUTLIER -54.88 -30.36 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.985 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 54' ' ' SER . 39.6 t -62.1 -34.54 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 110.517 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.99 -31.75 34.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.755 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -62.23 -38.55 89.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 11' ' ' ALA . 6.1 mt -70.93 -46.2 69.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.667 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.8 -32.62 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.28 -38.4 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.9 -24.33 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.145 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.71 -22.11 21.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.914 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.43 64.8 0.83 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' OD2' ' A' ' 71' ' ' ASP . 14.7 mt -158.9 139.2 12.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 44.0 p -96.12 145.0 25.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -46.29 -31.75 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.518 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -59.77 -18.48 43.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.715 ' OD2' HD22 ' A' ' 67' ' ' LEU . 3.2 p-10 -88.58 -21.27 24.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 126' ' ' ILE . 64.3 mt -59.35 109.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.853 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.528 ' HB ' HG21 ' B' ' 22' ' ' VAL . 2.8 m -81.11 -36.84 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.971 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HE2' HD22 ' B' ' 29' ' ' LEU . 8.6 mtmt -130.55 175.23 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.319 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.61 ' H ' ' HB2' ' A' ' 107' ' ' ARG . 13.4 t 177.71 110.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 0.0 111.36 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -70.18 130.1 41.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.1 t -115.33 91.6 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 76' ' ' THR . 5.3 m-85 -91.7 143.77 26.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.089 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.514 HG11 ' CD1' ' A' ' 85' ' ' PHE . 35.3 m -139.31 150.0 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.023 0.44 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.57 ' HE2' HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -90.95 -4.31 56.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.796 178.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.04 108.99 0.46 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.687 HD12 ' HB3' ' B' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.25 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.97 -24.64 59.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 110.282 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -78.46 -15.34 58.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.832 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.514 ' CD1' HG11 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -55.52 -22.98 23.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.01 -46.63 84.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.08 -33.22 19.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 84' ' ' ASP . 32.6 t -70.08 -49.66 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.673 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 36.4 t-20 -63.09 -35.99 82.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.14 94.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.016 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.62 -31.1 19.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.448 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 48.7 t80 -57.67 -51.35 69.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.727 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 7.7 tt0 -73.32 -27.34 61.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -25.11 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.765 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -79.31 -41.02 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.934 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 95' ' ' PHE . 57.1 m-85 -56.45 -50.43 71.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.8 69.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.77 58.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.402 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -110.54 -6.88 14.79 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.7 m-20 89.68 30.9 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.514 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 19.9 t-160 -127.57 72.17 77.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.96 -11.04 16.65 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.539 2.159 . . . . 0.0 112.153 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.844 ' OD1' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.03 42.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.447 . . . . 0.0 110.439 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CG ' ' HA ' ' B' ' 17' ' ' PRO . 92.7 m-85 70.99 144.0 0.1 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.515 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 104' ' ' PHE . 2.0 Cg_endo -82.96 165.82 15.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.057 2.504 . . . . 0.0 112.0 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' B' ' 31' ' ' SER . . . -115.28 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.779 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.61 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -169.27 -163.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.944 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.36 107.57 16.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.493 ' O ' HG13 ' A' ' 110' ' ' VAL . 5.3 m -95.25 129.16 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.798 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.519 HG12 HD23 ' B' ' 115' ' ' LEU . 7.0 m -157.79 165.71 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.949 0.405 . . . . 0.0 111.666 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 9.4 tt0 -99.75 102.87 14.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.777 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.82 162.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -79.07 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.685 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.0 OUTLIER -140.81 168.08 20.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.722 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.622 HD22 ' HB2' ' A' ' 122' ' ' GLU . 3.0 mt -144.19 161.9 42.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 119' ' ' VAL . 32.7 Cg_exo -59.7 135.94 67.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.649 2.233 . . . . 0.0 112.183 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.58 18.28 7.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.87 17.47 8.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 116' ' ' PRO . 21.2 m -55.18 172.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.61 14.08 20.29 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.011 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 121' ' ' LEU . 4.5 pp -176.64 149.0 0.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.123 0.487 . . . . 0.0 111.508 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.622 ' HB2' HD22 ' A' ' 115' ' ' LEU . 44.5 tt0 -150.86 137.85 19.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.918 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 76' ' ' THR . 3.4 mp -144.67 138.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 112.101 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.36 149.91 28.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.613 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.569 ' C ' HD13 ' A' ' 126' ' ' ILE . . . -132.03 125.99 32.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.414 . . . . 0.0 112.027 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.569 HD13 ' C ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -114.42 132.16 64.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.876 178.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.95 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -121.74 153.14 38.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.063 0.459 . . . . 0.0 112.038 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.111 HG21 HG21 ' B' ' 3' ' ' THR . 34.6 m -124.13 116.37 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.987 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.464 ' CD ' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -106.3 57.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.971 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.849 0.357 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.6 -172.5 4.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 1.111 HG21 HG21 ' A' ' 128' ' ' VAL . 0.9 OUTLIER 61.63 113.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.72 132.95 5.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.844 HD13 ' OD1' ' A' ' 103' ' ' ASN . 4.4 mp -55.2 152.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' B' ' 21' ' ' ALA . 32.7 mt -103.43 139.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -143.59 117.19 9.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.575 HG23 ' H ' ' B' ' 11' ' ' ALA . 11.6 t -133.86 165.97 23.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.804 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 26.32 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.58 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 7.6 mmtt -121.6 -36.61 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -68.18 172.03 4.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 18.7 Cg_endo -59.33 -16.06 32.7 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.632 2.221 . . . . 0.0 112.905 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 77.23 151.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.411 . . . . 0.0 111.281 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.586 ' O ' HD13 ' B' ' 15' ' ' ILE . . . -104.68 120.75 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.597 HG22 ' O ' ' B' ' 15' ' ' ILE . 22.1 mm -133.53 15.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.08 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.79 -146.1 4.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.974 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.509 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . 94.4 Cg_endo -87.38 44.49 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.637 2.224 . . . . 0.0 112.916 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -163.26 154.53 17.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.915 0.388 . . . . 0.0 110.991 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 103' ' ' ASN . 27.2 m -110.83 169.25 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.304 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.575 ' OE1' HG22 ' B' ' 8' ' ' THR . 56.3 mt-30 -59.04 -53.58 56.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -170.46 -177.16 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.528 HG21 ' HB ' ' A' ' 73' ' ' VAL . 9.2 m -142.31 132.63 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.636 ' HA ' HG23 ' B' ' 28' ' ' VAL . 20.8 t70 -103.51 104.94 15.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.554 ' CD2' HG23 ' B' ' 3' ' ' THR . 19.5 mt -80.44 -16.4 54.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -103.96 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.972 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -53.3 -29.56 34.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.082 0.468 . . . . 0.0 110.189 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.644 HD23 ' N ' ' B' ' 28' ' ' VAL . 5.0 tt -135.3 140.65 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.52 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.945 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 9.9 p -120.07 160.84 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.657 HD22 ' HE2' ' A' ' 74' ' ' LYS . 2.9 mp -145.87 127.42 15.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.68 136.36 46.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.06 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.843 ' HB2' ' HB1' ' A' ' 106' ' ' ALA . 1.1 t -59.69 179.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.01 95.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.834 ' HG2' HG22 ' B' ' 58' ' ' VAL . 2.9 mp0 -61.92 138.09 58.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.553 HG22 ' O ' ' B' ' 121' ' ' LEU . 0.7 OUTLIER -145.98 170.19 8.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.665 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' B' ' 34' ' ' ILE . 52.2 Cg_exo -54.34 -137.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.069 2.513 . . . . 0.0 112.319 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t 74.21 73.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' B' ' 41' ' ' GLY . 2.1 t-20 -34.86 115.66 0.52 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.964 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.65 -13.71 11.53 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.4 2.067 . . . . 0.0 112.11 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.54 -26.78 27.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.459 HG23 ' HG2' ' B' ' 42' ' ' GLU . 8.0 t -161.65 -33.23 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 97.1 66.02 0.92 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.791 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.459 ' HG2' HG23 ' B' ' 40' ' ' THR . 2.8 mt-10 -82.77 -53.36 5.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.371 . . . . 0.0 111.292 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 t 68.91 72.59 0.34 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.83 140.7 81.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.662 2.242 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.39 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.35 93.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.618 HD13 ' NE2' ' B' ' 50' ' ' GLN . 28.9 mm -38.94 -33.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.443 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.02 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.91 -54.98 38.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.618 ' NE2' HD13 ' B' ' 47' ' ' ILE . 15.8 pt20 -61.1 -26.16 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.522 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -72.18 -44.2 63.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.901 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.33 -51.54 65.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.533 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.22 72.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.9 ' O ' HG23 ' B' ' 58' ' ' VAL . 1.3 m -68.4 -46.37 70.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.32 -26.38 68.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.963 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -57.99 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.163 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.8 OUTLIER -54.86 -30.39 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.931 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.9 HG23 ' O ' ' B' ' 54' ' ' SER . 39.7 t -62.13 -34.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -80.95 -31.77 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.791 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -62.21 -38.49 89.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.571 HG12 ' HB2' ' B' ' 11' ' ' ALA . 6.0 mt -71.25 -46.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mt -69.83 -32.53 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.656 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.31 -38.49 60.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.34 65.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.136 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 -22.06 21.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.919 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 64.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.711 HD22 ' OD2' ' B' ' 71' ' ' ASP . 14.7 mt -158.91 139.2 12.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.022 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.41 ' O ' ' OD1' ' B' ' 71' ' ' ASP . 43.8 p -96.1 144.99 25.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -46.26 -31.79 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.574 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -59.83 -18.27 42.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.425 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.711 ' OD2' HD22 ' B' ' 67' ' ' LEU . 3.3 p-10 -88.65 -21.23 24.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.714 0.292 . . . . 0.0 110.87 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.512 HG23 ' O ' ' B' ' 126' ' ' ILE . 64.4 mt -59.4 109.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.874 0.369 . . . . 0.0 110.839 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' C' ' 22' ' ' VAL . 2.8 m -81.12 -36.88 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.969 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.667 ' HE2' HD22 ' C' ' 29' ' ' LEU . 8.6 mtmt -130.56 175.22 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.302 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.612 ' H ' ' HB2' ' B' ' 107' ' ' ARG . 13.4 t 177.67 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 111.337 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.753 ' O ' HG23 ' B' ' 123' ' ' ILE . 0.0 OUTLIER -70.15 130.12 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.325 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.43 91.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.404 ' CZ ' ' HB ' ' B' ' 76' ' ' THR . 5.3 m-85 -91.66 143.72 26.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.151 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' B' ' 85' ' ' PHE . 35.1 m -139.32 150.01 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.072 0.463 . . . . 0.0 111.718 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' B' ' 47' ' ' ILE . 0.3 OUTLIER -90.94 -4.12 56.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.839 178.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -169.23 109.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.321 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' C' ' 114' ' ' ARG . 0.4 OUTLIER -58.53 -17.32 20.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.228 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.94 -24.63 59.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.275 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.547 ' O ' HG23 ' B' ' 88' ' ' VAL . 0.6 OUTLIER -78.52 -15.37 58.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.51 ' CD1' HG11 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -55.46 -23.03 23.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.267 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.99 -46.62 84.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.09 -33.23 19.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 84' ' ' ASP . 33.0 t -70.09 -49.59 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.721 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 36.4 t-20 -63.21 -35.96 82.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.04 94.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.67 -31.19 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.078 0.466 . . . . 0.0 110.577 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 48.8 t80 -57.62 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 7.7 tt0 -73.41 -27.32 61.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.462 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -25.19 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.786 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -79.25 -41.09 28.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.97 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' B' ' 95' ' ' PHE . 57.2 m-85 -56.36 -50.45 71.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.818 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -28.82 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.945 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.83 -3.8 58.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.98 14.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.505 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 11.7 m-20 89.78 30.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.502 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.0 t-160 -127.48 72.19 77.52 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.98 -11.02 16.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.537 2.158 . . . . 0.0 112.153 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.83 ' OD1' HD13 ' C' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.03 0.443 . . . . 0.0 110.445 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.506 ' CG ' ' HA ' ' C' ' 17' ' ' PRO . 92.7 m-85 70.89 144.04 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.494 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 104' ' ' PHE . 2.0 Cg_endo -83.02 165.85 14.91 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.016 2.477 . . . . 0.0 111.917 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.835 ' HB1' ' HB2' ' C' ' 31' ' ' SER . . . -115.27 137.95 51.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.612 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -169.23 -163.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -111.38 107.56 16.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.571 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . 0.504 ' O ' HG13 ' B' ' 110' ' ' VAL . 5.2 m -95.21 129.11 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.845 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.533 HG12 HD23 ' C' ' 115' ' ' LEU . 7.0 m -157.71 165.59 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.958 0.409 . . . . 0.0 111.632 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 9.3 tt0 -99.57 102.86 14.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.785 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.73 162.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -79.05 -46.27 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -140.82 168.11 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' B' ' 122' ' ' GLU . 3.0 mt -144.21 161.87 42.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.549 ' O ' HG22 ' B' ' 119' ' ' VAL . 33.1 Cg_exo -59.62 135.97 67.82 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.157 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.53 18.29 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 61.88 17.46 8.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.549 HG22 ' O ' ' B' ' 116' ' ' PRO . 21.5 m -55.18 172.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.082 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.63 13.95 20.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.025 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.553 ' O ' HG22 ' B' ' 34' ' ' ILE . 4.6 pp -176.62 148.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.449 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.615 ' HB2' HD22 ' B' ' 115' ' ' LEU . 44.5 tt0 -150.78 137.88 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.935 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.753 HG23 ' O ' ' B' ' 76' ' ' THR . 3.4 mp -144.68 138.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.46 . . . . 0.0 112.14 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.33 149.81 28.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.627 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.572 ' C ' HD13 ' B' ' 126' ' ' ILE . . . -131.94 126.01 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.956 0.408 . . . . 0.0 112.041 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.572 HD13 ' C ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -114.33 132.14 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.947 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.945 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -121.75 153.2 38.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.096 0.474 . . . . 0.0 111.994 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 1.04 HG21 HG21 ' C' ' 3' ' ' THR . 34.7 m -124.26 116.32 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.474 ' CD ' HD21 ' B' ' 67' ' ' LEU . 0.0 OUTLIER -106.23 57.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.015 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.851 0.358 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 -172.51 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 1.04 HG21 HG21 ' B' ' 128' ' ' VAL . 0.9 OUTLIER 61.67 113.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.68 132.97 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.83 HD13 ' OD1' ' B' ' 103' ' ' ASN . 4.4 mp -55.18 152.35 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' C' ' 21' ' ' ALA . 32.5 mt -103.46 139.23 24.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -143.59 117.2 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.572 HG22 ' OE1' ' C' ' 20' ' ' GLN . 11.7 t -133.93 165.96 23.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 26.32 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.051 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.542 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 7.6 mmtp -121.59 -36.84 2.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.01 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.885 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -67.93 172.02 4.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.885 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 18.8 Cg_endo -59.31 -16.11 32.83 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.675 2.25 . . . . 0.0 112.899 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 77.24 151.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.977 0.418 . . . . 0.0 111.304 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.591 ' O ' HD13 ' C' ' 15' ' ' ILE . . . -104.69 120.76 42.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.002 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.591 HD13 ' O ' ' C' ' 14' ' ' ALA . 22.5 mm -133.54 15.81 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.042 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.81 -146.14 4.73 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.001 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' B' ' 104' ' ' PHE . 94.1 Cg_endo -87.37 44.51 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 112.917 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.532 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -163.23 154.55 17.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.026 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.469 HG13 ' O ' ' B' ' 103' ' ' ASN . 27.2 m -110.87 169.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.36 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.572 ' OE1' HG22 ' C' ' 8' ' ' THR . 56.2 mt-30 -59.02 -53.38 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' C' ' 6' ' ' ILE . . . -170.6 -177.19 2.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' B' ' 73' ' ' VAL . 9.2 m -142.24 132.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.64 ' HA ' HG23 ' C' ' 28' ' ' VAL . 20.8 t70 -103.48 104.98 15.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.549 ' CD2' HG23 ' C' ' 3' ' ' THR . 19.5 mt -80.47 -16.35 54.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.0 -104.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.978 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.27 -29.59 33.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.648 HD23 ' N ' ' C' ' 28' ' ' VAL . 5.0 tt -135.22 140.64 45.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.575 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.947 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 9.9 p -120.04 160.84 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.667 HD22 ' HE2' ' B' ' 74' ' ' LYS . 2.9 mp -145.85 127.45 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 22.7 p -106.6 136.31 46.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . 0.835 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 1.1 t -59.62 179.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.13 95.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.25 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.821 ' HG2' HG22 ' C' ' 58' ' ' VAL . 2.9 mp0 -62.06 138.17 58.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.002 0.429 . . . . 0.0 111.259 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.528 HG22 ' O ' ' C' ' 121' ' ' LEU . 0.7 OUTLIER -146.0 170.23 8.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.654 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' C' ' 34' ' ' ILE . 52.4 Cg_exo -54.36 -137.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.063 2.509 . . . . 0.0 112.29 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t 74.17 73.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.427 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' C' ' 41' ' ' GLY . 2.1 t-20 -34.93 115.67 0.52 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.967 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.61 -13.76 11.54 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.36 2.04 . . . . 0.0 112.088 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.56 -26.65 27.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.133 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.45 HG23 ' HG2' ' C' ' 42' ' ' GLU . 8.0 t -161.62 -33.31 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.928 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 96.98 66.09 0.92 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.79 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' C' ' 40' ' ' THR . 2.8 mt-10 -82.74 -53.36 5.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.886 0.374 . . . . 0.0 111.287 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 t 68.96 72.52 0.34 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.931 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.88 140.74 81.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.637 2.225 . . . . 0.0 112.358 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.45 68.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.083 0.468 . . . . 0.0 110.913 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 93.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.621 HD13 ' NE2' ' C' ' 50' ' ' GLN . 28.7 mm -39.01 -33.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.447 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.04 -48.06 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.711 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -54.96 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.621 ' NE2' HD13 ' C' ' 47' ' ' ILE . 15.8 pt20 -61.2 -26.24 67.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.474 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -72.07 -44.36 63.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -63.36 -51.5 65.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.523 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.74 -31.24 72.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.354 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.903 ' O ' HG23 ' C' ' 58' ' ' VAL . 1.3 m -68.35 -46.4 70.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.58 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -65.32 -26.36 68.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -58.01 4.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.8 OUTLIER -54.9 -30.36 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.984 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.903 HG23 ' O ' ' C' ' 54' ' ' SER . 39.6 t -62.07 -34.62 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -80.86 -31.79 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -62.26 -38.52 89.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.019 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' C' ' 11' ' ' ALA . 6.0 mt -70.95 -46.31 68.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.89 -32.54 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.33 -38.39 60.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.093 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.86 -24.31 65.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.139 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.1 21.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.87 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.445 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.712 HD22 ' OD2' ' C' ' 71' ' ' ASP . 14.7 mt -158.9 139.23 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.036 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.0 p -96.16 145.01 25.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -46.21 -31.81 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.598 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -59.74 -18.28 41.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.477 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.712 ' OD2' HD22 ' C' ' 67' ' ' LEU . 3.3 p-10 -88.78 -21.16 23.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 110.896 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.503 HG23 ' O ' ' C' ' 126' ' ' ILE . 64.2 mt -59.39 109.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.496 ' HB ' HG21 ' A' ' 22' ' ' VAL . 2.8 m -81.04 -36.88 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.933 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.646 ' HE2' HD22 ' A' ' 29' ' ' LEU . 8.6 mtmt -130.6 175.25 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.369 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' C' ' 107' ' ' ARG . 13.4 t 177.72 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.313 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.754 ' O ' HG23 ' C' ' 123' ' ' ILE . 0.0 OUTLIER -70.23 130.2 41.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 t -115.43 91.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' C' ' 76' ' ' THR . 5.3 m-85 -91.64 143.8 26.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.143 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' C' ' 85' ' ' PHE . 34.8 m -139.35 149.98 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 111.691 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . 0.591 ' HE2' HD11 ' C' ' 47' ' ' ILE . 0.3 OUTLIER -90.99 -4.23 56.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.816 178.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -169.1 109.04 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.305 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.685 HD12 ' HB3' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -58.58 -17.19 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.0 -24.62 59.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.297 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.546 ' O ' HG23 ' C' ' 88' ' ' VAL . 0.6 OUTLIER -78.5 -15.28 58.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.827 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.513 ' CD1' HG11 ' C' ' 79' ' ' VAL . 0.3 OUTLIER -55.53 -23.04 24.26 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.261 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.63 84.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.01 -33.32 19.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.969 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.546 HG23 ' O ' ' C' ' 84' ' ' ASP . 32.8 t -70.06 -49.66 54.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 36.4 t-20 -63.12 -35.99 82.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.337 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.22 -42.14 94.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.973 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -87.68 -31.16 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.567 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.457 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 48.7 t80 -57.64 -51.31 70.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.756 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 7.7 tt0 -73.36 -27.37 61.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -25.19 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.77 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -79.32 -41.03 28.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' C' ' 95' ' ' PHE . 56.7 m-85 -56.38 -50.4 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.781 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -28.72 69.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.954 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -84.91 -3.78 58.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.362 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 0.3 OUTLIER -110.53 -6.91 14.79 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 11.7 m-20 89.79 30.84 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.822 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.499 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.0 t-160 -127.55 72.17 77.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.705 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.03 -10.97 16.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.495 2.13 . . . . 0.0 112.146 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.82 ' OD1' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -79.14 -35.02 42.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.998 0.428 . . . . 0.0 110.429 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.512 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 92.8 m-85 70.91 144.1 0.1 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.42 ' HB2' HG22 ' C' ' 75' ' ' THR . 2.0 Cg_endo -83.05 165.85 14.87 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.028 2.485 . . . . 0.0 111.948 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.812 ' HB1' ' HB2' ' A' ' 31' ' ' SER . . . -115.29 137.96 51.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.6 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -169.22 -163.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 5.4 p -111.36 107.48 16.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.589 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . 0.502 ' O ' HG13 ' C' ' 110' ' ' VAL . 5.2 m -95.21 129.18 42.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.788 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.514 HG12 HD23 ' A' ' 115' ' ' LEU . 7.1 m -157.82 165.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 9.4 tt0 -99.76 102.86 14.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.75 162.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -79.08 -46.24 18.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.671 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -140.83 168.09 20.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.778 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' C' ' 122' ' ' GLU . 3.0 mt -144.21 161.82 43.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.913 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.544 ' O ' HG22 ' C' ' 119' ' ' VAL . 33.7 Cg_exo -59.52 135.99 68.34 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.608 2.205 . . . . 0.0 112.221 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.51 18.29 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 61.8 17.55 8.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.544 HG22 ' O ' ' C' ' 116' ' ' PRO . 21.2 m -55.18 172.65 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.065 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -114.79 14.08 19.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.988 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.534 ' O ' HD12 ' C' ' 121' ' ' LEU . 4.6 pp -176.62 148.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.489 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.619 ' HB2' HD22 ' C' ' 115' ' ' LEU . 44.4 tt0 -150.83 137.93 19.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.754 HG23 ' O ' ' C' ' 76' ' ' THR . 3.4 mp -144.74 138.35 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.11 0.481 . . . . 0.0 112.142 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.3 149.82 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.648 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.573 ' C ' HD13 ' C' ' 126' ' ' ILE . . . -131.98 126.13 33.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 112.004 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.573 HD13 ' C ' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -114.41 132.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 178.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.947 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -121.76 153.11 38.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.082 0.468 . . . . 0.0 112.029 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 3' ' ' THR . 34.6 m -124.15 116.32 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.47 ' CD ' HD21 ' C' ' 67' ' ' LEU . 0.0 OUTLIER -106.27 56.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.99 0.424 . . . . 0.0 110.892 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.894 0.378 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mtt -95.93 -170.65 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.76 HG21 HG21 ' C' ' 128' ' ' VAL . 0.2 OUTLIER 62.99 106.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.83 107.65 13.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.971 HD11 HG11 ' A' ' 19' ' ' VAL . 1.7 tp -54.31 125.88 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.311 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 23' ' ' ASP . 22.4 mm -83.67 137.49 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.46 92.4 1.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -115.24 163.65 15.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.08 29.06 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -113.94 -41.78 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.807 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -72.34 178.16 1.49 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 32.3 Cg_exo -57.56 -13.83 14.98 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.808 2.339 . . . . 0.0 113.006 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 77.39 163.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 0.0 111.075 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 19' ' ' VAL . . . -117.17 125.0 50.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.407 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 15' ' ' ILE . 3.3 mp -144.89 18.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.025 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.1 -137.25 3.45 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.429 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' C' ' 92' ' ' TYR . 89.8 Cg_endo -88.82 32.42 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.795 2.33 . . . . 0.0 113.23 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' C' ' 105' ' ' PRO . 0.7 OUTLIER -152.49 -178.03 6.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.392 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.971 HG11 HD11 ' A' ' 5' ' ' ILE . 10.3 m -136.68 179.79 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.689 ' NE2' ' HB3' ' A' ' 11' ' ' ALA . 15.6 mm-40 -68.86 -49.58 57.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.517 ' HB3' HG13 ' A' ' 6' ' ' ILE . . . -174.48 -177.42 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.48 HG11 ' HB ' ' C' ' 73' ' ' VAL . 4.7 m -137.88 141.58 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.714 ' HB2' HD11 ' A' ' 6' ' ' ILE . 53.5 t0 -117.97 91.01 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.59 HD11 ' CG1' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -65.95 -20.97 66.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.073 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.06 -108.85 0.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.846 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -57.85 -30.17 65.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.096 0.474 . . . . 0.0 110.229 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.411 HD23 ' C ' ' A' ' 27' ' ' LEU . 7.6 tt -124.71 124.55 42.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.736 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.072 HG23 ' HB3' ' A' ' 127' ' ' ALA . 3.4 m -105.54 171.61 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.594 HD22 ' HD2' ' C' ' 74' ' ' LYS . 1.3 mp -144.7 164.81 29.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.751 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 p -138.47 143.9 39.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.911 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.842 ' HB3' ' HB1' ' C' ' 106' ' ' ALA . 3.4 p -72.47 179.55 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.27 95.43 0.96 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.377 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.581 ' OE1' HD11 ' A' ' 61' ' ' ILE . 14.4 mm-40 -66.93 165.13 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.342 . . . . 0.0 111.015 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.645 ' HB ' HG11 ' A' ' 119' ' ' VAL . 8.6 pt -159.5 157.59 26.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.294 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 35.5 Cg_exo -58.35 -15.05 22.51 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.075 2.517 . . . . 0.0 113.024 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.606 ' CG2' HD12 ' A' ' 34' ' ' ILE . 44.0 t -50.03 89.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -43.86 117.35 2.62 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.576 -179.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 31.3 Cg_exo -58.28 -14.19 19.03 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.292 1.994 . . . . 0.0 112.249 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.78 -26.92 25.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.305 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.2 t -158.77 -32.82 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.991 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 37' ' ' ASN . . . 92.68 66.73 1.1 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.408 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -77.55 -65.17 1.0 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.962 0.411 . . . . 0.0 111.104 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 35' ' ' PRO . 14.7 t 69.52 62.44 0.55 Allowed Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.966 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 43' ' ' VAL . 51.8 Cg_exo -54.33 153.04 23.55 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.652 2.235 . . . . 0.0 112.414 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.74 60.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -55.02 95.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.868 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.604 HD13 ' OD2' ' A' ' 84' ' ' ASP . 8.2 tp -40.34 -32.98 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.797 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.62 -48.14 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.83 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -61.48 -48.51 80.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.827 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.636 ' HG3' HD21 ' A' ' 121' ' ' LEU . 18.8 pt20 -65.97 -33.78 76.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.481 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -71.89 -35.88 69.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.008 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.61 -45.67 78.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.681 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -39.39 85.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.656 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.809 ' O ' HG23 ' A' ' 58' ' ' VAL . 4.7 t -69.75 -32.16 70.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.656 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.632 HD13 ' CE2' ' A' ' 95' ' ' PHE . 17.3 mt -70.94 -44.97 65.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.53 -42.27 96.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.824 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -58.95 -38.16 78.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 54' ' ' SER . 12.4 t -61.56 -38.0 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.762 ' HG3' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -80.68 -31.02 36.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.763 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -58.72 -41.0 85.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.599 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 15.4 mt -71.54 -42.17 72.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.615 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.583 ' CD1' HD11 ' A' ' 72' ' ' ILE . 17.1 mt -68.48 -33.05 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.583 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.5 -42.82 67.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.224 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -21.36 63.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.404 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.39 -28.85 19.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.703 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.99 52.82 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.61 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 129' ' ' ARG . 6.2 mt -161.28 -172.69 3.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 0.0 110.731 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -141.75 165.09 28.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.779 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.066 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -59.69 -32.33 70.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.876 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.962 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -56.67 -26.49 56.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.473 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -82.67 -22.64 34.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.22 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.583 HD11 ' CD1' ' A' ' 62' ' ' ILE . 89.7 mt -53.59 110.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.921 0.391 . . . . 0.0 111.243 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 74' ' ' LYS . 34.4 m -78.65 -46.08 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.838 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.608 ' HD2' HD22 ' B' ' 29' ' ' LEU . 7.5 mttt -119.55 154.36 34.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.345 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.663 HG23 ' HB2' ' A' ' 105' ' ' PRO . 76.1 p -153.77 102.37 2.53 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.622 HG22 ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -69.38 124.32 23.56 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -111.07 111.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.622 ' CE1' HG22 ' A' ' 76' ' ' THR . 13.7 m-30 -109.88 133.41 53.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.995 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.686 HG11 ' HD1' ' A' ' 85' ' ' PHE . 3.1 m -130.34 150.43 34.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.1 0.476 . . . . 0.0 111.858 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.6 -1.38 58.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.889 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.31 118.95 0.31 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.477 HD23 HG21 ' A' ' 79' ' ' VAL . 51.6 mt -62.29 -14.55 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.23 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -74.14 -21.83 59.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.301 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.604 ' OD2' HD13 ' A' ' 47' ' ' ILE . 3.7 m-20 -87.0 -18.71 30.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.991 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.686 ' HD1' HG11 ' A' ' 79' ' ' VAL . 1.3 t80 -53.48 -30.98 43.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.8 -34.91 72.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.287 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.76 -42.78 13.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.324 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.1 -45.84 79.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -63.0 -38.57 91.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.081 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.21 73.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.499 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -15.08 32.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.545 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.517 ' HH ' ' HZ ' ' A' ' 96' ' ' PHE . 12.2 t80 -81.05 -38.39 27.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 111.338 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' A' ' 104' ' ' PHE . 2.4 tt0 -83.2 -27.97 29.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.516 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.83 -24.39 55.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.773 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.632 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -85.31 -37.44 19.96 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.719 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.521 ' CE1' ' CZ ' ' A' ' 95' ' ' PHE . 3.9 m-85 -55.76 -55.19 35.32 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.168 0.509 . . . . 0.0 109.998 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -32.66 72.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.27 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.01 -6.72 57.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.385 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.709 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 1.5 t-20 -111.91 -4.62 14.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.494 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' A' ' 99' ' ' ASN . 15.6 m120 84.47 32.21 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.772 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 1.066 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.4 m170 -115.81 53.16 0.93 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.605 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 58.4 Cg_endo -70.56 -22.27 28.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.539 2.159 . . . . 0.0 112.47 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.767 ' ND2' HD13 ' B' ' 5' ' ' ILE . 2.8 t30 -50.14 -33.07 17.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.897 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.594 ' HB2' HG13 ' B' ' 19' ' ' VAL . 13.2 m-85 64.54 131.01 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.193 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.663 ' HB2' HG23 ' A' ' 75' ' ' THR . 94.2 Cg_endo -88.51 133.58 2.72 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.978 2.452 . . . . 0.0 112.615 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.964 ' HB2' HG23 ' B' ' 19' ' ' VAL . . . -97.87 129.09 44.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.058 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -162.73 -164.37 0.99 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.996 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.69 114.13 24.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.113 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.415 ' O ' HG13 ' A' ' 110' ' ' VAL . 14.6 m -92.85 138.36 31.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.219 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.771 HG12 HD23 ' B' ' 115' ' ' LEU . 23.1 m -156.73 158.38 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.986 0.422 . . . . 0.0 111.634 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.862 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 3.6 tt0 -98.99 86.29 3.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.655 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.488 HG21 HD21 ' A' ' 115' ' ' LEU . 29.0 m -57.14 156.91 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.233 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.875 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -65.74 -36.14 82.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.04 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.53 -178.25 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.735 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.783 HD23 HG12 ' C' ' 110' ' ' VAL . 27.7 mt -148.83 152.42 37.13 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.837 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.551 ' O ' HG22 ' A' ' 119' ' ' VAL . 25.9 Cg_endo -62.12 137.72 68.23 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.504 2.136 . . . . 0.0 112.162 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.409 ' HB3' HG13 ' A' ' 119' ' ' VAL . 1.1 tptt 75.17 14.1 3.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.29 13.62 8.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.188 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.645 HG11 ' HB ' ' A' ' 34' ' ' ILE . 23.0 m -58.1 156.72 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.727 0.299 . . . . 0.0 110.947 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.38 10.06 65.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.999 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.636 HD21 ' HG3' ' A' ' 50' ' ' GLN . 4.1 pp -177.26 148.26 0.59 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.085 0.469 . . . . 0.0 111.372 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.755 ' HB2' HD22 ' A' ' 115' ' ' LEU . 2.1 tt0 -126.41 150.3 48.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.087 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.679 HG21 HG21 ' A' ' 58' ' ' VAL . 29.5 mt -128.92 121.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.146 0.498 . . . . 0.0 112.277 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -130.88 144.77 51.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' A' ' 75' ' ' THR . . . -168.8 167.42 11.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 28' ' ' VAL . 1.4 mt -123.9 145.21 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.645 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 1.072 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -123.87 148.03 47.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.115 0.483 . . . . 0.0 111.868 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.752 HG21 HG21 ' B' ' 3' ' ' THR . 28.7 m -114.87 142.88 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.859 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 67' ' ' LEU . 3.2 ttm-85 -123.09 47.55 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.939 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.918 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.802 0.334 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mtt -95.89 -170.7 2.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.752 HG21 HG21 ' A' ' 128' ' ' VAL . 0.2 OUTLIER 63.04 106.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.83 107.64 13.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.963 HD11 HG11 ' B' ' 19' ' ' VAL . 1.7 tp -54.35 125.87 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.221 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' B' ' 23' ' ' ASP . 22.1 mm -83.58 137.55 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.147 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.48 92.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -115.21 163.7 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.13 29.04 3.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.448 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 0.0 OUTLIER -113.98 -41.92 3.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.872 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.705 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -71.94 178.15 1.43 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.705 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 32.3 Cg_exo -57.63 -13.8 15.14 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.787 2.325 . . . . 0.0 113.008 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 77.39 163.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.896 0.379 . . . . 0.0 111.032 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.423 ' C ' HD12 ' B' ' 15' ' ' ILE . . . -117.18 125.06 50.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.377 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.589 HG22 ' O ' ' B' ' 15' ' ' ILE . 3.3 mp -144.94 18.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.993 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.06 -137.23 3.45 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.44 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -88.81 32.4 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.844 2.363 . . . . 0.0 113.269 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -152.49 -178.09 6.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.427 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 106' ' ' ALA . 10.5 m -136.64 179.7 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.21 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.686 ' NE2' ' HB3' ' B' ' 11' ' ' ALA . 15.6 mm-40 -68.82 -49.75 55.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.944 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.509 ' HB3' HG13 ' B' ' 6' ' ' ILE . . . -174.6 -177.42 1.18 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.219 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.489 HG23 HD13 ' B' ' 29' ' ' LEU . 4.6 m -137.99 141.59 38.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.714 ' HB2' HD11 ' B' ' 6' ' ' ILE . 53.6 t0 -117.94 91.05 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.975 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.578 HD11 ' CG1' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -66.04 -20.94 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.01 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.05 -108.83 0.78 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.881 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -57.82 -30.26 65.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.048 0.452 . . . . 0.0 110.194 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.411 HD23 ' C ' ' B' ' 27' ' ' LEU . 7.6 tt -124.65 124.54 42.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.726 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.051 HG23 ' HB3' ' B' ' 127' ' ' ALA . 3.4 m -105.46 171.62 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.608 HD22 ' HD2' ' A' ' 74' ' ' LYS . 1.3 mp -144.69 164.8 29.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.7 p -138.46 143.87 39.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.818 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 3.3 p -71.93 179.67 3.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.801 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.31 95.49 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.369 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.575 ' OE1' HD11 ' B' ' 61' ' ' ILE . 14.3 mm-40 -66.95 165.09 16.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 111.004 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.608 HD12 ' CG2' ' B' ' 36' ' ' VAL . 8.7 pt -159.48 157.64 27.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.301 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' B' ' 43' ' ' VAL . 36.5 Cg_exo -58.41 -15.05 22.79 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.094 2.529 . . . . 0.0 113.045 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.608 ' CG2' HD12 ' B' ' 34' ' ' ILE . 44.1 t -50.01 89.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.397 . . . . 0.0 111.17 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' B' ' 41' ' ' GLY . 0.8 OUTLIER -43.89 117.39 2.64 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.558 -179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.409 ' HB3' ' O ' ' B' ' 11' ' ' ALA . 31.4 Cg_exo -58.35 -14.16 19.21 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.272 1.981 . . . . 0.0 112.191 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.75 -26.96 25.54 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.311 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 12.2 t -158.71 -33.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.972 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 92.7 66.86 1.1 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.418 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -77.56 -65.18 0.99 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.978 0.418 . . . . 0.0 111.116 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' B' ' 35' ' ' PRO . 14.6 t 69.58 62.34 0.55 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.982 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' B' ' 43' ' ' VAL . 51.8 Cg_exo -54.32 153.09 23.37 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.586 2.191 . . . . 0.0 112.424 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.17 -30.8 60.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.838 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.2 OUTLIER -55.04 95.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.91 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.626 HD13 ' OD2' ' B' ' 84' ' ' ASP . 8.2 tp -40.34 -32.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.86 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.57 -48.12 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -61.5 -48.55 80.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.86 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.667 ' HG3' HD21 ' B' ' 121' ' ' LEU . 18.8 pt20 -65.86 -33.9 76.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.542 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -71.75 -35.88 70.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.912 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.6 -45.71 78.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.687 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -39.32 85.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.714 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.803 ' O ' HG23 ' B' ' 58' ' ' VAL . 4.8 t -69.74 -32.23 70.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.648 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.709 HD13 ' CE2' ' B' ' 95' ' ' PHE . 17.3 mt -70.93 -44.97 65.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.59 -42.23 96.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.804 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -58.95 -38.11 78.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.854 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.803 HG23 ' O ' ' B' ' 54' ' ' SER . 12.3 t -61.6 -38.01 79.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.793 ' HG3' ' HB2' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -80.67 -30.99 36.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.799 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -58.58 -41.02 84.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.94 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.646 HG12 ' HB2' ' B' ' 11' ' ' ALA . 15.7 mt -71.51 -42.04 72.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.551 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.568 ' CD1' HD11 ' B' ' 72' ' ' ILE . 17.0 mt -68.41 -33.13 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.48 -42.76 67.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.258 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -21.36 63.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.366 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.39 -28.83 19.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.71 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.99 52.71 0.38 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.619 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' B' ' 129' ' ' ARG . 6.2 mt -161.27 -172.73 3.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.689 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 22.5 p -141.69 165.05 28.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.765 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 1.056 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -59.68 -32.37 70.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.856 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.96 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -56.63 -26.56 56.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.478 ' CG ' HD22 ' B' ' 67' ' ' LEU . 0.9 OUTLIER -82.42 -22.72 35.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.174 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.568 HD11 ' CD1' ' B' ' 62' ' ' ILE . 89.7 mt -53.61 110.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 111.24 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.492 HG23 ' N ' ' B' ' 74' ' ' LYS . 34.4 m -78.66 -46.11 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.89 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.591 ' HD2' HD22 ' C' ' 29' ' ' LEU . 7.5 mttt -119.56 154.4 33.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.316 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.661 HG23 ' HB2' ' B' ' 105' ' ' PRO . 75.8 p -153.78 102.32 2.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.616 HG22 ' CE1' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -69.28 124.29 23.45 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -111.04 111.84 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.616 ' CE1' HG22 ' B' ' 76' ' ' THR . 13.6 m-30 -109.85 133.36 53.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.998 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.686 HG11 ' HD1' ' B' ' 85' ' ' PHE . 3.2 m -130.33 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.14 0.495 . . . . 0.0 111.866 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.69 -1.41 58.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.849 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.27 118.91 0.31 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.488 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.474 HD23 HG21 ' B' ' 79' ' ' VAL . 52.4 mt -62.25 -14.56 39.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.263 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -74.07 -21.89 59.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.91 0.386 . . . . 0.0 110.314 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.626 ' OD2' HD13 ' B' ' 47' ' ' ILE . 3.7 m-20 -87.02 -18.71 29.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.686 ' HD1' HG11 ' B' ' 79' ' ' VAL . 1.3 t80 -53.44 -31.0 43.42 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.133 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.95 72.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.278 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.67 -42.81 13.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.338 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.44 HG22 HG13 ' B' ' 47' ' ' ILE . 26.5 t -69.08 -45.83 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.212 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -62.99 -38.51 91.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.09 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.2 73.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.503 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.94 -14.96 33.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.561 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' B' ' 96' ' ' PHE . 12.3 t80 -81.16 -38.36 27.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 111.264 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' B' ' 104' ' ' PHE . 2.4 tt0 -83.21 -27.89 29.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.545 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.87 -24.31 55.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.794 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.709 ' CE2' HD13 ' B' ' 55' ' ' LEU . 0.1 OUTLIER -85.44 -37.35 19.87 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.672 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.521 ' CE1' ' CZ ' ' B' ' 95' ' ' PHE . 3.9 m-85 -55.85 -55.18 35.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.172 0.51 . . . . 0.0 109.954 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -32.71 72.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.254 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.92 -6.82 57.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.385 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.714 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 1.5 t-20 -111.84 -4.63 14.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.499 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' B' ' 99' ' ' ASN . 15.6 m120 84.38 32.24 0.05 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.786 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 1.056 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 3.5 m170 -115.82 53.13 0.93 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.618 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 58.5 Cg_endo -70.54 -22.33 28.65 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.565 2.177 . . . . 0.0 112.428 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.765 ' ND2' HD13 ' C' ' 5' ' ' ILE . 2.8 t30 -50.09 -33.18 17.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.93 0.395 . . . . 0.0 110.865 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.609 ' HB2' HG13 ' C' ' 19' ' ' VAL . 13.1 m-85 64.64 130.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.2 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.661 ' HB2' HG23 ' B' ' 75' ' ' THR . 94.0 Cg_endo -88.48 133.64 2.74 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.004 2.469 . . . . 0.0 112.579 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 1.014 ' HB2' HG23 ' C' ' 19' ' ' VAL . . . -97.91 128.98 44.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.546 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -162.61 -164.33 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.958 179.325 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.73 114.13 24.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.076 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . 0.404 ' O ' HG13 ' B' ' 110' ' ' VAL . 14.5 m -92.84 138.42 31.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.21 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.789 HG12 HD23 ' C' ' 115' ' ' LEU . 23.0 m -156.74 158.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.985 0.421 . . . . 0.0 111.659 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.86 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 3.6 tt0 -99.05 86.31 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.648 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.481 HG21 HD21 ' B' ' 115' ' ' LEU . 29.3 m -57.14 156.93 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -65.74 -36.18 82.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.5 -178.22 7.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.728 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.771 HD23 HG12 ' A' ' 110' ' ' VAL . 27.7 mt -148.84 152.43 37.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.819 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.562 ' O ' HG22 ' B' ' 119' ' ' VAL . 26.1 Cg_endo -62.1 137.73 68.39 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.509 2.139 . . . . 0.0 112.18 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.403 ' HB3' HG13 ' B' ' 119' ' ' VAL . 1.1 tptt 75.13 14.12 3.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.249 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.28 13.64 8.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.142 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.589 HG11 ' HB ' ' B' ' 34' ' ' ILE . 23.0 m -58.08 156.84 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.55 9.8 64.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.019 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.667 HD21 ' HG3' ' B' ' 50' ' ' GLN . 4.1 pp -176.87 148.18 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.02 0.438 . . . . 0.0 111.39 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.754 ' HB2' HD22 ' B' ' 115' ' ' LEU . 2.1 tt0 -126.34 150.28 48.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.082 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.69 HG21 HG21 ' B' ' 58' ' ' VAL . 29.6 mt -128.96 121.34 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 112.31 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' B' ' 76' ' ' THR . 4.3 tp10 -130.77 144.82 51.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' B' ' 74' ' ' LYS . . . -168.8 167.48 11.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.439 HG22 ' O ' ' B' ' 28' ' ' VAL . 1.4 mt -123.89 145.2 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.661 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 1.051 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -123.86 147.94 47.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.111 0.481 . . . . 0.0 111.867 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.762 HG21 HG21 ' C' ' 3' ' ' THR . 28.9 m -114.75 142.8 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.887 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.484 ' HB2' HD11 ' B' ' 67' ' ' LEU . 3.2 ttm-85 -122.98 47.49 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.951 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.861 0.363 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mtt -95.92 -170.69 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.762 HG21 HG21 ' B' ' 128' ' ' VAL . 0.2 OUTLIER 62.98 106.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.901 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.85 107.65 13.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.973 HD11 HG11 ' C' ' 19' ' ' VAL . 1.7 tp -54.37 125.93 10.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.237 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.701 HD11 ' HB2' ' C' ' 23' ' ' ASP . 22.2 mm -83.6 137.51 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -156.44 92.41 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -115.22 163.68 15.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -98.13 29.12 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.453 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 0.0 OUTLIER -113.96 -41.73 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.84 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.714 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -72.4 178.18 1.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.899 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.714 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 32.3 Cg_exo -57.56 -13.78 14.85 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.801 2.334 . . . . 0.0 113.003 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 77.35 163.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.114 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' C' ' 19' ' ' VAL . . . -117.09 125.04 50.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.469 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.592 HG22 ' O ' ' C' ' 15' ' ' ILE . 3.3 mp -144.93 18.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.007 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.09 -137.28 3.45 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.439 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . 0.447 ' HB2' ' CD1' ' B' ' 92' ' ' TYR . 88.0 Cg_endo -88.74 32.36 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.782 2.322 . . . . 0.0 113.254 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' B' ' 105' ' ' PRO . 0.7 OUTLIER -152.48 -178.03 6.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.868 0.366 . . . . 0.0 111.354 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 1.014 HG23 ' HB2' ' B' ' 106' ' ' ALA . 10.4 m -136.71 179.72 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.193 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.685 ' NE2' ' HB3' ' C' ' 11' ' ' ALA . 15.6 mm-40 -68.87 -49.62 56.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.969 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.521 ' HB3' HG13 ' C' ' 6' ' ' ILE . . . -174.42 -177.47 1.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.471 HG23 HD13 ' C' ' 29' ' ' LEU . 4.7 m -137.92 141.56 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.157 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.701 ' HB2' HD11 ' C' ' 6' ' ' ILE . 53.7 t0 -117.95 91.04 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.594 HD11 ' CG1' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -65.96 -21.0 66.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.06 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.1 -108.82 0.78 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.893 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -57.9 -30.2 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.015 0.436 . . . . 0.0 110.189 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.409 HD23 ' C ' ' C' ' 27' ' ' LEU . 7.6 tt -124.67 124.57 42.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.745 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 1.005 HG23 ' HB3' ' C' ' 127' ' ' ALA . 3.3 m -105.53 171.64 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.591 HD22 ' HD2' ' B' ' 74' ' ' LYS . 1.3 mp -144.72 164.79 29.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 15.3 p -138.44 143.76 39.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . 0.825 ' HB3' ' HB1' ' B' ' 106' ' ' ALA . 3.4 p -72.18 179.54 3.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.27 95.47 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.359 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.573 ' OE1' HD11 ' C' ' 61' ' ' ILE . 14.3 mm-40 -66.96 165.19 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.635 ' HB ' HG11 ' C' ' 119' ' ' VAL . 8.7 pt -159.56 157.57 26.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.292 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.504 ' HB2' ' HA ' ' C' ' 43' ' ' VAL . 36.2 Cg_exo -58.4 -15.03 22.68 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.066 2.511 . . . . 0.0 112.997 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.607 ' CG2' HD12 ' C' ' 34' ' ' ILE . 43.9 t -49.97 89.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.39 . . . . 0.0 111.186 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' C' ' 41' ' ' GLY . 0.8 OUTLIER -43.92 117.41 2.66 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.579 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' C' ' 11' ' ' ALA . 31.3 Cg_exo -58.32 -14.14 19.04 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.297 1.998 . . . . 0.0 112.239 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.79 -26.94 25.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.288 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 12.2 t -158.75 -32.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.712 -0.395 . . . . 0.0 112.02 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 92.79 66.72 1.09 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.397 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -77.58 -65.15 1.0 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.992 0.425 . . . . 0.0 111.107 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.504 ' HA ' ' HB2' ' C' ' 35' ' ' PRO . 14.7 t 69.55 62.4 0.55 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.964 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' C' ' 43' ' ' VAL . 51.7 Cg_exo -54.39 153.12 23.62 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.608 2.206 . . . . 0.0 112.404 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.64 60.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -55.01 95.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.888 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.642 HD13 ' OD2' ' C' ' 84' ' ' ASP . 8.2 tp -40.35 -32.94 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.891 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.63 -48.17 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -61.44 -48.51 80.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.849 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.666 ' HG3' HD21 ' C' ' 121' ' ' LEU . 18.7 pt20 -65.99 -33.9 76.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -71.84 -35.93 70.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.996 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -66.64 -45.63 78.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.696 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -39.33 85.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.682 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.799 ' O ' HG23 ' C' ' 58' ' ' VAL . 4.8 t -69.74 -32.2 70.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.641 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.681 HD13 ' CE2' ' C' ' 95' ' ' PHE . 17.3 mt -70.99 -44.94 64.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.741 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.58 -42.26 96.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -58.94 -38.15 78.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.799 HG23 ' O ' ' C' ' 54' ' ' SER . 12.3 t -61.58 -37.97 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.774 ' HG3' ' HB2' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -80.69 -31.02 36.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.784 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -58.67 -41.07 85.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.601 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 15.7 mt -71.4 -42.17 73.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.507 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.587 ' CD1' HD11 ' C' ' 72' ' ' ILE . 16.8 mt -68.38 -33.22 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.593 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -71.37 -42.83 67.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.291 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.25 -21.3 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.409 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.45 -28.81 19.45 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.714 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.04 52.72 0.37 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.579 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' C' ' 129' ' ' ARG . 6.2 mt -161.26 -172.65 3.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 110.73 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 22.6 p -141.77 165.05 28.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 1.057 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -59.71 -32.29 70.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.903 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.951 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -56.72 -26.47 57.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.481 ' CG ' HD22 ' C' ' 67' ' ' LEU . 0.9 OUTLIER -82.59 -22.67 34.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.587 HD11 ' CD1' ' C' ' 62' ' ' ILE . 90.0 mt -53.62 110.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.191 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.488 HG23 ' N ' ' C' ' 74' ' ' LYS . 34.4 m -78.66 -46.05 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.9 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.594 ' HD2' HD22 ' A' ' 29' ' ' LEU . 7.5 mttt -119.61 154.38 34.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.295 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.647 HG23 ' HB2' ' C' ' 105' ' ' PRO . 76.7 p -153.75 102.33 2.53 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.614 HG22 ' CE1' ' C' ' 78' ' ' PHE . 0.2 OUTLIER -69.35 124.32 23.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 11.0 t -111.03 111.78 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.614 ' CE1' HG22 ' C' ' 76' ' ' THR . 13.6 m-30 -109.83 133.45 53.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.989 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.669 HG11 ' HD1' ' C' ' 85' ' ' PHE . 3.1 m -130.38 150.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.132 0.492 . . . . 0.0 111.831 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.64 -1.28 57.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.946 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -173.32 118.86 0.31 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.431 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.472 HD23 HG21 ' C' ' 79' ' ' VAL . 52.1 mt -62.17 -14.6 39.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.3 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -74.09 -21.84 59.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.868 0.366 . . . . 0.0 110.286 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.642 ' OD2' HD13 ' C' ' 47' ' ' ILE . 3.7 m-20 -87.06 -18.69 29.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.973 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.669 ' HD1' HG11 ' C' ' 79' ' ' VAL . 1.3 t80 -53.49 -30.94 43.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.141 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.95 72.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.257 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.67 -42.83 13.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.358 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.442 HG22 HG13 ' C' ' 47' ' ' ILE . 27.1 t -69.11 -45.76 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.209 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -63.05 -38.51 91.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.044 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.32 -35.3 73.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.487 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.83 -14.99 33.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.511 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.527 ' HH ' ' HZ ' ' C' ' 96' ' ' PHE . 12.3 t80 -81.14 -38.36 27.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.0 111.286 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . 0.45 ' HG3' ' CE1' ' C' ' 104' ' ' PHE . 2.4 tt0 -83.2 -27.94 29.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.508 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -75.88 -24.36 55.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.752 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.681 ' CE2' HD13 ' C' ' 55' ' ' LEU . 0.1 OUTLIER -85.37 -37.36 19.97 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.713 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.527 ' HZ ' ' HH ' ' C' ' 92' ' ' TYR . 3.9 m-85 -55.83 -55.17 35.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.132 0.492 . . . . 0.0 109.984 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -32.65 72.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.214 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -6.72 56.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.424 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.717 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 1.5 t-20 -111.86 -4.65 14.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.548 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' C' ' 99' ' ' ASN . 15.5 m120 84.4 32.17 0.05 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.81 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 1.057 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 3.5 m170 -115.79 53.18 0.93 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.587 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.403 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 58.5 Cg_endo -70.57 -22.22 28.64 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.519 2.146 . . . . 0.0 112.483 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.763 ' ND2' HD13 ' A' ' 5' ' ' ILE . 2.8 t30 -50.18 -33.11 18.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 110.879 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.611 ' HB2' HG13 ' A' ' 19' ' ' VAL . 13.1 m-85 64.59 131.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.184 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.647 ' HB2' HG23 ' C' ' 75' ' ' THR . 94.1 Cg_endo -88.5 133.62 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.962 2.442 . . . . 0.0 112.638 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.963 ' HB2' HG23 ' A' ' 19' ' ' VAL . . . -97.94 129.01 44.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.031 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.534 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -162.61 -164.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 179.298 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -115.68 114.11 24.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . 0.416 ' O ' HG13 ' C' ' 110' ' ' VAL . 14.6 m -92.85 138.4 31.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.297 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.783 HG12 HD23 ' A' ' 115' ' ' LEU . 23.1 m -156.69 158.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.97 0.414 . . . . 0.0 111.682 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.875 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 3.6 tt0 -99.0 86.32 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.644 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.487 HG21 HD21 ' C' ' 115' ' ' LEU . 29.1 m -57.12 156.88 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.219 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.86 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -65.71 -36.21 82.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.51 -178.2 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.767 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.789 HD23 HG12 ' B' ' 110' ' ' VAL . 27.8 mt -148.85 152.42 37.07 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.825 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.55 ' O ' HG22 ' C' ' 119' ' ' VAL . 25.8 Cg_endo -62.13 137.71 68.12 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.523 2.149 . . . . 0.0 112.151 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.422 ' HB3' HG13 ' C' ' 119' ' ' VAL . 1.1 tptt 75.16 14.12 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.219 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t0 65.25 13.63 8.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.152 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.635 HG11 ' HB ' ' C' ' 34' ' ' ILE . 23.3 m -58.06 156.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.771 0.32 . . . . 0.0 110.965 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.48 10.16 64.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.044 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.666 HD21 ' HG3' ' C' ' 50' ' ' GLN . 4.1 pp -177.33 148.18 0.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.063 0.459 . . . . 0.0 111.388 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.766 ' HB2' HD22 ' C' ' 115' ' ' LEU . 2.1 tt0 -126.3 150.34 48.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.096 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.683 HG21 HG21 ' C' ' 58' ' ' VAL . 29.3 mt -128.98 121.31 54.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.502 . . . . 0.0 112.322 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' C' ' 76' ' ' THR . 4.3 tp10 -130.79 144.75 51.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' C' ' 75' ' ' THR . . . -168.75 167.5 11.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.431 HG22 ' O ' ' C' ' 28' ' ' VAL . 1.4 mt -123.96 145.27 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.624 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 1.005 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -123.89 147.95 47.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.125 0.488 . . . . 0.0 111.848 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.76 HG21 HG21 ' A' ' 3' ' ' THR . 28.8 m -114.76 142.87 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.853 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' C' ' 67' ' ' LEU . 3.2 ttm-85 -123.07 47.54 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.926 0.393 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.814 0.34 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.3 ttt 59.5 -172.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.806 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 24' ' ' LEU . 90.1 m 62.39 149.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.977 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.537 ' O ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 60.57 -173.31 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.873 179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 4' ' ' GLN . 1.1 tp 57.67 120.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.907 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.516 HG21 HG22 ' A' ' 61' ' ' ILE . 13.7 mt -148.67 134.93 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.252 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.8 138.81 48.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 0.0 111.238 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.661 HG21 ' CG1' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -139.07 148.03 42.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.838 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.01 37.16 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -137.88 -45.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.992 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.7 110.95 7.43 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.33 -14.68 45.4 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.517 2.145 . . . . 0.0 112.36 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.77 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.198 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.555 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 61.22 -165.19 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.358 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 15' ' ' ILE . 21.8 mt 77.38 17.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.252 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.02 -135.2 3.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.009 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.84 43.13 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.658 2.239 . . . . 0.0 112.568 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.555 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -177.33 -176.3 0.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.859 0.362 . . . . 0.0 110.983 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.781 HG13 ' HB2' ' C' ' 104' ' ' PHE . 16.6 m -115.26 165.25 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -56.38 -48.25 77.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 110.63 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.548 ' CB ' HG21 ' A' ' 61' ' ' ILE . . . -161.41 -175.96 5.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.523 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.476 HG11 ' O ' ' C' ' 73' ' ' VAL . 30.6 m -132.09 131.47 61.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.975 0.417 . . . . 0.0 111.42 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB2' HG12 ' A' ' 6' ' ' ILE . 61.7 t0 -105.85 86.83 2.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.056 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.613 ' HA ' HG23 ' A' ' 3' ' ' THR . 31.7 mt -60.79 -19.58 59.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.154 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.52 -108.49 0.88 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.669 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.553 ' C ' HD12 ' A' ' 27' ' ' LEU . 34.8 m-80 -57.63 -30.22 65.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.182 0.515 . . . . 0.0 109.948 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 27' ' ' LEU . 3.2 mp -124.16 136.62 54.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.506 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.977 HG23 ' HB3' ' A' ' 127' ' ' ALA . 0.7 OUTLIER -104.7 177.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.253 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.464 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -157.15 133.6 9.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.4 p -110.08 138.78 45.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 0.0 111.118 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.79 175.66 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.84 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.85 84.09 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.298 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.11 152.81 12.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 0.0 111.167 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.639 HD12 ' CG2' ' A' ' 36' ' ' VAL . 10.3 pt -132.07 142.1 43.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.023 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HG2' HG23 ' A' ' 43' ' ' VAL . 90.7 Cg_endo -79.9 53.97 4.99 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.95 2.433 . . . . 0.0 112.975 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.639 ' CG2' HD12 ' A' ' 34' ' ' ILE . 45.5 t -63.01 85.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.167 0.508 . . . . 0.0 110.575 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -35.76 131.72 0.56 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.953 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.62 -13.46 32.53 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.256 1.97 . . . . 0.0 112.077 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.64 -19.96 10.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.576 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.96 -29.99 7.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.924 0.392 . . . . 0.0 110.664 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.72 51.83 23.18 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.518 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -171.06 -80.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.772 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.682 HG23 ' HG3' ' A' ' 50' ' ' GLN . 7.3 p -166.04 112.72 0.75 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.173 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -50.97 139.61 41.15 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.345 2.03 . . . . 0.0 112.174 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.39 72.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.046 0.451 . . . . 0.0 111.009 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.38 91.66 1.02 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.853 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.0 mm -41.42 -35.05 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.155 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.78 -45.49 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.434 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.81 95.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.408 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.682 ' HG3' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -68.39 -32.11 71.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.189 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.56 -38.45 74.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.004 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -70.83 -48.96 51.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.51 -28.18 68.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.779 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -66.84 -45.61 77.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.795 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.25 -22.28 64.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 59' ' ' LYS . 2.7 mm-40 -72.9 -54.59 8.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.417 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 58' ' ' VAL . 29.1 p30 -55.72 -30.92 61.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.285 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 54' ' ' SER . 40.3 t -69.32 -50.36 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.929 0.395 . . . . 0.0 110.721 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 56' ' ' GLU . 2.8 ptmm? -67.39 -33.78 75.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.694 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.56 -40.92 84.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.963 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.661 ' CG1' HG21 ' A' ' 8' ' ' THR . 5.3 mt -64.99 -56.56 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.653 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.637 HD12 ' CB ' ' A' ' 127' ' ' ALA . 5.2 tt -64.43 -26.32 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.812 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.44 -41.04 33.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 110.376 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -15.49 63.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.723 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.22 -26.99 17.93 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.954 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.09 44.32 0.49 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.381 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.867 HD11 ' HB2' ' A' ' 129' ' ' ARG . 4.5 mt -157.2 139.58 14.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.878 0.371 . . . . 0.0 110.851 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 p -92.73 159.32 15.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.082 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -57.31 -34.79 69.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.892 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -49.71 -27.39 4.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.35 -28.05 47.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.081 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.483 HD12 ' HB1' ' A' ' 69' ' ' ALA . 78.8 mt -44.48 118.47 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.925 0.393 . . . . 0.0 110.984 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.696 HG11 HG13 ' A' ' 128' ' ' VAL . 10.3 m -83.62 -46.3 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.134 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.563 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 6.8 tttm -141.67 147.73 37.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.604 0.24 . . . . 0.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.761 HG21 ' OH ' ' A' ' 92' ' ' TYR . 2.3 t -141.59 117.51 10.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.396 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 108' ' ' SER . 0.2 OUTLIER -85.98 162.57 18.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.523 HG12 HG13 ' A' ' 79' ' ' VAL . 20.4 t -150.8 103.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.932 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.498 ' CD2' HG11 ' C' ' 110' ' ' VAL . 9.5 m-85 -94.06 96.24 9.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.214 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.854 HG12 HD23 ' A' ' 121' ' ' LEU . 26.9 m -97.23 148.48 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.662 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.43 ' HG3' HD12 ' A' ' 115' ' ' LEU . 7.7 mttt -79.96 -5.06 54.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.017 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.97 143.05 9.17 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.468 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 82' ' ' LEU . 8.8 mt -85.82 2.13 46.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.24 -19.98 26.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.584 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.91 -29.99 16.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.903 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.427 ' CD2' ' HB2' ' A' ' 89' ' ' ASN . 35.2 t80 -57.18 -26.31 60.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.05 -35.8 69.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.246 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.95 -33.15 18.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.25 -42.31 66.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 32.2 t30 -67.73 -39.45 84.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.59 -30.46 69.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.28 -32.55 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.761 ' OH ' HG21 ' A' ' 75' ' ' THR . 4.1 t80 -58.55 -47.71 83.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.55 -20.87 58.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.282 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 0.1 OUTLIER -77.3 -32.01 55.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.447 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -89.48 -33.34 16.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.116 0.484 . . . . 0.0 110.737 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.514 ' CG ' ' HB2' ' A' ' 101' ' ' HIS . 0.1 OUTLIER -58.05 -53.68 55.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.893 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -32.09 70.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 95' ' ' PHE . 3.8 pt-20 -72.76 -12.61 61.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.67 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.561 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . 6.4 m-80 -102.88 -13.94 16.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.103 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 58.9 m-20 97.48 41.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.986 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 1.082 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.9 m170 -120.14 52.02 2.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.705 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 101' ' ' HIS . 74.0 Cg_endo -74.11 -3.74 14.28 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.523 2.149 . . . . 0.0 113.077 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 0.6 OUTLIER -60.14 -30.75 69.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.764 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.4 m-85 65.23 113.08 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.59 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.498 ' HD3' ' CE2' ' A' ' 96' ' ' PHE . 78.2 Cg_endo -96.54 151.37 1.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.375 2.717 . . . . 0.0 112.671 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.563 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -60.01 163.36 4.79 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 137.72 10.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.176 0.513 . . . . 0.0 112.03 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.486 ' O ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -127.16 84.42 2.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.007 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 52.7 t -90.57 145.23 25.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.208 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.596 HG12 HD23 ' B' ' 115' ' ' LEU . 32.8 m -152.97 132.99 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.088 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.807 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 4.5 tt0 -67.22 82.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.876 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.745 HG21 HD21 ' A' ' 115' ' ' LEU . 12.6 m -67.03 161.71 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -79.91 -44.21 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HB3' HD12 ' C' ' 82' ' ' LEU . 0.4 OUTLIER -148.61 164.62 33.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.817 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.745 HD21 HG21 ' A' ' 112' ' ' VAL . 4.8 mt -139.79 159.95 62.87 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.762 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 119' ' ' VAL . 75.9 Cg_exo -50.52 134.64 39.75 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.478 2.119 . . . . 0.0 112.259 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.43 14.31 9.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.41 17.89 8.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.84 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.582 HG11 ' HB ' ' A' ' 34' ' ' ILE . 16.1 m -53.83 164.77 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.167 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.596 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -87.91 -24.38 35.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.646 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.854 HD23 HG12 ' A' ' 79' ' ' VAL . 4.4 mp -153.25 147.35 25.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.163 0.506 . . . . 0.0 111.27 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.4 ' OE1' ' CD2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -132.39 138.62 47.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.779 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.8 138.02 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.384 0.611 . . . . 0.0 112.324 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.61 107.92 4.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.185 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 75' ' ' THR . . . -121.86 161.63 22.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 28' ' ' VAL . 2.3 mp -111.71 155.51 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.027 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.977 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.42 149.99 40.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.01 0.433 . . . . 0.0 111.475 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.696 HG13 HG11 ' A' ' 73' ' ' VAL . 16.0 m -113.04 179.64 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.061 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.867 ' HB2' HD11 ' A' ' 67' ' ' LEU . 20.4 ttp180 -162.2 45.59 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.925 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.819 0.342 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 1.3 ttt 59.46 -172.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.639 HG23 ' HA ' ' B' ' 24' ' ' LEU . 90.1 m 62.43 149.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.03 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.536 ' O ' HG22 ' B' ' 5' ' ' ILE . 0.0 OUTLIER 60.39 -173.34 0.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.88 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.536 HG22 ' O ' ' B' ' 4' ' ' GLN . 1.1 tp 57.77 120.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.921 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.498 HG21 HG22 ' B' ' 61' ' ' ILE . 13.6 mt -148.67 134.93 12.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.245 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -131.81 138.93 48.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 111.171 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.648 HG21 ' CG1' ' B' ' 61' ' ' ILE . 0.9 OUTLIER -139.12 148.01 42.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.778 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.09 37.17 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -137.79 -45.37 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.99 110.96 7.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.42 -14.56 44.91 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.453 2.102 . . . . 0.0 112.392 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.81 -167.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.182 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.55 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 61.26 -165.17 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.381 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.619 HG22 ' O ' ' B' ' 15' ' ' ILE . 21.6 mt 77.33 17.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.253 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.11 -135.24 3.46 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.967 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.83 43.22 1.26 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.619 2.212 . . . . 0.0 112.535 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.55 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -177.47 -176.3 0.61 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.923 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.764 HG13 ' HB2' ' A' ' 104' ' ' PHE . 16.6 m -115.25 165.27 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.443 ' HG2' ' CB ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -56.45 -48.42 77.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.032 0.444 . . . . 0.0 110.607 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' B' ' 61' ' ' ILE . . . -161.16 -175.95 5.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.477 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.478 HG11 ' O ' ' A' ' 73' ' ' VAL . 30.5 m -132.15 131.45 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.011 0.434 . . . . 0.0 111.369 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.436 ' HB2' HG12 ' B' ' 6' ' ' ILE . 61.6 t0 -105.82 86.76 2.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.06 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.639 ' HA ' HG23 ' B' ' 3' ' ' THR . 31.4 mt -60.78 -19.54 59.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.198 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.53 -108.52 0.88 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.669 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . 0.546 ' C ' HD12 ' B' ' 27' ' ' LEU . 34.7 m-80 -57.66 -30.16 65.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.14 0.495 . . . . 0.0 109.906 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.641 ' N ' HD12 ' B' ' 27' ' ' LEU . 3.2 mp -124.21 136.68 54.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.496 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.966 HG23 ' HB3' ' B' ' 127' ' ' ALA . 0.7 OUTLIER -104.72 177.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.173 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.459 ' O ' ' HB1' ' B' ' 21' ' ' ALA . 0.0 OUTLIER -157.22 133.63 9.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.776 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 81.7 p -110.09 139.28 45.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.884 0.373 . . . . 0.0 111.194 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -78.86 175.68 10.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.915 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.89 84.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.09 152.81 12.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.899 0.38 . . . . 0.0 111.198 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.645 HD12 ' CG2' ' B' ' 36' ' ' VAL . 10.3 pt -132.06 142.14 44.02 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.998 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.472 ' HG2' HG23 ' B' ' 43' ' ' VAL . 91.6 Cg_endo -79.92 53.91 4.96 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.931 2.421 . . . . 0.0 112.986 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.645 ' CG2' HD12 ' B' ' 34' ' ' ILE . 45.4 t -62.93 85.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.51 . . . . 0.0 110.586 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 41' ' ' GLY . 28.0 t-20 -35.75 131.69 0.56 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.011 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.66 -13.41 32.38 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.259 1.972 . . . . 0.0 112.031 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.6 -20.02 10.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.562 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.89 -30.01 7.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.045 0.45 . . . . 0.0 110.654 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 37' ' ' ASN . . . 69.65 51.82 23.6 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.56 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -171.09 -80.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.796 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.666 HG23 ' HG3' ' B' ' 50' ' ' GLN . 7.4 p -166.06 112.75 0.75 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.127 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.403 ' HD2' ' HG3' ' B' ' 50' ' ' GLN . 65.6 Cg_exo -50.95 139.64 40.9 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.366 2.044 . . . . 0.0 112.144 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.46 72.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.067 0.46 . . . . 0.0 111.031 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.36 91.67 1.01 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.828 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 24.0 mm -41.44 -35.01 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.158 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.86 -45.44 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.397 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.8 95.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.432 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.666 ' HG3' HG23 ' B' ' 43' ' ' VAL . 0.0 OUTLIER -68.31 -31.68 71.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.163 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.53 -38.5 74.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.027 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -70.79 -48.91 51.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -60.58 -28.18 68.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.774 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 58' ' ' VAL . 0.2 OUTLIER -66.81 -45.54 78.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.3 -22.28 64.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.401 ' HA ' ' HG2' ' B' ' 59' ' ' LYS . 2.7 mm-40 -72.88 -54.61 8.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.401 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -55.71 -30.86 61.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.38 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 54' ' ' SER . 40.4 t -69.38 -50.36 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 110.691 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.414 ' HA ' HG22 ' B' ' 62' ' ' ILE . 2.8 ptmm? -67.31 -33.8 76.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.71 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.5 -40.72 83.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.998 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.648 ' CG1' HG21 ' B' ' 8' ' ' THR . 5.3 mt -65.07 -56.53 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.667 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.652 HD12 ' CB ' ' B' ' 127' ' ' ALA . 5.2 tt -64.45 -26.26 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.44 -41.0 34.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.968 0.413 . . . . 0.0 110.423 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -15.5 63.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.74 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.17 -27.0 17.97 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.961 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.08 44.32 0.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.399 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' B' ' 129' ' ' ARG . 4.5 mt -157.23 139.6 14.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.807 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 27.2 p -92.73 159.36 15.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 1.066 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -57.32 -34.79 69.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.897 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -49.71 -27.23 4.53 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.999 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.65 -27.94 45.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.462 HD12 ' HB1' ' B' ' 69' ' ' ALA . 78.8 mt -44.5 118.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 120.897 0.38 . . . . 0.0 111.003 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.719 HG11 HG13 ' B' ' 128' ' ' VAL . 10.4 m -83.65 -46.24 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.13 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.58 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 6.8 tttm -141.72 147.7 37.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.645 0.26 . . . . 0.0 110.892 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.768 HG21 ' OH ' ' B' ' 92' ' ' TYR . 2.3 t -141.57 117.42 10.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.43 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.493 HG22 ' O ' ' B' ' 108' ' ' SER . 0.2 OUTLIER -85.85 162.6 18.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.332 179.366 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.521 HG12 HG13 ' B' ' 79' ' ' VAL . 20.5 t -150.82 103.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.879 0.371 . . . . 0.0 111.931 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.492 ' CD2' HG11 ' A' ' 110' ' ' VAL . 9.5 m-85 -94.03 96.28 9.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.227 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.845 HG12 HD23 ' B' ' 121' ' ' LEU . 26.9 m -97.24 148.44 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.705 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.408 ' HG3' HD12 ' B' ' 115' ' ' LEU . 7.8 mttt -80.0 -5.01 54.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.014 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.84 143.09 9.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.458 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' B' ' 82' ' ' LEU . 8.8 mt -85.85 2.09 47.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.095 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.26 -19.98 26.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.613 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.95 -29.98 16.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' B' ' 89' ' ' ASN . 35.2 t80 -57.2 -26.27 60.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.169 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.85 69.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.324 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.93 -33.18 18.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.27 -42.39 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.426 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 32.0 t30 -67.66 -39.49 84.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.65 -30.52 69.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.26 -32.49 22.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.768 ' OH ' HG21 ' B' ' 75' ' ' THR . 4.1 t80 -58.48 -47.71 83.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.56 -20.9 58.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.295 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' B' ' 98' ' ' GLU . 0.1 OUTLIER -77.3 -31.95 55.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.493 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.2 OUTLIER -89.51 -33.35 16.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.455 . . . . 0.0 110.741 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.521 ' CG ' ' HB2' ' B' ' 101' ' ' HIS . 0.1 OUTLIER -57.97 -53.7 55.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -32.04 70.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.961 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' B' ' 94' ' ' ARG . 3.8 pt-20 -72.72 -12.62 61.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 0.0 110.625 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.564 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . 6.4 m-80 -102.96 -13.93 16.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.099 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 59.2 m-20 97.5 41.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.964 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 1.066 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 4.0 m170 -120.01 52.07 2.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.757 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' B' ' 101' ' ' HIS . 74.2 Cg_endo -74.14 -3.76 14.32 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.566 2.178 . . . . 0.0 113.087 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -30.7 69.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.806 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.3 m-85 65.16 113.14 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.594 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.498 ' HD3' ' CE2' ' B' ' 96' ' ' PHE . 80.2 Cg_endo -96.67 151.37 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.357 2.705 . . . . 0.0 112.675 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.58 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -59.96 163.34 4.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.6 137.76 10.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.203 0.525 . . . . 0.0 112.017 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.493 ' O ' HG22 ' B' ' 76' ' ' THR . 0.1 OUTLIER -127.15 84.34 2.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.055 179.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 52.7 t -90.43 145.27 25.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.265 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.593 HG12 HD23 ' C' ' 115' ' ' LEU . 32.7 m -153.11 133.29 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.812 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 4.5 tt0 -67.49 82.05 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.755 HG21 HD21 ' B' ' 115' ' ' LEU . 12.6 m -67.02 161.7 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -79.93 -44.19 20.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.081 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.56 164.66 33.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.805 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.755 HD21 HG21 ' B' ' 112' ' ' VAL . 4.8 mt -139.81 159.96 62.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.783 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.564 ' O ' HG22 ' B' ' 119' ' ' VAL . 74.8 Cg_exo -50.5 134.61 39.59 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.521 2.147 . . . . 0.0 112.254 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.41 14.33 9.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.208 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.38 17.91 8.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.819 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.578 HG11 ' HB ' ' B' ' 34' ' ' ILE . 16.0 m -53.81 164.79 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.14 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . 0.603 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -87.89 -24.27 35.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.652 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.845 HD23 HG12 ' B' ' 79' ' ' VAL . 4.4 mp -153.45 147.41 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.111 0.482 . . . . 0.0 111.238 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.34 138.64 47.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.795 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.8 137.98 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.324 0.583 . . . . 0.0 112.348 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.59 107.91 4.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.214 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.485 ' HB2' ' CB ' ' B' ' 75' ' ' THR . . . -121.91 161.71 22.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.297 0.57 . . . . 0.0 112.507 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.437 HG23 ' O ' ' B' ' 28' ' ' VAL . 2.3 mp -111.79 155.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.977 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.966 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.34 150.06 40.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.403 . . . . 0.0 111.527 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.719 HG13 HG11 ' B' ' 73' ' ' VAL . 16.0 m -113.1 179.67 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.977 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.851 ' HB2' HD11 ' B' ' 67' ' ' LEU . 20.4 ttp180 -162.21 45.62 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.948 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.838 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.78 0.324 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 1.3 ttt 59.52 -172.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.644 HG23 ' HA ' ' C' ' 24' ' ' LEU . 90.1 m 62.42 149.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.546 ' O ' HG22 ' C' ' 5' ' ' ILE . 0.0 OUTLIER 60.56 -173.35 0.12 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.824 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.546 HG22 ' O ' ' C' ' 4' ' ' GLN . 1.1 tp 57.67 120.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.916 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.518 HG21 HG22 ' C' ' 61' ' ' ILE . 13.5 mt -148.66 134.95 12.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.247 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -131.85 138.86 48.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 111.205 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.651 HG21 ' CG1' ' C' ' 61' ' ' ILE . 0.9 OUTLIER -139.12 148.01 42.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.835 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.06 37.11 1.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -137.91 -45.97 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.4 111.0 7.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.092 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.41 -14.62 45.23 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.496 2.131 . . . . 0.0 112.396 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.78 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.2 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 61.2 -165.16 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.385 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.607 HG22 ' O ' ' C' ' 15' ' ' ILE . 21.9 mt 77.33 17.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.262 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.01 -135.2 3.46 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.029 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.85 43.15 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 112.561 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.557 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -177.34 -176.29 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.986 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.806 HG13 ' HB2' ' B' ' 104' ' ' PHE . 16.5 m -115.25 165.32 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.446 ' HG2' ' CB ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -56.38 -47.87 78.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.099 0.476 . . . . 0.0 110.519 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.548 ' CB ' HG21 ' C' ' 61' ' ' ILE . . . -162.02 -175.78 4.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.476 HG11 ' O ' ' B' ' 73' ' ' VAL . 30.2 m -132.08 131.42 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.409 . . . . 0.0 111.351 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' C' ' 6' ' ' ILE . 61.6 t0 -105.85 86.88 2.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.093 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.644 ' HA ' HG23 ' C' ' 3' ' ' THR . 31.5 mt -60.82 -19.61 60.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.154 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.54 -108.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.693 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . 0.548 ' C ' HD12 ' C' ' 27' ' ' LEU . 34.7 m-80 -57.62 -30.21 65.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.159 0.504 . . . . 0.0 109.917 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.628 ' N ' HD12 ' C' ' 27' ' ' LEU . 3.2 mp -124.22 136.62 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.482 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 1.002 HG23 ' HB3' ' C' ' 127' ' ' ALA . 0.7 OUTLIER -104.7 177.17 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.249 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.447 ' O ' ' HB1' ' C' ' 21' ' ' ALA . 0.0 OUTLIER -157.2 133.54 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 81.3 p -109.94 138.16 46.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.83 0.348 . . . . 0.0 110.971 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . 0.422 ' HB2' ' HB1' ' B' ' 106' ' ' ALA . 8.1 t -78.42 175.37 10.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.863 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.84 84.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.284 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -57.06 152.81 12.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 111.191 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.64 HD12 ' CG2' ' C' ' 36' ' ' VAL . 10.3 pt -132.05 142.17 44.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.455 ' HG2' HG23 ' C' ' 43' ' ' VAL . 91.8 Cg_endo -80.0 53.93 4.97 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.964 2.443 . . . . 0.0 112.975 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.64 ' CG2' HD12 ' C' ' 34' ' ' ILE . 45.7 t -63.0 85.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.134 0.492 . . . . 0.0 110.537 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' C' ' 41' ' ' GLY . 27.9 t-20 -35.74 131.67 0.56 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.015 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.64 -13.42 32.44 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.318 2.012 . . . . 0.0 112.008 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.66 -20.0 10.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.548 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.02 -30.16 7.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.988 0.423 . . . . 0.0 110.634 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' C' ' 37' ' ' ASN . . . 69.77 51.98 22.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.484 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -170.98 -80.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.724 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.685 HG23 ' HG3' ' C' ' 50' ' ' GLN . 7.4 p -165.99 112.71 0.76 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.169 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.401 ' HD2' ' HG3' ' C' ' 50' ' ' GLN . 67.1 Cg_exo -50.97 139.64 41.05 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.318 2.012 . . . . 0.0 112.161 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.44 72.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.026 0.441 . . . . 0.0 111.001 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.46 91.7 1.05 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 24.1 mm -41.33 -35.13 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.192 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.79 -45.41 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.467 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.76 95.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.438 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.685 ' HG3' HG23 ' C' ' 43' ' ' VAL . 0.0 OUTLIER -68.7 -32.44 72.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.214 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.88 -38.5 73.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.116 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -70.76 -48.9 51.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.55 -28.12 68.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.799 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.597 ' O ' HG23 ' C' ' 58' ' ' VAL . 0.2 OUTLIER -66.81 -45.6 77.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 mt -68.38 -22.2 64.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.94 -54.53 8.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.417 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' C' ' 58' ' ' VAL . 29.2 p30 -55.8 -30.9 62.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.304 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.597 HG23 ' O ' ' C' ' 54' ' ' SER . 40.3 t -69.31 -50.33 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 110.744 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' C' ' 62' ' ' ILE . 2.8 ptmm? -67.36 -33.84 76.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.753 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.52 -41.08 84.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.057 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.651 ' CG1' HG21 ' C' ' 8' ' ' THR . 5.3 mt -65.17 -56.47 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.748 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.637 HD12 ' CB ' ' C' ' 127' ' ' ALA . 5.2 tt -64.52 -26.19 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.826 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.53 -41.01 33.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.873 0.368 . . . . 0.0 110.335 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -15.48 63.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.724 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.12 -27.01 18.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.856 0.36 . . . . 0.0 111.003 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.15 44.24 0.49 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.36 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.841 HD11 ' HB2' ' C' ' 129' ' ' ARG . 4.5 mt -157.21 139.59 14.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.385 . . . . 0.0 110.828 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 27.1 p -92.75 159.38 15.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.782 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 1.088 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -57.34 -34.76 69.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.8 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -49.77 -27.4 4.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.909 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.07 -27.99 48.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.046 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.47 HD12 ' HB1' ' C' ' 69' ' ' ALA . 78.8 mt -44.47 118.42 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.901 0.381 . . . . 0.0 111.003 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.728 HG11 HG13 ' C' ' 128' ' ' VAL . 10.3 m -83.58 -46.26 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.196 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.571 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 6.8 tttm -141.7 147.7 37.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.626 0.25 . . . . 0.0 110.966 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.767 HG21 ' OH ' ' C' ' 92' ' ' TYR . 2.3 t -141.52 117.5 10.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.41 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.493 HG22 ' O ' ' C' ' 108' ' ' SER . 0.2 OUTLIER -85.98 162.56 18.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.309 179.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.51 HG12 HG13 ' C' ' 79' ' ' VAL . 20.4 t -150.81 103.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.366 . . . . 0.0 111.929 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.521 ' CD2' HG11 ' B' ' 110' ' ' VAL . 9.5 m-85 -94.04 96.32 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.187 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.831 HG12 HD23 ' C' ' 121' ' ' LEU . 27.0 m -97.27 148.46 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.652 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . 0.431 ' HG3' HD12 ' C' ' 115' ' ' LEU . 7.8 mttt -79.98 -5.21 55.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.027 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.87 143.06 9.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.454 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' C' ' 82' ' ' LEU . 8.8 mt -85.87 2.11 47.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -88.27 -19.94 26.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.571 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.93 -29.99 16.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.423 ' CD2' ' HB2' ' C' ' 89' ' ' ASN . 35.1 t80 -57.24 -26.24 60.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.129 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.84 69.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.248 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.98 -33.11 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.23 -42.35 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . 0.423 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 31.9 t30 -67.68 -39.52 84.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.43 -30.4 69.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.063 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.41 -32.48 22.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.767 ' OH ' HG21 ' C' ' 75' ' ' THR . 4.1 t80 -58.58 -47.71 83.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -75.57 -20.84 58.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.281 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' C' ' 98' ' ' GLU . 0.1 OUTLIER -77.39 -31.87 54.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.453 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.2 OUTLIER -89.53 -33.37 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 110.672 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.528 ' CG ' ' HB2' ' C' ' 101' ' ' HIS . 0.1 OUTLIER -57.94 -53.78 54.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.866 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -32.09 70.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.934 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' C' ' 95' ' ' PHE . 3.8 pt-20 -72.73 -12.6 61.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.652 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.563 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . 6.5 m-80 -102.9 -13.97 16.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.089 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 59.1 m-20 97.49 41.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.974 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 1.088 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 3.9 m170 -119.95 51.99 2.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.76 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' C' ' 101' ' ' HIS . 74.0 Cg_endo -74.12 -3.77 14.33 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.549 2.166 . . . . 0.0 113.086 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' C' ' 104' ' ' PHE . 0.6 OUTLIER -60.16 -30.69 69.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.846 0.355 . . . . 0.0 111.144 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.781 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.4 m-85 65.18 113.1 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.638 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.483 ' HD3' ' CE2' ' C' ' 96' ' ' PHE . 79.1 Cg_endo -96.61 151.3 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.388 2.725 . . . . 0.0 112.691 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.571 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -59.92 163.39 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.68 137.73 10.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.21 0.528 . . . . 0.0 112.067 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . 0.493 ' O ' HG22 ' C' ' 76' ' ' THR . 0.1 OUTLIER -127.19 84.45 2.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.975 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 52.6 t -90.6 145.21 25.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.608 HG12 HD23 ' A' ' 115' ' ' LEU . 32.8 m -152.97 132.82 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.051 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.82 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 4.5 tt0 -67.17 82.04 0.13 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.736 HG21 HD21 ' C' ' 115' ' ' LEU . 12.5 m -67.1 161.71 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -79.93 -44.17 20.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.431 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.4 OUTLIER -148.63 164.65 33.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.736 HD21 HG21 ' C' ' 112' ' ' VAL . 4.8 mt -139.76 159.98 62.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.567 ' O ' HG22 ' C' ' 119' ' ' VAL . 75.3 Cg_exo -50.57 134.61 40.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.471 2.114 . . . . 0.0 112.283 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.44 14.37 9.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.174 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.35 17.97 8.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.793 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.586 HG11 ' HB ' ' C' ' 34' ' ' ILE . 16.0 m -53.84 164.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.115 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . 0.659 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -88.14 -24.47 34.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.592 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.831 HD23 HG12 ' C' ' 79' ' ' VAL . 4.4 mp -153.27 147.33 25.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.13 0.491 . . . . 0.0 111.338 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.39 138.62 47.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.773 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . . . . . . . . . 10.3 mt -130.78 138.02 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.371 0.605 . . . . 0.0 112.286 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.56 107.94 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.19 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' C' ' 75' ' ' THR . . . -121.95 161.74 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.34 0.591 . . . . 0.0 112.486 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.414 HG23 ' O ' ' C' ' 28' ' ' VAL . 2.3 mp -111.78 155.45 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.998 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 1.002 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.4 150.04 40.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.027 0.442 . . . . 0.0 111.47 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.728 HG13 HG11 ' C' ' 73' ' ' VAL . 16.0 m -113.03 179.71 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.042 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.841 ' HB2' HD11 ' C' ' 67' ' ' LEU . 20.4 ttp180 -162.23 45.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.921 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . 0.408 ' HE3' HD11 ' C' ' 27' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mmm . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.807 0.337 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.81 175.19 10.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.932 HG21 HG21 ' C' ' 128' ' ' VAL . 0.6 OUTLIER 62.15 117.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.59 121.0 7.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.755 HG21 HG11 ' A' ' 19' ' ' VAL . 4.7 mp -56.3 141.66 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.172 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 32.3 mt -92.58 146.42 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.271 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.431 ' CD2' ' HG3' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -151.28 117.32 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.699 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 t -129.29 161.58 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.031 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.68 24.85 6.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 -51.95 3.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.63 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.06 112.82 38.66 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.018 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -60.66 -16.16 41.55 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.446 2.097 . . . . 0.0 112.531 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HB1' ' OH ' ' A' ' 18' ' ' TYR . . . -56.76 -168.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.293 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . 63.65 -167.48 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.341 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 15' ' ' ILE . 19.4 mm 78.26 16.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.239 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.21 -134.69 3.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.141 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HG2' ' CZ ' ' C' ' 107' ' ' ARG . 96.3 Cg_endo -85.91 23.17 0.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.657 2.238 . . . . 0.0 112.868 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.611 ' CE1' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -154.18 -168.73 3.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.764 0.316 . . . . 0.0 110.822 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.755 HG11 HG21 ' A' ' 5' ' ' ILE . 15.4 m -124.86 172.23 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.264 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.431 ' HG3' ' CD2' ' A' ' 7' ' ' HIS . 0.3 OUTLIER -67.59 -55.09 14.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.866 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 61' ' ' ILE . . . -157.78 178.5 10.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.038 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.753 HG23 HD13 ' A' ' 29' ' ' LEU . 7.1 m -127.96 134.31 65.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.9 t70 -117.77 96.3 5.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.839 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.715 HD13 HD21 ' C' ' 27' ' ' LEU . 12.3 mt -76.35 -20.39 57.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.984 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.89 -106.02 0.73 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.825 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -59.58 -29.59 68.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 110.148 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.626 HD21 HD13 ' B' ' 24' ' ' LEU . 0.6 OUTLIER -123.15 120.12 32.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.866 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.95 HG23 ' HB3' ' A' ' 127' ' ' ALA . 5.1 m -111.13 167.51 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.992 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.753 HD13 HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.84 155.33 38.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.838 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -117.51 136.03 53.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.945 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 55.7 m -68.74 167.04 16.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.11 82.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.323 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -76.38 145.95 39.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.097 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.442 ' HB ' HG11 ' A' ' 119' ' ' VAL . 8.3 pt -128.49 160.31 63.2 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.604 ' O ' HG12 ' A' ' 36' ' ' VAL . 84.7 Cg_exo -43.3 -47.85 8.6 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.721 2.281 . . . . 0.0 111.778 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.847 HG22 ' HA2' ' A' ' 41' ' ' GLY . 9.8 p 46.91 21.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.751 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 36' ' ' VAL . 7.2 t-20 58.7 138.7 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.881 0.372 . . . . 0.0 111.45 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HG3' ' A' ' 44' ' ' PRO . 5.4 Cg_endo -47.71 -34.02 20.11 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.009 2.473 . . . . 0.0 113.258 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.63 17.75 0.13 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.4 HG21 ' OE2' ' A' ' 42' ' ' GLU . 2.3 m -107.22 -17.69 14.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.366 . . . . 0.0 110.428 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.847 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . 70.09 43.18 65.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.887 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -143.34 -83.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.567 0.222 . . . . 0.0 110.791 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.653 ' HB ' HG12 ' A' ' 119' ' ' VAL . 8.2 p 174.11 128.06 0.11 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.943 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 14.2 Cg_exo -69.97 143.57 50.22 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.606 2.204 . . . . 0.0 112.226 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.65 63.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.079 0.466 . . . . 0.0 110.957 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -68.3 96.05 0.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.617 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.01 -32.16 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.629 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.07 -52.45 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.592 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -63.33 -28.49 70.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.478 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HG2' ' CG ' ' A' ' 35' ' ' PRO . 0.9 OUTLIER -79.75 -28.68 40.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.458 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.49 58.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.031 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -74.42 -41.74 60.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.083 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.21 -43.81 87.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.026 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.64 ' O ' HG23 ' A' ' 58' ' ' VAL . 73.6 m -59.51 -43.62 93.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD23 HD13 ' A' ' 123' ' ' ILE . 75.4 mt -66.4 -35.41 80.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.988 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.88 -38.27 82.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.011 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.64 -36.41 84.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.746 HG21 ' CG2' ' A' ' 123' ' ' ILE . 16.0 t -69.82 -46.94 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.947 0.403 . . . . 0.0 110.943 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -72.51 -31.37 65.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.827 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.77 91.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.487 HG21 ' CB ' ' A' ' 21' ' ' ALA . 6.5 mt -65.44 -56.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 127' ' ' ALA . 4.9 tt -63.83 -26.22 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.742 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 -40.12 60.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.374 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -10.78 59.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.788 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.84 -29.62 18.48 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.875 0.369 . . . . 0.0 110.905 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.61 52.42 0.33 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.52 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.537 HD22 ' CB ' ' A' ' 71' ' ' ASP . 2.3 mt -147.88 -169.89 3.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.09 160.09 41.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.99 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.783 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -59.97 -33.56 72.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.119 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 100' ' ' ASN . . . -62.82 -17.18 60.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.461 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.0 m-20 -85.28 -24.57 27.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.814 0.34 . . . . 0.0 110.829 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 127' ' ' ALA . 47.0 mt -53.71 118.55 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.128 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.568 ' O ' HG11 ' B' ' 22' ' ' VAL . 12.4 m -89.28 -37.19 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.707 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.755 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -141.25 149.33 41.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.705 0.288 . . . . 0.0 110.774 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.689 HG23 ' HB2' ' A' ' 125' ' ' ALA . 89.3 m -144.96 110.36 5.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.95 0.405 . . . . 0.0 111.323 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.566 ' O ' HG13 ' A' ' 77' ' ' VAL . 87.8 m -95.22 157.81 15.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.246 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.665 HG12 HG12 ' A' ' 123' ' ' ILE . 3.3 m -159.1 142.46 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.084 0.468 . . . . 0.0 111.761 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' C' ' 110' ' ' VAL . 3.5 m-85 -114.0 119.09 36.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.283 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.802 HG12 HD21 ' A' ' 121' ' ' LEU . 33.2 m -107.34 152.23 9.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.114 0.483 . . . . 0.0 111.735 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.51 0.17 39.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.821 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -163.28 107.5 1.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.566 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.87 -13.89 60.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.222 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -79.66 -27.79 40.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.909 0.385 . . . . 0.0 110.493 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.32 -12.18 55.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.831 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.652 ' CD1' HG11 ' A' ' 79' ' ' VAL . 1.6 t80 -58.63 -24.52 61.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.82 -56.52 11.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.352 . . . . 0.0 111.38 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.48 -36.83 83.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 t -64.8 -42.07 93.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.16 -42.32 89.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.481 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.81 75.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.895 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 94' ' ' ARG . 20.3 mm-40 -88.69 -30.01 19.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.693 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.428 ' O ' ' CD2' ' A' ' 95' ' ' PHE . 58.7 t80 -57.72 -49.7 75.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.014 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.44 -17.49 45.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 91' ' ' GLU . 4.6 mtp180 -75.12 -27.92 60.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.658 0.265 . . . . 0.0 111.38 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -86.19 -33.35 20.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.38 . . . . 0.0 110.525 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.471 ' CZ ' ' CD ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -56.27 -55.7 30.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.334 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.62 -28.81 70.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.889 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.47 -6.22 59.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.35 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.783 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 1.5 m120 -111.47 -5.13 14.62 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.56 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.716 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 7.0 m120 85.42 33.31 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.803 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 20.1 t-160 -128.88 67.3 77.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.529 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 4.5 Cg_exo -75.48 -20.24 16.13 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.602 2.202 . . . . 0.0 112.525 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.704 ' CG ' HD13 ' B' ' 5' ' ' ILE . 0.3 OUTLIER -69.15 -36.69 77.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.063 0.459 . . . . 0.0 110.344 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' A' ' 102' ' ' PRO . 15.8 m-85 74.06 142.56 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.427 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.471 ' CD ' ' CZ ' ' A' ' 96' ' ' PHE . 73.2 Cg_endo -90.07 165.88 4.71 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.209 2.606 . . . . 0.0 111.956 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.755 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -50.1 154.11 1.24 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.424 ' HB3' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -119.02 140.98 49.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.227 0.537 . . . . 0.0 112.048 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.6 t -144.28 45.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.986 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 28.7 p -81.37 135.08 35.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.249 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' B' ' 78' ' ' PHE . 23.0 m -153.85 149.34 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.203 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.831 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -84.4 91.04 7.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.771 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.666 HG21 HD21 ' A' ' 115' ' ' LEU . 27.7 m -71.15 177.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.841 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -81.83 -45.95 14.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.005 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.405 ' CB ' ' HB3' ' C' ' 111' ' ' GLU . 0.1 OUTLIER -151.72 -179.72 7.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.788 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.666 HD21 HG21 ' A' ' 112' ' ' VAL . 60.0 mt -149.2 155.6 39.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.704 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.551 ' O ' HG22 ' A' ' 119' ' ' VAL . 9.2 Cg_endo -52.33 139.23 55.06 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.523 2.149 . . . . 0.0 111.977 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 7.9 mmtm 66.46 17.72 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.278 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 61.63 17.45 8.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.025 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.653 HG12 ' HB ' ' A' ' 43' ' ' VAL . 30.1 m -55.76 167.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.073 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.03 8.49 42.24 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.918 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.802 HD21 HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -172.58 154.6 3.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.086 0.469 . . . . 0.0 111.226 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.2 159.01 43.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.002 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.746 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.9 mt -144.25 145.75 21.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.38 0.609 . . . . 0.0 112.301 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.16 101.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.322 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.689 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -119.07 163.59 16.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.171 0.51 . . . . 0.0 112.194 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 72' ' ' ILE . 5.7 mt -114.43 151.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.133 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.95 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -136.06 148.39 48.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.034 0.445 . . . . 0.0 111.574 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.897 HG21 HG21 ' B' ' 3' ' ' THR . 35.0 m -115.92 151.44 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.122 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.401 ' HD2' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.08 70.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.819 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.884 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 71.2 mmm . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.821 0.343 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.87 175.14 10.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.897 HG21 HG21 ' A' ' 128' ' ' VAL . 0.6 OUTLIER 62.16 117.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.58 120.97 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.769 HG21 HG11 ' B' ' 19' ' ' VAL . 4.7 mp -56.26 141.66 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 31.8 mt -92.61 146.33 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.318 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.406 ' CD2' ' HG3' ' B' ' 20' ' ' GLN . 0.1 OUTLIER -151.2 117.41 5.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.718 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 14.3 t -129.32 161.6 29.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.036 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.69 24.85 6.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.807 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.5 -52.47 3.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.677 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.5 112.93 38.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.7 -16.16 41.84 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.436 2.09 . . . . 0.0 112.473 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.479 ' HB1' ' OH ' ' B' ' 18' ' ' TYR . . . -56.75 -168.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.252 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.617 ' HA ' ' CE1' ' B' ' 18' ' ' TYR . . . 63.73 -167.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.315 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.588 HG22 ' O ' ' B' ' 15' ' ' ILE . 19.4 mm 78.23 16.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.288 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.26 -134.73 3.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.163 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 107' ' ' ARG . 96.9 Cg_endo -85.84 23.18 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.685 2.256 . . . . 0.0 112.926 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.617 ' CE1' ' HA ' ' B' ' 14' ' ' ALA . 0.1 OUTLIER -154.13 -168.71 3.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.755 0.312 . . . . 0.0 110.829 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.769 HG11 HG21 ' B' ' 5' ' ' ILE . 15.5 m -124.88 172.31 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.362 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.406 ' HG3' ' CD2' ' B' ' 7' ' ' HIS . 0.3 OUTLIER -67.71 -55.16 14.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.802 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.494 ' CB ' HG21 ' B' ' 61' ' ' ILE . . . -158.13 178.44 10.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.995 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.748 HG23 HD13 ' B' ' 29' ' ' LEU . 7.2 m -127.88 134.27 65.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.463 ' HA ' HG12 ' B' ' 28' ' ' VAL . 7.8 t70 -117.67 96.23 5.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.626 HD13 HD21 ' A' ' 27' ' ' LEU . 12.4 mt -76.34 -20.42 57.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.002 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.97 -106.03 0.73 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.83 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -59.62 -29.51 68.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.038 0.447 . . . . 0.0 110.152 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.786 HD21 HD13 ' C' ' 24' ' ' LEU . 0.7 OUTLIER -123.19 120.07 32.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.872 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.998 HG23 ' HB3' ' B' ' 127' ' ' ALA . 5.1 m -111.07 167.54 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.01 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.748 HD13 HG23 ' B' ' 22' ' ' VAL . 0.0 OUTLIER -150.91 155.31 38.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -117.38 135.8 53.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 56.5 m -68.89 166.97 16.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.13 82.13 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.307 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -76.39 145.89 39.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.357 . . . . 0.0 111.15 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.436 ' HB ' HG11 ' B' ' 119' ' ' VAL . 8.2 pt -128.48 160.3 63.23 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.545 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.604 ' O ' HG12 ' B' ' 36' ' ' VAL . 84.5 Cg_exo -43.2 -47.93 8.38 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.755 2.303 . . . . 0.0 111.753 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.872 HG22 ' HA2' ' B' ' 41' ' ' GLY . 9.8 p 46.91 21.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.717 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.412 ' O ' ' O ' ' B' ' 36' ' ' VAL . 7.2 t-20 58.72 138.69 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.895 0.378 . . . . 0.0 111.455 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' HG3' ' B' ' 44' ' ' PRO . 5.4 Cg_endo -47.75 -34.01 20.38 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.042 2.495 . . . . 0.0 113.207 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.63 17.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -107.35 -17.79 14.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 110.445 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.872 ' HA2' HG22 ' B' ' 36' ' ' VAL . . . 70.14 43.36 64.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.89 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.442 ' O ' ' HB ' ' B' ' 43' ' ' VAL . 0.0 OUTLIER -143.37 -83.31 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.602 0.239 . . . . 0.0 110.833 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.684 ' HB ' HG12 ' B' ' 119' ' ' VAL . 8.2 p 174.08 128.05 0.11 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.927 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' B' ' 43' ' ' VAL . 14.2 Cg_exo -69.96 143.6 50.38 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.636 2.224 . . . . 0.0 112.214 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.65 63.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.995 0.426 . . . . 0.0 110.896 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 0.4 OUTLIER -68.22 96.05 0.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.677 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.0 -32.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.589 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.95 -52.51 15.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.64 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' B' ' 46' ' ' ASP . . . -63.35 -28.43 69.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.469 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.458 ' HG2' ' CG ' ' B' ' 35' ' ' PRO . 0.9 OUTLIER -79.76 -28.61 40.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.485 179.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.51 -35.45 58.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -74.38 -41.76 60.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.23 -43.75 87.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.615 ' O ' HG23 ' B' ' 58' ' ' VAL . 73.8 m -59.47 -43.62 93.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.034 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.503 HD23 HD13 ' B' ' 123' ' ' ILE . 75.2 mt -66.44 -35.34 80.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.89 -38.35 82.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.6 -36.35 83.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.06 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.736 HG21 ' CG2' ' B' ' 123' ' ' ILE . 16.2 t -69.85 -46.91 72.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 0.0 110.956 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' B' ' 62' ' ' ILE . 0.0 OUTLIER -72.6 -31.29 65.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.812 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.24 -40.85 91.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.932 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.494 HG21 ' CB ' ' B' ' 21' ' ' ALA . 6.4 mt -65.48 -56.86 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.749 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' B' ' 127' ' ' ALA . 5.0 tt -63.83 -26.2 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.725 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -40.07 60.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.924 0.393 . . . . 0.0 110.446 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -10.84 59.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.812 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.78 -29.72 18.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.69 52.42 0.32 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.543 HD22 ' CB ' ' B' ' 71' ' ' ASP . 2.3 mt -147.94 -169.94 3.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 110.577 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.08 160.14 40.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.982 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' B' ' 99' ' ' ASN . . . -59.98 -33.52 72.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' B' ' 100' ' ' ASN . . . -62.83 -17.17 60.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.448 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.543 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.0 m-20 -85.16 -24.64 27.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 110.805 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.69 118.53 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.095 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.621 ' O ' HG11 ' C' ' 22' ' ' VAL . 12.5 m -89.23 -37.22 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.73 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.789 ' HG3' ' HB3' ' B' ' 106' ' ' ALA . 0.0 OUTLIER -141.21 149.37 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.708 0.29 . . . . 0.0 110.78 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.685 HG23 ' HB2' ' B' ' 125' ' ' ALA . 89.2 m -144.99 110.29 5.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.568 ' O ' HG13 ' B' ' 77' ' ' VAL . 87.8 m -95.09 157.75 15.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.242 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.667 HG12 HG12 ' B' ' 123' ' ' ILE . 3.2 m -159.05 142.5 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.758 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 110' ' ' VAL . 3.5 m-85 -114.01 119.09 36.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.248 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.797 HG12 HD21 ' B' ' 121' ' ' LEU . 33.9 m -107.33 152.18 9.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.125 0.488 . . . . 0.0 111.765 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.53 -0.14 38.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.817 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.85 107.51 1.11 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.578 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.99 -13.78 60.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.215 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -79.67 -27.85 40.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 0.0 110.484 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.27 -12.17 55.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.864 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.661 ' CD1' HG11 ' B' ' 79' ' ' VAL . 1.6 t80 -58.68 -24.43 61.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.007 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.87 -56.52 11.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 111.331 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.83 83.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 34.3 t -64.83 -42.06 93.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.715 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.18 -42.2 89.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.5 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.04 -36.09 76.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.938 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' B' ' 94' ' ' ARG . 20.4 mm-40 -88.45 -29.96 19.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.724 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.419 ' O ' ' CD2' ' B' ' 95' ' ' PHE . 58.6 t80 -57.75 -49.66 75.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.028 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.47 -17.46 45.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.504 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' B' ' 91' ' ' GLU . 4.6 mtp180 -75.09 -27.94 60.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.699 0.285 . . . . 0.0 111.414 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' B' ' 95' ' ' PHE . 0.9 OUTLIER -86.15 -33.48 20.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.499 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' B' ' 101' ' ' HIS . 0.9 OUTLIER -56.19 -55.76 29.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.344 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.54 -28.9 70.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.914 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -6.24 59.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.397 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.751 ' HB3' ' HB3' ' B' ' 69' ' ' ALA . 1.5 m120 -111.41 -5.15 14.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.718 ' O ' ' HB2' ' B' ' 70' ' ' ALA . 6.9 m120 85.44 33.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.894 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.549 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 20.1 t-160 -128.81 67.42 77.46 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.534 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 4.6 Cg_exo -75.48 -20.25 16.12 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.621 2.214 . . . . 0.0 112.519 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.659 ' CG ' HD13 ' C' ' 5' ' ' ILE . 0.3 OUTLIER -69.17 -36.68 77.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.307 179.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' B' ' 102' ' ' PRO . 15.8 m-85 74.07 142.52 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.453 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.462 ' CD ' ' CZ ' ' B' ' 96' ' ' PHE . 72.2 Cg_endo -90.09 165.86 4.69 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.107 2.538 . . . . 0.0 111.98 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.789 ' HB3' ' HG3' ' B' ' 74' ' ' LYS . . . -50.02 154.18 1.19 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.462 ' HB3' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -119.1 141.0 49.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.215 0.531 . . . . 0.0 112.068 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 30.8 t -144.26 45.83 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.954 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' B' ' 77' ' ' VAL . 28.7 p -81.44 135.02 35.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.277 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' C' ' 78' ' ' PHE . 23.4 m -153.7 149.06 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.149 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.855 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -84.49 91.04 7.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.822 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.651 HG21 HD21 ' B' ' 115' ' ' LEU . 27.6 m -71.15 177.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.206 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -81.79 -45.92 14.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.44 ' CB ' ' HB3' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -151.7 -179.53 7.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.753 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.651 HD21 HG21 ' B' ' 112' ' ' VAL . 59.5 mt -149.33 155.56 39.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.669 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.548 ' O ' HG22 ' B' ' 119' ' ' VAL . 9.3 Cg_endo -52.35 139.25 55.23 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.537 2.158 . . . . 0.0 111.987 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' B' ' 116' ' ' PRO . 8.0 mmtm 66.38 17.81 10.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.253 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 61.53 17.52 8.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.065 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.684 HG12 ' HB ' ' B' ' 43' ' ' VAL . 30.3 m -55.8 167.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.062 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.11 8.12 41.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.888 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.797 HD21 HG12 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -172.47 154.5 3.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.165 0.507 . . . . 0.0 111.296 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.12 158.95 43.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.025 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.736 ' CG2' HG21 ' B' ' 58' ' ' VAL . 28.2 mt -144.21 145.75 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.309 0.576 . . . . 0.0 112.309 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.17 101.48 1.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.344 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.685 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -119.02 163.56 16.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.198 0.523 . . . . 0.0 112.245 -178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.7 mt -114.41 151.9 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.114 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.998 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -136.06 148.32 48.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.993 0.425 . . . . 0.0 111.618 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.983 HG21 HG21 ' C' ' 3' ' ' THR . 35.0 m -115.82 151.38 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.06 70.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.84 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mmm . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.792 0.33 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.83 175.15 10.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.983 HG21 HG21 ' B' ' 128' ' ' VAL . 0.6 OUTLIER 62.15 117.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.56 121.02 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.728 HG21 HG11 ' C' ' 19' ' ' VAL . 4.7 mp -56.31 141.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 32.0 mt -92.61 146.37 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.234 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . 0.423 ' CD2' ' HG3' ' C' ' 20' ' ' GLN . 0.1 OUTLIER -151.24 117.37 5.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.705 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 14.3 t -129.3 161.61 29.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.037 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.72 24.89 6.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 -52.34 3.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.751 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.62 112.86 37.78 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.05 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.65 -16.13 41.34 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.436 2.09 . . . . 0.0 112.525 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.481 ' HB1' ' OH ' ' C' ' 18' ' ' TYR . . . -56.8 -168.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.249 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.627 ' HA ' ' CE1' ' C' ' 18' ' ' TYR . . . 63.69 -167.45 0.21 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.332 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.587 HG22 ' O ' ' C' ' 15' ' ' ILE . 19.4 mm 78.26 16.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.215 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.21 -134.78 3.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.14 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.8 23.16 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.609 2.206 . . . . 0.0 112.9 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.627 ' CE1' ' HA ' ' C' ' 14' ' ' ALA . 0.1 OUTLIER -154.1 -168.61 3.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.738 0.304 . . . . 0.0 110.855 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.728 HG11 HG21 ' C' ' 5' ' ' ILE . 15.4 m -124.97 172.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.29 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . 0.423 ' HG3' ' CD2' ' C' ' 7' ' ' HIS . 0.3 OUTLIER -67.61 -55.01 15.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.936 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -157.95 178.57 10.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.026 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.761 HG23 HD13 ' C' ' 29' ' ' LEU . 7.2 m -127.92 134.21 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.47 ' HA ' HG12 ' C' ' 28' ' ' VAL . 7.9 t70 -117.73 96.32 5.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.786 HD13 HD21 ' B' ' 27' ' ' LEU . 12.4 mt -76.37 -20.36 57.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.0 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.92 -106.03 0.73 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.839 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.62 -29.55 68.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.119 0.485 . . . . 0.0 110.186 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.715 HD21 HD13 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -123.2 120.08 32.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.875 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.982 HG23 ' HB3' ' C' ' 127' ' ' ALA . 5.2 m -111.06 167.52 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.761 HD13 HG23 ' C' ' 22' ' ' VAL . 0.0 OUTLIER -150.83 155.35 39.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.2 p -117.52 135.91 53.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.862 0.363 . . . . 0.0 110.914 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 56.3 m -68.55 166.99 15.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.818 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.03 82.14 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.341 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -76.43 145.92 38.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 111.178 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.44 ' HB ' HG11 ' C' ' 119' ' ' VAL . 8.3 pt -128.47 160.32 63.08 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.574 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.602 ' O ' HG12 ' C' ' 36' ' ' VAL . 85.6 Cg_exo -43.22 -47.92 8.43 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.73 2.286 . . . . 0.0 111.757 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.899 HG22 ' HA2' ' C' ' 41' ' ' GLY . 9.8 p 46.94 21.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.769 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' C' ' 36' ' ' VAL . 7.1 t-20 58.73 138.71 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.902 0.382 . . . . 0.0 111.496 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HG3' ' C' ' 44' ' ' PRO . 5.4 Cg_endo -47.78 -33.99 20.53 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.058 2.505 . . . . 0.0 113.215 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.64 17.71 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -107.16 -17.59 14.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 110.46 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.899 ' HA2' HG22 ' C' ' 36' ' ' VAL . . . 69.95 43.19 66.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.894 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.444 ' O ' ' HB ' ' C' ' 43' ' ' VAL . 0.0 OUTLIER -143.32 -83.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.61 0.243 . . . . 0.0 110.842 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.659 ' HB ' HG12 ' C' ' 119' ' ' VAL . 8.2 p 174.06 128.05 0.11 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.936 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.427 ' HG3' ' HD3' ' C' ' 38' ' ' PRO . 14.2 Cg_exo -69.97 143.63 50.4 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.616 2.21 . . . . 0.0 112.235 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.62 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.044 0.45 . . . . 0.0 110.897 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.4 OUTLIER -68.29 96.06 0.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.602 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 tp -42.03 -32.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.605 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.95 -52.53 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.623 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -63.36 -28.45 70.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.492 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.465 ' HG2' ' CG ' ' C' ' 35' ' ' PRO . 0.9 OUTLIER -79.69 -28.52 40.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.452 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.54 58.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -74.23 -41.87 60.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -58.24 -43.72 87.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.643 ' O ' HG23 ' C' ' 58' ' ' VAL . 73.7 m -59.47 -43.71 93.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.497 HD23 HD13 ' C' ' 123' ' ' ILE . 75.1 mt -66.38 -35.38 80.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.003 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.86 -38.3 82.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.014 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -64.63 -36.34 83.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.745 HG21 ' CG2' ' C' ' 123' ' ' ILE . 16.1 t -69.9 -46.93 72.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.923 0.392 . . . . 0.0 110.936 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' C' ' 62' ' ' ILE . 0.0 OUTLIER -72.49 -31.47 65.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.764 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.8 90.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.907 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.48 HG21 ' CB ' ' C' ' 21' ' ' ALA . 6.4 mt -65.39 -56.78 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.71 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' C' ' 127' ' ' ALA . 4.9 tt -63.89 -26.19 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.746 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.01 -40.03 60.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.921 0.391 . . . . 0.0 110.431 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -10.75 59.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.8 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.89 -29.64 18.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.837 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.63 52.42 0.33 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.485 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.545 HD22 ' CB ' ' C' ' 71' ' ' ASP . 2.3 mt -147.91 -169.89 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 110.585 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.12 160.15 40.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.032 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' C' ' 99' ' ' ASN . . . -60.0 -33.5 72.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' C' ' 100' ' ' ASN . . . -62.92 -17.31 61.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.42 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.545 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.0 m-20 -85.18 -24.43 27.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.784 0.326 . . . . 0.0 110.786 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 47.1 mt -53.79 118.62 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.08 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.614 ' O ' HG11 ' A' ' 22' ' ' VAL . 12.5 m -89.32 -37.16 9.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.693 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.763 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 0.0 OUTLIER -141.26 149.36 41.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.782 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.699 HG23 ' HB2' ' C' ' 125' ' ' ALA . 89.5 m -145.0 110.31 5.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.92 0.391 . . . . 0.0 111.343 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.574 ' O ' HG13 ' C' ' 77' ' ' VAL . 87.8 m -95.14 157.82 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.217 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.659 HG12 HG12 ' C' ' 123' ' ' ILE . 3.3 m -159.15 142.47 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.081 0.467 . . . . 0.0 111.774 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' B' ' 110' ' ' VAL . 3.5 m-85 -114.0 119.07 35.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.283 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.772 HG12 HD21 ' C' ' 121' ' ' LEU . 33.5 m -107.31 152.23 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.102 0.477 . . . . 0.0 111.744 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.55 -0.15 38.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.806 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.85 107.45 1.11 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.572 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -65.89 -13.82 60.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.213 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -79.69 -27.78 40.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.482 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.29 -12.17 55.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.83 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.651 ' CD1' HG11 ' C' ' 79' ' ' VAL . 1.6 t80 -58.7 -24.45 61.43 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.996 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.86 -56.51 11.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.338 . . . . 0.0 111.353 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.82 83.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 t -64.84 -42.07 93.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.72 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.13 -42.35 89.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.483 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.97 76.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.865 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' C' ' 94' ' ' ARG . 20.4 mm-40 -88.63 -29.88 19.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.7 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.424 ' O ' ' CD2' ' C' ' 95' ' ' PHE . 59.0 t80 -57.77 -49.68 75.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.011 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -82.46 -17.46 45.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.496 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . 0.413 ' HB2' ' HA ' ' C' ' 91' ' ' GLU . 4.6 mtp180 -75.1 -27.91 60.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.711 0.291 . . . . 0.0 111.381 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' C' ' 95' ' ' PHE . 0.9 OUTLIER -86.19 -33.45 20.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 110.493 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.461 ' CZ ' ' CD ' ' C' ' 105' ' ' PRO . 0.9 OUTLIER -56.2 -55.79 28.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.329 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.53 -28.91 70.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.882 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.39 -6.24 59.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.381 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.735 ' HB3' ' HB3' ' C' ' 69' ' ' ALA . 1.5 m120 -111.43 -5.14 14.64 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.588 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.716 ' O ' ' HB2' ' C' ' 70' ' ' ALA . 6.9 m120 85.45 33.18 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.851 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.547 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 20.1 t-160 -128.89 67.38 77.73 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.481 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 4.5 Cg_exo -75.42 -20.32 16.16 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.667 2.244 . . . . 0.0 112.528 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.685 ' CG ' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -69.12 -36.77 77.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.452 . . . . 0.0 110.336 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.417 ' CB ' ' HA ' ' A' ' 18' ' ' TYR . 15.8 m-85 74.1 142.56 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.404 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.461 ' CD ' ' CZ ' ' C' ' 96' ' ' PHE . 73.5 Cg_endo -90.12 165.85 4.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.176 2.584 . . . . 0.0 111.929 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.763 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -49.99 154.03 1.22 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -119.0 140.98 49.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.275 0.559 . . . . 0.0 112.086 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 30.5 t -144.28 45.87 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.963 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' C' ' 77' ' ' VAL . 28.8 p -81.44 135.01 35.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.312 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' A' ' 78' ' ' PHE . 23.1 m -153.82 149.23 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.19 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.841 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -84.24 91.0 7.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.72 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.643 HG21 HD21 ' C' ' 115' ' ' LEU . 27.7 m -71.16 177.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.246 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -81.8 -46.0 14.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.999 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.4 ' CB ' ' HB3' ' B' ' 111' ' ' GLU . 0.1 OUTLIER -151.71 -179.79 7.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.739 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.643 HD21 HG21 ' C' ' 112' ' ' VAL . 59.7 mt -149.14 155.58 40.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.727 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.558 ' O ' HG22 ' C' ' 119' ' ' VAL . 9.2 Cg_endo -52.31 139.22 54.9 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.536 2.157 . . . . 0.0 111.992 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' C' ' 116' ' ' PRO . 8.0 mmtm 66.45 17.73 10.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.212 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 61.64 17.43 8.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.042 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.659 HG12 ' HB ' ' C' ' 43' ' ' VAL . 30.5 m -55.71 167.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . . . . . . . . . . . -105.86 8.35 42.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.914 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.772 HD21 HG12 ' C' ' 79' ' ' VAL . 0.2 OUTLIER -172.37 154.46 3.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.069 0.461 . . . . 0.0 111.22 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.12 159.0 43.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.027 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.745 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.8 mt -144.26 145.75 21.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.359 0.599 . . . . 0.0 112.334 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.17 101.49 1.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.333 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -119.04 163.57 16.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.203 0.525 . . . . 0.0 112.185 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.403 HG23 ' HG ' ' C' ' 29' ' ' LEU . 5.7 mt -114.4 151.87 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.099 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.982 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -136.03 148.39 48.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 0.0 111.629 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.932 HG21 HG21 ' A' ' 3' ' ' THR . 35.0 m -115.89 151.42 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.12 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.09 70.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.811 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.774 0.321 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.03 111.98 23.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.08 HG21 HG21 ' C' ' 128' ' ' VAL . 3.1 m 61.68 114.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -171.06 125.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.798 HD13 ' OD1' ' C' ' 103' ' ' ASN . 4.2 mp -56.54 141.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.585 HD12 ' HB3' ' A' ' 21' ' ' ALA . 21.9 mt -98.01 149.84 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.24 26.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.27 171.11 20.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.3 28.44 8.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.033 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.557 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 8.1 mttm -120.5 -44.96 2.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' A' ' 12' ' ' PRO . . . -66.55 171.48 4.23 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.868 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.889 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 29.6 Cg_endo -63.6 -12.68 32.33 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.572 2.181 . . . . 0.0 112.523 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 69.44 147.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.492 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 19' ' ' VAL . . . -126.28 120.95 31.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.838 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 15' ' ' ILE . 3.1 mp -135.23 17.1 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.073 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.92 -118.88 2.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.382 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.81 14.92 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.675 2.25 . . . . 0.0 113.316 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -147.04 -174.06 4.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.994 0.426 . . . . 0.0 111.517 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.913 HG23 ' HB2' ' C' ' 106' ' ' ALA . 18.0 m -138.61 169.34 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.798 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -49.09 79.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.602 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB3' HD12 ' A' ' 6' ' ' ILE . . . -177.02 -178.07 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.962 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 29' ' ' LEU . 15.0 m -141.48 133.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 28' ' ' VAL . 37.6 t70 -110.8 115.39 29.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.839 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.963 HD11 HD12 ' A' ' 29' ' ' LEU . 2.8 mt -90.98 -16.03 28.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -99.3 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.755 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -56.91 -29.12 62.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.183 0.516 . . . . 0.0 110.072 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -136.21 135.19 38.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.774 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.962 ' CG1' ' HB3' ' A' ' 127' ' ' ALA . 4.8 p -109.51 164.55 5.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.871 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.963 HD12 HD11 ' A' ' 24' ' ' LEU . 3.4 mt -142.6 131.28 22.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.3 p -104.71 144.9 31.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.9 ' HB3' ' HB1' ' C' ' 106' ' ' ALA . 10.2 p -82.98 178.88 7.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.4 89.73 0.82 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.195 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.803 ' HG3' HG22 ' A' ' 58' ' ' VAL . 88.3 mm-40 -56.22 144.25 30.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.969 HG23 HG23 ' A' ' 36' ' ' VAL . 9.5 tt -125.51 132.89 24.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.702 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.688 ' HB2' HG23 ' A' ' 43' ' ' VAL . 21.9 Cg_exo -65.02 65.24 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.666 2.244 . . . . 0.0 112.56 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.969 HG23 HG23 ' A' ' 34' ' ' ILE . 63.3 t -84.8 88.21 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.122 0.487 . . . . 0.0 110.625 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -33.86 134.48 0.35 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.893 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.27 -20.79 20.84 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.489 2.126 . . . . 0.0 112.277 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.35 -3.59 14.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.601 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.543 HG22 ' CG ' ' A' ' 42' ' ' GLU . 3.7 m -126.22 -30.26 2.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.829 0.347 . . . . 0.0 110.83 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.99 53.44 30.27 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.325 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.543 ' CG ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER -165.59 -82.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.507 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' A' ' 35' ' ' PRO . 7.2 p 175.55 125.17 0.14 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.074 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.29 138.98 23.02 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.354 2.036 . . . . 0.0 112.191 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.73 -31.08 71.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.061 0.458 . . . . 0.0 110.902 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 94.9 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.904 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 47' ' ' ILE . 21.5 mm -44.26 -31.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.878 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.78 -38.8 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.576 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.75 -54.34 36.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.47 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.38 -26.4 68.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.341 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.88 -40.77 72.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.4 -48.82 16.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.789 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.53 -46.73 88.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.745 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.855 ' O ' HG23 ' A' ' 58' ' ' VAL . 89.2 p -60.05 -37.25 79.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 92' ' ' TYR . 22.0 mt -76.54 -23.41 53.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.043 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -52.14 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' A' ' 54' ' ' SER . 0.7 OUTLIER -58.08 -29.19 65.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.982 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 123' ' ' ILE . 54.4 t -65.06 -46.39 91.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.984 0.421 . . . . 0.0 110.643 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -28.96 61.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.844 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' A' ' 10' ' ' LYS . . . -60.84 -40.74 93.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.025 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.442 HD11 ' OE1' ' A' ' 33' ' ' GLN . 12.8 mt -73.59 -41.77 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.619 HD13 HD11 ' A' ' 72' ' ' ILE . 18.1 mt -69.48 -31.24 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.553 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.61 -37.33 59.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.034 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -22.41 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.272 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.87 -28.82 20.1 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.787 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.97 50.51 0.63 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.591 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.552 ' HB2' HG22 ' A' ' 62' ' ' ILE . 6.1 mt -146.66 -176.56 5.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.409 . . . . 0.0 110.716 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.77 163.83 31.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.778 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.459 ' O ' ' CD2' ' A' ' 101' ' ' HIS . . . -50.26 -34.57 23.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.031 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HA ' ' CG ' ' A' ' 101' ' ' HIS . . . -67.49 -24.78 65.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.359 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.529 ' HB3' HD22 ' A' ' 67' ' ' LEU . 58.0 m-20 -80.46 -6.58 58.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.717 0.294 . . . . 0.0 110.959 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 62' ' ' ILE . 24.2 mt -83.81 116.1 27.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.249 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.49 HG23 ' N ' ' A' ' 74' ' ' LYS . 35.4 m -76.58 -46.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.041 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.84 ' HD3' HD12 ' A' ' 126' ' ' ILE . 11.0 mtpt -118.41 -177.6 3.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.59 0.233 . . . . 0.0 111.093 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 105' ' ' PRO . 11.1 t -179.99 101.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.895 0.378 . . . . 0.0 111.496 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.52 HG23 ' NH1' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -71.21 126.72 30.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.198 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.8 t -114.71 98.88 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -98.17 147.49 24.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.951 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -144.76 151.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.09 0.471 . . . . 0.0 111.899 -179.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.0 -2.6 56.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.764 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.29 110.31 0.57 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.416 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.63 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.0 mt -56.81 -18.6 13.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.322 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -75.86 -23.47 55.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.844 0.354 . . . . 0.0 110.583 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 88' ' ' VAL . 47.4 m-20 -77.97 -12.77 60.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -27.21 59.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.252 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.46 71.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.779 0.323 . . . . 0.0 111.415 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.88 -29.45 20.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.287 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 84' ' ' ASP . 26.2 t -73.84 -47.1 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -64.86 -39.32 93.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.47 -37.27 85.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -33.34 19.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.621 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.562 ' OH ' HG21 ' A' ' 75' ' ' THR . 35.3 t80 -61.16 -56.47 20.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.346 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -70.19 -15.29 62.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.333 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -40.06 66.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -84.95 -38.78 18.91 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.342 -179.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.493 ' CE1' ' CE1' ' A' ' 92' ' ' TYR . 11.1 m-85 -53.92 -50.63 65.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 110.32 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.94 -32.36 74.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.875 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.65 -1.9 54.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.432 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -110.4 -8.6 14.67 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.66 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.7 t-20 97.08 19.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.796 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 70' ' ' ALA . 1.3 t60 -118.77 59.93 4.32 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.858 0.361 . . . . 0.0 110.927 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.403 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 43.9 Cg_endo -68.19 -17.78 45.16 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.493 2.129 . . . . 0.0 112.175 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.763 ' OD1' HD13 ' B' ' 5' ' ' ILE . 0.1 OUTLIER -75.42 -34.2 61.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.7 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.469 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 33.2 m-85 72.26 140.19 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.103 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.688 ' HB2' HG22 ' A' ' 75' ' ' THR . 7.2 Cg_exo -71.83 166.77 28.51 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.747 2.298 . . . . 0.0 112.138 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.919 ' HB1' ' HB3' ' B' ' 31' ' ' SER . . . -107.52 131.01 54.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.726 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.582 ' HB2' ' H ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -167.48 -165.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.089 0.471 . . . . 0.0 111.303 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -116.24 114.93 25.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.209 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.519 ' O ' HG13 ' A' ' 110' ' ' VAL . 16.0 m -95.69 131.47 41.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.275 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.573 HG12 HD23 ' B' ' 115' ' ' LEU . 7.4 m -158.96 170.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.494 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.866 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 6.9 tt0 -110.6 95.34 5.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.804 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.3 m -60.46 157.3 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.876 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -60.89 -45.73 93.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.992 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.567 ' HB3' HD12 ' C' ' 82' ' ' LEU . 12.4 mmt180 -151.87 173.99 14.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.688 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.531 HD23 HG12 ' C' ' 110' ' ' VAL . 1.3 mt -143.66 156.26 59.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.69 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.436 ' O ' HG22 ' A' ' 119' ' ' VAL . 12.4 Cg_endo -55.93 137.75 79.91 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.489 2.126 . . . . 0.0 111.988 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.445 ' HB2' HD11 ' A' ' 34' ' ' ILE . 10.3 mttt 68.18 16.03 9.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.328 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.97 15.58 9.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.783 HG11 HG13 ' A' ' 34' ' ' ILE . 29.3 m -51.79 169.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.713 0.292 . . . . 0.0 111.075 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.532 ' O ' HD12 ' A' ' 121' ' ' LEU . . . -116.67 17.02 13.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.027 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 120' ' ' GLY . 0.2 OUTLIER -175.17 153.44 1.59 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.102 0.477 . . . . 0.0 111.397 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.5 ' HB2' HD22 ' A' ' 115' ' ' LEU . 1.1 tp10 -142.5 140.22 31.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.884 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.889 HG21 HG21 ' A' ' 58' ' ' VAL . 28.1 mm -121.79 127.01 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 112.141 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 76' ' ' THR . 1.0 OUTLIER -140.21 146.23 38.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.08 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 124' ' ' GLU . . . -170.05 174.22 5.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.267 0.555 . . . . 0.0 112.275 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.84 HD12 ' HD3' ' A' ' 74' ' ' LYS . 5.2 mt -132.28 151.28 34.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.188 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.962 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -132.48 150.78 52.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.15 0.5 . . . . 0.0 111.756 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.032 HG21 HG21 ' B' ' 3' ' ' THR . 13.0 m -110.64 116.23 51.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.874 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.546 ' HB2' HD21 ' A' ' 67' ' ' LEU . 2.1 tmt_? -122.67 75.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.933 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.866 179.928 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.841 0.353 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.01 112.04 23.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 1.032 HG21 HG21 ' A' ' 128' ' ' VAL . 3.1 m 61.6 114.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -170.98 125.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.763 HD13 ' OD1' ' A' ' 103' ' ' ASN . 4.2 mp -56.5 141.38 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' B' ' 21' ' ' ALA . 21.8 mt -97.97 149.85 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.209 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.25 26.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.3 171.14 20.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.36 28.48 8.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.99 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.549 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 8.1 mttm -120.64 -44.5 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.747 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.891 ' HB1' ' HD2' ' B' ' 12' ' ' PRO . . . -66.68 171.3 4.53 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.971 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.891 ' HD2' ' HB1' ' B' ' 11' ' ' ALA . 29.7 Cg_endo -63.67 -12.72 32.73 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.563 2.176 . . . . 0.0 112.488 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 69.52 147.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.474 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.61 ' HB3' ' HA ' ' B' ' 19' ' ' VAL . . . -126.32 120.94 31.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.795 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.579 HG22 ' O ' ' B' ' 15' ' ' ILE . 3.1 mp -135.21 17.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.162 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.91 -118.96 2.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.39 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -89.64 14.72 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.787 2.325 . . . . 0.0 113.306 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.99 -174.04 4.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 0.0 111.506 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' A' ' 106' ' ' ALA . 18.1 m -138.55 169.34 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.823 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -49.17 78.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 110.636 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.582 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -177.14 -177.93 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' B' ' 29' ' ' LEU . 14.9 m -141.51 133.29 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.151 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.553 ' HA ' HG23 ' B' ' 28' ' ' VAL . 37.6 t70 -110.77 115.36 29.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.928 HD11 HD12 ' B' ' 29' ' ' LEU . 2.9 mt -90.88 -16.01 28.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.231 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.65 -99.29 0.81 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.767 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -56.93 -29.05 62.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.171 0.51 . . . . 0.0 110.111 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.679 HD23 ' O ' ' B' ' 127' ' ' ALA . 0.2 OUTLIER -136.18 135.18 38.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.717 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.947 ' CG1' ' HB3' ' B' ' 127' ' ' ALA . 4.8 p -109.54 164.48 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.923 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.928 HD12 HD11 ' B' ' 24' ' ' LEU . 3.4 mt -142.49 131.32 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.888 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 41.1 p -104.71 144.85 31.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.972 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.919 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 10.3 p -83.32 179.17 7.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.013 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.43 89.75 0.82 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.199 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.823 ' HG3' HG22 ' B' ' 58' ' ' VAL . 88.3 mm-40 -56.18 144.16 30.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.936 0.398 . . . . 0.0 111.275 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.929 HG23 HG23 ' B' ' 36' ' ' VAL . 9.6 tt -125.45 132.87 24.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.703 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.676 ' HB2' HG23 ' B' ' 43' ' ' VAL . 21.9 Cg_exo -64.98 65.2 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.69 2.26 . . . . 0.0 112.59 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.929 HG23 HG23 ' B' ' 34' ' ' ILE . 63.7 t -84.85 88.25 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.12 0.486 . . . . 0.0 110.584 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -33.82 134.48 0.35 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.849 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.28 -20.82 20.78 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.443 2.095 . . . . 0.0 112.232 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.25 -3.76 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.61 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.535 HG22 ' CG ' ' B' ' 42' ' ' GLU . 3.7 m -126.16 -30.17 2.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.851 0.358 . . . . 0.0 110.793 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.85 53.44 30.8 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.232 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.535 ' CG ' HG22 ' B' ' 40' ' ' THR . 0.0 OUTLIER -165.55 -82.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.49 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.676 HG23 ' HB2' ' B' ' 35' ' ' PRO . 7.2 p 175.6 125.17 0.14 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.053 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.16 138.91 23.25 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.399 2.066 . . . . 0.0 112.283 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.68 -31.13 71.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 110.892 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.84 94.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 21.4 mm -44.27 -31.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.879 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 22.4 t -79.72 -38.8 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.78 -54.26 38.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.451 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.48 -26.74 68.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.344 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.68 -40.69 72.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.01 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.45 -48.71 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -59.6 -46.71 88.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.712 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.861 ' O ' HG23 ' B' ' 58' ' ' VAL . 89.9 p -60.06 -37.25 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.859 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.496 HD21 ' CD2' ' B' ' 92' ' ' TYR . 21.9 mt -76.6 -23.3 53.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -52.07 12.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.169 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' B' ' 54' ' ' SER . 0.7 OUTLIER -58.01 -29.32 65.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.893 HG21 HG21 ' B' ' 123' ' ' ILE . 54.0 t -65.02 -46.39 91.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.921 0.391 . . . . 0.0 110.6 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.09 -28.94 61.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' B' ' 10' ' ' LYS . . . -60.86 -40.91 94.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.431 HD11 ' OE1' ' B' ' 33' ' ' GLN . 13.0 mt -73.21 -41.64 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.506 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.619 HD13 HD11 ' B' ' 72' ' ' ILE . 18.0 mt -69.51 -31.31 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.535 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.51 -37.39 60.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.1 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -22.38 66.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.276 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.83 -28.9 20.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.04 50.58 0.63 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.516 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.564 HD22 ' HB3' ' B' ' 71' ' ' ASP . 6.1 mt -146.73 -176.68 5.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.988 0.423 . . . . 0.0 110.672 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.68 163.92 31.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.751 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' B' ' 101' ' ' HIS . . . -50.31 -34.62 24.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.043 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.543 ' HA ' ' CG ' ' B' ' 101' ' ' HIS . . . -67.49 -24.86 65.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.315 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.564 ' HB3' HD22 ' B' ' 67' ' ' LEU . 57.9 m-20 -80.38 -6.6 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.929 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.619 HD11 HD13 ' B' ' 62' ' ' ILE . 24.4 mt -83.82 116.11 27.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.221 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.499 HG23 ' N ' ' B' ' 74' ' ' LYS . 35.4 m -76.52 -47.03 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.05 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.851 ' HD3' HD12 ' B' ' 126' ' ' ILE . 10.8 mtpt -118.35 -177.58 3.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.569 0.223 . . . . 0.0 111.153 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.695 HG22 ' HB2' ' B' ' 105' ' ' PRO . 11.2 t 179.98 101.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 111.539 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.525 HG23 ' NH1' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -71.18 126.76 30.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.18 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.73 98.92 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -98.21 147.36 24.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.991 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' B' ' 111' ' ' GLU . 0.9 OUTLIER -144.68 151.76 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.173 0.511 . . . . 0.0 111.927 -179.252 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.03 -2.85 56.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.732 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.13 110.37 0.59 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.402 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.641 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.0 mt -56.92 -18.59 13.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.305 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -75.76 -23.58 55.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.558 ' O ' HG23 ' B' ' 88' ' ' VAL . 47.5 m-20 -77.91 -12.78 60.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -27.18 59.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.293 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.54 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.351 . . . . 0.0 111.408 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.87 -29.38 20.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.277 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.558 HG23 ' O ' ' B' ' 84' ' ' ASP . 26.2 t -73.87 -47.09 44.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.128 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -64.9 -39.26 93.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.59 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.34 85.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.011 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.83 -33.34 19.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.646 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.534 ' OH ' HG21 ' B' ' 75' ' ' THR . 35.4 t80 -61.23 -56.39 21.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.351 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' B' ' 104' ' ' PHE . 0.2 OUTLIER -70.28 -15.21 62.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.268 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -40.04 66.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.48 ' CE2' ' CE1' ' B' ' 96' ' ' PHE . 0.0 OUTLIER -84.95 -38.81 18.86 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.378 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.498 ' CE1' ' CE1' ' B' ' 92' ' ' TYR . 11.2 m-85 -53.86 -50.68 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.042 0.449 . . . . 0.0 110.328 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.96 -32.31 73.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.877 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.63 -1.93 55.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.463 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' B' ' 100' ' ' ASN . 1.0 OUTLIER -110.39 -8.63 14.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.637 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.546 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 2.7 t-20 97.09 19.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.761 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 0.543 ' CG ' ' HA ' ' B' ' 70' ' ' ALA . 1.3 t60 -118.53 59.86 4.01 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.961 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.411 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 44.0 Cg_endo -68.18 -17.79 45.23 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.457 2.105 . . . . 0.0 112.181 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.776 ' OD1' HD13 ' C' ' 5' ' ' ILE . 0.1 OUTLIER -75.4 -34.22 61.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' B' ' 105' ' ' PRO . 33.0 m-85 72.26 140.19 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.695 ' HB2' HG22 ' B' ' 75' ' ' THR . 7.2 Cg_exo -71.87 166.74 28.61 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.724 2.283 . . . . 0.0 112.113 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.943 ' HB1' ' HB3' ' C' ' 31' ' ' SER . . . -107.45 131.02 54.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.761 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.581 ' HB2' ' H ' ' B' ' 75' ' ' THR . 0.0 OUTLIER -167.51 -165.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.049 0.452 . . . . 0.0 111.33 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -116.16 114.93 25.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.224 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . 0.529 ' O ' HG13 ' B' ' 110' ' ' VAL . 16.0 m -95.69 131.52 41.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.207 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.543 HG12 HD23 ' C' ' 115' ' ' LEU . 7.2 m -158.96 170.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 111.413 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.872 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 6.9 tt0 -110.2 95.4 5.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.676 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -60.62 157.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.065 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -60.77 -45.67 93.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.041 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.63 ' HB3' HD12 ' A' ' 82' ' ' LEU . 12.4 mmt180 -151.94 173.98 14.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.733 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.573 HD23 HG12 ' A' ' 110' ' ' VAL . 1.3 mt -143.66 156.31 59.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.7 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.433 ' O ' HG22 ' B' ' 119' ' ' VAL . 12.4 Cg_endo -55.98 137.76 80.12 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.449 2.1 . . . . 0.0 112.052 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.446 ' HB2' HG13 ' B' ' 119' ' ' VAL . 10.3 mttt 68.23 15.97 9.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.356 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.99 15.62 9.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.088 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.781 HG11 HG13 ' B' ' 34' ' ' ILE . 29.2 m -51.84 169.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.057 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . 0.53 ' O ' HD12 ' B' ' 121' ' ' LEU . . . -116.67 16.81 13.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.016 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.53 HD12 ' O ' ' B' ' 120' ' ' GLY . 0.2 OUTLIER -175.11 153.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.109 0.481 . . . . 0.0 111.433 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.479 ' HB2' HD22 ' B' ' 115' ' ' LEU . 1.1 tp10 -142.43 140.25 31.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.903 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.893 HG21 HG21 ' B' ' 58' ' ' VAL . 28.2 mm -121.81 127.05 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.146 0.498 . . . . 0.0 112.12 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' B' ' 76' ' ' THR . 1.0 OUTLIER -140.29 146.21 38.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.051 179.146 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' B' ' 124' ' ' GLU . . . -170.01 174.24 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.286 0.565 . . . . 0.0 112.269 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.851 HD12 ' HD3' ' B' ' 74' ' ' LYS . 5.2 mt -132.35 151.2 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.172 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.947 ' HB3' ' CG1' ' B' ' 28' ' ' VAL . . . -132.45 150.82 52.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.053 0.454 . . . . 0.0 111.731 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.998 HG21 HG21 ' C' ' 3' ' ' THR . 13.2 m -110.67 116.21 51.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.891 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.547 ' HB2' HD21 ' B' ' 67' ' ' LEU . 2.1 tmt_? -122.66 75.88 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.975 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.915 179.931 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.812 0.339 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.0 112.0 23.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.998 HG21 HG21 ' B' ' 128' ' ' VAL . 3.1 m 61.6 114.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -171.06 125.28 0.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.776 HD13 ' OD1' ' B' ' 103' ' ' ASN . 4.2 mp -56.42 141.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.6 HD12 ' HB3' ' C' ' 21' ' ' ALA . 22.0 mt -98.05 149.88 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -148.32 143.24 26.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -155.28 171.15 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -107.34 28.42 8.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.023 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.549 ' HB2' ' HB1' ' C' ' 60' ' ' ALA . 8.0 mttm -120.65 -44.6 2.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.74 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' C' ' 12' ' ' PRO . . . -66.79 171.22 4.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.042 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.889 ' HD2' ' HB1' ' C' ' 11' ' ' ALA . 29.6 Cg_endo -63.61 -12.71 32.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.533 2.155 . . . . 0.0 112.506 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 69.45 147.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.488 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' C' ' 19' ' ' VAL . . . -126.35 120.99 31.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.756 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.572 HG22 ' O ' ' C' ' 15' ' ' ILE . 3.1 mp -135.24 17.14 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.11 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.95 -118.88 2.91 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.418 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.75 14.81 2.07 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.784 2.323 . . . . 0.0 113.306 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -147.07 -174.06 4.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.948 0.404 . . . . 0.0 111.495 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.89 HG23 ' HB2' ' B' ' 106' ' ' ALA . 17.8 m -138.55 169.35 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.75 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -48.89 79.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 110.592 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.6 ' HB3' HD12 ' C' ' 6' ' ' ILE . . . -177.4 -177.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.898 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' C' ' 29' ' ' LEU . 15.0 m -141.47 133.34 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.05 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.542 ' HA ' HG23 ' C' ' 28' ' ' VAL . 37.5 t70 -110.77 115.4 29.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.937 HD11 HD12 ' C' ' 29' ' ' LEU . 2.9 mt -91.01 -16.07 28.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.143 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.67 -99.27 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.762 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -56.99 -29.0 62.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.159 0.504 . . . . 0.0 110.081 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.687 HD23 ' O ' ' C' ' 127' ' ' ALA . 0.2 OUTLIER -136.17 135.22 38.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.746 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.967 ' CG1' ' HB3' ' C' ' 127' ' ' ALA . 4.8 p -109.59 164.49 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.847 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.937 HD12 HD11 ' C' ' 24' ' ' LEU . 3.4 mt -142.55 131.3 22.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.887 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 40.9 p -104.63 144.35 31.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . 0.943 ' HB3' ' HB1' ' B' ' 106' ' ' ALA . 10.1 p -83.03 179.1 7.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.51 89.74 0.83 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.177 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.821 ' HG3' HG22 ' C' ' 58' ' ' VAL . 88.3 mm-40 -56.12 144.17 30.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.286 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.972 HG23 HG23 ' C' ' 36' ' ' VAL . 9.5 tt -125.49 132.9 24.44 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.691 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.685 ' HB2' HG23 ' C' ' 43' ' ' VAL . 21.9 Cg_exo -64.93 65.25 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.657 2.238 . . . . 0.0 112.574 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.972 HG23 HG23 ' C' ' 34' ' ' ILE . 63.5 t -84.9 88.24 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.59 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -33.83 134.47 0.35 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.867 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.25 -20.84 20.83 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.445 2.097 . . . . 0.0 112.249 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.27 -3.64 14.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.619 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.535 HG22 ' CG ' ' C' ' 42' ' ' GLU . 3.7 m -126.25 -30.21 2.93 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.9 53.49 30.32 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.306 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.535 ' CG ' HG22 ' C' ' 40' ' ' THR . 0.0 OUTLIER -165.52 -82.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.486 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.685 HG23 ' HB2' ' C' ' 35' ' ' PRO . 7.3 p 175.62 125.14 0.14 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.102 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.24 138.92 23.09 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.407 2.072 . . . . 0.0 112.242 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.72 -31.07 71.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 94.96 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.887 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . . . . . . . . . 21.5 mm -44.32 -31.0 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.933 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.79 -38.73 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.6 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.79 -54.28 37.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.478 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.52 -26.82 68.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.332 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.65 72.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.1 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.44 -48.7 16.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.763 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.62 -46.65 88.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.767 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.857 ' O ' HG23 ' C' ' 58' ' ' VAL . 90.3 p -60.04 -37.29 79.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.487 HD21 ' CD2' ' C' ' 92' ' ' TYR . 21.9 mt -76.56 -23.35 53.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.094 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.69 -52.08 12.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.203 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' C' ' 54' ' ' SER . 0.6 OUTLIER -58.09 -29.2 65.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.939 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.908 HG21 HG21 ' C' ' 123' ' ' ILE . 54.3 t -65.16 -46.25 91.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.905 0.383 . . . . 0.0 110.602 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -28.87 61.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' C' ' 10' ' ' LYS . . . -60.87 -40.88 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.03 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.432 HD11 ' OE1' ' C' ' 33' ' ' GLN . 13.0 mt -73.13 -41.69 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.518 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.611 HD13 HD11 ' C' ' 72' ' ' ILE . 18.2 mt -69.5 -31.38 48.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.485 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.47 -37.33 60.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.106 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -22.43 66.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.276 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.88 -28.81 20.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.824 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.99 50.51 0.63 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.568 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' C' ' 71' ' ' ASP . 6.1 mt -146.67 -176.66 5.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 110.68 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.68 163.85 31.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.47 ' O ' ' CD2' ' C' ' 101' ' ' HIS . . . -50.21 -34.74 23.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.548 ' HA ' ' CG ' ' C' ' 101' ' ' HIS . . . -67.38 -24.72 65.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.324 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.566 ' HB3' HD22 ' C' ' 67' ' ' LEU . 57.9 m-20 -80.67 -6.52 58.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.934 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.611 HD11 HD13 ' C' ' 62' ' ' ILE . 24.7 mt -83.88 116.08 27.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.188 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.504 HG23 ' N ' ' C' ' 74' ' ' LYS . 35.4 m -76.57 -46.93 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.014 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.872 ' HD3' HD12 ' C' ' 126' ' ' ILE . 10.8 mtpt -118.4 -177.7 3.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.591 0.234 . . . . 0.0 111.158 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.683 HG22 ' HB2' ' C' ' 105' ' ' PRO . 11.1 t -179.94 101.04 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.84 0.352 . . . . 0.0 111.509 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.52 HG23 ' NH1' ' C' ' 107' ' ' ARG . 0.0 OUTLIER -71.18 126.72 30.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.233 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.67 98.89 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -98.21 147.38 24.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.957 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' C' ' 111' ' ' GLU . 0.9 OUTLIER -144.68 151.79 15.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.479 . . . . 0.0 111.959 -179.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -92.05 -2.91 56.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.727 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -168.09 110.28 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.327 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.0 mt -56.89 -18.57 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -75.79 -23.57 55.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.617 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.552 ' O ' HG23 ' C' ' 88' ' ' VAL . 47.7 m-20 -77.88 -12.79 60.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -27.11 60.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.27 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.59 -42.54 71.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.815 0.34 . . . . 0.0 111.381 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.84 -29.45 20.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.275 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . 0.552 HG23 ' O ' ' C' ' 84' ' ' ASP . 26.1 t -73.82 -47.16 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.102 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -64.82 -39.32 93.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.596 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.42 -37.28 85.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.051 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.8 -33.33 19.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.594 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.545 ' OH ' HG21 ' C' ' 75' ' ' THR . 35.5 t80 -61.23 -56.43 20.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.36 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . 0.426 ' HG3' ' CZ ' ' C' ' 104' ' ' PHE . 0.2 OUTLIER -70.22 -15.22 62.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.302 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -40.1 66.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.483 ' CE2' ' CE1' ' C' ' 96' ' ' PHE . 0.0 OUTLIER -84.91 -38.85 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.343 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.495 ' CE1' ' CE1' ' C' ' 92' ' ' TYR . 11.2 m-85 -53.86 -50.65 65.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 0.0 110.371 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -64.96 -32.24 73.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.911 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -83.76 -1.81 54.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.432 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' C' ' 100' ' ' ASN . 1.0 OUTLIER -110.39 -8.69 14.66 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.667 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 2.8 t-20 97.09 19.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.795 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 0.548 ' CG ' ' HA ' ' C' ' 70' ' ' ALA . 1.3 t60 -118.57 59.88 4.07 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.859 0.362 . . . . 0.0 110.91 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.408 ' O ' ' CE2' ' C' ' 104' ' ' PHE . 43.4 Cg_endo -68.16 -17.85 45.35 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.486 2.124 . . . . 0.0 112.15 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.798 ' OD1' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -75.41 -34.16 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.694 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' C' ' 105' ' ' PRO . 33.2 m-85 72.24 140.14 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.08 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.683 ' HB2' HG22 ' C' ' 75' ' ' THR . 7.2 Cg_exo -71.71 166.72 28.59 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.777 2.318 . . . . 0.0 112.113 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.913 ' HB2' HG23 ' A' ' 19' ' ' VAL . . . -107.54 130.91 54.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.792 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.593 ' HB2' ' H ' ' C' ' 75' ' ' THR . 0.0 OUTLIER -167.41 -165.53 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.0 111.324 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . . . . . . . . . 3.1 p -116.2 114.84 24.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.256 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . 0.524 ' O ' HG13 ' C' ' 110' ' ' VAL . 15.8 m -95.67 131.49 41.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.265 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 115' ' ' LEU . 7.2 m -158.97 170.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.947 0.403 . . . . 0.0 111.478 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.876 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 6.9 tt0 -110.26 95.36 5.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 29.9 m -60.51 157.27 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -60.93 -45.63 93.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.011 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.641 ' HB3' HD12 ' B' ' 82' ' ' LEU . 12.3 mmt180 -151.93 173.94 14.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.727 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.543 HD23 HG12 ' B' ' 110' ' ' VAL . 1.3 mt -143.65 156.25 59.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.71 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.438 ' O ' HG22 ' C' ' 119' ' ' VAL . 12.4 Cg_endo -55.89 137.7 79.65 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.472 2.114 . . . . 0.0 112.069 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.439 ' HB2' HG13 ' C' ' 119' ' ' VAL . 10.3 mttt 68.21 16.02 9.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.392 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.89 15.69 9.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.808 HG11 HG13 ' C' ' 34' ' ' ILE . 29.3 m -51.83 169.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.736 0.303 . . . . 0.0 111.034 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . 0.541 ' O ' HD12 ' C' ' 121' ' ' LEU . . . -116.67 16.97 13.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.045 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.541 HD12 ' O ' ' C' ' 120' ' ' GLY . 0.2 OUTLIER -175.22 153.44 1.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.173 0.511 . . . . 0.0 111.367 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.492 ' HB2' HD22 ' C' ' 115' ' ' LEU . 1.1 tp10 -142.46 140.26 31.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.89 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.908 HG21 HG21 ' C' ' 58' ' ' VAL . 28.3 mm -121.78 127.01 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.094 0.474 . . . . 0.0 112.162 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' C' ' 76' ' ' THR . 1.0 OUTLIER -140.19 146.19 38.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.071 179.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' C' ' 124' ' ' GLU . . . -169.99 174.33 5.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.214 0.531 . . . . 0.0 112.332 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.872 HD12 ' HD3' ' C' ' 74' ' ' LYS . 5.2 mt -132.41 151.21 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.214 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.967 ' HB3' ' CG1' ' C' ' 28' ' ' VAL . . . -132.45 150.73 52.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.08 0.467 . . . . 0.0 111.739 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 1.08 HG21 HG21 ' A' ' 3' ' ' THR . 13.0 m -110.62 116.33 52.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.861 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.527 ' HB2' HD21 ' C' ' 67' ' ' LEU . 2.1 tmt_? -122.74 75.92 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.897 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.869 0.366 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.23 168.49 19.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.486 HG23 ' CD2' ' A' ' 24' ' ' LEU . 18.8 m -165.16 116.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HD23 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 48.23 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.674 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.694 HD11 ' OD1' ' C' ' 103' ' ' ASN . 26.1 mm 70.87 111.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.818 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 21' ' ' ALA . 60.5 mt -141.69 106.58 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.723 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.51 150.71 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.39 167.08 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.45 39.99 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 3.8 tttp -139.98 -45.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.719 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . . . -58.54 177.73 0.22 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.684 ' CD ' ' HB1' ' A' ' 11' ' ' ALA . 24.6 Cg_exo -63.08 -12.25 28.96 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.836 2.357 . . . . 0.0 112.722 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 12' ' ' PRO . . . 75.93 153.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -114.6 124.59 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 14' ' ' ALA . 16.4 mm -140.46 16.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.983 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.91 -135.16 3.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.261 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' C' ' 104' ' ' PHE . 98.1 Cg_endo -88.01 21.87 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.699 2.266 . . . . 0.0 113.117 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.843 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -151.05 156.02 40.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' C' ' 104' ' ' PHE . 27.3 m -100.65 162.35 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 1.1 mt-30 -47.44 -41.98 21.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . . . -165.77 -178.62 4.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.276 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 29' ' ' LEU . 35.6 m -136.6 127.11 40.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.072 0.463 . . . . 0.0 112.045 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.565 ' N ' ' HA ' ' A' ' 4' ' ' GLN . 8.3 t0 -109.33 96.06 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.986 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.916 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.4 tm? -73.1 -12.77 61.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 26' ' ' ASN . . . 96.63 106.85 2.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.416 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 8.0 m120 84.09 -36.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.013 0.435 . . . . 0.0 109.911 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 128' ' ' VAL . 66.5 tp -124.38 100.6 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.693 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.959 HG23 ' HB3' ' A' ' 127' ' ' ALA . 4.4 m -90.45 167.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.147 0.499 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.18 136.86 17.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.426 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.72 HG21 HD11 ' A' ' 62' ' ' ILE . 18.5 p -108.6 136.67 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.5 171.23 10.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.02 85.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.39 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.1 mp0 -63.63 172.37 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 0.0 111.048 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.693 ' HB ' HG11 ' A' ' 119' ' ' VAL . 6.6 pt -153.81 147.73 18.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.38 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.868 2.379 . . . . 0.0 112.984 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 34' ' ' ILE . 32.9 t -63.02 85.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 41' ' ' GLY . 36.7 t-20 -35.11 129.88 0.5 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.989 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.53 -10.59 29.14 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 112.178 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.5 -21.36 8.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.68 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.416 HG22 ' CG ' ' A' ' 42' ' ' GLU . 3.5 m -114.75 -25.2 8.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 63.67 56.06 21.4 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.323 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' CG ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER -164.27 -81.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.704 0.288 . . . . 0.0 111.625 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 ' H ' ' A' ' 120' ' ' GLY . 9.2 p -173.89 106.83 0.3 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.31 141.37 88.84 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.65 72.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 91.65 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 29.1 mm -40.69 -33.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.497 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.53 -43.98 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.72 76.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.746 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.406 ' OE1' HD13 ' A' ' 47' ' ' ILE . 18.1 pt20 -67.16 -32.74 74.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -70.52 -31.35 68.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.967 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -42.14 34.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.768 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -41.25 98.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.782 ' O ' HG23 ' A' ' 58' ' ' VAL . 2.8 t -60.39 -36.47 78.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.767 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 95' ' ' PHE . 11.0 mt -69.53 -35.95 75.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -40.67 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.49 -45.92 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 54' ' ' SER . 23.3 t -63.74 -35.44 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.42 -33.66 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 10' ' ' LYS . . . -59.9 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.719 ' CG1' ' HB2' ' A' ' 11' ' ' ALA . 5.5 mt -70.3 -46.73 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 30' ' ' THR . 24.0 mt -67.48 -32.06 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.45 -41.41 66.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.263 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.09 -18.26 65.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.08 -32.24 18.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.91 44.51 0.45 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.84 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.29 38.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.044 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -60.22 -33.63 72.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.895 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -55.38 -31.92 62.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.205 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 67' ' ' LEU . 2.5 m-20 -75.25 -20.57 59.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 126' ' ' ILE . 89.3 mt -45.81 118.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.97 0.414 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 128' ' ' VAL . 35.3 m -81.37 -45.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.064 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 106' ' ' ALA . 25.0 tttm -138.75 159.79 41.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.437 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 125' ' ' ALA . 60.3 m -146.45 144.67 29.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.087 0.47 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 108' ' ' SER . 56.7 m -134.18 136.72 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 122' ' ' GLU . 15.3 t -145.77 122.1 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 111.951 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.712 ' CD2' HG11 ' C' ' 110' ' ' VAL . 6.3 m-85 -89.84 132.32 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.278 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 85' ' ' PHE . 18.9 m -116.95 149.75 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.22 -5.28 33.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.773 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.28 96.84 1.72 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.525 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' B' ' 114' ' ' ARG . 8.2 mt -57.15 -18.46 15.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.21 -22.6 57.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.588 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.43 -20.39 31.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' A' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.05 18.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.67 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.15 -35.16 17.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.084 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.66 -41.19 71.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.2 t30 -67.9 -37.98 82.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.757 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.56 82.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.08 21.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.475 ' OH ' HG21 ' A' ' 75' ' ' THR . 89.5 t80 -67.33 -42.91 82.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.89 -30.88 35.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.306 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.84 -18.9 62.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.787 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CE2' ' CD1' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.297 . . . . 0.0 110.992 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.479 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 3.4 m-85 -56.69 -58.91 6.04 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.228 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.11 -28.83 70.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.136 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.04 -11.44 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.539 ' HB3' ' NE2' ' A' ' 101' ' ' HIS . 2.2 m-80 -111.39 -5.02 14.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.327 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 12.7 t30 89.2 36.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.29 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 1.044 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.3 m170 -116.48 52.92 1.05 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.137 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 100' ' ' ASN . 72.2 Cg_endo -74.67 -11.96 22.19 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.59 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.691 ' CG ' HD11 ' B' ' 5' ' ' ILE . 22.5 t30 -52.81 -32.75 45.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.731 ' HB2' HG13 ' B' ' 19' ' ' VAL . 15.7 m-85 62.27 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.298 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 72' ' ' ILE . 12.0 Cg_exo -69.53 155.59 66.29 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.659 2.239 . . . . 0.0 111.624 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 74' ' ' LYS . . . -51.75 157.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.61 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' B' ' 18' ' ' TYR . 0.0 OUTLIER -123.43 151.01 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.477 . . . . 0.0 111.503 -179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 76' ' ' THR . 39.2 t -160.26 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 13.0 m -101.17 141.88 33.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' B' ' 78' ' ' PHE . 15.1 m -152.4 158.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.301 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' B' ' 113' ' ' ALA . 0.0 OUTLIER -83.6 98.56 9.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.96 159.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' C' ' 111' ' ' GLU . . . -63.28 -47.85 80.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.596 ' HB3' HD12 ' C' ' 82' ' ' LEU . 2.4 ttt180 -152.23 177.72 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 78' ' ' PHE . 5.6 mt -145.15 155.91 54.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.832 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.2 Cg_endo -58.27 136.1 72.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.562 2.175 . . . . 0.0 112.119 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER 72.29 16.81 5.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 17.36 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 34' ' ' ILE . 22.0 m -58.99 143.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.058 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.795 ' H ' HG21 ' A' ' 43' ' ' VAL . . . -86.25 7.7 77.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.832 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.493 HD11 ' HG3' ' A' ' 35' ' ' PRO . 3.8 pp -175.03 149.07 1.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.217 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.7 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.4 tt0 -131.65 151.24 51.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.272 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 58' ' ' VAL . 27.1 mt -131.14 132.45 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 111.879 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 104.78 2.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.748 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.725 ' HB2' HG23 ' A' ' 75' ' ' THR . . . -129.01 164.37 23.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 112.005 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' ILE . 14.4 mm -110.48 155.17 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.21 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.959 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -142.72 150.94 40.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.97 0.414 . . . . 0.0 111.659 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 73' ' ' VAL . 6.5 m -122.3 173.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.041 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.522 ' HB3' HD21 ' A' ' 67' ' ' LEU . 14.1 ptm180 -164.77 46.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.832 0.349 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.24 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.481 HG23 ' CD2' ' B' ' 24' ' ' LEU . 19.0 m -165.18 116.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.568 ' OE1' HD23 ' B' ' 24' ' ' LEU . 0.8 OUTLIER 48.22 -169.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.662 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.691 HD11 ' CG ' ' A' ' 103' ' ' ASN . 26.0 mm 70.89 111.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.796 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' B' ' 21' ' ' ALA . 60.2 mt -141.76 106.6 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.747 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.55 150.74 21.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.0 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.35 167.09 22.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 40.0 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.485 ' HB3' ' HB1' ' B' ' 60' ' ' ALA . 3.7 tttp -139.96 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.956 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.722 ' HB2' ' CG1' ' B' ' 61' ' ' ILE . . . -58.39 177.87 0.22 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.205 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.677 ' CD ' ' HB1' ' B' ' 11' ' ' ALA . 24.7 Cg_exo -63.04 -12.41 29.61 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.881 2.388 . . . . 0.0 112.673 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 12' ' ' PRO . . . 76.03 153.63 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.381 . . . . 0.0 111.237 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' B' ' 18' ' ' TYR . . . -114.73 124.61 52.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.786 HD13 ' O ' ' B' ' 14' ' ' ALA . 16.3 mm -140.48 16.85 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.981 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.9 -135.19 3.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.252 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 97.0 Cg_endo -87.94 21.81 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.744 2.296 . . . . 0.0 113.187 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.84 ' O ' ' HB1' ' B' ' 14' ' ' ALA . 0.3 OUTLIER -151.02 156.03 40.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.923 0.392 . . . . 0.0 111.485 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 104' ' ' PHE . 27.3 m -100.68 162.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 11' ' ' ALA . 1.1 mt-30 -47.47 -41.73 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.002 0.429 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 6' ' ' ILE . . . -165.78 -178.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.245 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.53 HG23 HD13 ' B' ' 29' ' ' LEU . 35.6 m -136.57 127.17 41.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 112.022 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.562 ' N ' ' HA ' ' B' ' 4' ' ' GLN . 8.2 t0 -109.36 96.04 6.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.967 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.4 tm? -73.0 -12.87 61.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.399 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' B' ' 26' ' ' ASN . . . 96.66 106.91 2.36 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' B' ' 25' ' ' GLY . 7.9 m120 83.99 -36.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.515 HD13 HG12 ' B' ' 128' ' ' VAL . 66.4 tp -124.38 100.55 6.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.677 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' B' ' 127' ' ' ALA . 4.4 m -90.5 167.01 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.141 0.496 . . . . 0.0 111.795 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.631 HD12 ' N ' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -151.14 136.87 18.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.737 HG21 HD11 ' B' ' 62' ' ' ILE . 18.7 p -108.59 136.94 47.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.92 171.38 10.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.14 85.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.434 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.484 ' HB2' HG22 ' B' ' 58' ' ' VAL . 1.1 mp0 -63.56 172.41 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.379 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.716 ' HB ' HG11 ' B' ' 119' ' ' VAL . 6.6 pt -153.81 147.66 18.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' B' ' 43' ' ' VAL . 16.6 Cg_exo -67.32 57.43 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.899 2.399 . . . . 0.0 112.935 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.565 HG23 HG13 ' B' ' 34' ' ' ILE . 33.3 t -63.01 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.577 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.402 ' HB3' ' HB ' ' B' ' 40' ' ' THR . 36.6 t-20 -35.14 129.93 0.51 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.935 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.58 -10.63 29.2 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.023 . . . . 0.0 112.192 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.4 -21.41 8.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.78 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' B' ' 37' ' ' ASN . 3.5 m -114.77 -25.32 8.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.456 ' HA2' HG12 ' B' ' 36' ' ' VAL . . . 63.81 56.13 20.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.357 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.401 ' CG ' HG22 ' B' ' 40' ' ' THR . 0.0 OUTLIER -164.36 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.623 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.791 HG21 ' H ' ' B' ' 120' ' ' GLY . 9.3 p -173.94 106.72 0.3 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.21 141.31 88.17 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.082 . . . . 0.0 112.199 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.51 -31.67 72.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.052 0.453 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.47 91.63 0.12 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.729 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 29.1 mm -40.72 -33.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.61 -44.02 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.786 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.73 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' B' ' 47' ' ' ILE . 18.1 pt20 -66.98 -32.29 73.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.487 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 47' ' ' ILE . . . -70.55 -31.45 68.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.917 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -42.2 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.803 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -41.16 98.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' B' ' 58' ' ' VAL . 2.8 t -60.49 -36.48 78.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' B' ' 95' ' ' PHE . 11.0 mt -69.49 -35.94 76.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.78 -40.75 79.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.45 -45.95 88.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' B' ' 54' ' ' SER . 23.3 t -63.71 -35.44 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.38 -33.7 36.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.774 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' B' ' 10' ' ' LYS . . . -59.98 -39.28 85.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.722 ' CG1' ' HB2' ' B' ' 11' ' ' ALA . 5.5 mt -69.9 -46.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.674 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.737 HD11 HG21 ' B' ' 30' ' ' THR . 23.9 mt -67.44 -32.07 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.612 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.53 -41.3 65.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.281 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.08 -18.32 65.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.03 -32.23 18.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.95 44.46 0.45 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' B' ' 128' ' ' VAL . 0.8 OUTLIER -147.97 -169.87 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.631 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 162.28 38.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 1.051 ' HB3' ' CE1' ' B' ' 101' ' ' HIS . . . -60.29 -33.56 72.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.897 ' HB2' ' CD2' ' B' ' 101' ' ' HIS . . . -55.28 -31.99 62.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.201 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.477 ' CB ' HD22 ' B' ' 67' ' ' LEU . 2.5 m-20 -75.48 -20.44 58.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.519 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 126' ' ' ILE . 89.2 mt -45.84 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.966 0.412 . . . . 0.0 111.564 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.635 HG13 HG22 ' B' ' 128' ' ' VAL . 35.4 m -81.35 -45.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' LYS . . . . . 0.681 ' CG ' ' HB3' ' B' ' 106' ' ' ALA . 25.0 tttm -138.69 159.85 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.435 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.727 HG23 ' HB2' ' B' ' 125' ' ' ALA . 60.0 m -146.43 144.62 29.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.123 0.487 . . . . 0.0 111.791 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 108' ' ' SER . 56.7 m -134.13 136.77 44.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.702 HG13 ' O ' ' B' ' 122' ' ' GLU . 15.3 t -145.76 122.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 111.981 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.29 35.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.27 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.507 HG11 ' HD1' ' B' ' 85' ' ' PHE . 18.9 m -116.91 149.75 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.162 0.506 . . . . 0.0 111.711 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.18 -5.28 33.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.82 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.35 96.87 1.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.49 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' C' ' 114' ' ' ARG . 8.2 mt -57.11 -18.45 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -75.2 -22.65 57.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.575 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.37 -20.38 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.507 ' HD1' HG11 ' B' ' 79' ' ' VAL . 6.7 t80 -54.39 -24.03 18.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.73 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.349 . . . . 0.0 111.229 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.14 -35.13 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.77 -41.14 70.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' B' ' 85' ' ' PHE . 1.2 t30 -67.88 -38.0 82.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.741 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.46 82.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.9 -26.1 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' B' ' 75' ' ' THR . 89.4 t80 -67.41 -42.85 82.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -80.87 -30.93 35.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.306 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.81 -18.93 62.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.839 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' PHE . . . . . 0.475 ' CE2' ' CD1' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -91.13 -36.45 13.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CD1' ' CE2' ' B' ' 95' ' ' PHE . 3.4 m-85 -56.71 -58.93 5.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.09 -28.93 70.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -76.93 -11.42 59.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.542 ' HB3' ' NE2' ' B' ' 101' ' ' HIS . 2.2 m-80 -111.43 -4.98 14.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.325 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' B' ' 99' ' ' ASN . 12.7 t30 89.14 36.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . 1.051 ' CE1' ' HB3' ' B' ' 69' ' ' ALA . 3.4 m170 -116.52 52.89 1.06 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' B' ' 100' ' ' ASN . 72.2 Cg_endo -74.66 -11.94 22.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.496 2.131 . . . . 0.0 112.607 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.7 ' CG ' HD11 ' C' ' 5' ' ' ILE . 22.5 t30 -52.78 -32.81 45.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.969 0.414 . . . . 0.0 110.762 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.72 ' HB2' HG13 ' C' ' 19' ' ' VAL . 15.8 m-85 62.31 89.09 0.11 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.27 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' B' ' 72' ' ' ILE . 12.0 Cg_exo -69.54 155.56 66.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.675 2.25 . . . . 0.0 111.655 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' B' ' 74' ' ' LYS . . . -51.67 157.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.66 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.431 ' HB2' ' CD2' ' C' ' 18' ' ' TYR . 0.0 OUTLIER -123.48 150.97 43.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 0.0 111.572 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.845 ' O ' HG23 ' B' ' 76' ' ' THR . 39.1 t -160.28 59.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' CYS . . . . . . . . . . . . . 12.7 m -101.12 141.85 33.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.06 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.729 HG11 ' CD2' ' C' ' 78' ' ' PHE . 15.1 m -152.44 158.2 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.237 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' C' ' 113' ' ' ALA . 0.0 OUTLIER -83.64 98.65 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -84.01 159.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLU . . . -63.32 -47.88 80.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.543 ' HB3' HD12 ' A' ' 82' ' ' LEU . 2.4 ttt180 -152.22 177.78 10.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.789 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HB2' ' B' ' 78' ' ' PHE . 5.6 mt -145.13 155.92 54.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.572 ' O ' HG22 ' B' ' 119' ' ' VAL . 18.9 Cg_endo -58.31 136.12 72.51 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.564 2.176 . . . . 0.0 112.124 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.482 ' HB3' HG13 ' B' ' 119' ' ' VAL . 0.0 OUTLIER 72.27 16.79 5.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.124 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.8 17.3 8.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . 0.716 HG11 ' HB ' ' B' ' 34' ' ' ILE . 21.8 m -59.02 143.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' GLY . . . . . 0.791 ' H ' HG21 ' B' ' 43' ' ' VAL . . . -86.26 8.04 75.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.899 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.468 HD11 ' HG3' ' B' ' 35' ' ' PRO . 3.8 pp -175.25 149.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 111.195 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.702 ' O ' HG13 ' B' ' 77' ' ' VAL . 3.4 tt0 -131.63 151.22 51.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.299 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.56 ' CG2' HG21 ' B' ' 58' ' ' VAL . 27.4 mt -131.13 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.178 0.513 . . . . 0.0 111.854 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' CE2' ' B' ' 78' ' ' PHE . 0.2 OUTLIER -152.41 104.8 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.734 179.424 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' B' ' 75' ' ' THR . . . -129.08 164.32 23.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.482 . . . . 0.0 112.074 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 72' ' ' ILE . 14.6 mm -110.49 155.16 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.2 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.997 ' HB3' HG23 ' B' ' 28' ' ' VAL . . . -142.74 151.01 40.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 111.617 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.635 HG22 HG13 ' B' ' 73' ' ' VAL . 6.5 m -122.39 173.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.075 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' B' ' 67' ' ' LEU . 14.1 ptm180 -164.83 46.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.964 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.951 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.21 168.53 19.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.48 HG23 ' CD2' ' C' ' 24' ' ' LEU . 19.0 m -165.22 116.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.562 ' OE1' HD23 ' C' ' 24' ' ' LEU . 0.7 OUTLIER 48.35 -169.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.676 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' ILE . . . . . 0.7 HD11 ' CG ' ' B' ' 103' ' ' ASN . 26.0 mm 70.73 111.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.877 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' C' ' 21' ' ' ALA . 60.5 mt -141.75 106.7 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.71 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 150.72 21.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 t -163.37 167.12 22.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 39.94 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . 0.497 ' HB3' ' HB1' ' C' ' 60' ' ' ALA . 3.8 tttp -139.95 -45.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.721 ' HB2' ' CG1' ' C' ' 61' ' ' ILE . . . -58.32 177.76 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' PRO . . . . . 0.67 ' CD ' ' HB1' ' C' ' 11' ' ' ALA . 24.7 Cg_exo -63.06 -12.33 29.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.853 2.369 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 12' ' ' PRO . . . 75.98 153.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' C' ' 18' ' ' TYR . . . -114.6 124.6 52.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.093 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.779 HD13 ' O ' ' C' ' 14' ' ' ALA . 16.1 mm -140.5 16.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.946 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.92 -135.21 3.92 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.266 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' B' ' 104' ' ' PHE . 96.0 Cg_endo -87.95 21.85 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.654 2.236 . . . . 0.0 113.187 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' TYR . . . . . 0.826 ' O ' ' HB1' ' C' ' 14' ' ' ALA . 0.3 OUTLIER -151.01 155.98 40.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.471 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.72 HG13 ' HB2' ' B' ' 104' ' ' PHE . 27.3 m -100.59 162.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.591 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -47.47 -41.86 21.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' C' ' 6' ' ' ILE . . . -165.85 -178.59 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.311 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' VAL . . . . . 0.535 HG23 HD13 ' C' ' 29' ' ' LEU . 35.7 m -136.64 127.21 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.941 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.559 ' N ' ' HA ' ' C' ' 4' ' ' GLN . 8.2 t0 -109.4 96.16 6.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.877 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.898 HD13 ' O ' ' C' ' 24' ' ' LEU . 2.4 tm? -73.12 -12.79 61.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.39 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' C' ' 26' ' ' ASN . . . 96.61 106.88 2.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.433 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' C' ' 25' ' ' GLY . 7.9 m120 84.0 -36.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.981 0.419 . . . . 0.0 109.897 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.482 HD13 HG12 ' C' ' 128' ' ' VAL . 66.6 tp -124.38 100.52 6.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.703 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' C' ' 127' ' ' ALA . 4.4 m -90.46 167.03 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 0.0 111.779 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.63 ' N ' HD12 ' C' ' 29' ' ' LEU . 0.2 OUTLIER -151.2 136.85 17.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.423 179.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.711 HG21 HD11 ' C' ' 62' ' ' ILE . 18.5 p -108.55 136.71 47.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -70.67 171.27 10.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.11 85.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' C' ' 58' ' ' VAL . 1.1 mp0 -63.62 172.38 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.691 ' HB ' HG11 ' C' ' 119' ' ' VAL . 6.6 pt -153.83 147.77 18.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' C' ' 43' ' ' VAL . 16.6 Cg_exo -67.43 57.49 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.882 2.388 . . . . 0.0 112.891 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . 0.561 HG23 HG13 ' C' ' 34' ' ' ILE . 32.8 t -63.06 85.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.213 0.53 . . . . 0.0 110.612 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' C' ' 41' ' ' GLY . 36.7 t-20 -35.13 129.94 0.51 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.56 -10.6 29.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.31 2.007 . . . . 0.0 112.18 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.44 -21.43 8.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.729 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' THR . . . . . 0.408 HG22 ' CG ' ' C' ' 42' ' ' GLU . 3.5 m -114.8 -25.24 8.32 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' C' ' 36' ' ' VAL . . . 63.64 56.1 21.27 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.395 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.408 ' CG ' HG22 ' C' ' 40' ' ' THR . 0.0 OUTLIER -164.26 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.61 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . 0.789 HG21 ' H ' ' C' ' 120' ' ' GLY . 9.3 p -173.93 106.74 0.3 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.365 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.27 141.32 88.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.404 2.069 . . . . 0.0 112.22 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.61 72.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' C' ' 49' ' ' ALA . 0.2 OUTLIER -65.54 91.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.751 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' C' ' 51' ' ' ALA . 29.1 mm -40.64 -33.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.448 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 -44.07 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.004 0.431 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 46' ' ' ASP . . . -65.09 -47.74 76.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.807 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.401 ' OE1' HD13 ' C' ' 47' ' ' ILE . 18.2 pt20 -67.04 -32.68 74.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.521 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' C' ' 47' ' ' ILE . . . -70.68 -31.36 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -42.05 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -41.14 98.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.786 ' O ' HG23 ' C' ' 58' ' ' VAL . 2.8 t -60.46 -36.53 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.698 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' C' ' 95' ' ' PHE . 10.9 mt -69.55 -35.88 75.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.71 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -40.67 79.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -63.46 -45.96 88.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.809 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 54' ' ' SER . 23.3 t -63.72 -35.41 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -80.44 -33.68 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 10' ' ' LYS . . . -59.93 -39.18 84.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.721 ' CG1' ' HB2' ' C' ' 11' ' ' ALA . 5.6 mt -70.1 -46.73 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . 0.711 HD11 HG21 ' C' ' 30' ' ' THR . 24.1 mt -67.47 -32.04 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -72.47 -41.35 66.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.296 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -65.12 -18.26 65.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.516 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.02 -32.26 18.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.9 44.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.704 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.534 HD21 ' O ' ' C' ' 128' ' ' VAL . 0.8 OUTLIER -147.98 -169.88 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.912 0.386 . . . . 0.0 110.629 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.6 162.31 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 1.059 ' HB3' ' CE1' ' C' ' 101' ' ' HIS . . . -60.23 -33.61 72.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.886 ' HB2' ' CD2' ' C' ' 101' ' ' HIS . . . -55.44 -31.97 62.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' ASP . . . . . 0.464 ' CB ' HD22 ' C' ' 67' ' ' LEU . 2.5 m-20 -75.3 -20.57 59.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.504 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . 0.484 HG23 ' O ' ' C' ' 126' ' ' ILE . 89.4 mt -45.85 118.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.991 0.424 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.636 HG13 HG22 ' C' ' 128' ' ' VAL . 35.4 m -81.32 -45.26 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.057 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . 0.687 ' HG3' ' HB3' ' C' ' 106' ' ' ALA . 25.0 tttm -138.69 159.86 41.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.414 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' ALA . 60.9 m -146.49 144.66 29.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.147 0.499 . . . . 0.0 111.701 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.847 HG23 ' O ' ' C' ' 108' ' ' SER . 56.9 m -134.11 136.84 44.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.917 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.714 HG13 ' O ' ' C' ' 122' ' ' GLU . 15.5 t -145.86 122.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.729 ' CD2' HG11 ' B' ' 110' ' ' VAL . 6.3 m-85 -89.78 132.27 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.269 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' C' ' 85' ' ' PHE . 18.9 m -116.88 149.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.149 0.499 . . . . 0.0 111.72 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -98.29 -5.37 33.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.804 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.22 96.86 1.73 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.449 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 114' ' ' ARG . 8.2 mt -57.14 -18.48 15.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -75.18 -22.57 57.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.871 0.367 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -20.36 31.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.502 ' HD1' HG11 ' C' ' 79' ' ' VAL . 6.7 t80 -54.38 -24.01 17.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.62 -35.68 70.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.219 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.17 -35.09 17.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.71 -41.14 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' C' ' 85' ' ' PHE . 1.2 t30 -67.86 -38.05 82.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.72 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.52 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -88.97 -26.15 21.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' TYR . . . . . 0.479 ' OH ' HG21 ' C' ' 75' ' ' THR . 89.5 t80 -67.33 -42.9 82.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.066 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -80.85 -30.95 35.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.339 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -71.77 -18.93 62.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' C' ' 96' ' ' PHE . 0.1 OUTLIER -91.11 -36.52 13.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 -179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' C' ' 101' ' ' HIS . 3.4 m-85 -56.61 -58.94 5.89 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -63.14 -28.84 70.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.13 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.0 -11.41 59.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.528 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.549 ' HB3' ' NE2' ' C' ' 101' ' ' HIS . 2.2 m-80 -111.41 -5.0 14.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.285 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' C' ' 99' ' ' ASN . 12.7 t30 89.18 36.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.352 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' HIS . . . . . 1.059 ' CE1' ' HB3' ' C' ' 69' ' ' ALA . 3.3 m170 -116.52 52.9 1.06 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' C' ' 100' ' ' ASN . 72.3 Cg_endo -74.7 -11.89 22.11 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.461 2.107 . . . . 0.0 112.585 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' ASN . . . . . 0.694 ' OD1' HD11 ' A' ' 5' ' ' ILE . 22.6 t30 -52.82 -32.79 46.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.898 0.38 . . . . 0.0 110.716 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.704 ' HB2' HG13 ' A' ' 19' ' ' VAL . 15.8 m-85 62.26 89.01 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 105' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' C' ' 72' ' ' ILE . 11.9 Cg_exo -69.42 155.58 66.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.681 2.254 . . . . 0.0 111.691 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.687 ' HB3' ' HG3' ' C' ' 74' ' ' LYS . . . -51.72 157.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.603 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 107' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -123.56 150.99 43.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 0.0 111.484 -179.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 108' ' ' SER . . . . . 0.847 ' O ' HG23 ' C' ' 76' ' ' THR . 39.3 t -160.25 59.95 0.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.343 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 109' ' ' CYS . . . . . . . . . . . . . 12.8 m -101.16 141.88 33.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.054 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.712 HG11 ' CD2' ' A' ' 78' ' ' PHE . 15.0 m -152.35 157.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.21 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . 0.731 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -83.51 98.63 9.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.98 159.25 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 111' ' ' GLU . . . -63.2 -47.94 80.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.581 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.4 ttt180 -152.18 177.8 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' C' ' 78' ' ' PHE . 5.6 mt -145.17 155.95 54.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.799 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 116' ' ' PRO . . . . . 0.582 ' O ' HG22 ' C' ' 119' ' ' VAL . 18.9 Cg_endo -58.32 136.09 72.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.598 2.199 . . . . 0.0 112.096 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 117' ' ' LYS . . . . . 0.484 ' HB3' HG13 ' C' ' 119' ' ' VAL . 0.0 OUTLIER 72.32 16.79 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.73 17.35 8.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.691 HG11 ' HB ' ' C' ' 34' ' ' ILE . 21.9 m -59.01 143.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 120' ' ' GLY . . . . . 0.789 ' H ' HG21 ' C' ' 43' ' ' VAL . . . -86.38 7.73 77.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.843 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' C' ' 35' ' ' PRO . 3.8 pp -175.01 149.11 1.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.023 0.44 . . . . 0.0 111.245 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 77' ' ' VAL . 3.4 tt0 -131.7 151.2 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 123' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' C' ' 58' ' ' VAL . 27.0 mt -131.09 132.53 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.157 0.503 . . . . 0.0 111.904 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' HB ' ' C' ' 76' ' ' THR . 0.2 OUTLIER -152.4 104.73 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.739 179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.705 ' HB2' HG23 ' C' ' 75' ' ' THR . . . -129.03 164.32 23.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.103 0.478 . . . . 0.0 112.069 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 126' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' ILE . 14.3 mm -110.49 155.17 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.186 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 127' ' ' ALA . . . . . 0.956 ' HB3' HG23 ' C' ' 28' ' ' VAL . . . -142.75 150.99 40.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.571 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 128' ' ' VAL . . . . . 0.636 HG22 HG13 ' C' ' 73' ' ' VAL . 6.4 m -122.37 173.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.043 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 129' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' C' ' 67' ' ' LEU . 14.1 ptm180 -164.81 46.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 179.932 . . . . . . . . 1 1 . 1 stop_ save_